PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Barbouche, R; Miquelis, R; Jones, IM; Fenouillet, E				Barbouche, R; Miquelis, R; Jones, IM; Fenouillet, E			Protein-disulfide isomerase-mediated reduction of two disulfide bonds of HIV envelope glycoprotein 120 occurs post-CXCR4 binding and is required for fusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; MEMBRANE-FUSION; CHEMOKINE RECEPTORS; CD4; GP120; ENTRY; GLYCOSYLATION; SURFACE; CXCR4; IDENTIFICATION	The human immunodeficiency virus (HIV) envelope (Env) glycoprotein (gp) 120 is a highly disulfide-bonded molecule that attaches HIV to the lymphocyte surface receptors CD4 and CXCR4. Conformation changes within gp120 result from binding and trigger HIV/cell fusion. Inhibition of lymphocyte surface-associated protein-disulfide isomerase (PDI) blocks HIV/cell fusion, suggesting that redox changes within Env are required. Using a sensitive assay based on a thiol reagent, we show that (i) the thiol content of gp120, either secreted by mammalian cells or bound to a lymphocyte surface enabling CD4 but not CXCR4 binding, was 0.5-1 pmol SH/pmol gp120 (SH/gp120), whereas that of gp120 after its interaction with a surface enabling both CD4 and CXCR4 binding was raised to 4 SH/gp120; (ii) PDI inhibitors prevented this change; and (iii) gp120 displaying 2 SH/gp120 exhibited CD4 but not CXCR4 binding capacity. In addition, PDI inhibition did not impair gp120 binding to receptors. We conclude that on average two of the nine disulfides of gp120 are reduced during interaction with the lymphocyte surface after CXCR4 binding prior to fusion and that cell surface PDI catalyzes this process. Disulfide bond restructuring within Env may constitute the molecular basis of the post-receptor binding conformational changes that induce fusion competence.	Fac Med Nord, CNRS, F-13015 Marseille, France; Univ Reading, Sch Anim & Microbial Sci, Reading RG6 6AJ, Berks, England	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; University of Reading	Fenouillet, E (corresponding author), Fac Med Nord, CNRS, Blvd Pierre Dramard, F-13015 Marseille, France.	fenouillet.e@jean-roche.univ.mrs.fr						AVRIL LE, 1994, FEBS LETT, V345, P81, DOI 10.1016/0014-5793(94)00410-2; Barbouche R, 2000, VIROLOGY, V273, P169, DOI 10.1006/viro.2000.0368; Barbouche R, 2002, AIDS RES HUM RETROV, V18, P201, DOI 10.1089/08892220252781257; Barbouche R, 2000, FEMS MICROBIOL LETT, V183, P235, DOI 10.1111/j.1574-6968.2000.tb08964.x; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Chan DC, 1998, CELL, V93, P681, DOI 10.1016/S0092-8674(00)81430-0; Couet J, 1996, BIOCHEMISTRY-US, V35, P14800, DOI 10.1021/bi961359w; Doms RW, 1997, VIROLOGY, V235, P179, DOI 10.1006/viro.1997.8703; Donoghue N, 2000, PROTEIN SCI, V9, P2436, DOI 10.1110/ps.9.12.2436; Doranz BJ, 1996, CELL, V85, P1149, DOI 10.1016/S0092-8674(00)81314-8; Doranz BJ, 1999, J VIROL, V73, P2752, DOI 10.1128/JVI.73.4.2752-2761.1999; Einfeld D, 1996, CURR TOP MICROBIOL, V214, P133; Fenouillet E, 2001, J INFECT DIS, V183, P744, DOI 10.1086/318823; FENOUILLET E, 1994, TRENDS BIOCHEM SCI, V19, P65, DOI 10.1016/0968-0004(94)90034-5; FENOUILLET E, 1989, J EXP MED, V169, P807, DOI 10.1084/jem.169.3.807; Ferrari DM, 1999, BIOCHEM J, V339, P1, DOI 10.1042/0264-6021:3390001; Finnegan CM, 2001, J VIROL, V75, P11096, DOI 10.1128/JVI.75.22.11096-11105.2001; Gilbert HF, 1998, METHOD ENZYMOL, V290, P26, DOI 10.1016/S0076-6879(98)90005-2; Guthapfel R, 1996, EUR J BIOCHEM, V242, P315, DOI 10.1111/j.1432-1033.1996.0315r.x; Jiang XM, 1999, J BIOL CHEM, V274, P2416, DOI 10.1074/jbc.274.4.2416; KIDO H, 1991, FEBS LETT, V286, P233, DOI 10.1016/0014-5793(91)80981-8; KIENY MP, 1988, PROTEIN ENG, V2, P219; Kozak SL, 1999, J BIOL CHEM, V274, P23499, DOI 10.1074/jbc.274.33.23499; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; LEONARD CK, 1990, J BIOL CHEM, V265, P10373; MALTHIERY Y, 1987, EUR J BIOCHEM, V165, P491, DOI 10.1111/j.1432-1033.1987.tb11466.x; MANDEL R, 1993, P NATL ACAD SCI USA, V90, P4112, DOI 10.1073/pnas.90.9.4112; Matthias LJ, 2002, NAT IMMUNOL, V3, P727, DOI 10.1038/ni815; Mezghrani A, 2000, J BIOL CHEM, V275, P1920, DOI 10.1074/jbc.275.3.1920; Papandreou MJ, 2002, MOL PHARMACOL, V61, P186, DOI 10.1124/mol.61.1.186; Papandreou MJ, 1996, FEBS LETT, V379, P171, DOI 10.1016/0014-5793(95)01505-1; PELCHENMATTHEWS A, 1989, EMBO J, V8, P3641, DOI 10.1002/j.1460-2075.1989.tb08538.x; RYSER HJP, 1994, P NATL ACAD SCI USA, V91, P4559, DOI 10.1073/pnas.91.10.4559; SATTENTAU QJ, 1991, J EXP MED, V174, P407, DOI 10.1084/jem.174.2.407; SAYLE RA, 1995, TRENDS BIOCHEM SCI, V20, P374, DOI 10.1016/S0968-0004(00)89080-5; Stathakis P, 1999, J BIOL CHEM, V274, P8910, DOI 10.1074/jbc.274.13.8910; Tsai B, 2001, CELL, V104, P937, DOI 10.1016/S0092-8674(01)00289-6; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Zai A, 1999, J CLIN INVEST, V103, P393, DOI 10.1172/JCI4890; Zhou HP, 1999, ARCH BIOCHEM BIOPHYS, V369, P267, DOI 10.1006/abbi.1999.1368	40	133	141	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2003	278	5					3131	3136		10.1074/jbc.M205467200	http://dx.doi.org/10.1074/jbc.M205467200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644JW	12218052	hybrid			2022-12-27	WOS:000180915000047
J	Kashiwagi, T; Yokoyama, K; Ishikawa, K; Ono, K; Ejima, D; Matsui, H; Suzuki, E				Kashiwagi, T; Yokoyama, K; Ishikawa, K; Ono, K; Ejima, D; Matsui, H; Suzuki, E			Crystal structure of microbial transglutaminase from Streptoverticillium mobaraense	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-SEQUENCE; HUMAN FACTOR-XIII; ESCHERICHIA-COLI; CROSS-LINKING; PURIFICATION; PROTEIN; CLONING; CROSSLINKING; EXPRESSION; SUBSTRATE	The crystal structure of a microbial transglutaminase from Streptoverticillium mobaraense has been determined at 2.4 Angstrom resolution. The protein folds into a plate-like shape, and has one deep cleft at the edge of the molecule. Its overall structure is completely different from that of the factor XIII-like transglutaminase, which possesses a cysteine protease-like catalytic triad. The catalytic residue, Cys(64), exists at the bottom of the cleft. Asp(255) resides at the position nearest to Cys(64) and is also adjacent to His(274). Interestingly, Cys(64), Asp(255), and His(274) superimpose well on the catalytic triad "Cys-His-Asp" of the factor XIII-like transglutaminase, in this order. The secondary structure frameworks around these residues are also similar to each other. These results imply that both transglutaminases are related by convergent evolution; however, the microbial transglutaminase has developed a novel catalytic mechanism specialized for the cross-linking reaction. The structure accounts well for the catalytic mechanism, in which Asp(255) is considered to be enzymatically essential, as well as for the causes of the higher reaction rate, the broader substrate specificity, and the lower deamidation activity of this enzyme.	Ajinomoto Co Inc, Cent Res Labs, Kawasaki Ku, Kawasaki, Kanagawa 2108681, Japan	Ajinomoto Co Inc	Suzuki, E (corresponding author), Ajinomoto Co Inc, Cent Res Labs, Kawasaki Ku, 1-1 Suzuki Cho, Kawasaki, Kanagawa 2108681, Japan.							AESCHLIMANN D, 1994, THROMB HAEMOSTASIS, V71, P402; ANDO H, 1989, AGR BIOL CHEM TOKYO, V53, P2613, DOI 10.1080/00021369.1989.10869735; BAKER EN, 1980, ACTA CRYSTALLOGR A, V36, P559, DOI 10.1107/S0567739480001210; BEILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760; BISHOP PD, 1990, BIOCHEMISTRY-US, V29, P1861, DOI 10.1021/bi00459a028; Brunger A. T., 1992, XPLOR VERSION 3 1 SY; CHUNG SI, 1972, P NATL ACAD SCI USA, V69, P303, DOI 10.1073/pnas.69.2.303; DRENTH J, 1976, BIOCHEMISTRY-US, V15, P3731, DOI 10.1021/bi00662a014; Duran R, 1998, BIOCHIMIE, V80, P313, DOI 10.1016/S0300-9084(98)80073-4; FOLK JE, 1985, METHOD ENZYMOL, V113, P358; GLADNER JA, 1983, THROMB RES, V30, P273, DOI 10.1016/0049-3848(83)90081-6; GRANT FJ, 1994, BIOCHEM BIOPH RES CO, V203, P1117, DOI 10.1006/bbrc.1994.2298; HORNYAK TJ, 1989, BIOCHEMISTRY-US, V28, P7326, DOI 10.1021/bi00444a027; HORNYAK TJ, 1991, BIOCHEMISTRY-US, V30, P6175, DOI 10.1021/bi00239a014; ICHINOSE A, 1986, BIOCHEMISTRY-US, V25, P6900, DOI 10.1021/bi00370a025; IKURA K, 1980, AGR BIOL CHEM TOKYO, V44, P1567, DOI 10.1080/00021369.1980.10864171; KANAJI T, 1993, J BIOL CHEM, V268, P11565; KLEIN JD, 1992, J BACTERIOL, V174, P2599, DOI 10.1128/jb.174.8.2599-2605.1992; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KURTH L, 1984, J FOOD SCI, V49, P573, DOI 10.1111/j.1365-2621.1984.tb12471.x; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LORAND J, 1966, NATURE, V210, P1273, DOI 10.1038/2101273a0; MARGOSIAK SA, 1990, PLANT PHYSIOL, V92, P88, DOI 10.1104/pp.92.1.88; MOTOKI M, 1983, J FOOD SCI, V48, P561, DOI 10.1111/j.1365-2621.1983.tb10790.x; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Noguchi K, 2001, J BIOL CHEM, V276, P12055, DOI 10.1074/jbc.M009862200; Ohtsuka T, 2001, J FOOD SCI, V66, P25, DOI 10.1111/j.1365-2621.2001.tb15576.x; Ohtsuka T, 2000, BIOSCI BIOTECH BIOCH, V64, P2608, DOI 10.1271/bbb.64.2608; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paetzel M, 2002, J BIOL CHEM, V277, P9512, DOI 10.1074/jbc.M110983200; Pasternack R, 1998, EUR J BIOCHEM, V257, P570, DOI 10.1046/j.1432-1327.1998.2570570.x; PEDERSEN LC, 1994, PROTEIN SCI, V3, P1131, DOI 10.1002/pro.5560030720; Rossmann MG, 1999, ACTA CRYSTALLOGR D, V55, P1631, DOI 10.1107/S0907444999008379; SAKABE N, 1991, NUCL INSTRUM METH A, V303, P448, DOI 10.1016/0168-9002(91)90282-U; Shimba N, 2002, FEBS LETT, V517, P175, DOI 10.1016/S0014-5793(02)02616-9; Shimba N, 2002, J AGR FOOD CHEM, V50, P1330, DOI 10.1021/jf010995k; SINGH RN, 1994, EUR J BIOCHEM, V225, P625, DOI 10.1111/j.1432-1033.1994.00625.x; TOKUNAGA F, 1993, J BIOL CHEM, V268, P262; Weiss MS, 1998, FEBS LETT, V423, P291, DOI 10.1016/S0014-5793(98)00098-2; WERAARCHAKULBOONMARK N, 1992, P NATL ACAD SCI USA, V89, P9804, DOI 10.1073/pnas.89.20.9804; WONG WSD, 1990, INT J BIOCHEM, V22, P53, DOI 10.1016/0020-711X(90)90077-G; WRIGHT CS, 1972, J MOL BIOL, V67, P151, DOI 10.1016/0022-2836(72)90391-9; YASUEDA H, 1995, EUR J BIOCHEM, V232, P411, DOI 10.1111/j.1432-1033.1995.tb20826.x; YEE VC, 1995, THROMB RES, V78, P389, DOI 10.1016/0049-3848(95)00072-Y; YEE VC, 1994, P NATL ACAD SCI USA, V91, P7296, DOI 10.1073/pnas.91.15.7296; Yokoyama K, 2000, BIOSCI BIOTECH BIOCH, V64, P1263, DOI 10.1271/bbb.64.1263; Zhu Y, 1995, APPL MICROBIOL BIOT, V44, P277, DOI 10.1007/s002530050554	47	179	205	6	80	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	2002	277	46					44252	44260		10.1074/jbc.M203933200	http://dx.doi.org/10.1074/jbc.M203933200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	615XE	12221081	hybrid			2022-12-27	WOS:000179272000094
J	Peng, J; Wu, ZJ; Wu, YQ; Hsu, M; Stevenson, FF; Boonplueang, R; Roffler-Tarlov, SK; Andersen, JK				Peng, J; Wu, ZJ; Wu, YQ; Hsu, M; Stevenson, FF; Boonplueang, R; Roffler-Tarlov, SK; Andersen, JK			Inhibition of caspases protects cerebellar granule cells of the weaver mouse from apoptosis and improves behavioral phenotype	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MURINE MUTATION WEAVER; MUTANT MICE; K+ CHANNELS; NEURONAL APOPTOSIS; PURKINJE-CELLS; DEATH; ACTIVATION; GENE; GIRK2; DIFFERENTIATION	The homozygous mouse mutant weaver exhibits a massive loss of cerebellar granule neurons postnatally. The death of these cells is associated with a single amino acid mutation in the G protein-activated inwardly rectifying potassium channel, Girk2. Evidence suggests that both the mutated Girk2 channel and the calcium channel-associated N-methyl-D-aspartate receptor play important roles in the apoptotic death of weaver cerebellar granule cells, but the downstream events associated with this process are unknown. In this study, we demonstrate that the consequences of the mutation result in caspase activation. In addition, our results show that caspase inhibition in vivo decreases caspase activation and granule cell apoptosis and significantly improves behavioral deficits associated with the weaver's phenotype.	Buck Inst Age Res, Novato, CA 94945 USA; Univ So Calif, Dept Biol Sci, Program Mol Biol, Los Angeles, CA 90089 USA; Tufts Univ, Sch Med, Dept Neurosci, Boston, MA 02111 USA; Tufts Univ, Sch Med, Dept Anat & Cell Biol, Boston, MA 02111 USA	Buck Institute for Research on Aging; University of Southern California; Tufts University; Tufts University	Andersen, JK (corresponding author), Buck Inst Age Res, 8001 Redwood Blvd, Novato, CA 94945 USA.		wu, zhijin/J-2282-2014; wu, zhijin/J-4995-2016	wu, zhijin/0000-0002-9596-9134; Hsu, Mike/0000-0001-7086-1808; Andersen, Julie/0000-0003-1324-4875; Boonplueang, Rapee/0000-0002-4384-0363	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020181] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG012141, R29AG012141] Funding Source: NIH RePORTER; NIA NIH HHS [AG51980, AG12141] Funding Source: Medline; NINDS NIH HHS [NS21461, NS20181] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bailly Y, 1996, J COMP NEUROL, V369, P150; BLATT GJ, 1985, J COMP NEUROL, V232, P117, DOI 10.1002/cne.902320110; CAVINESS VS, 1978, ANNU REV NEUROSCI, V1, P297, DOI 10.1146/annurev.ne.01.030178.001501; CLAPHAM DE, 1994, ANNU REV NEUROSCI, V17, P441; CLEM RJ, 1991, SCIENCE, V254, P1388, DOI 10.1126/science.1962198; Cryns V, 1998, GENE DEV, V12, P1551, DOI 10.1101/gad.12.11.1551; Ehrengruber MU, 1997, P NATL ACAD SCI USA, V94, P7070, DOI 10.1073/pnas.94.13.7070; GAO WQ, 1992, CELL, V68, P841, DOI 10.1016/0092-8674(92)90028-B; GRAYBIEL AM, 1990, J NEUROSCI, V10, P720; Harrison SMW, 1998, DEV BIOL, V195, P174, DOI 10.1006/dbio.1998.8848; HATTEN ME, 1985, J CELL BIOL, V100, P384, DOI 10.1083/jcb.100.2.384; Henderson CE, 1996, NEURON, V17, P579, DOI 10.1016/S0896-6273(00)80191-9; HERRUP K, 1987, NEUROSCIENCE, V23, P871, DOI 10.1016/0306-4522(87)90164-3; Jensen P, 1999, J NEUROSCI, V19, P7991; Kofuji P, 1996, NEURON, V16, P941, DOI 10.1016/S0896-6273(00)80117-8; Kuida K, 1998, CELL, V94, P325, DOI 10.1016/S0092-8674(00)81476-2; Lauritzen I, 1997, BRAIN RES, V753, P8, DOI 10.1016/S0006-8993(96)01491-6; Maricich SM, 1997, J NEUROSCI, V17, P3675; Migheli A, 1999, AM J PATHOL, V155, P365, DOI 10.1016/S0002-9440(10)65133-4; Miller LK, 1999, TRENDS CELL BIOL, V9, P323, DOI 10.1016/S0962-8924(99)01609-8; Namura S, 1998, J NEUROSCI, V18, P3659; Navarro B, 1996, SCIENCE, V272, P1950, DOI 10.1126/science.272.5270.1950; Nunez G, 1998, ONCOGENE, V17, P3237, DOI 10.1038/sj.onc.1202581; PATIL N, 1995, NAT GENET, V11, P126, DOI 10.1038/ng1095-126; RAKIC P, 1973, J COMP NEUROL, V152, P133, DOI 10.1002/cne.901520203; RAKIC P, 1973, J COMP NEUROL, V152, P103, DOI 10.1002/cne.901520202; RAY CA, 1992, CELL, V69, P597, DOI 10.1016/0092-8674(92)90223-Y; REZAI Z, 1972, DEV BIOL, V29, P17, DOI 10.1016/0012-1606(72)90039-5; RofflerTarlov S, 1996, J NEUROSCI, V16, P1819; ROFFLERTARLOV S, 1984, NATURE, V307, P62, DOI 10.1038/307062a0; Rossi P, 1998, J NEUROSCI, V18, P3537; Salvesen GS, 1997, CELL, V91, P443, DOI 10.1016/S0092-8674(00)80430-4; Schein JC, 1998, DEV BIOL, V204, P432, DOI 10.1006/dbio.1998.9076; SCHMIDT MJ, 1982, J NEUROSCI, V2, P376; SIDMAN RL, 1965, CATALOG NEUROLOGICAL, P66; Silverman SK, 1996, P NATL ACAD SCI USA, V93, P15429, DOI 10.1073/pnas.93.26.15429; Slesinger PA, 1996, NEURON, V16, P321, DOI 10.1016/S0896-6273(00)80050-1; SMEYNE RJ, 1989, J NEUROSCI, V9, P1608; SMEYNE RJ, 1990, DEV BRAIN RES, V52, P211, DOI 10.1016/0165-3806(90)90237-S; Stennicke HR, 2000, BBA-PROTEIN STRUCT M, V1477, P299, DOI 10.1016/S0167-4838(99)00281-2; SUGIMOTO A, 1994, EMBO J, V13, P2023, DOI 10.1002/j.1460-2075.1994.tb06475.x; Surmeier DJ, 1996, P NATL ACAD SCI USA, V93, P11191, DOI 10.1073/pnas.93.20.11191; Tang DM, 2000, J BIOL CHEM, V275, P9303, DOI 10.1074/jbc.275.13.9303; TRIARHOU LC, 1988, EXP BRAIN RES, V70, P256; Viswanath V, 2000, P NATL ACAD SCI USA, V97, P2270, DOI 10.1073/pnas.030365297; Viswanath V, 2001, J NEUROSCI, V21, P9519, DOI 10.1523/JNEUROSCI.21-24-09519.2001; Wolf BB, 1999, J BIOL CHEM, V274, P20049, DOI 10.1074/jbc.274.29.20049; Wullner U, 1998, ACTA NEUROPATHOL, V96, P233, DOI 10.1007/s004010050889; Yakovlev AG, 1997, J NEUROSCI, V17, P7415; YAMAMOTO M, 1990, J NEUROCYTOL, V19, P619, DOI 10.1007/BF01188031	50	25	27	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	2002	277	46					44285	44291		10.1074/jbc.M207407200	http://dx.doi.org/10.1074/jbc.M207407200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	615XE	12221097	hybrid			2022-12-27	WOS:000179272000098
J	Byrd, DR; Sampson, JK; Ragonese, HM; Matson, SW				Byrd, DR; Sampson, JK; Ragonese, HM; Matson, SW			Structure-function analysis of Escherichia coli DNA helicase I reveals non-overlapping transesterase and helicase domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; UNWINDING REACTION; TRANSFER SYSTEMS; NICKING REACTION; GENE-PRODUCT; PLASMID R388; SEX FACTOR; TRAI; PURIFICATION; CATALYZES	TraI (DNA helicase 1) is an Escherichia coli F plasmid-encoded protein required for bacterial conjugative DNA transfer. The protein is a sequence-specific DNA transesterase that provides the site- and strand-specific nick required to initiate DNA strand transfer and a 5' to 3' DNA helicase that unwinds the F plasmid to provide the single-stranded DNA that is transferred from donor to recipient. Sequence comparisons with other transesterases and helicases suggest that these activities reside in the N- and C-terminal regions of TraI, respectively. Computer-assisted secondary structure probability analysis identified a potential interdomain region spanning residues 304-309. Proteins encoded by segments of traI, whose N or C terminus either flanked or coincided with this region, were purified and assessed for catalytic activity. Amino acids 1-306 contain the transesterase activity, whereas amino acids 309-1504 contain the helicase activity. The C-terminal 252 amino acids of the 1756-amino acid TraI protein are not required for either helicase or transesterase activity. Protein and nucleic acid sequence similarity searches indicate that the occurrence of both transesterase- and helicase-associated motifs in a conjugative DNA transfer initiator protein is rare. Only two examples (other than R100 plasmid TraI) were found: R388 plasmid TrwC and R46 plasmid (pKM101) TraH, belonging to the IncW and IncN groups of broad host range conjugative plasmids, respectively. The most significant structural difference between these proteins and TraI is that TraI contains an additional region of similar to650 residues between the transesterase domain and the helicase-associated motifs. This region is required for helicase activity.	Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA; Univ N Carolina, Program Mol & Cellular Biophys, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Matson, SW (corresponding author), Univ N Carolina, Dept Biol, CB 3280,Coker Hall, Chapel Hill, NC 27599 USA.	smatson@bio.unc.edu			NIGMS NIH HHS [GM 61020, GM 33476] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061020, R01GM033476] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABDELMONEM M, 1976, EUR J BIOCHEM, V65, P441, DOI 10.1111/j.1432-1033.1976.tb10359.x; ABDELMONEM M, 1983, P NATL ACAD SCI-BIOL, V80, P4659, DOI 10.1073/pnas.80.15.4659; ABDELMONEM M, 1976, EUR J BIOCHEM, V65, P431, DOI 10.1111/j.1432-1033.1976.tb10358.x; [Anonymous], 1996, ESCHERICHIA COLI SAL; BROSH RM, 1995, J BACTERIOL, V177, P5612, DOI 10.1128/jb.177.19.5612-5621.1995; Brosh RM, 1996, J BIOL CHEM, V271, P25360, DOI 10.1074/jbc.271.41.25360; Brosh RM, 1997, J BIOL CHEM, V272, P572; Byrd DR, 1997, MOL MICROBIOL, V25, P1011, DOI 10.1046/j.1365-2958.1997.5241885.x; DUNN JJ, 1983, J MOL BIOL, V166, P477, DOI 10.1016/S0022-2836(83)80282-4; Farrand SK, 1996, J BACTERIOL, V178, P4233, DOI 10.1128/jb.178.14.4233-4247.1996; Fukuda H, 1997, GENES CELLS, V2, P735, DOI 10.1046/j.1365-2443.1997.1580356.x; FUKUDA H, 1995, J BIOL CHEM, V270, P21319, DOI 10.1074/jbc.270.36.21319; GORBALENYA AE, 1989, NUCLEIC ACIDS RES, V17, P4713, DOI 10.1093/nar/17.12.4713; GRANDOSO G, 1994, EUR J BIOCHEM, V226, P403, DOI 10.1111/j.1432-1033.1994.tb20065.x; Hall MC, 1997, J BIOL CHEM, V272, P18614, DOI 10.1074/jbc.272.30.18614; Hall MC, 1999, MOL MICROBIOL, V34, P867, DOI 10.1046/j.1365-2958.1999.01659.x; ILYINA TV, 1992, NUCLEIC ACIDS RES, V20, P3279, DOI 10.1093/nar/20.13.3279; KOONIN EV, 1993, BIOSYSTEMS, V30, P241, DOI 10.1016/0303-2647(93)90074-M; KUHN B, 1979, J BIOL CHEM, V254, P1343; LAHUE EE, 1988, J BIOL CHEM, V263, P3208; LANKA E, 1995, ANNU REV BIOCHEM, V64, P141, DOI 10.1146/annurev.bi.64.070195.001041; LEDERBERG J, 1946, NATURE, V158, P558, DOI 10.1038/158558a0; LLOSA M, 1994, J MOL BIOL, V235, P448, DOI 10.1006/jmbi.1994.1005; Llosa M, 1996, J MOL BIOL, V264, P56, DOI 10.1006/jmbi.1996.0623; MATSON SW, 1991, J BIOL CHEM, V266, P16232; MATSON SW, 1986, J BIOL CHEM, V261, P169; Matson SW, 2001, J BIOL CHEM, V276, P2372, DOI 10.1074/jbc.M008728200; MATSON SW, 1993, J BACTERIOL, V175, P2599, DOI 10.1128/JB.175.9.2599-2606.1993; PANICKER M, 1985, THESIS CARNEIGE MELL; PANSEGRAU W, 1993, P NATL ACAD SCI USA, V90, P2925, DOI 10.1073/pnas.90.7.2925; PANSEGRAU W, 1991, NUCLEIC ACIDS RES, V19, P3455, DOI 10.1093/nar/19.12.3455; REYGERS U, 1991, EMBO J, V10, P2689, DOI 10.1002/j.1460-2075.1991.tb07812.x; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; TRAXLER BA, 1987, J BACTERIOL, V169, P3251, DOI 10.1128/jb.169.7.3251-3259.1987; TRAXLER BA, 1988, J MOL BIOL, V204, P205, DOI 10.1016/0022-2836(88)90609-2; WONG I, 1993, P NATL ACAD SCI USA, V90, P5428, DOI 10.1073/pnas.90.12.5428; XIAOQUIN H, 1991, ADV APPL MATH, V12, P337	37	28	28	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					42645	42653		10.1074/jbc.M205984200	http://dx.doi.org/10.1074/jbc.M205984200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12207019	hybrid, Green Published			2022-12-27	WOS:000179081200029
J	Castellano, R; Van Lint, C; Peri, V; Veithen, E; Morel, Y; Costello, R; Olive, D; Collette, Y				Castellano, R; Van Lint, C; Peri, V; Veithen, E; Morel, Y; Costello, R; Olive, D; Collette, Y			Mechanisms regulating expression of the tumor necrosis factor-related light gene - Role of calcium-signaling pathway in the transcriptional control	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED T-CELLS; HERPESVIRUS ENTRY MEDIATOR; FACTOR-ALPHA GENE; TNF SUPERFAMILY; B-CELLS; NUCLEAR FACTOR; IN-VIVO; LIGAND; PROMOTER; NFAT	LIGHT (TNFSF14) is a newly identified tumor necrosis factor superfamily member involved in the regulation of immune responses by control of activation, maturation, and survival of immune effector cells. Despite the immunological relevance of the LIGHT protein, little knowledge is available as to how light gene expression is regulated. In T-lymphocytes, most LIGHT surface expression and transcript accumulation occurs after T cell activation. In this study, we have shown that these events are blocked at the transcriptional level by cyclosporin A, an immuno-suppressive drug. Besides, we identified a role for Ca2+-signaling pathways and NFAT transcription factors in T cell activation-induced LIGHT expression. To further investigate this process, we have identified, cloned, and characterized a 2.1-kilobase 5'-flanking DNA genomic fragment from the human light gene. We have shown the transcriptional activity of the herein-identified minimal 5' regulatory region of human light gene parallels the endogenous expression of light in T cells. Moreover, we demonstrated that induced LIGHT promoter activity can be equally blocked by cyclosporin A treatment or dominant negative NFAT overexpression and further identified by site-directed mutagenesis and electrophoretic mobility supershift analysis of a NFAT transcription factor binding site within the human light minimal promoter. Finally, Sp1 and Ets1 binding sites were identified and shown to regulate light basal promoter activity. Thus, the present study establishes a molecular basis to further understand the mechanisms governing human light gene expression and, consequently, could potentially lead to novel therapeutic manipulations that control the signaling cascade, resulting in LIGHT production in conditions characterized by immunopathologic activation of T cells.	INSERM, U119, Inst Cancerol & Immunol Marseille, F-13009 Marseille, France; Free Univ Brussels, Inst Biol & Med Mol, Chim Biol Lab, B-6041 Gosselies, Belgium; Inst J Paoli I Calmettes, Lab Immunol Tumeurs, F-13009 Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Institut Paoli-Calmette (IPC)	Collette, Y (corresponding author), INSERM, U119, Inst Cancerol & Immunol Marseille, 27 Blvd Lei Roure, F-13009 Marseille, France.		COLLETTE, Yves/F-2270-2013; Costello, Régis T/N-5079-2016; morel, yves/C-4757-2017	COLLETTE, Yves/0000-0001-5359-7099; Costello, Régis T/0000-0002-4086-1302; 				BAGNASCO M, 1989, EUR J IMMUNOL, V19, P823, DOI 10.1002/eji.1830190507; Bassuk AG, 1997, ADV IMMUNOL, V64, P65, DOI 10.1016/S0065-2776(08)60887-1; Benedict CA, 2001, IMMUNITY, V15, P617, DOI 10.1016/S1074-7613(01)00222-9; BORIES JC, 1995, NATURE, V377, P635, DOI 10.1038/377635a0; Chou CF, 2000, J BIOMED SCI, V7, P136, DOI 10.1159/000025439; Chow CW, 1999, MOL CELL BIOL, V19, P2300; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; COSTELLO R, 1993, EUR J IMMUNOL, V23, P608, DOI 10.1002/eji.1830230304; GOLDFELD AE, 1994, J EXP MED, V180, P763, DOI 10.1084/jem.180.2.763; Granger SW, 2001, J IMMUNOL, V167, P5122, DOI 10.4049/jimmunol.167.9.5122; HAN J, 1991, J IMMUNOL, V146, P1843; Harrop JA, 1998, J BIOL CHEM, V273, P27548, DOI 10.1074/jbc.273.42.27548; Kiani A, 2000, IMMUNITY, V12, P359, DOI 10.1016/S1074-7613(00)80188-0; Kontoyiannis D, 1999, IMMUNITY, V10, P387, DOI 10.1016/S1074-7613(00)80038-2; KRAMER B, 1995, J BIOL CHEM, V270, P6577; Latinis KM, 1997, J BIOL CHEM, V272, P31427, DOI 10.1074/jbc.272.50.31427; Li RZ, 2000, ONCOGENE, V19, P6514, DOI 10.1038/sj.onc.1204035; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Luo C, 1996, J EXP MED, V184, P141, DOI 10.1084/jem.184.1.141; Macian F, 2001, ONCOGENE, V20, P2476, DOI 10.1038/sj.onc.1204386; Mariani SM, 1998, EUR J IMMUNOL, V28, P1492, DOI 10.1002/(SICI)1521-4141(199805)28:05<1492::AID-IMMU1492>3.0.CO;2-X; Matsumoto Mitsuru, 1999, Journal of Medical Investigation, V46, P141; Mauri DN, 1998, IMMUNITY, V8, P21, DOI 10.1016/S1074-7613(00)80455-0; McClure RF, 1999, J BIOL CHEM, V274, P7756, DOI 10.1074/jbc.274.12.7756; Misawa K, 2000, CYTOGENET CELL GENET, V89, P89, DOI 10.1159/000015570; Morel Y, 2000, J IMMUNOL, V165, P4397, DOI 10.4049/jimmunol.165.8.4397; Morel Y, 2001, J IMMUNOL, V167, P2479, DOI 10.4049/jimmunol.167.5.2479; MUTHUSAMY N, 1995, NATURE, V377, P639, DOI 10.1038/377639a0; Scheu S, 2002, J EXP MED, V195, P1613, DOI 10.1084/jem.20020215; SCHUBERT LA, 1995, J BIOL CHEM, V270, P29624; Shaikh RB, 2001, J IMMUNOL, V167, P6330, DOI 10.4049/jimmunol.167.11.6330; Sharma K, 2000, PHARMACOL THERAPEUT, V88, P333, DOI 10.1016/S0163-7258(00)00096-6; Tamada K, 2000, J IMMUNOL, V164, P4105, DOI 10.4049/jimmunol.164.8.4105; Tamada K, 2000, NAT MED, V6, P283; Tomaras GD, 1999, J LEUKOCYTE BIOL, V66, P183, DOI 10.1002/jlb.66.1.183; Tsai EY, 1996, MOL CELL BIOL, V16, P5232; Tsai EY, 2000, MOL CELL BIOL, V20, P6084, DOI 10.1128/MCB.20.16.6084-6094.2000; VanLint C, 1996, EMBO J, V15, P1112, DOI 10.1002/j.1460-2075.1996.tb00449.x; Wang J, 2001, J CLIN INVEST, V108, P1771, DOI 10.1172/JCI200113827; Wang J, 2001, J IMMUNOL, V167, P5099, DOI 10.4049/jimmunol.167.9.5099; Xiao S, 1999, EUR J IMMUNOL, V29, P3456, DOI 10.1002/(SICI)1521-4141(199911)29:11<3456::AID-IMMU3456>3.3.CO;2-2; Xiao S, 2001, EUR J IMMUNOL, V31, P3339, DOI 10.1002/1521-4141(200111)31:11<3339::AID-IMMU3339>3.0.CO;2-U; Yang WC, 2000, INT IMMUNOL, V12, P1547, DOI 10.1093/intimm/12.11.1547; Ye QR, 2002, J EXP MED, V195, P795, DOI 10.1084/jem.20012088; Yu KY, 1999, J BIOL CHEM, V274, P13733, DOI 10.1074/jbc.274.20.13733; Zhai YF, 1998, J CLIN INVEST, V102, P1142, DOI 10.1172/JCI3492	46	20	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					42841	42851		10.1074/jbc.M207689200	http://dx.doi.org/10.1074/jbc.M207689200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12215452	hybrid			2022-12-27	WOS:000179081200056
J	Chen, JY; Levy-Wilson, B; Goodart, S; Cooper, AD				Chen, JY; Levy-Wilson, B; Goodart, S; Cooper, AD			Mice expressing the human CYP7A1 gene in the mouse CYP7A1 knock-out background lack induction of CYP7A1 expression by cholesterol feeding and have increased hypercholesterolemia when fed a high fat diet	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BILE-ACID SYNTHESIS; 7 ALPHA-HYDROXYLASE; NUCLEAR RECEPTOR; 7-ALPHA-HYDROXYLASE GENE; FEEDBACK-REGULATION; METABOLISM; SECRETION; LXR; IDENTIFICATION; DISRUPTION	Cholesterol 7alpha-hydroxylase (CYP7A1) catalyzes the rate-limiting step in the pathway responsible for the formation of the majority of bile acids. Transcription of the gene is regulated by the size of the bile acid pool and dietary and hormonal factors. The farnesoid X receptor and the liver X receptor (LXR) are responsible for regulation by bile acids and cholesterol, respectively. To study the effects of dietary cholesterol and fat upon expression of the human CYP7A1 gene, mice were generated by crossing transgenic mice carrying the human CYP7A1 gene with mice that were homozygous knockouts (CYP7A1(-/-)). The mice (mCYP7A1(-/-)/hCYP7A1) expressed the human gene at much higher levels than did the transgenics bred in the wild-type background. A diet containing 1% cholic acid reduced the expression of the human gene in mCYP7A1(-/-)/hCYP7A1 mice to undetectable levels. Cholestyramine (5%) increased the level of expression of the human gene and the mouse gene. Thus, farnesoid X receptor-mediated regulation was preserved. A diet containing 2% cholesterol increased expression of the mouse gene in wild-type mice, but it did not affect expression of the human gene in mCYP7A1(-/-)[hCYP7A1 mice. None of the diets altered the serum cholesterol or triglyceride levels in these mice; 1% cholic acid caused a redistribution of cholesterol from the high density lipoprotein to the low density lipoprotein density in the humanized mice but not in wild-type mice. A diet containing 30% saturated fat and 2% cholesterol caused a decrease in CYP7A1 levels in mCYP7A1(-/-)[hCYP7A1 mice. The serum cholesterol levels rose in all mice fed this diet. The increase was greater in the mCYP7A1(-/-)/hCYP7A1 mice. Together, these data suggest that the lack of an LXR element in the region from -56 to -49 of the human CYP7A1 promoter may account for some of the differences in response to diets between humans and rodents.	Palo Alto Med Res Fdn, Res Inst, Palo Alto, CA 94301 USA; Stanford Univ, Dept Med, Stanford, CA 94305 USA	Palo Alto Medical Foundation Research Institute; Stanford University	Cooper, AD (corresponding author), Palo Alto Med Res Fdn, Res Inst, Ames Bldg,795 El Camino Real, Palo Alto, CA 94301 USA.	adc@stanford.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054775] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038318, P30DK056339] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL54775] Funding Source: Medline; NIDDK NIH HHS [DK56339, DK38318] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Agellon LB, 2002, J BIOL CHEM, V277, P20131, DOI 10.1074/jbc.C200105200; Chen J, 1999, BIOCHEM BIOPH RES CO, V260, P829, DOI 10.1006/bbrc.1999.0980; CHIANG JYL, 1994, J BIOL CHEM, V269, P17502; Cooper AD, 1997, J BIOL CHEM, V272, P3444, DOI 10.1074/jbc.272.6.3444; Cooper AD, 2001, CIRCULATION, V104, P14; Cooper AD, 1997, GASTROENTEROLOGY, V113, P2005; COOPER AD, 1994, HEPATOLOGY, V20, P1522, DOI 10.1002/hep.1840200623; Costet P, 2000, J BIOL CHEM, V275, P28240; EINARSSON K, 1985, NEW ENGL J MED, V313, P277, DOI 10.1056/NEJM198508013130501; ELLSWORTH JL, 1986, J LIPID RES, V27, P858; Erickson SK, 1999, HEPATOLOGY, V30, p319A; Fruchart JC, 2001, PHARMACOL RES, V44, P345, DOI 10.1006/phrs.2001.0871; Fu X, 2001, J BIOL CHEM, V276, P38378, DOI 10.1074/jbc.M105805200; Goldstein JL, 2002, ARCH BIOCHEM BIOPHYS, V397, P139, DOI 10.1006/abbi.2001.2615; Goodart SA, 1999, BIOCHEM BIOPH RES CO, V266, P454, DOI 10.1006/bbrc.1999.1799; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; Ishibashi S, 1996, J BIOL CHEM, V271, P18017, DOI 10.1074/jbc.271.30.18017; Janowski BA, 1999, P NATL ACAD SCI USA, V96, P266, DOI 10.1073/pnas.96.1.266; Lehmann JM, 1997, J BIOL CHEM, V272, P3137, DOI 10.1074/jbc.272.6.3137; Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2; Lu TT, 2001, J BIOL CHEM, V276, P37735, DOI 10.1074/jbc.R100035200; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; Miyake JH, 2001, J BIOL CHEM, V276, P23304, DOI 10.1074/jbc.M101853200; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; Peet DJ, 1998, CELL, V93, P693, DOI 10.1016/S0092-8674(00)81432-4; PLUMP AS, 1992, CELL, V71, P343, DOI 10.1016/0092-8674(92)90362-G; Pullingr CR, 2002, J CLIN INVEST, V110, P109, DOI 10.1172/JCI200215387; Rosen ED, 2001, J BIOL CHEM, V276, P37731, DOI 10.1074/jbc.R100034200; RUDEL L, 1994, J CLIN INVEST, V93, P2463, DOI 10.1172/JCI117255; SCHONFELD G, 1982, J CLIN INVEST, V69, P1072, DOI 10.1172/JCI110542; Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400; Schwarz M, 2001, J LIPID RES, V42, P1594; Schwarz M, 1996, J BIOL CHEM, V271, P18024, DOI 10.1074/jbc.271.30.18017; TANIGUCHI T, 1994, J BIOL CHEM, V269, P10071; Turley SD, 1998, HEPATOLOGY, V28, P1088, DOI 10.1002/hep.510280425; Vlahcevic ZR, 1997, GASTROENTEROLOGY, V113, P1949, DOI 10.1016/S0016-5085(97)70015-5; Vlahcevic ZR, 1999, GASTROENTEROL CLIN N, V28, P1, DOI 10.1016/S0889-8553(05)70041-8; Wang HB, 1999, MOL CELL, V3, P543, DOI 10.1016/S1097-2765(00)80348-2; Xu GR, 1997, GASTROENTEROLOGY, V113, P1958, DOI 10.1016/S0016-5085(97)70016-7; XU GR, 1995, J CLIN INVEST, V95, P1497, DOI 10.1172/JCI117821; Xu GR, 1998, J LIPID RES, V39, P1608; YU SM, 1995, AM J CLIN NUTR, V61, P1129, DOI 10.1093/ajcn/61.5.1129	42	64	65	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					42588	42595		10.1074/jbc.M205117200	http://dx.doi.org/10.1074/jbc.M205117200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12202481	hybrid			2022-12-27	WOS:000179081200022
J	Natalizio, BJ; Muniz, LC; Arhin, GK; Wilusz, J; Lutz, CS				Natalizio, BJ; Muniz, LC; Arhin, GK; Wilusz, J; Lutz, CS			Upstream elements present in the 3'-Untranslated region of collagen genes influence the processing efficiency of overlapping polyadenylation signals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMERASE-CHAIN-REACTION; POLY(A) SITE SELECTION; PRE-MESSENGER-RNA; SNRNP-A PROTEIN; II COLLAGEN; DOWNSTREAM ELEMENTS; ARTICULAR-CARTILAGE; 3' END; SEQUENCE; TRANSCRIPTION	3'-Untranslated regions (UTRs) of genes often contain key regulatory elements involved in gene expression control. A high degree of evolutionary conservation in regions of the 3'-UTR suggests important, conserved elements. In particular, we are interested in those elements involved in regulation of 3' end formation. In addition to canonical sequence elements, auxiliary sequences likely play an important role in determining the polyadenylation efficiency of mammalian pre-mRNAs. We identified highly conserved sequence elements upstream of the AAUAAA in three human collagen genes, COL1A1, COL1A2, and COL2A1, and demonstrate that these upstream sequence elements (USEs) influence polyadenylation efficiency. Mutation of the USEs decreases polyadenylation efficiency both in vitro and in vivo, and inclusion of competitor oligoribonucleotides representing the USEs specifically inhibit polyadenylation. We have also shown that insertion of a USE into a weak polyadenylation signal can enhance 3' end formation. Close inspection of the COL1A2 3'-UTR reveals an unusual feature of two closely spaced, competing polyadenylation signals. Taken together, these data demonstrate that USEs are important auxiliary polyadenylation elements in mammalian genes.	Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Biochem & Mol Biol, Newark, NJ 07103 USA; Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Microbiol & Mol Genet, Newark, NJ 07103 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Lutz, CS (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Biochem & Mol Biol, MSB E671,185 S Orange Ave, Newark, NJ 07103 USA.	lutzcsC@umdnj.edu						AIYAR A, 1993, BIOTECHNIQUES, V14, P366; Arhin GK, 2002, NUCLEIC ACIDS RES, V30, P1842, DOI 10.1093/nar/30.8.1842; Brackenridge S, 1997, NUCLEIC ACIDS RES, V25, P2326, DOI 10.1093/nar/25.12.2326; BROWN PH, 1991, J VIROL, V65, P3340, DOI 10.1128/JVI.65.6.3340-3343.1991; Chao LC, 1999, MOL CELL BIOL, V19, P5588; CHEN F, 1995, NUCLEIC ACIDS RES, V23, P2614, DOI 10.1093/nar/23.14.2614; Chen F, 1998, NUCLEIC ACIDS RES, V26, P2891, DOI 10.1093/nar/26.12.2891; CHOU ZF, 1994, NUCLEIC ACIDS RES, V22, P2525, DOI 10.1093/nar/22.13.2525; Colgan DF, 1997, GENE DEV, V11, P2755, DOI 10.1101/gad.11.21.2755; DENOME RM, 1988, MOL CELL BIOL, V8, P4829, DOI 10.1128/MCB.8.11.4829; DEWET W, 1987, J BIOL CHEM, V262, P16032; DEZAZZO JD, 1991, MOL CELL BIOL, V11, P1624, DOI 10.1128/MCB.11.3.1624; DEZAZZO JD, 1989, MOL CELL BIOL, V9, P4951, DOI 10.1128/MCB.9.11.4951; EDWALDSGILBERT G, 1993, MOL CELL BIOL, V13, P3472, DOI 10.1128/MCB.13.6.3472; EdwaldsGilbert G, 1997, NUCLEIC ACIDS RES, V25, P2547, DOI 10.1093/nar/25.13.2547; ELIMA K, 1987, NUCLEIC ACIDS RES, V15, P9499, DOI 10.1093/nar/15.22.9499; Fehr JE, 2000, AM J VET RES, V61, P900, DOI 10.2460/ajvr.2000.61.900; GILMARTIN GM, 1995, GENE DEV, V9, P72, DOI 10.1101/gad.9.1.72; GILMARTIN GM, 1992, EMBO J, V11, P4419, DOI 10.1002/j.1460-2075.1992.tb05542.x; Graber JH, 1999, P NATL ACAD SCI USA, V96, P14055, DOI 10.1073/pnas.96.24.14055; Jacobson A, 1996, ANNU REV BIOCHEM, V65, P693, DOI 10.1146/annurev.bi.65.070196.003401; Jimenez SA, 1996, RHEUM DIS CLIN N AM, V22, P647, DOI 10.1016/S0889-857X(05)70294-5; Keller W, 1997, CURR OPIN CELL BIOL, V9, P329, DOI 10.1016/S0955-0674(97)80004-X; Le Graverand MPH, 2002, J ORTHOP RES, V20, P535, DOI 10.1016/S0736-0266(01)00126-7; Lewis JD, 1995, J CELL SCI, P13; Lou H, 1998, MOL CELL BIOL, V18, P4977, DOI 10.1128/MCB.18.9.4977; LUTZ CS, 1994, GENE DEV, V8, P576, DOI 10.1101/gad.8.5.576; Lutz CS, 1996, GENE DEV, V10, P325, DOI 10.1101/gad.10.3.325; Lutz CS, 1998, RNA, V4, P1493, DOI 10.1017/S1355838298981183; MAATTA A, 1991, FEBS LETT, V279, P9, DOI 10.1016/0014-5793(91)80237-W; Martin I, 2001, OSTEOARTHR CARTILAGE, V9, P112, DOI 10.1053/joca.2000.0366; Martincic K, 1998, P NATL ACAD SCI USA, V95, P11095, DOI 10.1073/pnas.95.19.11095; METSARANTA M, 1991, J BIOL CHEM, V266, P16862; MOORE CL, 1990, METHOD ENZYMOL, V181, P49; MOREIRA A, 1995, EMBO J, V14, P3809, DOI 10.1002/j.1460-2075.1995.tb00050.x; Moreira A, 1998, GENE DEV, V12, P2522, DOI 10.1101/gad.12.16.2522; MYERS JC, 1983, J BIOL CHEM, V258, P128; NINOMIYA Y, 1984, BIOCHEMISTRY-US, V23, P617, DOI 10.1021/bi00299a005; Osheim YN, 1999, MOL CELL, V3, P379, DOI 10.1016/S1097-2765(00)80465-7; Persikov AV, 2002, P NATL ACAD SCI USA, V99, P1101, DOI 10.1073/pnas.042707899; PRESCOTT J, 1994, MOL CELL BIOL, V14, P4682, DOI 10.1128/MCB.14.7.4682; Proudfoot N, 1996, CELL, V87, P779, DOI 10.1016/S0092-8674(00)81982-0; Proudfoot N, 2000, TRENDS BIOCHEM SCI, V25, P290, DOI 10.1016/S0968-0004(00)01591-7; Proudfoot NJ, 2002, CELL, V108, P501, DOI 10.1016/S0092-8674(02)00617-7; RUSSNAK R, 1990, GENE DEV, V4, P764, DOI 10.1101/gad.4.5.764; Sachs AB, 1997, CELL, V89, P831, DOI 10.1016/S0092-8674(00)80268-8; SANDELL LJ, 1984, J BIOL CHEM, V259, P7826; SANFACON H, 1991, GENE DEV, V5, P141, DOI 10.1101/gad.5.1.141; SANGIORGI FO, 1985, NUCLEIC ACIDS RES, V13, P2815, DOI 10.1093/nar/13.8.2815; SCHEK N, 1992, MOL CELL BIOL, V12, P5386, DOI 10.1128/MCB.12.12.5386; Shatkin AJ, 2000, NAT STRUCT BIOL, V7, P838, DOI 10.1038/79583; Takagaki Y, 1996, CELL, V87, P941, DOI 10.1016/S0092-8674(00)82000-0; Tasanen K, 1998, BRIT J DERMATOL, V139, P23; UPHOLT WB, 1985, ANN NY ACAD SCI, V460, P130, DOI 10.1111/j.1749-6632.1985.tb51161.x; VALSAMAKIS A, 1991, P NATL ACAD SCI USA, V88, P2108, DOI 10.1073/pnas.88.6.2108; VALSAMAKIS A, 1992, MOL CELL BIOL, V12, P3699, DOI 10.1128/MCB.12.9.3699; Wickens M, 1997, CURR OPIN GENET DEV, V7, P220, DOI 10.1016/S0959-437X(97)80132-3; WILUSZ J, 1988, MOL CELL BIOL, V8, P4477, DOI 10.1128/MCB.8.10.4477; Zhao J, 1999, MICROBIOL MOL BIOL R, V63, P405, DOI 10.1128/MMBR.63.2.405-445.1999	59	63	65	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					42733	42740		10.1074/jbc.M208070200	http://dx.doi.org/10.1074/jbc.M208070200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12200454	hybrid			2022-12-27	WOS:000179081200041
J	Guo, YJ; Pakneshan, P; Gladu, J; Slack, A; Szyf, M; Rabbani, SA				Guo, YJ; Pakneshan, P; Gladu, J; Slack, A; Szyf, M; Rabbani, SA			Regulation of DNA methylation in human breast cancer - Effect on the urokinase-type plasminogen activator gene production and tumor invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE DEACETYLASE COMPLEX; TRANSCRIPTIONAL REGULATION; IN-VIVO; HA-RAS; EXPRESSION; CELLS; UPA; METASTASIS; GROWTH; DEMETHYLATION	Urokinase-type plasminogen activator (uPA) is a member of the serine protease family and can break down various components of the extracellular matrix to promote growth, invasion, and metastasis of several malignancies including breast cancer. In the current study we examined the role that the DNA methylation machinery might be playing in regulating differential uPA gene expression in breast cancer cell lines. uPA mRNA is expressed in the highly invasive, hormone-insensitive human breast cancer cell line MDA-MB-231 but not in hormone-responsive cell line MCF-7. Using methylation-sensitive PCR, we show that 90% of CpG dinucleotides in the uPA promoter are methylated in MCF-7 cells, whereas fully demethylated CpGs were detected in MDA-MB-231 cells. uPA promoter activity, which is directly regulated by the Ets-1 transcription factor, is inhibited by methylation as determined by uPA promoter-luciferase reporter assays. We then tested whether the state of expression and methylation of the uPA promoter correlates with the global level of DNA methyltransferase and demethylase activities in these cell lines. We show that maintenance DNA methyltransferase activity is significantly higher in MCF-7 cells than in MDA-MB-231 cells, whereas demethylase activity is higher in MDA-MB-231 cells. We suggest that the combination of increased DNA methyltransferase activity with reduced demethylase activity contributes to the methylation and silencing of uPA expression in MCF-7 cells. The converse is true in MDA-MB-231 cells, which represents a late stage highly invasive breast cancer. The histone deacetylase inhibitor, Trichostatin A, induces the expression of the uPA gene in MDA-MB-231 cells but not in MCF-7 cells. This supports the hypothesis that DNA methylation is the dominant mechanism involved in the silencing of uPA gene expression. Taken together, these results provide insight into the mechanism regulating the transcription of the uPA gene in the complex multistep process of breast cancer progression.	McGill Univ, Ctr Hlth, Dept Med, Montreal, PQ H3A 1A1, Canada; McGill Univ, Ctr Hlth, Dept Pharmacol, Montreal, PQ H3A 1A1, Canada	McGill University; McGill University	Rabbani, SA (corresponding author), McGill Univ, Ctr Hlth, Dept Med, 687 Pine Ave W,Rm H4-67, Montreal, PQ H3A 1A1, Canada.	srabbani@med.mcgill.ca		rabbani, shafaat/0000-0001-5594-3899				Altschmied J, 1997, BIOL CHEM, V378, P1457, DOI 10.1515/bchm.1997.378.12.1457; Andreasen PA, 1997, INT J CANCER, V72, P1, DOI 10.1002/(SICI)1097-0215(19970703)72:1<1::AID-IJC1>3.0.CO;2-Z; Cannon RE, 1998, MOL CARCINOGEN, V21, P244, DOI 10.1002/(SICI)1098-2744(199804)21:4<244::AID-MC3>3.0.CO;2-K; Dobosy JR, 2001, CELL MOL LIFE SCI, V58, P721, DOI 10.1007/PL00000895; Frandsen TL, 2001, CANCER RES, V61, P532; Fujita N, 2000, MOL CELL BIOL, V20, P5107, DOI 10.1128/MCB.20.14.5107-5118.2000; GAMASOSA MA, 1983, NUCLEIC ACIDS RES, V11, P6883, DOI 10.1093/nar/11.19.6883; Guo YJ, 2000, FASEB J, V14, P1400, DOI 10.1096/fj.14.10.1400; Hen BG, 2001, J BIOL CHEM, V276, P7937, DOI 10.1074/jbc.M007470200; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; HERMANN R, 1991, FEBS LETT, V281, P191, DOI 10.1016/0014-5793(91)80391-F; Ignar DM, 1998, CLIN EXP METASTAS, V16, P9; ISSA JPJ, 1993, J NATL CANCER I, V85, P1235, DOI 10.1093/jnci/85.15.1235; JUTTERMANN R, 1994, P NATL ACAD SCI USA, V91, P11797, DOI 10.1073/pnas.91.25.11797; Kost TA, 1997, GENE, V190, P139, DOI 10.1016/S0378-1119(97)00019-X; LIU DF, 1995, PROSTATE, V27, P269, DOI 10.1002/pros.2990270506; Lubbert M, 2000, CURR TOP MICROBIOL, V249, P135; MACLEOD AR, 1995, J BIOL CHEM, V270, P8037, DOI 10.1074/jbc.270.14.8037; Momparler RL, 2000, J CELL PHYSIOL, V183, P145, DOI 10.1002/(SICI)1097-4652(200005)183:2<145::AID-JCP1>3.0.CO;2-V; Mueller BM, 1996, CURR TOP MICROBIOL, V213, P65; Naito S, 2000, PATHOL RES PRACT, V196, P103, DOI 10.1016/S0344-0338(00)80041-2; Nakada M, 1999, J NEUROPATH EXP NEUR, V58, P329, DOI 10.1097/00005072-199904000-00003; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Ng HH, 1999, NAT GENET, V23, P58, DOI 10.1038/12659; Rabbani S A, 2001, Surg Oncol Clin N Am, V10, P393; Rabbani SA, 2002, CANCER RES, V62, P2390; Rabbani SA, 1995, INT J CANCER, V63, P840, DOI 10.1002/ijc.2910630615; Ramchandani S, 1999, P NATL ACAD SCI USA, V96, P6107, DOI 10.1073/pnas.96.11.6107; Rha SY, 2000, CANCER LETT, V150, P137, DOI 10.1016/S0304-3835(99)00376-6; RICCIO A, 1985, NUCLEIC ACIDS RES, V13, P2759, DOI 10.1093/nar/13.8.2759; ROSENTHAL N, 1987, METHOD ENZYMOL, V152, P704; Rountree MR, 2000, NAT GENET, V25, P269, DOI 10.1038/77023; Schmalfeldt B, 2001, CLIN CANCER RES, V7, P2396; SIMILE MM, 1994, CANCER LETT, V79, P9, DOI 10.1016/0304-3835(94)90056-6; Szyf M, 2001, FRONT BIOSCI-LANDMRK, V6, pD599, DOI 10.2741/szyf; SZYF M, 1995, J BIOL CHEM, V270, P12690, DOI 10.1074/jbc.270.21.12690; SZYF M, 2002, METHODS MOL BIOL EXT; SZYF M, 2002, METHODS MOL BIOL MEA; Van Zee KJ, 1998, ONCOGENE, V16, P2723; Watabe T, 1998, INT J CANCER, V77, P128, DOI 10.1002/(SICI)1097-0215(19980703)77:1<128::AID-IJC20>3.0.CO;2-9; Watt PM, 2000, GENE CHROMOSOME CANC, V29, P371, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1050>3.0.CO;2-Y; Xing RH, 1999, INT J CANCER, V81, P443, DOI 10.1002/(SICI)1097-0215(19990505)81:3<443::AID-IJC19>3.0.CO;2-T; Xing RH, 1997, CANCER RES, V57, P3585; Xing RH, 1996, INT J CANCER, V67, P423, DOI 10.1002/(SICI)1097-0215(19960729)67:3<423::AID-IJC18>3.0.CO;2-8; Yang X, 2001, ENDOCR-RELAT CANCER, V8, P115, DOI 10.1677/erc.0.0080115	45	102	105	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					41571	41579		10.1074/jbc.M201864200	http://dx.doi.org/10.1074/jbc.M201864200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12198113	hybrid			2022-12-27	WOS:000178985300036
J	Higashi, Y; Asanuma, M; Miyazaki, I; Haque, ME; Fujita, N; Tanaka, K; Ogawa, N				Higashi, Y; Asanuma, M; Miyazaki, I; Haque, ME; Fujita, N; Tanaka, K; Ogawa, N			The p53-activated gene, PAG608, requires a zinc finger domain for nuclear localization and oxidative stress-induced	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DEATH; 6-HYDROXYDOPAMINE-INDUCED APOPTOSIS; BRAIN MITOCHONDRIA; PC12 CELLS; P53; BAX; PERMEABILITY; EXPRESSION; VIABILITY; NEURONS	The p53-activated gene PAG608, which encodes a nuclear zinc finger protein, is a p53-inducible gene that contributes to p53-mediated apoptosis. However, the mechanisms by which PAG608 is involved in the apoptosis of neuronal cells are still obscure. In this study, we demonstrated that expression of p53 was induced by 100 muM 6-hydroxydopamine (6-OHDA), accompanied by increased PAG608 expression in PC12 cells. On the other hand, transient or permanent transfection of antisense PAG608 cDNA into PC12 cells significantly prevented apoptotic cell death induced by 100 muM 6-OHDA or 200 muM hydrogen peroxide but not by 250 muM 1-methyl-4phenylpyridinium ion. The 6-OHDA-induced activation of caspase-3, DNA fragmentation, loss of mitochondria membrane potential, and induction of p53 and Bax were also prevented in PC12 cells that stably expressed antisense PAG608 cDNA. These results suggest that PAG608 is associated with the apoptotic pathway induced by these oxidative stress-generating reagents, upstream of the collapse in the mitochondrial membrane potential in PC12 cells. Interestingly, transient transfection with PAG608 cDNA increased p53 expression in both PC12 cells and B65 cells, indicating that PAG608 induced by p53 is able to induce p53 expression in these cells inversely. Furthermore, transient transfection of a truncated mutant PAG608 cDNA, lacking the first zinc finger domain, inhibited 6-OHDA-induced cell death and altered the nuclear and nucleolar localization of wild-type PAG608 in PC12 cells. These results suggest that PAG608 may induce or regulate p53 expression and translocate to the nucleus and nucleolus using its first zinc finger domain during oxidative stress-induced apoptosis of catecholamine-containing cells.	Okayama Univ, Sch Med & Dent, Dept Brain Sci, Okayama 7008558, Japan	Okayama University	Higashi, Y (corresponding author), Okayama Univ, Sch Med & Dent, Dept Brain Sci, 2-5-1 Shikatacho, Okayama 7008558, Japan.	ogawakun@cc.okayama-u.acjp						ASANUMA M, 1995, MOL BRAIN RES, V33, P29, DOI 10.1016/0169-328X(95)00102-X; BEAL MF, 1995, ANN NEUROL, V38, P357, DOI 10.1002/ana.410380304; Blum D, 1997, BRAIN RES, V751, P139, DOI 10.1016/S0006-8993(96)01358-3; Blum D, 2000, NEUROSCI LETT, V283, P193, DOI 10.1016/S0304-3940(00)00948-4; BossyWetzel E, 1997, EMBO J, V16, P1695, DOI 10.1093/emboj/16.7.1695; Chao C, 2000, EMBO J, V19, P4967, DOI 10.1093/emboj/19.18.4967; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHIANG MY, 1991, J BIOL CHEM, V266, P18162; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Clarkson ED, 1999, P SOC EXP BIOL MED, V222, P157, DOI 10.1046/j.1525-1373.1999.d01-126.x; DAVIES AM, 1995, TRENDS NEUROSCI, V18, P355, DOI 10.1016/0166-2236(95)93928-Q; Gillardon F, 1999, MOL BRAIN RES, V73, P138, DOI 10.1016/S0169-328X(99)00251-X; Goldberg Z, 2002, EMBO J, V21, P3715, DOI 10.1093/emboj/cdf384; He Y, 2000, BRAIN RES, V858, P163, DOI 10.1016/S0006-8993(99)02459-2; Hellborg F, 2001, ONCOGENE, V20, P5466, DOI 10.1038/sj.onc.1204722; Hermann DM, 2001, NEUROSCIENCE, V102, P779, DOI 10.1016/S0306-4522(00)00522-4; Higashi Y, 2000, J NEUROCHEM, V75, P1771, DOI 10.1046/j.1471-4159.2000.0751771.x; Hsu YT, 1997, P NATL ACAD SCI USA, V94, P3668, DOI 10.1073/pnas.94.8.3668; Israeli D, 1997, EMBO J, V16, P4384, DOI 10.1093/emboj/16.14.4384; Jiang DM, 2001, J NEUROCHEM, V76, P1745, DOI 10.1046/j.1471-4159.2001.00151.x; Kim DH, 2001, EUR J NEUROSCI, V13, P1861, DOI 10.1046/j.0953-816x.2001.01563.x; Lee CS, 2002, NEUROCHEM INT, V40, P361, DOI 10.1016/S0197-0186(01)00069-9; Li PF, 1999, EMBO J, V18, P6027, DOI 10.1093/emboj/18.21.6027; Lotharius J, 1999, J NEUROSCI, V19, P1284; Marchenko ND, 2000, J BIOL CHEM, V275, P16202, DOI 10.1074/jbc.275.21.16202; Marzo I, 1998, SCIENCE, V281, P2027, DOI 10.1126/science.281.5385.2027; Nagai M, 2001, J NEUROSCI, V21, P9246, DOI 10.1523/JNEUROSCI.21-23-09246.2001; Narita M, 1998, P NATL ACAD SCI USA, V95, P14681, DOI 10.1073/pnas.95.25.14681; Ochu EE, 1998, J NEUROCHEM, V70, P2637; Pastorino JG, 1998, J BIOL CHEM, V273, P7770, DOI 10.1074/jbc.273.13.7770; Satoh T, 1997, J NEUROSCI RES, V50, P413, DOI 10.1002/(SICI)1097-4547(19971101)50:3<413::AID-JNR7>3.0.CO;2-L; Soldner F, 1999, EXP CELL RES, V250, P75, DOI 10.1006/excr.1999.4504; TIPTON KF, 1993, J NEUROCHEM, V61, P1191, DOI 10.1111/j.1471-4159.1993.tb13610.x; Tomasevic G, 1999, MOL BRAIN RES, V70, P304, DOI 10.1016/S0169-328X(99)00146-1; VarmehZiaie S, 1997, ONCOGENE, V15, P2699, DOI 10.1038/sj.onc.1201454; Volbracht C, 2001, NEUROREPORT, V12, P3645, DOI 10.1097/00001756-200112040-00008; Vousden KH, 2000, CELL, V103, P691, DOI 10.1016/S0092-8674(00)00171-9; Weber JD, 2000, MOL CELL BIOL, V20, P2517, DOI 10.1128/MCB.20.7.2517-2528.2000; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Woodgate A, 1999, MOL BRAIN RES, V69, P84, DOI 10.1016/S0169-328X(99)00103-5; Wu W, 2001, J Tradit Chin Med, V21, P136; Yamakawa H, 2000, NEUROL RES, V22, P556; Yang ML, 1999, J BIOL CHEM, V274, P27399, DOI 10.1074/jbc.274.39.27399; Zhang YP, 2001, CELL GROWTH DIFFER, V12, P175; Zuch CL, 2000, J COMP NEUROL, V427, P440, DOI 10.1002/1096-9861(20001120)427:3<440::AID-CNE10>3.0.CO;2-7	45	24	26	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					42224	42232		10.1074/jbc.M203594200	http://dx.doi.org/10.1074/jbc.M203594200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12196512	Green Submitted, hybrid			2022-12-27	WOS:000178985300117
J	Massimi, I; Park, E; Rice, K; Muller-Esterl, W; Sauder, D; McGavin, MJ				Massimi, I; Park, E; Rice, K; Muller-Esterl, W; Sauder, D; McGavin, MJ			Identification of a novel maturation mechanism and restricted substrate specificity for the SspB cysteine protease of Staphylococcus aureus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-WEIGHT KININOGEN; AMINO-ACID-SEQUENCE; INTRAMOLECULAR CHAPERONE; STREPTOCOCCUS-PYOGENES; PROTEOLYTIC ACTIVITY; PLASMA FIBRONECTIN; TERMINAL FRAGMENTS; BINDING-PROTEIN; SERINE-PROTEASE; CLEAVAGE SITES	The SspB cysteine protease of Staphylococcus aureus is expressed in an operon, flanked by the sspA serine protease, and sspC, encoding a 12.9-kDa protein of unknown function. SspB was expressed as a 40-kDa prepropeptide pSspB, which did not undergo autocatalytic maturation. Activity of pSspB was reduced compared with 22-kDa mature SspB, but it was equivalent to mature SspB after incubation with SspA, which specifically removed the pSspB N-terminal propeptide. SspC abrogated the activity of pSspB when incubated in a 1:1 complex but had no effect on SspA or papain. Activity of the pSspB-SspC complex was restored when incubated with SspA, and SspC was cleaved by SspA but not pSspB. Thus, SspC maintains pSspB as an inert zymogen, and SspA is required for removal of the propeptide and inactivation of SspC. Like the papain protease family, SspB cleaved substrates with a hydrophobic amino acid at P2 but had a strong preference for arginine at P1. It did not cleave casein, serum albumin, IgG, or IgA, but it promoted detachment of cultured keratinocytes and cleaved fibronectin and fibrinogen at sites recognized by urokinase plasminogen activator and plasmin, respectively. It also processed high molecular weight kininogen in a manner resembling plasma kallikrein. Thus, SspB exhibits a novel maturation mechanism and mimics the specificity of plasma serine proteases.	Goethe Univ Frankfurt, Sch Med, Inst Biochem 2, D-60590 Frankfurt, Germany; Sunnybrook & Womens Coll, Hlth Sci Ctr, Dept Dermatol, Toronto, ON M4N 3M5, Canada; Univ Toronto, Dept Med, Toronto, ON M5G 1L5, Canada; Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5G 1L5, Canada	Goethe University Frankfurt; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Toronto	McGavin, MJ (corresponding author), Sunnybrook & Womens Coll, Hlth Sci Ctr, Dept Microbiol S112, 2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	martin.mcgavin@swchsc.on.ca		McGavin, Martin/0000-0001-5955-0689				Archer GL, 1998, CLIN INFECT DIS, V26, P1179, DOI 10.1086/520289; ASAKURA S, 1992, J CELL BIOL, V116, P465, DOI 10.1083/jcb.116.2.465; BHOOLA KD, 1992, PHARMACOL REV, V44, P1; Chavakis T, 2000, BLOOD, V96, P514; Collin M, 2001, INFECT IMMUN, V69, P7187, DOI 10.1128/IAI.69.11.7187-7189.2001; Colman RW, 2001, BIOL CHEM, V382, P65, DOI 10.1515/BC.2001.011; Coulter SN, 1998, MOL MICROBIOL, V30, P393, DOI 10.1046/j.1365-2958.1998.01075.x; DOOLITTLE RF, 1984, ANNU REV BIOCHEM, V53, P195, DOI 10.1146/annurev.bi.53.070184.001211; Doran JD, 1999, EUR J BIOCHEM, V263, P145, DOI 10.1046/j.1432-1327.1999.00473.x; DRAPEAU GR, 1972, J BIOL CHEM, V247, P6720; DRAPEAU GR, 1978, J BACTERIOL, V136, P607, DOI 10.1128/JB.136.2.607-613.1978; Fitzgerald JR, 2001, P NATL ACAD SCI USA, V98, P8821, DOI 10.1073/pnas.161098098; Fu X, 2000, J BIOL CHEM, V275, P16871, DOI 10.1074/jbc.275.22.16871; GOLD LI, 1992, J CELL BIOCHEM, V50, P441, DOI 10.1002/jcb.240500412; GRINNELL F, 1980, CELL, V19, P517, DOI 10.1016/0092-8674(80)90526-7; HAMAGUCHI M, 1993, BLOOD, V81, P2348; Herwald H, 1998, NAT MED, V4, P298, DOI 10.1038/nm0398-298; Herwald H, 1996, J EXP MED, V184, P665, DOI 10.1084/jem.184.2.665; HOUMARD J, 1972, P NATL ACAD SCI USA, V69, P3506, DOI 10.1073/pnas.69.12.3506; HUFF S, 1994, J BIOL CHEM, V269, P15563; HURLETJENSEN A, 1983, THROMB RES, V29, P609, DOI 10.1016/0049-3848(83)90215-3; Jarraud S, 2002, INFECT IMMUN, V70, P631, DOI 10.1128/IAI.70.2.631-641.2002; KAPUR V, 1993, MICROB PATHOGENESIS, V15, P327, DOI 10.1006/mpat.1993.1083; Karlsson A, 2001, INFECT IMMUN, V69, P4742, DOI 10.1128/IAI.69.8.4742-4748.2001; KAUFMANN J, 1993, J BIOL CHEM, V268, P9079; Kim W, 1996, APPL ENVIRON MICROB, V62, P2482, DOI 10.1128/AEM.62.7.2482-2488.1996; KONDO S, 1993, J INVEST DERMATOL, V101, P690, DOI 10.1111/1523-1747.ep12371677; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LI YY, 1995, J BIOL CHEM, V270, P25127, DOI 10.1074/jbc.270.42.25127; Lima APCA, 2002, J BIOL CHEM, V277, P5875, DOI 10.1074/jbc.M108518200; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Matsui T, 1998, EUR J BIOCHEM, V252, P569, DOI 10.1046/j.1432-1327.1998.2520569.x; Matsuka YV, 1999, INFECT IMMUN, V67, P4326, DOI 10.1128/IAI.67.9.4326-4333.1999; Matsuka YV, 1997, J PROTEIN CHEM, V16, P739, DOI 10.1023/A:1026307731751; McAleese FM, 2001, J BIOL CHEM, V276, P29969, DOI 10.1074/jbc.M102389200; MCDONAGH RP, 1981, FEBS LETT, V127, P174, DOI 10.1016/0014-5793(81)80198-6; McGavin MJ, 1997, INFECT IMMUN, V65, P2621, DOI 10.1128/IAI.65.7.2621-2628.1997; Motta G, 1998, BLOOD, V91, P516, DOI 10.1182/blood.V91.2.516.516_516_528; Musser JM, 1996, INFECT IMMUN, V64, P1913, DOI 10.1128/IAI.64.6.1913-1917.1996; Nomizu M, 2001, J BIOL CHEM, V276, P44551, DOI 10.1074/jbc.M106306200; NOVICK RP, 1993, EMBO J, V12, P3967, DOI 10.1002/j.1460-2075.1993.tb06074.x; NOVICK RP, 1991, METHOD ENZYMOL, V204, P587; Rice K, 2001, INFECT IMMUN, V69, P159, DOI 10.1128/IAI.69.1.159-169.2001; Sabat A, 2000, INFECT IMMUN, V68, P973, DOI 10.1128/IAI.68.2.973-976.2000; SCOTT CF, 1984, J CLIN INVEST, V73, P954, DOI 10.1172/JCI111319; SHINDE U, 1995, J MOL BIOL, V247, P390, DOI 10.1006/jmbi.1994.0147; SIGNAS C, 1989, P NATL ACAD SCI USA, V86, P699, DOI 10.1073/pnas.86.2.699; Stockbauer KE, 1999, P NATL ACAD SCI USA, V96, P242, DOI 10.1073/pnas.96.1.242; STORER AC, 1994, METHOD ENZYMOL, V244, P486; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Yabuta Y, 2001, J BIOL CHEM, V276, P44427, DOI 10.1074/jbc.M107573200; YUEN SW, 1989, BIOTECHNIQUES, V7, P74; Ziebandt AK, 2001, PROTEOMICS, V1, P480, DOI 10.1002/1615-9861(200104)1:4<480::AID-PROT480>3.0.CO;2-O	53	79	84	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					41770	41777		10.1074/jbc.M207162200	http://dx.doi.org/10.1074/jbc.M207162200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12207024	hybrid			2022-12-27	WOS:000178985300061
J	Opazo, C; Huang, XD; Cherny, RA; Moir, RD; Roher, AE; White, AR; Cappai, R; Masters, CL; Tanzi, RE; Inestrosa, NC; Bush, AI				Opazo, C; Huang, XD; Cherny, RA; Moir, RD; Roher, AE; White, AR; Cappai, R; Masters, CL; Tanzi, RE; Inestrosa, NC; Bush, AI			Metalloenzyme-like activity of Alzheimer's disease beta-amyloid - Cu-dependent catalytic conversion of dopamine, cholesterol, and biological reducing agents to neurotoxic H2O2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							A-BETA; OXIDATIVE STRESS; TRANSGENIC MICE; NEUROFIBRILLARY TANGLES; SUPEROXIDE-DISMUTASE; SENILE PLAQUES; ZINC; PROTEIN; NEURONS; COPPER	beta-Amyloid (Abeta) 1-42, implicated in the pathogenesis of Alzheimer's disease, forms an oligomeric complex that binds copper at a CuZn superoxide dismutase-like binding site. Abeta.Cu complexes generate neurotoxic H2O2 from O-2 through Cu2+ reduction, but the reaction mechanism has been unclear. We now report that Abeta1-42, when binding up to 2 eq of Cu2+, generates the H2O2 catalytically by recruiting biological reducing agents as substrates under conditions where the Cu2+ or reducing agents will not form H2O2 themselves. Cholesterol is an important substrate for this activity, as are vitamin C, L-DOPA, and dopamine (V-max for dopamine = 34.5 nM/min, K-m = 8.9 muM). The activity was inhibited by anti-Abeta antibodies, Cu2+ chelators, and Zn2+. Toxicity of Abeta in neuronal culture was consistent with catalytic H2O2 production. All was not toxic in cell cultures in the absence of Cu2+, and dopamine (5 pm) markedly exaggerated the neurotoxicity of 200 rim Abeta1-42.Cu. Therefore, microregional catalytic H2O2 production, combined with the exhaustion of reducing agents, may mediate the neurotoxicity of Abeta in Alzheimer's disease, and inhibitors of this novel activity may be of therapeutic value.	Sun Hlth Res Inst, Haldeman Lab Alzheimer Dis Res, Sun City, AZ 85351 USA; Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Neurol, Charlestown, MA 02129 USA; Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia; Univ Melbourne, Mental Hlth Res Inst, Oxidat Disorders Lab, Parkville, Vic 3052, Australia; Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Psychiat, Charlestown, MA 02129 USA; Massachusetts Gen Hosp, Lab Oxidat Biol, Genet & Aging Res Unit, Charlestown, MA 02129 USA; Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Biol Celular & Mol, Ctr Regulac Celular & Patol, Santiago 114D, Chile	Banner Research; Banner Health; Banner Sun Health Research Institute; Harvard University; Massachusetts General Hospital; University of Melbourne; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Pontificia Universidad Catolica de Chile	Bush, AI (corresponding author), Massachusetts Gen Hosp, Lab Oxidat Biol, Genet & Aging Res Unit, Bldg 114,16th St, Charlestown, MA 02129 USA.	bush@helix.mgh.harvard.edu	Bush, Ashley I/A-1186-2007; Bush, Ashley/Y-2457-2019; Moir, Robert D./M-7612-2017; Tanzi, Rudolph/AAE-9622-2019; White, Anthony/P-5596-2016; Cappai, Roberto/B-3347-2010	Bush, Ashley I/0000-0001-8259-9069; Bush, Ashley/0000-0001-8259-9069; Moir, Robert D./0000-0001-5431-3553; Tanzi, Rudolph/0000-0002-7032-1454; White, Anthony/0000-0003-1802-9891; Opazo, Carlos/0000-0003-3473-7548; Cappai, Roberto/0000-0002-9505-8496	NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH002001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG012685] Funding Source: NIH RePORTER; NIA NIH HHS [2R01 AG 12685] Funding Source: Medline; NIMH NIH HHS [1K01 MH 02001] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Aksenov MY, 1998, J MOL NEUROSCI, V11, P151, DOI 10.1385/JMN:11:2:151; Atwood CS, 1998, J BIOL CHEM, V273, P12817, DOI 10.1074/jbc.273.21.12817; Atwood CS, 2000, J NEUROCHEM, V75, P1219, DOI 10.1046/j.1471-4159.2000.0751219.x; BEHL C, 1994, CELL, V77, P817, DOI 10.1016/0092-8674(94)90131-7; BUSH AI, 1994, J BIOL CHEM, V269, P12152; Bush AI, 2002, P NATL ACAD SCI USA, V99, P7317, DOI 10.1073/pnas.122249699; BUSH AI, 1994, SCIENCE, V265, P1464, DOI 10.1126/science.8073293; Cherny RA, 2001, NEURON, V30, P665, DOI 10.1016/S0896-6273(01)00317-8; Cherny RA, 1999, J BIOL CHEM, V274, P23223, DOI 10.1074/jbc.274.33.23223; Cuajungco MP, 2000, J BIOL CHEM, V275, P19439, DOI 10.1074/jbc.C000165200; Curtain CC, 2001, J BIOL CHEM, V276, P20466, DOI 10.1074/jbc.M100175200; Estevez AG, 1999, SCIENCE, V286, P2498, DOI 10.1126/science.286.5449.2498; Gotz J, 2001, SCIENCE, V293, P1491, DOI 10.1126/science.1062097; Gouras GK, 2000, AM J PATHOL, V156, P15, DOI 10.1016/S0002-9440(10)64700-1; HARRIS ME, 1995, EXP NEUROL, V131, P193, DOI 10.1016/0014-4886(95)90041-1; Huang XD, 1999, BIOCHEMISTRY-US, V38, P7609, DOI 10.1021/bi990438f; Huang XD, 1997, J BIOL CHEM, V272, P26464, DOI 10.1074/jbc.272.42.26464; Huang XD, 1999, J BIOL CHEM, V274, P37111, DOI 10.1074/jbc.274.52.37111; Kuo YM, 1996, J BIOL CHEM, V271, P4077; Lee JY, 1999, J NEUROSCI, V19, DOI 10.1523/jneurosci.19-11-j0002.1999; Lee JY, 2002, P NATL ACAD SCI USA, V99, P7705, DOI 10.1073/pnas.092034699; Lovell MA, 1998, J NEUROL SCI, V158, P47, DOI 10.1016/S0022-510X(98)00092-6; MARTINS RN, 1986, J NEUROCHEM, V46, P1042, DOI 10.1111/j.1471-4159.1986.tb00615.x; MASON RP, 1992, NEUROBIOL AGING, V13, P413, DOI 10.1016/0197-4580(92)90116-F; MASTERS CL, 1985, EMBO J, V4, P2757, DOI 10.1002/j.1460-2075.1985.tb04000.x; MASTERS CL, 2002, 7 INT GEN SPRINGF AL; Mori T, 2001, J NEUROPATH EXP NEUR, V60, P778, DOI 10.1093/jnen/60.8.778; Nunomura A, 1999, J NEUROSCI, V19, P1959; POWERS RE, 1988, NEUROSCIENCE, V25, P401, DOI 10.1016/0306-4522(88)90248-5; Pratico D, 2000, ANN NEUROL, V48, P809, DOI 10.1002/1531-8249(200011)48:5<809::AID-ANA19>3.0.CO;2-9; Roher AE, 1996, J BIOL CHEM, V271, P20631, DOI 10.1074/jbc.271.34.20631; Russell RL, 1999, ARCH BIOCHEM BIOPHYS, V370, P236, DOI 10.1006/abbi.1999.1404; Sagara Y, 1996, J NEUROSCI, V16, P497; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; SHIVERS BD, 1988, EMBO J, V7, P1365, DOI 10.1002/j.1460-2075.1988.tb02952.x; SMITH CD, 1991, P NATL ACAD SCI USA, V88, P10540, DOI 10.1073/pnas.88.23.10540; Smith MA, 1998, J NEUROCHEM, V70, P2212, DOI 10.1046/j.1471-4159.1998.70052212.x; Suh SW, 2000, BRAIN RES, V852, P274, DOI 10.1016/S0006-8993(99)02096-X; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; Tamagno E, 2000, NEUROREPORT, V11, P1865, DOI 10.1097/00001756-200006260-00013; Varadarajan S, 1999, BRAIN RES BULL, V50, P133, DOI 10.1016/S0361-9230(99)00093-3; VAUGHAN DW, 1981, J NEUROPATH EXP NEUR, V40, P472, DOI 10.1097/00005072-198107000-00009; VIGOPELFREY C, 1993, J NEUROCHEM, V61, P1965, DOI 10.1111/j.1471-4159.1993.tb09841.x; White AR, 2001, J NEUROCHEM, V76, P1509, DOI 10.1046/j.1471-4159.2001.00178.x; Wolozin B, 2000, ARCH NEUROL-CHICAGO, V57, P1439, DOI 10.1001/archneur.57.10.1439; YANKNER BA, 1990, SCIENCE, V250, P279, DOI 10.1126/science.2218531	47	496	535	2	78	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2002	277	43					40302	40308		10.1074/jbc.M206428200	http://dx.doi.org/10.1074/jbc.M206428200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	607KU	12192006	hybrid			2022-12-27	WOS:000178791400021
J	Washington, K; Ammosova, T; Beullens, M; Jerebtsova, M; Kumar, A; Bollen, M; Nekhai, S				Washington, K; Ammosova, T; Beullens, M; Jerebtsova, M; Kumar, A; Bollen, M; Nekhai, S			Protein phosphatase-1 dephosphorylates the C-terminal domain of RNA polymerase-II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHORYLATION; TRANSCRIPTION; KINASE; PURIFICATION; ACTIVATION; SUBUNIT; PEPTIDE; CDK2; CTD	Transcription by RNA polymerase-II (RNAPII) is controlled by multisite phosphorylation of the heptapeptide repeats in the C-terminal domain (CTD) of the largest subunit. Phosphorylation of CTD is mediated by the cyclin-dependent protein kinases Cdk7 and Cdk9, whereas protein serine/threonine phosphatase FCP1 dephosphorylates CTD. We have recently reported that human immunodeficiency virus-1 (HIV-1) transcription is positively regulated by protein phosphatase-1 (PP1) and that PP1 dephosphorylates recombinant CTD. Here, we provide further evidence that PP1 can dephosphorylate RNAPII CTD. In vitro, PP1 dephosphorylated recombinant CTD as well as purified RNAPII CTD. HeLa nuclear extracts were found to contain a species of PP1 that dephosphorylates both serine 2 and serine 5 of the heptapeptide repeats. In nuclear extracts, PP1 and FCP1 contributed roughly equally to the dephosphorylation of serine 2. PP1 co-purified with RNAPII by gel filtration and associated with RNAPII on immunoaffinity columns prepared with anti-CTD antibodies. In cultured cells treated with CTD kinase inhibitors, the dephosphorylation of RNAPII on serine 2 was inhibited by 45% by preincubation with okadaic acid, which inhibits phosphatases of PPP family, including PP1 but not FCP1. Our data demonstrate that RNAPII CTD is dephosphorylated by PP1 in vitro and by PPP-type phosphatase, distinct from FCP1, in vivo.	Howard Univ, Ctr Sickle Cell Dis, Washington, DC 20059 USA; Howard Univ, Dept Biochem & Mol Biol, Washington, DC 20059 USA; Howard Univ, Genet Program, Washington, DC 20059 USA; Catholic Univ Louvain, Div Biochem, B-3000 Louvain, Belgium; Childrens Natl Med Ctr, Washington, DC 20010 USA; George Washington Univ, Dept Biochem & Mol Biol, Washington, DC 20037 USA	Howard University; Howard University; Howard University; Universite Catholique Louvain; Children's National Health System; George Washington University	Nekhai, S (corresponding author), Howard Univ, Ctr Sickle Cell Dis, 2121 Georgia Ave,NW, Washington, DC 20059 USA.	snekhai@howard.edu	, nekhai/AFO-2652-2022; , nekhai/AAW-3105-2021		NHLBI NIH HHS [UH1 HL 03679] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [UH1HL003679] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALLET B, 1988, GENE, V65, P259, DOI 10.1016/0378-1119(88)90462-3; Bensaude O, 1999, BIOCHEM CELL BIOL, V77, P249, DOI 10.1139/bcb-77-4-249; BEULLENS M, 1992, J BIOL CHEM, V267, P16538; Beullens M, 1999, J BIOL CHEM, V274, P14053, DOI 10.1074/jbc.274.20.14053; Beullens M, 1998, METH MOL B, V93, P145; Beullens M, 2000, BIOCHEM J, V352, P651, DOI 10.1042/0264-6021:3520651; Bharucha DC, 2002, VIROLOGY, V296, P6, DOI 10.1006/viro.2002.1438; Bollen M, 2002, TRENDS CELL BIOL, V12, P138, DOI 10.1016/S0962-8924(01)02247-4; Boudrez A, 2000, J BIOL CHEM, V275, P25411, DOI 10.1074/jbc.M001676200; Chambers RS, 1996, J BIOL CHEM, V271, P24498, DOI 10.1074/jbc.271.40.24498; COOPER JA, 1983, METHOD ENZYMOL, V99, P387; Cujec TP, 1997, GENE DEV, V11, P2645, DOI 10.1101/gad.11.20.2645; Dahmus ME, 1996, J BIOL CHEM, V271, P19009, DOI 10.1074/jbc.271.32.19009; DEGUZMAN A, 1988, METHOD ENZYMOL, V159, P356; Deng LW, 2002, J BIOL CHEM, V277, P33922, DOI 10.1074/jbc.M111349200; DIGNAM JD, 1983, METHOD ENZYMOL, V101, P582; DUBOIS MF, 1994, J CELL PHYSIOL, V158, P417, DOI 10.1002/jcp.1041580305; Fernandez JJ, 2002, CURR MED CHEM, V9, P229, DOI 10.2174/0929867023371247; Garrett S, 2001, MOL CELL BIOL, V21, P88, DOI 10.1128/MCB.21.1.88-99.2001; Hausmann S, 2002, J BIOL CHEM, V277, P21213, DOI 10.1074/jbc.M202056200; Hengartner CJ, 1998, MOL CELL, V2, P43, DOI 10.1016/S1097-2765(00)80112-4; JAGIELLO I, 1995, J BIOL CHEM, V270, P17257, DOI 10.1074/jbc.270.29.17257; Lavoie SB, 2001, J MOL BIOL, V312, P675, DOI 10.1006/jmbi.2001.4991; Marshall NF, 1998, J BIOL CHEM, V273, P31726, DOI 10.1074/jbc.273.48.31726; Morris MC, 2002, J BIOL CHEM, V277, P23847, DOI 10.1074/jbc.M107890200; Nekhai S, 2000, PEPTIDES, V21, P1449, DOI 10.1016/S0196-9781(00)00297-7; Nekhai S, 2000, VIROLOGY, V266, P246, DOI 10.1006/viro.1999.0035; Nekhai S, 2002, BIOCHEM J, V364, P649, DOI 10.1042/BJ20011191; Okamoto H, 2000, VIROLOGY, V270, P337, DOI 10.1006/viro.2000.0311; PETERSON SR, 1992, GENE DEV, V6, P426, DOI 10.1101/gad.6.3.426; Price DH, 2000, MOL CELL BIOL, V20, P2629, DOI 10.1128/MCB.20.8.2629-2634.2000; Proudfoot NJ, 2002, CELL, V108, P501, DOI 10.1016/S0092-8674(02)00617-7	32	52	55	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2002	277	43					40442	40448		10.1074/jbc.M205687200	http://dx.doi.org/10.1074/jbc.M205687200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	607KU	12185079	hybrid			2022-12-27	WOS:000178791400038
J	Cozier, GE; Carlton, J; McGregor, AH; Gleeson, PA; Teasdale, BD; Mellor, H; Cullen, PJ				Cozier, GE; Carlton, J; McGregor, AH; Gleeson, PA; Teasdale, BD; Mellor, H; Cullen, PJ			The Phox Homology (PX) domain-dependent, 3-phosphoinositide-mediated association of sorting nexin-1 with an early sorting endosomal compartment is required for its ability to regulate epidermal growth factor receptor degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLINOSITOL 3-PHOSPHATE; PLASMA-MEMBRANE; SACCHAROMYCES-CEREVISIAE; INOSITOL LIPIDS; MAMMALIAN-CELLS; BINDING; KINASE; FAB1P; TRANSLOCATION; LOCALIZATION	Recent studies have shown that phox homology (PX) domains act as phosphoinositide-binding motifs. The majority of PX domains studied show binding to phosphatidylinositol 3-monophosphate (Ptdlns(3)P), an association that allows the host protein to localize to membranes of the endocytic pathway. One issue, however, is whether PX domains may have alternative phosphoinositide binding specificities that could target their host protein to distinct subcellular compartments or allow their allosteric regulation by phosphoinositides other than PtdIns(3)P. It has been reported that the PX domain of sorting nexin 1 (SNX1) specifically binds phosphatidylinositol 3,4,5-trisphosphate (PtdIns(3,4,5)P-3) (Zhong, Q., Lazar, C. S., Tronchere, H., Sato, T., Meerloo, T., Yeo, M., Songyang, Z., Emr, S. D., and Gill, G. N. (2002) Proc. Natl. Acad. Sci. U. S. A. 99,6767-6772). In the present study, we have shown that whereas SNX1 binds PtdIns(3,4,5)P-3 in protein:lipid overlay assays, in liposomes-based assays, binding is observed to PtdIns(3)P and phosphatidylinositol 3,5-bisphosphate (PtdIns(3,5)P-2) but not to PtdIns(3,4,5)P-3. To address the significance of PtdIns(3,4,5)P-3 binding, we examined the subcellular localization of SNX1 under conditions in which plasma membrane PtdIns(3,4,5)P-3 levels were significantly elevated. Under these conditions, we failed to observe association of SNX1 with this membrane. However, consistent with the binding to PtdIns(3)P and PtdIns(3,5)P-2 being of more physiological significance was the observation that the association of SNX1 with an early endosomal compartment was dependent on a 3-phosphoinositide-binding PX domain and the presence of PtdIns(3)P on this compartment. Finally, we somal association of SNX1 is important for its ability to regulate the targeting of internalized epidermal growth factor receptor for lysosomal degradation.	Univ Bristol, Sch Med Sci, Dept Biochem, Inositide Grp,Henry Wellcome Integrated Signallin, Bristol BS8 1TD, Avon, England; Univ Bristol, Sch Med Sci, Dept Biochem, Bristol BS8 1TD, Avon, England; Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic 3010, Australia; Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia	University of Bristol; University of Bristol; University of Melbourne; University of Queensland	Cullen, PJ (corresponding author), Univ Bristol, Sch Med Sci, Dept Biochem, Inositide Grp,Henry Wellcome Integrated Signallin, Bristol BS8 1TD, Avon, England.		Cozier, Gyles/A-5891-2009; Carlton, Jeremy/X-2918-2019; Carlton, Jeremy/C-7702-2014; Teasdale, Rohan D/B-2538-2009; Teasdale, Rohan/AAD-6698-2019	Carlton, Jeremy/0000-0002-7255-1894; Teasdale, Rohan D/0000-0001-7455-5269; Teasdale, Rohan/0000-0001-7455-5269; Cullen, Peter/0000-0002-9070-8349; Gleeson, Paul/0000-0002-5336-6503; Mellor, Harry/0000-0003-3894-0623; Cozier, Gyles/0000-0003-2851-0902				Ago T, 2001, BIOCHEM BIOPH RES CO, V287, P733, DOI 10.1006/bbrc.2001.5629; Balla T, 2000, TRENDS PHARMACOL SCI, V21, P238, DOI 10.1016/S0165-6147(00)01500-5; Bravo J, 2001, MOL CELL, V8, P829, DOI 10.1016/S1097-2765(01)00372-0; Cheever ML, 2001, NAT CELL BIOL, V3, P613, DOI 10.1038/35083000; Cooke FT, 1998, CURR BIOL, V8, P1219, DOI 10.1016/S0960-9822(07)00513-1; Cozier GE, 2000, J BIOL CHEM, V275, P28261; Cullen PJ, 2001, CURR BIOL, V11, pR882, DOI 10.1016/S0960-9822(01)00523-1; Deak M, 1999, FEBS LETT, V451, P220, DOI 10.1016/S0014-5793(99)00556-6; Dowler S, 1999, BIOCHEM J, V342, P7, DOI 10.1042/0264-6021:3420007; Dumas JJ, 2001, MOL CELL, V8, P947, DOI 10.1016/S1097-2765(01)00385-9; Ellson CD, 2001, NAT CELL BIOL, V3, P679, DOI 10.1038/35083076; Ellson CD, 2002, J CELL SCI, V115, P1099; Ford MGJ, 2001, SCIENCE, V291, P1051, DOI 10.1126/science.291.5506.1051; Gampel A, 1999, CURR BIOL, V9, P955, DOI 10.1016/S0960-9822(99)80422-9; Gary JD, 1998, J CELL BIOL, V143, P65, DOI 10.1083/jcb.143.1.65; Gillooly DJ, 2001, BIOCHEM J, V355, P249, DOI 10.1042/0264-6021:3550249; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Haft CR, 1998, MOL CELL BIOL, V18, P7278, DOI 10.1128/MCB.18.12.7278; Hurley JH, 2001, CURR OPIN CELL BIOL, V13, P146, DOI 10.1016/S0955-0674(00)00191-5; Ikonomov OC, 2001, J BIOL CHEM, V276, P26141, DOI 10.1074/jbc.M101722200; Itoh T, 2001, SCIENCE, V291, P1047, DOI 10.1126/science.291.5506.1047; Jun X, 2001, J CELL BIOL, V154, P699; Kanai F, 2001, NAT CELL BIOL, V3, P675, DOI 10.1038/35083070; Kurten RC, 1996, SCIENCE, V272, P1008, DOI 10.1126/science.272.5264.1008; Kurten RC, 2001, J CELL SCI, V114, P1743; Lemmon MA, 2000, BIOCHEM J, V350, P1, DOI 10.1042/0264-6021:3500001; Lockyer PJ, 1997, CURR BIOL, V7, P1007, DOI 10.1016/S0960-9822(06)00423-4; McEwen RK, 1999, J BIOL CHEM, V274, P33905, DOI 10.1074/jbc.274.48.33905; Misra S, 2001, CELL, V107, P559, DOI 10.1016/S0092-8674(01)00594-3; Oatey PB, 1999, BIOCHEM J, V344, P511, DOI 10.1042/0264-6021:3440511; Odorizzi G, 2000, TRENDS BIOCHEM SCI, V25, P229, DOI 10.1016/S0968-0004(00)01543-7; Odorizzi G, 1998, CELL, V95, P847, DOI 10.1016/S0092-8674(00)81707-9; Pattni K, 2001, CURR BIOL, V11, P1636, DOI 10.1016/S0960-9822(01)00486-9; Ponting CP, 1996, PROTEIN SCI, V5, P2353, DOI 10.1002/pro.5560051122; Sato TK, 2001, SCIENCE, V294, P1881, DOI 10.1126/science.1065763; Shisheva A, 2001, CELL BIOL INT, V25, P1201, DOI 10.1006/cbir.2001.0803; Shisheva A, 1999, MOL CELL BIOL, V19, P623; SHRISSA D, 1999, J BIOL CHEM, V274, P21589; Simonsen A, 2001, NAT CELL BIOL, V3, pE179, DOI 10.1038/35087112; Song X, 2001, BIOCHEMISTRY-US, V40, P8940, DOI 10.1021/bi0155100; Stevenson JM, 1998, J BIOL CHEM, V273, P22761, DOI 10.1074/jbc.273.35.22761; Teasdale RD, 2001, BIOCHEM J, V358, P7, DOI 10.1042/0264-6021:3580007; Teruel MN, 2000, CELL, V103, P181, DOI 10.1016/S0092-8674(00)00109-4; Toker A, 1997, NATURE, V387, P673, DOI 10.1038/42648; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; Venkateswarlu K, 1998, BIOCHEM J, V335, P139, DOI 10.1042/bj3350139; Venkateswarlu K, 1998, CURR BIOL, V8, P463, DOI 10.1016/S0960-9822(98)70181-2; Virbasius JV, 2001, P NATL ACAD SCI USA, V98, P12908, DOI 10.1073/pnas.221352898; Watton SJ, 1999, CURR BIOL, V9, P433, DOI 10.1016/S0960-9822(99)80192-4; Wishart MJ, 2001, CELL, V105, P817, DOI 10.1016/S0092-8674(01)00414-7; Xu Y, 2001, BIOCHEM J, V360, P513, DOI 10.1042/0264-6021:3600513; Xu Y, 2001, NAT CELL BIOL, V3, P658, DOI 10.1038/35083051; Yu JW, 2001, J BIOL CHEM, V276, P44179, DOI 10.1074/jbc.M108811200; Zhan Y, 2002, J BIOL CHEM, V277, P4512, DOI 10.1074/jbc.M109520200; Zhong Q, 2002, P NATL ACAD SCI USA, V99, P6767, DOI 10.1073/pnas.092142699	55	130	136	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 13	2002	277	50					48730	48736		10.1074/jbc.M206986200	http://dx.doi.org/10.1074/jbc.M206986200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	624YK	12198132	hybrid			2022-12-27	WOS:000179789600099
J	Tu, X; Batta, P; Innocent, N; Prisco, M; Casaburi, I; Belletti, B; Baserga, R				Tu, X; Batta, P; Innocent, N; Prisco, M; Casaburi, I; Belletti, B; Baserga, R			Nuclear translocation of insulin receptor substrate-1 by oncogenes and Igf-I - Effect on ribosomal RNA synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-I; PHOSPHOTYROSINE-BINDING DOMAINS; LARGE TUMOR-ANTIGEN; PLECKSTRIN HOMOLOGY; POSTNATAL-GROWTH; S6 KINASE; PROTEIN; CELL; TRANSFORMATION; TRANSCRIPTION	The insulin receptor substrate-1 (IRS-1) is one of the major substrates of both the insulin and IGF-1 receptors and is generally localized in the cytosol/membrane fraction of the cell. We show here that a substantial fraction of IRS-1 is translocated to the nucleus in mouse embryo fibroblasts (MEF) expressing the simian virus 40 T antigen. Nuclear translocation of IRS-1 occurs also in MEF stimulated with IGF-1 or in MEF expressing the oncogene v-src. Nuclear translocation of IRS-1 can be demonstrated by confocal microscopy, immunohistochemistry, or subcellular fractionation. An antibody to IRS-1 immunoprecipitates from nuclear fractions (but not from cytosolic fractions) the upstream binding factor, which is a key regulator of RNA polymerase I activity and ribosomal RNA (rRNA) synthesis. In agreement with this finding, in 32D murine hemopoietic cells, nuclear translocation of IRS-1 correlates with a markedly increased rRNA synthesis. Our experiments suggest that nuclear IRS-1 may play a specialized role in rRNA synthesis and/or processing.	Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA	Jefferson University	Baserga, R (corresponding author), Thomas Jefferson Univ, Kimmel Canc Ctr, 233 S 10th St,624 BLSB, Philadelphia, PA 19107 USA.	R_Baserga@jci.tju.edu	Belletti, Barbara/J-2028-2018	Belletti, Barbara/0000-0003-2249-0285	NATIONAL CANCER INSTITUTE [R01CA089640] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG020956] Funding Source: NIH RePORTER; NCI NIH HHS [CA 089640] Funding Source: Medline; NIA NIH HHS [AG 20956] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Baserga R, 2000, ONCOGENE, V19, P5574, DOI 10.1038/sj.onc.1203854; Baserga R, 1985, BIOL CELL REPROD; Bohni R, 1999, CELL, V97, P865, DOI 10.1016/S0092-8674(00)80799-0; Bollen M, 2002, TRENDS CELL BIOL, V12, P138, DOI 10.1016/S0962-8924(01)02247-4; Bromberg J, 2000, ONCOGENE, V19, P2468, DOI 10.1038/sj.onc.1203476; Burks DJ, 1998, J BIOL CHEM, V273, P31061, DOI 10.1074/jbc.273.47.31061; COHEN LS, 1967, J CELL PHYSIOL, V69, P331, DOI 10.1002/jcp.1040690309; Comai L, 2000, CELL GROWTH DIFFER, V11, P63; Dufner A, 1999, EXP CELL RES, V253, P100, DOI 10.1006/excr.1999.4683; Fei ZL, 1997, ONCOGENE, V15, P961, DOI 10.1038/sj.onc.1201265; FUKUDA M, 1953, J BIOCHEM, V40, P95, DOI 10.1093/oxfordjournals.jbchem.a126356; Gil D, 2001, J BIOL CHEM, V276, P11174, DOI 10.1074/jbc.M010114200; Ginisty H, 1999, J CELL SCI, V112, P761; Grummt I, 1999, PROG NUCLEIC ACID RE, V62, P109; Hovanessian AG, 2000, EXP CELL RES, V261, P312, DOI 10.1006/excr.2000.5071; Jacobs AR, 2001, J BIOL CHEM, V276, P40795, DOI 10.1074/jbc.M105194200; Jans DA, 1998, BIOESSAYS, V20, P400, DOI 10.1002/(SICI)1521-1878(199805)20:5<400::AID-BIES7>3.0.CO;2-R; Kabuta T, 2002, J BIOL CHEM, V277, P6846, DOI 10.1074/jbc.M107058200; KELLER SR, 1993, BIOCHIM BIOPHYS ACTA, V1172, P323, DOI 10.1016/0167-4781(93)90222-Y; Kim JE, 2000, P NATL ACAD SCI USA, V97, P14340, DOI 10.1073/pnas.011511898; KUHN A, 1992, P NATL ACAD SCI USA, V89, P7340, DOI 10.1073/pnas.89.16.7340; Lassak A, 2002, J BIOL CHEM, V277, P17231, DOI 10.1074/jbc.M110885200; LENORMAND P, 1993, J CELL BIOL, V122, P1079, DOI 10.1083/jcb.122.5.1079; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/0092-8674(93)90679-K; Montagne J, 1999, SCIENCE, V285, P2126, DOI 10.1126/science.285.5436.2126; Morali OG, 2001, ONCOGENE, V20, P4942, DOI 10.1038/sj.onc.1204660; Myers MG, 1996, ANNU REV PHARMACOL, V36, P615, DOI 10.1146/annurev.pa.36.040196.003151; MYERS MG, 1994, J BIOL CHEM, V269, P28783; Ni CY, 2001, SCIENCE, V294, P2179, DOI 10.1126/science.1065412; Ogawa W, 1998, MOL CELL BIOCHEM, V182, P13, DOI 10.1023/A:1006862807598; Pete G, 1999, ENDOCRINOLOGY, V140, P5478, DOI 10.1210/en.140.12.5478; Peterson JE, 1996, J BIOL CHEM, V271, P31562, DOI 10.1074/jbc.271.49.31562; Prisco M, 2002, J BIOL CHEM, V277, P32078, DOI 10.1074/jbc.M204658200; Razzini G, 2000, MOL ENDOCRINOL, V14, P823, DOI 10.1210/me.14.6.823; Reddy EP, 2000, ONCOGENE, V19, P2532, DOI 10.1038/sj.onc.1203594; REINHARD C, 1994, EMBO J, V13, P1557, DOI 10.1002/j.1460-2075.1994.tb06418.x; Reiss K, 2001, ONCOGENE, V20, P490, DOI 10.1038/sj.onc.1204112; Ringertz Nils R., 1976, CELL HYBRIDS; Romano G, 1999, J CELL BIOCHEM, V72, P294, DOI 10.1002/(SICI)1097-4644(19990201)72:2<294::AID-JCB14>3.0.CO;2-0; SANTOS M, 1982, J CELL BIOCHEM, V19, P127, DOI 10.1002/jcb.240190204; Schnarr B, 2000, INT J CANCER, V89, P506, DOI 10.1002/1097-0215(20001120)89:6<506::AID-IJC7>3.0.CO;2-F; SELL C, 1994, MOL CELL BIOL, V14, P3604, DOI 10.1128/MCB.14.6.3604; SELL C, 1993, P NATL ACAD SCI USA, V90, P11217, DOI 10.1073/pnas.90.23.11217; Shima H, 1998, EMBO J, V17, P6649, DOI 10.1093/emboj/17.22.6649; SOLER AP, 1989, P NATL ACAD SCI USA, V86, P6640, DOI 10.1073/pnas.86.17.6640; Valentinis B, 1997, MOL CELL BIOL, V17, P3744, DOI 10.1128/MCB.17.7.3744; Valentinis B, 1999, J BIOL CHEM, V274, P12423, DOI 10.1074/jbc.274.18.12423; Valentinis B, 2000, J BIOL CHEM, V275, P25451, DOI 10.1074/jbc.M002271200; Vandromme M, 2001, J BIOL CHEM, V276, P8173, DOI 10.1074/jbc.M005587200; WANG LM, 1993, SCIENCE, V261, P1591, DOI 10.1126/science.8372354; White MF, 1998, MOL CELL BIOCHEM, V182, P3, DOI 10.1023/A:1006806722619; Yenush L, 1998, MOL CELL BIOL, V18, P6784, DOI 10.1128/MCB.18.11.6784; Zhou-Li Fei, 1995, Molecular and Cellular Biology, V15, P4232	54	82	82	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2002	277	46					44357	44365		10.1074/jbc.M208001200	http://dx.doi.org/10.1074/jbc.M208001200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	615XE	12202493	hybrid			2022-12-27	WOS:000179272000107
J	Chouchane, S; Girotto, S; Yu, SW; Magliozzo, RS				Chouchane, S; Girotto, S; Yu, SW; Magliozzo, RS			Identification and characterization of tyrosyl radical formation in Mycobacterium tuberculosis catalase-peroxidase (KatG)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTAGLANDIN-H SYNTHASE-1; SITE-DIRECTED MUTAGENESIS; ELECTRON-PARAMAGNETIC-RESONANCE; RIBONUCLEOTIDE REDUCTASE; ESCHERICHIA-COLI; ISONIAZID ACTIVATION; COMPOUND-I; GHZ EPR; OXIDATION; GENE	The catalytic function of Mycobacterium tuberculosis catalase-peroxidase (KatG) and its role in activation of the anti-tuberculosis antibiotic isoniazid were investigated using rapid freeze-quench electron paramagnetic resonance (RFQ-EPR) experiments. The reaction of KatG with peroxyacetic acid was followed as a function of time using x-band EPR at 77 K. A doublet EPR signal appears within 6.4 ms after mixing and at time points through hundreds of milliseconds. Thereafter, a singlet signal develops and finally predominates after 1 s, with a total yield of radical similar to0.5 spin/heme. Simulation of the spectra provided EPR parameters consistent with those for tyrosyl radicals. Changes in the hyperfine splitting and/or line width in spectra for L-3,3-[H-2(2)]tyrosine-labeled, but not L-2,4,5,6,7-[H-2(5)]tryptophan-labeled KatG confirmed this assignment. The initial rate of radical formation was unchanged using a 3-fold or 10-fold excess of peroxyacetic acid, consistent with a rate-determining step involving an intermediate. Although Compound I is likely to be the precursor of tyrosyl radical in KatG, neither its EPR signal nor its reduction to Compound II during formation of the radical(s) could be observed. The tyrosyl radical doublet signal was rapidly quenched by addition of isoniazid and benzoic hydrazide, but not by iproniazid, which binds poorly to KatG.	CUNY Brooklyn Coll, Dept Chem, Brooklyn, NY 11210 USA; CUNY, Grad Ctr, Brooklyn, NY 11210 USA	City University of New York (CUNY) System; Brooklyn College (CUNY); City University of New York (CUNY) System	Chouchane, S (corresponding author), CUNY Brooklyn Coll, Dept Chem, 2900 Bedford Ave, Brooklyn, NY 11210 USA.		Girotto, Stefania/F-5997-2012		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043582] Funding Source: NIH RePORTER; NIAID NIH HHS [AI43582] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BENDER CJ, 1989, J AM CHEM SOC, V111, P8076, DOI 10.1021/ja00203a002; Chouchane S, 2000, BIOCHEMISTRY-US, V39, P9975, DOI 10.1021/bi0005815; Collins DM, 1996, TRENDS MICROBIOL, V4, P426, DOI 10.1016/0966-842X(96)10066-4; Engleder M, 2000, BIOCHIMIE, V82, P211, DOI 10.1016/S0300-9084(00)00204-2; FUNK CD, 1991, FASEB J, V5, P2304, DOI 10.1096/fasebj.5.9.1907252; GERFEN GJ, 1993, J AM CHEM SOC, V115, P6420, DOI 10.1021/ja00067a071; HEYM B, 1993, J BACTERIOL, V175, P4255, DOI 10.1128/JB.175.13.4255-4259.1993; Hillar A, 2000, BIOCHEMISTRY-US, V39, P5868, DOI 10.1021/bi0000059; HILLAR A, 1995, ARCH BIOCHEM BIOPHYS, V323, P438, DOI 10.1006/abbi.1995.0065; Ivancich A, 1999, J AM CHEM SOC, V121, P5743, DOI 10.1021/ja990562m; Ivancich A, 2001, BIOCHEMISTRY-US, V40, P6860, DOI 10.1021/bi002826j; Ivancich A, 2001, J AM CHEM SOC, V123, P5050, DOI 10.1021/ja0036514; Ivancich A, 1997, BIOCHEMISTRY-US, V36, P9356, DOI 10.1021/bi970886s; JOHNSSON K, 1995, J AM CHEM SOC, V117, P5009, DOI 10.1021/ja00122a038; JOHNSSON K, 1994, J AM CHEM SOC, V116, P7425, DOI 10.1021/ja00095a063; KOSAKA T, 1994, EUR J BIOCHEM, V221, P889, DOI 10.1111/j.1432-1033.1994.tb18804.x; KULMACZ RJ, 1990, BIOCHEMISTRY-US, V29, P8760, DOI 10.1021/bi00489a037; Lei BF, 2000, J BIOL CHEM, V275, P2520, DOI 10.1074/jbc.275.4.2520; Lendzian F, 1996, J AM CHEM SOC, V118, P8111, DOI 10.1021/ja960917r; Lu GQ, 1999, J BIOL CHEM, V274, P16162, DOI 10.1074/jbc.274.23.16162; Magliozzo RS, 1996, J AM CHEM SOC, V118, P11303, DOI 10.1021/ja962047j; MARCINKEVICIENE JA, 1995, J BIOL CHEM, V270, P22290, DOI 10.1074/jbc.270.38.22290; NEESE F, 1997, THESIS U KONSTANZ KO; NEESE F, 1995, QUANTUM CHEM PROGRAM, P5; Obinger C, 1999, FREE RADICAL RES, V31, pS243; Pym AS, 2001, MOL MICROBIOL, V40, P879, DOI 10.1046/j.1365-2958.2001.02427.x; Regelsberger G, 2000, J BIOL CHEM, V275, P22854, DOI 10.1074/jbc.M002371200; Regelsberger G, 1999, BIOCHEMISTRY-US, V38, P10480, DOI 10.1021/bi990886n; ROBITZEK EH, 1952, AM REV TUBERC PULM, V65, P402; Rozwarski DA, 1998, SCIENCE, V279, P98, DOI 10.1126/science.279.5347.98; SAHLIN M, 1982, J BIOL CHEM, V257, P366; Saint-Joanis B, 1999, BIOCHEM J, V338, P753, DOI 10.1042/0264-6021:3380753; Shi WJ, 2000, BIOCHEMISTRY-US, V39, P4112, DOI 10.1021/bi992561c; SINHA BK, 1983, J BIOL CHEM, V258, P796; SJOBERG BM, 1978, J BIOL CHEM, V253, P6863; SJOBERG BM, 1977, J BIOL CHEM, V252, P536; SJOBERG BM, 1977, CIBA F SYMP, V60, P187; TSAI AL, 1994, J BIOL CHEM, V269, P5085; Tsai AL, 1999, J BIOL CHEM, V274, P21695, DOI 10.1074/jbc.274.31.21695; WELINDER KG, 1992, BIOCHEM SOC T, V20, P337, DOI 10.1042/bst0200337; Wengenack NL, 1999, J AM CHEM SOC, V121, P9748, DOI 10.1021/ja992590a; Wengenack NL, 2001, BIOCHEMISTRY-US, V40, P8990, DOI 10.1021/bi002614m; Yu SW, 2002, PROTEIN SCI, V11, P58, DOI 10.1110/ps.ps.09902; Zamocky M, 2001, FEBS LETT, V492, P177, DOI 10.1016/S0014-5793(01)02237-2; Zhang WH, 2001, BIOCHEMISTRY-US, V40, P4123, DOI 10.1021/bi002589k; ZHANG Y, 1992, NATURE, V358, P591, DOI 10.1038/358591a0	46	59	59	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					42633	42638		10.1074/jbc.M207916200	http://dx.doi.org/10.1074/jbc.M207916200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12205099	hybrid			2022-12-27	WOS:000179081200027
J	Denisov, IG; Makris, TM; Sligar, SG				Denisov, IG; Makris, TM; Sligar, SG			Formation and decay of hydroperoxo-ferric heme complex in horseradish peroxidase studied by cryoradiolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ONE-ELECTRON REDUCTION; COMPOUND-I FORMATION; CYTOCHROME P450CAM; HYDROGEN-PEROXIDE; OXYGEN ACTIVATION; ELEMENTARY STEPS; RESIDUE; EPR; INTERMEDIATE; MECHANISM	Using radiolytic reduction of the oxy-ferrous horseradish peroxidase (HRP) at 77 K, we observed the formation and decay of the putative intermediate, the hydroperoxo-ferric heme complex, often called "Compound 0." This intermediate is common for several different enzyme systems as the precursor of the Compound I (ferryl-oxo pi-cation radical) intermediate. EPR and UV-visible absorption spectra show that protonation of the primary intermediate of radiolytic reduction, the peroxo-ferric complex, to form the hydroperoxo-ferric complex is completed only after annealing at temperatures 150-180 K. After further annealing at 195-205 K, this complex directly transforms to ferric HRP without any observable intervening species. The lack of Compound I formation is explained by inability of the enzyme to deliver the second proton to the distal oxygen atom of hydroperoxide ligand, shown to be necessary for dioxygen bond heterolysis on the "oxidase pathway," which is nonphysiological for HRP. Alternatively, the physiological substrate H2O2 brings both protons to the active site of HRP, and Compound I is subsequently formed via rearrangement of the proton from the proximal to the distal oxygen atom of the bound peroxide.	Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA; Univ Illinois, Dept Chem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Sligar, SG (corresponding author), Univ Illinois, Dept Biochem, 505 S Goodwin Ave, Urbana, IL 61801 USA.		Denisov, Gleb S/J-6549-2013; Denisov, Ilia G/J-6590-2013; Makris, Thomas/W-9965-2019	Denisov, Gleb S/0000-0002-1246-0552; Denisov, Ilia G/0000-0002-7878-2626; Makris, Thomas/0000-0001-7927-620X	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001811] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM031756] Funding Source: NIH RePORTER; NCRR NIH HHS [P-41-RR01811] Funding Source: Medline; NIGMS NIH HHS [R37-GM31756] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAEK HK, 1989, BIOCHEMISTRY-US, V28, P5714, DOI 10.1021/bi00440a003; BAEK HK, 1992, J AM CHEM SOC, V114, P718, DOI 10.1021/ja00028a046; Berglund GI, 2002, NATURE, V417, P463, DOI 10.1038/417463a; BLUMBERG WE, 1968, J BIOL CHEM, V243, P1854; Brittain T, 1997, BIOCHEM J, V326, P109, DOI 10.1042/bj3260109; Davydov R, 1999, J AM CHEM SOC, V121, P10654, DOI 10.1021/ja9918829; Davydov R, 2001, J AM CHEM SOC, V123, P1403, DOI 10.1021/ja003583l; Davydov R, 2002, J AM CHEM SOC, V124, P1798, DOI 10.1021/ja0122391; DAVYDOV R, 1991, FEBS LETT, V295, P113, DOI 10.1016/0014-5793(91)81398-R; Davydov RM, 1999, J AM CHEM SOC, V121, P10656, DOI 10.1021/ja992425v; DAVYDOV RM, 1980, BIOFIZIKA+, V25, P203; Denisov IG, 2001, J BIOL CHEM, V276, P11648, DOI 10.1074/jbc.M010219200; Denisov IG, 2001, J INORG BIOCHEM, V87, P215, DOI 10.1016/S0162-0134(01)00328-2; DUNFORD HB, 1999, HEME PEROXIDES; DUNFORD HB, 1991, PEROXIDASES CHEM BIO, V2, P2; Filizola M, 2000, J AM CHEM SOC, V122, P18, DOI 10.1021/ja992793z; GASYNA Z, 1979, FEBS LETT, V106, P213, DOI 10.1016/0014-5793(79)80730-9; GASYNA Z, 1988, BIOCHEMISTRY-US, V27, P2502; GERBER NC, 1994, J BIOL CHEM, V269, P4260; Groves John T., 1995, P3; Groves JT, 2000, CURR OPIN CHEM BIOL, V4, P687, DOI 10.1016/S1367-5931(00)00146-0; Harris DL, 1996, J AM CHEM SOC, V118, P10588, DOI 10.1021/ja9617247; Hiner ANP, 2002, J INORG BIOCHEM, V91, P27, DOI 10.1016/S0162-0134(02)00390-2; IMAI M, 1989, P NATL ACAD SCI USA, V86, P7823, DOI 10.1073/pnas.86.20.7823; KAPPL R, 1985, BIOCHIM BIOPHYS ACTA, V827, P327, DOI 10.1016/0167-4838(85)90218-3; KOBAYASHI K, 1981, J BIOL CHEM, V256, P2350; Loew G, 1996, J AM CHEM SOC, V118, P10584, DOI 10.1021/ja961723e; MAGONOV S N, 1978, Molekulyarnaya Biologiya (Moscow), V12, P1182; MAGONOV S N, 1978, Molekulyarnaya Biologiya (Moscow), V12, P947; MAGONOV S N, 1978, Molekulyarnaya Biologiya (Moscow), V12, P1191; MARTINIS SA, 1989, J AM CHEM SOC, V111, P9252, DOI 10.1021/ja00208a031; Mueller Ernest J., 1995, P83; Nicholls P, 2001, ADV INORG CHEM, V51, P51; POULOS TL, 1980, J BIOL CHEM, V255, P8199; Primus JL, 2002, J AM CHEM SOC, V124, P1214, DOI 10.1021/ja016907u; Rodriguez-Lopez JN, 2001, J AM CHEM SOC, V123, P11838, DOI 10.1021/ja011853+; RodriguezLopez JN, 1997, J BIOL CHEM, V272, P389; RodriguezLopez JN, 1996, J BIOL CHEM, V271, P4023; Schlichting I, 2000, SCIENCE, V287, P1615, DOI 10.1126/science.287.5458.1615; Sjogren T, 2001, J BIOL CHEM, V276, P13072, DOI 10.1074/jbc.M011312200; Sono M, 1996, CHEM REV, V96, P2841, DOI 10.1021/cr9500500; SYMONS MCR, 1978, PROC R SOC SER B-BIO, V201, P285, DOI 10.1098/rspb.1978.0046; SYMONS MCR, 1978, BIOCHIM BIOPHYS ACTA, V535, P241, DOI 10.1016/0005-2795(78)90090-9; TAJIMA K, 1989, INORG CHIM ACTA, V163, P115, DOI 10.1016/S0020-1693(00)87150-9; Tanaka M, 1998, BIOCHEMISTRY-US, V37, P2629, DOI 10.1021/bi9725273; Tanaka M, 1997, BIOCHEMISTRY-US, V36, P9889, DOI 10.1021/bi970906q; Tsaprailis G., 1995, ADV INORG CHEM, V43, P79; Veeger C, 2002, J INORG BIOCHEM, V91, P35, DOI 10.1016/S0162-0134(02)00393-8; Veitch NC, 2001, ADV INORG CHEM, V51, P107; Vidakovic M, 1998, BIOCHEMISTRY-US, V37, P9211, DOI 10.1021/bi980189f; WATANABE Y, 1992, ENZYMES, V20, P405; Wirstam M, 1999, J AM CHEM SOC, V121, P10178, DOI 10.1021/ja991997c; Woods R.J., 1994, APPL RAD CHEM RAD PR; Woon DE, 1998, J PHYS CHEM A, V102, P10380, DOI 10.1021/jp9829896; Yeh HC, 2001, J BIOL INORG CHEM, V6, P770, DOI 10.1007/s007750100253	55	62	63	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					42706	42710		10.1074/jbc.M207949200	http://dx.doi.org/10.1074/jbc.M207949200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12215454	hybrid			2022-12-27	WOS:000179081200037
J	Goldschmidt, V; Rigourd, M; Ehresmann, C; Le Grice, SFJ; Ehresmann, B; Marquet, R				Goldschmidt, V; Rigourd, M; Ehresmann, C; Le Grice, SFJ; Ehresmann, B; Marquet, R			Direct and indirect contributions of RNA secondary structure elements to the initiation of HIV-1 reverse transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PRIMER-BINDING-SITE; DEPENDENT DNA-POLYMERASE; YEAST TY1 RETROTRANSPOSON; EFFICIENT INITIATION; TYPE-1 RNA; ANTISENSE OLIGONUCLEOTIDES; MUTATIONAL ANALYSIS; GENETIC-ANALYSIS; TEMPLATE-PRIMER	Initiation of human immunodeficiency virus type 1 (HIV-1) reverse transcription requires specific recognition between the viral RNA (vRNA), tRNA(3)(Lys), which acts as primer, and reverse transcriptase (RT). The specificity of this ternary complex is mediated by intricate interactions between the HIV-1 RNA and tRNA(3)(Lys). Here, we compared the relative importance of the secondary structure elements of this complex in the initiation process. To this aim, we used the previously published three-dimensional model of the initiation complex to rationally introduce a series of deletions and substitutions in the vRNA. When necessary, we used chemical probing to check the structure of the tRNA(3)(Lys)-mutant vRNA complexes. For each of them, we measured the binding affinity of RT and the kinetics of initial extension of tRNA(3)(Lys) and of synthesis of the (-) strand strong stop DNA. Our results were overall in keeping with the three-dimensional model of the initiation complex. Surprisingly, we found that disruption of the intermolecular template-primer interactions, which are not directly recognized by RT, more severely affected reverse transcription than deletions or disruption of one of the intramolecular helices to which RT directly binds. Perturbations of the highly constrained junction between the intermolecular helix formed by the primer binding site and the 3' end of tRNA(3)(Lys) and the helix immediately upstream also had dramatic effects on the initiation of reverse transcription. Taken together, our results demonstrate the overwhelming importance of the overall three-dimensional structure of the initiation complex and identify structural elements that constitute promising targets for anti-initiation-specific drugs.	Univ Strasbourg 1, Inst Biol Mol & Cellulaire, CNRS, UPR 9002, F-67084 Strasbourg, France; NCI, Resistance Mech Lab, NIH, Frederick, MD 21702 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Marquet, R (corresponding author), Univ Strasbourg 1, Inst Biol Mol & Cellulaire, CNRS, UPR 9002, 15 Rue Rene Descartes, F-67084 Strasbourg, France.			Marquet, Roland/0000-0002-4209-3976				AIYAR A, 1994, J VIROL, V68, P611, DOI 10.1128/JVI.68.2.611-618.1994; AIYAR A, 1992, J VIROL, V66, P2464, DOI 10.1128/JVI.66.4.2464-2472.1992; Arts EJ, 1998, PROG NUCLEIC ACID RE, V58, P339; Arts EJ, 1996, J BIOL CHEM, V271, P9054, DOI 10.1074/jbc.271.15.9054; Arts EJ, 1996, P NATL ACAD SCI USA, V93, P10063, DOI 10.1073/pnas.93.19.10063; BALTIMORE D, 1970, NATURE, V226, P1209, DOI 10.1038/2261209a0; BAUDIN F, 1993, J MOL BIOL, V229, P382, DOI 10.1006/jmbi.1993.1041; BEARD WA, 1993, BIOCHEMISTRY-US, V32, P9745, DOI 10.1021/bi00088a029; Beerens N, 2001, J BIOL CHEM, V276, P31247, DOI 10.1074/jbc.M102441200; Beerens N, 2000, J VIROL, V74, P2227, DOI 10.1128/JVI.74.5.2227-2238.2000; Benas P, 2000, RNA, V6, P1347, DOI 10.1017/S1355838200000911; Berkhout B, 1996, PROG NUCLEIC ACID RE, V54, P1, DOI 10.1016/S0079-6603(08)60359-1; BORDIER B, 1995, P NATL ACAD SCI USA, V92, P9383, DOI 10.1073/pnas.92.20.9383; Boulme F, 2000, EUR J BIOCHEM, V267, P2803, DOI 10.1046/j.1432-1327.2000.01310.x; Brule F, 2002, RNA, V8, P8, DOI 10.1017/S1355838202010981; COBRINIK D, 1988, J VIROL, V62, P3622, DOI 10.1128/JVI.62.10.3622-3630.1988; COBRINIK D, 1991, J VIROL, V65, P3864, DOI 10.1128/JVI.65.7.3864-3872.1991; DESTEFANO JJ, 1993, BIOCHEMISTRY-US, V32, P6908, DOI 10.1021/bi00078a014; EHRESMANN C, 1987, NUCLEIC ACIDS RES, V15, P9109, DOI 10.1093/nar/15.22.9109; Essink BBO, 1996, J MOL BIOL, V264, P243, DOI 10.1006/jmbi.1996.0638; Freund F, 2001, NUCLEIC ACIDS RES, V29, P2757, DOI 10.1093/nar/29.13.2757; Friant S, 1998, MOL CELL BIOL, V18, P799, DOI 10.1128/MCB.18.2.799; Friant S, 1996, NUCLEIC ACIDS RES, V24, P441, DOI 10.1093/nar/24.3.441; Friant S, 1997, YEAST, V13, P639, DOI 10.1002/(SICI)1097-0061(19970615)13:7<639::AID-YEA143>3.0.CO;2-Y; Gabus C, 1998, EMBO J, V17, P4873, DOI 10.1093/emboj/17.16.4873; Gotte M, 1999, ARCH BIOCHEM BIOPHYS, V365, P199, DOI 10.1006/abbi.1999.1209; Harrich D, 1997, EMBO J, V16, P1224, DOI 10.1093/emboj/16.6.1224; Harrich D, 2000, J VIROL, V74, P5639, DOI 10.1128/JVI.74.12.5639-5646.2000; HSIEH JC, 1993, J BIOL CHEM, V268, P24607; Huang Y, 1996, J VIROL, V70, P4700, DOI 10.1128/JVI.70.7.4700-4706.1996; Huthoff H, 2001, RNA, V7, P143, DOI 10.1017/S1355838201001881; Isel C, 1998, NUCLEIC ACIDS RES, V26, P1198, DOI 10.1093/nar/26.5.1198; ISEL C, 1993, J BIOL CHEM, V268, P25269; Isel C, 1999, EMBO J, V18, P1038, DOI 10.1093/emboj/18.4.1038; ISEL C, 1995, J MOL BIOL, V247, P236, DOI 10.1006/jmbi.1994.0136; Isel C, 1996, EMBO J, V15, P917, DOI 10.1002/j.1460-2075.1996.tb00426.x; JAJU M, 1995, J BIOL CHEM, V270, P9740, DOI 10.1074/jbc.270.17.9740; Kang SM, 1999, J VIROL, V73, P1818, DOI 10.1128/JVI.73.3.1818-1827.1999; Kang SM, 1999, VIROLOGY, V257, P95, DOI 10.1006/viro.1999.9615; Kang SM, 1997, J VIROL, V71, P207, DOI 10.1128/JVI.71.1.207-217.1997; Kaushik N, 2001, NUCLEIC ACIDS RES, V29, P5099, DOI 10.1093/nar/29.24.5099; Lanchy JM, 1998, J BIOL CHEM, V273, P24425, DOI 10.1074/jbc.273.38.24425; Lanchy JM, 2000, J BIOL CHEM, V275, P12306, DOI 10.1074/jbc.275.16.12306; Lanchy JM, 1996, EMBO J, V15, P7178, DOI 10.1002/j.1460-2075.1996.tb01109.x; LeGrice SFJ, 1995, METHOD ENZYMOL, V262, P130, DOI 10.1016/0076-6879(95)62015-X; Li Y, 1997, J VIROL, V71, P6315, DOI 10.1128/JVI.71.9.6315-6322.1997; Liang C, 1997, J VIROL, V71, P5750, DOI 10.1128/JVI.71.8.5750-5757.1997; Mak J, 1997, J VIROL, V71, P8087, DOI 10.1128/JVI.71.11.8087-8095.1997; MARQUET R, 1995, BIOCHIMIE, V77, P113, DOI 10.1016/0300-9084(96)88114-4; MARQUET R, 1991, NUCLEIC ACIDS RES, V19, P2349, DOI 10.1093/nar/19.9.2349; Miller JT, 2001, J BIOL CHEM, V276, P27721, DOI 10.1074/jbc.M100513200; PAILLART JC, 1994, J BIOL CHEM, V269, P27486; Rong LW, 2001, J BIOL CHEM, V276, P47725, DOI 10.1074/jbc.M105124200; Skripkin E, 1996, NUCLEIC ACIDS RES, V24, P509, DOI 10.1093/nar/24.3.509; Suo ZC, 1997, BIOCHEMISTRY-US, V36, P12459, DOI 10.1021/bi971217h; TEMIN HM, 1970, NATURE, V226, P1211, DOI 10.1038/2261211a0; Thrall SH, 1998, BIOCHEMISTRY-US, V37, P13349; Vaccaro JA, 1999, BIOCHEMISTRY-US, V38, P15978, DOI 10.1021/bi990945x; Wakefield JK, 1996, J VIROL, V70, P966, DOI 10.1128/JVI.70.2.966-975.1996; Wei X, 2000, NUCLEIC ACIDS RES, V28, P3065, DOI 10.1093/nar/28.16.3065; WILHELM M, 1994, NUCLEIC ACIDS RES, V22, P4560, DOI 10.1093/nar/22.22.4560; Zhang ZJ, 1998, J VIROL, V72, P5464, DOI 10.1128/JVI.72.7.5464-5471.1998; Zhang ZJ, 1998, AIDS RES HUM RETROV, V14, P979, DOI 10.1089/aid.1998.14.979; Zhang ZJ, 1998, RNA, V4, P394; Zhang ZJ, 1996, VIROLOGY, V226, P306, DOI 10.1006/viro.1996.0658	65	31	31	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					43233	43242		10.1074/jbc.M205295200	http://dx.doi.org/10.1074/jbc.M205295200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12194974	hybrid			2022-12-27	WOS:000179081200105
J	Narendra, U; Zhu, LY; Li, BR; Wilken, J; Weiss, MA				Narendra, U; Zhu, LY; Li, BR; Wilken, J; Weiss, MA			Sex-specific gene regulation - The doublesex DM motif is a bipartite DNA-binding domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YOLK-PROTEIN GENES; DROSOPHILA-MELANOGASTER; CAENORHABDITIS-ELEGANS; TRANSCRIPTION FACTOR; CRYSTAL-STRUCTURE; TESTIS DIFFERENTIATION; DOSAGE COMPENSATION; GONADAL-DYSGENESIS; MOLECULAR ANALYSIS; DETERMINING REGION	Sex-specific gene expression in Drosophila melanogaster is regulated in part by the Doublesex (DSX) transcription factor. Male- and female-specific splicing isoforms share a novel DNA-binding domain, designated the DM motif. This domain is conserved among a newly recognized family of vertebrate transcription factors involved in developmental patterning and sex determination. The DM motif consists of an N-terminal zinc module and a disordered C-terminal tail, hypothesized to fold on specific DNA binding as a recognition alpha-helix. Truncation of the tail does not perturb the structure of the zinc module but impairs DNA binding and DNA-dependent dimerization. Chemical protein synthesis and alanine scanning mutagenesis are employed to test the contributions of 13 side chains to specific DNA binding. Selected arginine or lysine residues in the zinc module were substituted by norleucine, an isostere that maintains the aliphatic portion of the side chain but lacks a positive charge. Arginine or glutamine residues in the tail were substituted by alanine. Evidence is obtained that both the zinc module and C-terminal tail contribute to a bipartite DNA-binding surface. Conserved arginine and glutamine residues in the tail are required for high affinity DNA recognition, consistent with its proposed role as a nascent recognition alpha-helix.	Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA	Case Western Reserve University	Weiss, MA (corresponding author), Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA.	weiss@biochemistry.cwru.edu		Li, Biaoru/0000-0002-5626-9557				Allain FHT, 1999, EMBO J, V18, P2563, DOI 10.1093/emboj/18.9.2563; AN WQ, 1995, EMBO J, V14, P1221, DOI 10.1002/j.1460-2075.1995.tb07105.x; An WQ, 1996, MOL CELL BIOL, V16, P3106; AN WQ, 1995, GENE DEV, V9, P256, DOI 10.1101/gad.9.2.256; BAKER BS, 1988, GENE DEV, V2, P477, DOI 10.1101/gad.2.4.477; BENNETT CP, 1993, J MED GENET, V30, P518, DOI 10.1136/jmg.30.6.518; BERTA P, 1990, NATURE, V348, P448, DOI 10.1038/348448A0; Bewley CA, 1998, ANNU REV BIOPH BIOM, V27, P105, DOI 10.1146/annurev.biophys.27.1.105; BOWNES M, 1983, J EMBRYOL EXP MORPH, V75, P241; BURTIS KC, 1991, EMBO J, V10, P2577, DOI 10.1002/j.1460-2075.1991.tb07798.x; BURTIS KC, 1989, CELL, V56, P997, DOI 10.1016/0092-8674(89)90633-8; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; CANTOR CR, 1980, BIOPHYSICAL CHEM, V3, P847; Cho S, 1997, J BIOL CHEM, V272, P3185, DOI 10.1074/jbc.272.6.3185; Cho S, 1998, BIOCHEMISTRY-US, V37, P11301, DOI 10.1021/bi972916x; Cline TW, 1996, ANNU REV GENET, V30, P637, DOI 10.1146/annurev.genet.30.1.637; COSCHIGANO KT, 1993, GENE DEV, V7, P42, DOI 10.1101/gad.7.1.42; CROCKER M, 1988, CLIN GENET, V34, P70; Dawes HE, 1999, SCIENCE, V284, P1800, DOI 10.1126/science.284.5421.1800; DAWSON PE, 1994, SCIENCE, V266, P776, DOI 10.1126/science.7973629; ELLENBERGER TE, 1992, CELL, V71, P1223, DOI 10.1016/S0092-8674(05)80070-4; Erdman SE, 1996, GENETICS, V144, P1639; ERDMAN SE, 1993, EMBO J, V12, P527, DOI 10.1002/j.1460-2075.1993.tb05684.x; FERREDAMARE AR, 1994, EMBO J, V13, P180, DOI 10.1002/j.1460-2075.1994.tb06247.x; FISHER DE, 1993, CELL, V72, P467, DOI 10.1016/0092-8674(93)90122-7; Flejter WL, 1998, AM J HUM GENET, V63, P794, DOI 10.1086/302016; FRYNS JP, 1986, ANN GENET-PARIS, V29, P49; GIESE K, 1992, CELL, V69, P185, DOI 10.1016/0092-8674(92)90129-Z; GLOVER JNM, 1995, NATURE, V373, P257, DOI 10.1038/373257a0; GUBBAY J, 1990, NATURE, V346, P245, DOI 10.1038/346245a0; Guioli S, 1998, AM J HUM GENET, V63, P905, DOI 10.1086/302017; HARRISON SC, 1990, ANNU REV BIOCHEM, V59, P933, DOI 10.1146/annurev.bi.59.070190.004441; HILDRETH PE, 1965, GENETICS, V51, P659; HINCK AP, 1993, PROTEIN ENG, V6, P221, DOI 10.1093/protein/6.2.221; HOCHSCHILD A, 1988, NATURE, V336, P353, DOI 10.1038/336353a0; HODGKIN J, 1983, GENETICS, V103, P43; HODGKIN J, 1987, ANNU REV GENET, V21, P133, DOI 10.1146/annurev.ge.21.120187.001025; KING CY, 1993, P NATL ACAD SCI USA, V90, P11990, DOI 10.1073/pnas.90.24.11990; KLUG A, 1995, FASEB J, V9, P597, DOI 10.1096/fasebj.9.8.7768350; KOLDIN B, 1995, NUCLEIC ACIDS RES, V23, P4162, DOI 10.1093/nar/23.20.4162; KOOPMAN P, 1991, NATURE, V351, P117, DOI 10.1038/351117a0; KOOPMAN P, 1990, NATURE, V348, P450, DOI 10.1038/348450a0; Kristensen C, 1997, J BIOL CHEM, V272, P12978, DOI 10.1074/jbc.272.20.12978; Li H, 1998, DEVELOPMENT, V125, P2641; LOVE JJ, 1995, NATURE, V376, P791, DOI 10.1038/376791a0; Magenis RE, 1990, AM J HUM GENET S, V47, pA33; Marin I, 1998, SCIENCE, V281, P1990, DOI 10.1126/science.281.5385.1990; McDonald MT, 1997, AM J MED GENET, V73, P321; Meng AM, 1999, DEVELOPMENT, V126, P1259; Muller CW, 1997, NATURE, V389, P884, DOI 10.1038/39929; Murphy FV, 2000, STRUCT FOLD DES, V8, pR83, DOI 10.1016/S0969-2126(00)00126-X; NAGOSHI RN, 1988, CELL, V53, P229, DOI 10.1016/0092-8674(88)90384-4; ONEIL KT, 1990, SCIENCE, V250, P646, DOI 10.1126/science.2237415; PABO CO, 1979, P NATL ACAD SCI USA, V76, P1608, DOI 10.1073/pnas.76.4.1608; PABO CO, 1992, ANNU REV BIOCHEM, V61, P1053, DOI 10.1146/annurev.bi.61.070192.005201; PU WT, 1991, MOL CELL BIOL, V11, P4918, DOI 10.1128/MCB.11.10.4918; Raymond CS, 2000, GENE DEV, V14, P2587, DOI 10.1101/gad.834100; Raymond CS, 1999, DEV BIOL, V215, P208, DOI 10.1006/dbio.1999.9461; Raymond CS, 1999, HUM MOL GENET, V8, P989, DOI 10.1093/hmg/8.6.989; Raymond CS, 1998, NATURE, V391, P691, DOI 10.1038/35618; SEEMAN NC, 1976, P NATL ACAD SCI USA, V73, P804, DOI 10.1073/pnas.73.3.804; SENEAR DF, 1991, J BIOL CHEM, V266, P13661; SHEN MM, 1988, CELL, V54, P1019, DOI 10.1016/0092-8674(88)90117-1; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; Skolnick J, 2000, NAT BIOTECHNOL, V18, P283, DOI 10.1038/73723; VANHOUTE L, 1993, J BIOL CHEM, V268, P18083; Veitia RA, 1998, AM J HUM GENET, V63, P901, DOI 10.1086/302023; Villeneuve A.M., 1990, Advances in Genetics, V27, P117; WEISS MA, 1990, NATURE, V347, P575, DOI 10.1038/347575a0; WERNER MH, 1995, CELL, V81, P705, DOI 10.1016/0092-8674(95)90532-4; WYMAN J, 1964, ADVANCES PROTEIN CHE, V19, P224; Xu B, 2002, J MOL BIOL, V316, P435, DOI 10.1006/jmbi.2001.5377; Xu B, 2002, PROTEIN SCI, V11, P104, DOI 10.1110/ps.ps.32102; YANG W, 1995, CELL, V82, P193, DOI 10.1016/0092-8674(95)90307-0; Yi WS, 1999, DEVELOPMENT, V126, P873; Zarkower D, 2001, NAT REV GENET, V2, P175, DOI 10.1038/35056032; Zhu LY, 2000, GENE DEV, V14, P1750	77	23	32	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					43463	43473		10.1074/jbc.M204616200	http://dx.doi.org/10.1074/jbc.M204616200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12198117	hybrid			2022-12-27	WOS:000179081200131
J	Riobo, NA; Melani, M; Sanjuan, N; Fiszman, ML; Gravielle, MC; Carreras, MC; Cadenas, E; Poderoso, JJ				Riobo, NA; Melani, M; Sanjuan, N; Fiszman, ML; Gravielle, MC; Carreras, MC; Cadenas, E; Poderoso, JJ			The modulation of mitochondrial nitric-oxide synthase activity in rat brain development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUPEROXIDE-DISMUTASE; HEART-MITOCHONDRIA; RADICAL PRODUCTION; OXYGEN; GLUTAMATE; NEURONS; DEPOLARIZATION; PEROXYNITRITE; ACTIVATION; APOPTOSIS	Different mitochondrial nitric-oxide synthase (mtNOS) isoforms have been described in rat and mouse tissues, such as liver, thymus, skeletal muscle, and more recently, heart and brain. The modulation of these variants by thyroid status, hypoxia, or gene deficiency opens a broad spectrum of mtNOS-dependent tissue-specific functions. In this study, a new NOS variant is described in rat brain with an M-r of 144 kDa and mainly localized in the inner mitochondrial membrane. During rat brain maturation, the expression and activity of mtNOS were maximal at the late embryonic stages and early postnatal days followed by a decreased expression in the adult stage (100 +/- 9 versus 19 +/- 2 pmol of [H-3]citrulline/min/mg of protein, respectively). This temporal pattern was opposite to that of the cytosolic 157 kDa nNOS protein. Mitochondrial redox changes followed the variations in mtNOS activity: mtNOS-dependent production of hydrogen peroxide was maximal in newborns and decreased markedly in the adult stage, thus reflecting the production and utilization of mitochondrial matrix nitric oxide. Moreover, the activity of brain Mn-superoxide dismutase followed a developmental pattern similar to that of mtNOS. Cerebellar granular cells isolated from newborn rats and with high mtNOS activity exhibited maximal proliferation rates, which were decreased by modifying the levels of either hydrogen peroxide or nitric oxide. Altogether, these findings support the notion that a coordinated modulation of mtNOS and Mn-superoxide dismutase contributes to establish the rat brain redox status and participate in the normal physiology of brain development.	Univ Hosp Buenos Aires, Lab Oxygen Metab, RA-1120 Buenos Aires, DF, Argentina; Univ Buenos Aires, Sch Med, Dept Microbiol, Lab Expt Pathol, RA-1121 Buenos Aires, DF, Argentina; Consejo Nacl Invest Cient & Tecn, Inst Invest Farmacol, RA-1113 Buenos Aires, DF, Argentina; Univ So Calif, Sch Pharm, Dept Mol Pharmacol & Toxicol, Los Angeles, CA 90089 USA	University of Buenos Aires; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Southern California	Poderoso, JJ (corresponding author), Univ Hosp Buenos Aires, Lab Oxygen Metab, Av Cordoba 2351, RA-1120 Buenos Aires, DF, Argentina.	jpoderos@fmed.uba.ar	Galdo, Natalia Riobo-Del/AAP-2938-2020; Melani, Mariana/GLR-0418-2022	Galdo, Natalia Riobo-Del/0000-0002-8942-7873; Melani, Mariana/0000-0002-9491-932X; Gravielle, Maria/0000-0003-4353-5526	NATIONAL INSTITUTE ON AGING [R01AG016718] Funding Source: NIH RePORTER; NIA NIH HHS [1 R01 AG 16718] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Almeida A, 1999, BRAIN RES, V816, P580, DOI 10.1016/S0006-8993(98)01240-2; Bates TE, 1996, BIOCHEM BIOPH RES CO, V218, P40, DOI 10.1006/bbrc.1996.0008; Borodinsky LN, 1998, DEV BRAIN RES, V107, P43, DOI 10.1016/S0165-3806(97)00217-4; BOVERIS A, 2000, NITRIC OXIDE BIOL PA, P355; BOVERIS A, 1997, OXYGEN GENE EXPRESSI, P3; Bringold U, 2000, FREE RADICAL BIO MED, V29, P343, DOI 10.1016/S0891-5849(00)00318-X; BROWN GC, 1994, FEBS LETT, V356, P295, DOI 10.1016/0014-5793(94)01290-3; Bustamante J, 2002, NITRIC OXIDE-BIOL CH, V6, P333, DOI 10.1006/niox.2001.0420; Carreras MC, 2001, AM J PHYSIOL-HEART C, V281, pH2282, DOI 10.1152/ajpheart.2001.281.6.H2282; Casanovas O, 2000, J BIOL CHEM, V275, P35091, DOI 10.1074/jbc.M006324200; Chen QM, 1998, BIOCHEM J, V332, P43, DOI 10.1042/bj3320043; Ciriolo MR, 2000, J BIOL CHEM, V275, P5065, DOI 10.1074/jbc.275.7.5065; Crossthwaite AJ, 2002, J NEUROCHEM, V80, P24, DOI 10.1046/j.0022-3042.2001.00637.x; Eliasson MJL, 1997, P NATL ACAD SCI USA, V94, P3396, DOI 10.1073/pnas.94.7.3396; French S, 2001, AM J PHYSIOL-HEART C, V280, pH2863, DOI 10.1152/ajpheart.2001.280.6.H2863; Ghafourifar P, 2001, BIOL SIGNAL RECEPT, V10, P57; Giulivi C, 1998, J BIOL CHEM, V273, P11038, DOI 10.1074/jbc.273.18.11038; Inglis FM, 1998, J NEUROSCI, V18, P10493; Ishikawa Y, 1999, BRAIN RES, V824, P71, DOI 10.1016/S0006-8993(99)01108-7; Kanai AJ, 2001, P NATL ACAD SCI USA, V98, P14126, DOI 10.1073/pnas.241380298; Kissner R, 1997, CHEM RES TOXICOL, V10, P1285, DOI 10.1021/tx970160x; Knowles RG, 1998, METH MOL B, V100, P67; Kurata S, 2000, J BIOL CHEM, V275, P23413, DOI 10.1074/jbc.C000308200; LANG JK, 1986, ANAL BIOCHEM, V157, P106, DOI 10.1016/0003-2697(86)90203-4; LICHTMAN JW, 1999, FUNDAMENTAL NEUROSCI, P547; Lopez MF, 2000, ELECTROPHORESIS, V21, P3427, DOI 10.1002/1522-2683(20001001)21:16<3427::AID-ELPS3427>3.0.CO;2-L; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; OGILVIE P, 1995, FASEB J, V9, P799, DOI 10.1096/fasebj.9.9.7541381; Poderoso JJ, 1996, ARCH BIOCHEM BIOPHYS, V328, P85, DOI 10.1006/abbi.1996.0146; Poderoso JJ, 1999, J BIOL CHEM, V274, P37709, DOI 10.1074/jbc.274.53.37709; Riobo NA, 2001, BIOCHEM J, V359, P139, DOI 10.1042/0264-6021:3590139; Sarkela TM, 2001, J BIOL CHEM, V276, P6945, DOI 10.1074/jbc.M007625200; Saur D, 2000, GASTROENTEROLOGY, V118, P849, DOI 10.1016/S0016-5085(00)70171-5; Stamler JS, 2001, PHYSIOL REV, V81, P209, DOI 10.1152/physrev.2001.81.1.209; Tatoyan A, 1998, J BIOL CHEM, V273, P11044, DOI 10.1074/jbc.273.18.11044; TYLER DD, 1975, BIOCHEM J, V147, P493, DOI 10.1042/bj1470493; Wharton DC., 1967, METHOD ENZYMOL, P245; White RJ, 1996, J NEUROSCI, V16, P5688; Yermolaieva O, 2000, P NATL ACAD SCI USA, V97, P448, DOI 10.1073/pnas.97.1.448	39	84	90	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					42447	42455		10.1074/jbc.M204580200	http://dx.doi.org/10.1074/jbc.M204580200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12202479	hybrid			2022-12-27	WOS:000179081200005
J	Szeltner, Z; Rea, D; Renner, V; Fulop, V; Polgar, L				Szeltner, Z; Rea, D; Renner, V; Fulop, V; Polgar, L			Electrostatic effects and binding determinants in the catalysis of prolyl oligopeptidase - Site-specific mutagenesis at the oxyanion binding site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPEPTIDASE INHIBITORS; SERINE; ENZYME; IDENTIFICATION; PEPTIDASES; SUBSTRATE; MECHANISM; PROTEIN; THIONO; MAPS	Prolyl oligopeptidase, a member of a new family of serine peptidases, plays an important role in memory disorders. Earlier x-ray crystallographic investigations indicated that stabilization of the tetrahedral transition state of the reaction involved hydrogen bond formation between the oxyanion of the tetrahedral intermediate and the OH group of Tyr(473). The contribution of the OH group was tested with the Y473F variant using various substrates. The charged suceinyl-Gly-Pro-4-nitroanilide was hydrolyzed with a much lower k(cat)/K-m compared with the neutral benzyloxycarbonyl-Gly-Pro-2-naphthylamide, although the binding modes of the two substrates were similar, as shown by x-ray crystallography. This suggested that electrostatic interactions between Arg(643) and the succinyl group competed with the productive binding mechanism. Unlike most enzyme reactions, catalysis by the wild-type enzyme exhibited positive activation entropy. In contrast, the activation entropy for the Y473F variant was negative, suggesting that the tyrosine OH group is involved in stabilizing both the transition state and the water shell at the active site. Importantly, Tyr(473) is also implicated in the formation of the enzyme-substrate complex. The nonlinear Arrhenius plot suggested a greater significance of the oxyanion binding site at physiological temperature. The results indicated that Tyr(473) was more needed at high pH, at high temperature, and with charged substrates exhibiting "internally competitive inhibition."	Hungarian Acad Sci, Biol Res Ctr, Inst Enzymol, H-1518 Budapest, Hungary; Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England	Hungarian Academy of Sciences; Hungarian Biological Research Center; Hungarian Research Centre for Natural Sciences; University of Warwick	Polgar, L (corresponding author), Hungarian Acad Sci, Biol Res Ctr, Inst Enzymol, POB 7,112, H-1518 Budapest, Hungary.	polgar@enzim.hu	Fulop, Vilmos/AAZ-7720-2021					ASBOTH B, 1983, BIOCHEMISTRY-US, V22, P117, DOI 10.1021/bi00270a017; ATACK JR, 1991, EUR J PHARMACOL, V205, P157, DOI 10.1016/0014-2999(91)90814-7; Ayala YM, 2000, PROTEIN SCI, V9, P1589, DOI 10.1110/ps.9.8.1589; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; BRUNGER AT, 1992, X PLOR VERSION 3 1; Cacabelos R, 2000, DRUG TODAY, V36, P415; Cleland W W, 1977, Adv Enzymol Relat Areas Mol Biol, V45, P273; Cunningham DF, 1997, BBA-PROTEIN STRUCT M, V1343, P160, DOI 10.1016/S0167-4838(97)00134-9; ERLANGER BF, 1961, ARCH BIOCHEM BIOPHYS, V95, P271, DOI 10.1016/0003-9861(61)90145-X; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; Fulop V, 2001, J BIOL CHEM, V276, P1262, DOI 10.1074/jbc.M007003200; Fulop V, 1998, CELL, V94, P161, DOI 10.1016/S0092-8674(00)81416-6; GLASOE PK, 1960, J PHYS CHEM-US, V64, P188, DOI 10.1021/j100830a521; GOOSSENS F, 1995, EUR J BIOCHEM, V233, P432, DOI 10.1111/j.1432-1033.1995.432_2.x; HAMILTON WC, 1968, HYDROGEN BOND SOLIDS; ISHIURA S, 1990, FEBS LETT, V260, P131, DOI 10.1016/0014-5793(90)80084-V; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KRANLIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946; LEATHERBARROW RJ, 1990, GRAFIT VERSION 2; MAES M, 1994, BIOL PSYCHIAT, V35, P545, DOI 10.1016/0006-3223(94)90101-5; MIURA N, 1995, NEUROSCI LETT, V196, P128, DOI 10.1016/0304-3940(95)11821-D; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Polg?r L., 1987, NEW COMPREHENSIVE BI, V16, P159; POLGAR L, 1993, FEBS LETT, V322, P227, DOI 10.1016/0014-5793(93)81575-K; POLGAR L, 1995, BIOCHEM J, V312, P267, DOI 10.1042/bj3120267; POLGAR L, 1992, FEBS LETT, V311, P281, DOI 10.1016/0014-5793(92)81120-B; POLGAR L, 1992, BIOCHEM J, V283, P647, DOI 10.1042/bj2830647; POLGAR L, 1991, EUR J BIOCHEM, V197, P441, DOI 10.1111/j.1432-1033.1991.tb15930.x; POLGAR L, 1994, METHOD ENZYMOL, V244, P188; POLGAR L, 1989, MECHANISMS PROTEASE, P87; Portevin B, 1996, J MED CHEM, V39, P2379, DOI 10.1021/jm950858c; RAWLINGS ND, 1991, BIOCHEM J, V279, P907, DOI 10.1042/bj2790907; RAWLINGS ND, 1994, METHOD ENZYMOL, V244, P19; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; RENNEX D, 1991, BIOCHEMISTRY-US, V30, P2195, DOI 10.1021/bi00222a025; Shinoda M, 1997, BIOCHEM BIOPH RES CO, V235, P641, DOI 10.1006/bbrc.1997.6730; STONE SR, 1991, BIOCHEM J, V276, P837, DOI 10.1042/bj2760837; Szeltner Z, 2000, J BIOL CHEM, V275, P15000, DOI 10.1074/jbc.M000942200; Szeltner Z, 2000, PROTEIN SCI, V9, P353; Vindigni A, 1996, BIOCHEMISTRY-US, V35, P4417, DOI 10.1021/bi952834d; WALTER R, 1980, MOL CELL BIOCHEM, V30, P111; WILK S, 1983, LIFE SCI, V33, P2149, DOI 10.1016/0024-3205(83)90285-0; Williams RSB, 1999, EMBO J, V18, P2734, DOI 10.1093/emboj/18.10.2734; Williams RSB, 2002, NATURE, V417, P292, DOI 10.1038/417292a; YOSHIMOTO T, 1987, J PHARMACOBIO-DYNAM, V10, P730, DOI 10.1248/bpb1978.10.730	45	35	35	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					42613	42622		10.1074/jbc.M208043200	http://dx.doi.org/10.1074/jbc.M208043200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12202494	hybrid			2022-12-27	WOS:000179081200025
J	Vales, LD; Friedl, EM				Vales, LD; Friedl, EM			Binding of C/EBP and RBP (CBF1) to overlapping sites regulates interleukin-6 gene expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; BARR-VIRUS EBNA2; TRANSCRIPTION FACTOR; IN-VITRO; PROMOTER; BETA; ACTIVATION; NOTCH; RECEPTOR; NF-IL6	The ILRE (interleukin response element) contained within the promoter of the interleukin-6 (IL-6) gene is defined as the site recognized by the p65 NF-kappaB transcriptional activator and is crucial for activation of the IL-6 gene. The region of the promoter containing the ILRE is complex containing a CCAAT enhancer-binding protein (C/EBP) site immediately upstream of the ILRE, which is required for optimal activation of the IL-6 gene. Additionally, the ILRE overlaps a site that is recognized by the mammalian transcriptional repressor RBP (CBF-1), and RBP binding within the ILRE region represses activated IL-6 expression. In this study, the complexity of this region is further revealed by the identification of a second nested C/EBP site, which overlaps that of RBP and therefore also the ILRE. Optimal activation requires both the upstream and newly identified C/EBP sites in conjunction with the p65 NF-kappaB binding site. We previously reported that RBP represses IL-6 activation but does not target p65. We extend these analyses here to show that RBP binding does not occlude p65 from binding but instead directly overlaps the newly identified downstream C/EBP site, thereby impeding p65-C/ EBP-mediated co-activation. This result suggests a role for RBP in the repression of other genes containing a C/EBP site that exhibits sequence overlap with the RBP site.	Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Vales, LD (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, 675 Hoes Ln, Piscataway, NJ 08854 USA.			vales, lynne/0000-0003-0117-3440	NIGMS NIH HHS [GM59473] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059473] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akira S, 1997, ADV IMMUNOL, V65, P1, DOI 10.1016/S0065-2776(08)60740-3; Baer M, 2000, J BIOL CHEM, V275, P26582, DOI 10.1074/jbc.M004268200; Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; BAILEY AM, 1995, GENE DEV, V9, P2609, DOI 10.1101/gad.9.21.2609; Calkhoven CF, 2000, GENE DEV, V14, P1920; DOU SB, 1994, MOL CELL BIOL, V14, P3310, DOI 10.1128/MCB.14.5.3310; Elberg G, 2000, J BIOL CHEM, V275, P27815; FORTINI ME, 1994, CELL, V79, P273, DOI 10.1016/0092-8674(94)90196-1; FUJITA T, 1992, GENE DEV, V6, P775, DOI 10.1101/gad.6.5.775; Honjo T, 1996, GENES CELLS, V1, P1, DOI 10.1046/j.1365-2443.1996.10010.x; HSIEH JJD, 1995, SCIENCE, V268, P560, DOI 10.1126/science.7725102; Hsieh JJD, 1999, P NATL ACAD SCI USA, V96, P23, DOI 10.1073/pnas.96.1.23; Hsieh JJD, 1996, MOL CELL BIOL, V16, P952; Hu HM, 1998, J IMMUNOL, V160, P2334; Kadesch T, 2000, EXP CELL RES, V260, P1, DOI 10.1006/excr.2000.4921; Kannabiran C, 1997, MOL CELL BIOL, V17, P1, DOI 10.1128/MCB.17.1.1; Kao HY, 1998, GENE DEV, V12, P2269, DOI 10.1101/gad.12.15.2269; KOWENZLEUTZ E, 1994, GENE DEV, V8, P2781, DOI 10.1101/gad.8.22.2781; LIEBERMANN TA, 1990, MOL CELL BIOL, V10, P2327; LIN RT, 1995, J BIOL CHEM, V270, P3123, DOI 10.1074/jbc.270.7.3123; Lu FM, 1996, P NATL ACAD SCI USA, V93, P5663, DOI 10.1073/pnas.93.11.5663; Maldonado E, 1996, METHOD ENZYMOL, V274, P72; MATSUSAKA T, 1993, P NATL ACAD SCI USA, V90, P10193, DOI 10.1073/pnas.90.21.10193; Merola M, 1996, J INTERF CYTOK RES, V16, P783, DOI 10.1089/jir.1996.16.783; Miyazawa K, 1998, J BIOL CHEM, V273, P7620, DOI 10.1074/jbc.273.13.7620; Morel V, 2000, GENE DEV, V14, P377; NAKAJIMA T, 1993, P NATL ACAD SCI USA, V90, P2207, DOI 10.1073/pnas.90.6.2207; Olave I, 1998, GENE DEV, V12, P1621, DOI 10.1101/gad.12.11.1621; Orphanides G, 1998, CELL, V92, P105, DOI 10.1016/S0092-8674(00)80903-4; Plaisance S, 1997, MOL CELL BIOL, V17, P3733, DOI 10.1128/MCB.17.7.3733; Poli V, 1998, J BIOL CHEM, V273, P29279, DOI 10.1074/jbc.273.45.29279; SHIMIZU H, 1990, MOL CELL BIOL, V10, P561, DOI 10.1128/MCB.10.2.561; STEIN B, 1993, MOL CELL BIOL, V13, P7191, DOI 10.1128/MCB.13.11.7191; STEIN B, 1995, MOL CELL BIOL, V15, P4971; Stein B, 1998, DRUG DISCOV TODAY, V3, P202, DOI 10.1016/S1359-6446(97)01164-1; STEIN B, 1993, MOL CELL BIOL, V13, P3964, DOI 10.1128/MCB.13.7.3964; TANAKA T, 1995, CELL, V80, P353, DOI 10.1016/0092-8674(95)90418-2; TUN T, 1994, NUCLEIC ACIDS RES, V22, P965, DOI 10.1093/nar/22.6.965; Xia CL, 1997, INT J BIOCHEM CELL B, V29, P1525, DOI 10.1016/S1357-2725(97)00083-6; ZHANG YH, 1994, P NATL ACAD SCI USA, V91, P2225, DOI 10.1073/pnas.91.6.2225	40	22	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					42438	42446		10.1074/jbc.M207363200	http://dx.doi.org/10.1074/jbc.M207363200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12200447	hybrid			2022-12-27	WOS:000179081200004
J	Xu, H; Vavilin, D; Vermaas, W				Xu, H; Vavilin, D; Vermaas, W			The presence of chlorophyll b in Synechocystis sp PCC 6803 disturbs tetrapyrrole biosynthesis and enhances chlorophyll degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NADPH-PROTOCHLOROPHYLLIDE OXIDOREDUCTASE; LIGHT-HARVESTING COMPLEX; PHOTOSYSTEM-I; HIGHER-PLANTS; GENE; PIGMENT; STRAIN; HEME; INVOLVEMENT; EXPRESSION	Both chlorophyll (Chl) a and b accumulate in the light in a Synechocystis sp. PCC 6803 strain that expresses higher plant genes coding for a light-harvesting complex 11 protein and Chl a oxygenase. This cyanobacterial strain also lacks photosystem (PS) I and cannot synthesize Chl in darkness because of the lack of chlL. When this PS I-less/chlL(-)/lhcb(+)/cao(+) strain was grown in darkness, small amounts of two unusual tetrapyrroles, protochlorophyllide (PChlide) b and pheophorbide (pheide) b, were identified. Accumulation of PChlide b trailed that of PChlide a by several days, suggesting that PChlide a is an inefficient substrate of Chl a oxygenase. The presence of pheide b in this organism suggests a breakdown of Chl b via a pathway that does not involve conversion to a-type pigments. When the PS I-less/chlL(-) control strain was grown in darkness, Chl degradation was much slower than in the PS I-less/chlL(-)/lhcb(+)/cao(+) strain, suggesting that the presence of Chl b leads to more rapid turnover of Chl-binding proteins and/or a more active Chl degradation pathway. Levels and biosynthesis kinetics of Chl and of its biosynthetic intermediates are very different in the PS I-less/chlL(-)/lhcb(+)/cao(+) strain versus in the control. Moreover, when grown in darkness for 14 days, upon the addition of 5-aminolevulinic acid, the level of magnesium-protoporphyrin IX increased 60-fold in the PS I-less/chlL(-)/lhcb(+)/cao(+) strain (only similar to2-fold in the PS I-less/chlL- control strain), whereas the PChlide and protoheme levels remained fairly constant. We propose that a b-type PChlide, Chl, or pheide in the PS I-less/chlL(-)/lhcb(+)/cao(+) strain may bind to tetrapyrrole biosynthesis regulatory protein(s) (for example, the small Cab-like proteins) and thus affect the regulation of this pathway.	Arizona State Univ, Dept Plant Biol, Tempe, AZ 85287 USA; Arizona State Univ, Ctr Study Early Events Photosynthesis, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Vermaas, W (corresponding author), Arizona State Univ, Dept Plant Biol, Box 871601, Tempe, AZ 85287 USA.	wim@asu.edu						ANDERSON SL, 1991, J BACTERIOL, V173, P2761, DOI 10.1128/JB.173.9.2761-2767.1991; [Anonymous], MOL BIOL CHLOROPLAST; Beale S. I., 1990, BIOSYNTHESIS HEME CH, P287; BEDNARIK DP, 1985, ARCH BIOCHEM BIOPHYS, V240, P369, DOI 10.1016/0003-9861(85)90042-6; Espineda CE, 1999, P NATL ACAD SCI USA, V96, P10507, DOI 10.1073/pnas.96.18.10507; Folly P, 1999, J BIOL CHEM, V274, P21811, DOI 10.1074/jbc.274.31.21811; FUJITA Y, 1993, PLANT CELL PHYSIOL, V34, P305; FUJITA Y, 1992, PLANT CELL PHYSIOL, V33, P81; Funk C, 1999, BIOCHEMISTRY-US, V38, P9397, DOI 10.1021/bi990545+; He QF, 1998, EUR J BIOCHEM, V253, P161, DOI 10.1046/j.1432-1327.1998.2530161.x; He QF, 2001, J BIOL CHEM, V276, P306, DOI 10.1074/jbc.M008686200; Helfrich M, 1996, J AM CHEM SOC, V118, P2606, DOI 10.1021/ja953440c; Hortensteiner S, 1999, CELL MOL LIFE SCI, V56, P330, DOI 10.1007/s000180050434; HORTENSTEINER S, 1995, NEW PHYTOL, V129, P237, DOI 10.1111/j.1469-8137.1995.tb04293.x; Ito H, 1996, J BIOL CHEM, V271, P1475, DOI 10.1074/jbc.271.3.1475; JANSSON S, 1994, BBA-BIOENERGETICS, V1184, P1, DOI 10.1016/0005-2728(94)90148-1; JOHANNINGMEIER U, 1984, J BIOL CHEM, V259, P3541; Klement H, 1999, EUR J BIOCHEM, V265, P862, DOI 10.1046/j.1432-1327.1999.00627.x; Kruse E, 1997, PLANTA, V202, P235, DOI 10.1007/s004250050124; KUHLBRANDT W, 1994, NATURE, V367, P614, DOI 10.1038/367614a0; Matile P, 1999, ANNU REV PLANT PHYS, V50, P67, DOI 10.1146/annurev.arplant.50.1.67; Oster U, 2000, PLANT J, V21, P305, DOI 10.1046/j.1365-313x.2000.00672.x; PORRA RJ, 1994, EUR J BIOCHEM, V219, P671, DOI 10.1111/j.1432-1033.1994.tb19983.x; Reinbothe C, 1999, NATURE, V397, P80, DOI 10.1038/16283; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Rudiger W., 1988, Plant pigments., P1; SAGER R, 1953, ANN NY ACAD SCI, V56, P831, DOI 10.1111/j.1749-6632.1953.tb30261.x; Scheumann V, 1999, PLANTA, V209, P364, DOI 10.1007/s004250050644; Scheumann V, 1999, FEBS LETT, V445, P445, DOI 10.1016/S0014-5793(99)00169-6; SCHNEEGURT MA, 1992, BIOCHEMISTRY-US, V31, P11677, DOI 10.1021/bi00162a002; SCHOCH S, 1995, EUR J BIOCHEM, V229, P291, DOI 10.1111/j.1432-1033.1995.tb20468.x; SHEDBALKAR VP, 1991, J BIOL CHEM, V266, P17151; SHEN GZ, 1993, PLANT CELL, V5, P1853, DOI 10.1105/tpc.5.12.1853; STILLMAN LC, 1978, ANAL BIOCHEM, V91, P166, DOI 10.1016/0003-2697(78)90827-8; SUZUKI JY, 1992, PLANT CELL, V4, P929, DOI 10.1105/tpc.4.8.929; Takamiya K, 2000, TRENDS PLANT SCI, V5, P426, DOI 10.1016/S1360-1385(00)01735-0; Tanaka A, 1998, P NATL ACAD SCI USA, V95, P12719, DOI 10.1073/pnas.95.21.12719; THOMAS J, 1992, PLANT PHYSIOL BIOCH, V30, P285; Vavilin DV, 2002, PHYSIOL PLANTARUM, V115, P9, DOI 10.1034/j.1399-3054.2002.1150102.x; Vothknecht UC, 1998, PHYTOCHEMISTRY, V47, P513, DOI 10.1016/S0031-9422(97)00538-4; Wu QG, 1995, PLANT MOL BIOL, V29, P933, DOI 10.1007/BF00014967; Xu H, 2002, PLANT MOL BIOL, V49, P149, DOI 10.1023/A:1014900806905; Xu H, 2001, P NATL ACAD SCI USA, V98, P14168, DOI 10.1073/pnas.251530298	43	14	18	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					42726	42732		10.1074/jbc.M205237200	http://dx.doi.org/10.1074/jbc.M205237200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12207014	hybrid			2022-12-27	WOS:000179081200040
J	Kondoh, O; Takasuka, T; Arisawa, M; Aoki, Y; Watanabe, T				Kondoh, O; Takasuka, T; Arisawa, M; Aoki, Y; Watanabe, T			Differential sensitivity between Fks1p and Fks2p against a novel beta-1,3-glucan synthase inhibitor, aerothricin1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNIDENTIFIED FUNGUS NO.11243; 1,3-BETA-D-GLUCAN SYNTHASE; SACCHAROMYCES-CEREVISIAE; ANTIFUNGAL ACTIVITIES; OVERLAP EXTENSION; MEMBRANE-PROTEIN; CANDIDA-ALBICANS; GENE ENCODES; IN-VITRO; YEAST	Fks1p and Fks2p are catalytic subunits of beta-1,3-glucan synthase, which synthesize beta-1,3-glucan, a main component of the cell wall in Saccharomyces cerevisiae. Although Fks1p and Fks2p are highly homologous, sharing 88.1% identity, it has been shown that Fks2p is more sensitive than Fks1p to one of echinocandin derivatives, which inhibits beta-1,3-glucan synthase activity. Here we show a similar differential sensitivity between Fks1p and Fks2p to a novel beta-1,3-glucan synthase inhibitor, aerothricin1. To investigate the molecular mechanism of this differential sensitivity, we constructed a series of chimeric genes of FKSs and examined their sensitivity to aerothricin1. As a result, it was shown that a region around the fourth extracellular domain of Fks2p, containing 10 different amino acid residues from those of Fks1p, provided Fks1p aerothricin1 sensitivity when the region was replaced with a corresponding region of Fks1p. In order to identify essential amino acid residues responsible for the sensitivity, each of the 10 non-conserved amino acids of Fks1p was substituted into the corresponding amino acid of Fks2p by site-directed mutagenesis. Surprisingly, only one amino acid substitution of Fks1p, (K1336I) conferred Fks1p hypersensitivity to aerothricin1. On the other hand, reverse substitution of the corresponding amino acid of Fks2p (I1355K) resulted in loss of hypersensitivity to aerothricin1. These results suggest that the 1355th isoleucine of Fks2p plays a key role in aerothricin1 sensitivity.	Nippon Roche Res Ctr, Dept Mycol, Kamakura, Kanagawa 2478530, Japan	Roche Holding	Kondoh, O (corresponding author), Nippon Roche Res Ctr, Dept Oncol, 200 Kajiwara, Kamakura, Kanagawa 2478530, Japan.	osamu.kondoh@roche.com	Arisawa, Mitsuhiro/D-9098-2012					AOKI M, 2001, Patent No. 0005251; AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; Balkovec J.M., 1994, EXPERT OPIN INV DRUG, V3, P65, DOI [10.1517/13543784.3.2.65, DOI 10.1517/13543784.3.2.65]; CASTRO C, 1995, J BACTERIOL, V177, P5732, DOI 10.1128/jb.177.20.5732-5739.1995; CID VJ, 1995, MICROBIOL REV, V59, P345, DOI 10.1128/MMBR.59.3.345-386.1995; Drgonova J, 1996, SCIENCE, V272, P277, DOI 10.1126/science.272.5259.277; ENG WK, 1994, GENE, V151, P61, DOI 10.1016/0378-1119(94)90633-5; Fujie A, 2000, J ANTIBIOT, V53, P920, DOI 10.7164/antibiotics.53.920; FUJIE A, 1998, P 38 INT C ANT AG CH; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; INOUE SB, 1995, EUR J BIOCHEM, V231, P845, DOI 10.1111/j.1432-1033.1995.tb20770.x; Kelly R, 1996, J BACTERIOL, V178, P4381, DOI 10.1128/jb.178.15.4381-4391.1996; KLIS FM, 1994, YEAST, V10, P851, DOI 10.1002/yea.320100702; Kondoh O, 1997, J BACTERIOL, V179, P7734, DOI 10.1128/jb.179.24.7734-7741.1997; Kurtz MB, 1997, J MED VET MYCOL, V35, P79; Kurtz MB, 1998, ASM NEWS, V64, P31; Maertens JA, 2000, CURR PHARM DESIGN, V6, P225, DOI 10.2174/1381612003401299; Masubuchi K, 2001, BIOORG MED CHEM LETT, V11, P1273, DOI 10.1016/S0960-894X(01)00178-0; Masubuchi K, 2001, BIOORG MED CHEM LETT, V11, P395, DOI 10.1016/S0960-894X(00)00678-8; Mazur P, 1996, J BIOL CHEM, V271, P14604, DOI 10.1074/jbc.271.24.14604; MAZUR P, 1995, MOL CELL BIOL, V15, P5671; Mio T, 1997, J BACTERIOL, V179, P4096, DOI 10.1128/jb.179.13.4096-4105.1997; Pereira M, 2000, YEAST, V16, P451, DOI 10.1002/(SICI)1097-0061(20000330)16:5&lt;451::AID-YEA540&gt;3.0.CO;2-O; Qadota H, 1996, SCIENCE, V272, P279, DOI 10.1126/science.272.5259.279; RAM AFJ, 1995, FEBS LETT, V358, P165, DOI 10.1016/0014-5793(94)01418-Z; SUDOH M, 1991, AGR BIOL CHEM TOKYO, V55, P2901, DOI 10.1080/00021369.1991.10857906; Thompson JR, 1999, J BACTERIOL, V181, P444, DOI 10.1128/JB.181.2.444-453.1999; Warrens AN, 1997, GENE, V186, P29, DOI 10.1016/S0378-1119(96)00674-9	29	15	16	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					41744	41749		10.1074/jbc.M206734200	http://dx.doi.org/10.1074/jbc.M206734200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12202487	hybrid			2022-12-27	WOS:000178985300057
J	Seidler, DG; Breuer, E; Grande-Allen, KJ; Hascall, VC; Kresse, H				Seidler, DG; Breuer, E; Grande-Allen, KJ; Hascall, VC; Kresse, H			Core protein dependence of epimerization of glucuronosyl residues in galactosaminoglycans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLONY-STIMULATING FACTOR; HEPARIN-COFACTOR-II; CULTURED HUMAN-FIBROBLASTS; IDURONIC ACID RESIDUES; DERMATAN SULFATE; CHONDROITIN SULFATE; HEPARIN/HEPARAN SULFATE; CAPSULAR POLYSACCHARIDE; PROTEODERMATAN SULFATE; STRUCTURAL FEATURES	Chondroitin sulfate and dermatan sulfate proteoglycans are distinguished by differences in their proportion of D-glucuronosyl and L-iduronosyl residues, the latter being formed by chondroitin-glucuronate 5-epimerase during or after glycosaminoglycan chain polymerization. To investigate the influence of the core protein on the extent of epimerization, we expressed chimeric proteins in 293 HEK cells constructed from intact or modified Met(1)-Gln(153) of decorin (DCN), which normally has a single dermatan sulfate chain at Ser(34), in combination with intact or modified Le -Ser CSF-1, which has a chondroitin sulfate attachment site at Ser(309). Transfected DCNM1-Q153, like full-length DCN, contained similar to20% L-iduronate. Conversely, transfected CSF-1(L241-S353), attached C-terminally on the DCN prepropeptide, contained almost exclusively D-glucuronate. Transfected intact chimeric DCNM1-Q153-CSF-1(L241.S353), with two glycosaminoglycan chains, also contained almost exclusively D-glucuronate in chains at both sites, as did chimeras in which alanine was substituted for serine at either of the glycosaminoglycan attachment sites. Nevertheless, undersulfated intact chimeric proteoglycan was an effective substrate for epimerization of glucuronate to iduronate residues when incubated with microsomal proteins and 3'-phosphoadenylylphosphosulfate. C-terminal truncation constructs were prepared from the full-length chimera with an alanine substitution at the CSF-1 glycosaminoglycan attachment site. Transfected truncations retaining the alanine-blocked site contained chains with essentially only glucuronate, whereas those further truncated by 49 or more amino acids and missing the modified attachment site contained chains with similar to15% iduronate. This 49-amino acid region contains a 7-amino acid motif that appears to be conserved in several chondroitin sulfate proteoglycans. The results are consistent with a model in which the core protein, possibly via this motif, is responsible for routing to subcellular compartments with or without sufficient access to chondroitin-glucuronate 5-epimerase for the addition of chains with or without iduronate residues, respectively.	Univ Munster, Inst Physiol Chem & Pathobiochem, D-48149 Munster, Germany; Cleveland Clin Fdn, Dept Biomed Engn, Cleveland, OH 44106 USA	University of Munster; Cleveland Clinic Foundation	Kresse, H (corresponding author), Univ Munster, Inst Physiol Chem & Pathobiochem, Waldeyerstr 15, D-48149 Munster, Germany.		Grande-Allen, Kathryn/P-4042-2014	Grande-Allen, Kathryn/0000-0003-1533-3767				Aspberg A, 1997, P NATL ACAD SCI USA, V94, P10116, DOI 10.1073/pnas.94.19.10116; Bai XM, 2001, J BIOL CHEM, V276, P48189, DOI 10.1074/jbc.M107339200; BEAVAN LA, 1993, J BIOL CHEM, V268, P9856; Bonfanti L, 1998, CELL, V95, P993, DOI 10.1016/S0092-8674(00)81723-7; Boskey AL, 1997, CALCIFIED TISSUE INT, V61, P298, DOI 10.1007/s002239900339; Calabro A, 2000, GLYCOBIOLOGY, V10, P273, DOI 10.1093/glycob/10.3.273; CALABRO A, 2000, PROTEOGLYCANS STRUCT, P5; CHENG F, 1994, GLYCOBIOLOGY, V4, P685, DOI 10.1093/glycob/4.5.685; DOEGE KJ, 1991, J BIOL CHEM, V266, P894; FERRO DR, 1990, CARBOHYD RES, V195, P157, DOI 10.1016/0008-6215(90)84164-P; FRANSSON LA, 1991, GLYCOCONJUGATE J, V8, P108, DOI 10.1007/BF00731020; GLOSSL J, 1984, J BIOL CHEM, V259, P4144; GREVE H, 1988, J BIOL CHEM, V263, P12886; Hagner-McWhirter A, 2000, GLYCOBIOLOGY, V10, P159, DOI 10.1093/glycob/10.2.159; Hamai A, 1997, J BIOL CHEM, V272, P9123; Hannesson HH, 1996, BIOCHEM J, V313, P589, DOI 10.1042/bj3130589; HAUSSER H, 1993, GLYCOBIOLOGY, V3, P557, DOI 10.1093/glycob/3.6.557; Hausser H, 1999, BIOCHEM J, V344, P827, DOI 10.1042/0264-6021:3440827; HIYAMA K, 1976, J BIOCHEM-TOKYO, V80, P1201, DOI 10.1093/oxfordjournals.jbchem.a131390; INOUE Y, 1990, BIOCHEM J, V265, P533, DOI 10.1042/bj2650533; Iozzo RV, 1999, J BIOL CHEM, V274, P18843, DOI 10.1074/jbc.274.27.18843; KEARNS AE, 1993, J BIOL CHEM, V268, P11097; KOKENYESI R, 1994, J BIOL CHEM, V269, P12304; Kresse H, 1997, J BIOL CHEM, V272, P18404, DOI 10.1074/jbc.272.29.18404; Kresse H, 2001, J BIOL CHEM, V276, P13411, DOI 10.1074/jbc.M009321200; Li JP, 1997, J BIOL CHEM, V272, P28158, DOI 10.1074/jbc.272.44.28158; LINHARDT RJ, 1991, BIOCHEM PHARMACOL, V42, P1609, DOI 10.1016/0006-2952(91)90431-4; MALMSTROM A, 1975, J BIOL CHEM, V250, P3419; MALMSTROM A, 1982, BIOCHEM J, V201, P489, DOI 10.1042/bj2010489; MALMSTROM A, 1981, BIOCHEM J, V198, P669, DOI 10.1042/bj1980669; MALMSTROM A, 1984, J BIOL CHEM, V259, P161; MASCELLANI G, 1993, BIOCHEM J, V296, P639, DOI 10.1042/bj2960639; MASCELLANI G, 1994, ANAL BIOCHEM, V223, P135, DOI 10.1006/abio.1994.1558; Mikhailov D, 1997, BIOCHEM J, V328, P51, DOI 10.1042/bj3280051; Mulloy B, 2000, GLYCOBIOLOGY, V10, P1147, DOI 10.1093/glycob/10.11.1147; OTOTANI N, 1979, CARBOHYD RES, V70, P295, DOI 10.1016/S0008-6215(00)87109-8; PARTENHEIMER A, 1995, J IMMUNOL, V155, P5557; Pelham HRB, 2000, CELL, V102, P713, DOI 10.1016/S0092-8674(00)00060-X; Prydz K, 2000, J CELL SCI, V113, P193; RAO VSR, 1995, GLYCOBIOLOGY, V5, P273, DOI 10.1093/glycob/5.3.273; SCHWARZ K, 1990, J BIOL CHEM, V265, P22023; Shirk RA, 2000, J BIOL CHEM, V275, P18085, DOI 10.1074/jbc.M001659200; Silbert JE, 1996, GLYCOCONJUGATE J, V13, P907, DOI 10.1007/BF01053185; SUZU S, 1992, J BIOL CHEM, V267, P4345; Ueno M, 2001, J BIOL CHEM, V276, P29134, DOI 10.1074/jbc.M102089200; ZIMMERMANN DR, 1989, EMBO J, V8, P2975, DOI 10.1002/j.1460-2075.1989.tb08447.x	47	34	36	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					42409	42416		10.1074/jbc.M208442200	http://dx.doi.org/10.1074/jbc.M208442200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12207034	hybrid			2022-12-27	WOS:000178985300139
J	Takemori, H; Katoh, Y; Horike, N; Doi, J; Okamoto, M				Takemori, H; Katoh, Y; Horike, N; Doi, J; Okamoto, M			ACTH-induced nucleocytoplasmic translocation of salt-inducible kinase - Implication in the protein kinase A-activated gene transcription in mouse adrenocortical tumor cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE REGULATORY PROTEIN; HORMONE-SENSITIVE LIPASE; EPIDERMAL GROWTH-FACTOR; NUCLEAR EXPORT SIGNAL; RAT-ADRENAL-CORTEX; STAR GENE; CYCLIC-AMP; 3-BETA-HYDROXYSTEROID DEHYDROGENASE; CHOLESTEROL TRANSFER; TYROSINE-PHOSPHATASE	Salt-inducible kinase (SIK), da serine/threonine protein kinase expressed at an early stage of adrenocorticotropic hormone (ACTH) stimulation in Y1 mouse adrenocortical tumor cells, repressed the cAMP-responsive element (CRE)-dependent gene transcription by acting on the basic leucine zipper domain of the CRE-binding protein (Doi, J., Takemori, H., Lin, X.-z., Horike, N., Katoh, Y., and Okamoto, M. (2002) J. Biol. Chem. 277, 15629-15637). The mechanism of SIK-mediated gene regulation has been further explored. Here we show that SIK changes its subcellular location after the addition of ACTH. The immunocytochemical and fluorocytochemical analyses showed that SIK was present both in the nuclear and cytoplasmic compartments of resting cell when the cells were stimulated with ACTH the nuclear SIK moved into the cytoplasm within 15 min; the level of SIK in the nuclear compartment gradually returned to the initial level after 12 h. SIK translocation was blocked by pretreatment with leptomycin B. A mutant SIK whose Ser-577, the cAMP-dependent protein kinase (PKA)-dependent phosphorylation site, was replaced with Ala could not move out of the nucleus under stimulation by ACTH. As expected, the degree of repression exerted by SIK on CRE reporter activity was weak as long as SIK was present in the cytoplasmic compartment. The same was true for the SIK-mediated repression of a steroidogenic acute regulatory (StAR) protein-gene promoter, which contained a CRE-like sequence at -95 to -85 bp. These results suggest that in the ACTH-stimulated Y1 cells the nuclear SIK was PKA-dependently phosphorylated, and the phosphorylated SIK was then translocated out of the nuclei. This intracellular translocation of SIK, a CRE-repressor, may account or the time-dependent change in the level of ACTH-activated expression of the StAR protein gene.	Osaka Univ, Grad Sch Med, Dept Biochem & Mol Biol, Suita, Osaka 5650871, Japan; Osaka Univ, Grad Sch Frontier Biosci, Labs Biomol Networks, Suita, Osaka 5650871, Japan; Kinran Coll, Dept Life Sci, Suita, Osaka 5650873, Japan	Osaka University; Osaka University	Okamoto, M (corresponding author), Osaka Univ, Grad Sch Med, Dept Biochem & Mol Biol, H-1,2-2 Yamadaoka, Suita, Osaka 5650871, Japan.							Arakane F, 1996, P NATL ACAD SCI USA, V93, P13731, DOI 10.1073/pnas.93.24.13731; Arakane F, 1998, J BIOL CHEM, V273, P16339, DOI 10.1074/jbc.273.26.16339; Ariyoshi N, 1998, J BIOL CHEM, V273, P7610, DOI 10.1074/jbc.273.13.7610; Artemenko IP, 2001, J BIOL CHEM, V276, P46583, DOI 10.1074/jbc.M107815200; BEINS DM, 1982, BIOCHEM J, V202, P631, DOI 10.1042/bj2020631; Bird IM, 1996, J CLIN ENDOCR METAB, V81, P2171, DOI 10.1210/jc.81.6.2171; Bose HS, 2002, NATURE, V417, P87, DOI 10.1038/417087a; Brunet A, 2002, J CELL BIOL, V156, P817, DOI 10.1083/jcb.200112059; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Caron KM, 1997, MOL ENDOCRINOL, V11, P138, DOI 10.1210/me.11.2.138; Chalmers DT, 1996, TRENDS PHARMACOL SCI, V17, P166, DOI 10.1016/0165-6147(96)81594-X; Christenson LK, 1999, J BIOL CHEM, V274, P26591, DOI 10.1074/jbc.274.37.26591; Christenson LK, 2001, ARCH MED RES, V32, P576, DOI 10.1016/S0188-4409(01)00338-1; Christenson LK, 2000, BBA-MOL CELL BIOL L, V1529, P175, DOI 10.1016/S1388-1981(00)00147-5; CLARK BJ, 1995, MOL ENDOCRINOL, V9, P1346, DOI 10.1210/me.9.10.1346; Clark BJ, 1995, MOL CELL ENDOCRINOL, V115, P215, DOI 10.1016/0303-7207(95)03683-0; CLARK BJ, 1994, J BIOL CHEM, V269, P28314; Clark BJ, 2001, MOL CELL ENDOCRINOL, V173, P183, DOI 10.1016/S0303-7207(00)00410-X; COOK KG, 1982, EUR J BIOCHEM, V125, P245, DOI 10.1111/j.1432-1033.1982.tb06675.x; Doi J, 2002, J BIOL CHEM, V277, P15629, DOI 10.1074/jbc.M109365200; Doi J, 2001, J ENDOCRINOL, V168, P87, DOI 10.1677/joe.0.1680087; FISCHER U, 1995, CELL, V82, P475, DOI 10.1016/0092-8674(95)90436-0; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; Gallo-Payet N, 1999, J STEROID BIOCHEM, V69, P335, DOI 10.1016/S0960-0760(99)00079-5; GWYNNE JT, 1982, ENDOCR REV, V3, P299, DOI 10.1210/edrv-3-3-299; Gyles SL, 2001, J BIOL CHEM, V276, P34888, DOI 10.1074/jbc.M102063200; Halder SK, 1998, ENDOCRINOLOGY, V139, P3316, DOI 10.1210/en.139.7.3316; HOLM C, 1987, BIOCHEM BIOPH RES CO, V148, P99, DOI 10.1016/0006-291X(87)91081-3; Hong SH, 2001, J BIOL CHEM, V276, P28098, DOI 10.1074/jbc.M010912200; Ikeda Y, 2000, J BIOL CHEM, V275, P31695, DOI 10.1074/jbc.M004892200; Jans DA, 2000, BIOESSAYS, V22, P532, DOI 10.1002/(SICI)1521-1878(200006)22:6<532::AID-BIES6>3.0.CO;2-O; Jones PM, 2000, J MOL ENDOCRINOL, V24, P233, DOI 10.1677/jme.0.0240233; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Kao HY, 2001, J BIOL CHEM, V276, P47496, DOI 10.1074/jbc.M107631200; KRAMER RE, 1984, J BIOL CHEM, V259, P707; Kuersten S, 2001, TRENDS CELL BIOL, V11, P497, DOI 10.1016/S0962-8924(01)02144-4; Le Roy C, 2000, ENDOCRINOLOGY, V141, P1599, DOI 10.1210/en.141.5.1599; Lin XZ, 2001, MOL ENDOCRINOL, V15, P1264, DOI 10.1210/me.15.8.1264; Manna PR, 2002, MOL ENDOCRINOL, V16, P184, DOI 10.1210/me.16.1.184; McKinsey TA, 2001, MOL CELL BIOL, V21, P6312, DOI 10.1128/MCB.21.18.6312-6321.2001; Ohno M, 1998, CELL, V92, P327, DOI 10.1016/S0092-8674(00)80926-5; OLSON MF, 1993, MOL ENDOCRINOL, V7, P477, DOI 10.1210/me.7.4.477; OssarehNazari B, 1997, SCIENCE, V278, P141, DOI 10.1126/science.278.5335.141; Paz C, 2000, ENDOCR RES, V26, P609, DOI 10.3109/07435800009048579; Peng CY, 1998, CELL GROWTH DIFFER, V9, P197; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; Reinhart AJ, 1999, MOL ENDOCRINOL, V13, P729, DOI 10.1210/me.13.5.729; REYLAND ME, 1993, MOL ENDOCRINOL, V7, P1021, DOI 10.1210/me.7.8.1021; Reyland ME, 2000, J BIOL CHEM, V275, P36637, DOI 10.1074/jbc.M006456200; Richards JS, 2001, MOL ENDOCRINOL, V15, P209, DOI 10.1210/me.15.2.209; Sanchez Y, 1997, SCIENCE, V277, P1497, DOI 10.1126/science.277.5331.1497; Seger R, 2001, J BIOL CHEM, V276, P13957, DOI 10.1074/jbc.M006852200; Sewer MB, 2002, ENDOCRINOLOGY, V143, P1769, DOI 10.1210/en.143.5.1769; Silverman E, 1999, J BIOL CHEM, V274, P17987, DOI 10.1074/jbc.274.25.17987; Stocco DM, 2000, BBA-MOL CELL BIOL L, V1486, P184, DOI 10.1016/S1388-1981(00)00056-1; Stocco DM, 2000, NAT STRUCT BIOL, V7, P445, DOI 10.1038/75834; Stocco DM, 2001, MOL CELL ENDOCRINOL, V177, P55, DOI 10.1016/S0303-7207(01)00423-3; Stocco DM, 2001, MOL ENDOCRINOL, V15, P1245, DOI 10.1210/me.15.8.1245; Sugawara T, 1996, BIOCHEMISTRY-US, V35, P9052, DOI 10.1021/bi960057r; Tiganis T, 1997, J BIOL CHEM, V272, P21548, DOI 10.1074/jbc.272.34.21548; Timpl P, 1998, NAT GENET, V19, P162, DOI 10.1038/520; TRZECIAK WH, 1973, EUR J BIOCHEM, V37, P327, DOI 10.1111/j.1432-1033.1973.tb02991.x; Tzivion G, 2002, J BIOL CHEM, V277, P3061, DOI 10.1074/jbc.R100059200; Wang XJ, 2000, J BIOL CHEM, V275, P20204, DOI 10.1074/jbc.M003113200; Wang ZN, 1999, FEBS LETT, V453, P135, DOI 10.1016/S0014-5793(99)00708-5; Whitehouse BJ, 2002, J ENDOCRINOL, V172, P583, DOI 10.1677/joe.0.1720583; WONG M, 1992, MOL ENDOCRINOL, V6, P1614, DOI 10.1210/me.6.10.1614; Yang WB, 2001, J BIOL CHEM, V276, P38341, DOI 10.1074/jbc.C100316200; Yoneda Y, 1999, CELL STRUCT FUNCT, V24, P425, DOI 10.1247/csf.24.425; Zhao X, 2001, J BIOL CHEM, V276, P35042, DOI 10.1074/jbc.M105086200	71	63	67	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					42334	42343		10.1074/jbc.M204602200	http://dx.doi.org/10.1074/jbc.M204602200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12200423	hybrid			2022-12-27	WOS:000178985300129
J	Yamashita, M; Ukai-Tadenuma, M; Kimura, M; Omori, M; Inami, M; Taniguchi, M; Nakayama, T				Yamashita, M; Ukai-Tadenuma, M; Kimura, M; Omori, M; Inami, M; Taniguchi, M; Nakayama, T			Identification of a conserved GATA3 response element upstream proximal from the interleukin-13 gene locus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELL DIFFERENTIATION; TRANSCRIPTION FACTOR GATA-3; HISTONE ACETYLTRANSFERASE; COORDINATE REGULATOR; CYTOKINE EXPRESSION; IN-VIVO; TH1; ACTIVATION; RECEPTOR; BINDING	Differentiation of naive CD4 T cells into type 2 helper (Th2) cells is accompanied by chromatin remodeling of Th2 cytokine gene loci. Hyperacetylation of histone H3 on nucleosomes associated with the interleukin (IL)-4, IL-13 and IL-5 genes was observed in developing Th2 cells but not in Th1 cells. Histone hyperacetylation on IL-5 gene-associated nucleosomes was Th2-specific but occurred with delayed kinetics, and hyperacetylation on RAD50 gene-associated nucleosomes was T cell antigen receptor stimulation-dependent but not Th2-specific. The induction of the Th2-specific histone hyperacetylation was STAT6- and GATA3-dependent, and interestingly, it was accompanied by the expression of intergenic transcripts within the IL-13 and IL-4 gene loci. A conserved GATA3 response element (CGRE) containing four GATA consensus sequences was identified 1.6 kbp upstream from the IL-13 gene, corresponding with the 5'-border of the Th2-specific histone hyperacetylation region. The CGRE was shown to bind to GATA3, histone acetyltransferase complexes including CBP/p300, and RNA polymerase IL Also, the CGRE showed a significant enhancing effect on the Th2 cytokine gene promoters. Thus, the CGRE may play a crucial role for GATA3-mediated targeting and downstream spreading of core histone hyperacetylation within the IL-13 and IL-4 gene loci.	Chiba Univ, Dept Med Immunol M2, Grad Sch Med, Chuo Ku, Chiba 2608670, Japan; Chiba Univ, Dept Mol Immunol, Grad Sch Med, Chuo Ku, Chiba 2608670, Japan; Japan Sci & Technol Corp, PRESTO Project, Yokohama, Kanagawa 2300045, Japan; RIKEN, Res Ctr Allergy & Immunol, Lab Immune Regulat, Yokohama, Kanagawa 2300045, Japan	Chiba University; Chiba University; Japan Science & Technology Agency (JST); RIKEN	Nakayama, T (corresponding author), Chiba Univ, Dept Med Immunol M2, Grad Sch Med, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	nakayama@med.m.chiba-u.ac.jp	Taniguchi, Masaru/N-7932-2015; Nakayama, Toshinori/E-1067-2017	Taniguchi, Masaru/0000-0001-7821-7179; Nakayama, Toshinori/0000-0002-1434-2007; Omori-Miyake, Miyuki/0000-0002-4643-4045				Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Agarwal S, 1998, CURR OPIN IMMUNOL, V10, P345, DOI 10.1016/S0952-7915(98)80174-X; Agarwal S, 2000, IMMUNITY, V12, P643, DOI 10.1016/S1074-7613(00)80215-0; Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; Blobel GA, 1998, P NATL ACAD SCI USA, V95, P2061, DOI 10.1073/pnas.95.5.2061; Constant SL, 1997, ANNU REV IMMUNOL, V15, P297, DOI 10.1146/annurev.immunol.15.1.297; Flavell RA, 1999, COLD SPRING HARB SYM, V64, P563, DOI 10.1101/sqb.1999.64.563; Francis NJ, 2001, NAT REV MOL CELL BIO, V2, P409, DOI 10.1038/35073039; Gately MK, 1998, ANNU REV IMMUNOL, V16, P495, DOI 10.1146/annurev.immunol.16.1.495; Gribnau J, 2000, MOL CELL, V5, P377, DOI 10.1016/S1097-2765(00)80432-3; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Hassan AH, 2001, CELL, V104, P817, DOI 10.1016/S0092-8674(01)00279-3; HEBBES TR, 1994, EMBO J, V13, P1823, DOI 10.1002/j.1460-2075.1994.tb06451.x; Jones KA, 2000, GENE DEV, V14, P1992; Kimura M, 2001, IMMUNITY, V15, P275, DOI 10.1016/S1074-7613(01)00182-0; Kingston RE, 1999, GENE DEV, V13, P2339, DOI 10.1101/gad.13.18.2339; Lee HJ, 2000, J EXP MED, V192, P105, DOI 10.1084/jem.192.1.105; Loots GG, 2000, SCIENCE, V288, P136, DOI 10.1126/science.288.5463.136; Mohrs M, 2001, NAT IMMUNOL, V2, P842, DOI 10.1038/ni0901-842; MOSMANN TR, 1989, ADV IMMUNOL, V46, P111, DOI 10.1016/S0065-2776(08)60652-5; Murphy KM, 2000, ANNU REV IMMUNOL, V18, P451, DOI 10.1146/annurev.immunol.18.1.451; Nelms K, 1999, ANNU REV IMMUNOL, V17, P701, DOI 10.1146/annurev.immunol.17.1.701; O'Garra A, 1998, IMMUNITY, V8, P275, DOI 10.1016/S1074-7613(00)80533-6; Ouyang W, 1998, IMMUNITY, V9, P745, DOI 10.1016/S1074-7613(00)80671-8; Ouyang WJ, 2000, IMMUNITY, V12, P27, DOI 10.1016/S1074-7613(00)80156-9; REINER SL, 1995, ANNU REV IMMUNOL, V13, P151, DOI 10.1146/annurev.iy.13.040195.001055; Reinke H, 2001, MOL CELL, V7, P529, DOI 10.1016/S1097-2765(01)00200-3; Rengarajan J, 2000, IMMUNOL TODAY, V21, P479, DOI 10.1016/S0167-5699(00)01712-6; SEDER RA, 1994, ANNU REV IMMUNOL, V12, P635, DOI 10.1146/annurev.iy.12.040194.003223; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Takeda K, 1996, NATURE, V380, P627, DOI 10.1038/380627a0; Takemoto N, 1998, INT IMMUNOL, V10, P1981, DOI 10.1093/intimm/10.12.1981; Travers A, 1999, P NATL ACAD SCI USA, V96, P13634, DOI 10.1073/pnas.96.24.13634; Wittschieben BO, 1999, MOL CELL, V4, P123, DOI 10.1016/S1097-2765(00)80194-X; Yamashita M, 1998, INT IMMUNOL, V10, P577, DOI 10.1093/intimm/10.5.577; Yamashita M, 1999, P NATL ACAD SCI USA, V96, P1024, DOI 10.1073/pnas.96.3.1024; Yamashita M, 2000, J EXP MED, V191, P1869, DOI 10.1084/jem.191.11.1869; Zhang DH, 1997, J BIOL CHEM, V272, P21597, DOI 10.1074/jbc.272.34.21597; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8	40	147	151	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					42399	42408		10.1074/jbc.M205876200	http://dx.doi.org/10.1074/jbc.M205876200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12205084	hybrid			2022-12-27	WOS:000178985300138
J	Xiong, LW; Newman, RA; Rodney, GG; Thomas, O; Zhang, JZ; Persechini, A; Shea, MA; Hamilton, SL				Xiong, LW; Newman, RA; Rodney, GG; Thomas, O; Zhang, JZ; Persechini, A; Shea, MA; Hamilton, SL			Lobe-dependent regulation of ryanodine receptor type 1 by calmodulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+ RELEASE CHANNEL; RABBIT SKELETAL-MUSCLE; CALCIUM-BINDING; SARCOPLASMIC-RETICULUM; ESCHERICHIA-COLI; ACTIVATION; SITES; RYR1; APOCALMODULIN; PURIFICATION	Calmodulin activates the skeletal muscle Ca2+ release channel RYR1 at nM Ca2+ concentrations and inhibits the channel at mum Ca2+ concentrations. Using a deletion mutant of calmodulin, we demonstrate that amino acids 2-8 are required for high affinity binding of calmodulin to RYR1 at both nM and muM Ca2+ concentrations and are required for maximum inhibition of the channel at Im Ca2+ concentrations. In contrast, the addition of three amino acids to the N terminus of calmodulin increased the affinity for RYR1 at both nM and gm Ca2+ concentrations, but destroyed its functional effects on RYR1 at nM Ca2+. Using both full-length RYR1 and synthetic peptides, we demonstrate that the calmodulin-binding site on RYR1 is likely to be noncontiguous, with the C-terminal lobe of both apocalmodulin and Ca2+-calmodulin binding to amino acids between positions 3614 and 3643 and the N-terminal lobe binding at sites that are not proximal in the primary sequence. Ca2+ binding to the C-terminal lobe of calmodulin converted it from an activator to an inhibitor, but an interaction with the N-terminal lobe was required for a maximum effect on RYR1. This interaction apparently depends on the native sequence or structure of the first few amino acids at the N terminus of calmodulin.	Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; Univ Iowa, Coll Med, Dept Biochem, Iowa City, IA 52242 USA; Univ Missouri, Div Mol Biol & Biochem, Sch Biol Sci, Kansas City, MO 64110 USA	Baylor College of Medicine; University of Iowa; University of Missouri System; University of Missouri Kansas City	Hamilton, SL (corresponding author), Baylor Coll Med, Dept Mol Physiol & Biophys, 1 Baylor Plaza, Houston, TX 77030 USA.		Shea, Madeline A/F-5798-2010	Hamilton, Susan/0000-0003-0241-9369; Shea, Madeline/0000-0003-0814-7069	NIAMS NIH HHS [AR 41729, AR 44802] Funding Source: Medline; NIDDK NIH HHS [DK 53863] Funding Source: Medline; NIGMS NIH HHS [GM 57001] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044802, R55AR041729, R01AR041729] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057001] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		[Anonymous], 1996, CIRCULAR DICHROISM C; Black DJ, 2000, BIOCHEMISTRY-US, V39, P13831, DOI 10.1021/bi001106+; CHU A, 1990, MOL PHARMACOL, V37, P735; Du GG, 1999, J BIOL CHEM, V274, P26120, DOI 10.1074/jbc.274.37.26120; Gao J, 1998, BIOPHYS J, V74, P1115, DOI 10.1016/S0006-3495(98)77830-0; GOPALAKRISHNA R, 1982, BIOCHEM BIOPH RES CO, V104, P830, DOI 10.1016/0006-291X(82)90712-4; HAWKES MJ, 1989, MEMBRANE BIOCHEM, V8, P133, DOI 10.3109/09687688909025827; Hayashi N, 1998, PROTEIN EXPRES PURIF, V12, P25, DOI 10.1006/prep.1997.0807; Krueger JK, 2001, J BIOL CHEM, V276, P4535, DOI 10.1074/jbc.C000857200; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LU XY, 1994, J BIOL CHEM, V269, P6511; Lydan M A, 1994, Methods Mol Biol, V31, P389; MARTIN SR, 1986, BIOCHEM J, V238, P485, DOI 10.1042/bj2380485; Moore CP, 1999, BIOCHEMISTRY-US, V38, P8532, DOI 10.1021/bi9907431; Murase T, 2002, BIOCHEMISTRY-US, V41, P1618, DOI 10.1021/bi011782r; OLWIN BB, 1985, BIOCHEMISTRY-US, V24, P8081, DOI 10.1021/bi00348a037; Pate P, 2000, J BIOL CHEM, V275, P39786, DOI 10.1074/jbc.M007158200; PEDIGO S, 1995, BIOCHEMISTRY-US, V34, P1179, DOI 10.1021/bi00004a011; Persechini A, 1996, J BIOL CHEM, V271, P19279, DOI 10.1074/jbc.271.32.19279; PESSAH IN, 1987, MOL PHARMACOL, V31, P232; Rodney GG, 2000, BIOCHEMISTRY-US, V39, P7807, DOI 10.1021/bi0005660; Rodney GG, 2001, BIOCHEMISTRY-US, V40, P12430, DOI 10.1021/bi011078a; Rodney GG, 2001, J BIOL CHEM, V276, P2069, DOI 10.1074/jbc.M008891200; Samso M, 2002, J BIOL CHEM, V277, P1349, DOI 10.1074/jbc.M109196200; Sencer S, 2001, J BIOL CHEM, V276, P38237; SMITH JS, 1988, J GEN PHYSIOL, V92, P1, DOI 10.1085/jgp.92.1.1; Sorensen BR, 1998, BIOCHEMISTRY-US, V37, P4244, DOI 10.1021/bi9718200; Sorensen BR, 2002, BIOCHEMISTRY-US, V41, P15, DOI 10.1021/bi011718+; Stoyanovsky D, 1997, CELL CALCIUM, V21, P19, DOI 10.1016/S0143-4160(97)90093-2; TAKESHIMA H, 1989, NATURE, V339, P439, DOI 10.1038/339439a0; TRIPATHY A, 1995, BIOPHYS J, V69, P106, DOI 10.1016/S0006-3495(95)79880-0; VALDIVIA HH, 1991, J BIOL CHEM, V266, P19135; Xiong LW, 2001, J NEUROCHEM, V79, P669, DOI 10.1046/j.1471-4159.2001.00606.x; Yamaguchi N, 2001, J BIOL CHEM, V276, P22579, DOI 10.1074/jbc.M102729200; Zhang JJ, 1999, BRIT J PHARMACOL, V126, P1066, DOI 10.1038/sj.bjp.0702400	35	65	66	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 25	2002	277	43					40862	40870		10.1074/jbc.M206763200	http://dx.doi.org/10.1074/jbc.M206763200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	607KU	12185083	hybrid			2022-12-27	WOS:000178791400091
J	Zheng, MZ; McKeown-Longo, PJ				Zheng, MZ; McKeown-Longo, PJ			Regulation of HEF1 expression and phosphorylation by TGF-beta 1 and cell adhesion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE PHOSPHORYLATION; DOCKING PROTEIN; EXTRACELLULAR-MATRIX; INTEGRIN; FIBRONECTIN; P130(CAS); KINASE; GROWTH; CYTOSKELETON; BINDING	Transforming growth factor-beta1 (TGF-beta1) is a multipotential cytokine, which regulates remodeling of tissue extracellular matrix during early tumorigenesis and wound healing. Human enhancer of filamentation-1 (HEF1), a multifunctional docking protein, is involved in integrin-based signaling, which affects cell motility, growth, and apoptosis. Our studies reveal that TGF-beta1 is a potent inducer of HEF1 gene transcription in human dermal fibroblasts. TGF-beta1 promoted HEF1 expression in a dose-dependent manner and resulted in a 16-fold increase in HEF1 protein level. TGF-beta1 had no effect on the stability of either HEF1 protein or mRNA. The TGF-beta1-induced HEF1 expression was independent of cell adhesion and resistant to cytoskeleton disruption. TGF-beta1 increased levels of both p105 and p115 HEF1 in adherent fibroblasts. Digestion with specific phosphatases indicated that the p115HEF1 resulted from serine/threonine phosphorylation of p105HEF1. The appearance of the p115HEF1 as well as tyrosine phosphorylation of p105HEF1 required cell adhesion and/or an organized cytoskeleton. An in vitro kinase assay indicated that p105HEF1 was a substrate for Src. PP1, a specific Src kinase inhibitor, was able to block adhesion-dependent tyrosine phosphorylation of p105HEF1. These findings suggest that TGF-beta1 regulates HEF1 gene expression and that HEF1 phosphorylation is dependent on cell adhesion and Src kinase activity.	Albany Med Coll, Ctr Cell Biol & Canc Res, Albany, NY 12208 USA	Albany Medical College	Zheng, MZ (corresponding author), Albany Med Coll, Ctr Cell Biol & Canc Res, Albany, NY 12208 USA.	zhengm@mail.amc.edu; Mckeowp@mail.amc.edu			NCI NIH HHS [CA-69612] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA069612] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALLENHOFFMANN BL, 1988, MOL CELL BIOL, V8, P4234, DOI 10.1128/MCB.8.10.4234; Astier A, 1997, J BIOL CHEM, V272, P19719, DOI 10.1074/jbc.272.32.19719; Berking C, 2001, CANCER RES, V61, P8306; BHATTACHARYA S, 1995, J BIOL CHEM, V270, P16781, DOI 10.1074/jbc.270.28.16781; Bittner M, 2000, NATURE, V406, P536, DOI 10.1038/35020115; BOCKHOLT SM, 1993, J BIOL CHEM, V268, P14565; Bombeli T, 1997, BLOOD, V89, P2429, DOI 10.1182/blood.V89.7.2429; BURRIDGE K, 1992, J CELL BIOL, V119, P893, DOI 10.1083/jcb.119.4.893; Cary LA, 1998, J CELL BIOL, V140, P211, DOI 10.1083/jcb.140.1.211; D'Ovidio MC, 1998, EUR J CANCER, V34, P1081, DOI 10.1016/S0959-8049(98)00041-0; de Jong R, 1997, J BIOL CHEM, V272, P32649, DOI 10.1074/jbc.272.51.32649; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; ENGVALL E, 1977, INT J CANCER, V20, P1, DOI 10.1002/ijc.2910200102; Fashena SJ, 2002, J CELL SCI, V115, P99; FEDER D, 1990, J BIOL CHEM, V265, P8205; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hudson JD, 1999, J EXP MED, V190, P1375, DOI 10.1084/jem.190.10.1375; IGNOTZ RA, 1986, J BIOL CHEM, V261, P4337; IGNOTZ RA, 1987, CELL, V51, P189, DOI 10.1016/0092-8674(87)90146-2; Kanda H, 1999, IMMUNOLOGY, V97, P56; Kutz SM, 2001, J CELL SCI, V114, P3905; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Law SF, 1998, MOL CELL BIOL, V18, P3540, DOI 10.1128/MCB.18.6.3540; Law SF, 1996, MOL CELL BIOL, V16, P3327; Law SF, 2000, MOL CELL BIOL, V20, P5184, DOI 10.1128/MCB.20.14.5184-5195.2000; LIPFERT L, 1992, J CELL BIOL, V119, P905, DOI 10.1083/jcb.119.4.905; Liu XH, 2000, EMBO J, V19, P6759, DOI 10.1093/emboj/19.24.6759; Manie SN, 1997, J BIOL CHEM, V272, P4230, DOI 10.1074/jbc.272.7.4230; Maruyama S, 1996, J BIOL CHEM, V271, P6631, DOI 10.1074/jbc.271.12.6631; MCKEOWNLONGO PJ, 1987, J CELL BIOL, V104, P601, DOI 10.1083/jcb.104.3.601; Minegishi M, 1996, J EXP MED, V184, P1365, DOI 10.1084/jem.184.4.1365; NOJIMA Y, 1995, J BIOL CHEM, V270, P15398, DOI 10.1074/jbc.270.25.15398; O'Neill GM, 2000, TRENDS CELL BIOL, V10, P111, DOI 10.1016/S0962-8924(99)01714-6; Ohashi Y, 1999, J IMMUNOL, V163, P3727; Olumi AF, 1999, CANCER RES, V59, P5002; REED MJ, 1994, J CELL PHYSIOL, V158, P169, DOI 10.1002/jcp.1041580121; RonnovJessen L, 1996, PHYSIOL REV, V76, P69, DOI 10.1152/physrev.1996.76.1.69; Sattler M, 1997, J BIOL CHEM, V272, P14320, DOI 10.1074/jbc.272.22.14320; Schoenwaelder SM, 1999, CURR OPIN CELL BIOL, V11, P274, DOI 10.1016/S0955-0674(99)80037-4; Serini G, 1998, J CELL BIOL, V142, P873, DOI 10.1083/jcb.142.3.873; Skobe M, 1998, P NATL ACAD SCI USA, V95, P1050, DOI 10.1073/pnas.95.3.1050; SPORN MB, 1993, J CLIN INVEST, V92, P2565, DOI 10.1172/JCI116868; van Seventer GA, 2001, EUR J IMMUNOL, V31, P1417, DOI 10.1002/1521-4141(200105)31:5<1417::AID-IMMU1417>3.0.CO;2-C; Vaughan MB, 2000, EXP CELL RES, V257, P180, DOI 10.1006/excr.2000.4869; Zhang ZY, 2000, J BIOL CHEM, V275, P37219, DOI 10.1074/jbc.M001818200	45	58	58	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2002	277	42					39599	39608		10.1074/jbc.M202263200	http://dx.doi.org/10.1074/jbc.M202263200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	605EA	12189134	hybrid			2022-12-27	WOS:000178662500071
J	Cataldi, M; Perez-Reyes, E; Tsien, RW				Cataldi, M; Perez-Reyes, E; Tsien, RW			Differences in apparent pore sizes of low and high voltage-activated Ca2+ channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VERTEBRATE SENSORY NEURONS; SENSITIVE CALCIUM-CHANNEL; MONO-VALENT CATIONS; SODIUM-CHANNEL; FUNCTIONAL EXPRESSION; SELECTIVITY FILTER; STRUCTURAL BASIS; SKELETAL-MUSCLE; ORGANIC CATIONS; ION PERMEATION	Pore size is of considerable interest in voltage-gated Ca2+ channels because they exemplify a fundamental ability of certain ion channels: to display large pore diameter, but also great selectivity for their ion of choice. We determined the pore size of several voltage-dependent Ca2+ channels of known molecular composition with large organic cations as probes. T-type channels supported by the Ca(V)3.1, Ca(V)3.2, and Ca(V)3.3 subunits; L-type channels encoded by the Ca(V)1.2,beta(1), and alpha(2)delta(1) subunits; and R-type channels encoded by the Ca(V)2.3 and beta(3) subunits were each studied using a Xenopus oocyte expression system. The weak permeabilities to organic cations were resolved by looking at inward tails generated upon repolarization after a large depolarizing pulse. Large inward NH4+ currents and sizable methylammonium. and dimethylammonium currents were observed in all of the channels tested, whereas trimethylammonium permeated only through L- and R-type channels, and tetramethylammonium currents were observed only in L-type channels. Thus, our experiments revealed an unexpected heterogeneity in pore size among different Ca2+ channels, with L-type channels having the largest pore (effective diameter = 6.2 Angstrom), T-type channels having the tiniest pore (effective diameter = 5.1 Angstrom), and R-type channels having a pore size intermediate between these extremes. These findings ran counter to first-order expectations for these channels based simply on their degree of selectivity among inorganic cations or on the bulkiness of their acidic side chains at the locus of selectivity.	Stanford Univ, Sch Med, Dept Cellular & Mol Physiol, Beckman Ctr, Stanford, CA 94305 USA; Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA	Stanford University; University of Virginia	Tsien, RW (corresponding author), Stanford Univ, Sch Med, Dept Cellular & Mol Physiol, Beckman Ctr, Rm B105, Stanford, CA 94305 USA.	rwtsien@stanford.edu	Cataldi, Mauro/AAB-3642-2019	Cataldi, Mauro/0000-0001-7787-3406	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024067, R01NS038691] Funding Source: NIH RePORTER; NINDS NIH HHS [NS24067, NS38691] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AKAIKE N, 1989, J PHYSIOL-LONDON, V412, P181, DOI 10.1113/jphysiol.1989.sp017610; ARMSTRONG CM, 1985, SCIENCE, V227, P65, DOI 10.1126/science.2578071; BEAN BP, 1985, J GEN PHYSIOL, V86, P1, DOI 10.1085/jgp.86.1.1; BEZANILLA F, 1972, J GEN PHYSIOL, V60, P588, DOI 10.1085/jgp.60.5.588; BOSSU JL, 1985, PFLUG ARCH EUR J PHY, V403, P360, DOI 10.1007/BF00589247; Bourinet E, 1996, J NEUROSCI, V16, P4983; CARBONE E, 1984, NATURE, V310, P501, DOI 10.1038/310501a0; CARBONE E, 1987, J PHYSIOL-LONDON, V386, P571, DOI 10.1113/jphysiol.1987.sp016552; CARBONE E, 1987, J PHYSIOL-LONDON, V386, P547, DOI 10.1113/jphysiol.1987.sp016551; CASTELLANO A, 1993, J BIOL CHEM, V268, P12359; Chiamvimonvat N, 1996, NEURON, V16, P1037, DOI 10.1016/S0896-6273(00)80127-0; Cibulsky SM, 2000, J GEN PHYSIOL, V116, P349, DOI 10.1085/jgp.116.3.349; Cloues RK, 2000, J PHYSIOL-LONDON, V524, P19, DOI 10.1111/j.1469-7793.2000.00019.x; CORONADO R, 1987, BIOPHYS J, V51, P497, DOI 10.1016/S0006-3495(87)83371-4; Corry B, 2001, BIOPHYS J, V80, P195, DOI 10.1016/S0006-3495(01)76007-9; Corry B, 2000, BBA-BIOMEMBRANES, V1509, P1, DOI 10.1016/S0005-2736(00)00330-8; Cougnon M, 1996, PFLUG ARCH EUR J PHY, V431, P658, DOI 10.1007/BF02191917; Cribbs LL, 1998, CIRC RES, V83, P103, DOI 10.1161/01.RES.83.1.103; DASCAL N, 1987, CRIT REV BIOCHEM MOL, V22, P317, DOI 10.3109/10409238709086960; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Durell SR, 1996, NEUROPHARMACOLOGY, V35, P761, DOI 10.1016/0028-3908(96)00097-4; DWYER TM, 1980, J GEN PHYSIOL, V75, P469, DOI 10.1085/jgp.75.5.469; ELLINOR PT, 1995, NEURON, V15, P1121, DOI 10.1016/0896-6273(95)90100-0; FALKE JJ, 1994, Q REV BIOPHYS, V27, P219, DOI 10.1017/S0033583500003012; FUKUSHIMA Y, 1985, J PHYSIOL-LONDON, V358, P255, DOI 10.1113/jphysiol.1985.sp015550; GOULDING EH, 1993, NATURE, V364, P61, DOI 10.1038/364061a0; HESS P, 1986, J GEN PHYSIOL, V88, P293, DOI 10.1085/jgp.88.3.293; HILLE B, 1973, J GEN PHYSIOL, V61, P669, DOI 10.1085/jgp.61.6.669; HILLE B, 1971, J GEN PHYSIOL, V58, P599, DOI 10.1085/jgp.58.6.599; HILLE B, 1992, IONIC CHANNELS EXCIT, P83; Huguenard JR, 1996, ANNU REV PHYSIOL, V58, P329, DOI 10.1146/annurev.physiol.58.1.329; KOSTYUK PG, 1988, PFLUG ARCH EUR J PHY, V411, P661, DOI 10.1007/BF00580863; Lee JH, 1999, J NEUROSCI, V19, P1912; Li RA, 2000, J GEN PHYSIOL, V115, P81, DOI 10.1085/jgp.115.1.81; Lipkind GM, 2000, BIOCHEMISTRY-US, V39, P8161, DOI 10.1021/bi000486w; LOIRAND G, 1986, PFLUG ARCH EUR J PHY, V407, P566, DOI 10.1007/BF00657519; MCCLESKEY EW, 1985, P NATL ACAD SCI USA, V82, P7149, DOI 10.1073/pnas.82.20.7149; McCleskey EW, 1999, J GEN PHYSIOL, V113, P765, DOI 10.1085/jgp.113.6.765; MIKAMI A, 1989, NATURE, V340, P230, DOI 10.1038/340230a0; Miller C, 1999, J GEN PHYSIOL, V113, P783, DOI 10.1085/jgp.113.6.783; MITRA R, 1986, P NATL ACAD SCI USA, V83, P5340, DOI 10.1073/pnas.83.14.5340; MULLINS LJ, 1959, J GEN PHYSIOL, V42, P817, DOI 10.1085/jgp.42.4.817; NILIUS B, 1985, NATURE, V316, P443, DOI 10.1038/316443a0; Nonner W, 2000, BIOPHYS J, V79, P1976, DOI 10.1016/S0006-3495(00)76446-0; Nonner W, 1999, J GEN PHYSIOL, V113, P773, DOI 10.1085/jgp.113.6.773; Nonner W, 1998, BIOPHYS J, V75, P1287, DOI 10.1016/S0006-3495(98)74048-2; Nonner W, 1998, BIOPHYS J, V74, P2327, DOI 10.1016/S0006-3495(98)77942-1; NOWYCKY MC, 1985, NATURE, V316, P440, DOI 10.1038/316440a0; Perez-Reyes E, 1999, CELL MOL LIFE SCI, V56, P660, DOI 10.1007/s000180050460; Perez-Reyes E, 1998, NATURE, V391, P896, DOI 10.1038/36110; PerezGarcia MT, 1996, P NATL ACAD SCI USA, V93, P300, DOI 10.1073/pnas.93.1.300; Piedras-Renteria ES, 1998, P NATL ACAD SCI USA, V95, P7760, DOI 10.1073/pnas.95.13.7760; ROSENBERG RL, 1988, CURR TOP MEMBR TRANS, V33, P393; RUTH P, 1989, SCIENCE, V245, P1115, DOI 10.1126/science.2549640; Sather William A., 1994, Current Opinion in Neurobiology, V4, P313, DOI 10.1016/0959-4388(94)90091-4; SCHNEIDER T, 1994, RECEPTOR CHANNEL, V2, P255; SOONG TW, 1993, SCIENCE, V260, P1133, DOI 10.1126/science.8388125; Sun YM, 1997, J GEN PHYSIOL, V110, P693, DOI 10.1085/jgp.110.6.693; Talavera K, 2001, J BIOL CHEM, V276, P45628, DOI 10.1074/jbc.M103047200; Tottene A, 2000, J NEUROSCI, V20, P171, DOI 10.1523/JNEUROSCI.20-01-00171.2000; TSIEN RW, 1988, TRENDS NEUROSCI, V11, P431, DOI 10.1016/0166-2236(88)90194-4; TSIEN RW, 1996, LOW VOLTAGE ACTIVATE; Tsushima RG, 1997, J GEN PHYSIOL, V109, P463, DOI 10.1085/jgp.109.4.463; Varadi G, 1999, CRIT REV BIOCHEM MOL, V34, P181, DOI 10.1080/10409239991209264; VYKLICKY L, 1988, NEUROSCI LETT, V89, P313, DOI 10.1016/0304-3940(88)90545-9; Williamson AV, 1999, BIOPHYS J, V77, P2575, DOI 10.1016/S0006-3495(99)77092-X; Wu XS, 2000, J BIOL CHEM, V275, P31778, DOI 10.1074/jbc.M004829200; Yang N, 1999, BIOPHYS J, V76, pA259; ZAREI MM, 1995, J NEUROSCI, V15, P1446	69	38	41	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2002	277	48					45969	45976		10.1074/jbc.M203922200	http://dx.doi.org/10.1074/jbc.M203922200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620JB	12198115	hybrid			2022-12-27	WOS:000179529300036
J	Maynard, CJ; Cappai, R; Volitakis, I; Cherny, RA; White, AR; Beyreuther, K; Masters, CL; Bush, AI; Li, QX				Maynard, CJ; Cappai, R; Volitakis, I; Cherny, RA; White, AR; Beyreuther, K; Masters, CL; Bush, AI; Li, QX			Overexpression of Alzheimer's disease amyloid-beta opposes the age-dependent elevations of brain copper and iron	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							A-BETA; TRANSGENIC MICE; TRACE-ELEMENTS; PRECURSOR PROTEIN; OXIDATIVE STRESS; CEREBROSPINAL-FLUID; CATALYZED OXIDATION; BINDING-SITE; SERUM ZINC; CONSEQUENCES	Increased brain metal levels have been associated with normal aging and a variety of diseases, including Alzheimer's disease (AD). Copper and iron levels both show marked increases with age and may adversely interact with the amyloid-beta (Abeta) peptide causing its aggregation and the production of neurotoxic hydrogen peroxide (H2O2), contributing to the pathogenesis of AD. Amyloid precursor protein (APP) possesses copper/zinc binding sites in its amino-terminal domain and in the Abeta domain. Here we demonstrate that overexpression of the carboxyl-terminal fragment of APP, containing Abeta, results in significantly reduced copper and iron levels in transgenic mouse brain, while overexpression of the APP in Tg2576 transgenic mice results in significantly reduced copper, but not iron, levels prior to the appearance of amyloid neuropathology and throughout the lifespan of the mouse. Concomitant increases in brain manganese levels were observed with both transgenic strains. These findings, complemented by our previous findings of elevated copper levels in APP knock-out mice, support roles for APP and Abeta in physiological metal regulation.	Mental Hlth Res Inst Victoria, Parkville, Vic 3052, Australia; Univ Heidelberg, Zentrum Mol Biol Heidelberg, D-69120 Heidelberg, Germany; Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Psychiat, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Massachusetts Gen Hosp, Lab Oxidat Biol Genet & Aging Res Unit, Charlestown, MA 02129 USA	Ruprecht Karls University Heidelberg; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Li, QX (corresponding author), Univ Melbourne, Dept Pathol, Melbourne, Vic 3010, Australia.		Bush, Ashley I/A-1186-2007; Bush, Ashley/Y-2457-2019; Cappai, Roberto/B-3347-2010; White, Anthony/P-5596-2016	Bush, Ashley I/0000-0001-8259-9069; Bush, Ashley/0000-0001-8259-9069; Volitakis, Irene/0000-0003-0766-817X; Cappai, Roberto/0000-0002-9505-8496; White, Anthony/0000-0003-1802-9891	NIA NIH HHS [R01AG12656] Funding Source: Medline	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Atwood CS, 1998, J BIOL CHEM, V273, P12817, DOI 10.1074/jbc.273.21.12817; Atwood CS, 2000, J NEUROCHEM, V75, P1219, DOI 10.1046/j.1471-4159.2000.0751219.x; Atwood CS, 1999, MET IONS BIOL SYST, V36, P309; Bartzokis G, 1997, MAGN RESON IMAGING, V15, P29, DOI 10.1016/S0730-725X(96)00234-2; BASUN H, 1991, J NEURAL TRANSM-PARK, V3, P231; BOHNEN N, 1994, Z GERONTOL, V27, P324; BUSH AI, 1994, J BIOL CHEM, V269, P12152; BUSH AI, 1994, SCIENCE, V265, P1464, DOI 10.1126/science.8073293; Bush AI, 2000, CURR OPIN CHEM BIOL, V4, P184, DOI 10.1016/S1367-5931(99)00073-3; BUSH AI, 1993, J BIOL CHEM, V268, P16109; Callahan MJ, 2001, AM J PATHOL, V158, P1173, DOI 10.1016/S0002-9440(10)64064-3; Cherny RA, 2001, NEURON, V30, P665, DOI 10.1016/S0896-6273(01)00317-8; Cherny RA, 1999, J BIOL CHEM, V274, P23223, DOI 10.1074/jbc.274.33.23223; CONNOR JR, 1992, J NEUROSCI RES, V31, P327, DOI 10.1002/jnr.490310214; Cornett CR, 1998, NEUROTOXICOLOGY, V19, P339; Cuajungco MP, 2000, J BIOL CHEM, V275, P19439, DOI 10.1074/jbc.C000165200; Deibel MA, 1996, J NEUROL SCI, V143, P137, DOI 10.1016/S0022-510X(96)00203-1; Del Corso L, 2000, PANMINERVA MED, V42, P273; DRAYER B, 1986, AM J ROENTGENOL, V147, P103, DOI 10.2214/ajr.147.1.103; Frederickson CJ, 2001, BIOMETALS, V14, P353, DOI 10.1023/A:1012934207456; Gonzalez C, 1999, EUR J CLIN INVEST, V29, P637; HARTTER DE, 1988, J BIOL CHEM, V263, P799; HESSE L, 1994, FEBS LETT, V349, P109, DOI 10.1016/0014-5793(94)00658-X; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; HSIAO KK, 1995, NEURON, V15, P1203, DOI 10.1016/0896-6273(95)90107-8; Huang XD, 1999, BIOCHEMISTRY-US, V38, P7609, DOI 10.1021/bi990438f; Huang XD, 1997, J BIOL CHEM, V272, P26464, DOI 10.1074/jbc.272.42.26464; Huang XD, 1999, J BIOL CHEM, V274, P37111, DOI 10.1074/jbc.274.52.37111; Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001; Kontush A, 2001, FREE RADICAL BIO MED, V30, P119, DOI 10.1016/S0891-5849(00)00458-5; Lee JY, 1999, J NEUROSCI, V19, DOI 10.1523/jneurosci.19-11-j0002.1999; Lee JY, 2002, P NATL ACAD SCI USA, V99, P7705, DOI 10.1073/pnas.092034699; Li QX, 1999, J NEUROCHEM, V72, P2479, DOI 10.1046/j.1471-4159.1999.0722479.x; Loeffler DA, 1996, BRAIN RES, V738, P265, DOI 10.1016/S0006-8993(96)00782-2; Lovell MA, 1998, J NEUROL SCI, V158, P47, DOI 10.1016/S0022-510X(98)00092-6; MARKESBERY WR, 1984, NEUROBIOL AGING, V5, P19, DOI 10.1016/0197-4580(84)90081-2; Martin WRW, 1998, MOVEMENT DISORD, V13, P281; MASSIE HR, 1979, MECH AGEING DEV, V10, P93, DOI 10.1016/0047-6374(79)90073-3; MASTERS CL, 2002, 7 INT GEN SPRINGF AL; McLoughlin DM, 2001, J BIOL CHEM, V276, P9303, DOI 10.1074/jbc.M010023200; MORITA A, 1994, BIOL TRACE ELEM RES, V42, P165, DOI 10.1007/BF02785387; Multhaup G, 1996, SCIENCE, V271, P1406, DOI 10.1126/science.271.5254.1406; PAPPOLLA MA, 1992, AM J PATHOL, V140, P621; PLANTIN LO, 1987, BIOL TRACE ELEM RES, V13, P69, DOI 10.1007/BF02796622; Rao KSJ, 1999, ALZHEIMERS REP, V2, P241; SAMUDRALWAR DL, 1995, J NEUROL SCI, V130, P139, DOI 10.1016/0022-510X(95)00018-W; SCOTT MR, 1992, PROTEIN SCI, V1, P986, DOI 10.1002/pro.5560010804; Smith MA, 2000, BBA-MOL BASIS DIS, V1502, P139, DOI 10.1016/S0925-4439(00)00040-5; Smith MA, 1995, J NEUROL SCI, V134, P92, DOI 10.1016/0022-510X(95)00213-L; Smith MA, 1998, J NEUROCHEM, V70, P2212, DOI 10.1046/j.1471-4159.1998.70052212.x; Squitti R, 2002, EUR J CLIN INVEST, V32, P51, DOI 10.1046/j.1365-2362.2002.00933.x; STADTMAN ER, 1991, J BIOL CHEM, V266, P2005; STADTMAN ER, 1990, FREE RADICAL BIO MED, V9, P315, DOI 10.1016/0891-5849(90)90006-5; THOMAS LO, 1993, AM J NEURORADIOL, V14, P1043; White AR, 1999, BRAIN RES, V842, P439, DOI 10.1016/S0006-8993(99)01861-2; WOODWARD WD, 1984, J GERONTOL, V39, P521, DOI 10.1093/geronj/39.5.521; Wu SM, 1997, J BIOL CHEM, V272, P20627, DOI 10.1074/jbc.272.33.20627; Yassin MS, 2000, J NEUROL SCI, V173, P40, DOI 10.1016/S0022-510X(99)00297-X; Zecca L, 2001, J NEUROCHEM, V76, P1766, DOI 10.1046/j.1471-4159.2001.00186.x	59	300	309	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 22	2002	277	47					44670	44676		10.1074/jbc.M204379200	http://dx.doi.org/10.1074/jbc.M204379200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	618EE	12215434	hybrid			2022-12-27	WOS:000179404800011
J	Ge, WW; Wu, JJ; Zhai, JB; Nie, ZY; Lin, H; Schlaepfer, WW; Canete-Soler, R				Ge, WW; Wu, JJ; Zhai, JB; Nie, ZY; Lin, H; Schlaepfer, WW; Canete-Soler, R			Binding of p190RhoGEF to a destabilizing element on the light neurofilament mRNA is competed by BC1 RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE FACTOR; SINGLE-STRANDED-DNA; MOLECULAR-CLONING; DENDRITIC LOCATION; PUR ALPHA; RAT CDNAS; EXPRESSION; GENE; PROTEIN; IDENTIFICATION	The enhancement of RNA-mediated motor neuron degeneration in transgenic mice by mutating a major mRNA instability determinant in a light neurofilament (NF-L) transgene implicates cognate RNA binding factors in the pathogenesis of motor neuron degeneration. p190RhoGEF is a neuron-enriched guanine exchange factor (GEF) that binds to the NF-L-destabilizing element, to c-Jun N-terminal kinase-interactive protein-1 (JIP-1), and to 14-3-3 and may link neurofilament expression to pathways affecting neuronal homeostasis. This study was undertaken to identify additional RNA species that bind p190RhoGEF and could affect interactions of the exchange factor with NF-L transcripts. The C-terminal domain of p190RhoGEF, containing the RNA-binding site, was expressed as a glutathione S-transferase fusion protein and was used as an affinity probe to isolate interactive RNAs in rat brain extracts. As expected, NF-L mRNA was identified as an RNA specie eluted from the affinity column. In addition, BC1 RNA was also found enriched in the bound RNA fraction. BC1 is a 152-nucleotide RNA that is highly expressed but untranslated in differentiated neurons. We show that BC1 and NF-L mRNA bind to a similar site in the C-terminal domain of p190RhoGEF, and their bindings to p190RhoGEF are readily cross-competed. Moreover, we identify a novel binding site in BC1 to account for its interaction with p190RhoGEF. The findings suggest a novel role of BC1 in differentiated neurons involving RNA-protein interactions of p190RhoGEF.	Univ Penn, Ctr Med, Stellar Chance Labs 609C, Div Neuropathol, Philadelphia, PA 19104 USA	University of Pennsylvania	Ge, WW (corresponding author), Univ Penn, Ctr Med, Stellar Chance Labs 609C, Div Neuropathol, 422 Curie Blvd, Philadelphia, PA 19104 USA.	wws435jp@mail.med.upenn.edu						Brosius J, 1999, GENE, V238, P115, DOI 10.1016/S0378-1119(99)00227-9; Canete-Soler R, 1999, J NEUROSCI, V19, P1273; Canete-Soler R, 2001, J BIOL CHEM, V276, P32046, DOI 10.1074/jbc.M104104200; COTE F, 1993, CELL, V73, P35, DOI 10.1016/0092-8674(93)90158-M; DECHIARA TM, 1987, P NATL ACAD SCI USA, V84, P2624, DOI 10.1073/pnas.84.9.2624; Deininger PL, 1996, PROG NUCLEIC ACID RE, V52, P67, DOI 10.1016/S0079-6603(08)60964-2; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; Gebbink MFBG, 1997, J CELL BIOL, V137, P1603, DOI 10.1083/jcb.137.7.1603; Hadano S, 2001, NAT GENET, V29, P166, DOI 10.1038/ng1001-166; KIM J, 1995, NUCLEIC ACIDS RES, V23, P2245, DOI 10.1093/nar/23.12.2245; Kobayashi S, 2000, BIOCHEM BIOPH RES CO, V277, P341, DOI 10.1006/bbrc.2000.3683; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; LEE MK, 1994, NEURON, V13, P975, DOI 10.1016/0896-6273(94)90263-1; Lee SY, 2000, J CELL SCI, V113, P1883; Li Z, 2000, NAT NEUROSCI, V3, P217, DOI 10.1038/72920; MARTIGNETTI JA, 1993, P NATL ACAD SCI USA, V90, P9698, DOI 10.1073/pnas.90.20.9698; MCKINNON RD, 1987, MOL CELL BIOL, V7, P2148, DOI 10.1128/MCB.7.6.2148; Meyer D, 1999, J BIOL CHEM, V274, P35113, DOI 10.1074/jbc.274.49.35113; Mighell AJ, 1997, FEBS LETT, V417, P1, DOI 10.1016/S0014-5793(97)01259-3; Mourelatos Z, 2002, GENE DEV, V16, P720, DOI 10.1101/gad.974702; Muslimov IA, 2002, J NEUROSCI, V22, P4293, DOI 10.1523/JNEUROSCI.22-11-04293.2002; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; Nie ZY, 2002, J NEUROSCI, V22, P7662; Ohashi S, 2000, J NEUROCHEM, V75, P1781, DOI 10.1046/j.1471-4159.2000.0751781.x; Pellet JB, 2000, EUR J NEUROSCI, V12, P621, DOI 10.1046/j.1460-9568.2000.00945.x; Reed R, 2002, CELL, V108, P523, DOI 10.1016/S0092-8674(02)00627-X; Roy AM, 2000, GENOME RES, V10, P1485, DOI 10.1101/gr.152300; SCHLAEPFER WW, 1990, J NEUROCHEM, V55, P453, DOI 10.1111/j.1471-4159.1990.tb04157.x; Steggerda SM, 2002, INT REV CYTOL, V217, P41; TIEDGE H, 1991, P NATL ACAD SCI USA, V88, P2093, DOI 10.1073/pnas.88.6.2093; TIEDGE H, 1993, J NEUROSCI, V13, P2382, DOI 10.1523/JNEUROSCI.13-06-02382.1993; Tomilin NV, 1999, INT REV CYTOL, V186, P1; van Horck FPG, 2001, J BIOL CHEM, V276, P4948, DOI 10.1074/jbc.M003839200; WATANABE M, 1991, MOL BRAIN RES, V10, P151, DOI 10.1016/0169-328X(91)90105-7; WATANABE M, 1993, MOL BRAIN RES, V17, P135, DOI 10.1016/0169-328X(93)90082-Z; WATANABE M, 1994, MOL BRAIN RES, V25, P113, DOI 10.1016/0169-328X(94)90285-2; WONG PC, 1995, J CELL BIOL, V130, P1413, DOI 10.1083/jcb.130.6.1413; XU ZS, 1993, CELL, V73, P23, DOI 10.1016/0092-8674(93)90157-L; Yang Y, 2001, NAT GENET, V29, P160, DOI 10.1038/ng1001-160; Zhai JB, 2001, J BIOL CHEM, V276, P41318, DOI 10.1074/jbc.M107709200	41	18	19	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					42701	42705		10.1074/jbc.M206635200	http://dx.doi.org/10.1074/jbc.M206635200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12215442	hybrid			2022-12-27	WOS:000179081200036
J	Nes, WD; Marshall, JA; Jia, ZH; Jaradat, TT; Song, ZH; Jayasimha, P				Nes, WD; Marshall, JA; Jia, ZH; Jaradat, TT; Song, ZH; Jayasimha, P			Active site mapping and substrate channeling in the sterol methyltransferase pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENOSYL-L-METHIONINE; DELTA(24(28))-STEROL METHYL TRANSFERASE; MECHANISM-BASED INHIBITOR; SACCHAROMYCES-CEREVISIAE; STRUCTURAL REQUIREMENTS; ANTIFUNGAL AGENTS; BIOSYNTHESIS; (S)-ADENOSYL-L-METHIONINE; TRANSFORMATION; DELTA(24(25))	Sterol methyltransferase (SMT) from Saccharomyces cerevisiae was purified from Escherichia coli BL21(DE3) and labeled with the mechanism-based irreversible inhibitor [3(-3)H]26,27-dehydrozymosterol (26,27-DHZ). A 5-kDa tryptic digest peptide fragment containing six acidic residues at positions Glu-64, Asp65, Glu-68, Asp-79, Glu-82, and Glu-98 was determined to contain the substrate analog covalently attached to Glu-68 by Edman sequencing and radioanalysis using C-18 reverse phase high performance liquid chromatography. Site-directed mutagenesis of the six acidic residues to leucine followed by activity assay of the purified mutants confirmed Glu-68 as the only residue to participate in affinity labeling. Equilibration studies indicated that zymosterol and 26,27-DHZ were bound to native and the E68L mutant with similar affinity, whereas S-adenosylmethionine was bound only to the native SMT, K-d of about 2 muM. Analysis of the incubation products of the wild-type and six leucine mutants by GC-MS demonstrated that zymosterol was converted to fecosterol, 26,27-DHZ was converted to 26-homo-cholesta-8(9),23(24)E,26(26')-trienol as well as 26-homocholesta-8(9),26(26')-3beta,24beta-dienol, and in the case of D79L and E82L mutants, zymosterol was also converted to a new product, 24-methylzymosta-8,25(27)-dienol. The structures of the methylenecyclopropane ring-opened olefins were determined unambiguously by a combination of H-1 and C-13 NMR techniques. A K-m of 15 mum, K-cat of 8 X 10(-4) s(-1), and partition ratio of 0.03 was established for 26,27-DHZ, suggesting that the methylenecyclopropane can serve as a lead structure for a new class of antifungal agents. Taken together, partitioning that leads to loss of enzyme function is the result of 26,27-DHZ catalysis forming a highly reactive cationic intermediate that interacts with the enzyme in a region normally not occupied by the zymosterol high energy intermediate as a consequence of less than perfect control. Alternatively, the gain in enzyme function resulting from the production of a Delta(25(27))-olefin originates with the leucine substitution directing substrate channeling along different reaction channels in a similar region at the active site.	Texas Tech Univ, Dept Chem & Biochem, Lubbock, TX 79409 USA	Texas Tech University System; Texas Tech University	Nes, WD (corresponding author), Texas Tech Univ, Dept Chem & Biochem, Lubbock, TX 79409 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063477] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM63477] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Beuchet P, 1999, BIOORG MED CHEM LETT, V9, P1599, DOI 10.1016/S0960-894X(99)00233-4; BLOCH KE, 1983, CRC CR REV BIOCH MOL, V14, P47, DOI 10.3109/10409238309102790; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chung SK, 1998, TETRAHEDRON, V54, P15899, DOI 10.1016/S0040-4020(98)01000-X; Contreras LM, 1997, BIOCHEM PHARMACOL, V53, P697, DOI 10.1016/S0006-2952(96)00903-3; COPELAND RA, 2000, ENZYMES PRACTICAL IN; CROTEAU R, 1993, ARCH BIOCHEM BIOPHYS, V307, P397, DOI 10.1006/abbi.1993.1606; DING L, 1999, J AM CHEM SOC, V121, P9034; Georgopapadakou NH, 1998, CURR OPIN MICROBIOL, V1, P547, DOI 10.1016/S1369-5274(98)80087-8; Giner JL, 1995, J AM CHEM SOC, V117, P12871, DOI 10.1021/ja00156a030; GINER JL, 1991, J AM CHEM SOC, V113, P1386, DOI 10.1021/ja00004a047; GOAD LJ, 1974, LIPIDS, V9, P582, DOI 10.1007/BF02532508; HARDWICK KG, 1994, YEAST, V10, P265, DOI 10.1002/yea.320100213; HARWOOD LM, 1979, INTRO ORGANIC SPECTR; JANSSEN GG, 1992, J BIOL CHEM, V267, P25856; JIA Z, 1996, SYNTHETIC COMMUN, V26, P1533; KALINOWSKA M, 1990, PHYTOCHEMISTRY, V29, P3427, DOI 10.1016/0031-9422(90)85251-A; Marshall JA, 1999, BIOORG MED CHEM LETT, V9, P1533, DOI 10.1016/S0960-894X(99)00242-5; MIHAILOVIC M, 1984, BIOSYNTHESIS PHYTOST; Nes WD, 1997, ARCH BIOCHEM BIOPHYS, V342, P68, DOI 10.1006/abbi.1997.9984; Nes WD, 2000, BBA-MOL CELL BIOL L, V1529, P63, DOI 10.1016/S1388-1981(00)00138-4; Nes WD, 1998, BIOORG MED CHEM LETT, V8, P3449; NES WD, 1991, J BIOL CHEM, V266, P15202; Nes WD, 1998, ARCH BIOCHEM BIOPHYS, V353, P297, DOI 10.1006/abbi.1998.0665; Nes WD, 1999, J ORG CHEM, V64, P1535, DOI 10.1021/jo9819943; NES WR, 1978, J BIOL CHEM, V253, P6218; OHTANI I, 1991, J AM CHEM SOC, V113, P4092, DOI 10.1021/ja00011a006; RAHIER A, 1984, J BIOL CHEM, V259, P5215; SIMMS SA, 1991, J BIOL CHEM, V266, P12741; Urbina JA, 1997, ANTIMICROB AGENTS CH, V41, P1428, DOI 10.1128/AAC.41.7.1428; Venkatramesh M, 1996, BBA-LIPID LIPID MET, V1299, P313, DOI 10.1016/0005-2760(95)00218-9; WAKEFIELD BJ, 1995, ORGANOMAGENISUM METH	32	37	38	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					42549	42556		10.1074/jbc.M204223200	http://dx.doi.org/10.1074/jbc.M204223200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12196515	hybrid			2022-12-27	WOS:000179081200017
J	Ratnam, S; Maclean, KN; Jacobs, RL; Brosnan, ME; Kraus, JP; Brosnan, JT				Ratnam, S; Maclean, KN; Jacobs, RL; Brosnan, ME; Kraus, JP; Brosnan, JT			Hormonal regulation of cystathionine beta-synthase expression in liver	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; HOMOCYSTEINE METABOLISM; ENDOTHELIAL DYSFUNCTION; PLASMA HOMOCYSTEINE; PHOSPHOENOLPYRUVATE CARBOXYKINASE; TRANSCRIPTIONAL REGULATION; DIABETES-MELLITUS; RAT HEPATOCYTES; GENE-EXPRESSION; INSULIN	Homocysteine metabolism is altered in diabetic patients. Cystathionine beta-synthase (CBS), a key enzyme involved in the transsulfuration pathway, which irreversibly converts homocysteine to cysteine, catalyzes the condensation of serine and homocysteine to cystathionine. Studies in streptozotocin-induced diabetic rats have shown that CBS enzyme activity is elevated in the liver but not in the kidney, and this effect is reversed by insulin treatment. To determine whether these effects resulted from alterations at the level of gene transcription, CBS mRNA was measured in diabetic and insulin-treated diabetic rats. CBS mRNA levels were found to be markedly higher in streptozotocin-induced diabetic rat livers; these were reduced by insulin administration. In H4IIE cells, a rat hepatoma cell culture model, glucocorticoids increased the cellular levels of CBS enzyme protein and CBS mRNA, insulin inhibited this stimulatory effect. Treatment with insulin also decreased CBS levels in HepG2 cells, a human hepatoma cell line. Nuclear run-on experiments in the rat cells confirmed that stimulation of CBS gene expression by glucocorticoids and the inhibition by insulin occurred at the transcriptional level. Transient transfections of HepG2 cells with a CBS-1b promoter luciferase reporter construct showed that the promoter activity was decreased by 70% after insulin treatment. These results show that insulin has a direct role in regulating homocysteine metabolism. Altered insulin levels in diseases such as diabetes may influence homocysteine metabolism by regulating the hepatic transsulfuration pathway.	Mem Univ Newfoundland, Dept Biochem, St John, NF A1B 3X9, Canada; Univ Colorado, Sch Med, Dept Pediat, Denver, CO 80262 USA	Memorial University Newfoundland; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Brosnan, JT (corresponding author), Mem Univ Newfoundland, Dept Biochem, St John, NF A1B 3X9, Canada.	jbrosnan@mun.ca		Jacobs, Rene/0000-0002-5525-1355				BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; BERGMEYER HU, 1981, METHOD ENZYMAT AN, V3, P1196; BOERS GHJ, 1985, NEW ENGL J MED, V313, P709, DOI 10.1056/NEJM198509193131201; BOSTOM A, 1995, ATHEROSCLEROSIS, V116, P59, DOI 10.1016/0021-9150(95)05522-X; BRATTSTROM L, 1988, METABOLISM, V37, P175, DOI 10.1016/S0026-0495(98)90014-2; BROSNAN JT, 1983, AM J PHYSIOL, V244, pE151, DOI 10.1152/ajpendo.1983.244.2.E151; CHADEFAUX B, 1988, LANCET, V2, P741; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Eberhardt RT, 2000, J CLIN INVEST, V106, P483, DOI 10.1172/JCI8342; FINKELSTEIN JD, 1984, J BIOL CHEM, V259, P9508; FINKELSTEIN JD, 1975, BIOCHEM BIOPH RES CO, V66, P81, DOI 10.1016/S0006-291X(75)80297-X; Finkelstein JD, 1998, EUR J PEDIATR, V157, pS40, DOI 10.1007/PL00014300; Freshney R.I, 2010, CULTURE ANIMAL CELLS, Vsixth, P732; Fukuda H, 2001, BIOCHEM BIOPH RES CO, V280, P1274, DOI 10.1006/bbrc.2001.4260; Ge YB, 2001, J BIOL CHEM, V276, P43570, DOI 10.1074/jbc.M104930200; GOSS SJ, 1986, J CELL SCI, V82, P309; GREENBERG ME, 1997, CURRENT PROTOCOLS MO; Hofmann MA, 1997, DIABETES CARE, V20, P1880, DOI 10.2337/diacare.20.12.1880; Hoogeveen EK, 1998, ARTERIOSCL THROM VAS, V18, P133, DOI 10.1161/01.ATV.18.1.133; House JD, 1997, BIOCHEM J, V328, P287; HULTBERG B, 1991, SCAND J CLIN LAB INV, V51, P277, DOI 10.3109/00365519109091615; Jacobs RL, 1998, DIABETES, V47, P1967, DOI 10.2337/diabetes.47.12.1967; Jacobs RL, 2001, J BIOL CHEM, V276, P43740, DOI 10.1074/jbc.M107553200; JONES BN, 1983, J CHROMATOGR, V266, P471, DOI 10.1016/S0021-9673(01)90918-5; KRAUS JP, 1987, METHOD ENZYMOL, V143, P388; Kraus JP, 1998, GENOMICS, V52, P312, DOI 10.1006/geno.1998.5437; KREBS HA, 1986, BIOCHEM J, V158, P341; KUTZBACH C, 1971, BIOCHIM BIOPHYS ACTA, V250, P459, DOI 10.1016/0005-2744(71)90247-6; LAMERS WH, 1982, P NATL ACAD SCI-BIOL, V79, P5137, DOI 10.1073/pnas.79.17.5137; Lentz SR, 2000, AM J PHYSIOL-HEART C, V279, pH970, DOI 10.1152/ajpheart.2000.279.3.H970; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maclean KN, 2002, J CELL PHYSIOL, V192, P81, DOI 10.1002/jcp.10118; MACLEAN KN, 2001, 3 INT C HOM MET SORR, P54; Marinovic AC, 2002, J BIOL CHEM, V277, P16673, DOI 10.1074/jbc.M200501200; MILLER JW, 1994, BIOCHEM J, V298, P415, DOI 10.1042/bj2980415; MUNKE M, 1988, AM J HUM GENET, V42, P550; NEBES VL, 1988, MOL ENDOCRINOL, V2, P444, DOI 10.1210/mend-2-5-444; O'Brien RM, 2001, BIOCHEM SOC T, V29, P552, DOI 10.1042/BST0290552; OBRIEN RM, 1991, BIOCHEM J, V278, P609, DOI 10.1042/bj2780609; Pogribna M, 2001, AM J HUM GENET, V69, P88, DOI 10.1086/321262; ROBILLON JF, 1994, DIABETES METAB, V20, P494; Roper MD, 1996, MAMM GENOME, V7, P754, DOI 10.1007/s003359900226; SASAKI K, 1984, J BIOL CHEM, V259, P5242; SCHMID E, 1987, EUR J BIOCHEM, V165, P499, DOI 10.1111/j.1432-1033.1987.tb11467.x; SKOVBY F, 1984, HUM GENET, V65, P291, DOI 10.1007/BF00286520; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SWAROOP M, 1992, J BIOL CHEM, V267, P11455; Taoka S, 1998, J BIOL CHEM, V273, P25179, DOI 10.1074/jbc.273.39.25179; UNGER RH, 1976, DIABETES, V25, P136, DOI 10.2337/diab.25.2.136; VESTER B, 1991, EUR J CLIN CHEM CLIN, V29, P549; WATANABE M, 1995, P NATL ACAD SCI USA, V92, P1585, DOI 10.1073/pnas.92.5.1585; Weiss N, 2002, ARTERIOSCL THROM VAS, V22, P34, DOI 10.1161/hq1201.100456; Weiss N, 2001, P NATL ACAD SCI USA, V98, P12503, DOI 10.1073/pnas.231428998; WILSON DE, 1983, ANN INTERN MED, V98, P219, DOI 10.7326/0003-4819-98-2-219; YAMAMOTO N, 1995, J NUTR SCI VITAMINOL, V41, P197, DOI 10.3177/jnsv.41.197; Yeromenko Y, 2001, NUTR METAB CARDIOVAS, V11, P108	56	117	119	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					42912	42918		10.1074/jbc.M206588200	http://dx.doi.org/10.1074/jbc.M206588200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12198128	hybrid			2022-12-27	WOS:000179081200064
J	Ruban, AV; Pascal, A; Lee, PJ; Robert, B; Horton, P				Ruban, AV; Pascal, A; Lee, PJ; Robert, B; Horton, P			Molecular configuration of xanthophyll cycle carotenoids in photosystem II antenna complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-HARVESTING COMPLEX; PLANTS; PHOTOPROTECTION; MEMBRANE; DYNAMICS; BINDING	The molecular configuration of the xanthophyll cycle carotenoids, violaxanthin and zeaxanthin, was studied in various isolated photosystem II antenna components in comparison to intact photosystem II membranes using resonance Raman combined with low-temperature absorption spectroscopy. The molecular configurations of zeaxanthin and violaxanthin in thylakoids and isolated photosystem II membranes were found to be the same within an isolated oligomeric LHCII antenna, confirming our recent conclusion that these molecules are not freely located in photosynthetic membranes (Ruban, A V., Pascal, A. A., Robert, B., and Horton, P. (2001) J. Biol. Chem. 276, 24862-24870). In contrast, xanthophyll cycle carotenoids bound to LHCII trimers had largely lost their in vivo configuration, suggesting their partial dissociation from the binding locus. Violaxanthin and zeaxanthin associated with the minor antenna complexes, CP26 and CP29, were also found to be in a relaxed configuration, similar to that of free pigment. The origin of the characteristic C-H vibrational bands of violaxanthin and zeaxanthin in vivo is discussed by comparison with those of neoxanthin and lutein in oligomeric and trimeric LHCII respectively.	Univ Sheffield, Dept Mol Biol & Biotechnol, Robert Hill Inst, Sheffield S10 2TN, S Yorkshire, England; Ecole Normale Super, CNRS, Dept Biol, Unite Mixte Rech 8543, F-75230 Paris 05, France; CEA Saclay, Serv Biophys Fonct Membranaires, F-91191 Gif Sur Yvette, France; CEA Saclay, CNRS, URA 2096, F-91191 Gif Sur Yvette, France	University of Sheffield; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); CEA; UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS)	Ruban, AV (corresponding author), Univ Sheffield, Dept Mol Biol & Biotechnol, Robert Hill Inst, Sheffield S10 2TN, S Yorkshire, England.	a.ruban@sheffield.ac.uk	Robert, Bruno/D-1264-2012; Horton, Peter/A-3958-2012; pascal, andrew a/B-6186-2014	Robert, Bruno/0000-0001-5999-4538; Horton, Peter/0000-0002-6095-1460; pascal, andrew a/0000-0002-1844-6065				Baker NR, 1994, PHOTOINHIBITION PHOT; BASSI R, 1993, EUR J BIOCHEM, V212, P297, DOI 10.1111/j.1432-1033.1993.tb17662.x; Boekema EJ, 2000, J MOL BIOL, V301, P1123, DOI 10.1006/jmbi.2000.4037; Boekema EJ, 1998, FEBS LETT, V424, P95, DOI 10.1016/S0014-5793(98)00147-1; DEMMIGADAMS B, 1990, BIOCHIM BIOPHYS ACTA, V1020, P1, DOI 10.1016/0005-2728(90)90088-L; Gilmore AM, 1997, PHYSIOL PLANTARUM, V99, P197, DOI 10.1034/j.1399-3054.1997.990127.x; Havaux M, 1999, P NATL ACAD SCI USA, V96, P8762, DOI 10.1073/pnas.96.15.8762; Horton P, 2000, PHILOS T R SOC B, V355, P1361, DOI 10.1098/rstb.2000.0698; Horton P, 1996, ANNU REV PLANT PHYS, V47, P655, DOI 10.1146/annurev.arplant.47.1.655; JOHNSON GN, 1993, PLANT CELL ENVIRON, V16, P681, DOI 10.1111/j.1365-3040.1993.tb00486.x; KUHLBRANDT W, 1994, NATURE, V367, P614, DOI 10.1038/367614a0; LEE AL, 1995, PLANT PHYSIOL, V85, P495; OWENS TG, 1992, RES PHOTOSYNTHESIS, V4, P179; PETER GF, 1991, J BIOL CHEM, V266, P16745; Peterman EJG, 1997, CHEM PHYS LETT, V264, P279, DOI 10.1016/S0009-2614(96)01334-6; Robert B, 1999, ADV PHOTOSYNTH, V8, P189; Ruban AV, 2000, FEBS LETT, V477, P181, DOI 10.1016/S0014-5793(00)01799-3; Ruban AV, 1999, J BIOL CHEM, V274, P10458, DOI 10.1074/jbc.274.15.10458; RUBAN AV, 1994, PLANT PHYSIOL, V104, P227, DOI 10.1104/pp.104.1.227; Ruban AV, 2001, J BIOL CHEM, V276, P24862, DOI 10.1074/jbc.M103263200; SAITO S, 1983, J RAMAN SPECTROSC, V14, P310, DOI 10.1002/jrs.1250140504; STURGIS JN, 1994, J MOL BIOL, V238, P445, DOI 10.1006/jmbi.1994.1303; Verhoeven AS, 1999, PLANT PHYSIOL, V120, P727, DOI 10.1104/pp.120.3.727; YAKUSHEVSKA AE, EUR J BIOCH, V268, P6020	24	61	62	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					42937	42942		10.1074/jbc.M207823200	http://dx.doi.org/10.1074/jbc.M207823200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12207030	hybrid			2022-12-27	WOS:000179081200067
J	Lew, CM; Gralla, JD				Lew, CM; Gralla, JD			New roles for conserved regions within a sigma(54)-dependent enhancer-binding protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COUPLING ATP HYDROLYSIS; ESCHERICHIA-COLI; RNA-POLYMERASE; TRANSCRIPTIONAL ACTIVATOR; SIGMA-FACTOR; IN-VIVO; NTRC; DOMAIN; DNA; OLIGOMERIZATION	23 amino acid substitutions were made in the C7 and C3 regions of pspFDeltaHTH, a protein required to convert sigma(54) closed promoter complexes to open complexes. These mutants were assayed for transcriptional competence, for the ability to hydrolyze ATP, for their multimerization state, and for their ability to interact with sigma(54) and its holoenzyme. C7 region mutants caused the protein to assume a compact form. This property could be mimicked by the addition of ATP, implying that compaction via C7 and ATP is part of the activation process. A number of C3 mutants were important for energy coupling, as indicated previously for several members of this activator family (1, 2). However, a patch within C3 influenced oligomerization. The C3 region was especially important in interacting with sigma(54) during the transition state but not important in inducing sigma(54) holoenzyme to engage the nontemplate strand of the promoter. It is proposed that both regions contain deterrent functions that prevent premature activation. Overall, the results imply unexpected roles for the C7 and C3 regions of this protein family during promoter activation.	Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Mol Biol Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Gralla, JD (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, POB 951569, Los Angeles, CA 90095 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035754] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM35754] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Casaz P, 1997, P NATL ACAD SCI USA, V94, P12145, DOI 10.1073/pnas.94.22.12145; Chaney M, 2001, GENE DEV, V15, P2282, DOI 10.1101/gad.205501; Dworkin J, 2000, J BACTERIOL, V182, P311, DOI 10.1128/JB.182.2.311-319.2000; FLASHNER Y, 1995, J MOL BIOL, V249, P700, DOI 10.1006/jmbi.1995.0330; FOSTERHARTNETT D, 1992, MOL MICROBIOL, V6, P1049, DOI 10.1111/j.1365-2958.1992.tb02170.x; Gonzalez V, 1998, MOL MICROBIOL, V28, P55, DOI 10.1046/j.1365-2958.1998.00772.x; Gralla JD, 2000, NAT STRUCT BIOL, V7, P530, DOI 10.1038/76732; Guo YL, 2000, GENE DEV, V14, P2242, DOI 10.1101/gad.794800; Guo YL, 1999, EMBO J, V18, P3736, DOI 10.1093/emboj/18.13.3736; Jovanovic G, 1996, J BACTERIOL, V178, P1936, DOI 10.1128/jb.178.7.1936-1945.1996; Jovanovic G, 1999, J MOL BIOL, V285, P469, DOI 10.1006/jmbi.1998.2263; KLOSE KE, 1994, J MOL BIOL, V241, P233, DOI 10.1006/jmbi.1994.1492; LEE JH, 1995, P NATL ACAD SCI USA, V92, P9702, DOI 10.1073/pnas.92.21.9702; MORETT E, 1993, J BACTERIOL, V175, P6067, DOI 10.1128/JB.175.19.6067-6074.1993; Neuwald AF, 1999, GENOME RES, V9, P27; North AK, 1996, J MOL BIOL, V260, P317, DOI 10.1006/jmbi.1996.0403; O'Neill E, 2001, EMBO J, V20, P819, DOI 10.1093/emboj/20.4.819; PerezMartin J, 1996, CELL, V86, P331, DOI 10.1016/S0092-8674(00)80104-X; PITTARD AJ, 1991, MOL MICROBIOL, V5, P1585, DOI 10.1111/j.1365-2958.1991.tb01904.x; PORTER SC, 1993, GENE DEV, V7, P2258, DOI 10.1101/gad.7.11.2258; Rombel I, 1999, J BACTERIOL, V181, P4628, DOI 10.1128/JB.181.15.4628-4638.1999; SASSEDWIGHT S, 1988, P NATL ACAD SCI USA, V85, P8934, DOI 10.1073/pnas.85.23.8934; Takata M, 2000, MOL MICROBIOL, V35, P454, DOI 10.1046/j.1365-2958.2000.01722.x; Traviglia SL, 1999, BIOCHEMISTRY-US, V38, P15774, DOI 10.1021/bi9917232; Volkman BF, 2001, SCIENCE, V291, P2429, DOI 10.1126/science.291.5512.2429; Walker John M., 1996, P51, DOI 10.1007/978-1-60327-259-9_10; Wang JT, 1997, P NATL ACAD SCI USA, V94, P9538, DOI 10.1073/pnas.94.18.9538; Wang YK, 1997, MOL MICROBIOL, V26, P373, DOI 10.1046/j.1365-2958.1997.5851955.x; WEDEL A, 1990, SCIENCE, V248, P486, DOI 10.1126/science.1970441; WEISS DS, 1991, CELL, V67, P155, DOI 10.1016/0092-8674(91)90579-N; Wyman C, 1997, SCIENCE, V275, P1658, DOI 10.1126/science.275.5306.1658; Yu RC, 1998, NAT STRUCT BIOL, V5, P803, DOI 10.1038/1843	32	15	15	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					41517	41524		10.1074/jbc.M206912200	http://dx.doi.org/10.1074/jbc.M206912200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12186874	hybrid			2022-12-27	WOS:000178985300029
J	Mueller, E; Drori, S; Aiyer, A; Yie, J; Sarraf, P; Chen, H; Hauser, S; Rosen, ED; Ge, K; Roeder, RG; Spiegelman, BM				Mueller, E; Drori, S; Aiyer, A; Yie, J; Sarraf, P; Chen, H; Hauser, S; Rosen, ED; Ge, K; Roeder, RG; Spiegelman, BM			Genetic analysis of adipogenesis through peroxisome proliferator-activated receptor gamma isoforms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PPAR-GAMMA; NUCLEAR RECEPTORS; C/EBP-ALPHA; DIFFERENTIATION; EXPRESSION; COACTIVATOR; INTERACTS; PROTEIN; COMPLEX; LIGAND	dPeroxisome proliferator-activated receptor (PPAR) gamma is a nuclear receptor that is a key regulator of adipogenesis and is present in two isoforms generated by alternative splicing, PPARgamma1 and PPARgamma2. Studies of the ability of each isoform to stimulate fat differentiation have yielded ambiguous results, in part because PPARgamma stimulates its own expression. We have thus undertaken a formal genetic analysis using PPARgamma-null fibroblast cell lines to assess the specific role of each individual isoform in adipogenesis. We show here that both PPARgamma1 and PPARgamma2 have the intrinsic ability to stimulate robust adipogenesis. Adipose cells stimulated by either PPARgamma1 or PPARgamma2 express a similar gene profile and show similar responses to insulin. However, in response to low ligand concentrations, PPARgamma2 shows a quantitatively greater ability to induce adipogenesis. Analyses involving coactivator binding and transcriptional assays indicate that PPARgamma2 has an enhanced ability to bind components of the DRIP/TRAP complex, coactivators required for fat differentiation.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Millenium Pharmaceut Inc, Cambridge, MA 02139 USA; Rockefeller Univ, Biochem & Mol Biol Lab, New York, NY 10021 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals; Rockefeller University	Spiegelman, BM (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, 1 Jimmy Fund Way, Boston, MA 02115 USA.		Ge, Kai/H-2810-2019	Ge, Kai/0000-0002-7442-5138	NIDDK NIH HHS [2R37DK31405] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK031405] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9; Brown KK, 1999, DIABETES, V48, P1415, DOI 10.2337/diabetes.48.7.1415; Castillo G, 1999, EMBO J, V18, P3676, DOI 10.1093/emboj/18.13.3676; Ge K, 2002, NATURE, V417, P563, DOI 10.1038/417563a; Herman MP, 2001, CIRCULATION, V104, P1899, DOI 10.1161/hc4101.097419; Hittelman AB, 1999, EMBO J, V18, P5380, DOI 10.1093/emboj/18.19.5380; HU ED, 1995, P NATL ACAD SCI USA, V92, P9856, DOI 10.1073/pnas.92.21.9856; KLIEWER SA, 1994, P NATL ACAD SCI USA, V91, P7355, DOI 10.1073/pnas.91.15.7355; Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318; KLIEWER SA, 1995, CELL, V83, P813, DOI 10.1016/0092-8674(95)90194-9; Kubota N, 1999, MOL CELL, V4, P597, DOI 10.1016/S1097-2765(00)80210-5; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Lin JD, 2002, J BIOL CHEM, V277, P1645, DOI 10.1074/jbc.C100631200; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Rachez C, 1998, GENE DEV, V12, P1787, DOI 10.1101/gad.12.12.1787; Ren DL, 2002, GENE DEV, V16, P27, DOI 10.1101/gad.953802; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; Sarraf P, 1999, MOL CELL, V3, P799, DOI 10.1016/S1097-2765(01)80012-5; TONTONOZ P, 1994, NUCLEIC ACIDS RES, V22, P5628, DOI 10.1093/nar/22.25.5628; TONTONOZ P, 1995, CURR OPIN GENET DEV, V5, P571, DOI 10.1016/0959-437X(95)80025-5; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Wu ZD, 1998, J CLIN INVEST, V101, P22, DOI 10.1172/JCI1244; Yuan CX, 1998, P NATL ACAD SCI USA, V95, P7939, DOI 10.1073/pnas.95.14.7939; Zhu YJ, 1996, GENE EXPRESSION, V6, P185; Zhu YJ, 1997, J BIOL CHEM, V272, P25500, DOI 10.1074/jbc.272.41.25500	26	197	210	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					41925	41930		10.1074/jbc.M206950200	http://dx.doi.org/10.1074/jbc.M206950200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12200443	hybrid			2022-12-27	WOS:000178985300080
J	See, RH; Caday-Malcolm, RA; Singaraja, RR; Zhou, S; Silverston, A; Huber, MT; Moran, J; James, ER; Janoo, R; Savill, JM; Rigot, V; Zhang, LH; Wang, MH; Chimini, G; Wellington, CL; Tafuri, SR; Hayden, MR				See, RH; Caday-Malcolm, RA; Singaraja, RR; Zhou, S; Silverston, A; Huber, MT; Moran, J; James, ER; Janoo, R; Savill, JM; Rigot, V; Zhang, LH; Wang, MH; Chimini, G; Wellington, CL; Tafuri, SR; Hayden, MR			Protein kinase a site-specific phosphorylation regulates ATP-binding cassette A1 (ABCA1)-mediated phospholipid efflux	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REVERSE CHOLESTEROL TRANSPORT; KAPPA B ALPHA; TANGIER-DISEASE; CELLULAR CHOLESTEROL; MEDIATED PHOSPHORYLATION; APOPTOTIC CELLS; P-GLYCOPROTEIN; MESSENGER-RNA; ABCA1; IDENTIFICATION	ATP-binding cassette A1 (ABCA1) is a key mediator of cholesterol and phospholipid efflux to apolipoprotein particles. We show that ABCA1 is a constitutively phosphorylated protein in both RAW macrophages and in a human embryonic kidney cell line expressing ABCA1. Furthermore, we demonstrate that phosphorylation of ABCA1 is mediated by protein kinase A (PKA) or a PKA-like kinase in vivo. Through site-directed mutagenesis studies of consensus PKA phosphorylation sites and in vitro PKA kinase assays, we show that Ser-1042 and Ser-2054, located in the nucleotide binding domains of ABCA1, are major phosphorylation sites for PKA. ApoA-I-dependent phospholipid efflux was decreased significantly by mutation of Ser-2054 alone and Ser-1042/Ser2054 but was not significantly impaired with Ser-1042 alone. The mechanism by which ABCA1 phosphorylation affected ApoA-I-dependent phospholipid efflux did not involve either alterations in ApoA-I binding or changes in ABCA1 protein stability. These studies demonstrate a novel serine (Ser-2054) on the ABCA1 protein crucial for PKA phosphorylation and for regulation of ABCA1 transporter activity.	Univ British Columbia, Ctr Mol Med & Therapeut, Dept Med Genet, Vancouver, BC V5Z 4H4, Canada; Univ British Columbia, Womens & Childrens Hosp, Vancouver, BC V5Z 4H4, Canada; Xenon Genet Inc, Burnaby, BC V5G 4W8, Canada; CNRS Marseille Luminy, INSERM, Ctr Immunol, F-13288 Marseille, France; Pfizer Global Res & Dev, Cardiovasc Mol Sci & Technol, Ann Arbor, MI 48105 USA	University of British Columbia; University of British Columbia; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Pfizer	Hayden, MR (corresponding author), Univ British Columbia, Ctr Mol Med & Therapeut, Dept Med Genet, 980 W 28th Ave, Vancouver, BC V5Z 4H4, Canada.	mrh@cmmt.ubc.ca	Hayden, Michael R/D-8581-2011; James, Erick R/D-4725-2012	Hayden, Michael R/0000-0001-5159-1419; Singaraja, Roshni/0000-0002-3418-3867				Attie AD, 2001, J LIPID RES, V42, P1717; Becq F, 1997, J BIOL CHEM, V272, P2695, DOI 10.1074/jbc.272.5.2695; Bodzioch M, 1999, NAT GENET, V22, P347, DOI 10.1038/11914; Bortnick AE, 2000, J BIOL CHEM, V275, P28634, DOI 10.1074/jbc.M003407200; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; Chambenoit O, 2001, J BIOL CHEM, V276, P9955, DOI 10.1074/jbc.M010265200; CHANG XB, 1993, J BIOL CHEM, V268, P11304; CHENG SH, 1991, CELL, V66, P1027, DOI 10.1016/0092-8674(91)90446-6; Clee SM, 2001, CIRCULATION, V103, P1198; Clee SM, 2000, J CLIN INVEST, V106, P1263, DOI 10.1172/JCI10727; Cohen P, 2002, NAT CELL BIOL, V4, pE127, DOI 10.1038/ncb0502-e127; Costet P, 2000, J BIOL CHEM, V275, P28240; Deeg MA, 1997, ARTERIOSCL THROM VAS, V17, P1667, DOI 10.1161/01.ATV.17.9.1667; Fielding PE, 2000, BIOCHEMISTRY-US, V39, P14113, DOI 10.1021/bi0004192; FRANCIS GA, 1995, J CLIN INVEST, V96, P78, DOI 10.1172/JCI118082; FRANGIONI JV, 1993, ANAL BIOCHEM, V210, P179, DOI 10.1006/abio.1993.1170; Gadsby DC, 1999, ADV SEC MESS PHOSPH, V33, P79; Germann UA, 1996, J BIOL CHEM, V271, P1708, DOI 10.1074/jbc.271.3.1708; Glavy JS, 1997, J BIOL CHEM, V272, P5909, DOI 10.1074/jbc.272.9.5909; Goodfellow HR, 1996, J BIOL CHEM, V271, P13668, DOI 10.1074/jbc.271.23.13668; GREGORY RJ, 1990, NATURE, V347, P382, DOI 10.1038/347382a0; Haidar B, 2001, J LIPID RES, V42, P249; Hamon Y, 2000, NAT CELL BIOL, V2, P399, DOI 10.1038/35017029; Huang W, 2001, BBA-MOL BASIS DIS, V1537, P71, DOI 10.1016/S0925-4439(01)00058-8; KENNELLY PJ, 1991, J BIOL CHEM, V266, P15555; Lawn RM, 1999, J CLIN INVEST, V104, pR25, DOI 10.1172/JCI8119; Li QQ, 1997, BIOCHEMISTRY-US, V36, P12045, DOI 10.1021/bi970079t; LUCIANI MF, 1994, GENOMICS, V21, P150, DOI 10.1006/geno.1994.1237; McElhinny JA, 1996, MOL CELL BIOL, V16, P899; MENDEZ AJ, 1991, T ASSOC AM PHYSICIAN, V104, P48; MENDEZ AJ, 1991, J BIOL CHEM, V266, P10104; OHTAKI S, 1983, ATHEROSCLEROSIS, V49, P79, DOI 10.1016/0021-9150(83)90009-6; Oram JF, 2000, J BIOL CHEM, V275, P34508, DOI 10.1074/jbc.M006738200; ORR GA, 1993, J BIOL CHEM, V268, P25054; PICCIOTTO MR, 1992, J BIOL CHEM, V267, P12742; Remaley AT, 1997, ARTERIOSCL THROM VAS, V17, P1813, DOI 10.1161/01.ATV.17.9.1813; Rust S, 1999, NAT GENET, V22, P352, DOI 10.1038/11921; Schwarz EM, 1996, MOL CELL BIOL, V16, P3554; SEIBERT FS, 1995, J BIOL CHEM, V270, P2158, DOI 10.1074/jbc.270.5.2158; Takahashi Y, 2000, BBA-GENE STRUCT EXPR, V1492, P385, DOI 10.1016/S0167-4781(00)00133-0; Tall AR, 2000, J CLIN INVEST, V106, P1205, DOI 10.1172/JCI11538; Torres J, 2001, J BIOL CHEM, V276, P993, DOI 10.1074/jbc.M009134200; Townsend RR, 1996, PROTEIN SCI, V5, P1865, DOI 10.1002/pro.5560050912; Vanoye CG, 1999, AM J PHYSIOL-CELL PH, V276, pC370, DOI 10.1152/ajpcell.1999.276.2.C370; Wang J, 2000, ARTERIOSCL THROM VAS, V20, P1983, DOI 10.1161/01.ATV.20.8.1983; Wang N, 2000, J BIOL CHEM, V275, P33053, DOI 10.1074/jbc.M005438200; Wang N, 2001, J BIOL CHEM, V276, P23742, DOI 10.1074/jbc.M102348200; Wellington CL, 2000, J BIOL CHEM, V275, P19831, DOI 10.1074/jbc.M001475200; Wellington CL, 2002, LAB INVEST, V82, P273, DOI 10.1038/labinvest.3780421	49	102	107	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					41835	41842		10.1074/jbc.M204923200	http://dx.doi.org/10.1074/jbc.M204923200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12196520	hybrid			2022-12-27	WOS:000178985300069
J	Ward, DG; Cornes, MP; Trayer, IP				Ward, DG; Cornes, MP; Trayer, IP			Structural consequences of cardiac troponin I phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID SEQUENCE; MUSCLE TROPONIN; REGULATORY DOMAIN; MOLECULAR-CLONING; ESCHERICHIA-COLI; PROTEIN-KINASE; LIGHT CHAIN; RESOLUTION; BINDING; MUTANTS	beta-Adrenergic stimulation of the heart results in bisphosphorylation of the N-terminal extension of cardiac troponin I (TnI). Bisphosphorylation of TnI reduces the affinity of the regulatory site on troponin C (TnC) for Ca2+ by increasing the rate of Ca2+ dissociation. What remains unclear is how the phosphorylation signal is transmitted from one subunit of troponin to another. We have produced a series of mutations in the N-terminal extension of TnI designed to further our understanding of the mechanisms involved. The ability of phosphorylation of the mutant TnIs to affect Ca2+ sensitivity has been assessed. We find that the Pro residues found in a conserved (Xaa-Pro)(4) motif N-terminal to the phosphorylation sites are not required for the effect of the N-terminal extension on Ca2+ binding in the presence or absence of phosphorylation. Our experiments also reveal that the full effects of phosphorylation are seen even when residues 1-15 of TnI are deleted. If further residues are removed, not only does the effect of phosphorylation diminish but deletion of the N-terminal extension mimics phosphorylation. We propose that TnI residues 16-29 bind to TnC stabilizing the "open" Ca2+. bound state. Phosphorylation (or deletion) prevents this binding, accelerating Ca2+ release.	Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England	University of Birmingham	Trayer, IP (corresponding author), Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England.	I.P.trayer@bham.ac.uk	Cornes, Mike/K-3166-2019	Ward, Douglas/0000-0002-2328-1445				Abbott MB, 2001, BIOCHEMISTRY-US, V40, P5992, DOI 10.1021/bi0100642; ALHILLAWI E, 1994, EUR J BIOCHEM, V225, P1195, DOI 10.1111/j.1432-1033.1994.1195b.x; AUSONI S, 1994, J BIOL CHEM, V269, P339; BHANDARI DG, 1986, EUR J BIOCHEM, V160, P349, DOI 10.1111/j.1432-1033.1986.tb09978.x; Bilmen JG, 2001, EUR J BIOCHEM, V268, P6318, DOI 10.1046/j.0014-2956.2001.02589.x; BREWER S, 1990, J MOL BIOL, V216, P883, DOI 10.1016/S0022-2836(99)80008-4; CALVERT MJ, 1999, J MUSCLE RES CELL M, V20, P830; Chandra M, 1999, BIOCHEM BIOPH RES CO, V263, P219, DOI 10.1006/bbrc.1999.1341; Dohet C, 1995, FEBS LETT, V377, P131, DOI 10.1016/0014-5793(95)01319-9; Dong WJ, 2000, PROTEINS, V41, P438, DOI 10.1002/1097-0134(20001201)41:4<438::AID-PROT20>3.0.CO;2-E; Dong WJ, 1997, BIOCHEMISTRY-US, V36, P6754, DOI 10.1021/bi9622276; Dong WJ, 1997, BIOPHYS J, V72, P850, DOI 10.1016/S0006-3495(97)78719-8; FARAH CS, 1994, J BIOL CHEM, V269, P5230; Ferrieres G, 2000, FEBS LETT, V479, P99, DOI 10.1016/S0014-5793(00)01881-0; Finley N, 1999, FEBS LETT, V453, P107, DOI 10.1016/S0014-5793(99)00693-6; Gaponenko V, 1999, J BIOL CHEM, V274, P16681, DOI 10.1074/jbc.274.24.16681; Gasmi-Seabrook GMC, 1999, BIOCHEMISTRY-US, V38, P8313, DOI 10.1021/bi9902642; GRAND RJA, 1976, BIOCHEM J, V159, P633, DOI 10.1042/bj1590633; GUO XD, 1994, J BIOL CHEM, V269, P15210; HERZBERG O, 1985, NATURE, V313, P653, DOI 10.1038/313653a0; Houdusse A, 1997, STRUCTURE, V5, P1695, DOI 10.1016/S0969-2126(97)00315-8; IKEBE M, 1991, J BIOL CHEM, V266, P21339; JAQUET K, 1993, BIOCHEMISTRY-US, V32, P13873, DOI 10.1021/bi00213a016; Jaquet K, 1998, J MUSCLE RES CELL M, V19, P647, DOI 10.1023/A:1005381131102; Keane NE, 1997, EUR J BIOCHEM, V248, P329, DOI 10.1111/j.1432-1033.1997.00329.x; LESZYK J, 1988, BIOCHEMISTRY-US, V27, P2821, DOI 10.1021/bi00408a024; Li MX, 1999, BIOCHEMISTRY-US, V38, P8289, DOI 10.1021/bi9901679; LIAO RL, 1992, BIOPHYS J, V63, P986, DOI 10.1016/S0006-3495(92)81685-5; LIAO RL, 1994, BIOCHEMISTRY-US, V33, P12729, DOI 10.1021/bi00208a026; Maytum R, 2001, BIOCHEMISTRY-US, V40, P7334, DOI 10.1021/bi010072i; McKay RT, 1998, BIOCHEMISTRY-US, V37, P12419, DOI 10.1021/bi9809019; MCKILLOP DFA, 1993, BIOPHYS J, V65, P693, DOI 10.1016/S0006-3495(93)81110-X; MURPHY AM, 1991, BIOCHEMISTRY-US, V30, P707, DOI 10.1021/bi00217a018; NOLAND TA, 1995, J BIOL CHEM, V270, P25445, DOI 10.1074/jbc.270.43.25445; RAY KP, 1976, FEBS LETT, V70, P11, DOI 10.1016/0014-5793(76)80716-8; ROBERTSON SP, 1982, J BIOL CHEM, V257, P260; Sia SK, 1997, J BIOL CHEM, V272, P18216, DOI 10.1074/jbc.272.29.18216; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; TRAYER IP, 1966, BIOCHEM Z, V345, P87; VALLINS WJ, 1990, FEBS LETT, V270, P57, DOI 10.1016/0014-5793(90)81234-F; VANEERD JP, 1976, BIOCHEMISTRY-US, V15, P1171, DOI 10.1021/bi00650a033; Vassylyev DG, 1998, P NATL ACAD SCI USA, V95, P4847, DOI 10.1073/pnas.95.9.4847; Ward DG, 2001, EUR J BIOCHEM, V268, P179, DOI 10.1046/j.1432-1327.2001.01871.x; WARD DG, 2000, J MUSCLE RES CELL M, V21, P808; WATTANAPERMPOOL J, 1995, J MOL CELL CARDIOL, V27, P1383, DOI 10.1006/jmcc.1995.0131; ZHANG R, 1995, CIRC RES, V76, P1028, DOI 10.1161/01.RES.76.6.1028	46	31	33	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					41795	41801		10.1074/jbc.M206744200	http://dx.doi.org/10.1074/jbc.M206744200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12207022	hybrid			2022-12-27	WOS:000178985300064
J	Wu, CH; Nusse, R				Wu, CH; Nusse, R			Ligand receptor interactions in the Wnt signaling pathway in Drosophila	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WINGLESS MORPHOGEN GRADIENT; HEDGEHOG RECEPTOR; SPEMANN ORGANIZER; FRIZZLED FAMILY; POLARITY GENES; CELL-SURFACE; PROTEIN; ENCODES; EXPRESSION; MUTATIONS	Secreted Wnt proteins have numerous signaling functions during development, mediated by Frizzled molecules that act as Wnt receptors on the cell surface. In the genome of Drosophila, seven Writ genes (including wingless; wg), and five frizzled genes have been identified. Relatively little is known about signaling and binding specificities of different Wnt and Frizzled proteins. We have developed an assay to determine the strength of binding between membrane-tethered Wnts and ligand binding domains of the Frizzled receptors. We found a wide spectrum of binding affinities, reflecting known genetic interactions. Most Wnt proteins can bind to multiple Frizzleds and vice versa, suggesting redundancy in vivo. In an extension of these experiments, we tested whether two different subdomains of the Wg protein would by themselves bind to Frizzled and generate a biological response. Whereas these two separate domains are secreted from cells, suggesting that they form independently folded parts of the protein, they were only able to evoke a response when co-transfected, indicating that both are required for function. In addition to the Frizzleds, members of the LRP family (represented by the arrow gene in Drosophila) are also necessary for Wnt signal transduction and have been postulated to act as co-receptors. We have therefore examined whether a soluble form of the Arrow molecule can bind to Wingless and Frizzled, but no interactions were detected.	Stanford Univ, Sch Med, Dept Dev Biol, Howard Hughes Med Inst, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University	Nusse, R (corresponding author), Stanford Univ, Sch Med, Dept Dev Biol, Howard Hughes Med Inst, Stanford, CA 94305 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060388] Funding Source: NIH RePORTER; NIGMS NIH HHS [1R01GM/CA60388-01] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Alcedo J, 1996, CELL, V86, P221, DOI 10.1016/S0092-8674(00)80094-X; Bafico A, 2001, NAT CELL BIOL, V3, P683, DOI 10.1038/35083081; BAKER NE, 1988, DEVELOPMENT, V102, P489; BARTHALAY Y, 1990, EMBO J, V9, P3603, DOI 10.1002/j.1460-2075.1990.tb07571.x; BEJSOVEC A, 1995, GENETICS, V139, P309; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Bhanot P, 1999, DEVELOPMENT, V126, P4175; Cadigan KM, 1998, CELL, V93, P767, DOI 10.1016/S0092-8674(00)81438-5; Chen CM, 1999, DEVELOPMENT, V126, P5441; Chen Y, 1998, DEVELOPMENT, V125, P4943; CHENG HJ, 1994, CELL, V79, P157, DOI 10.1016/0092-8674(94)90408-1; Cohen ED, 2002, DEV CELL, V2, P437, DOI 10.1016/S1534-5807(02)00142-9; Dann CE, 2001, NATURE, V412, P86, DOI 10.1038/35083601; DELAESCALERA S, 1990, EMBO J, V9, P3593, DOI 10.1002/j.1460-2075.1990.tb07570.x; Denef N, 2000, CELL, V102, P521, DOI 10.1016/S0092-8674(00)00056-8; Dierick HA, 1998, DEVELOPMENT, V125, P4729; FLANAGAN JG, 1990, CELL, V63, P185, DOI 10.1016/0092-8674(90)90299-T; FRADKIN LG, 1995, DEV BIOL, V168, P202, DOI 10.1006/dbio.1995.1072; Hays R, 1997, DEVELOPMENT, V124, P3727; He X, 1997, SCIENCE, V275, P1652, DOI 10.1126/science.275.5306.1652; Hsieh JC, 1999, P NATL ACAD SCI USA, V96, P3546, DOI 10.1073/pnas.96.7.3546; Ingham PW, 2000, CURR BIOL, V10, P1315, DOI 10.1016/S0960-9822(00)00755-7; Janson K, 2001, MECH DEVELOP, V103, P117, DOI 10.1016/S0925-4773(01)00323-9; Kennerdell JR, 1998, CELL, V95, P1017, DOI 10.1016/S0092-8674(00)81725-0; Kozopas KM, 1998, GENE DEV, V12, P1155, DOI 10.1101/gad.12.8.1155; Kozopas KM, 2002, DEV BIOL, V243, P312, DOI 10.1006/dbio.2002.0572; Leyns L, 1997, CELL, V88, P747, DOI 10.1016/S0092-8674(00)81921-2; Lin KM, 1997, P NATL ACAD SCI USA, V94, P11196, DOI 10.1073/pnas.94.21.11196; Mao BY, 2001, NATURE, V411, P321, DOI 10.1038/35077108; Marigo V, 1996, NATURE, V384, P176, DOI 10.1038/384176a0; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Rattner A, 1997, P NATL ACAD SCI USA, V94, P2859, DOI 10.1073/pnas.94.7.2859; Rocheleau CE, 1997, CELL, V90, P707, DOI 10.1016/S0092-8674(00)80531-0; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Rulifson EJ, 2000, MOL CELL, V6, P117, DOI 10.1016/S1097-2765(00)00013-7; RUSSELL J, 1992, DEVELOPMENT, V115, P475; Sato A, 1999, DEVELOPMENT, V126, P4421; Sawa H, 1996, GENE DEV, V10, P2189, DOI 10.1101/gad.10.17.2189; Semenov MV, 2001, CURR BIOL, V11, P951, DOI 10.1016/S0960-9822(01)00290-1; Shibamoto S, 1998, GENES CELLS, V3, P659; Sivasankaran R, 2000, MECH DEVELOP, V91, P427, DOI 10.1016/S0925-4773(99)00313-5; Stone DM, 1996, NATURE, V384, P129, DOI 10.1038/384129a0; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; VANDENHEUVEL M, 1993, EMBO J, V12, P5293, DOI 10.1002/j.1460-2075.1993.tb06225.x; VANDENHEUVEL M, 1989, CELL, V59, P739, DOI 10.1016/0092-8674(89)90020-2; vandenHeuvel M, 1996, NATURE, V382, P547, DOI 10.1038/382547a0; VANLEEUWEN F, 1994, NATURE, V368, P342, DOI 10.1038/368342a0; VINSON CR, 1989, NATURE, V338, P263, DOI 10.1038/338263a0; Wang SW, 1997, CELL, V88, P757, DOI 10.1016/S0092-8674(00)81922-4; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; Willert K, 1999, DEVELOPMENT, V126, P4165; WONG LL, 1993, J CELL BIOL, V123, P209, DOI 10.1083/jcb.123.1.209; YangSnyder J, 1996, CURR BIOL, V6, P1302, DOI 10.1016/S0960-9822(02)70716-1; Zecca M, 1996, CELL, V87, P833, DOI 10.1016/S0092-8674(00)81991-1	57	143	163	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					41762	41769		10.1074/jbc.M207850200	http://dx.doi.org/10.1074/jbc.M207850200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12205098	hybrid			2022-12-27	WOS:000178985300060
J	Haggie, PM; Verkman, AS				Haggie, PM; Verkman, AS			Diffusion of tricarboxylic acid cycle enzymes in the mitochondrial matrix in vivo - Evidence for restricted mobility of a multienzyme complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GREEN FLUORESCENT PROTEIN; CITRATE SYNTHASE; SACCHAROMYCES-CEREVISIAE; MALATE-DEHYDROGENASE; FUSION PROTEIN; TCA CYCLE; YEAST; ORGANIZATION; METABOLON; CELLS	It has been proposed that enzymes in many metabolic pathways, including the tricarboxylic acid cycle in the mitochondrial matrix, are physically associated to facilitate substrate channeling and overcome diffusive barriers. We have used fluorescence recovery after photobleaching to measure the diffusional mobilities of chimeras consisting of green fluorescent protein (GFP) fused to the C terminus of four tricarboxylic acid cycle enzymes: malate dehydrogenase, citrate synthase, isocitrate dehydrogenase, and succinyl-CoA synthetase. The GFP-enzyme chimeras were localized selectively in the mitochondrial matrix in transfected Chinese hamster ovary (CHO) and COS7 cells. Laser photobleaching using a 0.7-mum diameter spot demonstrated restricted diffusion of the GFP-enzyme chimeras. Interestingly, all four chimeras had similar diffusional characteristics, similar to45% of each chimera was mobile and had a diffusion coefficient of 4 x 10(-8) cm(2)/s. In contrast, unconjugated GFP in the mitochondrial matrix (targeted using COX8 leader sequence) diffused freely (nearly 100% mobility) with a greater diffusion coefficient of 20 x 10(-8) cm(2)/s. The mobility of the GFP-enzyme chimeras was insensitive to substrate source, ATP depletion, or inhibition of the adenine nucleotide translocase. These results indicate similar mobility characteristics of unrelated tricarboxylic acid cycle enzymes having different sizes and physical properties, providing biophysical evidence for a diffusible multienzyme complex in the mitochondrial matrix.	Univ Calif San Francisco, Cardiovasc Res Inst, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Cardiovasc Res Inst, Dept Physiol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Haggie, PM (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, Dept Med, 1246 Hlth Sci East Tower, San Francisco, CA 94143 USA.				NEI NIH HHS [EY 13574] Funding Source: Medline; NHLBI NIH HHS [HL 60288, HL 59198] Funding Source: Medline; NIBIB NIH HHS [EB 00415] Funding Source: Medline; NIDDK NIH HHS [DK 35124] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY013574] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL060288, R01HL059198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000415, R37EB000415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK035124, R37DK035124] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Anderson KS, 1999, METHOD ENZYMOL, V308, P111; BARNES SJ, 1986, FEBS LETT, V201, P267, DOI 10.1016/0014-5793(86)80621-4; Dayel MJ, 1999, BIOPHYS J, V76, P2843, DOI 10.1016/S0006-3495(99)77438-2; Duchen MR, 2000, J PHYSIOL-LONDON, V529, P57, DOI 10.1111/j.1469-7793.2000.00057.x; Elcock AH, 1996, BIOCHEMISTRY-US, V35, P12652, DOI 10.1021/bi9614747; FEDER TJ, 1996, BIOPHYS J, V70, P2367; Grandier-Vazeille X, 2001, BIOCHEMISTRY-US, V40, P9758, DOI 10.1021/bi010277r; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Haggie PM, 1999, J BIOL CHEM, V274, P3941, DOI 10.1074/jbc.274.7.3941; Haggie PM, 2002, J BIOL CHEM, V277, P16419, DOI 10.1074/jbc.M112361200; Hess ST, 2002, BIOCHEMISTRY-US, V41, P697, DOI 10.1021/bi0118512; Hochachka PW, 1999, P NATL ACAD SCI USA, V96, P12233, DOI 10.1073/pnas.96.22.12233; Hom EFY, 2002, BIOPHYS J, V83, P533, DOI 10.1016/S0006-3495(02)75189-8; Jouaville LS, 1999, P NATL ACAD SCI USA, V96, P13807, DOI 10.1073/pnas.96.24.13807; Kawasaki K, 2001, BIOCHEM J, V354, P9, DOI 10.1042/0264-6021:3540009; KISPAL G, 1989, J BIOL CHEM, V264, P11204; LINDBLADH C, 1994, BIOCHEMISTRY-US, V33, P11684, DOI 10.1021/bi00205a003; LINDBLADH C, 1994, BIOCHEMISTRY-US, V33, P11692, DOI 10.1021/bi00205a004; Mitchell CG, 1996, BIOCHEM J, V313, P769, DOI 10.1042/bj3130769; Olveczky BP, 1998, BIOPHYS J, V74, P2722, DOI 10.1016/S0006-3495(98)77978-0; PAGLIARO L, 1992, J CELL BIOL, V118, P859, DOI 10.1083/jcb.118.4.859; Partikian A, 1998, J CELL BIOL, V140, P821, DOI 10.1083/jcb.140.4.821; Periasamy N, 1998, BIOPHYS J, V75, P557, DOI 10.1016/S0006-3495(98)77545-9; Rizzuto R, 2001, CURR OPIN NEUROBIOL, V11, P306, DOI 10.1016/S0959-4388(00)00212-9; ROBINSON JB, 1987, J BIOL CHEM, V262, P1786; ROBINSON JB, 1985, J BIOL CHEM, V260, P800; Saraste M, 1999, SCIENCE, V283, P1488, DOI 10.1126/science.283.5407.1488; Shatalin K, 1999, BIOCHEMISTRY-US, V38, P881, DOI 10.1021/bi982195h; Spivey HO, 1999, METHODS, V19, P306, DOI 10.1006/meth.1999.0858; SRERE PA, 1985, TRENDS BIOCHEM SCI, V10, P109, DOI 10.1016/0968-0004(85)90266-X; SRERE PA, 1987, ANNU REV BIOCHEM, V56, P89, DOI 10.1146/annurev.bi.56.070187.000513; Srere PA, 1997, CHANNELING INTERMEDI, P201; SUMEGI B, 1990, BIOCHEMISTRY-US, V29, P9106, DOI 10.1021/bi00491a002; SUMEGI B, 1993, BIOCHEMISTRY-US, V32, P12725, DOI 10.1021/bi00210a022; Swaminathan R, 1997, BIOPHYS J, V72, P1900, DOI 10.1016/S0006-3495(97)78835-0; Velot C, 1999, BIOCHEMISTRY-US, V38, P16195, DOI 10.1021/bi991695n; Velot C, 1997, BIOCHEMISTRY-US, V36, P14271, DOI 10.1021/bi972011j; Verkman AS, 2002, TRENDS BIOCHEM SCI, V27, P27, DOI 10.1016/S0968-0004(01)02003-5; VERKMAN AS, 2001, METHODS CELLULAR IMA, P112; WELCH GR, 1994, TRENDS BIOCHEM SCI, V19, P193; WESTERHOFF HV, 1992, CURR TOP CELL REGUL, V33, P361; Wu YK, 1996, BIOPHYS J, V71, P91, DOI 10.1016/S0006-3495(96)79243-3	42	49	50	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 25	2002	277	43					40782	40788		10.1074/jbc.M207456200	http://dx.doi.org/10.1074/jbc.M207456200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	607KU	12198136	hybrid			2022-12-27	WOS:000178791400081
J	Zigrino, P; Kamiguti, AS; Eble, J; Drescher, C; Nischt, R; Fox, JW; Mauch, C				Zigrino, P; Kamiguti, AS; Eble, J; Drescher, C; Nischt, R; Fox, JW; Mauch, C			The reprolysin jararhagin, a snake venom metalloproteinase, functions as a fibrillar collagen agonist involved in fibroblast cell adhesion and signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-TYPE-1 MATRIX-METALLOPROTEINASE; GENE-EXPRESSION; INTEGRIN ALPHA-2-BETA-1; PLATELET-AGGREGATION; TISSUE INHIBITOR; BINDING-SITE; I-DOMAIN; ALPHA(2)BETA(1); CONTRACTION; DISINTEGRIN	The integrins alpha(2)beta(1) and alpha(1)beta(1) have been shown to modulate cellular activities of fibroblasts on contact with fibrillar collagen. Previously it has been shown that collagen binding to alpha(2)beta(1) regulates matrix metalloproteinase MMP-1 and membrane-type MT1-MMP expression. Jararhagin is a snake venom metalloproteinase of the Reprolysin family of zinc metalloproteinases, containing a metalloproteinase domain followed by disintegrin-like and cysteine-rich domains. Jararhagin blocks type I collagen-induced platelet aggregation by binding to the alpha(2)beta(1) integrin and inhibiting collagen-mediated intracellular signaling events. Here we present evidence that, in contrast to the observations in platelets, jararhagin binding to the integrin receptor alpha(2)beta(1) in fibroblasts produces collagen-like cell signaling events such as up-regulation of MMP-1 and MT1-MMP. Inactivation of the metalloproteinase domain had no effect on these properties of jararhagin. Thus, in fibroblasts the snake venom metalloproteinase jararhagin functions as a collagen-mimetic substrate that binds to and activates integrins. Given the homology between the metalloproteinase, disintegrin-like and cysteine-rich domains of jararhagin and those of the members of the ADAMs (a disintegrin-like and metalloproteinase) family of proteins, this work demonstrates the potential of the disintegrin-like/cysteine-rich domains in the ADAMs as cellular signaling agents to elicit responses relevant to the biological function of these proteins.	Univ Cologne, Dept Dermatol, D-50924 Cologne, Germany; Univ Virginia, Biomol Res Facil, Charlottesville, VA 22903 USA; Univ Liverpool, Dept Hematol, Liverpool L69 3BX, Merseyside, England; Univ Munster, Dept Physiol Chem, D-48149 Munster, Germany	University of Cologne; University of Virginia; University of Liverpool; University of Munster	Mauch, C (corresponding author), Univ Cologne, Dept Dermatol, D-50924 Cologne, Germany.			Zigrino, Paola/0000-0002-7470-0064				ANGEL P, 1987, MOL CELL BIOL, V7, P2256, DOI 10.1128/MCB.7.6.2256; BELL E, 1979, P NATL ACAD SCI USA, V76, P1274, DOI 10.1073/pnas.76.3.1274; Cal S, 2000, MOL BIOL CELL, V11, P1457, DOI 10.1091/mbc.11.4.1457; CHAN BMC, 1991, SCIENCE, V251, P1600, DOI 10.1126/science.2011740; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; DELUCA M, 1995, BIOCHEM BIOPH RES CO, V206, P570, DOI 10.1006/bbrc.1995.1081; Eble JA, 1998, BIOCHEMISTRY-US, V37, P10945, DOI 10.1021/bi980175+; EBLE JA, 1993, EMBO J, V12, P4795, DOI 10.1002/j.1460-2075.1993.tb06168.x; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; Eto B, 2000, J BIOL CHEM, V275, P34922, DOI 10.1074/jbc.M001953200; EYANS JP, 2001, BIOESSAYS, V23, P628; FOX JW, 1998, SNAKE VENOM ENZYMES, P151; Grinnell F, 1999, J BIOL CHEM, V274, P918, DOI 10.1074/jbc.274.2.918; GRINNELL F, 1994, J CELL BIOL, V124, P401, DOI 10.1083/jcb.124.4.401; Hati R, 1999, CRIT REV TOXICOL, V29, P1, DOI 10.1080/10408449991349168; HEMLER ME, 1990, ANNU REV IMMUNOL, V8, P365, DOI 10.1146/annurev.iy.08.040190.002053; HEMLER ME, 1985, J BIOL CHEM, V260, P1524; HOWARD EW, 1991, J BIOL CHEM, V266, P13064; HUGHES AL, 1992, MOL BIOL EVOL, V9, P216; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Ivaska J, 1999, J BIOL CHEM, V274, P3513, DOI 10.1074/jbc.274.6.3513; Jia LG, 1996, TOXICON, V34, P1269, DOI 10.1016/S0041-0101(96)00108-0; Jia LG, 1997, J BIOL CHEM, V272, P13094, DOI 10.1074/jbc.272.20.13094; Kamiguti AS, 1996, TOXICON, V34, P627, DOI 10.1016/0041-0101(96)00017-7; Kamiguti AS, 1997, J BIOL CHEM, V272, P32599, DOI 10.1074/jbc.272.51.32599; Kamiguti AS, 1998, BRAZ J MED BIOL RES, V31, P853, DOI 10.1590/S0100-879X1998000700001; Kamiguti AS, 2000, ARCH BIOCHEM BIOPHYS, V374, P356, DOI 10.1006/abbi.1999.1627; Kamiguti AS, 1996, BIOCHEM J, V320, P635, DOI 10.1042/bj3200635; KLEIN CE, 1991, J CELL BIOL, V115, P1427, DOI 10.1083/jcb.115.5.1427; Knight CG, 2000, J BIOL CHEM, V275, P35, DOI 10.1074/jbc.275.1.35; Kurschat P, 1999, J BIOL CHEM, V274, P21056, DOI 10.1074/jbc.274.30.21056; Langholz O, 1995, J CELL BIOL, V131, P1903, DOI 10.1083/jcb.131.6.1903; Lehti K, 1998, BIOCHEM J, V334, P345, DOI 10.1042/bj3340345; MAUCH C, 1988, EXP CELL RES, V178, P493, DOI 10.1016/0014-4827(88)90417-X; MAUCH C, 1989, FEBS LETT, V250, P301, DOI 10.1016/0014-5793(89)80743-4; PAINE MJI, 1992, J BIOL CHEM, V267, P22869; RIIKONEN T, 1995, J BIOL CHEM, V270, P13548, DOI 10.1074/jbc.270.22.13548; SATO H, 1994, NATURE, V370, P61, DOI 10.1038/370061a0; SELTZER JL, 1994, EXP CELL RES, V213, P365, DOI 10.1006/excr.1994.1211; Smith C, 2000, J BIOL CHEM, V275, P4205, DOI 10.1074/jbc.275.6.4205; Stricker TP, 2001, J BIOL CHEM, V276, P29375, DOI 10.1074/jbc.M102217200; TUCKWELL D, 1995, J CELL SCI, V108, P1629; Zigrino P, 1996, BIOCHEM BIOPH RES CO, V221, P51, DOI 10.1006/bbrc.1996.0543; Zigrino P, 2001, EUR J CELL BIOL, V80, P68, DOI 10.1078/0171-9335-00134	45	56	58	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 25	2002	277	43					40528	40535		10.1074/jbc.M202049200	http://dx.doi.org/10.1074/jbc.M202049200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	607KU	12186858	hybrid			2022-12-27	WOS:000178791400049
J	Nyalwidhe, J; Baumeister, S; Hibbs, AR; Tawill, S; Papakrivos, J; Volker, U; Lingelbach, K				Nyalwidhe, J; Baumeister, S; Hibbs, AR; Tawill, S; Papakrivos, J; Volker, U; Lingelbach, K			A nonpermeant biotin derivative gains access to the parasitophorous vacuole in Plasmodium falciparum-infected erythrocytes permeabilized with streptolysin O	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MALARIA PARASITES; MEMBRANE; LOCALIZATION; TRANSPORT; PROTEIN; TRAFFICKING; TOXOPLASMA; ANTIGEN; CELLS	In its host erythrocyte, the malaria parasite Plasmodium falciparum resides within a parasitophorous vacuole, the membrane of which forms a barrier between the host cell cytosol and the parasite surface. The vacuole is a unique compartment because it contains specific proteins that are believed to be involved in cell biological functions essential for parasite survival. As a prerequisite for the characterization of the vacuolar proteome, we have developed an experimental approach that allows the selective biotinylation of soluble vacuolar proteins. This approach utilizes nonpermeant biotin derivatives that can be introduced into infected erythrocytes after selective permeabilization of the erythrocyte membrane with the pore-forming protein streptolysin O. The derivatives gain access to the vacuolar lumen but not to the parasite cytosol, thus providing supportive evidence for the existence of nonselective pores within the vacuolar membrane that have been postulated based on electrophysiological studies. Soluble vacuolar proteins that are biotin-labeled can be isolated by affinity chromatography using streptavidin-agarose.	Univ Marburg, FB Biol, D-35032 Marburg, Germany; BIOCON, Ringwood E, Vic 3135, Australia	Philipps University Marburg	Lingelbach, K (corresponding author), Univ Marburg, FB Biol, D-35032 Marburg, Germany.	lingelba@mailer.uni-marburg.de		Volker, Uwe/0000-0002-5689-3448; Baumeister, Stefan/0000-0002-7784-3474				ANSORGE I, 1995, BIOCHEM J, V308, P335, DOI 10.1042/bj3080335; Ansorge I, 1996, BIOCHEM J, V315, P307, DOI 10.1042/bj3150307; BENTING J, 1994, BIOCHEM J, V300, P821, DOI 10.1042/bj3000821; BOSIA A, 1993, J CELL PHYSIOL, V154, P527, DOI 10.1002/jcp.1041540311; Burghaus PA, 2001, J BIOL CHEM, V276, P26838, DOI 10.1074/jbc.M100111200; Cheresh P, 2002, J BIOL CHEM, V277, P16265, DOI 10.1074/jbc.M109331200; Cooke BM, 2000, PARASITOL TODAY, V16, P416, DOI 10.1016/S0169-4758(00)01753-1; CULVENOR JG, 1990, J PROTOZOOL, V37, P59, DOI 10.1111/j.1550-7408.1990.tb01117.x; Desai SA, 1997, P NATL ACAD SCI USA, V94, P2045, DOI 10.1073/pnas.94.5.2045; DESAI SA, 1993, NATURE, V362, P643, DOI 10.1038/362643a0; DLUZEWSKI AR, 1992, J CELL SCI, V102, P527; Guevara-Patino JA, 1997, J EXP MED, V186, P1689, DOI 10.1084/jem.186.10.1689; Kirk K, 2001, PHYSIOL REV, V81, P495, DOI 10.1152/physrev.2001.81.2.495; KNAPP B, 1989, MOL BIOCHEM PARASIT, V32, P73, DOI 10.1016/0166-6851(89)90131-X; Krishna S, 2001, INT J PARASITOL, V31, P1331, DOI 10.1016/S0020-7519(01)00254-5; KUMAR N, 1991, MOL BIOCHEM PARASIT, V48, P47, DOI 10.1016/0166-6851(91)90163-Z; Lingelbach K, 1998, J CELL SCI, V111, P1467; PASVOL G, 1978, ANN TROP MED PARASIT, V72, P87, DOI 10.1080/00034983.1978.11719283; POUVELLE B, 1994, MOL BIOCHEM PARASIT, V66, P83, DOI 10.1016/0166-6851(94)90038-8; Saliba KJ, 2001, INT J PARASITOL, V31, P1321, DOI 10.1016/S0020-7519(01)00258-2; Salmon BL, 2001, P NATL ACAD SCI USA, V98, P271, DOI 10.1073/pnas.011413198; SCHWAB JC, 1994, P NATL ACAD SCI USA, V91, P509, DOI 10.1073/pnas.91.2.509; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; WARD GE, 1993, J CELL SCI, V106, P237; Wickham ME, 2001, EMBO J, V20, P5636, DOI 10.1093/emboj/20.20.5636; Wunsch S, 1998, J CELL BIOL, V140, P335, DOI 10.1083/jcb.140.2.335	26	27	28	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2002	277	42					40005	40011		10.1074/jbc.M207077200	http://dx.doi.org/10.1074/jbc.M207077200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	605EA	12186876	hybrid			2022-12-27	WOS:000178662500120
J	Graille, M; Harrison, S; Crump, MP; Findlow, SC; Housden, NG; Muller, BH; Battail-Poirot, N; Sibai, G; Sutton, BJ; Taussig, MJ; Jolivet-Reynaud, C; Gore, MG; Stura, EA				Graille, M; Harrison, S; Crump, MP; Findlow, SC; Housden, NG; Muller, BH; Battail-Poirot, N; Sibai, G; Sutton, BJ; Taussig, MJ; Jolivet-Reynaud, C; Gore, MG; Stura, EA			Evidence for plasticity and structural mimicry at the immunoglobulin light chain-protein L interface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN GROWTH-HORMONE; X-RAY-DIFFRACTION; PEPTOSTREPTOCOCCUS-MAGNUS; CRYSTAL-STRUCTURE; BINDING DOMAIN; STAPHYLOCOCCUS-AUREUS; EXTRACELLULAR DOMAIN; FAB FRAGMENT; EPO RECEPTOR; HUMAN-IGG	The multidomain bacterial surface protein L (PpL) is a virulence factor expressed by only 10% of Peptostreptococcus magnus strains, and its expression is correlated with bacterial vaginosis. The molecular basis for its ability to recognize 60% of mammalian immunoglobulin light chain variable regions (V-L) has been described recently by x-ray crystallography, which suggested the presence of two V-L binding sites on each protein L domain (Graille, M., Stura, E. A., Housden, N.G., Beekingham, J.A., Bottomley, S. P., Beale, D., Taussig, M.J., Sutton, B.J., Gore, M. G., and Charbonnier, J. (2001) Structure, 679-687). Here, we report the crystal structure at 2.1 Angstrom resolution of a protein L mutant complexed to an Fab' fragment with only 50% of the VL residues interacting with PpL site 1 conserved. Comparison of the site 1 interface from both structures shows how protein L is able to accommodate these sequence differences and therefore bind to a large repertoire of Ig. The x-ray structure and NMR results confirm the existence of two V-L binding sites on a single protein L domain. These sites exhibit a remarkable structural mimicry of growth factors binding to their receptors. This could explain the protein L superantigenic activity on human B lymphocytes.	Univ Southampton, Inst Biomol Sci, Dept Biochem, Southampton SO16 7PX, Hants, England; CEA, Ctr Etud Saclay, Lab Struct Prot, F-91191 Gif Sur Yvette, France; CEA, Ctr Etud Saclay, UMR CEA Biomerieux, DIEP, F-91191 Gif Sur Yvette, France; Biomerieux, Dept R&D Immunoessais & Proteom, F-69280 Marcy Letoile, France; Kings Coll London, Randall Ctr, London SE1 1UL, England; Babraham Inst, Technol Res Grp, Cambridge CB2 4AT, England	University of Southampton; CEA; UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay; bioMerieux; University of London; King's College London; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Gore, MG (corresponding author), Univ Southampton, Inst Biomol Sci, Dept Biochem, Bassett Crescent E, Southampton SO16 7PX, Hants, England.	M.G.Gore@soton.ac.uk; estura@cea.fr	Stura, Enrico A./A-2793-2010; GRAILLE, Marc/D-3242-2014	Stura, Enrico A./0000-0001-6718-2118; GRAILLE, Marc/0000-0002-7853-5852; Crump, Matthew/0000-0002-7868-5818; Housden, Nicholas/0000-0002-4706-8278				AKERSTROM B, 1989, J BIOL CHEM, V264, P19740; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beckingham JA, 2001, BIOCHEM J, V353, P395, DOI 10.1042/0264-6021:3530395; Beckingham JA, 1999, BIOCHEM J, V340, P193, DOI 10.1042/0264-6021:3400193; Bettsworth F, 2001, J MOL RECOGNIT, V14, P99, DOI 10.1002/jmr.525; BJORCK L, 1988, J IMMUNOL, V140, P1194; BJORCK L, 1984, J IMMUNOL, V133, P969; Bottomley SP, 1995, BIOSEPARATION, V5, P359; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CUNNINGHAM BC, 1991, SCIENCE, V254, P821, DOI 10.1126/science.1948064; DEISENHOFER J, 1981, BIOCHEMISTRY-US, V20, P2361, DOI 10.1021/bi00512a001; DERRICK JP, 1992, NATURE, V359, P752, DOI 10.1038/359752a0; DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776; Genovese A, 2000, INFECT IMMUN, V68, P5517, DOI 10.1128/IAI.68.10.5517-5524.2000; Graille M, 2001, STRUCTURE, V9, P679, DOI 10.1016/S0969-2126(01)00630-X; Graille M, 2000, P NATL ACAD SCI USA, V97, P5399, DOI 10.1073/pnas.97.10.5399; Jolivet-Reynaud C, 1998, J MED VIROL, V56, P300, DOI 10.1002/(SICI)1096-9071(199812)56:4&lt;300::AID-JMV3&gt;3.0.CO;2-8; KASTERN W, 1992, J BIOL CHEM, V267, P12820; KASTERN W, 1990, INFECT IMMUN, V58, P1217, DOI 10.1128/IAI.58.5.1217-1222.1990; LANGONE JJ, 1982, ADV IMMUNOL, V32, P157; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Livnah O, 1998, NAT STRUCT BIOL, V5, P993, DOI 10.1038/2965; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; MURPHY JP, 1994, MOL MICROBIOL, V12, P911, DOI 10.1111/j.1365-2958.1994.tb01079.x; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NILSON BHK, 1992, J BIOL CHEM, V267, P2234; O'Neill JW, 2001, ACTA CRYSTALLOGR D, V57, P480, DOI 10.1107/S0907444901000373; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Philo JS, 1996, BIOCHEMISTRY-US, V35, P1681, DOI 10.1021/bi9524272; Ricci S, 2001, MICROB PATHOGENESIS, V30, P229, DOI 10.1006/mpat.2000.0427; ROUSSEL A, 1989, SILICON GRAPHICS GEO, P77; RUBERTI F, 1994, J IMMUNOL METHODS, V173, P33, DOI 10.1016/0022-1759(94)90280-1; SATOW Y, 1986, J MOL BIOL, V190, P593, DOI 10.1016/0022-2836(86)90245-7; SAUERERIKSSON AE, 1995, STRUCTURE, V3, P265, DOI 10.1016/S0969-2126(01)00157-5; STURA EA, 1991, J CRYST GROWTH, V110, P270, DOI 10.1016/0022-0248(91)90896-D; Stura EA, 2002, ACTA CRYSTALLOGR D, V58, P1744, DOI 10.1107/S0907444902012805; Syed RS, 1998, NATURE, V395, P511, DOI 10.1038/26773; WIKSTROM M, 1994, BIOCHEMISTRY-US, V33, P14011, DOI 10.1021/bi00251a008; Wikstrom M, 1996, EUR J BIOCHEM, V235, P543, DOI 10.1111/j.1432-1033.1996.00543.x; WIKSTROM M, 1995, J MOL BIOL, V250, P128, DOI 10.1006/jmbi.1995.0364	41	34	39	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 6	2002	277	49					47500	47506		10.1074/jbc.M206105200	http://dx.doi.org/10.1074/jbc.M206105200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622TT	12221088	hybrid, Green Published			2022-12-27	WOS:000179663700087
J	Kishimoto, M; Okimura, Y; Yagita, K; Iguchi, G; Fumoto, M; Iida, K; Kaji, H; Okamura, H; Chihara, K				Kishimoto, M; Okimura, Y; Yagita, K; Iguchi, G; Fumoto, M; Iida, K; Kaji, H; Okamura, H; Chihara, K			Novel function of the transactivation domain of a pituitary-specific transcription factor, Pit-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RUBINSTEIN-TAYBI-SYNDROME; HORMONE GENE-EXPRESSION; CREB-BINDING-PROTEIN; GROWTH-HORMONE; POU-DOMAIN; CYCLIC ADENOSINE-3',5'-MONOPHOSPHATE; PROLACTIN GENE; RECEPTOR GENE; MESSENGER-RNA; CELL-GROWTH	Pit-1 stimulates the expression of growth hormone, prolactin, and thyrotropin J3 subunit genes. Consequently, abnormality of the Pit-1 gene results in combined pituitary hormone deficiency (CPHD). In this study, we analyzed the function of Pit-1 with a mutation (proline to leucine at codon 24) in the transactivation domain, P24L, which has a normal POU domain important for binding to DNA, because this mutation had been reported in a patient with CPHD. We found that codon 24 proline in the transactivation domain as well as the POU domain of Pit-1 was crucial to recruit coactivator CREB-binding protein (CBP) in the cultured cells. P24L completely lost the responsiveness to cAMP to stimulate the expression of the Pit-l-targeted genes. Furthermore, CBP and Pit-1, but not P24L, markedly enhanced the expression of the Pit-l-targeted gene to cAMP, and adenovirus E1a that binds to CBP and abrogates its function blocked the induction by cAMP of Pit-1-stimulated gene transcription in the pituitary-derived GH3 cells. These results suggest that CBP and proline at codon 24 in the transactivation domain of Pit-1 are important for the cAMP-induced activation of Pit-1-targeted genes. However, P24L maintained basal transcriptional activity, suggesting that CBP is unlikely to be an essential coactivator for Pit-1.	Kobe Univ, Grad Sch Med, Dept Clin Mol Med, Sch Med,Suma Ku, Kobe, Hyogo 6540142, Japan; Kobe Univ, Sch Med, Dept Basic Allied Med,Suma Ku, Div Endocrinol Metab Neurol & Hematol Oncol, Kobe, Hyogo 6540142, Japan; Kobe Univ, Sch Med, Grad Sch Med, Dept Basic Allied Med,Suma Ku, Kobe, Hyogo 6540142, Japan; Kobe Univ, Sch Med, Grad Sch Med, Dept Brain Sci,Suma Ku, Kobe, Hyogo 6540142, Japan	Kobe University; Kobe University; Kobe University; Kobe University	Okimura, Y (corresponding author), Kobe Univ, Sch Med, Dept Basic Allied Med,Suma Ku, Div Endocrinol Metab Neurol & Hematol Oncol, 7-10-2 Tomogaoka, Kobe, Hyogo 6540142, Japan.	okimura@ams.kobe-u.ac.jp	Iida, Keiji/ABB-5126-2021	Iida, Keiji/0000-0002-1516-7757				Andersen B, 2001, ENDOCR REV, V22, P2, DOI 10.1210/er.22.1.2; Blankenstein O, 2001, HORM RES, V56, P81, DOI 10.1159/000048096; BODNER M, 1988, CELL, V55, P505, DOI 10.1016/0092-8674(88)90037-2; Brown MR, 1998, HORM RES, V49, P98, DOI 10.1159/000023134; Cohen LE, 1999, J CLIN INVEST, V104, P1123, DOI 10.1172/JCI7308; Cohen LE, 1999, MOL ENDOCRINOL, V13, P476, DOI 10.1210/me.13.3.476; DOLLE P, 1990, CELL, V60, P809, DOI 10.1016/0092-8674(90)90095-V; Eckner R, 1996, GENE DEV, V10, P2478, DOI 10.1101/gad.10.19.2478; Fofanova OV, 1998, AM J MED GENET, V77, P360, DOI 10.1002/(SICI)1096-8628(19980605)77:5<360::AID-AJMG4>3.0.CO;2-R; Gat-Yablonski G, 2002, J PEDIATR ENDOCR MET, V15, P325; Goodman RH, 2000, GENE DEV, V14, P1553; Hendriks-Stegeman BI, 2001, J CLIN ENDOCR METAB, V86, P1545, DOI 10.1210/jc.86.4.1545; Iguchi G, 1999, J BIOL CHEM, V274, P12108, DOI 10.1074/jbc.274.17.12108; INGRAHAM HA, 1988, CELL, V55, P519, DOI 10.1016/0092-8674(88)90038-4; IRIE Y, 1995, ENDOCR J, V42, P351, DOI 10.1507/endocrj.42.351; Jacobson EM, 1997, GENE DEV, V11, P198, DOI 10.1101/gad.11.2.198; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; KAPILOFF MS, 1991, SCIENCE, V253, P786, DOI 10.1126/science.1652153; KWOK RPS, 1994, NATURE, V370, P223, DOI 10.1038/370223a0; LI S, 1990, NATURE, V347, P528, DOI 10.1038/347528a0; LIANG J, 1992, MOL ENDOCRINOL, V6, P885, DOI 10.1210/me.6.6.885; LIANG J, 1995, J BIOL CHEM, V270, P25520, DOI 10.1074/jbc.270.43.25520; Lill NL, 1997, NATURE, V387, P823, DOI 10.1038/42981; LIN CJ, 1992, NATURE, V360, P765, DOI 10.1038/360765a0; OHTA K, 1992, BIOCHEM BIOPH RES CO, V189, P851, DOI 10.1016/0006-291X(92)92281-2; Oike Y, 1999, BLOOD, V93, P2771; OKAMOTO N, 1994, HUM MOL GENET, V3, P1565, DOI 10.1093/hmg/3.9.1565; OKIMURA Y, 1994, MOL ENDOCRINOL, V8, P1559, DOI 10.1210/me.8.11.1559; Olson DP, 1997, J CLIN ENDOCR METAB, V82, P3264, DOI 10.1210/jc.82.10.3264; PARKS JS, 1993, HORM RES, V40, P54, DOI 10.1159/000183768; PEERS B, 1991, J BIOL CHEM, V266, P18127; PellegriniBouiller I, 1996, J CLIN ENDOCR METAB, V81, P2790, DOI 10.1210/jc.81.8.2790; Perkins ND, 1997, SCIENCE, V275, P523, DOI 10.1126/science.275.5299.523; Pernasetti F, 1998, J CLIN ENDOCR METAB, V83, P2079, DOI 10.1210/jc.83.6.2079; Petersenn S, 1998, MOL ENDOCRINOL, V12, P233, DOI 10.1210/me.12.2.233; PETRIJ F, 1995, NATURE, V376, P348, DOI 10.1038/376348a0; Pfaffle R, 1996, HORM RES, V45, P25, DOI 10.1159/000184824; RADOVICK S, 1992, SCIENCE, V257, P1115, DOI 10.1126/science.257.5073.1115; RHODES SJ, 1993, GENE DEV, V7, P913, DOI 10.1101/gad.7.6.913; RUBINSTEIN JH, 1990, AM J MED GENET, P3; Ryan AK, 1997, GENE DEV, V11, P1207, DOI 10.1101/gad.11.10.1207; SIMMONS DM, 1990, GENE DEV, V4, P695, DOI 10.1101/gad.4.5.695; Sock E, 1996, J BIOL CHEM, V271, P17512, DOI 10.1074/jbc.271.29.17512; Tatsumi K, 1999, GROWTH HORM IGF RES, V9, P18, DOI 10.1016/S1096-6374(99)80076-8; Xu L, 1998, NATURE, V395, P301, DOI 10.1038/26270; Zanger K, 1999, MOL ENDOCRINOL, V13, P268, DOI 10.1210/me.13.2.268; Zhang JJ, 1996, P NATL ACAD SCI USA, V93, P15092, DOI 10.1073/pnas.93.26.15092	47	27	27	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2002	277	47					45141	45148		10.1074/jbc.M202991200	http://dx.doi.org/10.1074/jbc.M202991200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	618EE	12200420	hybrid			2022-12-27	WOS:000179404800071
J	Jarvis, SE; Barr, W; Feng, ZP; Hamid, J; Zamponi, GW				Jarvis, SE; Barr, W; Feng, ZP; Hamid, J; Zamponi, GW			Molecular determinants of syntaxin 1 modulation of N-type calcium channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							G-PROTEIN MODULATION; G-BETA-GAMMA; CA2+ CHANNELS; SNARE COMPLEX; NEUROTRANSMITTER RELEASE; 3-DIMENSIONAL STRUCTURE; FUNCTIONAL INTERACTION; BINDING; 1A; SUBUNIT	We have previously reported that syntaxin 1A, a component of the presynaptic SNARE complex, directly modulates N-type calcium channel gating in addition to promoting tonic G-protein inhibition of the channels, whereas syntaxin 1B affects channel gating but does not support G-protein modulation (Jarvis, S. E., and Zamponi, G. W. (2001) J. Neurosci. 21, 2939 -2948). Here, we have investigated the molecular determinants that govern the action of syntaxin 1 isoforms on N-type calcium channel function. In vitro evidence shows that both syntaxin 1 isoforms physically interact with the G-protein beta subunit and the synaptic protein interaction (synprint) site contained within the N-type calcium channel domain H-Ill linker region. Moreover, in vitro evidence suggests that distinct domains of syntaxin participate in each interaction, with the COOH-terminal SNARE domain (residues 183-230) binding to Gbeta and the N-terminal (residues 1-69) binding to the synprint motif of the channel. Electrophysiological analysis of chimeric syntaxin 1A/1B constructs reveals that the variable NH2-terminal domains of syntaxin 1 are responsible for the differential effects of syntaxin 1A and 1B on N-type calcium channel function. Because syntaxin 1 exists in both "open" and "closed" conformations during exocytosis, we produced a constitutively open form of syntaxin 1A and found that it still promoted G-protein inhibition of the channels, but it did not affect N-type channel availability. This state dependence of the ability of syntaxin 1 to mediate N-type calcium channel availability suggests that syntaxin 1 dynamically regulates N-type channel function during various steps of exocytosis. Finally, syntaxin 1A appeared to compete with Ggamma for the Gbeta subunit both in vitro and under physiological conditions, suggesting that syntaxin 1A may contain a G-protein gamma subunit-like domain.	Univ Calgary, Dept Physiol & Biophys, Calgary, AB T2N 4N1, Canada; Univ Calgary, Dept Pharmacol & Therapeut, Calgary, AB T2N 4N1, Canada; NeuroMed Technol Inc, Vancouver, BC V6T 1Z4, Canada	University of Calgary; University of Calgary	Zamponi, GW (corresponding author), Univ Calgary, Dept Physiol & Biophys, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	Zamponi@ucalgary.ca		Zamponi, Gerald W./0000-0002-0644-9066				Aguado F, 1999, NEUROSCIENCE, V88, P437, DOI 10.1016/S0306-4522(98)00247-4; Arnot MI, 2000, J PHYSIOL-LONDON, V527, P203, DOI 10.1111/j.1469-7793.2000.00203.x; Bergsman JB, 2000, J NEUROSCI, V20, P4368, DOI 10.1523/JNEUROSCI.20-12-04368.2000; Bezprozvanny I, 2000, P NATL ACAD SCI USA, V97, P13943, DOI 10.1073/pnas.220389697; BEZPROZVANNY I, 1995, NATURE, V378, P623, DOI 10.1038/378623a0; Blackmer T, 2001, SCIENCE, V292, P293, DOI 10.1126/science.1058803; Brose N, 2000, CURR OPIN NEUROBIOL, V10, P303, DOI 10.1016/S0959-4388(00)00105-7; Coppola T, 2001, J BIOL CHEM, V276, P32756, DOI 10.1074/jbc.M100929200; Degtiar VE, 2000, J NEUROSCI, V20, P4355, DOI 10.1523/JNEUROSCI.20-12-04355.2000; DeWaard M, 1997, NATURE, V385, P446, DOI 10.1038/385446a0; Dulubova I, 1999, EMBO J, V18, P4372, DOI 10.1093/emboj/18.16.4372; ELFAR O, 1995, FEBS LETT, V361, P101, DOI 10.1016/0014-5793(95)00156-4; ELMSLIE KS, 1990, NEURON, V5, P75, DOI 10.1016/0896-6273(90)90035-E; Fernandez I, 1998, CELL, V94, P841, DOI 10.1016/S0092-8674(00)81742-0; Fiebig KM, 1999, NAT STRUCT BIOL, V6, P117; Forsythe ID, 1998, NEURON, V20, P797, DOI 10.1016/S0896-6273(00)81017-X; Herlitze S, 1996, NATURE, V380, P258, DOI 10.1038/380258a0; Hibino H, 2002, NEURON, V34, P411, DOI 10.1016/S0896-6273(02)00667-0; Hicks A, 1997, NEUROSCIENCE, V79, P329, DOI 10.1016/S0306-4522(96)00700-2; IKEDA SR, 1989, J PHYSIOL-LONDON, V409, P221, DOI 10.1113/jphysiol.1989.sp017494; IKEDA SR, 1992, J PHYSIOL-LONDON, V458, P339, DOI 10.1113/jphysiol.1992.sp019421; Ikeda SR, 1996, NATURE, V380, P255, DOI 10.1038/380255a0; Jahn R, 1999, ANNU REV BIOCHEM, V68, P863, DOI 10.1146/annurev.biochem.68.1.863; Jarvis SE, 2000, J BIOL CHEM, V275, P6388, DOI 10.1074/jbc.275.9.6388; Jarvis SE, 2001, J NEUROSCI, V21, P2939, DOI 10.1523/JNEUROSCI.21-09-02939.2001; KEE Y, 1995, NEURON, V14, P991, DOI 10.1016/0896-6273(95)90337-2; Koushika SP, 2001, NAT NEUROSCI, V4, P997, DOI 10.1038/nn732; LEVEQUE C, 1994, J BIOL CHEM, V269, P6306; Leveque C, 1998, J BIOL CHEM, V273, P13488, DOI 10.1074/jbc.273.22.13488; Lu Q, 2001, J NEUROSCI, V21, P2949, DOI 10.1523/JNEUROSCI.21-09-02949.2001; Magga JM, 2000, NEURON, V28, P195, DOI 10.1016/S0896-6273(00)00096-9; Martin TFJ, 2002, NEURON, V34, P9, DOI 10.1016/S0896-6273(02)00651-7; Misura KMS, 2000, NATURE, V404, P355, DOI 10.1038/35006120; Neves G, 2001, P NATL ACAD SCI USA, V98, P15282, DOI 10.1073/pnas.261311698; Page KM, 1998, J NEUROSCI, V18, P4815; PEVSNER J, 1994, NEURON, V13, P353, DOI 10.1016/0896-6273(94)90352-2; Poirier MA, 1998, NAT STRUCT BIOL, V5, P765, DOI 10.1038/1799; Qin N, 1997, P NATL ACAD SCI USA, V94, P8866, DOI 10.1073/pnas.94.16.8866; Rettig J, 1996, P NATL ACAD SCI USA, V93, P7363, DOI 10.1073/pnas.93.14.7363; Richmond JE, 2001, NATURE, V412, P338, DOI 10.1038/35085583; RuizMontasell B, 1996, EUR J NEUROSCI, V8, P2544, DOI 10.1111/j.1460-9568.1996.tb01548.x; SHENG ZH, 1994, NEURON, V13, P1303, DOI 10.1016/0896-6273(94)90417-0; Snow BE, 1998, P NATL ACAD SCI USA, V95, P13307, DOI 10.1073/pnas.95.22.13307; Sondek J, 2001, BIOCHEM PHARMACOL, V61, P1329, DOI 10.1016/S0006-2952(01)00633-5; Stanley EF, 1997, NATURE, V385, P340, DOI 10.1038/385340a0; STANLEY EF, 1993, NEURON, V11, P1007, DOI 10.1016/0896-6273(93)90214-C; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; TURNER TJ, 1993, P NATL ACAD SCI USA, V90, P9518, DOI 10.1073/pnas.90.20.9518; TURNER TJ, 1992, SCIENCE, V258, P310, DOI 10.1126/science.1357749; WHEELER DB, 1994, SCIENCE, V264, P107, DOI 10.1126/science.7832825; Wiser O, 1996, EMBO J, V15, P4100, DOI 10.1002/j.1460-2075.1996.tb00785.x; Wu MN, 1999, NEURON, V23, P593, DOI 10.1016/S0896-6273(00)80811-9; Yang B, 2000, J CELL BIOL, V148, P247, DOI 10.1083/jcb.148.2.247; YOSHIDA A, 1992, J BIOL CHEM, V267, P24925; Zamponi GW, 1997, NATURE, V385, P442, DOI 10.1038/385442a0; Zhong HJ, 1999, NAT NEUROSCI, V2, P939, DOI 10.1038/14721	56	73	78	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2002	277	46					44399	44407		10.1074/jbc.M206902200	http://dx.doi.org/10.1074/jbc.M206902200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	615XE	12221094	hybrid			2022-12-27	WOS:000179272000111
J	Jongbloed, JDH; Antelmann, H; Hecker, M; Nijland, R; Bron, S; Airaksinen, U; Pries, F; Quax, WJ; van Dijl, JM; Braun, PG				Jongbloed, JDH; Antelmann, H; Hecker, M; Nijland, R; Bron, S; Airaksinen, U; Pries, F; Quax, WJ; van Dijl, JM; Braun, PG			Selective contribution of the twin-arginine translocation pathway to protein secretion in Bacillus subtilis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNER MEMBRANE-PROTEIN; SIGNAL PEPTIDASE-I; ESCHERICHIA-COLI; ALPHA-AMYLASE; EFFICIENT SECRETION; SEC; IDENTIFICATION; MOTIF; EXPRESSION; PREDICTION	The availability of the complete genome sequence of Bacillus subtilis has allowed the prediction of all exported proteins of this Gram-positive eubacterium. Recently, similar to180 secretory and 114 lipoprotein signal peptides were predicted to direct protein export from the cytoplasm. Whereas most exported proteins appear to use the Sec pathway, 69 of these proteins could potentially use the Tat pathway, as their signal peptides contain RR- or KR-motifs. In the present studies, proteomic techniques were applied to verify how many extracellular B. subtilis proteins follow the Tat pathway. Strikingly, the extracellular accumulation of 13 proteins with potential RR/KR-signal peptides was Tat-independent, showing that their RR/KR-motifs are not recognized by the Tat machinery. In fact, only the phosphodiesterase PhoD was shown to be secreted in a strictly Tat-dependent manner. Sodium azide-inhibition of SecA strongly affected the extracellular appearance of de novo synthesized proteins, including the lipase LipA and two other proteins with predicted RR/KR-signal peptides. The SecA-dependent export of pre-LipA is particularly remarkable, because its RR-signal peptide conforms well to stringent criteria for the prediction of Tat-dependent export in Escherichia coli. Taken together, our observations show that the Tat pathway makes a highly selective contribution to the extracellular proteome of B. subtilis.	Univ Groningen, Dept Pharmaceut Biol, NL-9713 AV Groningen, Netherlands; Groningen Biomol Sci & Biotechnol Inst, Dept Genet, NL-9751 NN Haren, Netherlands; Univ Greifswald, Inst Mikrobiol & Mol Biol, D-17487 Greifswald, Germany; Natl Publ Hlth Inst, FIN-00300 Helsinki, Finland	University of Groningen; University of Groningen; Ernst Moritz Arndt Universitat Greifswald; Finland National Institute for Health & Welfare	van Dijl, JM (corresponding author), Univ Groningen, Dept Pharmaceut Biol, A Deusinglaan 1, NL-9713 AV Groningen, Netherlands.		van Dijl, Jan Maarten/G-1205-2013; Quax, Wim/O-2875-2019; Antelmann, Haike/I-3129-2019; Nijland, Reindert/B-8206-2008; Quax, Wim/K-2802-2012	Quax, Wim/0000-0002-5162-9947; Antelmann, Haike/0000-0002-1766-4386; Nijland, Reindert/0000-0003-0049-3768; Quax, Wim/0000-0002-5162-9947; Braun, Peter/0000-0002-9870-465X				Antelmann H, 2000, J BACTERIOL, V182, P4478, DOI 10.1128/JB.182.16.4478-4490.2000; Antelmann H, 1997, J BACTERIOL, V179, P7251, DOI 10.1128/jb.179.23.7251-7256.1997; Antelmann H, 2002, PROTEOMICS, V2, P591, DOI 10.1002/1615-9861(200205)2:5<591::AID-PROT591>3.0.CO;2-8; Antelmann H, 2001, GENOME RES, V11, P1484, DOI 10.1101/gr.182801; Berks BC, 2000, MOL MICROBIOL, V35, P260, DOI 10.1046/j.1365-2958.2000.01719.x; Bernhardt J, 1999, ELECTROPHORESIS, V20, P2225, DOI 10.1002/(SICI)1522-2683(19990801)20:11<2225::AID-ELPS2225>3.3.CO;2-#; Bogsch E, 1997, EMBO J, V16, P3851, DOI 10.1093/emboj/16.13.3851; Bogsch EG, 1998, J BIOL CHEM, V273, P18003, DOI 10.1074/jbc.273.29.18003; Bolhuis A, 2001, J BIOL CHEM, V276, P20213, DOI 10.1074/jbc.M100682200; Bolhuis A, 1998, J BIOL CHEM, V273, P21217, DOI 10.1074/jbc.273.33.21217; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brink S, 1998, FEBS LETT, V434, P425, DOI 10.1016/S0014-5793(98)01028-X; BRON S, 1972, MUTAT RES, V15, P1, DOI 10.1016/0027-5107(72)90086-3; Cristobal S, 1999, EMBO J, V18, P2982, DOI 10.1093/emboj/18.11.2982; Cserzo M, 1997, PROTEIN ENG, V10, P673, DOI 10.1093/protein/10.6.673; Dalbey RE, 1999, TRENDS BIOCHEM SCI, V24, P17, DOI 10.1016/S0968-0004(98)01333-4; DARTOIS V, 1994, APPL ENVIRON MICROB, V60, P1670, DOI 10.1128/AEM.60.5.1670-1673.1994; de Gier JWL, 1998, P NATL ACAD SCI USA, V95, P14646, DOI 10.1073/pnas.95.25.14646; GueroutFleury AM, 1995, GENE, V167, P335, DOI 10.1016/0378-1119(95)00652-4; Henry R, 1997, J CELL BIOL, V136, P823, DOI 10.1083/jcb.136.4.823; Hinsley AP, 2001, FEBS LETT, V497, P45, DOI 10.1016/S0014-5793(01)02428-0; Hirose I, 2000, MICROBIOL-SGM, V146, P65, DOI 10.1099/00221287-146-1-65; Ignatova Z, 2002, BIOCHEM BIOPH RES CO, V291, P146, DOI 10.1006/bbrc.2002.6420; Jongbloed JDH, 2000, J BIOL CHEM, V275, P41350, DOI 10.1074/jbc.M004887200; KLEIN M, 1994, FEMS MICROBIOL LETT, V124, P393; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leloup L, 1999, J BACTERIOL, V181, P1820, DOI 10.1128/JB.181.6.1820-1826.1999; LESUISSE E, 1993, EUR J BIOCHEM, V216, P155, DOI 10.1111/j.1432-1033.1993.tb18127.x; Molik S, 2001, J BIOL CHEM, V276, P42761, DOI 10.1074/jbc.M106690200; Muller JP, 1999, FEMS MICROBIOL LETT, V180, P287; Muller JP, 1997, MICROBIOL-SGM, V143, P947, DOI 10.1099/00221287-143-3-947; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Nielsen H, 1999, PROTEIN ENG, V12, P3, DOI 10.1093/protein/12.1.3; Otto A, 1996, ELECTROPHORESIS, V17, P1643, DOI 10.1002/elps.1150171027; PALVA I, 1982, GENE, V19, P81, DOI 10.1016/0378-1119(82)90191-3; Robinson C, 2001, NAT REV MOL CELL BIO, V2, P350, DOI 10.1038/35073038; Sambrook J., 2002, MOL CLONING LAB MANU; Sargent F, 1998, EMBO J, V17, P3640, DOI 10.1093/emboj/17.13.3640; Sargent F, 1999, J BIOL CHEM, V274, P36073, DOI 10.1074/jbc.274.51.36073; SCHAEFFER P, 1965, P NATL ACAD SCI USA, V271, P5463; Scotti PA, 1999, J BIOL CHEM, V274, P29883, DOI 10.1074/jbc.274.42.29883; SIPOS L, 1993, EUR J BIOCHEM, V213, P1333, DOI 10.1111/j.1432-1033.1993.tb17885.x; Stanley NR, 2000, J BIOL CHEM, V275, P11591, DOI 10.1074/jbc.275.16.11591; Tjalsma H, 1999, J BIOL CHEM, V274, P1698, DOI 10.1074/jbc.274.3.1698; Tjalsma H, 1998, GENE DEV, V12, P2318, DOI 10.1101/gad.12.15.2318; Tjalsma H, 2000, MICROBIOL MOL BIOL R, V64, P515, DOI 10.1128/MMBR.64.3.515-547.2000; TJALSMA H, 2001, ENZYMES, P3; Vagner V, 1998, MICROBIOL-SGM, V144, P3097, DOI 10.1099/00221287-144-11-3097; VanDijl J. M., 2001, BACILLUS SUBTILIS IT, P337; VANDIJL JM, 1991, MOL GEN GENET, V227, P40, DOI 10.1007/BF00260704; VANDIJL JM, 1995, J BIOL CHEM, V270, P3611, DOI 10.1074/jbc.270.8.3611; VANDIJL JM, 1991, J GEN MICROBIOL, V137, P2073, DOI 10.1099/00221287-137-9-2073; VIEIRA J, 1991, GENE, V100, P189, DOI 10.1016/0378-1119(91)90365-I; WERTMAN KF, 1986, GENE, V49, P253, DOI 10.1016/0378-1119(86)90286-6	56	107	113	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	2002	277	46					44068	44078		10.1074/jbc.M203191200	http://dx.doi.org/10.1074/jbc.M203191200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	615XE	12218047	hybrid, Green Published			2022-12-27	WOS:000179272000070
J	Piwien-Pilipuk, G; MacDougald, O; Schwartz, J				Piwien-Pilipuk, G; MacDougald, O; Schwartz, J			Dual regulation of phosphorylation and dephosphorylation of C/EBP beta modulate its transcriptional activation and DNA binding in response to growth hormone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; KIDNEY MINERALOCORTICOID RECEPTOR; TERNARY COMPLEX FACTORS; GENE-EXPRESSION; TYROSINE PHOSPHORYLATION; 3T3-L1 PREADIPOCYTES; GLUCOSE-TRANSPORT; MAMMALIAN-CELLS; FAMILY MEMBERS; FOS	The phosphorylation state of transcription factors is a critical determinant of their function. C/EBPbeta occurs in cells as the transcriptional activator liver-enriched activating protein (LAP) and in the truncated form liver-enriched inhibitory protein (LIP) that inhibits transcription. Analysis of C/EBPbeta phosphorylation by isoelectric focusing (IEF) shows that LAP is present in multiple forms, each with a different degree of phosphorylation in 3T3-F442A fibroblasts. Growth hormone (GH) treatment induces a new band near the negative pole, consistent, with GH-promoted dephosphorylation of LAP. In addition, bands near the positive pole are rapidly and transiently induced, suggesting that GH also stimulates phosphorylation at some site(s) on LAP. C/EBPbeta contains a highly conserved MAPK consensus site that corresponds to Thr(188) in murine (m) LAP and Thr(37) in mLIP. Immunoblotting with antiphosphopeptide antibodies specific for Thr(188/37) of C/EBPbeta (anti-P-C/EBPbeta) shows that GH rapidly and transiently promotes phosphorylation of mLAP and mLIP on the MAPK site. MEK inhibitors prevent this GH-promoted phosphorylation of LAP and LIP, suggesting that such phosphorylation depends on GH-activated MAPK signaling. Mutation of Thr(235) to Ala in the homologous MAPK site of human (h) LAP (hLAPT235A) inhibits transcription mediated by the c-fos promoter in response to GH, indicating that phosphorylation at the MAPK site is required for LAP to be transcriptionally active in the context of GH-stimulated activation of the c-fos promoter. Complexes bound to the c-fos C/EBP site transiently contain C/EBPbeta phosphorylated at the MAPK site. As phosphorylation subsides, the binding of less transcriptionally active forms of LAP increases, consistent with the transient nature of c-fos stimulation by GH and other growth factors. Thus, both phosphorylation and dephosphorylation of C/EBPbeta, in response to a single physiological stimulus such as GH, coordinately modulate the ability of C/EBPbeta to activate transcription by modulating its DNA binding activity and its transactivation capacity.	Univ Michigan, Sch Med, Dept Physiol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Schwartz, J (corresponding author), Univ Michigan, Sch Med, Dept Physiol, Ann Arbor, MI 48109 USA.			MacDougald, Ormond/0000-0001-6907-7960	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046072] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK46072] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BILLESTRUP N, 1994, P SOC EXP BIOL MED, V206, P205; BOYLE WJ, 1991, CELL, V64, P573, DOI 10.1016/0092-8674(91)90241-P; Buck M, 1999, MOL CELL, V4, P1087, DOI 10.1016/S1097-2765(00)80237-3; Buck M, 2001, MOL CELL, V8, P807, DOI 10.1016/S1097-2765(01)00374-4; CAMPBELL GS, 1992, J BIOL CHEM, V267, P6074; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Chen XN, 1997, BLOOD, V90, P156; Chinery R, 1997, J BIOL CHEM, V272, P30356, DOI 10.1074/jbc.272.48.30356; CHRISTY RJ, 1989, GENE DEV, V3, P1323, DOI 10.1101/gad.3.9.1323; CLARKSON RWE, 1995, MOL ENDOCRINOL, V9, P108, DOI 10.1210/me.9.1.108; Croniger C, 1997, J BIOL CHEM, V272, P26306, DOI 10.1074/jbc.272.42.26306; Darlington GJ, 1998, J BIOL CHEM, V273, P30057, DOI 10.1074/jbc.273.46.30057; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; Diehl AM, 1998, J BIOL CHEM, V273, P30843, DOI 10.1074/jbc.273.47.30843; DOGLIO A, 1989, P NATL ACAD SCI USA, V86, P1148, DOI 10.1073/pnas.86.4.1148; Galigniana MD, 1998, BIOCHEM J, V333, P555, DOI 10.1042/bj3330555; GILLE H, 1995, EMBO J, V14, P951, DOI 10.1002/j.1460-2075.1995.tb07076.x; Gong TWL, 1998, ENDOCRINOLOGY, V139, P1863, DOI 10.1210/en.139.4.1863; GURLAND G, 1990, ENDOCRINOLOGY, V127, P3187, DOI 10.1210/endo-127-6-3187; Hanlon M, 2001, J BIOL CHEM, V276, P38449, DOI 10.1074/jbc.M102165200; HARVAT BL, 1995, CELL GROWTH DIFFER, V6, P955; Hodge C, 1998, J BIOL CHEM, V273, P31327, DOI 10.1074/jbc.273.47.31327; HUNTER T, 1992, CELL, V70, P375, DOI 10.1016/0092-8674(92)90162-6; Ihle JN, 1996, CELL, V84, P331, DOI 10.1016/S0092-8674(00)81277-5; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Kowenz-Leutz E, 1999, MOL CELL, V4, P735, DOI 10.1016/S1097-2765(00)80384-6; KOWENZLEUTZ E, 1994, GENE DEV, V8, P2781, DOI 10.1101/gad.8.22.2781; Kwok RPS, 1996, NATURE, V380, P642, DOI 10.1038/380642a0; Liao J, 1999, J BIOL CHEM, V274, P31597, DOI 10.1074/jbc.274.44.31597; Liao JF, 1997, J BIOL CHEM, V272, P25951, DOI 10.1074/jbc.272.41.25951; LIN FT, 1992, GENE DEV, V6, P533, DOI 10.1101/gad.6.4.533; MAHONEY CW, 1992, J BIOL CHEM, V267, P19396; Mink S, 1997, MOL CELL BIOL, V17, P6609, DOI 10.1128/MCB.17.11.6609; MOLLER C, 1992, J BIOL CHEM, V267, P23403; Muller R, 1986, Biochim Biophys Acta, V823, P207, DOI 10.1016/0304-419X(86)90003-X; NAKAJIMA T, 1993, P NATL ACAD SCI USA, V90, P2207, DOI 10.1073/pnas.90.6.2207; NERLOV C, 1995, EMBO J, V14, P4318, DOI 10.1002/j.1460-2075.1995.tb00106.x; Pall M, 1997, EMBO J, V16, P5273, DOI 10.1093/emboj/16.17.5273; Piwien-Pilipuk G, 2001, J BIOL CHEM, V276, P19664, DOI 10.1074/jbc.M010193200; Piwien-Pilipuk G, 1998, MOL CELL ENDOCRINOL, V144, P119, DOI 10.1016/S0303-7207(98)00142-7; Price MA, 1996, EMBO J, V15, P6552, DOI 10.1002/j.1460-2075.1996.tb01046.x; Robinson GW, 1998, GENE DEV, V12, P1907, DOI 10.1101/gad.12.12.1907; Ruocco MR, 1996, J BIOL CHEM, V271, P22479, DOI 10.1074/jbc.271.37.22479; SCHWARTZ J, 1988, ENDOCRINOLOGY, V122, P2247; SCOTT LM, 1992, BLOOD, V80, P1725; SCREPANTI I, 1995, EMBO J, V14, P1932, DOI 10.1002/j.1460-2075.1995.tb07185.x; STEIN B, 1993, MOL CELL BIOL, V13, P3964, DOI 10.1128/MCB.13.7.3964; Sterneck E, 1997, GENE DEV, V11, P2153, DOI 10.1101/gad.11.17.2153; TANAKA T, 1995, CELL, V80, P353, DOI 10.1016/0092-8674(95)90418-2; TRAUTWEIN C, 1994, J CLIN INVEST, V93, P2554, DOI 10.1172/JCI117266; TRAUTWEIN C, 1993, NATURE, V364, P544, DOI 10.1038/364544a0; TREISMAN R, 1992, TRENDS BIOCHEM SCI, V17, P423, DOI 10.1016/0968-0004(92)90013-Y; Vanderkuur JA, 1997, ENDOCRINOLOGY, V138, P4301, DOI 10.1210/en.138.10.4301; WEGNER M, 1992, SCIENCE, V256, P370, DOI 10.1126/science.256.5055.370; WILLIAMS SC, 1995, EMBO J, V14, P3170, DOI 10.1002/j.1460-2075.1995.tb07319.x; WINSTON LA, 1992, J BIOL CHEM, V267, P4747	59	86	87	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	2002	277	46					44557	44565		10.1074/jbc.M206886200	http://dx.doi.org/10.1074/jbc.M206886200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	615XE	12213825	hybrid, Green Submitted			2022-12-27	WOS:000179272000128
J	Sasagawa, K; Matsudo, Y; Kang, M; Fujimura, L; Iitsuka, Y; Okada, S; Ochiai, T; Tokuhisa, T; Hatano, M				Sasagawa, K; Matsudo, Y; Kang, M; Fujimura, L; Iitsuka, Y; Okada, S; Ochiai, T; Tokuhisa, T; Hatano, M			Identification of Nd1, a novel murine kelch family protein, involved in stabilization of actin filaments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-ACTININ; BINDING PROTEIN; CELL MOTILITY; V(D)J RECOMBINATION; INTERACTION MOTIF; FINGER PROTEIN; CYTOCHALASIN-D; 3T3 CELLS; GENE; DROSOPHILA	We isolated Nd1, a novel kelch family gene that encodes two forms of proteins, Nd1-L and Nd1-S. Nd1-L contains a BTB/POZ domain in its N terminus and six kelch repeats in the C terminus. Nd1-S has the BTB/POZ domain but lacks the six kelch repeats. Nd1-L but not Nd1-S mRNA is detected ubiquitously in normal mouse tissues. Nd1-L and Nd1-S proteins can form a dimer through the BTB/POZ domain. Nd1-L colocalizes with actin filaments detected using a confocal microscope, and its kelch repeats bind to them in vitro. Overexpression of Nd1-L in NIH3T3 cells delayed cell growth by affecting the transition of cytokinesis. Furthermore, the overexpression prevented NIH3T3 cells from cell death induced by actin destabilization but not by microtubule dysfunction. These data suggest that Nd1-L functions as a stabilizer of actin filaments as an actin-binding protein and may play a role in the dynamic organization of the actin cytoskeleton.	Chiba Univ, Grad Sch Med, Dept Dev Genet H2, Chuo Ku, Chiba 2608670, Japan; Chiba Univ, Grad Sch Med, Dept Acad Surg M9, Chuo Ku, Chiba 2608670, Japan	Chiba University; Chiba University	Hatano, M (corresponding author), Chiba Univ, Grad Sch Med, Dept Dev Genet H2, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.		Okada, Seiji/F-5785-2013					Adams J, 2000, TRENDS CELL BIOL, V10, P17, DOI 10.1016/S0962-8924(99)01673-6; Akiba H, 1998, J BIOL CHEM, V273, P13353, DOI 10.1074/jbc.273.21.13353; ALBAGLI O, 1995, CELL GROWTH DIFFER, V6, P1193; BARDWELL VJ, 1994, GENE DEV, V8, P1664, DOI 10.1101/gad.8.14.1664; Bomont P, 2000, NAT GENET, V26, P370, DOI 10.1038/81701; BRAUN BS, 1995, MOL CELL BIOL, V15, P4623; CHANGYEH A, 1991, NUCLEIC ACIDS RES, V19, P3667, DOI 10.1093/nar/19.13.3667; CHEN W, 1995, MOL CELL BIOL, V15, P3424; CHEN Z, 1993, EMBO J, V12, P1161, DOI 10.1002/j.1460-2075.1993.tb05757.x; COOLEY L, 1994, SCIENCE, V266, P590, DOI 10.1126/science.7939713; COOPER JA, 1987, J CELL BIOL, V105, P1473, DOI 10.1083/jcb.105.4.1473; Dalakas MC, 2000, NEW ENGL J MED, V342, P770, DOI 10.1056/NEJM200003163421104; Djinovic-Carugo K, 1999, CELL, V98, P537, DOI 10.1016/S0092-8674(00)81981-9; Ellenberg J, 1997, J CELL BIOL, V138, P1193, DOI 10.1083/jcb.138.6.1193; Frazer JK, 1997, J IMMUNOL METHODS, V207, P1, DOI 10.1016/S0022-1759(97)00091-4; GLUCK U, 1994, J CELL SCI, V107, P1773; GLUCK U, 1993, P NATL ACAD SCI USA, V90, P383, DOI 10.1073/pnas.90.2.383; GODT D, 1993, DEVELOPMENT, V119, P799; Gomez CA, 2000, MOL CELL BIOL, V20, P5653, DOI 10.1128/MCB.20.15.5653-5664.2000; HALL A, 1994, ANNU REV CELL BIOL, V10, P31, DOI 10.1146/annurev.cb.10.110194.000335; HARRISON SD, 1990, EMBO J, V9, P207, DOI 10.1002/j.1460-2075.1990.tb08097.x; Hatano M, 1997, J CLIN INVEST, V100, P795, DOI 10.1172/JCI119593; Hernandez MC, 1998, EXP CELL RES, V242, P470, DOI 10.1006/excr.1998.4109; Hernandez MC, 1997, J NEUROSCI, V17, P3038; Honda K, 1998, J CELL BIOL, V140, P1383, DOI 10.1083/jcb.140.6.1383; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Kang M, 2001, BBA-GENE STRUCT EXPR, V1519, P167, DOI 10.1016/S0167-4781(01)00231-7; KELLER H, 1995, EUR J CELL BIOL, V66, P157; KERCKAERT JP, 1993, NAT GENET, V5, P66, DOI 10.1038/ng0993-66; Kim TA, 1998, J CELL BIOL, V141, P553, DOI 10.1083/jcb.141.3.553; Kobayashi K, 1999, P NATL ACAD SCI USA, V96, P1457, DOI 10.1073/pnas.96.4.1457; Mata J, 1997, CELL, V89, P939, DOI 10.1016/S0092-8674(00)80279-2; MIKI T, 1994, BLOOD, V83, P26; Mitchison TJ, 1996, CELL, V84, P371, DOI 10.1016/S0092-8674(00)81281-7; Okabe S, 1998, MOL CELL BIOL, V18, P4235, DOI 10.1128/MCB.18.7.4235; Olson TM, 1998, SCIENCE, V280, P750, DOI 10.1126/science.280.5364.750; PETERSON MG, 1986, EUR J BIOCHEM, V160, P579, DOI 10.1111/j.1432-1033.1986.tb10077.x; Robinson DN, 1997, J CELL BIOL, V138, P799, DOI 10.1083/jcb.138.4.799; ROBINSON DN, 1994, DEVELOPMENT, V120, P2015; SCHLIWA M, 1982, J CELL BIOL, V92, P79, DOI 10.1083/jcb.92.1.79; Schwarz K, 1996, SCIENCE, V274, P97, DOI 10.1126/science.274.5284.97; Shirasawa S, 1997, NAT MED, V3, P646, DOI 10.1038/nm0697-646; SMALL JV, 1993, SYM SOC EXP BIOL, V47, P57; Soltysik-Espanola M, 1999, MOL BIOL CELL, V10, P2361, DOI 10.1091/mbc.10.7.2361; Sung KLP, 1996, P NATL ACAD SCI USA, V93, P9182, DOI 10.1073/pnas.93.17.9182; VARKEY JP, 1995, GENE DEV, V9, P1074, DOI 10.1101/gad.9.9.1074; Villa A, 1998, CELL, V93, P885, DOI 10.1016/S0092-8674(00)81448-8; WATKINS H, 1995, NAT GENET, V11, P434, DOI 10.1038/ng1295-434; WAY M, 1995, J CELL BIOL, V128, P51, DOI 10.1083/jcb.128.1.51; XUE FY, 1993, CELL, V72, P681, DOI 10.1016/0092-8674(93)90397-9; YE BHH, 1993, CANCER RES, V53, P2732	51	42	45	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	2002	277	46					44140	44146		10.1074/jbc.M202596200	http://dx.doi.org/10.1074/jbc.M202596200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	615XE	12213805	hybrid			2022-12-27	WOS:000179272000079
J	Dong, XC; Ghoshal, K; Majumder, S; Yadav, SP; Jacob, ST				Dong, XC; Ghoshal, K; Majumder, S; Yadav, SP; Jacob, ST			RETRACTED: Mitochondrial transcription factor A and its downstream targets are up-regulated in a rat hepatoma (Retracted article. See vol. 293, pg. 12947, 2018)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Retracted Publication							NUCLEAR RESPIRATORY FACTOR-1; CANCER CELL PHYSIOLOGY; GENE-EXPRESSION; MAMMALIAN-CELLS; DNA-BINDING; FACTOR-A; FACTOR-I; RNA; PHOSPHORYLATION; POLYMERASE	Mitochondrial transcription factor A is a key regulator involved in mitochondrial DNA transcription and replication. In a poorly differentiated rat hepatoma, Morris hepatoma 3924A, the mRNA and protein levels of this factor were elevated about 10- and 11-fold, respectively, relative to the host liver. The mRNA levels for the hepatoma cytochrome c oxidase 1, 11, and NADH dehydrogenase 5,6, the downstream targets of Tfam, were augmented 10-, 8-, 5-, and 3-fold, respectively. Interestingly, Tfam was also found in the hepatoma nucleus. The mRNA levels for nuclear respiratory factor 1 and 2 (NRF-1 and -2), the proteins that are known to interact with specific regulatory elements on human TFAM promoter, were 5- and 3-fold higher, respectively, in the hepatoma relative to the host liver. Unlike the human promoter, the rat Tfam promoter did not form a specific complex with the NRF-1 in the liver or hepatoma nuclear extracts, which is consistent with the absence of an NRF-1 consensus sequence in the proximal rat promoter. A single specific complex formed between the rat promoter and the NRF-2 protein was comparable in the two extracts. The DNA binding activity of Sp1 in the hepatoma nuclear extract was 4-fold greater than that in the liver extract. In vivo genomic footprinting showed occupancy of NRF-2 and Sp1 consensus sites on the promoter of rat Tfam gene. Tfam was also up-regulated. in other hepatoma cells. Together, these results show up-regulation of Tfam in some tumors, particularly the liver tumors. Further, the relatively high level of Sp1 binding to the promoter in the hepatoma could play a major role in the up-regulation of Tfam in these tumor cells.	Ohio State Univ, Coll Med, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA; Cleveland Clin Fdn, Lerner Res Inst, Cleveland, OH 44195 USA	University System of Ohio; Ohio State University; Cleveland Clinic Foundation	Jacob, ST (corresponding author), Ohio State Univ, Coll Med, Dept Mol & Cellular Biochem, 333 Hamilton Hall,1645 Neil Ave, Columbus, OH 43210 USA.	Jacob.42@osu.edu	Jacob, Samson/H-3135-2011		NATIONAL CANCER INSTITUTE [R01CA081024] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES010874] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA081024-02, R01 CA081024-03, R01 CA081024, R01 CA081024-01A2, CA 81024, R01 CA081024-04] Funding Source: Medline; NIEHS NIH HHS [ES 10874, R01 ES010874-02, R01 ES010874-01, R01 ES010874, R01 ES010874-05, R01 ES010874-04, R01 ES010874-03] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Brand K, 1997, J BIOENERG BIOMEMBR, V29, P355, DOI 10.1023/A:1022498714522; Capuano F, 1997, J BIOENERG BIOMEMBR, V29, P379, DOI 10.1023/A:1022402915431; Cavalli LR, 1997, CELL GROWTH DIFFER, V8, P1189; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COOPER HM, 1997, CURRENT PROTOCOLS MO, V2; CORRAL M, 1989, EXP CELL RES, V184, P158, DOI 10.1016/0014-4827(89)90374-1; Dorward A, 1997, J BIOENERG BIOMEMBR, V29, P385, DOI 10.1023/A:1022454932269; Dunah AW, 2002, SCIENCE, V296, P2238, DOI 10.1126/science.1072613; EVANS MJ, 1990, GENE DEV, V4, P1023, DOI 10.1101/gad.4.6.1023; Ferri KF, 2001, BIOESSAYS, V23, P111, DOI 10.1002/1521-1878(200102)23:2<111::AID-BIES1016>3.3.CO;2-P; FISHER RP, 1985, J BIOL CHEM, V260, P1330; FISHER RP, 1987, CELL, V50, P247, DOI 10.1016/0092-8674(87)90220-0; Ghoshal K, 2000, J BIOL CHEM, V275, P539, DOI 10.1074/jbc.275.1.539; Gugneja S, 1997, J BIOL CHEM, V272, P18732, DOI 10.1074/jbc.272.30.18732; Gugneja S, 1996, MOL CELL BIOL, V16, P5708; HARLOW E, 1999, USING ATIBODIES LAB, P228; HAYASHI JI, 1992, SOMAT CELL MOLEC GEN, V18, P123, DOI 10.1007/BF01233159; Iborra FJ, 2001, SCIENCE, V293, P1139, DOI 10.1126/science.1061216; LANDSMAN D, 1993, BIOESSAYS, V15, P539, DOI 10.1002/bies.950150807; Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231; Larsson NG, 1996, NAT GENET, V13, P296, DOI 10.1038/ng0796-296; LU X, 1992, CANCER RES, V52, P3718; LUCIAKOVA K, 1992, EUR J BIOCHEM, V205, P1187, DOI 10.1111/j.1432-1033.1992.tb16889.x; Majumder S, 2002, J BIOL CHEM, V277, P16048, DOI 10.1074/jbc.M111662200; Mathupala SP, 1997, J BIOENERG BIOMEMBR, V29, P339, DOI 10.1023/A:1022494613613; PARISI MA, 1991, SCIENCE, V252, P965, DOI 10.1126/science.2035027; Penta JS, 2001, MUTAT RES-REV MUTAT, V488, P119, DOI 10.1016/S1383-5742(01)00053-9; Preston TJ, 2001, ADV DRUG DELIVER REV, V49, P45, DOI 10.1016/S0169-409X(01)00127-2; QUERTERMOUS T, 1996, CURRENT PROTOCOLS MO, V1; Rantanen A, 2001, MAMM GENOME, V12, P787, DOI 10.1007/s00335-001-2052-8; Rice J.E., 1997, SUBCELLULAR FRACTION, V1st, P107; ROSE KM, 1975, BIOCHEMISTRY-US, V14, P1025, DOI 10.1021/bi00676a022; Scarpulla RC, 1997, J BIOENERG BIOMEMBR, V29, P109, DOI 10.1023/A:1022681828846; Scheffler IE, 2001, ADV DRUG DELIVER REV, V49, P3, DOI 10.1016/S0169-409X(01)00123-5; SHARP MGF, 1992, J PATHOL, V168, P163, DOI 10.1002/path.1711680203; SRERE PA, 1961, J BIOL CHEM, V236, P2557; Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3; TOMINAGA K, 1992, BIOCHIM BIOPHYS ACTA, V1131, P217, DOI 10.1016/0167-4781(92)90082-B; VIRBASIUS JV, 1994, P NATL ACAD SCI USA, V91, P1309, DOI 10.1073/pnas.91.4.1309	39	46	49	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					43309	43318		10.1074/jbc.M206958200	http://dx.doi.org/10.1074/jbc.M206958200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12198131	hybrid, Green Accepted, Green Published			2022-12-27	WOS:000179081200114
J	Flannery, CR; Zeng, WL; Corcoran, C; Collins-Racie, LA; Chockalingam, PS; Hebert, T; Mackie, SA; McDonagh, T; Crawford, TK; Tomkinson, KN; LaVallie, ER; Morris, EA				Flannery, CR; Zeng, WL; Corcoran, C; Collins-Racie, LA; Chockalingam, PS; Hebert, T; Mackie, SA; McDonagh, T; Crawford, TK; Tomkinson, KN; LaVallie, ER; Morris, EA			Autocatalytic cleavage of ADAMTS-4 (Aggrecanase-1) reveals multiple glycosaminoglycan-binding sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATRIX METALLOPROTEINASES; CARTILAGE PROTEOGLYCAN; INTERGLOBULAR DOMAIN; IDENTIFICATION; EXPRESSION; PROTEINS; CLONING; HYALURONAN; CATABOLISM; MEMBER	ADAMTS-4, also referred to as aggrecanase-1, is a glutamyl endopeptidase capable of generating catabolic fragments of aggrecan analogous to those released from articular cartilage during degenerative joint diseases such as osteoarthritis. Efficient aggrecanase activity requires the presence of sulfated glycosaminoglycans (GAGs) attached to the aggrecan core protein, implying the contribution of substrate recognition/binding site(s) to ADAMTS-4 activity. In the present study, we demonstrate that full-length ADAMTS-4 (M-r similar to68,000) undergoes autocatalytic C-terminal truncation to generate two discrete isoforms (M-r similar to53,000 and M-r similar to40,000), which exhibit a marked reduction in affinity of binding to sulfated GAGs. C-terminal sequencing and mass analyses revealed that the GAGbinding thrombospondin type I motif was retained following autocatalysis, indicating that sites present in the C-terminal cysteine (cys)-rich and/or spacer domains also effect binding of full-length ADAMTS-4 to sulfated GAGs. Binding-competition experiments conducted using native and deglycosylated aggrecan provided direct evidence for interaction of the ADAMTS-4 cysteine-rich/spacer domains with aggrecan GAGs. Furthermore, synthetic peptides mimicking putative (consensus) GAG-binding sequences located within the ADAMTS-4 cysteine-rich and spacer domains competitively blocked binding of sulfated GAGs to full-length ADAMTS-4, thereby identifying multiple GAG-binding sites, which may contribute to the regulation of ADAMTS-4 function.	Wyeth Res, Cambridge, MA 02140 USA	Pfizer	Flannery, CR (corresponding author), Wyeth Res, Cambridge, MA 02140 USA.	cflannery@wyeth.com						Abbaszade I, 1999, J BIOL CHEM, V274, P23443, DOI 10.1074/jbc.274.33.23443; Arner EC, 2002, CURR OPIN PHARMACOL, V2, P322, DOI 10.1016/S1471-4892(02)00148-0; BOYD VL, 1992, ANAL BIOCHEM, V206, P344, DOI 10.1016/0003-2697(92)90376-I; Cal S, 2001, J BIOL CHEM, V276, P17932, DOI 10.1074/jbc.M100534200; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; Caterson B, 2000, MATRIX BIOL, V19, P333, DOI 10.1016/S0945-053X(00)00078-0; Colige A, 1997, P NATL ACAD SCI USA, V94, P2374, DOI 10.1073/pnas.94.6.2374; Colige A, 2002, J BIOL CHEM, V277, P5756, DOI 10.1074/jbc.M105601200; Fernandes RJ, 2001, J BIOL CHEM, V276, P31502, DOI 10.1074/jbc.M103466200; Flannery CR, 1999, BIOCHEM BIOPH RES CO, V260, P318, DOI 10.1006/bbrc.1999.0909; Fujikawa K, 2001, BLOOD, V98, P1662, DOI 10.1182/blood.V98.6.1662; Gao G, 2002, J BIOL CHEM, V277, P11034, DOI 10.1074/jbc.M107443200; Gerritsen HE, 2001, BLOOD, V98, P1654, DOI 10.1182/blood.V98.6.1654; HASCALL VC, 1982, METHOD ENZYMOL, V82, P769; HUGHES CE, 1995, BIOCHEM J, V305, P799, DOI 10.1042/bj3050799; Hughes CE, 1998, J BIOL CHEM, V273, P30576, DOI 10.1074/jbc.273.46.30576; Kuno K, 1998, J BIOL CHEM, V273, P13912, DOI 10.1074/jbc.273.22.13912; Kuno K, 2000, FEBS LETT, V478, P241, DOI 10.1016/S0014-5793(00)01854-8; Larsen MR, 2000, FRESEN J ANAL CHEM, V366, P677, DOI 10.1007/s002160051562; Lemons ML, 2001, J NEUROSCI, V21, P4772, DOI 10.1523/JNEUROSCI.21-13-04772.2001; Levy GG, 2001, NATURE, V413, P488, DOI 10.1038/35097008; Little CB, 1999, BIOCHEM J, V344, P61, DOI 10.1042/0264-6021:3440061; Little CB, 2002, MATRIX BIOL, V21, P271, DOI 10.1016/S0945-053X(02)00004-5; Malfait AM, 2002, J BIOL CHEM, V277, P22201, DOI 10.1074/jbc.M200431200; Matthews RT, 2000, J BIOL CHEM, V275, P22695, DOI 10.1074/jbc.M909764199; Melrose J, 1996, ELECTROPHORESIS, V17, P205, DOI 10.1002/elps.1150170134; NAGASE H, 2001, CONNECT TISSUE, V33, P27; Pratta MA, 2000, J BIOL CHEM, V275, P39096, DOI 10.1074/jbc.M006201200; Rees SG, 2000, BIOCHEM J, V350, P181, DOI 10.1042/0264-6021:3500181; Roberts S, 2000, SPINE, V25, P3005, DOI 10.1097/00007632-200012010-00007; Rodriguez-Manzaneque JC, 2000, J BIOL CHEM, V275, P33471, DOI 10.1074/jbc.M002599200; Rodriguez-Manzaneque JC, 2002, BIOCHEM BIOPH RES CO, V293, P501; Sandy JD, 2001, J BIOL CHEM, V276, P13372, DOI 10.1074/jbc.M009737200; Sztrolovics R, 1997, BIOCHEM J, V326, P235, DOI 10.1042/bj3260235; Tortorella M, 2000, J BIOL CHEM, V275, P25791, DOI 10.1074/jbc.M001065200; Tortorella MD, 1999, SCIENCE, V284, P1664, DOI 10.1126/science.284.5420.1664; Tortorella MD, 2001, OSTEOARTHR CARTILAGE, V9, P539, DOI 10.1053/joca.2001.0427; Vankemmelbeke MN, 2001, EUR J BIOCHEM, V268, P1259, DOI 10.1046/j.1432-1327.2001.01990.x; VANWART HE, 1990, P NATL ACAD SCI USA, V87, P5578, DOI 10.1073/pnas.87.14.5578; Wei P, 2002, BIOCHEM BIOPH RES CO, V293, P478, DOI 10.1016/S0006-291X(02)00255-3; Westling J, 2002, J BIOL CHEM, V277, P16059, DOI 10.1074/jbc.M108607200; YANG BH, 1994, EMBO J, V13, P286, DOI 10.1002/j.1460-2075.1994.tb06261.x	42	121	125	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					42775	42780		10.1074/jbc.M205309200	http://dx.doi.org/10.1074/jbc.M205309200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12202483	hybrid			2022-12-27	WOS:000179081200047
J	Ma, KY; Temiakov, D; Jiang, ML; Anikin, M; McAllister, WT				Ma, KY; Temiakov, D; Jiang, ML; Anikin, M; McAllister, WT			Major conformational changes occur during the transition from an initiation complex to an elongation complex by T7 RNA polymerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION INITIATION; STRUCTURAL BASIS; TERMINATION SIGNAL; BACTERIOPHAGE-T7; PROMOTER; MECHANISM; MODEL; BINDING; BUBBLE; SITE	To examine changes that occur during the transition from an initiation complex (IC) to an elongation complex (EC) in T7 RNA polymerase (RNAP), we used nucleic acid-protein cross-linking methods to probe interactions of the RNAP with RNA and DNA in a halted EC. As the RNA is displaced from the RNA-DNA hybrid similar to9 hp upstream from the active site (at -9) it interacts with a region within the specificity loop (residues 744-750) and is directed toward a positively charged surface that surrounds residues Lys-302 and Lys-303. Surprisingly, the template and non-template strands of the DNA at the upstream edge of the hybrid (near the site where the RNA is displaced) interact with a region in the N-terininal domain of the RNAP (residues 172-191) that is far away from the specificity loop before isomerization (in the IC). To bring these two regions of the RNAP into proximity, major conformational changes must occur during the transition from an IC to an EC. The observed nucleic acid-protein interactions help to explain the behavior of a number of mutant RNAPs that are affected at various stages in the initiation process and in termination.	SUNY Hlth Sci Ctr, Dept Microbiol & Immunol, Morse Inst Mol Genet, Brooklyn, NY 11203 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	McAllister, WT (corresponding author), SUNY Hlth Sci Ctr, Dept Microbiol & Immunol, Morse Inst Mol Genet, 450 Clarkson Ave, Brooklyn, NY 11203 USA.	pogo51@aol.com	Hu, Ruogu/B-2203-2008		NIGMS NIH HHS [R01 GM038147, GM38147, R01 GM038147-14] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038147] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BARTHOLOMEW B, 1994, J BIOL CHEM, V269, P18090; Brieba LG, 2001, EMBO J, V20, P6826, DOI 10.1093/emboj/20.23.6826; Brieba LG, 2001, J BIOL CHEM, V276, P10306, DOI 10.1074/jbc.M009866200; Brieba LG, 2000, BIOCHEMISTRY-US, V39, P919, DOI 10.1021/bi992324+; Cermakian N, 1997, J MOL EVOL, V45, P671, DOI 10.1007/PL00006271; Cheetham GMT, 1999, SCIENCE, V286, P2305, DOI 10.1126/science.286.5448.2305; Cheetham GMT, 1999, NATURE, V399, P80, DOI 10.1038/19999; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Gopal V, 1999, J MOL BIOL, V290, P411, DOI 10.1006/jmbi.1999.2836; GRODBERG J, 1988, J BACTERIOL, V170, P1245, DOI 10.1128/jb.170.3.1245-1253.1988; Guajardo R, 1997, J MOL BIOL, V265, P8, DOI 10.1006/jmbi.1996.0707; Hartvig L, 1996, EMBO J, V15, P4767, DOI 10.1002/j.1460-2075.1996.tb00854.x; He B, 1997, PROTEIN EXPRES PURIF, V9, P142, DOI 10.1006/prep.1996.0663; He B, 1997, J MOL BIOL, V265, P275, DOI 10.1006/jmbi.1996.0741; He B, 1998, J BIOL CHEM, V273, P18802, DOI 10.1074/jbc.273.30.18802; Huang JB, 2000, J MOL BIOL, V303, P347, DOI 10.1006/jmbi.2000.4150; IKEDA RA, 1987, J BIOL CHEM, V262, P3790; IKEDA RA, 1986, P NATL ACAD SCI USA, V83, P3614, DOI 10.1073/pnas.83.11.3614; Imburgio D, 2002, J MOL BIOL, V319, P37, DOI 10.1016/S0022-2836(02)00261-9; Jeruzalmi D, 1998, EMBO J, V17, P4101, DOI 10.1093/emboj/17.14.4101; Jia YP, 1997, BIOCHEMISTRY-US, V36, P4223, DOI 10.1021/bi9630467; Jiang ML, 2001, J MOL BIOL, V310, P509, DOI 10.1006/jmbi.2001.4793; Korzheva N, 2000, SCIENCE, V289, P619, DOI 10.1126/science.289.5479.619; Kwon YS, 1999, J BIOL CHEM, V274, P29149, DOI 10.1074/jbc.274.41.29149; Li Y, 1998, EMBO J, V17, P7514, DOI 10.1093/emboj/17.24.7514; Liu CH, 2002, J BIOL CHEM, V277, P2725, DOI 10.1074/jbc.M108856200; Liu CH, 2001, J MOL BIOL, V308, P465, DOI 10.1006/jmbi.2001.4601; Lyakhov DL, 1998, J MOL BIOL, V280, P201, DOI 10.1006/jmbi.1998.1854; Lyakhov DL, 1997, J MOL BIOL, V269, P28, DOI 10.1006/jmbi.1997.1015; MACDONALD LE, 1993, J MOL BIOL, V232, P1030, DOI 10.1006/jmbi.1993.1458; MACDONALD LE, 1994, J MOL BIOL, V238, P145, DOI 10.1006/jmbi.1994.1277; MARTIN CT, 1988, BIOCHEMISTRY-US, V27, P3966, DOI 10.1021/bi00411a012; MCALLISTER WT, 1993, MOL MICROBIOL, V10, P1, DOI 10.1111/j.1365-2958.1993.tb00897.x; MCALLISTER WT, 1997, NUCL ACIDS MOL BIOL, V11, P15; Mentesana PE, 2000, J MOL BIOL, V302, P1049, DOI 10.1006/jmbi.2000.4114; Mukherjee S, 2002, CELL, V110, P81, DOI 10.1016/S0092-8674(02)00815-2; Place C, 1999, BIOCHEMISTRY-US, V38, P4948, DOI 10.1021/bi982689e; Sambrook J., 1989, MOL CLONING, pA1; Shen HH, 2001, J BIOL CHEM, V276, P4080, DOI 10.1074/jbc.M008616200; SOUSA R, 1992, J MOL BIOL, V224, P319, DOI 10.1016/0022-2836(92)90997-X; Sousa R, 2001, Uirusu, V51, P81; SOUSA R, 1993, NATURE, V364, P593, DOI 10.1038/364593a0; SOUSA R, 1995, EMBO J, V14, P4609, DOI 10.1002/j.1460-2075.1995.tb00140.x; Temiakov D, 2000, PRACT APPROACH SER, P351; Temiakov D, 2000, P NATL ACAD SCI USA, V97, P14109, DOI 10.1073/pnas.250473197; TUNITSKAYA VL, 1990, EUR J BIOCHEM, V191, P99, DOI 10.1111/j.1432-1033.1990.tb19098.x	46	28	32	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					43206	43215		10.1074/jbc.M206658200	http://dx.doi.org/10.1074/jbc.M206658200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12186873	hybrid			2022-12-27	WOS:000179081200102
J	Peoc'h, K; Serres, C; Frobert, Y; Martin, C; Lehmann, S; Chasseigneaux, S; Sazdovitch, V; Grassi, J; Jouannet, P; Launay, JM; Laplanche, JL				Peoc'h, K; Serres, C; Frobert, Y; Martin, C; Lehmann, S; Chasseigneaux, S; Sazdovitch, V; Grassi, J; Jouannet, P; Launay, JM; Laplanche, JL			The human "prion-like" protein doppel is expressed in both sertoli cells and spermatozoa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRP-LIKE PROTEIN; GENE; MICE; BRAIN; IDENTIFICATION; DEGENERATION; DEFICIENT; DISEASES; CLEAVAGE; SEQUENCE	The prion-like Doppel protein (Dpl) has many biochemical and structural properties in common with the cellular prion protein (PrPc), and the physiological role of neither protein is known. Experimental data suggest either direct or indirect interaction between the two proteins. In this study, we investigated the expression pattern and biochemical characteristics of Dpl in human tissues and in Chinese hamster ovary cells transfected with wild-type or variant human Dpl gene constructs. Human Dpl appears to be a glycosylphosphatidylinositol-anchored glycoprotein with N- and O-linked sugars. It was found on Sertoli cells in the testis, on the flagella of epididymal and mature spermatozoa, and in seminal plasma. Dpl coexists only with N-terminally truncated isoforms of PrPc on mature spermatozoa. The localization of human Dpl on both Sertoli cells (somatic cells) and spermatozoa (germinal cells) strongly suggests that this protein may play a major role in human male fertility. Finally, our data indicate that spermatozoa are thus an interesting model for studies of the potential interaction between Dpl and PrPc.	Hop Lariboisiere, Serv Biochim & Biol Mol, F-75475 Paris 10, France; Fac Sci Pharmaceut & Biol Paris, EA 3621, IFR 71, F-75006 Paris, France; CHU Cochin, GREFH, Lab Histol & Embryol Biol Reprod, F-75014 Paris, France; Commissariat Energie Atom, Serv Pharmacol & Immunol, F-91191 Gif Sur Yvette, France; CNRS, UPR 1142, IGH, F-34396 Montpellier 5, France; INSERM, U360, Grp Hosp Pitie Salpetriere, Lab Neuropathol R Escourolle, F-75013 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Peoc'h, K (corresponding author), Hop Lariboisiere, Serv Biochim & Biol Mol, 2 Rue Ambroise Pare, F-75475 Paris 10, France.	katell.peoch@lrb.ap-hop-paris.fr	Peoc'h, Katell/V-1604-2017; Lehmann, Sylvain/P-1301-2017; Chasseigneaux, Stephanie/A-4291-2017; LAPLANCHE, Jean-Louis/S-8707-2016; Peoc'h, Katell/D-5261-2014; SCHMITT, Caroline/P-2859-2017	Peoc'h, Katell/0000-0002-8203-1243; Lehmann, Sylvain/0000-0001-6117-562X; Chasseigneaux, Stephanie/0000-0003-2859-371X; SCHMITT, Caroline/0000-0001-5145-7260; LAPLANCHE, Jean-Louis/0000-0003-2836-2903				Behrens A, 2002, EMBO J, V21, P3652, DOI 10.1093/emboj/cdf386; Behrens A, 2001, EMBO REP, V2, P347, DOI 10.1093/embo-reports/kve088; BENDHEIM PE, 1992, NEUROLOGY, V42, P149, DOI 10.1212/WNL.42.1.149; Blobel CP, 2000, REV REPROD, V5, P75, DOI 10.1530/revreprod/5.2.75; Brown DR, 1997, NATURE, V390, P684, DOI 10.1038/37733; CARR SA, 1993, PROTEIN SCI, V2, P183; CHEN SG, 1995, J BIOL CHEM, V270, P19173, DOI 10.1074/jbc.270.32.19173; DACHEUX JL, 1987, ANN NY ACAD SCI, V513, P560, DOI 10.1111/j.1749-6632.1987.tb25107.x; Demart S, 1999, BIOCHEM BIOPH RES CO, V265, P652, DOI 10.1006/bbrc.1999.1730; Fortna RR, 1999, BIOL REPROD, V61, P1042, DOI 10.1095/biolreprod61.4.1042; Jimenez-Huete A, 1998, AM J PATHOL, V153, P1561, DOI 10.1016/S0002-9440(10)65744-6; Kirchhoff C, 1996, MOL HUM REPROD, V2, P177, DOI 10.1093/molehr/2.3.177; KRETZSCHMAR HA, 1986, AM J PATHOL, V122, P1; Kuwahara C, 1999, NATURE, V400, P225, DOI 10.1038/22241; Lehmann S, 2002, CURR OPIN CHEM BIOL, V6, P187, DOI 10.1016/S1367-5931(02)00295-8; LEHMANN S, 1995, J BIOL CHEM, V270, P24589, DOI 10.1074/jbc.270.41.24589; Li AM, 2000, CELL MOL NEUROBIOL, V20, P553, DOI 10.1023/A:1007059827541; Li AM, 2000, AM J PATHOL, V157, P1447, DOI 10.1016/S0002-9440(10)64782-7; Lu K, 2000, BIOCHEMISTRY-US, V39, P13575, DOI 10.1021/bi001523m; Mead S, 2000, NEUROSCI LETT, V290, P117, DOI 10.1016/S0304-3940(00)01319-7; Milhavet O, 2000, P NATL ACAD SCI USA, V97, P13937, DOI 10.1073/pnas.250289197; Mo HP, 2001, P NATL ACAD SCI USA, V98, P2352, DOI 10.1073/pnas.051627998; Moore RC, 1999, J MOL BIOL, V292, P797, DOI 10.1006/jmbi.1999.3108; Moore RC, 2001, P NATL ACAD SCI USA, V98, P15288, DOI 10.1073/pnas.251550798; Mouillet-Richard S, 2000, SCIENCE, V289, P1925, DOI 10.1126/science.289.5486.1925; Nishida N, 1999, LAB INVEST, V79, P689; Peoc'h K, 2000, NEUROSCI LETT, V286, P144, DOI 10.1016/S0304-3940(00)01100-9; Rooney IA, 1996, J CLIN INVEST, V97, P1675, DOI 10.1172/JCI118594; Rossi D, 2001, EMBO J, V20, P694, DOI 10.1093/emboj/20.4.694; Sakaguchi S, 1996, NATURE, V380, P528, DOI 10.1038/380528a0; Schroter S, 1999, J BIOL CHEM, V274, P29862, DOI 10.1074/jbc.274.42.29862; Shaked Y, 1999, J BIOL CHEM, V274, P32153, DOI 10.1074/jbc.274.45.32153; SHYNG SL, 1993, J BIOL CHEM, V268, P15922; Silverman GL, 2000, J BIOL CHEM, V275, P26834; Tranulis MA, 2001, MAMM GENOME, V12, P376, DOI 10.1007/s003350010285; Tuzi NL, 2002, J GEN VIROL, V83, P705, DOI 10.1099/0022-1317-83-3-705; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; World Health Organization, 1992, WHO LAB MAN EX HUM S	38	69	71	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					43071	43078		10.1074/jbc.M206357200	http://dx.doi.org/10.1074/jbc.M206357200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12200435	hybrid			2022-12-27	WOS:000179081200085
J	You, ZY; Ishimi, Y; Masai, H; Hanaoka, F				You, ZY; Ishimi, Y; Masai, H; Hanaoka, F			Roles of Mcm7 and Mcm4 subunits in the DNA helicase activity of the mouse Mcm4/6/7 complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MINICHROMOSOME MAINTENANCE PROTEINS; LARGE T-ANTIGEN; ESCHERICHIA-COLI; BIOCHEMICAL-ANALYSIS; BINDING-ACTIVITY; ZINC-FINGER; REPLICATION; HYDROLYSIS; DOMAIN; ORIGIN	Mcm, which is composed of six structurally related subunits (Mcm2-7), is essential for eukaryotic DNA replication. A subassembly of Mcm, the Mcm4/6/7 doubletrimeric complex, possesses DNA helicase activity, and it has been proposed that Mcm may function as a replicative helicase at replication forks. We show here that conserved ATPase motifs of Mcm7 are essential for ATPase and DNA helicase activities of the Mcm4/6/7 complex. Because uncomplexed Mcm7 displayed neither ATPase nor DNA helicase activity, Mcm7 contributes to the DNA helicase activity of the Mcm complex through interaction with other subunits. In contrast, the Mcm4/ 6/7 complex containing a zinc finger mutant of Mcm4 with partially impaired DNA binding activity exhibited elevated DNA helicase activity. The Mcm4/6/7 complex containing this Mcm4 mutant tended to dissociate into trimeric complexes, suggesting that the zinc finger of Mcm4 is involved in subunit interactions of trimers. The Mcm4 mutants lacking the N-terminal 35 or 112 amino acids could form hexameric Mcm4/6/7 complexes, but displayed very little DNA helicase activity. In conjunction with the previously reported essential role of Mcm6 in ATP binding (You, Z., Komamura, Y., and Ishimi, Y. (1999) Mol Cell Biol 19, 8003-8015), our data indicate distinct roles of Mcm4, Mcm6, and Mcm7 subunits in activation of the DNA helicase activity of the Mcm.4/6/7 complex.	Tokyo Metropolitan Inst Med Sci, Dept Cell Biol, Bunkyo Ku, Tokyo 1138613, Japan; RIKEN, Inst Phys & Chem Res, Wako, Saitama 3510198, Japan; Mitsubishi Kagaku Inst Life Sci, Biomol Sci & Technol Dept, Tokyo 1948511, Japan; Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; Japan Sci & Technol, Core Res & Evolut Sci & Technol, Suita, Osaka 5650871, Japan	Tokyo Metropolitan Institute of Medical Science; RIKEN; Mitsubishi Kagaku Institute of Life Sciences (MITILS); Osaka University; Japan Science & Technology Agency (JST)	You, ZY (corresponding author), Tokyo Metropolitan Inst Med Sci, Dept Cell Biol, Bunkyo Ku, 18-22 Honkomagome 3-chome, Tokyo 1138613, Japan.	yzhiying@rinshoken.or.jp						Aparicio OM, 1997, CELL, V91, P59, DOI 10.1016/S0092-8674(01)80009-X; Bird LE, 1998, CURR OPIN STRUC BIOL, V8, P14, DOI 10.1016/S0959-440X(98)80004-3; Biswas EE, 1999, BIOCHEMISTRY-US, V38, P10929, DOI 10.1021/bi990049l; BUJALOWSKI W, 1994, J BIOL CHEM, V269, P31350; Cao WH, 1998, J BIOL CHEM, V273, P20629, DOI 10.1074/jbc.273.32.20629; Cox EH, 2000, CURR OPIN CHEM BIOL, V4, P162, DOI 10.1016/S1367-5931(99)00070-8; DEAN FB, 1992, J BIOL CHEM, V267, P14129; Diffley TFX, 1996, GENE DEV, V10, P2819, DOI 10.1101/gad.10.22.2819; GORBALENYA AE, 1993, CURR OPIN STRUC BIOL, V3, P419, DOI 10.1016/S0959-440X(05)80116-2; Hendrickson M, 1996, P NATL ACAD SCI USA, V93, P12223, DOI 10.1073/pnas.93.22.12223; Hingorani MM, 1997, P NATL ACAD SCI USA, V94, P5012, DOI 10.1073/pnas.94.10.5012; Ishimi Y, 2000, J BIOL CHEM, V275, P16235, DOI 10.1074/jbc.M909040199; Ishimi Y, 1996, J BIOL CHEM, V271, P24115, DOI 10.1074/jbc.271.39.24115; Ishimi Y, 1997, J BIOL CHEM, V272, P24508, DOI 10.1074/jbc.272.39.24508; Ishimi Y, 2001, J BIOL CHEM, V276, P34428, DOI 10.1074/jbc.M104480200; Kearsey SE, 1998, BBA-GENE STRUCT EXPR, V1398, P113, DOI 10.1016/S0167-4781(98)00033-5; Kelly TJ, 2000, ANNU REV BIOCHEM, V69, P829, DOI 10.1146/annurev.biochem.69.1.829; KOONIN EV, 1993, NUCLEIC ACIDS RES, V21, P2541, DOI 10.1093/nar/21.11.2541; Labib K, 2000, SCIENCE, V288, P1643, DOI 10.1126/science.288.5471.1643; Lee JK, 2000, J BIOL CHEM, V275, P18871, DOI 10.1074/jbc.M001118200; Lee JK, 2001, P NATL ACAD SCI USA, V98, P54, DOI 10.1073/pnas.98.1.54; Lei M, 2001, J CELL SCI, V114, P1447; LOEBER G, 1991, J VIROL, V65, P3167, DOI 10.1128/JVI.65.6.3167-3174.1991; Lohman TM, 1996, ANNU REV BIOCHEM, V65, P169, DOI 10.1146/annurev.bi.65.070196.001125; Mackay JP, 1998, TRENDS BIOCHEM SCI, V23, P1, DOI 10.1016/S0968-0004(97)01168-7; Marintcheva B, 2001, J BIOL CHEM, V276, P6605, DOI 10.1074/jbc.M007743200; MCENTEE K, 1980, P NATL ACAD SCI-BIOL, V77, P857, DOI 10.1073/pnas.77.2.857; PATEL SS, 1994, BIOCHEMISTRY-US, V33, P7857, DOI 10.1021/bi00191a013; Patel SS, 2000, ANNU REV BIOCHEM, V69, P651, DOI 10.1146/annurev.biochem.69.1.651; PERRIER V, 1994, BIOCHEMISTRY-US, V33, P9960, DOI 10.1021/bi00199a019; Poplawski A, 2001, J BIOL CHEM, V276, P49371, DOI 10.1074/jbc.M108519200; REHRAUER WM, 1993, J BIOL CHEM, V268, P1292; ROSE PE, 1995, J VIROL, V69, P2842, DOI 10.1128/JVI.69.5.2842-2849.1995; Sato M, 2000, J MOL BIOL, V300, P421, DOI 10.1006/jmbi.2000.3865; Schwacha A, 2001, MOL CELL, V8, P1093, DOI 10.1016/S1097-2765(01)00389-6; Turnage MA, 2000, MOL CELL BIOL, V20, P8198, DOI 10.1128/MCB.20.21.8198-8208.2000; Tye BK, 2000, J BIOL CHEM, V275, P34833, DOI 10.1074/jbc.R000018200; Tye BK, 1999, ANNU REV BIOCHEM, V68, P649, DOI 10.1146/annurev.biochem.68.1.649; Washington MT, 1996, J BIOL CHEM, V271, P26825, DOI 10.1074/jbc.271.43.26825; Weng YM, 1996, MOL CELL BIOL, V16, P5477; YAN H, 1991, GENE DEV, V5, P944, DOI 10.1101/gad.5.6.944; You ZY, 1999, MOL CELL BIOL, V19, P8003	42	64	68	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					42471	42479		10.1074/jbc.M205769200	http://dx.doi.org/10.1074/jbc.M205769200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12207017	hybrid			2022-12-27	WOS:000179081200008
J	Benarafa, C; Cooley, J; Zeng, WL; Bird, PI; Remold-O'Donnell, E				Benarafa, C; Cooley, J; Zeng, WL; Bird, PI; Remold-O'Donnell, E			Characterization of four murine homologs of the human ov-serpin monocyte neutrophil elastase inhibitor MNEI (SERPINB1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REACTIVE CENTER LOOP; ENDOGENOUS RETROVIRUS; CHROMOSOMAL LOCALIZATION; PROTEINASE COMPLEX; CYSTIC-FIBROSIS; GENE; SEQUENCE; FAMILY; SUPERFAMILY; EXPRESSION	The human ov-serpin monocyte neutrophil elastase inhibitor (MNEI) is encoded by a single gene SERPINB1. It is a highly efficient inhibitor of neutrophil granule proteases. Four murine genes with high sequence identity with MNEI were identified and fully sequenced, and these were named EIA, EIB, EIC, and EID. EIA, EIB and EIC showed the same seven-exon gene structure as SERPINB1. However, EIC included an additional, alternatively spliced, exon due to the insertion of an endogenous retrovirus-like sequence. EID lacked several exons and is a pseudogene. Reverse transcriptase-PCR showed that EIA, like MNEI, is expressed at high levels in many tissues. EIB is mainly expressed in brain, and EIC was only expressed as splicing variants unlikely to encode a functional serpin. Upon incubation with serine proteases, EIA formed inhibitory covalent complexes with pancreatic and neutrophil elastases, cathepsin G, proteinase-3, and chymotrypsin, as previously shown for MNEI, whereas EIB was only able to do so with cathepsin G. According to the new serpin nomenclature, the genes encoding EIIA, EIB, EIC, and EID will be called Serpinb1, Serpinb1b, Serpinb1c, and Serpinb1-ps1. These data demonstrate that the four murine homologs of MNEI have met different evolutionary fates, and that EIA is the mouse ortholog of MNEI.	Harvard Univ, Sch Med, Ctr Blood Res, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; Monash University	Benarafa, C (corresponding author), Harvard Univ, Sch Med, Ctr Blood Res, 800 Huntington Ave, Boston, MA 02115 USA.			Bird, Phillip/0000-0002-6695-606X; Benarafa, Charaf/0000-0002-2049-7769	NHLBI NIH HHS [HL66548-02, R01 HL066548] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066548] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abts HF, 2001, DNA CELL BIOL, V20, P123, DOI 10.1089/104454901300068924; Atchley WR, 2001, MOL BIOL EVOL, V18, P1502, DOI 10.1093/oxfordjournals.molbev.a003936; Bartuski AJ, 1998, GENOMICS, V54, P297, DOI 10.1006/geno.1998.5586; Benit L, 1997, J VIROL, V71, P5652; Benit L, 1999, J VIROL, V73, P3301; Bird CH, 2001, MOL CELL BIOL, V21, P5396, DOI 10.1128/MCB.21.16.5396-5407.2001; BIRRER P, 1995, RESPIRATION, V62, P25; Cooley J, 2001, BIOCHEMISTRY-US, V40, P15762, DOI 10.1021/bi0113925; EVANS E, 1995, GENOMICS, V28, P235, DOI 10.1006/geno.1995.1136; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; Hughes DC, 2001, J MOL EVOL, V53, P77, DOI 10.1007/s002390010195; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; Irving JA, 2000, GENOME RES, V10, P1845, DOI 10.1101/gr.GR-1478R; JIANG HB, 1994, J BIOL CHEM, V269, P55; Jiang HB, 1996, J BIOL CHEM, V271, P28017, DOI 10.1074/jbc.271.45.28017; Kaiserman D, 2002, GENOMICS, V79, P349, DOI 10.1006/geno.2002.6716; Kapitonov VV, 1999, J MOL EVOL, V48, P248, DOI 10.1007/PL00013153; Lennon G, 1996, GENOMICS, V33, P151, DOI 10.1006/geno.1996.0177; PATSTON PA, 1991, BIOCHEMISTRY-US, V30, P8876, DOI 10.1021/bi00100a022; POTEMPA J, 1994, J BIOL CHEM, V269, P15957; Ragg H, 2001, MOL BIOL EVOL, V18, P577, DOI 10.1093/oxfordjournals.molbev.a003838; Rees DD, 1999, AM J RESP CELL MOL, V20, P69, DOI 10.1165/ajrcmb.20.1.3306; Reeves EP, 2002, NATURE, V416, P291, DOI 10.1038/416291a; REMOLDODONNELL E, 1992, P NATL ACAD SCI USA, V89, P5635, DOI 10.1073/pnas.89.12.5635; REMOLDODONNELL E, 1989, J EXP MED, V169, P1071, DOI 10.1084/jem.169.3.1071; REMOLDODONNELL E, 1993, FEBS LETT, V315, P105, DOI 10.1016/0014-5793(93)81143-N; Scott FL, 1996, J BIOL CHEM, V271, P1605, DOI 10.1074/jbc.271.3.1605; Scott FL, 1999, BLOOD, V93, P2089, DOI 10.1182/blood.V93.6.2089.406k10_2089_2097; SEPERACK PK, 1995, EMBO J, V14, P2326, DOI 10.1002/j.1460-2075.1995.tb07227.x; Sheng S, 1996, P NATL ACAD SCI USA, V93, P11669, DOI 10.1073/pnas.93.21.11669; Silverman GA, 2001, J BIOL CHEM, V276, P33293, DOI 10.1074/jbc.R100016200; Stratikos E, 1997, P NATL ACAD SCI USA, V94, P453, DOI 10.1073/pnas.94.2.453; Stratikos E, 1999, P NATL ACAD SCI USA, V96, P4808, DOI 10.1073/pnas.96.9.4808; SUGIMORI T, 1995, AM J RESP CELL MOL, V13, P314, DOI 10.1165/ajrcmb.13.3.7654387; Suminami Y, 2001, BBA-GENE STRUCT EXPR, V1519, P122, DOI 10.1016/S0167-4781(01)00208-1; Sun J, 1998, CYTOGENET CELL GENET, V82, P273, DOI 10.1159/000015118; Vandivier RW, 2002, J CLIN INVEST, V109, P661, DOI 10.1172/JCI200213572; Xia ZN, 1998, BIOCHEM BIOPH RES CO, V243, P384, DOI 10.1006/bbrc.1998.8102; Zeng WL, 1998, GENE, V213, P179, DOI 10.1016/S0378-1119(98)00189-9; Zhou AW, 2001, J BIOL CHEM, V276, P27541, DOI 10.1074/jbc.M102594200	40	48	52	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					42028	42033		10.1074/jbc.M207080200	http://dx.doi.org/10.1074/jbc.M207080200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12189154	hybrid			2022-12-27	WOS:000178985300092
J	Cao, ZY; Said, N; Amin, S; Wu, HK; Bruce, A; Garate, M; Hsu, DK; Kuwabara, I; Liu, FT; Panjwani, N				Cao, ZY; Said, N; Amin, S; Wu, HK; Bruce, A; Garate, M; Hsu, DK; Kuwabara, I; Liu, FT; Panjwani, N			Galectins-3 and-7, but not galectin-1, play a role in re-epithelialization of wounds	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL GROWTH-FACTOR; BINDING-PROTEIN; CELL-ADHESION; MIGRATION; LECTIN; FAMILY; OVEREXPRESSION; PROLIFERATION; EXPRESSION; LAMININ	Disorders of wound healing characterized by impaired or delayed re-epithelialization are a serious medical problem. These conditions affect many tissues, are painful, and are difficult to treat. In this study, using cornea as a model, we demonstrate for the first time the importance of carbohydrate-binding proteins galectins-3 and -7 in re-epithelialization of wounds. In two different models of corneal wound healing, re-epithelialization of wounds was significantly slower in galectin-3-deficient (gal3(-/-)) mice compared with wild-type (gal3(+/+)) mice. In contrast, there was no difference in corneal epithelial wound closure rates between galectin-1-deficient and wild-type mice. Quantitation of the bromodeoxyuridine-labeled cells in gal3(+/+) and gal3(-/-) corneas revealed that corneal epithelial cell proliferation rate is not perturbed in gal3(-/-) corneas. Exogenous galectin-3 accelerated re-epithelialization of wounds in gal3(+/+) mice but, surprisingly, not in the gal3(-/-) mice. Gene expression analysis using cDNA microarrays revealed that healing corneas of gal3(-/-) mice contain markedly reduced levels of galectin-7 compared with those of gal3(+/+) mice. More importantly, unlike galectin-3, galectin-7 accelerated re-epithelialization of wounds in both gal3(-/-) and gal3(+/+) mice. In corresponding experiments, recombinant galectin-1 did not stimulate the corneal epithelial wound closure rate. The extent of acceleration of re-epithelialization of wounds with both galectin-3 and galectin-7 was greater than that observed in most of the published studies using growth factors. These findings have broad implications for developing novel therapeutic strategies for treating nonhealing wounds.	Tufts Univ, Sch Med, Dept Ophthalmol, Ctr Vis Res, Boston, MA 02111 USA; Tufts Univ, Sch Med, New England Eye Ctr, Boston, MA 02111 USA; Tufts Univ, Sch Med, Dept Biochem, Boston, MA 02111 USA; Univ Calif Davis, Sch Med, Dept Dermatol, Davis, CA 95616 USA	Tufts University; Tufts University; Tufts University; University of California System; University of California Davis	Panjwani, N (corresponding author), Tufts Univ, Sch Med, Dept Ophthalmol, Ctr Vis Res, 136 Harrison Ave, Boston, MA 02111 USA.	Noorjahan.Panjwani@tufts.edu	Liu, FU-TONG/A-5749-2019; Said, Neveen/K-1563-2019	Liu, FU-TONG/0000-0002-3354-1001; 	NEI NIH HHS [EYP30 13078, EY09349, EY07088] Funding Source: Medline; NIAID NIH HHS [AI20958] Funding Source: Medline; NATIONAL EYE INSTITUTE [P30EY013078, R01EY009349] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI020958] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BARONDES SH, 1994, J BIOL CHEM, V269, P20807; Bernerd F, 1999, P NATL ACAD SCI USA, V96, P11329, DOI 10.1073/pnas.96.20.11329; Bresalier RS, 1996, CANCER RES, V56, P4354; BUMBINER BM, 1996, CELL, V84, P354; Cao ZY, 2001, J BIOL CHEM, V276, P21714, DOI 10.1074/jbc.M009672200; Chung EH, 1999, INVEST OPHTH VIS SCI, V40, P1952; COOPER DNW, 1991, J CELL BIOL, V115, P1437, DOI 10.1083/jcb.115.5.1437; DAGHER SF, 1995, P NATL ACAD SCI USA, V92, P1213, DOI 10.1073/pnas.92.4.1213; Dudas SP, 2000, GASTROENTEROLOGY, V118, pA273, DOI 10.1016/S0016-5085(00)83173-X; Eaglstein WH, 1997, SURG CLIN N AM, V77, P689, DOI 10.1016/S0039-6109(05)70575-2; HANNA C, 1966, AM J OPHTHALMOL, V61, P55, DOI 10.1016/0002-9394(66)90747-1; HO MK, 1982, J IMMUNOL, V128, P1221; Hsu DK, 2000, AM J PATHOL, V156, P1073, DOI 10.1016/S0002-9440(10)64975-9; HSU DK, 1992, J BIOL CHEM, V267, P14167; Hughes RC, 1997, BIOCHEM SOC T, V25, P1194, DOI 10.1042/bst0251194; JENG KCG, 1994, IMMUNOL LETT, V42, P113, DOI 10.1016/0165-2478(94)90072-8; KANDARAKIS AS, 1984, AM J OPHTHALMOL, V98, P411, DOI 10.1016/0002-9394(84)90121-1; KLIMAN GH, 1999, REFRACTIVE SURG, P469; Kuwabara I, 2002, J BIOL CHEM, V277, P3487, DOI 10.1074/jbc.M109360200; LAIBSON PR, OPHTHALMOLOGY ANN, P65; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Leonidas DD, 1998, BIOCHEMISTRY-US, V37, P13930, DOI 10.1021/bi981056x; Liu FT, 2000, CLIN IMMUNOL, V97, P79, DOI 10.1006/clim.2000.4912; Macaluso DC, 1997, CORNEA, V1, P199; MADSEN P, 1995, J BIOL CHEM, V270, P5823, DOI 10.1074/jbc.270.11.5823; Magnaldo T, 1998, DIFFERENTIATION, V63, P159, DOI 10.1046/j.1432-0436.1998.6330159.x; Matarrese P, 2000, INT J CANCER, V85, P545, DOI 10.1002/(SICI)1097-0215(20000215)85:4<545::AID-IJC17>3.3.CO;2-E; Mohan R, 2002, J BIOL CHEM, V277, P2065, DOI 10.1074/jbc.M107611200; PANJWANI N, 1995, J BIOL CHEM, V270, P14015, DOI 10.1074/jbc.270.23.14015; Perillo NL, 1998, J MOL MED, V76, P402, DOI 10.1007/s001090050232; POIRIER F, 1993, DEVELOPMENT, V119, P1229; SATO S, 1992, J BIOL CHEM, V267, P6983; SCHULTZ G, 1994, EYE, V8, P184, DOI 10.1038/eye.1994.43; SEILER WO, 1989, AM J CLIN PATHOL, V92, P430, DOI 10.1093/ajcp/92.4.430; SINGH G, 1989, CORNEA, V8, P45; SINGH G, 1987, AM J OPHTHALMOL, V103, P802, DOI 10.1016/S0002-9394(14)74397-1; Timmons PM, 1999, INT J DEV BIOL, V43, P229; WANG L, 1995, BIOCHEM BIOPH RES CO, V217, P292, DOI 10.1006/bbrc.1995.2777; Warfield PR, 1997, INVAS METAST, V17, P101; WATANABE K, 1987, INVEST OPHTH VIS SCI, V28, P205; WOO HJ, 1990, J BIOL CHEM, V265, P7097; Woodley DT, 1996, MOL CELLULAR BIOL WO, P339; Zagon IS, 2000, BRAIN RES, V882, P169, DOI 10.1016/S0006-8993(00)02864-X; Zieske JD, 2000, PRINCIPLES PRACTICE, P364	44	154	160	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					42299	42305		10.1074/jbc.M200981200	http://dx.doi.org/10.1074/jbc.M200981200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12194966	hybrid			2022-12-27	WOS:000178985300125
J	Donovan, JCH; Rothenstein, JM; Slingerland, JM				Donovan, JCH; Rothenstein, JM; Slingerland, JM			Non-malignant and tumor-derived cells differ in their requirement for p27(Kip1) in transforming growth factor-beta-mediated G(1) arrest	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMARY EPITHELIAL-CELLS; HUMAN BREAST-CANCER; TGF-BETA; CYCLE ARREST; DEPENDENT KINASE; C-MYC; NEGATIVE REGULATORS; DOWN-REGULATION; CDK INHIBITORS; MICE LACKING	Transforming growth factor beta (TGF-beta) induces G(1) arrest in susceptible cells by multiple mechanisms that inhibit the G(1) cyclin-dependent kinases (Cdks), including Cdk2, Cdk4, and Cdk6. TGF-beta treatment of early passage finite lifespan human mammary epithelial cells (HMECs) led to an accumulation of p271(Kipl) in cyclin E1-Cdk2 complexes and kinase inhibition. The requirement for p27 in the G(1) arrest by TGF-beta was assessed by transfection of antisense p27 (ASp27) oligonucleotides into TGF-beta-treated HMECs. Despite a reduction in total and cyclin E-Cdk2 bound p27 after ASp27 transfection, HMECs remained arrested in the G(1) phase. Maintenance of the G(1) arrest was accompanied by increased association of the Cdk inhibitor p21(WAF-1/Cip-1) and the retinoblastoma family member p130(Rb2) in cyclin E1-Cdk2 complexes along with kinase inhibition. In contrast to the findings in HMECs, p27 was essential for G(1) arrest by TGF-beta in two tumor-derived lines. ASp27 transfection into two TGF-beta-responsive, cancer-derived lines was not associated with increased compensatory binding of p21 and p130 to cyclin E1-Cdk2, and these cell lines failed to maintain G(1) arrest despite the continued presence of TGF-beta. Progressive cell cycle deregulation leading to impaired checkpoint controls during malignant tumor progression may alter the role of p27 from a redundant to an essential inhibitor of G(1)-to-S phase progression.	Sunnybrook & Womens Coll, Hlth Sci Ctr, Dept Mol & Cell Biol, Toronto, ON M4N 3M5, Canada	University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Slingerland, JM (corresponding author), UM Sylvester Comprehens Canc Ctr, D8-4,1475 NW 12th Ave, Miami, FL 33136 USA.							Amati B, 1998, FRONT BIOSCI, V3, pd250, DOI [10.2741/a239, DOI 10.2741/A239]; Cangi MG, 2000, J CLIN INVEST, V106, P753, DOI 10.1172/JCI9174; Cariou S, 2000, P NATL ACAD SCI USA, V97, P9042, DOI 10.1073/pnas.160016897; Ciarallo S, 2002, MOL CELL BIOL, V22, P2993, DOI 10.1128/MCB.22.9.2993-3002.2002; Coats S, 1999, CURR BIOL, V9, P163, DOI 10.1016/S0960-9822(99)80086-4; Collado M, 2000, J BIOL CHEM, V275, P21960, DOI 10.1074/jbc.M000759200; Donovan J, 2000, BREAST CANCER RES, V2, P116, DOI 10.1186/bcr43; DULIC V, 1992, SCIENCE, V257, P1958, DOI 10.1126/science.1329201; Feng XH, 2002, MOL CELL, V9, P133, DOI 10.1016/S1097-2765(01)00430-0; Fero ML, 1996, CELL, V85, P733, DOI 10.1016/S0092-8674(00)81239-8; Florenes VA, 1996, ONCOGENE, V13, P2447; FYNAN TM, 1993, CRIT REV ONCOGENESIS, V4, P493; Galaktionov K, 1996, NATURE, V382, P511, DOI 10.1038/382511a0; HANNON GJ, 1994, NATURE, V371, P257, DOI 10.1038/371257a0; HERZINGER T, 1995, ONCOGENE, V10, P2079; HOFFMANN I, 1994, EMBO J, V13, P4302, DOI 10.1002/j.1460-2075.1994.tb06750.x; HOSOBUCHI M, 1989, IN VITRO CELL DEV B, V25, P705; Iavarone A, 1997, NATURE, V387, P417; Jonuleit T, 2000, BLOOD, V96, P1933, DOI 10.1182/blood.V96.5.1933.h8001933_1933_1939; Kiyokawa H, 1996, CELL, V85, P721, DOI 10.1016/S0092-8674(00)81238-6; KOFF A, 1993, SCIENCE, V260, P536, DOI 10.1126/science.8475385; Lee MH, 2001, CELL MOL LIFE SCI, V58, P1907, DOI 10.1007/PL00000826; Liang J, 2002, NAT MED, V8, P1153, DOI 10.1038/nm761; Liu XD, 2000, ONCOGENE, V19, P5926, DOI 10.1038/sj.onc.1203991; Mal A, 1996, NATURE, V380, P262, DOI 10.1038/380262a0; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Massaro-Giordano M, 1999, CLIN CANCER RES, V5, P1455; Mateyak MK, 1999, MOL CELL BIOL, V19, P4672; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; Petrocelli T, 1996, ONCOGENE, V12, P1387; PIETENPOL JA, 1990, CELL, V61, P777, DOI 10.1016/0092-8674(90)90188-K; Queva C, 1999, CELL GROWTH DIFFER, V10, P785; Reiss M, 1997, BREAST CANCER RES TR, V45, P81, DOI 10.1023/A:1005865812918; REYNISDOTTIR I, 1995, GENE DEV, V9, P1831, DOI 10.1101/gad.9.15.1831; Sandhu C, 1997, MOL CELL BIOL, V17, P2458, DOI 10.1128/MCB.17.5.2458; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Slingerland J, 2000, J CELL PHYSIOL, V183, P10, DOI 10.1002/(SICI)1097-4652(200004)183:1<10::AID-JCP2>3.0.CO;2-I; SLINGERLAND JM, 1994, MOL CELL BIOL, V14, P3683, DOI 10.1128/MCB.14.6.3683; SOULE HD, 1973, J NATL CANCER I, V51, P1409, DOI 10.1093/jnci/51.5.1409; Staller P, 2001, NAT CELL BIOL, V3, P392, DOI 10.1038/35070076; Stampfer M, 1985, J TISSUE CULTURE MET, V9, P107; Susini T, 1998, J CLIN ONCOL, V16, P1085, DOI 10.1200/JCO.1998.16.3.1085; TAIT L, 1990, CANCER RES, V50, P6087; Tanaka N, 2001, CANCER, V92, P2117, DOI 10.1002/1097-0142(20011015)92:8<2117::AID-CNCR1553>3.0.CO;2-O; Warner BJ, 1999, MOL CELL BIOL, V19, P5913	45	19	21	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					41686	41692		10.1074/jbc.M204307200	http://dx.doi.org/10.1074/jbc.M204307200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12202478	hybrid			2022-12-27	WOS:000178985300050
J	Jimenez, C; Hernandez, C; Pimental, B; Carrera, AC				Jimenez, C; Hernandez, C; Pimental, B; Carrera, AC			The p85 regulatory subunit controls sequential activation of phosphoinositide 3-kinase by Tyr kinases and Ras	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLINOSITOL 3-KINASE; PROTEIN-KINASE; PI 3-KINASE; SH2 DOMAINS; CATALYTIC SUBUNIT; TYROSINE KINASE; RECEPTOR; BINDING; AKT; PHOSPHORYLATION	Class IA phosphoinositide 3-kinase (PI3K) is a heterodimer composed of a p85 regulatory and a p110 catalytic subunit that regulates a variety of cell responses, including cell division and survival. PI3K is activated following Tyr kinase stimulation and by Ras. We found that the C-terminal region of p85, including the C-Src homology 2 (C-SH2) domain and part of the inter-SH2 region, protects the p110 catalytic subunit from Ras-induced activation. Although the p110 activity associated with a C-terminal p85 deletion mutant increased significantly in the presence of an active form of Ras, purified wild type p85-p110 was only slightly stimulated by active Ras. Nonetheless, incubation of purified p85-p110 with Tyr-phosphorylated peptides, which mimic the activated platelet-derived growth factor receptor, restored Ras-induced p85-p110 activation. In conclusion, p85 inhibits p110 activation by Ras; this blockage is released by Tyr kinase stimulation, showing that the classical mechanism of class IA, PI3K stimulation mediated by Tyr kinases also regulates Ras-induced PI3K activation.	Univ Autonoma Madrid, CSIC, Ctr Nacl Biotecnol, Dept Immunol & Oncol, E-28049 Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Carrera, AC (corresponding author), Univ Autonoma Madrid, CSIC, Ctr Nacl Biotecnol, Dept Immunol & Oncol, Carretera Colmenar Km 15, E-28049 Madrid, Spain.	acarrera@cnb.uam.es	Pimentel, Belén/AAI-7986-2020; Pimentel, Belén/I-8339-2016	Pimentel, Belén/0000-0003-4194-9231; Pimentel, Belén/0000-0003-4194-9231; Jimenez, Maria Concepcion/0000-0002-7011-9328; Carrera, Ana/0000-0002-3999-5434				Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alvarez B, 2001, NATURE, V413, P744, DOI 10.1038/35099574; Borlado LR, 2000, FASEB J, V14, P895; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; CARPENTER CL, 1993, J BIOL CHEM, V268, P9478; CARRERA AC, 1995, J BIOL CHEM, V270, P3385, DOI 10.1074/jbc.270.7.3385; Chantry D, 1997, J BIOL CHEM, V272, P19236, DOI 10.1074/jbc.272.31.19236; Cipres A, 2001, FEBS LETT, V500, P99, DOI 10.1016/S0014-5793(01)02594-7; Cuevas B, 1999, J BIOL CHEM, V274, P27583, DOI 10.1074/jbc.274.39.27583; Cuevas BD, 2001, J BIOL CHEM, V276, P27455, DOI 10.1074/jbc.M100556200; DHAND R, 1994, EMBO J, V13, P511, DOI 10.1002/j.1460-2075.1994.tb06289.x; Di Cristofano A, 1999, SCIENCE, V285, P2122, DOI 10.1126/science.285.5436.2122; Downward J, 1998, SCIENCE, V279, P673, DOI 10.1126/science.279.5351.673; ESCOBEDO JA, 1991, CELL, V65, P75, DOI 10.1016/0092-8674(91)90409-R; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Fruman DA, 1998, ANNU REV BIOCHEM, V67, P481, DOI 10.1146/annurev.biochem.67.1.481; Fruman DA, 1996, GENOMICS, V37, P113, DOI 10.1006/geno.1996.0527; GonzalezGarcia A, 1997, J BIOL CHEM, V272, P10220; HATAKEYAMA M, 1991, SCIENCE, V252, P1523, DOI 10.1126/science.2047859; HILES ID, 1992, CELL, V70, P419, DOI 10.1016/0092-8674(92)90166-A; HOLT KH, 1994, MOL CELL BIOL, V14, P42, DOI 10.1128/MCB.14.1.42; Janssen JWG, 1998, ONCOGENE, V16, P1767, DOI 10.1038/sj.onc.1201695; Jimenez C, 2000, J CELL BIOL, V151, P249, DOI 10.1083/jcb.151.2.249; Jimenez C, 1998, EMBO J, V17, P743, DOI 10.1093/emboj/17.3.743; Jucker M, 2002, LEUKEMIA, V16, P894, DOI 10.1038/sj.leu.2402484; KLIPPEL A, 1994, MOL CELL BIOL, V14, P2675, DOI 10.1128/MCB.14.4.2675; Klippel A, 1997, MOL CELL BIOL, V17, P338, DOI 10.1128/MCB.17.1.338; KODAKI T, 1994, CURR BIOL, V4, P798, DOI 10.1016/S0960-9822(00)00177-9; Layton MJ, 1998, J BIOL CHEM, V273, P33379, DOI 10.1074/jbc.273.50.33379; MIYAZAKI T, 1995, CELL, V81, P223, DOI 10.1016/0092-8674(95)90332-1; Nolte RT, 1996, NAT STRUCT BIOL, V3, P364, DOI 10.1038/nsb0496-364; OTSU M, 1991, CELL, V65, P91, DOI 10.1016/0092-8674(91)90411-Q; PANAYOTOU G, 1992, EMBO J, V11, P4261, DOI 10.1002/j.1460-2075.1992.tb05524.x; Paulson RF, 1996, NAT GENET, V13, P309, DOI 10.1038/ng0796-309; Philp AJ, 2001, CANCER RES, V61, P7426; PLEIMAN CM, 1994, SCIENCE, V263, P1609, DOI 10.1126/science.8128248; RAMEH LE, 1995, CELL, V83, P821, DOI 10.1016/0092-8674(95)90195-7; REMILLARD B, 1991, J BIOL CHEM, V266, P14167; RodriguezViciana P, 1996, EMBO J, V15, P2442, DOI 10.1002/j.1460-2075.1996.tb00602.x; SHOELSON SE, 1993, EMBO J, V12, P795, DOI 10.1002/j.1460-2075.1993.tb05714.x; SKOLNIK EY, 1991, CELL, V65, P83, DOI 10.1016/0092-8674(91)90410-Z; STEPHENS L, 1993, EMBO J, V12, P2265, DOI 10.1002/j.1460-2075.1993.tb05880.x; STEPHENS LR, 1993, BIOCHIM BIOPHYS ACTA, V1179, P27, DOI 10.1016/0167-4889(93)90072-W; TAICHMAN R, 1993, J BIOL CHEM, V268, P20031; Vanhaesebroeck B, 1999, EXP CELL RES, V253, P239, DOI 10.1006/excr.1999.4701; YU FX, 1992, J BIOL CHEM, V267, P14616; Yu JH, 1998, MOL CELL BIOL, V18, P1379, DOI 10.1128/MCB.18.3.1379; Zvelebil MJ, 1996, PHILOS T R SOC B, V351, P217, DOI 10.1098/rstb.1996.0019	49	98	125	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					41556	41562		10.1074/jbc.M205893200	http://dx.doi.org/10.1074/jbc.M205893200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12196526	hybrid			2022-12-27	WOS:000178985300034
J	Nguyen, TB; Manova, K; Capodieci, P; Lindon, C; Bottega, S; Wang, XY; Refik-Rogers, J; Pines, J; Wolgemuth, DJ; Koff, A				Nguyen, TB; Manova, K; Capodieci, P; Lindon, C; Bottega, S; Wang, XY; Refik-Rogers, J; Pines, J; Wolgemuth, DJ; Koff, A			Characterization and expression of mammalian cyclin B3, a prepachytene meiotic cyclin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR TFIIH; CELL-CYCLE; DEPENDENT KINASE-5; XENOPUS OOCYTES; MESSENGER-RNA; MEIOSIS-I; A-TYPE; MOUSE; LOCALIZATION; COMPLEX	We report the identification and expression pattern of a full-length human cDNA and a partial mouse cDNA encoding cyclin B3. Cyclin B3 (CCNB3) is conserved from Caenorhabditis elegans to Homo sapiens and has an undefined meiotic function in female, but not male Drosophila melanogaster. We show that H. sapiens cyclin B3 interacts with cdk2, is localized to the nucleus, and is degraded during anaphase entry after the degradation of cyclin B1. Degradation is dependent on sequences conserved in a destruction box motif. Overexpression of nondegradable cyclin B3 blocks the mitotic cell cycle in late anaphase, and at higher doses it can interfere with progression through G, and entry into S phase. H. sapiens cyclin B3 mRNA and protein are detected readily in developing germ cells in the human testis and not in any other tissue. The mouse cDNA has allowed us to further localize cyclin B3 mRNA to leptotene and zygotene spermatocytes. The expression pattern of mammalian cyclin B3 suggests that it may be important for events occurring in early meiotic prophase I.	Mem Sloan Kettering Canc Ctr, Dept Biol Mol, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Expt Pathol, New York, NY 10021 USA; Wellcome Trust Canc Res UK, Inst Canc & Dev Biol, Cambridge CB2 1QR, England; Columbia Univ, Coll Phys & Surg, Dept Genet & Dev, New York, NY 10032 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cancer Research UK; Columbia University	Koff, A (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Biol Mol, RRL917D,Box 207,1275 York Ave, New York, NY 10021 USA.	a-koff@ski.mskcc.org		Pines, Jonathon/0000-0002-5227-6004; Koff, Andrew/0000-0003-3271-3067; Lindon, Catherine/0000-0003-3554-2574	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052597, R55GM052597] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM52597] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akoulitchev S, 2000, NATURE, V407, P102, DOI 10.1038/35024111; Ashley T, 2001, J CELL SCI, V114, P685; BELLVE AR, 1977, J CELL BIOL, V74, P68, DOI 10.1083/jcb.74.1.68; Beumer TL, 2000, BIOL REPROD, V63, P1893, DOI 10.1095/biolreprod63.6.1893; BROWN NR, 1995, STRUCTURE, V3, P1235, DOI 10.1016/S0969-2126(01)00259-3; CHAPMAN DL, 1994, DEV BIOL, V165, P500, DOI 10.1006/dbio.1994.1270; CLERMONT Y, 1993, SERTOLI CELL, P305; Clute P, 1999, NAT CELL BIOL, V1, P82, DOI 10.1038/10049; Cordon-Cardo C, 1998, JNCI-J NATL CANCER I, V90, P1284, DOI 10.1093/jnci/90.17.1284; Draviam VM, 2001, J CELL BIOL, V152, P945, DOI 10.1083/jcb.152.5.945; Ellenberg J, 1999, TRENDS CELL BIOL, V9, P52, DOI 10.1016/S0962-8924(98)01420-2; Furstenthal L, 2001, J CELL BIOL, V152, P1267, DOI 10.1083/jcb.152.6.1267; GALLANT P, 1994, EMBO J, V13, P595, DOI 10.1002/j.1460-2075.1994.tb06297.x; Handel M. A., 1998, MEIOSIS GAMETOGENESI; HARTUNG M, 1977, CYTOGENET CELL GENET, V18, P309, DOI 10.1159/000130777; Hunt T, 1989, CURR OPIN CELL BIOL, V1, P268, DOI 10.1016/0955-0674(89)90099-9; Jacobs HW, 1998, GENE DEV, V12, P3741, DOI 10.1101/gad.12.23.3741; KOFF A, 1991, CELL, V66, P1217, DOI 10.1016/0092-8674(91)90044-Y; KOFF A, 1992, SCIENCE, V257, P1689, DOI 10.1126/science.1388288; LEBLOND CP, 1952, AM J ANAT, V90, P167, DOI 10.1002/aja.1000900202; LEW J, 1994, NATURE, V371, P423, DOI 10.1038/371423a0; Liu D, 1998, NAT GENET, V20, P377, DOI 10.1038/3855; Lozano JC, 2002, BIOCHEM BIOPH RES CO, V291, P406, DOI 10.1006/bbrc.2002.6458; LUCIANI JM, 1977, J EMBRYOL EXP MORPH, V38, P175; Manova K, 1998, DEV DYNAM, V213, P293, DOI 10.1002/(SICI)1097-0177(199811)213:3<293::AID-AJA6>3.0.CO;2-D; MANOVA K, 1990, DEVELOPMENT, V110, P1057; Miller ME, 2000, MOL CELL BIOL, V20, P542, DOI 10.1128/MCB.20.2.542-555.2000; Morgan DO, 1996, CURR OPIN CELL BIOL, V8, P767, DOI 10.1016/S0955-0674(96)80076-7; OAKBERG EF, 1956, AM J ANAT, V99, P507, DOI 10.1002/aja.1000990307; OAKBERG EF, 1956, AM J ANAT, V99, P391, DOI 10.1002/aja.1000990303; ONeill EM, 1996, SCIENCE, V271, P209, DOI 10.1126/science.271.5246.209; Parry DH, 2001, CURR BIOL, V11, P671, DOI 10.1016/S0960-9822(01)00204-4; Peter M, 2001, NAT CELL BIOL, V3, P83, DOI 10.1038/35050607; PINES J, 1989, CELL, V58, P833, DOI 10.1016/0092-8674(89)90936-7; Ravnik SE, 1996, DEV BIOL, V173, P69, DOI 10.1006/dbio.1996.0007; Ravnik SE, 1999, DEV BIOL, V207, P408, DOI 10.1006/dbio.1998.9156; Roeder GS, 1997, GENE DEV, V11, P2600, DOI 10.1101/gad.11.20.2600; Russell L. D., 1990, HISTOLOGICAL HISTOPA; Schulman BA, 1998, P NATL ACAD SCI USA, V95, P10453, DOI 10.1073/pnas.95.18.10453; SERIZAWA H, 1995, NATURE, V374, P280, DOI 10.1038/374280a0; SHIEKHATTAR R, 1995, NATURE, V374, P283, DOI 10.1038/374283a0; Sorensen CS, 2001, MOL CELL BIOL, V21, P3692, DOI 10.1128/MCB.21.11.3692-3703.2001; TACHIBANA K, 1990, DEV BIOL, V140, P241, DOI 10.1016/0012-1606(90)90074-S; Taieb FE, 2001, CURR BIOL, V11, P508, DOI 10.1016/S0960-9822(01)00145-2; TSAI LH, 1994, NATURE, V371, P419, DOI 10.1038/371419a0; WESTENDORF JM, 1989, J CELL BIOL, V108, P1431, DOI 10.1083/jcb.108.4.1431; WILLARD HF, 1989, HUM GENET, V81, P234; ZHANG H, 1995, CELL, V82, P915, DOI 10.1016/0092-8674(95)90271-6	48	102	109	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					41960	41969		10.1074/jbc.M203951200	http://dx.doi.org/10.1074/jbc.M203951200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12185076	hybrid			2022-12-27	WOS:000178985300085
J	van Balkom, BWM; Savelkoul, PJM; Markovich, D; Hofman, E; Nielsen, S; van der Sluijs, P; Deen, PMT				van Balkom, BWM; Savelkoul, PJM; Markovich, D; Hofman, E; Nielsen, S; van der Sluijs, P; Deen, PMT			The role of putative phosphorylation sites in the targeting and shuttling of the aquaporin-2 water channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDULLARY COLLECTING DUCT; NEPHROGENIC DIABETES-INSIPIDUS; PROTEIN-KINASE-C; VASOPRESSIN-MEDIATED TRANSLOCATION; RENAL PRINCIPAL CELLS; PERMEABILITY RESPONSE; EPITHELIAL-CELLS; RECEPTOR; LOCALIZATION; CYTOSKELETON	In renal collecting ducts, a vasopressin-induced cAMP increase results in the phosphorylation of aquaporin-2 (AQP2) water channels at Ser-256 and its redistribution from intracellular vesicles to the apical membrane. Hormones that activate protein kinase C (PKC) proteins counteract this process. To determine the role of the putative kinase sites in the trafficking and hormonal regulation of human AQP2, three putative casein kinase II (Ser-148, Ser-229, Thr-244), one PKC (Ser-231), and one protein kinase A (Ser-256) site were altered to mimic a constitutively non-phosphorylated/phosphorylated state and were expressed in Madin-Darby canine kidney cells. Except for Ser-256 mutants, seven correctly folded AQP2 kinase mutants trafficked as wild-type AQP2 to the apical membrane via forskolin-sensitive intracellular vesicles. With or without forskolin, AQP2-Ser-256A was localized in intracellular vesicles, whereas AQP2-S256D was localized in the apical membrane. Phorbol 12-myristate 13-acetate-induced PKC activation following forskolin treatment resulted in vesicular distribution of all AQP2 kinase mutants, while all were still phosphorylated at Ser-256. Our data indicate that in collecting duct cells, AQP2 trafficking to vasopressin-sensitive vesicles is phosphorylation-independent, that phosphorylation of Ser-256 is necessary and sufficient for expression of AQP2 in the apical membrane, and that PMA-induced PKC-mediated endocytosis of AQP2 is independent of the AQP2 phosphorylation state.	Nijmegen Ctr Mol Life Sci, Dept Cell Physiol, NL-6500 HB Nijmegen, Netherlands; Univ Queensland, Dept Physiol & Pharmacol, Sch Biomed Sci, Brisbane, Qld 4072, Australia; Aarhus Univ, Water & Salt Res Ctr, DK-8000 Aarhus, Denmark; Univ Utrecht, Sch Med, Dept Cell Biol, NL-3584 CX Utrecht, Netherlands	Radboud University Nijmegen; University of Queensland; Aarhus University; Utrecht University	Deen, PMT (corresponding author), UMC St Radboud, Dept Cell Physiol 160, Res Tower,7th Floor,POB 9101, NL-6500 HB Nijmegen, Netherlands.		Deen, Peter MT/B-9854-2013; Deen, P.M.T./H-8023-2014; Markovich, Daniel/F-7884-2012	Deen, Peter MT/0000-0002-7868-4655; Deen, P.M.T./0000-0002-7868-4655; 				Berl T, 1997, KIDNEY INT, pS2; Bren GD, 2000, J MOL BIOL, V297, P1245, DOI 10.1006/jmbi.2000.3630; Breton S, 1998, J AM SOC NEPHROL, V9, P155; BREWER CB, 1994, METHOD CELL BIOL, V43, P233; Chou CL, 2000, J BIOL CHEM, V275, P36839, DOI 10.1074/jbc.M005552200; Christensen BM, 2000, AM J PHYSIOL-RENAL, V278, pF29, DOI 10.1152/ajprenal.2000.278.1.F29; Deen PMT, 1996, J AM SOC NEPHROL, V7, P836; Deen PMT, 1997, J AM SOC NEPHROL, V8, P1493; DEEN PMT, 1995, J CLIN INVEST, V95, P2291, DOI 10.1172/JCI117920; Deen PMT, 2002, AM J PHYSIOL-RENAL, V282, pF330, DOI 10.1152/ajprenal.0168.2001; Deen PMT, 1998, CURR OPIN NEPHROL HY, V7, P37; Deen PMT, 1997, PFLUG ARCH EUR J PHY, V433, P780, DOI 10.1007/s004240050345; DEEN PMT, 2001, TRAFFICKING NATIVE M, P235; EGELHOFF TT, 1993, CELL, V75, P363, DOI 10.1016/0092-8674(93)80077-R; Estrera VT, 2001, J BIOL CHEM, V276, P15547, DOI 10.1074/jbc.M008156200; Fujioka T, 2001, EUR J BIOCHEM, V268, P25, DOI 10.1046/j.1432-1327.2001.01831.x; Fushimi K, 1997, J BIOL CHEM, V272, P14800, DOI 10.1074/jbc.272.23.14800; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; HAN JS, 1994, AM J PHYSIOL, V266, pF139, DOI 10.1152/ajprenal.1994.266.1.F139; JONES BG, 1995, EMBO J, V14, P5869, DOI 10.1002/j.1460-2075.1995.tb00275.x; Kamsteeg EJ, 2000, J CELL BIOL, V151, P919, DOI 10.1083/jcb.151.4.919; Katsura T, 1997, AM J PHYSIOL-RENAL, V272, pF816; Keenan C, 1998, CELL SIGNAL, V10, P225, DOI 10.1016/S0898-6568(97)00121-6; Kishore BK, 1995, AM J PHYSIOL-RENAL, V269, pF863, DOI 10.1152/ajprenal.1995.269.6.F863; Klussmann E, 2000, REV PHYSIOL BIOCH P, V141, P33, DOI 10.1007/BFb0119577; Klussmann E, 1999, J BIOL CHEM, V274, P4934, DOI 10.1074/jbc.274.8.4934; Klussmann E, 2001, J BIOL CHEM, V276, P20451, DOI 10.1074/jbc.M010270200; MACIEJEWSKI PM, 1995, J BIOL CHEM, V270, P27661, DOI 10.1074/jbc.270.46.27661; MAEDA Y, 1992, AM J PHYSIOL, V263, pF319, DOI 10.1152/ajprenal.1992.263.2.F319; Marr N, 2002, HUM MOL GENET, V11, P779, DOI 10.1093/hmg/11.7.779; Mulders SM, 1998, J CLIN INVEST, V102, P57, DOI 10.1172/JCI2605; NADLER SP, 1992, AM J PHYSIOL, V262, pF229, DOI 10.1152/ajprenal.1992.262.2.F229; NADLER SP, 1992, J CLIN INVEST, V90, P1458, DOI 10.1172/JCI116013; Nielsen S, 1998, CURR OPIN NEPHROL HY, V7, P509, DOI 10.1097/00041552-199809000-00005; Nishimoto G, 1999, AM J PHYSIOL-RENAL, V276, pF254, DOI 10.1152/ajprenal.1999.276.2.F254; PEARL M, 1985, BIOL CELL, V55, P163, DOI 10.1111/j.1768-322X.1985.tb00421.x; PHILLIPS ME, 1989, J PHYSIOL-LONDON, V411, P529, DOI 10.1113/jphysiol.1989.sp017588; PHILLIPS ME, 1992, J PHYSIOL-LONDON, V456, P591, DOI 10.1113/jphysiol.1992.sp019355; PRICNO G, 1999, J AM SOC NEPHROL, V10, P23; SANGHERA JS, 1992, BIOCHEM J, V283, P829, DOI 10.1042/bj2830829; Schlegel A, 2001, J BIOL CHEM, V276, P4398, DOI 10.1074/jbc.M005448200; Scott DB, 2001, J NEUROSCI, V21, P3063, DOI 10.1523/JNEUROSCI.21-09-03063.2001; SIMON H, 1993, AM J PHYSIOL, V265, pC757, DOI 10.1152/ajpcell.1993.265.3.C757; Straussman R, 2001, J CELL SCI, V114, P3047; Tamma G, 2001, AM J PHYSIOL-RENAL, V281, pF1092, DOI 10.1152/ajprenal.0091.2001; Vaaraniemi J, 1999, J CELL PHYSIOL, V181, P83, DOI 10.1002/(SICI)1097-4652(199910)181:1<83::AID-JCP9>3.0.CO;2-G; van Tiel CM, 2002, J BIOL CHEM, V277, P22447, DOI 10.1074/jbc.M201532200; WALL SM, 1992, AM J PHYSIOL, V262, pF989, DOI 10.1152/ajprenal.1992.262.6.F989; Zelenina M, 2000, AM J PHYSIOL-RENAL, V278, pF388, DOI 10.1152/ajprenal.2000.278.3.F388; Zhang WY, 1997, J BIOL CHEM, V272, P31700, DOI 10.1074/jbc.272.50.31700	50	190	192	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					41473	41479		10.1074/jbc.M207525200	http://dx.doi.org/10.1074/jbc.M207525200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12194985	Green Published, hybrid			2022-12-27	WOS:000178985300024
J	Xu, MG; Chen, JF; Martin, F; Zhao, MW; Eriani, G; Wang, ED				Xu, MG; Chen, JF; Martin, F; Zhao, MW; Eriani, G; Wang, ED			Leucyl-tRNA synthetase consisting of two subunits from hyperthermophilic bacteria Aquifex aeolicus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RNA-SYNTHETASE; ESCHERICHIA-COLI; EVOLUTIONARY RELATIONSHIPS; BINDING DOMAIN; PURIFICATION; PROTEIN; DISCRIMINATION; RECOGNITION; MECHANISM; COMPLEX	In a hyperthermophilic bacterium, Aquifex aeolicus, leucyl-tRNA synthetase (LeuRS) consists of two nonidentical polypeptide subunits (alpha and beta), different from the canonical LeuRS, which has a single polypeptide chain. By PCR, using genome DNA of A. aeolicus as a template, genes encoding the alpha and beta subunits were amplified and cloned in Escherichia coli. The alpha subunit could not be expressed stably in vivo, whereas the beta subunit was overproduced and purified by a simple procedure. The beta subunit was inactive in catalysis but was able to bind tRNA(Leu). Interestingly, the heterodimer alphabeta-LeuRS could be overproduced in E. coli cells containing both genes and was purified to 95% homogeneity as a hybrid dimer. The kinetics of A. aeolicus LeuRS in pre-steady and steady states and cross-recognition of LeuRS and tRNA(Leu) from A. aeolicus and E. coli were studied. Magnesium concentration, pH value, and temperature aminoacylation optima were determined to be 12 mm, 7.8, and 70 degreesC, respectively. Under optimal conditions, A. aeolicus alphabeta-LeuRS is stable up to 65 degreesC.	Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai 200031, Peoples R China; CNRS, Inst Biol Mol & Cellulaire, UPR9002, F-67084 Strasbourg, France	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Wang, ED (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, 320 Yueyang Rd, Shanghai 200031, Peoples R China.	wed@server.shcnc.ac.cn	MARTIN, Franck/D-9042-2015	MARTIN, Franck/0000-0001-9724-4025; Eriani, Gilbert/0000-0002-8518-4675				BURBAUM JJ, 1991, J BIOL CHEM, V266, P16965; Cahuzac B, 2000, EMBO J, V19, P445, DOI 10.1093/emboj/19.3.445; CARTER CW, 1993, ANNU REV BIOCHEM, V62, P715, DOI 10.1146/annurev.bi.62.070193.003435; Chen JF, 2000, BIOCHEMISTRY-US, V39, P6726, DOI 10.1021/bi000108r; Cusack S, 2000, EMBO J, V19, P2351, DOI 10.1093/emboj/19.10.2351; CUSACK S, 1991, NUCLEIC ACIDS RES, V19, P3489, DOI 10.1093/nar/19.13.3489; Deckert G, 1998, NATURE, V392, P353, DOI 10.1038/32831; Delagoutte B, 2000, EMBO J, V19, P5599, DOI 10.1093/emboj/19.21.5599; DELARUE M, 1995, CURR OPIN STRUC BIOL, V5, P48, DOI 10.1016/0959-440X(95)80008-O; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; FERSHT AR, 1980, BIOCHEMISTRY-US, V19, P5520, DOI 10.1021/bi00565a009; FERSHT AR, 1975, BIOCHEMISTRY-US, V14, P1, DOI 10.1021/bi00672a001; FERSHT AR, 1979, BIOCHEMISTRY-US, V18, P2627, DOI 10.1021/bi00579a030; Fukai S, 2000, CELL, V103, P793, DOI 10.1016/S0092-8674(00)00182-3; Geslain R, 2000, RNA, V6, P434, DOI 10.1017/S1355838200992331; Gouda M, 2002, FEBS LETT, V518, P139, DOI 10.1016/S0014-5793(02)02675-3; GRANDA S, 1979, MOL CELL BIOCHEM, V24, P175; HOPFIELD JJ, 1974, P NATL ACAD SCI USA, V71, P4135, DOI 10.1073/pnas.71.10.4135; Houman F, 2000, P NATL ACAD SCI USA, V97, P13743, DOI 10.1073/pnas.240465597; Kaminska M, 2000, EMBO J, V19, P6908, DOI 10.1093/emboj/19.24.6908; Li T, 1999, BIOCHEMISTRY-US, V38, P13063, DOI 10.1021/bi990384+; Li T, 1999, BIOCHEMISTRY-US, V38, P9084, DOI 10.1021/bi9901984; LI T, 1995, ACTA BIOCH BIOPH SIN, V27, P279; Li Y, 1999, PROTEIN EXPRES PURIF, V16, P355, DOI 10.1006/prep.1999.1083; Li Y, 1998, SCI CHINA SER C, V41, P225, DOI 10.1007/BF02895095; MEHLER AH, 1967, J BIOL CHEM, V242, P5495; MORAS D, 1992, TRENDS BIOCHEM SCI, V17, P159, DOI 10.1016/0968-0004(92)90326-5; NAGEL GM, 1991, P NATL ACAD SCI USA, V88, P8121, DOI 10.1073/pnas.88.18.8121; PAPAS TS, 1972, BIOCHEMISTRY-US, V11, P4602, DOI 10.1021/bi00774a029; Quevillon S, 1997, J BIOL CHEM, V272, P32573, DOI 10.1074/jbc.272.51.32573; Rho SB, 1998, J BIOL CHEM, V273, P11267, DOI 10.1074/jbc.273.18.11267; SCHIMMEL P, 1987, ANNU REV BIOCHEM, V56, P125, DOI 10.1146/annurev.bi.56.070187.001013; SCHIMMEL PR, 1979, ANNU REV BIOCHEM, V48, P601, DOI 10.1146/annurev.bi.48.070179.003125; Schmitt E, 1997, EUR J BIOCHEM, V246, P539, DOI 10.1111/j.1432-1033.1997.00539.x; SHI JP, 1988, ACTA BIOCH BIOPH SIN, V20, P76; SHIBA K, 1992, P NATL ACAD SCI USA, V89, P1880, DOI 10.1073/pnas.89.5.1880; SHIBA K, 1992, J BIOL CHEM, V267, P22703; Silvian LF, 1999, SCIENCE, V285, P1074, DOI 10.1126/science.285.5430.1074; Tardif KD, 2001, BIOCHEMISTRY-US, V40, P8118, DOI 10.1021/bi0103213; VELTEROP JS, 1995, GENE, V153, P63, DOI 10.1016/0378-1119(94)00790-Y; Wu JF, 1999, ACTA BIOCH BIOPH SIN, V31, P226; YANG JT, 1986, METHOD ENZYMOL, V130, P208	42	29	29	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					41590	41596		10.1074/jbc.M205126200	http://dx.doi.org/10.1074/jbc.M205126200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12196521	hybrid			2022-12-27	WOS:000178985300038
J	Lin, KD; Wang, DX; Sadee, WG				Lin, KD; Wang, DX; Sadee, WG			Serum response factor activation by muscarinic receptors via RhoA - Novel pathway specific to M1 subtype involving calmodulin, calcineurin, and Pyk2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; GROWTH-FACTOR RECEPTOR; CHOLINERGIC-RECEPTOR; SIGNAL-TRANSDUCTION; MAP KINASE; C-FOS; TYROSINE KINASE; ANGIOTENSIN-II; EXPRESSION; BINDING	The muscarinic cholinergic receptor (mAChR) subtypes share high sequence similarity except in their third intracellular loop and COOH terminus, domains thought to be involved in signal transduction. Subtypes M1, M3, and M5 couple mainly through Galpha(i/o). and M2 and M4 couple mainly through Galpha(i/o)., Whether subtypes within each of these two groups differ in their signaling pathways remains to be resolved. This study focused on nuclear signaling pathways leading to activation of the transcription factor, serum response factor (SRF). Genes encoding M1, M2, and M3 were co-expressed in Jurkat T lymphocytes with a reporter gene driven by a mutant serum response element, SRE.L, which responds to SRF activation. We show that only M1 mAChR activated SRF through a pathway involving the small GTPase RhoA, with no response observed for M2 and M3. Transfection of GTPase-deficient Got subunits (GalphaQL; constitutively active form) demonstrated that SRF was activated by Galpha(13)QL but only marginally by Galpha(q)QL and Galpha(12)QL in Jurkat cells. Yet transfection of regulator of G protein-signaling protein, RGS2 and RGS4, which inhibit Galpha(q/11), activity, indicated that Galpha(q/11) and Ca2+ mobilization were required for SRF activation by M1. Calmodulin inhibitors suppressed the M1 and the Galpha(13)QL pathways, acting both upstream and downstream of RhoA. However, calcineurin inhibitors and the tyrosine kinase inhibitor genistein selectively suppressed SRF activation by M1, but not by GaIAL, indicating the presence of separate pathways. The calmodulin-dependent tyrosine kinase Pyk2 was also activated by M1 but not M3, and Pyk2 appears also to play a role in M1-SRF activation, as judged by experiments with two dominant-negative Pyk2 mutants. These results reveal a novel calmodulin-dependent RhoA-SRF signaling pathway unique to the M1 mAChR subtype.	Ohio State Univ, Coll Med & Publ Hlth, Program Pharmacogenom, Dept Pharmacol, Columbus, OH 43210 USA; Univ Calif San Francisco, Dept Biopharmaceut Sci, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA	University System of Ohio; Ohio State University; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Sadee, WG (corresponding author), Ohio State Univ, Coll Med & Publ Hlth, Program Pharmacogenom, Dept Pharmacol, 5072 Graves Hall,333 W 10th Ave, Columbus, OH 43210 USA.	sadee.l@osu.edu	Wang, Danxin/I-5810-2019	Wang, Danxin/0000-0002-7134-3065	NIDA NIH HHS [DA 04166] Funding Source: Medline; NIGMS NIH HHS [GM 43102] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043102] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA004166] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Belcheva MM, 2001, J BIOL CHEM, V276, P33847, DOI 10.1074/jbc.M101535200; Bourne HR, 1997, CURR OPIN CELL BIOL, V9, P134, DOI 10.1016/S0955-0674(97)80054-3; Brown JH, 1997, LIFE SCI, V60, P1077; BUHL AM, 1995, J BIOL CHEM, V270, P24631, DOI 10.1074/jbc.270.42.24631; Burford NT, 2000, BIOCHEM J, V348, P531, DOI 10.1042/0264-6021:3480531; Burstein ES, 1998, ONCOGENE, V17, P1617, DOI 10.1038/sj.onc.1202067; CHOU H, 1992, J NEURAL TRANSM-GEN, V90, P171, DOI 10.1007/BF01250959; Cohen RI, 1996, MOL BRAIN RES, V43, P193, DOI 10.1016/S0169-328X(96)00176-3; DellaRocca GJ, 1997, J BIOL CHEM, V272, P19125, DOI 10.1074/jbc.272.31.19125; Dikic I, 1998, J BIOL CHEM, V273, P14301, DOI 10.1074/jbc.273.23.14301; Dikic I, 1996, NATURE, V383, P547, DOI 10.1038/383547a0; Ding WQ, 1998, J NEUROCHEM, V70, P1722; Felsch JS, 1998, P NATL ACAD SCI USA, V95, P5051, DOI 10.1073/pnas.95.9.5051; Fisher A, 1998, J NEUROCHEM, V70, P1991; Frank GD, 2002, MOL ENDOCRINOL, V16, P367, DOI 10.1210/me.16.2.367; Fromm C, 1997, P NATL ACAD SCI USA, V94, P10098, DOI 10.1073/pnas.94.19.10098; Gineitis D, 2001, J BIOL CHEM, V276, P24531, DOI 10.1074/jbc.M102678200; Gohla A, 1998, J BIOL CHEM, V273, P4653, DOI 10.1074/jbc.273.8.4653; Guo FF, 2001, J BIOL CHEM, V276, P25568, DOI 10.1074/jbc.M101277200; Gutkind JS, 1997, LIFE SCI, V60, P999; Gutkind JS, 1998, J BIOL CHEM, V273, P1839, DOI 10.1074/jbc.273.4.1839; Gutkind JS, 1998, ONCOGENE, V17, P1331, DOI 10.1038/sj.onc.1202186; Hall A, 1998, SCIENCE, V280, P2074, DOI 10.1126/science.280.5372.2074; Hamilton SE, 2001, J BIOL CHEM, V276, P15850, DOI 10.1074/jbc.M011563200; HILL CS, 1993, CELL, V73, P395, DOI 10.1016/0092-8674(93)90238-L; HILL CS, 1994, EMBO J, V13, P5421, DOI 10.1002/j.1460-2075.1994.tb06877.x; Huang CF, 1997, P NATL ACAD SCI USA, V94, P6159, DOI 10.1073/pnas.94.12.6159; JAIN JN, 1993, NATURE, V365, P352, DOI 10.1038/365352a0; Johnson CM, 1997, J NEUROSCI, V17, P6189; Kimura K, 2000, J BIOL CHEM, V275, P17233, DOI 10.1074/jbc.C000212200; Kostenis E, 1998, J BIOL CHEM, V273, P17886, DOI 10.1074/jbc.273.28.17886; Kuo CT, 1999, ANNU REV IMMUNOL, V17, P149, DOI 10.1146/annurev.immunol.17.1.149; Lai MM, 1998, J BIOL CHEM, V273, P18325, DOI 10.1074/jbc.273.29.18325; LAMEH J, 1992, J BIOL CHEM, V267, P13406; LARSSON C, 1994, EUR J PHARM-MOLEC PH, V268, P19; Lin KD, 1999, BIOTECHNIQUES, V26, P318, DOI 10.2144/99262rr02; MAEDA S, 1990, FEBS LETT, V269, P386, DOI 10.1016/0014-5793(90)81199-X; Mao JH, 1998, J BIOL CHEM, V273, P27118, DOI 10.1074/jbc.273.42.27118; Marinissen MJ, 1999, MOL CELL BIOL, V19, P4289; MORO O, 1993, J BIOL CHEM, V268, P6862; Murasawa S, 1998, CIRC RES, V82, P1338, DOI 10.1161/01.RES.82.12.1338; Post GR, 1996, FASEB J, V10, P741, DOI 10.1096/fasebj.10.7.8635691; QUILLIAM LA, 1989, FEBS LETT, V247, P221, DOI 10.1016/0014-5793(89)81339-0; Reid T, 1996, J BIOL CHEM, V271, P13556, DOI 10.1074/jbc.271.23.13556; Shi CS, 2000, J BIOL CHEM, V275, P24470, DOI 10.1074/jbc.M908449199; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; Spencer JA, 1996, J BIOL CHEM, V271, P16535, DOI 10.1074/jbc.271.28.16535; STRATHMANN MP, 1991, P NATL ACAD SCI USA, V88, P5582, DOI 10.1073/pnas.88.13.5582; Treisman R, 1998, COLD SPRING HARB SYM, V63, P643, DOI 10.1101/sqb.1998.63.643; TREISMAN R, 1994, CURR OPIN GENET DEV, V4, P96, DOI 10.1016/0959-437X(94)90097-3; TSIOKAS L, 1995, MOL PHARMACOL, V47, P272; Wang DX, 1999, J BIOL CHEM, V274, P22081, DOI 10.1074/jbc.274.31.22081; Wang DX, 2000, J NEUROCHEM, V74, P1418, DOI 10.1046/j.1471-4159.2000.0741418.x; Wess J, 1996, CRIT REV NEUROBIOL, V10, P69, DOI 10.1615/CritRevNeurobiol.v10.i1.40; Xu X, 1999, J BIOL CHEM, V274, P3549, DOI 10.1074/jbc.274.6.3549; Yamauchi J, 2001, J BIOL CHEM, V276, P23362, DOI 10.1074/jbc.M011752200; Yu H, 1996, J BIOL CHEM, V271, P29993, DOI 10.1074/jbc.271.47.29993	57	20	20	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2002	277	43					40789	40798		10.1074/jbc.M202745200	http://dx.doi.org/10.1074/jbc.M202745200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	607KU	12200418	hybrid			2022-12-27	WOS:000178791400082
J	Carveth, K; Buck, T; Anthony, V; Skach, WR				Carveth, K; Buck, T; Anthony, V; Skach, WR			Cooperativity and flexibility of cystic fibrosis transmembrane conductance regulator transmembrane segments participate in membrane localization of a charged residue	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM MEMBRANE; HUMAN P-GLYCOPROTEIN; PROTEIN TRANSLOCATION; SIGNAL SEQUENCE; POSTTRANSLATIONAL TRANSLOCATION; SPANNING REGIONS; CHLORIDE CHANNEL; ER MEMBRANE; CFTR; BIOGENESIS	Polytopic protein topology is established in the endoplasmic reticulum (ER) by sequence determinants encoded throughout the nascent polypeptide. Here we characterize 12 topogenic determinants in the cystic fibrosis transmembrane conductance regulator, and identify a novel mechanism by which a charged residue is positioned within the plane of the lipid bilayer. During cystic fibrosis transmembrane conductance regulator biogenesis, topology of the C-terminal transmembrane domain (TMs 7-12) is directed by alternating signal (TMs 7,9, and 11) and stop transfer (TMs 8, 10, and 12) sequences. Unlike conventional stop transfer sequences, however, TM8 is unable to independently terminate translocation due to the presence of a single charged residue, Asp 121, within the TM segment. Instead, TM8 stop transfer activity is specifically dependent on TM7, which functions both to initiate translocation and to compensate for the charged residue within TM8. Moreover, even in the presence of TM7, the N terminus of TM8 extends significantly into the ER lumen, suggesting a high degree of flexibility in establishing TM8 transmembrane boundaries. These studies demonstrate that signal sequences can markedly influence stop transfer behavior and indicate that ER translocation machinery simultaneously integrates information from multiple topogenic determinants as they are presented in rapid succession during polytopic protein biogenesis.	Oregon Hlth & Sci Univ, Div Mol Med, Portland, OR 97201 USA	Oregon Health & Science University	Skach, WR (corresponding author), Oregon Hlth & Sci Univ, Div Mol Med, Portland, OR 97201 USA.	skachw@ohsu.edu		Buck, Teresa/0000-0002-9013-9756	NIDDK NIH HHS [DK 51818] Funding Source: Medline; NIGMS NIH HHS [GM 53457] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051818] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AKABAS MH, 1994, J BIOL CHEM, V269, P14865; Beckmann R, 2001, CELL, V107, P361, DOI 10.1016/S0092-8674(01)00541-4; Beckmann R, 1997, SCIENCE, V278, P2123, DOI 10.1126/science.278.5346.2123; BLOBEL G, 1980, P NATL ACAD SCI-BIOL, V77, P1496, DOI 10.1073/pnas.77.3.1496; Borel AC, 1996, CELL, V85, P379, DOI 10.1016/S0092-8674(00)81116-2; CHANG XB, 1994, J BIOL CHEM, V269, P18572; CHAVEZ RA, 1992, J CELL BIOL, V116, P385, DOI 10.1083/jcb.116.2.385; Chen MG, 1999, BIOCHEMISTRY-US, V38, P5471, DOI 10.1021/bi982153t; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Cotten JF, 1999, J BIOL CHEM, V274, P5429, DOI 10.1074/jbc.274.9.5429; CROWLEY KS, 1993, CELL, V73, P1101, DOI 10.1016/0092-8674(93)90640-C; CROWLEY KS, 1994, CELL, V78, P461, DOI 10.1016/0092-8674(94)90424-3; Do H, 1996, CELL, V85, P369, DOI 10.1016/S0092-8674(00)81115-0; Goder V, 1999, J CELL BIOL, V147, P257, DOI 10.1083/jcb.147.2.257; Hamman BD, 1998, CELL, V92, P747, DOI 10.1016/S0092-8674(00)81403-8; Hamman BD, 1997, CELL, V89, P535, DOI 10.1016/S0092-8674(00)80235-4; Hammerle MM, 2000, GLYCOCONJUGATE J, V17, P807, DOI 10.1023/A:1010992827511; Hammerle MM, 2001, J BIOL CHEM, V276, P14848, DOI 10.1074/jbc.M011017200; HASEGAWA H, 1992, SCIENCE, V258, P1477, DOI 10.1126/science.1279809; Hegde RS, 1997, CELL, V91, P575, DOI 10.1016/S0092-8674(00)80445-6; Heinrich SU, 2000, CELL, V102, P233, DOI 10.1016/S0092-8674(00)00028-3; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Johnson AE, 1999, ANNU REV CELL DEV BI, V15, P799, DOI 10.1146/annurev.cellbio.15.1.799; JUNGNICKEL B, 1995, CELL, V82, P261, DOI 10.1016/0092-8674(95)90313-5; Kim SJ, 2002, DEV CELL, V2, P207, DOI 10.1016/S1534-5807(01)00120-4; Kim SJ, 2001, J BIOL CHEM, V276, P26132, DOI 10.1074/jbc.M101638200; Kuroiwa T, 1996, J BIOL CHEM, V271, P6423, DOI 10.1074/jbc.271.11.6423; Liao SR, 1997, CELL, V90, P31, DOI 10.1016/S0092-8674(00)80311-6; LIPP J, 1989, J CELL BIOL, V109, P2013, DOI 10.1083/jcb.109.5.2013; Lu Y, 2000, MOL BIOL CELL, V11, P2973, DOI 10.1091/mbc.11.9.2973; Lu Y, 1998, J BIOL CHEM, V273, P568, DOI 10.1074/jbc.273.1.568; Mansoura MK, 1998, BIOPHYS J, V74, P1320, DOI 10.1016/S0006-3495(98)77845-2; Menetret JF, 2000, MOL CELL, V6, P1219, DOI 10.1016/S1097-2765(00)00118-0; Mingarro I, 2000, BMC Cell Biol, V1, P3, DOI 10.1186/1471-2121-1-3; Monne M, 1998, J MOL BIOL, V284, P1177, DOI 10.1006/jmbi.1998.2218; Mothes W, 1997, CELL, V89, P523, DOI 10.1016/S0092-8674(00)80234-2; NILSSON I, 1993, J BIOL CHEM, V268, P5798; Ota K, 1998, MOL CELL, V2, P495, DOI 10.1016/S1097-2765(00)80149-5; Popov M, 1997, J BIOL CHEM, V272, P18325, DOI 10.1074/jbc.272.29.18325; Rapoport TA, 1999, BIOL CHEM, V380, P1143, DOI 10.1515/BC.1999.145; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROTHMAN RE, 1988, J BIOL CHEM, V263, P10470; Rutkowski DT, 2001, P NATL ACAD SCI USA, V98, P7823, DOI 10.1073/pnas.141125098; Schroder K, 1999, EMBO J, V18, P4804, DOI 10.1093/emboj/18.17.4804; SHEPPARD DN, 1993, NATURE, V362, P160, DOI 10.1038/362160a0; Sheppard DN, 1999, PHYSIOL REV, V79, P23; SHI LB, 1995, BIOCHEMISTRY-US, V34, P8250, DOI 10.1021/bi00026a006; SIMON SM, 1991, CELL, V65, P371, DOI 10.1016/0092-8674(91)90455-8; Skach WR, 1998, METHOD ENZYMOL, V292, P265; SKACH WR, 1994, CANCER RES, V54, P3202; SKACH WR, 1994, J CELL BIOL, V125, P803, DOI 10.1083/jcb.125.4.803; SKACH WR, 1993, J BIOL CHEM, V268, P23552; Skach WR, 2000, KIDNEY INT, V57, P825, DOI 10.1046/j.1523-1755.2000.00921.x; Tector M, 1999, EMBO J, V18, P6290, DOI 10.1093/emboj/18.22.6290; Tsalkova T, 1998, J MOL BIOL, V278, P713, DOI 10.1006/jmbi.1998.1721; WESSELS HP, 1988, CELL, V55, P61, DOI 10.1016/0092-8674(88)90009-8; Whitley P, 1996, J BIOL CHEM, V271, P6241, DOI 10.1074/jbc.271.11.6241; Wigley WC, 2002, NAT STRUCT BIOL, V9, P381, DOI 10.1038/nsb784; Wilkinson BM, 2000, J BIOL CHEM, V275, P521, DOI 10.1074/jbc.275.1.521; Xiong XM, 1997, J CLIN INVEST, V100, P1079, DOI 10.1172/JCI119618	61	29	29	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2002	277	42					39507	39514		10.1074/jbc.M205759200	http://dx.doi.org/10.1074/jbc.M205759200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	605EA	12186867	hybrid			2022-12-27	WOS:000178662500059
J	Silverman, JA; Harbury, PB				Silverman, JA; Harbury, PB			Rapid mapping of protein structure, interactions, and ligand binding by misincorporation proton-alkyl exchange	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYACRYLAMIDE-GEL-ELECTROPHORESIS; CYSTEINE; SITE; DNA; MUTAGENESIS; EFFICIENT; RESIDUES; CLEAVAGE; COMPLEX; VILLIN	Understanding protein conformation, interactions, and ligand binding is essential to all biological inquiry. We report a novel biochemical technique, called mis-incorporation proton-alkyl exchange (MPAX), that can be used to footprint protein structure at single amino acid resolution. MPAX exploits translational misincorporation of cysteine residues to generate probes for physical analysis. We apply MPAX to the triosephosphate isomerase (beta/alpha)(8) barrel, accurately determining its substrate-binding site, a protein-protein interaction surface, the solvent-accessible protein surface, and the stability of the barrel. Because MPAX requires only microgram quantities of material and is not limited by protein size, it is ideally suited for proteins not amenable to conventional structural methods, such as membrane proteins, partially folded or insoluble proteins, and large protein complexes.	Stanford Univ, Dept Biochem, Stanford, CA 94305 USA	Stanford University	Harbury, PB (corresponding author), Stanford Univ, Dept Biochem, 279 Campus Dr W, Stanford, CA 94305 USA.	harbury@cmgm.stanford.edu						Arnold U, 1999, ANAL BIOCHEM, V271, P197, DOI 10.1006/abio.1999.4149; AUSUBEL FM, 1995, CURRENT PROTOCOLS MO, V1, P11; BAI YW, 1995, SCIENCE, V269, P192, DOI 10.1126/science.7618079; Bowers PM, 2000, J BIOMOL NMR, V18, P311, DOI 10.1023/A:1026744431105; BRUNGER AT, 1992, X PLOR; CREIGHTON TE, 1993, PROTEINS, P333; DAVENPORT RC, 1991, BIOCHEMISTRY-US, V30, P5821, DOI 10.1021/bi00238a002; DEARRUDA MV, 1992, J BIOL CHEM, V267, P13079; Doering DS, 1996, BIOCHEMISTRY-US, V35, P12677, DOI 10.1021/bi9615699; DOONAN S, 1975, EUR J BIOCHEM, V56, P421, DOI 10.1111/j.1432-1033.1975.tb02248.x; Doring V, 1998, GENETICS, V150, P543; GALAS DJ, 1978, NUCLEIC ACIDS RES, V5, P3157, DOI 10.1093/nar/5.9.3157; Gygi SP, 1999, NAT BIOTECHNOL, V17, P994, DOI 10.1038/13690; Ha JH, 1998, NAT STRUCT BIOL, V5, P730, DOI 10.1038/1436; HANAI R, 1994, P NATL ACAD SCI USA, V91, P11904, DOI 10.1073/pnas.91.25.11904; HARTMAN JC, 1975, BIOCHEMISTRY-US, V14, P5274; JACOBSON GR, 1973, J BIOL CHEM, V248, P6583; KOBAYASHI M, 1992, BIOCHEMISTRY-US, V31, P9000, DOI 10.1021/bi00152a042; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KUNKEL TA, 1991, METHOD ENZYMOL, V204, P125; LASKI FA, 1989, P NATL ACAD SCI USA, V86, P6696, DOI 10.1073/pnas.86.17.6696; Liu XC, 2000, METHODS MOL BIOL, V147, P119; Park HJ, 1998, MOL CELL BIOL, V18, P4418, DOI 10.1128/MCB.18.8.4418; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Silverman JA, 2001, P NATL ACAD SCI USA, V98, P3092, DOI 10.1073/pnas.041613598; STRYER L, 1996, BIOCHEMISTRY-US, P886; Tu BP, 1999, P NATL ACAD SCI USA, V96, P4862, DOI 10.1073/pnas.96.9.4862; Turner J, 1999, EMBO J, V18, P771, DOI 10.1093/emboj/18.3.771; WILTFANG J, 1991, ELECTROPHORESIS, V12, P352, DOI 10.1002/elps.1150120507; Wu J, 1998, ANAL BIOCHEM, V258, P268, DOI 10.1006/abio.1998.2596	30	31	33	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2002	277	34					30968	30975		10.1074/jbc.M203172200	http://dx.doi.org/10.1074/jbc.M203172200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	586JA	12185208	hybrid			2022-12-27	WOS:000177579800073
J	Angus, SP; Wheeler, LJ; Ranmal, SA; Zhang, XP; Markey, MP; Mathews, CK; Knudsen, ES				Angus, SP; Wheeler, LJ; Ranmal, SA; Zhang, XP; Markey, MP; Mathews, CK; Knudsen, ES			Retinoblastoma tumor suppressor targets dNTP metabolism to regulate DNA replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE ARREST; S-PHASE; RIBONUCLEOTIDE REDUCTASE; DIHYDROFOLATE-REDUCTASE; PRB PHOSPHORYLATION; G(1)/S TRANSITION; G1 ARREST; PROTEIN; INHIBITION; GENE	The retinoblastoma tumor suppressor, 1113, is a negative regulator of the cell cycle that is inactivated in the majority of human tumors. Cell cycle inhibition elicited by RB has been attributed to the attenuation of CDK2 activity. Although ectopic cyclins partially overcome RB-mediated S-phase arrest at the replication fork, DNA replication remains inhibited and cells fail to progress to G(2) phase. These data suggest that RB regulates an additional execution point in S phase. We observed that constitutively active 1113 attenuates the expression of specific dNTP synthetic enzymes: dihydrofolate reductase, ribonucleotide reductase (RNR) subunits R1/R2, and thymidylate synthase (TS). Activation of endogenous RB and related proteins by p16ink4a yielded similar effects on enzyme expression. Conversely, targeted disruption of RB resulted in increased metabolic protein levels (dihydrofolate reductase, TS, RNR-R2) and conferred resistance to the effect of TS or RNR inhibitors that diminish available dNTPs. Analysis of dNTP pools during RB-mediated cell cycle arrest revealed significant depletion, concurrent with the loss of TS and RNR protein. Importantly, the effect of active RB on cell cycle position and available dNTPs was comparable to that observed with specific antimetabolites. Together, these results show that RB-mediated transcriptional repression attenuates available dNTP pools to control S-phase progression. Thus, RB employs both canonical cyclin-dependent kinase/cyclin regulation and metabolic regulation as a means to limit proliferation, underscoring its potency in tumor suppression.	Univ Cincinnati, Coll Med, Dept Cell Biol, Vontz Ctr Mol Studies, Cincinnati, OH 45267 USA; Oregon State Univ, Dept Biochem & Biophys, Corvallis, OR 97331 USA	University System of Ohio; University of Cincinnati; Oregon State University	Angus, SP (corresponding author), Univ Cincinnati, Coll Med, Dept Cell Biol, Vontz Ctr Mol Studies, Cincinnati, OH 45267 USA.			Angus, Steven/0000-0002-7655-657X; Markey, Michael/0000-0002-8593-2290	NCI NIH HHS [CA82525] Funding Source: Medline; NIGMS NIH HHS [GM55134] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA082525] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055134] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALMASAN A, 1995, P NATL ACAD SCI USA, V92, P5436, DOI 10.1073/pnas.92.12.5436; Angus SP, 2002, EXP CELL RES, V276, P201, DOI 10.1006/excr.2002.5510; Bartek J, 1997, EXP CELL RES, V237, P1, DOI 10.1006/excr.1997.3776; BERTINO JR, 1992, MT SINAI J MED, V59, P391; Bruce JL, 2000, MOL CELL, V6, P737, DOI 10.1016/S1097-2765(00)00072-1; Chabes A, 1999, J BIOL CHEM, V274, P36679, DOI 10.1074/jbc.274.51.36679; Chew YP, 1998, ONCOGENE, V17, P2177, DOI 10.1038/sj.onc.1202443; COLLINS JM, 1978, J BIOL CHEM, V253, P8570; DEGREGORI J, 1995, MOL CELL BIOL, V15, P4215; Dimitrova DS, 1999, J CELL BIOL, V146, P709, DOI 10.1083/jcb.146.4.709; DOU QP, 1994, J BIOL CHEM, V269, P1306; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; ELLEDGE SJ, 1992, TRENDS BIOCHEM SCI, V17, P119, DOI 10.1016/0968-0004(92)90249-9; Fukushima M, 2001, EUR J CANCER, V37, P1681, DOI 10.1016/S0959-8049(01)00174-5; GRIFFIG J, 1989, CANCER RES, V49, P6923; Harbour JW, 2000, GENE DEV, V14, P2393, DOI 10.1101/gad.813200; Herrera RE, 1996, MOL CELL BIOL, V16, P2402; Hurford RK, 1997, GENE DEV, V11, P1447, DOI 10.1101/gad.11.11.1447; Ishida S, 2001, MOL CELL BIOL, V21, P4684, DOI 10.1128/MCB.21.14.4684-4699.2001; Kaelin WG, 1997, CANCER INVEST, V15, P243, DOI 10.3109/07357909709039722; Kelly TJ, 2000, ANNU REV BIOCHEM, V69, P829, DOI 10.1146/annurev.biochem.69.1.829; Knudsen ES, 1998, GENE DEV, V12, P2278, DOI 10.1101/gad.12.15.2278; Knudsen KE, 1999, J BIOL CHEM, V274, P27632, DOI 10.1074/jbc.274.39.27632; Knudsen KE, 2000, MOL CELL BIOL, V20, P7751, DOI 10.1128/MCB.20.20.7751-7763.2000; Knudsen KE, 1998, J BIOL CHEM, V273, P20213, DOI 10.1074/jbc.273.32.20213; LEEDS JM, 1985, MOL CELL BIOL, V5, P3443, DOI 10.1128/MCB.5.12.3443; LI WW, 1995, P NATL ACAD SCI USA, V92, P10436, DOI 10.1073/pnas.92.22.10436; LUKAS J, 1995, NATURE, V375, P503, DOI 10.1038/375503a0; Lukas J, 1997, GENE DEV, V11, P1479, DOI 10.1101/gad.11.11.1479; Lukas J, 1999, ONCOGENE, V18, P3930, DOI 10.1038/sj.onc.1202777; MATHEWS CK, 1992, BIOESSAYS, V14, P295, DOI 10.1002/bies.950140502; MATHEWS CK, 1993, PROG NUCLEIC ACID RE, V44, P167, DOI 10.1016/S0079-6603(08)60220-2; Mittnacht S, 1998, CURR OPIN GENET DEV, V8, P21, DOI 10.1016/S0959-437X(98)80057-9; OHTSUBO M, 1995, MOL CELL BIOL, V15, P2612; Petre CE, 2002, J BIOL CHEM, V277, P2207, DOI 10.1074/jbc.M106399200; PINEDO HM, 1988, J CLIN ONCOL, V6, P1653, DOI 10.1200/JCO.1988.6.10.1653; Reed SI, 1997, CANCER SURV, V29, P7; REICHARD P, 1988, ANNU REV BIOCHEM, V57, P349, DOI 10.1146/annurev.bi.57.070188.002025; REICHARD P, 1993, SCIENCE, V260, P1773, DOI 10.1126/science.8511586; SARGENT RG, 1987, J BIOL CHEM, V262, P5546; SCHWEITZER BI, 1990, FASEB J, V4, P2441, DOI 10.1096/fasebj.4.8.2185970; Sever-Chroneos Z, 2001, MOL CELL BIOL, V21, P4032, DOI 10.1128/MCB.21.12.4032-4045.2001; SHERMAN PA, 1989, ANAL BIOCHEM, V180, P222, DOI 10.1016/0003-2697(89)90420-X; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Slansky JE, 1996, BIOESSAYS, V18, P55, DOI 10.1002/bies.950180111; Strobeck MW, 2000, P NATL ACAD SCI USA, V97, P7748, DOI 10.1073/pnas.97.14.7748; Waga S, 1998, ANNU REV BIOCHEM, V67, P721, DOI 10.1146/annurev.biochem.67.1.721; WANG JYJ, 1994, ADV CANCER RES, V64, P25, DOI 10.1016/S0065-230X(08)60834-9; Wells J, 2000, MOL CELL BIOL, V20, P5797, DOI 10.1128/MCB.20.16.5797-5807.2000; Zhang HS, 2000, CELL, V101, P79, DOI 10.1016/S0092-8674(00)80625-X; Zhang HS, 1999, CELL, V97, P53, DOI 10.1016/S0092-8674(00)80714-X; Zhao XL, 1998, MOL CELL, V2, P329, DOI 10.1016/S1097-2765(00)80277-4	52	74	81	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	2002	277	46					44376	44384		10.1074/jbc.M205911200	http://dx.doi.org/10.1074/jbc.M205911200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	615XE	12221087	Green Published, hybrid			2022-12-27	WOS:000179272000109
J	Deepa, SS; Umehara, Y; Higashiyama, S; Itoh, N; Sugahara, K				Deepa, SS; Umehara, Y; Higashiyama, S; Itoh, N; Sugahara, K			Specific molecular interactions of oversulfated chondroitin sulfate E with various heparin-binding growth factors - Implications as a physiological binding partner in the brain and other tissues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; PHOSPHATASE ZETA/RPTP-BETA; AMYLOID PRECURSOR PROTEIN; CENTRAL-NERVOUS-SYSTEM; NEURITE OUTGROWTH; FACTOR MIDKINE; MESSENGER-RNA; CELL-ADHESION; N-SYNDECAN; HB-EGF	We previously observed that the cortical neuronal cell adhesion mediated by midkine (AM), a heparin (Hep)-binding growth factor, is specifically inhibited by oversulfated chondroitin sulfate-E (CS-E) (Ueoka, C., Kaneda, N., Okazaki, I., Nadanaka, S., Muramatsu, T., and Sugahara, K. (2000) J. BioL ChenL 275, 37407-37413) and that CS-E exhibits neurite outgrowth promoting activities toward embryonic rat hippocampal neurons. We have also shown oversulfated CS chains in embryonic chick and rat brains and demonstrated that the CS disaccharide composition changes during brain development. In view of these findings, here we tested the possibility of CS-E interacting with Hep-binding growth factors during development, using squid cartilage CS-E. The binding ability of Hep-binding growth factors (MK, pleiotrophin (PTN), fibroblast growth factor-1 (FGF-1), FGF-2, Hep-binding epidermal growth factor-like growth factor (HB-EGF), FGF-10, FGF-16, and FGF-18) toward [H-3]CS-E was first tested by a filter binding assay, which demonstrated direct binding of all growth factors, except FGF-1, to CS-E. The bindings were characterized further in an Interaction Analysis system, where all of the growth factors, except FGF-1, gave concentration-dependent and specific bindings. The kinetic constants k(a), k(d), and K-d suggested that MK, PTN, FGF-16, FGF-18, and HB-EGF bound strongly to CS-E, in comparable degrees to the binding to Hep, whereas the intensity of binding of FGF-2 and FGF-10 toward CS-E was lower than that for Hep. These findings suggest the possibility of CS-E being a binding partner, a coreceptor, or a genuine receptor for various Hep-binding growth factors in the brain and possibly also in other tissues.	Kobe Pharmaceut Univ, Dept Biochem, Higashinada Ku, Kobe, Hyogo 6588558, Japan; Ehime Univ, Sch Med, Dept Biochem Med, Onsen, Ehime 7910295, Japan; Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Biochem Genet, Kyoto 6068501, Japan	Kobe Pharmaceutical University; Ehime University; Kyoto University	Sugahara, K (corresponding author), Kobe Pharmaceut Univ, Dept Biochem, Higashinada Ku, 4-19-1 Motoyama Kita Machi, Kobe, Hyogo 6588558, Japan.	k-sugar@kobepharma-u.ac.jp		Deepa, Sathyaseelan/0000-0002-3669-4820				Asakura M, 2002, NAT MED, V8, P35, DOI 10.1038/nm0102-35; Bagai S, 2002, J BIOL CHEM, V277, P23828, DOI 10.1074/jbc.M201658200; BITTER T, 1962, ANAL BIOCHEM, V4, P330, DOI 10.1016/0003-2697(62)90095-7; CAREY DJ, 1992, J CELL BIOL, V117, P191, DOI 10.1083/jcb.117.1.191; CHERNOUSOV MA, 1993, J BIOL CHEM, V268, P16810; Clement AM, 1999, NEUROSCI LETT, V269, P125, DOI 10.1016/S0304-3940(99)00432-2; Clement AM, 1998, J BIOL CHEM, V273, P28444, DOI 10.1074/jbc.273.43.28444; Danilenko DM, 1999, ARCH BIOCHEM BIOPHYS, V361, P34, DOI 10.1006/abbi.1998.0967; DEEPA SS, 2002, 23 JAP CARB S YOK JA; FAISSNER A, 1994, J CELL BIOL, V126, P783, DOI 10.1083/jcb.126.3.783; Farkas LM, 2002, J NEURAL TRANSM, V109, P267, DOI 10.1007/s007020200022; Feyzi E, 1998, J BIOL CHEM, V273, P13395, DOI 10.1074/jbc.273.22.13395; FOXALL C, 1995, ANAL BIOCHEM, V231, P366, DOI 10.1006/abio.1995.0065; Garwood J, 1999, J NEUROSCI, V19, P3888; GREEN NM, 1965, BIOCHEM J, V94, pC23, DOI 10.1042/bj0940023C; Hajihosseini MK, 2002, MECH DEVELOP, V113, P79, DOI 10.1016/S0925-4773(01)00656-6; Harada H, 2002, DEVELOPMENT, V129, P1533; Hascall V.C., 1981, CELL BIOL EXTRACELLU, P39; Hattori Y, 1997, MOL BRAIN RES, V47, P139, DOI 10.1016/S0169-328X(97)00044-2; HERNDON ME, 1990, NEURON, V4, P949, DOI 10.1016/0896-6273(90)90148-9; HIGASHIYAMA S, 1991, SCIENCE, V251, P936, DOI 10.1126/science.1840698; HIGASHIYAMA S, 1992, J BIOL CHEM, V267, P6205; Hu MCT, 1998, MOL CELL BIOL, V18, P6063, DOI 10.1128/MCB.18.10.6063; Jemth P, 2002, J BIOL CHEM, V277, P30567, DOI 10.1074/jbc.M203404200; KADOMATSU K, 1988, BIOCHEM BIOPH RES CO, V151, P1312, DOI 10.1016/S0006-291X(88)80505-9; Kaneda N, 1996, J BIOCHEM-TOKYO, V119, P1150; Kawashima H, 2002, J BIOL CHEM, V277, P12921, DOI 10.1074/jbc.M200396200; Kinoshita A, 2001, BIOCHEMISTRY-US, V40, P12654, DOI 10.1021/bi015577n; Kitagawa H, 1997, J BIOL CHEM, V272, P31377, DOI 10.1074/jbc.272.50.31377; Konishi M, 2000, J BIOL CHEM, V275, P12119, DOI 10.1074/jbc.275.16.12119; Kreuger J, 2001, J BIOL CHEM, V276, P30744, DOI 10.1074/jbc.M102628200; Kreuger J, 1999, GLYCOBIOLOGY, V9, P723, DOI 10.1093/glycob/9.7.723; Lander A D, 1993, Curr Opin Neurobiol, V3, P716, DOI 10.1016/0959-4388(93)90143-M; Lander AD, 1998, MATRIX BIOL, V17, P465, DOI 10.1016/S0945-053X(98)90093-2; LEE MK, 1991, P NATL ACAD SCI USA, V88, P2768, DOI 10.1073/pnas.88.7.2768; Maeda N, 1999, J BIOL CHEM, V274, P12474, DOI 10.1074/jbc.274.18.12474; Maeda N, 1996, J BIOL CHEM, V271, P21446, DOI 10.1074/jbc.271.35.21446; Maeda N, 1998, J CELL BIOL, V142, P203, DOI 10.1083/jcb.142.1.203; MARK M P, 1990, International Journal of Developmental Biology, V34, P191; MERENMIES J, 1990, J BIOL CHEM, V265, P16721; Milev P, 1998, J BIOL CHEM, V273, P21439, DOI 10.1074/jbc.273.34.21439; Miyake A, 1998, BIOCHEM BIOPH RES CO, V243, P148, DOI 10.1006/bbrc.1998.8073; MURAMATSU H, 1991, BIOCHEM BIOPH RES CO, V177, P652, DOI 10.1016/0006-291X(91)91838-4; Muramatsu T, 2001, TRENDS GLYCOSCI GLYC, V13, P563, DOI 10.4052/tigg.13.563; Nadanaka S, 1998, J BIOL CHEM, V273, P3296, DOI 10.1074/jbc.273.6.3296; Nakagawa T, 1998, DEV BRAIN RES, V108, P263, DOI 10.1016/S0165-3806(98)00057-1; Nakanishi T, 1997, J BIOCHEM-TOKYO, V121, P197; Ohbayashi N, 1998, J BIOL CHEM, V273, P18161, DOI 10.1074/jbc.273.29.18161; Ohmachi S, 2000, BIOCHEM BIOPH RES CO, V277, P355, DOI 10.1006/bbrc.2000.3675; Ohuchi H, 2000, MECH DEVELOP, V95, P55, DOI 10.1016/S0925-4773(00)00331-2; Oohira A, 2000, ARCH BIOCHEM BIOPHYS, V374, P24, DOI 10.1006/abbi.1999.1598; Owada K, 1999, J NEUROCHEM, V73, P2084; Patrie KM, 1999, BIOCHEMISTRY-US, V38, P9264, DOI 10.1021/bi9903345; Perrimon N, 2000, NATURE, V404, P725, DOI 10.1038/35008000; POOLE AR, 1986, BIOCHEM J, V236, P1; Qi MS, 2001, J BIOL CHEM, V276, P15868, DOI 10.1074/jbc.M005911200; RAUVALA H, 1989, EMBO J, V8, P2933, DOI 10.1002/j.1460-2075.1989.tb08443.x; RODEN L, 1980, BIOCH GLYCOPROTEINS, P491; RUOSLAHTI E, 1989, J BIOL CHEM, V264, P13369; SAIGO K, 1970, J NEUROCHEM, V17, P633, DOI 10.1111/j.1471-4159.1970.tb00543.x; Sakaue H, 2002, GENE DEV, V16, P908, DOI 10.1101/gad.983202; Salinero O, 2000, J NEUROSCI RES, V60, P87, DOI 10.1002/(SICI)1097-4547(20000401)60:1<87::AID-JNR9>3.0.CO;2-C; Sekine K, 1999, NAT GENET, V21, P138, DOI 10.1038/5096; Souttou B, 1997, J BIOL CHEM, V272, P19588, DOI 10.1074/jbc.272.31.19588; Sugahara K, 1996, J BIOL CHEM, V271, P26745, DOI 10.1074/jbc.271.43.26745; Sugahara K, 2000, CURR OPIN STRUC BIOL, V10, P518, DOI 10.1016/S0959-440X(00)00125-1; Sugahara K, 2000, TRENDS GLYCOSCI GLYC, V12, P321, DOI 10.4052/tigg.12.321; SUGAHARA K, 2002, IN PRESS IUBMB LIFE; Tsuchida K, 2001, J BIOL CHEM, V276, P37155, DOI 10.1074/jbc.M105818200; Ueno M, 2001, J BIOL CHEM, V276, P29134, DOI 10.1074/jbc.M102089200; Ueoka C, 2000, J BIOL CHEM, V275, P37407, DOI 10.1074/jbc.M002538200; Whitsett JA, 2002, J BIOL CHEM, V277, P22743, DOI 10.1074/jbc.M202253200; Wu AF, 1997, J NEUROSCI, V17, P4987; Xian CJ, 1999, MOL NEUROBIOL, V20, P157, DOI 10.1007/BF02742440; Xu JS, 2000, DEVELOPMENT, V127, P1833; Yamane Y, 1998, J BIOL CHEM, V273, P7375, DOI 10.1074/jbc.273.13.7375; YANG BH, 1995, ANAL BIOCHEM, V228, P299, DOI 10.1006/abio.1995.1354; Zou K, 2000, EUR J BIOCHEM, V267, P4046, DOI 10.1046/j.1432-1327.2000.01440.x	78	284	290	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2002	277	46					43707	43716		10.1074/jbc.M207105200	http://dx.doi.org/10.1074/jbc.M207105200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	615XE	12221095	hybrid			2022-12-27	WOS:000179272000023
J	He, L; Ronis, MJJ; Badger, TM				He, L; Ronis, MJJ; Badger, TM			Ethanol induction of Class I alcohol dehydrogenase expression in the rat occurs through alterations in CCAAT/enhancer binding proteins beta and gamma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRIMARY HEPATOCYTE CULTURE; MESSENGER-RNA; GROWTH-HORMONE; 5'-FLANKING SEQUENCE; RESPONSE ELEMENT; C/EBP-GAMMA; ADH-1 GENE; CYCLIC-AMP; TRANSCRIPTION; FAMILY	Alcohol dehydrogenase (ADH) is the principal ethanol-metabolizing enzyme. Ethanol induces rat Class I ADH mRNA and activity by an as yet unknown mechanism. In the current study, adult male rats were fed an ethanol-containing diet by continuous intragastric infusion for 42 days. Hepatic Class I ADH mRNA, protein, and activity levels in the ethanol-infused rats increased 3.9-, 3.3-, and 1.7-fold, respectively (p <0.05). Cis-acting elements within the proximal promoter region of the ADH gene were studied by electrophoretic mobility shift assay (EMSA). Hepatic nuclear extract (HNE) binding to either the consensus or ADH-specific CCAAT/enhancer binding protein (C/EBP) sites was >2.4-fold greater in ethanol-fed rats (p <0.05) than controls. Antibody-specific EMSA assays demonstrated binding of the transcription factor C/EBPbeta to the C/EBP site. Western blot immunoblot analysis of HNEs demonstrated 3.5- and 2.3-fold increases in C/EBPbeta (LAP) and C/EBPdelta (p <0.05), respectively, in ethanol-fed rats compared with controls, whereas levels of the truncated C/EBP&delta; (LIP) and C/EBP&gamma; were lower in ethanol-fed rats (p &LT;0.05). HNE from ethanol-fed rats increased (3-fold) the in vitro transcription of rat Class I ADH (p &LT;0.05), and mutation of the C/EBP element in the proximal promoter region blocked this effect. Antisera against LIP or C/EBP&gamma; enhanced transcription efficiency (p &LT;0.05). These data provide the first evidence for the mechanism by which ethanol regulates rat hepatic Class I ADH gene expression in vivo. This mechanism involves the C/EBP site and the enhancer binding proteins &beta; and &gamma;.	Arkansas Childrens Nutr Ctr, Little Rock, AR 72202 USA		Badger, TM (corresponding author), Arkansas Childrens Nutr Ctr, 1120 Marshall St, Little Rock, AR 72202 USA.				NIAAA NIH HHS [AA0845] Funding Source: Medline	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		BADGER TM, 1993, J PHARMACOL EXP THER, V264, P938; Badger TM, 2000, BIOCHEM BIOPH RES CO, V274, P684, DOI 10.1006/bbrc.2000.3186; BAGCHI MK, 1990, J BIOL CHEM, V265, P5129; BOLEDA MD, 1992, BIOCHEM PHARMACOL, V43, P1555, DOI 10.1016/0006-2952(92)90214-4; BUETLER TM, 1995, TOXICOL APPL PHARM, V135, P45, DOI 10.1006/taap.1995.1207; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; Chen B, 2000, CANCER RES, V60, P3290; COOPER C, 1995, NUCLEIC ACIDS RES, V23, P4371, DOI 10.1093/nar/23.21.4371; CORTESE JF, 1994, J BIOL CHEM, V269, P21898; CRABB DW, 1989, GENOMICS, V5, P906, DOI 10.1016/0888-7543(89)90133-X; CRABB DW, 1986, GENE, V48, P287, DOI 10.1016/0378-1119(86)90087-9; CRABB DW, 1987, PHARMACOL THERAPEUT, V34, P59, DOI 10.1016/0163-7258(87)90092-1; DAVYDOV IV, 1995, GENE, V161, P271, DOI 10.1016/0378-1119(95)00271-7; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; DUESTER G, 1986, J BIOL CHEM, V261, P2027; DUSTER G, 1991, MOL CELL BIOL, V11, P1638; Edenberg HJ, 2000, PROG NUCLEIC ACID RE, V64, P295, DOI 10.1016/S0079-6603(00)64008-4; ESTONIUS M, 1993, EUR J BIOCHEM, V215, P497, DOI 10.1111/j.1432-1033.1993.tb18059.x; FELDER MR, 1988, J BIOL CHEM, V263, P14531; LANDSCHULZ WH, 1989, SCIENCE, V243, P1681, DOI 10.1126/science.2494700; LANDSCHULZ WH, 1988, GENE DEV, V2, P786, DOI 10.1101/gad.2.7.786; Lekstrom-Himes J, 1998, J BIOL CHEM, V273, P28545, DOI 10.1074/jbc.273.44.28545; McGehee RE, 1997, DNA CELL BIOL, V16, P725, DOI 10.1089/dna.1997.16.725; MCKNIGHT SL, 1989, GENE DEV, V3, P2021, DOI 10.1101/gad.3.12b.2021; MEZEY E, 1986, GASTROENTEROLOGY, V91, P1271, DOI 10.1016/S0016-5085(86)80027-0; MEZEY E, 1986, HEPATOLOGY, V6, P1386, DOI 10.1002/hep.1840060627; MEZEY E, 1990, ARCH BIOCHEM BIOPHYS, V280, P390, DOI 10.1016/0003-9861(90)90347-2; MEZEY E, 1993, ARCH BIOCHEM BIOPHYS, V225, P787; POTTER JJ, 1992, ARCH BIOCHEM BIOPHYS, V295, P360, DOI 10.1016/0003-9861(92)90529-6; POTTER JJ, 1993, BIOCHEM BIOPH RES CO, V191, P1040, DOI 10.1006/bbrc.1993.1322; POTTER JJ, 1995, ARCH BIOCHEM BIOPHYS, V321, P329, DOI 10.1006/abbi.1995.1402; POTTER JJ, 1989, ARCH BIOCHEM BIOPHYS, V274, P548, DOI 10.1016/0003-9861(89)90469-4; QULALI M, 1991, ARCH BIOCHEM BIOPHYS, V288, P406, DOI 10.1016/0003-9861(91)90213-3; Roesler WJ, 1998, J BIOL CHEM, V273, P14950, DOI 10.1074/jbc.273.24.14950; RONIS MJJ, 1993, J PHARMACOL EXP THER, V264, P944; TSUKAMOTO H, 1985, ALCOHOL CLIN EXP RES, V9, P31, DOI 10.1111/j.1530-0277.1985.tb05046.x; WILLIAMS SC, 1991, GENE DEV, V5, P1553, DOI 10.1101/gad.5.9.1553; WINTER LA, 1990, GENE, V91, P233, DOI 10.1016/0378-1119(90)90093-7; ZHANG K, 1987, GENE, V57, P27, DOI 10.1016/0378-1119(87)90173-9	39	36	36	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	2002	277	46					43572	43577		10.1074/jbc.M204535200	http://dx.doi.org/10.1074/jbc.M204535200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	615XE	12213809	hybrid			2022-12-27	WOS:000179272000006
J	Ito, M; Tchoua, U; Okamoto, M; Tojo, H				Ito, M; Tchoua, U; Okamoto, M; Tojo, H			Purification and properties of a phospholipase A(2)/lipase preferring phosphatidic acid, bis(monoacylglycerol) phosphate, and monoacylglycerol from rat testis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DRUG-INDUCED LIPIDOSIS; LYSOPHOSPHATIDIC ACID; CRYSTAL-STRUCTURE; CATALYTIC TRIAD; BOVINE TESTIS; GUINEA-PIG; LIPASE; LIVER; A(2); CARBOXYLESTERASE	Phospholipase A(2) (PLA(2)) was purified to homogeneity from the supernatant fraction of rat testis homogenate. The purified 63-kDa enzyme did not require Ca2+ ions for activity and exhibited both phosphatidic acid-preferring PLA(2) and monoacylglycerol lipase activities with a modest specificity toward unsaturated acyl chains. Anionic detergents enhanced these activities. Serine-modifying irreversible inhibitors, (p-amidinophenyl) methanesulfonyl fluoride and methylarachidonyl fluorophosphonate, inhibited both activities to a similar extent, indicating a single active site is involved in PLA(2) and lipase activities. The sequence of NH2-terminal 12 amino acids of purified enzyme was identical to that of a carboxylesterase from rat liver. The optimal pH for PLA(2) activity (around 5.5) differed from that for lipase activity (around 8.0). At pH 5.5 the enzyme also hydrolyzed bis(monoacylglycerol) phosphate, or lysobisphosphatidic acid (LBPA), that has been hitherto known as a secretory PLA(2)-resistant phospholipid and a late endosome marker. LBPA-enriched fractions were prepared from liver lysosome fractions of chloroquine-treated rats, treated with excess of pancreatic PLA(2) and then used for assaying LBPA-hydrolyzing activity. LBPA and the reaction products were identified by microbore normal phase high performance liquid chromatography/electrospray ionization ion-trap mass spectrometry. These enzymatic properties suggest that the enzyme can metabolize phosphatidic and lysobisphosphatidic acids in cellular acidic compartments.	Osaka Univ, Grad Sch Med, Dept Mol Physiol Chem, Suita, Osaka 5650871, Japan	Osaka University	Tojo, H (corresponding author), Osaka Univ, Grad Sch Med, Dept Mol Physiol Chem, H-1,2-2 Yamadaoka, Suita, Osaka 5650871, Japan.							Abe A, 1998, J BIOL CHEM, V273, P8467, DOI 10.1074/jbc.273.14.8467; AMIDON B, 1995, BIOCHEMISTRY-US, V34, P5554, DOI 10.1021/bi00016a029; BACHOVCHIN WW, 1978, J AM CHEM SOC, V100, P8041, DOI 10.1021/ja00494a001; Bencharit S, 2002, NAT STRUCT BIOL, V9, P337, DOI 10.1038/nsb790; Bhattacharyya D, 1999, MOL CELL BIOCHEM, V198, P179, DOI 10.1023/A:1006902031255; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Chen JW, 2000, J BIOL CHEM, V275, P28421, DOI 10.1074/jbc.M005073200; Chevallier J, 2000, ORG LETT, V2, P1859, DOI 10.1021/ol0059246; Contos JJA, 2000, MOL PHARMACOL, V58, P1188, DOI 10.1124/mol.58.6.1188; DAS AK, 1989, LIPIDS, V24, P329, DOI 10.1007/BF02535172; FOURCADE O, 1995, CELL, V80, P919, DOI 10.1016/0092-8674(95)90295-3; Gaits F, 1997, FEBS LETT, V410, P54, DOI 10.1016/S0014-5793(97)00411-0; GERRARD JM, 1989, BIOCHIM BIOPHYS ACTA, V1001, P282, DOI 10.1016/0005-2760(89)90112-4; Ghosh S, 1995, BBA-LIPID LIPID MET, V1259, P305, DOI 10.1016/0005-2760(95)00184-0; Higgs HN, 1998, J BIOL CHEM, V273, P5468, DOI 10.1074/jbc.273.10.5468; Higgs HN, 1996, J BIOL CHEM, V271, P10874, DOI 10.1074/jbc.271.18.10874; Karlsson M, 1997, J BIOL CHEM, V272, P27218, DOI 10.1074/jbc.272.43.27218; Kobayashi T, 1998, NATURE, V392, P193, DOI 10.1038/32440; Lehner R, 1999, BIOCHEM J, V343, P1, DOI 10.1042/0264-6021:3430001; Luquain C, 2000, BIOCHEM J, V351, P795, DOI 10.1042/0264-6021:3510795; MASON RJ, 1972, J CLIN INVEST, V51, P2399, DOI 10.1172/JCI107052; MATSUZAWA Y, 1980, J LIPID RES, V21, P202; MAUCO G, 1978, BIOCHIMIE, V60, P653, DOI 10.1016/S0300-9084(78)80784-6; MENTLEIN R, 1984, ARCH BIOCHEM BIOPHYS, V228, P230, DOI 10.1016/0003-9861(84)90064-X; Moolenaar WH, 1997, CURR OPIN CELL BIOL, V9, P168, DOI 10.1016/S0955-0674(97)80059-2; Mukherjee S, 1997, PHYSIOL REV, V77, P759, DOI 10.1152/physrev.1997.77.3.759; ROBBI M, 1990, BIOCHEM J, V269, P451, DOI 10.1042/bj2690451; Roussel A, 1999, J BIOL CHEM, V274, P16995, DOI 10.1074/jbc.274.24.16995; Satoh T, 1998, ANNU REV PHARMACOL, V38, P257, DOI 10.1146/annurev.pharmtox.38.1.257; Shinozaki K, 1999, BIOCHEMISTRY-US, V38, P1669, DOI 10.1021/bi982123q; Simons K, 2000, TRENDS CELL BIOL, V10, P459, DOI 10.1016/S0962-8924(00)01847-X; Snitko Y, 1997, BIOCHEM J, V321, P737, DOI 10.1042/bj3210737; Stennicke HR, 1996, BIOCHEMISTRY-US, V35, P7131, DOI 10.1021/bi952758e; Tang J, 1997, J BIOL CHEM, V272, P8567, DOI 10.1074/jbc.272.13.8567; THOMSON FJ, 1995, BIOCHEM J, V306, P305, DOI 10.1042/bj3060305; TOJO H, 1993, EUR J BIOCHEM, V215, P81, DOI 10.1111/j.1432-1033.1993.tb18009.x; Tojo H, 1998, J BIOL CHEM, V273, P2214, DOI 10.1074/jbc.273.4.2214; TOJO H, 1993, J LIPID RES, V34, P837; TORNQVIST H, 1976, J BIOL CHEM, V251, P813; WAITE M, 1992, BIOCHIM BIOPHYS ACTA, V1128, P281, DOI 10.1016/0005-2760(92)90319-Q; Wallace TJ, 2001, J BIOL CHEM, V276, P33165, DOI 10.1074/jbc.M105644200; WHERRETT JR, 1973, LIPIDS, V8, P531, DOI 10.1007/BF02531989; WithersMartinez C, 1996, STRUCTURE, V4, P1363, DOI 10.1016/S0969-2126(96)00143-8; Wu MM, 2001, J BIOL CHEM, V276, P33027, DOI 10.1074/jbc.M103917200; YAMAMOTO A, 1976, LIPIDS, V11, P616, DOI 10.1007/BF02532875; YANG SF, 1967, J BIOL CHEM, V242, P477	46	32	33	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	2002	277	46					43674	43681		10.1074/jbc.M202817200	http://dx.doi.org/10.1074/jbc.M202817200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	615XE	12223468	hybrid			2022-12-27	WOS:000179272000019
J	Sasaki, T; Knyazev, PG; Cheburkin, Y; Gohring, W; Tisi, D; Ullrich, A; Timpl, R; Hohenester, E				Sasaki, T; Knyazev, PG; Cheburkin, Y; Gohring, W; Tisi, D; Ullrich, A; Timpl, R; Hohenester, E			Crystal structure of a C-terminal fragment of growth arrest-specific protein Gas6 - Receptor tyrosine kinase activation by laminin G-like domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SHBG-LIKE REGION; ALPHA-DYSTROGLYCAN; BINDING-SITES; LIGAND; AXL; PERLECAN; PRODUCT; CELLS; SKY; IDENTIFICATION	Receptor tyrosine kinases of the Axl family are activated by Gas6, the product of growth arrest-specific gene 6. Gas6-Axl signaling is implicated in cell survival, adhesion, and migration. The receptor-binding site of Gas6 is located within a C-terminal pair of laminin G-like (LG) domains that do not resemble any other receptor tyrosine kinase ligand. We report the crystal structure at 2.2-Angstrom resolution of a Gas6 fragment spanning both LG domains (Gas6-LG). The structure reveals a V-shaped arrangement of LG domains strengthened by an interdomain calcium-binding site. LG2 of Gas6-LG contains two unusual features: an a-helix cradled by one edge of the LG beta-sandwich and a conspicuous patch of surface-exposed hydrophobic residues. Mutagenesis of some residues in this patch reduces Gas6-LG binding to the extracellular domain of Axl as well as Axl activation in glioblastoma cells, identifying a component of the receptor-binding site of Gas6.	Univ London Imperial Coll Sci Technol & Med, Blackett Lab, Biophys Sect, Dept Biol Sci, London SW7 2BW, England; Max Planck Inst Biochem, D-82152 Martinsried, Germany	Imperial College London; Max Planck Society	Hohenester, E (corresponding author), Univ London Imperial Coll Sci Technol & Med, Blackett Lab, Biophys Sect, Dept Biol Sci, Prince Consort Rd, London SW7 2BW, England.	e.hohenester@ic.ac.uk	Cheburkin, Yuri/AAD-9521-2019	Cheburkin, Yuri/0000-0002-1896-5703	Wellcome Trust [054334] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Allen MP, 2002, MOL CELL BIOL, V22, P599, DOI 10.1128/MCB.22.2.599-613.2002; Angelillo-Scherrer A, 2001, NAT MED, V7, P215, DOI 10.1038/84667; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bellosta P, 1997, ONCOGENE, V15, P2387, DOI 10.1038/sj.onc.1201419; BELLOSTA P, 1995, MOL CELL BIOL, V15, P614; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Dahlback B, 2000, LANCET, V355, P1627, DOI 10.1016/S0140-6736(00)02225-X; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; Evenas P, 2000, BIOL CHEM, V381, P199, DOI 10.1515/BC.2000.027; Evenas P, 1999, EUR J BIOCHEM, V266, P935, DOI 10.1046/j.1432-1327.1999.00928.x; Fridell YWC, 1998, J BIOL CHEM, V273, P7123, DOI 10.1074/jbc.273.12.7123; Fridell YWC, 1996, MOL CELL BIOL, V16, P135; Giri TK, 2002, J BIOL CHEM, V277, P15099, DOI 10.1074/jbc.M103036200; GODOWSKI PJ, 1995, CELL, V82, P355, DOI 10.1016/0092-8674(95)90424-7; Gohring W, 1998, EUR J BIOCHEM, V255, P60, DOI 10.1046/j.1432-1327.1998.2550060.x; Goruppi S, 1999, ONCOGENE, V18, P4224, DOI 10.1038/sj.onc.1202788; Goruppi S, 1996, ONCOGENE, V12, P471; Grishkovskaya I, 2000, EMBO J, V19, P504, DOI 10.1093/emboj/19.4.504; He XH, 1997, BIOCHEMISTRY-US, V36, P3745, DOI 10.1021/bi962315q; Himanen JP, 2001, NATURE, V414, P933, DOI 10.1038/414933a; Hohenester E, 1999, MOL CELL, V4, P783, DOI 10.1016/S1097-2765(00)80388-3; JANSSEN JWG, 1991, ONCOGENE, V6, P2113; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kohfeldt E, 1998, J MOL BIOL, V282, P99, DOI 10.1006/jmbi.1998.2004; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leslie AGW, 1994, MOSFLM USERS GUIDE; Li RH, 1996, J NEUROSCI, V16, P2012; Lu QX, 1999, NATURE, V398, P723, DOI 10.1038/19554; Lu QX, 2001, SCIENCE, V293, P306, DOI 10.1126/science.1061663; MANFIOLETTI G, 1993, MOL CELL BIOL, V13, P4976, DOI 10.1128/MCB.13.8.4976; Mark MR, 1996, J BIOL CHEM, V271, P9785, DOI 10.1074/jbc.271.16.9785; McCloskey P, 1997, J BIOL CHEM, V272, P23285, DOI 10.1074/jbc.272.37.23285; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Nagata K, 1996, J BIOL CHEM, V271, P30022, DOI 10.1074/jbc.271.47.30022; Nakano T, 1997, J BIOL CHEM, V272, P29411, DOI 10.1074/jbc.272.47.29411; Nyberg P, 1997, EUR J BIOCHEM, V246, P147, DOI 10.1111/j.1432-1033.1997.t01-2-00147.x; OBRYAN JP, 1991, MOL CELL BIOL, V11, P5016, DOI 10.1128/MCB.11.10.5016; OHASHI K, 1995, J BIOL CHEM, V270, P22681, DOI 10.1074/jbc.270.39.22681; PAULSSON M, 1987, J MOL BIOL, V197, P297, DOI 10.1016/0022-2836(87)90125-2; Pellegrini L, 2000, NATURE, V407, P1029, DOI 10.1038/35039551; Plotnikov AN, 1999, CELL, V98, P641, DOI 10.1016/S0092-8674(00)80051-3; Rudenko G, 1999, CELL, V99, P93, DOI 10.1016/S0092-8674(00)80065-3; Rudenko G, 2001, TRENDS BIOCHEM SCI, V26, P363, DOI 10.1016/S0968-0004(01)01832-1; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; STITT TN, 1995, CELL, V80, P661, DOI 10.1016/0092-8674(95)90520-0; Talts JF, 1999, EMBO J, V18, P863, DOI 10.1093/emboj/18.4.863; Tisi D, 2000, EMBO J, V19, P1432, DOI 10.1093/emboj/19.7.1432; VARNUM BC, 1995, NATURE, V373, P623, DOI 10.1038/373623a0; Villoutreix BO, 2001, PROTEINS, V43, P203, DOI 10.1002/1097-0134(20010501)43:2<203::AID-PROT1031>3.0.CO;2-W; Wiesmann C, 2000, J MOL MED, V78, P247, DOI 10.1007/s001090000082	50	71	78	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2002	277	46					44164	44170		10.1074/jbc.M207340200	http://dx.doi.org/10.1074/jbc.M207340200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	615XE	12218057	hybrid			2022-12-27	WOS:000179272000082
J	Schneider, G; Oswald, F; Wahl, C; Greten, FR; Adler, G; Schmid, RM				Schneider, G; Oswald, F; Wahl, C; Greten, FR; Adler, G; Schmid, RM			Cyclosporine inhibits growth through the activating transcription factor/cAMP-responsive element-binding protein binding site in the cyclin D1 promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRE-DECOY OLIGONUCLEOTIDE; CELL-LINE AR42J; GENE-TRANSCRIPTION; PHOSPHATASE-ACTIVITY; ENDOTHELIAL-CELLS; CANCER CELLS; GLIOMA-CELLS; FACTOR-BETA; T-CELLS; CAMP	The immunosuppressive agent cyclosporine affects proliferation depending on the cellular system used. In an attempt to study the inhibitory effect of cyclosporine on proliferation of pancreatic acinar cells, we used AR42J cells as a model system. Here we demonstrate that cyclosporine inhibits growth of these cells by inducing G, cell cycle arrest. This effect is mediated by the 5' regulatory region of the cyclin D1 gene and leads to a reduction of cyclin D1 mRNA expression and protein abundance. We show that in AR42J cells the proximal cyclin D1 promoter contains a cis-regulated element, which is important for the maintenance of basal transcriptional activity. This element overlaps the described cAMP-responsive element (CRE) and confers cyclosporine sensitivity to the cyclin D1 promoter. Furthermore, the DNA binding activity of the CRE-binding protein (CREB) decreases through cyclosporine treatment and this is mediated by cyclosporine-induced reduction of CREB steady-state levels. These results demonstrate that cyclosporine can inhibit proliferation of acinar cells by targeting the cyclin D1 promoter at the proximal CRE via a reduction of CREB protein abundance.	Univ Ulm, Dept Internal Med 1, D-89081 Ulm, Germany; Univ Ulm, Dept Med Microbiol & Hyg, D-89081 Ulm, Germany	Ulm University; Ulm University	Schmid, RM (corresponding author), Univ Ulm, Dept Internal Med 1, Robert Koch Str 8, D-89081 Ulm, Germany.		Greten, Florian R/AAF-5196-2020; Oswald, Franz/AAO-9584-2020	Greten, Florian R/0000-0002-3928-6080; 				ALBERTS AS, 1994, MOL CELL BIOL, V14, P4398, DOI 10.1128/MCB.14.7.4398; ANDRES D, 2001, BIOCHEM PHARMACOL, V61, P27; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; Brown JR, 1998, MOL CELL BIOL, V18, P5609, DOI 10.1128/MCB.18.9.5609; Cardenas ME, 1998, TRENDS BIOTECHNOL, V16, P427, DOI 10.1016/S0167-7799(98)01239-6; Cho-Chung YS, 2000, MOL CELL BIOCHEM, V212, P29, DOI 10.1023/A:1007144618589; CHRISTOPHE J, 1994, AM J PHYSIOL, V266, pG963, DOI 10.1152/ajpgi.1994.266.6.G963; COHEN P, 1989, ANNU REV BIOCHEM, V58, P453, DOI 10.1146/annurev.bi.58.070189.002321; D'Amico M, 2000, J BIOL CHEM, V275, P32649, DOI 10.1074/jbc.M000643200; Diehl JA, 1997, GENE DEV, V11, P957, DOI 10.1101/gad.11.8.957; Esposito C, 2000, KIDNEY INT, V58, P123, DOI 10.1046/j.1523-1755.2000.00147.x; EWEN ME, 1993, CELL, V74, P1009, DOI 10.1016/0092-8674(93)90723-4; Florio T, 1996, ENDOCRINOLOGY, V137, P4409, DOI 10.1210/en.137.10.4409; Fukami-Kobayashi J, 1998, EXP CELL RES, V241, P435, DOI 10.1006/excr.1998.4079; Guerini D, 1997, BIOCHEM BIOPH RES CO, V235, P271, DOI 10.1006/bbrc.1997.6802; Guttridge DC, 1999, MOL CELL BIOL, V19, P5785; HANNON GJ, 1994, NATURE, V371, P257, DOI 10.1038/371257a0; Harbour JW, 2000, GENE DEV, V14, P2393, DOI 10.1101/gad.813200; HERBER B, 1994, ONCOGENE, V9, P1295; Hinz M, 1999, MOL CELL BIOL, V19, P2690; Hojo M, 1999, NATURE, V397, P530, DOI 10.1038/17401; Karashima T, 1996, J DERMATOL SCI, V12, P246, DOI 10.1016/0923-1811(95)00480-7; Khanna AK, 1999, TRANSPLANTATION, V67, P1262, DOI 10.1097/00007890-199905150-00011; KleinHessling S, 1996, P NATL ACAD SCI USA, V93, P15311, DOI 10.1073/pnas.93.26.15311; Lally C, 1999, KIDNEY INT, V56, P1254, DOI 10.1046/j.1523-1755.1999.00696.x; Lee RJ, 1999, J BIOL CHEM, V274, P7341, DOI 10.1074/jbc.274.11.7341; LI B, 1991, J EXP MED, V174, P1259, DOI 10.1084/jem.174.5.1259; LOGSDON CD, 1992, AM J PHYSIOL, V262, pG364, DOI 10.1152/ajpgi.1992.262.2.G364; Longoni B, 2001, FASEB J, V15, P731, DOI 10.1096/fj.00-0163com; Medina J, 2000, BIOCHEM PHARMACOL, V59, P1459, DOI 10.1016/S0006-2952(00)00262-8; MEYER TE, 1993, ENDOCRINOLOGY, V132, P770, DOI 10.1210/en.132.2.770; Miracco C, 2000, BRIT J DERMATOL, V143, P950, DOI 10.1046/j.1365-2133.2000.03826.x; Mosieniak G, 1997, J NEUROCHEM, V68, P1142; Nagata D, 2001, J BIOL CHEM, V276, P662, DOI 10.1074/jbc.M005522200; NAIR AP, 1994, NATURE, V19, P239; NICKOLOFF BJ, 1988, AM J PATHOL, V131, P12; Park YG, 2001, BIOCHEM BIOPH RES CO, V281, P1213, DOI 10.1006/bbrc.2001.4521; Perry SS, 1999, CELL TRANSPLANT, V8, P339, DOI 10.1177/096368979900800401; PINES J, 1995, BIOCHEM J, V308, P697, DOI 10.1042/bj3080697; Pyrzynska B, 2000, J NEUROCHEM, V74, P42, DOI 10.1046/j.1471-4159.2000.0740042.x; Sabbah M, 1999, P NATL ACAD SCI USA, V96, P11217, DOI 10.1073/pnas.96.20.11217; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; SCHREIBER SL, 1992, IMMUNOL TODAY, V13, P136, DOI 10.1016/0167-5699(92)90111-J; SCHWANINGER M, 1993, J BIOL CHEM, V268, P23111; SCHWANINGER M, 1995, J BIOL CHEM, V270, P8860, DOI 10.1074/jbc.270.15.8860; SCHWANINGER M, 1993, N-S ARCH PHARMACOL, V348, P541; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; SHERR CJ, 1994, CELL, V79, P551, DOI 10.1016/0092-8674(94)90540-1; Shin GT, 1997, TRANSPL P, V29, P284, DOI 10.1016/S0041-1345(96)00094-2; Siemann G, 1999, MOL PHARMACOL, V55, P1094, DOI 10.1124/mol.55.6.1094; Tavares P, 1998, J CARDIOVASC PHARM, V31, P46, DOI 10.1097/00005344-199801000-00007; Taylor CT, 2000, P NATL ACAD SCI USA, V97, P12091, DOI 10.1073/pnas.220211797; Thommesen L, 2000, J BIOL CHEM, V275, P4244, DOI 10.1074/jbc.275.6.4244; TWENTYMAN PR, 1992, BRIT J CANCER, V65, P335, DOI 10.1038/bjc.1992.68; Vaquero E, 1999, GUT, V45, P269, DOI 10.1136/gut.45.2.269; Wagner M, 2001, GENE DEV, V15, P286, DOI 10.1101/gad.184701; Watanabe G, 1996, P NATL ACAD SCI USA, V93, P12861, DOI 10.1073/pnas.93.23.12861; Zhang LZ, 2001, AM J PHYSIOL-GASTR L, V280, pG1247, DOI 10.1152/ajpgi.2001.280.6.G1247	59	33	34	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	2002	277	46					43599	43607		10.1074/jbc.M204787200	http://dx.doi.org/10.1074/jbc.M204787200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	615XE	12215435	hybrid			2022-12-27	WOS:000179272000010
J	Zhao, MJ; Tang, D; Lechpammer, S; Hoffman, A; Asea, A; Stevenson, MA; Calderwood, SK				Zhao, MJ; Tang, D; Lechpammer, S; Hoffman, A; Asea, A; Stevenson, MA; Calderwood, SK			Double-stranded RNA-dependent protein kinase (pkr) is essential for thermotolerance, accumulation of HSP70, and stabilization of ARE-containing HSP70 mRNA during stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK FACTOR; AU-RICH ELEMENTS; TRANSCRIPTIONAL ACTIVATION; BINDING-PROTEINS; C-FOS; GENE; EXPRESSION; STABILITY; FACTOR-1; DESTABILIZATION	We have investigated the role of the double-stranded RNA-dependent protein kinase gene (pkr) in the regulation of the heat shock response. We show that the pkr gene is essential for efficient activation of the heat shock response and that pkr disruption profoundly inhibits heat shock protein 70 (HSP70) synthesis and blocks the development of thermotolerance. Despite these profound effects, pkr disruption did not markedly affect the activation of heat shock factor 1 by heat and did not reduce the rate of transcription of the HSP70 gene after heat shock. However, despite the lack of effect of pkr disruption on HSP70 gene transcription, we found a significant decrease in the expression of HSP70 mRNA in pkr-/- cells after heat shock. Kinetic studies of mRNA turnover suggested a block in the thermal stabilization of HSP70 mRNA in pkr-/- cells. As the thermal stabilization of HSP70 mRNA is thought to involve cis-acting A+U rich (ARE) elements in the 3'-untranslated region (UTR), we examined a potential role for pkr in this process. We found that a reporter beta-galactosidase mRNA destabilized by introduction of a functional ARE into the 3'-UTR became stabilized by heat but only in cells containing an intact pkr gene. Our studies suggest therefore that pkr plays a significant role in the stabilization of mRNA species containing ARE destruction sequences in the 3'-UTR and through this mechanism, contributes to the regulation of the heat shock response and other processes.	Boston Univ, Sch Med, Boston, MA 02118 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Radiat Oncol, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Radiat Oncol, Boston, MA 02115 USA; CALTECH, Pasadena, CA 91125 USA	Boston University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; California Institute of Technology	Calderwood, SK (corresponding author), Boston Med Ctr, Ctr Mol Stress Response, 88 E Newton St,E645, Boston, MA 02118 USA.	stuart_calderwood@medicine.bu.edu	Asea, Alexzander/X-6432-2019; Asea, Alexzander A/I-4112-2013	Asea, Alexzander A/0000-0003-3592-3481	NATIONAL CANCER INSTITUTE [R01CA077465, R01CA047407, R01CA083890] Funding Source: NIH RePORTER; NCI NIH HHS [CA47407-11, CA83890-01, CA77465] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Berlanga JJ, 1999, EUR J BIOCHEM, V265, P754, DOI 10.1046/j.1432-1327.1999.00780.x; Brostrom CO, 1998, PROG NUCLEIC ACID RE, V58, P79; Bruce JL, 1999, CELL STRESS CHAPERON, V4, P36, DOI 10.1054/csac.1999.0005; Chen CM, 1997, J BIOL CHEM, V272, P26803, DOI 10.1074/jbc.272.43.26803; Chen CY, 2001, CELL, V107, P451, DOI 10.1016/S0092-8674(01)00578-5; CHEN CYA, 1995, MOL CELL BIOL, V15, P5777; Chu BY, 1996, J BIOL CHEM, V271, P30847, DOI 10.1074/jbc.271.48.30847; deHaro C, 1996, FASEB J, V10, P1378, DOI 10.1096/fasebj.10.12.8903508; GEORGOPOULOS C, 1993, ANNU REV CELL BIOL, V9, P601, DOI 10.1146/annurev.cb.09.110193.003125; Guhaniyogi J, 2001, GENE, V265, P11, DOI 10.1016/S0378-1119(01)00350-X; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Henics T, 1999, J BIOL CHEM, V274, P17318, DOI 10.1074/jbc.274.24.17318; HICKEY E, 1982, HEAT SHOCK BACTERIA, P199; Hinnebusch Alan G., 1994, Seminars in Cell Biology, V5, P417, DOI 10.1006/scel.1994.1049; LaGrandeur TE, 1998, EMBO J, V17, P1487, DOI 10.1093/emboj/17.5.1487; Lai WS, 1999, MOL CELL BIOL, V19, P4311; LAROIA G, SCIENCE, V284, P498; Lechpammer S, 2002, INT J HYPERTHER, V18, P203, DOI 10.1080/02656730110110034; LI GC, 1982, INT J RADIAT ONCOL, V8, P63, DOI 10.1016/0360-3016(82)90386-8; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Loflin P, 1999, GENE DEV, V13, P1884, DOI 10.1101/gad.13.14.1884; McMillan DR, 1998, J BIOL CHEM, V273, P7523, DOI 10.1074/jbc.273.13.7523; Melville MW, 1999, J BIOL CHEM, V274, P3797, DOI 10.1074/jbc.274.6.3797; Mitchell P, 1997, CELL, V91, P457, DOI 10.1016/S0092-8674(00)80432-8; MOORE M, 1987, MOL CELL BIOL, V7, P4505, DOI 10.1128/MCB.7.12.4505; MORIMOTO RI, 1993, SCIENCE, V259, P1409, DOI 10.1126/science.8451637; MOSELEY PL, 1993, AM J PHYSIOL, V264, pL533, DOI 10.1152/ajplung.1993.264.6.L533; PETERSEN RB, 1989, CELL REGUL, V1, P135, DOI 10.1091/mbc.1.1.135; PRICE BD, 1992, J CELL PHYSIOL, V153, P392, DOI 10.1002/jcp.1041530219; Proud CG, 2001, ESSAYS BIOCHEM, V37, P97, DOI 10.1042/bse0370097; Quijada L, 2000, MOL BIOCHEM PARASIT, V110, P79, DOI 10.1016/S0166-6851(00)00258-9; SCHLESINGER MJ, 1994, PEDIATR RES, V36, P1; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; SIMCOX AA, 1985, MOL CELL BIOL, V5, P3397, DOI 10.1128/MCB.5.12.3397; SISTONEN L, 1994, MOL CELL BIOL, V14, P2087, DOI 10.1128/MCB.14.3.2087; SUBJECK JR, 1982, HEAT SHOCK BACTERIA, P405; Voellmy Richard, 1994, Critical Reviews in Eukaryotic Gene Expression, V4, P357; Wang ZR, 2000, MOL CELL BIOL, V20, P6334, DOI 10.1128/MCB.20.17.6334-6341.2000; WESTWOOD JT, 1993, MOL CELL BIOL, V13, P3481, DOI 10.1128/MCB.13.6.3481; Wilson GM, 2001, J BIOL CHEM, V276, P44450, DOI 10.1074/jbc.M108521200; WU B, 1985, MOL CELL BIOL, V5, P330, DOI 10.1128/MCB.5.2.330; Wu C, 1995, ANNU REV CELL DEV BI, V11, P441, DOI 10.1146/annurev.cellbio.11.1.441; Yang YL, 1995, EMBO J, V14, P6095, DOI 10.1002/j.1460-2075.1995.tb00300.x; YOST HJ, 1990, TRENDS GENET, V6, P223, DOI 10.1016/0168-9525(90)90183-7; ZHANG W, 1993, MOL CELL BIOL, V13, P7652, DOI 10.1128/MCB.13.12.7652	45	42	43	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2002	277	46					44539	44547		10.1074/jbc.M208408200	http://dx.doi.org/10.1074/jbc.M208408200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	615XE	12207033	hybrid, Green Accepted			2022-12-27	WOS:000179272000126
J	Meng, JW; Casey, PJ				Meng, JW; Casey, PJ			Activation of G(z) attenuates Rap1-mediated differentiation of PC12 cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN ALPHA-SUBUNIT; HETEROTRIMERIC G-PROTEINS; GTP-BINDING PROTEIN; NERVE GROWTH-FACTOR; CYCLIC-AMP; ADENYLATE-CYCLASE; PERTUSSIS TOXIN; MESSENGER-RNA; RGS PROTEINS; MAP KINASE	We previously identified a specific activation-dependent interaction between the a subunit of the heterotrimeric G protein, G(z), and a regulator of Rap1 signaling, Rap1GAP (Meng, J., Glick, J. L., Polakis, P., and Casey, P. J. (1999) J. Biol. Chem 274, 36663-36669). We now demonstrate that activated forms of Galpha(z) are able to recruit Rap1GAP from a cytosolic location to the membrane. Using PC12 cells as a model for neuronal differentiation, the influence of G(z) activation on Rap1-mediated cell differentiation was examined. Introduction of constitutively-activated Galpha(z) into PC12 cells markedly attenuated the differentiation process of these cells induced by a cAMP analogue. Treatment of PC12 cells expressing wild type Galpha(z) with a specific agonist to the alpha(2A)-adrenergic receptor also attenuated cAMP-induced PC12 cell differentiation, demonstrating that receptor-mediated activation of G(z) was also effective in this regard. Furthermore, activation of G(z) decreased the ability of the cAMP analogue to trigger both Rap1 and extracellular-regulated kinase (ERK) activation. Differentiation of PC12 cells induced by nerve growth factor (NGF) is also thought to be a Rap1-mediated process, and G(z) activation was found to attenuate this process as well. Rap1 activation, ERK phosphorylation, and PC12 cell differentation induced by NGF treatment were all significantly attenuated by either transfection of constitutively activated Galpha(z) or receptor-mediated G(z) activation. Based on these findings, a model is proposed in which activation of G(z) results in recruitment of Rap1GAP to the membrane where it can effectively down-regulate Rap1 signaling. The implications of these findings in regard to a possible role for G(z) in neuronal development are discussed.	Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA	Duke University	Casey, PJ (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA.	casey006@mc.duke.edu	Meng, Jingwei/K-8880-2015	Casey, Patrick/0000-0002-7366-9309	NIGMS NIH HHS [GM55717] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055717, R55GM055717] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barker SA, 2001, GENOMICS, V78, P223, DOI 10.1006/geno.2001.6659; Berman DM, 1998, J BIOL CHEM, V273, P1269, DOI 10.1074/jbc.273.3.1269; Bos JL, 2001, NAT REV MOL CELL BIO, V2, P369, DOI 10.1038/35073073; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; CASEY PJ, 1990, J BIOL CHEM, V265, P2383; Cavalli A, 2000, J BIOL CHEM, V275, P23693, DOI 10.1074/jbc.M910395199; CHABRE O, 1994, J BIOL CHEM, V269, P5730; Dohlman HG, 1997, J BIOL CHEM, V272, P3871, DOI 10.1074/jbc.272.7.3871; FONG HKW, 1988, P NATL ACAD SCI USA, V85, P3066, DOI 10.1073/pnas.85.9.3066; Franke B, 1997, EMBO J, V16, P252, DOI 10.1093/emboj/16.2.252; Glick JL, 1998, J BIOL CHEM, V273, P26008, DOI 10.1074/jbc.273.40.26008; HALENBECK R, 1990, J BIOL CHEM, V265, P21922; Hendry IA, 2000, BRAIN RES, V870, P10, DOI 10.1016/S0006-8993(00)02387-8; HINTON DR, 1990, J NEUROSCI, V10, P2763; Hunt TW, 1996, NATURE, V383, P175, DOI 10.1038/383175a0; Inoue K, 2001, FEBS LETT, V506, P180, DOI 10.1016/S0014-5793(01)02809-5; Jordan JD, 1999, J BIOL CHEM, V274, P21507, DOI 10.1074/jbc.274.31.21507; Kao SC, 2001, J BIOL CHEM, V276, P18169, DOI 10.1074/jbc.M008870200; Kelleher KL, 1998, DEV BRAIN RES, V107, P247, DOI 10.1016/S0165-3806(98)00020-0; KITAYAMA H, 1989, CELL, V56, P77, DOI 10.1016/0092-8674(89)90985-9; LEE V, 1977, P NATL ACAD SCI USA, V74, P5021, DOI 10.1073/pnas.74.11.5021; LINDER ME, 1993, P NATL ACAD SCI USA, V90, P3675, DOI 10.1073/pnas.90.8.3675; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; MATSUOKA M, 1988, P NATL ACAD SCI USA, V85, P5384, DOI 10.1073/pnas.85.15.5384; Meng JW, 1999, J BIOL CHEM, V274, P36663, DOI 10.1074/jbc.274.51.36663; Morales J, 1998, MOL BIOL CELL, V9, P1, DOI 10.1091/mbc.9.1.1; MUMBY SM, 1990, P NATL ACAD SCI USA, V87, P728, DOI 10.1073/pnas.87.2.728; NEER EJ, 1995, CELL, V80, P249, DOI 10.1016/0092-8674(95)90407-7; NIBUYA M, 1995, J NEUROSCI, V15, P7539; RAO AK, 1988, BLOOD, V71, P494; REMAURY A, 1993, BIOCHEM J, V292, P283, DOI 10.1042/bj2920283; RUBINFELD B, 1991, CELL, V65, P1033, DOI 10.1016/0092-8674(91)90555-D; RUBINFELD B, 1992, MOL CELL BIOL, V12, P4634, DOI 10.1128/MCB.12.10.4634; Schmitt JM, 2001, MOL CELL BIOL, V21, P3671, DOI 10.1128/MCB.21.11.3671-3683.2001; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Tsygankova OM, 2001, MOL CELL BIOL, V21, P1921, DOI 10.1128/MCB.21.6.1921-1929.2001; Vanvooren V, 2001, EUR J ENDOCRINOL, V144, P605, DOI 10.1530/eje.0.1440605; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; WILSON PT, 1995, J BIOL CHEM, V270, P9667, DOI 10.1074/jbc.270.16.9667; WONG YH, 1992, SCIENCE, V255, P339, DOI 10.1126/science.1347957; Yang J, 2000, P NATL ACAD SCI USA, V97, P9984, DOI 10.1073/pnas.180194597; York RD, 1998, NATURE, V392, P622, DOI 10.1038/33451	42	43	46	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					43417	43424		10.1074/jbc.M204074200	http://dx.doi.org/10.1074/jbc.M204074200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12198116	hybrid			2022-12-27	WOS:000179081200126
J	O'Rourke, L; Gronning, LM; Yeaman, SJ; Shepherd, PR				O'Rourke, L; Gronning, LM; Yeaman, SJ; Shepherd, PR			Glucose-dependent regulation of cholesterol ester metabolism in macrophages by insulin and leptin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORMONE-SENSITIVE LIPASE; ACYL-COENZYME; FOAM CELLS; ATHEROSCLEROSIS; EXPRESSION; RESISTANCE; DISEASE; DIFFERENTIATION; ACYLTRANSFERASE; ESTERIFICATION	Insulin resistance, obesity, and diabetes are characterized by hyperglycemia, hyperinsulinemia, and hyperleptinemia and are associated with increased risk of atherosclerosis. In an effort to understand how this occurs, we have investigated whether these factors cause disregulation of cholesterol ester metabolism in J774.2 macrophages. Raising glucose levels alone was sufficient to increase uptake of acetylated low density lipoprotein but did not stimulate synthesis of cholesterol esters. In the presence of high glucose, both insulin and leptin increased the rate of cholesterol ester synthesis, although they did not further increase uptake of acetylated low density lipoprotein. However, in the presence of high glucose both insulin and leptin caused a significant increase in the activity of acyl-CoA. cholesterol O-acyltransferase (ACAT) combined with a significant reduction in the level of hormone-sensitive lipase (HSL). Because ACAT is the main enzyme responsible for cholesterol ester synthesis and HSL contributes significantly to neutral cholesterol ester hydrolase activity, this suggests that glucose primes the J774.2 cells so that in the presence of high insulin or leptin they will store cholesterol esters. This contrasts with 3T3-L1 adipocytes, where HSL activity and expression are increased by insulin in high glucose conditions. These findings may provide an explanation for the observation that in conditions characterized by hyperglycemia, hyperleptinemia, and hyperinsulinemia, triglyceride lipolysis in adipocytes is increased while hydrolysis of cholesterol esters in macrophages is decreased, contributing to foam cell formation.	UCL, Dept Biochem & Mol Biol, London WC1E 6BT, England; Newcastle Univ, Sch Biochem & Genet, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	University of London; University College London; Newcastle University - UK	Shepherd, PR (corresponding author), UCL, Dept Biochem & Mol Biol, Gower St, London WC1E 6BT, England.	p.shepherd@biochem.ucl.ac.uk						BASU SK, 1976, P NATL ACAD SCI USA, V73, P3178, DOI 10.1073/pnas.73.9.3178; Botion LM, 1999, DIABETES, V48, P1691, DOI 10.2337/diabetes.48.9.1691; Bressler P, 1996, DIABETOLOGIA, V39, P1345, DOI 10.1007/s001250050581; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; BROWN MS, 1980, J BIOL CHEM, V255, P9344; Chang TY, 1997, ANNU REV BIOCHEM, V66, P613, DOI 10.1146/annurev.biochem.66.1.613; CHUNG BH, 1986, METHOD ENZYMOL, V128, P181; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; DEFRONZO RA, 1991, DIABETES CARE, V14, P173, DOI 10.2337/diacare.14.3.173; DEFRONZO RA, 1988, DIABETES, V37, P667, DOI 10.2337/diab.37.6.667; Escary JL, 1998, ARTERIOSCL THROM VAS, V18, P991, DOI 10.1161/01.ATV.18.6.991; Griffin E, 2001, NAT MED, V7, P840, DOI 10.1038/89969; Heine RJ, 2002, DIABETOLOGIA, V45, P461, DOI 10.1007/s00125-001-0726-0; James RW, 2001, CURR OPIN LIPIDOL, V12, P425, DOI 10.1097/00041433-200108000-00009; Jepson CA, 1996, BIOCHEM J, V318, P173, DOI 10.1042/bj3180173; KANG ES, 1993, DIABETES, V42, P1415, DOI 10.2337/diabetes.42.10.1415; Khaw KT, 2001, BMJ-BRIT MED J, V322, P15, DOI 10.1136/bmj.322.7277.15; KHOO JC, 1976, J BIOL CHEM, V251, P2882; Laakso M, 1999, DIABETES, V48, P937, DOI 10.2337/diabetes.48.5.937; MAZIERE C, 1987, J BIOCHEM BIOPH METH, V14, P267, DOI 10.1016/0165-022X(87)90052-2; Maziere C, 1996, BBA-LIPID LIPID MET, V1300, P30, DOI 10.1016/0005-2760(95)00232-4; Nave BT, 1996, BIOCHEM J, V318, P55, DOI 10.1042/bj3180055; O'Rourke L, 2001, DIABETES, V50, P955, DOI 10.2337/diabetes.50.5.955; Ohgami N, 2001, J BIOL CHEM, V276, P3195, DOI 10.1074/jbc.M006545200; Okazaki H, 2002, J BIOL CHEM, V277, P31893, DOI 10.1074/jbc.M204016200; Osuga J, 2000, P NATL ACAD SCI USA, V97, P787, DOI 10.1073/pnas.97.2.787; Raines EW, 1996, BIOESSAYS, V18, P271, DOI 10.1002/bies.950180405; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Shepherd PR, 1999, NEW ENGL J MED, V341, P248, DOI 10.1056/NEJM199907223410406; SMITH F, 2002, DIABETES, V51, P293; STARY HC, 1994, CIRCULATION, V89, P2462, DOI 10.1161/01.CIR.89.5.2462; TABAS I, 1995, CURR OPIN LIPIDOL, V6, P260, DOI 10.1097/00041433-199510000-00004; UELMEN PJ, 1995, J BIOL CHEM, V270, P26192, DOI 10.1074/jbc.270.44.26192; Unger RH, 1999, P NATL ACAD SCI USA, V96, P2327, DOI 10.1073/pnas.96.5.2327; Wang HX, 1996, ARTERIOSCL THROM VAS, V16, P809, DOI 10.1161/01.ATV.16.6.809; Winzell MS, 2001, DIABETES, V50, P2225, DOI 10.2337/diabetes.50.10.2225; YEAMAN SJ, 1994, ADV ENZYME REGUL, V34, P355, DOI 10.1016/0065-2571(94)90022-1; Yip J, 1998, J CLIN ENDOCR METAB, V83, P2773, DOI 10.1210/jc.83.8.2773	38	86	90	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					42557	42562		10.1074/jbc.M202151200	http://dx.doi.org/10.1074/jbc.M202151200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12200416	hybrid			2022-12-27	WOS:000179081200018
J	Okada, Y; Yamada, S; Toyoshima, M; Dong, J; Nakajima, M; Sugahara, K				Okada, Y; Yamada, S; Toyoshima, M; Dong, J; Nakajima, M; Sugahara, K			Structural recognition by recombinant human heparanase that plays critical roles in tumor metastasis - Hierarchical sulfate groups with differential effects and the essential target disulfated trisaccharide sequence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PORCINE INTESTINAL HEPARIN; SUBSTRATE-SPECIFICITY; CELL-SURFACE; MACROMOLECULAR HEPARIN; MAMMALIAN HEPARANASE; MOUSE MASTOCYTOMA; GENE-EXPRESSION; PURIFICATION; TETRASACCHARIDES; PROTEOGLYCANS	Human heparanase is an endo-beta-D-glucuronidase that degrades heparan sulfate/heparin and has been implicated in a variety of biological processes, such as inflammation, tumor angiogenesis, and metastasis. Although the cloned enzyme has been demonstrated to have a critical role in tumor metastasis, the substrate specificity has been poorly understood. In the present study, the specificity of the purified recombinant human heparanase was investigated for the first time using a series of structurally defined oligosaccharides isolated from heparin/heparan sulfate. The best substrates were DeltaHexUA(+/-2S)-GlcN(NS,6S)-GIcUA-GlcN(NS,6S)-GlcUA-GlcN(NS,6S) and DeltaHexUA(2S)-GlcN(NS,6S)-GIcUA-GlcN(NS,6S) (where DeltaHexUA, GlcN, GlcUA NS, 2S, and 6S represent unsaturated hexuronic acid, D-glucosamine, D-glucuronic acid, 2-N-sulfate, 2-O-sulfate, and 6-O-disulfate, respectively). Based on the percentage conversion of the substrates to products under identical assay conditions, several aspects of the recognition structures were revealed. 1) The minimum recognition backbone is the trisaccharide GlcN-GlcUA-GlcN. 2) The target GlcUA residues are in the sulfated region. 3) The -GlcN(6S)-GlcUA-GlcN(NS)-sequence is essential but not sufficient as the cleavage site. 4) The IdoUA(2S) residue, located two saccharides away from the target GlcUA residue, claimed previously to be essential, is not indispensable. 5) The 3-O-sulfate group on the GlcN is dispensable and even has an inhibitory effect when located in a highly sulfated region. 6) Based on these and previous results, HexUA(2S)-GlcN(NS,6S)-ldoUA-GlcNAc(6S)GlcUA-GlcN(NS, 6S)-ldoUA(2S)-GlcN(NS,6S) (where HexUA represents hexuronic acid) has been proposed as a probable physioloGlcal target octasaccharide sequence. These findings will aid establishing a quantitative assay method using the above tetrasaccharide and designing heparan sulfate-based specific inhibitors of the heparanase for new therapeutic strategies.	Kobe Pharmaceut Univ, Dept Biochem, Higashinada Ku, Kobe, Hyogo 6588558, Japan; Novartis Pharma KK, Tsukuba Res Inst, Tsukuba, Ibaraki 3002611, Japan	Kobe Pharmaceutical University; Novartis	Sugahara, K (corresponding author), Kobe Pharmaceut Univ, Dept Biochem, Higashinada Ku, Kobe, Hyogo 6588558, Japan.							Bai XM, 1997, J BIOL CHEM, V272, P23172, DOI 10.1074/jbc.272.37.23172; Bame KJ, 2000, GLYCOBIOLOGY, V10, P715, DOI 10.1093/glycob/10.7.715; Bame KJ, 1998, BIOCHEM J, V336, P191, DOI 10.1042/bj3360191; Bame KJ, 2001, GLYCOBIOLOGY, V11, p91R, DOI 10.1093/glycob/11.6.91R; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Brickman YG, 1998, GLYCOBIOLOGY, V8, P463, DOI 10.1093/glycob/8.5.463; Casu B, 2001, ADV CARBOHYD CHEM BI, V57, P159, DOI 10.1016/S0065-2318(01)57017-1; Chuang WL, 2000, BIOCHEMISTRY-US, V39, P3542, DOI 10.1021/bi9926025; CONRAD HE, 1998, HEPARIN BINDING PROT, P301; DAVID G, 1991, BIOCHEM SOC T, V19, P816, DOI 10.1042/bst0190816; DESAI UR, 1993, ARCH BIOCHEM BIOPHYS, V306, P461, DOI 10.1006/abbi.1993.1538; Erickson AC, 2000, J HISTOCHEM CYTOCHEM, V48, P1291, DOI 10.1177/002215540004801001; Fairbanks MB, 1999, J BIOL CHEM, V274, P29587, DOI 10.1074/jbc.274.42.29587; Feyzi E, 1998, J BIOL CHEM, V273, P13395, DOI 10.1074/jbc.273.22.13395; Freeman C, 1998, BIOCHEM J, V330, P1341, DOI 10.1042/bj3301341; Gohji K, 2001, J UROLOGY, V166, P1286, DOI 10.1016/S0022-5347(05)65754-0; Gohji K, 2001, INT J CANCER, V95, P295, DOI 10.1002/1097-0215(20010920)95:5<295::AID-IJC1051>3.0.CO;2-A; Hulett MD, 1999, NAT MED, V5, P803, DOI 10.1038/10525; IOZZO RV, 1994, BIOCHEM J, V302, P625, DOI 10.1042/bj3020625; Iozzo RV, 1998, ANNU REV BIOCHEM, V67, P609, DOI 10.1146/annurev.biochem.67.1.609; JACOBSSON KG, 1987, BIOCHEM J, V246, P409, DOI 10.1042/bj2460409; Jayson GC, 1998, J BIOL CHEM, V273, P51, DOI 10.1074/jbc.273.1.51; KJELLEN L, 1991, ANNU REV BIOCHEM, V60, P443, DOI 10.1146/annurev.bi.60.070191.002303; Kussie PH, 1999, BIOCHEM BIOPH RES CO, V261, P183, DOI 10.1006/bbrc.1999.0962; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lindahl U, 1998, J BIOL CHEM, V273, P24979, DOI 10.1074/jbc.273.39.24979; Lindahl U., 1989, HEPARIN, P159; LINKER A, 1984, CARBOHYD RES, V127, P75, DOI 10.1016/0008-6215(84)85107-1; Liu DF, 2002, P NATL ACAD SCI USA, V99, P568, DOI 10.1073/pnas.012578299; Lyon M, 1998, MATRIX BIOL, V17, P485, DOI 10.1016/S0945-053X(98)90096-8; Mikami S, 2001, JPN J CANCER RES, V92, P1062, DOI 10.1111/j.1349-7006.2001.tb01061.x; NADER HB, 1990, J BIOL CHEM, V265, P16807; NAKAJIMA M, 1983, SCIENCE, V220, P611, DOI 10.1126/science.6220468; NAKAJIMA M, 1984, J BIOL CHEM, V259, P2283; NAKAJIMA M, 1988, J CELL BIOCHEM, V36, P157, DOI 10.1002/jcb.240360207; NURCOMBE V, 1993, SCIENCE, V260, P103, DOI 10.1126/science.7682010; OGREN S, 1976, BIOCHEM J, V154, P605; OGREN S, 1975, J BIOL CHEM, V250, P2690; OLDBERG A, 1980, BIOCHEMISTRY-US, V19, P5755, DOI 10.1021/bi00566a014; OLDBERG A, 1990, BIOCHEM SOC T, V18, P789, DOI 10.1042/bst0180789; OOSTA GM, 1982, J BIOL CHEM, V257, P1249; Parish CR, 2001, BIOCHIM BIOPHYS ACTA, V1471, P99, DOI DOI 10.1016/S0304-419X(01)00017-8; Pikas DS, 1998, J BIOL CHEM, V273, P18770, DOI 10.1074/jbc.273.30.18770; Podyma-Inoue KA, 2002, J BIOL CHEM, V277, P32459, DOI 10.1074/jbc.M203282200; Salmivirta M, 1996, FASEB J, V10, P1270, DOI 10.1096/fasebj.10.11.8836040; Sanderson RD, 2001, SEMIN CELL DEV BIOL, V12, P89, DOI 10.1006/scdb.2000.0241; Stringer SE, 1997, INT J BIOCHEM CELL B, V29, P709, DOI 10.1016/S1357-2725(96)00170-7; SUGAHARA K, 1994, GLYCOBIOLOGY, V4, P535, DOI 10.1093/glycob/4.4.535; Sugahara K, 2000, CURR OPIN STRUC BIOL, V10, P518, DOI 10.1016/S0959-440X(00)00125-1; SUGAHARA K, 1989, BIOCHEM BIOPH RES CO, V162, P189, DOI 10.1016/0006-291X(89)91980-3; THUNBERG L, 1982, J BIOL CHEM, V257, P278; Toyoshima M, 1999, J BIOL CHEM, V274, P24153, DOI 10.1074/jbc.274.34.24153; Tsuda H, 1996, J BIOL CHEM, V271, P10495, DOI 10.1074/jbc.271.18.10495; Tumova S, 2000, INT J BIOCHEM CELL B, V32, P269, DOI 10.1016/S1357-2725(99)00116-8; Turnbull JE, 1999, P NATL ACAD SCI USA, V96, P2698, DOI 10.1073/pnas.96.6.2698; Uno F, 2001, CANCER RES, V61, P7855; VLODAVSKY I, 1990, CANCER METAST REV, V9, P203, DOI 10.1007/BF00046361; Vlodavsky I, 1999, NAT MED, V5, P793, DOI 10.1038/10518; Yamada S, 1998, J BIOL CHEM, V273, P1863, DOI 10.1074/jbc.273.4.1863; Yamada S, 1999, BIOCHEMISTRY-US, V38, P838, DOI 10.1021/bi981889n; YAMADA S, 1995, J BIOL CHEM, V270, P8696; YAMADA S, 1994, GLYCOBIOLOGY, V4, P69, DOI 10.1093/glycob/4.1.69; Yamada SH, 1998, TRENDS GLYCOSCI GLYC, V10, P95, DOI 10.4052/tigg.10.95; YAMADA SH, 1993, J BIOL CHEM, V268, P4780	64	116	118	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					42488	42495		10.1074/jbc.M206510200	http://dx.doi.org/10.1074/jbc.M206510200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12213822	hybrid			2022-12-27	WOS:000179081200010
J	Sigurdsson, S; Van Komen, S; Petukhovan, G; Sung, P				Sigurdsson, S; Van Komen, S; Petukhovan, G; Sung, P			Homologous DNA pairing by human recombination factors Rad51 and Rad54	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; SACCHAROMYCES-CEREVISIAE; YEAST RAD51; PROTEIN; EXCHANGE; MOUSE	Human Rad51 (hRad51) and Rad54 proteins are key members of the RAD52 group required for homologous recombination. We show an ability of hRad54 to promote transient separation of the strands in duplex DNA via its ATP hydrolysis-driven DNA supercoiling function. The ATPase, DNA supercoiling, and DNA strand opening activities of hRad54 are greatly stimulated through an interaction with hRad51. Importantly, we demonstrate that hRad51 and hRad54 functionally cooperate in the homologous DNA pairing reaction that forms recombination DNA intermediates. Our results should provide a biochemical model for dissecting the role of hRad51 and hRad54 in recombination reactions in human cells.	Univ Texas, Hlth Sci Ctr, Dept Mol Med, San Antonio, TX 78254 USA; Univ Texas, Hlth Sci Ctr, Inst Biotechnol, San Antonio, TX 78254 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Sung, P (corresponding author), Univ Texas, Hlth Sci Ctr, Dept Mol Med, 7703 Floyd Curl Dr, San Antonio, TX 78254 USA.	sung@uthscsa.edu	Sigurdsson, Stefan/L-9820-2015	Sigurdsson, Stefan/0000-0002-5284-0058	NATIONAL CANCER INSTITUTE [P01CA081020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057814] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000165] Funding Source: NIH RePORTER; NCI NIH HHS [CA81020] Funding Source: Medline; NIA NIH HHS [T32AG00165] Funding Source: Medline; NIGMS NIH HHS [GM57814] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baumann P, 1996, CELL, V87, P757, DOI 10.1016/S0092-8674(00)81394-X; Benson FE, 1998, NATURE, V391, P401, DOI 10.1038/34937; BENSON FE, 1994, EMBO J, V13, P5764, DOI 10.1002/j.1460-2075.1994.tb06914.x; BIANCO PR, 1998, FRONT BIOSCI, V3, pD580; EISEN JA, 1995, NUCLEIC ACIDS RES, V23, P2715, DOI 10.1093/nar/23.14.2715; Golub EI, 1997, NUCLEIC ACIDS RES, V25, P4106, DOI 10.1093/nar/25.20.4106; Gupta RC, 1997, P NATL ACAD SCI USA, V94, P463, DOI 10.1073/pnas.94.2.463; Kanaar R, 1996, CURR BIOL, V6, P828, DOI 10.1016/S0960-9822(02)00606-1; LYNN RM, 1989, PROTEINS, V6, P231, DOI 10.1002/prot.340060305; Mazin AV, 2000, MOL CELL, V6, P583, DOI 10.1016/S1097-2765(00)00057-5; Mazin AV, 2000, EMBO J, V19, P1148, DOI 10.1093/emboj/19.5.1148; McIlwraith MJ, 2000, J MOL BIOL, V304, P151, DOI 10.1006/jmbi.2000.4180; Morrison C, 1999, MOL CELL BIOL, V19, P6891; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Petukhova G, 1998, NATURE, V393, P91, DOI 10.1038/30037; Pierce AJ, 2001, TRENDS CELL BIOL, V11, pS52, DOI 10.1016/S0962-8924(01)02149-3; Ristic D, 2001, P NATL ACAD SCI USA, V98, P8454, DOI 10.1073/pnas.151056798; SHIBATA T, 1982, J BIOL CHEM, V257, P3981; SHINOHARA A, 1993, NAT GENET, V4, P239, DOI 10.1038/ng0793-239; Sigurdsson S, 2001, GENE DEV, V15, P3308, DOI 10.1101/gad.935501; Sigurdsson S, 2001, J BIOL CHEM, V276, P8798, DOI 10.1074/jbc.M010011200; Stark JM, 2002, J BIOL CHEM, V277, P20185, DOI 10.1074/jbc.M112132200; Sung P, 1996, J BIOL CHEM, V271, P27983, DOI 10.1074/jbc.271.45.27983; Sung P, 1997, GENE DEV, V11, P1111, DOI 10.1101/gad.11.9.1111; SUNG P, 1987, P NATL ACAD SCI USA, V84, P8951, DOI 10.1073/pnas.84.24.8951; Sung P, 2000, MUTAT RES-FUND MOL M, V451, P257, DOI 10.1016/S0027-5107(00)00054-3; Swagemakers SMA, 1998, J BIOL CHEM, V273, P28292, DOI 10.1074/jbc.273.43.28292; Tan TLR, 1999, CURR BIOL, V9, P325, DOI 10.1016/S0960-9822(99)80142-0; Van Komen S, 2000, MOL CELL, V6, P563, DOI 10.1016/S1097-2765(00)00055-1; Yu X, 2001, P NATL ACAD SCI USA, V98, P8419, DOI 10.1073/pnas.111005398	30	108	112	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					42790	42794		10.1074/jbc.M208004200	http://dx.doi.org/10.1074/jbc.M208004200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12205100	hybrid			2022-12-27	WOS:000179081200049
J	Szaszi, K; Paulsen, A; Szabo, EZ; Numata, M; Grinstein, S; Orlowski, J				Szaszi, K; Paulsen, A; Szabo, EZ; Numata, M; Grinstein, S; Orlowski, J			Clathrin-mediated endocytosis and recycling of the neuron-specific Na+/H+ exchanger NHE5 isoform - Regulation by phosphatidylinositol 3 '-kinase and the actin cytoskeleton	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HAMSTER OVARY CELLS; PROTEIN-KINASE-A; CULTURED HIPPOCAMPAL-NEURONS; INTRACELLULAR PH; MAMMALIAN-CELLS; FUNCTIONAL EXPRESSION; MOLECULAR-CLONING; EXTRACELLULAR PH; HUMAN BRAIN; TRANSFERRIN RECEPTORS	Mammalian Na+/H+ exchangers (NHEs) are a family of integral membrane proteins that play central roles in sodium, acid-base, and cell volume homeostasis. The recently cloned NHE5 isoform is expressed predominantly in brain, but its functional and cellular properties are poorly understood. To facilitate its characterization, an epitope-tagged construct of NHE5 was ectopically expressed in nonneuronal and neuronal cells. In NHE-deficient Chinese hamster ovary AP-1 cells, NHE5 localized at the plasmalemma, but a significant fraction accumulated intracellularly in vesicles that concentrated in a juxtanuclear region. Similarly, in nerve growth factor-differentiated neuroendocrine PC12 cells and primary hippocampal neurons, immunolabeling of NHE5 was detected in endomembrane vesicles in the perinuclear region of the cell body but also along the processes. More detailed characterization in AP-1 cells using organelle-specific markers showed that NHE5 colocalized with internalized transferrin, a marker of recycling endosomes. Transient transfection of a dominant negative mutant of dynamin-1, which inhibits clathrin-mediated endocytosis, blocked uptake of transferrin as well as internalization of NHE5. Likewise, wortmannin inhibition of phosphatidylinositol X-kinase, a lipid kinase implicated in endosomal traffic, induced coalescence of vesicles containing NHE5 and caused a pronounced inhibition of plasmalemmal Na+/H+ exchange. By contrast, disruption of the F-actin cytoskeleton with cytochalasin D increased cell surface NHE5 activity and abundance. These observations demonstrate that NHE5 is localized to the recycling endosomal pathway and is dynamically regulated by phosphatidylinositol 3'-kinase and by the state of F-actin assembly.	McGill Univ, Dept Physiol, Montreal, PQ H3G 1Y6, Canada; Hosp Sick Children, Res Inst, Cell Biol Programme, Toronto, ON M5G 1X8, Canada	McGill University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Orlowski, J (corresponding author), McGill Univ, Dept Physiol, McIntyre Med Sci Bldg,3655 Promenade Sri William, Montreal, PQ H3G 1Y6, Canada.		Szaszi, Katalin/J-7522-2012	Szaszi, Katalin/0000-0002-2490-8422; Orlowski, John/0000-0001-7371-175X	Canadian Institutes of Health Research [37401] Funding Source: Medline	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))		Attaphitaya S, 1999, J BIOL CHEM, V274, P4383, DOI 10.1074/jbc.274.7.4383; Attaphitaya S, 2001, AM J PHYSIOL-CELL PH, V281, pC1146, DOI 10.1152/ajpcell.2001.281.4.C1146; AZARANI A, 1995, J BIOL CHEM, V270, P20004, DOI 10.1074/jbc.270.34.20004; Baird NR, 1999, J BIOL CHEM, V274, P4377, DOI 10.1074/jbc.274.7.4377; Bell SM, 1999, AM J PHYSIOL-CELL PH, V276, pC788, DOI 10.1152/ajpcell.1999.276.4.C788; BIEMESDERFER D, 1997, AM J PHYSIOL, V273, P289; Bondarenko A, 2001, GLIA, V34, P134, DOI 10.1002/glia.1048; CAMERON IL, 1993, CELL BIOL INT, V17, P93, DOI 10.1006/cbir.1993.1009; CAMERON PL, 1991, J CELL BIOL, V115, P151, DOI 10.1083/jcb.115.1.151; Chavez RA, 1996, J CELL BIOL, V133, P1177, DOI 10.1083/jcb.133.6.1177; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Chow CW, 1999, J BIOL CHEM, V274, P37551, DOI 10.1074/jbc.274.53.37551; Church J, 1998, J PHYSIOL-LONDON, V511, P119, DOI 10.1111/j.1469-7793.1998.119bi.x; Coorssen JR, 1996, EMBO J, V15, P3787, DOI 10.1002/j.1460-2075.1996.tb00752.x; Cox GA, 1997, CELL, V91, P139, DOI 10.1016/S0092-8674(01)80016-7; D'Souza S, 1998, J BIOL CHEM, V273, P2035, DOI 10.1074/jbc.273.4.2035; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Deitmer JW, 1996, PROG NEUROBIOL, V48, P73, DOI 10.1016/0301-0082(95)00039-9; DeVries SH, 2001, NEURON, V32, P1107, DOI 10.1016/S0896-6273(01)00535-9; Douglas RM, 2001, NEUROSCIENCE, V102, P217, DOI 10.1016/S0306-4522(00)00473-5; FRANCHI A, 1986, P NATL ACAD SCI USA, V83, P9388, DOI 10.1073/pnas.83.24.9388; Fujimoto LM, 2000, TRAFFIC, V1, P161, DOI 10.1034/j.1600-0854.2000.010208.x; GOTTLIEB TA, 1993, J CELL BIOL, V120, P695, DOI 10.1083/jcb.120.3.695; Gu XQ, 2001, AM J PHYSIOL-CELL PH, V281, pC496, DOI 10.1152/ajpcell.2001.281.2.C496; HAVENGA MJE, 1994, MOL BRAIN RES, V25, P97, DOI 10.1016/0169-328X(94)90283-6; HOPKINS CR, 1983, CELL, V35, P321, DOI 10.1016/0092-8674(83)90235-0; Horikawa N, 2001, PHARMACOLOGY, V63, P76, DOI 10.1159/000056116; Hu MC, 2001, J BIOL CHEM, V276, P26906, DOI 10.1074/jbc.M011338200; HUETTNER JE, 1986, J NEUROSCI, V6, P3044; Janecki AJ, 1998, J BIOL CHEM, V273, P8790, DOI 10.1074/jbc.273.15.8790; Jess TJ, 1996, CELL SIGNAL, V8, P297, DOI 10.1016/0898-6568(96)00054-X; Kempski O, 2001, SEMIN NEPHROL, V21, P303, DOI 10.1053/snep.2001.21665; Kempski O, 1990, Adv Neurol, V52, P39; Khurana S, 1996, J BIOL CHEM, V271, P9919, DOI 10.1074/jbc.271.17.9919; Kim JH, 1998, P NATL ACAD SCI USA, V95, P2997, DOI 10.1073/pnas.95.6.2997; Kiwull-Schone H, 2001, AM J RESP CRIT CARE, V164, P1303, DOI 10.1164/ajrccm.164.7.2010147; Kneen M, 1998, BIOPHYS J, V74, P1591, DOI 10.1016/S0006-3495(98)77870-1; KOBAYASHI S, 1994, J NEUROSCI, V14, P6266; KRISHTAL OA, 1987, BRAIN RES, V436, P352, DOI 10.1016/0006-8993(87)91678-7; Kurashima K, 1999, J BIOL CHEM, V274, P29843, DOI 10.1074/jbc.274.42.29843; Kurashima K, 1997, J BIOL CHEM, V272, P28672, DOI 10.1074/jbc.272.45.28672; Kurashima K, 1998, J BIOL CHEM, V273, P20828, DOI 10.1074/jbc.273.33.20828; Lamaze C, 1997, J BIOL CHEM, V272, P20332, DOI 10.1074/jbc.272.33.20332; Li PA, 1997, ACTA PHYSIOL SCAND, V161, P567, DOI 10.1046/j.1365-201X.1997.00264.x; Liu YJ, 1997, ANNU REV NEUROSCI, V20, P125; Ma E, 1997, NEUROSCIENCE, V79, P591, DOI 10.1016/S0306-4522(96)00674-4; MACLEANFLETCHER S, 1980, CELL, V20, P329, DOI 10.1016/0092-8674(80)90619-4; Martys JL, 1996, J BIOL CHEM, V271, P10953, DOI 10.1074/jbc.271.18.10953; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; Miyazaki E, 2001, J BIOL CHEM, V276, P49221, DOI 10.1074/jbc.M106267200; MORIMOTO T, 1995, NEURON, V15, P689, DOI 10.1016/0896-6273(95)90156-6; MUNDIGL O, 1993, J CELL BIOL, V122, P1207, DOI 10.1083/jcb.122.6.1207; Numata M, 2001, J BIOL CHEM, V276, P17387, DOI 10.1074/jbc.M101319200; ORLOWSKI J, 1993, J BIOL CHEM, V268, P16369; Orlowski J, 1997, J BIOL CHEM, V272, P22373, DOI 10.1074/jbc.272.36.22373; POUYSSEGUR J, 1984, P NATL ACAD SCI-BIOL, V81, P4833, DOI 10.1073/pnas.81.15.4833; Putnam RW, 2001, RESP PHYSIOL, V129, P37, DOI 10.1016/S0034-5687(01)00281-X; RALEYSUSMAN KM, 1991, J BIOL CHEM, V266, P2739; Ransom BR, 2000, PROG BRAIN RES, V125, P217; ROOS A, 1981, PHYSIOL REV, V61, P296, DOI 10.1152/physrev.1981.61.2.296; ROTIN D, 1989, AM J PHYSIOL, V257, pC1158, DOI 10.1152/ajpcell.1989.257.6.C1158; SANDVIG K, 1990, J BIOL CHEM, V265, P6382; Schultheis PJ, 1998, NAT GENET, V19, P282, DOI 10.1038/969; Shpetner H, 1996, J CELL BIOL, V132, P595, DOI 10.1083/jcb.132.4.595; Slepnev VI, 2000, NAT REV NEUROSCI, V1, P161, DOI 10.1038/35044540; Szabo EZ, 2000, J BIOL CHEM, V275, P6302, DOI 10.1074/jbc.275.9.6302; Szaszi K, 2000, J BIOL CHEM, V275, P28599, DOI 10.1074/jbc.M001193200; Szaszi K, 2001, J BIOL CHEM, V276, P40761, DOI 10.1074/jbc.M106724200; Takahashi KI, 1996, NEUROSCI RES, V24, P109, DOI 10.1016/0168-0102(95)00989-2; THOMAS JA, 1979, BIOCHEMISTRY-US, V18, P2210, DOI 10.1021/bi00578a012; Tombaugh GC, 1996, J PHYSIOL-LONDON, V493, P719, DOI 10.1113/jphysiol.1996.sp021417; TRAYNELIS SF, 1990, NATURE, V345, P347, DOI 10.1038/345347a0; VANDYKE RW, 1995, AM J PHYSIOL-CELL PH, V269, pC943, DOI 10.1152/ajpcell.1995.269.4.C943; VELASCO A, 1993, J CELL BIOL, V122, P39, DOI 10.1083/jcb.122.1.39; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Wang T, 2001, AM J PHYSIOL-RENAL, V281, pF1117, DOI 10.1152/ajprenal.2001.281.6.F1117; Wheeler DG, 2001, J BIOL CHEM, V276, P31978, DOI 10.1074/jbc.M103667200; Wiemann M, 2001, RESP PHYSIOL, V129, P57, DOI 10.1016/S0034-5687(01)00282-1; Wiemann M, 1999, PFLUG ARCH EUR J PHY, V438, P255, DOI 10.1007/s004240050907; Wilson JM, 1997, J CELL BIOL, V136, P319, DOI 10.1083/jcb.136.2.319; Wymann MP, 1996, MOL CELL BIOL, V16, P1722; Yip JW, 1997, J BIOL CHEM, V272, P18473, DOI 10.1074/jbc.272.29.18473; Yoshimori T, 1996, J CELL BIOL, V133, P247, DOI 10.1083/jcb.133.2.247; Zhai J, 1998, PFLUG ARCH EUR J PHY, V435, P539, DOI 10.1007/s004240050550; Zizak M, 1999, J BIOL CHEM, V274, P24753, DOI 10.1074/jbc.274.35.24753	86	47	47	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					42623	42632		10.1074/jbc.M206629200	http://dx.doi.org/10.1074/jbc.M206629200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12205089	hybrid			2022-12-27	WOS:000179081200026
J	Fukuyama, R; Nakayama, A; Nakase, T; Toba, H; Mukainaka, T; Sakaguchi, H; Saiwaki, T; Wada, M; Sakurai, H; Fushiki, S				Fukuyama, R; Nakayama, A; Nakase, T; Toba, H; Mukainaka, T; Sakaguchi, H; Saiwaki, T; Wada, M; Sakurai, H; Fushiki, S			A newly established neuronal rho-0 cell line highly susceptible to oxidative stress accumulates iron and other metals - Relevance to the origin of metal ion deposits in brains with neurodegenerative disorders	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; KEARNS-SAYRE SYNDROME; CYTOCHROME-C-OXIDASE; ALZHEIMERS-DISEASE; MITOCHONDRIAL-DNA; MEDIATED APOPTOSIS; PARKINSONS-DISEASE; FRIEDREICH ATAXIA; LACKING MTDNA; PHOSPHORYLATION	From human neuroblastoma-derived SILA cells we have established a p-0 cell line that is deficient in both respiration and mitochondrial DNA. Lactate dehydrogenase activity, lactate production, and growth in the medium without glucose indicate that these cells shift from aerobic to anaerobic metabolism. Electron microscopic observations revealed abnormal mitochondria with unique cristae structures. Staining with MitoTracker dye showed that the mitochondrial transmembrane potential was reduced by 30-40% from the parent cell levels. These cells were markedly susceptible to H2O2 and died apparently by a necrotic mechanism, a process blocked by deferoxamine in the parent cells but not p-0 cells. Analysis by inductively coupled plasma-mass spectrometry revealed an approximately 3-fold accumulation of iron in the p-0 cells at confluence (n = 4-6, three clones, *p < 0.05). Iron and four other metals were all elevated in the cells of one of the p-0 clones and were similar to control levels in the control cybrid cells, which were replenished with normal mitochondrial DNA. Their sensitivity to H2O2 was also similar to that of the parent cells. These results indicate that a newly established neuronal related p-0 cell line is highly susceptible to active oxygen species and that these toxicity effects appear to be related to an accumulation of transition metals, which probably occurs through the respiratory impairment.	Kyoto Prefectural Univ Med, Dept Pathol & Appl Neurobiol, Res Inst Neurol Dis & Geriatr, Kamigyo Ku, Kyoto 6028566, Japan; Kyoto Prefectural Univ Med, Cent Lab, Kamigyo Ku, Kyoto 6028566, Japan; Kyoto Prefectural Univ Med, Dept Otolaryngol, Kamigyo Ku, Kyoto 6028566, Japan; Kyoto Pharmaceut Univ, Dept Analyt & Bioinorgan Chem, Yamashina Ku, Kyoto 6078414, Japan; Kyoto Pharmaceut Univ, Dept Clin Pharmacol, Yamashina Ku, Kyoto 6078414, Japan	Kyoto Prefectural University of Medicine; Kyoto Prefectural University of Medicine; Kyoto Prefectural University of Medicine; Kyoto Pharmaceutical University; Kyoto Pharmaceutical University	Fukuyama, R (corresponding author), Case Western Reserve Univ, Sch Med, Dept Neurosci, Alzheimers Res Lab, E504,10900 Euclid Ave, Cleveland, OH 44106 USA.							Aksenov MY, 1999, NEUROCHEM RES, V24, P767, DOI 10.1023/A:1020783614031; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Asoh S, 1997, BIOCHEM BIOPH RES CO, V237, P659, DOI 10.1006/bbrc.1997.7210; BALOYANNIS K, 2000, NEUROBIOL AGING, V21, pS264; Bartzokis G, 2000, CELL MOL BIOL, V46, P821; Beauchemin D, 1998, ANAL CHEM, V70, P1026, DOI 10.1021/ac970783f; Berg D, 2001, J NEUROCHEM, V79, P225, DOI 10.1046/j.1471-4159.2001.00608.x; Bonilla E, 1999, BBA-BIOENERGETICS, V1410, P171, DOI 10.1016/S0005-2728(98)00165-0; BRENNAN WA, 1985, J NEUROCHEM, V44, P1948, DOI 10.1111/j.1471-4159.1985.tb07192.x; Buchet K, 1998, J BIOL CHEM, V273, P22983, DOI 10.1074/jbc.273.36.22983; Cassarino DS, 1999, BRAIN RES REV, V29, P1, DOI 10.1016/S0165-0173(98)00046-0; CHOMYN A, 1994, AM J HUM GENET, V54, P966; Cuajungco MP, 2000, ANN NY ACAD SCI, V920, P292; Delatycki MB, 1999, ANN NEUROL, V45, P673, DOI 10.1002/1531-8249(199905)45:5<673::AID-ANA20>3.3.CO;2-H; DIEBEL MA, 1996, J NEUROL SCI, V143, P137; Fosslien E, 2001, ANN CLIN LAB SCI, V31, P25; Fukuyama R, 1996, BRAIN RES, V713, P290, DOI 10.1016/0006-8993(95)01517-5; Garcia JJ, 2000, J BIOL CHEM, V275, P11075, DOI 10.1074/jbc.275.15.11075; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; GUTTERIDGE JMC, 1994, ANN NY ACAD SCI, V738, P201; Harris ZL, 1999, P NATL ACAD SCI USA, V96, P10812, DOI 10.1073/pnas.96.19.10812; Hirai K, 2001, J NEUROSCI, V21, P3017, DOI 10.1523/JNEUROSCI.21-09-03017.2001; HUG G, 1970, LAB INVEST, V22, P541; Jiang SN, 1999, J BIOL CHEM, V274, P29905, DOI 10.1074/jbc.274.42.29905; Kennedy ED, 1998, DIABETES, V47, P374, DOI 10.2337/diabetes.47.3.374; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; LOEFFLER DA, 1995, J NEUROCHEM, V65, P710; Macho A, 1996, CYTOMETRY, V25, P333, DOI 10.1002/(SICI)1097-0320(19961201)25:4<333::AID-CYTO4>3.0.CO;2-E; Marrif H, 1999, J NEUROSCI RES, V57, P255; Martinus RD, 1996, EUR J BIOCHEM, V240, P98, DOI 10.1111/j.1432-1033.1996.0098h.x; Matsumura T, 1989, Hum Cell, V2, P206; Miller SW, 1996, J NEUROCHEM, V67, P1897; MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001; MORAIS R, 1980, J CELL PHYSIOL, V103, P455, DOI 10.1002/jcp.1041030311; NAKAJIMAIIJIMA S, 1985, P NATL ACAD SCI USA, V82, P6133, DOI 10.1073/pnas.82.18.6133; Nakayama A, 2002, BIOL PHARM BULL, V25, P426, DOI 10.1248/bpb.25.426; OKUSKY J, 1983, ACTA NEUROPATHOL, V61, P116, DOI 10.1007/BF00697390; PORTER JB, 1988, BLOOD, V72, P1497; Puccio H, 2001, NAT GENET, V27, P181, DOI 10.1038/84818; Ristow M, 2000, P NATL ACAD SCI USA, V97, P12239, DOI 10.1073/pnas.220403797; Saiwaki T, 2000, J CLIN PATHOL-MOL PA, V53, P333, DOI 10.1136/mp.53.6.333; SCHWARTZKOPFF B, 1988, J AM COLL CARDIOL, V12, P1522, DOI 10.1016/S0735-1097(88)80020-2; SCHWARTZKOPFF B, 1991, VIRCHOWS ARCH A, V419, P63, DOI 10.1007/BF01600154; Smeitink J, 2001, NAT REV GENET, V2, P342, DOI 10.1038/35072063; SOSLAU G, 1971, J CELL BIOL, V51, P514, DOI 10.1083/jcb.51.2.514; STEWART MA, 1965, J NEUROCHEM, V12, P719, DOI 10.1111/j.1471-4159.1965.tb06786.x; Thomas F, 1999, HEALTH CARE FINANC R, V20, P1; Thompson KJ, 2001, BRAIN RES BULL, V55, P155, DOI 10.1016/S0361-9230(01)00510-X; Trimmer PA, 2000, EXP NEUROL, V162, P37, DOI 10.1006/exnr.2000.7333; VAILLANT F, 1991, BIOCHEM INT, V23, P571; VANDOMBURG PHM, 1996, BRAIN, V199, P997; Waggoner DJ, 1999, NEUROBIOL DIS, V6, P221, DOI 10.1006/nbdi.1999.0250; Zhou B, 2001, NAT GENET, V28, P345, DOI 10.1038/ng572	53	20	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					41455	41462		10.1074/jbc.M204176200	http://dx.doi.org/10.1074/jbc.M204176200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12194972	hybrid			2022-12-27	WOS:000178985300022
J	Willcockson, IU; Hong, AL; Whisenant, RP; Edwards, JB; Wang, HJ; Sarkar, HK; Pedersen, SE				Willcockson, IU; Hong, AL; Whisenant, RP; Edwards, JB; Wang, HJ; Sarkar, HK; Pedersen, SE			Orientation of d-tubocurarine in the muscle nicotinic acetylcholine receptor-binding site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-CONOTOXIN MI; GAMMA-SUBUNIT; DELTA-SUBUNIT; COMPETITIVE ANTAGONISTS; PAIRWISE INTERACTIONS; MOLECULAR DISSECTION; CRYSTAL-STRUCTURE; AMINO-ACIDS; IDENTIFICATION; RESIDUES	Ligand modification and receptor site-directed mutagenesis were used to examine binding of the competitive antagonist, d-tubocurarine (dTC), to the muscle-type nicotinic acetylcholine receptor (AChR). By using various dTC analogs, we measured the interactions of specific dTC functional groups with amino acid positions in the AChR gamma-subunit. Because data for mutations at residue gammaTyr(117) were the most consistent with direct interaction with dTC, we focused on that residue. Double mutant thermodynamic cycle analysis showed apparent interactions of gammaTyr(117) with both the 2-N and the 13'-positions of dTC. Examination of a dTC analog with a negative charge at the 13'-position failed to reveal electrostatic interaction with charged side-chain substitutions at gamma117, but the effects of side-chain substitutions remained consistent with proximity of Tyr(117) to the cationic 2-N of dTC. The apparent interaction of,gammaTyr(117) with the 13'-position of dTC was likely mediated by allosteric changes in either dTC or the receptor. The data also show that cation-pi electron stabilization of the 2-N position is not required for high affinity binding. Molecular modeling of dTC within the binding pocket of the acetylcholine-binding protein places the 2-N in proximity to the residue homologous to gammaTyr(117). This model provides a plausible structural basis for binding of dTC within the acetylcholine-binding site of the AChR family that appears consistent with findings from photoaffinity labeling studies and with site-directed mutagenesis studies of the AChR.	Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA	Baylor College of Medicine	Pedersen, SE (corresponding author), Baylor Coll Med, Dept Mol Physiol, 1 Baylor Plaza, Houston, TX 77030 USA.	pedersen@bcm.tmc.edu		Pedersen, Steen E./0000-0001-8755-8899	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007676] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035212] Funding Source: NIH RePORTER; NHLBI NIH HHS [T32-HL07676] Funding Source: Medline; NINDS NIH HHS [NS35212] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ackermann EJ, 1998, J BIOL CHEM, V273, P10958, DOI 10.1074/jbc.273.18.10958; ACKERS GK, 1985, ANNU REV BIOCHEM, V54, P597, DOI 10.1146/annurev.bi.54.070185.003121; BLOUNT P, 1989, NEURON, V3, P349, DOI 10.1016/0896-6273(89)90259-6; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Bren N, 2000, J BIOL CHEM, V275, P12692, DOI 10.1074/jbc.275.17.12692; Chiara DC, 1999, BIOCHEMISTRY-US, V38, P6689, DOI 10.1021/bi9901735; Chiara DC, 1998, FEBS LETT, V423, P223, DOI 10.1016/S0014-5793(98)00093-3; Chiara DC, 1997, J BIOL CHEM, V272, P32940, DOI 10.1074/jbc.272.52.32940; CODDING PW, 1972, J CHEM SOC CHEM COMM, P1174, DOI 10.1039/c39720001174; COHEN JB, 1991, J BIOL CHEM, V266, P23354; Corringer PJ, 2000, ANNU REV PHARMACOL, V40, P431, DOI 10.1146/annurev.pharmtox.40.1.431; DENNIS M, 1988, BIOCHEMISTRY-US, V27, P2346, DOI 10.1021/bi00407a016; Densmore CL, 2000, MOL THER, V1, P180, DOI 10.1006/mthe.1999.0021; DUTCHER JD, 1952, J AM CHEM SOC, V74, P2221, DOI 10.1021/ja01129a021; FILATOV GN, 1993, MOL PHARMACOL, V44, P237; FU DX, 1994, J BIOL CHEM, V269, P26152; KAO PN, 1986, J BIOL CHEM, V261, P8085; Ma JC, 1997, CHEM REV, V97, P1303, DOI 10.1021/cr9603744; Martin M, 1996, J BIOL CHEM, V271, P13497, DOI 10.1074/jbc.271.23.13497; NEUBIG RR, 1979, BIOCHEMISTRY-US, V18, P5464, DOI 10.1021/bi00591a032; NOWAK MW, 1995, SCIENCE, V268, P439, DOI 10.1126/science.7716551; OLEARY ME, 1994, AM J PHYSIOL, V266, pC648, DOI 10.1152/ajpcell.1994.266.3.C648; Osaka H, 2000, J BIOL CHEM, V275, P5478, DOI 10.1074/jbc.275.8.5478; Papineni RVL, 1997, J BIOL CHEM, V272, P24891, DOI 10.1074/jbc.272.40.24891; Papineni RVL, 2001, J BIOL CHEM, V276, P23589, DOI 10.1074/jbc.M102350200; Pedersen S E, 1999, Methods Enzymol, V294, P117; Pedersen SE, 1995, J BIOL CHEM, V270, P31141, DOI 10.1074/jbc.270.52.31141; PEDERSEN SE, 1990, P NATL ACAD SCI USA, V87, P2785, DOI 10.1073/pnas.87.7.2785; Prince RJ, 1998, J BIOL CHEM, V273, P7843, DOI 10.1074/jbc.273.14.7843; REYNOLDS CD, 1976, ACTA CRYSTALLOGR B, V32, P1431, DOI 10.1107/S0567740876005517; REYNOLDS CD, 1975, BIOCHIM BIOPHYS ACTA, V404, P341, DOI 10.1016/0304-4165(75)90342-6; SINE SM, 1993, P NATL ACAD SCI USA, V90, P9436, DOI 10.1073/pnas.90.20.9436; SINE SM, 1995, NEURON, V15, P205, DOI 10.1016/0896-6273(95)90077-2; SOBELL HM, 1972, P NATL ACAD SCI USA, V69, P2212, DOI 10.1073/pnas.69.8.2212; Wang D, 2000, J BIOL CHEM, V275, P28666, DOI 10.1074/jbc.M005441200; WILSON PT, 1988, MOL PHARMACOL, V34, P643; Zhong WG, 1998, P NATL ACAD SCI USA, V95, P12088, DOI 10.1073/pnas.95.21.12088; ZHOROV BS, 1993, J MEMBRANE BIOL, V135, P19	38	18	18	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					42249	42258		10.1074/jbc.M205383200	http://dx.doi.org/10.1074/jbc.M205383200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12196523	hybrid			2022-12-27	WOS:000178985300120
J	Zamze, S; Martinez-Pomares, L; Jones, H; Taylor, PR; Stillion, RJ; Gordon, S; Wong, SYC				Zamze, S; Martinez-Pomares, L; Jones, H; Taylor, PR; Stillion, RJ; Gordon, S; Wong, SYC			Recognition of bacterial capsular polysaccharides and lipopolysaccharides by the macrophage mannose receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE-RICH DOMAIN; KLEBSIELLA-PNEUMONIAE; BINDING LECTIN; DENDRITIC CELLS; CONFORMATIONAL-ANALYSIS; NEISSERIA-MENINGITIDIS; POLYACRYLAMIDE GELS; ENDOTHELIAL-CELLS; INNATE IMMUNITY; MARGINAL ZONE	The in vitro binding of the macrophage mannose receptor to a range of different bacterial polysaccharides was investigated. The receptor was shown to bind to purified capsular polysaccharides from Streptococcus pneumoniae and to the lipopolysaccharides, but not capsular polysaccharides, from Klebsiella pneumoniae. Binding was Ca2+-dependent and inhibitable with D-mannose. A fusion protein of the mannose receptor containing carbohydrate recognition domains 4-7 and a full-length soluble form of the mannose receptor containing all domains external to the transmembrane region both displayed very similar binding specificities toward bacterial polysaccharides, suggesting that domains 4-7 are sufficient for recognition of these structures. Surprisingly, no direct correlation could be made between polysaccharide structure and binding to the mannose receptor, suggesting that polysaccharide conformation may play an important role in recognition. The full-length soluble form of the mannose receptor was able to bind simultaneously both polysaccharide via the carbohydrate recognition domains and sulfated oli-gosaccharide via the cysteine-rich domain. The possible involvement of the mannose receptor, either cell surface or soluble, in the innate and adaptive immune responses to bacterial polysaccharides is discussed.	Edward Jenner Inst Vaccine Res, Compton RG20 7NN, Berks, England; Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	University of Oxford	Zamze, S (corresponding author), Edward Jenner Inst Vaccine Res, Compton RG20 7NN, Berks, England.			Taylor, Philip/0000-0003-0163-1421; Martinez-Pomares, Luisa/0000-0002-2331-127X				Albanyan EA, 2000, INFECT IMMUN, V68, P5794, DOI 10.1128/IAI.68.10.5794-5802.2000; ANDERSEN SR, 1995, MICROB PATHOGENESIS, V19, P159, DOI 10.1006/mpat.1995.0054; ATHAMNA A, 1991, INFECT IMMUN, V59, P1673, DOI 10.1128/IAI.59.5.1673-1682.1991; Berney C, 1999, J EXP MED, V190, P851, DOI 10.1084/jem.190.6.851; Brown GD, 2001, NATURE, V413, P36, DOI 10.1038/35092620; Carroll MC, 1998, ANNU REV IMMUNOL, V16, P545, DOI 10.1146/annurev.immunol.16.1.545; CESCUTTI P, 1993, EUR J BIOCHEM, V213, P445, DOI 10.1111/j.1432-1033.1993.tb17780.x; CIUFFREDA P, 1992, CARBOHYD RES, V232, P327, DOI 10.1016/0008-6215(92)80064-8; Crouch E, 2000, IMMUNOL REV, V173, P52, DOI 10.1034/j.1600-065X.2000.917311.x; Devyatyrova-Johnson M, 2000, INFECT IMMUN, V68, P3894, DOI 10.1128/IAI.68.7.3894-3899.2000; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; DUTTON GGS, 1986, CARBOHYD RES, V149, P411, DOI 10.1016/S0008-6215(00)90061-2; Engering AJ, 1997, EUR J IMMUNOL, V27, P2417, DOI 10.1002/eji.1830270941; Fiete DJ, 1998, P NATL ACAD SCI USA, V95, P2089, DOI 10.1073/pnas.95.5.2089; GALFRE G, 1979, NATURE, V277, P131, DOI 10.1038/277131a0; Hansen DS, 1999, J CLIN MICROBIOL, V37, P56, DOI 10.1128/JCM.37.1.56-62.1999; Harms G, 1996, INFECT IMMUN, V64, P4220, DOI 10.1128/IAI.64.10.4220-4225.1996; ISAAC DH, 1985, POLYSACCHARIDES TOPI, P141; Jack DL, 2001, IMMUNOL REV, V180, P86, DOI 10.1034/j.1600-065X.2001.1800108.x; Jedrzejas MJ, 2001, MICROBIOL MOL BIOL R, V65, P187, DOI 10.1128/MMBR.65.2.187-207.2001; JENNINGS HJ, 1996, POLYSACCHARIDES MED, P443; JONES C, 1991, CARBOHYD RES, V221, P95, DOI 10.1016/0008-6215(91)80051-N; Kenne L., 1983, POLYSACCHARIDES, P287; KNUTSON CA, 1968, ANAL BIOCHEM, V24, P470, DOI 10.1016/0003-2697(68)90154-1; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lawson PR, 2000, IMMUNOL REV, V173, P66, DOI 10.1034/j.1600-065X.2000.917308.x; Leteux C, 2000, J EXP MED, V191, P1117, DOI 10.1084/jem.191.7.1117; Linehan SA, 1999, J EXP MED, V189, P1961, DOI 10.1084/jem.189.12.1961; Linehan SA, 2001, EUR J IMMUNOL, V31, P1857, DOI 10.1002/1521-4141(200106)31:6<1857::AID-IMMU1857>3.0.CO;2-D; Martinez-Pomares L, 1998, J BIOL CHEM, V273, P23376, DOI 10.1074/jbc.273.36.23376; Martinez-Pomares L, 1999, IMMUNOLOGIST, V7, P119; MartinezPomares L, 1996, J EXP MED, V184, P1927, DOI 10.1084/jem.184.5.1927; Masoud H, 1997, BIOCHEMISTRY-US, V36, P2091, DOI 10.1021/bi961989y; MIN H, 1986, ANAL BIOCHEM, V155, P275, DOI 10.1016/0003-2697(86)90437-9; Mullin NP, 1997, J BIOL CHEM, V272, P5668, DOI 10.1074/jbc.272.9.5668; Neth O, 2000, INFECT IMMUN, V68, P688, DOI 10.1128/IAI.68.2.688-693.2000; ORSKOV I, 1984, METHOD MICROBIOL, V14, P143, DOI 10.1016/S0580-9517(08)70449-5; PAROLIS LAS, 1988, CARBOHYD RES, V179, P301, DOI 10.1016/0008-6215(88)84126-0; PAVLIAK V, 1993, J BIOL CHEM, V268, P14146; Peiser L, 2002, CURR OPIN IMMUNOL, V14, P123, DOI 10.1016/S0952-7915(01)00307-7; PONTOW SE, 1992, INT REV CYTOL, V137B, P221; RAETZ CRH, 1990, ANNU REV BIOCHEM, V59, P129, DOI 10.1146/annurev.biochem.59.1.129; RAVENSCROFT N, 1987, CARBOHYD RES, V167, P257, DOI 10.1016/0008-6215(87)80283-5; Roseman DS, 2000, P NATL ACAD SCI USA, V97, P9949, DOI 10.1073/pnas.170184597; RUTHERFORD TJ, 1994, CARBOHYD RES, V265, P79, DOI 10.1016/0008-6215(94)80084-7; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; Severn WB, 1996, J BACTERIOL, V178, P1731, DOI 10.1128/jb.178.6.1731-1741.1996; Stahl PD, 1998, CURR OPIN IMMUNOL, V10, P50, DOI 10.1016/S0952-7915(98)80031-9; Stenutz R, 1997, CARBOHYD RES, V302, P79, DOI 10.1016/S0008-6215(97)00106-7; STRAUS DC, 1987, INFECT IMMUN, V55, P44, DOI 10.1128/IAI.55.1.44-48.1987; Susskind M, 1998, J BIOL CHEM, V273, P7006, DOI 10.1074/jbc.273.12.7006; TAYLOR ME, 1992, J BIOL CHEM, V267, P1719; TAYLOR ME, 1993, J BIOL CHEM, V268, P399; Thornton BP, 1996, J IMMUNOL, V156, P1235; TOMAS JM, 1991, INFECT IMMUN, V59, P2006; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; Vinogradov E, 2001, CARBOHYD RES, V335, P291, DOI 10.1016/S0008-6215(01)00216-6; Weis WI, 1998, IMMUNOL REV, V163, P19, DOI 10.1111/j.1600-065X.1998.tb01185.x; WESSELS MR, 1989, J EXP MED, V169, P2121, DOI 10.1084/jem.169.6.2121; WESTPHAL O, 1965, METHODS CARB CHEM, V5, P453	60	163	171	3	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					41613	41623		10.1074/jbc.M207057200	http://dx.doi.org/10.1074/jbc.M207057200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12196537	hybrid			2022-12-27	WOS:000178985300041
J	Hou, LM; Kang, I; Marchant, RE; Zagorski, MG				Hou, LM; Kang, I; Marchant, RE; Zagorski, MG			Methionine 35 oxidation reduces fibril assembly of the amyloid A beta-(1-42) peptide of Alzheimer's disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-PROTEIN FIBRILLOGENESIS; A-BETA; NEUROTOXICITY; BRAIN; MORPHOLOGY; TOXICITY; STRESS; AGGREGATION; INHIBITION; OLIGOMERS	The major component of amyloid plaques in Alzheimer's disease (AD) is Abeta, a small peptide that has high propensity to assemble as aggregated 13-sheet structures. Using three well established techniques for studying amyloid structure, namely circular dichroism, thio-flavin-T fluorescence, and atomic force microscopy, we demonstrate that oxidation of the Met-35 side chain to a methionine sulfoxide (Met-35(ox)) significantly hinders the rate of fibril formation for the 42-residue Abeta-(1-42) at physiological pH. Met-35(ox) also alters the characteristic Abeta fibril morphology and prevents formation of the protofibril, which is a key intermediate in beta-amyloidosis and the associated neurotoxicity. The implications of these results for the biological function and role of Abeta with oxidative stress in AD are discussed.	Case Western Reserve Univ, Dept Chem, Cleveland, OH 44106 USA; Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University	Zagorski, MG (corresponding author), Case Western Reserve Univ, Dept Chem, Cleveland, OH 44106 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL040047, R01HL047300, R29HL040047, R01HL070263] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG014363] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 70263-01, HL 40047-12, HL 47300-05] Funding Source: Medline; NIA NIH HHS [AG 14363-04] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Aksenov MY, 2001, NEUROSCIENCE, V103, P373, DOI 10.1016/S0306-4522(00)00580-7; Aliev G, 2002, BRAIN PATHOL, V12, P21; BARROW CJ, 1992, J MOL BIOL, V225, P1075, DOI 10.1016/0022-2836(92)90106-T; Butterfield DA, 2001, TRENDS MOL MED, V7, P548, DOI 10.1016/S1471-4914(01)02173-6; Ertekin-Taner N, 2000, SCIENCE, V290, P2303, DOI 10.1126/science.290.5500.2303; Fezoui Y, 2000, AMYLOID, V7, P166, DOI 10.3109/13506120009146831; Gabbita SP, 1999, J NEUROCHEM, V73, P1660, DOI 10.1046/j.1471-4159.1999.0731660.x; Harper JD, 1999, BIOCHEMISTRY-US, V38, P8972, DOI 10.1021/bi9904149; Hartley DM, 1999, J NEUROSCI, V19, P8876, DOI 10.1523/JNEUROSCI.19-20-08876.1999; Head E, 2001, NEUROBIOL DIS, V8, P792, DOI 10.1006/nbdi.2001.0431; Hensley K, 1998, J NEUROSCI, V18, P8126; Huang THJ, 2000, J MOL BIOL, V297, P73, DOI 10.1006/jmbi.2000.3559; Huang XD, 1999, BIOCHEMISTRY-US, V38, P7609, DOI 10.1021/bi990438f; Iwata N, 2001, SCIENCE, V292, P1550, DOI 10.1126/science.1059946; Kim YH, 2001, PROTEIN ENG, V14, P343, DOI 10.1093/protein/14.5.343; Kirkitadze MD, 2001, J MOL BIOL, V312, P1103, DOI 10.1006/jmbi.2001.4970; Klein WL, 2001, TRENDS NEUROSCI, V24, P219, DOI 10.1016/S0166-2236(00)01749-5; Kontush A, 2001, FREE RADICAL BIO MED, V31, P1120, DOI 10.1016/S0891-5849(01)00688-8; Kuo YM, 2001, J BIOL CHEM, V276, P12991, DOI 10.1074/jbc.M007859200; LEVINE H, 1995, AMYLOID, V2, P1, DOI 10.3109/13506129509031881; Levine RL, 1996, P NATL ACAD SCI USA, V93, P15036, DOI 10.1073/pnas.93.26.15036; Lorenzo A., 1993, Society for Neuroscience Abstracts, V19, P184; MAY PC, 1992, NEUROBIOL AGING, V13, P605, DOI 10.1016/0197-4580(92)90064-5; NASLUND J, 1994, P NATL ACAD SCI USA, V91, P8378, DOI 10.1073/pnas.91.18.8378; Nichols MR, 2002, BIOCHEMISTRY-US, V41, P6115, DOI 10.1021/bi015985r; Palmblad M, 2002, J BIOL CHEM, V277, P19506, DOI 10.1074/jbc.M112218200; Pappolla M, 1998, J BIOL CHEM, V273, P7185, DOI 10.1074/jbc.273.13.7185; PERCZEL A, 1992, ANAL BIOCHEM, V203, P83, DOI 10.1016/0003-2697(92)90046-A; PIKE CJ, 1995, J NEUROCHEM, V64, P253, DOI 10.1046/j.1471-4159.1995.64010253.x; Riek R, 2001, EUR J BIOCHEM, V268, P5930, DOI 10.1046/j.0014-2956.2001.02537.x; Roher AE, 1996, J BIOL CHEM, V271, P20631, DOI 10.1074/jbc.271.34.20631; Sayre LM, 2000, CELL MOL BIOL, V46, P731; Schoneich C, 2002, ARCH BIOCHEM BIOPHYS, V397, P370, DOI 10.1006/abbi.2001.2621; Seilheimer B, 1997, J STRUCT BIOL, V119, P59, DOI 10.1006/jsbi.1997.3859; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Shao HY, 1999, J MOL BIOL, V285, P755, DOI 10.1006/jmbi.1998.2348; SHEN CL, 1995, BIOPHYS J, V69, P640, DOI 10.1016/S0006-3495(95)79940-4; SNYDER SW, 1994, BIOPHYS J, V67, P1216, DOI 10.1016/S0006-3495(94)80591-0; SOTO C, 1995, J BIOL CHEM, V270, P3063, DOI 10.1074/jbc.270.7.3063; Stine WB, 1996, J PROTEIN CHEM, V15, P193, DOI 10.1007/BF01887400; Uversky VN, 2002, FEBS LETT, V517, P239, DOI 10.1016/S0014-5793(02)02638-8; Varadarajan S, 2001, J AM CHEM SOC, V123, P5625, DOI 10.1021/ja010452r; Varadarajan S, 2000, J STRUCT BIOL, V130, P184, DOI 10.1006/jsbi.2000.4274; VOGT W, 1995, FREE RADICAL BIO MED, V18, P93, DOI 10.1016/0891-5849(94)00158-G; Walsh DM, 1997, J BIOL CHEM, V272, P22364, DOI 10.1074/jbc.272.35.22364; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Watson AA, 1998, BIOCHEMISTRY-US, V37, P12700, DOI 10.1021/bi9810757; Zagorski MG, 1999, METHOD ENZYMOL, V309, P189	48	186	196	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 25	2002	277	43					40173	40176		10.1074/jbc.C200338200	http://dx.doi.org/10.1074/jbc.C200338200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	607KU	12198111	hybrid			2022-12-27	WOS:000178791400002
J	Mengerink, KJ; Vacquier, VD				Mengerink, KJ; Vacquier, VD			An ATP-binding cassette transporter is a major glycoprotein of sea urchin sperm membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYACRYLAMIDE GELS; ACROSOME REACTION; PLASMA-MEMBRANE; LOW-DENSITY; PROTEIN; FRACTION; IDENTIFICATION; SPERMATOZOA; TOPOLOGY; CLEAVAGE	Sperm are terminally differentiated cells that undergo several membrane-altering events before fusion with eggs. One event, the sea urchin sperm acrosome reaction (AR), is blocked by the lectin wheat germ agglutinin (WGA). In an effort to identify proteins involved in the AR induction, the peptide sequence was obtained from a 220-kDa WGA-binding protein. Degenerate PCR and library screening resulted in the full-length deduced amino acid sequence of an ATP-binding cassette transporter, suABCA. The protein of 1,764 residues has two transmembrane regions, two nucleotide-binding domains, and is most closely related to the human ABC subfamily A member 3 transporter (ABCA3). Sequence analysis suggests a large extracellular loop between transmembrane spanning segments 7 and 8, with five N-linked glycosylation sites. An antibody made to the loop region binds to non-permeabilized cells, supporting that this region is extracellular. suABCA is found in sperm membrane vesicles, it can be solubilized with nonionic detergents, and it shifts from 220 to 200 kDa upon protein:N-glycanase F digestion. suABCA localizes to the entire surface of sperm in a punctate pattern, but is not detected in lipid rafts. Based on its relationship to subfamily A, suABCA is most likely involved in phospholipid or cholesterol transport. This is the first investigation of an ABC transporter in animal sperm.	Univ Calif San Diego, Scripps Inst Oceanog, Ctr Marine Biotechnol & Biomed, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography	Vacquier, VD (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, Ctr Marine Biotechnol & Biomed, 9500 Gilman Dr, La Jolla, CA 92093 USA.							ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BEARER EL, 1990, J ELECTRON MICR TECH, V16, P281, DOI 10.1002/jemt.1060160403; Broccardo C, 1999, BBA-BIOMEMBRANES, V1461, P395, DOI 10.1016/S0005-2736(99)00170-4; Bungert S, 2001, J BIOL CHEM, V276, P23539, DOI 10.1074/jbc.M101902200; Croop JM, 1998, METHOD ENZYMOL, V292, P101; Dean M, 2001, J LIPID RES, V42, P1007; Higgins DG, 1996, METHOD ENZYMOL, V266, P383; Klein I, 1999, BBA-BIOMEMBRANES, V1461, P237, DOI 10.1016/S0005-2736(99)00161-3; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE C, 1987, ANAL BIOCHEM, V166, P308, DOI 10.1016/0003-2697(87)90579-3; Lin GR, 2002, BIOCHEM BIOPH RES CO, V291, P727, DOI 10.1006/bbrc.2002.6505; Mendez AJ, 2001, J BIOL CHEM, V276, P3158, DOI 10.1074/jbc.M007717200; Mengerink KJ, 2002, J BIOL CHEM, V277, P943, DOI 10.1074/jbc.M109673200; Mengerink KJ, 2001, GLYCOBIOLOGY, V11, p37R, DOI 10.1093/glycob/11.4.37R; MORRISSEY JH, 1981, ANAL BIOCHEM, V117, P307, DOI 10.1016/0003-2697(81)90783-1; Moy GW, 1996, J CELL BIOL, V133, P809, DOI 10.1083/jcb.133.4.809; Mulugeta S, 2002, J BIOL CHEM, V277, P22147, DOI 10.1074/jbc.M201812200; Nicholas KB, 1997, EMBNEW NEWS, V4, P14; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Ohta K, 1999, BIOCHEM BIOPH RES CO, V258, P616, DOI 10.1006/bbrc.1999.0686; Ohta K, 2000, GLYCOCONJUGATE J, V17, P205, DOI 10.1023/A:1026589223811; Oram JF, 2001, J LIPID RES, V42, P1173; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; PODELL SB, 1984, BIOCHIM BIOPHYS ACTA, V778, P25, DOI 10.1016/0005-2736(84)90444-9; PODELL SB, 1985, J BIOL CHEM, V260, P2715; PODELL SB, 1984, J CELL BIOL, V99, P1598, DOI 10.1083/jcb.99.5.1598; Schmitz G, 2001, CURR OPIN LIPIDOL, V12, P129, DOI 10.1097/00041433-200104000-00006; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vacquier VD, 1997, DEV BIOL, V192, P125, DOI 10.1006/dbio.1997.8729; VACQUIER VD, 1986, METHOD CELL BIOL, V27, P15, DOI 10.1016/S0091-679X(08)60340-4; Visconti PE, 2002, J REPROD IMMUNOL, V53, P133, DOI 10.1016/S0165-0378(01)00103-6; WARD GE, 1986, J CELL BIOL, V103, P95, DOI 10.1083/jcb.103.1.95; Yamano G, 2001, FEBS LETT, V508, P221, DOI 10.1016/S0014-5793(01)03056-3	35	18	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 25	2002	277	43					40729	40734		10.1074/jbc.M207184200	http://dx.doi.org/10.1074/jbc.M207184200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	607KU	12193601	hybrid			2022-12-27	WOS:000178791400074
J	Wen, KK; Yao, XY; Rubenstein, PA				Wen, KK; Yao, XY; Rubenstein, PA			GTP-yeast actin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-I RELEASE; SACCHAROMYCES-CEREVISIAE; ANGSTROM RESOLUTION; BETA-ACTIN; POLYMERIZATION; CONFORMATION; PROFILIN; PROTEIN; COMPLEX; NUCLEOTIDES	Because of the apparently greater conformational flexibility of yeast versus muscle actin and the ability of other members in the actin protein superfamily to efficiently use both ATP and GTP, we assessed the ability of yeast actin to function with GTP. Etheno-ATP exchange studies showed that the binding of GTP to yeast actin is about 1/9 as tight as that of ATP in contrast to the 1/1,240 ratio for muscle actin. Proteolysis of GTP-bound G-yeast actin suggests that the conformation of subdomain 2 is very much like that of ATP-bound actin, but CD studies show that GTP-bound actin is less thermostable than ATP-bound actin. GTP-actin polymerizes with an apparent critical concentration of 1.5 mum, higher than that of ATP-actin (0.3 mum) although filament structures observed by electron microscopy were similar. Yeast actin hydrolyzes GTP in a polymerization-dependent manner, and GTP-bound F-actin decorates with the myosin S1. Conversion of Phe(306) in the nucleotide binding site to the Tyr found in muscle actin raised the nucleotide discrimination ratio from the 1/9 of wild-type actin to 1/125. This result agrees with modeling that predicts that removal of the Tyr hydroxyl will create a space for the C2 amino group of the GTP guanine.	Univ Iowa, Coll Med, Dept Biochem, Iowa City, IA 52242 USA	University of Iowa	Rubenstein, PA (corresponding author), Univ Iowa, Coll Med, Dept Biochem, Iowa City, IA 52242 USA.			Rubenstein, Peter/0000-0003-1225-4414	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045728] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033689] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 45728] Funding Source: Medline; NIGMS NIH HHS [GM 33689] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Belmont LD, 1999, P NATL ACAD SCI USA, V96, P29, DOI 10.1073/pnas.96.1.29; BERTAZZON A, 1990, BIOCHEMISTRY-US, V29, P291, DOI 10.1021/bi00453a040; Buzan JM, 1996, P NATL ACAD SCI USA, V93, P91, DOI 10.1073/pnas.93.1.91; Carlier MF, 1991, CURR OPIN CELL BIOL, V3, P12, DOI 10.1016/0955-0674(91)90160-Z; CARLIER MF, 1991, J BIOL CHEM, V266, P1; CEDERGRENZEPPEZAUER ES, 1994, J MOL BIOL, V240, P459, DOI 10.1006/jmbi.1994.1461; CHEN X, 1995, J BIOL CHEM, V270, P11415, DOI 10.1074/jbc.270.19.11415; CHEN X, 1993, J CELL BIOL, V123, P1185, DOI 10.1083/jcb.123.5.1185; Chik JK, 1996, J MOL BIOL, V263, P607, DOI 10.1006/jmbi.1996.0602; COOK RK, 1992, J BIOL CHEM, V267, P9430; FLAHERTY KM, 1991, P NATL ACAD SCI USA, V88, P5041, DOI 10.1073/pnas.88.11.5041; Hurley JH, 1996, ANNU REV BIOPH BIOM, V25, P137; IYENGAR MR, 1964, BIOCHIM BIOPHYS ACTA, V86, P543, DOI 10.1016/0304-4165(64)90094-7; KABSCH W, 1995, FASEB J, V9, P167, DOI 10.1096/fasebj.9.2.7781919; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; Kim E, 1996, BIOCHEMISTRY-US, V35, P16566, DOI 10.1021/bi9623892; Kinosian HJ, 2000, BIOCHEMISTRY-US, V39, P13176, DOI 10.1021/bi001520+; Klumb LA, 1998, BIOCHEMISTRY-US, V37, P7657, DOI 10.1021/bi9803123; Kuang B, 1997, J BIOL CHEM, V272, P4412, DOI 10.1074/jbc.272.7.4412; LIBEREK K, 1991, J BIOL CHEM, V266, P14491; MANNHERZ HG, 1992, J MOL BIOL, V226, P899, DOI 10.1016/0022-2836(92)90641-V; MARTONOSI A, 1961, J BIOL CHEM, V236, P1345; Melki R, 1996, BIOCHEMISTRY-US, V35, P12038, DOI 10.1021/bi961325o; NAGAYAMA F, 1980, BIOCHIM BIOPHYS ACTA, V615, P85, DOI 10.1016/0005-2744(80)90011-X; Nyman T, 2002, J MOL BIOL, V317, P577, DOI 10.1006/jmbi.2002.5436; ORLOVA A, 1993, J MOL BIOL, V232, P334, DOI 10.1006/jmbi.1993.1393; Otterbein LR, 2001, SCIENCE, V293, P708, DOI 10.1126/science.1059700; Rudoni S, 2001, BBA-MOL CELL RES, V1538, P181, DOI 10.1016/S0167-4889(01)00067-2; SCHUTT CE, 1993, NATURE, V365, P810, DOI 10.1038/365810a0; SMITH NH, 1995, MOL BIOL EVOL, V12, P363; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; STRZELECKAGOLASZEWSKA H, 1993, EUR J BIOCHEM, V211, P731, DOI 10.1111/j.1432-1033.1993.tb17603.x; STRZELECKAGOLASZEWSKA H, 1985, EUR J BIOCHEM, V147, P331, DOI 10.1111/j.1432-1033.1985.tb08754.x; van den Ent F, 2001, NATURE, V413, P39, DOI 10.1038/35092500; Vinson VK, 1998, BIOCHEMISTRY-US, V37, P10871, DOI 10.1021/bi980093l; WEBB MR, 1992, P NATL ACAD SCI USA, V89, P4884, DOI 10.1073/pnas.89.11.4884; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724; Yao XY, 2002, J BIOL CHEM, V277, P22875, DOI 10.1074/jbc.M201685200; Yao XY, 2001, J BIOL CHEM, V276, P25598, DOI 10.1074/jbc.M011797200; Yao XY, 1999, J BIOL CHEM, V274, P37443, DOI 10.1074/jbc.274.52.37443	40	12	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 25	2002	277	43					41101	41109		10.1074/jbc.M204025200	http://dx.doi.org/10.1074/jbc.M204025200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	607KU	12191996	hybrid			2022-12-27	WOS:000178791400120
J	Eto, M; Elliott, E; Prickett, TD; Brautigan, DL				Eto, M; Elliott, E; Prickett, TD; Brautigan, DL			Inhibitor-2 regulates protein phosphatase-1 complexed with NimA-related kinase to induce centrosome separation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYOSIN PHOSPHATASE; MAMMALIAN INHIBITOR-2; CELLULAR-REGULATION; CATALYTIC SUBUNIT; SMOOTH-MUSCLE; PHOSPHORYLATION; IDENTIFICATION; LOCALIZATION; NEK2; ACTIVATION	Centrosome separation is regulated by balance of in situ protein kinase/phosphatase activities during the cell cycle. The mammalian NimA-related kinase Nek2 forms a complex with the catalytic subunit of protein phosphatase-1 (PP1C). This complex is located at centrosomes and has been implicated in regulation of the cycle of duplication and separation. Inhibitor-2 (Inh2) is an inhibitor protein specific for PP1C, and its expression level fluctuates during the cell cycle. Here we report cellular regulation of the Nek2(.)PP1C complex by Inh2. PP1C-binding segments of Nek2 were isolated by yeast two-hybrid screening using Inh2 bait. Inh2 indirectly associates with Nek2 via PP1C, which binds to both proteins, forming a bridged heterotrimeric complex. Double Ala mutation of the PP1C-binding site (KVHF) in Nek2 eliminated both PPIC and Inh2 interactions in both a yeast conjugation assay and an in vitro binding assay. The kinase activity of Nek2(.)PP1C was enhanced 2-fold by addition of recombinant Inh2, with EC50 = 10 am. Immunofluorescence showed concentration of endogenous Inh2 at centrosomes and in a region surrounding the centrosomes. Transient expression of wild-type Inh2 increased by 5-fold dispersed/split centrosomes in fibroblasts, mimicking the phenotype produced by overexpression of Nek2. Deletion of the Inh2 C-terminal domain yielded Inh2-(1-118), which failed to interact with or activate the Nek2(.)PP1C complex, suggesting that the C-terminal region of Inh2 is required for regulation of the Nek2(.)PP1C complex. Thus, Inh2 can enhance the kinase activity of the Nek2-PP1C complex via inhibition of phosphatase activity to initiate centrosome separation.	Univ Virginia, Sch Med, Ctr Cell Signaling, Charlottesville, VA 22908 USA	University of Virginia	Eto, M (corresponding author), Univ Virginia, Sch Med, Ctr Cell Signaling, POB 800577,W Complex Rm 7225,1400 Jefferson Pk, Charlottesville, VA 22908 USA.	me2h@virginia.edu	Eto, Masumi/ABE-4700-2020	Eto, Masumi/0000-0002-0651-5836	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056362] Funding Source: NIH RePORTER; NCI NIH HHS [CA40042] Funding Source: Medline; NIGMS NIH HHS [GM56362] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agarwal-Mawal A, 2001, J BIOL CHEM, V276, P23712, DOI 10.1074/jbc.M010002200; ALESSI D, 1992, EUR J BIOCHEM, V210, P1023, DOI 10.1111/j.1432-1033.1992.tb17508.x; Andreassen PR, 1998, J CELL BIOL, V141, P1207, DOI 10.1083/jcb.141.5.1207; BEULLENS M, 1992, J BIOL CHEM, V267, P16538; Bollen M, 2001, TRENDS BIOCHEM SCI, V26, P426, DOI 10.1016/S0968-0004(01)01836-9; BRAUTIGAN DL, 1990, NATURE, V344, P74, DOI 10.1038/344074a0; Cohen PTW, 2002, J CELL SCI, V115, P241; Connor JH, 2000, J BIOL CHEM, V275, P18670, DOI 10.1074/jbc.M909312199; Connor JH, 2001, MOL CELL BIOL, V21, P6841, DOI 10.1128/MCB.21.20.6841-6850.2001; Di Agostino S, 2002, DEVELOPMENT, V129, P1715; Doxsey S, 2001, NAT REV MOL CELL BIO, V2, P688, DOI 10.1038/35089575; Egloff MP, 1997, EMBO J, V16, P1876, DOI 10.1093/emboj/16.8.1876; Endo S, 1996, BIOCHEMISTRY-US, V35, P5220, DOI 10.1021/bi952940f; Eto M, 1999, BIOCHEMISTRY-US, V38, P16952, DOI 10.1021/bi992030o; Eto M, 1997, FEBS LETT, V410, P356, DOI 10.1016/S0014-5793(97)00657-1; ETO M, 1995, J BIOCHEM, V118, P1104, DOI 10.1093/oxfordjournals.jbchem.a124993; Eto M, 2000, CELL MOTIL CYTOSKEL, V46, P222, DOI 10.1002/1097-0169(200007)46:3<222::AID-CM6>3.3.CO;2-2; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; Fry AM, 1998, J CELL BIOL, V141, P1563, DOI 10.1083/jcb.141.7.1563; Fry AM, 1998, EMBO J, V17, P470, DOI 10.1093/emboj/17.2.470; Hayashi Y, 2001, J BIOL CHEM, V276, P39858, DOI 10.1074/jbc.M107302200; Helps NR, 2000, BIOCHEM J, V349, P509, DOI 10.1042/0264-6021:3490509; Helps NR, 1998, FEBS LETT, V438, P131, DOI 10.1016/S0014-5793(98)01286-1; HUANG FL, 1976, FEBS LETT, V62, P326, DOI 10.1016/0014-5793(76)80086-5; Huang HB, 1999, J BIOL CHEM, V274, P7870, DOI 10.1074/jbc.274.12.7870; INGEBRITSEN TS, 1983, EUR J BIOCHEM, V132, P255, DOI 10.1111/j.1432-1033.1983.tb07357.x; Kakinoki Y, 1997, J BIOL CHEM, V272, P32308, DOI 10.1074/jbc.272.51.32308; Leach C, 2002, J CELL SCI, V115, P3739, DOI 10.1242/jcs.00052; Liu J, 2001, P NATL ACAD SCI USA, V98, P6650, DOI 10.1073/pnas.111154698; Liu QR, 2002, J BIOL CHEM, V277, P13312, DOI 10.1074/jbc.M107558200; MacKintosh C, 1996, FEBS LETT, V397, P235, DOI 10.1016/S0014-5793(96)01175-1; Meraldi P, 2001, J CELL SCI, V114, P3749; Meraldi P, 2002, FEBS LETT, V521, P9, DOI 10.1016/S0014-5793(02)02865-X; PARK IK, 1994, J BIOL CHEM, V269, P28919; PUNTONI F, 1995, BIOCHEM BIOPH RES CO, V207, P732, DOI 10.1006/bbrc.1995.1248; SCHULTZ SJ, 1994, CELL GROWTH DIFFER, V5, P625; Senba S, 1999, J BIOCHEM-TOKYO, V125, P354, DOI 10.1093/oxfordjournals.jbchem.a022294; SHERLINE P, 1982, J CELL BIOL, V93, P507, DOI 10.1083/jcb.93.2.507; SHERLINE P, 1982, J CELL BIOL, V95, P316, DOI 10.1083/jcb.95.1.316; Shirato H, 2000, BIOCHEMISTRY-US, V39, P13848, DOI 10.1021/bi001326n; STRALFORS P, 1985, EUR J BIOCHEM, V149, P295, DOI 10.1111/j.1432-1033.1985.tb08926.x; TUNG HYL, 1995, MOL CELL BIOL, V15, P6064; WANG QM, 1995, J BIOL CHEM, V270, P18352, DOI 10.1074/jbc.270.31.18352; Watanabe T, 2001, P NATL ACAD SCI USA, V98, P3080, DOI 10.1073/pnas.051003898; Yang J, 2000, J BIOL CHEM, V275, P22635, DOI 10.1074/jbc.M003082200	45	81	84	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2002	277	46					44013	44020		10.1074/jbc.M208035200	http://dx.doi.org/10.1074/jbc.M208035200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	615XE	12221103	hybrid			2022-12-27	WOS:000179272000063
J	Wang, XH; Krupczak-Hollis, K; Tan, YJ; Dennewitz, MB; Adami, GR; Costa, RH				Wang, XH; Krupczak-Hollis, K; Tan, YJ; Dennewitz, MB; Adami, GR; Costa, RH			Increased hepatic forkhead box M1B (FoxM1B) levels in old-aged mice stimulated liver regeneration through diminished p27(KiP1) protein levels and increased Cdc25B expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR HFH-11B; CELL-CYCLE REGULATION; HEPATOCYTE ENTRY; S-PHASE; GROWTH; HEAD; PHOSPHORYLATION; ENDODERM; LACKING; INJURY	Recent liver regeneration studies indicate that maintaining hepatic Forkhead Box M1B (FoxM1B) expression in 12-month-old (old-aged) Transthyretin-FoxM1B transgenic mice increases hepatocyte proliferation and expression of cell cycle regulatory genes. Because these transgenic CD-1 mice maintain FoxM1B levels during the aging process, we conducted the current study to determine whether adenovirus delivery of the FoxM1B gene (AdFoxM1B) is sufficient to stimulate liver regeneration in old-aged Balb/c mice. Here we show that AdFoxM1B infection of old-aged mice caused a significant increase in FoxM1B expression, hepatocyte DNA replication, and mitosis following partial hepatectomy. This stimulation in hepatocyte S-phase progression was associated with diminished protein expression and perinuclear localization of cyclin-dependent kinase (Cdk) inhibitor p27(Kip1) (p27) protein following partial hepatectomy. In contrast, old-aged mice infected with control virus displayed high hepatocyte levels of p27 protein, which had been localized to the nucleus prior to S-phase. Furthermore, we found that restoring FoxM1B expression did not influence p27 mRNA levels, and this new finding implicates FoxM1B in regulation of p27 protein levels. Likewise, AdFoxM1B-infected regenerating livers displayed elevated S-phase levels of Cdk2 kinase activity compared with old-aged mice infected with control virus. Furthermore, restoring FoxM1B expression in old-aged mice caused elevated levels of Cyclin B1, Cyclin B2, Cdc25B, Cdk1, and p55CDC mRNA as well as stimulating Cdc25B nuclear localization during liver regeneration, all of which are required for mitosis. These studies indicated that an acute delivery of the FoxM1B gene in old-aged mice is sufficient to re-establish proliferation of regenerating hepatocytes, suggesting that FoxM1B can be used for therapeutic intervention to alleviate the reduction in cellular proliferation observed in the elderly.	Univ Illinois, Coll Med & Dent, Dept Mol Genet, Chicago, IL 60607 USA; Univ Illinois, Coll Med & Dent, Dept Oral Med & Diagnost Sci, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Costa, RH (corresponding author), Univ Illinois, Dept Mol Genet MC699, Coll Med, 900 S Ashland Ave,Rm 2220 MBRB, Chicago, IL 60607 USA.				NIDDK NIH HHS [R01 DK 54687-04] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054687] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Benihoud K, 2000, J GENE MED, V2, P194, DOI 10.1002/(SICI)1521-2254(200005/06)2:3<194::AID-JGM102>3.0.CO;2-5; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; CLARK KL, 1993, NATURE, V364, P412, DOI 10.1038/364412a0; Costa RH, 2001, AM J PHYSIOL-LUNG C, V280, pL823, DOI 10.1152/ajplung.2001.280.5.L823; Cressman DE, 1996, SCIENCE, V274, P1379, DOI 10.1126/science.274.5291.1379; Diehl AM, 2000, IMMUNOL REV, V174, P160, DOI 10.1034/j.1600-0528.2002.017411.x; Duncan SA, 2000, DEV DYNAM, V219, P131, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1051>3.3.CO;2-E; Guo SD, 1999, J BIOL CHEM, V274, P17184, DOI 10.1074/jbc.274.24.17184; Hara T, 2001, J BIOL CHEM, V276, P48937, DOI 10.1074/jbc.M107274200; Harbour JW, 2000, GENE DEV, V14, P2393, DOI 10.1101/gad.813200; Kaestner KH, 2000, TRENDS ENDOCRIN MET, V11, P281, DOI 10.1016/S1043-2760(00)00271-X; Kaestner KH, 2000, GENE DEV, V14, P142; Karlsson C, 1999, J CELL BIOL, V146, P573, DOI 10.1083/jcb.146.3.573; Kaufmann E, 1996, MECH DEVELOP, V57, P3, DOI 10.1016/0925-4773(96)00539-4; Kiyokawa H, 1996, CELL, V85, P721, DOI 10.1016/S0092-8674(00)81238-6; Ly DH, 2000, SCIENCE, V287, P2486, DOI 10.1126/science.287.5462.2486; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Nilsson I, 2000, Prog Cell Cycle Res, V4, P107; Rausa FM, 2000, MOL CELL BIOL, V20, P8264, DOI 10.1128/MCB.20.21.8264-8282.2000; Rausa FM, 1998, METHODS, V16, P29, DOI 10.1006/meth.1998.0642; Rodier G, 2001, EMBO J, V20, P6672, DOI 10.1093/emboj/20.23.6672; SCHWARZ JK, 1995, P NATL ACAD SCI USA, V92, P483, DOI 10.1073/pnas.92.2.483; SEBASTIAN B, 1993, P NATL ACAD SCI USA, V90, P3521, DOI 10.1073/pnas.90.8.3521; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Tan YJ, 2002, HEPATOLOGY, V35, P30, DOI 10.1053/jhep.2002.30317; Tan YJ, 2001, GENE EXPRESSION, V9, P237, DOI 10.3727/000000001783992542; Taub R, 1999, SEMIN LIVER DIS, V19, P117, DOI 10.1055/s-2007-1007104; Tomoda K, 1999, NATURE, V398, P160, DOI 10.1038/18230; Tomoda K, 2002, J BIOL CHEM, V277, P2302, DOI 10.1074/jbc.M104431200; Trembley JH, 1996, CELL GROWTH DIFFER, V7, P903; Wang XH, 2001, P NATL ACAD SCI USA, V98, P11468, DOI 10.1073/pnas.201360898; Wang XH, 2001, HEPATOLOGY, V33, P1404, DOI 10.1053/jhep.2001.24666; Yamada Y, 1997, P NATL ACAD SCI USA, V94, P1441, DOI 10.1073/pnas.94.4.1441; Ye HG, 1999, MOL CELL BIOL, V19, P8570; Ye HG, 1997, MOL CELL BIOL, V17, P1626, DOI 10.1128/MCB.17.3.1626; Zachariae W, 1999, GENE DEV, V13, P2039, DOI 10.1101/gad.13.16.2039; Zaret K, 1999, DEV BIOL, V209, P1, DOI 10.1006/dbio.1999.9228	39	126	136	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	2002	277	46					44310	44316		10.1074/jbc.M207510200	http://dx.doi.org/10.1074/jbc.M207510200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	615XE	12221098	hybrid			2022-12-27	WOS:000179272000101
J	Chenal, A; Savarin, P; Nizard, P; Guillain, F; Gillet, D; Forge, V				Chenal, A; Savarin, P; Nizard, P; Guillain, F; Gillet, D; Forge, V			Membrane protein insertion regulated by bringing electrostatic and hydrophobic interactions into play - A case study with the translocation domain of the diphtheria toxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOPLASMIC-RETICULUM ATPASE; MOLTEN GLOBULE STATE; T-DOMAIN; ANTIMICROBIAL PEPTIDE; LIPID BILAYERS; CA2+ BINDING; ANIONIC PHOSPHOLIPIDS; TRANSMEMBRANE DOMAIN; ALPHA-LACTALBUMIN; MECHANISM	The study of the membrane insertion of the translocation domain of diphtheria toxin deepens our insight into the interactions between proteins and membranes. During cell intoxication, this domain undergoes a change from a soluble and folded state at alkaline pH to a functional membrane-inserted state at acid pH. We found that hydrophobic and electrostatic interactions occur in a sequential manner between the domain and the membrane during the insertion. The first step involves hydrophobic interactions by the C-terminal region. This is because of the pH-induced formation of a molten globule specialized for binding to the membrane. Accumulation of this molten globule follows a precise molecular mechanism adapted to the toxin function. The second step, as the pH decreases, leads to the functional inserted state. It arises from the changes in the balance of electrostatic attractions and repulsions between the N-terminal part and the membrane. Our study shows how the structural changes and the interaction with membranes of the translocation domain are finely tuned by pH changes to take advantage of the cellular uptake system.	CEA Saclay, Dept Ingn & Etud Prot, F-91191 Gif Sur Yvette, France; CEA, UMR 5090, Dept Reponse & Dynam Cellulaire, F-38054 Grenoble 9, France	CEA; UDICE-French Research Universities; Universite Paris Saclay; CEA	Gillet, D (corresponding author), CEA Saclay, Dept Ingn & Etud Prot, F-91191 Gif Sur Yvette, France.		Gillet, Daniel/C-5592-2008; Chenal, Alexandre/C-2240-2009	Gillet, Daniel/0000-0003-0477-3599; Chenal, Alexandre/0000-0002-4959-1003; Nizard, Philippe/0000-0002-7880-7029				ABRUZOVA A, 2002, BIOCHEM J, V362, P1; Arai M, 2000, ADV PROTEIN CHEM, V53, P209; BACKLUND BM, 1994, BBA-BIOMEMBRANES, V1190, P337, DOI 10.1016/0005-2736(94)90092-2; BALBACH J, 1995, NAT STRUCT BIOL, V2, P865, DOI 10.1038/nsb1095-865; BEAUMELLE B, 1992, J BIOL CHEM, V267, P11525; BENNETT MJ, 1994, PROTEIN SCI, V3, P1464, DOI 10.1002/pro.5560030912; Booth Paula J., 1999, Current Opinion in Structural Biology, V9, P115, DOI 10.1016/S0959-440X(99)80015-3; Chenal A, 2002, PROTEIN ENG, V15, P383, DOI 10.1093/protein/15.5.383; Chenal A, 2002, J TOXICOL-TOXIN REV, V21, P321, DOI 10.1081/TXR-120014408; CHOE S, 1992, NATURE, V357, P216, DOI 10.1038/357216a0; Clague MJ, 1998, BIOCHEM J, V336, P271, DOI 10.1042/bj3360271; D'Silva PR, 2000, J BIOL CHEM, V275, P11771, DOI 10.1074/jbc.275.16.11771; Dathe M, 1996, BIOCHEMISTRY-US, V35, P12612, DOI 10.1021/bi960835f; DUMOULIN M, 1908, PROTEIN SCI, V11, P500; FALNES PO, 1992, J BIOL CHEM, V267, P12284; FORGE V, 1993, J BIOL CHEM, V268, P10953; FORGE V, 1993, J BIOL CHEM, V268, P10961; GUILLAIN F, 1980, J BIOL CHEM, V255, P2072; Han X, 2001, NAT STRUCT BIOL, V8, P715, DOI 10.1038/90434; Heymann JB, 1996, BIOCHEMISTRY-US, V35, P2717, DOI 10.1021/bi951535l; Hunt JF, 1997, BIOCHEMISTRY-US, V36, P15177, DOI 10.1021/bi970147b; Jamin M, 2001, P NATL ACAD SCI USA, V98, P6127, DOI 10.1073/pnas.111157998; Kachel K, 1998, J BIOL CHEM, V273, P22950, DOI 10.1074/jbc.273.36.22950; Kaul P, 1996, PROTEIN SCI, V5, P687; KIM JY, 1991, BIOPHYS J, V60, P135, DOI 10.1016/S0006-3495(91)82037-9; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; KUWAJIMA K, 1989, J MOL BIOL, V206, P547, DOI 10.1016/0022-2836(89)90500-7; Kuwajima K, 1996, FASEB J, V10, P102, DOI 10.1096/fasebj.10.1.8566530; Ladokhin AS, 2001, J MOL BIOL, V309, P543, DOI 10.1006/jmbi.2001.4684; LEENHOUTS JM, 1995, FEBS LETT, V370, P189, DOI 10.1016/0014-5793(95)00823-R; Lemichez E, 1997, MOL MICROBIOL, V23, P445, DOI 10.1111/j.1365-2958.1997.tb02669.x; Lesieur C, 1997, MOL MEMBR BIOL, V14, P45, DOI 10.3109/09687689709068435; Liu LP, 1997, BIOCHEMISTRY-US, V36, P5476, DOI 10.1021/bi970030n; Malenbaum SE, 1998, BIOCHEMISTRY-US, V37, P17915, DOI 10.1021/bi981230h; Matsuzaki K, 1996, BIOCHEMISTRY-US, V35, P11361, DOI 10.1021/bi960016v; Matsuzaki K, 1996, BIOCHEMISTRY-US, V35, P8450, DOI 10.1021/bi960342a; MATSUZAKI K, 1995, BIOCHEMISTRY-US, V34, P6521, DOI 10.1021/bi00019a033; MATSUZAKI K, 1995, BIOCHEMISTRY-US, V34, P3423, DOI 10.1021/bi00010a034; Matsuzaki K, 1997, BIOCHEMISTRY-US, V36, P2104, DOI 10.1021/bi961870p; Mindell JA, 1998, P NATL ACAD SCI USA, V95, P4081, DOI 10.1073/pnas.95.8.4081; MOSIOR M, 1995, J BIOL CHEM, V270, P25526, DOI 10.1074/jbc.270.43.25526; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; NILSSON IM, 1990, CELL, V62, P1135, DOI 10.1016/0092-8674(90)90390-Z; Nizard P, 1998, FEBS LETT, V433, P83, DOI 10.1016/S0014-5793(98)00890-4; Nizard P, 2001, PROTEIN ENG, V14, P439, DOI 10.1093/protein/14.6.439; Oh KJ, 1999, BIOCHEMISTRY-US, V38, P10336, DOI 10.1021/bi990520a; Oh KJ, 1999, P NATL ACAD SCI USA, V96, P8467, DOI 10.1073/pnas.96.15.8467; PARKER MW, 1993, TRENDS BIOCHEM SCI, V18, P391, DOI 10.1016/0968-0004(93)90096-6; PRATS M, 1986, NATURE, V322, P756, DOI 10.1038/322756a0; Rankin SE, 1998, BIOCHEMISTRY-US, V37, P12588, DOI 10.1021/bi980408x; Ren JH, 1999, BIOCHEMISTRY-US, V38, P976, DOI 10.1021/bi981576s; RIGAUD JL, 1983, BIOCHEM BIOPH RES CO, V111, P373, DOI 10.1016/0006-291X(83)90316-9; SANDVIG K, 1986, J BIOL CHEM, V261, P1639; Schulman BA, 1997, NAT STRUCT BIOL, V4, P630, DOI 10.1038/nsb0897-630; Senzel L, 1998, J GEN PHYSIOL, V112, P317, DOI 10.1085/jgp.112.3.317; Senzel L, 2000, J GEN PHYSIOL, V115, P421, DOI 10.1085/jgp.115.4.421; Smith ER, 1999, J BIOL CHEM, V274, P35325, DOI 10.1074/jbc.274.50.35325; Stahelin RV, 2001, BIOCHEMISTRY-US, V40, P4672, DOI 10.1021/bi0020325; Umata T, 1998, J BIOL CHEM, V273, P8351, DOI 10.1074/jbc.273.14.8351; VANDERGOOT FG, 1991, NATURE, V354, P408, DOI 10.1038/354408a0; Watts A, 1995, BIOCHEM SOC T, V23, P959, DOI 10.1042/bst0230959; WHITE SH, 1994, CURR OPIN STRUC BIOL, V4, P79, DOI 10.1016/S0959-440X(94)90063-9; ZHAN HJ, 1994, BIOCHEMISTRY-US, V33, P11254, DOI 10.1021/bi00203a022; ZHAN HJ, 1995, BIOCHEMISTRY-US, V34, P4856, DOI 10.1021/bi00014a043; Zhang LJ, 2001, J BIOL CHEM, V276, P35714, DOI 10.1074/jbc.M104925200	65	68	68	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					43425	43432		10.1074/jbc.M204148200	http://dx.doi.org/10.1074/jbc.M204148200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12193591	hybrid			2022-12-27	WOS:000179081200127
J	Basu, A; Lu, DM; Sun, BH; Moor, AN; Akkaraju, GR; Huang, J				Basu, A; Lu, DM; Sun, BH; Moor, AN; Akkaraju, GR; Huang, J			Proteolytic activation of protein kinase C-is an element of by caspase-mediated processing and transduction of antiapoptotic signals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; BREAST-CANCER CELLS; INDUCED APOPTOSIS; INVOLVEMENT; CLEAVAGE; EPSILON; FAMILY; DELTA; SPECIFICITIES; SENSITIVITY	Several novel protein kinase C (PKC) isozymes have been identified as substrates for caspase-3. We have previously shown that novel PKCepsilon is cleaved during apoptosis in MCF-7 cells that lack any functional caspase-3. In the present study, we show that in vitro-translated PKCepsilon is processed by human recombinant caspase-3, -7, and -9. Tumor necrosis factor-alpha (TNF) triggered processing of PKCepsilon to a 43-kDa carboxyl-terminal fragment, and cell-permeable caspase inhibitors prevented TNF-induced processing of PKCe in MCF-7 cells. PKCepsilon was cleaved primarily at the SSPD down arrow G site to generate two fragments with an approximate molecular mass of 43 kDa. It was also cleaved at the DDVD down arrow C site to generate two fragments with molecular masses of 52 and 35 kDa. Treatment of MCF-7 cells with TNF resulted in the activation of PKCepsilon, and mutation at the SSPD down arrow G (D383A) site inhibited proteolytic activation of PKCepsilon. Overexpression of wild-type but not dominant-negative PKCepsilon in MCF-7 cells delayed TNF-induced apoptosis, and mutation at the D383A site prevented antiapoptotic activity of PKCepsilon. These results suggest that cleavage of PKCepsilon by caspase-7 at the SSPD down arrow G site results in the activation of PKCepsilon. Furthermore, activation of PKCepsilon was associated with its antiapoptotic function.	Univ N Texas, Hlth Sci Ctr, Dept Mol Biol & Immunol, Ft Worth, TX 76107 USA	University of North Texas System; University of North Texas Health Science Center	Basu, A (corresponding author), Univ N Texas, Hlth Sci Ctr, Dept Mol Biol & Immunol, 3500 Camp Bowie Blvd, Ft Worth, TX 76107 USA.			Basu, Alakananda/0000-0002-1656-0788; Sun, Baohua/0000-0003-0393-8099	NATIONAL CANCER INSTITUTE [R01CA071727, R01CA085682] Funding Source: NIH RePORTER; NCI NIH HHS [CA71727, CA85682] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BASU A, 1995, INT J CANCER, V63, P597, DOI 10.1002/ijc.2910630422; Basu A, 1999, BIOCHEMISTRY-US, V38, P4245, DOI 10.1021/bi982854q; Basu A, 2001, CELL DEATH DIFFER, V8, P899, DOI 10.1038/sj.cdd.4400885; BASU A, 1993, PHARMACOL THERAPEUT, V59, P257, DOI 10.1016/0163-7258(93)90070-T; Basu A, 2001, BIOCHEM BIOPH RES CO, V280, P883, DOI 10.1006/bbrc.2000.4209; Basu A, 1998, MOL PHARMACOL, V53, P105, DOI 10.1124/mol.53.1.105; Datta R, 1997, J BIOL CHEM, V272, P20317, DOI 10.1074/jbc.272.33.20317; Emoto Y, 1995, EMBO J, V14, P6148, DOI 10.1002/j.1460-2075.1995.tb00305.x; Endo K, 2000, J BIOL CHEM, V275, P18476, DOI 10.1074/jbc.M002266200; Garcia-Calvo M, 1998, J BIOL CHEM, V273, P32608, DOI 10.1074/jbc.273.49.32608; Germain M, 1999, J BIOL CHEM, V274, P28379, DOI 10.1074/jbc.274.40.28379; JACKSON RJ, 1983, METHOD ENZYMOL, V96, P50; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; JOHANNES FJ, 1994, J BIOL CHEM, V269, P6140; Koriyama H, 1999, CELL SIGNAL, V11, P831, DOI 10.1016/S0898-6568(99)00055-8; Lavie Y, 1998, INT J CANCER, V77, P928, DOI 10.1002/(SICI)1097-0215(19980911)77:6<928::AID-IJC22>3.0.CO;2-W; Mayne GC, 1998, J BIOL CHEM, V273, P24115, DOI 10.1074/jbc.273.37.24115; Mizuno K, 1997, EUR J BIOCHEM, V250, P7, DOI 10.1111/j.1432-1033.1997.00007.x; NEWTON AC, 1995, J BIOL CHEM, V270, P28495, DOI 10.1074/jbc.270.43.25526; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; Perletti GP, 1998, ONCOGENE, V16, P3345, DOI 10.1038/sj.onc.1201871; Salvesen GS, 1997, CELL, V91, P443, DOI 10.1016/S0092-8674(00)80430-4; Smith L, 2000, J BIOL CHEM, V275, P40620, DOI 10.1074/jbc.M908517199; STABEL S, 1991, PHARMACOL THERAPEUT, V51, P71, DOI 10.1016/0163-7258(91)90042-K; Talanian RV, 1997, J BIOL CHEM, V272, P9677; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907	27	73	77	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					41850	41856		10.1074/jbc.M205997200	http://dx.doi.org/10.1074/jbc.M205997200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12198125	hybrid			2022-12-27	WOS:000178985300071
J	Gengs, CX; Leung, HT; Skingsley, DR; Iovchev, MI; Yin, Z; Semenov, EP; Burg, MG; Hardie, RC; Pak, WL				Gengs, CX; Leung, HT; Skingsley, DR; Iovchev, MI; Yin, Z; Semenov, EP; Burg, MG; Hardie, RC; Pak, WL			The target of Drosophila photoreceptor synaptic transmission is a histamine-gated chloride channel encoded by ort (hclA)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE; RECEPTOR; MELANOGASTER; MUTATIONS; CLONING; IDENTIFICATION; EXPRESSION; PROTEINS; SEQUENCE; DOMAINS	By screening Drosophila mutants that are potentially defective in synaptic transmission between photoreceptors and their target laminar neurons, L1/L2, (lack of electroretinogram on/off transients), we identified ort as a candidate gene encoding a histamine receptor subunit on Ll/L2. We provide evidence that the ort gene corresponds to CG7411 (referred to as hclA), identified in the Drosophila genome data base, by P-element-mediated germ line rescue of the ort phenotype using cloned hclA cDNA and by showing that several ort mutants exhibit alterations in hclA regulatory or coding sequences and/or allele-dependent reductions in hclA transcript levels. Other workers have shown that hclA, when expressed in Xenopus oocytes, forms histamine-sensitive chloride channels. However, the connection between these chloride channels and photoreceptor synaptic transmission was not established. We show unequivocally that hclA-encoded channels are the channels required in photoreceptor synaptic transmission by 1) establishing the identity between hclA and ort and 2) showing that ort mutants are defective in photoreceptor synaptic transmission. Moreover, the present work shows that this function of the HCLA (ORT) protein is its native function in vivo.	Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; Univ Cambridge, Dept Anat, Cambridge CB2 3EJ, England; Bulgarian Acad Sci, Inst Mol Biol, BU-1113 Sofia, Bulgaria	Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Cambridge; University of Cambridge; Bulgarian Academy of Sciences	Pak, WL (corresponding author), Purdue Univ, Dept Biol Sci, 1392 Lilly Hall, W Lafayette, IN 47907 USA.			Hardie, Roger/0000-0001-5531-3264; Skingsley, David/0000-0003-1025-7574	NATIONAL EYE INSTITUTE [R56EY000033, R37EY000033, R01EY000033] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH049727] Funding Source: NIH RePORTER; NEI NIH HHS [EY00033] Funding Source: Medline; NIMH NIH HHS [MH49727] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BONINI NM, 1993, CELL, V72, P379, DOI 10.1016/0092-8674(93)90115-7; BUCHNER E, 1991, J NEUROGENET, V7, P153, DOI 10.3109/01677069109167432; BURG MG, 1993, EMBO J, V12, P911, DOI 10.1002/j.1460-2075.1993.tb05732.x; COHEN GB, 1995, CELL, V80, P237, DOI 10.1016/0092-8674(95)90406-9; Cully DF, 1996, J BIOL CHEM, V271, P20187, DOI 10.1074/jbc.271.33.20187; DIANTONIO A, 1994, NEURON, V12, P909, DOI 10.1016/0896-6273(94)90342-5; GANTZ I, 1991, P NATL ACAD SCI USA, V88, P429, DOI 10.1073/pnas.88.2.429; Gisselmann G, 2002, NAT NEUROSCI, V5, P11, DOI 10.1038/nn787; HARDIE RC, 1989, NATURE, V339, P704, DOI 10.1038/339704a0; HARRISON SD, 1994, NEURON, V13, P555, DOI 10.1016/0896-6273(94)90025-6; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; LARRIVEE DC, 1981, J GEN PHYSIOL, V78, P521, DOI 10.1085/jgp.78.5.521; Li CJ, 1999, P NATL ACAD SCI USA, V96, P13474, DOI 10.1073/pnas.96.23.13474; LINDSLEY DL, 1990, DROSOPHILA INFORMATI, V68, P100; Liu CL, 2001, MOL PHARMACOL, V59, P420, DOI 10.1124/mol.59.3.420; Lovenberg TW, 1999, MOL PHARMACOL, V55, P1101, DOI 10.1124/mol.55.6.1101; Nguyen T, 2001, MOL PHARMACOL, V59, P427, DOI 10.1124/mol.59.3.427; OCONNELL P, 1984, NUCLEIC ACIDS RES, V12, P5495, DOI 10.1093/nar/12.13.5495; OTOUSA JE, 1989, J NEUROGENET, V6, P41, DOI 10.3109/01677068909107099; Pak W.L., 1979, P67; PAK WL, 1995, INVEST OPHTH VIS SCI, V36, P2340; PAK WL, 2002, IN PRESS RECEPTORS C; PAK WL, 1975, HDB GENETICS, V3, P703; PETROVICH TZ, 1993, GENETICS, V133, P955; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Semenov EP, 1999, J NEUROCHEM, V72, P66, DOI 10.1046/j.1471-4159.1999.0720066.x; SKINGSLEY DR, 1995, J COMP PHYSIOL A, V176, P611, DOI 10.1007/BF01021581; Stuart AE, 1999, NEURON, V22, P431, DOI 10.1016/S0896-6273(00)80699-6; Sved J, 1986, DROSOPH INF SERV, V63, P169; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Zheng YC, 2002, J BIOL CHEM, V277, P2000, DOI 10.1074/jbc.M107635200; Zhu Y, 2001, MOL PHARMACOL, V59, P434, DOI 10.1124/mol.59.3.434; ZINSMAIER KE, 1994, SCIENCE, V263, P977, DOI 10.1126/science.8310297	33	91	95	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					42113	42120		10.1074/jbc.M207133200	http://dx.doi.org/10.1074/jbc.M207133200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12196539	hybrid			2022-12-27	WOS:000178985300102
J	Lecat, S; Bucher, B; Mely, Y; Galzi, JL				Lecat, S; Bucher, B; Mely, Y; Galzi, JL			Mutations in the extracellular amino-terminal domain of the NK2 neurokinin receptor abolish cAMP signaling but preserve intracellular calcium responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE G-PROTEINS; HAMSTER OVARY CELLS; SUBSTANCE-P; BETA(2)-ADRENERGIC RECEPTOR; ACETYLCHOLINE-RECEPTOR; DOPAMINE-RECEPTORS; LIGAND-BINDING; NK-1 RECEPTOR; HIGH-AFFINITY; KINASE-A	By combining real time measurements of agonist binding, by fluorescence resonance energy transfer, and of subsequent responses, we proposed previously that the neurokinin NK2 receptor preexists in equilibrium between three states: inactive, calcium-triggering, and cAMP-producing. Thr(24) and Phe(26) of the NK2 receptor extracellular domain are considered to interact with neuropeptide agonists based on the reduction of affinity when they are substituted by alanine. Using fluorescence resonance energy transfer, we now quantify the binding kinetics of two Texas Red-modified neurokinin A agonists to the fluorescent wild-type (Y-NK2wt) an the mutant (Y-NK2mut) receptor carrying Thr(24) --> Ala and Phe(26) --> Ala mutations. TR1-neurokinin A binds with a fast component and a slow component to the Y-NK2wt receptor and triggers both a calcium and a cAMP response. In contrast, on the mutant receptor, it binds in a single fast step with a lower apparent affinity and activates only the calcium response. Another agonist, TRC4-neurokinin A, binds to both wild-type and mutant receptors in a single fast step, with similar affinities and kinetics and promotes only calcium signaling. Kinetic modeling of ligand binding and receptor interconversions is carried out to analyze phenotypic changes in terms of binding alterations or changes in the transitions between conformational states. We show that the binding and response properties of the Y-NK2mut receptor are best described according to a phenotype where a reduction of the transition between the inactive and the active states occurs.	Ecole Super Biotechnol Strasbourg, CNRS, UPR Recepteurs & Prot Membranaires 9050, F-67400 Illkirch Graffenstaden, France; Univ Louis Pasteur Strasbourg 1, CNRS, UMR Pharmacol & Physicochim Interact Cellulaires, Fac Pharm, F-67401 Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Galzi, JL (corresponding author), Ecole Super Biotechnol Strasbourg, CNRS, UPR Recepteurs & Prot Membranaires 9050, Blvd Sebastien Brandt, F-67400 Illkirch Graffenstaden, France.							ALBLAS J, 1995, J BIOL CHEM, V270, P8944, DOI 10.1074/jbc.270.15.8944; Bremer AA, 2000, FEBS LETT, V486, P43, DOI 10.1016/S0014-5793(00)02228-6; Bremer AA, 2001, J BIOL CHEM, V276, P22857, DOI 10.1074/jbc.M100824200; Catalioto RM, 1998, N-S ARCH PHARMACOL, V358, P395, DOI 10.1007/PL00005270; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Ciucci A, 1998, BRIT J PHARMACOL, V125, P393, DOI 10.1038/sj.bjp.0702070; Daaka Y, 1997, NATURE, V390, P88, DOI 10.1038/36362; Edelstein SJ, 1996, BIOL CYBERN, V75, P361, DOI 10.1007/s004220050302; FONG TM, 1992, BIOCHEMISTRY-US, V31, P11806, DOI 10.1021/bi00162a019; Fuchs S, 2001, MOL MED, V7, P115, DOI 10.1007/BF03401945; Galzi JL, 1996, P NATL ACAD SCI USA, V93, P1853, DOI 10.1073/pnas.93.5.1853; Gicquiaux H, 2002, J BIOL CHEM, V277, P6645, DOI 10.1074/jbc.M107224200; Grammatopoulos DK, 2001, J NEUROCHEM, V76, P509, DOI 10.1046/j.1471-4159.2001.00067.x; Hawes BE, 2000, ENDOCRINOLOGY, V141, P4524, DOI 10.1210/en.141.12.4524; HEIDMANN T, 1980, BIOCHEM BIOPH RES CO, V97, P889, DOI 10.1016/0006-291X(80)91460-6; HUANG RRC, 1994, MOL PHARMACOL, V45, P690; HUANG RRC, 1995, BIOCHEMISTRY-US, V34, P10048, DOI 10.1021/bi00031a029; Imamura F, 2000, BIOCHEMISTRY-US, V39, P686, DOI 10.1021/bi991981z; KARLIN A, 1967, J THEOR BIOL, V16, P306, DOI 10.1016/0022-5193(67)90011-2; KIMURA K, 1995, J NEUROCHEM, V64, P2118; Labrou NE, 1999, PEPTIDES, V20, P795, DOI 10.1016/S0196-9781(99)00064-9; Labrou NE, 2001, J BIOL CHEM, V276, P37944; Lawler OA, 2001, J BIOL CHEM, V276, P33596, DOI 10.1074/jbc.M104434200; LEFF P, 1995, TRENDS PHARMACOL SCI, V16, P89, DOI 10.1016/S0165-6147(00)88989-0; Lezcano N, 2000, SCIENCE, V287, P1660, DOI 10.1126/science.287.5458.1660; LI YM, 1995, J BIOL CHEM, V270, P1213, DOI 10.1074/jbc.270.3.1213; Lorenzen A, 1998, BIOCHEM PHARMACOL, V56, P1287, DOI 10.1016/S0006-2952(98)00207-X; Luo X, 1999, J BIOL CHEM, V274, P17684, DOI 10.1074/jbc.274.25.17684; NAKAJIMA Y, 1992, J BIOL CHEM, V267, P2437; Palanche T, 2001, J BIOL CHEM, V276, P34853, DOI 10.1074/jbc.M104363200; Pellegrini M, 2001, J BIOL CHEM, V276, P22862, DOI 10.1074/jbc.M101057200; Pindon A, 2002, MOL PHARMACOL, V61, P85, DOI 10.1124/mol.61.1.85; Roush ED, 1998, FEBS LETT, V428, P291, DOI 10.1016/S0014-5793(98)00553-5; Rumenapp U, 2001, J BIOL CHEM, V276, P2474, DOI 10.1074/jbc.M004957200; SAMAMA P, 1993, J BIOL CHEM, V268, P4625; Schwindinger WF, 1998, ENDOCRINE, V8, P201, DOI 10.1385/ENDO:8:2:201; Sidhu A, 1998, MOL NEUROBIOL, V16, P125, DOI 10.1007/BF02740640; Vollmer JY, 1999, J BIOL CHEM, V274, P37915, DOI 10.1074/jbc.274.53.37915; Weiss JM, 1996, J THEOR BIOL, V181, P381, DOI 10.1006/jtbi.1996.0139	40	46	46	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					42034	42048		10.1074/jbc.M203606200	http://dx.doi.org/10.1074/jbc.M203606200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12185075	hybrid			2022-12-27	WOS:000178985300093
J	Misra, UK; Gonzalez-Gronow, M; Gawdi, G; Hart, JP; Johnson, CE; Pizzo, SV				Misra, UK; Gonzalez-Gronow, M; Gawdi, G; Hart, JP; Johnson, CE; Pizzo, SV			The role of Grp 78 in alpha(2)-macroglobulin-induced signal transduction - Evidence from RNA interference that the low density lipoprotein receptor-related protein is associated with, but not necessary for, Grp 78-mediated signal transduction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEVATES INTRACELLULAR CALCIUM; METHYL-D-ASPARTATE; RECOGNIZED FORMS; PROTEIN/ALPHA(2)-MACROGLOBULIN RECEPTOR; PARTIAL-PURIFICATION; BINDING; ALPHA-2-MACROGLOBULIN; LIGATION; SOLUBILIZATION; ALPHA(2)M	The low density lipoprotein receptor-related protein (LRP) is a scavenger receptor that binds to many proteins, some of which trigger signal transduction. Receptor-recognized forms of alpha(2)-Macroglobulin (alpha(2)M*) bind to LRP, but the pattern of signal transduction differs significantly from that observed with other LRP ligands. For example, neither Ni2+ nor the receptor-associated protein, which blocks binding of all known ligands to LRP, block alpha(2)M*-induced signal transduction. In the current study, we employed alpha(2)-macroglobulin (alpha(2)M)agarose column chromatography to purify cell surface membrane binding proteins from 1-LN human prostate cancer cells and murine macrophages. The predominant binding protein purified from 1-LN prostate cancer cells was Grp 78 with small amounts of LRP, a fact that is consistent with our previous observations that there is little LRP present on the surface of these cells. The ratio of LRP:Grp 78 is much higher in macrophages. Flow cytometry was employed to demonstrate the presence of Grp 78 on the cell surface of 1-LN cells. Purified Grp 78 binds to alpha(2)M* with high affinity (K-d similar to150 pm). A monoclonal antibody directed against Grp 78 both abolished alpha(2)M*-induced signal transduction and co-precipitated LRP. Ligand blotting with alpha(2)M* showed binding to both Grp 78 and LRP heavy chains in these preparations. Use of RNA interference to silence LRP expression had no effect on alpha(2)M*-mediated signaling. We conclude that Grp 78 is essential for alpha(2)M*-induced signal transduction and that a "co-receptor" relationship exists with LRP like that seen with several other ligands and receptors such as the uPA/uPAR (urinary type plasminogen activator or urokinase/uPA receptor) system.	Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA	Duke University	Pizzo, SV (corresponding author), Duke Univ, Med Ctr, Dept Pathol, Box 3712, Durham, NC 27710 USA.	pizzo001@mc.duke.edu						Asplin IR, 2000, ARCH BIOCHEM BIOPHYS, V383, P135, DOI 10.1006/abbi.2000.2052; Bacskai BJ, 2000, P NATL ACAD SCI USA, V97, P11551, DOI 10.1073/pnas.200238297; Berger CL, 1997, INT J CANCER, V71, P1077; Delpino A, 1998, MOL MEMBR BIOL, V15, P21, DOI 10.3109/09687689809027514; DICKSON RB, 1981, FEBS LETT, V126, P265, DOI 10.1016/0014-5793(81)80257-8; Gething MJ, 1999, SEMIN CELL DEV BIOL, V10, P465, DOI 10.1006/scdb.1999.0318; Goretzki L, 1998, BIOCHEM J, V336, P381, DOI 10.1042/bj3360381; HANOVER JA, 1983, J BIOL CHEM, V258, P370; HANOVER JA, 1983, ANN NY ACAD SCI, V421, P410, DOI 10.1111/j.1749-6632.1983.tb18135.x; Howard GC, 1996, J BIOL CHEM, V271, P14105, DOI 10.1074/jbc.271.24.14105; Howard GC, 1996, J CLIN INVEST, V97, P1193, DOI 10.1172/JCI118533; JENSEN PEH, 1989, BIOCHEM ARCH, V5, P171; Jorgensen MM, 2000, J BIOL CHEM, V275, P33861, DOI 10.1074/jbc.M004663200; KRIEGER M, 1994, ANNU REV BIOCHEM, V63, P601, DOI 10.1146/annurev.bi.63.070194.003125; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; Misra UK, 1998, CELL SIGNAL, V10, P441, DOI 10.1016/S0898-6568(97)00171-X; MISRA UK, 1995, BIOCHEM J, V309, P151, DOI 10.1042/bj3090151; Misra UK, 1997, J BIOL CHEM, V272, P497; Misra UK, 1999, J BIOL CHEM, V274, P25785, DOI 10.1074/jbc.274.36.25785; Misra UK, 1999, ARCH BIOCHEM BIOPHYS, V372, P238, DOI 10.1006/abbi.1999.1521; MISRA UK, 1993, BIOCHEM J, V290, P885, DOI 10.1042/bj2900885; Misra UK, 1998, J BIOL CHEM, V273, P13399, DOI 10.1074/jbc.273.22.13399; MISRA UK, 1994, J BIOL CHEM, V269, P12541; Misra UK, 2002, J BIOL CHEM, V277, P4069, DOI 10.1074/jbc.M109764200; Misra UK, 2002, J BIOL CHEM, V277, P36509, DOI 10.1074/jbc.M203543200; MISRA UK, 1994, J BIOL CHEM, V269, P18303; Misra UK, 1999, ARCH BIOCHEM BIOPHYS, V363, P68, DOI 10.1006/abbi.1998.1074; Morishima Y, 2000, J BIOL CHEM, V275, P18054, DOI 10.1074/jbc.M000434200; Moser TL, 1999, P NATL ACAD SCI USA, V96, P2811, DOI 10.1073/pnas.96.6.2811; Odom AR, 1997, BIOCHEMISTRY-US, V36, P12395, DOI 10.1021/bi970806k; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Qiu ZH, 2002, J BIOL CHEM, V277, P14458, DOI 10.1074/jbc.M112066200; STRICKLAND DK, 1990, J BIOL CHEM, V265, P17401; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Triantafilou M, 2001, HUM IMMUNOL, V62, P764, DOI 10.1016/S0198-8859(01)00269-5; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; WU S, 2001, HEMOSTASIS THROMBOSE, P367; Xu M, 1998, J BIOL CHEM, V273, P13918, DOI 10.1074/jbc.273.22.13918	38	117	124	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					42082	42087		10.1074/jbc.M206174200	http://dx.doi.org/10.1074/jbc.M206174200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12194978	hybrid			2022-12-27	WOS:000178985300098
J	Planey, SL; Derfoul, A; Steplewski, A; Robertson, NM; Litwack, G				Planey, SL; Derfoul, A; Steplewski, A; Robertson, NM; Litwack, G			Inhibition of glucocorticoid-induced apoptosis in 697 pre-B lymphocytes by the mineralocorticoid receptor N-terminal domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C RELEASE; BCL-2 HOMOLOG; CASPASE ACTIVATION; DEATH RECEPTORS; CELL-DEATH; KAPPA-B; MITOCHONDRIA; PROTEIN; HETERODIMERIZATION; TRANSACTIVATION	The glucocorticoid and mineralocorticoid receptors (GR and MR) share considerable structural and functional homology and bind as homodimers to hormone-response elements. We have shown previously that MR and GR can form heterodimers that inhibit transcription from a glucocorticoid (GC)-responsive gene and that this inhibition was mediated by the N-terminal domain (NTD) of MR. In this report, we examined the effect of NTD-MR on GC-induced apoptosis in the GC-sensitive pre-B lymphoma cell line, 697. In GC-treated 697 cells, we demonstrated that stable expression of NTD-MR blocks apoptosis and inhibits proteolytic processing of pro-caspases-3, -8, and -9 and poly(ADP-ribose) polymerase. Importantly, gel shift and immunoprecipitation analyses revealed a direct association between the GR and amino acids 203-603 of NTD-MR. We observed down-regulation of c-Myc and of the anti-apoptotic proteins Bcl-2 and Bfl-1 as well as high levels of the proapoptotic proteins Bax and Bid. Conversely, cells stably expressing NTD-MR exhibited increased expression of Bcl-2 and Bfl-1 and diminished levels of Bid and Bax. These data provide a potential mechanism for the observed inhibition of cytochrome c and Smac release from the mitochondria of NTD-MR cells and resultant resistance to GC-induced apoptosis. Thus, NTD-MR may mediate GC effects through heterodimerization with GR and ensuing inhibition of GC-regulated gene transcription.	Thomas Jefferson Univ, Jefferson Med Coll, Dept Biochem & Mol Pharmacol, Philadelphia, PA 19107 USA	Jefferson University	Litwack, G (corresponding author), Thomas Jefferson Univ, Jefferson Med Coll, Dept Biochem & Mol Pharmacol, 233 S 10th St,BLSB 350, Philadelphia, PA 19107 USA.	Gerry.Litwack@mail.tju.edu	Lobo, Sonia/H-6889-2018	Lobo, Sonia/0000-0002-7406-6956	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040976] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007705] Funding Source: NIH RePORTER; NIAID NIH HHS [AI/HL 40976] Funding Source: Medline; NIDDK NIH HHS [5T32 DK07705] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Almeida OFX, 2000, FASEB J, V14, P779, DOI 10.1096/fasebj.14.5.779; ALNEMRI ES, 1991, J BIOL CHEM, V266, P18072; ALNEMRI ES, 1992, CANCER RES, V52, P491; ARRIZA JL, 1987, SCIENCE, V237, P268, DOI 10.1126/science.3037703; ARRIZA JL, 1988, NEURON, V1, P887, DOI 10.1016/0896-6273(88)90136-5; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Brunet CL, 1998, CELL DEATH DIFFER, V5, P107, DOI 10.1038/sj.cdd.4400334; CARONLESLIE LAM, 1991, MOL ENDOCRINOL, V5, P1169, DOI 10.1210/mend-5-8-1169; D'Sa-Eipper C, 1998, ONCOGENE, V16, P3105, DOI 10.1038/sj.onc.1201851; Dallaporta B, 2000, CELL DEATH DIFFER, V7, P368, DOI 10.1038/sj.cdd.4400661; Derfoul A, 2000, ENDOCRINE, V13, P287, DOI 10.1385/ENDO:13:3:287; Derfoul A, 1998, J BIOL CHEM, V273, P20702, DOI 10.1074/jbc.273.33.20702; DIEKEN ES, 1992, MOL CELL BIOL, V12, P589, DOI 10.1128/MCB.12.2.589; Distelhorst CW, 2002, CELL DEATH DIFFER, V9, P6, DOI 10.1038/sj.cdd.4400969; DSaEipper C, 1996, CANCER RES, V56, P3879; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; EVANSSTORMS RB, 1995, J STEROID BIOCHEM, V53, P1, DOI 10.1016/0960-0760(95)00034-W; Feinman R, 1999, BLOOD, V93, P3044; Finucane DM, 1999, J BIOL CHEM, V274, P2225, DOI 10.1074/jbc.274.4.2225; Gil-Gomez G, 1998, EMBO J, V17, P7209, DOI 10.1093/emboj/17.24.7209; Green DR, 2000, CELL, V102, P1, DOI 10.1016/S0092-8674(00)00003-9; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Gross A, 1999, J BIOL CHEM, V274, P1156, DOI 10.1074/jbc.274.2.1156; Hakem A, 1999, J EXP MED, V189, P957, DOI 10.1084/jem.189.6.957; HARBOUR DV, 1990, J STEROID BIOCHEM, V35, P1, DOI 10.1016/0022-4731(90)90137-H; Hassan AHS, 1996, EXP NEUROL, V140, P43, DOI 10.1006/exnr.1996.0113; He HL, 1998, J BIOL CHEM, V273, P25015, DOI 10.1074/jbc.273.39.25015; HOLLENBERG SM, 1988, CELL, V55, P899, DOI 10.1016/0092-8674(88)90145-6; Hu YM, 1998, J BIOL CHEM, V273, P33489, DOI 10.1074/jbc.273.50.33489; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; LIU W, 1995, MOL CELL BIOL, V15, P1005; Liu WH, 1995, P NATL ACAD SCI USA, V92, P12480, DOI 10.1073/pnas.92.26.12480; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; NAZARETH LV, 1991, J BIOL CHEM, V266, P12976; Nunez G, 1998, ONCOGENE, V17, P3237, DOI 10.1038/sj.onc.1202581; OLTVAI ZN, 1994, CELL, V79, P189, DOI 10.1016/0092-8674(94)90188-0; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Ou XM, 2001, J BIOL CHEM, V276, P14299, DOI 10.1074/jbc.M005363200; PEARCE D, 1993, SCIENCE, V259, P1161, DOI 10.1126/science.8382376; Perlmann T, 1997, CELL, V90, P391, DOI 10.1016/S0092-8674(00)80498-5; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Robertson NM, 1997, CANCER RES, V57, P43; ROBERTSON NM, 1993, MOL ENDOCRINOL, V7, P1226, DOI 10.1210/me.7.9.1226; Roy S, 2000, J EXP MED, V192, pF21, DOI 10.1084/jem.192.8.F21; RUPPRECHT R, 1993, MOL ENDOCRINOL, V7, P597, DOI 10.1210/me.7.4.597; Saleh A, 1999, J BIOL CHEM, V274, P17941, DOI 10.1074/jbc.274.25.17941; Srinivasula SM, 2000, J BIOL CHEM, V275, P36152, DOI 10.1074/jbc.C000533200; THOMPSON EB, 1994, MOL ENDOCRINOL, V8, P665, DOI 10.1210/me.8.6.665; THOMPSON EB, 1995, ANN NY ACAD SCI, V761, P261, DOI 10.1111/j.1749-6632.1995.tb31383.x; Trapp T, 1996, TRENDS PHARMACOL SCI, V17, P145, DOI 10.1016/0165-6147(96)81590-2; TRAPP T, 1994, NEURON, V13, P1457, DOI 10.1016/0896-6273(94)90431-6; Tronche F, 1998, CURR OPIN GENET DEV, V8, P532, DOI 10.1016/S0959-437X(98)80007-5; TRUSS M, 1993, ENDOCR REV, V14, P459, DOI 10.1210/er.14.4.459; TSUJIMOTO Y, 1985, SCIENCE, V228, P1440, DOI 10.1126/science.3874430; Ueda T, 2002, J BIOL CHEM, V277, P7076, DOI 10.1074/jbc.M108255200; VanderHeiden MG, 1997, CELL, V91, P627, DOI 10.1016/S0092-8674(00)80450-X; vanSteensel B, 1996, J CELL SCI, V109, P787; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Wang CY, 1999, MOL CELL BIOL, V19, P5923; Werner AB, 2002, J BIOL CHEM, V277, P22781, DOI 10.1074/jbc.M201469200; Wickert L, 1998, EUR J ENDOCRINOL, V138, P702, DOI 10.1530/eje.0.1380702; WILLIAMS DL, 1984, CELL, V36, P101, DOI 10.1016/0092-8674(84)90078-3; WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0; Yang Y, 2000, SCIENCE, V288, P874, DOI 10.1126/science.288.5467.874; Yin XM, 2000, J MOL MED-JMM, V78, P203, DOI 10.1007/s001090000099; Zennaro MC, 1997, J CLIN ENDOCR METAB, V82, P1345, DOI 10.1210/jc.82.5.1345; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	69	29	49	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					42188	42196		10.1074/jbc.M205085200	http://dx.doi.org/10.1074/jbc.M205085200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12194973	hybrid			2022-12-27	WOS:000178985300112
J	Dainese, E; Minafra, R; Sabatucci, A; Vachette, P; Melloni, E; Cozzani, I				Dainese, E; Minafra, R; Sabatucci, A; Vachette, P; Melloni, E; Cozzani, I			Conformational changes of calpain from human erythrocytes in the presence of Ca2+	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; SOLUTION SCATTERING; BIOLOGICAL MACROMOLECULES; CATALYTIC SUBUNIT; ACTIVE-SITE; DOMAIN-VI; EF-HAND; CELL; DISSOCIATION; RESOLUTION	Small angle x-ray scattering has been used to monitor calpain structural transitions during the activation process triggered by Ca2+ binding. The scattering pattern of the unliganded enzyme in solution does not display any significant difference with that calculated from the crystal structure. The addition of Ca2+ promotes the formation of large aggregates, indicating the exposure of hydrophobic patches on the surface of the protease. In contrast, Ca2+ addition in the presence of the thiol proteinase inhibitor E64 or of the inhibitor leupeptin causes a small conformational change with no dissociation of the heterodimer. The resulting conformation appears to be slightly more extended than the unliganded form. From the comparison between ab initio models derived from our data with the crystal structure, the major observable conformational change appears to be localized at level of the L-subunit and in particular seems to confirm the mutual movement already observed by the crystallographic analysis of the dII (dIIb) and the dI (dIIa) domains creating a functional active site. This work not only provides another piece of supporting evidence for the calpain conformational change in the presence of Ca2+, but actually constitutes the first experimental observation of this change for intact heterodimeric calpain in solution.	Univ Teramo, Dept Biomed Sci, I-64100 Teramo, Italy; Univ Paris 11, Utilisat Rayonnement Electromagnet Lab, F-91898 Orsay, France; Univ Genoa, Ctr Excellence Biomed Res, I-16032 Genoa, Italy; Univ Genoa, Dept Expt Med, I-16032 Genoa, Italy	University of Teramo; UDICE-French Research Universities; Universite Paris Saclay; University of Genoa; University of Genoa	Dainese, E (corresponding author), Univ Teramo, Dept Biomed Sci, Piazza A Moro 45, I-64100 Teramo, Italy.	dainese@unite.it	; SABATUCCI, Annalaura/E-9996-2013	Dainese, Enrico/0000-0001-7163-9344; SABATUCCI, Annalaura/0000-0002-8004-2547				Bessiere BA, 1999, BBA-PROTEIN STRUCT M, V1430, P254, DOI 10.1016/S0167-4838(99)00006-0; Blanchard H, 1997, NAT STRUCT BIOL, V4, P532, DOI 10.1038/nsb0797-532; BOULIN C, 1986, NUCL INSTRUM METH A, V249, P399, DOI 10.1016/0168-9002(86)90694-7; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carafoli E, 1998, BIOCHEM BIOPH RES CO, V247, P193, DOI 10.1006/bbrc.1998.8378; CRAWFORD C, 1993, BIOCHEM J, V296, P135, DOI 10.1042/bj2960135; Cygler Miroslaw, 2002, Methods Mol Biol, V172, P243; Dainese E, 1998, EUR J BIOCHEM, V256, P350, DOI 10.1046/j.1432-1327.1998.2560350.x; Dubuisson JM, 1997, J APPL CRYSTALLOGR, V30, P49, DOI 10.1107/S002188989600876X; Grossmann JG, 2001, BIOCHEMISTRY-US, V40, P6267, DOI 10.1021/bi0028946; Guinier A., 1955, SMALL ANGLE SCATTERI; Hosfield CM, 1999, EMBO J, V18, P6880, DOI 10.1093/emboj/18.24.6880; Hosfield CM, 2001, J BIOL CHEM, V276, P7404, DOI 10.1074/jbc.M007352200; Kozin MB, 1997, J APPL CRYSTALLOGR, V30, P811, DOI 10.1107/S0021889897001830; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Kulkarni S, 2002, J BIOL CHEM, V277, P24435, DOI 10.1074/jbc.M203457200; Lin GD, 1997, NAT STRUCT BIOL, V4, P539, DOI 10.1038/nsb0797-539; Melloni E, 1996, BIOCHEM BIOPH RES CO, V229, P193, DOI 10.1006/bbrc.1996.1779; Melloni E, 1998, J BIOL CHEM, V273, P12827, DOI 10.1074/jbc.273.21.12827; Michetti M, 1997, BIOCHEM J, V325, P721, DOI 10.1042/bj3250721; Michetti M, 1996, FEBS LETT, V392, P11, DOI 10.1016/0014-5793(96)00775-2; Moldoveanu T, 2002, CELL, V108, P649, DOI 10.1016/S0092-8674(02)00659-1; Nakagawa K, 2001, J BIOCHEM-TOKYO, V130, P605, DOI 10.1093/oxfordjournals.jbchem.a003025; OHNO S, 1984, NATURE, V312, P566, DOI 10.1038/312566a0; Pal GP, 2001, J BIOL CHEM, V276, P47233, DOI 10.1074/jbc.M105149200; Pontremoli S, 1999, CALCIUM AS A CELLULAR REGULATOR, P371; Richard I, 1999, AM J HUM GENET, V64, P1524, DOI 10.1086/302426; Santella L, 2000, EXP CELL RES, V259, P117, DOI 10.1006/excr.2000.4969; SASAKI T, 1984, J BIOL CHEM, V259, P2489; SCHRODER E, 1993, FEBS LETT, V315, P38, DOI 10.1016/0014-5793(93)81128-M; Shi L, 1996, BIOCHEMISTRY-US, V35, P3297, DOI 10.1021/bi951984l; Sorimachi H, 2001, J BIOCHEM-TOKYO, V129, P653, DOI 10.1093/oxfordjournals.jbchem.a002903; Sorimachi H, 1997, BIOCHEM J, V328, P721, DOI 10.1042/bj3280721; SPENCER MJ, 1995, J BIOL CHEM, V270, P10909, DOI 10.1074/jbc.270.18.10909; Strobl S, 2000, P NATL ACAD SCI USA, V97, P588, DOI 10.1073/pnas.97.2.588; Suo S, 1999, BIOCHEM BIOPH RES CO, V257, P63, DOI 10.1006/bbrc.1999.0407; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 1997, PROTEINS, V27, P110; TAKANO E, 1995, FEBS LETT, V362, P93, DOI 10.1016/0014-5793(95)00219-Y; VARUGHESE KI, 1989, BIOCHEMISTRY-US, V28, P1330, DOI 10.1021/bi00429a058; Xu Y, 2002, J BIOL CHEM, V277, P21474, DOI 10.1074/jbc.M111689200; YOSHIZAWA T, 1995, FEBS LETT, V358, P101, DOI 10.1016/0014-5793(94)01401-L	44	21	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2002	277	43					40296	40301		10.1074/jbc.M204471200	http://dx.doi.org/10.1074/jbc.M204471200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	607KU	12189137	hybrid			2022-12-27	WOS:000178791400020
J	Hill, JJ; Davies, MV; Pearson, AA; Wang, JH; Hewick, RM; Wolfman, NM; Qiu, YC				Hill, JJ; Davies, MV; Pearson, AA; Wang, JH; Hewick, RM; Wolfman, NM; Qiu, YC			The myostatin propeptide and the follistatin-related gene are inhibitory binding proteins of myostatin in normal serum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; MOLECULAR-WEIGHT COMPLEX; TRANSCRIPTION ACTIVATION; TRANSGENIC MICE; HUMAN-PLATELETS; MUSCLE GROWTH; PRO DOMAIN; ACTIVIN-A; FACTOR-BETA-1; CELLS	Myostatin, also known as growth and differentiation factor 8, is a member of the transforming growth factor 13 superfamily that negatively regulates skeletal muscle mass (1). Recent experiments have shown that myostatin activity is detected in serum by a reporter gene assay only after activation by acid, suggesting that native myostatin circulates as a latent complex (2). We have used a monoclonal myostatin antibody, JA16, to isolate the native myostatin complex from normal mouse and human serum. Analysis by mass spectrometry and Western blot shows that circulating myostatin is bound to at least two major proteins, the myostatin propeptide and the follistatin-related gene (FLRG). The myostatin propeptide is known to bind and inhibit myostatin in vitro (3). Here we show that this interaction is relevant in vivo, with a majority (>70%) of myostatin in serum bound to its propeptide. Studies with recombinant V5-His-tagged FLRG protein confirm a direct interaction between mature myostatin and FLRG. Functional studies show that FLRG inhibits myostatin activity in a reporter gene assay. These experiments suggest that the myostatin propeptide and FLRG are major negative regulators of myostatin in vivo.	Wyeth Res, Dept Prot Chem & Prote, Cambridge, MA 02140 USA; Wyeth Res, Dept Musculoskeletal Sci, Cambridge, MA 02140 USA	Pfizer; Pfizer	Hill, JJ (corresponding author), Wyeth Res, Dept Prot Chem & Prote, 87 Cambridge Pk Dr, Cambridge, MA 02140 USA.	jhill@wyeth.com						Bartholin L, 2002, ONCOGENE, V21, P2227, DOI 10.1038/sj.onc.1205294; Bartholin L, 2001, ONCOGENE, V20, P5409, DOI 10.1038/sj.onc.1204720; Bottinger EP, 1996, P NATL ACAD SCI USA, V93, P5877, DOI 10.1073/pnas.93.12.5877; Brownh PD, 1990, GROWTH FACTORS, V3, DOI 10.3109/08977199009037500; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; DERYNCK R, 1985, NATURE, V316, P701, DOI 10.1038/316701a0; Fainsod A, 1997, MECH DEVELOP, V63, P39, DOI 10.1016/S0925-4773(97)00673-4; Gamer LW, 1999, DEV BIOL, V208, P222, DOI 10.1006/dbio.1998.9191; GENTRY LE, 1990, BIOCHEMISTRY-US, V29, P6851, DOI 10.1021/bi00481a014; Gleizes PE, 1997, STEM CELLS, V15, P190, DOI 10.1002/stem.150190; GRAY AM, 1990, SCIENCE, V247, P1328, DOI 10.1126/science.2315700; Hayette S, 1998, ONCOGENE, V16, P2949, DOI 10.1038/sj.onc.1201807; Hu PPC, 1998, ENDOCR REV, V19, P349, DOI 10.1210/er.19.3.349; KRUMMEN LA, 1993, ENDOCRINOLOGY, V132, P431, DOI 10.1210/en.132.1.431; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; Lin J, 2002, BIOCHEM BIOPH RES CO, V291, P701, DOI 10.1006/bbrc.2002.6500; LYONS RM, 1988, J CELL BIOL, V106, P1659, DOI 10.1083/jcb.106.5.1659; LYONS RM, 1990, J CELL BIOL, V110, P1361, DOI 10.1083/jcb.110.4.1361; Massague J, 2000, GENE DEV, V14, P627; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; McPherron AC, 1997, P NATL ACAD SCI USA, V94, P12457, DOI 10.1073/pnas.94.23.12457; McPherron AC, 2002, J CLIN INVEST, V109, P595, DOI 10.1172/JCI200213562; MIYAZONO K, 1988, J BIOL CHEM, V263, P6407; NAKAMURA T, 1991, J BIOL CHEM, V266, P19432; NAKAMURA T, 1990, SCIENCE, V247, P836, DOI 10.1126/science.2106159; Oi V.T., 1980, SELECTED METHODS CEL, P351; Schneyer A, 2001, MOL CELL ENDOCRINOL, V180, P33, DOI 10.1016/S0303-7207(01)00501-9; SCHNEYER AL, 1994, ENDOCRINOLOGY, V135, P667, DOI 10.1210/en.135.2.667; SCHNEYER AL, 1992, J CLIN ENDOCR METAB, V74, P1320, DOI 10.1210/jc.74.6.1320; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Smith WC, 1999, TRENDS GENET, V15, P3, DOI 10.1016/S0168-9525(98)01641-2; SUGINO K, 1993, J BIOL CHEM, V268, P15579; Taylor WE, 2001, AM J PHYSIOL-ENDOC M, V280, pE221, DOI 10.1152/ajpendo.2001.280.2.E221; Thies RS, 2001, GROWTH FACTORS, V18, P251; Thomas M, 2000, J BIOL CHEM, V275, P40235, DOI 10.1074/jbc.M004356200; Tsuchida K, 2000, J BIOL CHEM, V275, P40788, DOI 10.1074/jbc.M006114200; Tsuchida K, 2001, MOL CELL ENDOCRINOL, V180, P25, DOI 10.1016/S0303-7207(01)00522-6; UENO N, 1987, P NATL ACAD SCI USA, V84, P8282, DOI 10.1073/pnas.84.23.8282; WAKEFIELD LM, 1988, J BIOL CHEM, V263, P7646; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; YAMASHITA H, 1995, J CELL BIOL, V130, P217, DOI 10.1083/jcb.130.1.217; Yang JZ, 2001, MOL REPROD DEV, V60, P351, DOI 10.1002/mrd.1097; Zimmers TA, 2002, SCIENCE, V296, P1486, DOI 10.1126/science.1069525	43	352	399	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2002	277	43					40735	40741		10.1074/jbc.M206379200	http://dx.doi.org/10.1074/jbc.M206379200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	607KU	12194980	hybrid			2022-12-27	WOS:000178791400075
J	Iancu, CV; Borza, T; Fromm, HJ; Honzatko, RB				Iancu, CV; Borza, T; Fromm, HJ; Honzatko, RB			Feedback inhibition and product complexes of recombinant mouse muscle adenylosuccinate synthetase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVE-SITE; MECHANISM; IMP; HYDANTOCIDIN; PURIFICATION; TARGET; GDP	Adenylosuccinate synthetase governs the committed step of AMP biosynthesis, the generation of 6-phosphoryl-IMP from GTP and IMP followed by the formation of adenylosuccinate from 6-phosphoryl-IMP and L-aspartate. The enzyme is subject to feedback inhibition by AMP and adenylosuccinate, but crystallographic complexes of the mouse muscle synthetase presented here infer mechanisms of inhibition that involve potentially synergistic ligand combinations. AMP alone adopts the productive binding mode of IMP and yet stabilizes the active site in a conformation that favors the binding of Mg2+-IMP to the GTP pocket. On the other hand, AMP, in the presence of GDP, orthophosphate, and Mg2+, adopts the binding mode of adenylosuccinate. Depending on circumstances then, AMP behaves as an analogue of IMP or as an analogue of adenylosuccinate. The complex of adenylosuccinate(.)GDP(.)Mg(2+)-sulfate, the first structure of an adenylosuccinate-bound synthetase, reveals significant geometric distortions and tight non-bonded contacts relevant to the proposed catalytic mechanism. Adenylosuccinate forms from 6-phosphoryl-IMP and L-aspartate by the movement of the purine ring into the alpha-amino group of L-aspartate.	Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA	Iowa State University	Honzatko, RB (corresponding author), Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA.	honzatko@iastate.edu	Borza, Tudor/A-8510-2012; Borza, Tudor/M-4937-2019	Borza, Tudor/0000-0002-2527-6551; Borza, Tudor/0000-0002-2527-6551	NINDS NIH HHS [NS 10546] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS010546, R56NS010546] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BASS MB, 1984, J BIOL CHEM, V259, P2330; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Choe JY, 1999, BIOCHEMISTRY-US, V38, P6953, DOI 10.1021/bi990159s; CLARK SW, 1976, BIOCHIM BIOPHYS ACTA, V437, P87, DOI 10.1016/0304-4165(76)90349-4; COOPER BF, 1986, BIOCHEMISTRY-US, V25, P7323, DOI 10.1021/bi00371a013; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; FonnePfister R, 1996, P NATL ACAD SCI USA, V93, P9431, DOI 10.1073/pnas.93.18.9431; GOODMAN MN, 1977, J BIOL CHEM, V252, P5054; Gorrell A, 2002, J BIOL CHEM, V277, P8817, DOI 10.1074/jbc.M111810200; Hanessian S, 1999, ANGEW CHEM INT EDIT, V38, P3160; Honzatko RB, 1999, ADV ENZYMOL RAMB, V73, P57, DOI 10.1002/9780470123195.ch3; Honzatko RB, 1999, ARCH BIOCHEM BIOPHYS, V370, P1, DOI 10.1006/abbi.1999.1383; Hou ZL, 2002, J BIOL CHEM, V277, P5970, DOI 10.1074/jbc.M109561200; Hou ZL, 1999, J BIOL CHEM, V274, P17505, DOI 10.1074/jbc.274.25.17505; Iancu CV, 2002, J BIOL CHEM, V277, P26779, DOI 10.1074/jbc.M203730200; Iancu CV, 2001, J BIOL CHEM, V276, P42146, DOI 10.1074/jbc.M106294200; KANG CH, 1995, J BIOL CHEM, V270, P15539, DOI 10.1074/jbc.270.26.15539; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LUZZATI V, 1952, ACTA CRYSTALLOGR, V5, P802, DOI 10.1107/S0365110X52002161; MARKHAM GD, 1977, ARCH BIOCHEM BIOPHYS, V184, P24, DOI 10.1016/0003-9861(77)90322-8; McRee DE, 1992, J MOL GRAPHICS, V10, P44, DOI DOI 10.1016/0263-7855(92)80022-6; MUIRHEAD KM, 1974, J BIOL CHEM, V249, P459; PAO CC, 1981, BIOCHIM BIOPHYS ACTA, V677, P358, DOI 10.1016/0304-4165(81)90247-6; Poland BW, 1996, J MOL BIOL, V264, P1013, DOI 10.1006/jmbi.1996.0693; Poland BW, 1997, J BIOL CHEM, V272, P15200, DOI 10.1074/jbc.272.24.15200; Poland BW, 1996, BIOCHEMISTRY-US, V35, P15753, DOI 10.1021/bi961758r; SPECTOR T, 1979, J BIOL CHEM, V254, P8422; SPECTOR T, 1976, BIOCHIM BIOPHYS ACTA, V445, P509, DOI 10.1016/0005-2744(76)90104-2; STAYTON MM, 1983, CURR TOP CELL REGUL, V22, P103; Walters EW, 1997, PLANT PHYSIOL, V114, P549, DOI 10.1104/pp.114.2.549	32	11	12	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2002	277	43					40536	40543		10.1074/jbc.M204952200	http://dx.doi.org/10.1074/jbc.M204952200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	607KU	12186864	hybrid			2022-12-27	WOS:000178791400050
J	Kim, HY; Heo, YS; Kim, JH; Park, MH; Moon, JH; Kim, E; Kwon, D; Yoon, J; Shin, D; Jeong, EJ; Park, SY; Lee, TG; Jeon, YH; Ro, S; Cho, JM; Hwang, KY				Kim, HY; Heo, YS; Kim, JH; Park, MH; Moon, JH; Kim, E; Kwon, D; Yoon, J; Shin, D; Jeong, EJ; Park, SY; Lee, TG; Jeon, YH; Ro, S; Cho, JM; Hwang, KY			Molecular basis for the local conformational rearrangement of human phosphoserine phosphatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-TYPE ATPASE; D-SERINE; NMDA RECEPTORS; DEHALOGENASE; GLYCINE; ASPARTATE; PROTEINS; ANALOG	Human phosphoserine phosphatase (HPSP) regulates the levels of glycine and D-serine, the putative co-agonists for the glycine site of the NMDA receptor in the brain. Here, we describe the first crystal structures of the HPSP in complexes with the competitive inhibitor 2-amino-3-phosphonopropionic acid (AP3) at 2.5 Angstrom, and the phosphate ion (Pi) and the product uncompetitive inhibitor L-serine ((HPSPL)-L-.-Ser(.)Pi) at 2.8 Angstrom. The complex structures reveal that the open-closed environmental change of the active site, generated by local rearrangement of the a-helical bundle domain, is important to substrate recognition and hydrolysis. The maximal extent of this structural rearrangement is shown to be about 13 Angstrom at the L4 loop and about 25degrees at the helix alpha3. Both the structural change and mutagenesis data suggest that Arg-65 and Glu-29 play an important role in the binding of the substrate. Interestingly, the AP3 binding mode turns out to be significantly different from that of the natural substrate, phospho-L-serine, and the (HPSPL)-L-.-Ser(.)Pi structure provides a structural basis for the feedback control mechanism of serine. These analyses allow us to provide a clear model for the mechanism of HPSP and a framework for structure-based drug development.	CrystalGenom Inc, Div Drug Discovery, Yuseong Gu, Taejon 305600, South Korea; Yokohama City Univ, Grad Sch Integrated Sci, Div Prot Design, Yokohama, Kanagawa 2300045, Japan	Yokohama City University	Hwang, KY (corresponding author), CrystalGenom Inc, Div Drug Discovery, Yuseong Gu, Taejon 305600, South Korea.	hwangky@crystalgenomics.com						Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P127, DOI 10.1016/S0968-0004(98)01189-X; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cho H, 2001, P NATL ACAD SCI USA, V98, P8525, DOI 10.1073/pnas.131213698; Collet JF, 1999, J BIOL CHEM, V274, P33985, DOI 10.1074/jbc.274.48.33985; Collet JF, 1998, J BIOL CHEM, V273, P14107, DOI 10.1074/jbc.273.23.14107; Collet JF, 1997, FEBS LETT, V408, P281, DOI 10.1016/S0014-5793(97)00438-9; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Dunlop DS, 1997, BIOCHEM BIOPH RES CO, V235, P26, DOI 10.1006/bbrc.1997.6724; GUYNN RW, 1986, ARCH BIOCHEM BIOPHYS, V245, P204, DOI 10.1016/0003-9861(86)90206-7; Hawkinson JE, 1996, EUR J PHARMACOL, V307, P219, DOI 10.1016/0014-2999(96)00253-1; Hawkinson JE, 1997, EUR J PHARMACOL, V337, P315, DOI 10.1016/S0014-2999(97)01304-6; MATSUI T, 1995, J NEUROCHEM, V65, P454; MOROFURLANI AM, 1980, ANN HUM GENET, V43, P323, DOI 10.1111/j.1469-1809.1980.tb01566.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paudice P, 1998, EUR J NEUROSCI, V10, P2934, DOI 10.1046/j.1460-9568.1998.00302.x; Ridder IS, 1999, BIOCHEM J, V339, P223, DOI 10.1042/0264-6021:3390223; Ridder IS, 1997, J BIOL CHEM, V272, P33015, DOI 10.1074/jbc.272.52.33015; ROSSMANN MG, 1974, NATURE, V250, P194, DOI 10.1038/250194a0; STOCK AM, 1989, NATURE, V337, P745, DOI 10.1038/337745a0; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Wang WR, 2001, STRUCTURE, V9, P65, DOI 10.1016/S0969-2126(00)00558-X; Wang WR, 2002, J MOL BIOL, V319, P421, DOI 10.1016/S0022-2836(02)00324-8; Wolosker H, 1999, P NATL ACAD SCI USA, V96, P721, DOI 10.1073/pnas.96.2.721; WOOD PL, 1995, LIFE SCI, V57, P301, DOI 10.1016/0024-3205(95)00288-H	24	32	35	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2002	277	48					46651	46658		10.1074/jbc.M204866200	http://dx.doi.org/10.1074/jbc.M204866200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620JB	12213811	hybrid			2022-12-27	WOS:000179529300123
J	Zhu, T; Ling, L; Lobie, PE				Zhu, T; Ling, L; Lobie, PE			Identification of a JAK2-independent pathway regulating growth hormone (GH)-stimulated p44/42 mitogen-activated protein kinase activity - GH activation of Ral and phospholipase D is Src-dependent	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-SRC; TYROSINE PHOSPHORYLATION; SIGNAL-TRANSDUCTION; HUMAN NEUTROPHILS; PHOSPHATIDIC-ACID; GENE-EXPRESSION; SH2 DOMAIN; RECEPTOR; JAK2; GTPASE	We have demonstrated here that growth hormone (GH) stimulates the formation of the active GTP-bound form of both RalA and RalB in NIH-3T3 cells. Full activation of RalA and RalB by GH required the combined activity of c-Src and JAK2, both kinases activated by GH independent of the other. Activation of RalA and RalB by growth hormone did not require the activity of JAK2 per se. Ras was also activated by GH and was required for the GH-stimulated formation of GTP-bound RalA and RalB. Activation of RalA by GH subsequently resulted in increased phospholipase D activity and the formation of its metabolite, phosphatidic acid. GH-stimulated RalA-phospholipase D-dependent formation of phosphatidic acid was required for activation of p44/42 MAPK and subsequent Elk-1-mediated transcription stimulated by GH. Thus we report the identification of a JAK2-independent pathway regulating GH-stimulated p44/42 MAPK activity.	Inst Mol & Cell Biol, Singapore 117609, Singapore; Natl Univ Singapore, Dept Med, Singapore 119074, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore	Lobie, PE (corresponding author), Inst Mol & Cell Biol, 30 Med Dr, Singapore 117609, Singapore.	mcbpel@imcb.nus.edu.sg						Aguirre-Ghiso JA, 1999, ONCOGENE, V18, P4718, DOI 10.1038/sj.onc.1202850; Arai A, 2001, J BIOL CHEM, V276, P33282, DOI 10.1074/jbc.M102924200; ARGETSINGER LS, 1995, J BIOL CHEM, V270, P14685, DOI 10.1074/jbc.270.24.14685; BERGAD PL, 1995, J BIOL CHEM, V270, P24903, DOI 10.1074/jbc.270.42.24903; BERLANGA JJ, 1995, MOL ENDOCRINOL, V9, P1461, DOI 10.1210/me.9.11.1461; BILLESTRUP N, 1995, P NATL ACAD SCI USA, V92, P2725, DOI 10.1073/pnas.92.7.2725; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bos JL, 1998, EMBO J, V17, P6776, DOI 10.1093/emboj/17.23.6776; CAMPBELL GS, 1992, J BIOL CHEM, V267, P6074; CANTOR SB, 1995, MOL CELL BIOL, V15, P4578; Chaturvedi P, 1998, ONCOGENE, V16, P1749, DOI 10.1038/sj.onc.1201972; De Ruiter ND, 2000, MOL CELL BIOL, V20, P8480, DOI 10.1128/MCB.20.22.8480-8488.2000; deRooij J, 1997, ONCOGENE, V14, P623, DOI 10.1038/sj.onc.1201005; Foschi M, 1997, EMBO J, V16, P6439, DOI 10.1093/emboj/16.21.6439; Franke B, 1997, EMBO J, V16, P252, DOI 10.1093/emboj/16.2.252; Frohman MA, 1999, BBA-MOL CELL BIOL L, V1439, P175, DOI 10.1016/S1388-1981(99)00093-1; Gaur S, 1996, AM J PHYSIOL-CELL PH, V270, pC1485, DOI 10.1152/ajpcell.1996.270.5.C1485; GAUR S, 2000, P 8I END SOC M TOR O; Goh ELK, 2000, J BIOL CHEM, V275, P17683, DOI 10.1074/jbc.M001972200; Goi T, 2000, EMBO J, V19, P623, DOI 10.1093/emboj/19.4.623; Gomez-Cambronero J, 1998, CELL SIGNAL, V10, P387, DOI 10.1016/S0898-6568(97)00197-6; Graichen R, 2002, J BIOL CHEM, V277, P26662, DOI 10.1074/jbc.M109931200; Gu YP, 2001, MOL CELL BIOCHEM, V223, P35, DOI 10.1023/A:1017941625858; Henry DO, 2000, MOL CELL BIOL, V20, P8084, DOI 10.1128/MCB.20.21.8084-8092.2000; Herrington J, 2001, TRENDS ENDOCRIN MET, V12, P252, DOI 10.1016/S1043-2760(01)00423-4; Hodge C, 1998, J BIOL CHEM, V273, P31327, DOI 10.1074/jbc.273.47.31327; Hofer F, 1998, CURR BIOL, V8, P839, DOI 10.1016/S0960-9822(98)70327-6; Ichiba T, 1997, J BIOL CHEM, V272, P22215, DOI 10.1074/jbc.272.35.22215; JIANG H, 1995, NATURE, V378, P409, DOI 10.1038/378409a0; Johnson SAS, 2000, MOL CELL BIOL, V20, P5000, DOI 10.1128/MCB.20.14.5000-5009.2000; Kariya K, 2000, J BIOL CHEM, V275, P18399, DOI 10.1074/jbc.M000521200; Kaulsay KK, 2001, ENDOCRINOLOGY, V142, P767, DOI 10.1210/en.142.2.767; Kopchick JJ, 2000, MOL GENET METAB, V71, P293, DOI 10.1006/mgme.2000.3068; LHEUREUX GP, 1995, BLOOD, V85, P522, DOI 10.1182/blood.V85.2.522.bloodjournal852522; Liao JF, 1997, J BIOL CHEM, V272, P25951, DOI 10.1074/jbc.272.41.25951; Liscovitch M, 2000, BIOCHEM J, V345, P401, DOI 10.1042/0264-6021:3450401; Liu KD, 1998, CURR OPIN IMMUNOL, V10, P271, DOI 10.1016/S0952-7915(98)80165-9; Lu ZM, 2000, MOL CELL BIOL, V20, P462, DOI 10.1128/MCB.20.2.462-467.2000; Luo JQ, 1998, P NATL ACAD SCI USA, V95, P3632, DOI 10.1073/pnas.95.7.3632; M'Rabet L, 1999, J BIOL CHEM, V274, P21847, DOI 10.1074/jbc.274.31.21847; M'Rabet L, 1998, BLOOD, V92, P2133, DOI 10.1182/blood.V92.6.2133.418k19_2133_2140; Matozaki T, 2000, CELL SIGNAL, V12, P515, DOI 10.1016/S0898-6568(00)00102-9; Mertani HC, 2001, J BIOL CHEM, V276, P21464, DOI 10.1074/jbc.M100437200; MOLLER C, 1992, J BIOL CHEM, V267, P23403; Ohta Y, 1999, P NATL ACAD SCI USA, V96, P2122, DOI 10.1073/pnas.96.5.2122; Park JB, 2001, EXP MOL MED, V33, P54, DOI 10.1038/emm.2001.10; Reuther GW, 2000, CURR OPIN CELL BIOL, V12, P157, DOI 10.1016/S0955-0674(99)00071-X; Rizzo MA, 2000, J BIOL CHEM, V275, P23911, DOI 10.1074/jbc.M001553200; Rizzo MA, 1999, J BIOL CHEM, V274, P1131, DOI 10.1074/jbc.274.2.1131; Rosario M, 2001, MOL CELL BIOL, V21, P3750, DOI 10.1128/MCB.21.11.3750-3762.2001; Saharinen P, 2000, MOL CELL BIOL, V20, P3387, DOI 10.1128/MCB.20.10.3387-3395.2000; Sayeski PP, 1999, CIRC RES, V84, P1332, DOI 10.1161/01.RES.84.11.1332; Sears RC, 2002, J BIOL CHEM, V277, P11617, DOI 10.1074/jbc.R100063200; Suzuki J, 2000, MOL CELL BIOL, V20, P4658, DOI 10.1128/MCB.20.13.4658-4665.2000; TOLLET P, 1995, J BIOL CHEM, V270, P12569, DOI 10.1074/jbc.270.21.12569; Vanderkuur JA, 1997, ENDOCRINOLOGY, V138, P4301, DOI 10.1210/en.138.10.4301; Vara JAF, 2000, BIOCHEM J, V345, P17, DOI 10.1042/0264-6021:3450017; Voss M, 1999, J BIOL CHEM, V274, P34691, DOI 10.1074/jbc.274.49.34691; Ward Y, 2001, MOL CELL BIOL, V21, P5958, DOI 10.1128/MCB.21.17.5958-5969.2001; Winston LA, 1995, J BIOL CHEM, V270, P30837, DOI 10.1074/jbc.270.52.30837; Wolthuis RMF, 1998, MOL CELL BIOL, V18, P2486, DOI 10.1128/MCB.18.5.2486; WOOD TJJ, 1995, J BIOL CHEM, V270, P9448, DOI 10.1074/jbc.270.16.9448; Xu YJ, 1996, AM J PHYSIOL-HEART C, V271, pH651, DOI 10.1152/ajpheart.1996.271.2.H651; Yamauchi T, 1997, NATURE, V390, P91, DOI 10.1038/36369; York RD, 1998, NATURE, V392, P622, DOI 10.1038/33451; Zhu T, 2000, J BIOL CHEM, V275, P2103, DOI 10.1074/jbc.275.3.2103; Zhu T, 2001, CELL SIGNAL, V13, P599, DOI 10.1016/S0898-6568(01)00186-3; Zhu T, 1998, J BIOL CHEM, V273, P33864, DOI 10.1074/jbc.273.50.33864; Zhu T, 1998, J BIOL CHEM, V273, P10682, DOI 10.1074/jbc.273.17.10682	69	63	65	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2002	277	47					45592	45603		10.1074/jbc.M201385200	http://dx.doi.org/10.1074/jbc.M201385200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	618EE	12218045	hybrid			2022-12-27	WOS:000179404800125
J	Luo, SH; Scott, DA; Docampo, R				Luo, SH; Scott, DA; Docampo, R			Trypanosoma cruzi H+-ATPase 1 (TcHA1) and 2 (TcHA2) genes complement yeast mutants defective in H+ pumps and encode plasma membrane P-type H+-ATPases with different enzymatic properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; LEISHMANIA-DONOVANI; SARCOPLASMIC-RETICULUM; ENDOPLASMIC-RETICULUM; FUNCTIONAL EXPRESSION; CHAGAS-DISEASE; CALCIUM-PUMP; PROTON PUMPS; PLANT; PROTEIN	Previous studies in Trypanosoma cruzi have shown that intracellular pH homeostasis requires ATP and is affected by H+-ATPase inhibitors, indicating a major role for ATP-driven proton pumps in intracellular pH control. In the present study, we report the cloning and sequencing of a pair of genes linked in tandem (TcHA1 and TcHA2) in T. cruzi which encode proteins with homology to fungal and plant P-type proton-pumping ATPases. The genes are expressed at the mRNA level in different developmental stages of T. cruzi: TcHA1 is expressed maximally in epimastigotes, whereas TcHA2 is expressed predominantly in trypomastigotes. The proteins predicted from the nucleotide sequence of the genes have 875 and 917 amino acids and molecular masses of 96.3 and 101.2 kDa, respectively. Full-length TcHA1 and an N-terminal truncated version of TcHA2 complemented a Saccharomyces cerevisiae strain deficient in P-type H+-ATPase activity, the proteins localized to the yeast plasma membrane, and ATP-driven proton pumping could be detected in proteoliposomes reconstituted from plasma membrane purified from transfected yeast. The reconstituted proton transport activity was reduced by inhibitors of P-type H+-ATPases. C-terminal truncation did not affect complementation of mutant yeast, suggesting the lack of C-terminal autoinhibitory domains in these proteins. ATPase activity in plasma membrane from TcHA1- and (N-terminal truncated) TcHA2-transfected yeast was inhibited to different extents by vanadate, whereas the latter yeast strain was more resistant to extremes of pH, suggesting that the native proteins may serve different functions at different stages in the T. cruzi life cycle.	Univ Illinois, Coll Vet Med, Mol Parasitol Lab, Dept Pathobiol, Urbana, IL 61802 USA; Univ Illinois, Ctr Zoonoses Res, Urbana, IL 61802 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Docampo, R (corresponding author), Univ Illinois, Coll Vet Med, Mol Parasitol Lab, Dept Pathobiol, 2001 S Lincoln Ave, Urbana, IL 61802 USA.	rodoc@uiuc.edu		Scott, David/0000-0002-8668-2449	NIAID NIH HHS [AI-23259] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI023259, R21AI023259] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALLEN G, 1976, FEBS LETT, V63, P188, DOI 10.1016/0014-5793(76)80223-2; Axelsen KB, 1998, J MOL EVOL, V46, P84, DOI 10.1007/PL00006286; Bagnat M, 2001, MOL BIOL CELL, V12, P4129, DOI 10.1091/mbc.12.12.4129; BENAIM G, 1995, BIOCHEM J, V306, P299, DOI 10.1042/bj3060299; Bockelmann C, 1998, J PLANT PHYSIOL, V152, P194, DOI 10.1016/S0176-1617(98)80132-6; BONE GJ, 1956, NATURE, V178, P308, DOI 10.1038/178308a0; CHIFFLET S, 1988, ANAL BIOCHEM, V168, P1, DOI 10.1016/0003-2697(88)90002-4; CHUNG SH, 1990, NUCLEIC ACIDS RES, V18, P4561, DOI 10.1093/nar/18.15.4561; CID A, 1987, CURR GENET, V12, P105, DOI 10.1007/BF00434664; DEXAERDE AD, 1995, J BIOL CHEM, V270, P23828, DOI 10.1074/jbc.270.40.23828; Drose S, 1997, J EXP BIOL, V200, P1; Ferreira T, 2001, J BIOL CHEM, V276, P29613, DOI 10.1074/jbc.R100022200; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; GOFFEAU A, 1981, BIOCHIM BIOPHYS ACTA, V639, P197, DOI 10.1016/0304-4173(81)90010-0; GONZALEZ A, 1985, NUCLEIC ACIDS RES, V13, P5789, DOI 10.1093/nar/13.16.5789; Hill JE, 2000, BIOCHEM J, V351, P281, DOI 10.1042/0264-6021:3510281; HILL JE, 1986, YEAST, V2, P163, DOI 10.1002/yea.320020304; JOHANSSON F, 1993, PLANT CELL, V5, P321, DOI 10.2307/3869599; KIRCHHOFF LV, 1993, NEW ENGL J MED, V329, P639, DOI 10.1056/NEJM199308263290909; Lu HG, 1998, MOL CELL BIOL, V18, P2309, DOI 10.1128/MCB.18.4.2309; Luo H, 1999, PLANT PHYSIOL, V119, P627, DOI 10.1104/pp.119.2.627; Maudoux O, 2000, J BIOL CHEM, V275, P17762, DOI 10.1074/jbc.M909690199; MEADE JC, 1987, MOL CELL BIOL, V7, P3937, DOI 10.1128/MCB.7.11.3937; MEADE JC, 1989, MOL BIOCHEM PARASIT, V33, P81, DOI 10.1016/0166-6851(89)90045-5; Meade JC, 2000, PARASITOL INT, V49, P309, DOI 10.1016/S1383-5769(00)00061-1; MEADE JC, 1991, MOL BIOCHEM PARASIT, V45, P29, DOI 10.1016/0166-6851(91)90024-Z; Moller JV, 1996, BBA-REV BIOMEMBRANES, V1286, P1, DOI 10.1016/0304-4157(95)00017-8; MONK BC, 1994, CRIT REV MICROBIOL, V20, P209, DOI 10.3109/10408419409114555; Morsomme P, 2000, BBA-BIOMEMBRANES, V1465, P1, DOI 10.1016/S0005-2736(00)00128-0; PALMGREN MG, 1994, J BIOL CHEM, V269, P3027; Palmgren MG, 2001, ANNU REV PLANT PHYS, V52, P817, DOI 10.1146/annurev.arplant.52.1.817; PERLIN DS, 1989, J BIOL CHEM, V264, P21857; PICK U, 1981, FEBS LETT, V123, P127, DOI 10.1016/0014-5793(81)80035-X; PRINGLE JR, 1991, METHOD ENZYMOL, V194, P565; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SCHLESSER A, 1988, J BIOL CHEM, V263, P19480; Scott DA, 1998, J BIOL CHEM, V273, P22151, DOI 10.1074/jbc.273.34.22151; Scott DA, 1998, BIOCHEM J, V331, P583, DOI 10.1042/bj3310583; Scott DA, 2000, J BIOL CHEM, V275, P24215, DOI 10.1074/jbc.M002454200; SERRANO R, 1990, BIOCHIM BIOPHYS ACTA, V1018, P195, DOI 10.1016/0005-2728(90)90247-2; SERRANO R, 1986, NATURE, V319, P689, DOI 10.1038/319689a0; SERRANO R, 1988, METHOD ENZYMOL, V157, P533; SKEIKY YAW, 1992, J EXP MED, V176, P201, DOI 10.1084/jem.176.1.201; Souto RP, 1996, MOL BIOCHEM PARASIT, V83, P141, DOI 10.1016/S0166-6851(96)02755-7; Stiles JK, 1999, MOL BIOCHEM PARASIT, V103, P105, DOI 10.1016/S0166-6851(99)00105-X; SUPPLY P, 1993, J BIOL CHEM, V268, P19753; Van Der Heyden N, 2000, MOL BIOCHEM PARASIT, V105, P237, DOI 10.1016/S0166-6851(99)00184-X; Vanderheyden N, 1996, BIOCHEM J, V318, P103, DOI 10.1042/bj3180103; VILLALBA JM, 1992, J BIOL CHEM, V267, P12341; WACH A, 1992, J BIOENERG BIOMEMBR, V24, P309; 1997, 13 PROGRAM REPORT UN, P112	51	15	15	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2002	277	46					44497	44506		10.1074/jbc.M202267200	http://dx.doi.org/10.1074/jbc.M202267200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	615XE	12221074	hybrid			2022-12-27	WOS:000179272000121
J	Obin, M; Lee, BY; Meinke, G; Bohm, A; Lee, RH; Gaudet, R; Hopp, JA; Arshavsky, VY; Willardson, BM; Taylor, A				Obin, M; Lee, BY; Meinke, G; Bohm, A; Lee, RH; Gaudet, R; Hopp, JA; Arshavsky, VY; Willardson, BM; Taylor, A			Ubiquitylation of the transducin beta gamma subunit complex - Regulation by phosducin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-CONJUGATING ENZYME; ROD OUTER SEGMENTS; HETEROTRIMERIC G-PROTEINS; DEPENDENT PROTEOLYSIS; PHOTORECEPTOR CELLS; ALPHA-SUBUNIT; 3RD FORM; IN-VIVO; IDENTIFICATION; DEGRADATION	G proteins (Galphabetagamma) are essential signaling molecules, which dissociate into Galpha and Gbetagamma upon activation by heptahelical membrane receptors. We have identified the betagamma subunit complex of the photoreceptor-specific G protein, transducin (T), as a target of the ubiquitin-proteasome pathway. Ubiquitylated species of the transducin gamma-subunit (Tgamma) but not the alpha- or beta-subunits were assembled de novo in bovine photoreceptor preparations. In addition, Tgamma was exclusively ubiquitylated when Tbetagamma was dissociated from Talpha. Ubiquitylation of Tbetagamma on Tgamma was selectively catalyzed by human ubiquitin-conjugating enzymes UbcH5 and UbcH7 and was coincident with degradation of the entire Tbetagamma subunit complex in vitro by a mechanism requiring ATP and the proteasome. We also show that Tbetagamma association with phosducin, a photoreceptor-specific protein of unknown physiological function, blocks Tbetagamma ubiquitylation and subsequent degradation. Phosphorylation of phosducin by Ca2+/calmodulin-dependent protein kinase II, which inhibits phosducin-Tbetagamma complex formation, completely restored Toy ubiquitylation and degradation. We conclude that Tbetagamma is a substrate of the ubiquitin-proteasome pathway and suggest that phosducin serves to protect Tbetagamma following the light-dependent dissociation of Talphabetagamma.	Tufts Univ, JMUSDA, HNRCA, Lab Nutr & Vis Res, Boston, MA 02111 USA; Tufts Ctr Vis Res, Boston, MA 02111 USA; Brigham Young Univ, Dept Chem & Biochem, Provo, UT 84602 USA; Boston Biomed Res Inst, Watertown, MA 02472 USA; Jules Stein Eye Inst, Sepulveda, CA 90095 USA; Greater Los Angeles Healthcare Syst, Sepulveda, CA 90095 USA; Harvard Univ, Dept Mol & Cellular Biol, Boston, MA 02138 USA; Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA 02114 USA; Massachusetts Eye & Ear Infirm, Boston, MA 02114 USA	Tufts University; United States Department of Agriculture (USDA); Brigham Young University; Boston Biomedical Research Institute; Harvard University; Harvard University; Harvard Medical School; Harvard University; Massachusetts Eye & Ear Infirmary	Obin, M (corresponding author), Tufts Univ, JMUSDA, HNRCA, Lab Nutr & Vis Res, 711 Washington St, Boston, MA 02111 USA.	mobin@hnrc.tufts.edu	Gaudet, Rachelle/I-4133-2014; Gaudet, Rachelle/Y-3985-2019	Gaudet, Rachelle/0000-0002-9177-054X; Gaudet, Rachelle/0000-0002-9177-054X; Willardson, Barry/0000-0002-8503-2268	NEI NIH HHS [EY11704, EY12287, EY13250, EY10336, P30 EY13078] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY010336, R01EY013250, R01EY012287, P30EY013078] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ARSHAVSKY VY, 2000, EXP EYE RES, V71, pS179; Barhite S, 1998, BBA-MOL CELL RES, V1402, P95, DOI 10.1016/S0167-4889(97)00141-9; Braun BC, 1999, NAT CELL BIOL, V1, P221, DOI 10.1038/12043; Burns ME, 2001, ANNU REV NEUROSCI, V24, P779, DOI 10.1146/annurev.neuro.24.1.779; Calvert PD, 2000, P NATL ACAD SCI USA, V97, P13913, DOI 10.1073/pnas.250478897; Chen FY, 1997, BIOCHEM BIOPH RES CO, V233, P370, DOI 10.1006/bbrc.1997.6460; CHEN P, 1993, CELL, V74, P357, DOI 10.1016/0092-8674(93)90426-Q; CIECHANOVER A, 1978, BIOCHEM BIOPH RES CO, V81, P1100, DOI 10.1016/0006-291X(78)91249-4; Ciechanover A, 2000, BIOESSAYS, V22, P442, DOI 10.1002/(SICI)1521-1878(200005)22:5<442::AID-BIES6>3.0.CO;2-Q; Clapham DE, 1997, ANNU REV PHARMACOL, V37, P167, DOI 10.1146/annurev.pharmtox.37.1.167; Dohlman HG, 2001, ANNU REV BIOCHEM, V70, P703, DOI 10.1146/annurev.biochem.70.1.703; Flanary PL, 2000, J BIOL CHEM, V275, P18462, DOI 10.1074/jbc.M002163200; FUNG BKK, 1992, J BIOL CHEM, V267, P24782; Gaudet R, 1996, CELL, V87, P577, DOI 10.1016/S0092-8674(00)81376-8; Gaudet R, 1999, MOL CELL, V3, P649, DOI 10.1016/S1097-2765(00)80358-5; GIROD PA, 1993, J BIOL CHEM, V268, P955; Haldeman MT, 1997, BIOCHEMISTRY-US, V36, P10526, DOI 10.1021/bi970750u; HEPLER JR, 1992, TRENDS BIOCHEM SCI, V17, P383, DOI 10.1016/0968-0004(92)90005-T; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Jensen JP, 1995, J BIOL CHEM, V270, P30408, DOI 10.1074/jbc.270.51.30408; Jiang JH, 2001, J BIOL CHEM, V276, P42938, DOI 10.1074/jbc.M101968200; JOHNSON ES, 1990, NATURE, V346, P287, DOI 10.1038/346287a0; Johnson PR, 1998, CELL, V94, P217, DOI 10.1016/S0092-8674(00)81421-X; Kimple Randall J, 2002, Mol Interv, V2, P88, DOI 10.1124/mi.2.2.88; KLEUSS C, 1987, J CHROMATOGR, V407, P281, DOI 10.1016/S0021-9673(01)92625-1; LEE RH, 1992, J BIOL CHEM, V267, P24776; LEE RH, 1990, J BIOL CHEM, V265, P15860; LEE RH, 1984, BIOCHEMISTRY-US, V23, P1972, DOI 10.1021/bi00304a014; LEE RH, 1992, J BIOL CHEM, V267, P25104; LEE RH, 1993, METH NEUROSCI, V15, P196; Loew A, 1998, STRUCT FOLD DES, V6, P1007, DOI 10.1016/S0969-2126(98)00102-6; MCGUIRE MJ, 1988, ARCH BIOCHEM BIOPHYS, V262, P273, DOI 10.1016/0003-9861(88)90189-0; Nakano K, 2001, P NATL ACAD SCI USA, V98, P4693, DOI 10.1073/pnas.071067198; NAVON SE, 1988, J BIOL CHEM, V263, P489; Obin M, 1999, J BIOL CHEM, V274, P11789, DOI 10.1074/jbc.274.17.11789; OBIN M, 1994, BIOCHEM BIOPH RES CO, V200, P1169, DOI 10.1006/bbrc.1994.1574; Obin M, 2002, FASEB J, V16, pA196; Obin MS, 1996, J BIOL CHEM, V271, P14473, DOI 10.1074/jbc.271.24.14473; Oughtred R, 1998, J BIOL CHEM, V273, P18435, DOI 10.1074/jbc.273.29.18435; Pickart CM, 2001, MOL CELL, V8, P499, DOI 10.1016/S1097-2765(01)00347-1; PICKART CM, 1998, UBIQUITIN BIOL CELL, P19; Pierce EA, 2001, BIOESSAYS, V23, P605, DOI 10.1002/bies.1086; PITCHER JA, 1992, SCIENCE, V257, P1264, DOI 10.1126/science.1325672; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Savage JR, 2000, J BIOL CHEM, V275, P30399, DOI 10.1074/jbc.M005120200; Schauber C, 1998, GENES CELLS, V3, P307, DOI 10.1046/j.1365-2443.1998.00192.x; SCHEFFNER M, 1994, P NATL ACAD SCI USA, V91, P8797, DOI 10.1073/pnas.91.19.8797; Schulz R, 2001, PHARMACOL RES, V43, P1, DOI 10.1006/phrs.2000.0757; SHAEFFER JR, 1995, BIOCHEMISTRY-US, V34, P4015, DOI 10.1021/bi00012a020; Sokolov M, 2002, NEURON, V34, P95, DOI 10.1016/S0896-6273(02)00636-0; STANCOVSKI I, 1995, MOL CELL BIOL, V15, P7106; Taylor A, 1997, MOL ASPECTS MED, V18, P307, DOI 10.1016/S0098-2997(95)00049-6; Thulin CD, 2001, J BIOL CHEM, V276, P23805, DOI 10.1074/jbc.M101482200; Thulin CD, 1999, MOL VIS, V5, pU13; TOUHARA K, 1994, J BIOL CHEM, V269, P10217; Varshavsky A., 1998, UBIQUITIN BIOL CELL, P223; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; Willardson BM, 1996, P NATL ACAD SCI USA, V93, P1475, DOI 10.1073/pnas.93.4.1475; WING SS, 1995, BIOCHEM J, V305, P125, DOI 10.1042/bj3050125; YOSHIDA T, 1994, J BIOL CHEM, V269, P24050; Zhu X, 1998, Mol Vis, V4, P13	61	53	54	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2002	277	46					44566	44575		10.1074/jbc.M205308200	http://dx.doi.org/10.1074/jbc.M205308200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	615XE	12215439	Green Published, hybrid			2022-12-27	WOS:000179272000129
J	Vishnivetskiy, SA; Hirsch, JA; Velez, MG; Gurevich, YV; Gurevich, VV				Vishnivetskiy, SA; Hirsch, JA; Velez, MG; Gurevich, YV; Gurevich, VV			Transition of arrestin into the active receptor-binding state requires an extended interdomain hinge	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VISUAL ARRESTIN; CRYSTAL-STRUCTURE; PHOSPHORYLATION-RECOGNITION; BETA-ARRESTIN; RHODOPSIN; MECHANISM; ROD; SELECTIVITY; ANGSTROM; COMPLEX	Arrestins selectively bind to the phosphorylated activated form of G protein-coupled receptors, thereby blocking further G protein activation. Structurally, arrestins consist of two domains topologically connected by a 12-residue long loop, which we term the "hinge" region. Both domains contain receptor-binding elements. The relative size and shape of arrestin and rhodopsin suggest that dramatic changes in arrestin conformation are required to bring all of its receptor-binding elements in contact with the cytoplasmic surface of the receptor. Here we use the visual arrestin/ rhodopsin system to test the hypothesis that the transition of arrestin into its active receptor-binding state involves a movement of the two domains relative to each other that might be limited by the length of the hinge. We have introduced three insertions and 24 deletions in the hinge region and measured the binding of all of these mutants to light-activated phosphorylated (P-Rh*), dark phosphorylated (P-Rh), dark unphosphorylated (Rh), and light-activated unphosphorylated rhodopsin (Rh*). The addition of 1-3 extra residues to the hinge has no effect on arrestin function. In contrast, sequential elimination of 1-8 residues results in a progressive decrease in P-Rh* binding without changing arrestin selectivity for P-Rh*. These results suggest that there is a minimum length of the hinge region necessary for high affinity binding, consistent with the idea that the two domains move relative to each other in the process of arrestin transition into its active receptor-binding state. The same length of the hinge is also necessary for the binding of constitutively active" arrestin mutants to P-Rh*, dark P-Rh, and Rh*, suggesting that the active (receptor-bound) arrestin conformation is essentially the same in both wild type and mutant forms.	Vanderbilt Univ, Dept Pharmacol, Sch Med, Nashville, TN 37232 USA; Tel Aviv Univ, Dept Biochem, George S Wise Fac Life Sci, IL-69978 Ramat Aviv, Israel	Vanderbilt University; Tel Aviv University	Gurevich, VV (corresponding author), Vanderbilt Univ, Dept Pharmacol, Sch Med, Nashville, TN 37232 USA.	Vsevolod.Gurevich@mcmail.vanderbilt.edu	Hirsch, Joel/AAC-8000-2021; Gurevich, Vsevolod/A-3236-2008; Vishnivetskiy, Sergey/AAJ-8661-2020	Hirsch, Joel/0000-0001-7544-8668; Gurevich, Vsevolod/0000-0002-3950-5351; 	NEI NIH HHS [EY11500] Funding Source: Medline; NIGMS NIH HHS [GM63097] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY011500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063097] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CHOU PY, 1978, ANNU REV BIOCHEM, V47, P251, DOI 10.1146/annurev.bi.47.070178.001343; Granzin J, 1998, NATURE, V391, P918, DOI 10.1038/36147; GrayKeller MP, 1997, BIOCHEMISTRY-US, V36, P7058, DOI 10.1021/bi963110k; GUREVICH VV, 1993, J BIOL CHEM, V268, P11628; Gurevich VV, 2000, METHOD ENZYMOL, V315, P422; Gurevich VV, 1997, J BIOL CHEM, V272, P28849, DOI 10.1074/jbc.272.46.28849; GUREVICH VV, 1994, J BIOL CHEM, V269, P8721; Gurevich VV, 1996, METHOD ENZYMOL, V275, P382; GUREVICH VV, 1995, J BIOL CHEM, V270, P720, DOI 10.1074/jbc.270.2.720; Gurevich VV, 1997, MOL PHARMACOL, V51, P161, DOI 10.1124/mol.51.1.161; Gurevich VV, 1998, J BIOL CHEM, V273, P15501, DOI 10.1074/jbc.273.25.15501; GUREVICH VV, 1995, J BIOL CHEM, V270, P6010, DOI 10.1074/jbc.270.11.6010; Han M, 2001, STRUCTURE, V9, P869, DOI 10.1016/S0969-2126(01)00644-X; Hirsch JA, 1999, CELL, V97, P257, DOI 10.1016/S0092-8674(00)80735-7; Kovoor A, 1999, J BIOL CHEM, V274, P6831, DOI 10.1074/jbc.274.11.6831; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Luttrell LM, 2002, J CELL SCI, V115, P455; McDowell J. H., 1993, PHOTORECEPTOR CELLS, V15, P123; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Milano SK, 2002, BIOCHEMISTRY-US, V41, P3321, DOI 10.1021/bi015905j; OHGURO H, 1994, PROTEIN SCI, V3, P2428, DOI 10.1002/pro.5560031226; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; PALCZEWSKI K, 1991, J BIOL CHEM, V266, P18649; Pulvermuller A, 2000, J BIOL CHEM, V275, P37679, DOI 10.1074/jbc.M006776200; Pulvermuller A, 1997, BIOCHEMISTRY-US, V36, P9253, DOI 10.1021/bi970772g; SCHLEICHER A, 1989, BIOCHEMISTRY-US, V28, P1770, DOI 10.1021/bi00430a052; SHINOHARA T, 1987, P NATL ACAD SCI USA, V84, P6975, DOI 10.1073/pnas.84.20.6975; Smith WC, 2000, INVEST OPHTH VIS SCI, V41, P2445; Vishnivetskiy SA, 2000, J BIOL CHEM, V275, P41049, DOI 10.1074/jbc.M007159200; Vishnivetskiy SK, 1999, J BIOL CHEM, V274, P11451, DOI 10.1074/jbc.274.17.11451	30	80	82	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2002	277	46					43961	43967		10.1074/jbc.M206951200	http://dx.doi.org/10.1074/jbc.M206951200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	615XE	12215448	hybrid			2022-12-27	WOS:000179272000056
J	Humphries, KM; Juliano, C; Taylor, SS				Humphries, KM; Juliano, C; Taylor, SS			Regulation of cAMP-dependent protein kinase activity by glutathionylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATALYTIC SUBUNIT; S-GLUTATHIONYLATION; MIXED DISULFIDES; DNA-BINDING; SITE; IDENTIFICATION; INACTIVATION; MECHANISM; CLASSIFICATION; EXPRESSION	The catalytic subunit of cAMP-dependent protein kinase (cAPK) is susceptible to inactivation by a number of thiol-modifying reagents. Inactivation occurs through modification of cysteine 199, which is located near the active site. Because cysteine 199 is reactive at physiological pH, and modification of this site inhibits activity, we hypothesized that cAPK is a likely target for regulation by an oxidative mechanism, specifically glutathionylation. In vitro studies demonstrated the susceptibility of kinase activity to the sulfhydryl oxidant diamide, which inhibited by promoting an intramolecular disulfide bond between cysteines 199 and 343. In the presence of a low concentration of diamide and reduced glutathione, the kinase was rapidly and reversibly inhibited by glutathionylation. Mutant kinase containing an alanine to cysteine mutation at position 199 was resistant to inhibition by both diamide and glutathionylation, thus implicating this as the oxidation-sensitive site. Mouse fibroblast cells treated with diamide showed a reversible decrease in cAPK activity. Inhibition was dramatically enhanced when cells were first treated with cAPK activators. Using biotin-cysteine as means for detecting and purifying thiolated cAPK from cells, we were able to show that, under conditions in which cAPK is inactivated by diamide, it is also readily thiolated.	Univ Calif San Diego, Howard Hughes Med Inst, Dept Chem & Biochem, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego	Taylor, SS (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, Dept Chem & Biochem, CMM-W 125,9500 Gilman Dr, La Jolla, CA 92093 USA.	staylor@ucsd.edu		Humphries, Kenneth/0000-0002-6167-3175	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM064991, R37GM019301, R01GM019301] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM19301, GM64991] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barrett WC, 1999, BIOCHEMISTRY-US, V38, P6699, DOI 10.1021/bi990240v; Boo YC, 2002, J BIOL CHEM, V277, P3388, DOI 10.1074/jbc.M108789200; Chrestensen CA, 2000, J BIOL CHEM, V275, P26556, DOI 10.1074/jbc.M004097200; Chu F, 2001, CARCINOGENESIS, V22, P1221, DOI 10.1093/carcin/22.8.1221; COOK PF, 1982, BIOCHEMISTRY-US, V21, P5794, DOI 10.1021/bi00266a011; Eaton P, 2002, J BIOL CHEM, V277, P9806, DOI 10.1074/jbc.M111454200; Eaton P, 2002, J BIOL CHEM, V277, P21189, DOI 10.1074/jbc.M200591200; FIRST EA, 1984, J BIOL CHEM, V259, P4011; FIRST EA, 1989, BIOCHEMISTRY-US, V28, P3598, DOI 10.1021/bi00434a067; FIRST EA, 1988, J BIOL CHEM, V263, P5176; Fratelli M, 2002, P NATL ACAD SCI USA, V99, P3505, DOI 10.1073/pnas.052592699; Ghezzi P, 2002, MOL IMMUNOL, V38, P773, DOI 10.1016/S0161-5890(01)00114-6; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; HANKS SK, 1991, METHOD ENZYMOL, V200, P38; HERBERG FW, 1993, PROTEIN ENG, V6, P771, DOI 10.1093/protein/6.7.771; JIMENEZ JS, 1982, BIOCHEMISTRY-US, V21, P1623, DOI 10.1021/bi00536a024; Klatt P, 1999, J BIOL CHEM, V274, P15857, DOI 10.1074/jbc.274.22.15857; KOSOWER NS, 1995, METHOD ENZYMOL, V251, P123, DOI 10.1016/0076-6879(95)51116-4; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; Li JF, 2001, J BIOL CHEM, V276, P3098, DOI 10.1074/jbc.M008260200; Macala LJ, 1998, KIDNEY INT, V54, P1746, DOI 10.1046/j.1523-1755.1998.00140.x; MCCLUNG M, 1977, BIOCHEM BIOPH RES CO, V76, P910, DOI 10.1016/0006-291X(77)91588-1; Michel JJC, 2002, ANNU REV PHARMACOL, V42, P235, DOI 10.1146/annurev.pharmtox.42.083101.135801; Mohr S, 1999, J BIOL CHEM, V274, P9427, DOI 10.1074/jbc.274.14.9427; NELSON NC, 1983, J BIOL CHEM, V258, P981; Percival MD, 1999, BIOCHEMISTRY-US, V38, P13574, DOI 10.1021/bi991028u; PETERS KA, 1977, BIOCHEMISTRY-US, V16, P5691, DOI 10.1021/bi00645a007; Pineda-Molina E, 2001, BIOCHEMISTRY-US, V40, P14134, DOI 10.1021/bi011459o; Rao RK, 2002, BIOCHEM BIOPH RES CO, V293, P610, DOI 10.1016/S0006-291X(02)00268-1; Reddy S, 2000, BIOCHEM J, V347, P821, DOI 10.1042/0264-6021:3470821; SHOJI S, 1981, P NATL ACAD SCI-BIOL, V78, P848, DOI 10.1073/pnas.78.2.848; Smith CM, 1997, TRENDS BIOCHEM SCI, V22, P444, DOI 10.1016/S0968-0004(97)01131-6; Sullivan DM, 2000, BIOCHEMISTRY-US, V39, P11121, DOI 10.1021/bi0007674; Wang J, 2001, J BIOL CHEM, V276, P47763, DOI 10.1074/jbc.C100415200; Ward NE, 2000, BIOCHEMISTRY-US, V39, P10319, DOI 10.1021/bi000781g; WEN W, 1995, J BIOL CHEM, V270, P2041, DOI 10.1074/jbc.270.5.2041; WEN W, 1994, J BIOL CHEM, V269, P32214; Zaccolo M, 2002, SCIENCE, V295, P1711, DOI 10.1126/science.1069982; ZHENG JH, 1993, BIOCHEMISTRY-US, V32, P2154, DOI 10.1021/bi00060a005	39	147	149	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					43505	43511		10.1074/jbc.M207088200	http://dx.doi.org/10.1074/jbc.M207088200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12189155	hybrid			2022-12-27	WOS:000179081200135
J	Roje, S; Janave, MT; Ziemak, MJ; Hanson, AD				Roje, S; Janave, MT; Ziemak, MJ; Hanson, AD			Cloning and characterization of mitochondrial 5-formyltetrahydrofolate cycloligase from higher plants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ONE-CARBON METABOLISM; HUMAN 5,10-METHENYLTETRAHYDROFOLATE SYNTHETASE; NITROUS-OXIDE INACTIVATION; METHENYLTETRAHYDROFOLATE SYNTHETASE; SERINE HYDROXYMETHYLTRANSFERASE; RABBIT LIVER; SACCHAROMYCES-CEREVISIAE; FOLATE DERIVATIVES; PURIFICATION; POLYGLUTAMATES	5-Formyltetrahydrofolate cycloligase (5-FCL) catalyzes the conversion of 5-formyltetrahydrofolate (5CHO-H(4)PteGlu(n)) to 5,10-methenyltetrahydrofolate and is considered to be the main means whereby 5-CHOH(4)PteGlu(n) is metabolized in mammals, yeast, and bacteria. 5-CHO-H(4)PteGlu(n) is known to occur in plants and to be highly abundant in leaf mitochondria. Genomics-based approaches identified Arabidopsis and tomato cDNAs encoding proteins homologous to 5-FCLs of other organisms but containing N-terminal extensions with the features of mitochondrial targeting peptides. These homologs were shown to have 5-FCL activity by characterizing recombinant enzymes produced in Escherichia coli and by functional complementation of a yeast fau1 mutation with the Arabidopsis 5-FCL cDNA. The recombinant Arabidopsis enzyme is active as a monomer, prefers the penta- to the monoglutamyl form of 5-CHOH(4)PteGlu(n), and has kinetic properties broadly similar to those of 5-FCLs from other organisms. Enzyme assays and immunoblot analyses indicated that 5-FCL is located predominantly if not exclusively in plant mitochondria and that the mature, active enzyme lacks the putative targeting sequence. Serine hydroxymethyltransferase (SHMT) from plant mitochondria was shown to be inhibited by 5-CHO-H(4)PteGlu(n) as are SEMs from other organisms. Since mitochondrial SHMT is crucial to photorespiration, 5-FCL may help prevent 5-CHO-H(4)PteGlu(n) from reaching levels that would inhibit this process. Consistent with this possibility, 5-FCL activity was far higher in leaf mitochondria than root mitochondria.	Univ Florida, Dept Hort Sci, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Hanson, AD (corresponding author), Univ Florida, Dept Hort Sci, POB 110690, Gainesville, FL 32611 USA.	adha@mail.ifas.ufl.edu		Roje, Sanja/0000-0002-6302-5382				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Baggott JE, 2000, BIOCHEMISTRY-US, V39, P14647, DOI 10.1021/bi001362m; BALAGHI M, 1993, BIOCHEM J, V291, P145, DOI 10.1042/bj2910145; BERTRAND R, 1995, BBA-MOL CELL RES, V1266, P245, DOI 10.1016/0167-4889(95)00020-S; BERTRAND R, 1987, BIOCHIM BIOPHYS ACTA, V911, P154, DOI 10.1016/0167-4838(87)90004-5; BERTRAND R, 1989, J BIOL CHEM, V264, P8843; BESSON V, 1995, PLANT PHYSIOL BIOCH, V33, P665; BESSON V, 1993, BIOCHEM J, V292, P425, DOI 10.1042/bj2920425; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen LF, 1997, PLANT PHYSIOL, V115, P299, DOI 10.1104/pp.115.1.299; CLINE K, 1986, J BIOL CHEM, V261, P4804; Cossins E, 2000, CAN J BOT, V78, P691, DOI 10.1139/cjb-78-6-691; Cossins EA, 1997, PHYTOCHEMISTRY, V45, P437, DOI 10.1016/S0031-9422(96)00833-3; DAYAN A, 1995, GENE, V165, P307, DOI 10.1016/0378-1119(95)00321-V; DOUCE R, 1987, METHOD ENZYMOL, V148, P403; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Gambonnet B, 2001, J SCI FOOD AGR, V81, P835, DOI 10.1002/jsfa.870; Girgis S, 1997, J BIOL CHEM, V272, P4729, DOI 10.1074/jbc.272.8.4729; GREENBERG DM, 1965, BIOCHEMISTRY-US, V4, P1872, DOI 10.1021/bi00885a026; GRIMSHAW CE, 1984, J BIOL CHEM, V259, P2728; Hanson AD, 2002, CURR OPIN PLANT BIOL, V5, P244, DOI 10.1016/S1369-5266(02)00249-2; Hanson AD, 2001, ANNU REV PLANT PHYS, V52, P119, DOI 10.1146/annurev.arplant.52.1.119; Harlow E., 1988, ANTIBODIES LAB MANUA; Higgins DG, 1996, METHOD ENZYMOL, V266, P383; Holmes WB, 2002, J BIOL CHEM, V277, P20205, DOI 10.1074/jbc.M201242200; HOPKINS S, 1984, J BIOL CHEM, V259, P5618; HORNE DW, 1989, ARCH BIOCHEM BIOPHYS, V270, P729, DOI 10.1016/0003-9861(89)90556-0; Horne DW, 1997, J NUTR, V127, P1772, DOI 10.1093/jn/127.9.1772; HORTON RM, 1993, METHOD ENZYMOL, V217, P270; HUENNEKENS FM, 1984, ADV ENZYME REGUL, V22, P3, DOI 10.1016/0065-2571(84)90005-0; Jolivet J, 1997, METHOD ENZYMOL, V281, P162; KRUSCHWITZ HL, 1994, J BIOL CHEM, V269, P28757; MARAS B, 1994, J BIOL CHEM, V269, P18429; Prabhu V, 1998, PLANT PHYSIOL, V116, P137, DOI 10.1104/pp.116.1.137; Raymond RK, 1999, ARCH BIOCHEM BIOPHYS, V372, P300, DOI 10.1006/abbi.1999.1498; Rebeille F, 1999, PR PHYT SOC, V42, P53; Schirch V, 1997, METHOD ENZYMOL, V281, P146; SHIN YS, 1975, CAN J BIOCHEM CELL B, V53, P338, DOI 10.1139/o75-047; Small I, 1998, PLANT MOL BIOL, V38, P265, DOI 10.1023/A:1006081903354; STORER AC, 1976, BIOCHEM J, V159, P1; STOVER P, 1993, TRENDS BIOCHEM SCI, V18, P102, DOI 10.1016/0968-0004(93)90162-G; STOVER P, 1990, J BIOL CHEM, V265, P14227; STOVER P, 1991, J BIOL CHEM, V266, P1543; Suh JR, 2000, J BIOL CHEM, V275, P35646, DOI 10.1074/jbc.M005864200; TAYLOR RT, 1965, ANAL BIOCHEM, V13, P80, DOI 10.1016/0003-2697(65)90120-X; Tissot G, 1997, BIOCHEM J, V323, P179, DOI 10.1042/bj3230179; Trossat C, 1996, PLANT PHYSIOL, V111, P965, DOI 10.1104/pp.111.4.965; VERNET T, 1987, GENE, V52, P225, DOI 10.1016/0378-1119(87)90049-7; Yamaguchi Y, 2002, J CONTROL RELEASE, V81, P235, DOI 10.1016/S0168-3659(02)00060-3	50	37	39	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					42748	42754		10.1074/jbc.M205632200	http://dx.doi.org/10.1074/jbc.M205632200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12207015	hybrid			2022-12-27	WOS:000179081200043
J	Schmitt, JM; Stork, PJS				Schmitt, JM; Stork, PJS			G alpha and G beta gamma require distinct Src-dependent pathways to activate Rap1 and ras	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; EPIDERMAL GROWTH-FACTOR; REGULATED KINASES ERKS; C-SRC; B-RAF; TYROSINE KINASES; MAP KINASE; BETA(2)-ADRENERGIC RECEPTOR; PHOSPHOINOSITIDE 3-KINASE; SIGNAL-TRANSDUCTION	The Src tyrosine kinase is necessary for activation of extracellular signal-regulated kinases (ERKs) by the beta-adrenergic receptor agonist, isoproterenol. In this study, we examined the role of Src in the stimulation of two small G proteins, Ras and Rap1, that have been implicated in isoproterenol's signaling to ERKs. We demonstrate that the activation of isoproterenol of both Rap1 and Ras requires Src. In HEK293 cells, isoproterenol activates Rap1, stimulates Rap1 association with B-Raf, and activates ERKs, all via PKA. In contrast, the activation by isoproterenol of Ras requires Gbetagamma sub-units, is independent of PKA, and results in the phosphoinositol 3-kinase-dependent activation of AKT. Interestingly, beta-adrenergic stimulation of both Rap1 and ERKs, but not Ras and AKT, can be blocked by a Src mutant (SrcS17A) that is incapable of being phosphorylated and activated by PKA. Furthermore, a Src mutant (SrcS17D), which mimics PKA phosphorylation at serine 17, stimulates Rap1 activation, Rap1/B-Raf association, and ERK activation but does not stimulate Ras or AKT. These data suggest that Rap1 activation, but not that of Ras, is mediated through the direct phosphorylation of Src by PKA. We propose that the beta(2)-adrenergic receptor activates Src via two independent mechanisms to mediate distinct signaling pathways, one through Galpha(s) to Rap1 and ERKs and the other through Gbetagamma to Ras and AKT.	Oregon Hlth Sci Univ, Vollum Inst, Portland, OR 97201 USA; Oregon Hlth Sci Univ, Dept Cell & Dev Biol, Portland, OR 97201 USA	Oregon Health & Science University; Oregon Health & Science University	Stork, PJS (corresponding author), Oregon Hlth Sci Univ, Vollum Inst, L474,SW Sam Jackson Pk Rd, Portland, OR 97201 USA.				NCI NIH HHS [CA07291] Funding Source: Medline; NHLBI NIH HHS [T32 HL07781] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007781] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Alexandropoulos K, 1996, GENE DEV, V10, P1341, DOI 10.1101/gad.10.11.1341; Andreev J, 2001, J BIOL CHEM, V276, P20130, DOI 10.1074/jbc.M102307200; BIRNBAUMER L, 1992, CELL, V71, P10069; Bisotto S, 2001, BIOCHEM J, V360, P77, DOI 10.1042/0264-6021:3600077; Bommakanti RK, 2000, J BIOL CHEM, V275, P38870, DOI 10.1074/jbc.M007403200; BOUSSIOTIS VA, 1994, SCIENCE, V266, P1039, DOI 10.1126/science.7973657; Broome MA, 1996, J BIOL CHEM, V271, P16798, DOI 10.1074/jbc.271.28.16798; Brown MT, 1996, BBA-REV CANCER, V1287, P121, DOI 10.1016/0304-419X(96)00003-0; Burnham MR, 2000, MOL CELL BIOL, V20, P5865, DOI 10.1128/MCB.20.16.5865-5878.2000; Busca R, 2000, EMBO J, V19, P2900, DOI 10.1093/emboj/19.12.2900; Carragher NO, 2001, J BIOL CHEM, V276, P4270, DOI 10.1074/jbc.M008972200; Cary LA, 2002, MOL CELL BIOL, V22, P2427, DOI 10.1128/MCB.22.8.2427-2440.2002; CHEN JH, 1994, SCIENCE, V263, P1278, DOI 10.1126/science.8122111; COOK SJ, 1993, SCIENCE, V262, P1069, DOI 10.1126/science.7694367; Daaka Y, 1997, NATURE, V390, P88, DOI 10.1038/36362; Daaka Y, 1998, J BIOL CHEM, V273, P685, DOI 10.1074/jbc.273.2.685; DellaRocca GJ, 1997, J BIOL CHEM, V272, P19125, DOI 10.1074/jbc.272.31.19125; Downward J, 1998, CURR OPIN GENET DEV, V8, P49, DOI 10.1016/S0959-437X(98)80061-0; Downward J, 1998, CURR OPIN CELL BIOL, V10, P262, DOI 10.1016/S0955-0674(98)80149-X; Franke B, 1997, EMBO J, V16, P252, DOI 10.1093/emboj/16.2.252; Fredriksson JM, 2000, J BIOL CHEM, V275, P13802, DOI 10.1074/jbc.275.18.13802; Friedman J, 2002, MOL PHARMACOL, V62, P1094, DOI 10.1124/mol.62.5.1094; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; GRAVES LM, 1993, P NATL ACAD SCI USA, V90, P10300, DOI 10.1073/pnas.90.21.10300; Guo FF, 2001, J BIOL CHEM, V276, P25568, DOI 10.1074/jbc.M101277200; Gutkind JS, 1998, J BIOL CHEM, V273, P1839, DOI 10.1074/jbc.273.4.1839; Hakak Y, 1999, MOL CELL BIOL, V19, P6953; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Iacovelli L, 2001, MOL PHARMACOL, V60, P924, DOI 10.1124/mol.60.5.924; Kao SC, 2001, J BIOL CHEM, V276, P18169, DOI 10.1074/jbc.M008870200; Kassenbrock CK, 2002, J BIOL CHEM, V277, P24967, DOI 10.1074/jbc.M201026200; Khwaja A, 1997, EMBO J, V16, P2783, DOI 10.1093/emboj/16.10.2783; Klinger M, 2002, J BIOL CHEM, V277, P32490, DOI 10.1074/jbc.M200556200; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; Kobierski LA, 1999, J NEUROCHEM, V73, P129, DOI 10.1046/j.1471-4159.1999.0730129.x; KOCH WJ, 1994, P NATL ACAD SCI USA, V91, P12706, DOI 10.1073/pnas.91.26.12706; Lefkowitz RJ, 1998, J BIOL CHEM, V273, P18677, DOI 10.1074/jbc.273.30.18677; Li LM, 2002, MOL CELL BIOL, V22, P1203, DOI 10.1128/MCB.22.4.1203-1217.2002; Liao YH, 2001, J BIOL CHEM, V276, P28478, DOI 10.1074/jbc.M101737200; Lindquist JM, 2000, J BIOL CHEM, V275, P22670, DOI 10.1074/jbc.M909093199; Lou LG, 2002, J BIOL CHEM, V277, P32799, DOI 10.1074/jbc.M201491200; Luttrell LM, 1997, J BIOL CHEM, V272, P4637, DOI 10.1074/jbc.272.7.4637; Luttrell LM, 1996, J BIOL CHEM, V271, P19443, DOI 10.1074/jbc.271.32.19443; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Marinissen MJ, 2001, TRENDS PHARMACOL SCI, V22, P368, DOI 10.1016/S0165-6147(00)01678-3; Marte BM, 1997, TRENDS BIOCHEM SCI, V22, P355, DOI 10.1016/S0968-0004(97)01097-9; Maudsley S, 2000, J BIOL CHEM, V275, P9572, DOI 10.1074/jbc.275.13.9572; McLeod SJ, 1998, J BIOL CHEM, V273, P29218, DOI 10.1074/jbc.273.44.29218; Miyake S, 1997, CRIT REV ONCOGENESIS, V8, P189, DOI 10.1615/CritRevOncog.v8.i2-3.30; Murga C, 2000, J BIOL CHEM, V275, P12069, DOI 10.1074/jbc.275.16.12069; Murga C, 1998, J BIOL CHEM, V273, P19080, DOI 10.1074/jbc.273.30.19080; Ohtsuka T, 1996, J BIOL CHEM, V271, P1258, DOI 10.1074/jbc.271.3.1258; Parsons JT, 1997, CURR OPIN CELL BIOL, V9, P187, DOI 10.1016/S0955-0674(97)80062-2; Pierce KL, 2000, P NATL ACAD SCI USA, V97, P1489, DOI 10.1073/pnas.97.4.1489; Qiu WS, 2000, J BIOL CHEM, V275, P31921, DOI 10.1074/jbc.M003327200; ROCHE S, 1995, SCIENCE, V269, P1567, DOI 10.1126/science.7545311; ROCHE S, 1995, MOL CELL BIOL, V15, P1102; Sadoshima J, 1996, EMBO J, V15, P775, DOI 10.1002/j.1460-2075.1996.tb00413.x; Sakkab D, 2000, J BIOL CHEM, V275, P10772, DOI 10.1074/jbc.275.15.10772; Schmitt JM, 2000, J BIOL CHEM, V275, P25342, DOI 10.1074/jbc.M003213200; Schmitt JM, 2002, MOL CELL, V9, P85, DOI 10.1016/S1097-2765(01)00432-4; Schmitt JM, 2001, MOL CELL BIOL, V21, P3671, DOI 10.1128/MCB.21.11.3671-3683.2001; Seidel MG, 1999, J BIOL CHEM, V274, P25833, DOI 10.1074/jbc.274.36.25833; Shah BH, 2002, MOL PHARMACOL, V61, P343, DOI 10.1124/mol.61.2.343; Shinohara M, 2001, J BIOL CHEM, V276, P18941, DOI 10.1074/jbc.M100909200; Stork PJS, 2002, TRENDS CELL BIOL, V12, P258, DOI 10.1016/S0962-8924(02)02294-8; Tsygankov AY, 1996, J BIOL CHEM, V271, P27130, DOI 10.1074/jbc.271.43.27130; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; WALKER F, 1993, J BIOL CHEM, V268, P19552; Wan Y, 1998, J BIOL CHEM, V273, P14533, DOI 10.1074/jbc.273.23.14533; WU J, 1993, SCIENCE, V262, P1065, DOI 10.1126/science.7694366; Xing LZ, 2000, MOL CELL BIOL, V20, P7363, DOI 10.1128/MCB.20.19.7363-7377.2000; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; York RD, 1998, NATURE, V392, P622, DOI 10.1038/33451; Yoshizumi M, 2000, J BIOL CHEM, V275, P11706, DOI 10.1074/jbc.275.16.11706; Zamah AM, 2002, J BIOL CHEM, V277, P31249, DOI 10.1074/jbc.M202753200; Zhong HY, 1999, BIOCHEM J, V344, P889, DOI 10.1042/0264-6021:3440889	77	52	53	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					43024	43032		10.1074/jbc.M204006200	http://dx.doi.org/10.1074/jbc.M204006200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12221082	hybrid			2022-12-27	WOS:000179081200079
J	Sohn, SJ; Sarvis, BK; Cado, D; Winoto, A				Sohn, SJ; Sarvis, BK; Cado, D; Winoto, A			ERK5 MAPK regulates embryonic angiogenesis and acts as a hypoxia-sensitive repressor of vascular endothelial growth factor expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; BLOOD-VESSEL FORMATION; TRANSCRIPTION FACTOR MEF2C; PROTEIN-KINASE-1 BMK1; GENE-EXPRESSION; TIE2 RECEPTOR; CELLS; VEGF; P38-ALPHA; DIFFERENTIATION	During angiogenesis, endothelial cells undergo proliferation, reorganization, and stabilization to establish a mature vascular network. This process is critical for establishing a functional circulatory system during development and contributes to the pathological process of tumor growth. Here we report that embryos deficient for the ERK5 MAPK die between embryonic days 10.5 and 11.5 with angiogenic failure and cardiovascular defects. We show that ERK5 deficiency leads to an increased expression of the vascular endothelial growth factor (VEGF), dysregulation of which has been shown to impede angiogenic remodeling and vascular stabilization. Our data also reveal that ERK5 negatively regulates transcription from the vegf locus during hypoxic responses. Importantly, ERK5 is required at an earlier developmental stage than p38a, and p38a does not compensate for ERK5 deficiency. These results demonstrate that ERK5 plays a specific role in the regulation of early angiogenesis.	Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Canc Res Lab, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Winoto, A (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol, 465 Life Sci Addit, Berkeley, CA 94720 USA.				NCI NIH HHS [CA66236] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA066236] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abe J, 1997, J BIOL CHEM, V272, P20389, DOI 10.1074/jbc.272.33.20389; Adams RH, 2000, MOL CELL, V6, P109, DOI 10.1016/S1097-2765(00)00012-5; ALAN T, 1995, NAT MED, V1, P1024; Ausubel FM., 1988, CURRENT PROTOCOLS MO; BALDWIN HS, 1996, CARDIOVASC RES, V31, P34; Beck L, 1997, FASEB J, V11, P365, DOI 10.1096/fasebj.11.5.9141503; Brutsaert DL, 1998, CARDIOVASC RES, V38, P281, DOI 10.1016/S0008-6363(98)00044-3; Carmeliet P, 1996, NATURE, V383, P73, DOI 10.1038/383073a0; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Cavanaugh JE, 2001, J NEUROSCI, V21, P434, DOI 10.1523/JNEUROSCI.21-02-00434.2001; Chao TH, 1999, J BIOL CHEM, V274, P36035, DOI 10.1074/jbc.274.51.36035; Cobb MH, 1999, PROG BIOPHYS MOL BIO, V71, P479, DOI 10.1016/S0079-6107(98)00056-X; Dong C, 1998, SCIENCE, V282, P2092, DOI 10.1126/science.282.5396.2092; Dor Y, 2001, AM J PHYSIOL-CELL PH, V280, pC1367, DOI 10.1152/ajpcell.2001.280.6.C1367; Dvorak HF, 1999, CURR TOP MICROBIOL, V237, P97; Esparis-Ogando A, 2002, MOL CELL BIOL, V22, P270, DOI 10.1128/MCB.22.1.270-285.2002; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Garrington TP, 2000, EMBO J, V19, P5387, DOI 10.1093/emboj/19.20.5387; Hellstrom M, 1999, DEVELOPMENT, V126, P3047; HOGAN B, 1984, MANIPULATING MOUSE E; Holash J, 1999, ONCOGENE, V18, P5356, DOI 10.1038/sj.onc.1203035; Ihle JN, 2000, CELL, V102, P131, DOI 10.1016/S0092-8674(00)00017-9; Kasler HG, 2000, MOL CELL BIOL, V20, P8382, DOI 10.1128/MCB.20.22.8382-8389.2000; Kato Y, 2000, J BIOL CHEM, V275, P18534, DOI 10.1074/jbc.M001573200; Kato Y, 1997, EMBO J, V16, P7054, DOI 10.1093/emboj/16.23.7054; Kato Y, 1998, NATURE, V395, P713, DOI 10.1038/27234; Kuan CY, 1999, NEURON, V22, P667, DOI 10.1016/S0896-6273(00)80727-8; Lin Q, 1997, SCIENCE, V276, P1404, DOI 10.1126/science.276.5317.1404; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; McKinsey TA, 2002, TRENDS BIOCHEM SCI, V27, P40, DOI 10.1016/S0968-0004(01)02031-X; Miquerol L, 2000, DEVELOPMENT, V127, P3941; Mudgett JS, 2000, P NATL ACAD SCI USA, V97, P10454, DOI 10.1073/pnas.180316397; Pages G, 1999, SCIENCE, V286, P1374, DOI 10.1126/science.286.5443.1374; PARDANAUD L, 1989, DEVELOPMENT, V105, P473; Patan S, 1998, MICROVASC RES, V56, P1, DOI 10.1006/mvre.1998.2081; Patan S, 2000, J NEURO-ONCOL, V50, P1, DOI 10.1023/A:1006493130855; Pierce EA, 1996, ARCH OPHTHALMOL-CHIC, V114, P1219, DOI 10.1001/archopht.1996.01100140419009; Regan CP, 2002, P NATL ACAD SCI USA, V99, P9248, DOI 10.1073/pnas.142293999; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; SATO TN, 1995, NATURE, V376, P70, DOI 10.1038/376070a0; Semenza GL, 2001, J CLIN INVEST, V108, P39, DOI 10.1172/JCI13374; SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0; Stone J, 1996, INVEST OPHTH VIS SCI, V37, P290; Sun WY, 2001, J BIOL CHEM, V276, P5093, DOI 10.1074/jbc.M003719200; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Tamura K, 2000, CELL, V102, P221, DOI 10.1016/S0092-8674(00)00027-1; Watson FL, 2001, NAT NEUROSCI, V4, P981, DOI 10.1038/nn720; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215; Yang CC, 1998, NUCLEIC ACIDS RES, V26, P4771, DOI 10.1093/nar/26.20.4771; Yang DD, 1998, IMMUNITY, V9, P575, DOI 10.1016/S1074-7613(00)80640-8; Yang JH, 2000, NAT GENET, V24, P309, DOI 10.1038/73550; Zelzer E, 1998, EMBO J, V17, P5085, DOI 10.1093/emboj/17.17.5085	53	147	150	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					43344	43351		10.1074/jbc.M207573200	http://dx.doi.org/10.1074/jbc.M207573200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12221099	hybrid			2022-12-27	WOS:000179081200118
J	Wang, QB; Sharma, D; Ren, Y; Fondell, JD				Wang, QB; Sharma, D; Ren, Y; Fondell, JD			A coregulatory role for the TRAP-Mediator complex in androgen receptor-mediated gene expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYROID-HORMONE RECEPTOR; PROLIFERATOR-ACTIVATED RECEPTOR; AMINO-TERMINAL DOMAIN; CREB-BINDING-PROTEIN; TRANSCRIPTIONAL ACTIVATION; NUCLEAR RECEPTORS; ESTROGEN-RECEPTOR; COACTIVATOR COMPLEXES; RESPONSE ELEMENT; LIGAND-BINDING	The human thyroid hormone receptor-associated protein (TRAP)-Mediator complex was originally identified as a large multimeric complex that copurifies with the thyroid hormone receptor (TR) from HeLa cells and markedly enhances TR-mediated transcription in vitro. More recent studies have implicated TRAP-Mediator as a coactivator for a broad range of nuclear hormone receptors as well as other classes of transcriptional activators. Here we present evidence that TRAP-Mediator plays a functional role in androgen receptor (AR)-mediated transcription. We show that several subunits of the complex ligand-dependently coimmunoprecipitate with AR from both prostate cancer LNCaP cells and from HeLa cells stably transfected with AR. The 220-kDa subunit of the complex (TRAP220) can contact the ligand-binding domain of AR in vitro, possibly implicating TRAP220 involvement in targeting AR to the holocomplex. Consistent with a TRAP-Mediator coactivator role, transient overexpression of the TRAP220, TRAP170, and TRAP100 subunits enhanced ligand-dependent transcription by AR in cultured cells. Finally, chromatin immunoprecipitation assays show that TRAP220 is recruited to the androgen-responsive prostate-specific antigen gene promoter in vivo in ligand-stimulated LNCaP cells. Collectively, these data suggest that TRAP-Mediator may play an important coregulatory role in AR-mediated gene expression.	Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Fondell, JD (corresponding author), UMDNJ, Robert Wood Johnson Med Sch, Dept Physiol & Biophys, 675 Hoes Lane, Piscataway, NJ 08854 USA.		Wang, Qianben/E-4267-2011		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060883] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK60883] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aarnisalo P, 1998, P NATL ACAD SCI USA, V95, P2122, DOI 10.1073/pnas.95.5.2122; Alen P, 1999, MOL CELL BIOL, V19, P6085; BARETTINO D, 1994, EMBO J, V13, P3039, DOI 10.1002/j.1460-2075.1994.tb06603.x; Bevan CL, 1999, MOL CELL BIOL, V19, P8383; Burakov D, 2000, J BIOL CHEM, V275, P20928, DOI 10.1074/jbc.M002013200; Chamberlain NL, 1996, J BIOL CHEM, V271, P26772, DOI 10.1074/jbc.271.43.26772; Cleutjens KBJM, 1997, MOL ENDOCRINOL, V11, P148, DOI 10.1210/me.11.2.148; Cleutjens KBJM, 1996, J BIOL CHEM, V271, P6379, DOI 10.1074/jbc.271.11.6379; DANIELIAN PS, 1992, EMBO J, V11, P1025, DOI 10.1002/j.1460-2075.1992.tb05141.x; Darimont BD, 1998, GENE DEV, V12, P3343, DOI 10.1101/gad.12.21.3343; DURAND B, 1994, EMBO J, V13, P5370, DOI 10.1002/j.1460-2075.1994.tb06872.x; Fondell JD, 1996, MOL CELL BIOL, V16, P281; Fondell JD, 1996, P NATL ACAD SCI USA, V93, P8329, DOI 10.1073/pnas.93.16.8329; Fondell JD, 1999, P NATL ACAD SCI USA, V96, P1959, DOI 10.1073/pnas.96.5.1959; Fronsdal K, 1998, J BIOL CHEM, V273, P31853, DOI 10.1074/jbc.273.48.31853; Glass CK, 2000, GENE DEV, V14, P121; He B, 1999, J BIOL CHEM, V274, P37219, DOI 10.1074/jbc.274.52.37219; Heinlein CA, 2002, ENDOCR REV, V23, P175, DOI 10.1210/er.23.2.175; Henttu PMA, 1997, MOL CELL BIOL, V17, P1832, DOI 10.1128/MCB.17.4.1832; Hittelman AB, 1999, EMBO J, V18, P5380, DOI 10.1093/emboj/18.19.5380; Horoszewicz J S, 1980, Prog Clin Biol Res, V37, P115; Ikonen T, 1997, J BIOL CHEM, V272, P29821, DOI 10.1074/jbc.272.47.29821; Ito M, 2001, TRENDS ENDOCRIN MET, V12, P127, DOI 10.1016/S1043-2760(00)00355-6; Kang YK, 2002, P NATL ACAD SCI USA, V99, P2642, DOI 10.1073/pnas.261715899; KATO S, 1995, SCIENCE, V270, P1491, DOI 10.1126/science.270.5241.1491; Malik S, 2000, TRENDS BIOCHEM SCI, V25, P277, DOI 10.1016/S0968-0004(00)01596-6; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; McKenna NJ, 1999, ENDOCR REV, V20, P321, DOI 10.1210/er.20.3.321; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; Myers LC, 2000, ANNU REV BIOCHEM, V69, P729, DOI 10.1146/annurev.biochem.69.1.729; NAGPAL S, 1992, CELL, V70, P1007, DOI 10.1016/0092-8674(92)90250-G; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; QUIGLEY CA, 1995, ENDOCR REV, V16, P271, DOI 10.1210/er.16.3.271; Rachez C, 1999, NATURE, V398, P824, DOI 10.1038/19783; Rachez C, 2000, MOL CELL BIOL, V20, P2718, DOI 10.1128/MCB.20.8.2718-2726.2000; Ren YS, 2000, MOL CELL BIOL, V20, P5433, DOI 10.1128/MCB.20.15.5433-5446.2000; Schuur ER, 1996, J BIOL CHEM, V271, P7043, DOI 10.1074/jbc.271.12.7043; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shang YF, 2002, MOL CELL, V9, P601, DOI 10.1016/S1097-2765(02)00471-9; Sharma D, 2000, MOL ENDOCRINOL, V14, P2001, DOI 10.1210/me.14.12.2001; Sharma D, 2002, P NATL ACAD SCI USA, V99, P7934, DOI 10.1073/pnas.122004799; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; SIMENTAL JA, 1991, J BIOL CHEM, V266, P510; Treuter E, 1999, J BIOL CHEM, V274, P6667, DOI 10.1074/jbc.274.10.6667; TSAI MJ, 1994, ANNU REV BIOCHEM, V63, P451, DOI 10.1146/annurev.bi.63.070194.002315; Wang G, 2001, MOL CELL BIOL, V21, P4604, DOI 10.1128/MCB.21.14.4604-4613.2001; Wang QB, 2001, ANAL BIOCHEM, V289, P217, DOI 10.1006/abio.2000.4960; Warnmark A, 2001, J BIOL CHEM, V276, P23397, DOI 10.1074/jbc.M011651200; Yoshikawa H, 1998, GENOMICS, V49, P237, DOI 10.1006/geno.1998.5246; Zhang JC, 1999, MOL ENDOCRINOL, V13, P1130, DOI 10.1210/me.13.7.1130; Zhu YJ, 1997, J BIOL CHEM, V272, P25500, DOI 10.1074/jbc.272.41.25500; Zhu YJ, 1999, P NATL ACAD SCI USA, V96, P10848, DOI 10.1073/pnas.96.19.10848	52	84	88	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					42852	42858		10.1074/jbc.M206061200	http://dx.doi.org/10.1074/jbc.M206061200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12218053	hybrid			2022-12-27	WOS:000179081200057
J	Baldwin, J; Farajallah, AM; Malmquist, NA; Rathod, PK; Phillips, MA				Baldwin, J; Farajallah, AM; Malmquist, NA; Rathod, PK; Phillips, MA			Malarial dihydroorotate dehydrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMODIUM-FALCIPARUM; PYRIMIDINE BIOSYNTHESIS; SELECTIVE ACTIVITY; PURIFICATION; INHIBITION; BREQUINAR; LEFLUNOMIDE; PURINE; COMBINATION; ATOVAQUONE	The malarial parasite relies on de novo pyrimidine biosynthesis to maintain its pyrimidine pools, and unlike the human host cell it is unable to scavenge preformed pyrimidines. Dihydroorotate dehydrogenase (DHODH) catalyzes the oxidation of dihydroorotate, (DHO) to produce orotate, a key step in pyrimidine biosynthesis. The enzyme is located in the outer membrane of the mitochondria of the malarial parasite. To characterize the biochemical properties of the malarial enzyme, an N-terminally truncated version of P. falciparum DHODH has been expressed as a soluble, active enzyme in E. coli. The recombinant enzyme binds 0.9 molar equivalents of the cofactor FMN and it has a pH maximum of 8.0 (k(cat) 8 s(-1), K-m(aPP) DHO (40-80 mum)). The substrate specificity of the ubiquinone cofactor (CoQ(n)) that is required for the oxidation of FMN in the second step of the reaction was also determined. The isoprenoid (n) length of CoQ(n) was a determinant of reaction efficiency; CoQ(4), CoQ(6) and decylubiquinone (COQ(D)) were efficiently utilized in the reaction, however cofactors lacking an isoprenoid tail (CoQ(0) and vitamin K-3) showed decreased catalytic efficiency resulting from a 4 to 7-fold increase in K-m(app). Five potent inhibitors of mammalian DHODH, Redoxal, dichloroallyl lawsone (DCL), and three analogs of A77 1726 were tested as inhibitors of the malarial enzyme. All five compounds were poor inhibitors of the malarial enzyme, with IC50's ranging from 0.1-1.0 mm. The IC50 values for inhibition of the malarial enzyme are 10(2)-10(4)-fold higher than the values reported for the mammalian enzyme, demonstrating that inhibitor binding to DHODH is species specific. These studies provide direct evidence that the malarial DHODH active site is different from the host enzyme, and that it is an attractive target for the development of new anti-malarial agents.	Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75390 USA; Univ Washington, Dept Chem, Seattle, WA 98195 USA; Seattle Biomed Res Inst, Seattle, WA 98109 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Washington; University of Washington Seattle; Center for Infectious Disease Research	Phillips, MA (corresponding author), Univ Texas, SW Med Ctr, Dept Pharmacol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Margaret.Phillips@UTSouthwestern.edu		Malmquist, Nicholas/0000-0003-2822-8245	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034432, R01AI040956, R29AI026912, R01AI026912] Funding Source: NIH RePORTER; NIAID NIH HHS [AI40956, R01-AI34432, AI26912] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Allison AC, 2000, IMMUNOPHARMACOLOGY, V47, P63, DOI 10.1016/S0162-3109(00)00186-7; Baca AM, 2000, INT J PARASITOL, V30, P113, DOI 10.1016/S0020-7519(00)00019-9; Batt DG, 1998, BIOORG MED CHEM LETT, V8, P1745, DOI 10.1016/S0960-894X(98)00308-4; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Breman JG, 2001, AM J TROP MED HYG, V64, P1; CLEAVELAND ES, 1995, BIOCHEM PHARMACOL, V49, P947, DOI 10.1016/0006-2952(95)00009-O; Copeland RA, 2000, J BIOL CHEM, V275, P33373, DOI 10.1074/jbc.M004451200; COPELAND RA, 1995, ARCH BIOCHEM BIOPHYS, V323, P79, DOI 10.1006/abbi.1995.0012; Gardner MJ, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P69; GERO AM, 1990, BLOOD CELLS, V16, P467; Goldenberg MM, 1999, CLIN THER, V21, P1837, DOI 10.1016/S0149-2918(00)86732-6; Grishin NV, 1996, PROTEINS, V24, P272, DOI 10.1002/(SICI)1097-0134(199602)24:2<272::AID-PROT17>3.0.CO;2-K; GUTTERIDGE WE, 1970, J PROTOZOOL, V17, P89, DOI 10.1111/j.1550-7408.1970.tb05163.x; HAMMOND DJ, 1984, MOL BIOCHEM PARASIT, V13, P243, DOI 10.1016/0166-6851(84)90117-8; Herrmann ML, 2000, IMMUNOPHARMACOLOGY, V47, P273, DOI 10.1016/S0162-3109(00)00191-0; HINES V, 1986, J BIOL CHEM, V261, P1386; Jiang L, 2000, ANTIMICROB AGENTS CH, V44, P1047, DOI 10.1128/AAC.44.4.1047-1050.2000; JONES ME, 1980, ANNU REV BIOCHEM, V49, P253, DOI 10.1146/annurev.bi.49.070180.001345; Knecht W, 2000, FEBS LETT, V467, P27, DOI 10.1016/S0014-5793(00)01117-0; Knecht W, 2000, CHEM-BIOL INTERACT, V124, P61, DOI 10.1016/S0009-2797(99)00144-1; KRUNGKRAI J, 1991, BIOCHEMISTRY-US, V30, P1934, DOI 10.1021/bi00221a029; KRUNGKRAI J, 1995, BBA-GEN SUBJECTS, V1243, P351, DOI 10.1016/0304-4165(94)00158-T; Kuo EA, 1996, J MED CHEM, V39, P4608, DOI 10.1021/jm9604437; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEBLANC SB, 1993, MOL BIOCHEM PARASIT, V60, P349, DOI 10.1016/0166-6851(93)90148-Q; Liu SP, 2000, STRUCT FOLD DES, V8, P25, DOI 10.1016/S0969-2126(00)00077-0; Marcinkeviciene J, 2000, BIOCHEM PHARMACOL, V60, P339, DOI 10.1016/S0006-2952(00)00348-8; McLean JE, 2001, BIOCHEMISTRY-US, V40, P2194, DOI 10.1021/bi001810q; McRobert L, 2002, MOL BIOCHEM PARASIT, V119, P273, DOI 10.1016/S0166-6851(01)00429-7; Miller R W, 1978, Methods Enzymol, V51, P63; NAGY M, 1992, P NATL ACAD SCI USA, V89, P8966, DOI 10.1073/pnas.89.19.8966; Nara T, 2000, GENE, V257, P209, DOI 10.1016/S0378-1119(00)00411-X; Phillips RS, 2001, CLIN MICROBIOL REV, V14, P208, DOI 10.1128/CMR.14.1.208-226.2001; Pitts WJ, 1998, BIOORG MED CHEM LETT, V8, P307, DOI 10.1016/S0960-894X(98)00010-9; RATHOD PK, 1992, ANTIMICROB AGENTS CH, V36, P704, DOI 10.1128/AAC.36.4.704; RATHOD PK, 1994, ANTIMICROB AGENTS CH, V38, P476, DOI 10.1128/AAC.38.3.476; RATHOD PK, 1989, ANTIMICROB AGENTS CH, V33, P1090, DOI 10.1128/AAC.33.7.1090; REYES P, 1982, MOL BIOCHEM PARASIT, V5, P275, DOI 10.1016/0166-6851(82)90035-4; SHERMAN IW, 1979, MICROBIOL REV, V43, P453, DOI 10.1128/MMBR.43.4.453-495.1979; Srivastava IK, 1999, MOL MICROBIOL, V33, P704, DOI 10.1046/j.1365-2958.1999.01515.x; Triglia T, 1998, EMBO J, V17, P3807, DOI 10.1093/emboj/17.14.3807; Ullrich A, 2001, EUR J BIOCHEM, V268, P1861, DOI 10.1046/j.1432-1033.2001.02061.x; WANG CC, 1983, J EXP MED, V158, P1703, DOI 10.1084/jem.158.5.1703; Wellems TE, 2001, J INFECT DIS, V184, P770, DOI 10.1086/322858; Wu YM, 1996, P NATL ACAD SCI USA, V93, P1130, DOI 10.1073/pnas.93.3.1130	45	96	99	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					41827	41834		10.1074/jbc.M206854200	http://dx.doi.org/10.1074/jbc.M206854200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12189151	hybrid			2022-12-27	WOS:000178985300068
J	Inoue, H; Furukawa, T; Giannakopoulos, S; Zhou, SL; King, DS; Tanese, N				Inoue, H; Furukawa, T; Giannakopoulos, S; Zhou, SL; King, DS; Tanese, N			Largest subunits of the human SWI/SNF chromatin-remodeling complex promote transcriptional activation by steroid hormone receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING PROTEINS; SWI-SNF COMPLEX; GLUCOCORTICOID RECEPTOR; ESTROGEN-RECEPTOR; REGULATE TRANSCRIPTION; HISTONE ACETYLATION; DROSOPHILA-BRAHMA; HUMAN HOMOLOGS; TARGET GENES; FAMILY	The mammalian SWI/SNF-related complexes facilitate gene transcription by remodeling chromatin using the energy of ATP hydrolysis. The recruitment of these complexes to promoters remains poorly understood and may involve histone modifications or direct interactions with site-specific transcription factors or other cofactors. Here we report the isolation of two related but distinct cDNA clones, hOsa1 and hOsa2, that encode the largest subunits of human SWI/SNF. hOsa1 is identical to previously reported BAF250, and hOsa2 shares a high degree of sequence similarity with hOsa1. Mass spectrometric analysis, and immunoblotting with antibodies specific to hOsa1 or hOsa2 demonstrate the presence of both proteins in SWI/SNF-A but not in the related polybromo-BRG1-associated factors complex purified from HeLa cells. Co-precipitation studies indicate that hOsal and hOsa2 associate with BRG1 and hBRM through the C-terminal domain of hOsa. We define multiple domains within hBRM and BRG1 that interact with the hOsa C terminus. In cultured mammalian cells, hOsa1 and hOsa2 stimulate transcription by the glucocorticoid, estrogen, and androgen receptors. The glucocorticoid receptor-mediated activation is not observed with the C-terminal domain or with the hOsa2 polypeptide lacking the ARID DNA binding domain. These results suggest that hOsa1 and hOsa2 participate in promoting transcriptional activation by the steroid hormone receptors.	NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA; NYU, Sch Med, Kaplan Canc Ctr, New York, NY 10016 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	New York University; New York University; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Tanese, N (corresponding author), NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA.			Tanese, Naoko/0000-0002-1946-3211				Bultman S, 2000, MOL CELL, V6, P1287, DOI 10.1016/S1097-2765(00)00127-1; CHIBA H, 1994, NUCLEIC ACIDS RES, V22, P1815, DOI 10.1093/nar/22.10.1815; Collins RT, 1999, EMBO J, V18, P7029, DOI 10.1093/emboj/18.24.7029; Collins RT, 2000, GENE DEV, V14, P3140, DOI 10.1101/gad.854300; Cosma MP, 1999, CELL, V97, P299, DOI 10.1016/S0092-8674(00)80740-0; Dallas PB, 2000, MOL CELL BIOL, V20, P3137, DOI 10.1128/MCB.20.9.3137-3146.2000; Dallas PB, 1998, MOL CELL BIOL, V18, P3596, DOI 10.1128/MCB.18.6.3596; DiRenzo J, 2000, MOL CELL BIOL, V20, P7541, DOI 10.1128/MCB.20.20.7541-7549.2000; Fryer CJ, 1998, NATURE, V393, P88, DOI 10.1038/30032; Gregory SL, 1996, MOL CELL BIOL, V16, P792; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Herrscher RF, 1995, GENE DEV, V9, P3067, DOI 10.1101/gad.9.24.3067; Hurlstone AFL, 2002, BIOCHEM J, V364, P255, DOI 10.1042/bj3640255; Ichinose H, 1997, GENE, V188, P95, DOI 10.1016/S0378-1119(96)00785-8; Imbert G, 1996, NAT GENET, V14, P285, DOI 10.1038/ng1196-285; Kal AJ, 2000, GENE DEV, V14, P1058; Kato H, 2002, J BIOL CHEM, V277, P5498, DOI 10.1074/jbc.M108702200; Kortschak RD, 2000, TRENDS BIOCHEM SCI, V25, P294, DOI 10.1016/S0968-0004(00)01597-8; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; Kozmik Z, 2001, GENOMICS, V73, P140, DOI 10.1006/geno.2001.6477; Krebs JE, 1999, GENE DEV, V13, P1412, DOI 10.1101/gad.13.11.1412; KWON H, 1994, NATURE, V370, P477, DOI 10.1038/370477a0; LEE KAW, 1988, GENE ANAL TECH, V5, P22, DOI 10.1016/0735-0651(88)90023-4; Lemon B, 2001, NATURE, V414, P924, DOI 10.1038/414924a; Mangel L, 1998, J BIOL CHEM, V273, P30466, DOI 10.1074/jbc.273.46.30466; Muchardt C, 1999, J MOL BIOL, V293, P187, DOI 10.1006/jmbi.1999.2999; MUCHARDT C, 1993, EMBO J, V12, P4279, DOI 10.1002/j.1460-2075.1993.tb06112.x; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Natarajan K, 1999, MOL CELL, V4, P657, DOI 10.1016/S1097-2765(00)80217-8; Neely KE, 1999, MOL CELL, V4, P649, DOI 10.1016/S1097-2765(00)80216-6; Nie ZQ, 2000, MOL CELL BIOL, V20, P8879, DOI 10.1128/MCB.20.23.8879-8888.2000; Peterson CL, 2000, CURR OPIN GENET DEV, V10, P187, DOI 10.1016/S0959-437X(00)00068-X; Pollard KJ, 1998, BIOESSAYS, V20, P771, DOI 10.1002/(SICI)1521-1878(199809)20:9<771::AID-BIES10>3.0.CO;2-V; Reyes JC, 1998, EMBO J, V17, P6979, DOI 10.1093/emboj/17.23.6979; Rogatsky I, 1999, J BIOL CHEM, V274, P22296, DOI 10.1074/jbc.274.32.22296; Rogatsky I, 1999, MOL CELL BIOL, V19, P5036; Saluja D, 1998, MOL CELL BIOL, V18, P5734, DOI 10.1128/MCB.18.10.5734; Sif S, 2001, GENE DEV, V15, P603, DOI 10.1101/gad.872801; SKOWRONSKI J, 1988, MOL CELL BIOL, V8, P1385, DOI 10.1128/MCB.8.4.1385; TAMKUN JW, 1992, CELL, V68, P561, DOI 10.1016/0092-8674(92)90191-E; Treisman JE, 1997, GENE DEV, V11, P1949, DOI 10.1101/gad.11.15.1949; Varga-Weisz PD, 1998, CURR OPIN CELL BIOL, V10, P346, DOI 10.1016/S0955-0674(98)80010-0; Vazquez M, 1999, DEVELOPMENT, V126, P733; Vignali M, 2000, MOL CELL BIOL, V20, P1899, DOI 10.1128/MCB.20.6.1899-1910.2000; Wallberg AE, 2000, MOL CELL BIOL, V20, P2004, DOI 10.1128/MCB.20.6.2004-2013.2000; Wang WD, 1998, P NATL ACAD SCI USA, V95, P492, DOI 10.1073/pnas.95.2.492; Wang WD, 1996, EMBO J, V15, P5370, DOI 10.1002/j.1460-2075.1996.tb00921.x; Wilson AC, 1997, MOL CELL BIOL, V17, P6139, DOI 10.1128/MCB.17.10.6139; WINSTON F, 1992, TRENDS GENET, V8, P387, DOI 10.1016/0168-9525(92)90167-3; Wolffe AP, 2000, J STRUCT BIOL, V129, P102, DOI 10.1006/jsbi.2000.4217; YOSHINAGA SK, 1992, SCIENCE, V258, P1598, DOI 10.1126/science.1360703; Yudkovsky N, 1999, GENE DEV, V13, P2369, DOI 10.1101/gad.13.18.2369	52	92	96	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					41674	41685		10.1074/jbc.M205961200	http://dx.doi.org/10.1074/jbc.M205961200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12200431	hybrid			2022-12-27	WOS:000178985300049
J	Sadlish, H; Williams, FMR; Flintoff, WF				Sadlish, H; Williams, FMR; Flintoff, WF			Functional role of arginine 373 in substrate translocation by the reduced folate carrier	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HAMSTER OVARY CELLS; METHOTREXATE RESISTANCE; FOLIC-ACID; ANTIFOLATE RESISTANCE; CROSS-LINKING; TRANSPORT; LEUKEMIA; GENE; MEMBRANE; 5,10-DIDEAZATETRAHYDROFOLATE	The reduced folate carrier (RFC) plays a critical role in the cellular uptake of folates. However, little is known regarding the mechanism used to transport substrates or the tertiary structure of the protein. Through the analysis of a Chinese hamster ovary cell line deficient in folate uptake, we have identified a single residue in TM10 (Arg-373) of RFC that appears to play a critical role in the translocation of substrate. Replacement of this position with various amino acids (KHQNA) diminished the rate of translocation by 16-50-fold, although substrate binding, protein stability, and localization were unaffected. Furthermore, the translocation capabilities of an R373C mutant in a cysteine-less form of the reduced folate carrier were enhanced 2.5-fold by the positively charged methanethiosulfonate reagent, confirming the essential role of a positive charge at this position. When considering the membrane-impermeable nature of this reagent, the data further suggest that the Arg-373 residue is located within the substrate translocation pathway of the RFC protein. Moreover, cross-linking analysis of the Arg-373 residue demonstrates that it is within 6 A of residue Glu-394 (TM11), providing the first definitive tertiary structural information for this protein.	Univ Western Ontario, Dept Microbiol & Immunol, London, ON N6A 5C1, Canada	Western University (University of Western Ontario)	Flintoff, WF (corresponding author), Univ Western Ontario, Dept Microbiol & Immunol, London, ON N6A 5C1, Canada.							BRIGLE KE, 1995, J BIOL CHEM, V270, P22974, DOI 10.1074/jbc.270.39.22974; CHAN FPH, 1995, CYTOGENET CELL GENET, V71, P148, DOI 10.1159/000134095; Ferguson PL, 1999, J BIOL CHEM, V274, P16269, DOI 10.1074/jbc.274.23.16269; FLINTOFF WF, 1976, IN VITRO CELL DEV B, V12, P749, DOI 10.1007/BF02835450; FLINTOFF WF, 1976, SOMAT CELL GENET, V2, P245, DOI 10.1007/BF01538963; FLINTOFF WF, 1983, ARCH BIOCHEM BIOPHYS, V223, P433, DOI 10.1016/0003-9861(83)90607-0; Frillingos S, 1998, FASEB J, V12, P1281, DOI 10.1096/fasebj.12.13.1281; Gorlick R, 1997, BLOOD, V89, P1013, DOI 10.1182/blood.V89.3.1013; GROSS-BELLARD MM, 1973, EUR J BIOCHEM, V36, P32, DOI 10.1111/j.1432-1033.1973.tb02881.x; Guo W, 1999, CLIN CANCER RES, V5, P621; Jansen G, 1998, J BIOL CHEM, V273, P30189, DOI 10.1074/jbc.273.46.30189; Kim YM, 2001, J BIOL CHEM, V276, P36681, DOI 10.1074/jbc.M106079200; Liu XY, 2001, BIOCHEM J, V358, P511, DOI 10.1042/0264-6021:3580511; Lucock M, 2000, MOL GENET METAB, V71, P121, DOI 10.1006/mgme.2000.3027; Ma DQ, 2000, BIOCHEM BIOPH RES CO, V279, P891, DOI 10.1006/bbrc.2000.4019; MURRAY RC, 1997, THESIS U W ONTARIO L; Roy K, 1998, J BIOL CHEM, V273, P2526, DOI 10.1074/jbc.273.5.2526; Sadlish H, 2000, BIOCHEM J, V346, P509, DOI 10.1042/0264-6021:3460509; Sadlish H, 2002, BIOCHEM J, V364, P777, DOI 10.1042/BJ20011361; SAMBROOK J, 1989, MOL CLONING, V2, P9; Sharina IG, 2002, BIOCHEM PHARMACOL, V63, P1717, DOI 10.1016/S0006-2952(02)00955-3; Sharina IG, 2001, MOL PHARMACOL, V59, P1022, DOI 10.1124/mol.59.5.1022; Sun JZ, 1997, BIOCHEMISTRY-US, V36, P11959, DOI 10.1021/bi971172k; Tse A, 1998, J BIOL CHEM, V273, P25953, DOI 10.1074/jbc.273.40.25953; UNDERHILL TM, 1989, SOMAT CELL MOLEC GEN, V15, P49, DOI 10.1007/BF01534669; Ward SDC, 2002, J BIOL CHEM, V277, P2247, DOI 10.1074/jbc.M107647200; WILLIAMS FMR, 1994, J BIOL CHEM, V269, P5810; Wong SC, 1999, J BIOL CHEM, V274, P10388, DOI 10.1074/jbc.274.15.10388; Zhao R, 2000, CLIN CANCER RES, V6, P3304; Zhao R, 1998, J BIOL CHEM, V273, P19065, DOI 10.1074/jbc.273.30.19065; Zhao RB, 1999, BIOCHEM PHARMACOL, V58, P1615, DOI 10.1016/S0006-2952(99)00257-9; Zhao RB, 1998, J BIOL CHEM, V273, P7873, DOI 10.1074/jbc.273.14.7873; Zhao RB, 2000, MOL PHARMACOL, V57, P317	33	17	17	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					42105	42112		10.1074/jbc.M206459200	http://dx.doi.org/10.1074/jbc.M206459200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12194981	hybrid			2022-12-27	WOS:000178985300101
J	Yoon, HY; Cho, EH; Kwon, HY; Choi, SY; Cho, SW				Yoon, HY; Cho, EH; Kwon, HY; Choi, SY; Cho, SW			Importance of glutamate 279 for the coenzyme binding of human glutamate dehydrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID SEQUENCE; BOVINE LIVER; ESCHERICHIA-COLI; CLOSTRIDIUM-SYMBIOSUM; SITE; IDENTIFICATION; BRAIN; ISOPROTEINS; DOMAIN; ADP	Although the structure of glutamate dehydrogenase (GDH) has been reported from various sources including mammalian GDH, there are conflicting views regarding the location and mechanism of actions of the coenzyme binding. We have expanded these speculations by photoaffinity labeling and cassette mutagenesis. Photoaffinity labeling with a specific probe, [P-32]nicotinamide 2-azidoadenosine dinucleotide, was used to identify the NAD(+) binding site within human GDH encoded by the synthetic human GDH gene and expressed in Escherichia coli as a soluble protein. Photolabel-containing peptides generated with trypsin were isolated by immobilized boronate affinity chromatography. Photolabeling of these peptides was most effectively prevented by the presence of NAD(+) during photolysis, demonstrating a selectivity of the photoprobe for the NAD(+) binding site. Amino acid sequencing and compositional analysis identified Glu(279) as the site of photoinsertion into human GDH, suggesting that Glu(279) is located at or near the NAD(+) binding site. The importance of the Glu(279) residue in the binding of NAD(+) was further examined by cassette mutagenesis with mutant enzymes containing Arg, Gly, Leu, Met, or Tyr at position 279. The mutagenesis at Glu(279) has no effects on the expression or stability of the different mutants. The K-m values for NAD(+) were 10 -14-fold greater for the mutant GDHs than for wild-type GDH, whereas the V-max values were similar for wild-type and mutant GDHs. The efficiency (k(cat)/ K-m) of the mutant GDH was reduced up to 18-fold. The decreased efficiency of the mutants results from the increase in K-m values for NAD(+). In contrast to the K-m values for NAD(+), wild-type and mutant GDHs show similar K. values for glutamate, indicating that substitution at position 279 had no appreciable effect on the affinity of enzyme for glutamate. There were no differences in sensitivities to ADP activation and GTP inhibition between wild-type and mutant GDH, suggesting that Glu(279) is not directly involved in allosteric regulation. The results with photoaffinity labeling and cassette mutagenesis studies suggest that Glu(279) plays an important role for efficient binding of NAD(+) to human GDH.	Univ Ulsan, Coll Med, Dept Biochem, Songpa Gu, Seoul 138736, South Korea; Chosun Univ, Dept Sci Educ, Coll Educ, Kwangju 501759, South Korea; Hallym Univ, Dept Physiol, Coll Med, Chunchon 200702, South Korea; Hallym Univ, Dept Gen Engn, Div Life Sci, Chunchon 200702, South Korea	University of Ulsan; Chosun University; Hallym University; Hallym University	Cho, SW (corresponding author), Univ Ulsan, Coll Med, Dept Biochem, Songpa Gu, 388-1 Poongnap Dong, Seoul 138736, South Korea.							BAILEY J, 1982, J BIOL CHEM, V257, P5579; BAILEY JM, 1987, J BIOL CHEM, V262, P12620; BANJEREE A, 1987, BIOCHEMISTRY-US, V26, P8443; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CAMPBELL S, 1990, P NATL ACAD SCI USA, V87, P1243, DOI 10.1073/pnas.87.3.1243; Cho SW, 1999, J BIOL CHEM, V274, P13948, DOI 10.1074/jbc.274.20.13948; Cho SW, 1998, J BIOL CHEM, V273, P31125, DOI 10.1074/jbc.273.47.31125; Cho SW, 1996, BIOCHEMISTRY-US, V35, P13907, DOI 10.1021/bi9618575; CHO SW, 1995, EUR J BIOCHEM, V233, P340, DOI 10.1111/j.1432-1033.1995.340_1.x; Cho SW, 2001, EUR J BIOCHEM, V268, P3205, DOI 10.1046/j.1432-1327.2001.02209.x; Choi SY, 1999, J NEUROCHEM, V72, P2162, DOI 10.1046/j.1471-4159.1999.0722162.x; DALZIEL K, 1972, BIOCHEM J, V126, P975, DOI 10.1042/bj1260975; Dalziel K, 1975, ENZYMES, V11, P1; FANG J, 1905, BIOCHEM J, V363, P81; FERSHT A, 1985, ENZYME STRUCTURE MEC, P98; FISHER HF, 1985, METHOD ENZYMOL, V113, P16; FRIEDEN C, 1963, J BIOL CHEM, V238, P3286; FRIEDEN C, 1959, J BIOL CHEM, V234, P809; GEORGE A, 1980, BIOCHEMISTRY-US, V19, P6057, DOI 10.1021/bi00567a017; Gonzalez R.A., 1983, ANAL BIOCHEM, V135, P69; GUNNERSEN D, 1992, P NATL ACAD SCI USA, V89, P11949, DOI 10.1073/pnas.89.24.11949; HAEFFNERGORMLEY L, 1992, BIOCHEMISTRY-US, V31, P7807, DOI 10.1021/bi00149a010; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; JULLIARD JH, 1979, J BIOL CHEM, V254, P3427; KIM H, 1991, BIOCONJUGATE CHEM, V2, P142, DOI 10.1021/bc00009a002; Knapp S, 1997, J MOL BIOL, V267, P916, DOI 10.1006/jmbi.1996.0900; Lee EY, 2001, J BIOL CHEM, V276, P47930, DOI 10.1074/jbc.M108918200; MAK AS, 1978, ANAL BIOCHEM, V84, P432, DOI 10.1016/0003-2697(78)90061-1; Maurizi MR, 2002, ARCH BIOCHEM BIOPHYS, V397, P206, DOI 10.1006/abbi.2001.2703; MAVROTHALASSITIS G, 1988, P NATL ACAD SCI USA, V85, P3494, DOI 10.1073/pnas.85.10.3494; MCPHERSON MJ, 1983, NUCLEIC ACIDS RES, V11, P5257, DOI 10.1093/nar/11.15.5257; OLCOTT M, 1994, BIOCHEMISTRY-US, V33, P11835; PAL PK, 1979, BIOCHEMISTRY-US, V18, P838, DOI 10.1021/bi00572a016; Peterson PE, 1999, STRUCTURE, V7, P769, DOI 10.1016/S0969-2126(99)80101-4; Peterson PE, 1997, J STRUCT BIOL, V120, P73, DOI 10.1006/jsbi.1997.3899; Plaitakis A, 2000, J NEUROCHEM, V75, P1862, DOI 10.1046/j.1471-4159.2000.0751862.x; RICE DW, 1985, J MOL BIOL, V181, P147, DOI 10.1016/0022-2836(85)90334-1; ROSSMANN MG, 1974, NATURE, V250, P194, DOI 10.1038/250194a0; SCHMIDT JA, 1984, J BIOL CHEM, V259, P4515; Shashidharan P, 1997, J NEUROCHEM, V68, P1804; SHOEMAKER MT, 1993, BIOCHEMISTRY-US, V32, P1883, DOI 10.1021/bi00058a023; Shoemaker MT, 1996, BIOCONJUGATE CHEM, V7, P302, DOI 10.1021/bc960014n; SINGH N, 1993, J BIOL CHEM, V268, P21; Smith E.L., 1975, ENZYMES, P293, DOI DOI 10.1016/S1874-6047(08)60213-9; SMITH T, 1982, BIOCHEMISTRY-US, V21, P733, DOI 10.1021/bi00533a023; Smith TJ, 2002, J MOL BIOL, V318, P765, DOI 10.1016/S0022-2836(02)00161-4; Smith TJ, 2001, J MOL BIOL, V307, P707, DOI 10.1006/jmbi.2001.4499; STILLMAN TJ, 1993, J MOL BIOL, V234, P1131, DOI 10.1006/jmbi.1993.1665; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; TELLER JK, 1992, EUR J BIOCHEM, V206, P151, DOI 10.1111/j.1432-1033.1992.tb16912.x; TZIMAGIORGIS G, 1991, BIOCHIM BIOPHYS ACTA, V1089, P250, DOI 10.1016/0167-4781(91)90017-G; VAILLANCOURT RR, 1995, BIOCHEM J, V311, P987, DOI 10.1042/bj3110987; VERONESE FM, 1974, J BIOL CHEM, V249, P7922; WOOTTON JC, 1974, NATURE, V252, P542, DOI 10.1038/252542a0; WOOTTON JC, 1974, P NATL ACAD SCI USA, V71, P4361, DOI 10.1073/pnas.71.11.4361; YIP KSP, 1995, STRUCTURE, V3, P1147, DOI 10.1016/S0969-2126(01)00251-9; Yoon HY, 2002, BIOCHEMISTRY-US, V41, P6817, DOI 10.1021/bi0121757	57	17	17	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					41448	41454		10.1074/jbc.M208208200	http://dx.doi.org/10.1074/jbc.M208208200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12193607	hybrid			2022-12-27	WOS:000178985300021
J	Huss, M; Ingenhorst, G; Konig, S; Gassel, M; Drose, S; Zeeck, A; Altendorf, K; Wieczorek, H				Huss, M; Ingenhorst, G; Konig, S; Gassel, M; Drose, S; Zeeck, A; Altendorf, K; Wieczorek, H			Concanamycin a, the specific inhibitor of V-ATPases, binds to the V-o subunit c	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOBACCO HORNWORM; PLASMA-MEMBRANE; H+-ATPASE; P-TYPE; PROTEINS; BAFILOMYCIN; CELLS; PURIFICATION; CONTAINS; MIDGUT	Vacuolar-type ATPase (V-ATPase) purified from the midgut of the tobacco hornworm Manduca sexta is inhibited 50% by 10 nm of the plecomacrolide concanamycin A, the specific inhibitor of V-ATPases. To determine the binding site(s) of that antibiotic in the enzyme complex, labeling with the semisynthetic 9-O-[p-(trifluoroethyldiazirinyl)-benzoyl]-21,23-dideoxy-23-[I-125]iodo-concanolide A (J-concanolide A) was performed, which still inhibits the V-ATPase 50% at a concentration of 15-20 mum. Upon treatment with UV light, a highly reactive carbene is generated from this concanamycin derivative, resulting in the formation of a covalent bond to the enzyme. In addition, the radioactive tracer 1251 makes the detection of the labeled subunit(s) feasible. Treatment of the V-1/V-o holoenzyme, the V-o complex, and the V-ATPase containing goblet cell apical membranes with concanolide resulted in the labeling of only the proteolipid, subunit c, of the proton translocating V-o complex. Binding of J-concanolide A to subunit c was prevented in a concentration-dependent manner by concanamycin A, indicating that labeling was specific. Binding was also prevented by the plecomacrolides bafilomycin A(1) and B-1 respectively, but not by the benzolactone enamide salicylihalamide, a member of a novel class of V-ATPase inhibitors.	Univ Osnabruck, Fachbereich Biol Chem, Abt Tierphysiol, D-49069 Osnabruck, Germany	University Osnabruck	Wieczorek, H (corresponding author), Univ Osnabruck, Fachbereich Biol Chem, Abt Tierphysiol, D-49069 Osnabruck, Germany.	wieczorek@biologie.uni-osnabrueck.de	König, Simone/B-6504-2008; Dröse, Stefan/E-4903-2010	König, Simone/0000-0003-0672-7246; Dröse, Stefan/0000-0002-9361-9034				ADACHI I, 1990, J BIOL CHEM, V265, P960; AZZI A, 1984, BIOCHIM BIOPHYS ACTA, V768, P209, DOI 10.1016/0304-4173(84)90017-X; BELL RA, 1974, J INSECT PHYSIOL, V20, P669, DOI 10.1016/0022-1910(74)90189-9; Bowman BJ, 2002, J BIOL CHEM, V277, P3965, DOI 10.1074/jbc.M109756200; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; CIOFFI M, 1983, TISSUE CELL, V15, P781, DOI 10.1016/0040-8166(83)90050-2; CRIDER BP, 1994, J BIOL CHEM, V269, P17379; DOW JAT, 1992, GENE, V122, P355, DOI 10.1016/0378-1119(92)90226-F; DROSE S, 1993, BIOCHEMISTRY-US, V32, P3902, DOI 10.1021/bi00066a008; Drose S, 2001, BIOCHEMISTRY-US, V40, P2816, DOI 10.1021/bi001759q; GILLESPIE J, 1991, FEBS LETT, V282, P69, DOI 10.1016/0014-5793(91)80446-A; GRAF R, 1994, J BIOL CHEM, V269, P3767; Graf R, 1996, J BIOL CHEM, V271, P20908, DOI 10.1074/jbc.271.34.20908; HANADA H, 1990, BIOCHEM BIOPH RES CO, V170, P873, DOI 10.1016/0006-291X(90)92172-V; Ingenhorst G, 2001, EUR J ORG CHEM, V2001, P4525; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lepier A, 1996, J BIOL CHEM, V271, P8502, DOI 10.1074/jbc.271.14.8502; Merzendorfer H, 1997, FEBS LETT, V411, P239, DOI 10.1016/S0014-5793(97)00699-6; Merzendorfer H, 1999, J BIOL CHEM, V274, P17372, DOI 10.1074/jbc.274.24.17372; Merzendorfer H, 2000, BBA-BIOMEMBRANES, V1467, P369, DOI 10.1016/S0005-2736(00)00233-9; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; RATAJCZAK R, 1994, BOT ACTA, V107, P201, DOI 10.1111/j.1438-8677.1994.tb00787.x; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHWEIKL H, 1989, J BIOL CHEM, V264, P11136; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; SUMNER JP, 1995, J BIOL CHEM, V270, P5649, DOI 10.1074/jbc.270.10.5649; Wieczorek H, 1999, BIOESSAYS, V21, P637, DOI 10.1002/(SICI)1521-1878(199908)21:8<637::AID-BIES3>3.3.CO;2-N; WIECZOREK H, 1991, J BIOL CHEM, V266, P15340; WIECZOREK H, 1992, J EXP BIOL, V172, P335; Wieczorek H, 1999, J BIOENERG BIOMEMBR, V31, P67, DOI 10.1023/A:1005448614450; Wieczorek H, 2000, J EXP BIOL, V203, P127; WIECZOREK H, 1990, METHOD ENZYMOL, V192, P608; ZHANG JM, 1994, J BIOL CHEM, V269, P23518; Zhang XL, 1998, ANAL CHEM, V70, P2050, DOI 10.1021/ac971207m	34	207	213	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2002	277	43					40544	40548		10.1074/jbc.M207345200	http://dx.doi.org/10.1074/jbc.M207345200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	607KU	12186879	hybrid			2022-12-27	WOS:000178791400051
J	Matsuura, H; Nishitoh, H; Takeda, K; Matsuzawa, A; Amagasa, T; Ito, M; Yoshioka, K; Ichijo, H				Matsuura, H; Nishitoh, H; Takeda, K; Matsuzawa, A; Amagasa, T; Ito, M; Yoshioka, K; Ichijo, H			Phosphorylation-dependent scaffolding role of JSAP1/JIP3 in the ASK1-JNK signaling pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN-BINDING PROTEIN-280; KINASE 1 ASK1; APOPTOSIS; STRESS; TRANSDUCTION; ACTIVATION; INHIBITOR; INDUCTION; COMPLEX; CLONING	JSAP1 (also termed JIP3) is a scaffold protein that interacts with specific components of the JNK signaling pathway. Apoptosis signal-regulating kinase (ASK) 1 is a MAP kinase kinase kinase that activates the JNK and p38 mitogen-activated protein (MAP) kinase cascades in response to environmental stresses such as reactive oxygen species. Here we show that JSAP1 bound ASK1 and enhanced ASK1- and H2O2-induced JNK activity. ASK1 phosphorylated JSAP1 in vitro and in vivo, and the phosphorylation facilitated interactions of JSAP1 with SEK1/MKK4, MKK7 and JNK3. Furthermore, ASK1-dependent phosphorylation was required for JSAP1 to recruit and thereby activate JNK in response to H2O2. We thus conclude that JSAP1 functions not only as a simple scaffold, but it dynamically participates in signal transduction by forming a phosphorylation-dependent signaling complex in the ASK1-JNK signaling module.	Kanazawa Univ, Canc Res Inst, Div Cell Cycle Regulat, Kanazawa, Ishikawa 9200934, Japan; Kitasato Univ, Sch Sci, Dept Biosci, Kanagawa 2288555, Japan; Tokyo Med & Dent Univ, Grad Sch, Lab Cell Signaling, Bunkyo Ku, Tokyo 1138549, Japan	Kanazawa University; Kitasato University; Tokyo Medical & Dental University (TMDU)		ichijo@mol.f.u-tokyo.ac.jp	Matsuzawa, Atsushi/GLU-1387-2022	Nishitoh, Hideki/0000-0002-8652-4109; Matsuzawa, Atsushi/0000-0001-8303-3905; Takeda, Kohsuke/0000-0002-8359-8399; Ichijo, Hidenori/0000-0002-5005-6438				Bonny C, 1998, J BIOL CHEM, V273, P1843, DOI 10.1074/jbc.273.4.1843; Byrd DT, 2001, NEURON, V32, P787, DOI 10.1016/S0896-6273(01)00532-3; Dickens M, 1997, SCIENCE, V277, P693, DOI 10.1126/science.277.5326.693; Girardin SE, 2001, EMBO J, V20, P3437, DOI 10.1093/emboj/20.13.3437; Hatai T, 2000, J BIOL CHEM, V275, P26576, DOI 10.1074/jbc.M003412200; Holtmann H, 1999, MOL CELL BIOL, V19, P6742; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Ichijo H, 1999, ONCOGENE, V18, P6087, DOI 10.1038/sj.onc.1203129; Ito M, 1999, MOL CELL BIOL, V19, P7539; Ito M, 2000, GENE, V255, P229, DOI 10.1016/S0378-1119(00)00335-8; Kelkar N, 2000, MOL CELL BIOL, V20, P1030, DOI 10.1128/MCB.20.3.1030-1043.2000; Kuboki Y, 2000, J BIOL CHEM, V275, P39815, DOI 10.1074/jbc.C000403200; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Leonardi A, 2000, J BIOL CHEM, V275, P271, DOI 10.1074/jbc.275.1.271; Mahanty SK, 1999, CELL, V98, P501, DOI 10.1016/S0092-8674(00)81978-9; Marti A, 1997, J BIOL CHEM, V272, P2620, DOI 10.1074/jbc.272.5.2620; McDonald PH, 2000, SCIENCE, V290, P1574, DOI 10.1126/science.290.5496.1574; Miller WE, 2001, CURR OPIN CELL BIOL, V13, P139, DOI 10.1016/S0955-0674(00)00190-3; Morita K, 2001, EMBO J, V20, P6028, DOI 10.1093/emboj/20.21.6028; Negri S, 2000, GENOMICS, V64, P324, DOI 10.1006/geno.2000.6129; Nishitoh H, 1998, MOL CELL, V2, P389, DOI 10.1016/S1097-2765(00)80283-X; Nishitoh H, 2002, GENE DEV, V16, P1345, DOI 10.1101/gad.992302; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Sayama K, 2001, J BIOL CHEM, V276, P999, DOI 10.1074/jbc.M003425200; Takeda K, 2000, J BIOL CHEM, V275, P9805, DOI 10.1074/jbc.275.13.9805; Tobiume K, 1997, BIOCHEM BIOPH RES CO, V239, P905, DOI 10.1006/bbrc.1997.7580; Tobiume K, 2002, J CELL PHYSIOL, V191, P95, DOI 10.1002/jcp.10080; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; Weston CR, 2001, SCIENCE, V292, P2439, DOI 10.1126/science.1063279; Whitmarsh AJ, 1998, SCIENCE, V281, P1671, DOI 10.1126/science.281.5383.1671; Whitmarsh AJ, 2001, GENE DEV, V15, P2421, DOI 10.1101/gad.922801; Yang DD, 1997, NATURE, V389, P865, DOI 10.1038/39899; Yasuda J, 1999, MOL CELL BIOL, V19, P7245; Zama T, 2002, J BIOL CHEM, V277, P23919, DOI 10.1074/jbc.M200838200	34	82	89	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2002	277	43					40703	40709		10.1074/jbc.M202004200	http://dx.doi.org/10.1074/jbc.M202004200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	607KU	12189133	hybrid, Green Submitted			2022-12-27	WOS:000178791400070
J	Chou, KC; Cai, YD				Chou, KC; Cai, YD			Using functional domain composition and support vector machines for prediction of protein subcellular location	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-COMPOSITION; STRUCTURAL CLASSES	Proteins are generally classified into the following 12 subcellular locations: 1) chloroplast, 2) cytoplasm, 3) cytoskeleton, 4) endoplasmic reticulum, 5) extracellular, 6) Golgi apparatus, 7) lysosome, 8) mitochondria, 9) nucleus, 10) peroxisome, 11) plasma membrane, and 12) vacuole. Because the function of a protein is closely correlated with its subcellular location, with the rapid increase in new protein sequences entering into databanks, it is vitally important for both basic research and pharmaceutical industry to establish a high throughput tool for predicting protein subcellular location. In this paper, a new concept, the so-called "functional domain composition" is introduced. Based on the novel concept, the representation for a protein can be defined as a vector in a high-dimensional space, where each of the clustered functional domains derived from the protein universe serves as a vector base. With such a novel representation for a protein, the support vector machine (SVM) algorithm is introduced for predicting protein subcellular location. High success rates are obtained by the self-consistency test, jackknife test, and independent dataset test, respectively. The current approach not only can play an important complementary role to the powerful covariant discriminant algorithm based on the pseudo amino acid composition representation (Chou, K. C. (2001) Proteins Struct. Funct. GeneL 43, 246-255; Correction (2001) Proteins Struct. Funct Genet. 44, 60), but also may greatly stimulate the development of this area.	Pharmacia & Upjohn Inc, Upjohn Labs, Kalamazoo, MI 49001 USA; Chinese Acad Sci, Shanghai Res Ctr Biotechnol, Shanghai 200233, Peoples R China	Pfizer; Chinese Academy of Sciences	Cai, YD (corresponding author), Univ Manchester, Biomol Sci Dept, PO Box 88, Manchester M60 1QD, Lancs, England.	y.cai@umist.ac.uk	Chou, Kuo-Chen/A-8340-2009	cai, yudong/0000-0001-5664-7979				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; APNIK VN, 1995, NATURE STAT LEARNING; Bairoch A, 1997, NUCLEIC ACIDS RES, V25, P31, DOI 10.1093/nar/25.1.31; Bock JR, 2001, BIOINFORMATICS, V17, P455, DOI 10.1093/bioinformatics/17.5.455; Cai YD, 2002, J CELL BIOCHEM, V84, P343, DOI 10.1002/jcb.10030; Cai YD, 2001, PROTEINS, V43, P336, DOI 10.1002/prot.1045; Cai Yu-Dong, 2000, Molecular Cell Biology Research Communications, V4, P230, DOI 10.1006/mcbr.2001.0285; Cai Yu-Dong, 2000, Molecular Cell Biology Research Communications, V4, P172, DOI 10.1006/mcbr.2001.0269; Cedano J, 1997, J MOL BIOL, V266, P594, DOI 10.1006/jmbi.1996.0804; Chou KC, 1998, BIOCHEM BIOPH RES CO, V252, P63, DOI 10.1006/bbrc.1998.9498; Chou KC, 2000, BIOCHEM BIOPH RES CO, V278, P477, DOI 10.1006/bbrc.2000.3815; Chou KC, 1999, PROTEINS, V34, P137, DOI 10.1002/(SICI)1097-0134(19990101)34:1<137::AID-PROT11>3.3.CO;2-F; Chou KC, 1999, PROTEIN ENG, V12, P107, DOI 10.1093/protein/12.2.107; CHOU KC, 1995, CRIT REV BIOCHEM MOL, V30, P275, DOI 10.3109/10409239509083488; CHOU KC, 1995, PROTEINS, V21, P319, DOI 10.1002/prot.340210406; Chou KC, 1998, PROTEINS, V31, P97, DOI 10.1002/(SICI)1097-0134(19980401)31:1<97::AID-PROT8>3.0.CO;2-E; CHOU KC, 1994, J BIOL CHEM, V269, P22014; Chou KC, 2001, PROTEINS, V43, P246, DOI 10.1002/prot.1035; Chou KC, 1999, BIOCHEM BIOPH RES CO, V264, P216, DOI 10.1006/bbrc.1999.1325; Chou KC, 2000, CURR PROTEIN PEPT SC, V1, P171, DOI 10.2174/1389203003381379; CHOU PY, 1989, PREDICTION PROTEIN S, P549; CHOU PY, 1980, 2 CHEM C N AM CONT L; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Cristianini N., 2000, INTRO SUPPORT VECTOR, DOI [10.1017/CBO9780511801389, DOI 10.1017/CBO9780511801389]; Ding CHQ, 2001, BIOINFORMATICS, V17, P349, DOI 10.1093/bioinformatics/17.4.349; Hua SJ, 2001, J MOL BIOL, V308, P397, DOI 10.1006/jmbi.2001.4580; Joachims T, 1999, ADVANCES IN KERNEL METHODS, P169; Liu WM, 1998, J PROTEIN CHEM, V17, P209, DOI 10.1023/A:1022576400291; Mardia K.V., 1979, MULTIVARIATE ANAL, P322; Murvai J, 2001, NUCLEIC ACIDS RES, V29, P58, DOI 10.1093/nar/29.1.58; NAKASHIMA H, 1994, J MOL BIOL, V238, P54, DOI 10.1006/jmbi.1994.1267; NAKASHIMA H, 1986, J BIOCHEM-TOKYO, V99, P153, DOI 10.1093/oxfordjournals.jbchem.a135454; Reinhardt A, 1998, NUCLEIC ACIDS RES, V26, P2230, DOI 10.1093/nar/26.9.2230; Vapnik V., 1998, STAT LEARNING THEORY; Wolfe P., 1961, Q APPL MATH, V19, P239, DOI DOI 10.1090/QAM/135625; Zhou GP, 1998, J PROTEIN CHEM, V17, P729, DOI 10.1023/A:1020713915365; Zhou GP, 2001, PROTEINS, V44, P57, DOI 10.1002/prot.1071	37	460	482	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2002	277	48					45765	45769		10.1074/jbc.M204161200	http://dx.doi.org/10.1074/jbc.M204161200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620JB	12186861	hybrid			2022-12-27	WOS:000179529300008
J	Bidder, M; Shao, JS; Charlton-Kachigian, N; Loewy, AP; Semenkovich, CF; Towler, DA				Bidder, M; Shao, JS; Charlton-Kachigian, N; Loewy, AP; Semenkovich, CF; Towler, DA			Osteopontin transcription in aortic vascular smooth muscle cells is controlled by glucose-regulated upstream stimulatory factor and activator protein-1 activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT OSTEOCALCIN PROMOTER; INTERSTITIAL COLLAGENASE PROMOTER; MEDIAL ARTERY CALCIFICATION; INDUCED BONE-RESORPTION; GENE-EXPRESSION; CARDIOVASCULAR RISK; DNA INTERACTIONS; BINDING-PROTEIN; DEFICIENT MICE; FACTOR USF	The expression of the matrix cytokine osteopontin (OPN) is up-regulated in aortic vascular smooth muscle Cells (VSMCs) by diabetes. OPN expression in cultured VSMCs is reciprocally regulated by glucose and 2-deoxy-glucose (2-DG; inhibitor of cellular glucose metabolism). Systematic analyses of OPN promoter-luciferase reporter constructs identify a CCTCATGAC motif at nucleotides -80 to -72 relative to the initiation site that supports OPN transcription in VSMCs. The region -83 to -45 encompassing this motif confers basal and glucose- and 2-DG-dependent transcription on an unresponsive promoter. Competition and gel mobility supershift assays identify upstream stimulatory factor (USF; USF1:USF2) and activator protein-1 (AP1; c-Fos:c-Jun) in complexes binding the composite CCTCATGAC element. Glucose up-regulates both AP1 and USF binding activities 2-fold in A7r5 cells and selectively up-regulates USF1 protein levels. By contrast, USF (but not AP1) binding activity is suppressed by 2-DG and restored by glucose treatment. Expression of either USF or AP1 activates the proximal OPN promoter in A7r5 VSMCs in part via the CCTCATGAC element. Moreover, glucose stimulates the transactivation functions of c-Fos and USF1, but not c-Jun, in one-hybrid assays. Mannitol does not regulate binding, transactivation functions, USF1 protein accumulation, or OPN transcription. Thus, OPN gene transcription is regulated by USF and AP1 in aortic VSMCs, entrained to changes in cellular glucose metabolism.	Washington Univ, Sch Med, Dept Internal Med, Div Bone & Mineral Dis, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Internal Med, Div Endocrinol Diabet & Metab, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Towler, DA (corresponding author), Washington Univ, Med Ctr, Div Bone & Mineral Dis, Barnes Jewish Hosp, N Campus,216 S Kingshighway Blvd, St Louis, MO 63110 USA.	dtowler@im.wustl.edu		Towler, Dwight/0000-0003-2107-7923; Semenkovich, Clay/0000-0003-1163-1871	NHLBI NIH HHS [HL69229] Funding Source: Medline; NIDDK NIH HHS [DK52446] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069229] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052446] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		APONE S, 1995, J BIOL CHEM, V270, P21420, DOI 10.1074/jbc.270.36.21420; Ashkar S, 2000, SCIENCE, V287, P860, DOI 10.1126/science.287.5454.860; Bidder M, 2000, BIOCHEMISTRY-US, V39, P8917, DOI 10.1021/bi000343+; Bini A, 1999, ARTERIOSCL THROM VAS, V19, P1852, DOI 10.1161/01.ATV.19.8.1852; Blacher J, 2001, HYPERTENSION, V38, P938, DOI 10.1161/hy1001.096358; BLANAR MA, 1992, SCIENCE, V256, P1014, DOI 10.1126/science.1589769; Bonnelye E, 1997, MOL ENDOCRINOL, V11, P905, DOI 10.1210/me.11.7.905; BOSTROM K, 1993, J CLIN INVEST, V91, P1800, DOI 10.1172/JCI116391; Botquin V, 1998, GENE DEV, V12, P2073, DOI 10.1101/gad.12.13.2073; Boudreaux JM, 1996, J BIOL CHEM, V271, P7508, DOI 10.1074/jbc.271.13.7508; Breen GAM, 2000, BBA-GENE STRUCT EXPR, V1517, P119, DOI 10.1016/S0167-4781(00)00269-4; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Chang PS, 2001, J BIOL CHEM, V276, P17206, DOI 10.1074/jbc.M010983200; Christian RC, 2002, J CLIN ENDOCR METAB, V87, P1062, DOI 10.1210/jc.87.3.1062; Cohn JN, 2001, AM J HYPERTENS, V14, p258S, DOI 10.1016/S0895-7061(01)02154-9; DEMER LL, 1991, CIRCULATION, V83, P2083, DOI 10.1161/01.CIR.83.6.2083; Demer LL, 2001, CIRCULATION, V104, P1881, DOI 10.1161/circ.104.16.1881; Denhardt DT, 2001, J CLIN INVEST, V107, P1055, DOI 10.1172/JCI12980; DIGLIO CA, 1989, LAB INVEST, V60, P523; DU H, 1993, EMBO J, V12, P501, DOI 10.1002/j.1460-2075.1993.tb05682.x; Dufresne SD, 2001, MOL CELL BIOL, V21, P81, DOI 10.1128/MCB.21.1.81-87.2001; Galibert MD, 2001, EMBO J, V20, P5022, DOI 10.1093/emboj/20.17.5022; Grueneberg DA, 1997, GENE DEV, V11, P2482, DOI 10.1101/gad.11.19.2482; GUO XJ, 1995, MOL CELL BIOL, V15, P476, DOI 10.1128/MCB.15.1.476; Halayko AJ, 2001, J APPL PHYSIOL, V90, P358, DOI 10.1152/jappl.2001.90.1.358; Hall JL, 2000, CIRC RES, V87, P574, DOI 10.1161/01.RES.87.7.574; HICKLER RB, 1990, CLIN CARDIOL, V13, P317, DOI 10.1002/clc.4960130504; Ihara H, 2001, J BIOL CHEM, V276, P13065, DOI 10.1074/jbc.M010938200; Ishijima M, 2001, J EXP MED, V193, P399, DOI 10.1084/jem.193.3.399; Isoda K, 2002, CIRC RES, V91, P77, DOI 10.1161/01.RES.0000025268.10302.0C; Jochum W, 2001, ONCOGENE, V20, P2401, DOI 10.1038/sj.onc.1204389; KIMES BW, 1976, EXP CELL RES, V98, P349, DOI 10.1016/0014-4827(76)90446-8; Lehmann ED, 1998, HYPERTENSION, V32, P565, DOI 10.1161/01.HYP.32.3.565; Lehto S, 1996, ARTERIOSCL THROM VAS, V16, P978, DOI 10.1161/01.ATV.16.8.978; Li GH, 2000, CIRCULATION, V101, P2949, DOI 10.1161/01.CIR.101.25.2949; Luo X, 1996, MOL CELL BIOL, V16, P1367; Malyankar UM, 1999, EXP CELL RES, V250, P535, DOI 10.1006/excr.1999.4537; MARK MP, 1987, J BONE MINER RES, V2, P337, DOI 10.1002/jbmr.5650020411; Merienne K, 2001, MOL CELL BIOL, V21, P7089, DOI 10.1128/MCB.21.20.7089-7096.2001; MIYAZAKI Y, 1990, J BIOL CHEM, V265, P14432; Mueller WM, 1998, ENDOCRINOLOGY, V139, P551, DOI 10.1210/en.139.2.551; Newberry EP, 1997, BIOCHEMISTRY-US, V36, P10451, DOI 10.1021/bi971008x; Newberry EP, 1999, BIOCHEMISTRY-US, V38, P10678, DOI 10.1021/bi990967j; Newberry EP, 1997, J BIOL CHEM, V272, P29607, DOI 10.1074/jbc.272.47.29607; Newberry EP, 1997, MOL ENDOCRINOL, V11, P1129, DOI 10.1210/me.11.8.1129; Nicolosi AC, 2002, J SURG RES, V102, P1, DOI 10.1006/jsre.2001.6303; NISKANEN L, 1994, DIABETES CARE, V17, P1252, DOI 10.2337/diacare.17.11.1252; NISKANEN LK, 1990, ATHEROSCLEROSIS, V84, P61, DOI 10.1016/0021-9150(90)90009-8; NODA M, 1990, P NATL ACAD SCI USA, V87, P9995, DOI 10.1073/pnas.87.24.9995; OBRIEN ER, 1994, ARTERIOSCLER THROMB, V14, P1648, DOI 10.1161/01.ATV.14.10.1648; Ohlsson R, 2001, TRENDS GENET, V17, P520, DOI 10.1016/S0168-9525(01)02366-6; Oyama Y, 2002, CIRC RES, V90, P348, DOI 10.1161/hh0302.105098; Panda D, 1997, P NATL ACAD SCI USA, V94, P9308, DOI 10.1073/pnas.94.17.9308; Parhami F, 2001, Z Kardiol, V90 Suppl 3, P27; POELLINGER L, 1989, MOL CELL BIOL, V9, P747, DOI 10.1128/MCB.9.2.747; Pognonec P, 1997, ONCOGENE, V14, P2091, DOI 10.1038/sj.onc.1201046; Qyang YB, 1999, MOL CELL BIOL, V19, P1508; Rifas L, 1997, P NATL ACAD SCI USA, V94, P7549, DOI 10.1073/pnas.94.14.7549; ROY AL, 1991, NATURE, V354, P245, DOI 10.1038/354245a0; ROY AL, 1993, NATURE, V365, P355, DOI 10.1038/365355a0; Sato M, 1998, ONCOGENE, V17, P1517, DOI 10.1038/sj.onc.1202064; Sirard C, 2000, J BIOL CHEM, V275, P2063, DOI 10.1074/jbc.275.3.2063; SOLWAY J, 1995, J BIOL CHEM, V270, P13460, DOI 10.1074/jbc.270.22.13460; Steitz SA, 2001, CIRC RES, V89, P1147, DOI 10.1161/hh2401.101070; Swanson KD, 1999, J BIOL CHEM, V274, P3385, DOI 10.1074/jbc.274.6.3385; Takemoto M, 2000, ANN NY ACAD SCI, V902, P357; TANIMURA A, 1986, Journal of Experimental Pathology (New York), V2, P261; Tintut Y, 2002, CIRCULATION, V105, P650, DOI 10.1161/hc0502.102969; TOWLER DA, 1994, MOL ENDOCRINOL, V8, P1484, DOI 10.1210/me.8.11.1484; TOWLER DA, 1994, MOL ENDOCRINOL, V8, P614, DOI 10.1210/me.8.5.614; Towler DA, 1998, J BIOL CHEM, V273, P30427, DOI 10.1074/jbc.273.46.30427; Turner J, 1999, TRENDS BIOCHEM SCI, V24, P236, DOI 10.1016/S0968-0004(99)01406-1; Vallet VS, 1997, J BIOL CHEM, V272, P21944, DOI 10.1074/jbc.272.35.21944; Vallet VS, 1998, J BIOL CHEM, V273, P20175, DOI 10.1074/jbc.273.32.20175; Vanacker JM, 1998, CELL GROWTH DIFFER, V9, P1007; Vanacker JM, 1999, EMBO J, V18, P4270, DOI 10.1093/emboj/18.15.4270; Vaulont S, 2000, J BIOL CHEM, V275, P31555, DOI 10.1074/jbc.R000016200; Wada T, 1999, CIRC RES, V84, P166, DOI 10.1161/01.RES.84.2.166; Walsh K, 2001, Z Kardiol, V90 Suppl 3, P12; Weigert C, 2000, J AM SOC NEPHROL, V11, P2007, DOI 10.1681/ASN.V11112007; WEIS L, 1992, FASEB J, V6, P3300, DOI 10.1096/fasebj.6.14.1426767; Yang XL, 2000, J BIOL CHEM, V275, P1065, DOI 10.1074/jbc.275.2.1065; Yin TT, 2000, CIRCULATION, V102, P2636, DOI 10.1161/01.cir.102.21.2636; Yoshitake H, 1999, P NATL ACAD SCI USA, V96, P8156, DOI 10.1073/pnas.96.14.8156	84	104	109	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2002	277	46					44485	44496		10.1074/jbc.M206235200	http://dx.doi.org/10.1074/jbc.M206235200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	615XE	12200434	hybrid			2022-12-27	WOS:000179272000120
J	Chadjichristos, C; Ghayor, C; Herrouin, JF; Ala-Kokko, L; Suske, G; Pujol, JP; Galera, P				Chadjichristos, C; Ghayor, C; Herrouin, JF; Ala-Kokko, L; Suske, G; Pujol, JP; Galera, P			Down-regulation of human type II collagen gene expression by transforming growth factor-beta 1 (TGF-beta 1) in articular chondrocytes involves SP3/SP1 ratio	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING PROTEINS; HUMAN COL2A1 GENE; FACTOR-BETA; TGF-BETA; SMAD PROTEINS; TRANSCRIPTIONAL COACTIVATORS; SIGNALING PATHWAYS; ATDC5 CELLS; SP1; RECEPTOR	Although transforming growth factor beta1 (TGF-beta1) is generally considered as a stimulator of type I collagen production in smooth organs, we found that it can inhibit type II collagen biosynthesis in primary rabbit articular chondrocytes (RAC) at transcriptional levels. Constructs of promoter and first intron sequences associated with the luciferase reporter gene were used to delineate the gene sequences involved in TGF-beta1 control of human COL2A1 gene transcription. Cotransfection of these DNA fragments with a TbetaRII/I cDNA hybrid receptor, capable of inducing a TGF-beta1 dominant negative effect, showed that TGF-beta1 inhibits specifically COL2A1 gene transcription in RAC by a 63-bp proximal promoter. Footprint and gel retardation analyses revealed that the TGF-beta1-induced inhibition effect exerted through the 63-bp promoter sequence implies a multimeric complex that binds to the -41/-33 sequence and involves Sp1 and Sp3 transcription factors. Transfection of decoy Sp-binding oligonucleotides corroborated the implication of the proximal promoter in the TGF-beta1-induced inhibition of COL2A1 gene transcription. In addition, TGF-beta1 was found to increase the expression of Sp3 without significant changes to its binding level, but repressed both the biosynthesis and binding activity of Sp1. In functional assays, Sp3 inhibited the 63-bp promoter activity and prevented Sp1 induction of transcription. These findings suggest that TGF-beta1 inhibition of COL2A1 gene transcription in RAC is mediated by an increase of the Sp3/Sp1 ratio and by the repression of Sp1 transactivating effects on that gene.	CHU Niveau, Lab Biochim Tissu Conjonct, Fac Med, F-14032 Caen, France; Div Malad Osseuses, CH-1211 Geneva 14, Switzerland; Univ Oulu, Bioctr, Collagen Res Unit, SF-90220 Oulu, Finland; Univ Oulu, Dept Med Biochem, SF-90220 Oulu, Finland; Univ Marburg, Inst Mol Biol & Tumorforsch, D-35037 Marburg, Germany	CHU de Caen NORMANDIE; Universite de Caen Normandie; University of Geneva; University of Oulu; University of Oulu; Philipps University Marburg	Galera, P (corresponding author), CHU Niveau, Lab Biochim Tissu Conjonct, Fac Med, 3 Ave Cote Nacre, F-14032 Caen, France.		Chadjichristos, Christos E/J-4871-2016	Chadjichristos, Christos E/0000-0001-6657-7900; Ghayor, Chafik/0000-0002-3016-3412; Suske, Guntram/0000-0002-4807-0513				ALAKOKKO L, 1990, P NATL ACAD SCI USA, V87, P6565, DOI 10.1073/pnas.87.17.6565; Alliston T, 2001, EMBO J, V20, P2254, DOI 10.1093/emboj/20.9.2254; Ammanamanchi S, 2001, J BIOL CHEM, V276, P3348, DOI 10.1074/jbc.M002462200; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Atfi A, 1997, J BIOL CHEM, V272, P1429, DOI 10.1074/jbc.272.3.1429; Attisano L, 2000, CURR OPIN CELL BIOL, V12, P235, DOI 10.1016/S0955-0674(99)00081-2; BENYA PD, 1977, BIOCHEMISTRY-US, V16, P865, DOI 10.1021/bi00624a009; BRADHAM DM, 1994, J CELL PHYSIOL, V158, P61, DOI 10.1002/jcp.1041580109; BRADHAM DM, 1998, CLIN ORTHOP RELAT R, V2, P39; CARCAMO J, 1994, MOL CELL BIOL, V14, P3810, DOI 10.1128/MCB.14.6.3810; CHANDRASEKHAR S, 1990, EXP CELL RES, V191, P105, DOI 10.1016/0014-4827(90)90042-9; Chen X, 1997, NATURE, V389, P85, DOI 10.1038/38008; DANIELPOUR D, 1990, J BIOL CHEM, V265, P6973; Datta PK, 2000, J BIOL CHEM, V275, P40014, DOI 10.1074/jbc.C000508200; Demoor-Fossard M, 1998, BBA-GENE STRUCT EXPR, V1398, P179, DOI 10.1016/S0167-4781(98)00044-X; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Derynck R, 1998, CELL, V95, P737, DOI 10.1016/S0092-8674(00)81696-7; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; EDWARDS DR, 1987, EMBO J, V6, P1899, DOI 10.1002/j.1460-2075.1987.tb02449.x; EYRE DR, 1992, ARTICULAR CARTILAGE AND OSTEOARTHRITIS, P119; GALERA P, 1992, EXP CELL RES, V200, P379, DOI 10.1016/0014-4827(92)90186-C; GALERA P, 1992, J CELL PHYSIOL, V153, P596, DOI 10.1002/jcp.1041530322; Ghayor C, 2000, J BIOL CHEM, V275, P27421; Ghayor C, 2001, J BIOL CHEM, V276, P36881, DOI 10.1074/jbc.M105083200; Ghosh AK, 2000, ONCOGENE, V19, P3546, DOI 10.1038/sj.onc.1203693; Glansbeek HL, 1998, LAB INVEST, V78, P133; GOLDBERG H, 1992, J BIOL CHEM, V267, P19622; HAGEN G, 1994, EMBO J, V13, P3843, DOI 10.1002/j.1460-2075.1994.tb06695.x; Harrison SM, 2000, DEV BIOL, V227, P358, DOI 10.1006/dbio.2000.9878; Hayashi H, 1997, CELL, V89, P1165, DOI 10.1016/S0092-8674(00)80303-7; HORTON WE, 1992, DNA CELL BIOL, V11, P193, DOI 10.1089/dna.1992.11.193; HORTON WE, 1988, J CELL PHYSL, V141, P8; HUANG SS, 1988, J BIOL CHEM, V263, P1535; KalffSuske M, 1996, GENOMICS, V37, P410, DOI 10.1006/geno.1996.0582; Kennett SB, 1997, NUCLEIC ACIDS RES, V25, P3110, DOI 10.1093/nar/25.15.3110; Lagna G, 1996, NATURE, V383, P832, DOI 10.1038/383832a0; Lai CF, 2000, J BIOL CHEM, V275, P36400, DOI 10.1074/jbc.M002131200; Lefebvre V, 1997, MOL CELL BIOL, V17, P2336, DOI 10.1128/MCB.17.4.2336; Liberati NT, 1999, P NATL ACAD SCI USA, V96, P4844, DOI 10.1073/pnas.96.9.4844; LYONS RM, 1990, J CELL BIOL, V110, P1361, DOI 10.1083/jcb.110.4.1361; Majello B, 1997, J BIOL CHEM, V272, P4021, DOI 10.1074/jbc.272.7.4021; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; Miyazaki Y, 2000, OSTEOARTHR CARTILAGE, V8, P378, DOI 10.1053/joca.1999.0313; Miyazono K, 2001, J CELL PHYSIOL, V187, P265, DOI 10.1002/jcp.1080; Nakamura K, 1999, EXP CELL RES, V250, P351, DOI 10.1006/excr.1999.4535; NIMNI M, 1973, SCIENCE, V181, P751, DOI 10.1126/science.181.4101.751; Pardali K, 2000, J BIOL CHEM, V275, P29244, DOI 10.1074/jbc.M909467199; Piek E, 1999, FASEB J, V13, P2105, DOI 10.1096/fasebj.13.15.2105; Poncelet AC, 2001, J BIOL CHEM, V276, P6983, DOI 10.1074/jbc.M006442200; PUJOL JP, 1987, LIFE SCI, V41, P1187, DOI 10.1016/0024-3205(87)90196-2; Qi WN, 1998, EXP CELL RES, V241, P142, DOI 10.1006/excr.1998.4032; Rao J, 1998, J CELL PHYSIOL, V175, P121, DOI 10.1002/(SICI)1097-4652(199805)175:2<121::AID-JCP1>3.0.CO;2-Q; REDINI F, 1991, BIOCHIM BIOPHYS ACTA, V1093, P196, DOI 10.1016/0167-4889(91)90123-F; REDINI F, 1988, FEBS LETT, V234, P172, DOI 10.1016/0014-5793(88)81327-9; Rediske J J, 1994, Osteoarthritis Cartilage, V2, P199, DOI 10.1016/S1063-4584(05)80069-X; Rippe RA, 1999, DNA CELL BIOL, V18, P751, DOI 10.1089/104454999314890; ROSEN DM, 1988, J CELL PHYSIOL, V134, P337, DOI 10.1002/jcp.1041340304; Shi YG, 2001, BIOESSAYS, V23, P223, DOI 10.1002/1521-1878(200103)23:3<223::AID-BIES1032>3.3.CO;2-L; SINGH H, 1989, BIOTECHNIQUES, V7, P252; SPORN MB, 1987, J CELL BIOL, V105, P1039, DOI 10.1083/jcb.105.3.1039; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; Takaishi H, 1997, BBA-GENE STRUCT EXPR, V1350, P253, DOI 10.1016/S0167-4781(96)00233-3; TSUKAZAKI T, 1994, EXP CELL RES, V215, P9, DOI 10.1006/excr.1994.1307; van Osch GJVM, 1998, OSTEOARTHR CARTILAGE, V6, P187, DOI 10.1053/joca.1998.0111; VANDERKRAAN PM, 1992, INT J EXP PATHOL, V73, P335; Verrecchia F, 2000, J BIOL CHEM, V275, P30226, DOI 10.1074/jbc.M005310200; VIVIEN D, 1993, EXP CELL RES, V205, P165, DOI 10.1006/excr.1993.1071; VIVIEN D, 1995, J BIOL CHEM, V270, P7134, DOI 10.1074/jbc.270.13.7134; VONDERMARK K, 1992, ARTHRITIS RHEUM-US, V35, P806, DOI 10.1002/art.1780350715; Watanabe H, 2001, J BIOL CHEM, V276, P14466, DOI 10.1074/jbc.M005724200; Wong WK, 2001, MOL PHARMACOL, V59, P852, DOI 10.1124/mol.59.4.852; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; Wu RY, 1997, MOL CELL BIOL, V17, P2521, DOI 10.1128/MCB.17.5.2521; Yaeger PC, 1997, EXP CELL RES, V237, P318, DOI 10.1006/excr.1997.3781; Yanagisawa J, 1999, SCIENCE, V283, P1317, DOI 10.1126/science.283.5406.1317; Zhang W, 2000, J BIOL CHEM, V275, P39237, DOI 10.1074/jbc.M003339200; Zhang Y, 1998, NATURE, V394, P909, DOI 10.1038/29814; Zhang Y, 1996, NATURE, V383, P168, DOI 10.1038/383168a0	78	59	61	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	2002	277	46					43903	43917		10.1074/jbc.M206111200	http://dx.doi.org/10.1074/jbc.M206111200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	615XE	12186868	hybrid			2022-12-27	WOS:000179272000050
J	Zhang, M; Xuan, SH; Bouxsein, ML; von Stechow, D; Akeno, N; Faugere, MC; Malluche, H; Zhao, GS; Rosen, CJ; Efstratiadis, A; Clemens, TL				Zhang, M; Xuan, SH; Bouxsein, ML; von Stechow, D; Akeno, N; Faugere, MC; Malluche, H; Zhao, GS; Rosen, CJ; Efstratiadis, A; Clemens, TL			Osteoblast-specific knockout of the insulin-like growth factor (IGF) receptor gene reveals an essential role of IGF signaling in bone matrix mineralization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-I; POSTNATAL-GROWTH; TRANSGENIC MICE; RAT BONE; EXPRESSION; MOUSE; APOPTOSIS; HORMONE; CELLS; PROLIFERATION	To examine the local actions of IGF signaling in skeletal tissue in a physiological context, we have used Cre-mediated recombination to disrupt selectively in mouse osteoblasts the gene encoding the type 1 IGF receptor (Igf1r). Mice carrying this bone-specific mutation were of normal size and weight but, in comparison with normal siblings, demonstrated a striking decrease in cancellous bone volume, connectivity, and trabecular number, and an increase in trabecular spacing. These abnormalities correlated with a striking decrease in the rate of mineralization of osteoid that occurred despite an unexpected osteoblast and osteoclast hyperactivity, detected from the significant increments in both osteoblast and erosion surfaces. Our findings indicate that IGF1 is essential for coupling matrix biosynthesis to sustained mineralization. This action is likely to be particularly important during the pubertal growth spurt when rapid bone formation and consolidation are required.	Univ Cincinnati, Dept Med, Cincinnati, OH 45267 USA; Columbia Univ, Dept Genet & Dev, New York, NY 10032 USA; Beth Israel Deaconess Med Ctr, Orthopaed Biomech Lab, Boston, MA 02215 USA; Univ Kentucky, Dept Med, Lexington, KY 40536 USA; St Josephs Hosp, Maine Ctr Osteoporosis Res & Educ, Bangor, ME 04401 USA	University System of Ohio; University of Cincinnati; Columbia University; Harvard University; Beth Israel Deaconess Medical Center; University of Kentucky	Clemens, TL (corresponding author), Vontz Ctr Mol Studies, Div Endocrinol & Metab, 3125 Eden Ave, Cincinnati, OH 45267 USA.		Zhang, Mei/O-6070-2015	Zhang, Mei/0000-0002-3960-9978	NCI NIH HHS [CA75553] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA075553] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alexander JM, 2001, J BONE MINER RES, V16, P1665, DOI 10.1359/jbmr.2001.16.9.1665; ANDERSON HC, 1995, CLIN ORTHOP RELAT R, P266; Baserga R, 1997, VITAM HORM, V53, P65, DOI 10.1016/S0083-6729(08)60704-9; BIRNBAUM RS, 1995, J ENDOCRINOL, V144, P251, DOI 10.1677/joe.0.1440251; Boskey AL, 1996, CONNECT TISSUE RES, V35, P357, DOI 10.3109/03008209609029212; CANALIS E, 1993, BONE, V14, P273, DOI 10.1016/8756-3282(93)90151-Y; Caverzasio J, 1996, KIDNEY INT, V49, P975, DOI 10.1038/ki.1996.138; Clemens TL, 1997, J BONE MINER RES, V12, P1570, DOI 10.1359/jbmr.1997.12.10.1570; Conover CA, 2000, GROWTH HORM IGF RES, V10, P107, DOI 10.1016/S1096-6374(00)80020-9; D'Ercole A. J., 2001, Growth Hormone and IGF Research, V11, P261, DOI 10.1054/ghir.2001.0243; Dietrich P, 2000, MAMM GENOME, V11, P196, DOI 10.1007/s003350010037; Dragatsis I, 2000, GENESIS, V26, P133, DOI 10.1002/(SICI)1526-968X(200002)26:2<133::AID-GENE10>3.0.CO;2-V; Efstratiadis A, 1998, INT J DEV BIOL, V42, P955; GOLDNER JACQUES, 1938, AMER JOUR PATH, V14, P237; Herrera PL, 2000, DEVELOPMENT, V127, P2317; Hill PA, 1997, ENDOCRINOLOGY, V138, P3849, DOI 10.1210/en.138.9.3849; HILL PA, 1995, ENDOCRINOLOGY, V136, P124, DOI 10.1210/en.136.1.124; Hughes DE, 1997, J CLIN PATHOL-MOL PA, V50, P132, DOI 10.1136/mp.50.3.132; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/0092-8674(93)90679-K; Lobe CG, 1999, DEV BIOL, V208, P281, DOI 10.1006/dbio.1999.9209; Ludwig T, 2001, ONCOGENE, V20, P3937, DOI 10.1038/sj.onc.1204512; MALLUCHE HH, 1982, CALCIFIED TISSUE INT, V34, P439, DOI 10.1007/BF02411282; Malluche HH, 1986, ATLAS MINERALIZED BO; Nakae J, 2001, ENDOCR REV, V22, P818, DOI 10.1210/edrv.22.6.0452; Olsen BR, 2000, ANNU REV CELL DEV BI, V16, P191, DOI 10.1146/annurev.cellbio.16.1.191; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Parfitt AM, 1996, J BONE MINER RES, V11, P150; PFEILSCHIFTER J, 1995, J CLIN INVEST, V96, P767, DOI 10.1172/JCI118121; Richman C, 2001, J BONE MINER RES, V16, P386, DOI 10.1359/jbmr.2001.16.2.386; Rizzoli R, 2001, J MOL ENDOCRINOL, V26, P79, DOI 10.1677/jme.0.0260079; Ruegsegger P, 1996, CALCIFIED TISSUE INT, V58, P24, DOI 10.1007/s002239900006; SHINAR DM, 1993, ENDOCRINOLOGY, V132, P1158, DOI 10.1210/en.132.3.1158; Sims Natalie, 2000, P1; Suzuki A, 2001, BONE, V28, P589, DOI 10.1016/S8756-3282(01)00459-8; WANG EM, 1995, ENDOCRINOLOGY, V136, P2741, DOI 10.1210/en.136.6.2741; Yakar S, 1999, P NATL ACAD SCI USA, V96, P7324, DOI 10.1073/pnas.96.13.7324; Zhang Q, 2001, J BONE MINER RES, V16, pS356; Zhao G, 2000, ENDOCRINOLOGY, V141, P2674, DOI 10.1210/en.141.7.2674	41	543	569	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	2002	277	46					44005	44012		10.1074/jbc.M208265200	http://dx.doi.org/10.1074/jbc.M208265200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	615XE	12215457	hybrid			2022-12-27	WOS:000179272000062
J	Akama, TO; Misra, AK; Hindsgaul, O; Fukuda, MN				Akama, TO; Misra, AK; Hindsgaul, O; Fukuda, MN			Enzymatic synthesis in vitro of the disulfated disaccharide unit of corneal keratan sulfate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLY-N-ACETYLLACTOSAMINE; I-EXTENSION ENZYME; L-SELECTIN LIGANDS; MOLECULAR-CLONING; GENE FAMILY; UDP-GALACTOSE; O-GLYCANS; CORE 2; LUMICAN; PROTEOGLYCAN	Among the enzymes of the carbohydrate sulfotransferase family, human corneal GIcNAc 6-O-sulfotransferase (hCGn6ST, also known as human GIcNAc6ST-5/ GST4beta]) and human intestinal GlcNAc 6-O-sulfotransferase (hIGn6ST or human GlcNAc6ST-3/GST4alpha) are highly homologous. In the mouse, intestinal GlcNAc 6-O-sulfotransferase (mIGn6ST or mouse GlcNAc6ST-3/ GST4beta) is the only orthologue of hCGn6ST and hIGn6ST. In the previous study, we found that hCGn6ST and mIGn6ST, but not hIGn6ST, have sulfotransferase activity to produce keratan sulfate (Akama, T.O., Nakayama, J., Nishida, K., Hiraoka, N., Suzuki, M., McAuliffe, J., Hindsgaul, 0., Fukuda, M., and Fukuda, M. N. (2001) J. Biol Chem. 276, 16271-16278). In this study, we analyzed the substrate specificities of these sulfotransferases in vitro using synthetic carbohydrate substrates. We found that all three sulfotransferases can transfer sulfate to the nonreducing terminal GlcNAc of short carbohydrate substrates. Both hCGn6ST and mIGn6ST, but not hIGn6ST, transfer sulfate to longer carbohydrate substrates that have poly-N-acetyllactosamine structures, suggesting the involvement of hCGn6ST and mIGn6ST in production of keratan sulfate. To clarify further the involvement of hCGn6ST in biosynthe is of keratan sulfate, we reconstituted the biosynthetic pathway in vitro by sequential enzymatic treatment of a synthetic carbohydrate substrate. Using four enzymes, beta1,4-galactosyltransferase-1, beta1,3-N-acetylglucosaminyl-transferase-2, hCGn6ST, and keratan sulfate Gal 6-O-sulfotransferase, we were able to synthesize in vitro a product that conformed to the basic structural unit of keratan sulfate. Based on these results, we propose a biosynthetic pathway for N-linked keratan sulfate on corneal proteoglycans.	Burnham Inst, Glycobiol Program, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute	Akama, TO (corresponding author), Burnham Inst, Glycobiol Program, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.				NCI NIH HHS [CA71932] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA071932] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Akama TO, 2000, NAT GENET, V26, P237, DOI 10.1038/79987; Akama TO, 2001, J BIOL CHEM, V276, P16271, DOI 10.1074/jbc.M009995200; Almeida R, 1997, J BIOL CHEM, V272, P31979, DOI 10.1074/jbc.272.51.31979; Angata K, 2000, J BIOL CHEM, V275, P18594, DOI 10.1074/jbc.M910204199; BIERHUIZEN MFA, 1992, P NATL ACAD SCI USA, V89, P9326, DOI 10.1073/pnas.89.19.9326; Bistrup A, 1999, J CELL BIOL, V145, P899, DOI 10.1083/jcb.145.4.899; Bowman KG, 2001, BIOCHEMISTRY-US, V40, P5382, DOI 10.1021/bi001750o; Chakravarti S, 2000, INVEST OPHTH VIS SCI, V41, P3365; Chakravarti S, 1998, J CELL BIOL, V141, P1277, DOI 10.1083/jcb.141.5.1277; CORNUET PK, 1994, INVEST OPHTH VIS SCI, V35, P870; Corpuz LM, 1996, J BIOL CHEM, V271, P9759, DOI 10.1074/jbc.271.16.9759; DICKENSON JM, 1991, BIOCHEM J, V278, P779, DOI 10.1042/bj2780779; Dunlevy JR, 2000, EXP EYE RES, V70, P349, DOI 10.1006/exer.1999.0789; Fukuta M, 1997, J BIOL CHEM, V272, P32321, DOI 10.1074/jbc.272.51.32321; Funderburgh JL, 2000, GLYCOBIOLOGY, V10, P951, DOI 10.1093/glycob/10.10.951; FUNDERBURGH JL, 1986, DEV BIOL, V116, P267, DOI 10.1016/0012-1606(86)90130-2; FUNDERBURGH JL, 1993, J BIOL CHEM, V268, P11874; Funderburgh JL, 1997, J BIOL CHEM, V272, P28089, DOI 10.1074/jbc.272.44.28089; Greiling H, 1994, EXS, V70, P101; Guo S, 2001, GLYCOBIOLOGY, V11, P813, DOI 10.1093/glycob/11.10.813; HART GW, 1976, J BIOL CHEM, V251, P6513; Hemmerich S, 2001, IMMUNITY, V15, P237, DOI 10.1016/S1074-7613(01)00188-1; Hemmerich S, 2001, GLYCOBIOLOGY, V11, P75, DOI 10.1093/glycob/11.1.75; Hiraoka N, 1999, IMMUNITY, V11, P79, DOI 10.1016/S1074-7613(00)80083-7; KELLER R, 1983, H-S Z PHYSIOL CHEM, V364, P239, DOI 10.1515/bchm2.1983.364.1.239; KELLER R, 1983, H-S Z PHYSIOL CHEM, V364, P253; Lee JK, 1999, BIOCHEM BIOPH RES CO, V263, P543, DOI 10.1006/bbrc.1999.1324; Liu CY, 1998, J BIOL CHEM, V273, P22584, DOI 10.1074/jbc.273.35.22584; Lo NW, 1998, GLYCOBIOLOGY, V8, P517, DOI 10.1093/glycob/8.5.517; MARCHUK D, 1991, NUCLEIC ACIDS RES, V19, P1154, DOI 10.1093/nar/19.5.1154; MASRI KA, 1988, BIOCHEM BIOPH RES CO, V157, P657, DOI 10.1016/S0006-291X(88)80300-0; NAKAZAWA K, 1995, J BIOCHEM-TOKYO, V117, P707, DOI 10.1093/oxfordjournals.jbchem.a124767; NAKAZAWA K, 1975, J BIOL CHEM, V250, P912; OEBEN M, 1987, BIOCHEM J, V248, P85, DOI 10.1042/bj2480085; Plaas AHK, 2001, GLYCOBIOLOGY, V11, P779, DOI 10.1093/glycob/11.10.779; Quantock AJ, 2001, INVEST OPHTH VIS SCI, V42, P1750; RADA JA, 1993, EXP EYE RES, V56, P635, DOI 10.1006/exer.1993.1081; Saika S, 2000, J BIOL CHEM, V275, P2607, DOI 10.1074/jbc.275.4.2607; Sato T, 1998, P NATL ACAD SCI USA, V95, P472, DOI 10.1073/pnas.95.2.472; Schwientek T, 1998, J BIOL CHEM, V273, P29331, DOI 10.1074/jbc.273.45.29331; SCOTT JE, 1992, J ANAT, V180, P155; Seko A, 1998, FEBS LETT, V440, P307, DOI 10.1016/S0014-5793(98)01458-6; SHAKLEE PN, 1986, BIOCHEM J, V235, P225, DOI 10.1042/bj2350225; Shiraishi N, 2001, J BIOL CHEM, V276, P3498, DOI 10.1074/jbc.M004800200; Tai GH, 1997, J BIOL CHEM, V272, P28227, DOI 10.1074/jbc.272.45.28227; Tai GH, 1996, J BIOL CHEM, V271, P23535, DOI 10.1074/jbc.271.38.23535; TODA N, 1970, BIOCHIM BIOPHYS ACTA, V208, P227, DOI 10.1016/0304-4165(70)90241-2; Torii T, 2000, GLYCOBIOLOGY, V10, P203, DOI 10.1093/glycob/10.2.203; Uchimura K, 2002, J BIOL CHEM, V277, P3979, DOI 10.1074/jbc.M106587200; Ujita M, 2000, J BIOL CHEM, V275, P15868, DOI 10.1074/jbc.M001034200; Ujita M, 1998, J BIOL CHEM, V273, P34843, DOI 10.1074/jbc.273.52.34843; Ujita M, 1999, J BIOL CHEM, V274, P16717, DOI 10.1074/jbc.274.24.16717; Yeh JC, 1999, J BIOL CHEM, V274, P3215, DOI 10.1074/jbc.274.5.3215; Ying SX, 1997, J BIOL CHEM, V272, P30306, DOI 10.1074/jbc.272.48.30306	54	36	39	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					42505	42513		10.1074/jbc.M207412200	http://dx.doi.org/10.1074/jbc.M207412200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12218059	hybrid			2022-12-27	WOS:000179081200012
J	Gu, JM; Crawley, JTB; Ferrell, G; Zhang, FJ; Li, WH; Esmon, NL; Esmon, CT				Gu, JM; Crawley, JTB; Ferrell, G; Zhang, FJ; Li, WH; Esmon, NL; Esmon, CT			Disruption of the endothelial cell protein C receptor gene in mice causes placental thrombosis and early embryonic lethality	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE FACTOR; EPCR GENE; THROMBOMODULIN; ACTIVATION; MURINE; EXPRESSION; IDENTIFICATION; INVOLVEMENT; MODEL	The endothelial cell protein C receptor (EPCR) is a type 1 transmembrane protein found primarily on endothelium that binds both protein C and activated protein C with similar affinity. EPCR augments the activation of protein C by the thrombin-thrombomodulin complex. To determine the physiological importance of EPCR, we generated EPCR-deficient mice by homologous targeting in embryonic stem cells. Genotyping of progeny obtained from EPCR+/- interbreeding indicated that EPCR-/- embryos died on or before embryonic day 10.5 (E10.5). Reverse transcriptase-PCR confirmed the absence of EPCR mRNA in EPCR-/- embryos. EPCR-/- embryos removed from extra-embryonic membranes and tissues at day E7.5 and cultured in vitro developed beyond E10.5, suggesting a role for EPCR in the normal function of the placenta and/or at the materno-embryonic interface. Immunohistochemistry revealed the lack of EPCR in trophoblast giant cells of EPCR-/- embryos. These cells, which normally express EPCR, are in direct contact with the maternal circulation and its clotting factors. In EPCR-/- embryos, greatly increased fibrin deposition was detected around these cells. To prevent this fibrin deposition, EPCR+/--crossed female mice received a daily subcutaneous injection of enoxaparin through pregnancy. Although some EPCR-/- embryos were rescued from midgestational lethality, this regimen yielded no EPCR-/- pups. We conclude that EPCR is essential for normal embryonic development. Moreover, EPCR plays a key role in preventing thrombosis at the maternal-embryonic interface.	Univ Oklahoma, Oklahoma Med Res Fdn, Howard Hughes Med Inst, Hlth Sci Ctr,Dept Pathol, Oklahoma City, OK 73104 USA; Univ Oklahoma, Oklahoma Med Res Fdn, Hlth Sci Ctr, Dept Biochem, Oklahoma City, OK 73104 USA; Univ Oklahoma, Oklahoma Med Res Fdn, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA	Howard Hughes Medical Institute; Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center	Esmon, CT (corresponding author), Univ Oklahoma, Oklahoma Med Res Fdn, Howard Hughes Med Inst, Hlth Sci Ctr,Dept Pathol, 825 NE 13th St, Oklahoma City, OK 73104 USA.	Charles-Esmon@omrf.ouhsc.edu	Crawley, James TB/A-9290-2008	Crawley, James TB/0000-0002-6723-7841	NHLBI NIH HHS [P50 HL54502] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL054502] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BALDWIN HS, 1994, CIRC RES, V74, P244, DOI 10.1161/01.RES.74.2.244; Biguzzi E, 2001, THROMB HAEMOSTASIS, V86, P945; Crawley JTB, 2002, THROMB HAEMOSTASIS, V88, P259; Erlich J, 1999, P NATL ACAD SCI USA, V96, P8138, DOI 10.1073/pnas.96.14.8138; Esmon CT, 1999, HAEMATOLOGICA, V84, P363; ESMON CT, 1981, P NATL ACAD SCI-BIOL, V78, P2249, DOI 10.1073/pnas.78.4.2249; ESMON CT, 1982, J BIOL CHEM, V257, P7944; Esmon CT, 2000, THROMB HAEMOSTASIS, V83, P639; FUKUDOME K, 1995, J BIOL CHEM, V270, P5571, DOI 10.1074/jbc.270.10.5571; Gu JM, 2000, J BIOL CHEM, V275, P12481, DOI 10.1074/jbc.275.17.12481; Gu JM, 2000, BLOOD, V95, P1687, DOI 10.1182/blood.V95.5.1687.005k08_1687_1693; HEALY AM, 1995, P NATL ACAD SCI USA, V92, P850, DOI 10.1073/pnas.92.3.850; Healy AM, 1998, BLOOD, V92, P4188, DOI 10.1182/blood.V92.11.4188.423k09_4188_4197; Isermann B, 2001, DEVELOPMENT, V128, P827; Iwaki T, 2002, AM J PATHOL, V160, P1021, DOI 10.1016/S0002-9440(10)64923-1; Jalbert LR, 1998, J CLIN INVEST, V102, P1481, DOI 10.1172/JCI3011; Kurosawa S, 1997, J CLIN INVEST, V100, P411, DOI 10.1172/JCI119548; Kurosawa S, 1998, BLOOD, V91, P725, DOI 10.1182/blood.V91.2.725; Kurosawa S, 2000, J IMMUNOL, V165, P4697, DOI 10.4049/jimmunol.165.8.4697; Laszik Z, 1997, CIRCULATION, V96, P3633; Liang Z, 1999, THROMB HAEMOSTASIS, V81, P585; Oganesyan V, 2002, J BIOL CHEM, V277, P24851, DOI 10.1074/jbc.C200163200; Riewald M, 2002, SCIENCE, V296, P1880, DOI 10.1126/science.1071699; Shu F, 2000, FEBS LETT, V477, P208, DOI 10.1016/S0014-5793(00)01740-3; Simmonds RE, 1999, BLOOD, V94, P632, DOI 10.1182/blood.V94.2.632.414k24_632_641; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; StearnsKurosawa DJ, 1996, P NATL ACAD SCI USA, V93, P10212, DOI 10.1073/pnas.93.19.10212; Taylor FB, 2000, BLOOD, V95, P1680, DOI 10.1182/blood.V95.5.1680.005k33_1680_1686; Taylor FB, 2001, BLOOD, V97, P1685, DOI 10.1182/blood.V97.6.1685; Weiler H, 2001, ARTERIOSCL THROM VAS, V21, P1531, DOI 10.1161/hq0901.094496; Xu J, 1999, J BIOL CHEM, V274, P6704, DOI 10.1074/jbc.274.10.6704; Xu J, 2000, J BIOL CHEM, V275, P6038, DOI 10.1074/jbc.275.8.6038	32	111	118	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					43335	43343		10.1074/jbc.M207538200	http://dx.doi.org/10.1074/jbc.M207538200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12218060	hybrid			2022-12-27	WOS:000179081200117
J	Newton, CN; DeLuca, JG; Himes, RH; Miller, HP; Jordan, MA; Wilson, L				Newton, CN; DeLuca, JG; Himes, RH; Miller, HP; Jordan, MA; Wilson, L			Intrinsically slow dynamic instability of HeLa cell microtubules in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							URCHIN EGG TUBULIN; ALPHA-BETA-III; IN-VITRO; INDIVIDUAL MICROTUBULES; MONOCLONAL-ANTIBODY; ASSEMBLY PROPERTIES; BOVINE BRAIN; LIVING CELLS; PURE TUBULIN; PURIFICATION	The dynamic behavior of mammalian microtubules has been extensively studied, both in living cells and with microtubules assembled from purified brain tubulin. To understand the intrinsic dynamic behavior of mammalian nonneural microtubules, we purified tubulin from cultured HeLa cells. We find that HeLa cell microtubules exhibit remarkably slow dynamic instability, spending most of their time in an attenuated state. The tempered dynamics contrast sharply with the dynamics of microtubules prepared from purified bovine brain tubulin under similar conditions. In accord with their minimal dynamic instability, assembled HeLa cell microtubules displayed a slow treadmilling rate and a low guanosine-5'-triphosphate hydrolysis rate at steady state. We find that unlike brain tubulin, which consists of a heterogeneous mixture of beta-tubulin isotypes (beta(II), beta(III),, and)beta(IV) and a low level of beta(I)), HeLa cell tubulin consists of beta(I) tubulin (similar to80%) and a minor amount of beta(IV) tubulin (similar to20%). The slow dynamic behavior of HeLa cell microtubules in vitro differs strikingly from the dynamic behavior of microtubules in living cultured mammalian cells, supporting the idea that accessory factors create the robust dynamics that occur in cells.	Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA; Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA	University of California System; University of California Santa Barbara; University of Kansas	Newton, CN (corresponding author), Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA.				NATIONAL CANCER INSTITUTE [R01CA057291] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS013560] Funding Source: NIH RePORTER; NCI NIH HHS [CA57291] Funding Source: Medline; NINDS NIH HHS [NS13560] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Andersen SSL, 1999, BIOESSAYS, V21, P53, DOI 10.1002/(SICI)1521-1878(199901)21:1<53::AID-BIES7>3.0.CO;2-L; BANERJEE A, 1992, J BIOL CHEM, V267, P5625; BANERJEE A, 1990, J BIOL CHEM, V265, P1794; BANERJEE A, 1988, J BIOL CHEM, V263, P3029; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BULINSKI JC, 1979, P NATL ACAD SCI USA, V76, P293, DOI 10.1073/pnas.76.1.293; CASSIMERIS L, 1993, CELL MOTIL CYTOSKEL, V26, P275, DOI 10.1002/cm.970260402; Cassimeris L, 1999, CURR OPIN CELL BIOL, V11, P134, DOI 10.1016/S0955-0674(99)80017-9; CASSIMERIS L, 1988, J CELL BIOL, V107, P2223, DOI 10.1083/jcb.107.6.2223; DAVIS A, 1993, BIOCHEMISTRY-US, V32, P8823, DOI 10.1021/bi00085a013; DeLuca JG, 2001, J BIOL CHEM, V276, P28014, DOI 10.1074/jbc.M102801200; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; DETRICH HW, 1985, J BIOL CHEM, V260, P9479; DETRICH HW, 1983, BIOCHEMISTRY-US, V22, P2453, DOI 10.1021/bi00279a023; Dougherty CA, 1998, BIOCHEMISTRY-US, V37, P10861, DOI 10.1021/bi980677n; Gupta ML, 2002, MOL BIOL CELL, V13, P2919, DOI 10.1091/mbc.E02-01-0003; HAYDEN JH, 1990, J CELL BIOL, V111, P1039, DOI 10.1083/jcb.111.3.1039; Heald R, 2000, NAT CELL BIOL, V2, pE11, DOI 10.1038/71394; HERZOG W, 1977, P NATL ACAD SCI USA, V74, P1860, DOI 10.1073/pnas.74.5.1860; HORIO T, 1986, NATURE, V321, P605, DOI 10.1038/321605a0; HYAMS JS, 1994, MOD CELL BIOL, V13, P1; Kinoshita K, 2001, SCIENCE, V294, P1340, DOI 10.1126/science.1064629; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; LU Q, 1994, J BIOL CHEM, V269, P2041; Luduena RF, 1998, INT REV CYTOL, V178, P207; Margolis RL, 1998, BIOESSAYS, V20, P830, DOI 10.1002/(SICI)1521-1878(199810)20:10<830::AID-BIES8>3.0.CO;2-N; MARGOLIS RL, 1978, CELL, V13, P1, DOI 10.1016/0092-8674(78)90132-0; McNally FJ, 1996, CURR OPIN CELL BIOL, V8, P23, DOI 10.1016/S0955-0674(96)80044-5; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; MURPHY DB, 1983, J BIOL CHEM, V258, P8357; Ngan VK, 2000, CANCER RES, V60, P5045; OKABE S, 1988, J CELL BIOL, V107, P651, DOI 10.1083/jcb.107.2.651; Panda D, 1996, J BIOL CHEM, V271, P29807, DOI 10.1074/jbc.271.47.29807; Panda D, 2000, BIOCHEMISTRY-US, V39, P5075, DOI 10.1021/bi992217f; Panda D, 1999, P NATL ACAD SCI USA, V96, P12459, DOI 10.1073/pnas.96.22.12459; PANDA D, 1994, P NATL ACAD SCI USA, V91, P11358, DOI 10.1073/pnas.91.24.11358; Rodionov VI, 1997, SCIENCE, V275, P215, DOI 10.1126/science.275.5297.215; Rusan NM, 2001, MOL BIOL CELL, V12, P971, DOI 10.1091/mbc.12.4.971; SACKETT DL, 1995, ANAL BIOCHEM, V228, P343, DOI 10.1006/abio.1995.1361; SEITZTUTTER D, 1988, EXP CELL RES, V178, P504, DOI 10.1016/0014-4827(88)90418-1; SIMON JR, 1992, CELL MOTIL CYTOSKEL, V21, P1, DOI 10.1002/cm.970210102; SUPRENANT KA, 1983, J BIOL CHEM, V258, P4518; SUPRENANT KA, 1984, J CELL BIOL, V98, P253, DOI 10.1083/jcb.98.1.253; Tournebize R, 2000, NAT CELL BIOL, V2, P13, DOI 10.1038/71330; TRINCZEK B, 1993, MOL BIOL CELL, V4, P323, DOI 10.1091/mbc.4.3.323; VERDE F, 1990, NATURE, V343, P233, DOI 10.1038/343233a0; WALKER RA, 1988, J CELL BIOL, V107, P1437, DOI 10.1083/jcb.107.4.1437	47	42	43	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					42456	42462		10.1074/jbc.M207134200	http://dx.doi.org/10.1074/jbc.M207134200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12207023	hybrid			2022-12-27	WOS:000179081200006
J	Tjernberg, L; Hosia, W; Bark, N; Thyberg, J; Johansson, J				Tjernberg, L; Hosia, W; Bark, N; Thyberg, J; Johansson, J			Charge attraction and beta propensity are necessary for amyloid fibril formation from tetrapeptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN; FRAGMENT; RESIDUE	Amyloid fibrils in which specific proteins have polymerized into a cross-beta-sheet structure are found in about 20 diseases. In contrast to the close structural similarity of fibrils formed in different amyloid diseases, the structures of the corresponding native proteins differ widely. We show here that peptides as short as 4 residues with the sequences KFFE or KVVE can form amyloid fibrils that are practically identical to fibrils formed in association with disease, as judged by electron microscopy and Congo red staining. In contrast, KLLE or KAAE do not form fibrils. The fibril-forming KFFE and KVVE show partial beta-strand conformation in solution, whereas the non-fibril-forming KLLE and KAAE show random structure only, suggesting that inherent propensity for beta-strand conformation promotes fibril formation. The peptides KFFK or EFFE do not form fibrils on their own but do so in an equimolar mixture. Thus, intermolecular electrostatic interactions, either between charged dipolar peptides or between complementary charges of co-fibrillating peptides favor fibril formation.	Karolinska Inst, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden; Karolinska Inst, Dept Neurotec, S-14157 Huddinge, Sweden; Karolinska Inst, Dept Clin Neurosci, S-17177 Stockholm, Sweden; Karolinska Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet	Johansson, J (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden.			Johansson, Jan/0000-0002-8719-4703				Azriel R, 2001, J BIOL CHEM, V276, P34156, DOI 10.1074/jbc.M102883200; Fandrich M, 2001, NATURE, V410, P165, DOI 10.1038/35065514; Gazit E, 2002, FASEB J, V16, P77, DOI 10.1096/fj.01-0442hyp; Kallberg Y, 2001, J BIOL CHEM, V276, P12945, DOI 10.1074/jbc.M010402200; Rochet JC, 2000, CURR OPIN STRUC BIOL, V10, P60, DOI 10.1016/S0959-440X(99)00049-4; SOTO C, 1995, J BIOL CHEM, V270, P3063, DOI 10.1074/jbc.270.7.3063; Sunde M, 1998, Q REV BIOPHYS, V31, P1, DOI 10.1017/S0033583598003400; Taddei N, 2001, J BIOL CHEM, V276, P37149, DOI 10.1074/jbc.M105720200; Tjernberg LO, 1996, J BIOL CHEM, V271, P8545, DOI 10.1074/jbc.271.15.8545; Tjernberg LO, 1999, J BIOL CHEM, V274, P12619, DOI 10.1074/jbc.274.18.12619; von Bergen M, 2000, P NATL ACAD SCI USA, V97, P5129, DOI 10.1073/pnas.97.10.5129; WOUTERS MA, 1995, PROTEINS, V22, P119, DOI 10.1002/prot.340220205; ZHANG SG, 1993, P NATL ACAD SCI USA, V90, P3334, DOI 10.1073/pnas.90.8.3334	13	199	201	1	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					43243	43246		10.1074/jbc.M205570200	http://dx.doi.org/10.1074/jbc.M205570200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12215440				2022-12-27	WOS:000179081200106
J	Cheng, IH; Roberts, LA; Tye, BK				Cheng, IH; Roberts, LA; Tye, BK			Mcm3 is polyubiquitinated during mitosis before establishment of the pre-replication complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-REPLICATION; CELL-CYCLE; SACCHAROMYCES-CEREVISIAE; NUCLEAR-LOCALIZATION; BIND CHROMATIN; S-PHASE; PROTEINS; UBIQUITIN; INITIATION; ORIGINS	To ensure fidelity in genome duplication, eukaryotes restrict DNA synthesis to once every cell division by a cascade of regulated steps. Central to this cascade is the periodic assembly of the hexameric MCM2-7 complex at replication origins. However, in Saccharomyces cerevisiae, only a fraction of each MCM protein is able to assemble into hexamers and associate with replication origins during M phase, suggesting that MCM complex assembly and recruitment may be regulated post-translationally. Here we show that a small fraction of Mcm3p is polyubiquitinated at the onset of MCM complex assembly. Reducing the rate of ubiquitination by uba1-165, a suppressor of mcm3-10, restored the interaction of Mcm3-10p with subunits of the MCM complex and its recruitment to the replication origin. Possible roles for ubiquitinated Mcm3p in the assembly of the MCM complex at replication origins are discussed.	Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA	Cornell University	Tye, BK (corresponding author), Cornell Univ, Dept Mol Biol & Genet, 325 Biotechnol Bldg, Ithaca, NY 14853 USA.	bt16@cornell.edu						Aparicio OM, 1997, CELL, V91, P59, DOI 10.1016/S0092-8674(01)80009-X; BLOW JJ, 1988, NATURE, V332, P546, DOI 10.1038/332546a0; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; CHONG JPJ, 1995, NATURE, V375, P418, DOI 10.1038/375418a0; Cosma MP, 1999, CELL, V97, P299, DOI 10.1016/S0092-8674(00)80740-0; Coue M, 1996, EMBO J, V15, P1085, DOI 10.1002/j.1460-2075.1996.tb00446.x; DIFFLEY JFX, 1994, CELL, V78, P303, DOI 10.1016/0092-8674(94)90299-2; Donovan S, 1997, P NATL ACAD SCI USA, V94, P5611, DOI 10.1073/pnas.94.11.5611; DURSO G, 1990, SCIENCE, V250, P786, DOI 10.1126/science.2173140; ELLISON MJ, 1991, J BIOL CHEM, V266, P21150; FINLEY D, 1994, MOL CELL BIOL, V14, P5501, DOI 10.1128/MCB.14.8.5501; Fujita M, 1997, J BIOL CHEM, V272, P10928; GIBSON SI, 1990, MOL CELL BIOL, V10, P5707, DOI 10.1128/MCB.10.11.5707; GIBSON SI, 1989, THESIS CORNELL U; Guthrie C., 1991, METHODS ENZYMOLOGY G, V194; Haase SB, 1997, METHOD ENZYMOL, V283, P322; HATFIELD PM, 1992, J BIOL CHEM, V267, P14799; Hecht A, 1996, NATURE, V383, P92, DOI 10.1038/383092a0; HENNESSY KM, 1991, GENE DEV, V5, P958, DOI 10.1101/gad.5.6.958; HENNESSY KM, 1990, GENE DEV, V4, P2252, DOI 10.1101/gad.4.12b.2252; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; HILT W, 1993, J BIOL CHEM, V268, P3479; Ishimi Y, 1997, J BIOL CHEM, V272, P24508, DOI 10.1074/jbc.272.39.24508; Jares P, 2000, GENE DEV, V14, P1528; Jiang W, 1999, EMBO J, V18, P5703, DOI 10.1093/emboj/18.20.5703; KIPPERT F, 1995, FEMS MICROBIOL LETT, V128, P201, DOI 10.1016/0378-1097(95)00113-J; Krude T, 1996, J CELL SCI, V109, P309; KUBOTA Y, 1995, CELL, V81, P601, DOI 10.1016/0092-8674(95)90081-0; Kuhne C, 1998, J BIOL CHEM, V273, P34302, DOI 10.1074/jbc.273.51.34302; Labib K, 2000, SCIENCE, V288, P1643, DOI 10.1126/science.288.5471.1643; Lee DH, 1998, MOL CELL BIOL, V18, P30, DOI 10.1128/MCB.18.1.30; Lee JK, 2000, J BIOL CHEM, V275, P18871, DOI 10.1074/jbc.M001118200; Lei M, 2002, J BIOL CHEM, V277, P30824, DOI 10.1074/jbc.M201816200; Lei M, 1996, MOL CELL BIOL, V16, P5081; Lei M, 2001, J CELL SCI, V114, P1447; Lei M, 1997, GENE DEV, V11, P3365, DOI 10.1101/gad.11.24.3365; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; Nguyen VQ, 2000, CURR BIOL, V10, P195, DOI 10.1016/S0960-9822(00)00337-7; Pasero P, 1999, GENE DEV, V13, P2159, DOI 10.1101/gad.13.16.2159; Pereverzeva I, 2000, MOL CELL BIOL, V20, P3667, DOI 10.1128/MCB.20.10.3667-3676.2000; Piatti S, 1996, GENE DEV, V10, P1516, DOI 10.1101/gad.10.12.1516; Pickart CM, 2001, MOL CELL, V8, P499, DOI 10.1016/S1097-2765(01)00347-1; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; ROWLEY A, 1995, EMBO J, V14, P2631, DOI 10.1002/j.1460-2075.1995.tb07261.x; Schwacha A, 2001, MOL CELL, V8, P1093, DOI 10.1016/S1097-2765(01)00389-6; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; SPENCE J, 1995, MOL CELL BIOL, V15, P1265; Swanson R, 2000, FEBS LETT, V477, P193, DOI 10.1016/S0014-5793(00)01802-0; Takei Y, 2001, EMBO REP, V2, P119, DOI 10.1093/embo-reports/kve026; Tanaka TU, 1997, CELL, V90, P649, DOI 10.1016/S0092-8674(00)80526-7; Tye BK, 2000, J BIOL CHEM, V275, P34833, DOI 10.1074/jbc.R000018200; Tye BK, 1999, ANNU REV BIOCHEM, V68, P649, DOI 10.1146/annurev.biochem.68.1.649; Tyers M, 2000, CURR OPIN GENET DEV, V10, P54, DOI 10.1016/S0959-437X(99)00049-0; Varshavsky A, 1997, TRENDS BIOCHEM SCI, V22, P383, DOI 10.1016/S0968-0004(97)01122-5; Wickner S, 1999, SCIENCE, V286, P1888, DOI 10.1126/science.286.5446.1888; YAN H, 1991, GENE DEV, V5, P944, DOI 10.1101/gad.5.6.944; YAN H, 1993, GENE DEV, V7, P2149, DOI 10.1101/gad.7.11.2149; Young MR, 1997, MOL BIOL CELL, V8, P1587, DOI 10.1091/mbc.8.8.1587	59	9	9	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					41706	41714		10.1074/jbc.M205793200	http://dx.doi.org/10.1074/jbc.M205793200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12200430	hybrid			2022-12-27	WOS:000178985300053
J	Haimeur, A; Deeley, RG; Cole, SPC				Haimeur, A; Deeley, RG; Cole, SPC			Charged amino acids in the sixth transmembrane helix of multidrug resistance protein 1 (MRP1/ABCC1) are critical determinants of transport activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORGANIC ANION TRANSPORTER; SUBSTRATE-SPECIFICITY; TRANSMEMBRANE DOMAINS; DEPENDENT TRANSPORT; MEMBRANE TOPOLOGY; CHLORIDE CHANNEL; DRUG-RESISTANCE; BASIC RESIDUES; MRP; GLUTATHIONE	The multidrug resistance protein, MRP1 (ABCC1), is an ATP-binding cassette transporter that confers resistance to chemotherapeutic agents. MRP1 also mediates transport of organic anions such as leukotriene C-4 (LTC4), 17beta-estradiol 17-(beta-D-glucuronide) (E(2)17betaG), estrone 3-sulfate, methotrexate (MTX), and GSH. We replaced three charged amino acids, Lys(332), His(335), and Asp(336), predicted to be in the sixth transmembrane (TM6) helix of MRP1 with neutral and oppositely charged amino acids and determined the effect on substrate specificity and transport activity. All mutants were expressed in transfected human embryonic kidney cells at levels comparable with wild-type MRP1, and confocal microscopy showed that they were correctly routed to the plasma membrane. Vesicular transport studies revealed that the MRP1-Lys(332) mutants had lost the ability to transport LTC4, and GSH transport was reduced; whereas E(2)17betaG, estrone 3-sulfate, and MTX transport were unaffected. E(2)17betaG transport was not inhibited by LTC4 and could not be photolabeled with [H-3]LTC4, indicating that the MRP1-Lys(332) mutants no longer bound this substrate. Substitutions of MRP1-His(335) also selectively diminished LTC4 transport and photolabeling but to a lesser extent. Kinetic analyses showed that V-max (LTC4) of these mutants was decreased but K-m was unchanged. In contrast to the selective loss of LTC4 transport in the Lys(332) and His(335) mutants, the MRP1-Asp(336) mutants no longer transported LTC4, E(2)17betaG, estrone 3-sulfate, or GSH, and transport of MTX was reduced by >50%. Lys(332), His(335), and Asp(336) of TM6 are predicted to be in the outer leaflet of the membrane and are all capable of forming intrahelical and interhelical ion pairs and hydrogen bonds. The importance of Lys(332) and His(335) in determining substrate specificity and of Asp(336) in overall transport activity suggests that such interactions are critical for the binding and transport of LTC4 and other substrates of MRP1.	Queens Univ, Canc Res Labs, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Cole, SPC (corresponding author), Queens Univ, Canc Res Labs, Botterell Hall,Rm 328, Kingston, ON K7L 3N6, Canada.	coles@post.queensu.ca	Deeley, Roger/J-4828-2012; Cole, Susan P.C./I-6389-2017	Cole, Susan P.C./0000-0001-6571-6884				AKABAS MH, 1994, J BIOL CHEM, V269, P14865; Allen JD, 2002, MOL CANCER THER, V1, P427; Ambudkar SV, 1999, ANNU REV PHARMACOL, V39, P361, DOI 10.1146/annurev.pharmtox.39.1.361; ANDERSON MP, 1991, SCIENCE, V253, P202, DOI 10.1126/science.1712984; Bakos E, 2000, MOL PHARMACOL, V57, P760, DOI 10.1124/mol.57.4.760; Borst P, 2000, JNCI-J NATL CANCER I, V92, P1295, DOI 10.1093/jnci/92.16.1295; COLE SPC, 1994, CANCER RES, V54, P5902; Cole SPC, 1998, BIOESSAYS, V20, P931, DOI 10.1002/(SICI)1521-1878(199811)20:11<931::AID-BIES8>3.0.CO;2-J; COLE SPC, 1992, SCIENCE, V258, P1650, DOI 10.1126/science.1360704; Conrad S, 2002, PHARMACOGENETICS, V12, P321, DOI 10.1097/00008571-200206000-00008; Cui YH, 1999, MOL PHARMACOL, V55, P929; DEELEY RG, 2002, ABC PROTEINS BACTERI, P393; Doyle LA, 1998, P NATL ACAD SCI USA, V95, P15665, DOI 10.1073/pnas.95.26.15665; Evers R, 2000, BRIT J CANCER, V83, P375, DOI 10.1054/bjoc.2000.1262; Hipfner DR, 1997, J BIOL CHEM, V272, P23623, DOI 10.1074/jbc.272.38.23623; Hipfner DR, 1999, J BIOL CHEM, V274, P15420, DOI 10.1074/jbc.274.22.15420; Hipfner DR, 1996, CANCER RES, V56, P3307; Hooijberg JH, 1999, CANCER RES, V59, P2532; Ilias A, 2002, J BIOL CHEM, V277, P16860, DOI 10.1074/jbc.M110918200; Ito K, 2001, MOL PHARMACOL, V59, P1077, DOI 10.1124/mol.59.5.1077; Ito K, 2001, J BIOL CHEM, V276, P15616, DOI 10.1074/jbc.M011246200; Ito K, 2001, J BIOL CHEM, V276, P38108; Jedlitschky G, 1996, CANCER RES, V56, P988; Kast C, 1997, J BIOL CHEM, V272, P26479, DOI 10.1074/jbc.272.42.26479; Kim MH, 2000, J BIOL CHEM, V275, P6175, DOI 10.1074/jbc.275.9.6175; Koike K, 1997, CANCER RES, V57, P5475; Konig J, 1999, BBA-BIOMEMBRANES, V1461, P377, DOI 10.1016/S0005-2736(99)00169-8; Kool M, 1999, P NATL ACAD SCI USA, V96, P6914, DOI 10.1073/pnas.96.12.6914; Leslie EM, 2001, TOXICOLOGY, V167, P3, DOI 10.1016/S0300-483X(01)00454-1; Leslie EM, 2001, J BIOL CHEM, V276, P27846, DOI 10.1074/jbc.M102453200; Leslie EM, 2001, MOL PHARMACOL, V59, P1171, DOI 10.1124/mol.59.5.1171; Litman T, 2000, J CELL SCI, V113, P2011; Loe DW, 2000, J PHARMACOL EXP THER, V293, P530; Loe DW, 1996, J BIOL CHEM, V271, P9683, DOI 10.1074/jbc.271.16.9683; Loe DW, 1998, CANCER RES, V58, P5130; Loe DW, 1996, J BIOL CHEM, V271, P9675, DOI 10.1074/jbc.271.16.9675; Mao QC, 2000, J BIOL CHEM, V275, P34166, DOI 10.1074/jbc.M004584200; Merickel A, 1997, J BIOL CHEM, V272, P5403, DOI 10.1074/jbc.272.9.5403; NUNES V, 1993, HUM MOL GENET, V2, P79, DOI 10.1093/hmg/2.1.79; Partridge AW, 2002, BIOCHEMISTRY-US, V41, P3647, DOI 10.1021/bi0120502; Popot JL, 2000, ANNU REV BIOCHEM, V69, P881, DOI 10.1146/annurev.biochem.69.1.881; Qian YM, 2001, J BIOL CHEM, V276, P6404, DOI 10.1074/jbc.M008251200; Raab-Graham KF, 1999, J BIOL CHEM, V274, P29122, DOI 10.1074/jbc.274.41.29122; Renes J, 1999, BRIT J PHARMACOL, V126, P681, DOI 10.1038/sj.bjp.0702360; Ryu S, 2000, J BIOL CHEM, V275, P39617, DOI 10.1074/jbc.M005149200; Seelig A, 2000, INT J CLIN PHARM TH, V38, P111; Tammur J, 2001, GENE, V273, P89, DOI 10.1016/S0378-1119(01)00572-8; Therien AG, 2001, NAT STRUCT BIOL, V8, P597, DOI 10.1038/89631; Zeng H, 2001, CANCER RES, V61, P7225; Zeng H, 1999, CANCER RES, V59, P5964; Zhang DW, 2001, J BIOL CHEM, V276, P34966, DOI 10.1074/jbc.M105063200; Zhang DW, 2001, J BIOL CHEM, V276, P13231, DOI 10.1074/jbc.M010008200	52	65	66	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					41326	41333		10.1074/jbc.M206228200	http://dx.doi.org/10.1074/jbc.M206228200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12186871	hybrid			2022-12-27	WOS:000178985300007
J	Vaca, L; Sampieri, A				Vaca, L; Sampieri, A			Calmodulin modulates the delay period between release of calcium from internal stores and activation of calcium influx via endogenous TRP1 channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; CAPACITATIVE CA2+ ENTRY; I-CRAC; VASCULAR ENDOTHELIUM; TRANSIENT RECEPTOR; TERMINAL DOMAIN; CATION CHANNEL; INSECT CELLS; IP3 RECEPTOR; PROTEIN	In the present study we have explored the role of calmodulin (CaM) and inositol 1,4,5-trisphosphate receptor (IP(3)R) in the communication process activated after the release of calcium from the endoplasmic reticulum. (ER) and the activation of calcium influx via endogenous TRP1 channels from Chinese hamster ovary cells. Experiments using combined rapid confocal calcium and electrophysiology measurements uncovered a consistent delay of around 900 ms between the first detectable calcium released from the ER and the activation of the calcium current. This delay was evident with two different methods used to release calcium from the ER: either the blockade of the microsomal calcium ATPase with thapsigargin or activation of bradykinin receptors linked to the IP(3) cascade. Direct application of IP(3) or a peptide from the NH(2)-terminal region of the IP(3)R activated store operated calcium, reducing the delay period. Introduction of CaM into the cell via the patch pipette increased the delay period from 900 +/- 100 ms to 10 +/- 2.1 s (n = 18). Furthermore, the use of selective CaM antagonists W7 and trifluoperazine maleate resulted in a substantial reduction of the delay period to 200 +/- 100 ms with 5 muM trifluoperazine maleate (n = 16) and 150 +/- 50 ms with 500 nM W7 (n = 22). CaM reduced also the current density activated by thapsigargin or brandykinin to about 60% from control. The CaM antagonists did not affect significantly the current density. The results presented here are consistent with an antagonistic effect of lP(3)R and CaM for the activation of store operated calcium after depletion of the ER. The functional competition between the activating effect of IP(3)R and the inhibiting effect of CaM may modulate the delay period between the release of calcium from the ER and the activation of calcium influx observed in different cells, as well as the amount of current activated a er depletion of the ER.	Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Biol Celular, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico	Vaca, L (corresponding author), Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Biol Celular, Ciudad Univ, Mexico City 04510, DF, Mexico.	lvaca@ifisiol.unam.mx	Sampieri, Alicia/L-3896-2019	Vaca, Luis/0000-0003-2266-4847				Bass BL, 2000, CELL, V101, P235, DOI 10.1016/S0092-8674(02)71133-1; Birnbaumer L, 2000, RECENT PROG HORM RES, V55, P127; Fierro L, 2000, PFLUG ARCH EUR J PHY, V440, P580, DOI 10.1007/s004240050009; Gailly P, 2001, CELL CALCIUM, V30, P157, DOI 10.1054/ceca.2001.0221; Hofer AM, 1998, J CELL BIOL, V140, P325, DOI 10.1083/jcb.140.2.325; HOTH M, 1993, J PHYSIOL-LONDON, V465, P359, DOI 10.1113/jphysiol.1993.sp019681; Huang Y, 1998, J BIOL CHEM, V273, P31815, DOI 10.1074/jbc.273.48.31815; Kiselyov K, 1999, MOL CELL, V4, P423, DOI 10.1016/S1097-2765(00)80344-5; LeppleWienhues A, 1996, BIOPHYS J, V71, P787, DOI 10.1016/S0006-3495(96)79278-0; Ma HT, 2000, SCIENCE, V287, P1647, DOI 10.1126/science.287.5458.1647; MAINE EM, 2000, GENOME BIOL, V1, P1; Martinez-Francois JR, 2002, J PHYSIOL-LONDON, V538, P79, DOI 10.1113/jphysiol.2001.013036; Montell C, 2002, CELL, V108, P595, DOI 10.1016/S0092-8674(02)00670-0; Montell C, 2002, MOL CELL, V9, P229, DOI 10.1016/S1097-2765(02)00448-3; Niemeyer BA, 2001, P NATL ACAD SCI USA, V98, P3600, DOI 10.1073/pnas.051511398; Okada T, 1999, J BIOL CHEM, V274, P27359, DOI 10.1074/jbc.274.39.27359; Putney JW, 1999, BIOESSAYS, V21, P38; Putney JW, 2001, J CELL SCI, V114, P2223; Putney JW, 1999, CELL, V99, P5, DOI 10.1016/S0092-8674(00)80056-2; PUTNEY JW, 1990, CELL CALCIUM, V11, P611, DOI 10.1016/0143-4160(90)90016-N; Reyes-Cruz G, 2000, J CELL BIOCHEM, V76, P658, DOI 10.1002/(SICI)1097-4644(20000315)76:4<658::AID-JCB14>3.3.CO;2-Z; Scott K, 1997, CELL, V91, P375, DOI 10.1016/S0092-8674(00)80421-3; Singh BB, 2000, J BIOL CHEM, V275, P36483, DOI 10.1074/jbc.C000529200; Sinkins WG, 1996, J BIOL CHEM, V271, P2955, DOI 10.1074/jbc.271.6.2955; Strubing C, 2001, NEURON, V29, P645, DOI 10.1016/S0896-6273(01)00240-9; Tang J, 2001, J BIOL CHEM, V276, P21303, DOI 10.1074/jbc.M102316200; Vaca L, 1996, FEBS LETT, V390, P289, DOI 10.1016/0014-5793(96)00675-8; VACA L, 1994, AM J PHYSIOL-CELL PH, V267, pC920, DOI 10.1152/ajpcell.1994.267.4.C920; VACA L, 1994, AM J PHYSIOL-CELL PH, V267, pC1501, DOI 10.1152/ajpcell.1994.267.5.C1501; Xu XZS, 1997, CELL, V89, P1155, DOI 10.1016/S0092-8674(00)80302-5; Yue LX, 2001, NATURE, V410, P705, DOI 10.1038/35070596; Zhang ZM, 2001, P NATL ACAD SCI USA, V98, P3168, DOI 10.1073/pnas.051632698; Zhu X, 1996, CELL, V85, P661, DOI 10.1016/S0092-8674(00)81233-7	33	46	49	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					42178	42187		10.1074/jbc.M204531200	http://dx.doi.org/10.1074/jbc.M204531200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12196518	hybrid			2022-12-27	WOS:000178985300111
J	Leksa, V; Godar, S; Cebecauer, M; Hilgert, I; Breuss, J; Weidle, UH; Horejsi, V; Binder, BR; Stockinger, H				Leksa, V; Godar, S; Cebecauer, M; Hilgert, I; Breuss, J; Weidle, UH; Horejsi, V; Binder, BR; Stockinger, H			The N terminus of mannose 6-phosphate/insulin-like growth factor 2 receptor in regulation of fibrinolysis and cell migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UROKINASE PLASMINOGEN-ACTIVATOR; FACTOR-II RECEPTOR; LYSOSOMAL-ENZYME; ADHESION; SURFACE; STREPTOKINASE; VITRONECTIN; PROTEIN; EXPRESSION; COMPLEXES	Leukocyte migration to sites of inflammation is a multistep process involving transient adhesion to the endothelium followed by cell surface-controlled proteolysis for transmigration through the vessel wall and chemotactic movement within tissues. One of the key players in this machinery appears to be the urokinase-type plasminogen activator (uPA)/uPA receptor system. The role of uPA and its receptor (CD87) in plasminogen (Plg) activation, cell adhesion, and chemotaxis is well established; however, less is known of how these activities are regulated. Here we provide evidence that the mannose 6-phosphate/insulin-like growth factor 2 receptor (CD222) controls CD87-mediated functions. Expression of human CD222 in CD222-/- mouse fibroblasts down-regulated Plg activation, cell adhesion, and chemotaxis induced by the uPA/CD87 system. In addition, we demonstrate that the N-terminal region of CD222, which is similar to the Plg-binding site of streptokinase, plays a crucial role in binding of CD87 and Plg. A peptide derived from this region in CD222 is able to disrupt the physical interaction of CD222 with CD87 and, furthermore, mimics the inhibitory effects of CD222 on CD87 functions. Taken together, our results indicate a novel role for CD222 in regulation of fibrinolysis, cell adhesion, and migration.	Univ Vienna, Inst Immunol, Vienna Int Res Cooperat Ctr, NFI, A-1235 Vienna, Austria; Roche Diagnost, Div Pharma, D-82372 Penzberg, Germany; Univ Vienna, Dept Vasc Biol & Thrombosis Res, A-1090 Vienna, Austria; Acad Sci Czech Republ, Inst Mol Genet, CR-14220 Prague, Czech Republic	Novartis; University of Vienna; Roche Holding; University of Vienna; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences	Stockinger, H (corresponding author), Univ Vienna, Inst Immunol, Vienna Int Res Cooperat Ctr, NFI, A-1235 Vienna, Austria.		Stockinger, Hannes/E-5173-2011; Cebecauer, Marek/F-5169-2014; Horejsi, Vaclav/G-3113-2014; Leksa, Vladimir/ABE-7876-2020	Stockinger, Hannes/0000-0001-6404-4430; Cebecauer, Marek/0000-0002-4606-1218; Horejsi, Vaclav/0000-0003-4925-0142; breuss, johannes/0000-0003-1312-3387; Leksa, vladimir/0000-0002-5430-2763				BAIER G, 1994, BIOTECHNIQUES, V17, P94; BEHRENDT N, 1995, BIOL CHEM H-S, V376, P269; Blasi F, 1997, IMMUNOL TODAY, V18, P415, DOI 10.1016/S0167-5699(97)01121-3; BOHUSLAV J, 1995, J EXP MED, V181, P1381, DOI 10.1084/jem.181.4.1381; BOYLE MDP, 1987, J IMMUNOL, V139, P169; BRAULKE T, 1989, EMBO J, V8, P681, DOI 10.1002/j.1460-2075.1989.tb03426.x; Chapman HA, 1999, THROMB HAEMOSTASIS, V82, P291; CONESE M, 1995, J CELL BIOL, V131, P1609, DOI 10.1083/jcb.131.6.1609; Dahms NM, 1996, BIOCHEM SOC T, V24, P136, DOI 10.1042/bst0240136; Degryse B, 2001, FEBS LETT, V505, P249, DOI 10.1016/S0014-5793(01)02797-1; Deng G, 1996, J CELL BIOL, V134, P1563, DOI 10.1083/jcb.134.6.1563; deSouza AT, 1997, FASEB J, V11, P60, DOI 10.1096/fasebj.11.1.9034167; Dunon D, 1996, CURR OPIN CELL BIOL, V8, P714, DOI 10.1016/S0955-0674(96)80114-1; Ellis V, 1999, BIOCHEMISTRY-US, V38, P651, DOI 10.1021/bi981714d; ELLIS V, 1993, METHOD ENZYMOL, V223, P223; Fazioli F, 1997, EMBO J, V16, P7279, DOI 10.1093/emboj/16.24.7279; Godar S, 1999, EUR J IMMUNOL, V29, P1004, DOI 10.1002/(SICI)1521-4141(199903)29:03<1004::AID-IMMU1004>3.0.CO;2-Q; GODAR S, 2000, PROTEIN REV WEB, V1, P50; Godar S., 2002, LEUKOCYTE TYPING, P482; GONZALEZGRONOW M, 1993, BIOCHIM BIOPHYS ACTA, V1180, P283, DOI 10.1016/0925-4439(93)90051-2; GYETKO MR, 1994, J CLIN INVEST, V93, P1380, DOI 10.1172/JCI117114; Horejsi V, 1999, IMMUNOL TODAY, V20, P356, DOI 10.1016/S0167-5699(99)01489-9; Kang JX, 1998, P NATL ACAD SCI USA, V95, P13687, DOI 10.1073/pnas.95.23.13687; Kanse SM, 1996, EXP CELL RES, V224, P344, DOI 10.1006/excr.1996.0144; Kim DM, 2000, THROMB RES, V99, P93, DOI 10.1016/S0049-3848(00)00225-5; Kinoshita S, 1997, IMMUNITY, V6, P235, DOI 10.1016/S1074-7613(00)80326-X; KORNFELD S, 1992, ANNU REV BIOCHEM, V61, P307, DOI 10.1146/annurev.bi.61.070192.001515; Koshelnick Y, 1997, J BIOL CHEM, V272, P28563, DOI 10.1074/jbc.272.45.28563; Koshelnick Y, 1999, THROMB HAEMOSTASIS, V82, P305, DOI 10.1055/s-0037-1615847; Kusch A, 2002, BIOL CHEM, V383, P217, DOI 10.1515/BC.2002.022; LEE SW, 1994, J BIOL CHEM, V269, P2411; Liu L, 2000, J BIOL CHEM, V275, P37686, DOI 10.1074/jbc.M003963200; Nykjaer A, 1998, J CELL BIOL, V141, P815, DOI 10.1083/jcb.141.3.815; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; PLOW EF, 1995, FASEB J, V9, P939, DOI 10.1096/fasebj.9.10.7615163; PRENCE EM, 1990, J CELL BIOL, V110, P319, DOI 10.1083/jcb.110.2.319; Resnati M, 1996, EMBO J, V15, P1572, DOI 10.1002/j.1460-2075.1996.tb00502.x; RONNE E, 1994, J IMMUNOL METHODS, V167, P91, DOI 10.1016/0022-1759(94)90078-7; SCOTT CD, 1988, BIOCHEM BIOPH RES CO, V151, P815, DOI 10.1016/S0006-291X(88)80354-1; Sendo F, 1999, J LEUKOCYTE BIOL, V66, P369, DOI 10.1002/jlb.66.3.369; Sitrin RG, 2001, J IMMUNOL, V166, P4822, DOI 10.4049/jimmunol.166.8.4822; STEFANOVA I, 1991, SCIENCE, V254, P1016, DOI 10.1126/science.1719635; SWIFT S, 1999, CURRENT PROTOCOLS IM; van der Pluijm G, 2001, AM J PATHOL, V159, P971, DOI 10.1016/S0002-9440(10)61773-7; Vilhardt F, 1999, MOL BIOL CELL, V10, P179, DOI 10.1091/mbc.10.1.179; Waltz DA, 1997, J CLIN INVEST, V100, P58, DOI 10.1172/JCI119521; WALTZ DA, 1994, J BIOL CHEM, V269, P14746; Waltz DA, 2000, AM J RESP CELL MOL, V22, P316, DOI 10.1165/ajrcmb.22.3.3713; Wang XQ, 1998, SCIENCE, V281, P1662, DOI 10.1126/science.281.5383.1662; WANG ZQ, 1994, NATURE, V372, P464, DOI 10.1038/372464a0; WEI Y, 1994, J BIOL CHEM, V269, P32380; Wei Y, 1996, SCIENCE, V273, P1551, DOI 10.1126/science.273.5281.1551; Wei Y, 1999, J CELL BIOL, V144, P1285, DOI 10.1083/jcb.144.6.1285; Xue W, 1997, CANCER RES, V57, P1682; Zhang JC, 1998, J BIOL CHEM, V273, P32273, DOI 10.1074/jbc.273.48.32273; Zhang QM, 1997, J BIOL CHEM, V272, P23703, DOI 10.1074/jbc.272.38.23703	56	52	55	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 25	2002	277	43					40575	40582		10.1074/jbc.M207979200	http://dx.doi.org/10.1074/jbc.M207979200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	607KU	12189157	hybrid			2022-12-27	WOS:000178791400055
J	Bellu, AR; Salomons, FA; Kiel, JAKW; Veenhuis, M; van der Klei, IJ				Bellu, AR; Salomons, FA; Kiel, JAKW; Veenhuis, M; van der Klei, IJ			Removal of Pex3p is an important initial stage in selective peroxisome degradation in Hansenula polymorpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; YEAST PICHIA-PASTORIS; ASSEMBLY PROTEIN; GENE ENCODES; BIOGENESIS; MEMBRANE; PROLIFERATION; AUTOPHAGY; TURNOVER; OXIDASE	Selective degradation of peroxisomes (macropexophagy) in Hansenula polymorpha involves the sequestration of individual organelles to be degraded by membranes prior to the fusion of this compartment with the vacuole and subsequent degradation of the whole organelle by vacuolar hydrolases. Here we show that Pex3p, a peroxisomal membrane protein essential for peroxisome biogenesis, escapes this autophagic process. Upon induction of macropexophagy, Pex3p is removed from the organelle tagged for degradation prior to its sequestration. Our data indicate that Pex3p degradation is essential to allow the initiation of the organellar degradation process. Also, in a specific peroxisome degradation-deficient (pdd) mutant in which sequestration still occurs but the vacuolar fusion event is disturbed, the turnover of Pex3p is still observed. Taken together, our data suggest that degradation of Pex3p is part of the initial degradation machinery of individual peroxisomes.	Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, NL-9750 AA Haren, Netherlands	University of Groningen	van der Klei, IJ (corresponding author), Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, POB 14, NL-9750 AA Haren, Netherlands.		van der Klei, Ida J/D-1919-2012	Van der Klei, Ida J./0000-0001-7165-9679				Abeliovich H, 2001, MICROBIOL MOL BIOL R, V65, P463, DOI 10.1128/MMBR.65.3.463-479.2001; Baerends RJS, 2000, J BIOL CHEM, V275, P9986, DOI 10.1074/jbc.275.14.9986; Baerends RJS, 1996, J BIOL CHEM, V271, P8887, DOI 10.1074/jbc.271.15.8887; Baerends RJS, 1997, YEAST, V13, P1449, DOI 10.1002/(SICI)1097-0061(199712)13:15<1449::AID-YEA191>3.0.CO;2-Q; Bellu AR, 2001, FEMS YEAST RES, V1, P23, DOI 10.1111/j.1567-1364.2001.tb00010.x; Bellu AR, 2001, J BIOL CHEM, V276, P44570, DOI 10.1074/jbc.M107599200; BELLU AR, 2002, IN PRESS MICROSC RES; Benharouga M, 2001, J CELL BIOL, V153, P957, DOI 10.1083/jcb.153.5.957; FABER KN, 1994, CURR GENET, V25, P305, DOI 10.1007/BF00351482; GLEESON MA, 1988, YEAST, V4, P293, DOI 10.1002/yea.320040407; Haan GJ, 2002, J BIOL CHEM, V277, P26609, DOI 10.1074/jbc.M108569200; Hicke L, 1999, TRENDS CELL BIOL, V9, P107, DOI 10.1016/S0962-8924(98)01491-3; HOHFELD J, 1991, J CELL BIOL, V114, P1167, DOI 10.1083/jcb.114.6.1167; Kammerer S, 1998, FEBS LETT, V429, P53, DOI 10.1016/S0014-5793(98)00557-2; Kiel JAKW, 1999, YEAST, V15, P741, DOI 10.1002/(SICI)1097-0061(19990630)15:9<741::AID-YEA416>3.0.CO;2-O; Kiel JAKW, 1995, FEBS LETT, V377, P434, DOI 10.1016/0014-5793(95)01385-7; Klionsky DT, 1999, ANNU REV CELL DEV BI, V15, P1, DOI 10.1146/annurev.cellbio.15.1.1; Komori M, 1997, EMBO J, V16, P44, DOI 10.1093/emboj/16.1.44; Komori M, 2000, CELL BIOCHEM BIOPHYS, V32, P283, DOI 10.1385/CBB:32:1-3:283; Kranz A, 2001, MOL BIOL CELL, V12, P711, DOI 10.1091/mbc.12.3.711; Langer T, 2000, TRENDS BIOCHEM SCI, V25, P247, DOI 10.1016/S0968-0004(99)01541-8; Muntau AC, 2000, BIOL CHEM, V381, P337, DOI 10.1515/BC.2000.044; Plemper RK, 1999, TRENDS BIOCHEM SCI, V24, P266, DOI 10.1016/S0968-0004(99)01420-6; Salomons FA, 2000, J BIOL CHEM, V275, P12603, DOI 10.1074/jbc.275.17.12603; Sambrook J., 2002, MOL CLONING LAB MANU; Shimozawa N, 2000, HUM MOL GENET, V9, P1995, DOI 10.1093/hmg/9.13.1995; Skach WR, 2000, KIDNEY INT, V57, P825, DOI 10.1046/j.1523-1755.2000.00921.x; Stromhaug PE, 2001, TRAFFIC, V2, P524, DOI 10.1034/j.1600-0854.2001.20802.x; Subramani S, 1998, PHYSIOL REV, V78, P171, DOI 10.1152/physrev.1998.78.1.171; Suzuki K, 2001, EMBO J, V20, P5971, DOI 10.1093/emboj/20.21.5971; TAN XQ, 1995, J CELL BIOL, V128, P307, DOI 10.1083/jcb.128.3.307; TITORENKO VI, 1995, J BACTERIOL, V177, P357, DOI 10.1128/jb.177.2.357-363.1995; TUTTLE DL, 1995, J CELL SCI, V108, P25; VANDIJKEN JP, 1976, ARCH MICROBIOL, V111, P137; Veenhuis M, 1996, FEBS LETT, V383, P114, DOI 10.1016/0014-5793(96)00220-7; VEENHUIS M, 1983, ARCH MICROBIOL, V134, P193, DOI 10.1007/BF00407757; VEENHUIS M, 1978, ARCH MICROBIOL, V117, P153, DOI 10.1007/BF00402303; Wiemer EAC, 1996, J BIOL CHEM, V271, P18973, DOI 10.1074/jbc.271.31.18973	38	68	70	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					42875	42880		10.1074/jbc.M205437200	http://dx.doi.org/10.1074/jbc.M205437200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12221086	Green Published, hybrid			2022-12-27	WOS:000179081200060
J	Goto, NK; Zor, T; Martinez-Yamout, M; Dyson, HJ; Wright, PE				Goto, NK; Zor, T; Martinez-Yamout, M; Dyson, HJ; Wright, PE			Cooperativity in transcription factor binding to the coactivator CREB-binding protein (CBP) - The mixed lineage leukemia protein (MLL) activation domain binds to an allosteric site on the KIX domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS TYPE-1 PROMOTER; IFN-BETA ENHANCEOSOME; C-MYB; CELL-LINES; DROSOPHILA-TRITHORAX; PHOSPHORYLATED CREB; MAMMALIAN TRITHORAX; SECONDARY STRUCTURE; SWI/SNF COMPLEX; MYELOID GENES	The interactions between cAMP-response element-binding protein (CREB)-binding protein (CBP) and gene-specific transcription factors play an important role in activation of transcription from numerous genes. Cooperative interactions between CBP and multiple transcriptional activators may provide a mechanism for synergistic increases in transcriptional activation. Here we report the characterization of ternary complexes formed by the KIX domain of CBP and the transactivation domain of the trithorax group protein mixed lineage leukemia protein (MLL), together with either the phosphorylated kinase-inducible domain (pKID) of CREB or the activation domain from c-Myb. Isothermal titration calorimetry experiments show that KIX in complex with the MLL activation domain binds the c-Myb activation domain and pKID domain with 2-fold higher affinity than does the KIX domain alone. Thus, the activation domains of Myb and MLL or of pKID and MLL bind cooperatively to KIX. The thermodynamics of these interactions imply different mechanisms of binding cooperativity for the two ternary complexes; the KIX(.)MLL(.)pKID complex is stabilized by entropy increases, whereas the enhancement of Myb binding in the presence of the MLL activation domain is due to more favorable enthalpy. NMR experiments show that the MLL-binding site on KIX is distinct from the surface that binds the pKID and c-Myb activation domains. Our data indicate that KIX can directly mediate cooperative interactions between pairs of transcriptional regulatory proteins. In the case of MLL and c-Myb, both proteins are involved in proliferation of hematopoietie cells and leukemogenesis, and synergistic interactions mediated by CBP may play a functional role.	The Scripps Res Inst, Dept Biol Mol, La Jolla, CA 92037 USA; The Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Dyson, HJ (corresponding author), The Scripps Res Inst, Dept Biol Mol, La Jolla, CA 92037 USA.		Zor, Tsaffrir/H-1802-2013; Goto, Natalie/AAO-7979-2020; Dyson, Jane/D-4160-2011	Zor, Tsaffrir/0000-0002-7224-3939; Goto, Natalie/0000-0003-4877-4884; Dyson, Jane/0000-0001-6855-3398; Wright, Peter/0000-0002-1368-0223	NCI NIH HHS [CA96865] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA096865] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; ANFOSSI G, 1989, P NATL ACAD SCI USA, V86, P3379, DOI 10.1073/pnas.86.9.3379; Ayton PM, 2001, ONCOGENE, V20, P5695, DOI 10.1038/sj.onc.1204639; BONNI A, 1995, MOL CELL NEUROSCI, V6, P168, DOI 10.1006/mcne.1995.1015; BritosBray M, 1997, MOL CELL BIOL, V17, P5127, DOI 10.1128/MCB.17.9.5127; Butler LH, 1997, BLOOD, V89, P3361, DOI 10.1182/blood.V89.9.3361; Caldas C, 1998, ONCOGENE, V16, P3233, DOI 10.1038/sj.onc.1201873; Cardinaux JR, 2000, MOL CELL BIOL, V20, P1546, DOI 10.1128/MCB.20.5.1546-1552.2000; Carey M, 1998, CELL, V92, P5, DOI 10.1016/S0092-8674(00)80893-4; Chen Y, 2000, MOL CELL BIOL, V20, P1616, DOI 10.1128/MCB.20.5.1616-1625.2000; Dai P, 1999, J BIOL CHEM, V274, P8143, DOI 10.1074/jbc.274.12.8143; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Demarest SJ, 2002, NATURE, V415, P549, DOI 10.1038/415549a; Di Cera E., 1995, THERMODYNAMIC THEORY; DJABALI M, 1992, NAT GENET, V2, P113, DOI 10.1038/ng1092-113; Ennas MG, 1997, CANCER RES, V57, P2035; Ernst P, 2001, MOL CELL BIOL, V21, P2249, DOI 10.1128/MCB.21.7.2249-2258.2001; Gachon F, 2000, MOL CELL BIOL, V20, P3470, DOI 10.1128/MCB.20.10.3470-3481.2000; Giebler HA, 2000, MOL CELL BIOL, V20, P4849, DOI 10.1128/MCB.20.13.4849-4858.2000; Giebler HA, 1997, MOL CELL BIOL, V17, P5156, DOI 10.1128/MCB.17.9.5156; GONDA TJ, 1989, EMBO J, V8, P1767, DOI 10.1002/j.1460-2075.1989.tb03570.x; Goodman RH, 2000, GENE DEV, V14, P1553; Graf T, 1992, CURR OPIN GENET DEV, V2, P249, DOI 10.1016/S0959-437X(05)80281-3; Hanson RD, 1999, P NATL ACAD SCI USA, V96, P14372, DOI 10.1073/pnas.96.25.14372; Harrod R, 1998, MOL CELL BIOL, V18, P5052, DOI 10.1128/MCB.18.9.5052; HERNANDEZMUNAIN C, 1994, MOL CELL BIOL, V14, P473, DOI 10.1128/MCB.14.1.473; Horvai AE, 1997, P NATL ACAD SCI USA, V94, P1074, DOI 10.1073/pnas.94.4.1074; Huntsman DG, 1999, ONCOGENE, V18, P7975, DOI 10.1038/sj.onc.1203291; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; Kowenz-Leutz E, 1999, MOL CELL, V4, P735, DOI 10.1016/S1097-2765(00)80384-6; Kwok RPS, 1996, NATURE, V380, P642, DOI 10.1038/380642a0; Lemon B, 2000, GENE DEV, V14, P2551, DOI 10.1101/gad.831000; Magli MC, 1997, J CELL PHYSIOL, V173, P168, DOI 10.1002/(SICI)1097-4652(199711)173:2<168::AID-JCP16>3.0.CO;2-C; Matise MP, 1999, ONCOGENE, V18, P7852, DOI 10.1038/sj.onc.1203243; Merika M, 1998, MOL CELL, V1, P277, DOI 10.1016/S1097-2765(00)80028-3; Mick JE, 2000, AIDS RES HUM RETROV, V16, P1597, DOI 10.1089/08892220050193010; MUCENSKI ML, 1991, CELL, V65, P677, DOI 10.1016/0092-8674(91)90099-K; NESS SA, 1993, GENE DEV, V7, P749, DOI 10.1101/gad.7.5.749; Oh IH, 1999, ONCOGENE, V18, P3017, DOI 10.1038/sj.onc.1202839; Parker D, 1999, MOL CELL BIOL, V19, P5601; Parker D, 1998, MOL CELL, V2, P353, DOI 10.1016/S1097-2765(00)80279-8; PETRIJ F, 1995, NATURE, V376, P348, DOI 10.1038/376348a0; Prasad R, 1995, P NATL ACAD SCI USA, V92, P12160, DOI 10.1073/pnas.92.26.12160; Ptashne M, 1997, NATURE, V386, P569, DOI 10.1038/386569a0; Radhakrishnan I, 1997, CELL, V91, P741, DOI 10.1016/S0092-8674(00)80463-8; Radhakrishnan I, 1999, J MOL BIOL, V287, P859, DOI 10.1006/jmbi.1999.2658; Ramirez S, 1997, J BIOL CHEM, V272, P31016, DOI 10.1074/jbc.272.49.31016; Rozenblatt-Rosen O, 1998, P NATL ACAD SCI USA, V95, P4152, DOI 10.1073/pnas.95.8.4152; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; SHAPIRO LH, 1995, J BIOL CHEM, V270, P8763, DOI 10.1074/jbc.270.15.8763; Shaywitz AJ, 2000, MOL CELL BIOL, V20, P9409, DOI 10.1128/MCB.20.24.9409-9422.2000; Van Orden K, 1999, J BIOL CHEM, V274, P26321, DOI 10.1074/jbc.274.37.26321; Vignali M, 2000, MOL CELL BIOL, V20, P1899, DOI 10.1128/MCB.20.6.1899-1910.2000; WESTIN EH, 1982, P NATL ACAD SCI-BIOL, V79, P2194, DOI 10.1073/pnas.79.7.2194; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; Wu YB, 1996, EMBO J, V15, P3951, DOI 10.1002/j.1460-2075.1996.tb00769.x; Yagi H, 1998, BLOOD, V92, P108, DOI 10.1182/blood.V92.1.108.413k11_108_117; Yie JM, 1999, P NATL ACAD SCI USA, V96, P13108, DOI 10.1073/pnas.96.23.13108; Yu BD, 1998, P NATL ACAD SCI USA, V95, P10632, DOI 10.1073/pnas.95.18.10632; YU BD, 1995, NATURE, V378, P505, DOI 10.1038/378505a0; ZELEZNIKLE NJ, 1994, P NATL ACAD SCI USA, V91, P10610, DOI 10.1073/pnas.91.22.10610; Zhang QH, 2000, MOL CELL BIOL, V20, P4970, DOI 10.1128/MCB.20.14.4970-4978.2000; Zor T, 2002, J BIOL CHEM, V277, P42241, DOI 10.1074/jbc.M207361200	65	136	137	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					43168	43174		10.1074/jbc.M207660200	http://dx.doi.org/10.1074/jbc.M207660200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12205094	Green Submitted, hybrid			2022-12-27	WOS:000179081200098
J	Lee, HC; Bernstein, HD				Lee, HC; Bernstein, HD			Trigger factor retards protein export in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL RECOGNITION PARTICLE; INNER MEMBRANE-PROTEINS; NASCENT CHAINS; SELECTIVE BINDING; BACTERIAL PROTEIN; CHAPERONE SECB; SRP; TRANSLOCATION; DNAK; SPECIFICITY	Trigger factor (TF) is a ribosome-associated protein that interacts with a wide variety of nascent polypeptides in Escherichia coli. Previous studies have indicated that TF cooperates with DnaK to facilitate protein folding, but the basis of this cooperation is unclear. In this study we monitored protein export in E. coli that lack or overproduce TF to obtain further insights into its function. Whereas inactivation of genes encoding most molecular chaperones (including dnaK) impairs protein export, inactivation of the TF gene accelerated protein export and suppressed the need for targeting factors to maintain the translocation competence of pre-secretory proteins. Furthermore, overproduction of TF (but not DnaK) markedly retarded protein export. Manipulation of TF levels produced similar effects on the export of a cytosolic enzyme fused to a signal peptide. The data strongly suggest that TF has a unique ability to sequester nascent polypeptides for a relatively prolonged period. Based on our results, we propose that TF and DnaK promote protein folding by distinct (but complementary) mechanisms.	NIDDK, Genet & Biochem Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Bernstein, HD (corresponding author), NIDDK, Genet & Biochem Branch, NIH, Bldg 10,Rm 9D-20, Bethesda, MD 20892 USA.							Beck K, 2000, EMBO J, V19, P134, DOI 10.1093/emboj/19.1.134; BERNSTEIN HD, 1989, CELL, V58, P1017, DOI 10.1016/0092-8674(89)90497-2; BOCHKAREVA ES, 1988, NATURE, V336, P254, DOI 10.1038/336254a0; BUCHBERGER A, 1994, EMBO J, V13, P1687, DOI 10.1002/j.1460-2075.1994.tb06433.x; CROOKE E, 1988, CELL, V54, P1003, DOI 10.1016/0092-8674(88)90115-8; de Gier JW, 2001, MOL MICROBIOL, V40, P314, DOI 10.1046/j.1365-2958.2001.02392.x; Deuerling E, 1999, NATURE, V400, P693, DOI 10.1038/23301; FREUDL R, 1986, J BIOL CHEM, V261, P1355; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; GOLDSTEIN J, 1991, J BIOL CHEM, V266, P14413; GUTHRIE B, 1990, J BACTERIOL, V172, P5555, DOI 10.1128/jb.172.10.5555-5562.1990; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; HARDY SJS, 1991, SCIENCE, V251, P439, DOI 10.1126/science.1989077; Hesterkamp T, 1996, P NATL ACAD SCI USA, V93, P4437, DOI 10.1073/pnas.93.9.4437; Izard JW, 1996, J BIOL CHEM, V271, P21579, DOI 10.1074/jbc.271.35.21579; Knoblauch NTM, 1999, J BIOL CHEM, V274, P34219, DOI 10.1074/jbc.274.48.34219; KUMAMOTO CA, 1985, J BACTERIOL, V163, P267, DOI 10.1128/JB.163.1.267-274.1985; KUMAMOTO CA, 1993, J BACTERIOL, V175, P2184, DOI 10.1128/JB.175.8.2184-2188.1993; KUSUKAWA N, 1989, EMBO J, V8, P3517, DOI 10.1002/j.1460-2075.1989.tb08517.x; LEE CA, 1986, J BACTERIOL, V166, P878, DOI 10.1128/jb.166.3.878-883.1986; Lee HC, 2001, P NATL ACAD SCI USA, V98, P3471, DOI 10.1073/pnas.051484198; LILL R, 1988, CELL, V54, P1013, DOI 10.1016/0092-8674(88)90116-X; Maier R, 2001, J MOL BIOL, V314, P1181, DOI 10.1006/jmbi.2000.5192; MILLER JD, 1994, NATURE, V367, P657, DOI 10.1038/367657a0; Neumann-Haefelin C, 2000, EMBO J, V19, P6419, DOI 10.1093/emboj/19.23.6419; Newitt JA, 1998, J BIOL CHEM, V273, P12451, DOI 10.1074/jbc.273.20.12451; OLIVER DB, 1990, P NATL ACAD SCI USA, V87, P8227, DOI 10.1073/pnas.87.21.8227; Patzelt H, 2001, P NATL ACAD SCI USA, V98, P14244, DOI 10.1073/pnas.261432298; POGLIANO KJ, 1993, GENETICS, V133, P763; PORITZ MA, 1990, SCIENCE, V250, P1111, DOI 10.1126/science.1701272; Prinz WA, 1996, EMBO J, V15, P5209, DOI 10.1002/j.1460-2075.1996.tb00906.x; Scholz C, 1997, EMBO J, V16, P54, DOI 10.1093/emboj/16.1.54; SIEGEL V, 1985, J CELL BIOL, V100, P1913, DOI 10.1083/jcb.100.6.1913; STOLLER G, 1995, EMBO J, V14, P4939, DOI 10.1002/j.1460-2075.1995.tb00177.x; Teter SA, 1999, CELL, V97, P755, DOI 10.1016/S0092-8674(00)80787-4; Tradler T, 1997, FEBS LETT, V407, P184, DOI 10.1016/S0014-5793(97)00345-1; Ulbrandt ND, 1997, CELL, V88, P187, DOI 10.1016/S0092-8674(00)81839-5; VALENT QA, 1995, EMBO J, V14, P5494, DOI 10.1002/j.1460-2075.1995.tb00236.x; Valent QA, 1998, EMBO J, V17, P2504, DOI 10.1093/emboj/17.9.2504; WANG S, 1995, J CELL BIOL, V130, P519, DOI 10.1083/jcb.130.3.519; Wild J, 1996, J BACTERIOL, V178, P3608, DOI 10.1128/jb.178.12.3608-3613.1996; WILD J, 1992, GENE DEV, V6, P1165, DOI 10.1101/gad.6.7.1165; Xu ZH, 2000, NAT STRUCT BIOL, V7, P1172, DOI 10.1038/82040	43	67	79	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					43527	43535		10.1074/jbc.M205950200	http://dx.doi.org/10.1074/jbc.M205950200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12205085	hybrid			2022-12-27	WOS:000179081200138
J	Paavilainen, VO; Merckel, MC; Falck, S; Ojala, PJ; Pohl, E; Wilmanns, M; Lappalainen, P				Paavilainen, VO; Merckel, MC; Falck, S; Ojala, PJ; Pohl, E; Wilmanns, M; Lappalainen, P			Structural conservation between the actin monomer-binding sites of twinfilin and actin-depolymerizing factor (ADF)/Cofilin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							F-ACTIN; ADP-ACTIN; CRYSTAL-STRUCTURE; PLASMA GELSOLIN; PROTEIN; COFILIN; YEAST; ACTOPHORIN; DYNAMICS; COMPLEX	Twinfilin is an evolutionarily conserved actin monomer-binding protein that regulates cytoskeletal dynamics in organisms from yeast to mammals. It is composed of two actin-depolymerization factor homology (ADF-H) domains that show similar to20% sequence identity to ADF/cofilin proteins. In contrast to ADF/cofilins, which bind both G-actin and F-actin and promote filament depolymerization, twinfilin interacts only with G-actin. To elucidate the molecular mechanisms of twinfilin-actin monomer interaction, we determined the crystal structure of the N-terminal ADF-H domain of twinfilin and mapped its actin-binding site by site-directed mutagenesis. This domain has similar overall structure to ADF/cofilins, and the regions important for actin monomer binding in ADF/cofilins are especially well conserved in twinfilin. Mutagenesis studies show that the N-terminal ADF-H domain of twinfilin and ADF/cofilins also interact with actin monomers through similar interfaces, although the binding surface is slightly extended in twinfilin. In contrast, the regions important for actin-filament interactions in ADF/cofilins are structurally different in twinfilin. This explains the differences in actin-interactions (monomer versus filament binding) between twinfilin and ADF/cofilins. Taken together, our data show that the ADF-H domain is a structurally conserved actin-binding motif and that relatively small structural differences at the actin interfaces of this domain are responsible for the functional variation between the different classes of ADF-H domain proteins.	Univ Helsinki, Program Cellular Biotechnol, Helsinki 00014, Finland; Univ Helsinki, Program Struct Biol & Biophys, Inst Biotechnol, Helsinki 00014, Finland; European Mol Biol Lab, EMBL Hamburg Outstn, D-22603 Hamburg, Germany	University of Helsinki; University of Helsinki; European Molecular Biology Laboratory (EMBL)	Lappalainen, P (corresponding author), Univ Helsinki, Program Cellular Biotechnol, POB 56, Helsinki 00014, Finland.	pekka.lappalainen@helsinki.fi	Pohl, Ehmke/I-2408-2012; Paavilainen, Ville/I-9131-2019	Pohl, Ehmke/0000-0002-9949-4471; Paavilainen, Ville/0000-0002-3160-7767; Lappalainen, Pekka/0000-0001-6227-0354; Wilmanns, Matthias/0000-0002-4643-5435				Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Blanchoin L, 2000, J MOL BIOL, V295, P203, DOI 10.1006/jmbi.1999.3336; Bowman GD, 2000, PROTEINS, V41, P374, DOI 10.1002/1097-0134(20001115)41:3<374::AID-PROT90>3.0.CO;2-F; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burtnick LD, 1997, CELL, V90, P661, DOI 10.1016/S0092-8674(00)80527-9; Carlier MF, 1999, J BIOL CHEM, V274, P33827, DOI 10.1074/jbc.274.48.33827; Carlier MF, 1997, J CELL BIOL, V136, P1307, DOI 10.1083/jcb.136.6.1307; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DETMERS P, 1981, J BIOL CHEM, V256, P99; Fedorov AA, 1997, NAT STRUCT BIOL, V4, P366, DOI 10.1038/nsb0597-366; Galkin VE, 2001, J CELL BIOL, V153, P75, DOI 10.1083/jcb.153.1.75; Goode BL, 1998, J CELL BIOL, V142, P723, DOI 10.1083/jcb.142.3.723; Goode BL, 2001, J CELL BIOL, V153, P627, DOI 10.1083/jcb.153.3.627; Guan JQ, 2002, BIOCHEMISTRY-US, V41, P5765, DOI 10.1021/bi0121104; Hatanaka H, 1996, CELL, V85, P1047, DOI 10.1016/S0092-8674(00)81305-7; Hayashi K, 1999, J NEUROSCI, V19, P3918; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Jiang CJ, 1997, P NATL ACAD SCI USA, V94, P9973, DOI 10.1073/pnas.94.18.9973; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kessels MM, 2001, J CELL BIOL, V153, P351, DOI 10.1083/jcb.153.2.351; Lappalainen P, 1998, MOL BIOL CELL, V9, P1951, DOI 10.1091/mbc.9.8.1951; Lappalainen P, 1997, EMBO J, V16, P5520, DOI 10.1093/emboj/16.18.5520; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leonard SA, 1997, NAT STRUCT BIOL, V4, P369, DOI 10.1038/nsb0597-369; MACIVER SK, 1994, FEBS LETT, V347, P251, DOI 10.1016/0014-5793(94)00552-4; MCLAUGHLIN PJ, 1993, NATURE, V364, P685, DOI 10.1038/364685a0; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Ojala PJ, 2002, MOL BIOL CELL, V13, P3811, DOI 10.1091/mbc.E02-03-0157; Ojala PJ, 2001, BIOCHEMISTRY-US, V40, P15562, DOI 10.1021/bi0117697; Ono S, 1999, J CELL BIOL, V145, P491, DOI 10.1083/jcb.145.3.491; Ono S, 2001, J BIOL CHEM, V276, P5952, DOI 10.1074/jbc.M007563200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palmgren S, 2002, J CELL SCI, V115, P881; Palmgren S, 2001, J CELL BIOL, V155, P251, DOI 10.1083/jcb.200106157; Peranen J, 1996, ANAL BIOCHEM, V236, P371, DOI 10.1006/abio.1996.0187; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; POLLARD TD, 1986, J CELL BIOL, V103, P2747, DOI 10.1083/jcb.103.6.2747; Sheldrick GM, 1997, METHOD ENZYMOL, V276, P628, DOI 10.1016/S0076-6879(97)76083-X; SILFHOUT RG, 1995, REV SCI INSTRUM, V66, P1818; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Van Troys M, 2000, BIOCHEMISTRY-US, V39, P12181, DOI 10.1021/bi000816c; Vartiainen M, 2000, MOL CELL BIOL, V20, P1772, DOI 10.1128/MCB.20.5.1772-1783.2000; Wahlstrom G, 2001, J CELL BIOL, V155, P787, DOI 10.1083/jcb.200108022; WEEDS AG, 1986, EUR J BIOCHEM, V161, P77, DOI 10.1111/j.1432-1033.1986.tb10126.x; Wriggers W, 1998, J MOL BIOL, V282, P921, DOI 10.1006/jmbi.1998.2048	47	39	42	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					43089	43095		10.1074/jbc.M208225200	http://dx.doi.org/10.1074/jbc.M208225200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12207032	hybrid			2022-12-27	WOS:000179081200087
J	Hoque, MT; Ishikawa, F				Hoque, MT; Ishikawa, F			Cohesin defects lead to premature sister chromatid separation, kinetochore dysfunction, and spindle-assembly checkpoint activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; ANAPHASE ONSET; YEAST COHESIN; REPLICATION; PROTEIN; PROTEOLYSIS; CENTROMERES; ATTACHMENT; MITOSIS; CELLS	Scc1/Mcd1 is a component of the cohesin complex that plays an essential role in sister chromatid cohesion in eukaryote cells. Knockout experiments of this gene have been described in budding yeast, fission yeast, and chicken cells, but no study has been reported on human Scc1 thus far. In this study, we found that an N-terminally truncated human Scc1 shows a dominant-negative effect, and we examined the phenotypes of human cells defective in Scc1 function. Scc1 defects led to failure of sister chromatid cohesion in both interphase and mitotic cells. Interestingly, four chromatids derived from two homologues occupied four distinct territories in the nucleus in chromosome painting experiments. In mitotic Scc1-defective cells, chromatids were disjoined with normal condensation, and the spindle-assembly checkpoint was activated. We also found that, although the disjoined kinetochore (half-kinetochore) in Scc1-defective cells contains CENP-A, -B, -C, and -E normally, it apparently does not establish the kinetochore-microtubule association. These results indicate that Scc1 is essential for the association of kinetochores with microtubules.	Kyoto Univ, Grad Sch Biostudies, Dept Gene Mech, Lab Cell Cycle Regulat,Sakyo Ku, Kyoto 6068502, Japan	Kyoto University	Ishikawa, F (corresponding author), Kyoto Univ, Grad Sch Biostudies, Dept Gene Mech, Lab Cell Cycle Regulat,Sakyo Ku, Kitashirakawa Oiwake Cho, Kyoto 6068502, Japan.		Ishikawa, Fuyuki/AAU-4056-2021	Ishikawa, Fuyuki/0000-0002-5580-2305				COOK PR, 1991, CELL, V66, P627, DOI 10.1016/0092-8674(91)90109-C; Darzynkiewicz Z, 1999, EXP CELL RES, V249, P1, DOI 10.1006/excr.1999.4477; Gorbsky GJ, 1998, J CELL BIOL, V141, P1193, DOI 10.1083/jcb.141.5.1193; GORBSKY GJ, 1993, J CELL BIOL, V122, P1311, DOI 10.1083/jcb.122.6.1311; Guacci V, 1997, CELL, V91, P47, DOI 10.1016/S0092-8674(01)80008-8; Hauf S, 2001, SCIENCE, V293, P1320, DOI 10.1126/science.1061376; HOLLOWAY SL, 1993, CELL, V73, P1393, DOI 10.1016/0092-8674(93)90364-V; Hoque MT, 2001, J BIOL CHEM, V276, P5059, DOI 10.1074/jbc.M007809200; Ishimi Y, 1998, J BIOL CHEM, V273, P8369, DOI 10.1074/jbc.273.14.8369; KING RW, 1995, CELL, V81, P279, DOI 10.1016/0092-8674(95)90338-0; KITAMURA T, 1995, P NATL ACAD SCI USA, V92, P9146, DOI 10.1073/pnas.92.20.9146; LICHTER P, 1988, P NATL ACAD SCI USA, V85, P9664, DOI 10.1073/pnas.85.24.9664; Losada A, 1998, GENE DEV, V12, P1986, DOI 10.1101/gad.12.13.1986; Maney T, 2000, INT REV CYTOL, V194, P67; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; Nasmyth K, 2001, ANNU REV GENET, V35, P673, DOI 10.1146/annurev.genet.35.102401.091334; NICKLAS RB, 1995, J CELL BIOL, V130, P929, DOI 10.1083/jcb.130.4.929; Nogami M, 2000, CHROMOSOMA, V108, P514, DOI 10.1007/s004120050403; PLUTA AF, 1995, SCIENCE, V270, P1591, DOI 10.1126/science.270.5242.1591; Postow L, 1999, BIOESSAYS, V21, P805, DOI 10.1002/(SICI)1521-1878(199910)21:10<805::AID-BIES1>3.0.CO;2-7; RIEDER CL, 1994, J CELL BIOL, V127, P1301, DOI 10.1083/jcb.127.5.1301; Rieder CL, 1998, TRENDS CELL BIOL, V8, P310, DOI 10.1016/S0962-8924(98)01299-9; Shimura M, 1999, FASEB J, V13, P621, DOI 10.1096/fasebj.13.6.621; Sonoda E, 2001, DEV CELL, V1, P759, DOI 10.1016/S1534-5807(01)00088-0; Sumara I, 2002, MOL CELL, V9, P515, DOI 10.1016/S1097-2765(02)00473-2; Tanaka TU, 2000, NAT CELL BIOL, V2, P492, DOI 10.1038/35019529; Tatebayashi K, 1998, GENETICS, V148, P49; Tomonaga T, 2000, GENE DEV, V14, P2757, DOI 10.1101/gad.832000; Toyoda Y, 2002, CURR BIOL, V12, P347, DOI 10.1016/S0960-9822(02)00692-9; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831; Waters JC, 1998, J CELL BIOL, V141, P1181, DOI 10.1083/jcb.141.5.1181; WINEY M, 1995, J CELL BIOL, V129, P1601, DOI 10.1083/jcb.129.6.1601; Wood KW, 1997, CELL, V91, P357, DOI 10.1016/S0092-8674(00)80419-5	36	56	58	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					42306	42314		10.1074/jbc.M206836200	http://dx.doi.org/10.1074/jbc.M206836200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12200439	hybrid			2022-12-27	WOS:000178985300126
J	Huang, LE; Pete, EA; Schau, M; Milligan, J; Gu, J				Huang, LE; Pete, EA; Schau, M; Milligan, J; Gu, J			Leu-574 of HIF-1 alpha is essential for the von Hippel-Lindau (VHL)-mediated degradation pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR PROTEIN; INDUCIBLE FACTOR 1-ALPHA; UBIQUITIN-PROTEASOME PATHWAY; ARNT TRANSCRIPTION FACTOR; PROLYL HYDROXYLATION; PROLINE HYDROXYLATION; SIGNAL-TRANSDUCTION; BINDING-PROTEIN; ALPHA-SUBUNIT; HIF-ALPHA	Oxygen homeostasis is crucial for a myriad of developmental, physiological, and pathophysiological processes. Hypoxia-inducible factor 1alpha (HIF-1alpha) plays a pivotal role in response to hypoxia by transcriptionally activating target genes involving oxygen uptake, transport, delivery, and consumption. HIF-1alpha activity is regulated primarily through the ubiquitin-proteasome degradation pathway, which targets the oxygen-dependent degradation domain (ODD) of HIF-1alpha. In particular, the von Hippel-Lindau (VHL) protein complex, an E3 ubiquitin ligase, binds to the ODD upon hydroxylation of HIF-1alpha Pro-564. Here, we show that in vivo VHL interacts with the N-terminal as well as the C-terminal ODD independently, supporting the notion of functional redundancy within the ODD. Moreover, we demonstrate that Leu-574 of HIF-1alpha is essential for VHL binding to the C-terminal ODD. Despite the presence of Pro-564, deletion or mutation of Leu-574 resulted in a loss of VHL binding and a gain of protein stability. Furthermore, the identification of Leu-574 redefines the N-terminal activation domain of HIF-1alpha to be constitutively active. Taken together, this study provides new insight into the mechanisms underlying VHL-mediated HIF-1alpha degradation and transcriptional activation, and a molecular basis for drug targeting.	NCI, Human Carcinogenesis Lab, NIH, Bethesda, MD 20892 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Hematol, Boston, MA 02115 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Brigham & Women's Hospital; Harvard Medical School	Huang, LE (corresponding author), NCI, Human Carcinogenesis Lab, NIH, Bethesda, MD 20892 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK041234] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK41234] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Arany Z, 1996, P NATL ACAD SCI USA, V93, P12969, DOI 10.1073/pnas.93.23.12969; Bhattacharya S, 1999, GENE DEV, V13, P64, DOI 10.1101/gad.13.1.64; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Bunn HF, 1996, PHYSIOL REV, V76, P839, DOI 10.1152/physrev.1996.76.3.839; Carrero P, 2000, MOL CELL BIOL, V20, P402, DOI 10.1128/MCB.20.1.402-415.2000; Cockman ME, 2000, J BIOL CHEM, V275, P25733, DOI 10.1074/jbc.M002740200; Dames SA, 2002, P NATL ACAD SCI USA, V99, P5271, DOI 10.1073/pnas.082121399; DUAN DR, 1995, SCIENCE, V269, P1402, DOI 10.1126/science.7660122; Elson DA, 2001, GENE DEV, V15, P2520, DOI 10.1101/gad.914801; Ema M, 1999, EMBO J, V18, P1905, DOI 10.1093/emboj/18.7.1905; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Freedman SJ, 2002, P NATL ACAD SCI USA, V99, P5367, DOI 10.1073/pnas.082117899; Gradin K, 1996, MOL CELL BIOL, V16, P5221; Gu J, 2001, J BIOL CHEM, V276, P3550, DOI 10.1074/jbc.M009522200; Hewitson KS, 2002, J BIOL CHEM, V277, P26351, DOI 10.1074/jbc.C200273200; Hon WC, 2002, NATURE, V417, P975, DOI 10.1038/nature00767; Huang LE, 1996, J BIOL CHEM, V271, P32253, DOI 10.1074/jbc.271.50.32253; Huang LE, 1999, J BIOL CHEM, V274, P9038, DOI 10.1074/jbc.274.13.9038; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Isaacs JS, 2002, J BIOL CHEM, V277, P29936, DOI 10.1074/jbc.M204733200; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jiang BH, 1997, J BIOL CHEM, V272, P19253, DOI 10.1074/jbc.272.31.19253; Kaelin WG, 1998, TRENDS GENET, V14, P423, DOI 10.1016/S0168-9525(98)01558-3; Kallio PJ, 1997, P NATL ACAD SCI USA, V94, P5667, DOI 10.1073/pnas.94.11.5667; Kallio PJ, 1998, EMBO J, V17, P6573, DOI 10.1093/emboj/17.22.6573; Kallio PJ, 1999, J BIOL CHEM, V274, P6519, DOI 10.1074/jbc.274.10.6519; Kamura T, 2000, P NATL ACAD SCI USA, V97, P10430, DOI 10.1073/pnas.190332597; Kamura T, 1999, SCIENCE, V284, P657, DOI 10.1126/science.284.5414.657; KIBEL A, 1995, SCIENCE, V269, P1444, DOI 10.1126/science.7660130; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Lando D, 2002, SCIENCE, V295, P858, DOI 10.1126/science.1068592; Mabjeesh NJ, 2002, CANCER RES, V62, P2478; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; Masson N, 2001, EMBO J, V20, P5197, DOI 10.1093/emboj/20.18.5197; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Min JH, 2002, SCIENCE, V296, P1886, DOI 10.1126/science.1073440; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Ohta T, 1999, MOL CELL, V3, P535, DOI 10.1016/S1097-2765(00)80482-7; Pause A, 1997, P NATL ACAD SCI USA, V94, P2156, DOI 10.1073/pnas.94.6.2156; Pugh CW, 1997, J BIOL CHEM, V272, P11205; Ravi R, 2000, GENE DEV, V14, P34; Semenza GL, 2000, GENE DEV, V14, P1983; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; Semenza GL, 2002, TRENDS MOL MED, V8, pS62, DOI 10.1016/S1471-4914(02)02317-1; Stebbins CE, 1999, SCIENCE, V284, P455, DOI 10.1126/science.284.5413.455; Tan PL, 1999, MOL CELL, V3, P527, DOI 10.1016/S1097-2765(00)80481-5; Tanimoto K, 2000, EMBO J, V19, P4298, DOI 10.1093/emboj/19.16.4298; WANG GL, 1995, J BIOL CHEM, V270, P1230, DOI 10.1074/jbc.270.3.1230; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wenger RH, 2000, J EXP BIOL, V203, P1253; Wood SM, 1996, J BIOL CHEM, V271, P15117, DOI 10.1074/jbc.271.25.15117; Yu F, 2001, P NATL ACAD SCI USA, V98, P9630, DOI 10.1073/pnas.181341498	53	36	43	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					41750	41755		10.1074/jbc.M207280200	http://dx.doi.org/10.1074/jbc.M207280200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12205091	hybrid			2022-12-27	WOS:000178985300058
J	Lee, JH; Skalnik, DG				Lee, JH; Skalnik, DG			CpG-binding protein is a nuclear matrix- and euchromatin-associated protein localized to nuclear speckles containing human trithorax - Identification of nuclear matrix targeting signals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA METHYLTRANSFERASE GENE; HUMAN ACUTE LEUKEMIAS; DROSOPHILA-TRITHORAX; SWI/SNF COMPLEX; AMINO-TERMINUS; MOUSE EMBRYO; CXXC DOMAIN; PHD FINGER; METHYLATION; CHROMATIN	CpG-binding protein (CGBP) binds unmethylated CpG dinucleotides and is essential for mammalian development. CGBP exhibits a punctate nuclear localization correlated with 4,6-diamidino-2-phenylindole light regions and is excluded from metaphase chromosomes. The distribution of CGBP is distinct from the heterochromatin-associated proteins MBD1, methyl-CpG-binding protein 2, and HP1alpha. Some CGBP-containing nuclear speckles co-localize with splicing factor SC-35 and actively transcribed regions of the genome, whereas most CGBP co-localizes with acetylated histones, indicating that CGBP is localized to active chromatin. CGBP contains two nuclear localization signals that are insufficient to direct punctate subnuclear distribution. Instead, localization of CGBP to nuclear speckles requires signals within the acidic, basic, and coiled-coil domains. CGBP associates with the nuclear matrix, and fragments of CGBP that fail to associate with the nuclear matrix fail to localize to nuclear speckles and exhibit reduced transcriptional activation activity. Mutated versions of CGBP that lack DNA binding activity exhibit a normal nuclear distribution, suggesting that CGBP accumulates at nuclear speckles as a result of protein/ protein interactions. Importantly, the subcellular distribution of CGBP is identical to human trithorax, suggesting that these proteins may be components of a multimeric complex analogous to the histone-methylating Set1 complex of Saccharomyces cerevisiae that contains CGBP and trithorax homologues.	Indiana Univ, Sch Med, Herman B Wells Ctr Pediat Res, Dept Pediat,Sect Pediat Hematol Oncol, Indianapolis, IN 46202 USA; Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis	Skalnik, DG (corresponding author), Indiana Univ, Sch Med, Herman B Wells Ctr Pediat Res, Dept Pediat,Sect Pediat Hematol Oncol, Canc Res Bldg,Rm 472,1044 W Walnut St, Indianapolis, IN 46202 USA.				NATIONAL CANCER INSTITUTE [R29CA058947, R01CA058947] Funding Source: NIH RePORTER; NCI NIH HHS [CA58947] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AASLAND R, 1995, TRENDS BIOCHEM SCI, V20, P56, DOI 10.1016/S0968-0004(00)88957-4; Adler HT, 1999, MOL CELL BIOL, V19, P7050; Adler HT, 1997, J BIOL CHEM, V272, P28407, DOI 10.1074/jbc.272.45.28407; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Bachman KE, 2001, J BIOL CHEM, V276, P32282, DOI 10.1074/jbc.M104661200; Baylin SB, 2000, TRENDS GENET, V16, P168, DOI 10.1016/S0168-9525(99)01971-X; Berube NG, 2000, HUM MOL GENET, V9, P539, DOI 10.1093/hmg/9.4.539; Biniszkiewicz D, 2002, MOL CELL BIOL, V22, P2124, DOI 10.1128/MCB.22.7.2124-2135.2002; BIRD AP, 1987, TRENDS GENET, V3, P342, DOI 10.1016/0168-9525(87)90294-0; Birke M, 2002, NUCLEIC ACIDS RES, V30, P958, DOI 10.1093/nar/30.4.958; Butler LH, 1997, BLOOD, V89, P3361, DOI 10.1182/blood.V89.9.3361; Carlone DL, 2001, MOL CELL BIOL, V21, P7601, DOI 10.1128/MCB.21.22.7601-7606.2001; Caslini C, 2000, LEUKEMIA, V14, P1898, DOI 10.1038/sj.leu.2401933; Caslini C, 2000, P NATL ACAD SCI USA, V97, P2797, DOI 10.1073/pnas.040574897; CHEN C, 1987, MOL CELL BIOL, V7, P274; Cobb BS, 2000, GENE DEV, V14, P2146, DOI 10.1101/gad.816400; Cross SH, 1997, NAT GENET, V16, P256, DOI 10.1038/ng0797-256; Ernst P, 2001, MOL CELL BIOL, V21, P2249, DOI 10.1128/MCB.21.7.2249-2258.2001; Fair K, 2001, MOL CELL BIOL, V21, P3589, DOI 10.1128/MCB.21.10.3589-3597.2001; Fujino T, 2000, BIOCHEM BIOPH RES CO, V271, P305, DOI 10.1006/bbrc.2000.2614; Fujita N, 1999, MOL CELL BIOL, V19, P6415; Gordon JA, 2000, J CELL BIOCHEM, V77, P30, DOI 10.1002/(SICI)1097-4644(20000401)77:1<30::AID-JCB4>3.3.CO;2-B; GU Y, 1992, CELL, V71, P701, DOI 10.1016/0092-8674(92)90603-A; Hendrich B, 1998, MOL CELL BIOL, V18, P6538, DOI 10.1128/MCB.18.11.6538; Huntsman DG, 1999, ONCOGENE, V18, P7975, DOI 10.1038/sj.onc.1203291; Jans DA, 1996, PHYSIOL REV, V76, P651, DOI 10.1152/physrev.1996.76.3.651; KAFRI T, 1992, GENE DEV, V6, P705, DOI 10.1101/gad.6.5.705; Kalkhoven E, 2002, MOL CELL BIOL, V22, P1961, DOI 10.1128/MCB.22.7.1961-1970.2002; Katsani KR, 2001, GENE DEV, V15, P2197, DOI 10.1101/gad.201901; Krogan NJ, 2002, J BIOL CHEM, V277, P10753, DOI 10.1074/jbc.C200023200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee JH, 2001, J BIOL CHEM, V276, P44669, DOI 10.1074/jbc.M107179200; Lee JH, 2000, MOL BRAIN RES, V80, P88, DOI 10.1016/S0169-328X(00)00129-7; Leshkowitz D, 1996, ONCOGENE, V13, P2027; LEWIS JD, 1992, CELL, V69, P905, DOI 10.1016/0092-8674(92)90610-O; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Miller T, 2001, P NATL ACAD SCI USA, V98, P12902, DOI 10.1073/pnas.231473398; MONK M, 1987, DEVELOPMENT, V99, P371; Murzina N, 1999, MOL CELL, V4, P529, DOI 10.1016/S1097-2765(00)80204-X; Nagy PL, 2002, P NATL ACAD SCI USA, V99, P90, DOI 10.1073/pnas.221596698; Ng HH, 1999, NAT GENET, V23, P58, DOI 10.1038/12659; Nislow C, 1997, MOL BIOL CELL, V8, P2421, DOI 10.1091/mbc.8.12.2421; O'Connell S, 2001, J BIOL CHEM, V276, P43065, DOI 10.1074/jbc.M104294200; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; RAZIN A, 1995, HUM MOL GENET, V4, P1751, DOI 10.1093/hmg/4.suppl_1.1751; Reyes JC, 1997, J CELL BIOL, V137, P263, DOI 10.1083/jcb.137.2.263; Roguev A, 2001, EMBO J, V20, P7137, DOI 10.1093/emboj/20.24.7137; Rozenblatt-Rosen O, 1998, P NATL ACAD SCI USA, V95, P4152, DOI 10.1073/pnas.95.8.4152; Schramke V, 2001, GENE DEV, V15, P1845, DOI 10.1101/gad.193901; Schultz DC, 2001, GENE DEV, V15, P428, DOI 10.1101/gad.869501; Strahl BD, 1999, P NATL ACAD SCI USA, V96, P14967, DOI 10.1073/pnas.96.26.14967; TKACHUK DC, 1992, CELL, V71, P691, DOI 10.1016/0092-8674(92)90602-9; Voo KS, 2000, MOL CELL BIOL, V20, P2108; Wade PA, 1999, NAT GENET, V23, P62, DOI 10.1038/12664; Xu GL, 1999, NATURE, V402, P187, DOI 10.1038/46052; Yano T, 1997, P NATL ACAD SCI USA, V94, P7286, DOI 10.1073/pnas.94.14.7286; ZENG CQ, 1994, CELL MOTIL CYTOSKEL, V29, P167, DOI 10.1002/cm.970290208; Zhang SS, 1999, J CELL SCI, V112, P2693	58	38	39	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					42259	42267		10.1074/jbc.M205054200	http://dx.doi.org/10.1074/jbc.M205054200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12200428	hybrid			2022-12-27	WOS:000178985300121
J	Takao, M; Kanno, S; Kobayashi, K; Zhang, QM; Yonei, S; van der Horst, GTJ; Yasui, A				Takao, M; Kanno, S; Kobayashi, K; Zhang, QM; Yonei, S; van der Horst, GTJ; Yasui, A			A back-up glycosylase in Nth1 knock-out mice is a functional Nei (endonuclease VIII) homologue	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN DNA GLYCOSYLASE; BASE EXCISION-REPAIR; ESCHERICHIA-COLI; IDENTIFICATION; 8-OXOGUANINE; DAMAGE; FPG; NUCLEAR; PROTEIN; CLONING	Thymine glycol, a potentially lethal DNA lesion produced by reactive oxygen species, can be removed by DNA glycosylase, Escherichia coli Nth (endonuclease III), or its mammalian homologue NTH1. We have found previously that mice deleted in the Nth homologue still retain at least two residual glycosylase activities for thymine glycol. We report herein that in cell extracts from the mNth1 knock-out mouse there is a third thymine glycol glycosylase activity that is encoded by one of three mammalian proteins with sequence similarity to E. coli Fpg (MutM) and Nei (endonuclease VIII). Tissue expression of this mouse Nei-like (designated as Neil1) gene is ubiquitous but much lower than that of mNth1 except in heart, spleen, and skeletal muscle. Recombinant NEIL1 can remove thymine glycol and 5-hydroxyuracil in double- and single-stranded DNA much more efficiently than 8-oxoguanine and can nick the strand by an associated (beta-delta) apurinic/apyrimidinic lyase activity. In addition, the mouse NEIL1 has a unique DNA glycosylase/lyase activity toward mismatched uracil and thymine, especially in U:C and T:C mismatches. These results suggest that NEIL1 is a back-up glycosylase for NTH1 with unique substrate specificity and tissue-specific expression.	Tohoku Univ, Inst Dev Aging & Canc, Dept Mol Genet, Sendai, Miyagi 9808575, Japan; Kyoto Univ, Grad Sch Sci, Dept Chem, Kyoto 6068502, Japan; Kyoto Univ, Grad Sch Sci, Radiat Biol Lab, Kyoto 6068502, Japan; Erasmus Univ, Ctr Med Genet, Dept Cell Biol & Genet, NL-3000 DR Rotterdam, Netherlands	Tohoku University; Kyoto University; Kyoto University; Erasmus University Rotterdam	Takao, M (corresponding author), Tohoku Univ, Inst Dev Aging & Canc, Dept Mol Genet, Sendai, Miyagi 9808575, Japan.	mtakao@idac.tohoku.ac.jp; ayasui@didac.tohoku.ac.jp	van der Horst, Gijsbertus TJ/E-3661-2015; Kanno, Shin-ichiro/AAE-4549-2019; Hoeijmakers, Jan/AAX-6972-2021	van der Horst, Gijsbertus TJ/0000-0002-7773-6396; Kobayashi-Nakamura, Kumiko/0000-0001-5579-3464				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; AMES BN, 1992, ANN NY ACAD SCI, V663, P85, DOI 10.1111/j.1749-6632.1992.tb38652.x; AMES BN, 1989, MUTAT RES, V214, P41, DOI 10.1016/0027-5107(89)90196-6; Avrutskaya AV, 2000, METHODS, V22, P127, DOI 10.1006/meth.2000.1053; Bandaru V, 2002, DNA REPAIR, V1, P517, DOI 10.1016/S1568-7864(02)00036-8; Beckman KB, 1997, J BIOL CHEM, V272, P19633, DOI 10.1074/jbc.272.32.19633; Blaisdell JO, 1999, J BACTERIOL, V181, P6396, DOI 10.1128/JB.181.20.6396-6402.1999; Burgess S, 2002, J BIOL CHEM, V277, P2938, DOI 10.1074/jbc.M110499200; CAMERON V, 1977, BIOCHEMISTRY-US, V16, P5120, DOI 10.1021/bi00642a027; EVANS J, 1993, MUTAT RES, V299, P147, DOI 10.1016/0165-1218(93)90092-R; Garcia-Ortiz MV, 2001, PLANT MOL BIOL, V47, P795, DOI 10.1023/A:1013644026132; Gogos A, 1999, J BIOL CHEM, V274, P30447, DOI 10.1074/jbc.274.43.30447; Hazra TK, 2002, J BIOL CHEM, V277, P30417, DOI 10.1074/jbc.C200355200; Hazra TK, 2002, P NATL ACAD SCI USA, V99, P3523, DOI 10.1073/pnas.062053799; Hazra TK, 2000, J BIOL CHEM, V275, P27762; Jiang DY, 1997, J BACTERIOL, V179, P3773, DOI 10.1128/jb.179.11.3773-3782.1997; Jiang DY, 1997, J BIOL CHEM, V272, P32230, DOI 10.1074/jbc.272.51.32230; Kreutzer DA, 1998, P NATL ACAD SCI USA, V95, P3578, DOI 10.1073/pnas.95.7.3578; Le Page F, 2000, CELL, V101, P159, DOI 10.1016/S0092-8674(00)80827-2; Le XC, 1998, SCIENCE, V280, P1066, DOI 10.1126/science.280.5366.1066; MATSUMOTO Y, 1989, MOL CELL BIOL, V9, P3750, DOI 10.1128/MCB.9.9.3750; MELAMEDE RJ, 1994, BIOCHEMISTRY-US, V33, P1255, DOI 10.1021/bi00171a028; Memisoglu A, 2000, MUTAT RES-FUND MOL M, V451, P39, DOI 10.1016/S0027-5107(00)00039-7; Nilsen H, 2001, CARCINOGENESIS, V22, P987, DOI 10.1093/carcin/22.7.987; Pearl LH, 2000, MUTAT RES-DNA REPAIR, V460, P165, DOI 10.1016/S0921-8777(00)00025-2; Rieger RA, 2000, J AM SOC MASS SPECTR, V11, P505, DOI 10.1016/S1044-0305(00)00117-3; Saito Y, 1997, J BACTERIOL, V179, P3783, DOI 10.1128/jb.179.11.3783-3785.1997; Sarker AH, 1998, J MOL BIOL, V282, P761, DOI 10.1006/jmbi.1998.2042; Scharer OD, 2001, BIOESSAYS, V23, P270, DOI 10.1002/1521-1878(200103)23:3<270::AID-BIES1037>3.0.CO;2-J; Shao XG, 2000, NUCLEIC ACIDS RES, V28, P2643, DOI 10.1093/nar/28.14.2643; Sidorkina OM, 2000, J BIOL CHEM, V275, P9924, DOI 10.1074/jbc.275.14.9924; Sugahara M, 2000, EMBO J, V19, P3857, DOI 10.1093/emboj/19.15.3857; Takao M, 1999, NUCLEIC ACIDS RES, V27, P3638, DOI 10.1093/nar/27.18.3638; Takao M, 2002, EMBO J, V21, P3486, DOI 10.1093/emboj/cdf350; TCHOU J, 1991, P NATL ACAD SCI USA, V88, P4690, DOI 10.1073/pnas.88.11.4690; Tsuchimoto D, 2001, NUCLEIC ACIDS RES, V29, P2349, DOI 10.1093/nar/29.11.2349; Wang ZG, 2001, MUTAT RES-DNA REPAIR, V486, P59, DOI 10.1016/S0921-8777(01)00089-1; Zhang QM, 2000, J BIOL CHEM, V275, P35471, DOI 10.1074/jbc.M006125200; Zharkov DO, 1997, J BIOL CHEM, V272, P5335, DOI 10.1074/jbc.272.8.5335	39	187	192	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					42205	42213		10.1074/jbc.M206884200	http://dx.doi.org/10.1074/jbc.M206884200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12200441	hybrid			2022-12-27	WOS:000178985300114
J	Simoni, RD; Hill, RL; Vaughan, M				Simoni, RD; Hill, RL; Vaughan, M			JBC classic papers for the centennial (1905-2005)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material																			0	3	3	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 22	2002	277	12					9623	9623						1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	533UR	12202621				2022-12-27	WOS:000174549200001
J	Ikonomov, OC; Sbrissa, D; Yoshimori, T; Cover, TL; Shisheva, A				Ikonomov, OC; Sbrissa, D; Yoshimori, T; Cover, TL; Shisheva, A			PIKfyve kinase and SKD1 AAA ATPase define distinct endocytic compartments - Only PIKfyve expression inhibits the cell-vacuolating activity of Helicobacter pylori VacA toxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID KINASE; MOUSE SKD1; CYTOTOXIN; TRAFFICKING; YEAST; INSULIN; MORPHOLOGY; ENDOSOMES; CLONING; VPS4P	The mammalian phosphatidylinositol (PtdIns)-5-P/-PtdIns-3,5-P-2-producing kinase PIKfyve and AAA ATPase SKD1, as their yeast counterparts, are implicated in the formation and function of multivesicular bodies/late endosomes. Point mutations inhibiting the enzyme activities convert PIKfyve and SKD1 into dominant-negative mutants (PIKfyve(K1831E) and SKD1(E235Q)), whose expression in cells of kidney origin induces a vacuolation phenotype. This phenotype closely resembles the changes in late endosomal-lysosomal morphology that occur following cell exposure to the vacuolating cytotoxin (VacA) from Helicobacter pylori. Here we have examined the possible functional relationship between PIKfyve and SKD1 as wen as the role of these enzymes in the molecular mechanism of VacA-induced intracellular vacuolation. When co-expressed in COS cells, PIKfyve(WT) reduced SKD1(E235Q) dependent vacuole formation, whereas SKD1(WT) did not alter the vacuolation induced by PIKfyve(K1831E). In addition, SED1(E235Q) disrupted the normal distribution of PIKfyve(WT). Expression of PEKfyve(WT) in COS and HEK293 cells inhibited vacuolation induced by subsequent intoxication with VacA, and microWection of the PIKfyve lipid product PtdIns-3,5,P-2 produced a similar inhibitory effect. In contrast, in COS cells expressing SKD1(WT), VacA induced the formation of characteristic vacuoles with an efficiency similar to that in the control cells. These observations demonstrate that, although PIKfyve and SKD1 are functionally related, only PIKfyve regulates VacA action, and suggest that the inhibition of PIKfyve Ptdlns-3,5-P-2-producing activity is a key molecular event in VacA-induced cellular vacuolation.	Wayne State Univ, Sch Med, Dept Phys, Detroit, MI 48201 USA; Natl Inst Genet, Dept Cell Genet, Shizuoka, Japan; Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Dept Microbiol & Immunol, Nashville, TN 37232 USA; Vet Affairs Med Ctr, Nashville, TN 37232 USA	Wayne State University; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Shisheva, A (corresponding author), Wayne State Univ, Sch Med, Dept Phys, 540 E Canfield, Detroit, MI 48201 USA.		Cover, Timothy/I-3814-2015	Cover, Timothy/0000-0001-8503-002X	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058058, R01DK053623] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK58058, DK53623] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Babst M, 1998, EMBO J, V17, P2982, DOI 10.1093/emboj/17.11.2982; Bishop N, 2000, MOL BIOL CELL, V11, P227, DOI 10.1091/mbc.11.1.227; COVER TL, 1991, INFECT IMMUN, V59, P1264, DOI 10.1128/IAI.59.4.1264-1270.1991; Cover TL, 1997, J CELL BIOL, V138, P759, DOI 10.1083/jcb.138.4.759; Hotchin NA, 2000, J BIOL CHEM, V275, P14009, DOI 10.1074/jbc.C000153200; Ikonomov OC, 2002, J BIOL CHEM, V277, P9206, DOI 10.1074/jbc.M108750200; Ikonomov OC, 2001, J BIOL CHEM, V276, P26141, DOI 10.1074/jbc.M101722200; Molinari M, 1997, J BIOL CHEM, V272, P25339, DOI 10.1074/jbc.272.40.25339; Odorizzi G, 2000, TRENDS BIOCHEM SCI, V25, P229, DOI 10.1016/S0968-0004(00)01543-7; Odorizzi G, 1998, CELL, V95, P847, DOI 10.1016/S0092-8674(00)81707-9; Papini E, 1997, EMBO J, V16, P15, DOI 10.1093/emboj/16.1.15; Papini E, 2001, TOXICON, V39, P1757, DOI 10.1016/S0041-0101(01)00162-3; PAPINI E, 1994, P NATL ACAD SCI USA, V91, P9720, DOI 10.1073/pnas.91.21.9720; Piper RC, 2001, TRAFFIC, V2, P612, DOI 10.1034/j.1600-0854.2001.20904.x; Sbrissa D, 1999, J BIOL CHEM, V274, P21589, DOI 10.1074/jbc.274.31.21589; Sbrissa D, 2000, BIOCHEMISTRY-US, V39, P15980, DOI 10.1021/bi001897f; SBRISSA D, 2002, IN PRESS J BIOL CHEM, V277; Scheuring S, 1999, GENE, V234, P149, DOI 10.1016/S0378-1119(99)00163-8; Shisheva A, 2001, J BIOL CHEM, V276, P11859, DOI 10.1074/jbc.M008437200; Shisheva A, 2001, CELL BIOL INT, V25, P1201, DOI 10.1006/cbir.2001.0803; Shisheva A, 1999, MOL CELL BIOL, V19, P623; Suzuki J, 2001, J CLIN INVEST, V107, P363, DOI 10.1172/JCI10254; Yoshimori T, 2000, MOL BIOL CELL, V11, P747, DOI 10.1091/mbc.11.2.747	23	26	29	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 29	2002	277	48					46785	46790		10.1074/jbc.M208068200	http://dx.doi.org/10.1074/jbc.M208068200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620JB	12213828	hybrid			2022-12-27	WOS:000179529300139
J	Micheau, O; Thome, M; Schneider, P; Holler, N; Tschopp, J; Nicholson, DW; Briand, C; Grutter, MG				Micheau, O; Thome, M; Schneider, P; Holler, N; Tschopp, J; Nicholson, DW; Briand, C; Grutter, MG			The long form of FLIP is an activator of caspase-8 at the fas death-inducing signaling complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; INTERLEUKIN-1-BETA CONVERTING-ENZYME; DOMAIN-CONTAINING PROTEIN; PROGRAMMED CELL-DEATH; INHIBITORY PROTEIN; KINASE RIP; 3-DIMENSIONAL STRUCTURE; CRYSTAL-STRUCTURE; INDUCED APOPTOSIS; C-FLIP	Death receptors, such as Fas and tumor necrosis factor-related apoptosis-inducing ligand receptors, recruit Fas-associated death domain and pro-caspase-8 homodimers, which are then autoproteolytically activated. Active caspase-8 is released into the cytoplasm, where it cleaves various proteins including pro-caspase-3, resulting in apoptosis. The cellular Fas-associated death domain-like interleukin-1-beta-converting enzyme-inhibitory protein long form (FLIPL), a structural homologue of caspase-8 lacking caspase activity because of several mutations in the active site, is a potent inhibitor of death receptor-induced apoptosis. FLIPL is proposed to block caspase-8 activity by forming a proteolytically in active heterodimer with caspase-8. In contrast, we propose that FLPLL-bound caspase-8 is an active protease. Upon heterocomplex formation, a limited caspase-8 autoprocessing occurs resulting in the generation of the p43/41 and the p12 subunits. This partially processed form but also the non-cleaved FLIPL-caspase-8 heterocomplex are proteolytically active because they both bind synthetic substrates efficiently. Moreover, FLIPL expression favors receptor-interacting kinase (RIP) processing within the Fas-signaling complex. We propose that FLIPL inhibits caspase-8 release-dependent pro-apoptotic signals, whereas the single, membrane-restricted active site of the FLIPL-caspase-8 heterocomplex is proteolytically active and acts on local substrates such as RIP.	Univ Lausanne, Inst Biochem, CH-1066 Epalinges, Switzerland; Merck Frosst Ctr Therapeut Res, Dept Biochem & Mol Biol, Pointe Claire, PQ H9R 4P8, Canada; Univ Zurich, Inst Biochem, CH-8057 Zurich, Switzerland	University of Lausanne; Merck & Company; University of Zurich	Tschopp, J (corresponding author), Univ Lausanne, Inst Biochem, 155 Chemin Boveresses, CH-1066 Epalinges, Switzerland.		micheau, olivier/C-3574-2011; Thome, Margot/F-8167-2011	micheau, olivier/0000-0001-8499-7984; Thome, Margot/0000-0002-5656-2139; Schneider, Pascal/0000-0003-0677-9409				Acehan D, 2002, MOL CELL, V9, P423, DOI 10.1016/S1097-2765(02)00442-2; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Blanchard H, 2000, J MOL BIOL, V302, P9, DOI 10.1006/jmbi.2000.4041; Blanchard H, 1999, STRUCTURE, V7, P1125, DOI 10.1016/S0969-2126(99)80179-8; Bodmer JL, 2002, TRENDS BIOCHEM SCI, V27, P19, DOI 10.1016/S0968-0004(01)01995-8; BOLDIN MP, 1995, J BIOL CHEM, V270, P7795, DOI 10.1074/jbc.270.14.7795; Chai JJ, 2001, CELL, V107, P399, DOI 10.1016/S0092-8674(01)00544-X; Chai JJ, 2001, CELL, V104, P769, DOI 10.1016/S0092-8674(02)02034-2; Chang DW, 2002, EMBO J, V21, P3704, DOI 10.1093/emboj/cdf356; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; CONNOLLY ML, 1983, J APPL CRYSTALLOGR, V16, P548, DOI 10.1107/S0021889883010985; DIEDERICHS K, 1995, PROTEINS, V23, P187, DOI 10.1002/prot.340230208; Djerbi M, 1999, J EXP MED, V190, P1025, DOI 10.1084/jem.190.7.1025; EVANS SV, 1993, J MOL GRAPHICS, V11, P127; Fukazawa T, 2001, ONCOGENE, V20, P5225, DOI 10.1038/sj.onc.1204673; Goltsev YV, 1997, J BIOL CHEM, V272, P19641, DOI 10.1074/jbc.272.32.19641; Han DKM, 1997, P NATL ACAD SCI USA, V94, P11333, DOI 10.1073/pnas.94.21.11333; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Hu SM, 1997, J BIOL CHEM, V272, P17255, DOI 10.1074/jbc.272.28.17255; Huang YH, 2001, CELL, V104, P781, DOI 10.1016/S0092-8674(01)00273-2; Inohara N, 1997, P NATL ACAD SCI USA, V94, P10717, DOI 10.1073/pnas.94.20.10717; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kangas E, 1998, J CHEM PHYS, V109, P7522, DOI 10.1063/1.477375; Kataoka T, 2000, CURR BIOL, V10, P640, DOI 10.1016/S0960-9822(00)00512-1; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; Kim Y, 2002, J BIOL CHEM, V277, P22320, DOI 10.1074/jbc.M202458200; Kirchhoff S, 2000, EUR J IMMUNOL, V30, P2765, DOI 10.1002/1521-4141(200010)30:10<2765::AID-IMMU2765>3.0.CO;2-W; KISCHKEL FC, 1995, EMBO J, V14, P5579, DOI 10.1002/j.1460-2075.1995.tb00245.x; Kischkel FC, 2001, J BIOL CHEM, V276, P46639, DOI 10.1074/jbc.M105102200; Kleywegt GJ, 1998, ACTA CRYSTALLOGR D, V54, P1119, DOI 10.1107/S0907444998007100; Krueger A, 2001, J BIOL CHEM, V276, P20633, DOI 10.1074/jbc.M101780200; Krueger A, 2001, MOL CELL BIOL, V21, P8247, DOI 10.1128/MCB.21.24.8247-8254.2001; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Lee D, 2000, J BIOL CHEM, V275, P16007, DOI 10.1074/jbc.275.21.16007; Lens SMA, 2002, MOL CELL BIOL, V22, P5419, DOI 10.1128/MCB.22.15.5419-5433.2002; Lin Y, 1999, GENE DEV, V13, P2514, DOI 10.1101/gad.13.19.2514; Martinon F, 2000, FEBS LETT, V468, P134, DOI 10.1016/S0014-5793(00)01212-6; Medema JP, 1999, J EXP MED, V190, P1033, DOI 10.1084/jem.190.7.1033; Medema JP, 1997, EMBO J, V16, P2794, DOI 10.1093/emboj/16.10.2794; Mittl PRE, 1997, J BIOL CHEM, V272, P6539, DOI 10.1074/jbc.272.10.6539; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Okamoto Y, 1999, CHEM PHARM BULL, V47, P11; Rano TA, 1997, CHEM BIOL, V4, P149, DOI 10.1016/S1074-5521(97)90258-1; Rasper DM, 1998, CELL DEATH DIFFER, V5, P271, DOI 10.1038/sj.cdd.4400370; Renatus M, 2001, P NATL ACAD SCI USA, V98, P14250, DOI 10.1073/pnas.231465798; Riedl SJ, 2001, P NATL ACAD SCI USA, V98, P14790, DOI 10.1073/pnas.221580098; Rotonda J, 1996, NAT STRUCT BIOL, V3, P619, DOI 10.1038/nsb0796-619; Roy S, 2001, P NATL ACAD SCI USA, V98, P6132, DOI 10.1073/pnas.111085198; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Scaffidi C, 1999, J BIOL CHEM, V274, P1541, DOI 10.1074/jbc.274.3.1541; Shi YG, 2002, MOL CELL, V9, P459, DOI 10.1016/S1097-2765(02)00482-3; Shu HB, 1997, IMMUNITY, V6, P751, DOI 10.1016/S1074-7613(00)80450-1; Siegel RM, 2000, SCIENCE, V288, P2354, DOI 10.1126/science.288.5475.2354; Srinivasula SM, 1997, J BIOL CHEM, V272, P18542, DOI 10.1074/jbc.272.30.18542; Thome M, 2001, NAT REV IMMUNOL, V1, P50, DOI 10.1038/35095508; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; THORNBERRY NA, 1995, PROTEIN SCI, V4, P3; Watt W, 1999, STRUCTURE, V7, P1135, DOI 10.1016/S0969-2126(99)80180-4; Wei YY, 2000, CHEM BIOL, V7, P423, DOI 10.1016/S1074-5521(00)00123-X; Willems F, 2000, BLOOD, V95, P3478, DOI 10.1182/blood.V95.11.3478.011k10_3478_3482; Wolf BB, 1999, J BIOL CHEM, V274, P20049, DOI 10.1074/jbc.274.29.20049; Yeh WC, 2000, IMMUNITY, V12, P633, DOI 10.1016/S1074-7613(00)80214-9; Yeh WC, 1997, IMMUNITY, V7, P715, DOI 10.1016/S1074-7613(00)80391-X	67	372	395	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 22	2002	277	47					45162	45171		10.1074/jbc.M206882200	http://dx.doi.org/10.1074/jbc.M206882200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	618EE	12215447	Green Published, hybrid			2022-12-27	WOS:000179404800074
J	Rogers, JT; Randall, JD; Cahill, CM; Eder, PS; Huang, XD; Gunshin, H; Leiter, L; McPhee, J; Sarang, SS; Utsuki, T; Greig, NH; Lahiri, DK; Tanzi, RE; Bush, AI; Giordano, T; Gullans, SR				Rogers, JT; Randall, JD; Cahill, CM; Eder, PS; Huang, XD; Gunshin, H; Leiter, L; McPhee, J; Sarang, SS; Utsuki, T; Greig, NH; Lahiri, DK; Tanzi, RE; Bush, AI; Giordano, T; Gullans, SR			An iron-responsive element type II in the 5 '-untranslated region of the Alzheimer's amyloid precursor protein transcript	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; BETA-PROTEIN; REGULATORY PROTEINS; BINDING PROTEIN; FERRITIN; DISEASE; TRANSLATION; GENE; INTERLEUKIN-1; EXPRESSION	Iron-responsive elements (IREs) are the RNA stem loops that control cellular iron homeostasis by regulating ferritin translation and transferrin receptor mRNA stability. We mapped a novel iron-responsive element (IRE-Type II) within the 5'-untranslated region (5'-UTR) of the Alzheimer's amyloid precursor protein (APP) transcript (+51 to +94 from the 5'-cap site). The APP mRNA IRE is located immediately upstream of an interleukin-1 responsive acute box domain (+101 to +146). APP 5'-UTR conferred translation was selectively down-regulated in response to intracellular iron chelation using three separate reporter assays (chloramphenicol acetyltransferase, luciferase, and red fluorescent protein reflecting an inhibition of APP holoprotein translation in response to iron chelation. Iron influx reversed this inhibition. As an internal control to ensure specificity, a viral internal ribosome entry sequence was unresponsive to intracellular iron chelation with desferrioxamine. Using RNA mobility shift assays, the APP 5'-UTRs, encompassing the IRE, bind specifically to recombinant iron-regulatory proteins (IRP) and to IRP from neuroblastoma cell lysates. IRP binding to the APP 5'-UTR is reduced after treatment of cells with desferrioxamine and increased after interleukin-1 stimulation. IRP binding is abrogated when APP cRNA probe is mutated in the core IRE domain (Delta4 bases:Delta83AGAG86). Iron regulation of APP mRNA through the APP 5'-UTR points to a role for iron in the metabolism of APP and confirms that this RNA structure can be a target for the selection of small molecule drugs, such as desferrioxamine We chelator) and clioquinol (Fe, Cu, and Zn chelator), which reduce Abeta peptide burden during Alzheimer's disease.	Massachusetts Gen Hosp, Genet & Aging Res Unit, Dept Psychiat, Charlestown, MA 02129 USA; Massachusetts Gen Hosp, Diabet Unit, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Neurol Dis, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med, Charlestown, MA 02129 USA; Indiana Univ, Sch Med, Dept Psychiat, Indianapolis, IN 46202 USA; Message Pharmaceut, Malvern, PA 19355 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Indiana University System; Indiana University-Purdue University Indianapolis	Rogers, JT (corresponding author), Harvard Univ, Sch Med, Genet & Aging Res Unit, Dept Psychiat Neurosci, Mass Gen E,Bldg 114,3850 16th St, Charlestown, MA 02129 USA.		Bush, Ashley/Y-2457-2019; Bush, Ashley I/A-1186-2007; Lahiri, Debomoy/AAZ-3322-2020; Tanzi, Rudolph/AAE-9622-2019	Bush, Ashley/0000-0001-8259-9069; Bush, Ashley I/0000-0001-8259-9069; Tanzi, Rudolph/0000-0002-7032-1454; Rogers, Jack/0000-0003-1262-8578	NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH002001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [Z01AG000311, ZIAAG000311] Funding Source: NIH RePORTER; NIMH NIH HHS [5K01MH02001] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bartzokis G, 2000, ARCH GEN PSYCHIAT, V57, P47, DOI 10.1001/archpsyc.57.1.47; BODOVITZ S, 1995, J NEUROCHEM, V64, P307; BUSH AI, 1994, SCIENCE, V265, P1464, DOI 10.1126/science.8073293; BUXBAUM JD, 1992, P NATL ACAD SCI USA, V89, P10075, DOI 10.1073/pnas.89.21.10075; Buxbaum JD, 1998, NAT MED, V4, P1177, DOI 10.1038/2673; Cherny RA, 2001, NEURON, V30, P665, DOI 10.1016/S0896-6273(01)00317-8; CONNOR JR, 1994, J NEUROSCI RES, V37, P461, DOI 10.1002/jnr.490370405; COX LA, 1993, BIOCHEMISTRY-US, V32, P4738, DOI 10.1021/bi00069a007; COX TC, 1991, EMBO J, V10, P1891, DOI 10.1002/j.1460-2075.1991.tb07715.x; Donovan A, 2000, NATURE, V403, P776, DOI 10.1038/35001596; Ekblom J, 2001, DRUG DISCOV TODAY, V6, P1259, DOI 10.1016/S1359-6446(01)02113-4; FENG Y, 1995, SCIENCE, V268, P731, DOI 10.1126/science.7732383; GRAY NK, 1993, EUR J BIOCHEM, V218, P657, DOI 10.1111/j.1432-1033.1993.tb18420.x; Iwai K, 1998, P NATL ACAD SCI USA, V95, P4924, DOI 10.1073/pnas.95.9.4924; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; KIM HY, 1995, J BIOL CHEM, V270, P4983, DOI 10.1074/jbc.270.10.4983; Komori N, 1997, MOL BRAIN RES, V49, P103, DOI 10.1016/S0169-328X(97)00133-2; LaVaute T, 2001, NAT GENET, V27, P209, DOI 10.1038/84859; Leedman PJ, 1996, J BIOL CHEM, V271, P12017, DOI 10.1074/jbc.271.20.12017; Lovell MA, 1998, J NEUROL SCI, V158, P47, DOI 10.1016/S0022-510X(98)00092-6; Mbella EGM, 2000, MOL CELL BIOL, V20, P4572, DOI 10.1128/MCB.20.13.4572-4579.2000; McKie AT, 2000, MOL CELL, V5, P299, DOI 10.1016/S1097-2765(00)80425-6; MCLACHLAN DRC, 1991, LANCET, V337, P1304, DOI 10.1016/0140-6736(91)92978-B; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; MULLNER EW, 1989, CELL, V58, P373, DOI 10.1016/0092-8674(89)90851-9; Multhaup G, 1996, SCIENCE, V271, P1406, DOI 10.1126/science.271.5254.1406; Pinero DJ, 2000, CELL MOL BIOL, V46, P761; ROBINSON SR, 1995, ALZ RES, V1, P191; ROGERS J, 1987, P NATL ACAD SCI USA, V84, P2277, DOI 10.1073/pnas.84.8.2277; Rogers JT, 1996, BLOOD, V87, P2525, DOI 10.1182/blood.V87.6.2525.bloodjournal8762525; Rogers JT, 1999, J BIOL CHEM, V274, P6421, DOI 10.1074/jbc.274.10.6421; SAITOH T, 1989, CELL, V58, P615, DOI 10.1016/0092-8674(89)90096-2; Sampietro M, 2001, NEUROBIOL AGING, V22, P563, DOI 10.1016/S0197-4580(01)00219-6; Schalinske KL, 1997, P NATL ACAD SCI USA, V94, P10681, DOI 10.1073/pnas.94.20.10681; Selkoe DJ, 1996, J BIOL CHEM, V271, P18295, DOI 10.1074/jbc.271.31.18295; SELKOE DJ, 1988, P NATL ACAD SCI USA, V85, P7341, DOI 10.1073/pnas.85.19.7341; TANZI RE, 1991, NATURE, V350, P564, DOI 10.1038/350564a0; TANZI RE, 1987, SCIENCE, V235, P880, DOI 10.1126/science.2949367; Theil EC, 2000, J BIOL CHEM, V275, P40659, DOI 10.1074/jbc.R000019200; THEIL EC, 1987, ANNU REV BIOCHEM, V56, P289, DOI 10.1146/annurev.biochem.56.1.289; Thomson AM, 2000, J BIOL CHEM, V275, P31609, DOI 10.1074/jbc.M002354200; Thomson AM, 1999, INT J BIOCHEM CELL B, V31, P1139, DOI 10.1016/S1357-2725(99)00080-1; Thomson AM, 1999, BIOTECHNIQUES, V27, P1032, DOI 10.2144/99275rr03; Toth I, 1999, J BIOL CHEM, V274, P4467, DOI 10.1074/jbc.274.7.4467; van Leeuwen FW, 1998, SCIENCE, V279, P242, DOI 10.1126/science.279.5348.242; Von Koch CS, 1997, NEUROBIOL AGING, V18, P661, DOI 10.1016/S0197-4580(97)00151-6; WASCO W, 1993, NAT GENET, V5, P95, DOI 10.1038/ng0993-95; ZUBENKO GS, 1992, J NEUROPATH EXP NEUR, V51, P459, DOI 10.1097/00005072-199207000-00008; ZUKER M, 1989, SCIENCE, V244, P48, DOI 10.1126/science.2468181	49	420	437	3	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2002	277	47					45518	45528		10.1074/jbc.M207435200	http://dx.doi.org/10.1074/jbc.M207435200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	618EE	12198135	hybrid			2022-12-27	WOS:000179404800117
J	Torres-Padilla, ME; Sladek, FM; Weiss, MC				Torres-Padilla, ME; Sladek, FM; Weiss, MC			Developmentally regulated N-terminal variants of the nuclear receptor hepatocyte nuclear factor 4 alpha mediate multiple interactions through coactivator and corepressor-histone deacetylase complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESTROGEN-RECEPTOR; TRANSCRIPTIONAL ACTIVATION; SMRT COREPRESSOR; APOLIPOPROTEIN-CIII; HORMONE-RECEPTORS; CELL-TYPE; REPRESSION; EXPRESSION; PROTEIN; GENE	To understand the mechanisms governing the regulation of nuclear receptor (NR) function, we compared the parameters of activation and repression of two isoforms of the orphan receptor hepatocyte nuclear factor (HNF) 4alpha. HNF4alpha7 and HNFalpha1 differ only in their N-terminal domains, and their expression in the liver is regulated developmentally. We show that the N-terminal activation function (AF)-1 of HNF4alpha1 possesses significant activity that can be enhanced through interaction with glucocorticoid receptor-interacting protein 1 (GRIP-1) and cAMP response element-binding protein-binding protein (CBP). In striking contrast, HNF4alpha7 possesses no measurable AF-1, implying major functional differences between the isoforms. Indeed, although HNF4alpha1 and HNF4a7 are able to interact via AF-2 with GRIP-1, p300, and silencing mediator for retinoid and thyroid receptors (SMRT), only HNF4alpha1 interacts in a synergistic fashion with GRIP-1 and p300. Although both isoforms interact physically and functionally with SMRT, the repression of HNF4alpha7 is less robust than that of HNF4alpha1, which may be caused by an increased ability of the latter to recruit histone deacetylase (HDAC) activity to target promoters. Moreover, association of SMRT with HDACs enhanced recruitment of HNF4alpha1 but not of HNF4alpha7. These observations suggest that NR isoform-specific association with SMRT could affect activity of the SMRT complex, implying that selection of HDAC partners is a novel point of regulation for NR activity. Possible physiological consequences of the multiple interactions with these coregulators are discussed.	Inst Pasteur, Dept Dev Biol, Unite Genet Differenciat, FRE 2364 CNRS, F-75724 Paris 15, France; Univ Calif Riverside, Dept Cell Biol & Neurosci, Riverside, CA 92521 USA	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of California System; University of California Riverside	Weiss, MC (corresponding author), Inst Pasteur, Dept Dev Biol, Unite Genet Differenciat, FRE 2364 CNRS, 25 Rue Dr Roux, F-75724 Paris 15, France.	mweiss@pasteur.fr			NIDDK NIH HHS [R01 DK053892, DK53892] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK053892, R01DK053892] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bailey P, 1999, MOL ENDOCRINOL, V13, P1155, DOI 10.1210/me.13.7.1155; Benecke A, 2000, EMBO REP, V1, P151, DOI 10.1093/embo-reports/kvd028; BERRY M, 1990, EMBO J, V9, P2811, DOI 10.1002/j.1460-2075.1990.tb07469.x; BREWER CB, 1994, METHOD CELL BIOL, V43, P233; Carmen AA, 1996, J BIOL CHEM, V271, P15837, DOI 10.1074/jbc.271.26.15837; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; CHEN WS, 1994, GENE DEV, V8, P2466, DOI 10.1101/gad.8.20.2466; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Dell H, 1999, J BIOL CHEM, V274, P9013, DOI 10.1074/jbc.274.13.9013; Ding XF, 1998, MOL ENDOCRINOL, V12, P302, DOI 10.1210/me.12.2.302; ECKNER R, 1994, GENE DEV, V8, P869, DOI 10.1101/gad.8.8.869; ELLISTON JF, 1990, MOL CELL BIOL, V10, P6607, DOI 10.1128/MCB.10.12.6607; Emiliani S, 1998, P NATL ACAD SCI USA, V95, P2795, DOI 10.1073/pnas.95.6.2795; Fischle W, 2002, MOL CELL, V9, P45, DOI 10.1016/S1097-2765(01)00429-4; Gelmetti V, 1998, MOL CELL BIOL, V18, P7185, DOI 10.1128/MCB.18.12.7185; Giguere V, 1999, ENDOCR REV, V20, P689, DOI 10.1210/er.20.5.689; Green VJ, 1998, J BIOL CHEM, V273, P29950, DOI 10.1074/jbc.273.45.29950; Grignani F, 1998, NATURE, V391, P815, DOI 10.1038/35901; Grozinger CM, 1999, P NATL ACAD SCI USA, V96, P4868, DOI 10.1073/pnas.96.9.4868; Guenther MG, 2000, GENE DEV, V14, P1048; Guenther MG, 2001, MOL CELL BIOL, V21, P6091, DOI 10.1128/MCB.21.18.6091-6101.2001; HadzopoulouCladaras M, 1997, J BIOL CHEM, V272, P539; Hassig CA, 1997, CELL, V89, P341, DOI 10.1016/S0092-8674(00)80214-7; Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001; Heinzel T, 1997, NATURE, V387, P43, DOI 10.1038/387043a0; Hittelman AB, 1999, EMBO J, V18, P5380, DOI 10.1093/emboj/18.19.5380; Hong SH, 2000, MOL CELL BIOL, V20, P6612, DOI 10.1128/MCB.20.17.6612-6625.2000; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Kan HY, 2000, J BIOL CHEM, V275, P30423, DOI 10.1074/jbc.M005641200; Kao HY, 2000, GENE DEV, V14, P55; KARATHANASIS SK, 1985, P NATL ACAD SCI USA, V82, P6374, DOI 10.1073/pnas.82.19.6374; Lavinsky RM, 1998, P NATL ACAD SCI USA, V95, P2920, DOI 10.1073/pnas.95.6.2920; Li H, 1997, MOL ENDOCRINOL, V11, P2025, DOI 10.1210/me.11.13.2025; Li JX, 2000, GENE DEV, V14, P464; Lin BC, 1997, MOL CELL BIOL, V17, P6131, DOI 10.1128/MCB.17.10.6131; Lizcano F, 2001, MOL CELL ENDOCRINOL, V172, P13, DOI 10.1016/S0303-7207(00)00400-7; Ma H, 1999, MOL CELL BIOL, V19, P6164; MAEVA Y, 2002, MOL ENDOCRINOL, V16, P402; Manet Evelyne, 1993, Gene Expression, V3, P49; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Misiti S, 1998, ENDOCRINOLOGY, V139, P2493, DOI 10.1210/en.139.5.2493; Nagy L, 1997, CELL, V89, P373, DOI 10.1016/S0092-8674(00)80218-4; Nakhei H, 1998, NUCLEIC ACIDS RES, V26, P497, DOI 10.1093/nar/26.2.497; Privalsky ML, 2001, CURR TOP MICROBIOL, V254, P117; Rundlett SE, 1996, P NATL ACAD SCI USA, V93, P14503, DOI 10.1073/pnas.93.25.14503; Ruse MD, 2002, MOL CELL BIOL, V22, P1626, DOI 10.1128/MCB.22.6.1626-1638.2002; SADOWSKI I, 1989, NUCLEIC ACIDS RES, V17, P7539, DOI 10.1093/nar/17.18.7539; Sande S, 1996, MOL ENDOCRINOL, V10, P813, DOI 10.1210/me.10.7.813; SCHOEPFER R, 1993, GENE, V124, P83, DOI 10.1016/0378-1119(93)90764-T; SLADEK FM, 1990, GENE DEV, V4, P2353, DOI 10.1101/gad.4.12b.2353; Sladek FM, 1999, MOL CELL BIOL, V19, P6509; Sladek FM, 1998, DIABETES, V47, P985, DOI 10.2337/diabetes.47.6.985; Sladek FM, 2001, NUCL RECEPTORS GENET; Soderstrom M, 1997, MOL ENDOCRINOL, V11, P682, DOI 10.1210/me.11.6.682; Spath GF, 1997, MOL CELL BIOL, V17, P1913; Stallcup MR, 2001, ONCOGENE, V20, P3014, DOI 10.1038/sj.onc.1204325; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Taunton J, 1996, SCIENCE, V272, P408, DOI 10.1126/science.272.5260.408; THOMPSON JF, 1991, GENE, V103, P171, DOI 10.1016/0378-1119(91)90270-L; TORA L, 1988, NATURE, V333, P185, DOI 10.1038/333185a0; Torchia J, 1998, CURR OPIN CELL BIOL, V10, P373, DOI 10.1016/S0955-0674(98)80014-8; Torres-Padilla ME, 2001, MECH DEVELOP, V109, P183, DOI 10.1016/S0925-4773(01)00521-4; Tremblay GB, 1999, MOL CELL BIOL, V19, P1919; Webb P, 1998, MOL ENDOCRINOL, V12, P1605, DOI 10.1210/me.12.10.1605; Wong CW, 1998, MOL CELL BIOL, V18, P5724, DOI 10.1128/MCB.18.10.5724; Wong CW, 1998, MOL CELL BIOL, V18, P5500, DOI 10.1128/MCB.18.9.5500; Wu XY, 2001, J BIOL CHEM, V276, P24177, DOI 10.1074/jbc.M100412200; Yang ZH, 1999, J BIOL CHEM, V274, P37131, DOI 10.1074/jbc.274.52.37131; Yoshida E, 1997, BIOCHEM BIOPH RES CO, V241, P664, DOI 10.1006/bbrc.1997.7871	69	51	56	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2002	277	47					44677	44687		10.1074/jbc.M207545200	http://dx.doi.org/10.1074/jbc.M207545200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	618EE	12205093	hybrid			2022-12-27	WOS:000179404800012
J	Efendiev, R; Yudowski, GA; Zwiller, J; Leibiger, B; Katz, AI; Berggren, PO; Pedemonte, CH; Leibiger, IB; Bertorello, AM				Efendiev, R; Yudowski, GA; Zwiller, J; Leibiger, B; Katz, AI; Berggren, PO; Pedemonte, CH; Leibiger, IB; Bertorello, AM			Relevance of dopamine signals anchoring dynamin-2 to the plasma membrane during Na+,K+-ATPase endocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+-K+-ATPASE; ALPHA-SUBUNIT; DISTINCT FUNCTIONS; PROTEIN; PHOSPHORYLATION; RECRUITMENT; INHIBITION; BINDING; DOMAIN; BETA	Clathrin-dependent endocytosis of Na+,K+-ATPase in response to dopamine regulates its catalytic activity in intact cells. Because fission of clathrin-coated pits requires dynamin, we examined the mechanisms by which dopamine receptor signals promote dynamin-2 recruitment and assembly at the site of Na+,K+-ATPase endocytosis. Western blotting revealed that dopamine increased the association of dynamin-2 with the plasma membrane and with phosphatidylinositol 3-kinase. Dopamine inhibited Na+,K+-ATPase activity in OK cells and in those overexpressing wild type dynamin-2 but not in cells expressing a dominant-negative mutant. Dephosphorylation of dynamin is important for its assembly. Dopamine increased protein phosphatase 2A activity and dephosphorylated dynamin-2. In cells expressing a dominant-negative mutant of protein phosphatase 2A, dopamine failed to dephosphorylate dynamin-2 and to reduce Na+,K+-ATPase activity. Dynamin-2 is phosphorylated at Ser(848), and expression of the S848A mutant significantly blocked the inhibitory effect of dopamine. These results demonstrate a distinct signaling network originating from the dopamine receptor that regulates the state of dynamin-2 phosphorylation and that promotes its location (by interaction with phosphatidylinositol 3-kinase) at the site of Na+,K+-ATPase endocytosis.	Karolinska Hosp, Dept Mol Med, Rolf Luft Ctr Diabet Res, Karolinska Inst, S-17176 Stockholm, Sweden; Univ Houston, Dept Pharmacol & Pharmaceut Sci, Coll Pharm, Houston, TX 77204 USA; INSERM, Unite 338, F-67084 Strasbourg, France; Univ Chicago, Dept Med, Chicago, IL 60637 USA	Karolinska Institutet; Karolinska University Hospital; University of Houston System; University of Houston; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Chicago	Bertorello, AM (corresponding author), Karolinska Hosp, Dept Mol Med, Rolf Luft Ctr Diabet Res, Karolinska Inst, L3, S-17176 Stockholm, Sweden.	alejandro.bertorello@molmed.ki.se		Yudowski, Guillermo/0000-0001-5989-4131; Berggren, Per-Olof/0000-0001-8991-413X	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053460] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 53460] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ahn S, 2002, J BIOL CHEM, V277, P26642, DOI 10.1074/jbc.M201499200; ALEXANDER RW, 1974, J CLIN INVEST, V54, P194, DOI 10.1172/JCI107743; Altschuler Y, 1998, J CELL BIOL, V143, P1871, DOI 10.1083/jcb.143.7.1871; BALL SG, 1970, BR J CLIN PHARM, V4, P115; BERTORELLO A, 1988, AM J PHYSIOL, V254, pF795, DOI 10.1152/ajprenal.1988.254.6.F795; Bertorello AM, 1999, AM J PHYSIOL-LUNG C, V276, pL20, DOI 10.1152/ajplung.1999.276.1.L20; BERTORELLO AM, 1993, AM J PHYSIOL, V265, pF743, DOI 10.1152/ajprenal.1993.265.6.F743; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cao H, 1998, MOL BIOL CELL, V9, P2595, DOI 10.1091/mbc.9.9.2595; Caplan MJ, 1997, AM J PHYSIOL-RENAL, V272, pF425, DOI 10.1152/ajprenal.1997.272.4.F425; Carranza ML, 1998, J PHYSIOL-LONDON, V511, P235, DOI 10.1111/j.1469-7793.1998.235bi.x; Chibalin AV, 1998, J BIOL CHEM, V273, P8814, DOI 10.1074/jbc.273.15.8814; Chibalin AV, 1997, AM J PHYSIOL-CELL PH, V273, pC1458, DOI 10.1152/ajpcell.1997.273.5.C1458; Chibalin AV, 1998, MOL BIOL CELL, V9, P1209, DOI 10.1091/mbc.9.5.1209; Chibalin AV, 1999, J BIOL CHEM, V274, P1920, DOI 10.1074/jbc.274.4.1920; COHEN P, 1988, METHOD ENZYMOL, V159, P390; Done SC, 2002, J BIOL CHEM, V277, P17108, DOI 10.1074/jbc.M201326200; Efendiev R, 1999, FEBS LETT, V456, P45, DOI 10.1016/S0014-5793(99)00925-4; Efendiev R, 2000, BIOCHEMISTRY-US, V39, P9884, DOI 10.1021/bi0007831; Evans DRH, 1999, J BIOL CHEM, V274, P24038, DOI 10.1074/jbc.274.34.24038; EWART HS, 1995, AM J PHYSIOL-CELL PH, V269, pC295, DOI 10.1152/ajpcell.1995.269.2.C295; Goldstien J, 2001, FR HIST STUD, V24, P1, DOI 10.1215/00161071-24-1-1; GOUT I, 1993, CELL, V75, P25, DOI 10.1016/0092-8674(93)90676-H; HARDER KW, 1994, BIOCHEM J, V298, P395, DOI 10.1042/bj2980395; Hu MC, 2001, J BIOL CHEM, V276, P26906, DOI 10.1074/jbc.M011338200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lai MM, 1999, J BIOL CHEM, V274, P25963, DOI 10.1074/jbc.274.37.25963; Larsson O, 1997, SCIENCE, V278, P471, DOI 10.1126/science.278.5337.471; LIU JP, 1994, J BIOL CHEM, V269, P21043; LIU JP, 1994, SCIENCE, V265, P970, DOI 10.1126/science.8052858; McNiven MA, 2000, TRENDS BIOCHEM SCI, V25, P115, DOI 10.1016/S0968-0004(99)01538-8; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; Moede T, 1999, FEBS LETT, V461, P229, DOI 10.1016/S0014-5793(99)01446-5; Muhlberg AB, 1997, EMBO J, V16, P6676, DOI 10.1093/emboj/16.22.6676; Ogimoto G, 2000, P NATL ACAD SCI USA, V97, P3242, DOI 10.1073/pnas.060025597; Okamoto PM, 1997, J BIOL CHEM, V272, P11629; Pedemonte CH, 1997, MOL PHARMACOL, V52, P88, DOI 10.1124/mol.52.1.88; Powell KA, 2000, J BIOL CHEM, V275, P11610, DOI 10.1074/jbc.275.16.11610; ROBINSON PJ, 1993, NATURE, V365, P163, DOI 10.1038/365163a0; RODRIGUEZBOULAN E, 1989, SCIENCE, V245, P718, DOI 10.1126/science.2672330; Schmid SL, 1998, CURR OPIN CELL BIOL, V10, P504, DOI 10.1016/S0955-0674(98)80066-5; Schmid SL, 1997, ANNU REV BIOCHEM, V66, P511, DOI 10.1146/annurev.biochem.66.1.511; Sever S, 1999, NATURE, V398, P481, DOI 10.1038/19024; SLOBODYANSKY E, 1995, AM J PHYSIOL-RENAL, V268, pF279, DOI 10.1152/ajprenal.1995.268.2.F279; SONTAG JM, 1994, J BIOL CHEM, V269, P4547; Therien AG, 2000, AM J PHYSIOL-CELL PH, V279, pC541, DOI 10.1152/ajpcell.2000.279.3.C541; Urrutia R, 1997, P NATL ACAD SCI USA, V94, P377, DOI 10.1073/pnas.94.2.377; Warnock Dale E., 1996, Bioessays, V18, P885, DOI 10.1002/bies.950181107; Yu PY, 2000, HYPERTENSION, V36, P1053, DOI 10.1161/01.HYP.36.6.1053; Yudowski GA, 2000, P NATL ACAD SCI USA, V97, P6556, DOI 10.1073/pnas.100128297	50	33	33	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2002	277	46					44108	44114		10.1074/jbc.M205173200	http://dx.doi.org/10.1074/jbc.M205173200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	615XE	12205083	hybrid			2022-12-27	WOS:000179272000075
J	DeGraff, JL; Gurevich, VV; Benovic, JL				DeGraff, JL; Gurevich, VV; Benovic, JL			The third intracellular loop of alpha(2)-adrenergic receptors determines subtype specificity of arrestin interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HAMSTER OVARY CELLS; BETA-ARRESTIN; ALPHA-2-ADRENERGIC RECEPTOR; ADRENERGIC-RECEPTOR; BETA(2)-ADRENERGIC RECEPTOR; DEPENDENT DESENSITIZATION; ADENYLATE-CYCLASE; CLATHRIN ADAPTER; PROTEIN-KINASE; BINDING	Nonvisual arrestins (arrestin-2 and -3) serve as adaptors to link agonist-activated G protein-coupled receptors to the endocytic machinery. Although many G protein-coupled receptors bind arrestins, the molecular determinants involved in binding remain largely unknown. Because arrestins selectively promote the internalization of the alpha(2b)- and alpha(2c)-adrenergic receptors (ARs) while having no effect on the alpha(2a)AR, here we used alpha(2)ARs to identify molecular determinants involved in arrestin binding. Initially, we assessed the ability of purified arrestins to bind glutathione S-transferase fusions containing the third intracellular loops of the alpha(2a)AR, alpha(2b)AR; or alpha(2c)AR. These studies revealed that arrestin-3 directly binds to the alpha(2b)AR and alpha(2c)AR but not the alpha(2a)AR, whereas arrestin-2 only binds to the alpha(2b)AR, Truncation mutagenesis of the alpha(2b)AR identified two arrestin-3 binding domains in the third intracellular loop, one at the N-terminal end (residues 194-214) and the other at the C-terminal end (residues 344-368). Site-directed mutagenesis further revealed a critical role for several basic residues in arrestin-3 binding to the alpha(2b)AR third intracellular loop. Mutation of these residues in the holo-alpha(2b)AR and subsequent expression in HEK 293 cells revealed that the mutations had no effect on the ability of the receptor to activate ERK1/2. However, agonist-promoted internalization of the mutant a2bAR was significantly attenuated as compared with wild type receptor. These results demonstrate that arrestin-3 binds to two discrete regions within the alpha(2b)AR third intracellular loop and that disruption of arrestin binding selectively abrogates agonist-promoted receptor internalization.	Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA; Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA	Jefferson University; Vanderbilt University	Benovic, JL (corresponding author), Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Microbiol & Immunol, 233 S 10th St, Philadelphia, PA 19107 USA.		Gurevich, Vsevolod/A-3236-2008	Gurevich, Vsevolod/0000-0002-3950-5351	NATIONAL EYE INSTITUTE [R01EY011500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007523] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063097] Funding Source: NIH RePORTER; NEI NIH HHS [EY11500] Funding Source: Medline; NIAID NIH HHS [T32-AI07523] Funding Source: Medline; NIGMS NIH HHS [GM63097, GM47419] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALBLAS J, 1993, J BIOL CHEM, V268, P22235; Altman JD, 1999, MOL PHARMACOL, V56, P154, DOI 10.1124/mol.56.1.154; Appleyard SM, 1999, J BIOL CHEM, V274, P23802, DOI 10.1074/jbc.274.34.23802; Barak LS, 2001, P NATL ACAD SCI USA, V98, P93, DOI 10.1073/pnas.011303698; Bennett TA, 2000, J BIOL CHEM, V275, P24590, DOI 10.1074/jbc.C000314200; Cheng ZJ, 2000, J BIOL CHEM, V275, P2479, DOI 10.1074/jbc.275.4.2479; Daunt DA, 1997, MOL PHARMACOL, V51, P711, DOI 10.1124/mol.51.5.711; DeGraff JL, 1999, J BIOL CHEM, V274, P11253, DOI 10.1074/jbc.274.16.11253; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; FLORDELLIS CS, 1995, J BIOL CHEM, V270, P3491, DOI 10.1074/jbc.270.8.3491; Gaidarov I, 1999, EMBO J, V18, P871, DOI 10.1093/emboj/18.4.871; Gelber EI, 1999, J NEUROCHEM, V72, P2206, DOI 10.1046/j.1471-4159.1999.0722206.x; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; GUREVICH VV, 1993, J BIOL CHEM, V268, P11628; Han M, 2001, STRUCTURE, V9, P869, DOI 10.1016/S0969-2126(01)00644-X; Huttenrauch F, 2002, J BIOL CHEM, V277, P30769, DOI 10.1074/jbc.M204033200; JEWELLMOTZ EA, 1995, BIOCHEMISTRY-US, V34, P11946, DOI 10.1021/bi00037a036; JONES SB, 1991, MOL PHARMACOL, V39, P239; KOBILKA BK, 1987, SCIENCE, V238, P650, DOI 10.1126/science.2823383; KRUPNICK JG, 1994, J BIOL CHEM, V269, P3226; Krupnick JG, 1998, ANNU REV PHARMACOL, V38, P289, DOI 10.1146/annurev.pharmtox.38.1.289; KUROSE H, 1994, J BIOL CHEM, V269, P10093; Laporte SA, 1999, P NATL ACAD SCI USA, V96, P3712, DOI 10.1073/pnas.96.7.3712; LIGGETT SB, 1992, J BIOL CHEM, V267, P4740; LIMBIRD LE, 1988, FASEB J, V2, P2686, DOI 10.1096/fasebj.2.11.2840317; Link RE, 1996, SCIENCE, V273, P803, DOI 10.1126/science.273.5276.803; LOHSE MJ, 1990, SCIENCE, V248, P1547, DOI 10.1126/science.2163110; LOMASNEY JW, 1990, P NATL ACAD SCI USA, V87, P5094, DOI 10.1073/pnas.87.13.5094; MacMillan LB, 1996, SCIENCE, V273, P801, DOI 10.1126/science.273.5276.801; MACNULTY EE, 1992, J BIOL CHEM, V267, P2149; Marinissen MJ, 2001, TRENDS PHARMACOL SCI, V22, P368, DOI 10.1016/S0165-6147(00)01678-3; Mukherjee S, 1999, J BIOL CHEM, V274, P12984, DOI 10.1074/jbc.274.19.12984; MURAKAMI A, 1993, FEBS LETT, V334, P203, DOI 10.1016/0014-5793(93)81712-9; OKAMOTO T, 1992, J BIOL CHEM, V267, P8342; Prezeau L, 1999, J BIOL CHEM, V274, P13462, DOI 10.1074/jbc.274.19.13462; REGAN JW, 1988, P NATL ACAD SCI USA, V85, P6301, DOI 10.1073/pnas.85.17.6301; RICHMAN JG, 2001, J BIOL CHEM, V40, P19; SEUWEN K, 1990, CELL REGUL, V1, P445, DOI 10.1091/mbc.1.6.445; STERNEMARR R, 1993, J BIOL CHEM, V268, P15640; Vilardaga JP, 2002, J BIOL CHEM, V277, P8121, DOI 10.1074/jbc.M110433200; Wade SM, 1999, MOL PHARMACOL, V56, P1005, DOI 10.1124/mol.56.5.1005; Wade SM, 1996, MOL PHARMACOL, V50, P351; Walker JKL, 1999, J BIOL CHEM, V274, P31515, DOI 10.1074/jbc.274.44.31515; Wu GY, 1997, J BIOL CHEM, V272, P17836, DOI 10.1074/jbc.272.28.17836; YAMAKI K, 1987, BIOCHEM BIOPH RES CO, V142, P904, DOI 10.1016/0006-291X(87)91499-9	45	72	72	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					43247	43252		10.1074/jbc.M207495200	http://dx.doi.org/10.1074/jbc.M207495200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12205092	hybrid			2022-12-27	WOS:000179081200107
J	Fukuda, A; Matsuyama, S; Hara, T; Nakayama, J; Nagasawa, H; Tokuda, H				Fukuda, A; Matsuyama, S; Hara, T; Nakayama, J; Nagasawa, H; Tokuda, H			Aminoacylation of the N-terminal cysteine is essential for Lol-dependent release of lipoproteins from membranes but does not depend on lipoprotein sorting signals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI LIPOPROTEINS; OUTER-MEMBRANE; CYTOPLASMIC MEMBRANE; LOCALIZATION; PROTEIN; TRANSLOCATION; ACYLTRANSFERASE; PEPTIDOGLYCAN; ACCUMULATION; MECHANISM	Lipoproteins are present in a wide variety of bacteria and are anchored to membranes through lipids attached to the N-terminal cysteine. The Lol system of Escherichia coli mediates the membrane-specific localization of lipoproteins. Aspartate at position 2 functions as a Lol avoidance signal and causes the retention of lipoproteins in the inner membrane, whereas lipoproteins having residues other than aspartate at position 2 are released from the inner membrane and localized to the outer membrane by the Lol system. Phospholipid:apolipoprotein transacylase, Lnt, catalyzes the last step of lipoprotein modification, converting apolipoprotein into mature lipoprotein. To reveal the importance of this aminoacylation for the Lol-dependent membrane localization, apolipoproteins were prepared by inhibiting lipoprotein maturation. Lnt was also purified and used to convert apolipoprotein into mature lipoprotein in vitro. The release of these lipoproteins was examined in proteoliposomes. We show here that the aminoacylation is essential for the Lol-dependent release of lipoproteins from membranes. Furthermore, lipoproteins with aspartate at position 2 were found to be aminoacylated both in vivo and in vitro, indicating that the lipoprotein-sorting signal does not affect lipid modification.	Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, Tokyo 1138657, Japan	University of Tokyo; University of Tokyo	Tokuda, H (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan.							CASADABAN MJ, 1976, J MOL BIOL, V104, P541, DOI 10.1016/0022-2836(76)90119-4; CHEN R, 1987, EUR J BIOCHEM, V163, P73, DOI 10.1111/j.1432-1033.1987.tb10738.x; GUPTA SD, 1993, J BIOL CHEM, V268, P16551; GUPTA SD, 1991, FEMS MICROBIOL LETT, V78, P37; HIRASHIMA A, 1973, J BIOL CHEM, V248, P5654; HIROTA Y, 1977, P NATL ACAD SCI USA, V74, P1417, DOI 10.1073/pnas.74.4.1417; HUSSAIN M, 1980, J BIOL CHEM, V255, P3707; HUSSAIN M, 1982, J BIOL CHEM, V257, P5177; INUKAI M, 1978, J ANTIBIOT, V31, P410, DOI 10.7164/antibiotics.31.410; Masuda K, 2002, P NATL ACAD SCI USA, V99, P7390, DOI 10.1073/pnas.112085599; MATSUYAMA S, 1995, EMBO J, V14, P3365, DOI 10.1002/j.1460-2075.1995.tb07342.x; Matsuyama S, 1997, EMBO J, V16, P6947, DOI 10.1093/emboj/16.23.6947; MIZUSHIMA S, 1987, BACTERIAL OUTER MEMB, P163; Narita S, 2002, J BACTERIOL, V184, P1417, DOI 10.1128/JB.184.5.1417-1422.2002; Navarre WW, 1996, J BACTERIOL, V178, P441, DOI 10.1128/jb.178.2.441-446.1996; NISHIYAMA K, 1993, EMBO J, V12, P3409, DOI 10.1002/j.1460-2075.1993.tb06015.x; PUGSLEY AP, 1993, MICROBIOL REV, V57, P50, DOI 10.1128/MMBR.57.1.50-108.1993; SANKARAN K, 1994, J BIOL CHEM, V269, P19701; Seydel A, 1999, MOL MICROBIOL, V34, P810, DOI 10.1046/j.1365-2958.1999.01647.x; Tajima T, 1998, FEBS LETT, V439, P51, DOI 10.1016/S0014-5793(98)01334-9; Tanaka K, 2001, J BACTERIOL, V183, P6538, DOI 10.1128/JB.183.22.6538-6542.2001; Terada M, 2001, J BIOL CHEM, V276, P47690, DOI 10.1074/jbc.M109307200; TOKUDA H, 1990, EUR J BIOCHEM, V192, P583, DOI 10.1111/j.1432-1033.1990.tb19264.x; Yakushi T, 1998, J BIOL CHEM, V273, P32576, DOI 10.1074/jbc.273.49.32576; Yakushi T, 2000, NAT CELL BIOL, V2, P212, DOI 10.1038/35008635; Yakushi T, 1997, J BACTERIOL, V179, P2857, DOI 10.1128/jb.179.9.2857-2862.1997; YAMADA H, 1989, J BIOL CHEM, V264, P18577; YAMAGUCHI K, 1988, CELL, V53, P423, DOI 10.1016/0092-8674(88)90162-6; Yokota N, 1999, J BIOL CHEM, V274, P30995, DOI 10.1074/jbc.274.43.30995	29	60	64	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					43512	43518		10.1074/jbc.M206816200	http://dx.doi.org/10.1074/jbc.M206816200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12198129	hybrid			2022-12-27	WOS:000179081200136
J	Klefstrom, J; Verschuren, EW; Evan, G				Klefstrom, J; Verschuren, EW; Evan, G			c-Myc augments the apoptotic activity of cytosolic death receptor signaling proteins by engaging the mitochondrial apoptotic pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; CYTOCHROME-C; CELL-DEATH; KINASE RIP; CASPASE FAMILY; TNF; BCL-2; FAS; RELEASE; LIGAND	Activation of c-Myc sensitizes cells to apoptosis induction by ligand-activated death receptors. Such sensitization to death receptors by oncogenes may well be the mechanism underlying tumor cell sensitivity to tumor necrosis factor (TNF) or TNF-related apoptosis-inducing ligand (TRAIL). The mechanism by which this c-Myc-induced sensitization occurs is unclear but could involve modulation of expression of death receptors or their ligands or potentiation of the sensitivity of mitochondria to release pro-apoptotic effectors such as holocytochrome c. Here, we show that ectopic expression of the death receptor signaling protein RIP (receptor-interactive protein) triggers apoptosis via a FAS-associated death domain protein (FADD) and caspase 8-dependent pathway. Induction of apoptosis by this intracellular activation of the death receptor signaling pathway is significantly augmented by c-Myc expression. Moreover, c-Myc expression strongly promotes the potential of RIP to induce cytochrome c release from mitochondria. This implicates the mitochondrial apoptotic pathway in this synergy, a notion confirmed by the inability of c-Myc to sensitize to RIP killing in cells lacking the obligate mitochondrial apoptotic effectors Bax and Bak. We conclude that the lethality of the RIP-activated cytosolic caspase 8 pathway is augmented by c-Myc priming mitochondria to release cytochrome c. This places the intersection of apoptotic synergy between c-Myc and death receptor signaling downstream of the death receptors.	Univ Calif San Francisco, San Franciso Comprehens Canc Ctr, San Francisco, CA 94115 USA	University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Evan, G (corresponding author), Univ Calif San Francisco, San Franciso Comprehens Canc Ctr, 2340 Sutter St, San Francisco, CA 94115 USA.			Verschuren, Emmy/0000-0001-5771-9129				Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; BOLDIN MP, 1995, J BIOL CHEM, V270, P387, DOI 10.1074/jbc.270.1.387; Brunner T, 2000, J BIOL CHEM, V275, P9767, DOI 10.1074/jbc.275.13.9767; Duan H, 1997, NATURE, V385, P86, DOI 10.1038/385086a0; Eischen CM, 2001, MOL CELL BIOL, V21, P5063, DOI 10.1128/MCB.21.15.5063-5070.2001; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; FANIDI A, 1992, NATURE, V359, P554, DOI 10.1038/359554a0; Fulda S, 2002, ONCOGENE, V21, P2283, DOI 10.1038/sj.onc.1205258; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; HARRINGTON EA, 1994, EMBO J, V13, P3286, DOI 10.1002/j.1460-2075.1994.tb06630.x; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Hsu HL, 1996, IMMUNITY, V4, P387, DOI 10.1016/S1074-7613(00)80252-6; Hueber AO, 1998, TRENDS GENET, V14, P364, DOI 10.1016/S0168-9525(98)01520-0; Hueber AO, 1997, SCIENCE, V278, P1305, DOI 10.1126/science.278.5341.1305; Juin P, 1999, GENE DEV, V13, P1367, DOI 10.1101/gad.13.11.1367; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; Klefstrom J, 1997, EMBO J, V16, P7382, DOI 10.1093/emboj/16.24.7382; KLEFSTROM J, 1994, EMBO J, V13, P5442, DOI 10.1002/j.1460-2075.1994.tb06879.x; Krammer PH, 2000, NATURE, V407, P789, DOI 10.1038/35037728; Kuwana T, 1998, J BIOL CHEM, V273, P16589, DOI 10.1074/jbc.273.26.16589; LeBlanc H, 2002, NAT MED, V8, P274, DOI 10.1038/nm0302-274; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; LITTLEWOOD TD, 1995, NUCLEIC ACIDS RES, V23, P1686, DOI 10.1093/nar/23.10.1686; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Lutz W, 1998, ONCOGENE, V17, P339, DOI 10.1038/sj.onc.1200201; Mitchell KO, 2000, CANCER RES, V60, P6318; Pelengaris S, 2002, CELL, V109, P321, DOI 10.1016/S0092-8674(02)00738-9; Phillips AC, 1999, MOL CELL, V4, P771, DOI 10.1016/S1097-2765(00)80387-1; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; STANGER BZ, 1995, CELL, V81, P513, DOI 10.1016/0092-8674(95)90072-1; Stennicke HR, 1997, J BIOL CHEM, V272, P25719, DOI 10.1074/jbc.272.41.25719; Talanian RV, 1997, J BIOL CHEM, V272, P9677; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; Tran SEF, 2001, J BIOL CHEM, V276, P16484, DOI 10.1074/jbc.M010384200; Van Antwerp DJ, 1998, TRENDS CELL BIOL, V8, P107, DOI 10.1016/S0962-8924(97)01215-4; Varfolomeev EE, 1996, J EXP MED, V183, P1271, DOI 10.1084/jem.183.3.1271; VAUX DL, 1988, NATURE, V335, P440, DOI 10.1038/335440a0; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108	40	66	67	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					43224	43232		10.1074/jbc.M206967200	http://dx.doi.org/10.1074/jbc.M206967200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12202489	hybrid			2022-12-27	WOS:000179081200104
J	Messner, KR; Imlay, JA				Messner, KR; Imlay, JA			Mechanism of superoxide and hydrogen peroxide formation by fumarate reductase, succinate dehydrogenase, and aspartate oxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; XANTHINE-OXIDASE; RESPIRATORY COMPLEX; OXIDATIVE STRESS; NADPH OXIDASE; BOUND FLAVIN; DNA-DAMAGE; ENZYME; OXYGEN; IDENTIFICATION	Oxidative stress is created in aerobic organisms when molecular oxygen chemically oxidizes redox enzymes, forming superoxide (O-2 and hydrogen peroxide (H2O2) Prior work identified several flavoenzymes from Escherichia coli that tend to autoxidize. Of these, fumarate reductase (Frd) is notable both for its high turnover number and for its production of substantial 07 in addition to H2O2. We have sought to identify characteristics of Frd that predispose it to this behavior. The ability of excess succinate to block autoxidation and the inhibitory effect of lowering the Flavin potential indicate that all detectable autoxidation occurs from its FAD site, rather than from iron-sulfur clusters or bound quinones. The flavin adenine dinucleotide (FAD) moiety of Frd is unusually solvent-exposed, as evidenced by its ability to bind sulfite, and this may make it more likely to react adventitiously with O-2. The autoxidizing species is apparently fully reduced flavin rather than flavosemiquinone, since treatments that more fully reduce the enzyme do not slow its turnover number. They do, however, switch the major product from O-2 to H2O2. A similar effect is achieved by lowering the potential of the proximal [2Fe-2S] cluster. These data suggest that Frd releases O-2 into bulk solution if this cluster is available to sequester the semiquinone electron; otherwise, that electron is rapidly transferred to the nascent superoxide, and H2O2 is the product that leaves the active site. This model is supported by the behavior of "aspartate oxidase" (aspartate:fumarate oxidoreductase), an Frd homologue that lacks Fe-S clusters. Its dihydroflavin also reacts avidly with oxygen, and H2O2 is the predominant product. In contrast, succinate dehydrogenase, with high potential clusters, generates O-2 exclusively. The identities of enzyme autoxidation products are Significant because O-2 and H2O2 damage cells in different ways.	Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Imlay, JA (corresponding author), Univ Illinois, Dept Microbiol, 131 Burrill Hall, Urbana, IL 61801 USA.	jimlay@uiuc.edu	Messner, Kevin/ABC-8801-2020; Messner, Kevin/J-2242-2014	Messner, Kevin/0000-0003-2516-0695	NIGMS NIH HHS [T32 GM07283-20, GM49640, R01 GM049640] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049640, R37GM049640, T32GM007283] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ackrell B. A.C, 1992, CHEM BIOCH FLAVOPROT, V3, P229; ACKRELL BAC, 1989, ARCH BIOCHEM BIOPHYS, V268, P26, DOI 10.1016/0003-9861(89)90561-4; BLAUT M, 1989, J BIOL CHEM, V264, P13599; Bossi RT, 2002, BIOCHEMISTRY-US, V41, P3018, DOI 10.1021/bi015939r; BOVERIS A, 1976, BIOCHEM J, V156, P435, DOI 10.1042/bj1560435; BRUICE TC, 1984, ISRAEL J CHEM, V24, P54; CARLIOZ A, 1986, EMBO J, V5, P623, DOI 10.1002/j.1460-2075.1986.tb04256.x; Cecchini G, 2002, BBA-BIOENERGETICS, V1553, P140, DOI 10.1016/S0005-2728(01)00238-9; CONDON C, 1985, J BIOL CHEM, V260, P9427; Flint DH, 1996, CHEM REV, V96, P2315, DOI 10.1021/cr950041r; FLINT DH, 1993, J BIOL CHEM, V268, P22369; FRIDOVICH I, 1970, J BIOL CHEM, V245, P4053; GARDNER PR, 1991, J BIOL CHEM, V266, P19328; GARDNER PR, 1991, J BIOL CHEM, V266, P1478; GREGORY EM, 1974, ANAL BIOCHEM, V58, P57, DOI 10.1016/0003-2697(74)90440-0; GUEST JR, 1981, J GEN MICROBIOL, V122, P171; Heering HA, 1997, J AM CHEM SOC, V119, P11628, DOI 10.1021/ja9723242; HILLE R, 1981, J BIOL CHEM, V256, P9090; IMLAY JA, 1991, J BIOL CHEM, V266, P6957; IMLAY JA, 1995, J BIOL CHEM, V270, P19767; Ishii N, 1998, NATURE, V394, P694, DOI 10.1038/29331; Iverson TM, 1999, SCIENCE, V284, P1961, DOI 10.1126/science.284.5422.1961; Iverson TM, 2000, CURR OPIN STRUC BIOL, V10, P448, DOI 10.1016/S0959-440X(00)00113-5; KEYER K, 1995, J BACTERIOL, V177, P6782, DOI 10.1128/jb.177.23.6782-6790.1995; Keyer K, 1996, P NATL ACAD SCI USA, V93, P13635, DOI 10.1073/pnas.93.24.13635; KOWAL AT, 1995, BIOCHEMISTRY-US, V34, P12284, DOI 10.1021/bi00038a024; KUO CF, 1987, J BIOL CHEM, V262, P4724; Leger C, 2001, BIOCHEMISTRY-US, V40, P11234, DOI 10.1021/bi010889b; LEMIRE BD, 1986, METHOD ENZYMOL, V126, P377; LIOCHEV SI, 1994, FREE RADICAL BIO MED, V16, P29, DOI 10.1016/0891-5849(94)90239-9; LIOCHEV SI, 1992, P NATL ACAD SCI USA, V89, P5892, DOI 10.1073/pnas.89.13.5892; Maklashina E, 1998, J BACTERIOL, V180, P5989, DOI 10.1128/JB.180.22.5989-5996.1998; MASSEY V, 1994, J BIOL CHEM, V269, P22459; MASSEY V, 1969, BIOCHEM BIOPH RES CO, V36, P891, DOI 10.1016/0006-291X(69)90287-3; MASSEY V, 1969, J BIOL CHEM, V244, P3999; MASSEY V, 1966, BIOCHEMISTRY-US, V5, P3181, DOI 10.1021/bi00874a016; Mattevi A, 1999, STRUCTURE, V7, P745, DOI 10.1016/S0969-2126(99)80099-9; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; MCCORD JM, 1971, P NATL ACAD SCI USA, V68, P1024, DOI 10.1073/pnas.68.5.1024; Messner KR, 1999, J BIOL CHEM, V274, P10119, DOI 10.1074/jbc.274.15.10119; MIKI T, 1992, J BIOL CHEM, V267, P18695; MILLER JH, 1972, EXPT MOL GENETICS, P37; MISRA HP, 1977, ANAL BIOCHEM, V79, P553, DOI 10.1016/0003-2697(77)90429-8; Mortarino M, 1996, EUR J BIOCHEM, V239, P418, DOI 10.1111/j.1432-1033.1996.0418u.x; MULLER F, 1987, FREE RADICAL BIO MED, V3, P215, DOI 10.1016/0891-5849(87)90009-8; NAQUI A, 1986, ANNU REV BIOCHEM, V55, P137, DOI 10.1146/annurev.biochem.55.1.137; Pan N, 2001, MOL MICROBIOL, V39, P1562, DOI 10.1046/j.1365-2958.2001.02343.x; PORRAS AG, 1981, J BIOL CHEM, V256, P9096; SALACH JI, 1974, J BIOL CHEM, V249, P3765; Seaver LC, 2001, J BACTERIOL, V183, P7173, DOI 10.1128/JB.183.24.7173-7181.2001; SEIFERT J, 1990, BIOL CHEM H-S, V371, P239, DOI 10.1515/bchm3.1990.371.1.239; Senoo-Matsuda N, 2001, J BIOL CHEM, V276, P41553, DOI 10.1074/jbc.M104718200; SILVIUS JR, 1980, P NATL ACAD SCI-BIOL, V77, P1255, DOI 10.1073/pnas.77.3.1255; Singer TP, 1971, METHODS ENZYMOL    B, V18, P416; Storz G, 1999, CURR OPIN MICROBIOL, V2, P188, DOI 10.1016/S1369-5274(99)80033-2; Tedeschi G, 1996, EUR J BIOCHEM, V239, P427, DOI 10.1111/j.1432-1033.1996.0427u.x; WERTH MT, 1990, P NATL ACAD SCI USA, V87, P8965, DOI 10.1073/pnas.87.22.8965; Zhou MJ, 1997, ANAL BIOCHEM, V253, P162, DOI 10.1006/abio.1997.2391	58	210	217	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					42563	42571		10.1074/jbc.M204958200	http://dx.doi.org/10.1074/jbc.M204958200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12200425	hybrid			2022-12-27	WOS:000179081200019
J	Michalski, C; Cui, YH; Nies, AT; Nuessler, AK; Neuhaus, P; Zanger, UM; Klein, K; Eichelbaum, M; Keppler, D; Konig, J				Michalski, C; Cui, YH; Nies, AT; Nuessler, AK; Neuhaus, P; Zanger, UM; Klein, K; Eichelbaum, M; Keppler, D; Konig, J			A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONJUGATE EXPORT PUMP; MULTIDRUG-RESISTANCE PROTEIN; DUBIN-JOHNSON-SYNDROME; HUMAN LIVER; CANALICULAR ISOFORM; EUROPEAN-AMERICANS; AFRICAN-AMERICANS; DRUG-RESISTANCE; IDENTIFICATION; EXPRESSION	The organic anion transporter SLC21A6 (also known as OATP2, OATP-C, or LST-1) is involved in the hepatocellular uptake of a variety of endogenous and xenobiotic substances and drugs. We analyzed 81 human liver samples by immunoblotting and found one with a strongly reduced amount of SLC21A6 protein suggesting mutations in the SLC21A6 gene. The SLC21A6 cDNA from this sample contained five base pair changes in one allele; three of the mutations resulted in amino acid substitutions designated SLC21A6-N130D, SLC21A6-P155T, and SLC21A6-L193R. The former two were polymorphisms (SLC21A6*1b and SLC21A6*4), whereas SLC21A6-L193R represents the first naturally occurring mutation identified in one allele of the SLC21A6 gene, which affects protein maturation and organic anion transport. We introduced each of the mutations into the SLC21A6 cDNA and established stably transfected MDCKII cells expressing the respective mutant SLC21A6 protein. Immunofluorescence microscopy and uptake measurements were used to study localization and transport properties of the mutated proteins. Both proteins carrying the polymorphisms were sorted to the lateral membrane like wild-type SLC21A6, but their transport properties for the substrates cholyltaurine and 17beta-glucuronosyl estradiol were altered. Importantly, most of the mutant protein SLC21A6-L193R was retained intracellularly, and this single amino acid exchange abolished transport function.	Deutsch Krebsforschungszentrum, Div Tumor Biochem, D-69120 Heidelberg, Germany; Humboldt Univ, Dept Surg, Charite, D-13353 Berlin, Germany; Dr Margarete Fischer Bosch Inst Clin Pharmacol, D-70376 Stuttgart, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Konig, J (corresponding author), Deutsch Krebsforschungszentrum, Div Tumor Biochem, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.		Zanger, Ulrich M./A-9364-2012; Cui, Yunhai/AAP-7670-2021; Michalski, Christoph/U-9167-2019; Nies, Anne T./D-7923-2016; Keppler, Dietrich/A-5528-2013	Zanger, Ulrich M./0000-0002-5276-2002; Cui, Yunhai/0000-0003-4969-072X; Nies, Anne T./0000-0001-6862-0730; Keppler, Dietrich/0000-0003-2964-2333; Koenig, Joerg/0000-0001-7016-5482				Abe T, 1999, J BIOL CHEM, V274, P17159, DOI 10.1074/jbc.274.24.17159; Buchler M, 1996, J BIOL CHEM, V271, P15091; Cui Y, 2001, J BIOL CHEM, V276, P9626, DOI 10.1074/jbc.M004968200; Cui YH, 1999, MOL PHARMACOL, V55, P929; Cui YH, 2001, MOL PHARMACOL, V60, P934, DOI 10.1124/mol.60.5.934; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; Hayes JD, 2000, PHARMACOLOGY, V61, P154, DOI 10.1159/000028396; Hoffmeyer S, 2000, P NATL ACAD SCI USA, V97, P3473, DOI 10.1073/pnas.050585397; Hsiang BN, 1999, J BIOL CHEM, V274, P37161, DOI 10.1074/jbc.274.52.37161; Ingelman-Sundberg M, 1999, TRENDS PHARMACOL SCI, V20, P342, DOI 10.1016/S0165-6147(99)01363-2; Ito K, 2001, AM J PHYSIOL-GASTR L, V281, pG1034, DOI 10.1152/ajpgi.2001.281.4.G1034; Ito S, 2001, PHARMACOGENETICS, V11, P175, DOI 10.1097/00008571-200103000-00008; Itoda M, 2002, DRUG METAB DISPOS, V30, P363, DOI 10.1124/dmd.30.4.363; Kartenbeck J, 1996, HEPATOLOGY, V23, P1061; Keitel V, 2000, HEPATOLOGY, V32, P1317, DOI 10.1053/jhep.2000.19791; KEPPLER D, 2001, LIVER BIOL PATHOBIOL, P373; Kim RB, 2001, CLIN PHARMACOL THER, V70, P189, DOI 10.1067/mcp.2001.117412; Konig J, 2000, J BIOL CHEM, V275, P23161, DOI 10.1074/jbc.M001448200; Konig J, 2000, AM J PHYSIOL-GASTR L, V278, pG156, DOI 10.1152/ajpgi.2000.278.1.G156; Konig J, 1999, HEPATOLOGY, V29, P1156, DOI 10.1002/hep.510290404; Konig J, 1999, BBA-BIOMEMBRANES, V1461, P377, DOI 10.1016/S0005-2736(99)00169-8; Kullak-Ublick GA, 2001, GASTROENTEROLOGY, V120, P525, DOI 10.1053/gast.2001.21176; Lang T, 2001, PHARMACOGENETICS, V11, P399, DOI 10.1097/00008571-200107000-00004; MAYER R, 1995, J CELL BIOL, V131, P137, DOI 10.1083/jcb.131.1.137; Meyer UA, 1997, ANNU REV PHARMACOL, V37, P269, DOI 10.1146/annurev.pharmtox.37.1.269; Nebert DW, 2000, PHARMACOGENETICS, V10, P279, DOI 10.1097/00008571-200006000-00001; Nies AT, 2001, INT J CANCER, V94, P492, DOI 10.1002/ijc.1498; Nozawa T, 2002, J PHARMACOL EXP THER, V302, P804, DOI 10.1124/jpet.302.2.804; Rodrigues AD, 2002, CURR DRUG METAB, V3, P289, DOI 10.2174/1389200023337522; SANGER F, 1980, J MOL BIOL, V143, P161, DOI 10.1016/0022-2836(80)90196-5; Schaub TP, 1997, J AM SOC NEPHROL, V8, P1213; SENGER M, 1995, COMPUT METH PROG BIO, V46, P131, DOI 10.1016/0169-2607(94)01610-R; Stieger B, 1998, CURR OPIN CELL BIOL, V10, P462, DOI 10.1016/S0955-0674(98)80059-8; Suzuki H, 2000, SEMIN LIVER DIS, V20, P251, DOI 10.1055/s-2000-8408; Tamai I, 2000, BIOCHEM BIOPH RES CO, V273, P251, DOI 10.1006/bbrc.2000.2922; Tirona RG, 2001, J BIOL CHEM, V276, P35669, DOI 10.1074/jbc.M103792200	36	105	109	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					43058	43063		10.1074/jbc.M207735200	http://dx.doi.org/10.1074/jbc.M207735200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12196548	hybrid			2022-12-27	WOS:000179081200083
J	Nowak, G				Nowak, G			Protein kinase C-alpha and ERK1/2 mediate mitochondrial dysfunction, decreases in active Na+ transport, and cisplatin-induced apoptosis in renal cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHLOROPLAST ATP SYNTHASE; SIGNAL-REGULATED KINASE; INDUCED NEPHROTOXICITY; CASPASE ACTIVATION; EPITHELIAL-CELLS; INDUCED TOXICITY; IN-VITRO; MEMBRANE; RAT; INHIBITION	Initiation of apoptosis by many agents is preceded by mitochondrial dysfunction and depolarization of the mitochondrial inner membrane. Here we demonstrate that, in renal proximal tubular cells (RPTC), cisplatin induces mitochondrial dysfunction associated with hyperpolarization of the mitochondrial membrane and that these events are mediated by protein kinase C (PKC)-alpha and ERK1/2. Cisplatin induced sustained decreases in RPTC respiration, oxidative phosphorylation, and increases in the mitochondrial transmembrane potential (Deltapsi(m)), which were preceded by the inhibition of F0F1-ATPase and cytochrome c release from the mitochondria, accompanied by caspase-3 activation, and followed by RPTC apoptosis. Cisplatin also decreased active Na+ transport as a result, in part, of the inhibition of Na+/K+-ATPase. These changes were preceded by PKC-alpha and ERK1/2 activation. Inhibition of cisplatin-induced PKC-alpha and ERK1/2 activation using Go6976 and PD98059, respectively, abolished increases in Deltapsi(m), diminished decreases in oxidative phosphorylation, active Na+ transport, and decreased caspase-3 activation without blocking cytochrome c release. Caspase inhibitor benzyloxycarbonyl-Val-Ala-Asp-Ruoromethylketone (zVAD-fmk) did not prevent increases in Deltapsi(m). Furthermore, inhibition of PKC-alpha did not prevent cisplatin-induced ERK1/2 activation. We concluded that in RFTC: 1) cisplatin-induced mitochondrial dysfunction, decreases in active Na+ transport, and apoptosis are mediated by PKC-alpha and ERK1/2; 2) PKC-alpha and ERK1/2 mediate activation of caspase-3 by acting downstream of cytochrome c release from mitochondria; and 3) ERK1/2 activation by cisplatin occurs through a PKC-alpha-independent pathway.	Univ Arkansas Med Sci, Dept Pharmaceut Sci, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences	Nowak, G (corresponding author), Univ Arkansas Med Sci, Dept Pharmaceut Sci, Slot 522-3,4301 W Markham St, Little Rock, AR 72205 USA.	nowakgrazyna@uams.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059558] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK059558, R01DK59558, R01 DK059558-01] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Autieri MV, 1999, DNA CELL BIOL, V18, P555, DOI 10.1089/104454999315105; Basu A, 1999, BIOCHEMISTRY-US, V38, P4245, DOI 10.1021/bi982854q; BRADY HR, 1990, AM J PHYSIOL, V258, pF1181, DOI 10.1152/ajprenal.1990.258.5.F1181; Bunney TD, 2001, P NATL ACAD SCI USA, V98, P4249, DOI 10.1073/pnas.061437498; Chanda B, 1999, BBA-BIOMEMBRANES, V1416, P92, DOI 10.1016/S0005-2736(98)00217-X; CHOPRA S, 1982, KIDNEY INT, V21, P54, DOI 10.1038/ki.1982.8; Di Mari JF, 1999, AM J PHYSIOL-RENAL, V277, pF195, DOI 10.1152/ajprenal.1999.277.2.F195; DILISA F, 1995, J PHYSIOL-LONDON, V486, P1; Dong Y, 1997, BIOCHEM PHARMACOL, V53, P1673, DOI 10.1016/S0006-2952(97)00015-4; DUCHEN MR, 1993, CARDIOVASC RES, V27, P1790, DOI 10.1093/cvr/27.10.1790; Dzeja PP, 2001, CIRC RES, V89, P744, DOI 10.1161/res.89.9.744; EASTMAN A, 1990, CANCER CELL-MON REV, V2, P275; Erhardt P, 1999, MOL CELL BIOL, V19, P5308; Evans RM, 1998, EXP CELL RES, V245, P69, DOI 10.1006/excr.1998.4250; Fuchs SY, 1998, GENE DEV, V12, P2658, DOI 10.1101/gad.12.17.2658; GOLDSTEIN RS, 1983, LIFE SCI, V32, P685, DOI 10.1016/0024-3205(83)90299-0; Gottlob K, 2001, GENE DEV, V15, P1406, DOI 10.1101/gad.889901; HANIGAN MH, 1994, CANCER RES, V54, P5925; Henkels KM, 1999, CANCER RES, V59, P3077; Ikeda S, 1999, INT J UROL, V6, P245, DOI 10.1046/j.1442-2042.1999.00058.x; Kanekatsu M, 1998, BIOCHEM MOL BIOL INT, V46, P99; Kazanietz MG, 2001, ARCH BIOCHEM BIOPHYS, V388, P74, DOI 10.1006/abbi.2000.2264; Khaled AR, 2001, J BIOL CHEM, V276, P6453, DOI 10.1074/jbc.M006391200; Kojima H, 1998, J BIOL CHEM, V273, P16647, DOI 10.1074/jbc.273.27.16647; KRUIDERING M, 1994, EXP NEPHROL, V2, P334; Kruidering M, 1998, CELL DEATH DIFFER, V5, P601, DOI 10.1038/sj.cdd.4400392; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASH LH, 1993, MITOCHONDRIAL DYSFUN, V2, P8; Lau AH, 1999, KIDNEY INT, V56, P1295, DOI 10.1046/j.1523-1755.1999.00687.x; Law RHP, 1995, METHOD ENZYMOL, V260, P133, DOI 10.1016/0076-6879(95)60135-X; LEIBBRANDT MEI, 1995, KIDNEY INT, V48, P761, DOI 10.1038/ki.1995.348; LEVI J, 1980, J PHARMACOL EXP THER, V213, P545; Li LW, 1999, MOL CELL BIOL, V19, P8547; Matsuyama S, 2000, NAT CELL BIOL, V2, P318, DOI 10.1038/35014006; Melendez-Zajgla J, 1999, BIOCHEM MOL BIOL INT, V47, P765; MIURA K, 1987, TOXICOLOGY, V44, P147, DOI 10.1016/0300-483X(87)90145-4; Nieminen AL, 1996, NEUROSCIENCE, V75, P993; Nowak G, 1996, AM J PHYSIOL-CELL PH, V271, pC2072, DOI 10.1152/ajpcell.1996.271.6.C2072; Nowak G, 2000, TOXICOL APPL PHARM, V167, P37, DOI 10.1006/taap.2000.8986; Okuda M, 2000, BIOCHEM PHARMACOL, V59, P195, DOI 10.1016/S0006-2952(99)00303-2; Osman AM, 2000, PHARMACOL RES, V41, P115; Persons DL, 1999, CLIN CANCER RES, V5, P1007; Persons DL, 2000, J BIOL CHEM, V275, P35778, DOI 10.1074/jbc.M004267200; Poppe M, 2001, J NEUROSCI, V21, P4551, DOI 10.1523/JNEUROSCI.21-13-04551.2001; SAFIRSTEIN R, 1987, INT J ANDROL, V10, P325, DOI 10.1111/j.1365-2605.1987.tb00200.x; Sanchez-Perez I, 1999, FEBS LETT, V453, P151, DOI 10.1016/S0014-5793(99)00690-0; Scarlett JL, 2000, FEBS LETT, V475, P267, DOI 10.1016/S0014-5793(00)01681-1; Sener G, 2000, FUNDAM CLIN PHARM, V14, P553; Shiraishi Y, 2000, LIFE SCI, V67, P1047, DOI 10.1016/S0024-3205(00)00704-9; Somani SM, 2000, PHARMACOL TOXICOL, V86, P234, DOI 10.1034/j.1600-0773.2000.d01-41.x; Tashker JS, 2002, MOL BIOL CELL, V13, P393, DOI 10.1091/mbc.01-06-0291; TKACOVA E, 1985, NEOPLASMA, V32, P679; van de Water B, 2000, J BIOL CHEM, V275, P25805, DOI 10.1074/jbc.M001680200; Van der Hoeven PCJ, 2000, BIOCHEM J, V345, P297, DOI 10.1042/0264-6021:3450297; Vander Heiden MG, 2000, P NATL ACAD SCI USA, V97, P4666, DOI 10.1073/pnas.090082297; Vander Heiden MG, 1999, NAT CELL BIOL, V1, pE209, DOI 10.1038/70237; VANVERHEIDEN MG, 2001, J BIOL CHEM, V276, P19414; Wang XT, 2000, J BIOL CHEM, V275, P39435, DOI 10.1074/jbc.M004583200; White RJ, 1996, J NEUROSCI, V16, P5688; Zhan Y, 1999, ONCOGENE, V18, P6505, DOI 10.1038/sj.onc.1203060; ZHANG JG, 1993, BIOCHEM PHARMACOL, V45, P2215; Zhang JG, 1996, TOXICOL LETT, V89, P11, DOI 10.1016/S0378-4274(96)03776-9	62	217	221	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					43377	43388		10.1074/jbc.M206373200	http://dx.doi.org/10.1074/jbc.M206373200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12218054	Green Accepted, hybrid			2022-12-27	WOS:000179081200122
J	Boesze-Battaglia, K; Dispoto, J; Kahoe, MA				Boesze-Battaglia, K; Dispoto, J; Kahoe, MA			Association of a photoreceptor-specific tetraspanin protein, ROM-1, with Triton X-100-resistant membrane rafts from rod outer segment disk membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE; ANCHORED PROTEINS; LIPID RAFTS; CHOLESTEROL; PERIPHERIN/RDS; LOCALIZATION; ACID; TRANSDUCIN; RECEPTOR; COMPLEX	This study reports the isolation and characterization of a Triton X-100-resistant membrane fraction from homogenates of rod outer segment (ROS) disk membranes purified free of the surrounding plasma membrane. A portion of the ROS disk membrane was found to be resistant to Triton X-100 extraction at 4 degreesC. This detergent-resistant fraction was isolated as a low buoyant density band on sucrose density gradients and exhibited an increase in light scattering detected at 600 nm. Biochemical analysis of the Triton X-100-resistant fraction showed it to be enriched in cholesterol and sphingomyelin relative to phospholipid and in phospholipid relative to protein compared with the soluble fraction. The Triton X-100-resistant membranes described herein did not arise simply from partial solubilization of the ROS disk membranes because detergent-treated low buoyant density fractions isolated from homogenates with octyl glucopyranoside had cholesterol and sphingomyelin content indistinguishable from that of solubilized ROS disk homogenates. Analysis of proteins associated with the Triton X-100-resistant fraction showed it to be enriched in the rim-specific protein ROM-1 and eaveolin; surprisingly, the fusion protein peripherin/rds (where rds is retinal degeneration slow), also localized to the disk rim, was entirely absent from the membrane raft domain. The lipid profiles of the Triton X-100-resistant membranes were virtually identical in preparations homogenized in either the light or dark. Slightly more ROM-1 was recovered from samples prepared in the light (23%) than from samples prepared in the dark (13%), but peripherin/rds could not be detected in either preparation. When the Triton X-100-resistant membranes were treated with methyl-beta-cyclodextran to deplete membrane cholesterol, the resultant membranes contained slightly lower levels of ROM-1, specifically in the dimeric form. Cholesterol depletion also resulted in the collapse of the large caveolin complex to monomeric caveolae. The results presented herein characterize a pool of ROM-1, a photoreceptor tetraspanin protein, that may play a regulatory role in peripherin/rds-dependent fusion.	Univ Med & Dent New Jersey, Sch Osteopath Med, Dept Mol Biol, Stratford, NJ 08084 USA; Univ Med & Dent New Jersey, Grad Sch Biomed Sci, Stratford, NJ 08084 USA	Rowan University; Rowan University School of Osteopathic Medicine; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Boesze-Battaglia, K (corresponding author), Univ Penn, Sch Dent Med, Dept Biochem, 4001 Spruce St, Philadelphia, PA 19104 USA.	battagli@biochem.dental.upenn.edu			NCRR NIH HHS [S10 RR026365-01, S10 RR026365] Funding Source: Medline; NEI NIH HHS [R01 EY010420, EY 10420, R01 EY010420-12, R01 EY010420-15, R29 EY010420, R01 EY010420-11, R01 EY010420-10A2, R01 EY010420-13A2, R01 EY010420-16, R01 EY010420-09, R01 EY010420-08, R21 EY018705, R21 EY018705-02, R01 EY010420-07, R29 EY010420-03, R01 EY010420-06, R21 EY018705-01A1, R01 EY010420-14] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026365] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY010420, R29EY010420, R21EY018705] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ALLAIN CC, 1974, CLIN CHEM, V20, P470; Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; ANDREWS LD, 1983, J CELL BIOL, V97, P749, DOI 10.1083/jcb.97.3.749; ARIKAWA K, 1992, J CELL BIOL, V116, P659, DOI 10.1083/jcb.116.3.659; BARTLETT GR, 1959, J BIOL CHEM, V234, P466; BASCOM RA, 1992, NEURON, V8, P1171, DOI 10.1016/0896-6273(92)90137-3; Bodin S, 2001, BIOCHEMISTRY-US, V40, P15290, DOI 10.1021/bi0109313; Boesze-Battaglia K, 1998, BIOCHEMISTRY-US, V37, P9477, DOI 10.1021/bi980173p; Boesze-Battaglia K, 2002, INT REV CYTOL, V217, P183; BOESZEBATTAGLIA K, 1994, EXP EYE RES, V58, P293, DOI 10.1006/exer.1994.1020; BOESZEBATTAGLIA K, 1989, J BIOL CHEM, V264, P8151; BOESZEBATTAGLIA K, 1990, J BIOL CHEM, V265, P20727; BOESZEBATTAGLIA K, 1992, EXP EYE RES, V54, P821, DOI 10.1016/0014-4835(92)90040-Y; BOESZEBATTAGLIA K, 1989, EXP EYE RES, V49, P699, DOI 10.1016/S0014-4835(89)80064-8; BoeszeBattaglia K, 1997, BIOCHEMISTRY-US, V36, P6835, DOI 10.1021/bi9627370; BOESZEBATTAGLIA K, 1990, J BIOL CHEM, V265, P18867; BOESZEBATTAGLIA K, 1999, INVESTIG OPHTHALMOL, V40, P4909; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; Christian AE, 1997, J LIPID RES, V38, P2264; Claas C, 2001, J BIOL CHEM, V276, P7974, DOI 10.1074/jbc.M008650200; Clarke G, 2000, NAT GENET, V25, P67, DOI 10.1038/75621; Dorahy DJ, 1996, BIOCHEM J, V319, P67, DOI 10.1042/bj3190067; FLIESLER SJ, 1983, PROG LIPID RES, V22, P79; Fliesler SJ, 1997, EXP EYE RES, V64, P279, DOI 10.1006/exer.1996.0201; FOLCH J, 1957, J BIOL CHEM, V226, P497; FRA AM, 1994, J BIOL CHEM, V269, P30745; Ghalayini AJ, 2002, J BIOL CHEM, V277, P1469, DOI 10.1074/jbc.M011432200; Goldberg AFX, 1998, BIOCHEMISTRY-US, V37, P680, DOI 10.1021/bi972036i; Goldberg AFX, 1996, BIOCHEMISTRY-US, V35, P6144, DOI 10.1021/bi960259n; GOLDBERG AFX, 1995, BIOCHEMISTRY-US, V34, P14213, DOI 10.1021/bi00043a028; LITMAN BJ, 1973, BIOCHEMISTRY-US, V12, P2545, DOI 10.1021/bi00737a028; Litman BJ, 2001, J MOL NEUROSCI, V16, P237, DOI 10.1385/JMN:16:2-3:237; Liu Y, 2000, J CELL SCI, V113, P2363; Loewen CJR, 2000, J BIOL CHEM, V275, P5370, DOI 10.1074/jbc.275.8.5370; Martin-Belmonte F, 2001, J BIOL CHEM, V276, P49337, DOI 10.1074/jbc.M106882200; MERRIL CR, 1982, ELECTROPHORESIS, V3, P17, DOI 10.1002/elps.1150030104; Mitchell DC, 2001, J BIOL CHEM, V276, P42801, DOI 10.1074/jbc.M105772200; Molday RS, 1998, INVEST OPHTH VIS SCI, V39, P2493; Nair KS, 2002, CURR BIOL, V12, P421, DOI 10.1016/S0960-9822(02)00691-7; Niu SL, 2001, J BIOL CHEM, V276, P42807, DOI 10.1074/jbc.M105778200; Poetsch A, 2001, J BIOL CHEM, V276, P48009, DOI 10.1074/jbc.M108941200; Polozova A, 2000, BIOPHYS J, V79, P2632, DOI 10.1016/S0006-3495(00)76502-7; Razani B, 2001, EXP CELL RES, V271, P36, DOI 10.1006/excr.2001.5372; Rietveld A, 1998, BBA-REV BIOMEMBRANES, V1376, P467, DOI 10.1016/S0304-4157(98)00019-7; Samuel BU, 2001, J BIOL CHEM, V276, P29319, DOI 10.1074/jbc.M101268200; SARGIACOMO M, 1993, J CELL BIOL, V122, P789, DOI 10.1083/jcb.122.4.789; Schubert AL, 2002, BIOCHEMISTRY-US, V41, P5754, DOI 10.1021/bi0121656; Seno K, 2001, J BIOL CHEM, V276, P20813, DOI 10.1074/jbc.C100032200; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SKIPSKI VP, 1964, BIOCHEM J, V90, P374, DOI 10.1042/bj0900374; SPRINGER HA, 1996, CURRENT PROTOCOLS IM; Wong V, 1997, AM J PHYSIOL-CELL PH, V273, pC1859, DOI 10.1152/ajpcell.1997.273.6.C1859; YOUNG RW, 1976, INVEST OPHTH VISUAL, V15, P700	56	54	55	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					41843	41849		10.1074/jbc.M207111200	http://dx.doi.org/10.1074/jbc.M207111200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12196538	Green Submitted, Green Accepted, hybrid, Green Published			2022-12-27	WOS:000178985300070
J	Boulanger, L; Sabatino, DE; Wong, EY; Cline, AP; Garrett, LJ; Garbarz, M; Dhermy, D; Bodine, DM; Gallagher, PG				Boulanger, L; Sabatino, DE; Wong, EY; Cline, AP; Garrett, LJ; Garbarz, M; Dhermy, D; Bodine, DM; Gallagher, PG			Erythroid expression of the human alpha-spectrin gene promoter is mediated by GATA-1-and NF-E2-binding proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR GATA-1; PORPHOBILINOGEN DEAMINASE GENE; MEMBRANE SKELETAL PROTEINS; DIMER-DIMER ASSOCIATION; LEUCINE ZIPPER PROTEIN; HUMAN ANKYRIN-1 GENE; LOCUS-CONTROL REGION; KRUPPEL-LIKE FACTOR; BETA-SPECTRIN; FACTOR NF-E2	alpha-Spectrin is a highly expressed membrane protein critical for the flexibility and stability of the erythrocyte. Qualitative and quantitative defects of alpha-spectrin are present in the erythrocytes of many patients with abnormalities of red blood cell shape including hereditary spherocytosis and elliptocytosis. We wished to determine the regulatory elements that determine the erythroid-specific expression of the alpha-spectrin gene. We mapped the 5' end of the alpha-spectrin erythroid cDNA and cloned the 5' flanking genomic DNA containing the putative alpha-spectrin gene promoter. Using transfection of promoter/reporter plasmids in human tissue culture cell lines, in vitro DNase I footprinting analyses, and gel mobility shift assays, an alpha-spectrin gene erythroid promoter with binding sites for GATA-1- and NF-E2-related proteins was identified. Both binding sites were required for full promoter activity. In transgenic mice, a reporter gene directed by the alpha-spectrin promoter was expressed in yolk sac, fetal liver, and erythroid cells of bone marrow but not adult reticulocytes. No expression of the reporter gene was detected in nonerythroid tissues. We conclude that this alpha-spectrin gene promoter contains the sequences necessary for low level expression in erythroid progenitor cells.	Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06520 USA; Univ Paris 07, Assoc Claude Bernard, INSERM, U409, F-75870 Paris 18, France; NHGRI, Genet & Mol Biol Branch, Hematopoiesis Sect, NIH, Bethesda, MD 20892 USA	Yale University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Gallagher, PG (corresponding author), Yale Univ, Sch Med, Dept Pediat, 333 Cedar St,POB 208064, New Haven, CT 06520 USA.				NHLBI NIH HHS [HL65448] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065448] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000083, Z01HG000083] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		AGRE P, 1982, NEW ENGL J MED, V306, P1155, DOI 10.1056/NEJM198205133061906; AGRE P, 1986, NEW ENGL J MED, V315, P1579, DOI 10.1056/NEJM198612183152504; AGRE P, 1985, NATURE, V314, P380, DOI 10.1038/314380a0; ANDREWS NC, 1993, NATURE, V362, P722, DOI 10.1038/362722a0; ANDREWS NC, 1993, P NATL ACAD SCI USA, V90, P11488, DOI 10.1073/pnas.90.24.11488; Andrews NC, 1998, INT J BIOCHEM CELL B, V30, P429, DOI 10.1016/S1357-2725(97)00135-0; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; Bieker J J, 1998, Curr Opin Hematol, V5, P145; BLOOM ML, 1993, BLOOD, V82, P2906, DOI 10.1182/blood.V82.9.2906.bloodjournal8292906; Cantor AB, 2002, ONCOGENE, V21, P3368, DOI 10.1038/sj.onc.1205326; CATERINA JJ, 1994, NUCLEIC ACIDS RES, V22, P2383, DOI 10.1093/nar/22.12.2383; CHAN JY, 1993, P NATL ACAD SCI USA, V90, P11371, DOI 10.1073/pnas.90.23.11371; CHAN JY, 1993, P NATL ACAD SCI USA, V90, P11366, DOI 10.1073/pnas.90.23.11366; CHASIS JA, 1988, J CLIN INVEST, V82, P617, DOI 10.1172/JCI113640; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COETZER T, 1990, BLOOD, V75, P2235; CROSSLEY M, 1994, J BIOL CHEM, V269, P15440; Crossley M, 1996, MOL CELL BIOL, V16, P1695; Deveaux S, 1997, EMBO J, V16, P5654, DOI 10.1093/emboj/16.18.5654; DIGNAM JD, 1983, METHOD ENZYMOL, V101, P582; EDWARDS JBDM, 1991, NUCLEIC ACIDS RES, V19, P5227, DOI 10.1093/nar/19.19.5227; ELEOUET JF, 1993, EUR J BIOCHEM, V212, P763, DOI 10.1111/j.1432-1033.1993.tb17716.x; FISCHER KD, 1993, J BIOL CHEM, V268, P23915; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; Gallagher PG, 1998, J BIOL CHEM, V273, P1339, DOI 10.1074/jbc.273.3.1339; Gallagher PG, 2000, BLOOD, V96, P1136, DOI 10.1182/blood.V96.3.1136.015k48_1136_1143; Gallagher PG, 1999, J BIOL CHEM, V274, P6062, DOI 10.1074/jbc.274.10.6062; Gregory RC, 1996, BLOOD, V87, P1793, DOI 10.1182/blood.V87.5.1793.bloodjournal8751793; HANSPAL M, 1987, J CELL BIOL, V105, P1417, DOI 10.1083/jcb.105.3.1417; HANSPAL M, 1992, BLOOD, V80, P530; HARTZOG GA, 1993, MOL CELL BIOL, V13, P44, DOI 10.1128/MCB.13.1.44; HOGAN B, 1986, MANIPULATING MOUSE E; IGARASHI K, 1994, NATURE, V367, P568, DOI 10.1038/367568a0; JAVAHERY R, 1994, MOL CELL BIOL, V14, P116, DOI 10.1128/MCB.14.1.116; KADONAGA JT, 1986, TRENDS BIOCHEM SCI, V11, P20, DOI 10.1016/0968-0004(86)90226-4; KOTKOW KJ, 1995, MOL CELL BIOL, V15, P4640; KOURY MJ, 1987, J CELL PHYSIOL, V133, P438, DOI 10.1002/jcp.1041330304; LIU SC, 1981, J CLIN INVEST, V68, P597, DOI 10.1172/JCI110293; LIU SC, 1982, P NATL ACAD SCI-BIOL, V79, P2072, DOI 10.1073/pnas.79.6.2072; LU SJ, 1994, P NATL ACAD SCI USA, V91, P8398, DOI 10.1073/pnas.91.18.8398; Lux SE, 1995, BLOOD PRINCIPLES PRA, P1701; MASON P, 1993, GENE TRANSCRIPTION P, P47; MERIKA M, 1995, MOL CELL BIOL, V15, P2437; MIGNOTTE V, 1989, NUCLEIC ACIDS RES, V17, P37, DOI 10.1093/nar/17.1.37; MIGNOTTE V, 1989, P NATL ACAD SCI USA, V86, P6548, DOI 10.1073/pnas.86.17.6548; MILLER IJ, 1993, MOL CELL BIOL, V13, P2776, DOI 10.1128/MCB.13.5.2776; MOI P, 1994, P NATL ACAD SCI USA, V91, P9926, DOI 10.1073/pnas.91.21.9926; MORROW JS, 1980, P NATL ACAD SCI-BIOL, V77, P6592, DOI 10.1073/pnas.77.11.6592; MORROW JS, 1997, HDB PHYSIOL 14, P485; NEY PA, 1993, MOL CELL BIOL, V13, P5604, DOI 10.1128/MCB.13.9.5604; NEY PA, 1990, NUCLEIC ACIDS RES, V18, P6011, DOI 10.1093/nar/18.20.6011; ORKIN SH, 1995, J BIOL CHEM, V270, P4955, DOI 10.1074/jbc.270.10.4955; Oyake T, 1996, MOL CELL BIOL, V16, P6083; Philipp S, 1998, FEBS LETT, V438, P315, DOI 10.1016/S0014-5793(98)01326-X; PTERES LL, 1992, P NATL ACAD SCI USA, V89, P5749; Sabatino DE, 1998, MOL CELL BIOL, V18, P6634, DOI 10.1128/MCB.18.11.6634; Sabatino DE, 2000, J BIOL CHEM, V275, P28549, DOI 10.1074/jbc.M004043200; SAHR KE, 1990, J BIOL CHEM, V265, P4434; SAHR KE, 1989, J CLIN INVEST, V84, P1243, DOI 10.1172/JCI114291; Sahr KE, 1996, BLOOD, V88, P4500, DOI 10.1182/blood.V88.12.4500.bloodjournal88124500; SPEICHER DW, 1984, NATURE, V311, P177, DOI 10.1038/311177a0; SPEICHER DW, 1982, J BIOL CHEM, V257, P9093; TALBOT D, 1990, EMBO J, V9, P2169, DOI 10.1002/j.1460-2075.1990.tb07386.x; TALBOT D, 1991, EMBO J, V10, P1391, DOI 10.1002/j.1460-2075.1991.tb07659.x; Tse WT, 1999, BRIT J HAEMATOL, V104, P2, DOI 10.1111/j.1365-2141.1999.01130.x; TUGORES A, 1994, J BIOL CHEM, V269, P30789; WALTERS M, 1992, P NATL ACAD SCI USA, V89, P10444, DOI 10.1073/pnas.89.21.10444; Wandersee N J, 2000, Hematol J, V1, P235, DOI 10.1038/sj.thj.6200030; WINKELMANN JC, 1993, BLOOD, V81, P3173; WINKELMANN JC, 1990, J BIOL CHEM, V265, P20449; ZON LI, 1991, P NATL ACAD SCI USA, V88, P10638, DOI 10.1073/pnas.88.23.10638	72	17	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					41563	41570		10.1074/jbc.M208184200	http://dx.doi.org/10.1074/jbc.M208184200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12196550	hybrid			2022-12-27	WOS:000178985300035
J	Chakraborty, S; Massey, V				Chakraborty, S; Massey, V			Reaction of reduced flavins and flavoproteins with diphenyliodonium chloride	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARA-HYDROXYBENZOATE HYDROXYLASE; 2-METHYL-3-HYDROXYPYRIDINE-5-CARBOXYLIC ACID OXYGENASE; OLD YELLOW ENZYME; NEUTROPHIL NADPH OXIDASE; PSEUDOMONAS-FLUORESCENS; PHENOL HYDROXYLASE; CRYSTAL-STRUCTURE; MECHANISM; INHIBITION; BINDING	The reaction of diphenyliodonium chloride with free reduced flavins has been studied by stopped flow spectrophotometry under anaerobic conditions, and second order rate constants were determined as a function of pH. The reactive flavin species was identified as the reduced anion, based on an observed reaction pK of 6.7. The product mixture was independent of the initial concentration of reactant and contained similar to20% oxidized flavin. The results can be modeled quantitatively on a modification of the mechanism proposed by Tew (Tew, D. G. (1993) Biochemistry 32,10209-10215). The composition of the complex reaction mixture has been analyzed, and four flavin-phenyl adducts with distinctive absorbance and fluorescence characteristics have been identified, involving substitution at the flavin C4a, N5, and C8 positions. Inactivation of flavoprotein enzymes by diphenyliodonium has also been studied, and several examples were found where inactivation occurs readily, despite noninvolvement of radical intermediates in their reaction mechanisms. It can be concluded that inactivation by phenyliodonium species is not a valid indicator of catalytic mechanism involving radical intermediates. One of the several factors determining inactivation is maintenance of the enzyme flavin in the reduced form in the steady state of catalysis, the other factors being redox potential and accessibility of the inhibitor to the flavin active site.	Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Chakraborty, S (corresponding author), Univ Michigan, Sch Med, Dept Biol Chem, 1301 Catherine St, Ann Arbor, MI 48109 USA.	sumita@umich.de						BANKS DF, 1966, CHEM REV, V66, P243, DOI 10.1021/cr60241a001; BERINGER FM, 1972, J ORG CHEM, V37, P2486; BRUSTLEIN M, 1971, ANGEW CHEM INT EDIT, V10, P804, DOI 10.1002/anie.197108041; Chaiyen P, 1997, BIOCHEMISTRY-US, V36, P8060, DOI 10.1021/bi970089u; Chaiyen P, 1997, BIOCHEMISTRY-US, V36, P2612, DOI 10.1021/bi962325r; Chaiyen PC, 1997, P NATL ACAD SCI USA, V94, P7233, DOI 10.1073/pnas.94.14.7233; Coves J, 1999, BIOCHEM J, V342, P465, DOI 10.1042/0264-6021:3420465; DETMER K, 1984, J BIOL CHEM, V259, P1265; DUPLATRE G, 1984, RADIAT PHYS CHEM, V24, P557, DOI 10.1016/0146-5724(84)90193-6; ENTSCH B, 1991, J BIOL CHEM, V266, P17341; FITZPATRICK PF, 1982, J BIOL CHEM, V257, P1166; FOX KM, 1994, STRUCTURE, V2, P1089, DOI 10.1016/S0969-2126(94)00111-1; Goez M, 1999, J PHYS CHEM A, V103, P5714, DOI 10.1021/jp990681o; HECHT HJ, 1993, J MOL BIOL, V229, P153, DOI 10.1006/jmbi.1993.1015; Hemmerich P, 1971, FLAVINS FLAVOPROTEIN, P83; Hennig H, 2001, CHEM-EUR J, V7, P2114, DOI 10.1002/1521-3765(20010518)7:10<2114::AID-CHEM2114>3.0.CO;2-D; HOWELL LG, 1972, J BIOL CHEM, V247, P4340; KOMAI H, 1969, J BIOL CHEM, V244, P1692; Kunze A, 1997, J PHOTOCH PHOTOBIO A, V110, P115, DOI 10.1016/S1010-6030(97)00178-0; LAND EJ, 1969, BIOCHEMISTRY-US, V8, P2117, DOI 10.1021/bi00833a050; LOCKRIDGE O, 1972, J BIOL CHEM, V247, P8097; LUDWIG ML, 1992, CHEM BIOCH FLAVOENZY, V3, P427; MAEDAYORITA K, 1993, J BIOL CHEM, V268, P4134; MASSEY V, 1960, BIOCHIM BIOPHYS ACTA, V37, P314, DOI 10.1016/0006-3002(60)90239-0; MASSEY V, 1969, J BIOL CHEM, V244, P1682; Massey V., 1973, OXIDASES RELATED RED, P25; MAYHEW SG, 1975, EUR J BIOCHEM, V59, P539, DOI 10.1111/j.1432-1033.1975.tb02480.x; MAYHEW SG, 1984, FLAVINS FLAVOPROTEIN, P261; MOONEN CTW, 1984, BIOCHEMISTRY-US, V23, P4859, DOI 10.1021/bi00316a007; Moran GR, 1996, BIOCHEMISTRY-US, V35, P9278, DOI 10.1021/bi960360s; MULLER F, 1991, CHEM BIOCH FLAVOENZY, V3, P557; MULLER F, 1987, FLAVINS FLAVOPROTEIN, P261; Mullis K B, 1991, PCR Methods Appl, V1, P1; ODONNELL VB, 1994, MOL PHARMACOL, V46, P778; ODONNELL VB, 1993, BIOCHEM J, V290, P41, DOI 10.1042/bj2900041; PALFEY BA, 1994, BIOCHEMISTRY-US, V33, P1545, DOI 10.1021/bi00172a035; Patil PV, 2000, ANAL BIOCHEM, V286, P187, DOI 10.1006/abio.2000.4802; POWLOWSKI JB, 1987, J BIOL CHEM, V262, P69; PRESS WH, 1992, NUMERICAL RECIPES; SAITO K, 1991, J BIOL CHEM, V266, P20720; SCHREUDER HA, 1989, J MOL BIOL, V208, P679, DOI 10.1016/0022-2836(89)90158-7; SPECTOR T, 1972, J BIOL CHEM, V247, P7123; SPECTOR T, 1972, J BIOL CHEM, V247, P4679; STEWART RC, 1985, J BIOL CHEM, V260, P3639; STRICKLAND S, 1973, J BIOL CHEM, V248, P2944; STUEHR DJ, 1991, FASEB J, V5, P98, DOI 10.1096/fasebj.5.1.1703974; SWOBODA BEP, 1965, J BIOL CHEM, V240, P2209; TEW DG, 1993, BIOCHEMISTRY-US, V32, P10209, DOI 10.1021/bi00089a042; VANDENBERGHESNOREK S, 1985, J BIOL CHEM, V260, P3373; Xu D, 2001, BIOCHEMISTRY-US, V40, P12369, DOI 10.1021/bi010962y; YEA CM, 1990, BIOCHEM J, V265, P95, DOI 10.1042/bj2650095	51	47	48	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					41507	41516		10.1074/jbc.M205432200	http://dx.doi.org/10.1074/jbc.M205432200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12186866	hybrid			2022-12-27	WOS:000178985300028
J	Hong, Q; Gutierrez-Aguirre, I; Barlic, A; Malovrh, P; Kristan, K; Podlesek, Z; Macek, P; Turk, D; Gonzalez-Manas, JM; Lakey, JH; Anderluh, G				Hong, Q; Gutierrez-Aguirre, I; Barlic, A; Malovrh, P; Kristan, K; Podlesek, Z; Macek, P; Turk, D; Gonzalez-Manas, JM; Lakey, JH; Anderluh, G			Two-step membrane binding by equinatoxin II, a pore-forming toxin from the sea anemone, involves an exposed aromatic cluster and a flexible helix	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SURFACE-PLASMON RESONANCE; ACTINIA-EQUINA; STICHODACTYLA-HELIANTHUS; PERFRINGOLYSIN-O; LIPID-MEMBRANES; CHOLESTEROL-BINDING; CRYSTAL-STRUCTURE; MODEL MEMBRANES; STICHOLYSIN-II; GOLD SURFACES	Equinatoxin 11 (EqtII) belongs to a unique family of 20-kDa pore-forming toxins from sea anemones. These toxins preferentially bind to membranes containing sphingomyelin and create cation-selective pores by oligomerization of 3-4 monomers. In this work we have studied the binding of EqtII to lipid membranes by the use of lipid monolayers and surface plasmon resonance (SPR). The binding is a two-step process, separately mediated by two regions of the molecule. An exposed aromatic cluster involving tryptophans 112 and 116 mediates the initial attachment that is prerequisite for the next step. Steric shielding of the aromatic cluster or mutation of Trp-112 and -116 to phenylalanine significantly reduces the toxin-lipid interaction. The second step is promoted by the N-terminal amphiphilic helix, which translocates into the lipid phase. The two steps were distinguished by the use of a double cysteine mutant having the N-terminal helix fixed to the protein core by a disulfide bond. The kinetics of membrane binding derived from the SPR experiments could be fitted to a two-stage binding model. Finally, by using membrane-embedded quenchers, we showed that EqtII does not insert deeply in the membrane. The first step of the EqtII binding is reminiscent of the binding of the evolutionarily distant cholesterol-dependant cytolysins, which share a similar structural motif in the membrane attachment domain.	Newcastle Univ, Sch Biochem & Genet, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Univ Basque Country, Unidad Biofis, CSIC, EHU, E-48080 Bilbao, Spain; Univ Basque Country, Dept Bioquim & Biol Mol, E-48080 Bilbao, Spain; Univ Ljubljana, Dept Biol, Biotech Fac, Ljubljana 1000, Slovenia; Jozef Stefan Inst, Dept Biochem & Mol Biol, Ljubljana 1000, Slovenia	Newcastle University - UK; Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC - UPV EHU - Instituto Biofisika; University of Basque Country; University of Ljubljana; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute	Anderluh, G (corresponding author), Newcastle Univ, Sch Biochem & Genet, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	gregor.anderluh@ncl.ac.uk	Maček, Peter/Y-9877-2019; Anderluh, Gregor/C-6905-2014; Maček, Peter/U-4662-2017	Maček, Peter/0000-0001-6470-7759; Anderluh, Gregor/0000-0002-9916-8465; Maček, Peter/0000-0001-6470-7759; Gutierrez Aguirre, Ion/0000-0002-8348-8616; GONZALEZ MANAS, JUAN MANUEL/0000-0002-1833-6982				Anderluh G, 1997, PROTEIN ENG, V10, P751, DOI 10.1093/protein/10.7.751; Anderluh G, 1999, EUR J BIOCHEM, V263, P128, DOI 10.1046/j.1432-1327.1999.00477.x; Anderluh G, 1998, BIOCHEM BIOPH RES CO, V242, P187, DOI 10.1006/bbrc.1997.7944; Anderluh G, 1996, BIOCHEM BIOPH RES CO, V220, P437, DOI 10.1006/bbrc.1996.0391; Anderluh G, 2002, TOXICON, V40, P111, DOI 10.1016/S0041-0101(01)00191-X; Athanasiadis A, 2001, STRUCTURE, V9, P341, DOI 10.1016/S0969-2126(01)00592-5; BELMONTE G, 1994, BBA-BIOMEMBRANES, V1192, P197, DOI 10.1016/0005-2736(94)90119-8; BELMONTE G, 1993, J MEMBRANE BIOL, V131, P11, DOI 10.1007/BF02258530; Caaveiro JMM, 2001, BIOPHYS J, V80, P1343, DOI 10.1016/S0006-3495(01)76107-3; Cho W, 2001, J BIOL CHEM, V276, P32407, DOI 10.1074/jbc.R100007200; Cho WW, 2001, ANAL BIOCHEM, V296, P153, DOI 10.1006/abio.2001.5225; De los Rios V, 1998, EUR J BIOCHEM, V252, P284, DOI 10.1046/j.1432-1327.1998.2520284.x; Driscoll PC, 1999, CURR BIOL, V9, pR857, DOI 10.1016/S0960-9822(00)80046-9; EAST JM, 1982, BIOCHEMISTRY-US, V21, P4144, DOI 10.1021/bi00260a035; ELLENS H, 1985, BIOCHEMISTRY-US, V24, P3099, DOI 10.1021/bi00334a005; FERGUSON KM, 1995, CELL, V83, P1037, DOI 10.1016/0092-8674(95)90219-8; GONZALEZMANAS JM, 1992, BIOCHEMISTRY-US, V31, P7294, DOI 10.1021/bi00147a013; Heuck AP, 2000, MOL CELL, V6, P1233, DOI 10.1016/S1097-2765(00)00119-2; Hinds MG, 2002, J MOL BIOL, V315, P1219, DOI 10.1006/jmbi.2001.5321; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Hurley JH, 2000, ANNU REV BIOPH BIOM, V29, P49, DOI 10.1146/annurev.biophys.29.1.49; Kem W.R., 1988, P375; Kennedy MW, 2000, CELL MOL LIFE SCI, V57, P1379, DOI 10.1007/PL00000623; Killian JA, 2000, TRENDS BIOCHEM SCI, V25, P429, DOI 10.1016/S0968-0004(00)01626-1; Kim KP, 2000, BIOCHEM J, V348, P643, DOI 10.1042/0264-6021:3480643; Kuziemko GM, 1996, BIOCHEMISTRY-US, V35, P6375, DOI 10.1021/bi952314i; Ladokhin AS, 2001, J MOL BIOL, V309, P543, DOI 10.1006/jmbi.2001.4684; LANG H, 1994, LANGMUIR, V10, P197, DOI 10.1021/la00013a029; Lemmon MA, 1996, CELL, V85, P621, DOI 10.1016/S0092-8674(00)81022-3; Lubkowski J, 1999, STRUCTURE, V7, P711, DOI 10.1016/S0969-2126(99)80092-6; Macedo-Ribeiro S, 1999, NATURE, V402, P434, DOI 10.1038/46594; MACEK P, 1994, TOXICOLOGY, V87, P205, DOI 10.1016/0300-483X(94)90252-6; MACEK P, 1981, TOXICON, V19, P233, DOI 10.1016/0041-0101(81)90026-X; MACEK P, 1995, EUR J BIOCHEM, V234, P329, DOI 10.1111/j.1432-1033.1995.329_c.x; MACEK P, 1988, TOXICON, V26, P441, DOI 10.1016/0041-0101(88)90183-3; MacKenzie CR, 1997, J BIOL CHEM, V272, P5533, DOI 10.1074/jbc.272.9.5533; Malovrh P, 2000, BIOCHEM J, V346, P223, DOI 10.1042/0264-6021:3460223; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; PARKER MW, 1996, PROTEIN TOXIN STRUCT; PERKINS SJ, 1986, EUR J BIOCHEM, V157, P169, DOI 10.1111/j.1432-1033.1986.tb09653.x; Pratt KP, 1999, NATURE, V402, P439, DOI 10.1038/46601; Rossjohn J, 1997, CELL, V89, P685, DOI 10.1016/S0092-8674(00)80251-2; SekinoSuzuki N, 1996, EUR J BIOCHEM, V241, P941, DOI 10.1111/j.1432-1033.1996.00941.x; Shatursky O, 1999, CELL, V99, P293, DOI 10.1016/S0092-8674(00)81660-8; Shepard LA, 1998, BIOCHEMISTRY-US, V37, P14563, DOI 10.1021/bi981452f; Stahelin RV, 2001, BIOCHEMISTRY-US, V40, P4672, DOI 10.1021/bi0020325; Tejuca M, 1996, BIOCHEMISTRY-US, V35, P14947, DOI 10.1021/bi960787z; Terrettaz S, 2002, PROTEIN SCI, V11, P1917, DOI 10.1110/ps.0206102; Tweten RK, 2001, CURR TOP MICROBIOL, V257, P15; Valcarcel CA, 2001, BIOPHYS J, V80, P2761, DOI 10.1016/S0006-3495(01)76244-3; van der Goot G., 2001, PORE FORMING TOXINS; Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; ZOREC R, 1990, J MEMBRANE BIOL, V118, P243, DOI 10.1007/BF01868608	54	177	191	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					41916	41924		10.1074/jbc.M204625200	http://dx.doi.org/10.1074/jbc.M204625200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12198118	hybrid			2022-12-27	WOS:000178985300079
J	Kwon, YH; Jovanovic, A; Serfas, MS; Kiyokawa, H; Tyner, AL				Kwon, YH; Jovanovic, A; Serfas, MS; Kiyokawa, H; Tyner, AL			p21 functions to maintain quiescence of p27-deficient hepatocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICE LACKING; CDK INHIBITORS; DEPENDENT KINASES; P27(KIP1); P21(CIP1); P21(WAF1/CIP1); EXPRESSION; PROLIFERATION; GROWTH; GENE	Hepatocytes rarely proliferate in the healthy adult liver. We explored the roles of the cyclin kinase inhibitors p21 and p27 in maintaining hepatocyte quiescence. p27 is expressed throughout the wild-type liver, but the related protein p21 was not detected. However, p21 was detected in livers of p27-deficient mice. Increased p21 protein levels did not result from an increase in p21 mRNA expression, indicating that p21 expression is regulated post-transcriptionally. p21 protein levels increased in cultured primary hepatocytes treated with the proteasome inhibitor MG132 and cycloheximide, indicating that p21 expression is regulated at the level of protein stability in liver cells. Although increased expression of cyclin-dependent kinase (Cdk) 4, Cdk2, and proliferating cell nuclear antigen was detected in p27-deficient livers, increased hepatocyte proliferation was detected only in livers of mice deficient for both p21 and p27. In p27-deficient livers, p21 was found in complexes with Cdk2 and CdK4 and can compensate for the absence of p27. Our data indicate that cyclin kinase inhibitor activity is important for maintaining hepatocyte quiescence in the adult liver. Significant increases in p21 were detected in multiple tissues of mature p27-deficient mice compared with wild-type mice, suggesting that the ability of p21 to functionally substitute for p27 is not liver-specific.	Univ Illinois, Coll Med, Dept Mol Genet, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Tyner, AL (corresponding author), Univ Illinois, Coll Med, Dept Mol Genet, MC 669,900 S Ashland Ave, Chicago, IL 60607 USA.	atyner@uic.edu		Kiyokawa, Hiroaki/0000-0002-7942-6455; Tyner, Angela/0000-0001-7448-8625	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056283] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01-DK56283, R01 DK056283-05, R01 DK056283] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Albrecht JH, 1998, ONCOGENE, V16, P2141, DOI 10.1038/sj.onc.1201728; Albrecht JH, 1997, HEPATOLOGY, V25, P557, DOI 10.1002/hep.510250311; Balomenos D, 2000, NAT MED, V6, P171, DOI 10.1038/72272; Bao WJ, 2002, MOL CELL BIOL, V22, P4587, DOI 10.1128/MCB.22.13.4587-4597.2002; BRUGAROLAS J, 1995, NATURE, V377, P552, DOI 10.1038/377552a0; Cayrol C, 1998, ONCOGENE, V17, P2437, DOI 10.1038/sj.onc.1202189; Cheng MG, 1999, EMBO J, V18, P1571, DOI 10.1093/emboj/18.6.1571; Cheng T, 2000, NAT MED, V6, P1235, DOI 10.1038/81335; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Coats S, 1996, SCIENCE, V272, P877, DOI 10.1126/science.272.5263.877; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; Dotto GP, 2000, BBA-REV CANCER, V1471, pM43, DOI 10.1016/S0304-419X(00)00019-6; Fausto N, 2000, J HEPATOL, V32, P19, DOI 10.1016/S0168-8278(00)80412-2; Fero ML, 1996, CELL, V85, P733, DOI 10.1016/S0092-8674(00)81239-8; Fero ML, 1998, NATURE, V396, P177, DOI 10.1038/24179; Franklin DS, 2000, MOL CELL BIOL, V20, P6147, DOI 10.1128/MCB.20.16.6147-6158.2000; Gartel AL, 1996, P SOC EXP BIOL MED, V213, P138; Gartel AL, 1999, EXP CELL RES, V246, P280, DOI 10.1006/excr.1998.4319; Hatano E, 2000, J BIOL CHEM, V275, P11814, DOI 10.1074/jbc.275.16.11814; Hui AM, 1998, CANCER LETT, V132, P67, DOI 10.1016/S0304-3835(98)00164-5; Ito Y, 1999, HEPATOLOGY, V30, P90, DOI 10.1002/hep.510300114; Karnezis AN, 2001, J CLIN INVEST, V108, P383, DOI 10.1172/JCI11933; Kim GY, 2002, J BIOL CHEM, V277, P29792, DOI 10.1074/jbc.M201299200; Kiyokawa H, 1996, CELL, V85, P721, DOI 10.1016/S0092-8674(00)81238-6; Klibanov SA, 2001, J CELL SCI, V114, P1867; LaBaer J, 1997, GENE DEV, V11, P847, DOI 10.1101/gad.11.7.847; Lee LA, 2001, J CLIN INVEST, V108, P367, DOI 10.1172/JCI200113650; Li Y, 2002, J BIOL CHEM, V277, P11352, DOI 10.1074/jbc.M109062200; Maki CG, 1997, MOL CELL BIOL, V17, P355, DOI 10.1128/MCB.17.1.355; Martin-Caballero J, 2001, CANCER RES, V61, P6234; Megyesi J, 1999, P NATL ACAD SCI USA, V96, P10830, DOI 10.1073/pnas.96.19.10830; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; NOURSE J, 1994, NATURE, V372, P570, DOI 10.1038/372570a0; Oh H, 2002, P NATL ACAD SCI USA, V99, P5430, DOI 10.1073/pnas.082123999; Ophascharoensuk V, 1998, NAT MED, V4, P575, DOI 10.1038/nm0598-575; Philipp J, 1999, ONCOGENE, V18, P4689, DOI 10.1038/sj.onc.1202840; Philipp-Staheli J, 2001, EXP CELL RES, V264, P148, DOI 10.1006/excr.2000.5143; Rivard N, 1996, J BIOL CHEM, V271, P18337, DOI 10.1074/jbc.271.31.18337; Rossig L, 2002, J BIOL CHEM, V277, P9684, DOI 10.1074/jbc.M106157200; Rossig L, 2001, MOL CELL BIOL, V21, P5644, DOI 10.1128/MCB.21.16.5644-5657.2001; Serfas MS, 1997, CELL GROWTH DIFFER, V8, P951; Sheaff RJ, 2000, MOL CELL, V5, P403, DOI 10.1016/S1097-2765(00)80435-9; Sherr CJ, 2000, CANCER RES, V60, P3689; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Slingerland J, 2000, J CELL PHYSIOL, V183, P10, DOI 10.1002/(SICI)1097-4652(200004)183:1<10::AID-JCP2>3.0.CO;2-I; Tannapfel A, 2000, INT J CANCER, V89, P350, DOI 10.1002/1097-0215(20000720)89:4<350::AID-IJC6>3.0.CO;2-3; Timchenko NA, 1997, MOL CELL BIOL, V17, P7353, DOI 10.1128/MCB.17.12.7353; Topley GI, 1999, P NATL ACAD SCI USA, V96, P9089, DOI 10.1073/pnas.96.16.9089; Touitou R, 2001, EMBO J, V20, P2367, DOI 10.1093/emboj/20.10.2367; Tsurimoto T., 1999, FRONT BIOSCI, V4, P849; Tsutsui T, 1999, MOL CELL BIOL, V19, P7011; Viollet B, 2001, MOL CELL BIOL, V21, P3662, DOI 10.1128/MCB.21.11.3662-3670.2001; Warbrick E, 2000, BIOESSAYS, V22, P997, DOI 10.1002/1521-1878(200011)22:11<997::AID-BIES6>3.3.CO;2-R; Zhang PM, 1998, GENE DEV, V12, P3162, DOI 10.1101/gad.12.20.3162; Zhang PM, 1999, GENE DEV, V13, P213, DOI 10.1101/gad.13.2.213; Zindy F, 1999, P NATL ACAD SCI USA, V96, P13462, DOI 10.1073/pnas.96.23.13462	57	33	33	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					41417	41422		10.1074/jbc.M203388200	http://dx.doi.org/10.1074/jbc.M203388200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12202477	hybrid			2022-12-27	WOS:000178985300017
J	Soriano, GM; Guo, LW; de Vitry, C; Kallas, T; Cramer, WA				Soriano, GM; Guo, LW; de Vitry, C; Kallas, T; Cramer, WA			Electron transfer from the Rieske iron-sulfur protein (ISP) to cytochrome f in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERNAL WATER CHAIN; LUMEN-SIDE DOMAIN; BC(1) COMPLEX; B(6)F COMPLEX; OXYGENIC PHOTOSYNTHESIS; REDOX REACTIONS; PH-DEPENDENCE; BOVINE HEART; BC1 COMPLEX; IN-VIVO	The time course of electron transfer in vitro between soluble domains of the Rieske iron-sulfur protein (ISP) and cytochrome f subunits of the cytochrome b(6)f complex of oxygenic photosynthesis was measured by stopped-flow mixing. The domains were derived from Chlamydomonas reinhardtii and expressed in Escherichia coli. The expressed 142-residue soluble ISP apoprotein was reconstituted with the [2Fe-2S] cluster. The second-order rate constant, k(2)((ISP-f)) = 1.5 X 10(6) m(-1) s(-1), for ISP to cytochrome f electron transfer was <10(-2) of the rate constant at low ionic strength, k(2)((f-PC))(> 200 X 10(6) M-1 s(-1)), for the reduction of plastocyanin by cytochrome f, and similar to1/30 of k(2)((f-PC)) at the ionic strength estimated mated for the thylakoid interior. In contrast to k(2)((f-PC)), k(2)((ISP-f)) was independent of pH and ionic strength, implying no significant role of electrostatic interactions. Effective pK values of 6.2 and 8.3, respectively, of oxidized and reduced ISP were derived from the pH dependence of the amplitude of cytochrome f reduction. The first-order rate constant, k(1)((ISP-f)), predicted from k(2)((ISP-f)) is similar to 10 and similar to150 times smaller than the millisecond and microsecond phases of cytochrome f reduction observed in vivo. It is proposed that in the absence of electrostatic guidance, a productive docking geometry for fast electron transfer is imposed by the guided trajectory of the ISP extrinsic domain. The requirement of a specific electrically neutral docking configuration for ISP electron transfer is consistent with structure data for the related cytochrome bc(1) complex.	Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; Purdue Univ, Program Biochem Mol Biol, W Lafayette, IN 47907 USA; Inst Biol Physicochim, CNRS UPR 1261, F-75005 Paris, France; Univ Wisconsin, Dept Biol & Microbiol, Oshkosh, WI 54901 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Centre National de la Recherche Scientifique (CNRS); University of Wisconsin System	Soriano, GM (corresponding author), Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038323, R56GM038323] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-38323] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AASA R, 1976, BIOCHIM BIOPHYS ACTA, V422, P260, DOI 10.1016/0005-2744(76)90137-6; BENDALL DS, 1982, BIOCHIM BIOPHYS ACTA, V683, P119, DOI 10.1016/0304-4173(82)90008-8; Bron P, 1999, J MOL BIOL, V287, P117, DOI 10.1006/jmbi.1999.2604; Carrell CJ, 1997, STRUCTURE, V5, P1613, DOI 10.1016/S0969-2126(97)00309-2; CHENG H, 1995, ARCH BIOCHEM BIOPHYS, V316, P619, DOI 10.1006/abbi.1995.1082; Cramer WA, 1996, ANNU REV PLANT PHYS, V47, P477, DOI 10.1146/annurev.arplant.47.1.477; Crofts AR, 1998, CURR OPIN STRUC BIOL, V8, P501, DOI 10.1016/S0959-440X(98)80129-2; CROFTS AR, 1999, BIOCHEMISTRY, V38; Darrouzet E, 2000, BIOCHEMISTRY-US, V39, P15475, DOI 10.1021/bi000750l; DELOSME R, 1991, PHOTOSYNTH RES, V29, P45, DOI 10.1007/BF00035205; Denke E, 1998, J BIOL CHEM, V273, P9085, DOI 10.1074/jbc.273.15.9085; GROSS R, 1999, GENE INSPECTOR SEQUE; Gutierrez-Cirlos EB, 2002, J BIOL CHEM, V277, P1195, DOI 10.1074/jbc.M109097200; HAEHNEL W, 1989, J CELL BIOL, V108, P1397, DOI 10.1083/jcb.108.4.1397; HAUSKA G, 1996, OXYGENIC PHOTOSYNTHE; Heimann S, 2000, BIOCHEMISTRY-US, V39, P2692, DOI 10.1021/bi9921992; Holton B, 1996, BIOCHEMISTRY-US, V35, P15485, DOI 10.1021/bi961367c; Hunte C, 2000, STRUCTURE, V8, P669, DOI 10.1016/S0969-2126(00)00152-0; HURT E, 1981, EUR J BIOCHEM, V117, P591; Iwata S, 1998, SCIENCE, V281, P64, DOI 10.1126/science.281.5373.64; Izrailev S, 1999, BIOPHYS J, V77, P1753, DOI 10.1016/S0006-3495(99)77022-0; JONES RW, 1988, BIOCHIM BIOPHYS ACTA, V933, P258, DOI 10.1016/0005-2728(88)90033-3; KAISER WM, 1983, Z PFLANZENPHYSIOL, V113, P15, DOI 10.1016/S0044-328X(83)80015-4; Kallas T, 1994, MOL BIOL CYANOBACTER, V1, P259, DOI DOI 10.1007/978-94-011-0227-8_9; Kim H, 1998, P NATL ACAD SCI USA, V95, P8026, DOI 10.1073/pnas.95.14.8026; Kramer DM, 1999, PHOTOSYNTH RES, V60, P151, DOI 10.1023/A:1006212014787; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LINK TA, 1992, EUR J BIOCHEM, V208, P685, DOI 10.1111/j.1432-1033.1992.tb17235.x; Martinez SE, 1996, PROTEIN SCI, V5, P1081; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Metzger SU, 1997, BBA-BIOENERGETICS, V1319, P233, DOI 10.1016/S0005-2728(96)00164-8; MEYER TE, 1993, BIOCHEMISTRY-US, V32, P4552, DOI 10.1021/bi00068a010; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; NITSCHKE W, 1992, BIOCHIM BIOPHYS ACTA, V1102, P266, DOI 10.1016/0167-4838(92)90519-J; Ponamarev MV, 1998, BIOCHEMISTRY-US, V37, P17199, DOI 10.1021/bi981814j; QIN L, 1992, BIOCHEMISTRY-US, V31, P5145, DOI 10.1021/bi00137a008; REDINBO MR, 1993, BIOCHEMISTRY-US, V32, P10560, DOI 10.1021/bi00091a005; Roberts AG, 2002, BIOCHEMISTRY-US, V41, P4070, DOI 10.1021/bi015996k; Sadoski RC, 2000, BIOCHEMISTRY-US, V39, P4231, DOI 10.1021/bi000003o; Sainz G, 2000, BIOCHEMISTRY-US, V39, P9164, DOI 10.1021/bi0004596; Schoepp B, 1999, FEBS LETT, V450, P245, DOI 10.1016/S0014-5793(99)00511-6; Soriano GM, 1996, BIOCHEMISTRY-US, V35, P14590, DOI 10.1021/bi9616211; Soriano GM, 1998, BIOCHEMISTRY-US, V37, P15120, DOI 10.1021/bi9807714; Soriano GM, 2001, BIOCHEMISTRY-US, V40, P15109, DOI 10.1021/bi011465k; THONYMEYER L, 1995, J BACTERIOL, V177, P4321; Tian H, 1998, J BIOL CHEM, V273, P27953, DOI 10.1074/jbc.273.43.27953; Ugulava NB, 1998, FEBS LETT, V440, P409, DOI 10.1016/S0014-5793(98)01493-8; WHITMARSH J, 1982, BIOCHIM BIOPHYS ACTA, V682, P404, DOI 10.1016/0005-2728(82)90054-8; WHITMARSH J, 1979, BIOPHYS J, V26, P223, DOI 10.1016/S0006-3495(79)85246-7; WIDGER WR, 1984, P NATL ACAD SCI-BIOL, V81, P674, DOI 10.1073/pnas.81.3.674; Zhang JM, 1996, J BIOL CHEM, V271, P31360, DOI 10.1074/jbc.271.49.31360; Zhang ZL, 1998, NATURE, V392, P677, DOI 10.1038/33612	52	17	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					41865	41871		10.1074/jbc.M205772200	http://dx.doi.org/10.1074/jbc.M205772200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12207018	hybrid, Green Submitted			2022-12-27	WOS:000178985300073
J	Zor, T; Mayr, BM; Dyson, HJ; Montminy, MR; Wright, PE				Zor, T; Mayr, BM; Dyson, HJ; Montminy, MR; Wright, PE			Roles of phosphorylation and helix propensity in the binding of the KIX domain of CREB-binding protein by constitutive (c-Myb) and inducible (CREB) activators	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSACTIVATION DOMAIN; COACTIVATOR COMPLEX; SECONDARY STRUCTURE; GENE ACTIVATION; CHEMICAL-SHIFTS; CELL-GROWTH; PEPTIDES; KINASE; CBP; DIFFERENTIATION	cAMP-response element-binding protein (CREB)binding protein (CBP) is a general transcriptional coactivator that mediates interactions between transcription factors and the basal transcription machinery. To obtain insights into the mechanism by which the KIX domain of CBP can recognize the transactivation domains of many different transcription factors, we have used NMR and biochemical analyses to study the interactions of KIX with the transactivation domain from the constitutive activator c-Myb and with the kinase-inducible transactivation domain (KID) from CREB. NAIR chemical shift mapping shows that both activation domains bind to the same surface of KIX. In the unbound state, both the phosphorylated KID and c-Myb activation domains are only partly structured, and binding to KIX is coupled with folding to form an amphipathic helix. Helix-destabilizing mutations significantly impair binding, whereas mutations that increase the intrinsic secondary structure content of the free phosphorylated KID peptide have only a small influence on binding affinity. Low affinity but specific binding of unphosphorylated KID to KIX was measured by ITC and was also observed in Western blot assays and by a fluorescence resonance energy transfer experiment in living cells. The large increase in the affinity for phosphorylated KID is due to favorable intermolecular interactions involving the phosphate moiety. After induction by phosphorylation, CREB is able to compete effectively with other transcriptional activators for binding to CBP.	Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Peptide Biol Lab, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Salk Institute	Wright, PE (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	wright@scripps.edu	Zor, Tsaffrir/H-1802-2013; Mayr, Bernhard M/F-6936-2012; Dyson, Jane/D-4160-2011	Zor, Tsaffrir/0000-0002-7224-3939; Mayr, Bernhard M/0000-0002-8973-4494; Dyson, Jane/0000-0001-6855-3398; Wright, Peter/0000-0002-1368-0223	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036643] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM36643] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bienkiewicz EA, 2002, BIOCHEMISTRY-US, V41, P752, DOI 10.1021/bi015763t; Bies J, 1997, ONCOGENE, V14, P203, DOI 10.1038/sj.onc.1200828; Blobel GA, 2000, BLOOD, V95, P745, DOI 10.1182/blood.V95.3.745.003k05_745_755; Buck M, 1998, Q REV BIOPHYS, V31, P297, DOI 10.1017/S003358359800345X; Cardinaux JR, 2000, MOL CELL BIOL, V20, P1546, DOI 10.1128/MCB.20.5.1546-1552.2000; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Dai P, 1996, GENE DEV, V10, P528, DOI 10.1101/gad.10.5.528; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Ernst P, 2001, MOL CELL BIOL, V21, P2249, DOI 10.1128/MCB.21.7.2249-2258.2001; Giebler HA, 2000, MOL CELL BIOL, V20, P4849, DOI 10.1128/MCB.20.13.4849-4858.2000; GONDA TJ, 1984, NATURE, V310, P249, DOI 10.1038/310249a0; Goodman RH, 2000, GENE DEV, V14, P1553; Grzesiek S, 1996, BIOCHEMISTRY-US, V35, P10256, DOI 10.1021/bi9611164; HAGIWARA M, 1992, CELL, V70, P105, DOI 10.1016/0092-8674(92)90537-M; HAGIWARA M, 1993, MOL CELL BIOL, V13, P4852, DOI 10.1128/MCB.13.8.4852; HOLTZER ME, 1992, BIOPOLYMERS, V32, P1675, DOI 10.1002/bip.360321209; Hua QX, 1998, BIOCHEMISTRY-US, V37, P5858, DOI 10.1021/bi9800808; KNIGHTON DR, 1991, SCIENCE, V253, P414, DOI 10.1126/science.1862343; Kohno T, 1998, J BIOMOL NMR, V12, P109, DOI 10.1023/A:1008254603368; Luo PZ, 1997, BIOCHEMISTRY-US, V36, P8413, DOI 10.1021/bi9707133; Mayr BM, 2001, P NATL ACAD SCI USA, V98, P10936, DOI 10.1073/pnas.191152098; Mestas SP, 1999, NAT STRUCT BIOL, V6, P613; MUNOZ V, 1995, J MOL BIOL, V245, P297, DOI 10.1006/jmbi.1994.0024; Oh IH, 1999, ONCOGENE, V18, P3017, DOI 10.1038/sj.onc.1202839; Parker D, 1999, MOL CELL BIOL, V19, P5601; Parker D, 1996, MOL CELL BIOL, V16, P694; Parker D, 1998, MOL CELL, V2, P353, DOI 10.1016/S1097-2765(00)80279-8; Radhakrishnan I, 1998, FEBS LETT, V430, P317, DOI 10.1016/S0014-5793(98)00680-2; Radhakrishnan I, 1997, CELL, V91, P741, DOI 10.1016/S0092-8674(00)80463-8; Radhakrishnan I, 1999, J MOL BIOL, V287, P859, DOI 10.1006/jmbi.1999.2658; Rohl CA, 1998, METHOD ENZYMOL, V295, P1; Shaywitz AJ, 2000, MOL CELL BIOL, V20, P9409, DOI 10.1128/MCB.20.24.9409-9422.2000; Shoemaker BA, 2000, P NATL ACAD SCI USA, V97, P8868, DOI 10.1073/pnas.160259697; Wagner BL, 2000, J BIOL CHEM, V275, P8263, DOI 10.1074/jbc.275.12.8263; WESTIN EH, 1982, P NATL ACAD SCI-BIOL, V79, P2194, DOI 10.1073/pnas.79.7.2194; Weston K, 1998, CURR OPIN GENET DEV, V8, P76, DOI 10.1016/S0959-437X(98)80065-8; WISHART DS, 1994, METHOD ENZYMOL, V239, P363; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; [No title captured]	39	125	132	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					42241	42248		10.1074/jbc.M207361200	http://dx.doi.org/10.1074/jbc.M207361200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12196545	hybrid			2022-12-27	WOS:000178985300119
J	Naughton, P; Foresti, R; Bains, SK; Hoque, M; Green, CJ; Motterlini, R				Naughton, P; Foresti, R; Bains, SK; Hoque, M; Green, CJ; Motterlini, R			Induction of heme oxygenase 1 by nitrosative stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; SMOOTH-MUSCLE CELLS; CARBON-MONOXIDE; NITROXYL ANION; OXIDATIVE STRESS; ENDOTHELIAL-CELLS; S-NITROSOTHIOLS; MESSENGER-RNA; INDUCIBLE EXPRESSION; HYDROGEN-PEROXIDE	Nitric oxide and S-nitrosothiols modulate a variety of important physiological activities. In vascular cells, agents that release NO and donate nitrosonium cation (NO+), such as S-nitrosoglutathione, are potent inducers of the antioxidant protein heme oxygenase 1 (HO-1) (Foresti, R., Clark, J. E., Green, C. J., and Motterlini, R. (1997) J. BioL Chem. 272, 18411-18417; Motterlini, R., Foresti, R., Bassi, R., Calabrese, V., Clark, J. E., and Green, C. J. (2000) J. BioL Chem. 275,13613-13620). Here, we report that Angeli's salt (AS) (0.25-2 mm), a compound that releases nitroxyl anion (NO-) at physiological pH, induces HO-1 mRNA and protein expression in a concentration- and time-dependent manner, resulting in increased heme oxygenase activity in rat H9c2 cells. A time course analysis revealed that NO--mediated HO-1 expression is transient and gradually disappears within 24 h, in accordance with the short half-life of AS at 37 degreesC (t(1/2) = 2.3 min). Interestingly, multiple additions of AS at lower concentrations (50 or 100 mum) over a period of time still promoted a significant increase in heme oxygenase activity. Experiments performed using a NO scavenger and the NO electrode confirmed that NO-, not NO, is the species involved in HO-1 induction by AS; however, the effect on heme oxygenase activity can be amplified by accelerating the rate of NO- oxidation. N-Acetylcysteine almost completely abolished AS-mediated induction of HO-1, whereas a glutathione synthesis inhibitor (buthionine sulfoximine) significantly decreased heme oxygenase activation by AS, indicating that sulfydryl groups are crucial targets in the regulation of HO-1 expression by NO-. We conclude that NO-, in analogy with other reactive nitrogen species, is a potent inducer of heme oxygenase activity and HO-1 protein expression. These findings indicate that heme oxygenase can act both as a sensor to and target of redox-based mechanisms involving NO and extend our knowledge on the biological function of HO-1 in response to nitrosative stress.	Northwick Pk Inst Med Res, Dept Surg Res, Vasc Biol Unit, Harrow HA1 3UJ, Middx, England	Imperial College London	Motterlini, R (corresponding author), Northwick Pk Inst Med Res, Dept Surg Res, Vasc Biol Unit, Harrow HA1 3UJ, Middx, England.		Motterlini, Roberto/Q-1890-2019; Motterlini, Roberto/G-2489-2013	Motterlini, Roberto/0000-0003-2684-2612; Motterlini, Roberto/0000-0003-2684-2612; foresti, roberta/0000-0002-0836-7937				ARNELLE DR, 1995, ARCH BIOCHEM BIOPHYS, V318, P279, DOI 10.1006/abbi.1995.1231; Bouton C, 2000, J BIOL CHEM, V275, P32688, DOI 10.1074/jbc.275.42.32688; Brouard S, 2000, J EXP MED, V192, P1015, DOI 10.1084/jem.192.7.1015; Chazotte-Aubert L, 1999, J BIOL CHEM, V274, P20909, DOI 10.1074/jbc.274.30.20909; Choi AMK, 1996, AM J RESP CELL MOL, V15, P9, DOI 10.1165/ajrcmb.15.1.8679227; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Clark JE, 2000, BIOCHEM J, V348, P615, DOI 10.1042/0264-6021:3480615; Clark JE, 2000, AM J PHYSIOL-HEART C, V278, pH643, DOI 10.1152/ajpheart.2000.278.2.H643; DARLEYUSMAR V, 1995, FEBS LETT, V369, P131, DOI 10.1016/0014-5793(95)00764-Z; Dore S, 1999, P NATL ACAD SCI USA, V96, P2445, DOI 10.1073/pnas.96.5.2445; Durante W, 1997, CIRC RES, V80, P557, DOI 10.1161/01.RES.80.4.557; Eu JP, 2000, BIOCHEMISTRY-US, V39, P1040, DOI 10.1021/bi992046e; EWING JF, 1993, J NEUROCHEM, V60, P1512, DOI 10.1111/j.1471-4159.1993.tb03315.x; Foresti R, 1999, BIOCHEM J, V339, P729, DOI 10.1042/0264-6021:3390729; Foresti R, 2001, AM J PHYSIOL-HEART C, V281, pH1976, DOI 10.1152/ajpheart.2001.281.5.H1976; Foresti R, 1999, FREE RADICAL RES, V31, P459, DOI 10.1080/10715769900301031; Foresti R, 1997, J BIOL CHEM, V272, P18411, DOI 10.1074/jbc.272.29.18411; Gow AJ, 1998, NATURE, V391, P169, DOI 10.1038/34402; Hara E, 1996, BIOCHEM BIOPH RES CO, V224, P153, DOI 10.1006/bbrc.1996.0999; Hartsfield CL, 1997, AM J PHYSIOL-LUNG C, V273, pL980; Hausladen A, 2001, P NATL ACAD SCI USA, V98, P10108, DOI 10.1073/pnas.181199698; Hausladen A, 1996, CELL, V86, P719, DOI 10.1016/S0092-8674(00)80147-6; Hayashi S, 1999, CIRC RES, V85, P663, DOI 10.1161/01.RES.85.8.663; Hughes MN, 1999, BBA-BIOENERGETICS, V1411, P263, DOI 10.1016/S0005-2728(99)00019-5; Ingi T, 1996, NEURON, V16, P835, DOI 10.1016/S0896-6273(00)80103-8; Ishikawa K, 1997, J CLIN INVEST, V100, P1209, DOI 10.1172/JCI119634; Kim WK, 1999, NEURON, V24, P461, DOI 10.1016/S0896-6273(00)80859-4; KIM YM, 1995, J BIOL CHEM, V270, P5710, DOI 10.1074/jbc.270.11.5710; KIM YM, 1995, FEBS LETT, V374, P228, DOI 10.1016/0014-5793(95)01115-U; LAUTIER D, 1992, CARCINOGENESIS, V13, P227, DOI 10.1093/carcin/13.2.227; Lee PJ, 1997, J BIOL CHEM, V272, P5375, DOI 10.1074/jbc.272.9.5375; Ma XL, 1999, P NATL ACAD SCI USA, V96, P14617, DOI 10.1073/pnas.96.25.14617; Maines MD, 1997, ANNU REV PHARMACOL, V37, P517, DOI 10.1146/annurev.pharmtox.37.1.517; MAINES MD, 1986, J BIOL CHEM, V261, P411; Marshall HE, 2000, FASEB J, V14, P1889, DOI 10.1096/fj.00.011rev; McCoubrey WK, 1997, EUR J BIOCHEM, V247, P725, DOI 10.1111/j.1432-1033.1997.00725.x; Miranda KM, 2001, J BIOL CHEM, V276, P1720, DOI 10.1074/jbc.M006174200; MORITA T, 1995, P NATL ACAD SCI USA, V92, P1475, DOI 10.1073/pnas.92.5.1475; Motterlini R, 2002, ANTIOXID REDOX SIGN, V4, P615, DOI 10.1089/15230860260220111; Motterlini R, 2000, FREE RADICAL BIO MED, V28, P1303, DOI 10.1016/S0891-5849(00)00294-X; Motterlini R, 2000, J BIOL CHEM, V275, P13613, DOI 10.1074/jbc.275.18.13613; Motterlini R, 1998, CIRC RES, V83, P568, DOI 10.1161/01.RES.83.5.568; MOTTERLINI R, 1996, AM J PHYSIOL, V270, P107; MURPHY ME, 1991, P NATL ACAD SCI USA, V88, P10860, DOI 10.1073/pnas.88.23.10860; Nelli S, 2000, BRIT J PHARMACOL, V131, P356, DOI 10.1038/sj.bjp.0703550; Paolocci N, 2001, P NATL ACAD SCI USA, V98, P10463, DOI 10.1073/pnas.181191198; Patel RP, 2000, FREE RADICAL BIO MED, V28, P1780, DOI 10.1016/S0891-5849(00)00235-5; Patel RP, 1999, BBA-BIOENERGETICS, V1411, P385, DOI 10.1016/S0005-2728(99)00028-6; Sammut IA, 1998, BRIT J PHARMACOL, V125, P1437, DOI 10.1038/sj.bjp.0702212; Sawle P, 2001, FEBS LETT, V508, P403, DOI 10.1016/S0014-5793(01)03117-9; Schmidt HHHW, 1996, P NATL ACAD SCI USA, V93, P14492, DOI 10.1073/pnas.93.25.14492; Shafirovich V, 2002, P NATL ACAD SCI USA, V99, P7340, DOI 10.1073/pnas.112202099; Sharpe MA, 1998, BIOCHEM J, V332, P9, DOI 10.1042/bj3320009; Shoeman DW, 2000, ALCOHOL, V20, P55, DOI 10.1016/S0741-8329(99)00056-7; Stamler JS, 2001, CELL, V106, P675, DOI 10.1016/S0092-8674(01)00495-0; STAMLER JS, 1992, SCIENCE, V258, P1898, DOI 10.1126/science.1281928; STAMLER JS, 1994, CELL, V78, P931, DOI 10.1016/0092-8674(94)90269-0; Vesely MJJ, 1998, AM J PHYSIOL-CELL PH, V275, pC1087, DOI 10.1152/ajpcell.1998.275.4.C1087; Wang R, 1998, CAN J PHYSIOL PHARM, V76, P1; Willis D, 1996, NAT MED, V2, P87, DOI 10.1038/nm0196-87; Wink DA, 1998, ARCH BIOCHEM BIOPHYS, V351, P66, DOI 10.1006/abbi.1997.0565; Wong PSY, 1998, BIOCHEMISTRY-US, V37, P5362, DOI 10.1021/bi973153g; Yet SF, 1997, J BIOL CHEM, V272, P4295, DOI 10.1074/jbc.272.7.4295	63	100	101	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 25	2002	277	43					40666	40674		10.1074/jbc.M203863200	http://dx.doi.org/10.1074/jbc.M203863200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	607KU	12194971	hybrid			2022-12-27	WOS:000178791400066
J	Robin, MA; Anandatheerthavarada, HK; Biswas, G; Sepuri, NBV; Gordon, DM; Pain, D; Avadhani, NG				Robin, MA; Anandatheerthavarada, HK; Biswas, G; Sepuri, NBV; Gordon, DM; Pain, D; Avadhani, NG			Bimodal targeting of microsomal CYP2E1 to mitochondria through activation of an N-terminal chimeric signal by cAMP-mediated phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM MEMBRANE; CYTOCHROME-P450 2E1; PROTEIN IMPORT; RECOGNITION PARTICLE; OXIDATIVE STRESS; TRANSLOCATION; P450; RAT; CHANNEL; IDENTIFICATION	Cytochrome P450 2E1 (CYP2E1) plays an important role in alcohol-induced toxicity and oxidative stress. Recently, we showed that this predominantly microsomal protein is also localized in rat hepatic mitochondria. In this report, we show that the N-terminal 30 amino acids of CYP2E1 contain a chimeric signal for bimodal targeting of the apoprotein to endoplasmic reticulum (ER) and mitochondria. We demonstrate that the cryptic mitochondrial targeting signal at sequence 21-31 of the protein is activated by cAMP-dependent phosphorylation at Ser-129. S129A mutation resulted in lower affinity for binding to cytoplasmic Hsp70, mitochondrial translocases (TOM40 and TIM44) and reduced mitochondrial import. S129A mutation, however, did not affect the extent of binding to the signal recognition particle and association with ER membrane translocator protein Sec61. Addition of saturating levels of signal recognition particle caused only a partial inhibition of CYP2E1 translation under in vitro conditions, and saturating levels of ER resulted only in partial membrane integration. cAMP enhanced the mitochondrial CYP2E1 (referred to as P450MT5) level but did not affect its level in the ER. Our results provide new insights on the mechanism of cAMP-mediated activation of a cryptic mitochondrial targeting signal and regulation of P450MT5 targeting to mitochondria.	Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA; Univ Penn, Sch Vet Med, Marie Lowe Ctr Comparat Oncol, Philadelphia, PA 19104 USA; Univ Med & Dent New Jersey, Dept Physiol & Pharmacol, Newark, NJ 07103 USA; Thomas Jefferson Univ, Sch Med, Dept Biochem & Pharmacol, Philadelphia, PA 19107 USA	University of Pennsylvania; University of Pennsylvania; Rutgers State University New Brunswick; Rutgers State University Medical Center; Jefferson University	Avadhani, NG (corresponding author), Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA.	narayan@vet.upenn.edu	Sepuri, Naresh/AAF-2704-2020		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057067, R01GM034883] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 57067, GM 34883, R01 GM057067, R01 GM034883] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Addya S, 1997, J CELL BIOL, V139, P589, DOI 10.1083/jcb.139.3.589; Amuthan G, 2001, EMBO J, V20, P1910, DOI 10.1093/emboj/20.8.1910; Anandatheerthavarada HK, 1999, EMBO J, V18, P5494, DOI 10.1093/emboj/18.20.5494; Banerjee A, 2000, DRUG METAB DISPOS, V28, P118; Belin D, 1996, EMBO J, V15, P468, DOI 10.1002/j.1460-2075.1996.tb00379.x; Biswas G, 1999, EMBO J, V18, P522, DOI 10.1093/emboj/18.3.522; CHUCK SL, 1992, CELL, V68, P9, DOI 10.1016/0092-8674(92)90202-N; Coon MJ, 1996, FASEB J, V10, P428, DOI 10.1096/fasebj.10.4.8647341; Dupont I, 2000, ALCOHOL ALCOHOLISM, V35, P98, DOI 10.1093/alcalc/35.1.98; ELIASSON E, 1992, J BIOL CHEM, V267, P15765; Fataccioli V, 1999, HEPATOLOGY, V29, P14, DOI 10.1002/hep.510290106; FUJIKI M, 1993, J BIOL CHEM, V268, P1914; GONZALEZ FJ, 1994, DRUG METAB REV, V26, P165, DOI 10.3109/03602539409029789; Gordon DM, 2001, BIOCHEM J, V356, P207, DOI 10.1042/0264-6021:3560207; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Greenfield JJA, 1999, J CELL SCI, V112, P1477; GUENGERICH FP, 1991, CHEM RES TOXICOL, V4, P391, DOI 10.1021/tx00022a001; Hill K, 1998, NATURE, V395, P516, DOI 10.1038/26780; Hinnah SC, 1997, EMBO J, V16, P7351, DOI 10.1093/emboj/16.24.7351; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; Keenan RJ, 2001, ANNU REV BIOCHEM, V70, P755, DOI 10.1146/annurev.biochem.70.1.755; KOCH JA, 1991, METHOD ENZYMOL, V206, P305; KOOP DR, 1986, ALCOHOL CLIN EXP RES, V10, pS44, DOI 10.1111/j.1530-0277.1986.tb05179.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laird V, 1997, J BIOL CHEM, V272, P1983, DOI 10.1074/jbc.272.3.1983; Lithgow T, 2000, FEBS LETT, V476, P22, DOI 10.1016/S0014-5793(00)01663-X; Mason N, 2000, EMBO J, V19, P4164, DOI 10.1093/emboj/19.15.4164; MONIER S, 1988, J CELL BIOL, V107, P457, DOI 10.1083/jcb.107.2.457; Neupert W, 1997, ANNU REV BIOCHEM, V66, P863, DOI 10.1146/annurev.biochem.66.1.863; Neve EPA, 1999, FEBS LETT, V460, P309, DOI 10.1016/S0014-5793(99)01361-7; Neve EPA, 2001, J BIOL CHEM, V276, P11317, DOI 10.1074/jbc.M008640200; Oesch-Bartlomowicz B, 1998, EXP CELL RES, V242, P294, DOI 10.1006/excr.1998.4120; PYERIN W, 1989, EMBO J, V8, P3003, DOI 10.1002/j.1460-2075.1989.tb08450.x; Robin MA, 2001, J BIOL CHEM, V276, P24680, DOI 10.1074/jbc.M100363200; SAKAGUCHI M, 1984, P NATL ACAD SCI-BIOL, V81, P3361, DOI 10.1073/pnas.81.11.3361; Sass E, 2001, J BIOL CHEM, V276, P46111, DOI 10.1074/jbc.M106061200; Schatz G, 1996, SCIENCE, V271, P1519, DOI 10.1126/science.271.5255.1519; SCHNEIDER HC, 1994, NATURE, V371, P768, DOI 10.1038/371768a0; Smith MD, 2001, CELL, V105, P293, DOI 10.1016/S0092-8674(01)00337-3; SONG BJ, 1986, J BIOL CHEM, V261, P6689; Song WQ, 2000, CELL, V100, P333, DOI 10.1016/S0092-8674(00)80669-8; Subramani S, 2000, ANNU REV BIOCHEM, V69, P399, DOI 10.1146/annurev.biochem.69.1.399; Szczesna-Skorupa E, 2000, ARCH BIOCHEM BIOPHYS, V374, P128, DOI 10.1006/abbi.1999.1628; SZCZESNASKORUPA E, 1991, METHOD ENZYMOL, V206, P64; Tanaka E, 2000, J CLIN PHARM THER, V25, P165; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Wu DF, 1999, ALCOHOL CLIN EXP RES, V23, P67	47	120	124	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2002	277	43					40583	40593		10.1074/jbc.M203292200	http://dx.doi.org/10.1074/jbc.M203292200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	607KU	12191992	Green Accepted, hybrid			2022-12-27	WOS:000178791400056
J	Ashiuchi, M; Kuwana, E; Yamamoto, T; Komatsu, K; Soda, K; Misono, H				Ashiuchi, M; Kuwana, E; Yamamoto, T; Komatsu, K; Soda, K; Misono, H			Glutamate racemase is an endogenous DNA gyrase inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; TOPOISOMERASE-I; GENE; MURI; IDENTIFICATION; PURIFICATION	Almost all bacteria possess glutamate racemase to synthesize D-glutamate as an essential component of peptidoglycans in the cell walls. The enforced production of glutamate racemase, however, resulted in suppression of cell proliferation. In the Escherichia coli JM109/pGR3 clone, the overproducer of glutamate racemase, the copy number (i.e. replication efficiency) of plasmid DNA declined dramatically, whereas the E. coli WM335 mutant that is defective in the gene of glutamate racemase showed little genetic competency. The comparatively low and high activities for DNA supercoiling were contained in the E. coli JM109/pGR3 and WM335 cells, respectively. Furthermore, we found that the DNA gyrase of E. coli was modulated by the glutamate racemase of E. coli in the presence of LTDP-N-acetylmuramyl-L-alanine, which is a peptidoglycan precursor and functions as an absolute activator for the racemase. This is the first finding of the enzyme protein participating in both D-amino acid metabolism and DNA processing.	Kochi Univ, Dept Bioresources Sci, Nankoku, Kochi 7838502, Japan; Kansai Univ, Dept Biotechnol, Suita, Osaka 5648680, Japan	Kochi University; Kansai University	Ashiuchi, M (corresponding author), Kochi Univ, Dept Bioresources Sci, Nankoku, Kochi 7838502, Japan.	ashiuchi@cc.kochi-u.ac.jp						ASHIUCHI M, 1995, J BIOCHEM, V117, P495, DOI 10.1093/oxfordjournals.jbchem.a124735; Ashiuchi M, 1998, J BIOCHEM-TOKYO, V123, P1156; Ashiuchi M, 1999, BIOSCI BIOTECH BIOCH, V63, P792, DOI 10.1271/bbb.63.792; BALIKO G, 1993, J BACTERIOL, V175, P6571, DOI 10.1128/jb.175.20.6571-6577.1993; Bhaduri T, 1998, J BIOL CHEM, V273, P13925, DOI 10.1074/jbc.273.22.13925; Chandler MS, 1996, GENE, V169, P25, DOI 10.1016/0378-1119(95)00777-6; CHUNG CT, 1989, P NATL ACAD SCI USA, V86, P2172, DOI 10.1073/pnas.86.7.2172; DOUBLET P, 1992, J BACTERIOL, V174, P5772, DOI 10.1128/jb.174.18.5772-5779.1992; Doublet P, 1996, MICROB DRUG RESIST, V2, P43, DOI 10.1089/mdr.1996.2.43; FERRO AM, 1984, J BIOL CHEM, V259, P547; INOUE N, 1991, J BACTERIOL, V173, P1208, DOI 10.1128/jb.173.3.1208-1214.1991; KATO J, 1992, J BIOL CHEM, V267, P25676; MIZUUCHI K, 1984, J BIOL CHEM, V259, P9199; Nakanishi A, 1998, J BIOL CHEM, V273, P1933, DOI 10.1074/jbc.273.4.1933; PROJAN SJ, 1983, PLASMID, V9, P182, DOI 10.1016/0147-619X(83)90019-7; Reina-San-Martin B, 2000, NAT MED, V6, P890, DOI 10.1038/78651; SAITO H, 1963, BIOCHIM BIOPHYS ACTA, V72, P619, DOI 10.1016/0926-6550(63)90386-4; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Snoep JL, 2002, EUR J BIOCHEM, V269, P1662, DOI 10.1046/j.1432-1327.2002.02803.x; STRAUSBERG R, 2000, HUMAN TUMOR INDEX CA; YOSHIMURA T, 1993, J BIOL CHEM, V268, P24242	21	27	29	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2002	277	42					39070	39073		10.1074/jbc.C200253200	http://dx.doi.org/10.1074/jbc.C200253200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	605EA	12213801	hybrid, Green Published			2022-12-27	WOS:000178662500004
J	Cattaruzza, S; Schiappacassi, M; Ljungberg-Rose, A; Spessotto, P; Perissinotto, D; Morgelin, M; Mucignat, MT; Colombatti, A; Perris, R				Cattaruzza, S; Schiappacassi, M; Ljungberg-Rose, A; Spessotto, P; Perissinotto, D; Morgelin, M; Mucignat, MT; Colombatti, A; Perris, R			Distribution of PG-M/versican variants in human tissues and de novo expression of isoform V3 upon endothelial cell activation, migration, and neoangiogenesis in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHONDROITIN SULFATE PROTEOGLYCAN; SMOOTH-MUSCLE CELLS; HYALURONAN-BINDING PROTEOGLYCANS; LARGE AGGREGATING PROTEOGLYCAN; EXTRACELLULAR-MATRIX; GROWTH-FACTOR; BOVINE AORTA; FETAL SKIN; VERSICAN; AGGRECAN	We have carried out a comprehensive molecular mapping of PG-M/versican isoforms V0-V3 in adult human tissues and have specifically investigated how the expression of these isoforms is regulated in endothelial cells in vitro. A survey of 21 representative tissues highlighted a prevalence of V1 mRNA, demonstrated that the relative frequency of expression was V1>V2>V3greater than or equal toV2; and showed that <15% of the tissues transcribed significant levels of all four isoforms. By employing novel and previously described anti-versican antibodies we verified a ubiquitous versican deposition in normal and tumor-associated vascular structures and disclosed differences in the glycanation profiles of versicans produced in different vascular beds. Resting endothelial cells isolated from different tissue sources transcribed several of the versican isoforms but consistently failed to translate these mRNAs into detectable proteoglycans. However, if stimulated with tumor necrosis factor-alpha or vascular endothelial growth factor, they altered their versican expression by de novo transcribing the V3 isoform and by exhibiting a moderate V1/V2 production. Induced versican synthesis and de novo V3 expression was also observed in endothelial cells elicited to migrate in a wound-healing model in vitro and in angiogenic endothelial cells forming tubule-like structures in Matrigel or fibrin clots. The results suggest that, independent of the degree of vascularization, human adult tissues show a limited expression of versican isoforms V0, V2, and V3 and that endothelial cells may contribute to the deposition of versican in vascular structures, but only following proper stimulation.	Univ Parma, Dept Evolutionary & Funct Biol, I-43100 Parma, Italy; Natl Canc Inst, Ctr Riferimento Oncol, Inst Ric & Cura Carattere Sci, Div Expt Oncol 2, I-33081 Aviano, Italy; Lund Univ, Dept Cell & Mol Biol, S-22100 Lund, Sweden; Univ Udine, Dept Tech & Biomed Sci, I-35100 Padua, Italy; Univ Udine, Micrograv Aging Training & Immobil Ctr Excellence, I-35100 Padua, Italy	University of Parma; IRCCS Aviano (CRO); Lund University; University of Udine; University of Udine	Perris, R (corresponding author), Univ Parma, Dept Evolutionary & Funct Biol, Viale Sci 11-A, I-43100 Parma, Italy.	rperris@cro.it	Mucignat, Maria Teresa/AAY-3908-2020; Schiappacassi, Monica/AAX-5505-2020; Spessotto, Paola/K-5005-2012	Mucignat, Maria Teresa/0000-0002-9601-054X; Schiappacassi, Monica/0000-0003-4804-4291; Spessotto, Paola/0000-0002-3033-404X; colombatti, alfonso/0000-0002-3676-2379				ASHER R, 1991, J NEUROSCI RES, V28, P410, DOI 10.1002/jnr.490280314; Asher RA, 2002, J NEUROSCI, V22, P2225, DOI 10.1523/JNEUROSCI.22-06-02225.2002; Aspberg A, 1999, J BIOL CHEM, V274, P20444, DOI 10.1074/jbc.274.29.20444; BodeLesniewska B, 1996, J HISTOCHEM CYTOCHEM, V44, P303, DOI 10.1177/44.4.8601689; CARRINO DA, 1994, BIOCHEM J, V298, P51, DOI 10.1042/bj2980051; DALFERES ER, 1987, EXP MOL PATHOL, V47, P363, DOI 10.1016/0014-4800(87)90019-0; DOURSZIMMERMANN MT, 1994, J BIOL CHEM, V269, P32992; Eriksen GV, 1999, BIOCHEM J, V340, P613, DOI 10.1042/0264-6021:3400613; Evanko SP, 1998, AM J PATHOL, V152, P533; HABUCHI H, 1986, J BIOL CHEM, V261, P1031; Henderson DJ, 1998, CIRC RES, V83, P523, DOI 10.1161/01.RES.83.5.523; Isogai Z, 2002, J BIOL CHEM, V277, P4565, DOI 10.1074/jbc.M110583200; Isogai Z, 1996, CANCER RES, V56, P3902; ITO K, 1995, J BIOL CHEM, V270, P958, DOI 10.1074/jbc.270.2.958; KAPOOR R, 1986, BIOCHEM J, V240, P575, DOI 10.1042/bj2400575; KIMATA K, 1986, J BIOL CHEM, V261, P3517; LANDOLT RM, 1995, ANAL BIOCHEM, V155, P275; LARK MW, 1988, J HISTOCHEM CYTOCHEM, V36, P1211, DOI 10.1177/36.10.3047228; LEBARON RG, 1992, J BIOL CHEM, V267, P10003; Lee RT, 2001, J BIOL CHEM, V276, P13847, DOI 10.1074/jbc.M010556200; Lemire JM, 2002, J CELL PHYSIOL, V190, P38, DOI 10.1002/jcp.10043; Lemire JM, 1999, ARTERIOSCL THROM VAS, V19, P1630, DOI 10.1161/01.ATV.19.7.1630; Matsuura R, 1996, J PATHOL, V180, P311, DOI 10.1002/(SICI)1096-9896(199611)180:3<311::AID-PATH657>3.0.CO;2-B; MAZZUCATO M, 2002, IN PRESS FASEB J; MCMURTREY J, 1979, J BIOL CHEM, V254, P1621; Merrilees MJ, 2002, CIRC RES, V90, P481, DOI 10.1161/hh0402.105791; Milev P, 1998, BIOCHEM BIOPH RES CO, V247, P207, DOI 10.1006/bbrc.1998.8759; MORITA H, 1990, BIOCHEM J, V265, P61, DOI 10.1042/bj2650061; OEGEMA TR, 1979, J BIOL CHEM, V254, P1312; Paulus W, 1996, J NEUROPATH EXP NEUR, V55, P528, DOI 10.1097/00005072-199605000-00005; PERIDES G, 1992, J BIOL CHEM, V267, P23883; Perissinotto D, 2000, DEVELOPMENT, V127, P2823; RIESSEN R, 1994, AM J PATHOL, V144, P962; Sandy JD, 2001, J BIOL CHEM, V276, P13372, DOI 10.1074/jbc.M009737200; Schmalfeldt M, 1998, J BIOL CHEM, V273, P15758, DOI 10.1074/jbc.273.25.15758; SCHONHERR E, 1991, J BIOL CHEM, V266, P17640; SHINOMURA T, 1995, J BIOL CHEM, V270, P10328, DOI 10.1074/jbc.270.17.10328; SHINOMURA T, 1990, ANAT EMBRYOL, V181, P227; SHINOMURA T, 1993, J BIOL CHEM, V268, P14461; Sorrell JM, 1999, ANAT EMBRYOL, V199, P45, DOI 10.1007/s004290050208; Stigson M, 1997, J BIOL CHEM, V272, P3246, DOI 10.1074/jbc.272.6.3246; TAN EML, 1991, LAB INVEST, V64, P474; Tufvesson E, 2000, J CELL BIOCHEM, V77, P298, DOI 10.1002/(SICI)1097-4644(20000501)77:2<298::AID-JCB12>3.0.CO;2-D; Wight TN, 1997, AM J PATHOL, V151, P963; YAMAGATA M, 1993, ANAT EMBRYOL, V187, P433; YAO LY, 1994, MATRIX BIOL, V14, P213, DOI 10.1016/0945-053X(94)90185-6; ZAKO M, 1995, J BIOL CHEM, V270, P3914, DOI 10.1074/jbc.270.8.3914; Zako M, 1997, J BIOL CHEM, V272, P9325, DOI 10.1074/jbc.272.14.9325; ZIMMERMANN DR, 1989, EMBO J, V8, P2975, DOI 10.1002/j.1460-2075.1989.tb08447.x	49	99	102	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2002	277	49					47626	47635		10.1074/jbc.M206521200	http://dx.doi.org/10.1074/jbc.M206521200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622TT	12221092	hybrid			2022-12-27	WOS:000179663700103
J	Brown, MT; McBride, KM; Baniecki, ML; Reich, NC; Marriotti, G; Mangel, WF				Brown, MT; McBride, KM; Baniecki, ML; Reich, NC; Marriotti, G; Mangel, WF			Actin can act as a cofactor for a viral proteinase in the cleavage of the cytoskeleton	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ADENOVIRUS PROTEINASE; CYTOKERATIN NETWORK; CRYSTAL-STRUCTURE; HELA-CELLS; PROTEASE; ACTIVATION; PEPTIDE; BINDING; PURIFICATION; PROFILIN	Cytoskeletal. proteins are exploited by many viruses during infection. We report a novel finding that actin can act as a cofactor for the adenovirus proteinase (AVP) in the degradation of cytoskeletal proteins. Transfection studies in HeLa cells revealed AVP localized with cytokeratin 18, and this was followed by destruction of the cytokeratin network. For AVP to cleave cytokeratin 18, a cellular cofactor was shown to be required, consistent with AVP being synthesized as an inactive proteinase. Actin was considered a cellular cofactor for AVP, because the C terminus of actin is homologous to a viral cofactor for AVP. AVP was shown to bind to the C terminus of actin, and in doing so AVP exhibited full enzymatic activity. In vitro, actin was a cofactor in the cleavage of cytokeratin 18 by AVP. The proteinase alone could not cleave cytokeratin 18, but in the presence of actin, AVP cleaved cytokeratin 18. Indeed, actin itself was shown to be a cofactor and a substrate for its own destruction in that it was cleaved by AVP in vitro. Cleavage of cytoskeletal proteins weakens the structure of the cell, and therefore, actin as a cofactor may play a role in cell lysis and release of nascent virions.	Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA; SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA; SUNY Stony Brook, Dept Pathol, Stony Brook, NY 11794 USA; Univ Wisconsin, Dept Physiol, Madison, WI 53706 USA	United States Department of Energy (DOE); Brookhaven National Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Wisconsin System; University of Wisconsin Madison	Mangel, WF (corresponding author), Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA.	Mangel@BNL.Gov	mcbride, kevin/E-8230-2011	Marriott, Gerard/0000-0003-3197-4839	NCI NIH HHS [R01CA50733, P01CA28146] Funding Source: Medline; NIAID NIH HHS [AI41599] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA028146] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041599, R56AI041599] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ANDERSON CW, 1993, PROTEIN EXPRES PURIF, V4, P8, DOI 10.1006/prep.1993.1002; Baniecki ML, 2001, BIOCHEMISTRY-US, V40, P12349, DOI 10.1021/bi0109008; BHATTI AR, 1979, VIROLOGY, V96, P478; BOSCHEK CB, 1981, CELL, V24, P175, DOI 10.1016/0092-8674(81)90513-4; Cabrita G, 1997, J BIOL CHEM, V272, P5635, DOI 10.1074/jbc.272.9.5635; CHEN PH, 1993, J VIROL, V67, P3507, DOI 10.1128/JVI.67.6.3507-3514.1993; Cudmore S, 1997, TRENDS MICROBIOL, V5, P142, DOI 10.1016/S0966-842X(97)01011-1; DE BP, 1991, J VIROL, V65, P3268, DOI 10.1128/JVI.65.6.3268-3275.1991; Ding JZ, 1996, EMBO J, V15, P1778, DOI 10.1002/j.1460-2075.1996.tb00526.x; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; HOUK TW, 1974, ANAL BIOCHEM, V62, P66, DOI 10.1016/0003-2697(74)90367-4; Lanier LM, 1996, VIROLOGY, V216, P380, DOI 10.1006/viro.1996.0073; MANGEL WF, 1993, NATURE, V361, P274, DOI 10.1038/361274a0; Mangel WF, 1996, J BIOL CHEM, V271, P536, DOI 10.1074/jbc.271.1.536; MARRIOTT G, 1988, BIOCHEMISTRY-US, V27, P6214, DOI 10.1021/bi00417a004; McGrath WJ, 2001, BIOCHEMISTRY-US, V40, P13237, DOI 10.1021/bi0111653; McGrath WJ, 2001, BIOCHEMISTRY-US, V40, P14468, DOI 10.1021/bi011562d; Ott DE, 1996, J VIROL, V70, P7734, DOI 10.1128/JVI.70.11.7734-7743.1996; Otterbein LR, 2001, SCIENCE, V293, P708, DOI 10.1126/science.1059700; RANCOURT C, 1995, VIROLOGY, V209, P167, DOI 10.1006/viro.1995.1240; Rey O, 1996, VIROLOGY, V220, P530, DOI 10.1006/viro.1996.0343; RIDDLES PW, 1983, METHOD ENZYMOL, V91, P49; ROZYCKI M, 1991, METHOD ENZYMOL, V196, P100; SCHUTT CE, 1993, NATURE, V365, P810, DOI 10.1038/365810a0; Seipelt J, 2000, J BIOL CHEM, V275, P20084, DOI 10.1074/jbc.275.26.20084; SHOEMAN RL, 1990, P NATL ACAD SCI USA, V87, P6336, DOI 10.1073/pnas.87.16.6336; STAUFENBIEL M, 1986, J VIROL, V60, P1186, DOI 10.1128/JVI.60.3.1186-1191.1986; WEBER G, 1979, BIOCHEMISTRY-US, V18, P3075, DOI 10.1021/bi00581a025; WEBER JM, 1994, METHOD ENZYMOL, V244, P595; WEBSTER A, 1994, J VIROL, V68, P7292, DOI 10.1128/JVI.68.11.7292-7300.1994; WEBSTER A, 1993, CELL, V72, P97, DOI 10.1016/0092-8674(93)90053-S; ZECHEL K, 1993, BIOCHEM J, V290, P411, DOI 10.1042/bj2900411; ZHANG Y, 1994, J VIROL, V68, P2544, DOI 10.1128/JVI.68.4.2544-2555.1994	33	20	20	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2002	277	48					46298	46303		10.1074/jbc.M202988200	http://dx.doi.org/10.1074/jbc.M202988200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620JB	12191991	hybrid			2022-12-27	WOS:000179529300079
J	Dunty, JM; Schaller, MD				Dunty, JM; Schaller, MD			The N termini of focal adhesion kinase family members regulate substrate phosphorylation, localization, and cell morphology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE KINASE; ACTIN CYTOSKELETON; GROWTH-FACTOR; STABLE ASSOCIATION; ANGIOTENSIN-II; FERM DOMAIN; PYK2; SRC; FAK; CALCIUM	The focal adhesion kinase (FAK) and cell adhesion kinase beta (CAKbeta, PYK2, CADTK, RAFTK) are highly homologous FAK family members, yet clearly have unique roles in the cell. Comparative analyses of FAK and CAKbeta have revealed intriguing differences in their activities. These differences were investigated further through the characterization of a set of FAF/CAKbeta chimeric kinases. CAKbeta exhibited greater catalytic activity than FAK in vitro, providing a molecular basis for differential substrate phosphorylation by FAK and CAKbeta in vivo. Furthermore, the N terminus may regulate catalytic activity since chimeras containing the FAK N terminus and CAKbeta catalytic domain exhibited a striking high level of catalytic activity and substrate phosphorylation. Unexpectedly, a modulatory role for the N termini in subcellular localization was also revealed. Chimeras containing the FAK N terminus and CAKbeta C terminus localized to focal adhesions, whereas chimeras containing the N and C termini of CAKbeta did not. Finally, prominent changes in cell morphology were induced upon expression of chimeras containing the CAKbeta N terminus, which were not associated with apoptotic cell death, cell cycle progression delay, or changes in Rho activity. These results demonstrate novel regulatory roles for the N terminus of FAK family kinases.	Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Schaller, MD (corresponding author), Univ N Carolina, Dept Cell & Dev Biol, CB7090, Chapel Hill, NC 27599 USA.				NATIONAL CANCER INSTITUTE [R01CA090901] Funding Source: NIH RePORTER; NCI NIH HHS [CA90901] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Andreev J, 1999, MOL CELL BIOL, V19, P2338; Arthur WT, 2001, MOL BIOL CELL, V12, P2711, DOI 10.1091/mbc.12.9.2711; Astier A, 1997, J BIOL CHEM, V272, P19719, DOI 10.1074/jbc.272.32.19719; Avraham H, 2000, CELL SIGNAL, V12, P123, DOI 10.1016/S0898-6568(99)00076-5; Brinson AE, 1998, J BIOL CHEM, V273, P1711, DOI 10.1074/jbc.273.3.1711; CALALB MB, 1995, MOL CELL BIOL, V15, P954; CHAN PY, 1994, J BIOL CHEM, V269, P20567; Chauhan D, 2000, J BIOL CHEM, V275, P27845; Chen RY, 2001, NAT CELL BIOL, V3, P439, DOI 10.1038/35074500; ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403; COBB BS, 1994, MOL CELL BIOL, V14, P147, DOI 10.1128/MCB.14.1.147; Cooley MA, 2000, MOL BIOL CELL, V11, P3247, DOI 10.1091/mbc.11.9.3247; Dikic I, 1996, NATURE, V383, P547, DOI 10.1038/383547a0; Du QS, 2001, J CELL SCI, V114, P2977; Duong LT, 2001, J BIOL CHEM, V276, P7484, DOI 10.1074/jbc.M008368200; Duong LT, 2000, CELL MOTIL CYTOSKEL, V47, P174, DOI 10.1002/1097-0169(200011)47:3<174::AID-CM2>3.0.CO;2-N; Frisch SM, 1996, J CELL BIOL, V134, P793, DOI 10.1083/jcb.134.3.793; Gabarra-Niecko V, 2002, BIOCHEM J, V365, P591, DOI 10.1042/BJ20020065; Girault JA, 1999, TRENDS BIOCHEM SCI, V24, P54, DOI 10.1016/S0968-0004(98)01331-0; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; HILDEBRAND JD, 1993, J CELL BIOL, V123, P993, DOI 10.1083/jcb.123.4.993; HUCKLE WR, 1992, P NATL ACAD SCI USA, V89, P8837, DOI 10.1073/pnas.89.18.8837; HUGHES SH, 1987, J VIROL, V61, P3004, DOI 10.1128/JVI.61.10.3004-3012.1987; Hungerford JE, 1996, J CELL BIOL, V135, P1383, DOI 10.1083/jcb.135.5.1383; Ilic Dusko, 1995, Nature (London), V377, P539, DOI 10.1038/377539a0; Ivankovic-Dikic I, 2000, NAT CELL BIOL, V2, P574, DOI 10.1038/35023515; Klingbeil CK, 2001, J CELL BIOL, V152, P97, DOI 10.1083/jcb.152.1.97; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lakkakorpi PT, 1999, J BIOL CHEM, V274, P4900, DOI 10.1074/jbc.274.8.4900; LEV S, 1995, NATURE, V376, P737, DOI 10.1038/376737a0; Li JZ, 1996, BLOOD, V88, P417, DOI 10.1182/blood.V88.2.417.bloodjournal882417; Li X, 1999, J BIOL CHEM, V274, P8917, DOI 10.1074/jbc.274.13.8917; Li X, 1998, J BIOL CHEM, V273, P9361, DOI 10.1074/jbc.273.16.9361; MACARTHUR H, 1984, J VIROL, V52, P483, DOI 10.1128/JVI.52.2.483-491.1984; Matsuya M, 1998, J BIOL CHEM, V273, P1003, DOI 10.1074/jbc.273.2.1003; Park SY, 2000, J BIOL CHEM, V275, P19768, DOI 10.1074/jbc.M909932199; Ren XD, 2000, J CELL SCI, V113, P3673; REYNOLDS AB, 1989, MOL CELL BIOL, V9, P629, DOI 10.1128/MCB.9.2.629; Sanjay A, 2001, J CELL BIOL, V152, P181, DOI 10.1083/jcb.152.1.181; SASAKI H, 1995, J BIOL CHEM, V270, P21206, DOI 10.1074/jbc.270.36.21206; Schaller MD, 1996, J ENDOCRINOL, V150, P1, DOI 10.1677/joe.0.1500001; Schaller MD, 2001, BBA-MOL CELL RES, V1540, P1, DOI 10.1016/S0167-4889(01)00123-9; Schaller MD, 1997, J BIOL CHEM, V272, P25319, DOI 10.1074/jbc.272.40.25319; SCHALLER MD, 1993, MOL CELL BIOL, V13, P785, DOI 10.1128/MCB.13.2.785; SCHALLER MD, 1995, J CELL BIOL, V130, P1181, DOI 10.1083/jcb.130.5.1181; Schaller MD, 1999, MOL BIOL CELL, V10, P3489, DOI 10.1091/mbc.10.10.3489; SCHALLER MD, 1994, CURR OPIN CELL BIOL, V6, P705, DOI 10.1016/0955-0674(94)90097-3; SCHALLER MD, 1992, P NATL ACAD SCI USA, V89, P5192, DOI 10.1073/pnas.89.11.5192; Schaller MD, 2001, ONCOGENE, V20, P6459, DOI 10.1038/sj.onc.1204786; Schlaepfer DD, 1999, PROG BIOPHYS MOL BIO, V71, P435, DOI 10.1016/S0079-6107(98)00052-2; Schlaepfer DD, 1998, MOL CELL BIOL, V18, P2571, DOI 10.1128/MCB.18.5.2571; Schlaepfer DD, 1996, MOL CELL BIOL, V16, P5623; Schwartz MA, 1995, ANNU REV CELL DEV BI, V11, P549, DOI 10.1146/annurev.cellbio.11.1.549; Shen Y, 1999, MOL BIOL CELL, V10, P2507, DOI 10.1091/mbc.10.8.2507; Sieg DJ, 1998, EMBO J, V17, P5933, DOI 10.1093/emboj/17.20.5933; Sieg DJ, 2000, NAT CELL BIOL, V2, P249, DOI 10.1038/35010517; Thomas JW, 1999, J BIOL CHEM, V274, P36684, DOI 10.1074/jbc.274.51.36684; Thomas JW, 1998, J BIOL CHEM, V273, P577, DOI 10.1074/jbc.273.1.577; Tokiwa G, 1996, SCIENCE, V273, P792, DOI 10.1126/science.273.5276.792; Watson JM, 2001, J BIOL CHEM, V276, P3536, DOI 10.1074/jbc.M006916200; Williams LM, 2000, J IMMUNOL, V164, P2028, DOI 10.4049/jimmunol.164.4.2028; Xiong WC, 1998, J CELL SCI, V111, P1981; Xiong WC, 1997, J CELL BIOL, V139, P529, DOI 10.1083/jcb.139.2.529; Yu H, 1996, J BIOL CHEM, V271, P29993, DOI 10.1074/jbc.271.47.29993; Zhao JH, 2000, J CELL SCI, V113, P3063; Zhao JH, 1998, J CELL BIOL, V143, P1997, DOI 10.1083/jcb.143.7.1997; Zheng CH, 1998, J BIOL CHEM, V273, P2384, DOI 10.1074/jbc.273.4.2384; Zhou YJ, 2001, MOL CELL, V8, P959, DOI 10.1016/S1097-2765(01)00398-7	68	34	34	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 22	2002	277	47					45644	45654		10.1074/jbc.M201779200	http://dx.doi.org/10.1074/jbc.M201779200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	618EE	12223467	Green Published, hybrid			2022-12-27	WOS:000179404800131
J	Schroder, K; Pulvermuller, A; Hofmann, KP				Schroder, K; Pulvermuller, A; Hofmann, KP			Arrestin and its splice variant Arr(1-370A) (P-44) - Mechanism and biological role of their interaction with rhodopsin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							G-PROTEIN COMPLEX; PHOTORECEPTOR-MEMBRANES; CRYSTAL-STRUCTURE; METARHODOPSIN-II; VISUAL ARRESTIN; 48-KDA PROTEIN; BINDING; LIGHT; ACTIVATION; TRANSDUCIN	Deactivation of G-protein-coupled receptors relies on a timely blockade by arrestin. However, under dim light conditions, virtually all arrestin is in the rod inner segment, and the splice variant p(44) (Arr(1-370A)) is the stop protein responsible for receptor deactivation. Using size exclusion chromatography and biophysical assays for membrane-bound protein-protein interaction, membrane binding, and G-protein activation, we have investigated the interactions of Arr(1-370A) and proteolytically truncated Arr(3-367) with rhodopsin. We find that these short arrestins do not only interact with the phosphorylated active receptor but also with inactive phosphorylated rhodopsin or opsin in membranes or solution. Because of the latter interaction they are not soluble (like arrestin) but membrane-bound in the dark. Upon photoexcitation, Arr(3-367) and Arr(1-370A) interact with pre-phosphorylated rhodopsin faster than arrestin and start to quench G(t) activation on a subsecond time scale. The data indicate that in the course of rhodopsin deactivation, Arr(1-370A) is handed over from inactive to active phosphorylated rhodopsin. This mechanism could provide a new aspect of receptor shutoff in the single photon operating range of the rod cell.	Humboldt Univ, Inst Med Phys & Biophys, Klinikum Charite, D-10098 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Pulvermuller, A (corresponding author), HU Berlin, IMPB, Charite, 5-9 Ziegelstr, D-10117 Berlin, Germany.	alexander.pulvermueller@charite.de						ANTONNY B, 1993, BIOCHEMISTRY-US, V32, P8646, DOI 10.1021/bi00084a036; AZARIAN SM, 1995, J BIOL CHEM, V270, P24375, DOI 10.1074/jbc.270.41.24375; Binder BM, 1996, J BIOL CHEM, V271, P19826, DOI 10.1074/jbc.271.33.19826; Bouvier M, 2001, NAT REV NEUROSCI, V2, P274, DOI 10.1038/35067575; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Ebrey T, 2001, PROG RETIN EYE RES, V20, P49, DOI 10.1016/S1350-9462(00)00014-8; Granzin J, 1998, NATURE, V391, P918, DOI 10.1038/36147; GUREVICH VV, 1992, J BIOL CHEM, V267, P21919; GUREVICH VV, 1993, J BIOL CHEM, V268, P11628; HAMM HE, 1988, SCIENCE, V241, P832, DOI 10.1126/science.3136547; Han M, 2001, STRUCTURE, V9, P869, DOI 10.1016/S0969-2126(01)00644-X; Heck M, 2000, METHOD ENZYMOL, V315, P329; HECK M, 1993, BIOCHEMISTRY-US, V32, P8220, DOI 10.1021/bi00083a024; Heck M, 2001, J BIOL CHEM, V276, P10000, DOI 10.1074/jbc.M009475200; Hirsch JA, 1999, CELL, V97, P257, DOI 10.1016/S0092-8674(00)80735-7; HOFMANN KP, 1985, BIOCHIM BIOPHYS ACTA, V810, P278, DOI 10.1016/0005-2728(85)90143-4; HOFMANN KP, 1992, J BIOL CHEM, V267, P15701; KAHLERT M, 1991, BIOPHYS J, V59, P375, DOI 10.1016/S0006-3495(91)82231-7; KOHL B, 1987, BIOPHYS J, V52, P271, DOI 10.1016/S0006-3495(87)83214-9; KONIG B, 1989, FEBS LETT, V257, P163, DOI 10.1016/0014-5793(89)81811-3; KUHN H, 1982, METHOD ENZYMOL, V81, P556; KUHN H, 1981, BIOCHEMISTRY-US, V20, P2410; Langlois G, 1996, P NATL ACAD SCI USA, V93, P4677, DOI 10.1073/pnas.93.10.4677; MANGINI NJ, 1988, INVEST OPHTH VIS SCI, V29, P1221; Marszalek JR, 2000, CELL, V102, P175, DOI 10.1016/S0092-8674(00)00023-4; McBee JK, 2001, PROG RETIN EYE RES, V20, P469, DOI 10.1016/S1350-9462(01)00002-7; MOLDAY RS, 2000, MOL MECH VISUAL TRAN, P143; Okada T, 2001, TRENDS BIOCHEM SCI, V26, P318, DOI 10.1016/S0968-0004(01)01799-6; PALCZEWSKI K, 1994, PROTEIN SCI, V3, P314; PALCZEWSKI K, 1992, BIOCHEMISTRY-US, V31, P3902, DOI 10.1021/bi00131a003; PALCZEWSKI K, 1991, J BIOL CHEM, V266, P18649; PALCZEWSKI K, 1991, J BIOL CHEM, V266, P15334; Palczewski K, 1997, EUR J BIOCHEM, V248, P261, DOI 10.1111/j.1432-1033.1997.00261.x; PAPERMASTER DS, 1982, METHOD ENZYMOL, V81, P48; Parkes JH, 1999, BIOCHEMISTRY-US, V38, P6862, DOI 10.1021/bi9827666; PHILP NJ, 1987, FEBS LETT, V225, P127, DOI 10.1016/0014-5793(87)81144-4; Pugh E.N., 2000, HDB BIOL PHYS, V3, P183, DOI DOI 10.1016/S1383-8121(00)80008-1; PUGH EN, 1993, BIOCHIM BIOPHYS ACTA, V1141, P111, DOI 10.1016/0005-2728(93)90038-H; PUIG J, 1995, FEBS LETT, V362, P185, DOI 10.1016/0014-5793(95)00225-X; Pulvermuller A, 2000, J BIOL CHEM, V275, P37679, DOI 10.1074/jbc.M006776200; PULVERMULLER A, 1993, BIOCHEMISTRY-US, V32, P14082, DOI 10.1021/bi00214a002; Pulvermuller A, 1997, BIOCHEMISTRY-US, V36, P9253, DOI 10.1021/bi970772g; Pulvermuller A, 2002, MOL CELL BIOL, V22, P2194, DOI 10.1128/MCB.22.7.2194-2203.2002; Sachs K, 2000, METHOD ENZYMOL, V315, P238; SCHLEICHER A, 1987, J MEMBRANE BIOL, V95, P271, DOI 10.1007/BF01869489; SCHLEICHER A, 1989, BIOCHEMISTRY-US, V28, P1770, DOI 10.1021/bi00430a052; SMITH WC, 1994, J BIOL CHEM, V269, P15407; Sokal I, 2002, METHOD ENZYMOL, V343, P578; Sokolov M, 2002, NEURON, V34, P95, DOI 10.1016/S0896-6273(02)00636-0; Vishnivetskiy SA, 2000, J BIOL CHEM, V275, P41049, DOI 10.1074/jbc.M007159200; Vishnivetskiy SK, 1999, J BIOL CHEM, V274, P11451, DOI 10.1074/jbc.274.17.11451; WHELAN JP, 1988, J NEUROSCI RES, V20, P263, DOI 10.1002/jnr.490200216; WILDEN U, 1986, P NATL ACAD SCI USA, V83, P1174, DOI 10.1073/pnas.83.5.1174; WILDEN U, 1982, BIOCHEMISTRY-US, V21, P3014, DOI 10.1021/bi00541a032; Xu J, 1997, NATURE, V389, P505, DOI 10.1038/39068	55	32	32	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2002	277	46					43987	43996		10.1074/jbc.M206211200	http://dx.doi.org/10.1074/jbc.M206211200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	615XE	12194979	hybrid			2022-12-27	WOS:000179272000060
J	Takayama, K; Garcia-Cardena, G; Sukhova, GK; Comander, J; Gimbrone, MA; Libby, P				Takayama, K; Garcia-Cardena, G; Sukhova, GK; Comander, J; Gimbrone, MA; Libby, P			Prostaglandin E-2 suppresses chemokine production in human macrophages through the EP4 receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Proceedings Paper	74th Annual Scientific Sessions of the American-Heart-Association	NOV 11-14, 2001	ANAHEIM, CA	Amer Heart Assoc			SMOOTH-MUSCLE CELLS; MONOCYTE CHEMOATTRACTANT PROTEIN-1; TISSUE FACTOR EXPRESSION; NF-KAPPA-B; ATHEROSCLEROTIC PLAQUES; DIFFERENTIAL EXPRESSION; ATHEROMATOUS PLAQUES; IMMUNE-RESPONSES; RABBIT ATHEROMA; DEFICIENT MICE	Pro-inflammatory pathways participate in the pathogenesis of atherosclerosis. However, the role of endogenous anti-inflammatory pathways in atheroma has received much less attention. Therefore, using cDNA microarrays, we screened for genes regulated by prostaglandin E-2 (PGE(2)), a potential endogenous anti-inflammatory mediator, in lipopolysaccharide (LPS)-treated human macrophages (MPhi). PGE(2) (50 nm) attenuated LPS-induced mRNA and protein expression of chemokines including monocyte chemoattractant protein-1, interleukin-8, macrophage inflammatory protein-1alpha and -1beta, and interferon-inducible protein-10. PGE(2) also inhibited the tumor necrosis factor-alpha-, interferon-gamma-, and interleukin-1beta-mediated expression of these chemokines. In contrast to the case of MPhi, PGE(2) did not suppress chemokine expression in human endothelial and smooth muscle cells (SMC) treated with LPS and pro-inflammatory cytokines. To assess the potential paracrine effect of endogenous PGE(2) on macrophage-derived chemokine production, we co-cultured MO with SMC in the presence of LPS. In these co-cultures, cyclooxygenase-2-dependent PGE2 production exceeded that in the mono-cultures, and MIP-1beta declined significantly compared with MPhi cultured without SMC. We further documented prominent expression of the PGE(2) receptor EP4 in MPhi in both culture and human atheroma. Moreover, a selective EP4 antagonist completely reversed PGE(2)-mediated suppression of chemokine production. Thus, endogenous PGE(2) may modulate inflammation during atherogenesis and other inflammatory diseases by suppressing macrophage-derived chemokine production via the EP4 receptor.	Harvard Univ, Brigham & Womens Hosp, Sch Med,Leducq Ctr Cardiovasc Res, Dept Med,Cardiovasc Div,Eugene Braunwald Res Ctr, Boston, MA 02115 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Excellence Vasc Biol,Dept Pathol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Libby, P (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med,Leducq Ctr Cardiovasc Res, Dept Med,Cardiovasc Div,Eugene Braunwald Res Ctr, Rm 307, Boston, MA 02115 USA.	plibby@rics.bwh.harvard.edu	Libby, Peter/AAY-6404-2021; Garcia-Cardena, Guillermo/Q-6649-2019	Libby, Peter/0000-0002-1502-502X; Comander, Jason/0000-0002-4257-7145	NHLBI NIH HHS [HL-34636] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL034636, R01HL034636] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abi-Younes S, 2000, CIRC RES, V86, P131, DOI 10.1161/01.RES.86.2.131; Aikawa M, 1999, CIRCULATION, V100, P1215, DOI 10.1161/01.CIR.100.11.1215; Aikawa M, 1998, CIRCULATION, V97, P2433, DOI 10.1161/01.CIR.97.24.2433; Apostolopoulos J, 1996, ARTERIOSCL THROM VAS, V16, P1007, DOI 10.1161/01.ATV.16.8.1007; BARNETT J, 1994, BBA-PROTEIN STRUCT M, V1209, P130, DOI 10.1016/0167-4838(94)90148-1; Belton O, 2000, CIRCULATION, V102, P840; BishopBailey D, 1997, ARTERIOSCL THROM VAS, V17, P1644, DOI 10.1161/01.ATV.17.9.1644; Boisvert WA, 1998, J CLIN INVEST, V101, P353, DOI 10.1172/JCI1195; Bonecchi R, 1998, J EXP MED, V187, P129, DOI 10.1084/jem.187.1.129; Boring L, 1998, NATURE, V394, P894, DOI 10.1038/29788; BrunwaldE, 2001, HEARTDISEASE ATEXTBO, P995; Bustos C, 1998, J AM COLL CARDIOL, V32, P2057, DOI 10.1016/S0735-1097(98)00487-2; Cipollone F, 2001, CIRCULATION, V104, P921, DOI 10.1161/hc3401.093152; COLEMAN RA, 1994, PHARMACOL REV, V46, P205; Comander J, 2001, GENOME RES, V11, P1603, DOI 10.1101/gr.186601; De Caterina R, 2000, AM J CLIN NUTR, V71, p213S, DOI 10.1093/ajcn/71.1.213S; DE CR, 1995, J CLIN INVEST, V96, P60; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; Garcia-Cardena G, 2001, P NATL ACAD SCI USA, V98, P4478, DOI 10.1073/pnas.071052598; Gilroy DW, 1999, NAT MED, V5, P698, DOI 10.1038/9550; Gu L, 1998, MOL CELL, V2, P275, DOI 10.1016/S1097-2765(00)80139-2; Gupta S, 1997, J CLIN INVEST, V99, P2752, DOI 10.1172/JCI119465; Hilkens C, 1996, ANN NY ACAD SCI, V795, P349, DOI 10.1111/j.1749-6632.1996.tb52689.x; HLA T, 1992, P NATL ACAD SCI USA, V89, P7384, DOI 10.1073/pnas.89.16.7384; Hwang D, 2000, ANNU REV NUTR, V20, P431, DOI 10.1146/annurev.nutr.20.1.431; JONES DA, 1993, J BIOL CHEM, V268, P9049; Kornbluth RS, 1998, P NATL ACAD SCI USA, V95, P5205, DOI 10.1073/pnas.95.9.5205; KRAAN TCTMV, 1995, J EXP MED, V181, P775, DOI 10.1084/jem.181.2.775; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; LIBBY P, 1995, CIRCULATION, V91, P2844, DOI 10.1161/01.CIR.91.11.2844; LIBBY P, 1988, J CLIN INVEST, V81, P487, DOI 10.1172/JCI113346; Mach F, 1999, J CLIN INVEST, V104, P1041, DOI 10.1172/JCI6993; Machwate M, 2001, MOL PHARMACOL, V60, P36, DOI 10.1124/mol.60.1.36; Marx N, 2001, CIRCULATION, V103, P213; Moriuchi H, 1997, J IMMUNOL, V158, P3483; Mukherjee D, 2001, JAMA-J AM MED ASSOC, V286, P954, DOI 10.1001/jama.286.8.954; Nataraj C, 2001, J CLIN INVEST, V108, P1229, DOI 10.1172/JCI13640; NELKEN NA, 1991, J CLIN INVEST, V88, P1121, DOI 10.1172/JCI115411; ONEILL GP, 1993, FEBS LETT, V330, P156, DOI 10.1016/0014-5793(93)80263-T; Parry GCN, 1997, J IMMUNOL, V159, P5450; ROLLAND PH, 1984, ARTERIOSCLEROSIS, V4, P70, DOI 10.1161/01.ATV.4.1.70; Schecter AD, 2000, J BIOL CHEM, V275, P5466, DOI 10.1074/jbc.275.8.5466; Schonbeck U, 1999, AM J PATHOL, V155, P1281, DOI 10.1016/S0002-9440(10)65230-3; Soler M, 2000, CIRC RES, V87, P504; TERKELTAUB R, 1994, ARTERIOSCLER THROMB, V14, P47, DOI 10.1161/01.ATV.14.1.47; Tomura K, 1999, INT J MOL MED, V3, P477; UEDA A, 1994, J IMMUNOL, V153, P2052; WANG JM, 1991, ARTERIOSCLER THROMB, V11, P1166, DOI 10.1161/01.ATV.11.5.1166; WIDMER U, 1993, J IMMUNOL, V150, P4996; ZIEGLER SF, 1991, J IMMUNOL, V147, P2234	50	268	278	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2002	277	46					44147	44154		10.1074/jbc.M204810200	http://dx.doi.org/10.1074/jbc.M204810200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Biochemistry & Molecular Biology	615XE	12215436	hybrid			2022-12-27	WOS:000179272000080
J	Bozinovski, S; Jones, JE; Vlahos, R; Hamilton, JA; Anderson, GP				Bozinovski, S; Jones, JE; Vlahos, R; Hamilton, JA; Anderson, GP			Granulocyte/macrophage-colony-stimulating factor (GM-CSF) regulates lung innate immunity to lipopolysaccharide through Akt/Erk activation of NF kappa B and AP-1 in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL ACTIVITY; MAP KINASE; C-JUN; ENDOTOXIN; MICE; AKT; INDUCTION; INSTILLATION; INFLAMMATION; APOPTOSIS	The lung innate immune response to lipopolysaccharide (LPS) coordinates cellular inflammation, mediator, and protease release essential for host defense but deleterious in asthma, chronic obstructive pulmonary disease, and cystic fibrosis. In vitro, LPS signals to the transcription factors NFkappaB via TLR4, MyD88, and IL-1R-associated kinase (IRAK), to AP-1 by mitogen-activated protein (MAP) kinases, and via an alternate route in IRAK-deficient mice, but the in vivo lung signaling pathway(s) are not understood. We investigated the role of Akt and Erk1/2 as LPS intensely stimulates granulocyte/macrophage-colony-stimulating factor (GM-CSF) release, and neutralizing GM-CSF profoundly suppressed LPS-induced inflammation, suppressed expression and activity of lung proteases, significantly reduced GMCSF and tumor necrosis factor alpha (TNFalpha) mRNA expression, and dampened nuclear localization of both NFkappaB (p50/65) and AP-1. LPS markedly activated Akt and Erk1/2, but not p38, in a GM-CSF-dependent manner in direct temporal association with NFkappaB and AP-1 activation. Pharmacological inhibition of Akt or Erk activation in LPS-treated tracheal explants ex vivo inhibited the release of GM-CSF. These data implicate GM-CSF-dependent activation of Akt in the amplification of this response and demonstrate the role of Erks rather than p38 in lung LPS inflammatory responses. Inhibition of GM-CSF may be of therapeutic benefit in inflammatory diseases in which LPS contributes to lung damage.	Univ Melbourne, Dept Pharmacol, CRC Chron Inflammatory Dis, Lung Dis Res Labs, Parkville, Vic 3010, Australia; Univ Melbourne, Arthrit & Inflammat Res Ctr, Dept Med,Royal Melbourne Hosp, Cooperat Res Ctr Chron Inflammatory Dis, Parkville, Vic 3010, Australia	University of Melbourne; Royal Melbourne Hospital; University of Melbourne	Anderson, GP (corresponding author), Univ Melbourne, Dept Pharmacol, CRC Chron Inflammatory Dis, Lung Dis Res Labs, Parkville, Vic 3010, Australia.	gpa@unimelb.edu.au	Vlahos, Ross/AAM-3837-2020	Vlahos, Ross/0000-0001-8443-7071; Anderson, Gary/0000-0001-6580-3398; Bozinovski, Steven/0000-0001-6533-8641; Hamilton, John A/0000-0002-9493-9224				Aljada A, 2001, J CLIN ENDOCR METAB, V86, P5988, DOI 10.1210/jc.86.12.5988; Basu S, 1997, J IMMUNOL, V159, P1412; Beutler B, 2000, CURR OPIN IMMUNOL, V12, P20, DOI 10.1016/S0952-7915(99)00046-1; Blyth DI, 1998, AM J RESP CELL MOL, V19, P38, DOI 10.1165/ajrcmb.19.1.2930; Bowie A, 2000, J LEUKOCYTE BIOL, V67, P508, DOI 10.1002/jlb.67.4.508; Coles LS, 2000, J BIOL CHEM, V275, P14482, DOI 10.1074/jbc.275.19.14482; deMoraes VLG, 1996, BRIT J PHARMACOL, V117, P1792; Dijkers PF, 1999, ONCOGENE, V18, P3334, DOI 10.1038/sj.onc.1202678; Gabri MR, 1999, PATHOBIOLOGY, V67, P180, DOI 10.1159/000028070; Goyal A, 2002, AM J RESP CELL MOL, V26, P224, DOI 10.1165/ajrcmb.26.2.4640; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; JONGENEEL CV, 1995, IMMUNOBIOLOGY, V193, P210, DOI 10.1016/S0171-2985(11)80545-0; Kim D, 2001, FASEB J, V15, P1953, DOI 10.1096/fj.01-0198com; Kim HG, 2000, BIOCHEM BIOPH RES CO, V269, P401; Klein JB, 2001, CELL SIGNAL, V13, P335, DOI 10.1016/S0898-6568(01)00151-6; Klein JB, 2000, J IMMUNOL, V164, P4286, DOI 10.4049/jimmunol.164.8.4286; Leppa S, 1998, EMBO J, V17, P4404, DOI 10.1093/emboj/17.15.4404; Li JD, 1997, P NATL ACAD SCI USA, V94, P967, DOI 10.1073/pnas.94.3.967; Madrid LV, 2000, MOL CELL BIOL, V20, P1626, DOI 10.1128/MCB.20.5.1626-1638.2000; Martin TR, 2000, AM J RESP CELL MOL, V23, P128, DOI 10.1165/ajrcmb.23.2.f189; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Meja KK, 2000, BRIT J PHARMACOL, V131, P1143, DOI 10.1038/sj.bjp.0703684; Metcalf D, 1999, BLOOD, V93, P1579, DOI 10.1182/blood.V93.5.1579.405k01_1579_1585; Michel O, 1996, AM J RESP CRIT CARE, V154, P1641, DOI 10.1164/ajrccm.154.6.8970348; Monick MM, 2001, J IMMUNOL, V166, P4713, DOI 10.4049/jimmunol.166.7.4713; Monick MM, 2001, J IMMUNOL, V167, P5977, DOI 10.4049/jimmunol.167.10.5977; Musti AM, 1997, SCIENCE, V275, P400, DOI 10.1126/science.275.5298.400; NAKATA K, 1991, J IMMUNOL, V147, P1266; O'Grady NP, 2001, AM J RESP CRIT CARE, V163, P1591, DOI 10.1164/ajrccm.163.7.2009111; O'Neill L, 2000, BIOCHEM SOC T, V28, P557, DOI 10.1042/bst0280557; Ozes ON, 1999, NATURE, V401, P82; Romashkova JA, 1999, NATURE, V401, P86, DOI 10.1038/43474; Santiago FS, 1999, AM J PATHOL, V154, P937, DOI 10.1016/S0002-9440(10)65341-2; Shibata Y, 2001, IMMUNITY, V15, P557, DOI 10.1016/S1074-7613(01)00218-7; STANLEY E, 1994, P NATL ACAD SCI USA, V91, P5592, DOI 10.1073/pnas.91.12.5592; STARCHER B, 1989, LAB ANIM, V23, P234, DOI 10.1258/002367789780810536; Swantek JL, 2000, J IMMUNOL, V164, P4301, DOI 10.4049/jimmunol.164.8.4301; Thomas JA, 1999, J IMMUNOL, V163, P978; Turner H, 1997, J EXP MED, V185, P43, DOI 10.1084/jem.185.1.43; Underwood DC, 2000, AM J PHYSIOL-LUNG C, V279, pL895, DOI 10.1152/ajplung.2000.279.5.L895; Vernooy JHJ, 2002, AM J RESP CELL MOL, V26, P152, DOI 10.1165/ajrcmb.26.1.4652; Xing Z, 1996, J CLIN INVEST, V97, P1102, DOI 10.1172/JCI118503; Zheng T, 2000, J CLIN INVEST, V106, P1081, DOI 10.1172/JCI10458	44	143	146	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					42808	42814		10.1074/jbc.M207840200	http://dx.doi.org/10.1074/jbc.M207840200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12208854	hybrid			2022-12-27	WOS:000179081200052
J	Couplan, E; Gelly, C; Goubern, M; Fleury, C; Quesson, B; Silberberg, M; Thiaudiere, E; Mateo, P; Lonchampt, M; Levens, N; de Montrion, C; Ortmann, S; Klaus, S; Gonzalez-Barroso, MDM; Cassard-Doulcier, AM; Ricquier, D; Bigard, AX; Diolez, P; Bouillaud, F				Couplan, E; Gelly, C; Goubern, M; Fleury, C; Quesson, B; Silberberg, M; Thiaudiere, E; Mateo, P; Lonchampt, M; Levens, N; de Montrion, C; Ortmann, S; Klaus, S; Gonzalez-Barroso, MDM; Cassard-Doulcier, AM; Ricquier, D; Bigard, AX; Diolez, P; Bouillaud, F			High level of uncoupling protein 1 expression in muscle of transgenic mice selectively affects muscles at rest and decreases their IIb fiber content	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR-A; SKELETAL-MUSCLE; ENERGY-METABOLISM; GENE ENCODES; BROWN-FAT; UCP1; MITOCHONDRIA; REGULATORS; MECHANISMS; HOMOLOGS	The mitochondrial uncoupling protein of brown adipose tissue (UCP1) was expressed in skeletal muscle and heart of transgenic mice at levels comparable with the amount found in brown adipose tissue mitochondria. These transgenic mice have a lower body weight, and when related to body weight, food intake and energy expenditure are increased. A specific reduction of muscle mass was observed but varied according to the contractile activity of muscles. Heart and soleus muscle are unaffected, indicating that muscles undergoing regular contractions, and therefore with a continuous mitochondrial ATP production, are protected. In contrast, the gastrocnemius and plantaris muscles showed a severely reduced mass and a fast to slow shift in fiber types promoting mainly IIa and IIx: fibers at the expense of fastest and glycolytic type IIb fibers. These observations are interpreted as a consequence of the strong potential dependence of the UCP1 protonophoric activity, which ensures a negligible proton leak at the membrane potential observed when mitochondrial ATP production is intense. Therefore UCP1 is not deleterious for an intense mitochondrial ATP production and this explains the tolerance of the heart to a high expression level of UCP1. In muscles at rest, where ATP production is low, the rise in membrane potential enhances UCP1 activity. The proton return through UCP1 mimics the effect of a sustained ATP production, permanently lowering mitochondrial membrane potential. This very likely constitutes the origin of the signal leading to the transition in fiber types at rest.	CNRS, UPR 9078, F-92190 Meudon, France; INRA, Lab Nutr & Securite Alimentaire, F-78352 Jouy En Josas, France; Univ Victor Segalen, CNRS, UMR 5536, F-33076 Bordeaux, France; Ctr Rech, Serv Sante Armees, Unite Bioenerget & Environm, F-38702 La Tronche, France; Univ Paris Sud, Fac Pharm, INSERM, U446, F-92296 Chatenay Malabry, France; Inst Rech Servier, F-92150 Suresnes, France; German Inst Human Nutr, DIfE, D-14558 Bergholz Rehbrucke, Germany	Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Servier; Institut de Recherches Internationales Servier; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE)	Bouillaud, F (corresponding author), CNRS, UPR 9078, Inst Rech Necker Enfants Malades, 156 Rue Vaugirard, F-75730 Paris 15, France.		CASSARD, Anne-Marie/B-6095-2019; Ortmann, Sylvia/B-7088-2015; Silberberg, Mathieu/X-9974-2019; Klaus, Susanne/P-9299-2018; Bouillaud, Frédéric R/L-3238-2017	CASSARD, Anne-Marie/0000-0002-1813-5128; Ortmann, Sylvia/0000-0003-2520-6251; Silberberg, Mathieu/0000-0003-3345-8088; Klaus, Susanne/0000-0001-8726-185X; Bouillaud, Frédéric R/0000-0002-7518-9237; GONZALEZ BARROSO, MARIA DEL MAR/0000-0002-0278-8298; Thiaudiere, Eric/0000-0002-9993-4035; Diolez, Philippe/0000-0002-7548-2070; quesson, bruno/0000-0001-6434-3684				Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; BOOTH FW, 1991, PHYSIOL REV, V71, P541, DOI 10.1152/physrev.1991.71.2.541; Boss O, 2000, DIABETES, V49, P143, DOI 10.2337/diabetes.49.2.143; Bouillaud F, 2001, BBA-BIOENERGETICS, V1504, P107, DOI 10.1016/S0005-2728(00)00241-3; Chin ER, 1998, GENE DEV, V12, P2499, DOI 10.1101/gad.12.16.2499; Clapham JC, 2000, NATURE, V406, P415, DOI 10.1038/35019082; DANIELSON PE, 1988, DNA-J MOLEC CELL BIO, V7, P261, DOI 10.1089/dna.1988.7.261; Echtay KS, 2001, P NATL ACAD SCI USA, V98, P1416, DOI 10.1073/pnas.98.4.1416; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Gong DW, 2000, J BIOL CHEM, V275, P16251, DOI 10.1074/jbc.M910177199; Gordon JW, 2001, J APPL PHYSIOL, V90, P389, DOI 10.1152/jappl.2001.90.1.389; Jackman MR, 1996, AM J PHYSIOL-CELL PH, V270, pC673, DOI 10.1152/ajpcell.1996.270.2.C673; JAYNES JB, 1986, MOL CELL BIOL, V6, P2855, DOI 10.1128/MCB.6.8.2855; Klaus S, 1998, AM J PHYSIOL-REG I, V274, pR287, DOI 10.1152/ajpregu.1998.274.2.R287; Klingenberg M, 1999, INT J OBESITY, V23, pS24, DOI 10.1038/sj.ijo.0800939; Larsson NG, 1996, NAT GENET, V13, P296, DOI 10.1038/ng0796-296; LAWSON JWR, 1979, J BIOL CHEM, V254, P6528; LEIFER D, 1993, P NATL ACAD SCI USA, V90, P1546, DOI 10.1073/pnas.90.4.1546; Li B, 2000, NAT MED, V6, P1115, DOI 10.1038/80450; LOCKE RM, 1982, EUR J BIOCHEM, V129, P373, DOI 10.1111/j.1432-1033.1982.tb07060.x; MCDERMOTT JC, 1993, MOL CELL BIOL, V13, P2564, DOI 10.1128/MCB.13.4.2564; NICHOLLS DG, 1984, PHYSIOL REV, V64, P1, DOI 10.1152/physrev.1984.64.1.1; NICHOLLS DG, 1973, EUR J BIOCHEM, V37, P523, DOI 10.1111/j.1432-1033.1973.tb03014.x; Pette D, 1998, ACTA PHYSIOL SCAND, V162, P367, DOI 10.1046/j.1365-201X.1998.0296e.x; REN JM, 1995, PFLUG ARCH EUR J PHY, V430, P389, DOI 10.1007/BF00373914; Rial E, 1999, EMBO J, V18, P5827, DOI 10.1093/emboj/18.21.5827; Ricquier D, 2000, BIOCHEM J, V345, P161, DOI 10.1042/0264-6021:3450161; SIECK GC, 1995, J APPL PHYSIOL, V79, P1629, DOI 10.1152/jappl.1995.79.5.1629; Sjogren K, 2001, J NUTR, V131, P2963, DOI 10.1093/jn/131.11.2963; Talmadge RJ, 2000, MUSCLE NERVE, V23, P661, DOI 10.1002/(SICI)1097-4598(200005)23:5<661::AID-MUS3>3.0.CO;2-J; TALMADGE RJ, 1993, J APPL PHYSIOL, V75, P2337, DOI 10.1152/jappl.1993.75.5.2337; VEECH RL, 1979, J BIOL CHEM, V254, P6538; Vidal-Puig AJ, 2000, J BIOL CHEM, V275, P16258, DOI 10.1074/jbc.M910179199; WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363	34	51	51	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					43079	43088		10.1074/jbc.M206726200	http://dx.doi.org/10.1074/jbc.M206726200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12221093	hybrid			2022-12-27	WOS:000179081200086
J	Erlitzki, R; Long, JC; Theil, EC				Erlitzki, R; Long, JC; Theil, EC			Multiple, conserved iron-responsive elements in the 3 '-untranslated region of transferrin receptor mRNA enhance binding of iron regulatory protein 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FERRITIN MESSENGER-RNA; MAMMALIAN-CELLS; MITOCHONDRIAL ACONITASE; DIETARY IRON; HAIRPIN LOOP; INTERNAL LOOP/BULGE; NMR-SPECTROSCOPY; RAT-LIVER; METABOLISM; EXPRESSION	Synthesis of proteins for iron homeostasis is regulated by specific, combinatorial mRNA/protein interactions between RNA stem-loop structures (iron-responsive elements, IREs) and iron-regulatory proteins (IRP1 and IRP2), controlling either mRNA translation or stability. The transferrin receptor W-untranslated region (TfR-3'-UTR) mRNA is unique in having five IREs, linked by AU-rich elements. A C-bulge in the stem of each TfR-IRE folds into an IRE that has low IRP2 binding, whereas a loop/bulge in the stem of the ferritin-IRE allows equivalent IRP1 and IRP2 binding. Effects of multiple IRE interactions with IRP1 and IRP2 were compared between the native TfR-3'-UTR sequence (5xIRE) and RNA with only 3 or 2 IREs. We show 1) equivalent IRP1 and IRP2 binding to multiple TfR-IRE RNAs; 2) increased IRP-dependent nuclease resistance of 5xIRE compared with lower IRE copy-number RNAs; 3) distorted TfR-IRE helix structure within the context of 5xIRE, detected by Cu-(phen)(2) binding/cleavage, that coincides with ferritin-IRE conformation and enhanced IRP2 binding, and 4) variable IRP1 and IRP2 expression in human cells and during development (IRP2-mRNA predominated). Changes in TfR-IRE structure conferred by the full length TfR-3'-UTR mRNA explain in part evolutionary conservation of multiple IRE-RNA, which allows TfR mRNA stabilization and receptor synthesis when IRP activity varies, and ensures iron uptake for cell growth.	Childrens Hosp, Oakland Res Inst, Inst Res, Oakland, CA 94609 USA; Med Ctr Oakland, Oakland, CA 94609 USA	Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute	Theil, EC (corresponding author), Childrens Hosp, Oakland Res Inst, Inst Res, 5700 Martin Luther King,Jr Way, Oakland, CA 94609 USA.	etheil@chori.org			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK020251, R37DK020251, R56DK020251] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-20251] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abboud S, 2000, J BIOL CHEM, V275, P19906, DOI 10.1074/jbc.M000713200; Addess KJ, 1997, J MOL BIOL, V274, P72, DOI 10.1006/jmbi.1997.1377; Aisen P, 1999, CURR OPIN CHEM BIOL, V3, P200, DOI 10.1016/S1367-5931(99)80033-7; Ausubel F. M., 2001, CURRENT PROTOCOLS MO; BINDER R, 1994, EMBO J, V13, P1969, DOI 10.1002/j.1460-2075.1994.tb06466.x; Bouton C, 2002, J BIOL CHEM, V277, P31220, DOI 10.1074/jbc.M203276200; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; Butt J, 1996, P NATL ACAD SCI USA, V93, P4345, DOI 10.1073/pnas.93.9.4345; Cairo G, 2000, BIOCHEM J, V352, P241, DOI 10.1042/0264-6021:3520241; Canonne-Hergaux F, 1999, BLOOD, V93, P4406, DOI 10.1182/blood.V93.12.4406.412k21_4406_4417; CASEY JL, 1989, EMBO J, V8, P3693, DOI 10.1002/j.1460-2075.1989.tb08544.x; CASEY JL, 1988, SCIENCE, V240, P924, DOI 10.1126/science.2452485; CHAN LNL, 1989, NUCLEIC ACIDS RES, V17, P3763, DOI 10.1093/nar/17.10.3763; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Chen OS, 1997, J NUTR, V127, P238, DOI 10.1093/jn/127.2.238; Chen OS, 1998, J NUTR, V128, P525, DOI 10.1093/jn/128.3.525; COX TC, 1991, EMBO J, V10, P1891, DOI 10.1002/j.1460-2075.1991.tb07715.x; DIX DJ, 1992, BIOCHEMISTRY-US, V31, P2818, DOI 10.1021/bi00125a024; DIX DJ, 1993, J MOL BIOL, V231, P230, DOI 10.1006/jmbi.1993.1278; Donovan A, 2000, NATURE, V403, P776, DOI 10.1038/35001596; Eisenstein RS, 2000, ANNU REV NUTR, V20, P627, DOI 10.1146/annurev.nutr.20.1.627; Gdaniec Z, 1998, BIOCHEMISTRY-US, V37, P1505, DOI 10.1021/bi9719814; Guhaniyogi J, 2001, GENE, V265, P11, DOI 10.1016/S0378-1119(01)00350-X; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; Gunshin H, 2001, FEBS LETT, V509, P309, DOI 10.1016/S0014-5793(01)03189-1; GUO B, 1995, J BIOL CHEM, V270, P16529, DOI 10.1074/jbc.270.28.16529; HARRELL CM, 1991, P NATL ACAD SCI USA, V88, P4166, DOI 10.1073/pnas.88.10.4166; HENDERSON BR, 1995, J BIOL CHEM, V270, P20509, DOI 10.1074/jbc.270.35.20509; Henderson ER, 1996, J BIOL CHEM, V271, P4900; HOROWITZ JA, 1992, NEW BIOL, V4, P330; JOHANSSON HE, 2002, MOL CELLULAR IRON TR, P237; Kaldy P, 1999, EMBO J, V18, P6073, DOI 10.1093/emboj/18.21.6073; Kawabata H, 1999, J BIOL CHEM, V274, P20826, DOI 10.1074/jbc.274.30.20826; Ke YH, 1998, J BIOL CHEM, V273, P23637, DOI 10.1074/jbc.273.37.23637; Ke YH, 2002, J BIOL CHEM, V277, P2373, DOI 10.1074/jbc.C100614200; Ke YH, 2000, BIOCHEMISTRY-US, V39, P6235, DOI 10.1021/bi9924765; Keene JD, 2001, P NATL ACAD SCI USA, V98, P7018, DOI 10.1073/pnas.111145598; Keene JD, 1999, P NATL ACAD SCI USA, V96, P5, DOI 10.1073/pnas.96.1.5; KOELLER DM, 1989, P NATL ACAD SCI USA, V86, P3574, DOI 10.1073/pnas.86.10.3574; LaVaute T, 2001, NAT GENET, V27, P209, DOI 10.1038/84859; Leibold EA, 2001, HISTOCHEM CELL BIOL, V115, P195; Levi S, 2001, J BIOL CHEM, V276, P24437, DOI 10.1074/jbc.C100141200; Meehan HA, 2001, J BIOL CHEM, V276, P14791, DOI 10.1074/jbc.M010295200; MULLNER EW, 1989, CELL, V58, P373, DOI 10.1016/0092-8674(89)90851-9; MURAKAWA GJ, 1989, NUCLEIC ACIDS RES, V17, P5361, DOI 10.1093/nar/17.13.5361; PATINO MM, 1992, J BIOL CHEM, V267, P19011; Pinero DJ, 2000, CELL MOL BIOL, V46, P761; ROSS J, 1995, MICROBIOL REV, V59, P423, DOI 10.1128/MMBR.59.3.423-450.1995; Rouault TA, 1996, J BIOL INORG CHEM, V1, P494, DOI 10.1007/s007750050083; ROUAULT TA, 1990, P NATL ACAD SCI USA, V87, P7958, DOI 10.1073/pnas.87.20.7958; SAMANIEGO F, 1994, J BIOL CHEM, V269, P30904; Schalinske KL, 1997, P NATL ACAD SCI USA, V94, P10681, DOI 10.1073/pnas.94.20.10681; Schalinske KL, 1996, J BIOL CHEM, V271, P7168, DOI 10.1074/jbc.271.12.7168; Schalinske KL, 1998, J BIOL CHEM, V273, P3740, DOI 10.1074/jbc.273.6.3740; Schlegl J, 1997, RNA, V3, P1159; SCHNEIDER C, 1984, NATURE, V311, P675, DOI 10.1038/311675b0; SIERZPUTOWSKAGRACZ H, 1995, NUCLEIC ACIDS RES, V23, P146, DOI 10.1093/nar/23.1.146; Theil EC, 2000, J BIOL CHEM, V275, P40659, DOI 10.1074/jbc.R000019200; Theil EC, 2000, BIOCHEM PHARMACOL, V59, P87, DOI 10.1016/S0006-2952(99)00300-7; WANG YH, 1990, NUCLEIC ACIDS RES, V18, P4463, DOI 10.1093/nar/18.15.4463; Wilusz CJ, 2001, NAT REV MOL CELL BIO, V2, P237, DOI 10.1038/35067025; Wu KJ, 1999, SCIENCE, V283, P676, DOI 10.1126/science.283.5402.676; Zhang L, 2000, BIOCHEM J, V349, P289, DOI 10.1042/0264-6021:3490289	63	69	69	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					42579	42587		10.1074/jbc.M207918200	http://dx.doi.org/10.1074/jbc.M207918200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12200453	hybrid			2022-12-27	WOS:000179081200021
J	Heng, JIT; Tan, SS				Heng, JIT; Tan, SS			Cloning and characterization of GRIPE, a novel interacting partner of the transcription factor E12 in developing mouse forebrain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-CONJUGATING ENZYME; LOOP-HELIX GENES; DNA-BINDING; NEURONAL PLASTICITY; TUBEROUS SCLEROSIS; E2A PROTEINS; EXPRESSION; DIFFERENTIATION; DIMERIZATION; SPECIFICITY	The helix-loop-helix (HLH) family of transcription factors are key contributors to a wide array of developmental processes, including neurogenesis and hematopoiesis. These factors are thought to exert their regulatory influences by binding to cognate promoter-DNA sequences as dimers. Although studies in mice have convincingly demonstrated that neurogenic HLH proteins such as NeuroD are intimately involved in neuronal fate determination, the role of the ubiquitously expressed HLH protein, E12, in mammalian neurogenesis remains ambiguous. To address this, a yeast two-hybrid interaction screen was employed to identify dimerization partners to E12. Screening of an embryonic day 11.5 forebrain library resulted in the cloning of GRIPE, a novel GAP-related interacting protein to E12. GRIPE binds to the HLH region of E12 and may require E12 for nuclear import. Furthermore, GRIPE may negatively regulate E12-dependent target gene transcription. High levels of GRIPE and E12 mRNA were coincidentally detected during embryogenesis, but only GRIPE mRNA levels remained high in adult brain, particularly in neurons of the cortex and hippocampus. These observations were recapitulated through an in vitro model of neurogenesis. Taken together, these results indicate that GRIPE is a novel protein dimerization of which with E12 has important consequences for cells undergoing neuronal differentiation.	Univ Melbourne, Howard Florey Inst, Brain Dev Grp, Melbourne, Vic 3010, Australia	Florey Institute of Neuroscience & Mental Health; University of Melbourne	Tan, SS (corresponding author), Univ Melbourne, Howard Florey Inst, Brain Dev Grp, Melbourne, Vic 3010, Australia.			Heng, Julian Ik-Tsen/0000-0002-0378-7078				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BAIN G, 1994, CELL, V79, P885, DOI 10.1016/0092-8674(94)90077-9; CHIARAMELLO A, 1995, MOL BRAIN RES, V29, P107, DOI 10.1016/0169-328X(94)00236-8; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHRISTY BA, 1991, P NATL ACAD SCI USA, V88, P1815, DOI 10.1073/pnas.88.5.1815; Goldfarb AN, 1998, J BIOL CHEM, V273, P2866, DOI 10.1074/jbc.273.5.2866; GUILLEMOT F, 1993, MECH DEVELOP, V42, P171, DOI 10.1016/0925-4773(93)90006-J; Hsueh YP, 2000, NATURE, V404, P298, DOI 10.1038/35005118; Ito N, 1999, CELL, V96, P529, DOI 10.1016/S0092-8674(00)80657-1; James P, 1996, GENETICS, V144, P1425; JOHNSON JE, 1992, DEVELOPMENT, V114, P75; Kho CJ, 1997, J BIOL CHEM, V272, P3845, DOI 10.1074/jbc.272.6.3845; Lee JE, 1997, CURR OPIN NEUROBIOL, V7, P13, DOI 10.1016/S0959-4388(97)80115-8; Loveys DA, 1997, GENE, V201, P169, DOI 10.1016/S0378-1119(97)00444-7; Maheshwar MM, 1997, HUM MOL GENET, V6, P1991, DOI 10.1093/hmg/6.11.1991; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; NEUMAN T, 1993, DEV BIOL, V160, P186, DOI 10.1006/dbio.1993.1297; Pak DTS, 2001, NEURON, V31, P289, DOI 10.1016/S0896-6273(01)00355-5; ROBERTS VJ, 1993, P NATL ACAD SCI USA, V90, P7583, DOI 10.1073/pnas.90.16.7583; RUEZINSKY D, 1991, GENE DEV, V5, P29, DOI 10.1101/gad.5.1.29; Runnicki M.A., 1987, TERATOCARCINOMAS EMB, P19; Scheffzek K, 1998, TRENDS BIOCHEM SCI, V23, P257, DOI 10.1016/S0968-0004(98)01224-9; Sharpe C, 2001, BIOESSAYS, V23, P311, DOI 10.1002/bies.1045; SHIRAKATA M, 1993, GENE DEV, V7, P2456, DOI 10.1101/gad.7.12a.2456; SHIRAKATA M, 1995, EMBO J, V14, P1766, DOI 10.1002/j.1460-2075.1995.tb07165.x; SOOSAAR A, 1994, MOL BRAIN RES, V25, P176, DOI 10.1016/0169-328X(94)90297-6; VAESSIN H, 1994, DEVELOPMENT, V120, P935; Wheeler DL, 2001, NUCLEIC ACIDS RES, V29, P11, DOI 10.1093/nar/29.1.11; Yan W, 1997, MOL CELL BIOL, V17, P7317, DOI 10.1128/MCB.17.12.7317; Zhuang Y, 1996, MOL CELL BIOL, V16, P2898; ZHUANG Y, 1994, CELL, V79, P875, DOI 10.1016/0092-8674(94)90076-0; Zhuang YA, 1998, MOL CELL BIOL, V18, P3340, DOI 10.1128/MCB.18.6.3340	34	13	15	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					43152	43159		10.1074/jbc.M204858200	http://dx.doi.org/10.1074/jbc.M204858200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12200424	hybrid			2022-12-27	WOS:000179081200096
J	Kobayashi, G; Nakamura, T; Ohmachi, H; Matsuoka, A; Ochiai, T; Shikama, K				Kobayashi, G; Nakamura, T; Ohmachi, H; Matsuoka, A; Ochiai, T; Shikama, K			Yeast flavohemoglobin from Candida norvegensis - Its structural, spectral, and stability properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-SEQUENCE; DISTAL HISTIDINE RESIDUE; NITRIC-OXIDE; TETRAHYMENA-PYRIFORMIS; ALCALIGENES-EUTROPHUS; AUTOXIDATION REACTION; APLYSIA OXYMYOGLOBIN; PROTOZOAN MYOGLOBIN; PARAMECIUM-CAUDATUM; MOLECULAR MECHANISM	Flavohemoglobin was isolated directly from the yeast Candida norvegensis and studied on its structural, spectral, and stability properties. In Candida flavohemoglobin, the 155 N-terminal residues make a heme-containing domain, while the remaining 234 C-terminal residues serve as a FAD-containing reductase domain. A pair of His-95 and Gln-63 was assigned to the proximal and distal residues, respectively. In purification procedure FAD was partially dissociated on a Butyl-Toyopearl column, so that FAD-lacking flavohemoglobin was also obtainable. In this ferric species, the Soret and charge-transfer bands were all characteristic of a pentacoordinate form. Compared with the recombinant heme domain expressed in Escherichia coli, we have measured the autoxidation rate over a wide pH range. The resulting pH dependence curves were then analyzed in terms of a nucleophilic displacement mechanism. As a result, the heme domain was found to be extremely susceptible to autoxidation, its rate being more than 100 times higher than that of sperm whale MbO(2). However, this inherently high oxidation rate was dramatically suppressed in Candida flavohemoglobin to an extent almost comparable to the stability of mammalian myoglobins. These new findings lead us to conclude that Candida flavohemoglobin, differently from bacterial flavohemoglobins, can serve as an oxygen storage protein in aerobic conditions.	Tohoku Univ, Grad Sch Life Sci, Inst Biol, Sendai, Miyagi 9808578, Japan; Fukushima Med Univ, Fukushima 9601295, Japan; PHP Lab Mol Biol, Sendai, Miyagi 9893203, Japan	Tohoku University; Fukushima Medical University	Shikama, K (corresponding author), Tohoku Univ, Grad Sch Life Sci, Inst Biol, Sendai, Miyagi 9808578, Japan.							BREDT DS, 1991, NATURE, V351, P714, DOI 10.1038/351714a0; Buisson N, 1998, J BIOL CHEM, V273, P9527, DOI 10.1074/jbc.273.16.9527; COUTURE M, 1994, MOL GEN GENET, V243, P185, DOI 10.1007/BF00280316; Couture M, 1999, P NATL ACAD SCI USA, V96, P11223, DOI 10.1073/pnas.96.20.11223; DEDUVE C, 1948, ACTA CHEM SCAND, V2, P264, DOI 10.3891/acta.chem.scand.02-0264; Ermler U, 1995, EMBO J, V14, P6067, DOI 10.1002/j.1460-2075.1995.tb00297.x; Gardner PR, 1998, P NATL ACAD SCI USA, V95, P10378, DOI 10.1073/pnas.95.18.10378; GOTOH T, 1976, J BIOCHEM-TOKYO, V80, P397, DOI 10.1093/oxfordjournals.jbchem.a131289; Ilari A, 2002, J BIOL CHEM, V277, P23725, DOI 10.1074/jbc.M202228200; IWAASA H, 1990, J BIOL CHEM, V265, P8603; IWAASA H, 1989, J MOL BIOL, V208, P355, DOI 10.1016/0022-2836(89)90395-1; IWAASA H, 1991, Zoological Science (Tokyo), V8, P1134; KARPLUS PA, 1991, SCIENCE, V251, P60, DOI 10.1126/science.1986412; Kim SO, 1999, FEBS LETT, V445, P389, DOI 10.1016/S0014-5793(99)00157-X; KOBAYASHI G, 2002, THESIS TOHOKU U SEND; KOBAYASHI G, 1995, PHYSIOL ZOOL, V68, P82; Korenaga S, 2000, BBA-PROTEIN STRUCT M, V1543, P131, DOI 10.1016/S0167-4838(00)00187-4; LIVINGSTON DJ, 1985, J BIOL CHEM, V260, P5699; MATSUOKA A, 1992, BIOCHIM BIOPHYS ACTA, V1118, P123; MATSUOKA A, 1992, EUR J BIOCHEM, V210, P337, DOI 10.1111/j.1432-1033.1992.tb17426.x; Ollesch G, 1999, EUR J BIOCHEM, V262, P396, DOI 10.1046/j.1432-1327.1999.00381.x; OSHINO R, 1973, EUR J BIOCHEM, V39, P581, DOI 10.1111/j.1432-1033.1973.tb03157.x; OSHINO R, 1973, EUR J BIOCHEM, V35, P23, DOI 10.1111/j.1432-1033.1973.tb02805.x; Pesce A, 2000, EMBO J, V19, P2424, DOI 10.1093/emboj/19.11.2424; PHILLIPS SEV, 1981, NATURE, V292, P81, DOI 10.1038/292081a0; POTTS M, 1992, SCIENCE, V256, P1690, DOI 10.1126/science.256.5064.1690; SHIKAMA K, 1986, BIOCHEMISTRY-US, V25, P3898, DOI 10.1021/bi00361a024; SHIKAMA K, 1994, BIOL REV, V69, P233, DOI 10.1111/j.1469-185X.1994.tb01507.x; SHIKAMA K, 1988, COORDIN CHEM REV, V83, P73, DOI 10.1016/0010-8545(88)80019-5; SHIKAMA K, 1989, J MOL BIOL, V209, P489, DOI 10.1016/0022-2836(89)90012-0; Shikama K, 1998, CHEM REV, V98, P1357, DOI 10.1021/cr970042e; Suzuki T, 2000, EUR J BIOCHEM, V267, P6166, DOI 10.1046/j.1432-1327.2000.01685.x; Tada T, 1998, BBA-PROTEIN STRUCT M, V1387, P165, DOI 10.1016/S0167-4838(98)00118-6; TSUBAMOTO Y, 1990, EUR J BIOCHEM, V193, P55, DOI 10.1111/j.1432-1033.1990.tb19303.x; Tsuruga M, 1998, J BIOL CHEM, V273, P8607, DOI 10.1074/jbc.273.15.8607; VASUDEVAN SG, 1991, MOL GEN GENET, V226, P49, DOI 10.1007/BF00273586; WAKABAYASHI S, 1986, NATURE, V322, P481, DOI 10.1038/322481a0; Wittenberg JB, 2002, J BIOL CHEM, V277, P871, DOI 10.1074/jbc.R100058200; Yasuda JP, 2002, EUR J BIOCHEM, V269, P202, DOI 10.1046/j.0014-2956.2002.02635.x; YUBISUI T, 1984, J BIOCHEM-TOKYO, V96, P579, DOI 10.1093/oxfordjournals.jbchem.a134871; YUBISUI T, 1986, J BIOCHEM-TOKYO, V99, P407, DOI 10.1093/oxfordjournals.jbchem.a135495; ZHU H, 1992, P NATL ACAD SCI USA, V89, P5015, DOI 10.1073/pnas.89.11.5015	42	19	20	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					42540	42548		10.1074/jbc.M206529200	http://dx.doi.org/10.1074/jbc.M206529200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12192008	hybrid			2022-12-27	WOS:000179081200016
J	Kowaltowski, AJ; Cosso, RG; Campos, CB; Fiskum, G				Kowaltowski, AJ; Cosso, RG; Campos, CB; Fiskum, G			Effect of Bcl-2 overexpression on mitochondrial structure and function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERMEABILITY TRANSITION; HEART-MITOCHONDRIA; CYTOCHROME-C; APOPTOSIS; MEMBRANE; PROTEIN; DEATH; CELLS; ONCOPROTEIN; DIGITONIN	Overexpression of the antiapoptotic Bcl-2 protein enhances the uptake of fluorimetric dyes sensitive to mitochondrial membrane potential, suggesting that Bcl-2 changes the mitochondrial proton gradient. In this study, we performed calibrated measurements of mitochondrial respiration, membrane potential, DeltapH, and intramitochondrial [K+] in digitonin-permeabilized PC12 and GT1-7 neural cells that either do not express human Bcl-2 (control transfectants) or that were transfected with and overexpressed the human bcl-2 gene to evaluate whether Bcl-2 alters mitochondrial inner membrane ion transport. We found that although Bcl-2-overexpressing cells exhibit higher fluorescence responses to membrane potential, pH, and K+-sensitive dyes, this increased response is due to an enhanced accumulation of these dyes and not an increased mitochondrial membrane potential, DeltapH, or [K+]. This result is supported by the presence of equal respiratory rates in Bcl-2+ and Bcl-2- cells. Possible structural alterations in Bcl-2+ mitochondria that could account for increases in fluorescent dye uptake were evaluated using flow cytometry particle sizing and light scattering determinations. These experiments established that Bcl-2-overexpressing mitochondria present both increased volume and structural complexity. We suggest that increased mitochondrial volume and structural complexity in Bcl-2+ cells may be related to many of the effects of this protein involved in the prevention of cell death.	Univ Estadual Campinas, Fac Ciencias Med, Dept Patol Clin, BR-13083970 Campinas, SP, Brazil; Univ Maryland, Sch Med, Dept Anesthesiol, Baltimore, MD 21201 USA	Universidade Estadual de Campinas; University System of Maryland; University of Maryland Baltimore	Kowaltowski, AJ (corresponding author), Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-05508900 Sao Paulo, Brazil.		Kowaltowski, Alicia J/H-8698-2012					Adams JM, 2001, TRENDS BIOCHEM SCI, V26, P61, DOI 10.1016/S0968-0004(00)01740-0; AKERMAN KEO, 1976, FEBS LETT, V68, P191, DOI 10.1016/0014-5793(76)80434-6; Armstrong JS, 2002, FASEB J, V16, P1263, DOI 10.1096/fj.02-0097fje; Ellerby LM, 1996, J NEUROCHEM, V67, P1259; Esposti MD, 1999, J BIOL CHEM, V274, P29831, DOI 10.1074/jbc.274.42.29831; Fiskum G, 2000, METHOD ENZYMOL, V322, P222; GARLID KD, 1985, J BIOL CHEM, V260, P3434; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; JUNG DW, 1995, J BIOL CHEM, V270, P672, DOI 10.1074/jbc.270.2.672; JUNG DW, 1990, BIOCHEMISTRY-US, V29, P4121, DOI 10.1021/bi00469a015; Jurgensmeier JM, 1998, P NATL ACAD SCI USA, V95, P4997, DOI 10.1073/pnas.95.9.4997; KANE DJ, 1993, SCIENCE, V262, P1274, DOI 10.1126/science.8235659; Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9; Kowaltowski A, 2000, CELL DEATH DIFFER, V7, P903, DOI 10.1038/sj.cdd.4400722; Kowaltowski AJ, 2001, FEBS LETT, V495, P12, DOI 10.1016/S0014-5793(01)02316-X; KRAJEWSKI S, 1993, CANCER RES, V53, P4701; Kroemer G, 1998, ANNU REV PHYSIOL, V60, P619, DOI 10.1146/annurev.physiol.60.1.619; MONAGHAN P, 1992, J HISTOCHEM CYTOCHEM, V40, P1819, DOI 10.1177/40.12.1453000; MOREADITH RW, 1984, ANAL BIOCHEM, V137, P360, DOI 10.1016/0003-2697(84)90098-8; MULLANEY PF, 1969, REV SCI INSTRUM, V40, P1029, DOI 10.1063/1.1684143; Murphy AN, 1996, P NATL ACAD SCI USA, V93, P9893, DOI 10.1073/pnas.93.18.9893; Ott M, 2002, P NATL ACAD SCI USA, V99, P1259, DOI 10.1073/pnas.241655498; Polster BM, 2001, J BIOL CHEM, V276, P37887; Reed John C., 1995, Current Opinion in Oncology, V7, P541, DOI 10.1097/00001622-199511000-00012; Shimizu S, 1998, P NATL ACAD SCI USA, V95, P1455, DOI 10.1073/pnas.95.4.1455; STEINMAN HM, 1995, J BIOL CHEM, V270, P3487; TSUJIMOTO Y, 1987, ONCOGENE, V2, P3; Zamzami N, 1996, J EXP MED, V183, P1533, DOI 10.1084/jem.183.4.1533	28	108	109	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					42802	42807		10.1074/jbc.M207765200	http://dx.doi.org/10.1074/jbc.M207765200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12207028	hybrid			2022-12-27	WOS:000179081200051
J	Chakrabarti, D; Da Silva, T; Barger, J; Paquette, S; Patel, H; Patterson, S; Allen, CM				Chakrabarti, D; Da Silva, T; Barger, J; Paquette, S; Patel, H; Patterson, S; Allen, CM			Protein farnesyltransferase and protein prenylation in Plasmodium falciparum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRYPANOSOMA-BRUCEI; PEPTIDOMIMETIC INHIBITORS; P21(RAS) FARNESYLTRANSFERASE; ISOPRENYLATION; CELLS; BIOSYNTHESIS; TRANSFERASE; FARNESYL; GERANYLGERANYLTRANSFERASE; MEVALONATE	Comparison of the malaria parasite and mammalian protein prenyltransferases and their cellular substrates is important for establishing this enzyme as a target for developing antimalarial agents. Nineteen heptapeptides differing only in their carboxyl-terminal amino acid were tested as alternative substrates of partially purified Plasmodium falciparum protein farnesyltransferase. Only NRSCAIM and NRSCAIQ serve as substrates, with NRSCAIM being the best. Peptidomimetics, FTI-276 and GGTI-287, inhibit the transferase with IC50 values of 1 and 32 nm, respectively. Incubation of P. falciparum-infected erythrocytes with [H-3]farnesol labels 50- and 22-28-kDa proteins, whereas [H-3]geranylgeraniol labels only 22-28-kDa proteins. The 50-kDa protein is shown to be farnesylated, whereas the 22-28-kDa proteins are geranylgeranylated, irrespective of the labeling prenol. Protein labeling is inhibited more than 50% by either 5 mum FTI-277 or GGTI-298. The same concentration of inhibitors also inhibits parasite growth from the ring stage by 50%, decreases expression of prenylated proteins as measured with prenyl-specific antibody, and inhibits parasite differentiation beyond the trophozoite stage. Furthermore, differentiation specific prenylation of P. falciparum proteins is demonstrated. Protein labeling is detected predominantly during the trophozoite to schizont and schizont to ring transitions. These results demonstrate unique properties of protein prenylation in P. falciparum: a limited specificity of the farnesyltransferase for peptide substrates compared with mammalian enzymes, the ability to use farnesol to label both farnesyl and geranylgeranyl moieties on proteins, differentiation specific protein prenylation, and the ability of peptidomimetic prenyltransferase inhibitors to block parasite differentiation.	Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA; Univ Cent Florida, Dept Mol Biol & Microbiol, Orlando, FL 32816 USA	State University System of Florida; University of Florida; State University System of Florida; University of Central Florida	Allen, CM (corresponding author), Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA.	callen@biochem.med.ufl.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043679] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI43679] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Arigoni D, 1997, P NATL ACAD SCI USA, V94, P10600, DOI 10.1073/pnas.94.20.10600; Ashar HR, 2000, J BIOL CHEM, V275, P30451, DOI 10.1074/jbc.M003469200; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; Buckner FS, 2000, J BIOL CHEM, V275, P21870, DOI 10.1074/jbc.M000975200; Buckner FS, 2002, MOL BIOCHEM PARASIT, V122, P181, DOI 10.1016/S0166-6851(02)00099-3; CASEY PJ, 1989, P NATL ACAD SCI USA, V86, P8323, DOI 10.1073/pnas.86.21.8323; CASEY PJ, 1991, P NATL ACAD SCI USA, V88, P8631, DOI 10.1073/pnas.88.19.8631; Cates CA, 1996, CANCER LETT, V110, P49, DOI 10.1016/S0304-3835(96)04459-X; Chakrabarti D, 1998, MOL BIOCHEM PARASIT, V94, P175, DOI 10.1016/S0166-6851(98)00065-6; CHEN GZ, 1993, MOL BIOCHEM PARASIT, V59, P287, DOI 10.1016/0166-6851(93)90226-N; Couto AS, 1999, BIOCHEM J, V341, P629, DOI 10.1042/0264-6021:3410629; Crespo NC, 2001, J BIOL CHEM, V276, P16161, DOI 10.1074/jbc.M006213200; Crick DC, 1997, BIOCHEM BIOPH RES CO, V237, P483, DOI 10.1006/bbrc.1997.7145; CRICK DC, 1994, BIOCHEM BIOPH RES CO, V205, P955, DOI 10.1006/bbrc.1994.2758; CRICK DC, 1995, BIOCHEM BIOPH RES CO, V211, P590, DOI 10.1006/bbrc.1995.1854; deCastro FA, 1996, MOL BIOCHEM PARASIT, V80, P77, DOI 10.1016/0166-6851(96)02670-9; DUGAN JM, 1995, BIOL REPROD, V53, P958, DOI 10.1095/biolreprod53.4.958; FARNSWORTH CC, 1989, J BIOL CHEM, V264, P20422; Field H, 1996, MOL BIOCHEM PARASIT, V82, P67, DOI 10.1016/0166-6851(96)02723-5; FINEGOLD AA, 1991, P NATL ACAD SCI USA, V88, P4448, DOI 10.1073/pnas.88.10.4448; FLESCH G, 1988, EUR J BIOCHEM, V175, P405, DOI 10.1111/j.1432-1033.1988.tb14210.x; GARCIA AM, 1993, J BIOL CHEM, V268, P18415; Gibbs JB, 1997, ANNU REV PHARMACOL, V37, P143, DOI 10.1146/annurev.pharmtox.37.1.143; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; HANCOCK JF, 1989, CELL, V57, P1167, DOI 10.1016/0092-8674(89)90054-8; HORIUCHI H, 1991, J BIOL CHEM, V266, P16981; Ibrahim M, 2001, INT J PARASITOL, V31, P1489, DOI 10.1016/S0020-7519(01)00268-5; INGLESE J, 1992, NATURE, V359, P147, DOI 10.1038/359147a0; Jomaa H, 1999, SCIENCE, V285, P1573, DOI 10.1126/science.285.5433.1573; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; LERNER EC, 1995, J BIOL CHEM, V270, P26770, DOI 10.1074/jbc.270.45.26770; LUJAN HD, 1995, MOL BIOCHEM PARASIT, V72, P121, DOI 10.1016/0166-6851(94)00070-4; MALTESE WA, 1987, J CELL PHYSIOL, V133, P471, DOI 10.1002/jcp.1041330307; MANNE V, 1990, P NATL ACAD SCI USA, V87, P7541, DOI 10.1073/pnas.87.19.7541; MBAYA B, 1990, BIOCHEM BIOPH RES CO, V173, P849, DOI 10.1016/S0006-291X(05)80864-2; McGuire TF, 1996, J BIOL CHEM, V271, P27402, DOI 10.1074/jbc.271.44.27402; MOORES SL, 1991, J BIOL CHEM, V266, P14603; Moura IC, 2001, ANTIMICROB AGENTS CH, V45, P2553, DOI 10.1128/AAC.45.9.2553-2558.2001; NIGAM M, 1993, J BIOL CHEM, V268, P20695; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; Ohkanda J, 2001, BIOORG MED CHEM LETT, V11, P761, DOI 10.1016/S0960-894X(01)00055-5; QIAN YM, 1994, J BIOL CHEM, V269, P12410; REISS Y, 1991, P NATL ACAD SCI USA, V88, P732, DOI 10.1073/pnas.88.3.732; REISS Y, 1990, CELL, V62, P81, DOI 10.1016/0092-8674(90)90242-7; SCHABER MD, 1990, J BIOL CHEM, V265, P14701; SEABRA MC, 1991, CELL, V65, P429, DOI 10.1016/0092-8674(91)90460-G; Sebti SM, 2000, ONCOGENE, V19, P6584, DOI 10.1038/sj.onc.1204146; SEPPLORENZINO L, 1989, FEBS LETT, V245, P110, DOI 10.1016/0014-5793(89)80202-9; SEPPLORENZINO L, 1991, EUR J BIOCHEM, V200, P579, DOI 10.1111/j.1432-1033.1991.tb16221.x; SINENSKY M, 1985, P NATL ACAD SCI USA, V82, P3257, DOI 10.1073/pnas.82.10.3257; TAKAI Y, 1992, INT REV CYTOL, V133, P187, DOI 10.1016/S0074-7696(08)61861-6; Tamanoi F, 2001, J CELL BIOCHEM, V84, P64, DOI 10.1002/jcb.10067; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; VIAL HJ, 1984, MOL BIOCHEM PARASIT, V13, P53, DOI 10.1016/0166-6851(84)90101-4; Wallace A, 1996, J BIOL CHEM, V271, P31306, DOI 10.1074/jbc.271.49.31306; YAMANE HK, 1990, P NATL ACAD SCI USA, V87, P5868, DOI 10.1073/pnas.87.15.5868; Yokoyama K, 1997, MOL BIOCHEM PARASIT, V87, P61, DOI 10.1016/S0166-6851(97)00043-1; Yokoyama K, 1998, J BIOL CHEM, V273, P26497, DOI 10.1074/jbc.273.41.26497; YOKOYAMA K, 1991, P NATL ACAD SCI USA, V88, P5302, DOI 10.1073/pnas.88.12.5302; Yokoyama K, 1998, MOL BIOCHEM PARASIT, V94, P87, DOI 10.1016/S0166-6851(98)00053-X	61	125	128	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					42066	42073		10.1074/jbc.M202860200	http://dx.doi.org/10.1074/jbc.M202860200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12194969	hybrid			2022-12-27	WOS:000178985300096
J	Funaba, M; Zimmerman, CM; Mathews, LS				Funaba, M; Zimmerman, CM; Mathews, LS			Modulation of Smad2-mediated signaling by extracellular signal-regulated kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; ACTIVATED PROTEIN-KINASE; SMAD PROTEINS; MESODERM INDUCTION; SERINE-THREONINE; I RECEPTORS; MAP KINASE; GS DOMAIN; PHOSPHORYLATION; ACTIVIN	Components of the transforming growth factor-beta and mitogen-activated protein kinase pathways interact in controlling cell growth and differentiation. We show that phosphorylation of Smad2, a mediator of the activin/transforming growth factor-beta signal, by activated extracellular signal-regulated kinase 1 (ERK1) increases the amount of Smad2 protein and leads to enhanced transcriptional activity. Epidermal growth factor increased phosphorylation of Smad2 in COS7 cells, and Smad2-dependent transcription in a mink lung epithelial cell line, L17, was enhanced by co-transfection of a constitutively active MEK1. In addition, transfection of Smad2 mutants lacking ERK sites resulted in reduced transcription, whereas mutants that mimicked ERK phosphorylation stimulated transcription. The amount of Smad2 protein was increased by transfection with a constitutively active MEK1 and reduced by co-transfection with the ERK phosphatase, HVH2. The elevation of Smad2 protein levels was because of increased half-life and resulted in increased complex formation with Smad4. A site of ERK-dependent phosphorylation on Smad2 was located to Thr(8), a site that overlaps with the calmodulin binding region. We show that calmodulin inhibits Smad2 phosphorylation by ERK1, and overexpressing calmodulin, or stimulating calmodulin activity with ionomycin, reduces Smad2 levels. These findings suggest that the ERK pathway positively regulates Smad2 signaling by phosphorylating Smad2 and that negative regulation of Smad2 signaling by calmodulin is achieved in part by inhibiting this phosphorylation.	Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Funaba, M (corresponding author), Azabu Univ, Sch Vet Med, 1-17-71 Fuchinobe, Sagamihara, Kanagawa 2298501, Japan.		Funaba, Masayuki/E-4676-2018	Funaba, Masayuki/0000-0002-4303-6682				Abdollah S, 1997, J BIOL CHEM, V272, P27678, DOI 10.1074/jbc.272.44.27678; Attisano L, 2000, CURR OPIN CELL BIOL, V12, P235, DOI 10.1016/S0955-0674(99)00081-2; ATTISANO L, 1993, CELL, V75, P671, DOI 10.1016/0092-8674(93)90488-C; Brown JD, 1999, J BIOL CHEM, V274, P8797, DOI 10.1074/jbc.274.13.8797; Campbell SL, 1998, ONCOGENE, V17, P1395, DOI 10.1038/sj.onc.1202174; Chen X, 1997, NATURE, V389, P85, DOI 10.1038/38008; Chen X, 1996, NATURE, V383, P691, DOI 10.1038/383691a0; de Caestecker MP, 1998, GENE DEV, V12, P1587, DOI 10.1101/gad.12.11.1587; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Funaba M, 2000, PROTEIN EXPRES PURIF, V20, P507, DOI 10.1006/prep.2000.1315; Funaba M, 2000, MOL ENDOCRINOL, V14, P1583, DOI 10.1210/me.14.10.1583; GOPALAKRISHNA R, 1982, BIOCHEM BIOPH RES CO, V104, P830, DOI 10.1016/0006-291X(82)90712-4; GUAN KL, 1995, J BIOL CHEM, V270, P7197, DOI 10.1074/jbc.270.13.7197; Hayashi H, 1997, CELL, V89, P1165, DOI 10.1016/S0092-8674(00)80303-7; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hocevar BA, 1999, EMBO J, V18, P1345, DOI 10.1093/emboj/18.5.1345; Hu PPC, 1999, J BIOL CHEM, V274, P35381, DOI 10.1074/jbc.274.50.35381; Ichijo H, 1999, ONCOGENE, V18, P6087, DOI 10.1038/sj.onc.1203129; Inohara N, 1998, EMBO J, V17, P2526, DOI 10.1093/emboj/17.9.2526; Kretzschmar M, 1999, GENE DEV, V13, P804, DOI 10.1101/gad.13.7.804; Labbe E, 1998, MOL CELL, V2, P109, DOI 10.1016/S1097-2765(00)80119-7; LABONNE C, 1994, DEVELOPMENT, V120, P463; LABONNE C, 1995, DEVELOPMENT, V121, P1475; Lagna G, 1996, NATURE, V383, P832, DOI 10.1038/383832a0; Lehmann K, 2000, GENE DEV, V14, P2610, DOI 10.1101/gad.181700; LIN HY, 1992, CELL, V68, P775, DOI 10.1016/0092-8674(92)90152-3; Liu F, 1997, GENE DEV, V11, P3157, DOI 10.1101/gad.11.23.3157; MaciasSilva M, 1996, CELL, V87, P1215, DOI 10.1016/S0092-8674(00)81817-6; Massague J, 2000, GENE DEV, V14, P627; MATHEWS LS, 1993, J BIOL CHEM, V268, P19013; Oft M, 2002, NAT CELL BIOL, V4, P487, DOI 10.1038/ncb807; Oft M, 1996, GENE DEV, V10, P2462, DOI 10.1101/gad.10.19.2462; Panitz F, 1998, EMBO J, V17, P4414, DOI 10.1093/emboj/17.15.4414; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Scherer A, 2000, J BIOL CHEM, V275, P41430, DOI 10.1074/jbc.M005727200; SCHWARZ LC, 1988, CANCER RES, V48, P6999; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Sears R, 1999, MOL CELL, V3, P169, DOI 10.1016/S1097-2765(00)80308-1; SETH A, 1992, J BIOL CHEM, V267, P24796; Songyang Z, 1996, MOL CELL BIOL, V16, P6486; Souchelnytskyi S, 1997, J BIOL CHEM, V272, P28107, DOI 10.1074/jbc.272.44.28107; Sugimoto T, 1998, EMBO J, V17, P1717, DOI 10.1093/emboj/17.6.1717; TANSEY MG, 1992, J BIOL CHEM, V267, P12511; TENDIJKE P, 1994, SCIENCE, V264, P101, DOI 10.1126/science.8140412; WHITMAN M, 1992, NATURE, V357, P252, DOI 10.1038/357252a0; Whitman M, 1998, GENE DEV, V12, P2445, DOI 10.1101/gad.12.16.2445; Wicks SJ, 2000, MOL CELL BIOL, V20, P8103, DOI 10.1128/MCB.20.21.8103-8111.2000; WIESER R, 1995, EMBO J, V14, P2199, DOI 10.1002/j.1460-2075.1995.tb07214.x; Willis SA, 1997, FEBS LETT, V420, P117, DOI 10.1016/S0014-5793(97)01499-3; Willis SA, 1996, MOL ENDOCRINOL, V10, P367, DOI 10.1210/me.10.4.367; Yamanashi Y, 2000, GENE DEV, V14, P11; Zhang Y, 1999, TRENDS CELL BIOL, V9, P274, DOI 10.1016/S0962-8924(99)01579-2; Zhang Y, 1996, NATURE, V383, P168, DOI 10.1038/383168a0; Zimmerman CM, 1998, J BIOL CHEM, V273, P677, DOI 10.1074/jbc.273.2.677; ZIMMERMAN CM, 2001, INHIBIN ACTIVIN FOLL, P239	55	146	154	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					41361	41368		10.1074/jbc.M204597200	http://dx.doi.org/10.1074/jbc.M204597200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12193595	hybrid			2022-12-27	WOS:000178985300011
J	Kirsch, T; Koyama, E; Liu, MF; Golub, EE; Pacifici, M				Kirsch, T; Koyama, E; Liu, MF; Golub, EE; Pacifici, M			Syndecan-3 is a selective regulator of chondrocyte proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST-GROWTH-FACTOR; HORMONE-RELATED PEPTIDE; PARATHYROID-HORMONE; FACTOR-I; CELL-PROLIFERATION; CORE PROTEIN; BONE-GROWTH; TENASCIN-C; EXPRESSION; SULFATE	Chondrocyte proliferation is important for skeletal development and growth, but the mechanisms regulating it are not completely clear. Previously, we showed that syndecan-3, a cell surface heparan sulfate proteoglycan, is expressed by proliferating chondrocytes in vivo and that proliferation of cultured chondrocytes in vitro is sensitive to heparitinase treatment. To further establish the link between syndecan-3 and chondrocyte proliferation, additional studies were carried out in vivo and in vitro. We found that the topographical location of proliferating chondrocytes in developing chick long bones changes with increasing embryonic age and that syndecan-3 gene expression changes in a comparable manner. For in vitro analysis, mitotically quiescent chondrocytes were exposed to increasing amounts of fibroblast growth factor-2 (FGF-2). Proliferation was stimulated by as much as 8-10-fold within 24 h; strikingly, this stimulation was significantly prevented when the cells were treated with both fibroblast growth factor-2 (FGF-2) and antibodies against syndecan-3 core protein. This neutralizing effect was dose-dependent and elicited a maximum of 50-60% inhibition. To establish specificity of neutralizing effect, cultured chondrocytes were exposed to FGF-2, insulin-like growth factor-1, or parathyroid hormone, all known mitogens for chondrocytes. The syndecan-3 antibodies interfered only with FGF-2 mitogenic action, but not that of insulin-like growth factor-1 or parathyroid hormone. Protein cross-linking experiments indicated that syndecan-3 is present in monomeric, dimeric, and oligomeric forms on the chondrocyte surface. In addition, molecular modeling indicated that contiguous syndecan-3 molecules might form stable complexes by parallel pairing of beta-sheet segments within the ectodomain of the core protein. In conclusion, the results suggest that syndecan-3 is a direct and selective regulator of the mitotic behavior of chondrocytes and its role may involve formation of dimeric/oligomeric structures on their cell surface.	Univ Maryland, Sch Med, Dept Orthopaed, Baltimore, MD 21201 USA; Univ Penn, Sch Dent Med, Dept Anat & Cell Biol, Philadelphia, PA 19104 USA; Univ Penn, Sch Dent Med, Dept Biochem, Philadelphia, PA 19104 USA	University System of Maryland; University of Maryland Baltimore; University of Pennsylvania; University of Pennsylvania	Kirsch, T (corresponding author), Univ Maryland, Sch Med, Dept Orthopaed, 22 S Greene St, Baltimore, MD 21201 USA.	tkirsch@psu.edu			NIAMS NIH HHS [AR45302, AR46245] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR046245] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ASUNDI VK, 1995, J BIOL CHEM, V270, P26404, DOI 10.1074/jbc.270.44.26404; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Butler AA, 2001, ENDOCRINOLOGY, V142, P1685, DOI 10.1210/en.142.5.1685; Carey DJ, 1997, BIOCHEM J, V327, P1; CHERNOUSOV MA, 1993, J BIOL CHEM, V268, P16810; Chung UI, 2001, J CLIN INVEST, V107, P295, DOI 10.1172/JCI11706; COFFIN JD, 1995, MOL BIOL CELL, V6, P1861, DOI 10.1091/mbc.6.12.1861; De Cat B, 2001, SEMIN CELL DEV BIOL, V12, P117, DOI 10.1006/scdb.2000.0240; Dealy CN, 1997, DEV BIOL, V184, P343, DOI 10.1006/dbio.1997.8525; FRANSSON LA, 1983, J BIOL CHEM, V258, P4342; Goretzki L, 1999, J BIOL CHEM, V274, P16831, DOI 10.1074/jbc.274.24.16831; GOULD SE, 1995, DEV BIOL, V168, P438, DOI 10.1006/dbio.1995.1093; HAMERMAN D, 1989, NEW ENGL J MED, V320, P1322; HUNZIKER EB, 1994, MICROSC RES TECHNIQ, V28, P505, DOI 10.1002/jemt.1070280606; Iwamoto M, 1995, J ORTHOPAED RES, V13, P838, DOI 10.1002/jor.1100130606; KATO Y, 1990, J BIOL CHEM, V265, P5903; Kirsch T, 2000, J BIOL CHEM, V275, P35577, DOI 10.1074/jbc.M005648200; Kirsch T, 1997, J CELL BIOL, V137, P1149, DOI 10.1083/jcb.137.5.1149; Klemm JD, 1998, ANNU REV IMMUNOL, V16, P569, DOI 10.1146/annurev.immunol.16.1.569; KOIKE T, 1990, J CLIN INVEST, V85, P626, DOI 10.1172/JCI114484; Koyama E, 1996, J ORTHOPAED RES, V14, P403, DOI 10.1002/jor.1100140310; KOYAMA E, 1995, DEV DYNAM, V203, P152, DOI 10.1002/aja.1002030204; Langford JK, 1998, J BIOL CHEM, V273, P29965, DOI 10.1074/jbc.273.45.29965; Legeai-Mallet L, 1998, J BIOL CHEM, V273, P13007, DOI 10.1074/jbc.273.21.13007; Liu ZH, 2002, GENE DEV, V16, P859, DOI 10.1101/gad.965602; LOVEYS LS, 1993, J ORTHOPAED RES, V11, P884, DOI 10.1002/jor.1100110615; MANKIN HJ, 2000, ORTHOPAEDIC BASIC SC, P471; MATSUMOTO T, 1994, ANN RHEUM DIS, V53, P128, DOI 10.1136/ard.53.2.128; Mongiat M, 2000, J BIOL CHEM, V275, P7095, DOI 10.1074/jbc.275.10.7095; Naski MC, 1998, DEVELOPMENT, V125, P4977; Nixon AJ, 1998, J ORTHOPAED RES, V16, P531, DOI 10.1002/jor.1100160503; Oh ES, 1997, J BIOL CHEM, V272, P11805, DOI 10.1074/jbc.272.18.11805; Ohbayashi N, 2002, GENE DEV, V16, P870, DOI 10.1101/gad.965702; RAPRAEGER AC, 1995, CHEM BIOL, V2, P645, DOI 10.1016/1074-5521(95)90025-X; Rapraeger AC, 2001, SEMIN CELL DEV BIOL, V12, P107, DOI 10.1006/scdb.2000.0239; Reizes O, 2001, CELL, V106, P105, DOI 10.1016/S0092-8674(01)00415-9; ROSS AM, 1988, NUCLEIC ACIDS RES, V16, P1801; ROSSELOT G, 1994, J BONE MINER RES, V9, P431; Sahni M, 1999, GENE DEV, V13, P1361, DOI 10.1101/gad.13.11.1361; SARKA T, 2000, INT J BIOCHEM CELL B, V32, P269; Saunders S, 1997, DEV BIOL, V190, P78, DOI 10.1006/dbio.1997.8690; SAVAGE MP, 1993, DEV DYNAM, V198, P159, DOI 10.1002/aja.1001980302; Schipani E, 1997, P NATL ACAD SCI USA, V94, P13689, DOI 10.1073/pnas.94.25.13689; Shimazu A, 1996, EXP CELL RES, V229, P126, DOI 10.1006/excr.1996.0350; SPRING J, 1994, P NATL ACAD SCI USA, V91, P3334, DOI 10.1073/pnas.91.8.3334; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Wilsman NJ, 1996, J ORTHOPAED RES, V14, P562, DOI 10.1002/jor.1100140410	48	30	30	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					42171	42177		10.1074/jbc.M207209200	http://dx.doi.org/10.1074/jbc.M207209200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12194984	hybrid			2022-12-27	WOS:000178985300110
J	Loberg, RD; Vesely, E; Brosius, FC				Loberg, RD; Vesely, E; Brosius, FC			Enhanced glycogen synthase kinase-3 beta activity mediates hypoxia-induced apoptosis of vascular smooth muscle cells and is prevented by glucose transport and metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SURVIVAL; INHIBITION; ACTIVATION	Hypoxia triggers apoptosis in a number of different cell types largely through a mitochondrial cell death pathway, which can be abrogated for the most part by enhanced glucose metabolism. The purpose of the current study was to identify intracellular signaling mechanisms that mediate hypoxia-induced apoptosis and are regulated by glucose metabolism. Hypoxia-induced apoptosis in vascular smooth muscle cells and COS-7 cells was accompanied by a significant reduction in Akt and glycogen synthase kinase-3 (GSK-3) phosphorylation resulting in increased GSK-3 activity. Morphologic features of apoptosis, as well as caspases 3 and 9 activation, were prevented by GSK-3 inhibition with either LiCl or SB216763. Phosphorylation of Akt and GSK-3 was enhanced by glucose metabolism or overexpression of the glucose transporter, GLUT1, and was prevented by glycolytic inhibition. These findings indicate that GSK-3 is an important mediator of hypoxia-induced apoptosis and that GSK-3-mediated apoptotic effects occur via activation of the mitochondrial death pathway. Moreover, the results suggest that prevention of hypoxia-mediated apoptosis by enhanced glucose transport and metabolism results, in part, from inhibition of GSK-3 activation.	Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Physiol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Brosius, FC (corresponding author), Univ Michigan, Dept Internal Med, 1560 MSRB2,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	fbrosius@umich.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065567, R01HL060156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008322] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 65567, R01 HL 60156] Funding Source: Medline; NIGMS NIH HHS [T32 GM008322, T32 GM08322] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bijur GN, 2000, J BIOL CHEM, V275, P7583, DOI 10.1074/jbc.275.11.7583; Bijur GN, 2001, J BIOL CHEM, V276, P37436, DOI 10.1074/jbc.M105725200; Chi MMY, 2000, J BIOL CHEM, V275, P40252, DOI 10.1074/jbc.M005508200; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Ekhterae D, 1999, CIRC RES, V85, pE70; Hall JL, 2001, DIABETES, V50, P1171, DOI 10.2337/diabetes.50.5.1171; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; King TD, 2001, BRAIN RES, V919, P106, DOI 10.1016/S0006-8993(01)03005-0; Li MT, 2000, MOL CELL BIOL, V20, P9356, DOI 10.1128/MCB.20.24.9356-9363.2000; Lin ZW, 2000, AM J PHYSIOL-ENDOC M, V278, pE958, DOI 10.1152/ajpendo.2000.278.5.E958; Malhotra R, 1999, J BIOL CHEM, V274, P12567, DOI 10.1074/jbc.274.18.12567; Malhotra R, 2001, AM J PHYSIOL-CELL PH, V281, pC1596, DOI 10.1152/ajpcell.2001.281.5.C1596; Moley KH, 1998, NAT MED, V4, P1421, DOI 10.1038/4013; Pap M, 2002, MOL CELL BIOL, V22, P578, DOI 10.1128/MCB.22.2.578-586.2002; Pap M, 1998, J BIOL CHEM, V273, P19929, DOI 10.1074/jbc.273.32.19929; Plas DR, 2001, J BIOL CHEM, V276, P12041, DOI 10.1074/jbc.M010551200; Rathmell JC, 2000, MOL CELL, V6, P683, DOI 10.1016/S1097-2765(00)00066-6; Schwabe RF, 2002, AM J PHYSIOL-GASTR L, V283, pG204, DOI 10.1152/ajpgi.00016.2002; Somervaille TCP, 2001, BLOOD, V98, P1374, DOI 10.1182/blood.V98.5.1374; Strasser A, 2000, ANNU REV BIOCHEM, V69, P217, DOI 10.1146/annurev.biochem.69.1.217; Turenne GA, 2001, BMC CELL BIOL, V2, DOI 10.1186/1471-2121-2-12; WOODGETT JR, 2001, SCI STKE; Yamaguchi H, 2001, ONCOGENE, V20, P7779, DOI 10.1038/sj.onc.1204984; Yusta B, 2002, J BIOL CHEM, V277, P24896, DOI 10.1074/jbc.M201358200	24	121	132	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					41667	41673		10.1074/jbc.M206405200	http://dx.doi.org/10.1074/jbc.M206405200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12200436	hybrid			2022-12-27	WOS:000178985300048
J	Overton, MC; Blumer, KJ				Overton, MC; Blumer, KJ			The extracellular N-terminal domain and transmembrane domains 1 and 2 mediate oligomerization of a yeast G protein-coupled receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METABOTROPIC GLUTAMATE-RECEPTOR; FUNCTIONAL GABA(B) RECEPTOR; ALPHA-FACTOR RECEPTOR; SACCHAROMYCES-CEREVISIAE; SIGNAL-TRANSDUCTION; SPLICE VARIANT; STE2 GENE; IN-VIVO; DIMERIZATION; TRAFFICKING	G protein-coupled receptors (GPCRs) can form homodimers/oligomers and/or heterodimers/oligomers. The mechanisms used to form specific GPCR oligomers are poorly understood because the domains that mediate such interactions and the step(s) in the secretory pathway where oligomerization occurs have not been well characterized. Here we have used subcellular fractionation and fluorescence resonance energy transfer (FRET) experiments to show that oligomerization of a GPCR (alpha-factor receptor; STE2 gene product) of the yeast Saccharomyces cerevisiae occurs in the endoplasmic reticulum. To identify domains of this receptor that mediate oligomerization, we used FRET and endocytosis assays of oligomerization in vivo to analyze receptor deletion mutants. A mutant lacking the N-terminal extracellular domain and transmembrane (TM) domain 1 was expressed at the cell surface but did not selfassociate. In contrast, a receptor fragment containing only the N-terminal extracellular domain and TM1 could self-associate and heterodimerize with wild type receptors. Analysis of other mutants suggested that oligomerization is facilitated by the N-terminal extracellular domain and TM2. Therefore, the N-terminal extracellular domain, TM1, and TM2 appear to stabilize alpha-factor receptor oligomers. These domains may form an interface in contact or domain-swapped oligomers. Similar domains may mediate dimerization of certain mammalian GPCRs.	Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Blumer, KJ (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, Box 8228, St Louis, MO 63110 USA.		Blumer, Kendall J/C-5268-2012		NIGMS NIH HHS [GM44596] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AbdAlla S, 1999, J BIOL CHEM, V274, P26079, DOI 10.1074/jbc.274.37.26079; AbdAlla S, 2000, NATURE, V407, P94, DOI 10.1038/35024095; Angers S, 2002, ANNU REV PHARMACOL, V42, P409, DOI 10.1146/annurev.pharmtox.42.091701.082314; Ayoub MA, 2002, J BIOL CHEM, V277, P21522, DOI 10.1074/jbc.M200729200; Bai M, 1998, J BIOL CHEM, V273, P23605, DOI 10.1074/jbc.273.36.23605; Benkirane M, 1997, J BIOL CHEM, V272, P30603, DOI 10.1074/jbc.272.49.30603; BLUMER KJ, 1990, P NATL ACAD SCI USA, V87, P4363, DOI 10.1073/pnas.87.11.4363; BLUMER KJ, 1988, J BIOL CHEM, V263, P10836; Bouvier M, 2001, NAT REV NEUROSCI, V2, P274, DOI 10.1038/35067575; Calver AR, 2001, J NEUROSCI, V21, P1203; Cvejic S, 1997, J BIOL CHEM, V272, P26959, DOI 10.1074/jbc.272.43.26959; Dean MK, 2001, J MED CHEM, V44, P4595, DOI 10.1021/jm010290+; Ding FX, 2001, BIOCHEMISTRY-US, V40, P8945, DOI 10.1021/bi010394m; Goldsmith PK, 1999, J BIOL CHEM, V274, P11303, DOI 10.1074/jbc.274.16.11303; Gouldson PR, 1997, BIOCHEM SOC T, V25, P1066, DOI 10.1042/bst0251066; Gouldson PR, 1998, PROTEIN ENG, V11, P1181, DOI 10.1093/protein/11.12.1181; Gouldson PR, 2000, NEUROPSYCHOPHARMACOL, V23, pS60, DOI 10.1016/S0893-133X(00)00153-6; Grosse R, 1997, MOL ENDOCRINOL, V11, P1305, DOI 10.1210/me.11.9.1305; Hebert TE, 1996, J BIOL CHEM, V271, P16384, DOI 10.1074/jbc.271.27.16384; Horvat RD, 2001, MOL ENDOCRINOL, V15, P534, DOI 10.1210/me.15.4.534; Jones KA, 1998, NATURE, V396, P674, DOI 10.1038/25348; Jordan BA, 1999, NATURE, V399, P697, DOI 10.1038/21441; Jordan BA, 2001, P NATL ACAD SCI USA, V98, P343, DOI 10.1073/pnas.011384898; Kammerer RA, 1999, BIOCHEMISTRY-US, V38, P13263, DOI 10.1021/bi991018t; KANG YS, 1990, MOL CELL BIOL, V10, P2582, DOI 10.1128/MCB.10.6.2582; KOBILKA BK, 1988, SCIENCE, V240, P1310, DOI 10.1126/science.2836950; Kuner R, 1999, SCIENCE, V283, P74, DOI 10.1126/science.283.5398.74; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; Levac BAR, 2002, CURR OPIN PHARMACOL, V2, P76, DOI 10.1016/S1471-4892(02)00124-8; MAGGIO R, 1993, P NATL ACAD SCI USA, V90, P3103, DOI 10.1073/pnas.90.7.3103; Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X; Margeta-Mitrovic M, 2001, P NATL ACAD SCI USA, V98, P14643, DOI 10.1073/pnas.251554798; Martin NP, 1999, BIOCHEMISTRY-US, V38, P682, DOI 10.1021/bi982062w; Mijares A, 2000, MOL PHARMACOL, V58, P373, DOI 10.1124/mol.58.2.373; Overton MC, 2000, CURR BIOL, V10, P341, DOI 10.1016/S0960-9822(00)00386-9; Pace AJ, 1999, J BIOL CHEM, V274, P11629, DOI 10.1074/jbc.274.17.11629; Pagano A, 2001, J NEUROSCI, V21, P1189; Patel RC, 2002, P NATL ACAD SCI USA, V99, P3294, DOI 10.1073/pnas.042705099; POTTER LT, 1991, MOL PHARMACOL, V39, P211; Ray K, 2000, J BIOL CHEM, V275, P34245, DOI 10.1074/jbc.M005581200; RENEKE JE, 1988, CELL, V55, P221, DOI 10.1016/0092-8674(88)90045-1; RIDGE KD, 1995, P NATL ACAD SCI USA, V92, P3204, DOI 10.1073/pnas.92.8.3204; Rios CD, 2001, PHARMACOL THERAPEUT, V92, P71, DOI 10.1016/S0163-7258(01)00160-7; Rocheville M, 2000, SCIENCE, V288, P154, DOI 10.1126/science.288.5463.154; Romano C, 2001, MOL PHARMACOL, V59, P46, DOI 10.1124/mol.59.1.46; Romano C, 1996, J BIOL CHEM, V271, P28612, DOI 10.1074/jbc.271.45.28612; Schulz A, 2000, J BIOL CHEM, V275, P2381, DOI 10.1074/jbc.275.4.2381; Schwarz DA, 2000, J BIOL CHEM, V275, P32174, DOI 10.1074/jbc.M005333200; Sommers CM, 1997, J MOL BIOL, V266, P559, DOI 10.1006/jmbi.1996.0816; STEFAN CJ, 1994, MOL CELL BIOL, V14, P3339, DOI 10.1128/MCB.14.5.3339; Stefan CJ, 1998, MOL BIOL CELL, V9, P885, DOI 10.1091/mbc.9.4.885; Stefan CJ, 1999, J BIOL CHEM, V274, P1835, DOI 10.1074/jbc.274.3.1835; Tsuchiya D, 2002, P NATL ACAD SCI USA, V99, P2660, DOI 10.1073/pnas.052708599; Tsuji Y, 2000, J BIOL CHEM, V275, P28144; WEINER JL, 1993, J BIOL CHEM, V268, P8070; White JH, 1998, NATURE, V396, P679, DOI 10.1038/25354; Xie HB, 2000, BIOCHEMISTRY-US, V39, P15462, DOI 10.1021/bi001432p; Yesilaltay A, 2000, MOL BIOL CELL, V11, P2873, DOI 10.1091/mbc.11.9.2873; Zeng FY, 1999, J BIOL CHEM, V274, P19487, DOI 10.1074/jbc.274.27.19487; Zhang ZX, 2001, J BIOL CHEM, V276, P5316, DOI 10.1074/jbc.M005958200	60	102	103	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					41463	41472		10.1074/jbc.M205368200	http://dx.doi.org/10.1074/jbc.M205368200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12194975	hybrid			2022-12-27	WOS:000178985300023
J	Vandenplas, ML; Carlson, RW; Jeyaretnam, BS; McNeill, B; Barton, MH; Norton, N; Murray, TF; Moore, JN				Vandenplas, ML; Carlson, RW; Jeyaretnam, BS; McNeill, B; Barton, MH; Norton, N; Murray, TF; Moore, JN			Rhizobium Sin-1 lipopolysaccharide (LPS) prevents enteric LPS-induced cytokine production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTOR-4; LIPID-A; BINDING-PROTEIN; BACTERIAL LIPOPOLYSACCHARIDE; IN-VITRO; CD14; RECOGNITION; ACTIVATION; ENDOTOXIN; INDUCTION	Endotoxin (lipopolysaccharide (LPS)), a component of Gram-negative bacteria, is among the most potent proinflammatory substances known. The lipid-A region of this molecule initiates the production of multiple host-derived inflammatory mediators, including cytokines (e.g. tumor necrosis factor-alpha (TNFalpha)). It has been a continuous effort to identify methods of interfering with the interaction between enteric LPS and inflammatory cells using natural and synthetic LPS analogs. Some of these LPS analogs (e.g. Rhodobacter spheroides LPS/lipid-A derivatives) are antagonists in human cells but act as potent agonists with cells of other species. Data reported here indicate that structurally novel LPS from symbiotic, nitrogen-fixing bacteria found in association with the root nodules of legumes do not stimulate human monocytes to produce TNFa. Furthermore, LPS from one of these symbiotic bacterial species, Rhizobium sp. Sin-1, significantly inhibits the synthesis of TNFa by human cells incubated with Escherichia coli LPS. Rhizobium Sin-1 LPS exerts these effects by competing with E. coli LPS for binding to LPS-binding protein and by directly competing with E. coli LPS for binding to human monocytes. Rhizobial lipid-A differs significantly from previously characterized lipid-A analogs in phosphate content, fatty acid acylation patterns, and carbohydrate backbone. These structural differences define the rhizobial lipid-A compounds as a potentially novel class of LPS antagonists that might well serve as therapeutic agents for the treatment of Gram-negative sepsis.	Univ Georgia, Coll Vet Med, Dept Large Anim Med, Athens, GA 30602 USA; Univ Georgia, Coll Vet Med, Dept Physiol & Pharmacol, Athens, GA 30602 USA; Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Vandenplas, ML (corresponding author), Univ Georgia, Coll Vet Med, Dept Large Anim Med, Athens, GA 30602 USA.	mvdplas@vet.uga.edu			NIGMS NIH HHS [GM89583, GM61761] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061761] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BARTON MH, 1994, CIRC SHOCK, V44, P216; BHAT UR, 1994, J BIOL CHEM, V269, P14402; Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; CHRIST WJ, 1995, SCIENCE, V268, P80, DOI 10.1126/science.7701344; *CTR DIS CONTR, 1990, MMWR-MORBID MORTAL W, V39, P31; Eperon S, 1996, J IMMUNOL METHODS, V194, P121, DOI 10.1016/0022-1759(96)00073-7; Forsberg LS, 1998, J BIOL CHEM, V273, P2747, DOI 10.1074/jbc.273.5.2747; GOLENBOCK DT, 1991, J BIOL CHEM, V266, P19490; HAILMAN E, 1994, J EXP MED, V179, P269, DOI 10.1084/jem.179.1.269; Henneke P, 2001, NAT IMMUNOL, V2, P828, DOI 10.1038/ni0901-828; Ingalls RR, 1999, INFECT DIS CLIN N AM, V13, P341, DOI 10.1016/S0891-5520(05)70078-7; Inohara N, 2001, J BIOL CHEM, V276, P2551, DOI 10.1074/jbc.M009728200; Jeyaretnam B, 2002, J BIOL CHEM, V277, P41802, DOI 10.1074/jbc.M112140200; KIRKLAND TN, 1993, J BIOL CHEM, V268, P24818; KITCHENS RL, 1995, J BIOL CHEM, V270, P9904, DOI 10.1074/jbc.270.17.9904; Lien E, 2000, J CLIN INVEST, V105, P497, DOI 10.1172/JCI8541; LOPPNOW H, 1990, INFECT IMMUN, V58, P3743, DOI 10.1128/IAI.58.11.3743-3750.1990; Medvedev AE, 2001, J IMMUNOL, V167, P2257, DOI 10.4049/jimmunol.167.4.2257; MORRIS D, 1992, AM J VET RES, P1565; MORRISON DC, 1987, ANNU REV MED, V38, P417, DOI 10.1146/annurev.me.38.020187.002221; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Page S, 1999, J BIOL CHEM, V274, P11611, DOI 10.1074/jbc.274.17.11611; Pedron T, 2000, IMMUNOLOGY, V101, P262, DOI 10.1046/j.1365-2567.2000.00107.x; Pollack M, 1996, CURR TOP MICROBIOL, V216, P275; Que NLS, 2000, J BIOL CHEM, V275, P28006; Que NLS, 2000, J BIOL CHEM, V275, P28017; QURESHI N, 1997, ENDOTOXIN SEPSIS MOL, P289; Scott MG, 2000, J IMMUNOL, V164, P549, DOI 10.4049/jimmunol.164.2.549; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; TAKAYAMA K, 1989, INFECT IMMUN, V57, P1336, DOI 10.1128/IAI.57.4.1336-1338.1989; TOBIAS PS, 1993, IMMUNOBIOLOGY, V187, P227, DOI 10.1016/S0171-2985(11)80341-4; TOBIAS PS, 1986, J EXP MED, V164, P777, DOI 10.1084/jem.164.3.777; Triantafilou K, 2001, NAT IMMUNOL, V2, P338, DOI 10.1038/86342; ULEVITCH RJ, 1990, J TRAUMA, V30, pS189; WRIGHT SD, 1995, J IMMUNOL, V155, P6; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Yang ZG, 1996, J LEUKOCYTE BIOL, V59, P241, DOI 10.1002/jlb.59.2.241; YORK WS, 1986, METHOD ENZYMOL, V118, P3; YOUNG LS, 1991, INFECTIOUS DISEASE C, V5, P739	39	33	34	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					41811	41816		10.1074/jbc.M205252200	http://dx.doi.org/10.1074/jbc.M205252200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12193596	hybrid			2022-12-27	WOS:000178985300066
J	Chou, DM; Petersen, P; Walter, JC; Walter, G				Chou, DM; Petersen, P; Walter, JC; Walter, G			Protein phosphatase 2A regulates binding of Cdc45 to the prereplication complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMOSOMAL DNA-REPLICATION; ORIGIN RECOGNITION COMPLEX; XENOPUS EGG EXTRACTS; IN-VITRO PHOSPHORYLATION; CYCLIN-DEPENDENT KINASES; SACCHAROMYCES-CEREVISIAE; CELL-CYCLE; S-PHASE; POLYMERASE-ALPHA; BUDDING YEAST	In eukaryotic cells, an ordered sequence of events leads to the initiation of DNA replication. During the G, phase of the cell cycle, a prereplication complex (pre-RC) consisting of ORC, Cdc6, Cdt1, and MCM2-7 is established at replication origins on the chromatin. At the G(1)/S transition, MCM10 and the protein kinases Cdc7-Dbf4 and Cdk2-cyclin E cooperate to recruit Cdc45 to the pre-RC, followed by origin unwinding, RPA binding, and recruitment of DNA polymerases. Using the soluble DNA replication system derived from Xenopus eggs, we demonstrate that immunodepletion of protein phosphatase 2A (PP2A) from egg extracts and inhibition of PP2A activity by okadaic acid abolish loading of Cdc45 to the pre-RC. Consistent with a defect in Cdc45 loading, origin unwinding and the loading of RPA and DNA polymerase a are also inhibited. Inhibition of PP2A has no effect on MCM10 loading and on Cdc7-Dbf4 or Cdk2 activity. The substrate of PP2A is neither a component of the pre-RC nor Cdc45. Instead, our data suggest that PP2A functions by dephosphorylating and activating a soluble factor that is required to recruit Cdc45 to the pre-RC. Furthermore, PP2A appears to counteract an unknown inhibitory kinase that phosphorylates and inactivates the same factor. Thus, the initiation of eukaryotic DNA replication is regulated at the level of Cdc45 loading by a combination of stimulatory and inhibitory phosphorylation events.	Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	University of California System; University of California San Diego; Harvard University; Harvard Medical School	Walter, G (corresponding author), Univ Calif San Diego, Dept Pathol 0612, 9500 Gilman Dr, La Jolla, CA 92093 USA.	gwalter@ucsd.edu		Walter, Johannes/0000-0002-4186-7570	NATIONAL CANCER INSTITUTE [R01CA036111] Funding Source: NIH RePORTER; NCI NIH HHS [CA 36111] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aparicio OM, 1999, P NATL ACAD SCI USA, V96, P9130, DOI 10.1073/pnas.96.16.9130; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; BELL SP, 1992, NATURE, V357, P128, DOI 10.1038/357128a0; BIALOJAN C, 1988, BIOCHEM J, V256, P283, DOI 10.1042/bj2560283; BLOW JJ, 1986, CELL, V47, P577, DOI 10.1016/0092-8674(86)90622-7; Brown AL, 1999, P NATL ACAD SCI USA, V96, P3745, DOI 10.1073/pnas.96.7.3745; Chaturvedi P, 1999, ONCOGENE, V18, P4047, DOI 10.1038/sj.onc.1202925; Chong JPJ, 1996, TRENDS BIOCHEM SCI, V21, P102, DOI 10.1016/0968-0004(96)10013-X; Chung HY, 1999, BIOCHEMISTRY-US, V38, P10371, DOI 10.1021/bi990902g; Cocker JH, 1996, NATURE, V379, P180, DOI 10.1038/379180a0; COHEN P, 1989, FEBS LETT, V250, P596, DOI 10.1016/0014-5793(89)80803-8; Costanzo V, 2000, MOL CELL, V6, P649, DOI 10.1016/S1097-2765(00)00063-0; Dehde S, 2001, MOL CELL BIOL, V21, P2581, DOI 10.1128/MCB.21.7.2581-2593.2001; FANG F, 1991, CELL, V66, P731, DOI 10.1016/0092-8674(91)90117-H; FANNING E, 1992, J VIROL, V66, P1289, DOI 10.1128/JVI.66.3.1289-1293.1992; Guo ZJ, 2000, GENE DEV, V14, P2745, DOI 10.1101/gad.842500; HARTWELL LH, 1973, J BACTERIOL, V115, P966, DOI 10.1128/JB.115.3.966-974.1973; Hekmat-Nejad M, 2000, CURR BIOL, V10, P1565, DOI 10.1016/S0960-9822(00)00855-1; HENNESSY KM, 1991, GENE DEV, V5, P958, DOI 10.1101/gad.5.6.958; HOGAN E, 1992, P NATL ACAD SCI USA, V89, P3098, DOI 10.1073/pnas.89.7.3098; HOLLINGSWORTH RE, 1990, P NATL ACAD SCI USA, V87, P6272, DOI 10.1073/pnas.87.16.6272; Hopwood B, 1996, P NATL ACAD SCI USA, V93, P12309, DOI 10.1073/pnas.93.22.12309; Hua XH, 1997, J CELL BIOL, V137, P183, DOI 10.1083/jcb.137.1.183; Hua XQH, 1998, J CELL BIOL, V140, P271, DOI 10.1083/jcb.140.2.271; JACKSON PK, 1995, J CELL BIOL, V130, P755, DOI 10.1083/jcb.130.4.755; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Jares P, 2000, GENE DEV, V14, P1528; Jiang W, 1999, EMBO J, V18, P5703, DOI 10.1093/emboj/18.20.5703; Kamimura Y, 2001, EMBO J, V20, P2097, DOI 10.1093/emboj/20.8.2097; KELLY TJ, 1988, J BIOL CHEM, V263, P17889; Kremmer E, 1997, MOL CELL BIOL, V17, P1692, DOI 10.1128/MCB.17.3.1692; Lei M, 1997, GENE DEV, V11, P3365, DOI 10.1101/gad.11.24.3365; LIANG C, 1995, CELL, V81, P667, DOI 10.1016/0092-8674(95)90528-6; LIN FC, 1995, EMBO J, V14, P2745, DOI 10.1002/j.1460-2075.1995.tb07275.x; Lin XH, 1998, P NATL ACAD SCI USA, V95, P14693, DOI 10.1073/pnas.95.25.14693; MAINE GT, 1984, GENETICS, V106, P365; Maiorano D, 2000, NATURE, V404, P622, DOI 10.1038/35007104; Masai H, 2000, J BIOL CHEM, V275, P29042, DOI 10.1074/jbc.M002713200; Masumoto H, 2000, MOL CELL BIOL, V20, P2809, DOI 10.1128/MCB.20.8.2809-2817.2000; Matsuoka S, 2000, P NATL ACAD SCI USA, V97, P10389, DOI 10.1073/pnas.190030497; Melchionna R, 2000, NAT CELL BIOL, V2, P762, DOI 10.1038/35036406; Mimura S, 2000, GENES CELLS, V5, P439, DOI 10.1046/j.1365-2443.2000.00340.x; Mimura S, 1998, EMBO J, V17, P5699, DOI 10.1093/emboj/17.19.5699; MOIR D, 1982, GENETICS, V100, P547; Murakami H, 2000, BIOCHEM J, V349, P1, DOI 10.1042/0264-6021:3490001; Nakajima R, 2002, MOL BIOL CELL, V13, P1462, DOI 10.1091/mbc.02-01-0006; NEWPORT J, 1987, CELL, V48, P205, DOI 10.1016/0092-8674(87)90424-7; Nishitani H, 2000, NATURE, V404, P625, DOI 10.1038/35007110; Nougarede R, 2000, MOL CELL BIOL, V20, P3795, DOI 10.1128/MCB.20.11.3795-3806.2000; Oshiro G, 1999, MOL CELL BIOL, V19, P4888; PATTERSON M, 1986, MOL CELL BIOL, V6, P1590, DOI 10.1128/MCB.6.5.1590; Rowles A, 1999, J CELL SCI, V112, P2011; Santocanale C, 1996, EMBO J, V15, P6671, DOI 10.1002/j.1460-2075.1996.tb01057.x; Sato N, 1997, EMBO J, V16, P4340, DOI 10.1093/emboj/16.14.4340; Sclafani RA, 2000, J CELL SCI, V113, P2111; STRAUSFELD UP, 1994, CURR BIOL, V4, P876, DOI 10.1016/S0960-9822(00)00196-2; Tada S, 2001, NAT CELL BIOL, V3, P107, DOI 10.1038/35055000; Takisawa H, 2000, CURR OPIN CELL BIOL, V12, P690, DOI 10.1016/S0955-0674(00)00153-8; Tanaka TU, 1998, EMBO J, V17, P5182, DOI 10.1093/emboj/17.17.5182; TOYOSHIMA H, 1994, CELL, V78, P67, DOI 10.1016/0092-8674(94)90573-8; Waiter J, 1997, SCIENCE, V275, P993, DOI 10.1126/science.275.5302.993; Walter J, 2000, MOL CELL, V5, P617, DOI 10.1016/S1097-2765(00)80241-5; Walter J, 1998, MOL CELL, V1, P519, DOI 10.1016/S1097-2765(00)80052-0; Walter JC, 2000, J BIOL CHEM, V275, P39773, DOI 10.1074/jbc.M008107200; Weinreich M, 1999, EMBO J, V18, P5334, DOI 10.1093/emboj/18.19.5334; Whittaker AJ, 2000, GENE DEV, V14, P1765; Wilson NJ, 1999, BIOCHEM J, V339, P517, DOI 10.1042/0264-6021:3390517; Wohlschlegel JA, 2002, MOL CELL, V9, P233, DOI 10.1016/S1097-2765(02)00456-2; Wohlschlegel JA, 2000, SCIENCE, V290, P2309, DOI 10.1126/science.290.5500.2309; Yan Z, 2000, MOL CELL BIOL, V20, P1021, DOI 10.1128/MCB.20.3.1021-1029.2000; YOON HJ, 1991, P NATL ACAD SCI USA, V88, P3574, DOI 10.1073/pnas.88.9.3574; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001; Zou L, 2000, MOL CELL BIOL, V20, P3086, DOI 10.1128/MCB.20.9.3086-3096.2000; Zou L, 1998, SCIENCE, V280, P593, DOI 10.1126/science.280.5363.593; Zou L, 1997, MOL CELL BIOL, V17, P553, DOI 10.1128/MCB.17.2.553	75	31	32	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2002	277	43					40520	40527		10.1074/jbc.M207226200	http://dx.doi.org/10.1074/jbc.M207226200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	607KU	12185086	hybrid			2022-12-27	WOS:000178791400048
J	Donnelly, MA; Steiner, TS				Donnelly, MA; Steiner, TS			Two nonadjacent regions in enteroaggregative Escherichia coli flagellin are required for activation of toll-like receptor 5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTESTINAL EPITHELIAL-CELLS; SALMONELLA-TYPHI FLAGELLA; BACTERIAL FLAGELLIN; PSEUDOMONAS-AERUGINOSA; ARABIDOPSIS-THALIANA; INTERLEUKIN-8; INFLAMMATION; SENSITIVITY; STIMULATION; INFECTION	Flagellin is the major structural protein of the flagella of Gram-negative bacteria. Recent work has demonstrated that flagellin is a potent trigger of innate immune responses in a number of eukaryotic cells and organisms, including both mammals and plants. In several different human epithelial cell lines, this innate immune response involves toll-like receptor 5 (TLR5). The mechanisms by which flagellin activates TLR5 and the importance of this interaction in other model systems of flagellin-induced inflammation remain unknown. In this work, random and site-directed mutagenesis of the inflammatory flagellin from enteroaggregative Escherichia coli identified two regions in the conserved D1 domain that are required for interleukin-8 release and TLR5 activation. In contrast, large regions of the variable domain could be excised without reducing the inflammatory activity. In addition, regions of the protein analogous to epitopes that trigger innate immune responses in plants are not involved in Caco-2 flagellin responses. These results highlight the complexity of the interaction between bacterial flagellin and its eukaryotic recognition partners and provide the basis for further studies to characterize the innate immune response to flagellin.	Univ Virginia, Hlth Sci Ctr, Div Geog & Int Med, Charlottesville, VA 22908 USA; Univ British Columbia, Div Infect Dis, Vancouver, BC V5Z 3J5, Canada	University of Virginia; University of British Columbia	Steiner, TS (corresponding author), Rm D452,HP,VGH,2733 Heather St, Vancouver, BC V5Z 3J5, Canada.			Steiner, Ted/0000-0002-3136-6668	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI001573] Funding Source: NIH RePORTER; NIAID NIH HHS [K08 AI 01573-02] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bauer Z, 2001, J BIOL CHEM, V276, P45669, DOI 10.1074/jbc.M102390200; Ciacci-Woolwine F, 1998, INFECT IMMUN, V66, P1127, DOI 10.1128/IAI.66.3.1127-1134.1998; DIMANGO E, 1995, J CLIN INVEST, V96, P2204, DOI 10.1172/JCI118275; Eaves-Pyles T, 2001, J IMMUNOL, V166, P1248, DOI 10.4049/jimmunol.166.2.1248; Eaves-Pyles TD, 2001, J IMMUNOL, V167, P7009, DOI 10.4049/jimmunol.167.12.7009; Feldman M, 1998, INFECT IMMUN, V66, P43, DOI 10.1128/IAI.66.1.43-51.1998; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; Gewirtz AT, 2001, J IMMUNOL, V167, P1882, DOI 10.4049/jimmunol.167.4.1882; Gewirtz AT, 2001, J CLIN INVEST, V107, P99, DOI 10.1172/JCI10501; Gomez-Gomez L, 1999, PLANT J, V18, P277, DOI 10.1046/j.1365-313X.1999.00451.x; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; IGIMI S, 2000, 100 GEN M AM SOC MIC, P62; IKEDA JS, 2000, 100 GEN M AM SOC MIC, P81; McDermott PF, 2000, INFECT IMMUN, V68, P5525, DOI 10.1128/IAI.68.10.5525-5529.2000; Meindl T, 2000, PLANT CELL, V12, P1783, DOI 10.1105/tpc.12.9.1783; Mobley HLT, 1996, INFECT IMMUN, V64, P5332, DOI 10.1128/IAI.64.12.5332-5340.1996; OhtaTada U, 1997, SCAND J GASTROENTERO, V32, P455, DOI 10.3109/00365529709025080; Ramphal R, 1996, AM J RESP CRIT CARE, V154, pS170, DOI 10.1164/ajrccm/154.4_Pt_2.S170; Samatey FA, 2000, J STRUCT BIOL, V132, P106, DOI 10.1006/jsbi.2000.4312; Samatey FA, 2001, NATURE, V410, P331, DOI 10.1038/35066504; Sierro F, 2001, P NATL ACAD SCI USA, V98, P13722, DOI 10.1073/pnas.241308598; STEINER T, 2000, J CLIN INVEST, V105; Steiner TS, 1998, J INFECT DIS, V177, P88, DOI 10.1086/513809; VONDERVISZT F, 1989, J MOL BIOL, V209, P127, DOI 10.1016/0022-2836(89)90176-9; Wyant TL, 1999, INFECT IMMUN, V67, P3619, DOI 10.1128/IAI.67.7.3619-3624.1999; Wyant TL, 1999, INFECT IMMUN, V67, P1338, DOI 10.1128/IAI.67.3.1338-1346.1999	26	112	122	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 25	2002	277	43					40456	40461		10.1074/jbc.M206851200	http://dx.doi.org/10.1074/jbc.M206851200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	607KU	12185085	hybrid			2022-12-27	WOS:000178791400040
J	Godsey, MH; Heldwein, EEZ; Brennan, RG				Godsey, MH; Heldwein, EEZ; Brennan, RG			Structural biology of bacterial multidrug resistance gene regulators	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							MULTIPLE ANTIBIOTIC-RESISTANCE; RESPONDING TRANSCRIPTIONAL REGULATOR; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; LIGAND-BINDING; DNA-BINDING; DRUG-BINDING; ACTIVATOR; PROTEIN; BMRR		Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; Howard Hughes Med Inst, Childrens Hosp, Mol Med Lab, Boston, MA 02115 USA	Oregon Health & Science University; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute	Brennan, RG (corresponding author), Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, L224,3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	brennanr@ohsu.edu		Brennan, Richard/0000-0001-7647-485X; Heldwein, Ekaterina/0000-0003-3113-6958; Godsey, Michael/0000-0003-1006-7084	NIAID NIH HHS [AI 48593] Funding Source: Medline; NIGMS NIH HHS [GM 08617-05] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048593] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AHMED M, 1994, J BIOL CHEM, V269, P28506; Alekshun MN, 1997, ANTIMICROB AGENTS CH, V41, P2067, DOI 10.1128/AAC.41.10.2067; Alekshun MN, 2001, NAT STRUCT BIOL, V8, P710, DOI 10.1038/90429; Alekshun MN, 1999, J BACTERIOL, V181, P4669, DOI 10.1128/JB.181.15.4669-4672.1999; Alekshun MN, 1999, TRENDS MICROBIOL, V7, P410, DOI 10.1016/S0966-842X(99)01589-9; ANSARI AZ, 1995, NATURE, V374, P371; Aramaki H, 1995, PROTEIN ENG, V8, P1259, DOI 10.1093/protein/8.12.1259; ARIZA RR, 1995, J BACTERIOL, V177, P1655, DOI 10.1128/jb.177.7.1655-1661.1995; Barbosa TM, 2000, J BACTERIOL, V182, P3467, DOI 10.1128/JB.182.12.3467-3474.2000; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bolhuis H, 1997, FEMS MICROBIOL REV, V21, P55, DOI 10.1016/S0168-6445(97)00051-X; Brooun A, 1999, J BACTERIOL, V181, P5131, DOI 10.1128/JB.181.16.5131-5133.1999; Brownlie P, 1997, STRUCTURE, V5, P509, DOI 10.1016/S0969-2126(97)00207-4; Chang G, 2001, SCIENCE, V293, P1793, DOI 10.1126/science.293.5536.1793; COLE MD, 1991, CELL, V65, P715, DOI 10.1016/0092-8674(91)90377-B; Gajiwala KS, 2000, CURR OPIN STRUC BIOL, V10, P110, DOI 10.1016/S0959-440X(99)00057-3; Garvie CW, 2001, MOL CELL, V8, P937, DOI 10.1016/S1097-2765(01)00392-6; GLOVER JNM, 1995, NATURE, V373, P257, DOI 10.1038/373257a0; Godsey MH, 2001, J BIOL CHEM, V276, P47178, DOI 10.1074/jbc.M105819200; Grkovic S, 1998, J BIOL CHEM, V273, P18665, DOI 10.1074/jbc.273.29.18665; Grkovic S, 2001, SEMIN CELL DEV BIOL, V12, P225, DOI 10.1006/scdb.2000.0248; Grkovic S, 2001, J BACTERIOL, V183, P7102, DOI 10.1128/JB.183.24.7102-7109.2001; HANKINSON O, 1995, ANNU REV PHARMACOL, V35, P307, DOI 10.1146/annurev.pharmtox.35.1.307; HARRISON SC, 1990, ANNU REV BIOCHEM, V59, P933, DOI 10.1146/annurev.bi.59.070190.004441; Heldwein EEZ, 2001, NATURE, V409, P378, DOI 10.1038/35053138; HINRICHS W, 1994, SCIENCE, V264, P418, DOI 10.1126/science.8153629; Huffman JL, 2002, CURR OPIN STRUC BIOL, V12, P98, DOI 10.1016/S0959-440X(02)00295-6; Jair KW, 1996, J BACTERIOL, V178, P2507, DOI 10.1128/jb.178.9.2507-2513.1996; Kwon HJ, 2000, NAT STRUCT BIOL, V7, P424; Levy SB, 2001, CLIN INFECT DIS, V33, pS124, DOI 10.1086/321837; Lewinson O, 2001, BIOCHEMISTRY-US, V40, P12612, DOI 10.1021/bi011040y; Markham PN, 1996, J BACTERIOL, V178, P1473, DOI 10.1128/jb.178.5.1473-1475.1996; Martin RG, 1996, J BACTERIOL, V178, P2216, DOI 10.1128/jb.178.8.2216-2223.1996; Martin RG, 2001, CURR OPIN MICROBIOL, V4, P132, DOI 10.1016/S1369-5274(00)00178-8; Outten CE, 1999, J BIOL CHEM, V274, P37517, DOI 10.1074/jbc.274.53.37517; Putman M, 2000, MICROBIOL MOL BIOL R, V64, P672, DOI 10.1128/MMBR.64.4.672-693.2000; Rhee S, 1998, P NATL ACAD SCI USA, V95, P10413, DOI 10.1073/pnas.95.18.10413; Rosner JL, 2002, J BACTERIOL, V184, P1407, DOI 10.1128/JB.184.5.1407-1416.2002; Schumacher MA, 2002, EMBO J, V21, P1210, DOI 10.1093/emboj/21.5.1210; Schumacher MA, 2001, SCIENCE, V294, P2158, DOI 10.1126/science.1066020; STEITZ TA, 1990, Q REV BIOPHYS, V23, P205, DOI 10.1017/S0033583500005552; SUMMERS AO, 1992, J BACTERIOL, V174, P3097, DOI 10.1128/jb.174.10.3097-3101.1992; Thoden JB, 1997, BIOCHEMISTRY-US, V36, P1212, DOI 10.1021/bi9626517; Vazquez-Laslop N, 1999, BIOCHEMISTRY-US, V38, P16925, DOI 10.1021/bi991988g; Watkins RE, 2001, SCIENCE, V292, P2329, DOI 10.1126/science.1060762; Zheleznova EE, 2000, TRENDS BIOCHEM SCI, V25, P39, DOI 10.1016/S0968-0004(99)01514-5; Zheleznova EE, 1999, CELL, V96, P353, DOI 10.1016/S0092-8674(00)80548-6; Zheleznova EE, 1997, PROTEIN SCI, V6, P2465	48	28	28	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2002	277	43					40169	40172		10.1074/jbc.R200018200	http://dx.doi.org/10.1074/jbc.R200018200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	607KU	12186881	hybrid			2022-12-27	WOS:000178791400001
J	Yanagi, K; Mizuno, T; You, ZY; Hanaoka, F				Yanagi, K; Mizuno, T; You, ZY; Hanaoka, F			Mouse geminin inhibits not only Cdt1-MCM6 interactions but also a novel intrinsic Cdt1 DNA binding activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORIGIN RECOGNITION COMPLEX; HELICASE ACTIVITY; FISSION YEAST; IN-VITRO; S-PHASE; REPLICATION; PROTEIN; INITIATION; MITOSIS; TRANSCRIPTION	DNA replication is controlled by the stepwise assembly of a pre-replicative complex and the replication apparatus. Cdt1 is a novel component of the pre-replicative complex and plays a role in loading the minichromosome maintenance (MCM) 2-7 complex onto chromatin. Cdt1 activity is inhibited by geminin, which is essential for the G2/M transition in metazoan cells. To understand the molecular basis of the Cdt1-geminin regulatory mechanism in mammalian cells, we cloned and expressed the mouse Cdt1 homologue cDNA in bacterial cells and purified mouse Cdt1 to near homogeneity. We found by yeast two-hybrid analysis that mouse Cdt1 associates with geminin, MCM6, and origin recognition complex 2. MCM6 interacts with the Cdt1 carboxyl-terminal region (amino acids 407-477), which is conserved among eukaryotes, whereas geminin associates with the Cdt1 central region (amino acids 177-380), which is conserved only in metazoans. In addition, we found that Cdt1 can bind DNA in a sequence-, strand-, and conformation-independent manner. The Cdt1 DNA binding domain overlaps with the geminin binding domain, and the binding of Cdt1 to DNA is inhibited by geminin. Taken together, we have defined structural domains and novel biochemical properties for mouse Cdt1 that suggest that Cdt1 behaves as an intrinsic DNA binding factor in the pre-replicative complex.	Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; Japan Sci & Technol Corp, CREST, Wako, Saitama 3510198, Japan; RIKEN Inst Phys & Chem Res, Cellular Physiol Lab, Wako, Saitama, Japan	Osaka University; Japan Science & Technology Agency (JST); RIKEN	Hanaoka, F (corresponding author), Osaka Univ, Grad Sch Frontier Biosci, 1-3 Yamadaoka, Suita, Osaka 5650871, Japan.							Adachi Y, 1997, GENES CELLS, V2, P467, DOI 10.1046/j.1365-2443.1997.1350333.x; Arentson E, 2002, ONCOGENE, V21, P1150, DOI 10.1038/sj.onc.1205175; Baker TA, 1998, CELL, V92, P295, DOI 10.1016/S0092-8674(00)80923-X; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Blow JJ, 2002, TRENDS CELL BIOL, V12, P72, DOI 10.1016/S0962-8924(01)02203-6; Chong JPJ, 2000, P NATL ACAD SCI USA, V97, P1530, DOI 10.1073/pnas.030539597; DEAN FB, 1991, J BIOL CHEM, V266, P5062; Devault A, 2002, CURR BIOL, V12, P689, DOI 10.1016/S0960-9822(02)00768-6; Diffley JFX, 2002, J CELL SCI, V115, P869; FACKELMAYER FO, 1994, EUR J BIOCHEM, V221, P749, DOI 10.1111/j.1432-1033.1994.tb18788.x; Gilbert DM, 2001, SCIENCE, V294, P96, DOI 10.1126/science.1061724; HOFMANN JFX, 1994, EMBO J, V13, P425, DOI 10.1002/j.1460-2075.1994.tb06277.x; Ishimi Y, 1997, J BIOL CHEM, V272, P24508, DOI 10.1074/jbc.272.39.24508; Izumi M, 2001, J BIOL CHEM, V276, P48526, DOI 10.1074/jbc.M107190200; Izumi M, 2000, NUCLEIC ACIDS RES, V28, P4769, DOI 10.1093/nar/28.23.4769; Kelly TJ, 2000, ANNU REV BIOCHEM, V69, P829, DOI 10.1146/annurev.biochem.69.1.829; Labib K, 2001, CURR OPIN GENET DEV, V11, P64, DOI 10.1016/S0959-437X(00)00158-1; LAI JS, 1992, P NATL ACAD SCI USA, V89, P6958, DOI 10.1073/pnas.89.15.6958; Lee DG, 2000, EMBO J, V19, P4774, DOI 10.1093/emboj/19.17.4774; Lee JK, 2000, J BIOL CHEM, V275, P18871, DOI 10.1074/jbc.M001118200; Lee JK, 2001, P NATL ACAD SCI USA, V98, P54, DOI 10.1073/pnas.98.1.54; Lei M, 2001, J CELL SCI, V114, P1447; MADINE MA, 1995, NATURE, V375, P421, DOI 10.1038/375421a0; Maiorano D, 2000, NATURE, V404, P622, DOI 10.1038/35007104; McGarry TJ, 1998, CELL, V93, P1043, DOI 10.1016/S0092-8674(00)81209-X; Mizuno T, 1999, MOL CELL BIOL, V19, P7886; Mizushima T, 2000, GENE DEV, V14, P1631; Nishitani H, 2002, GENES CELLS, V7, P523, DOI 10.1046/j.1365-2443.2002.00544.x; Nishitani H, 2000, NATURE, V404, P625, DOI 10.1038/35007110; Nishitani H, 2001, J BIOL CHEM, V276, P44905, DOI 10.1074/jbc.M105406200; Perkins G, 1998, MOL CELL, V2, P23, DOI 10.1016/S1097-2765(00)80110-0; Reeves R, 2001, BBA-GENE STRUCT EXPR, V1519, P13, DOI 10.1016/S0167-4781(01)00215-9; Rialland M, 2002, J CELL SCI, V115, P1435; Ritzi M, 2000, GENE, V245, P13, DOI 10.1016/S0378-1119(00)00020-2; Sato M, 2000, J MOL BIOL, V300, P421, DOI 10.1006/jmbi.2000.3865; Tada S, 2001, NAT CELL BIOL, V3, P107, DOI 10.1038/35055000; Takisawa H, 2000, CURR OPIN CELL BIOL, V12, P690, DOI 10.1016/S0955-0674(00)00153-8; Tanaka S, 2002, NAT CELL BIOL, V4, P198, DOI 10.1038/ncb757; Whittaker AJ, 2000, GENE DEV, V14, P1765; Wilmes GM, 2002, P NATL ACAD SCI USA, V99, P101, DOI 10.1073/pnas.012578499; Wohlschlegel JA, 2000, SCIENCE, V290, P2309, DOI 10.1126/science.290.5500.2309; You ZY, 1999, MOL CELL BIOL, V19, P8003	42	113	116	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 25	2002	277	43					40871	40880		10.1074/jbc.M206202200	http://dx.doi.org/10.1074/jbc.M206202200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	607KU	12192004	hybrid			2022-12-27	WOS:000178791400092
J	Chuang, JL; Wynn, RM; Chuang, DT				Chuang, JL; Wynn, RM; Chuang, DT			The C-terminal hinge region of lipoic acid-bearing domain of E2b is essential for domain interaction with branched-chain alpha-keto acid dehydrogenase kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; BOVINE KIDNEY; DIHYDROLIPOYL ACETYLTRANSFERASE; COMPLEX; PHOSPHORYLATION; PURIFICATION; EXPRESSION; RAT	The branched-chain a-keto acid dehydrogenase (BCKD) kinase (abbreviated as BCK) down-regulates activity of the mammalian mitochondrial. BCKD complex by reversible phosphorylation of the decarboxylase (E1b) component of the complex. The binding of BCK to the holotransacylase (E2b) core of the BCKD complex results in the stimulation of BCK activity. Here we show that the lipoylated lipoic acid-bearing domain (lip-LBD) (residues 1-84) of E2b alone does not interact with BCK. However, lip-LBD constructs containing various lengths of the C-terminal hinge region of LBD are able to bind to BCK as measured by a newly developed solubility-based binding assay. Isothermal titration calorimetry measurements produced a dissociation constant of 8.06 x 10(-6) m and binding enthalpy of -3.68 kcal/mol for the interaction of BCK with a construct containing lip-LBD and the Glu-Glu-Asp-Xaa-Xaa-Glu sequence of the C-terminal hinge region of LBD. These thermodynamic parameters are similar to those obtained for binding of BCK to a lipoylated di-domain construct, which harbors LBD, the entire hinge region, and the downstream subunit-binding domain of E2b. Our data establish that the C-terminal hinge region of LBD containing the above negatively charged residues is essential for the interaction between the lip-LBD construct and BCK.	Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Chuang, DT (corresponding author), Univ Texas, SW Med Ctr, Dept Biochem, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	David.Chuang@UTSouthwestern.edu		Wynn, Richard/0000-0002-1879-2136	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK026758] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-26758] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Baker JC, 2000, J BIOL CHEM, V275, P15773, DOI 10.1074/jbc.M909488199; Bilwes AM, 1999, CELL, V96, P131, DOI 10.1016/S0092-8674(00)80966-6; Chang CF, 2002, J BIOL CHEM, V277, P15865, DOI 10.1074/jbc.M110952200; Chuang D.T., 2001, METABOLIC MOL BASES, P1971; Chuang JL, 2000, METHOD ENZYMOL, V324, P192; Chuang JL, 1997, J CLIN INVEST, V100, P736, DOI 10.1172/JCI119586; COOK KG, 1984, EUR J BIOCHEM, V145, P587, DOI 10.1111/j.1432-1033.1984.tb08597.x; DAMUNI Z, 1984, P NATL ACAD SCI-BIOL, V81, P4335, DOI 10.1073/pnas.81.14.4335; DAVIE JR, 1995, J BIOL CHEM, V270, P19861, DOI 10.1074/jbc.270.34.19861; Harris RA, 1997, ADV ENZYME REGUL, V37, P271, DOI 10.1016/S0065-2571(96)00009-X; Jung HI, 2002, PROTEIN SCI, V11, P1091, DOI 10.1110/ps.4970102; LIU SJ, 1995, ARCH BIOCHEM BIOPHYS, V316, P926, DOI 10.1006/abbi.1995.1124; Machius M, 2001, P NATL ACAD SCI USA, V98, P11218, DOI 10.1073/pnas.201220098; Mann WR, 2000, BBA-PROTEIN STRUCT M, V1480, P283, DOI 10.1016/S0167-4838(00)00079-0; PAXTON R, 1982, J BIOL CHEM, V257, P4433; PETTIT FH, 1978, P NATL ACAD SCI USA, V75, P4881, DOI 10.1073/pnas.75.10.4881; Qu BH, 1996, J BIOL CHEM, V271, P7261, DOI 10.1074/jbc.271.13.7261; RADKE GA, 1993, BIOCHEM BIOPH RES CO, V190, P982, DOI 10.1006/bbrc.1993.1146; ROCHE TE, 1989, ANN NY ACAD SCI, V573, P66, DOI 10.1111/j.1749-6632.1989.tb14987.x; Steussy CN, 2001, J BIOL CHEM, V276, P37443, DOI 10.1074/jbc.M104285200; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Tuganova A, 2002, BIOCHEM J, V366, P129, DOI 10.1042/BJ20020301	22	15	15	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2002	277	40					36905	36908		10.1074/jbc.C200430200	http://dx.doi.org/10.1074/jbc.C200430200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	601LH	12189132	hybrid			2022-12-27	WOS:000178447100001
J	Behne, MJ; Meyer, JW; Hanson, KM; Barry, NP; Murata, S; Crumrine, D; Clegg, RW; Gratton, E; Holleran, WM; Elias, PM; Mauro, TM				Behne, MJ; Meyer, JW; Hanson, KM; Barry, NP; Murata, S; Crumrine, D; Clegg, RW; Gratton, E; Holleran, WM; Elias, PM; Mauro, TM			NHE1 regulates the stratum corneum permeability barrier homeostasis - Microenvironment acidification assessed with fluorescence lifetime imaging	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GLUCOCEREBROSIDASE ACTIVITY; PHOSPHOLIPASE A(2); KERATINOCYTE DIFFERENTIATION; MURINE EPIDERMIS; CROSSOVER TRIAL; FATTY-ACIDS; PH GRADIENT; HUMAN-SKIN; IN-VIVO; AMILORIDE	The outermost epidermal layer, the stratum corneum (SC), exhibits an acidic surface pH, whereas the pH at its base approaches neutrality. NHE1 is the only Na+/H+ antiporter isoform in keratinocytes and epidermis, and has been shown to regulate intracellular pH. We now demonstrate a novel function for NHE1, as we find that it also controls acidification of extracellular "microdomains" in the SC that are essential for activation of pH-sensitive enzymes and the formation of the epidermal permeability barrier. NHE1 expression in epidermis is most pronounced in granular cell layers, and although the surface pH of NHE1 knockout mice is only slightly more alkaline than normal using conventional pH measurements, a more sensitive method, fluorescence lifetime imaging, demonstrates that the acidic intercellular domains at the surface and of the lower SC disappear in NHE1 -/- animals. Fluorescence lifetime imaging studies also reveal that SC acidification does not occur through a uniform gradient, but through the progressive accumulation of acidic microdomains. These findings not only visualize the spatial distribution of the SC pH gradient, but also demonstrate a role for NHE1 in the generation of acidic extracellular domains of the lower SC, thus providing the acidification of deep SC interstices necessary for lipid processing and barrier homeostasis.	Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94121 USA; Vet Affairs Med Ctr, Dermatol Serv, San Francisco, CA 94121 USA; Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA; Univ Illinois, Dept Phys, Fluorescence Dynam Lab, Urbana, IL 61801 USA	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); University System of Ohio; University of Cincinnati; University of Illinois System; University of Illinois Urbana-Champaign	Behne, MJ (corresponding author), Univ Calif San Francisco, Dept Dermatol, 4150 Clement St, San Francisco, CA 94121 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061974] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R29AR044341, R01AR019098] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL61974] Funding Source: Medline; NIAMS NIH HHS [AR19098, AR44341] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ALY R, 1978, J INVEST DERMATOL, V71, P378, DOI 10.1111/1523-1747.ep12556778; Bell SM, 1999, AM J PHYSIOL-CELL PH, V276, pC788, DOI 10.1152/ajpcell.1999.276.4.C788; BERG RW, 1994, PEDIATR DERMATOL, V11, P18, DOI 10.1111/j.1525-1470.1994.tb00066.x; BLANK IRVIN H., 1939, JOUR INVEST DERMAT, V2, P67; Bonnet U, 2000, EUR NEUROPSYCHOPHARM, V10, P97, DOI 10.1016/S0924-977X(99)00063-2; Bouwstra J A, 1998, J Investig Dermatol Symp Proc, V3, P69; Bouwstra JA, 2000, CELL MOL BIOL, V46, P979; Capasso G, 1997, MINER ELECTROL METAB, V23, P243; CHRISTOPHERS E, 1971, J INVEST DERMATOL, V56, P165, DOI 10.1111/1523-1747.ep12260765; COUNILLON L, 1993, MOL PHARMACOL, V44, P1041; Fluhr JW, 2001, J INVEST DERMATOL, V117, P44, DOI 10.1046/j.0022-202x.2001.01399.x; FRELIN C, 1987, KIDNEY INT, V32, P785, DOI 10.1038/ki.1987.277; Hanson KM, 2002, BIOPHYS J, V83, P1682, DOI 10.1016/S0006-3495(02)73936-2; HOLLERAN WM, 1992, J LIPID RES, V33, P1201; HOLLERAN WM, 1993, J CLIN INVEST, V91, P1656, DOI 10.1172/JCI116374; Jensen JM, 1999, J CLIN INVEST, V104, P1761, DOI 10.1172/JCI5307; Komuves LG, 2000, J INVEST DERMATOL, V115, P361, DOI 10.1046/j.1523-1747.2000.00076.x; KORTING HC, 1987, ACTA DERM-VENEREOL, V67, P41; KORTING HC, 1990, ACTA DERM-VENEREOL, V70, P429; Krien PM, 2000, J INVEST DERMATOL, V115, P414, DOI 10.1046/j.1523-1747.2000.00083.x; LEE SH, 1994, J INVEST DERMATOL, V102, P976, DOI 10.1111/1523-1747.ep12384225; LIECKFELDT R, 1995, PHARM RES-DORDR, V12, P1614, DOI 10.1023/A:1016280714593; Loh SH, 1996, BRIT J PHARMACOL, V118, P1905, DOI 10.1111/j.1476-5381.1996.tb15623.x; MACKENZI.JC, 1969, NATURE, V222, P881, DOI 10.1038/222881a0; MACKENZIE IC, 1981, J INVEST DERMATOL, V76, P459, DOI 10.1111/1523-1747.ep12521107; MAN MQ, 1993, ARCH DERMATOL, V129, P728, DOI 10.1001/archderm.129.6.728; MaoQiang M, 1996, J INVEST DERMATOL, V106, P57, DOI 10.1111/1523-1747.ep12327246; Masters BR, 1997, BIOPHYS J, V72, P2405, DOI 10.1016/S0006-3495(97)78886-6; Mauro T, 1998, ARCH DERMATOL RES, V290, P215, DOI 10.1007/s004030050293; Mauro T, 2002, J INVEST DERMATOL, V118, P589, DOI 10.1046/j.1523-1747.2002.01721.x; MAURO T, 1995, J INVEST DERMATOL, V105, P203, DOI 10.1111/1523-1747.ep12317130; MENON GK, 1992, J INVEST DERMATOL, V98, P209, DOI 10.1111/1523-1747.ep12555880; Menon GK, 1997, SKIN PHARMACOL, V10, P235; NOEL J, 1995, AM J PHYSIOL-CELL PH, V268, pC283, DOI 10.1152/ajpcell.1995.268.2.C283; Ogata Y, 2002, COMP BIOCHEM PHYS C, V131, P315, DOI 10.1016/S1532-0456(02)00005-4; Ohman H, 1998, J INVEST DERMATOL, V111, P674, DOI 10.1046/j.1523-1747.1998.00356.x; OHMAN H, 1994, ACTA DERM-VENEREOL, V74, P375; Pannabecker TL, 2002, PFLUG ARCH EUR J PHY, V443, P446, DOI 10.1007/s004240100705; Patterson MJ, 2000, EXP PHYSIOL, V85, P869, DOI 10.1017/S0958067000020583; Reshkin SJ, 2000, FASEB J, V14, P2185, DOI 10.1096/fj.00-0029com; Rousselle AV, 2002, BONE, V30, P533, DOI 10.1016/S8756-3282(02)00672-5; Sarangarajan R, 2001, BBA-BIOMEMBRANES, V1511, P181, DOI 10.1016/S0005-2736(01)00273-5; Schadow A, 2001, J INVEST DERMATOL, V116, P31, DOI 10.1046/j.1523-1747.2001.00179.x; Schmuth M, 2000, J INVEST DERMATOL, V115, P459, DOI 10.1046/j.1523-1747.2000.00081.x; SIT KH, 1993, ANAT RECORD, V235, P183, DOI 10.1002/ar.1092350202; Six DA, 2000, BBA-MOL CELL BIOL L, V1488, P1, DOI 10.1016/S1388-1981(00)00105-0; SZMACINSKI H, 1993, ANAL CHEM, V65, P1668, DOI 10.1021/ac00061a007; Tadrous PJ, 2000, J PATHOL, V191, P229; Takagi Y, 1999, J LIPID RES, V40, P861; THUNE P, 1988, ACTA DERM-VENEREOL, V68, P277; Tominaga T, 1998, MOL BIOL CELL, V9, P2287, DOI 10.1091/mbc.9.8.2287; Turner N G, 1998, J Investig Dermatol Symp Proc, V3, P110; Uchida Y, 2001, J INVEST DERMATOL, V117, P1307, DOI 10.1046/j.0022-202x.2001.01555.x; VIGNE P, 1984, MOL PHARMACOL, V25, P131; Wepf R, 2002, J INVEST DERMATOL, V119, P250	55	138	147	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 6	2002	277	49					47399	47406		10.1074/jbc.M204759200	http://dx.doi.org/10.1074/jbc.M204759200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622TT	12221084	hybrid			2022-12-27	WOS:000179663700074
J	Sun, HJ; Unoki, H; Wang, XF; Liang, JY; Ichikawa, T; Arai, Y; Shiomi, M; Marcovina, SM; Watanabe, T; Fan, JL				Sun, HJ; Unoki, H; Wang, XF; Liang, JY; Ichikawa, T; Arai, Y; Shiomi, M; Marcovina, SM; Watanabe, T; Fan, JL			Lipoprotein(a) enhances advanced atherosclerosis and vascular calcification in WHHL transgenic rabbits expressing human apolipoprotein(a)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORONARY HEART-DISEASE; LOW-DENSITY LIPOPROTEINS; RISK FACTOR; ARTERIAL CALCIFICATION; LDL RECEPTOR; IN-VITRO; MICE; LESIONS; ASSOCIATION; PLASMA	High lipoprotein(a) (Lp(a)) levels are a major risk factor for the development of atherosclerosis. The risk of elevated Lp(a) concentration is increased significantly in patients who also have high levels of low density lipoprotein (LDL) cholesterol. To test the hypothesis that increased plasma levels of Lp(a) may enhance the development of atherosclerosis in the setting of hypercholesterolemia, we generated Watanabe heritable hyperlipidemic (WHHL) transgenic (Tg) rabbits expressing human apolipoprotein(a) (apo(a)). We report here that Tg WHHL rabbits developed more extensive advanced atherosclerotic lesions than did non-Tg WHHL rabbits. In particular, the advanced atherosclerotic lesions in Tg WHHL rabbits were frequently associated with calcification, which was barely evident in non-Tg WHHL rabbits. To investigate the molecular mechanism of Lp(a)-induced vascular calcification, we examined the effect of human Lp(a) on cultured rabbit aortic smooth muscle cells and found that smooth muscle cells treated with Lp(a) showed increased alkaline phosphatase activity and enhanced calcium accumulation. These results demonstrate for the first time that Lp(a) accelerates advanced atherosclerotic lesion formation and may play an important role in vascular calcification.	Univ Tsukuba, Inst Basic Med Sci, Dept Pathol, Lab Cardiovasc Dis, Tsukuba, Ibaraki 3058575, Japan; Kobe Univ, Sch Med, Inst Expt Anim, Kobe, Hyogo 6500017, Japan; Univ Washington, Dept Med, NW Lipid Res Labs, Seattle, WA 98103 USA; Saga Med Sch, Saga 8498501, Japan	University of Tsukuba; Kobe University; University of Washington; University of Washington Seattle; Saga University	Fan, JL (corresponding author), Univ Tsukuba, Inst Basic Med Sci, Dept Pathol, Lab Cardiovasc Dis, Tsukuba, Ibaraki 3058575, Japan.		Unoki-Kubota, Hiroyuki/H-7268-2019; Liang, Jingyan/F-6630-2014	Unoki-Kubota, Hiroyuki/0000-0003-4827-8805; Fan, Jianglin/0000-0002-1737-6130				ARMSTRONG VW, 1986, ATHEROSCLEROSIS, V62, P249, DOI 10.1016/0021-9150(86)90099-7; BERG K, 1963, ACTA PATHOL MIC SC, V59, P369; Boonmark NW, 1997, J CLIN INVEST, V100, P558, DOI 10.1172/JCI119565; Cantin B, 1998, J AM COLL CARDIOL, V31, P519, DOI 10.1016/S0735-1097(97)00528-7; CHIESA G, 1992, J BIOL CHEM, V267, P24369; Dangas G, 1998, J AM COLL CARDIOL, V32, P2035, DOI 10.1016/S0735-1097(98)00469-0; DEMER LL, 1991, CIRCULATION, V83, P2083, DOI 10.1161/01.CIR.83.6.2083; Djurovic S, 1997, CLIN GENET, V52, P281; DOHERTY TM, 1994, CALCIFIED TISSUE INT, V54, P224, DOI 10.1007/BF00301683; Edelstein C, 2001, ANAL BIOCHEM, V288, P201, DOI 10.1006/abio.2000.4904; Fan JL, 1998, J CLIN INVEST, V101, P2151, DOI 10.1172/JCI1599; Fan JL, 1999, BIOCHEM BIOPH RES CO, V255, P639, DOI 10.1006/bbrc.1999.0242; Fan JL, 2000, J LIPID RES, V41, P1004; Fan JL, 2001, ARTERIOSCL THROM VAS, V21, P88, DOI 10.1161/01.ATV.21.1.88; Galle J, 1999, KIDNEY INT, V55, P1450, DOI 10.1046/j.1523-1755.1999.00351.x; GUREWICH V, 1994, JAMA-J AM MED ASSOC, V271, P1025, DOI 10.1001/jama.271.13.1025; HANSEN PR, 1994, EUR J CLIN INVEST, V24, P497, DOI 10.1111/j.1365-2362.1994.tb02381.x; Hsu HHT, 2000, ATHEROSCLEROSIS, V153, P337, DOI 10.1016/S0021-9150(00)00425-1; Ichikawa T, 2002, AM J PATHOL, V160, P227, DOI 10.1016/S0002-9440(10)64366-0; JURGENS G, 1993, ARTERIOSCLER THROMB, V13, P1689, DOI 10.1161/01.ATV.13.11.1689; KROON PA, 1985, ATHEROSCLEROSIS, V56, P323, DOI 10.1016/0021-9150(85)90007-3; LAPLAUD PM, 1988, J LIPID RES, V29, P1157; LAWN RM, 1992, NATURE, V360, P670, DOI 10.1038/360670a0; Lawn RM, 1996, J BIOL CHEM, V271, P31367, DOI 10.1074/jbc.271.49.31367; LIU AC, 1994, J LIPID RES, V35, P2263; MAHER VMG, 1995, CURR OPIN LIPIDOL, V6, P229, DOI 10.1097/00041433-199508000-00007; MANCINI FP, 1995, ARTERIOSCL THROM VAS, V15, P1911, DOI 10.1161/01.ATV.15.11.1911; Marcovina SM, 1998, AM J CARDIOL, V82, p57U, DOI 10.1016/S0002-9149(98)00954-0; Parhami F, 1997, ARTERIOSCL THROM VAS, V17, P680, DOI 10.1161/01.ATV.17.4.680; Parhami F, 2001, Z Kardiol, V90 Suppl 3, P27; Proudfoot D, 2000, CIRC RES, V87, P1055, DOI 10.1161/01.RES.87.11.1055; Proudfoot D, 1998, ARTERIOSCL THROM VAS, V18, P379, DOI 10.1161/01.ATV.18.3.379; RATH M, 1989, ARTERIOSCLEROSIS, V9, P579, DOI 10.1161/01.ATV.9.5.579; RIDKER PM, 1993, JAMA-J AM MED ASSOC, V270, P2195, DOI 10.1001/jama.270.18.2195; Rouy D, 1998, J BIOL CHEM, V273, P1247, DOI 10.1074/jbc.273.2.1247; Sanan DA, 1998, P NATL ACAD SCI USA, V95, P4544, DOI 10.1073/pnas.95.8.4544; SEED M, 1990, NEW ENGL J MED, V322, P1494, DOI 10.1056/NEJM199005243222104; STARY HC, 1995, ARTERIOSCL THROM VAS, V15, P1512, DOI 10.1161/01.ATV.15.9.1512; Tintut Y, 2001, CURR OPIN LIPIDOL, V12, P555, DOI 10.1097/00041433-200110000-00012; UTERMANN G, 1995, METABOLIC MOL BASES, P1887; Veniant MM, 2000, J CLIN INVEST, V106, P1501, DOI 10.1172/JCI10695; WATANABE Y, 1980, ATHEROSCLEROSIS, V36, P261, DOI 10.1016/0021-9150(80)90234-8; YAMAMOTO T, 1986, SCIENCE, V232, P1230, DOI 10.1126/science.3010466	43	55	59	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 6	2002	277	49					47486	47492		10.1074/jbc.M205814200	http://dx.doi.org/10.1074/jbc.M205814200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622TT	12196525	hybrid			2022-12-27	WOS:000179663700085
J	Zhang, JS; Ferreira, C				Zhang, JS; Ferreira, C			Transient state kinetic investigation of 5-aminolevulinate synthase reaction mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PYRIDOXAL 5'-PHOSPHATE COFACTOR; DELTA-AMINOLEVULINATE SYNTHASE; O-ACETYLSERINE SULFHYDRYLASE; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; 8-AMINO-7-OXONONANOATE SYNTHASE; DIALKYLGLYCINE DECARBOXYLASE; SERINE PALMITOYLTRANSFERASE; ASPARTATE-AMINOTRANSFERASE; CONFORMATIONAL CHANGE	5-Aminolevulinate synthase (ALAS), a pyridoxal 5'-phosphate-dependent enzyme, catalyzes the first, and regulatory, step of the heme biosynthetic pathway in nonplant eukaryotes and some bacteria. 5-Aminolevulinate synthase is a dimeric protein having an ordered kinetic mechanism with glycine binding before succinyl-CoA and with aminolevulinate release after CoA and carbon dioxide. Rapid scanning stopped-flow absorption spectrophotometry in conjunction with multiple turnover chemical quenched-flow kinetic analyses and a newly developed CoA detection method were use to examine the ALAS catalytic reaction and identify the rate-determining step. The reaction of glycine with ALAS follows a three-step kinetic process, ascribed to the formation of the Michaelis complex and the pyridoxal 5'-phosphate-glycine aldimine, followed by the abstraction of the glycine pro-R proton from the external aldimine. Significantly, the rate associated with this third step (k(3) = 0.002 s(-1)) is consistent with the rate determined for the ALAS-catalyzed removal of tritium from [2-H-3(2)]glycine. Succinyl-CoA and acetoacetyl-CoA increased the rate of glycine proton removal similar to250,000 and 10-fold, respectively, supporting our previous proposal that the physiological substrate, succinyl-CoA, promotes a protein conformational change, which accelerates the conversion of the external aldimine into the initial quinonoid intermediate (Hunter, G. A., and Ferreira, G. C. (1999) J. Biol. Chem. 274,12222-12228). Rapid scanning stopped-flow and quenched-flow kinetic analyses of the ALAS reaction under single turnover conditions lend evidence for two quinonoid reaction intermediates and a model of the ALAS kinetic mechanism in which product release is at least the partially rate-limiting step. Finally, the carbonyl and carboxylate groups of 5-aminolevulinate play a major protein-interacting role by inducing a conformational change in ALAS and, thus, possibly modulating product release.	Univ S Florida, Coll Med, Dept Biochem & Mol Biol, Tampa, FL 33612 USA; Univ S Florida, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA; Univ S Florida, Inst Biomol Sci, Tampa, FL 33612 USA	State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Ferreira, C (corresponding author), Univ S Florida, Coll Med, Dept Biochem & Mol Biol, 12901 Bruce B Downs Blvd, Tampa, FL 33612 USA.				NIDDK NIH HHS [R01 DK063191] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063191] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ABBOUD MM, 1974, J CHEM SOC CHEM COMM, P643, DOI 10.1039/c39740000643; AHKTAR M, 1979, COMPREHENSIVE ORGANI, V5, P1121; ALEXANDER FW, 1994, EUR J BIOCHEM, V219, P953, DOI 10.1111/j.1432-1033.1994.tb18577.x; Alexeev D, 1998, J MOL BIOL, V284, P401, DOI 10.1006/jmbi.1998.2086; BEECHEM JM, 1992, METHOD ENZYMOL, V210, P37; BISHOP DF, 1990, GENOMICS, V7, P207, DOI 10.1016/0888-7543(90)90542-3; BOTTOMLEY SS, 1999, WINTROBES CLIN HEMAT, P1022; Burkhard P, 1999, J MOL BIOL, V291, P941, DOI 10.1006/jmbi.1999.3002; Cheltsov AV, 2001, J BIOL CHEM, V276, P19141, DOI 10.1074/jbc.M100329200; Clausen T, 1996, J MOL BIOL, V262, P202, DOI 10.1006/jmbi.1996.0508; COTTER PD, 1992, GENOMICS, V13, P211, DOI 10.1016/0888-7543(92)90223-F; FANICAGA.M, 1973, EUR J BIOCHEM, V40, P19, DOI 10.1111/j.1432-1033.1973.tb03164.x; Farazi TA, 2000, BIOCHEMISTRY-US, V39, P15807, DOI 10.1021/bi002074t; FERREIRA GC, 1993, PROTEIN SCI, V2, P1959, DOI 10.1002/pro.5560021117; FERREIRA GC, 1995, J BIOENERG BIOMEMBR, V27, P151, DOI 10.1007/BF02110030; FERREIRA GC, 1993, J BIOL CHEM, V268, P585; Ferreira GC., 1999, IRON METABOLISM, P15, DOI [10.1002/9783527613700.CH02., DOI 10.1002/9783527613700.CH02]; FERSHT A, 1998, STRUCTURE MECH PROTE, P152; Gable K, 2000, J BIOL CHEM, V275, P7597, DOI 10.1074/jbc.275.11.7597; Gong J, 1998, BIOCHEMISTRY-US, V37, P3509, DOI 10.1021/bi9719298; GRISHIN NV, 1995, PROTEIN SCI, V4, P1291, DOI 10.1002/pro.5560040705; Hayashi H, 1999, BIOCHEMISTRY-US, V38, P15615, DOI 10.1021/bi9909795; HUNTER GA, 1995, ANAL BIOCHEM, V226, P221, DOI 10.1006/abio.1995.1217; Hunter GA, 1999, BIOCHEMISTRY-US, V38, P3711, DOI 10.1021/bi982390w; Hunter GA, 1999, J BIOL CHEM, V274, P12222, DOI 10.1074/jbc.274.18.12222; Ikushiro H, 2001, J BIOL CHEM, V276, P18249, DOI 10.1074/jbc.M101550200; JAGER J, 1994, J MOL BIOL, V239, P285, DOI 10.1006/jmbi.1994.1368; JOHNSON MD, 1992, PHYSICIAN SPORTSMED, V20, P61; Krupka HI, 2000, EMBO J, V19, P3168, DOI 10.1093/emboj/19.13.3168; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAGHAI A, 1977, BIOCHEM SOC T, V5, P299, DOI 10.1042/bst0050299; LIEN LF, 1982, ENZYME, V28, P120; MATHESON IBC, 1990, COMPUT CHEM, V14, P49, DOI 10.1016/0097-8485(90)80007-O; MCCLURE GD, 1994, BIOCHEMISTRY-US, V33, P1674, DOI 10.1021/bi00173a009; MILES EW, 1994, ADV LIF SCI-SERIES, P113; Nakajima O, 1999, EMBO J, V18, P6282, DOI 10.1093/emboj/18.22.6282; NANDI DL, 1978, J BIOL CHEM, V253, P8872; Ploux O, 1999, EUR J BIOCHEM, V259, P63, DOI 10.1046/j.1432-1327.1999.00006.x; Rhee S, 1997, J BIOL CHEM, V272, P17293, DOI 10.1074/jbc.272.28.17293; Schmidt A, 2001, BIOCHEMISTRY-US, V40, P5151, DOI 10.1021/bi002204y; Schneider G, 2000, STRUCT FOLD DES, V8, pR1, DOI 10.1016/S0969-2126(00)00085-X; Sun SX, 1998, BIOCHEMISTRY-US, V37, P3876, DOI 10.1021/bi972056k; Tan DW, 1996, BIOCHEMISTRY-US, V35, P8934, DOI 10.1021/bi952918m; Tan DW, 1998, BIOCHEMISTRY-US, V37, P1478, DOI 10.1021/bi971928f; Webster SP, 2000, BIOCHEMISTRY-US, V39, P516, DOI 10.1021/bi991620j; ZAMAN Z, 1973, BIOCHEM J, V135, P257, DOI 10.1042/bj1350257; Zhou XZ, 2001, BIOCHEMISTRY-US, V40, P1367, DOI 10.1021/bi001237a	47	40	42	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 22	2002	277	47					44660	44669		10.1074/jbc.M203584200	http://dx.doi.org/10.1074/jbc.M203584200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	618EE	12191993	Green Accepted, hybrid			2022-12-27	WOS:000179404800010
J	Cramer, J; Strerath, M; Marx, A; Restle, T				Cramer, J; Strerath, M; Marx, A; Restle, T			Exploring the effects of active site constraints on HIV-1 reverse transcriptase DNA polymerase fidelity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPLICATION FIDELITY; STERIC HINDRANCE; 3TC RESISTANCE; SUBSTRATE; MECHANISM; SELECTIVITY; INFIDELITY; INHIBITORS; KINETICS; SUGAR	To examine the concept of polymerase active site tightness as a criteria for DNA polymerase fidelity, we performed pre-steady-state single nucleotide incorporation kinetic analyses with sugar modified thymidine 5'- triphosphate (TTP) analogues and human immunodeficiency virus (HIV-1) reverse transcriptase (RT). The employed TTP analogues (TTP) are modified at the 4'-position of the sugar moiety with alkyl groups, gradually expanding their steric demand. Introduction of a methyl group reduces the maximum rate of nucleotide incorporation by about 200-fold for RTWT and about 400-fold for RTM184V. Interestingly, the affinity of RT for the modified nucleotide is only marginally affected. Increasing the size to an ethyl group leads to further reduction of the rate of incorporation and first effects on binding affinities are observed. Finally, substitution for an isopropyl group results not only in a further reduction of I. incorporation rates but also in a dramatic loss of bin,ding affinity for the nucleotide analogue. By increasing the steric demand the effects on RTM184V in comparison with RTWT become progressively more pronounced. Mis-incorporation of either TTP or (TTP)-T-Me opposite a template G causes additional decline in incorporation rates accompanied by a drastic decrease in binding affinities. This results in relative incorporation efficiencies [(k(pol)/K-d)(incorrect)/(k(pol)/K-d)(TTPcorrect)] of of 4.1 X 10(-5) for TTP and 3.4 X 10(-6) for (TTP)-T-Me in case of RTWT and 1.4 X 10(-5) for TTP and 2.9 X 10(-8) for (TTP)-T-Me in case of RTM184V.	Max Planck Inst Mol Physiol, Phys Biochem Abt, D-44227 Dortmund, Germany; Univ Bonn, Kekule Inst Organ Chem & Biochem, D-53121 Bonn, Germany	Max Planck Society; University of Bonn	Restle, T (corresponding author), Max Planck Inst Mol Physiol, Phys Biochem Abt, Otto Hahn Str 11, D-44227 Dortmund, Germany.							Beard WA, 2001, NAT STRUCT BIOL, V8, P915, DOI 10.1038/nsb1101-915; Creighton S, 1995, METHOD ENZYMOL, V262, P232; ECHOLS H, 1991, ANNU REV BIOCHEM, V60, P477, DOI 10.1146/annurev.biochem.60.1.477; Ellenberger T, 2001, NAT STRUCT BIOL, V8, P827, DOI 10.1038/nsb1001-827; Feng JY, 1999, BIOCHEMISTRY-US, V38, P9440, DOI 10.1021/bi990709m; Friedberg EC, 2000, P NATL ACAD SCI USA, V97, P5681, DOI 10.1073/pnas.120152397; Friedberg EC, 2001, CELL, V107, P9, DOI 10.1016/S0092-8674(01)00509-8; Fygenson DK, 1997, J BIOL CHEM, V272, P27931, DOI 10.1074/jbc.272.44.27931; Gao HQ, 2000, J MOL BIOL, V300, P403, DOI 10.1006/jmbi.2000.3823; Goodman MF, 2000, NAT REV MOL CELL BIO, V1, P101, DOI 10.1038/35040051; Goodman MF, 1997, P NATL ACAD SCI USA, V94, P10493, DOI 10.1073/pnas.94.20.10493; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; JOHNSON KA, 1993, ANNU REV BIOCHEM, V62, P685, DOI 10.1146/annurev.bi.62.070193.003345; Joyce CM, 1997, P NATL ACAD SCI USA, V94, P1619, DOI 10.1073/pnas.94.5.1619; KATI WM, 1992, J BIOL CHEM, V267, P25988; Kool ET, 2002, ANNU REV BIOCHEM, V71, P191, DOI 10.1146/annurev.biochem.71.110601.135453; Kool ET, 1998, BIOPOLYMERS, V48, P3, DOI 10.1002/(SICI)1097-0282(1998)48:1<3::AID-BIP2>3.0.CO;2-7; Kool ET, 2000, ANGEW CHEM INT EDIT, V39, P990, DOI 10.1002/(SICI)1521-3773(20000317)39:6<990::AID-ANIE990>3.0.CO;2-0; Krebs R, 1997, BIOCHEMISTRY-US, V36, P10292, DOI 10.1021/bi970512z; Kunkel TA, 2000, ANNU REV BIOCHEM, V69, P497, DOI 10.1146/annurev.biochem.69.1.497; LOEB LA, 1982, ANNU REV BIOCHEM, V51, P429, DOI 10.1146/annurev.bi.51.070182.002241; Marx A, 2002, CHEMBIOCHEM, V3, P405, DOI 10.1002/1439-7633(20020503)3:5<405::AID-CBIC405>3.0.CO;2-4; Matsuda T, 2000, NATURE, V404, P1011, DOI 10.1038/35010014; Morales JC, 2000, J AM CHEM SOC, V122, P1001, DOI 10.1021/ja993464+; Moran S, 1997, P NATL ACAD SCI USA, V94, P10506, DOI 10.1073/pnas.94.20.10506; MULLER B, 1989, J BIOL CHEM, V264, P13975; Ohmori H, 2001, MOL CELL, V8, P7, DOI 10.1016/S1097-2765(01)00278-7; Pandey VN, 1996, BIOCHEMISTRY-US, V35, P2168, DOI 10.1021/bi9516642; Patel PH, 2001, NAT STRUCT BIOL, V8, P656, DOI 10.1038/90344; PRESTON BD, 1988, SCIENCE, V242, P1168, DOI 10.1126/science.2460924; RITTINGER K, 1995, P NATL ACAD SCI USA, V92, P8046, DOI 10.1073/pnas.92.17.8046; ROBERTS JD, 1988, SCIENCE, V242, P1171, DOI 10.1126/science.2460925; Sarafianos SG, 1999, P NATL ACAD SCI USA, V96, P10027, DOI 10.1073/pnas.96.18.10027; Souquet M, 1998, BIOCHEMISTRY-US, V37, P12144, DOI 10.1021/bi9731596; Strerath M, 2002, CHEMBIOCHEM, V3, P578, DOI 10.1002/1439-7633(20020603)3:6<578::AID-CBIC578>3.0.CO;2-W; Strerath M, 2002, J AM CHEM SOC, V124, P11230, DOI 10.1021/ja027060k; Summerer D, 2001, ANGEW CHEM INT EDIT, V40, P3693, DOI 10.1002/1521-3773(20011001)40:19<3693::AID-ANIE3693>3.0.CO;2-O; Thrall SH, 1998, BIOCHEMISTRY-US, V37, P13349; Wainberg MA, 1996, SCIENCE, V271, P1282, DOI 10.1126/science.271.5253.1282; Wohrl BM, 1999, J MOL BIOL, V292, P333, DOI 10.1006/jmbi.1999.3057	40	23	24	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	2002	277	46					43593	43598		10.1074/jbc.M207854200	http://dx.doi.org/10.1074/jbc.M207854200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	615XE	12200452	Green Published, hybrid			2022-12-27	WOS:000179272000009
J	Kim, BE; Smith, K; Meagher, CK; Petris, MJ				Kim, BE; Smith, K; Meagher, CK; Petris, MJ			A conditional mutation affecting localization of the Menkes disease copper ATPase - Suppression by copper supplementation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-TYPE ATPASE; TERMINAL DI-LEUCINE; FUNCTIONAL EXPRESSION; CANDIDATE GENE; BIOCHEMICAL-CHARACTERIZATION; DEPENDENT TRAFFICKING; CYSTIC-FIBROSIS; PLASMA-MEMBRANE; BINDING SITES; PROTEIN	Copper is an essential co-factor for several key metabolic processes. This requirement in humans is underscored by Menkes disease, an X-linked copper deficiency disorder caused by mutations in the copper transporting P-type ATPase, MNK. MNK is located in the trans-Golgi network where it transports copper to secreted cuproenzymes. Increases in copper concentration stimulate the trafficking of MNK to the plasma membrane where it effluxes copper. In this study, a Menkes disease mutation, G1019D, located in the large cytoplasmic loop of MNK, was characterized in transfected cultured cells. In copper-limiting conditions the G1019D mutant protein was retained in the endoplasmic reticulum. However, this mislocalization was corrected by the addition of copper to cells via a process that was dependent upon the copper binding sites at the N-terminal region of MNK. Reduced growth temperature and the chemical chaperone, glycerol, were found to correct the mislocalization of the G1019D mutant, suggesting this mutation interferes with protein folding in the secretory pathway. These findings identify G1019D as the first conditional mutation associated with Menkes disease and demonstrate correction of the mislocalized protein by copper supplementation. Our findings provide a molecular framework for understanding how mutations that affect the proper folding of the MNK transporter in Menkes patients may be responsive to parenteral copper therapy.	Univ Missouri, Dept Nutr Sci, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia	Petris, MJ (corresponding author), Univ Missouri, Dept Nutr Sci, 217 Gwynn Hall, Columbia, MO 65211 USA.	PetrisM@missouri.edu	Petris, Carisa/Z-4470-2019	Petris, Carisa/0000-0001-9059-1956	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059893] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 59893] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		CAMAKARIS J, 1995, HUM MOL GENET, V4, P2117, DOI 10.1093/hmg/4.11.2117; CHELLY J, 1993, NAT GENET, V3, P14, DOI 10.1038/ng0193-14; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Forbes JR, 2000, HUM MOL GENET, V9, P1927, DOI 10.1093/hmg/9.13.1927; Gal CSL, 2001, CARDIOVASC DRUG REV, V19, P201; Goodyer ID, 1999, HUM MOL GENET, V8, P1473, DOI 10.1093/hmg/8.8.1473; Halaban R, 2000, P NATL ACAD SCI USA, V97, P5889, DOI 10.1073/pnas.97.11.5889; Hung IH, 1997, J BIOL CHEM, V272, P21461, DOI 10.1074/jbc.272.34.21461; Kaler SG, 1996, BIOCHEM MOL MED, V57, P37, DOI 10.1006/bmme.1996.0007; Kaler SG, 1998, AM J CLIN NUTR, V67, p1029S, DOI 10.1093/ajcn/67.5.1029S; La Fontaine S, 1998, J BIOL CHEM, V273, P31375; Linder MC, 1998, AM J CLIN NUTR, V67, p965S, DOI 10.1093/ajcn/67.5.965S; Loo TW, 1997, J BIOL CHEM, V272, P709, DOI 10.1074/jbc.272.2.709; LOO TW, 1994, J BIOL CHEM, V269, P7243; MERCER JFB, 1993, NAT GENET, V3, P20, DOI 10.1038/ng0193-20; Morello JP, 2000, J CLIN INVEST, V105, P887, DOI 10.1172/JCI8688; Partridge CJ, 2001, J BIOL CHEM, V276, P35947, DOI 10.1074/jbc.M104762200; Payne AS, 1998, P NATL ACAD SCI USA, V95, P10854, DOI 10.1073/pnas.95.18.10854; Payne AS, 1998, J BIOL CHEM, V273, P3765, DOI 10.1074/jbc.273.6.3765; Petris MJ, 1999, HUM MOL GENET, V8, P2107, DOI 10.1093/hmg/8.11.2107; Petris MJ, 1996, EMBO J, V15, P6084, DOI 10.1002/j.1460-2075.1996.tb00997.x; Petris MJ, 1998, HUM MOL GENET, V7, P2063, DOI 10.1093/hmg/7.13.2063; Petris MJ, 2000, HUM MOL GENET, V9, P2845, DOI 10.1093/hmg/9.19.2845; Sato S, 1996, J BIOL CHEM, V271, P635, DOI 10.1074/jbc.271.2.635; Strausak D, 1999, J BIOL CHEM, V274, P11170, DOI 10.1074/jbc.274.16.11170; Tsivkovskii R, 2001, J BIOL CHEM, V276, P2234, DOI 10.1074/jbc.M003238200; Tumer Z, 1997, AM J HUM GENET, V60, P63; Voskoboinik I, 2001, J BIOL CHEM, V276, P28620, DOI 10.1074/jbc.M103532200; VULPE C, 1993, NAT GENET, V3, P7, DOI 10.1038/ng0193-7; Wang J, 1999, J BIOL CHEM, V274, P12883, DOI 10.1074/jbc.274.18.12883; Yamaguchi Y, 1996, P NATL ACAD SCI USA, V93, P14030, DOI 10.1073/pnas.93.24.14030	31	34	35	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2002	277	46					44079	44084		10.1074/jbc.M208737200	http://dx.doi.org/10.1074/jbc.M208737200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	615XE	12221109	hybrid			2022-12-27	WOS:000179272000071
J	Regelsberger, G; Atzenhofer, W; Ruker, F; Peschek, GA; Jakopitsch, C; Paumann, M; Furtmuller, PG; Obinger, C				Regelsberger, G; Atzenhofer, W; Ruker, F; Peschek, GA; Jakopitsch, C; Paumann, M; Furtmuller, PG; Obinger, C			Biochemical characterization of a membrane-bound manganese-containing superoxide dismutase from the cyanobacterium Anabaena PCC 7120	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLUE-GREEN-ALGAE; CYTOCHROME-C-OXIDASE; ANACYSTIS-NIDULANS; ESCHERICHIA-COLI; PURIFIED PLASMA; PROTEIN; LOCALIZATION; PURIFICATION; CYLINDRICA; RESOLUTION	The filamentous cyanobacterium Anabaena PCC 7120 (now renamed Nostoc PCC 7120) possesses two genes for superoxide dismutase (SOD). One is an iron-containing (FeSOD) whereas the other is a manganese-containing superoxide dismutase (MnSOD). Localization experiments and analysis of the sequence showed that the FeSOD is cytosolic, whereas the MnSOD is a membrane-bound homodimeric protein containing one transmembrane helix, a spacer region, and a soluble catalytic domain. It is localized in both cytoplasmic and thylakoid membranes at the same extent with the catalytic domains positioned either in the periplasm or the thylakoid lumen. A phylogenetic analysis revealed that generally the highly homologous MnSODs of filamentous cyanobacteria are unique in being membrane-bound. Two recombinant variants of Anabaena MnSOD lacking either the hydrophobic region (MnSOD(Delta28)) or the hydrophobic and the linker region (MnSOD(Delta60)) are shown to exhibit the characteristic manganese peak at 480 nm, an almost 100% occupancy of manganese per subunit, a specific activity using the ferricytochrome assay of (660 +/- 90) unit mg(-1) protein and a dissociation constant for the inhibitor azide of (0.84 +/- 0.05) mm. Using stopped-flow spectroscopy it is shown that the decay of superoxide in the presence of various (MnSOD(Delta28)) or (MnSOD(Delta60)) concentrations is first-order in enzyme concentration allowing the calculation of catalytic rate constants which increase with decreasing pH: 8 x 106 M-1 s(-1) (pH 10) and 6 X 10(7) M-1 S-1 (pH 7). The physiological relevance of these findings is discussed with respect to the bioenergetic peculiarities of cyanobacteria.	Univ Agr Sci, Inst Chem, A-1190 Vienna, Austria; Max Planck Inst Biochem, Abt Strukturforsch, D-82152 Martinsried, Germany; Univ Agr Sci, Inst Appl Microbiol, A-1190 Vienna, Austria; Univ Vienna, Inst Phys Chem, Mol Bioenerget Grp, A-1090 Vienna, Austria	University of Natural Resources & Life Sciences, Vienna; Max Planck Society; University of Natural Resources & Life Sciences, Vienna; University of Vienna	Obinger, C (corresponding author), Univ Agr Sci, Inst Chem, Muthgasse 18, A-1190 Vienna, Austria.		Furtmüller, Paul G./Y-5819-2018; Obinger, Christian/AAV-3173-2021	Furtmüller, Paul G./0000-0002-1199-2469; Rueker, Florian/0000-0001-7639-2686; Jakopitsch, Christa/0000-0002-5855-2057; Regelsberger, Gunther/0000-0002-3233-1491; Obinger, Christian/0000-0002-7133-3430				Asada K., 1994, Causes of photooxidative stress and amelioration of defense systems in plants., P77; ASADA K, 1975, J BIOL CHEM, V250, P2801; BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; BORGSTAHL GEO, 1992, CELL, V71, P107, DOI 10.1016/0092-8674(92)90270-M; BULL C, 1985, J AM CHEM SOC, V107, P3295, DOI 10.1021/ja00297a040; BULL C, 1991, J AM CHEM SOC, V113, P4076; CAMPBELL WS, 1995, J BACTERIOL, V177, P964, DOI 10.1128/jb.177.4.964-972.1995; Canini A, 1998, NEW PHYTOL, V139, P247, DOI 10.1046/j.1469-8137.1998.00187.x; CANINI A, 1992, PLANTA, V187, P438, DOI 10.1007/BF00199961; Edwards RA, 1998, J BIOL INORG CHEM, V3, P161, DOI 10.1007/s007750050217; Felsenstein J, 1996, METHOD ENZYMOL, V266, P418; GREGORY EM, 1973, J BACTERIOL, V114, P543, DOI 10.1128/JB.114.2.543-548.1973; GREGORY EM, 1973, J BACTERIOL, V114, P1193, DOI 10.1128/JB.114.3.1193-1197.1973; Hennig L, 1999, BIOTECHNIQUES, V26, P1170, DOI 10.2144/99266bc02; HENRY LEA, 1978, BIOCHEM J, V174, P373, DOI 10.1042/bj1740373; Hsu JL, 1996, J BIOL CHEM, V271, P17687, DOI 10.1074/jbc.271.30.17687; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Johnson E A, 1996, Adv Biochem Eng Biotechnol, V53, P119; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAUDENBACH DE, 1989, MOL GEN GENET, V216, P455, DOI 10.1007/BF00334390; Liu YF, 2000, BBA-GENE STRUCT EXPR, V1491, P248, DOI 10.1016/S0167-4781(00)00022-1; LUDWIG ML, 1991, J MOL BIOL, V219, P335, DOI 10.1016/0022-2836(91)90569-R; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; MITTLER R, 1991, FREE RADICAL RES COM, V12-3, P845, DOI 10.3109/10715769109145866; MOLITOR V, 1987, CURR MICROBIOL, V14, P263, DOI 10.1007/BF01568134; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; OKADA S, 1979, FEBS LETT, V103, P106, DOI 10.1016/0014-5793(79)81260-0; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; PARKER MW, 1988, J MOL BIOL, V199, P649, DOI 10.1016/0022-2836(88)90308-7; Peschek G A, 1984, Subcell Biochem, V10, P85; PESCHEK GA, 1989, BIOCHEMISTRY-US, V28, P3057, DOI 10.1021/bi00433a048; Peschek GA, 1996, BIOCHEM SOC T, V24, P729, DOI 10.1042/bst0240729; PESCHEK GA, 1994, FEMS MICROBIOL LETT, V124, P431, DOI 10.1111/j.1574-6968.1994.tb07320.x; REISS U, 1976, EUR J BIOCHEM, V63, P617, DOI 10.1111/j.1432-1033.1976.tb10266.x; RILEY DP, 1991, ANAL BIOCHEM, V196, P344, DOI 10.1016/0003-2697(91)90476-A; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Shirkey B, 2000, J BACTERIOL, V182, P189, DOI 10.1128/JB.182.1.189-197.2000; STANIER RY, 1971, BACTERIOL REV, V35, P171, DOI 10.1128/MMBR.35.2.171-205.1971; STUDIER WF, 1990, METHOD ENZYMOL, V185, P60, DOI DOI 10.1016/0076-6879(90)85008-C; TYTLER EM, 1984, FEMS MICROBIOL LETT, V23, P239	42	34	35	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	2002	277	46					43615	43622		10.1074/jbc.M207691200	http://dx.doi.org/10.1074/jbc.M207691200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	615XE	12215453	hybrid			2022-12-27	WOS:000179272000012
J	Tahir, TA; Berrin, JG; Flatman, R; Roussel, A; Roepstorff, P; Williamson, G; Juge, N				Tahir, TA; Berrin, JG; Flatman, R; Roussel, A; Roepstorff, P; Williamson, G; Juge, N			Specific characterization of substrate and inhibitor binding sites of a glycosyl hydrolase family 11 xylanase from Aspergillus niger	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-SEQUENCE; BIOSPECIFIC INTERACTION ANALYSIS; SURFACE-PLASMON RESONANCE; HIGH-LEVEL PRODUCTION; 3-DIMENSIONAL STRUCTURE; ENDOXYLANASE INHIBITOR; ENDO-1,4-XYLANASE II; DIRECTED MUTAGENESIS; ENZYME INTERMEDIATE; TRICHODERMA-REESEI	The importance of aromatic and charged residues at the surface of the active site of a family 11 xylanase from Aspergillus niger was evaluated using site-directed mutagenesis. Ten mutant proteins were heterologously produced in Pichia pastoris, and their biochemical properties and kinetic parameters were determined. The specific activity of the Y6A, Y10A, Y89A, Y164A, and W172A mutant enzymes was drastically reduced. The low specific activities of Y6A and Y89A were entirely accounted for by a change in k(cat) and K-m, respectively, whereas the lower values of Y10A, Y164A and W172A were due to a combination of increased K. and decreased k(cat), Tyr(6), Tyr(10), Tyr(89), Tyr(164), and Trp(172) are proposed as substrate-binding residues, a finding consistent with structural sequence alignments of family 11 xylanases and with the three-dimensional structure of the A niger xylanase in complex with the modeled xylobiose. All other variants, D113A, D113N, N117A, E118A, and E118Q, retained full wild-type activity. Only N117A lost its sensitivity to xylanase inhibitor protein I (XIP-1), a protein inhibitor isolated from wheat, and this mutation did not affect the fold of the xylanase as revealed by circular dichroism. The N117A variant showed kinetics, pH stability, hydrolysis products pattern, substrate specificity, and structural properties identical to that of the wild-type xylanase. The loss of inhibition, as measured in activity assays, was due to abolition of the interaction between XIP-1 and the mutant enzyme, as demonstrated by surface plasmon resonance and electrophoretic titration. A close inspection of the three-dimensional structure of A. niger xylanase suggests that the binding site of XIP-1 is located at the conserved "thumb" hairpin loop of family 11 xylanases.	IFR, Norwich NR4 7UA, Norfolk, England; Fac Sci & Tech St Jerome, Inst Mediterraneen Rech Nutr, UMR 1111, INRA, F-13397 Marseille 20, France; CNRS, AFMB, UMR 6098, F-13402 Marseille 20, France; Univ So Denmark, Dept Biochem & Mol Biol, DK-5230 Odense M, Denmark	INRAE; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; University of Southern Denmark	Juge, N (corresponding author), IFR, Norwich Res Pk, Norwich NR4 7UA, Norfolk, England.	nathalie.juge@bbsrc.ac.uk	BERRIN, Jean-Guy/AAF-3107-2021; BERRIN, Jean-Guy/E-1460-2014; Williamson, Gary/AAE-9665-2019	BERRIN, Jean-Guy/0000-0001-7570-3745; Williamson, Gary/0000-0002-5624-6267; Juge, Nathalie/0000-0001-8515-1315; Tahir, Tariq/0000-0002-3992-6877				BAILEY MJ, 1992, J BIOTECHNOL, V23, P257, DOI 10.1016/0168-1656(92)90074-J; BEDFORD MR, 1992, PROGR BIOTECHNOL, V7, P361; Berrin JG, 2000, PROTEIN EXPRES PURIF, V19, P179, DOI 10.1006/prep.2000.1229; BIELY P, 1993, PORT PR R M, V4, P29; BIELY P, 1985, TRENDS BIOTECHNOL, V3, P286, DOI 10.1016/0167-7799(85)90004-6; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CAMPBELL RL, 1993, P 2 TRICEL S TRICH R, P63; CHRISTOPHER JA, 1998, SPOCK MANUAL; Christophersen C, 1997, STARCH-STARKE, V49, P5, DOI 10.1002/star.19970490104; CREGG JM, 1985, MOL CELL BIOL, V5, P3376, DOI 10.1128/MCB.5.12.3376; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; Debyser W, 1997, J AM SOC BREW CHEM, V55, P153; Debyser W, 1999, J CEREAL SCI, V30, P39, DOI 10.1006/jcrs.1999.0272; DEBYSER W, 1998, Patent No. 9849278; Flatman R, 2002, BIOCHEM J, V365, P773, DOI 10.1042/BJ20020168; Fushinobu S, 1998, PROTEIN ENG, V11, P1121, DOI 10.1093/protein/11.12.1121; Gebruers K, 2001, BIOCHEM J, V353, P239, DOI 10.1042/0264-6021:3530239; Gobom J, 1999, J MASS SPECTROM, V34, P105, DOI 10.1002/(SICI)1096-9888(199902)34:2<105::AID-JMS768>3.0.CO;2-4; Goesaert H, 2001, CEREAL CHEM, V78, P453, DOI 10.1094/CCHEM.2001.78.4.453; GRAHAM H, 1992, PROGR BIOTECHNOL, V7, P535; GRANZOW R, 1992, BIO-TECHNOL, V10, P390, DOI 10.1038/nbt0492-390; Gruber K, 1998, BIOCHEMISTRY-US, V37, P13475, DOI 10.1021/bi980864l; Harris GW, 1997, PROTEINS, V29, P77, DOI 10.1002/(SICI)1097-0134(199709)29:1<77::AID-PROT6>3.3.CO;2-K; Havukainen R, 1996, BIOCHEMISTRY-US, V35, P9617, DOI 10.1021/bi953052n; Henrissat B, 1996, BIOCHEM J, V316, P695, DOI 10.1042/bj3160695; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; HENRISSAT B, 1993, BIOCHEM J, V293, P781, DOI 10.1042/bj2930781; HESSING JGM, 1994, CURR GENET, V26, P228, DOI 10.1007/BF00309552; HESSING JGM, 1991, Patent No. 9119782; HESSING M, 2000, Patent No. 0979830; HINNEN A, 1978, P NATL ACAD SCI USA, V75, P1929, DOI 10.1073/pnas.75.4.1929; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Jeffries TW, 1996, CURR OPIN BIOTECH, V7, P337, DOI 10.1016/S0958-1669(96)80041-3; JOHNSSON B, 1991, ANAL BIOCHEM, V198, P268, DOI 10.1016/0003-2697(91)90424-R; JONSSON U, 1991, BIOTECHNIQUES, V11, P620; Joshi MD, 2001, BIOCHEMISTRY-US, V40, P10115, DOI 10.1021/bi0105429; Juge N, 2001, FEMS YEAST RES, V1, P127, DOI 10.1111/j.1567-1364.2001.tb00023.x; Krengel U, 1996, J MOL BIOL, V263, P70, DOI 10.1006/jmbi.1996.0556; Kumar PR, 2000, J MOL BIOL, V295, P581, DOI 10.1006/jmbi.1999.3348; Luttig M, 1997, BIOTECHNOL LETT, V19, P411, DOI 10.1023/A:1018327623422; MAAT J, 1992, PROGR BIOTECHNOL, V7, P349; MCCARTER JD, 1994, CURR OPIN STRUC BIOL, V4, P885, DOI 10.1016/0959-440X(94)90271-2; McCarthy AA, 2000, ACTA CRYSTALLOGR D, V56, P1367, DOI 10.1107/S0907444900009896; McLauchlan WR, 1999, BIOCHEM J, V338, P441, DOI 10.1042/0264-6021:3380441; McLauchlan WR, 2000, VTT SYMP, V207, P55; Muilu J, 1998, PROTEINS, V31, P434; Rouau X, 1998, J CEREAL SCI, V28, P63, DOI 10.1006/jcrs.1997.0180; Roussel A, 1991, SILICON GRAPHICS GEO, P86; Sabini E, 2001, ACTA CRYSTALLOGR D, V57, P1344, DOI 10.1107/S0907444901010873; Sabini E, 1999, CHEM BIOL, V6, P483, DOI 10.1016/S1074-5521(99)80066-0; Sapag A, 2002, J BIOTECHNOL, V95, P109, DOI 10.1016/S0168-1656(02)00002-0; SCHUSTER SC, 1993, NATURE, V365, P343, DOI 10.1038/365343a0; Sidhu G, 1999, BIOCHEMISTRY-US, V38, P5346, DOI 10.1021/bi982946f; TORRONEN A, 1994, EMBO J, V13, P2493, DOI 10.1002/j.1460-2075.1994.tb06536.x; TORRONEN A, 1995, BIOCHEMISTRY-US, V34, P847, DOI 10.1021/bi00003a019; Torronen A, 1997, J BIOTECHNOL, V57, P137, DOI 10.1016/S0168-1656(97)00095-3; Vocadlo DJ, 2001, NATURE, V412, P835, DOI 10.1038/35090602; WAKARCHUK WW, 1994, PROTEIN SCI, V3, P467; WILKINSON AJ, 1983, BIOCHEMISTRY-US, V22, P3581, DOI 10.1021/bi00284a007; Withers SG, 1995, PROGR BIOTECHNOL, V10, P97, DOI 10.1016/S0921-0423(06)80097-3; Wouters J, 2001, ACTA CRYSTALLOGR D, V57, P1813, DOI 10.1107/S0907444901015153	62	62	65	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2002	277	46					44035	44043		10.1074/jbc.M205657200	http://dx.doi.org/10.1074/jbc.M205657200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	615XE	12207016	hybrid			2022-12-27	WOS:000179272000066
J	Zhang, RZ; Sabatelli, P; Pan, TC; Squarzoni, S; Mattioli, E; Bertini, E; Pepe, G; Chu, ML				Zhang, RZ; Sabatelli, P; Pan, TC; Squarzoni, S; Mattioli, E; Bertini, E; Pepe, G; Chu, ML			Effects on collagen VI mRNA stability and microfibrillar assembly of three COL6A2 mutations in two families with Ullrich congenital muscular dystrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VON-WILLEBRAND-FACTOR; BETHLEM MYOPATHY; VONWILLEBRAND-FACTOR; GLOBULAR DOMAINS; ALPHA-3 CHAIN; TRIPLE-HELIX; A-DOMAINS; GENE; PROCOLLAGEN; VARIANTS	We recently reported a severe deficiency in collagen type VI, resulting from recessive mutations of the COMA2 gene, in patients with Ullrich congenital muscular dystrophy. Their parents, who are all carriers of one mutant allele, are unaffected, although heterozygous mutations in collagen VI caused Bethlem myopathy. Here we investigated the consequences of three COMA2 mutations in fibroblasts from patients and their parents in two Ullrich families. All three mutations lead to nonsense-mediated mRNA decay. However, very low levels of undegraded mutant mRNA remained in patient B with compound heterozygous mutations at the distal part of the triple-helical domain, resulting in deposition of abnormal microfibrils that cannot form extensive networks. This observation suggests that the C-terminal globular domain is not essential for triple-helix formation but is critical for microfibrillar assembly. In all parents, the COMA2 mRNA levels are reduced to 57-73% of the control, but long term collagen VI matrix depositions are comparable with that of the control. The almost complete absence of abnormal protein and near-normal accumulation of microfibrils in the parents may account for their lack of myopathic symptoms.	Thomas Jefferson Univ, Dept Dermatol & Cutaneous Biol, Philadelphia, PA 19107 USA; Thomas Jefferson Univ, Dept Mol Pharmacol & Biochem, Philadelphia, PA 19107 USA; IOR, CNR, Inst Normal & Pathol Cytomorphol, I-40136 Bologna, Italy; IOR, Neuromuscular Unit, I-40136 Bologna, Italy; IRCCS, Bambino Gesu Hosp, Dept Neurosci Mol Med, I-00165 Rome, Italy; Univ Florence, Dept Med & Surg Crit Care, I-50134 Florence, Italy	Jefferson University; Jefferson University; Consiglio Nazionale delle Ricerche (CNR); IRCCS Bambino Gesu; University of Florence	Chu, ML (corresponding author), Thomas Jefferson Univ, Dept Dermatol & Cutaneous Biol, 233 S 10th St, Philadelphia, PA 19107 USA.	Mon-Li.Chu@mail.tju.edu	Pepe, Guglielmina/K-8013-2016; Bertini, Enrico/A-2284-2014; Bertini, Enrico/ABG-1278-2020; Squarzoni, Stefano/AAM-9729-2020; Sabatelli, Patrizia/C-7479-2019	Pepe, Guglielmina/0000-0001-9825-6618; Bertini, Enrico/0000-0001-9276-4590; Squarzoni, Stefano/0000-0001-6538-5923; Sabatelli, Patrizia/0000-0003-2345-5094; Mattioli, Elisabetta/0000-0002-1395-1927	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR038912] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR38912] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BACHINGER HP, 1981, J BIOL CHEM, V256, P3193; Ball SG, 2001, J BIOL CHEM, V276, P7422, DOI 10.1074/jbc.M002816200; BETHLEM J, 1976, BRAIN, V99, P91, DOI 10.1093/brain/99.1.91; BRUNS RR, 1986, J CELL BIOL, V103, P393, DOI 10.1083/jcb.103.2.393; Bulleid NJ, 1997, EMBO J, V16, P6694, DOI 10.1093/emboj/16.22.6694; Chen Q, 1999, MOL BIOL CELL, V10, P2149, DOI 10.1091/mbc.10.7.2149; CHENG J, 1990, MOL CELL BIOL, V10, P5502, DOI 10.1128/MCB.10.10.5502; CHU ML, 1990, EMBO J, V9, P385, DOI 10.1002/j.1460-2075.1990.tb08122.x; CHU ML, 1989, EMBO J, V8, P1939, DOI 10.1002/j.1460-2075.1989.tb03598.x; Demir E, 2002, AM J HUM GENET, V70, P1446, DOI 10.1086/340608; DOEGE KJ, 1986, J BIOL CHEM, V261, P8924; Frischmeyer PA, 1999, HUM MOL GENET, V8, P1893, DOI 10.1093/hmg/8.10.1893; FURTHMAYR H, 1983, BIOCHEM J, V211, P303, DOI 10.1042/bj2110303; Hentze MW, 1999, CELL, V96, P307, DOI 10.1016/S0092-8674(00)80542-5; Higuchi I, 2001, ANN NEUROL, V50, P261, DOI 10.1002/ana.1120; Higuchi I, 2001, ANN NEUROL, V49, P544, DOI 10.1002/ana.109; Illidge C, 1998, J BIOL CHEM, V273, P22091, DOI 10.1074/jbc.273.34.22091; Jobsis GJ, 1996, NAT GENET, V14, P113, DOI 10.1038/ng0996-113; Lamande SR, 1999, J BIOL CHEM, V274, P21817, DOI 10.1074/jbc.274.31.21817; Lamande SR, 1998, HUM MOL GENET, V7, P981, DOI 10.1093/hmg/7.6.981; Marks DS, 1999, J BIOL CHEM, V274, P3632, DOI 10.1074/jbc.274.6.3632; Mendell JT, 2001, CELL, V107, P411, DOI 10.1016/S0092-8674(01)00583-9; NONAKA I, 1981, NEUROPEDIATRICS, V12, P197, DOI 10.1055/s-2008-1059651; Pan TC, 1998, HUM MOL GENET, V7, P807, DOI 10.1093/hmg/7.5.807; PELTZ SW, 1993, GENE DEV, V7, P1737, DOI 10.1101/gad.7.9.1737; Pepe G, 1999, BIOCHEM BIOPH RES CO, V258, P802, DOI 10.1006/bbrc.1999.0680; Pepe G, 1999, NEUROMUSCULAR DISORD, V9, P264, DOI 10.1016/S0960-8966(99)00014-0; SAITTA B, 1994, EUR J BIOCHEM, V223, P675, DOI 10.1111/j.1432-1033.1994.tb19040.x; SAITTA B, 1992, J BIOL CHEM, V267, P6188; SAITTA B, 1990, J BIOL CHEM, V265, P6473; Scacheri PC, 2002, NEUROLOGY, V58, P593, DOI 10.1212/WNL.58.4.593; SPECKS U, 1992, EMBO J, V11, P4281, DOI 10.1002/j.1460-2075.1992.tb05527.x; STOKES DG, 1991, J BIOL CHEM, V266, P8626; Timpl R, 1994, EXTRACELLULAR MATRIX, P207, DOI 10.1016/B978-0-12-775170-2.50012-3; Ullrich O, 1930, MONATSSCHR KINDERH, V47, P502; Vanegas OC, 2002, MUSCLE NERVE, V25, P513, DOI 10.1002/mus.10100; Vanegas OC, 2001, P NATL ACAD SCI USA, V98, P7516; Voit T, 1998, BRAIN DEV-JPN, V20, P65, DOI 10.1016/S0387-7604(97)00094-6; WEIL D, 1988, AM J HUM GENET, V42, P435	39	53	54	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2002	277	46					43557	43564		10.1074/jbc.M207696200	http://dx.doi.org/10.1074/jbc.M207696200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	615XE	12218063	hybrid			2022-12-27	WOS:000179272000004
J	Fukuda, M; Kuroda, TS				Fukuda, M; Kuroda, TS			Slac2-c (synaptotagmin-like protein homologue lacking C2 domains-c), a novel linker protein that interacts with Rab27, myosin Va/VIIa, and actin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MELANOSOME TRANSPORT; BINDING DOMAIN; PC12 CELLS; FAMILY; VA; GENE; EFFECTOR; GTPASES; IDENTIFICATION; MELANOCYTES	Slac2-a (synaptotagmin-like protein (Slp) homologue lacking C2 domains-a)/melanophilin is a melanosome-associated protein that links Rab27A on melanosomes with myosin Va, an actin-based motor protein, and formation of the tripartite protein complex (Rab27A(.)Slac2a(.)myosin Va) has been suggested to regulate melanosome transport (Fukuda, M., Kuroda, T. S., and Mikoshiba, K. (2002) J. Biol. Chem. 277, 12432-12436). Here we report the structure of a novel form of Slac2, named Slac2-c, that is homologous to Slac2-a. Slac2-a and Slac2-c exhibit the same overall structure, consisting of a highly conserved N-terminal Slp homology domain (about 50% identity) and a less conserved C-terminal myosin Va-binding domain (about 20% identity). As with other Slac2 members and the Slp family, the Slp homology domain of Slac2-c was found to interact specifically with the GTP-bound form of Rab27A/B both in vitro and in intact cells, and the C-terminal domain of Slac2-c interacted with myosin Va and myosin VIIa. In addition, we discovered that the most C-terminal conserved region of Slac2-a (amino acids 400-590) and Slac2-c (amino acids 670-856), which is not essential for myosin Va binding, directly binds actin and that expression of these regions in PC12 cells and melanoma cells colocalized with actin filaments at the cell periphery, suggesting a novel role of Slac2-a/c in capture of Rab27-containing organelles in the actin-enriched cell periphery.	RIKEN Inst Phys & Chem Res, Fukuda Initiat Res Unit, Wako, Saitama 3510198, Japan	RIKEN	Fukuda, M (corresponding author), RIKEN Inst Phys & Chem Res, Fukuda Initiat Res Unit, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	mnfukuda@brain.riken.go.jp	Fukuda, MItsunori/I-1511-2015	Fukuda, MItsunori/0000-0002-8620-5853; Kuroda, Taruho/0000-0001-6693-4496				Bahadoran P, 2001, J CELL BIOL, V152, P843, DOI 10.1083/jcb.152.4.843; Berkowitz JKM, 2001, J BIOL CHEM, V276, P18855, DOI 10.1074/jbc.M011167200; Bock JB, 2001, NATURE, V409, P839, DOI 10.1038/35057024; Chen D, 1997, BIOCHEM MOL MED, V60, P27, DOI 10.1006/bmme.1996.2559; Echard A, 1998, SCIENCE, V279, P580, DOI 10.1126/science.279.5350.580; El-Amraoui A, 2002, EMBO REP, V3, P463, DOI 10.1093/embo-reports/kvf090; Fukuda M, 2001, J BIOL CHEM, V276, P40319, DOI 10.1074/jbc.M105356200; Fukuda M, 1999, J BIOL CHEM, V274, P31421, DOI 10.1074/jbc.274.44.31421; Fukuda M, 1999, J BIOL CHEM, V274, P31428, DOI 10.1074/jbc.274.44.31428; FUKUDA M, 1994, J BIOL CHEM, V269, P29206; Fukuda M, 2002, J BIOL CHEM, V277, P40118, DOI 10.1074/jbc.M205765200; Fukuda M, 2002, J BIOL CHEM, V277, P39673, DOI 10.1074/jbc.M205349200; Fukuda M, 2002, J BIOL CHEM, V277, P4601, DOI 10.1074/jbc.C100588200; Fukuda M, 2002, J BIOL CHEM, V277, P12432, DOI 10.1074/jbc.C200005200; Fukuda M, 2001, BIOCHEM BIOPH RES CO, V283, P513, DOI 10.1006/bbrc.2001.4803; Fukuda M, 2001, J BIOL CHEM, V276, P27670, DOI 10.1074/jbc.M100851200; Fukuda M, 2001, BIOCHEM BIOPH RES CO, V281, P1226, DOI 10.1006/bbrc.2001.4512; GIBSON F, 1995, NATURE, V374, P62, DOI 10.1038/374062a0; Hales CM, 2001, J BIOL CHEM, V276, P39067, DOI 10.1074/jbc.M104831200; Hammer JA, 2002, CURR OPIN CELL BIOL, V14, P69, DOI 10.1016/S0955-0674(01)00296-4; Huang JD, 1998, GENETICS, V148, P1963; Hume AN, 2002, TRAFFIC, V3, P193, DOI 10.1034/j.1600-0854.2002.030305.x; Hume AN, 2001, J CELL BIOL, V152, P795, DOI 10.1083/jcb.152.4.795; Ibata K, 2000, J NEUROCHEM, V74, P518, DOI 10.1046/j.1471-4159.2000.740518.x; Ishikawa K, 1998, DNA Res, V5, P169, DOI 10.1093/dnares/5.3.169; Kuroda TS, 2002, BIOCHEM BIOPH RES CO, V293, P899, DOI 10.1016/S0006-291X(02)00320-0; Kuroda TS, 2002, J BIOL CHEM, V277, P9212, DOI 10.1074/jbc.M112414200; Lapierre LA, 2001, MOL BIOL CELL, V12, P1843, DOI 10.1091/mbc.12.6.1843; Lindsay AJ, 2002, J BIOL CHEM, V277, P12190, DOI 10.1074/jbc.M108665200; Matesic LE, 2001, P NATL ACAD SCI USA, V98, P10238, DOI 10.1073/pnas.181336698; Menasche G, 2000, NAT GENET, V25, P173, DOI 10.1038/76024; MERCER JA, 1991, NATURE, V349, P709, DOI 10.1038/349709a0; Miyata M, 2000, NEURON, V28, P233, DOI 10.1016/S0896-6273(00)00099-4; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Ostermeier C, 1999, CELL, V96, P363, DOI 10.1016/S0092-8674(00)80549-8; Pastural E, 1997, NAT GENET, V16, P289, DOI 10.1038/ng0797-289; Pereira-Leal JB, 2001, J MOL BIOL, V313, P889, DOI 10.1006/jmbi.2001.5072; Pereira-Leal JB, 2000, J MOL BIOL, V301, P1077, DOI 10.1006/jmbi.2000.4010; Perelroizen I, 1996, J BIOL CHEM, V271, P12302, DOI 10.1074/jbc.271.21.12302; Pfeffer SR, 2001, TRENDS CELL BIOL, V11, P487, DOI 10.1016/S0962-8924(01)02147-X; Prekeris R, 2001, J BIOL CHEM, V276, P38966, DOI 10.1074/jbc.M106133200; Provance DW, 2002, TRAFFIC, V3, P124, DOI 10.1034/j.1600-0854.2002.030205.x; Ramalho JS, 2001, BMC GENET, V2, DOI 10.1186/1471-2156-2-2; Reck-Peterson SL, 2000, BBA-MOL CELL RES, V1496, P36, DOI 10.1016/S0167-4889(00)00007-0; Rodriguez OC, 2002, J CELL SCI, V115, P991; Schott D, 1999, J CELL BIOL, V147, P791, DOI 10.1083/jcb.147.4.791; Seabra MC, 2002, TRENDS MOL MED, V8, P23, DOI 10.1016/S1471-4914(01)02227-4; Segev N, 2001, CURR OPIN CELL BIOL, V13, P500, DOI 10.1016/S0955-0674(00)00242-8; Sellers JR, 2000, BBA-MOL CELL RES, V1496, P3, DOI 10.1016/S0167-4889(00)00005-7; SEPERACK PK, 1995, EMBO J, V14, P2326, DOI 10.1002/j.1460-2075.1995.tb07227.x; Strom M, 2002, J BIOL CHEM, V277, P25423, DOI 10.1074/jbc.M202574200; Tabb JS, 1998, J CELL SCI, V111, P3221; Takagishi Y, 1996, NEUROSCI LETT, V215, P169, DOI 10.1016/S0304-3940(96)12967-0; Wang J, 1999, J BIOL CHEM, V274, P28542, DOI 10.1074/jbc.274.40.28542; Wilson SM, 2000, P NATL ACAD SCI USA, V97, P7933, DOI 10.1073/pnas.140212797; Wu XFS, 2002, NAT CELL BIOL, V4, P271, DOI 10.1038/ncb760; Yi Z, 2002, MOL CELL BIOL, V22, P1858, DOI 10.1128/MCB.22.6.1858-1867.2002; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhang XD, 2002, NEURON, V34, P599, DOI 10.1016/S0896-6273(02)00671-2; Zhao LP, 1996, P NATL ACAD SCI USA, V93, P10826, DOI 10.1073/pnas.93.20.10826; Zhao SL, 2002, ENDOCRINOLOGY, V143, P1817, DOI 10.1210/en.143.5.1817	61	131	140	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					43096	43103		10.1074/jbc.M203862200	http://dx.doi.org/10.1074/jbc.M203862200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12221080	hybrid			2022-12-27	WOS:000179081200088
J	Karni, R; Dor, Y; Keshet, E; Meyuhas, O; Levitzki, A				Karni, R; Dor, Y; Keshet, E; Meyuhas, O; Levitzki, A			Activated pp60(c-Src) leads to elevated hypoxia-inducible factor (HIF)-1 alpha expression under normoxia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; FACTOR 1-ALPHA HIF-1-ALPHA; TYROSINE KINASE INHIBITOR; TUMOR-SUPPRESSOR PROTEIN; C-SRC; FACTOR-I; MESSENGER-RNA; CELL-LINE; INDUCTION; HIF-1	Hypoxia-inducible factor (HIF)-1 is a master transcription factor, which up-regulates glycolysis, erythropoiesis, and angiogenesis under hypoxia. HIF-1alpha accumulates in normoxic tumor cells, leading to glycolysis under aerobic conditions. This phenomenon, known as the "Warburg effect," is caused by a yet unknown mechanism. Here we show that transformed cells that express constitutively active pp60(c-Src) (Src) express HIF-1alpha protein under normoxia, which results in the expression of multiple HIF-1alpha target genes. We show that this occurrence is due to an enhanced rate of HIF-1alpha protein synthesis and not due to reduced HIF-1alpha degradation. Furthermore, we show that the Src-induced increase in protein synthesis is due to the global increase in the rate of cap-dependent translation and does not involve inhibition of HIF-1alpha degradation.	Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel; Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Biol Mol, IL-91120 Jerusalem, Israel; Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Biochem, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem	Levitzki, A (corresponding author), Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel.		Dor, Yuval/C-2405-2011; Keshet, Eli/GQR-0445-2022					CARROLL RC, 1978, P NATL ACAD SCI USA, V75, P5015, DOI 10.1073/pnas.75.10.5015; Chen CH, 2001, J BIOL CHEM, V276, P9519, DOI 10.1074/jbc.M010144200; Cockman ME, 2000, J BIOL CHEM, V275, P25733, DOI 10.1074/jbc.M002740200; Conrad PW, 1999, J BIOL CHEM, V274, P33709, DOI 10.1074/jbc.274.47.33709; Dang CV, 1999, TRENDS BIOCHEM SCI, V24, P68, DOI 10.1016/S0968-0004(98)01344-9; Ellis LM, 1998, J BIOL CHEM, V273, P1052, DOI 10.1074/jbc.273.2.1052; Feldser D, 1999, CANCER RES, V59, P3915; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; Gleadle JM, 1997, BLOOD, V89, P503, DOI 10.1182/blood.V89.2.503; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Jiang BH, 1997, CANCER RES, V57, P5328; Krystal GW, 1998, CANCER RES, V58, P4660; Laughner E, 2001, MOL CELL BIOL, V21, P3995, DOI 10.1128/MCB.21.12.3995-4004.2001; LEE J, 1989, EMBO J, V8, P167, DOI 10.1002/j.1460-2075.1989.tb03361.x; Li SL, 1996, CELL BIOL INT, V20, P723; Mao WG, 1997, ONCOGENE, V15, P3083, DOI 10.1038/sj.onc.1201496; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Mazure NM, 1997, BLOOD, V90, P3322, DOI 10.1182/blood.V90.9.3322; MUKHOPADHYAY D, 1995, NATURE, V375, P577, DOI 10.1038/375577a0; OSHEROV N, 1994, EUR J BIOCHEM, V225, P1047, DOI 10.1111/j.1432-1033.1994.1047b.x; Raught B, 1999, INT J BIOCHEM CELL B, V31, P43, DOI 10.1016/S1357-2725(98)00131-9; Richard DE, 2000, J BIOL CHEM, V275, P26765; Richard DE, 1999, J BIOL CHEM, V274, P32631, DOI 10.1074/jbc.274.46.32631; Salceda S, 1997, J BIOL CHEM, V272, P22642, DOI 10.1074/jbc.272.36.22642; Sanna PP, 2000, P NATL ACAD SCI USA, V97, P8653, DOI 10.1073/pnas.140219097; Schindler T, 1999, MOL CELL, V3, P639, DOI 10.1016/S1097-2765(00)80357-3; Seagroves TN, 2001, MOL CELL BIOL, V21, P3436, DOI 10.1128/MCB.21.10.3436-3444.2001; Seko Y, 1996, BIOCHEM BIOPH RES CO, V226, P530, DOI 10.1006/bbrc.1996.1389; Semenza GL, 2001, CELL, V107, P1, DOI 10.1016/S0092-8674(01)00518-9; Verbeek BS, 1996, J PATHOL, V180, P383, DOI 10.1002/(SICI)1096-9896(199612)180:4<383::AID-PATH686>3.0.CO;2-N; Xing XM, 2000, NAT MED, V6, P189, DOI 10.1038/72294; Zelzer E, 1998, EMBO J, V17, P5085, DOI 10.1093/emboj/17.17.5085; Zhong H, 1999, CANCER RES, V59, P5830	35	93	96	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					42919	42925		10.1074/jbc.M206141200	http://dx.doi.org/10.1074/jbc.M206141200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12200433	hybrid			2022-12-27	WOS:000179081200065
J	Li, ZY; Wang, CC				Li, ZY; Wang, CC			Functional characterization of the 11 Non-ATPase subunit proteins in the trypanosome 19 S proteasomal regulatory Complex*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIUBIQUITIN-CHAIN-BINDING; YEAST SACCHAROMYCES-CEREVISIAE; 26S PROTEASOME; CELL-CYCLE; GENE-EXPRESSION; MITOCHONDRIAL-DNA; RNA INTERFERENCE; BRUCEI; TRANSCRIPTION; PROTEOLYSIS	The ubiquitin-proteasome pathway is responsible for selective degradation of short-lived and dysfunctional proteins in eukaryotes. The recently demonstrated presence of a functional 26 S proteasome in Trypanosoma brucei led to the identification and isolation of genes encoding all 11 non-ATPase (Rpn) subunit proteins in the trypanosome 19 S regulatory complex. Using the technique of RNA interference, expression of individual RPN genes was disrupted in the procyclic form of T. brucei, resulting, in each case, in intracellular accumulation of polyubiquitinated protein, cell arrest at the G(2)/M phase, and eventual cell death. With the exception of Rpn10, depletion of individual Rpn proteins disrupted also trypanosome 19 S complex formation, with the complex virtually depleted in the cell lysate. This functional and structural essentiality of 10 of the 11 Rpn proteins in T. brucei differs significantly from that observed in other organisms. When Rpn10 was deficient in trypanosomes, a 19 S complex without Rpn10 was still formed, whereas cell growth was arrested. This structural dispensability but functional indispensability of Rpn10 may constitute another unique aspect of the proteasomes in T. brucei.	Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Wang, CC (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, 513 Parnassus Ave, San Francisco, CA 94143 USA.			Li, Ziyin/0000-0002-3960-9716	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI021786] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI-21786, R01 AI021786] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bailly E, 1999, MOL CELL BIOL, V19, P6872; Bech-Otschir D, 2002, J CELL SCI, V115, P467; BERBEROF M, 1995, EMBO J, V14, P2925, DOI 10.1002/j.1460-2075.1995.tb07292.x; BURNS N, 1994, GENE DEV, V8, P1087, DOI 10.1101/gad.8.9.1087; CAMPBELL DA, 1984, NATURE, V311, P350, DOI 10.1038/311350a0; Chen L, 2002, MOL CELL BIOL, V22, P4902, DOI 10.1128/MCB.22.13.4902-4913.2002; Ferrell K, 2000, TRENDS BIOCHEM SCI, V25, P83, DOI 10.1016/S0968-0004(99)01529-7; Fu HY, 2001, EMBO J, V20, P7096, DOI 10.1093/emboj/20.24.7096; Fu HY, 1998, J BIOL CHEM, V273, P1970, DOI 10.1074/jbc.273.4.1970; Fujimuro M, 1998, FEBS LETT, V423, P149, DOI 10.1016/S0014-5793(98)00084-2; GHISLAIN M, 1993, NATURE, V366, P358, DOI 10.1038/366358a0; Girod PA, 1999, PLANT CELL, V11, P1457; Glickman MH, 1998, MOL CELL BIOL, V18, P3149, DOI 10.1128/MCB.18.6.3149; Glickman MH, 1998, CELL, V94, P615, DOI 10.1016/S0092-8674(00)81603-7; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Haracska L, 1997, FEBS LETT, V412, P331, DOI 10.1016/S0014-5793(97)00808-9; Henke W, 1999, MOL BIOL REP, V26, P29, DOI 10.1023/A:1006991419464; Hofmann K, 1998, TRENDS BIOCHEM SCI, V23, P204, DOI 10.1016/S0968-0004(98)01217-1; Hua SB, 1996, MOL BIOCHEM PARASIT, V78, P33, DOI 10.1016/S0166-6851(96)02599-6; Huang L, 2001, J BIOL CHEM, V276, P28327, DOI 10.1074/jbc.M008342200; Kapelari B, 2000, J MOL BIOL, V300, P1169, DOI 10.1006/jmbi.2000.3912; Kawamura M, 1996, MOL GEN GENET, V251, P146; Kim TH, 2001, TRENDS PLANT SCI, V6, P379, DOI 10.1016/S1360-1385(01)02015-5; Koepp DM, 1999, CELL, V97, P431, DOI 10.1016/S0092-8674(00)80753-9; KOMINAMI K, 1995, EMBO J, V14, P3105, DOI 10.1002/j.1460-2075.1995.tb07313.x; Kominami K, 1997, MOL BIOL CELL, V8, P171, DOI 10.1091/mbc.8.1.171; Lam YA, 2002, NATURE, V416, P763, DOI 10.1038/416763a; Lambertson D, 1999, GENETICS, V153, P69; Li ZY, 2002, J BIOL CHEM, V277, P15486, DOI 10.1074/jbc.M109029200; Lupas A, 1997, TRENDS BIOCHEM SCI, V22, P195, DOI 10.1016/S0968-0004(97)01058-X; Mannhaupt G, 1999, FEBS LETT, V450, P27, DOI 10.1016/S0014-5793(99)00467-6; Monaco JJ, 1995, ANNU REV GENET, V29, P729, DOI 10.1146/annurev.ge.29.120195.003501; Mutomba MC, 1997, MOL BIOCHEM PARASIT, V90, P491, DOI 10.1016/S0166-6851(97)00197-7; Pamer E, 1998, ANNU REV IMMUNOL, V16, P323, DOI 10.1146/annurev.immunol.16.1.323; Preckel T, 1999, SCIENCE, V286, P2162, DOI 10.1126/science.286.5447.2162; Rinaldi T, 1998, MOL BIOL CELL, V9, P2917, DOI 10.1091/mbc.9.10.2917; Rubin DM, 1998, EMBO J, V17, P4909, DOI 10.1093/emboj/17.17.4909; Saeki Y, 2002, BIOCHEM BIOPH RES CO, V293, P986, DOI 10.1016/S0006-291X(02)00340-6; Shi HF, 2000, RNA, V6, P1069, DOI 10.1017/S1355838200000297; SHIMANUKI M, 1995, J CELL SCI, V108, P569; SOGIN ML, 1989, SCIENCE, V243, P75, DOI 10.1126/science.2911720; Takeuchi J, 1999, MOL CELL BIOL, V19, P6575; Takeuchi J, 2001, BIOCHIMIE, V83, P333, DOI 10.1016/S0300-9084(01)01238-X; To WY, 1997, FEBS LETT, V404, P253, DOI 10.1016/S0014-5793(97)00116-6; vanNocker S, 1996, MOL CELL BIOL, V16, P6020; vanNocker S, 1996, P NATL ACAD SCI USA, V93, P856, DOI 10.1073/pnas.93.2.856; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; Wang ZF, 2001, EMBO J, V20, P4674, DOI 10.1093/emboj/20.17.4674; Wang ZF, 2000, J BIOL CHEM, V275, P40174, DOI 10.1074/jbc.M008405200; Wilkinson CRM, 2000, J BIOL CHEM, V275, P15182, DOI 10.1074/jbc.275.20.15182; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Xie YM, 2001, P NATL ACAD SCI USA, V98, P3056, DOI 10.1073/pnas.071022298; Young P, 1998, J BIOL CHEM, V273, P5461, DOI 10.1074/jbc.273.10.5461	54	43	45	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					42686	42693		10.1074/jbc.M207183200	http://dx.doi.org/10.1074/jbc.M207183200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12213827	hybrid			2022-12-27	WOS:000179081200034
J	Cybulsky, AV; Takano, T; Papillon, J; Khadir, A; Liu, JH; Peng, HW				Cybulsky, AV; Takano, T; Papillon, J; Khadir, A; Liu, JH; Peng, HW			Complement C5b-9 membrane attack complex increases expression of endoplasmic reticulum stress proteins in glomerular epithelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOSOLIC PHOSPHOLIPASE A(2); PASSIVE HEYMANN NEPHRITIS; SIGNAL-TRANSDUCTION; PLASMA-MEMBRANE; NUCLEATED CELLS; ACTIVATION; NEPHROPATHY; INJURY; DEATH; RATS	In the passive Heymann nephritis (PHN) model of membranous nephropathy, complement C5b-9 induces glomerular epithelial cell (GEC) injury, proteinuria, and activation of cytosolic phospholipase A(2) (cPLA(2)). This study addresses the role of endoplasmic reticulum (ER) stress proteins (bip, grp94) in GEC injury. GEC that overexpress cPLA(2) (produced by transfection) and "neo" GEC (which expresses cPLA(2) at a lower level) were incubated with complement (40 min), and leakage of constitutively expressed bip and grp94 from ER into cytosol was measured to monitor ER injury. Greater leakage of bip and grp94 occurred in complement-treated GEC that overexpress cPLA(2), as compared with neo, implying that cPLA(2) activation perturbed ER membrane integrity. After chronic incubation (4-24 h), C5b-9 increased bip and grp94 mRNAs and proteins, and the increases were dependent on cPLA(2). Expression of bip-antisense mRNA reduced stimulated bip protein expression and enhanced complement-dependent GEC injury. Glomerular hip and grp94 proteins were up-regulated in proteinuric rats with PHN, as compared with normal control. Pretreatment of rats with tunicamycin or adriamycin, which increase ER stress protein expression, reduced proteinuria in PHN. Thus, C5b-9 injures the ER and enhances ER stress protein expression, in part, via activation of cPLA(2). ER stress protein induction is a novel mechanism of protection from complement attack.	McGill Univ, Dept Med, Ctr Hlth, Montreal, PQ H3A 1A1, Canada; McGill Univ, Dept Physiol, Montreal, PQ H3A 1A1, Canada	McGill University; McGill University	Cybulsky, AV (corresponding author), Royal Victoria Hosp, Div Nephrol, 687 Pine Ave W, Montreal, PQ H3A 1A1, Canada.	andrey.cybulsky@mcgill.ca	Cybulsky, Andrey V./AAG-8238-2020	Cybulsky, Andrey V./0000-0003-4348-2348				BAKER PJ, 1989, AM J PATHOL, V135, P185; Balsinde J, 1996, J BIOL CHEM, V271, P6758, DOI 10.1074/jbc.271.12.6758; Bonventre JV, 1997, NATURE, V390, P622, DOI 10.1038/37635; Bush KT, 1999, AM J PHYSIOL-RENAL, V277, pF211, DOI 10.1152/ajprenal.1999.277.2.F211; Choukroun GJ, 2000, J CLIN INVEST, V106, P983, DOI 10.1172/JCI8914; CYBULSKY AV, 1986, J CLIN INVEST, V77, P1096, DOI 10.1172/JCI112408; CYBULSKY AV, 1986, J IMMUNOL, V137, P1511; CYBULSKY AV, 1987, AM J PATHOL, V128, P45; Cybulsky AV, 2000, KIDNEY INT, V57, P1052, DOI 10.1046/j.1523-1755.2000.00932.x; CYBULSKY AV, 1995, AM J PHYSIOL-RENAL, V269, pF739, DOI 10.1152/ajprenal.1995.269.5.F739; Cybulsky AV, 1998, KIDNEY INT, V54, P360, DOI 10.1046/j.1523-1755.1998.00013.x; Cybulsky AV, 1999, AM J PATHOL, V155, P1701, DOI 10.1016/S0002-9440(10)65485-5; CYBULSKY AV, 2000, KIDNEY PHYSL PATHOPH, P2645; Dessen A, 2000, BBA-MOL CELL BIOL L, V1488, P40, DOI 10.1016/S1388-1981(00)00108-6; GOLBETZ H, 1989, AM J PHYSIOL, V256, pF44, DOI 10.1152/ajprenal.1989.256.1.F44; GROND J, 1984, LAB INVEST, V51, P277; HALPERIN JA, 1993, J CLIN INVEST, V91, P1974, DOI 10.1172/JCI116418; Hirabayashi T, 2000, BBA-MOL CELL BIOL L, V1488, P124, DOI 10.1016/S1388-1981(00)00115-3; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; KERJASCHKI D, 1989, J IMMUNOL, V143, P546; Kilgore KS, 1997, AM J PATHOL, V150, P2019; KIRSCHENBAUM MA, 1985, PROSTAGLANDINS, V30, P295, DOI 10.1016/0090-6980(85)90192-3; Kopito RR, 1997, CELL, V88, P427, DOI 10.1016/S0092-8674(00)81881-4; LEE A S, 1992, Current Opinion in Cell Biology, V4, P267, DOI 10.1016/0955-0674(92)90042-B; LI LJ, 1992, J CELL PHYSIOL, V153, P575, DOI 10.1002/jcp.1041530319; Liu H, 1997, J BIOL CHEM, V272, P21751, DOI 10.1074/jbc.272.35.21751; Liu JH, 2001, BIOCHEM J, V353, P79, DOI 10.1042/bj3530079; Ma YJ, 2001, CELL, V107, P827, DOI 10.1016/S0092-8674(01)00623-7; MORGAN BP, 1992, CURR TOP MICROBIOL, V178, P115; Nagao T, 1996, EUR J PHARMACOL, V316, P73, DOI 10.1016/S0014-2999(96)00662-0; NICHOLSONWELLER A, 1993, IMMUNOL RES, V12, P244, DOI 10.1007/BF02918256; NICULESCU F, 1994, J BIOL CHEM, V269, P4417; Niculescu F, 1997, J IMMUNOL, V158, P4405; Pahl HL, 1999, PHYSIOL REV, V79, P683, DOI 10.1152/physrev.1999.79.3.683; Panesar M, 1997, J IMMUNOL, V159, P3584; PAPADIMITRIOU JC, 1994, CELL CALCIUM, V15, P217, DOI 10.1016/0143-4160(94)90061-2; PAPADIMITRIOU JC, 1991, J IMMUNOL, V147, P212; PAPADIMITRIOU JC, 1994, VIRCHOWS ARCH, V424, P677, DOI 10.1007/BF01069750; PRUCHNO CJ, 1991, AM J PATHOL, V138, P203; QUIGG RJ, 1988, KIDNEY INT, V34, P43, DOI 10.1038/ki.1988.143; Rao RV, 2001, J BIOL CHEM, V276, P33869, DOI 10.1074/jbc.M102225200; Rus HG, 1996, J IMMUNOL, V156, P4892; SALANT DJ, 1988, METHOD ENZYMOL, V162, P421; Samstein B, 2001, J AM SOC NEPHROL, V12, P182, DOI 10.1681/ASN.V121182; Shankland SJ, 1999, KIDNEY INT, V56, P538, DOI 10.1046/j.1523-1755.1999.00560.x; Takano T, 2000, AM J PATHOL, V156, P2091, DOI 10.1016/S0002-9440(10)65080-8; Tisher CC, 2000, J AM SOC NEPHROL, V11, P183; Topham PS, 1999, KIDNEY INT, V55, P1763, DOI 10.1046/j.1523-1755.1999.00407.x; WEISE WJ, 1993, KIDNEY INT, V43, P359, DOI 10.1038/ki.1993.54; Yedgar S, 2000, BBA-MOL CELL BIOL L, V1488, P182, DOI 10.1016/S1388-1981(00)00120-7; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982; ZOJA C, 1987, KIDNEY INT, V31, P1335, DOI 10.1038/ki.1987.147	52	98	109	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					41342	41351		10.1074/jbc.M204694200	http://dx.doi.org/10.1074/jbc.M204694200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12191998	hybrid			2022-12-27	WOS:000178985300009
J	Xiao, BL; Masumiya, H; Jiang, DW; Wang, RW; Sei, Y; Zhang, L; Murayama, T; Ogawa, Y; Lai, FA; Wagenknecht, T; Chen, SRW				Xiao, BL; Masumiya, H; Jiang, DW; Wang, RW; Sei, Y; Zhang, L; Murayama, T; Ogawa, Y; Lai, FA; Wagenknecht, T; Chen, SRW			Isoform-dependent formation of heteromeric Ca2+ release channels (ryanodine receptors)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCLE SARCOPLASMIC-RETICULUM; VASCULAR SMOOTH-MUSCLE; SKELETAL-MUSCLE; MOLECULAR-IDENTIFICATION; TYPE-3; COMPLEX; CELLS; RYR3; PURIFICATION; MYOCYTES	Three ryanodine receptor (RyR) isoforms, RyR1, RyR2, and RyR3, are expressed in mammalian tissues. It is unclear whether RyR isoforms are capable of forming heteromeric channels. To investigate their ability to form heteromeric channels, we co-expressed different RyR isoforms in HEK293 cells and examined their interactions biochemically and functionally. Immunoprecipitation studies revealed that RyR2 is able to interact physically with RyR3 and RyR1 in HEK293 cells and that RyR1 does not interact with RyR3. Co-expression of a ryanodine binding deficient mutant of RyR2, RyR2 (14827T), with RyR3 (wt) restored [H-3]ryanodine binding to the mutant. Interactions between RyR isoforms were further assessed by complementation analysis using mutants RyR2 (14827T), RyR2 (E3987A), RyR3 (14732T), RyR3 (E3885A), and RyR1 (E4032A), all of which are deficient in caffeine response. Caffeine-induced Ca2+ release was restored in HEK293 cells co-transfected with mutants RyR2 (14827T) and RyR3 (E3885A), RyR2 (E3987A) and RyR3 (14732T), or RyR2 (14827T) and RyR1 (E4032A), but not with RyR1 (E4032A) and RyR3 (14732T), indicating that mutants of RyR2 and RyR,3, or RyR2 and RyR1, but not RyR1 and RyR3, are able to complement each other. Co-expression of RyR3 (wt) and a pore mutant of RyR2, RyR2 (G4824A), produced regulatable single channels with intermediate unitary conductances. These observations demonstrate that RyR2 is capable of forming functional heteromeric channels with RyR,3 and RyR1, whereas RyR1 is incapable of forming heteromeric channels with RyR3.	Univ Calgary, Dept Physiol & Biophys, Cardiovasc Res Grp, Calgary, AB T2N 4N1, Canada; Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada; New York State Dept Hlth, Wadsworth Ctr Labs & Res, Albany, NY 12201 USA; Univ Wales Coll Med, Wales Heart Res Inst, Dept Cardiol, Cardiff CF14 4XN, S Glam, Wales; Juntendo Univ, Sch Med, Dept Pharmacol, Tokyo 1138421, Japan; Uniformed Serv Univ Hlth Sci, Dept Anesthesiol, Bethesda, MD 20814 USA	University of Calgary; University of Calgary; State University of New York (SUNY) System; Wadsworth Center; Cardiff University; Juntendo University; Uniformed Services University of the Health Sciences - USA	Chen, SRW (corresponding author), Univ Calgary, Dept Physiol & Biophys, Cardiovasc Res Grp, Calgary, AB T2N 4N1, Canada.		Xiao, Bailong/B-6187-2012	Lai, Tony/0000-0003-2852-8547	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040615] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR40615] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Chen SRW, 1998, J BIOL CHEM, V273, P14675, DOI 10.1074/jbc.273.24.14675; Chen SRW, 1997, J BIOL CHEM, V272, P24234, DOI 10.1074/jbc.272.39.24234; CHEN SRW, 1993, J BIOL CHEM, V268, P22642; Coussin F, 2000, J BIOL CHEM, V275, P9596, DOI 10.1074/jbc.275.13.9596; Flucher BE, 1999, J CELL BIOL, V146, P621, DOI 10.1083/jcb.146.3.621; FranziniArmstrong C, 1997, PHYSIOL REV, V77, P699, DOI 10.1152/physrev.1997.77.3.699; GIANNINI G, 1995, J CELL BIOL, V128, P893, DOI 10.1083/jcb.128.5.893; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hosoi E, 2001, J IMMUNOL, V167, P4887, DOI 10.4049/jimmunol.167.9.4887; Jeyakumar LH, 1998, J BIOL CHEM, V273, P16011, DOI 10.1074/jbc.273.26.16011; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAI FA, 1989, J BIOL CHEM, V264, P16776; Li P, 2001, J GEN PHYSIOL, V118, P33, DOI 10.1085/jgp.118.1.33; Liu Z, 2001, P NATL ACAD SCI USA, V98, P6104, DOI 10.1073/pnas.111382798; Lohn M, 2001, CIRC RES, V89, P1051, DOI 10.1161/hh2301.100250; Lynch PJ, 1999, P NATL ACAD SCI USA, V96, P4164, DOI 10.1073/pnas.96.7.4164; Mironneau J, 2002, J PHYSIOL-LONDON, V538, P707, DOI 10.1113/jphysiol.2001.013046; Mironneau J, 2001, J BIOL CHEM, V276, P11257, DOI 10.1074/jbc.M005994200; MONKAWA T, 1995, J BIOL CHEM, V270, P14700, DOI 10.1074/jbc.270.24.14700; Murayama T, 1997, J BIOL CHEM, V272, P24030, DOI 10.1074/jbc.272.38.24030; Murayama T, 1996, J BIOL CHEM, V271, P5079; MURAYAMA T, 1992, J BIOCHEM, V112, P514, DOI 10.1093/oxfordjournals.jbchem.a123931; Murayama T, 2001, J BIOL CHEM, V276, P2953, DOI 10.1074/jbc.M005809200; NEYLON CB, 1995, BIOCHEM BIOPH RES CO, V215, P814, DOI 10.1006/bbrc.1995.2536; O'Brien JJ, 2002, BIOPHYS J, V82, P2428, DOI 10.1016/S0006-3495(02)75586-0; Ogawa Y, 1999, ADV BIOPHYS, V36, P27, DOI 10.1016/S0065-227X(99)80004-5; Sambrook J., 2002, MOL CLONING LAB MANU; Sutko JL, 1996, PHYSIOL REV, V76, P1027, DOI 10.1152/physrev.1996.76.4.1027; Tanna B, 1998, J GEN PHYSIOL, V112, P55, DOI 10.1085/jgp.112.1.55; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WOJCIKIEWICZ RJH, 1995, BIOCHEM BIOPH RES CO, V213, P334, DOI 10.1006/bbrc.1995.2134; Zhao MC, 1999, J BIOL CHEM, V274, P25971, DOI 10.1074/jbc.274.37.25971	34	32	35	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					41778	41785		10.1074/jbc.M208210200	http://dx.doi.org/10.1074/jbc.M208210200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12213830	hybrid			2022-12-27	WOS:000178985300062
J	Battaglioli, E; Andres, ME; Rose, DW; Chenoweth, JG; Rosenfeld, MG; Anderson, ME; Mandel, G				Battaglioli, E; Andres, ME; Rose, DW; Chenoweth, JG; Rosenfeld, MG; Anderson, ME; Mandel, G			REST repression of neuronal genes requires components of the hSWI-SNF complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESTRICTIVE SILENCER FACTOR; CHROMATIN-REMODELING COMPLEXES; HISTONE DEACETYLASE COMPLEX; TRANSCRIPTIONAL REPRESSION; TARGET GENES; SANT DOMAIN; CELL-CYCLE; SWI-SNF; IN-VIVO; N-COR	A function of the transcription factor REST is to block the expression of neuronal phenotypic traits in non-neuronal cells. Previous studies have shown that REST-mediated repression requires histone deacetylase activity and that recruitment of deacetylases is mediated by two co-repressors, Sin3A and CoREST. In this study, we show that a repressor domain in CoREST interacts with BRG1-associated factor (BAF) 57, a component of the hSWI-SNF complex. In vivo, BAF57 occupies the neuronal sodium channel gene (Nav1.2) promoter, and targeting to this gene requires REST. In addition to BAF57, the ATPase BRG1 and BAF170, other members of the hSWI-SNF complex, are also present in the REST-CoREST repressor complex. Microinjection of specific antibodies against BRG1, BAF57, or BAF170 into Rat1 fibroblasts relieves repression of REI reporter genes. Together, our data suggest that ATP-dependent chromatin remodeling, as well as histone deacetylation, is needed for REST-mediated repression.	SUNY Stony Brook, Howard Hughes Med Inst, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA; Univ Calif San Diego, Howard Hughes Med Inst, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Div Endocrinol & Metab, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego	Mandel, G (corresponding author), SUNY Stony Brook, Howard Hughes Med Inst, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA.		battaglioli, elena/H-9350-2017	Battaglioli, Elena/0000-0001-9168-7212	NIDDK NIH HHS [DK 54802] Funding Source: Medline; NINDS NIH HHS [NS 22518] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054802] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS022518] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aasland R, 1996, TRENDS BIOCHEM SCI, V21, P87, DOI 10.1016/S0968-0004(96)30009-1; Andres ME, 1999, P NATL ACAD SCI USA, V96, P9873, DOI 10.1073/pnas.96.17.9873; Ballas N, 2001, NEURON, V31, P353, DOI 10.1016/S0896-6273(01)00371-3; Chen ZF, 1998, NAT GENET, V20, P136, DOI 10.1038/2431; Cheung P, 2000, CELL, V103, P263, DOI 10.1016/S0092-8674(00)00118-5; Chi TH, 2002, NATURE, V418, P195, DOI 10.1038/nature00876; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; Corona DFV, 2002, EMBO REP, V3, P242, DOI 10.1093/embo-reports/kvf056; Grimes JA, 2000, J BIOL CHEM, V275, P9461, DOI 10.1074/jbc.275.13.9461; Hakimi MA, 2002, P NATL ACAD SCI USA, V99, P7420, DOI 10.1073/pnas.112008599; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Huang YF, 1999, NAT NEUROSCI, V2, P867, DOI 10.1038/13165; Humphrey GW, 2001, J BIOL CHEM, V276, P6817, DOI 10.1074/jbc.M007372200; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jones FS, 1999, BIOESSAYS, V21, P372, DOI 10.1002/(SICI)1521-1878(199905)21:5<372::AID-BIES3>3.0.CO;2-3; Khochbin S, 2001, CURR OPIN GENET DEV, V11, P162, DOI 10.1016/S0959-437X(00)00174-X; Kingston RE, 1999, GENE DEV, V13, P2339, DOI 10.1101/gad.13.18.2339; Kuzmichev A, 2002, MOL CELL BIOL, V22, P835, DOI 10.1128/MCB.22.3.835-848.2002; Liu R, 2001, CELL, V106, P309, DOI 10.1016/S0092-8674(01)00446-9; Murphy DJ, 1999, MOL CELL BIOL, V19, P2724; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Naruse Y, 1999, P NATL ACAD SCI USA, V96, P13691, DOI 10.1073/pnas.96.24.13691; Nie ZQ, 2000, MOL CELL BIOL, V20, P8879, DOI 10.1128/MCB.20.23.8879-8888.2000; Paquette AJ, 2000, P NATL ACAD SCI USA, V97, P12318, DOI 10.1073/pnas.97.22.12318; Peterson CL, 2000, CURR OPIN GENET DEV, V10, P187, DOI 10.1016/S0959-437X(00)00068-X; Phelan ML, 1999, MOL CELL, V3, P247, DOI 10.1016/S1097-2765(00)80315-9; Roopra A, 2000, MOL CELL BIOL, V20, P2147, DOI 10.1128/MCB.20.6.2147-2157.2000; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Sif S, 2001, GENE DEV, V15, P603, DOI 10.1101/gad.872801; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Strobeck MW, 2000, P NATL ACAD SCI USA, V97, P7748, DOI 10.1073/pnas.97.14.7748; Sudarsanam P, 2000, P NATL ACAD SCI USA, V97, P3364, DOI 10.1073/pnas.050407197; TapiaRamirez J, 1997, P NATL ACAD SCI USA, V94, P1177, DOI 10.1073/pnas.94.4.1177; Tong JK, 1998, NATURE, V395, P917, DOI 10.1038/27699; TRIMMER JS, 1985, CELL, V40, P697, DOI 10.1016/0092-8674(85)90218-1; Underhill C, 2000, J BIOL CHEM, V275, P40463, DOI 10.1074/jbc.M007864200; VANDENBERGH DJ, 1989, NEURON, V3, P507, DOI 10.1016/0896-6273(89)90209-2; Vignali M, 2000, MOL CELL BIOL, V20, P1899, DOI 10.1128/MCB.20.6.1899-1910.2000; Wang WD, 1998, P NATL ACAD SCI USA, V95, P492, DOI 10.1073/pnas.95.2.492; Wang WD, 1996, GENE DEV, V10, P2117, DOI 10.1101/gad.10.17.2117; Wu DY, 1996, J VIROL, V70, P6020, DOI 10.1128/JVI.70.9.6020-6028.1996; Wu JS, 2000, TRENDS BIOCHEM SCI, V25, P619, DOI 10.1016/S0968-0004(00)01718-7; Xue YT, 1998, MOL CELL, V2, P851, DOI 10.1016/S1097-2765(00)80299-3; You A, 2001, P NATL ACAD SCI USA, V98, P1454, DOI 10.1073/pnas.98.4.1454; Zhang HS, 2000, CELL, V101, P79, DOI 10.1016/S0092-8674(00)80625-X; Zhang Y, 1998, CELL, V95, P279, DOI 10.1016/S0092-8674(00)81758-4	46	149	156	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 25	2002	277	43					41038	41045		10.1074/jbc.M205691200	http://dx.doi.org/10.1074/jbc.M205691200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	607KU	12192000	hybrid			2022-12-27	WOS:000178791400113
J	Kamal, JKA; Nazeerunnisa, M; Behere, DV				Kamal, JKA; Nazeerunnisa, M; Behere, DV			Thermal unfolding of soybean peroxidase - Appropriate high denaturant concentrations induce cooperativity allowing the correct measurement of thermodynamic parameters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEED COAT PEROXIDASE; GUANIDINE-HYDROCHLORIDE; CIRCULAR-DICHROISM; HEAT-CAPACITY; GLYCINE-MAX; STABILITY; PROTEIN; BACTERIORHODOPSIN; FLEXIBILITY; EQUILIBRIUM	We have earlier reported that both guanidine hydrochloride (GdnHCl)-induced and heat-induced unfolding of seed coat soybean peroxidase (SBP), monitored by far UV CD, show single step transition. However, although GdnHCl-induced unfolding follows a two-state pathway, the heat-induced denaturation proceeds through intermediates as indicated by the very low cooperativity of transition. In the former case, analysis of the data based on the two-state model gives true thermodynamic parameters, whereas underestimated values are obtained in the latter case. Available complex equations also cannot be applied for the analysis of the thermal unfolding of SBP due to the absence of separate transitions for the intermediates. In the present study, we report a method to obtain true thermodynamic parameters from thermal transition curves of SBP using the two-state model. When SBP is subjected to thermal unfolding at high GdnHCl concentrations (5.8-6.9 m), cooperative behavior is observed, which allowed the analysis by the two-state model to determine their thermodynamic parameters. We then obtained the thermodynamic parameters in the absence of GdnHCl by extrapolating the graph of linear dependence of DeltaH(m) on T-m to the T-m corresponding to 0 m GdnHCl. Another key point for checking the validity of our method was the fact that the unfolded state of SBP generated by either heat or GdnHCl is the same by which we could cross-check our results with that obtained from GdnHCl unfolding. Having obtained the true thermodynamic parameters, we report a detailed thermodynamic study of SBP. Further we address the effect of heme in the thermal unfolding mechanism of SBP.	Tata Inst Fundamental Res, Dept Chem Engn, Bombay 400005, Maharashtra, India	Tata Institute of Fundamental Research (TIFR)	Behere, DV (corresponding author), Tata Inst Fundamental Res, Dept Chem Engn, Homi Bhabha Rd, Bombay 400005, Maharashtra, India.							AGASHE VR, 1995, BIOCHEMISTRY-US, V34, P3286, DOI 10.1021/bi00010a019; BECKTEL WJ, 1987, BIOPOLYMERS, V26, P1859, DOI 10.1002/bip.360261104; Chiti F, 1998, BIOCHEMISTRY-US, V37, P1447, DOI 10.1021/bi971692f; Feher VA, 1999, NATURE, V400, P289, DOI 10.1038/22357; Fitter J, 1998, FEBS LETT, V433, P321, DOI 10.1016/S0014-5793(98)00938-7; Fitter J, 2001, BIOCHEMISTRY-US, V40, P10723, DOI 10.1021/bi010808b; Freire E, 1995, METHOD ENZYMOL, V259, P144; Gershenson A, 2000, BIOCHEMISTRY-US, V39, P4658, DOI 10.1021/bi992473s; Gijzen M, 1997, PLANT J, V12, P991, DOI 10.1046/j.1365-313X.1997.12050991.x; GILLIKIN JW, 1991, PLANT PHYSIOL, V96, P214, DOI 10.1104/pp.96.1.214; HAWKES R, 1984, J MOL BIOL, V175, P195, DOI 10.1016/0022-2836(84)90474-1; Heberle J, 2000, BIOPHYS CHEM, V85, P229, DOI 10.1016/S0301-4622(99)00154-4; Henriksen A, 2001, PROTEIN SCI, V10, P108, DOI 10.1110/ps.37301; Ionescu RM, 2000, BIOCHEMISTRY-US, V39, P9540, DOI 10.1021/bi000511y; Kamal JKA, 2002, BIOCHEMISTRY-US, V41, P9034, DOI 10.1021/bi025621e; LUMRY R, 1954, J PHYS CHEM-US, V58, P110, DOI 10.1021/j150512a005; Makhatadze GI, 1995, ADV PROTEIN CHEM, V47, P307, DOI 10.1016/S0065-3233(08)60548-3; McEldoon JP, 1996, BIOTECHNOL PROGR, V12, P555, DOI 10.1021/bp960010x; MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020; NICHOLSON LK, 1995, NAT STRUCT BIOL, V2, P274, DOI 10.1038/nsb0495-274; Otlewski J, 1996, EUR J BIOCHEM, V242, P601, DOI 10.1111/j.1432-1033.1996.0601r.x; Pace C N, 1986, Methods Enzymol, V131, P266; PAPPA HS, 1993, EUR J BIOCHEM, V212, P227, DOI 10.1111/j.1432-1033.1993.tb17654.x; PFEIL W, 1976, BIOPHYS CHEM, V4, P33, DOI 10.1016/0301-4622(76)80004-X; Privalov P L, 1979, Adv Protein Chem, V33, P167, DOI 10.1016/S0065-3233(08)60460-X; PRIVALOV PL, 1990, J MOL BIOL, V213, P385, DOI 10.1016/S0022-2836(05)80198-6; SANCHEZRUIZ JM, 1992, BIOPHYS J, V61, P921, DOI 10.1016/S0006-3495(92)81899-4; Schmitz N, 1997, CAN J BOT, V75, P1336, DOI 10.1139/b97-845; SIEVERS G, 1978, BIOCHIM BIOPHYS ACTA, V536, P212, DOI 10.1016/0005-2795(78)90067-3; TEALE FWJ, 1959, BIOCHIM BIOPHYS ACTA, V35, P543, DOI 10.1016/0006-3002(59)90407-X; Vallee B, 1999, EUR J BIOCHEM, V266, P40, DOI 10.1046/j.1432-1327.1999.00812.x; Wittung-Stafshede P, 1998, BIOCHEMISTRY-US, V37, P3172, DOI 10.1021/bi972901z	32	25	25	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 25	2002	277	43					40717	40721		10.1074/jbc.M208129200	http://dx.doi.org/10.1074/jbc.M208129200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	607KU	12192011	hybrid			2022-12-27	WOS:000178791400072
J	Kickhoefer, VA; Poderycki, MJ; Chan, EKL; Rome, LH				Kickhoefer, VA; Poderycki, MJ; Chan, EKL; Rome, LH			The La RNA-binding protein interacts with the vault RNA and is a vault-associated protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL CYTOPLASMIC RIBONUCLEOPROTEINS; MULTIDRUG-RESISTANT CANCER; POLYMERASE-III; PARTICLES; TEP1; RO; CONTAIN; CELLS; RAT	Vaults are highly conserved ubiquitous ribonucleoprotein particles with an undefined function. Three protein species (p240/TEP1, p193/VPARP, and p100/MVP) and a small RNA comprise the 13-MDa vault particle. The expression of the unique 100-kDa major vault protein is sufficient to form the basic vault structure. Previously, we have shown that stable association of the vault RNA with the vault particle is dependent on its interaction with the p240/TEP1 protein. To identify other proteins that interact with the vault RNA, we used a UV-cross-linking assay. We find that a portion of the vault RNA is complexed with the La autoantigen in a separate smaller ribonucleoprotein particle. La interacts with the vault RNA (both in vivo and in vitro) presumably through binding to 3'-uridylates. Moreover, we also demonstrate that the La autoantigen is the 50-kDa protein that we have previously reported as a protein that co-purifies with vaults.	Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; Scripps Res Inst, Wm Keck Autoimmune Dis Ctr, Dept Mol & Expt Med, La Jolla, CA 92037 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Scripps Research Institute	Kickhoefer, VA (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, 33-131 CHS Mail Code 173717,10833 Le Conte Ave, Los Angeles, CA 90095 USA.	vkick@mednet.ucla.edu	Rome, Leonard H/E-8786-2016; Chan, Edward K. L./B-5671-2009	Rome, Leonard H/0000-0002-1236-2063; Chan, Edward K. L./0000-0003-3938-9503; Kickhoefer, Valerie/0000-0002-0048-0580	NIGMS NIH HHS [GM 38097] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038097] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CHAN EKL, 1987, J EXP MED, V166, P1627, DOI 10.1084/jem.166.6.1627; Fan H, 1998, MOL CELL BIOL, V18, P3201, DOI 10.1128/MCB.18.6.3201; HENDRICK JP, 1981, MOL CELL BIOL, V1, P1138, DOI 10.1128/MCB.1.12.1138; KEDERSHA NL, 1986, ANAL BIOCHEM, V156, P161, DOI 10.1016/0003-2697(86)90168-5; KEDERSHA NL, 1991, J CELL BIOL, V112, P225, DOI 10.1083/jcb.112.2.225; KEDERSHA NL, 1986, J CELL BIOL, V103, P699, DOI 10.1083/jcb.103.3.699; KICKHOEFER VA, 1993, J BIOL CHEM, V268, P7868; Kickhoefer VA, 1996, TRENDS CELL BIOL, V6, P174, DOI 10.1016/0962-8924(96)10014-3; Kickhoefer VA, 1999, J BIOL CHEM, V274, P32712, DOI 10.1074/jbc.274.46.32712; Kickhoefer VA, 1998, J BIOL CHEM, V273, P8971, DOI 10.1074/jbc.273.15.8971; Kickhoefer VA, 1999, J CELL BIOL, V146, P917, DOI 10.1083/jcb.146.5.917; Kickhoefer VA, 2001, J CELL BIOL, V152, P157, DOI 10.1083/jcb.152.1.157; Kong LB, 2000, RNA, V6, P890, DOI 10.1017/S1355838200000157; Liu Y, 2000, MOL CELL BIOL, V20, P8178, DOI 10.1128/MCB.20.21.8178-8184.2000; Maraia RJ, 2002, GENE EXPRESSION, V10, P41; Maraia RJ, 2001, J CELL BIOL, V153, pF13, DOI 10.1083/jcb.153.4.F13; PINOLROMA S, 1989, METHOD ENZYMOL, V180, P410; Rome L, 1991, Trends Cell Biol, V1, P47, DOI 10.1016/0962-8924(91)90088-Q; Scheffer GL, 2000, CURR OPIN ONCOL, V12, P550, DOI 10.1097/00001622-200011000-00007; Siva AC, 2001, INT J CANCER, V92, P195, DOI 10.1002/1097-0215(200102)9999:9999<::AID-IJC1168>3.0.CO;2-7; Stephen AG, 2001, J BIOL CHEM, V276, P23217, DOI 10.1074/jbc.C100226200; van Zon A, 2001, J BIOL CHEM, V276, P37715, DOI 10.1074/jbc.M106055200; VANVENROOIJ WJ, 1993, MOL BIOL REP, V18, P113, DOI 10.1007/BF00986765; VILALTA A, 1994, J BIOL CHEM, V269, P29752; Wolin SL, 2002, ANNU REV BIOCHEM, V71, P375, DOI 10.1146/annurev.biochem.71.090501.150003; WOLIN SL, 1984, P NATL ACAD SCI-BIOL, V81, P1996, DOI 10.1073/pnas.81.7.1996	26	27	27	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2002	277	43					41282	41286		10.1074/jbc.M206980200	http://dx.doi.org/10.1074/jbc.M206980200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	607KU	12196535	hybrid			2022-12-27	WOS:000178791400141
J	Osman, H; Murigande, C; Nadakal, A; Capponi, AM				Osman, H; Murigande, C; Nadakal, A; Capponi, AM			Repression of DAX-1 and induction of SF-1 expression - Two mechanisms contributing to the activation of aldosterone biosynthesis in adrenal glomerulosa cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE REGULATORY PROTEIN; ANGIOTENSIN-II; MINERALOCORTICOID BIOSYNTHESIS; STEROIDOGENIC FACTOR-1; PROMOTER ACTIVITY; RECEPTOR DAX-1; STAR GENE; CALCIUM; TRANSCRIPTION; HORMONE	Angiotensin II (Ang II) and adrenocorticotropic hormone stimulate aldosterone biosynthesis in the zona glomerulosa of the adrenal cortex through induction of the expression of the steroidogenic acute regulatory (StAR) protein, which promotes intramitochondrial cholesterol transfer. To understand the mechanism of this induction of the StAR protein, we have examined the effect of Ang II and forskolin, a mimicker of adrenocorticotropic hormone action, on two transcription factors known to modulate StAR gene expression in opposite ways, DAX-1 and SF-1, in bovine adrenal glomerulosa cells in primary culture. Ang II markedly inhibited DAX-1 protein expression in a time- and concentration-dependent manner (to 38.7 +/- 12.9% of controls at 3 nm after 6 h, p < 0.01), an effect that required de novo protein synthesis and ERK2/1 activation. This effect was associated with a concomitant decrease in DAX-1 mRNA and an increase in mitochondrial StAR protein levels. Similarly, forskolin dramatically repressed DAX-1 protein and mRNA expression (to 19.6 +/- 1.8 and 50.3 +/- 4.7% of controls, respectively, p < 0.01). Neither Ang II nor forskolin affected DAX-1 protein and mRNA stability. The aldosterone response to Ang H was markedly reduced (to 59 +/- 4% of controls, p < 0.01) in transiently transfected cells overexpressing DAX-1. Whereas Ang II was without effect on SF-1 expression, forskolin significantly increased SF-1 protein and mRNA levels in a cycloheximide-sensitive manner (to 167.4 +/- 16.6 and 173.1 +/- 25.1% of controls after 6 h, respectively, p < 0.01). These results demonstrate that the balance between repressor and inducer function of DAX-1 and SF-1 are of critical importance in the regulation of adrenal aldosterone biosynthesis.	Univ Hosp Geneva, Div Endocrinol & Diabetol, CH-111 Geneva 14, Switzerland	University of Geneva	Capponi, AM (corresponding author), Univ Hosp Geneva, Div Endocrinol & Diabetol, 24 Rue Micheli du Crest, CH-111 Geneva 14, Switzerland.	alessandro.capponi@medecine.unige.ch	Osman-Ponchet, Hanan/AAD-3939-2022	Osman-Ponchet, Hanan/0000-0003-4994-5673				AEsoy R, 2002, ENDOCRINOLOGY, V143, P295, DOI 10.1210/en.143.1.295; Babu PS, 2002, ENDOCRINOLOGY, V143, P665, DOI 10.1210/en.143.2.665; Babu PS, 2000, ENDOCR RES, V26, P985, DOI 10.3109/07435800009048628; BAUKAL AJ, 1994, J BIOL CHEM, V269, P24546; CAPPONI AM, 1988, J BIOL CHEM, V263, P16113; Capponi AM, 1996, CURR OPIN ENDOCRINOL, V3, P248, DOI [10.1097/00060793-199606000-00010, DOI 10.1097/00060793-199606000-00010]; Caron KM, 1997, MOL ENDOCRINOL, V11, P138, DOI 10.1210/me.11.2.138; CHABRE O, 1995, ENDOCRINOLOGY, V136, P956, DOI 10.1210/en.136.3.956; Cherradi N, 1998, MOL ENDOCRINOL, V12, P962, DOI 10.1210/me.12.7.962; Cherradi N, 1997, J BIOL CHEM, V272, P7899, DOI 10.1074/jbc.272.12.7899; Cherradi N, 1998, EUR J ENDOCRINOL, V139, P249, DOI 10.1530/eje.0.1390249; Cherradi N, 1998, TRENDS ENDOCRIN MET, V9, P412, DOI 10.1016/S1043-2760(98)00099-X; Christenson LK, 2000, BBA-MOL CELL BIOL L, V1529, P175, DOI 10.1016/S1388-1981(00)00147-5; Clark BJ, 1999, ENDOCRINOLOGY, V140, P4390, DOI 10.1210/en.140.10.4390; Clark BJ, 1995, MOL CELL ENDOCRINOL, V115, P215, DOI 10.1016/0303-7207(95)03683-0; Cote M, 1998, ENDOCR RES, V24, P415, DOI 10.3109/07435809809032625; Crawford PA, 1998, MOL CELL BIOL, V18, P2949, DOI 10.1128/MCB.18.5.2949; Das S, 1996, ENDOCRINOLOGY, V137, P967, DOI 10.1210/en.137.3.967; ELLIOTT ME, 1984, BIOCHEM PHARMACOL, V33, P1519, DOI 10.1016/0006-2952(84)90422-2; Gyles SL, 2001, J BIOL CHEM, V276, P34888, DOI 10.1074/jbc.M102063200; Hammer GD, 1999, MOL CELL, V3, P521, DOI 10.1016/S1097-2765(00)80480-3; Hanley NA, 2001, MOL ENDOCRINOL, V15, P57, DOI 10.1210/me.15.1.57; Hosokawa K, 1998, ENDOCRINOLOGY, V139, P4679, DOI 10.1210/en.139.11.4679; Ito M, 1997, MOL CELL BIOL, V17, P1476, DOI 10.1128/MCB.17.3.1476; JEFCOATE CR, 1992, J STEROID BIOCHEM, V43, P751, DOI 10.1016/0960-0760(92)90305-3; Lalli E, 1997, MOL ENDOCRINOL, V11, P1950, DOI 10.1210/me.11.13.1950; Lalli E, 1998, ENDOCRINOLOGY, V139, P4237, DOI 10.1210/en.139.10.4237; Lalli E, 2000, MOL CELL BIOL, V20, P4910, DOI 10.1128/MCB.20.13.4910-4921.2000; Lalli E, 1999, CURR OPIN ENDOCRINOL, V6, P185; MOROHASHI K, 1993, MOL ENDOCRINOL, V7, P1196, DOI 10.1210/me.7.9.1196; Muller J., 1988, REGULATION ALDOSTERO; MUSCATELLI F, 1994, NATURE, V372, P672, DOI 10.1038/372672a0; Parker KL, 1997, ENDOCR REV, V18, P361, DOI 10.1210/er.18.3.361; PYTHON CP, 1993, ENDOCRINOLOGY, V132, P1489, DOI 10.1210/en.132.4.1489; Rust W, 1998, J MOL ENDOCRINOL, V21, P189, DOI 10.1677/jme.0.0210189; Sandhoff TW, 1998, ENDOCRINOLOGY, V139, P4820, DOI 10.1210/en.139.12.4820; Shibata H, 2001, MOL GENET METAB, V74, P206, DOI 10.1006/mgme.2001.3231; Silverman E, 1999, J BIOL CHEM, V274, P17987, DOI 10.1074/jbc.274.25.17987; Sugawara T, 1997, STEROIDS, V62, P5, DOI 10.1016/S0039-128X(96)00152-3; Sugawara T, 2000, ENDOCRINOLOGY, V141, P2895, DOI 10.1210/en.141.8.2895; Sugawara T, 1997, BIOCHEMISTRY-US, V36, P7249, DOI 10.1021/bi9628984; Sugawara T, 1996, BIOCHEMISTRY-US, V35, P9052, DOI 10.1021/bi960057r; Tai CJ, 2001, ENDOCRINOLOGY, V142, P1554, DOI 10.1210/en.142.4.1554; Tamai KT, 1996, MOL ENDOCRINOL, V10, P1561, DOI 10.1210/me.10.12.1561; Tian Y, 1998, ENDOCRINOLOGY, V139, P1801, DOI 10.1210/en.139.4.1801; Wooton-Kee CR, 2000, ENDOCRINOLOGY, V141, P1345, DOI 10.1210/en.141.4.1345; Yu RN, 1998, TRENDS ENDOCRIN MET, V9, P169, DOI 10.1016/S1043-2760(98)00048-4; Zazopoulos E, 1997, NATURE, V390, P311, DOI 10.1038/36899	48	43	43	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2002	277	43					41259	41267		10.1074/jbc.M206595200	http://dx.doi.org/10.1074/jbc.M206595200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	607KU	12186872	hybrid			2022-12-27	WOS:000178791400138
J	Siripurkpong, P; Yuvaniyama, J; Wilairat, P; Goldberg, DE				Siripurkpong, P; Yuvaniyama, J; Wilairat, P; Goldberg, DE			Active site contribution to specificity of the aspartic proteases plasmepsins I and II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FALCIPARUM HEMOGLOBIN DEGRADATION; PARASITE PLASMODIUM-FALCIPARUM; DIGESTIVE VACUOLE; PATHWAY; PROTEINASE; EXPRESSION; INHIBITION; ENZYME	Plasmepsins I and II (PM I and II) are aspartic proteases involved in the initial steps of Plasmodium hemoglobin degradation. They are attractive targets for antimalarial drug development. The two enzymes are 73% identical, yet have different substrate and inhibitor specificities. The x-ray structures of proform and mature PM II have been determined, but models of PM I do not adequately explain the selectivity of the two proteases. To better understand the basis of these recognition differences, we have identified nine residues of PM II that are in proximity to the inhibitor pepstatin in the crystal structure and differ in PM I. We mutated these residues in PM II to the cognate amino acids of PM I. Kinetic parameters for substrate and inhibitors for the PM II-mutant were similar to those of PM II-wild type (WT). Cleavage specificity was assessed using hemoglobin or a random decamer peptide library as substrate. Again, PM II-mutant behaved like PM II-WT rather than PM I-WT. These results indicate that differences in plasmepsin specificity depend more on conformational differences from distant sites than on specific active site variation.	Washington Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Microbiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Howard Hughes Med Inst, Dept Med, St Louis, MO 63110 USA; Mahidol Univ, Fac Sci, Dept Biochem, Bangkok 10400, Thailand	Howard Hughes Medical Institute; Washington University (WUSTL); Howard Hughes Medical Institute; Washington University (WUSTL); Mahidol University	Goldberg, DE (corresponding author), Washington Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Microbiol, St Louis, MO 63110 USA.			Yuvaniyama, Jirundon/0000-0002-6800-8944	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047798] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 47798] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Banerjee R, 2002, P NATL ACAD SCI USA, V99, P990, DOI 10.1073/pnas.022630099; Bernstein NK, 1999, NAT STRUCT BIOL, V6, P32, DOI 10.1038/4905; Coombs GH, 2001, TRENDS PARASITOL, V17, P532, DOI 10.1016/S1471-4922(01)02037-2; COPELAND RA, 2000, ENZYMES PRACTICAL IN; DAME JB, 1994, MOL BIOCHEM PARASIT, V64, P177, DOI 10.1016/0166-6851(94)90024-8; Eggleson KK, 1999, J BIOL CHEM, V274, P32411, DOI 10.1074/jbc.274.45.32411; FRANCIS SE, 1994, EMBO J, V13, P306, DOI 10.1002/j.1460-2075.1994.tb06263.x; Francis SE, 1996, MOL BIOCHEM PARASIT, V83, P189, DOI 10.1016/S0166-6851(96)02772-7; Gavigan CS, 2001, MOL BIOCHEM PARASIT, V117, P37, DOI 10.1016/S0166-6851(01)00327-9; GLUZMAN IY, 1994, J CLIN INVEST, V93, P1602, DOI 10.1172/JCI117140; GOLDBERG DE, 1992, INFECT AGENT DIS, V1, P207; GOLDBERG DE, 1991, J EXP MED, V173, P961, DOI 10.1084/jem.173.4.961; Haque TS, 1999, J MED CHEM, V42, P1428, DOI 10.1021/jm980641t; Khan AR, 1999, P NATL ACAD SCI USA, V96, P10968, DOI 10.1073/pnas.96.20.10968; KNIGHT CG, 1995, METHOD ENZYMOL, V248, P85; Kolakovich KA, 1997, MOL BIOCHEM PARASIT, V87, P123, DOI 10.1016/S0166-6851(97)00062-5; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Luker KE, 1996, MOL BIOCHEM PARASIT, V79, P71, DOI 10.1016/0166-6851(96)02651-5; Moon RP, 1997, EUR J BIOCHEM, V244, P552, DOI 10.1111/j.1432-1033.1997.00552.x; POORMAN RA, 1991, J BIOL CHEM, V266, P14554; Silva AM, 1996, P NATL ACAD SCI USA, V93, P10034, DOI 10.1073/pnas.93.19.10034; Trigg PI, 1998, B WORLD HEALTH ORGAN, V76, P11; Turk BE, 2001, NAT BIOTECHNOL, V19, P661, DOI 10.1038/90273; Williams J W, 1979, Methods Enzymol, V63, P437	24	22	22	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 25	2002	277	43					41009	41013		10.1074/jbc.M204852200	http://dx.doi.org/10.1074/jbc.M204852200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	607KU	12189138	hybrid			2022-12-27	WOS:000178791400109
J	Das, S; Lin, JH; Papamatheakis, J; Sykulev, Y; Tsichlis, PN				Das, S; Lin, JH; Papamatheakis, J; Sykulev, Y; Tsichlis, PN			Differential splicing generates Tvl-1/RFXANK isoforms with different functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BARE LYMPHOCYTE SYNDROME; CLASS-II DEFICIENCY; ADAPTER PROTEIN TVL-1; REGULATORY FACTOR-X; HISTOCOMPATIBILITY COMPLEX; DNA-BINDING; GENE-EXPRESSION; COMPLEMENTATION GROUP; TRANSACTIVATOR CIITA; EPH RECEPTOR	Earlier studies have shown that Tvl-1 gives rise to at least two differentially spliced mRNAs, one of which (Tvl-S) encodes a protein that lacks amino acids 91-112. DNA binding of RFX complexes assembled in the presence of Tvl-S is impaired. As a result, Tvl-S does not support the expression of Class 11 major histocompatibility complex (MHQ genes. Here, we show that the reason Tvl-S is inactive as a transcriptional regulator of Class H MHC genes is that the RFX complexes assembled in the presence of Tvl-S are unstable. Additionally, we show that interferon-gamma, which induces Class 11 MHC gene expression in 293 cells, promotes a shift in the splicing pattern of RFXANK/Tvl-1 toward the transcriptionally active TvI-L isoform, suggesting that differential splicing of Tvl-1 is a signal-regulated process. Finally, we show that Tvl-1 regulates the expression of non-MHC genes. One such gene encodes the ephrin receptor EphA3. Since both Tvl-L and Tvl-S are identical in their ability to induce the expression of EphA3, we conclude that Tvl-1 regulates the expression of non-MHC genes by RFX-independent mechanisms.	Tufts Univ, New England Med Ctr, Mol Oncol Res Inst, Boston, MA 02111 USA; Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; Fdn Res & Technol, Inst Mol Biol & Biotechnol, Iraklion 71110, Crete, Greece	Tufts Medical Center; Tufts University; Jefferson University	Tsichlis, PN (corresponding author), Tufts Univ, New England Med Ctr, Mol Oncol Res Inst, 75 Kneeland St,10th Floor,Rm 10025, Boston, MA 02111 USA.	p_tsichlis@lifespan.org			NCI NIH HHS [R01 CA/GM80219] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA080219] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BENICHOU B, 1991, P NATL ACAD SCI USA, V88, P4285, DOI 10.1073/pnas.88.10.4285; BENOIST C, 1990, ANNU REV IMMUNOL, V8, P681, DOI 10.1146/annurev.immunol.8.1.681; Beresford GW, 2001, NAT IMMUNOL, V2, P652, DOI 10.1038/89810; Bontron S, 1997, HUM GENET, V99, P541, DOI 10.1007/s004390050403; Boss JM, 1997, CURR OPIN IMMUNOL, V9, P107, DOI 10.1016/S0952-7915(97)80166-5; Brown A, 2000, CELL, V102, P77, DOI 10.1016/S0092-8674(00)00012-X; Cattaruzza M, 2002, J BIOL CHEM, V277, P6582, DOI 10.1074/jbc.M108283200; Cella M, 1997, NATURE, V388, P782, DOI 10.1038/42030; CHANG CH, 1994, J EXP MED, V180, P1367, DOI 10.1084/jem.180.4.1367; CHENG HJ, 1995, CELL, V82, P371, DOI 10.1016/0092-8674(95)90426-3; Chiari R, 2000, CANCER RES, V60, P4855; CHIN KC, 1994, IMMUNITY, V1, P687, DOI 10.1016/1074-7613(94)90039-6; COOPER TA, 2001, SCI STKE; Cressman DE, 1999, IMMUNITY, V10, P163, DOI 10.1016/S1074-7613(00)80017-5; DeSandro AM, 2000, MOL CELL BIOL, V20, P6587, DOI 10.1128/MCB.20.17.6587-6599.2000; Dottori M, 1999, BLOOD, V94, P2477, DOI 10.1182/blood.V94.7.2477.419k13_2477_2486; Durand B, 1997, EMBO J, V16, P1045, DOI 10.1093/emboj/16.5.1045; Emery P, 1996, MOL CELL BIOL, V16, P4486; Emery P, 1996, NUCLEIC ACIDS RES, V24, P803, DOI 10.1093/nar/24.5.803; FLAVELL RA, 1986, SCIENCE, V233, P437, DOI 10.1126/science.3726537; FOX GM, 1995, ONCOGENE, V10, P897; Gajiwala KS, 2000, NATURE, V403, P916, DOI 10.1038/35002634; Gale NW, 1996, NEURON, V17, P9, DOI 10.1016/S0896-6273(00)80276-7; HAMMERLING GJ, 1975, ISRAEL J MED SCI, V11, P1331; Harton JA, 2000, MOL CELL BIOL, V20, P6185, DOI 10.1128/MCB.20.17.6185-6194.2000; Harton JA, 2001, J BIOL CHEM, V276, P38715, DOI 10.1074/jbc.M106652200; Huai JS, 2001, J BIOL CHEM, V276, P6689, DOI 10.1074/jbc.M008127200; KLEIN C, 1993, J PEDIATR-US, V123, P921, DOI 10.1016/S0022-3476(05)80388-9; Kwak B, 2000, NAT MED, V6, P1399, DOI 10.1038/82219; Lanzavecchia A, 1997, J EXP MED, V185, P1717, DOI 10.1084/jem.185.10.1717; Lennon AM, 1996, IMMUNOGENETICS, V43, P352; Lezzi G, 1998, IMMUNITY, V8, P89, DOI 10.1016/S1074-7613(00)80461-6; Lin JH, 1999, J BIOL CHEM, V274, P14706, DOI 10.1074/jbc.274.21.14706; MACH B, 1994, IMMUNOL REV, V138, P207, DOI 10.1111/j.1600-065X.1994.tb00853.x; Mach B, 1996, ANNU REV IMMUNOL, V14, P301, DOI 10.1146/annurev.immunol.14.1.301; Magner WJ, 2000, J IMMUNOL, V165, P7017, DOI 10.4049/jimmunol.165.12.7017; Masternak K, 1998, NAT GENET, V20, P273, DOI 10.1038/3081; Masternak K, 2000, Rev Immunogenet, V2, P267; Moreno CS, 1997, J IMMUNOL, V158, P5841; Nagarajan UM, 1999, IMMUNITY, V10, P153, DOI 10.1016/S1074-7613(00)80016-3; Nekrep N, 2000, MOL CELL BIOL, V20, P4455, DOI 10.1128/MCB.20.12.4455-4461.2000; Nekrep N, 2001, MOL CELL BIOL, V21, P5566, DOI 10.1128/MCB.21.16.5566-5576.2001; Orioli D, 1997, TRENDS GENET, V13, P354, DOI 10.1016/S0168-9525(97)01220-1; PANDEY A, 1995, SCIENCE, V268, P567, DOI 10.1126/science.7536959; Patriotis C, 2001, J CELL PHYSIOL, V187, P176, DOI 10.1002/jcp.1066; Piskurich JF, 1999, MOL CELL BIOL, V19, P431; REITH W, 1988, CELL, V53, P897, DOI 10.1016/S0092-8674(88)90389-3; Reith W, 2001, ANNU REV IMMUNOL, V19, P331, DOI 10.1146/annurev.immunol.19.1.331; SANCHEZ CH, 1992, MOL CELL BIOL, V12, P4076, DOI 10.1128/MCB.12.9.4076; SEIDL C, 1992, J IMMUNOL, V148, P1576; Spilianakis C, 2000, MOL CELL BIOL, V20, P8489, DOI 10.1128/MCB.20.22.8489-8498.2000; STEIMLE V, 1993, CELL, V75, P135, DOI 10.1016/0092-8674(93)90685-J; STEIMLE V, 1995, GENE DEV, V9, P1021, DOI 10.1101/gad.9.9.1021; VALITUTTI S, 1995, NATURE, V375, P148, DOI 10.1038/375148a0; Villard J, 1997, NEW ENGL J MED, V337, P748, DOI 10.1056/NEJM199709113371104; Waldburger JM, 2000, IMMUNOL REV, V178, P148, DOI 10.1034/j.1600-065X.2000.17813.x; Westerheide SD, 1999, NUCLEIC ACIDS RES, V27, P1635, DOI 10.1093/nar/27.7.1635	57	5	5	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2002	277	47					45172	45180		10.1074/jbc.M204117200	http://dx.doi.org/10.1074/jbc.M204117200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	618EE	12215433	hybrid			2022-12-27	WOS:000179404800075
J	Antenos, M; Casper, RF; Brown, TJ				Antenos, M; Casper, RF; Brown, TJ			Interaction with Nedd8, a ubiquitin-like protein, enhances the transcriptional activity of the aryl hydrocarbon receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AH RECEPTOR; SUBCELLULAR-LOCALIZATION; PATHWAY; DEGRADATION; EXPRESSION; RESVERATROL; BINDING; SYSTEM; ARNT	The aryl hydrocarbon receptor (AhR) is a ligand-activated member of the basic helix-loop-helix period aryl hydrocarbon nuclear translocator single-minded (PAS) transcription factor family. This receptor has been shown to be important in various aspects of growth and development as demonstrated by AhR-null mice. A yeast two-hybrid screen of a mouse embryonic day 11 library for AhR-interacting proteins revealed Nedd8 as a candidate. The interaction was confirmed in a cell-free system and in mammalian cells by co-immunoprecipitation; however, in vitro neddylation assays showed that Nedd8 does not covalently modify AhR. Transfection of Nedd8 into a cell line stably transfected with a dioxin response element linked to a chloramphenicol acetyltransferase reporter gene demonstrated that Nedd8 amplified ligand-induced transcription. Deletion of the Gly-76 residue in the carboxyl terminus of Nedd8 abolished this effect and prevented AhR-Nedd8 interaction. Nedd8 overexpression also resulted in accumulation of AhR protein in the nucleus, independent of exogenous ligand. These studies demonstrate that the AhR interacts with Nedd8 and suggest that this interaction enhances the transcriptional activity of the receptor, perhaps involving increased nuclear accumulation or retention. Immunohistochemistry performed on embryonic day 11.5 mouse sections indicated Nedd8 and AhR localize to overlapping areas in the heart and spinal ganglia, raising the possibility that this interaction may play a role in organogenesis.	Mt Sinai Hosp, Div Reprod Sci, Samuel Lunenfeld Res Inst, Dept Obstet & Gynecol, Toronto, ON M5G 1X5, Canada; Univ Toronto, Dept Zool, Toronto, ON M5G 1X5, Canada; Univ Toronto, Dept Physiol, Toronto, ON M5G 1X5, Canada; Univ Toronto, Dept Obstet & Gynecol, Toronto, ON M5G 1X5, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University of Toronto	Brown, TJ (corresponding author), Mt Sinai Hosp, Div Reprod Sci, Samuel Lunenfeld Res Inst, Dept Obstet & Gynecol, 600 Univ Ave,Rm 876, Toronto, ON M5G 1X5, Canada.	brown@mshri.on.ca	Antenos, Monica/J-8985-2017; Brown, Theodore J./E-2192-2013; Casper, Robert F./E-3775-2013	Antenos, Monica/0000-0001-6350-2911; Brown, Theodore J./0000-0002-3074-4516; Casper, Robert F./0000-0002-6249-462X				ABBOTT BD, 1995, DEV DYNAM, V204, P133, DOI 10.1002/aja.1002040204; Casper RF, 1999, MOL PHARMACOL, V56, P784; Deshaies RJ, 1999, CURR OPIN CELL BIOL, V11, P705, DOI 10.1016/S0955-0674(99)00040-X; Fan MY, 2002, MOL ENDOCRINOL, V16, P315, DOI 10.1210/me.16.2.315; FERNANDEZSALGUERO P, 1995, SCIENCE, V268, P722, DOI 10.1126/science.7732381; Furukawa M, 2000, MOL CELL BIOL, V20, P8185, DOI 10.1128/MCB.20.21.8185-8197.2000; Gonzalez FJ, 1998, DRUG METAB DISPOS, V26, P1194; HANKINSON O, 1995, ANNU REV PHARMACOL, V35, P307, DOI 10.1146/annurev.pharmtox.35.1.307; Hochstrasser M, 1998, GENE DEV, V12, P901, DOI 10.1101/gad.12.7.901; Holmes JL, 1997, MOL PHARMACOL, V52, P202, DOI 10.1124/mol.52.2.202; Hori T, 1999, ONCOGENE, V18, P6829, DOI 10.1038/sj.onc.1203093; Ivan M, 2001, CURR OPIN GENET DEV, V11, P27, DOI 10.1016/S0959-437X(00)00152-0; Jain S, 1998, MECH DEVELOP, V73, P117, DOI 10.1016/S0925-4773(98)00038-0; Kamitani T, 1997, J BIOL CHEM, V272, P28557, DOI 10.1074/jbc.272.45.28557; Kamitani T, 2001, J BIOL CHEM, V276, P46655, DOI 10.1074/jbc.M108636200; KUMAR S, 1992, BIOCHEM BIOPH RES CO, V185, P1155, DOI 10.1016/0006-291X(92)91747-E; Kurz T, 2002, SCIENCE, V295, P1294, DOI 10.1126/science.1067765; Laney JD, 1999, CELL, V97, P427, DOI 10.1016/S0092-8674(00)80752-7; Lin TM, 2001, J TOXICOL ENV HEAL A, V64, P327, DOI 10.1080/152873901316981312; Ma Q, 2000, J BIOL CHEM, V275, P8432, DOI 10.1074/jbc.275.12.8432; Ma Q, 1997, J BIOL CHEM, V272, P8878; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Mitchell SH, 1999, CANCER RES, V59, P5892; NICOLAS GPD, 2001, PROMEGA ENOTES APPL; Ohh M, 2002, EMBO REP, V3, P177, DOI 10.1093/embo-reports/kvf028; Okino S T, 2000, Vitam Horm, V59, P241, DOI 10.1016/S0083-6729(00)59009-8; Pagano M, 1997, FASEB J, V11, P1067, DOI 10.1096/fasebj.11.13.9367342; Petrulis JR, 2000, J BIOL CHEM, V275, P37448, DOI 10.1074/jbc.M006873200; Pickart CM, 2001, MOL CELL, V8, P499, DOI 10.1016/S1097-2765(01)00347-1; Roberts BJ, 1999, J BIOL CHEM, V274, P36351, DOI 10.1074/jbc.274.51.36351; Sambrook J., 2001, MOL CLONING LAB MANU; Savouret JF, 2001, J BIOL CHEM, V276, P3054, DOI 10.1074/jbc.M005988200; Schmidt JV, 1996, P NATL ACAD SCI USA, V93, P6731, DOI 10.1073/pnas.93.13.6731; Tateishi K, 2001, J CELL BIOL, V155, P571, DOI 10.1083/jcb.200104035; Whitby FG, 1998, J BIOL CHEM, V273, P34983, DOI 10.1074/jbc.273.52.34983; Yeh ETH, 2000, GENE, V248, P1, DOI 10.1016/S0378-1119(00)00139-6	36	18	22	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2002	277	46					44028	44034		10.1074/jbc.M202413200	http://dx.doi.org/10.1074/jbc.M202413200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	615XE	12215427	hybrid			2022-12-27	WOS:000179272000065
J	Grzesik, WJ; Frazier, CR; Shapiro, JR; Sponseller, PD; Robey, PG; Fedarko, NS				Grzesik, WJ; Frazier, CR; Shapiro, JR; Sponseller, PD; Robey, PG; Fedarko, NS			Age-related changes in human bone proteoglycan structure - Impact of osteogenesis imperfecta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; PERFORMANCE LIQUID-CHROMATOGRAPHY; COLLAGEN-MUTATION-DATABASE; TRANSFORMING GROWTH-FACTOR-BETA-1; DERMATAN SULFATE; HYALURONIC-ACID; CELLS-INVITRO; NITROUS-ACID; OSTEOBLASTS; BIOSYNTHESIS	Proteoglycans (PGs) are a family of molecules that undergo extensive post-translational modifications that include addition of glycosaminoglycan (GAG) chains as well as N- and O-linked oligosaccharides to the protein core. PG composition and structure have been reported to alter with age. To test whether the post-translational modifications to PGs can serve as in vitro surrogate end point markers for chronological age, the extent of GAG modifications was determined for PGs derived from normal human bone cells of 14 donors (age range, fetal to 60 years). Isolated cells were steady state radiolabeled with (SO42-)-S-35 and [H-3]GlcN. For biglycan and decorin, iduronate content was linearly correlated with age (increased 1.5X between fetal and age 60 years). For the syndecan-like heparan sulfate PG, the N-sulfation of post-natal cells increased over 3.5-fold until reaching a plateau during the 4th decade of life. The amount of O-linked oligosaccharides was also found to decrease as a function of increasing normal donor age, whereas the specific activity of the metabolic precursor pool remained constant regardless of donor age. These age-related changes in post-translational modifications were then used to demonstrate that osteoblasts derived from patients with osteogenesis imperfecta did not exhibit facets of a pre-mature aging, but rather were arrested in a fetal-like phenotypic state. A growth matrix rich in thrombospondin altered PG metabolism in osteoblastic cells, resulting in the production and secretion of the fetal-like (rich in O-linked oligosaccharides) forms of decorin and biglycan. This effect was qualitatively different from the effect of transforming growth factor-beta, which predominantly altered GAGs rather than O-linked oligosaccharides. No other Arg-Gly-Asp protein (fibronectin, vitronectin, type I collagen, osteopontin, and bone sialoprotein) showed any detectable effect on PG metabolism in bone cells. These results indicate that a proper matrix stoichiometry is critical for metabolism of PGs.	Johns Hopkins Univ, Sch Med, Dept Med, Div Geriatr Med & Gerontol, Baltimore, MD 21224 USA; Univ N Carolina, Dent Res Ctr, Sch Dent, Chapel Hill, NC 27599 USA; Johns Hopkins Univ, Kennedy Krieger Inst, Osteogenesis Imperfecta Program, Baltimore, MD 21205 USA; Johns Hopkins Univ, Dept Orthoped, Baltimore, MD 21205 USA; NIDCR, Craniofacial & Skeletal Dis Branch, NIH, Bethesda, MD 20892 USA	Johns Hopkins University; University of North Carolina; University of North Carolina Chapel Hill; Johns Hopkins University; Kennedy Krieger Institute; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Fedarko, NS (corresponding author), Rm 5A-64 JHAAC,5501 Hopkins Bayview Circle, Baltimore, MD 21224 USA.	ndarko@jhmi.edu	Robey, Pamela Gehron/H-1429-2011	Robey, Pamela Gehron/0000-0002-5316-5576; Fedarko, Neal/0000-0001-6055-6279	NIAMS NIH HHS [AR 42358] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR042358, R55AR042358] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000649] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000649] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		ADAMS P, 1977, RHEUMATOL REHABIL, V16, P22, DOI 10.1093/rheumatology/16.1.22; ADAMS P, 1976, ANN RHEUM DIS, V35, P289, DOI 10.1136/ard.35.4.289; ASCH AS, 1991, J BIOL CHEM, V266, P1740; BARSH GS, 1985, P NATL ACAD SCI USA, V82, P2870, DOI 10.1073/pnas.82.9.2870; BARTOLD PM, 1986, J CELL PHYSIOL, V126, P37, DOI 10.1002/jcp.1041260106; BERESFORD JN, 1987, J BIOL CHEM, V262, P17164; BIENKOWSKI MJ, 1985, J BIOL CHEM, V260, P356; BREUER B, 1990, BIOCHEM J, V269, P551, DOI 10.1042/bj2690551; Buckwalter J A, 1988, Electron Microsc Rev, V1, P87; BUCKWALTER JA, 1994, MICROSC RES TECHNIQ, V28, P398, DOI 10.1002/jemt.1070280506; BYERS PH, 1992, ANNU REV MED, V43, P269, DOI 10.1146/annurev.med.43.1.269; Carrino DA, 2000, ARCH BIOCHEM BIOPHYS, V373, P91, DOI 10.1006/abbi.1999.1545; Dalgleish R, 1998, NUCLEIC ACIDS RES, V26, P253, DOI 10.1093/nar/26.1.253; Dalgleish R, 1997, NUCLEIC ACIDS RES, V25, P181, DOI 10.1093/nar/25.1.181; DELANEY SR, 1980, ANAL BIOCHEM, V108, P25, DOI 10.1016/0003-2697(80)90689-2; FEDARKO NS, 1986, J CELL BIOL, V102, P587, DOI 10.1083/jcb.102.2.587; FEDARKO NS, 1990, ANAL BIOCHEM, V188, P398, DOI 10.1016/0003-2697(90)90627-L; FEDARKO NS, 1992, J BONE MINER RES, V7, P921; FEDARKO NS, 1990, J BIOL CHEM, V265, P12200; FEDARKO NS, 1995, J BONE MINER RES, V10, P1705; Fedarko NS, 1996, J BONE MINER RES, V11, P800; FEDARKO NS, 1995, J BONE MINER RES, V10, P1122; FEDARKO NS, 1992, J CELL PHYSIOL, V151, P215, DOI 10.1002/jcp.1041510202; Frazier WA, 1991, CURR OPIN CELL BIOL, V3, P792, DOI 10.1016/0955-0674(91)90052-Z; Gebken J, 2000, PATHOBIOLOGY, V68, P106, DOI 10.1159/000055910; Glorieux FH, 2000, J BONE MINER RES, V15, P1650, DOI 10.1359/jbmr.2000.15.9.1650; GRZESIK WJ, 1994, J BONE MINER RES, V9, P487, DOI 10.1002/jbmr.5650090408; JOHNSTONE B, 1995, SPINE, V20, P674, DOI 10.1097/00007632-199503150-00008; Jones SJ, 1999, CALCIFIED TISSUE INT, V64, P8, DOI 10.1007/s002239900571; Kauppila S, 1998, EUR J CLIN INVEST, V28, P831; KIM JJ, 1976, J BIOL CHEM, V251, P6210; KOBAYASHI K, 1990, BIOCHEM BIOPH RES CO, V172, P217, DOI 10.1016/S0006-291X(05)80196-2; LINDAHL U, 1990, HAEMOSTASIS, V20, P146; MALMSTROM A, 1975, J BIOL CHEM, V250, P3419; McCarthy EF, 1997, CLIN ORTHOP RELAT R, P254; McKusick V A, 1975, Birth Defects Orig Artic Ser, V11, P1; MINTZ KP, 1993, J BONE MINER RES, V8, P985; MORIKE M, 1993, J ORTHOPAED RES, V11, P564, DOI 10.1002/jor.1100110411; PROCKOP DJ, 1988, ARTHRITIS RHEUM, V31, P1, DOI 10.1002/art.1780310101; Rauch F, 2000, BONE, V26, P581, DOI 10.1016/S8756-3282(00)00269-6; ROBERTS CR, 1991, AM J PHYSIOL, V261, pL92, DOI 10.1152/ajplung.1991.261.2.L92; ROBERTS DD, 1987, J CELL BIOL, V104, P131, DOI 10.1083/jcb.104.1.131; Roden L., 1980, BIOCH GLYCOPROTEINS, P267; ROWE DW, 1985, J CLIN INVEST, V76, P604, DOI 10.1172/JCI112012; SALUSTRI A, 1989, J BIOL CHEM, V264, P13840; Sames K, 1994, EXS, V70, P243; SCHONHERR E, 1993, ARTERIOSCLER THROMB, V13, P1026, DOI 10.1161/01.ATV.13.7.1026; Schwartz NB, 2000, FRONT BIOSCI, V5, pD649; SCHWARTZ NB, 1985, FED PROC, V44, P369; SHIRAGA H, 1992, P NATL ACAD SCI USA, V89, P426, DOI 10.1073/pnas.89.1.426; SHIVELY JE, 1970, BIOCHEMISTRY-US, V9, P33, DOI 10.1021/bi00803a005; Sillence D O, 1988, Ann N Y Acad Sci, V543, P1, DOI 10.1111/j.1749-6632.1988.tb55311.x; SILLENCE DO, 1978, LANCET, V1, P1041; SYKES B, 1990, NATURE, V348, P18, DOI 10.1038/348018a0; TAKEUCHI Y, 1993, J BONE MINER RES, V8, P823; Ward L M, 2001, Hum Mutat, V17, P434, DOI 10.1002/humu.1124; YANAGISHITA M, 1989, METHOD ENZYMOL, V179, P435; ZEBROWER ME, 1986, ANAL BIOCHEM, V157, P93, DOI 10.1016/0003-2697(86)90201-0	58	61	63	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2002	277	46					43638	43647		10.1074/jbc.M202124200	http://dx.doi.org/10.1074/jbc.M202124200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	615XE	12221073	hybrid			2022-12-27	WOS:000179272000015
J	Gual, P; Shigematsu, S; Kanzaki, M; Gremeaux, T; Gonzalez, T; Pessin, JE; Le Marchand-Brustel, Y; Tanti, JF				Gual, P; Shigematsu, S; Kanzaki, M; Gremeaux, T; Gonzalez, T; Pessin, JE; Le Marchand-Brustel, Y; Tanti, JF			A Crk-II/TC10 signaling pathway is required for osmotic shock-stimulated glucose transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOLIPASE C-GAMMA; BINDING PROTEIN-RHO; DIFFICILE TOXIN-B; 3T3-L1 ADIPOCYTES; INSULIN-RECEPTOR; CLOSTRIDIUM-DIFFICILE; GLUT4 TRANSLOCATION; HYPEROSMOTIC STRESS; COMPLEX-FORMATION; 3T3L1 ADIPOCYTES	Osmotic shock stimulates the translocation of the glucose transporter Glut 4 to plasma membrane by a tyrosine kinase signaling pathway involving Gab-1 (the Grb2-associated binder-1 protein). We show here that, in response to osmotic shock, Gab-1 acts as a docking protein for phospholipase Cgammal, the p85 subunit of the phosphoinositide 3-kinase and Crk-II. It has been shown that the adapter Crk-II is constitutively associated with C3G, a GDP to GTP exchange factor for several small GTP-binding proteins. We found that inhibition of the activity of phosphoinositide 3-kinase or phospholipase C did not prevent the stimulation of glucose transport by osmotic shock, whereas inactivation of Rho proteins by Clostridium difficile toxin B severely inhibited glucose uptake. Among the Rho family members, overexpression of dominant-interfering TC10/T31N mutant inhibited osmotic shock-mediated Glut 4 translocation suggesting that TC10 is required for this process. Further, disruption of cortical actin integrity by latrunculin B or jasplakinolide severely impaired osmotic shock-induced glucose transport. In contrast, osmotic shock increased the amount of cortical actin associated with caveolin-enriched plasma membrane domains. These data provide the first evidence that activation of TC10 and remodeling of cortical actin, which could occur through the TC10 signaling, are required for osmotic shock-mediated Glut 4 translocation and glucose uptake.	INSERM, U568, Fac Med, F-06107 Nice 02, France; IFR 50, Fac Med, F-06107 Nice, France; Univ Iowa, Dept Physiol & Biophys, Iowa City, IA 52242 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; University of Iowa	Tanti, JF (corresponding author), INSERM, U568, Fac Med, Ave Vallombrose, F-06107 Nice 02, France.		Gual, Philippe/M-8787-2017; Gual, Philippe/P-9833-2019; Kanzaki, Makoto/H-6680-2017	Gual, Philippe/0000-0001-7393-8356; Gual, Philippe/0000-0001-7393-8356; Kanzaki, Makoto/0000-0002-6884-2955; Gonzalez, Teresa/0000-0001-7558-6833; Tanti, Jean-Francois/0000-0003-1782-1318				Ahmed Z, 2000, FEBS LETT, V475, P31, DOI 10.1016/S0014-5793(00)01621-5; Barros LF, 2001, PFLUG ARCH EUR J PHY, V442, P614; Baumann CA, 2000, NATURE, V407, P202, DOI 10.1038/35025089; Chen D, 1999, MOL CELL BIOL, V19, P4684; Chen D, 1997, J BIOL CHEM, V272, P27401, DOI 10.1074/jbc.272.43.27401; Chiang SH, 2001, NATURE, V410, P944, DOI 10.1038/35073608; Feller SM, 2001, ONCOGENE, V20, P6348, DOI 10.1038/sj.onc.1204779; Garcia-Guzman M, 1999, ONCOGENE, V18, P7775, DOI 10.1038/sj.onc.1203198; Gual P, 2000, ONCOGENE, V19, P1509, DOI 10.1038/sj.onc.1203514; HolgadoMadruga M, 1996, NATURE, V379, P560, DOI 10.1038/379560a0; HolgadoMadruga M, 1997, P NATL ACAD SCI USA, V94, P12419, DOI 10.1073/pnas.94.23.12419; Holman GD, 2001, TRENDS CELL BIOL, V11, P173, DOI 10.1016/S0962-8924(01)01953-5; Janez A, 2000, J BIOL CHEM, V275, P26870; JUST I, 1995, J CLIN INVEST, V95, P1026, DOI 10.1172/JCI117747; JUST I, 1994, J BIOL CHEM, V269, P10706; JUST I, 1995, NATURE, V375, P500, DOI 10.1038/375500a0; Kanzaki M, 2002, J BIOL CHEM, V277, P25867, DOI 10.1074/jbc.C200292200; Kanzaki M, 2001, J BIOL CHEM, V276, P42436, DOI 10.1074/jbc.M108297200; Kanzaki M, 2001, J BIOL CHEM, V276, P49331, DOI 10.1074/jbc.M109657200; Kayali AG, 1998, J BIOL CHEM, V273, P13808, DOI 10.1074/jbc.273.22.13808; KIM HK, 1991, CELL, V65, P435, DOI 10.1016/0092-8674(91)90461-7; Kultz D, 2001, COMP BIOCHEM PHYS A, V130, P421, DOI 10.1016/S1095-6433(01)00440-8; Li DL, 2001, J BIOL CHEM, V276, P22883, DOI 10.1074/jbc.M010143200; Meier R, 1998, EMBO J, V17, P7294, DOI 10.1093/emboj/17.24.7294; Sakaue H, 1997, MOL ENDOCRINOL, V11, P1552, DOI 10.1210/me.11.10.1552; Sakkab D, 2000, J BIOL CHEM, V275, P10772, DOI 10.1074/jbc.275.15.10772; Saltiel AR, 2002, TRENDS CELL BIOL, V12, P65, DOI 10.1016/S0962-8924(01)02207-3; STUDENT AK, 1980, J BIOL CHEM, V255, P4745; TANTI JF, 1994, J BIOL CHEM, V269, P6051; Thurmond DC, 2001, MOL MEMBR BIOL, V18, P237; Tong P, 2001, J CLIN INVEST, V108, P371, DOI 10.1172/JCI12348; Ueno E, 2001, HORM METAB RES, V33, P402, DOI 10.1055/s-2001-16227; Waters MG, 2000, TRAFFIC, V1, P588, DOI 10.1034/j.1600-0854.2000.010802.x; Watson RT, 2001, EXP CELL RES, V271, P75, DOI 10.1006/excr.2001.5375; Watson RT, 2000, J BIOL CHEM, V275, P1261, DOI 10.1074/jbc.275.2.1261; Weidner KM, 1996, NATURE, V384, P173, DOI 10.1038/384173a0; Zhang XY, 2001, J BIOL CHEM, V276, P46745, DOI 10.1074/jbc.M107464200	37	27	27	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	2002	277	46					43980	43986		10.1074/jbc.M203042200	http://dx.doi.org/10.1074/jbc.M203042200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	615XE	12215429	hybrid			2022-12-27	WOS:000179272000059
J	Slabas, AR; Kroon, JTM; Scheirer, TP; Gilroy, JS; Hayman, M; Rice, DW; Turnbull, AP; Rafferty, JB; Fawcett, T; Simon, WJ				Slabas, AR; Kroon, JTM; Scheirer, TP; Gilroy, JS; Hayman, M; Rice, DW; Turnbull, AP; Rafferty, JB; Fawcett, T; Simon, WJ			Squash glycerol-3-phosphate (1)-acyltransferase - Alteration of substrate selectivity and identification of arginine and lysine residues important in catalytic activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHILLING-SENSITIVE PLANT; SN-GLYCEROL-3-PHOSPHATE ACYLTRANSFERASE; ARABIDOPSIS-THALIANA; AMARANTHUS-LIVIDUS; ESCHERICHIA-COLI; LIPIDS; CHLOROPLASTS; SPECIFICITY; PEA; PURIFICATION	Glycerol-3-phosphate 1-acyltransferase is a soluble chloroplast enzyme involved in glycerol-lipid biosynthesis associated with chilling resistance in plants (1). Resistance is associated with higher selectivity for unsaturated acyl substrates over saturated ones. In vitro substrate selectivity assays performed under physiologically relevant conditions have been established that discriminate between selective and non-selective forms of the enzyme. A mutation, L261F, in the squash protein converts it from a non-selective enzyme into a selective one. The mutation lies within 10 Angstrom of the predicted acyl binding site and results in a higher K-m for 16:0 acyl carrier protein (ACP). Site-directed mutagenesis was used to determine the importance of four residues, Arg(235), Arg(237), Lys(193), and His(194), implicated to be in volved in binding of the phosphate group of glycerol 3-phosphate to the enzyme. All the proteins were highly homologous in structure to the wild type enzyme. Mutations in Arg(235), Arg(237), and Lys(193) resulted in inactive enzyme, while His 194 had reduced catalytic activity. The mutant proteins retained the ability to bind stoichiometric quantities of acyl-ACPs supporting the potential role of these residues in glycerol 3-phosphate binding.	Univ Durham, Sci Labs, Dept Biol & Biomed Sci, Durham DH1 3LE, England; Univ Sheffield, Dept Mol Biol & Biotechnol, Krebs Inst Biomol Res, Sheffield S10 2TN, S Yorkshire, England	Durham University; University of Sheffield	Slabas, AR (corresponding author), Univ Durham, Sci Labs, Dept Biol & Biomed Sci, Durham DH1 3LE, England.		Kroon, Johan Theodorus Maria/S-8415-2019; Fawcett, Tony/O-8033-2015	Kroon, Johan Theodorus Maria/0000-0003-2086-6074; Fawcett, Tony/0000-0001-7657-0120; Rafferty, John/0000-0003-1183-7474				[Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Broun P, 1998, SCIENCE, V282, P1315, DOI 10.1126/science.282.5392.1315; Brown AP, 1998, PLANT PHYSIOL BIOCH, V36, P629, DOI 10.1016/S0981-9428(98)80011-9; CRONAN JE, 1987, PLANT PHYSIOL, V83, P676, DOI 10.1104/pp.83.3.676; Ferri SR, 1997, ARCH BIOCHEM BIOPHYS, V337, P202, DOI 10.1006/abbi.1996.9769; FRENTZEN M, 1983, EUR J BIOCHEM, V129, P629; FRENTZEN M, 1987, PLANT CELL PHYSIOL, V28, P1195; GREEN PR, 1981, J BIOL CHEM, V256, P1151; Hayman MW, 2002, FEBS LETT, V514, P281, DOI 10.1016/S0014-5793(02)02381-5; Heath RJ, 1998, J BACTERIOL, V180, P1425, DOI 10.1128/JB.180.6.1425-1430.1998; ISHIZAKI O, 1988, FEBS LETT, V238, P424, DOI 10.1016/0014-5793(88)80525-8; JOHNSON BH, 1994, BIO-TECHNOL, V12, P1357, DOI 10.1038/nbt1294-1357; LEEGOOD RC, 1993, PLANT BIOCH MOL BIOL, P30; Lewin TM, 1999, BIOCHEMISTRY-US, V38, P5764, DOI 10.1021/bi982805d; MURATA N, 1983, PLANT CELL PHYSIOL, V24, P81, DOI 10.1093/oxfordjournals.pcp.a076516; MURATA N, 1992, NATURE, V356, P710, DOI 10.1038/356710a0; Murata N, 1997, BBA-LIPID LIPID MET, V1348, P10, DOI 10.1016/S0005-2760(97)00115-X; NISHIDA I, 1993, PLANT MOL BIOL, V21, P267, DOI 10.1007/BF00019943; ROUGHAN G, 1990, ARCH BIOCHEM BIOPHYS, V276, P38, DOI 10.1016/0003-9861(90)90007-L; SAUER A, 1984, Z NATURFORSCH C, V39, P593; SIMON JW, 2002, MOL STRUCTURAL STUDI; Slabas AR, 2001, J PLANT PHYSIOL, V158, P505, DOI 10.1078/0176-1617-00363; SOL J, 1982, FEBS LETT, V146, P189; Turnbull AP, 2001, STRUCTURE, V9, P347, DOI 10.1016/S0969-2126(01)00595-0; WEBER S, 1991, PLANT MOL BIOL, V17, P1067, DOI 10.1007/BF00037145; WOLTER FP, 1992, EMBO J, V11, P4685, DOI 10.1002/j.1460-2075.1992.tb05573.x	26	19	20	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	2002	277	46					43918	43923		10.1074/jbc.M206429200	http://dx.doi.org/10.1074/jbc.M206429200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	615XE	12205087	hybrid			2022-12-27	WOS:000179272000051
J	Aziz, QH; Partridge, CJ; Munsey, TS; Sivaprasadarao, A				Aziz, QH; Partridge, CJ; Munsey, TS; Sivaprasadarao, A			Depolarization induces intersubunit cross-linking in a S4 cysteine mutant of the shaker potassium channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED K+ CHANNEL; SLOW INACTIVATION; VOLTAGE SENSOR; ION CHANNELS; MOVEMENT; ACTIVATION; SEGMENT; DOMAIN; PORE; CONFORMATIONS	Voltage-gated potassium (K-v) channels are integral membrane proteins, composed of four subunits, each comprising six (S1-S6) transmembrane segments. S1-S4 comprise the voltage-sensing domain, and S5-S6 with the linker P-loop forms the ion conducting pore domain. During activation, S4 undergoes structural rearrangements that lead to the opening of the channel pore and ion conduction. To obtain details of these structural changes we have used the engineered disulfide bridge approach. For this we have introduced the L361C mutation at the extracellular end of S4 of the Shaker K channel and expressed the mutant channel in Xenopus oocytes. When exposed to mild oxidizing conditions (ambient oxygen or copper phenanthroline), Cys-361 formed an intersubunit disulfide bridge as revealed by the appearance of a dimeric band on Western blotting. As a consequence, the mutant channel suffered a significant loss in conductance (measured by two-electrode voltage clamp). Removal of native cysteines failed to prevent the disulfide formation, indicating that Cys-361 forms a disulfide with its counterpart in the neighboring subunit. The effect was voltage-dependent and occurred during channel activation after Cys-361 has been exposed to the extracellular phase. Although the disulfide bridge reduced the maximal conductance, it caused a hyperpolarizing shift in the conductance-voltage relationship and reduced the deactivation kinetics of the channel. The latter two effects suggest stabilization of the open state of the channel. In conclusion, we report that during activation the intersubunit distance between the N-terminal ends of the S4 segments of the L361C mutant Shaker K channel is reduced.	Univ Leeds, Sch Biomed Sci, Leeds LS2 9JT, W Yorkshire, England	University of Leeds	Sivaprasadarao, A (corresponding author), Univ Leeds, Sch Biomed Sci, Leeds LS2 9JT, W Yorkshire, England.		Aziz, Qasim/AAC-4730-2020	Aziz, Qadeer/0000-0002-7636-6813; Sivaprasadarao, Asipu/0000-0002-6755-3502				Baker OS, 1998, NEURON, V20, P1283, DOI 10.1016/S0896-6273(00)80507-3; Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; Blaustein RO, 2000, NAT STRUCT BIOL, V7, P309; BOLAND LM, 1994, BIOPHYS J, V66, P694, DOI 10.1016/S0006-3495(94)80843-4; Cha A, 1999, NATURE, V402, P809, DOI 10.1038/45552; CHERVITZ SA, 1995, J BIOL CHEM, V270, P24043, DOI 10.1074/jbc.270.41.24043; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Durell SR, 1998, J STRUCT BIOL, V121, P263, DOI 10.1006/jsbi.1998.3962; Elinder F, 2001, J GEN PHYSIOL, V118, P1, DOI 10.1085/jgp.118.1.1; Elinder F, 2001, BIOPHYS J, V80, P1802, DOI 10.1016/S0006-3495(01)76150-4; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; Gandhi CS, 2000, NEURON, V27, P585, DOI 10.1016/S0896-6273(00)00068-4; Glauner KS, 1999, NATURE, V402, P813, DOI 10.1038/45561; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; Krovetz HS, 1997, BIOPHYS J, V72, P117, DOI 10.1016/S0006-3495(97)78651-X; Larsson HP, 2000, NEURON, V27, P573, DOI 10.1016/S0896-6273(00)00067-2; Larsson HP, 1996, NEURON, V16, P387, DOI 10.1016/S0896-6273(00)80056-2; Li-Smerin YY, 2000, NEURON, V25, P411, DOI 10.1016/S0896-6273(00)80904-6; Li-Smerin YY, 2000, J GEN PHYSIOL, V115, P33, DOI 10.1085/jgp.115.1.33; Liu DT, 1998, NEURON, V21, P235, DOI 10.1016/S0896-6273(00)80530-9; Liu Y, 1996, NEURON, V16, P859, DOI 10.1016/S0896-6273(00)80106-3; Loots E, 2000, J GEN PHYSIOL, V116, P623, DOI 10.1085/jgp.116.5.623; Loots E, 1998, J GEN PHYSIOL, V112, P377, DOI 10.1085/jgp.112.4.377; MacKinnon R, 1998, SCIENCE, V280, P106, DOI 10.1126/science.280.5360.106; Monks SA, 1999, J GEN PHYSIOL, V113, P415, DOI 10.1085/jgp.113.3.415; Olcese R, 1997, J GEN PHYSIOL, V110, P579, DOI 10.1085/jgp.110.5.579; Ruegg U T, 1977, Methods Enzymol, V47, P111; Schumacher MA, 2001, NATURE, V410, P1120, DOI 10.1038/35074145; Shammat IM, 1999, NEURON, V23, P809, DOI 10.1016/S0896-6273(01)80038-6; SIGWORTH FJ, 1994, Q REV BIOPHYS, V27, P1, DOI 10.1017/S0033583500002894; Tiwari-Woodruff SK, 2000, J GEN PHYSIOL, V115, P123, DOI 10.1085/jgp.115.2.123; TiwariWoodruff SK, 1997, BIOPHYS J, V72, P1489, DOI 10.1016/S0006-3495(97)78797-6; Tu LW, 1999, BIOPHYS J, V76, P2004, DOI 10.1016/S0006-3495(99)77358-3; Wang MH, 1999, J PHYSIOL-LONDON, V521, P315, DOI 10.1111/j.1469-7793.1999.00315.x; YANG NB, 1995, NEURON, V15, P213, DOI 10.1016/0896-6273(95)90078-0; Yellen G, 2001, TRENDS PHARMACOL SCI, V22, P439, DOI 10.1016/S0165-6147(00)01798-3; Yellen G, 1998, Q REV BIOPHYS, V31, P239, DOI 10.1017/S0033583598003448; Yusaf SP, 1996, PFLUG ARCH EUR J PHY, V433, P91, DOI 10.1007/s004240050253; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	40	28	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					42719	42725		10.1074/jbc.M207258200	http://dx.doi.org/10.1074/jbc.M207258200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12196543	hybrid			2022-12-27	WOS:000179081200039
J	Braathen, R; Sorensen, V; Brandtzaeg, P; Sandlie, I; Johansen, FE				Braathen, R; Sorensen, V; Brandtzaeg, P; Sandlie, I; Johansen, FE			The carboxyl-terminal domains of IgA and IgM direct Isotype-specific polymerization and interaction with the polymeric immunoglobulin receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN SECRETORY COMPONENT; MEDIATED EPITHELIAL TRANSPORT; J-CHAIN; DIMERIC IGA; STRUCTURAL REQUIREMENTS; EFFECTOR FUNCTIONS; C-ALPHA-3 DOMAIN; PENTAMERIC IGM; IN-VITRO; ANTIBODIES	Mucosal surfaces are protected by polymeric immunoglobulins that are transported across the epithelium by the polymeric immunoglobulin receptor (pIgR). Only polymeric IgA and IgM containing a small polypeptide called the "joining" (J) chain can bind to the pIgR. J chain-positive IgA consists of dimers, and some larger polymers, whereas only IgM pentamers incorporate the J chain. We made domain swap chimeras between human IgA1 and IgM and found that the COOH-terminal domains of the heavy chains (Calpha3 and Cmu4, respectively) dictated the size of the polymers formed and also which polymers incorporated the J chain. We also showed that chimeric IgM molecules engineered to contain Calpha3 were able to bind the rabbit pIgR. Since the rabbit pIgR normally does not bind IgM, these results suggest that the COOH-terminal domain of the polymeric immunoglobulins is primarily responsible for interaction with the pIgR. Finally, we made a novel chimeric IgA immunoglobulin, containing the terminal domain from IgM. This recombinant molecule formed J chain-containing pentamers that could, like IgA, efficiently form covalent complexes with the human pIgR ectodomain, known as secretory component.	Univ Oslo, Inst Pathol, Rikshosp, Lab Immunohistochem & Immunopathol, N-0027 Oslo, Norway; Univ Oslo, Inst Biol, Dept Mol Cell Biol, N-0316 Oslo, Norway	University of Oslo; National Hospital Norway; University of Oslo	Braathen, R (corresponding author), Univ Oslo, Inst Pathol, Rikshosp, Lab Immunohistochem & Immunopathol, N-0027 Oslo, Norway.	ranveig.braathen@labmed.uio.no						BEALE D, 1969, BIOCHEM J, V112, P187, DOI 10.1042/bj1120187; BORNEMANN KD, 1995, P NATL ACAD SCI USA, V92, P4912, DOI 10.1073/pnas.92.11.4912; BRANDTZAEG P, 1975, SCAND J IMMUNOL, V4, P837, DOI 10.1111/j.1365-3083.1975.tb03725.x; BRANDTZAEG P, 1977, IMMUNOCHEMISTRY, V14, P179, DOI 10.1016/0019-2791(77)90192-6; Brandtzaeg P, 1999, IMMUNOL REV, V171, P45, DOI 10.1111/j.1600-065X.1999.tb01342.x; BRANDTZAEG P, 1976, SCAND J IMMUNOL, V5, P411, DOI 10.1111/j.1365-3083.1976.tb00295.x; BRANDTZAEG P, 1974, SCAND J IMMUNOL, V3, P579, DOI 10.1111/j.1365-3083.1974.tb01291.x; BRANDTZAEG P, 1984, NATURE, V311, P71, DOI 10.1038/311071a0; BRANDTZAEG P, 1975, SCAND J IMMUNOL, V4, P309, DOI 10.1111/j.1365-3083.1975.tb02631.x; Brewer JW, 1997, MOL IMMUNOL, V34, P323, DOI 10.1016/S0161-5890(97)00029-1; CARAYANNOPOULOS L, 1994, P NATL ACAD SCI USA, V91, P8348, DOI 10.1073/pnas.91.18.8348; CATTANEO A, 1987, EMBO J, V6, P2753, DOI 10.1002/j.1460-2075.1987.tb02569.x; Chintalacharuvu KR, 2001, CLIN IMMUNOL, V101, P21, DOI 10.1006/clim.2001.5083; Crottet P, 1998, J IMMUNOL, V161, P5445; DAVIS AC, 1989, EMBO J, V8, P2519, DOI 10.1002/j.1460-2075.1989.tb08389.x; ESKELAND T, 1974, IMMUNOCHEMISTRY, V11, P161, DOI 10.1016/0019-2791(74)90214-6; FALLGREENGEBAUER E, 1993, BIOL CHEM H-S, V374, P1023, DOI 10.1515/bchm3.1993.374.7-12.1023; HENDRICKSON BA, 1995, J EXP MED, V182, P1905, DOI 10.1084/jem.182.6.1905; Hexham JM, 1999, J EXP MED, V189, P747, DOI 10.1084/jem.189.4.747; Johansen FE, 1999, EUR J IMMUNOL, V29, P1701, DOI 10.1002/(SICI)1521-4141(199905)29:05<1701::AID-IMMU1701>3.0.CO;2-Z; Johansen FE, 2000, SCAND J IMMUNOL, V52, P240; Johansen FE, 2001, J IMMUNOL, V167, P5185, DOI 10.4049/jimmunol.167.9.5185; KABAT EA, 1991, SEQUENCES PROTEINS I, P661; KOHLER G, 1982, EMBO J, V1, P555, DOI 10.1002/j.1460-2075.1982.tb01208.x; Krugmann S, 1997, J IMMUNOL, V159, P244; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; MA JKC, 1995, SCIENCE, V268, P716, DOI 10.1126/science.7732380; MACH JP, 1970, NATURE, V228, P1278, DOI 10.1038/2281278a0; MILSTEIN CP, 1975, BIOCHEM J, V151, P615, DOI 10.1042/bj1510615; MOSTOV K, 1999, MUCOSAL IMMUNOLOGY, P181; Natvig IB, 1997, J IMMUNOL, V159, P4330; NILES MJ, 1995, P NATL ACAD SCI USA, V92, P2884, DOI 10.1073/pnas.92.7.2884; Norderhaug IN, 1999, EUR J IMMUNOL, V29, P3401, DOI 10.1002/(SICI)1521-4141(199910)29:10<3401::AID-IMMU3401>3.0.CO;2-G; Norderhaug IN, 1999, CRIT REV IMMUNOL, V19, P481; POON PH, 1995, J BIOL CHEM, V270, P8571, DOI 10.1074/jbc.270.15.8571; RANDALL TD, 1992, J BIOL CHEM, V267, P18002; Roe M, 1999, J IMMUNOL, V162, P6046; SITIA R, 1990, CELL, V60, P781, DOI 10.1016/0092-8674(90)90092-S; SMITH RIF, 1994, BIO-TECHNOL, V12, P683, DOI 10.1038/nbt0794-683; SMITH RIF, 1995, J IMMUNOL, V154, P2226; Sorensen V, 1996, J IMMUNOL, V156, P2858; Sorensen V, 1999, J IMMUNOL, V162, P3448; Sorensen V, 2000, INT IMMUNOL, V12, P19, DOI 10.1093/intimm/12.1.19; SWITZER IC, 1992, MOL IMMUNOL, V29, P31, DOI 10.1016/0161-5890(92)90153-O; Vaerman JP, 1998, IMMUNOLOGY, V95, P90; Vaerman JP, 1998, EUR J IMMUNOL, V28, P171, DOI 10.1002/(SICI)1521-4141(199801)28:01<171::AID-IMMU171>3.0.CO;2-#; VAERMAN JP, 1995, IMMUNOL INVEST, V24, P631, DOI 10.3109/08820139509066863; WARR GW, 1995, IMMUNOL TODAY, V16, P392, DOI 10.1016/0167-5699(95)80008-5; WEICKER J, 1975, J IMMUNOL, V114, P1337; WIERSMA EJ, 1995, J IMMUNOL, V154, P5265; Wiersma EJ, 1998, J IMMUNOL, V160, P5979; Yoo EM, 1999, J BIOL CHEM, V274, P33771, DOI 10.1074/jbc.274.47.33771	52	41	51	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					42755	42762		10.1074/jbc.M205502200	http://dx.doi.org/10.1074/jbc.M205502200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12213814	Green Published, hybrid			2022-12-27	WOS:000179081200044
J	Hoffmann, N; Amara, AA; Beermann, BB; Q, QS; Hinz, HJ; Rehm, BHA				Hoffmann, N; Amara, AA; Beermann, BB; Q, QS; Hinz, HJ; Rehm, BHA			Biochemical characterization of the Pseudomonas putida 3-hydroxyacyl ACP : CoA transacylase, which diverts intermediates of fatty acid de novo biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARRIER PROTEIN TRANSACYLASE; CHAIN-LENGTH CONSTITUENTS; NONRELATED CARBON-SOURCES; ESCHERICHIA-COLI; POLYHYDROXYALKANOIC ACID; PHAG GENE; COENZYME-A; AERUGINOSA; SYNTHASE; OLEOVORANS	The 3-hydroxyacyl ACP:CoA transacylase (PhaG) wasrecently identified in various Pseudomonas species and catalyzes the diversion of ACP thioester intermediates of fatty acid de novo biosynthesis toward the respective CoA thioesters, which serve as precursors for polyester and rhamnolipid biosynthesis. PhaG from Pseudomonas putida was overproduced in Escherichia coli as a C-terminal hexahistidine-tagged (His(6)) fusion protein in high yield. The His(6)-PhaG was purified to homogeneity by refolding of PhaG obtained from inclusion bodies, and a new enzyme assay was established. Kinetic analysis of the 3-hydroxyacyl transfer to ACP, catalyzed by His(6)-PhaG, gave K-0.5 values of 28 mum (ACP) and 65 mum (3-hydroxyacyl-CoA) considering V-max values of 11.7 milliunits/mg and 12.4 milliunits/mg, respectively. A Hill coefficient of 1.38 (ACP) and 1.32 (3-hydroxyacyl-CoA) indicated a positive substrate cooperativity. Subcellular localization studies showed that PhaG is not attached to polyester granules and resides in the cytosol. Gel filtration chromatography analysis in combination with light scattering analysis indicated substrate-induced dimerization of the transacylase. A threading model of PhaG was developed based on the homology to an epoxide hydrolase (1cqz). In addition, the alignment with the alpha/beta-hydrolase fold region indicated that PhaG belongs to alpha/beta-hydrolase superfamily. Accordingly, CD analysis suggested a secondary structure composition of 29% alpha-helix, 22% beta-sheet, 18% beta-turn, and 31% random coil. Site-specific mutagenesis of seven highly conserved amino acid residues (Asp-60, Ser-102, His-177, Asp-182, His-192, Asp-223, His-251) was used to validate the protein model and to investigate organization of the transacylase active site. Only the D182(A/E) mutation was permissive with about 30% specific activity of the wild type enzyme. Furthermore, this mutation caused a change in substrate specificity, indicating a functional role in substrate binding. The serine-specific agent phenylmethylsulfonyl fluoride (PMSF) or the histidine-specific agent diethylpyrocarbonate (DEPC) caused inhibition of 3-hydroxyacyl transfer to holo-ACP, and the S102(A/T) or H251(A/R) PhaG mutant was incapable of catalyzing 3-hydroxyacyl transfer, suggesting that these residues are part of a catalytic triad.	Univ Munster, Inst Mikrobiol, D-48149 Munster, Germany; Univ Munster, Inst Phys Chem, D-48149 Munster, Germany	University of Munster; University of Munster	Rehm, BHA (corresponding author), Univ Munster, Inst Mikrobiol, Corrensstr 3, D-48149 Munster, Germany.		Rehm, Bernd HA/B-3675-2011; Amara, Amro A/E-3889-2010; Qi, Qingsheng/F-7418-2013	Amara, Amro A/0000-0003-4629-5476; Rehm, Bernd/0000-0003-3908-8903				Argiriadi MA, 1999, P NATL ACAD SCI USA, V96, P10637, DOI 10.1073/pnas.96.19.10637; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; BRANDL H, 1988, APPL ENVIRON MICROB, V54, P1977, DOI 10.1128/AEM.54.8.1977-1982.1988; BULLOCK WO, 1987, BIOTECHNIQUES, V5, P376; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Fiedler S, 2000, APPL ENVIRON MICROB, V66, P2117, DOI 10.1128/AEM.66.5.2117-2124.2000; Fischer D, 1996, PROTEIN SCI, V5, P947; Gokhale RS, 1998, BIOCHEMISTRY-US, V37, P2524, DOI 10.1021/bi971887n; Hoffmann N, 2000, FEMS MICROBIOL LETT, V184, P253, DOI 10.1016/S0378-1097(00)00047-1; Hoffmann N, 2000, APPL MICROBIOL BIOT, V54, P665, DOI 10.1007/s002530000441; Joshi AK, 1998, BIOCHEMISTRY-US, V37, P2515, DOI 10.1021/bi971886v; JOSHI VC, 1971, ARCH BIOCHEM BIOPHYS, V143, P493, DOI 10.1016/0003-9861(71)90234-7; Karplus K, 1998, BIOINFORMATICS, V14, P846, DOI 10.1093/bioinformatics/14.10.846; KELLEY LA, 1999, ASS COMPUTING MACH; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LIPMANN F, 1950, BIOCHIM BIOPHYS ACTA, V4, P301, DOI 10.1016/0006-3002(50)90036-9; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Matsumoto K, 2001, BIOMACROMOLECULES, V2, P142, DOI 10.1021/bm005604+; Miles E W, 1977, Methods Enzymol, V47, P431; Rehm BH, 1996, J BACTERIOL, V178, P3346, DOI 10.1128/jb.178.11.3346-3349.1996; Rehm BHA, 1998, J BIOL CHEM, V273, P24044, DOI 10.1074/jbc.273.37.24044; Rehm BHA, 2001, APPL ENVIRON MICROB, V67, P3102, DOI 10.1128/AEM.67.7.3102-3109.2001; Sambrook J., 2002, MOL CLONING LAB MANU; SERRE L, 1995, J BIOL CHEM, V270, P12961, DOI 10.1074/jbc.270.22.12961; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; TIMM A, 1990, APPL ENVIRON MICROB, V56, P3360, DOI 10.1128/AEM.56.11.3360-3367.1990; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350	28	41	44	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					42926	42936		10.1074/jbc.M207821200	http://dx.doi.org/10.1074/jbc.M207821200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12200450	hybrid, Green Published			2022-12-27	WOS:000179081200066
J	Lutz, C; Nimpf, J; Jenny, M; Boecklinger, K; Enzinger, C; Utermann, G; Baier-Bitterlich, G; Baier, G				Lutz, C; Nimpf, J; Jenny, M; Boecklinger, K; Enzinger, C; Utermann, G; Baier-Bitterlich, G; Baier, G			Evidence of functional modulation of the MEKK/JNK/cJun signaling cascade by the low density lipoprotein receptor-related protein (LRP)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; N-TERMINAL KINASE; APOLIPOPROTEIN-E RECEPTORS; FACTOR-INDUCED ACTIVATION; T-CELL-ACTIVATION; NEURITE OUTGROWTH; TYROSINE PHOSPHORYLATION; ALZHEIMERS-DISEASE; CYTOPLASMIC DOMAIN; CYTOSOLIC ADAPTER	Lipoprotein receptors, such as LRP, have been shown to assemble multiprotein complexes containing intracellular signaling molecules; however, in vivo, their signaling function is poorly understood. Using a novel LRP receptor fusion construct, a type I transmembrane protein chimera, termed sIgG-LRP (bearing the intracellular COOH-terminal tail of human LRP as recombinant fusion to a transmembrane region plus the extracellular IgG-F-c domain), we here investigated LRP signal transduction specificity in intact cells. First and similar to activated alpha2-macroglobulin as agonist of endogenous LRP, expression of sIgG-LRP demonstrated significant apoptosis protection. Second and similar to a2-macroglobulin-induced endogenous LRP, sIgG-LRP is sufficient to negatively modulate mitogen-induced Elk-1 and cJun (but not NF-kappaB) transcriptional activity. Third, expression of sIgG-LRP also impaired cJun transactivation mediated by constitutive active mutants of Rac-1 and MEKK-1. Fourth and unexpectedly, sIgG-LRP expression was found to be associated with a marked enhancement of mitogen-induced cJun amino-terminal kinase (JNK) activation. Fifth, confocal microscopic examination and subcellular fractionation demonstrated that sIgG-LRP and JNK co-localize in transfected cells. Therefore, sIgG-LRP expression was found to significantly impair activation-induced translocation of JNK into the nucleus. Taken together, we here demonstrate that sIgG-LRP protein sequesters activated JNK into the plasma membrane compartment in intact cells, inhibiting nuclear activation of the JNK-dependent transcription factors Elk-1 and cJun.	Univ Innsbruck, Inst Med Biol & Human Genet, A-6020 Innsbruck, Austria; Univ Innsbruck, Inst Med Chem & Biochem, A-6020 Innsbruck, Austria; Univ Vienna, Inst Med Biochem, A-1030 Vienna, Austria; Bioctr, A-1030 Vienna, Austria	University of Innsbruck; University of Innsbruck; University of Vienna	Baier, G (corresponding author), Univ Innsbruck, Inst Med Biol & Human Genet, Schoepfstr 41, A-6020 Innsbruck, Austria.	Gottfried.Baier@uibk.ac.at	Baier, Gottfried/E-8755-2012	Baier, Gottfried/0000-0002-2085-8325; Nimpf, Johannes/0000-0002-9273-3492				Barnes H, 2001, J BIOL CHEM, V276, P19119, DOI 10.1074/jbc.M011437200; Bauer B, 2000, EUR J IMMUNOL, V30, P3645, DOI 10.1002/1521-4141(200012)30:12<3645::AID-IMMU3645>3.0.CO;2-#; BELLOSTA S, 1995, J BIOL CHEM, V270, P27063, DOI 10.1074/jbc.270.45.27063; Bonny C, 1998, J BIOL CHEM, V273, P1843, DOI 10.1074/jbc.273.4.1843; Boucher P, 2002, J BIOL CHEM, V277, P15507, DOI 10.1074/jbc.M200428200; Buschmann T, 2001, MOL CELL BIOL, V21, P2743, DOI 10.1128/MCB.21.8.2743-2754.2001; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; CAVIGELLI M, 1995, EMBO J, V14, P5957, DOI 10.1002/j.1460-2075.1995.tb00284.x; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Dickens M, 1997, SCIENCE, V277, P693, DOI 10.1126/science.277.5326.693; Enzinger C, 2002, EUR J CELL BIOL, V81, P197, DOI 10.1078/0171-9335-00236; Fagan AM, 1996, J BIOL CHEM, V271, P30121, DOI 10.1074/jbc.271.47.30121; Fuchs SY, 1998, P NATL ACAD SCI USA, V95, P10541, DOI 10.1073/pnas.95.18.10541; Ghaffari-Tabrizi N, 1999, EUR J IMMUNOL, V29, P132; Gotthardt M, 2000, J BIOL CHEM, V275, P25616, DOI 10.1074/jbc.M000955200; Hashimoto A, 1999, J BIOL CHEM, V274, P20139, DOI 10.1074/jbc.274.29.20139; Hashimoto K, 2001, J NEUROSCI, V21, P9701, DOI 10.1523/JNEUROSCI.21-24-09701.2001; HATTEN ME, 1985, J CELL BIOL, V100, P384, DOI 10.1083/jcb.100.2.384; Herz J, 2000, NAT REV NEUROSCI, V1, P51, DOI 10.1038/35036221; HERZ J, 1992, CELL, V71, P411, DOI 10.1016/0092-8674(92)90511-A; Herz J, 2001, NEURON, V29, P571, DOI 10.1016/S0896-6273(01)00234-3; Herz J, 2000, CURR OPIN LIPIDOL, V11, P161, DOI 10.1097/00041433-200004000-00009; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; Ho YY, 2001, J BIOL CHEM, V276, P43455, DOI 10.1074/jbc.M105325200; HOLTZMAN DM, 1995, P NATL ACAD SCI USA, V92, P9480, DOI 10.1073/pnas.92.21.9480; Inamura N, 2001, BRAIN RES, V904, P270, DOI 10.1016/S0006-8993(01)02472-6; Kang DE, 1997, NEUROLOGY, V49, P56, DOI 10.1212/WNL.49.1.56; Kerkhoff E, 2001, CURR BIOL, V11, P1963, DOI 10.1016/S0960-9822(01)00602-9; Kinoshita A, 2001, J NEUROSCI, V21, P8354, DOI 10.1523/JNEUROSCI.21-21-08354.2001; Kobayashi K, 2001, BBA-MOL BASIS DIS, V1537, P79, DOI 10.1016/S0925-4439(01)00059-X; KOLANUS W, 1993, CELL, V74, P171, DOI 10.1016/0092-8674(93)90304-9; KOUNNAS MZ, 1995, CELL, V82, P331, DOI 10.1016/0092-8674(95)90320-8; KRIEGER M, 1994, ANNU REV BIOCHEM, V63, P601, DOI 10.1146/annurev.bi.63.070194.003125; Logan SK, 1997, MOL CELL BIOL, V17, P5784, DOI 10.1128/MCB.17.10.5784; LopezIlasaca M, 1997, SCIENCE, V275, P394, DOI 10.1126/science.275.5298.394; Loukinova E, 2002, J BIOL CHEM, V277, P15499, DOI 10.1074/jbc.M200427200; Mao BY, 2001, NATURE, V411, P321, DOI 10.1038/35077108; Marzolo MP, 2000, J NEUROSCI RES, V60, P401, DOI 10.1002/(SICI)1097-4547(20000501)60:3<401::AID-JNR15>3.3.CO;2-C; Matsuda S, 2001, J NEUROSCI, V21, P6597; May P, 2002, J BIOL CHEM, V277, P18736, DOI 10.1074/jbc.M201979200; Narita M, 1997, J NEUROCHEM, V68, P587; Otto IM, 2000, CURR BIOL, V10, P345, DOI 10.1016/S0960-9822(00)00388-2; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Postuma RB, 1998, FEBS LETT, V428, P13, DOI 10.1016/S0014-5793(98)00475-X; ROMEO C, 1992, COLD SPRING HARB SYM, V57, P117, DOI 10.1101/SQB.1992.057.01.015; Roses Allen D., 1994, Current Opinion in Biotechnology, V5, P663, DOI 10.1016/0958-1669(94)90091-4; ROZEMULLER JM, 1992, RES IMMUNOL, V143, P646, DOI 10.1016/0923-2494(92)80050-U; Russo T, 1998, FEBS LETT, V434, P1, DOI 10.1016/S0014-5793(98)00941-7; Scheinfeld MH, 2002, J BIOL CHEM, V277, P3767, DOI 10.1074/jbc.M108357200; Sheng JG, 1997, ACTA NEUROPATHOL, V94, P1, DOI 10.1007/s004010050664; Sluss HK, 1996, GENE DEV, V10, P2745, DOI 10.1101/gad.10.21.2745; Stockinger W, 2000, J BIOL CHEM, V275, P25625, DOI 10.1074/jbc.M004119200; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Trommsdorff R, 1998, J BIOL CHEM, V273, P33556, DOI 10.1074/jbc.273.50.33556; Verhey KJ, 2001, J CELL BIOL, V152, P959, DOI 10.1083/jcb.152.5.959; Villunger A, 1999, EUR J IMMUNOL, V29, P3549, DOI 10.1002/(SICI)1521-4141(199911)29:11<3549::AID-IMMU3549>3.0.CO;2-Q; Weidemann A, 2002, BIOCHEMISTRY-US, V41, P2825, DOI 10.1021/bi015794o; Whitmarsh AJ, 2000, NATURE, V403, P255, DOI 10.1038/35002220; Whitmarsh AJ, 2001, GENE DEV, V15, P2421, DOI 10.1101/gad.922801; WILLNOW TE, 1994, J BIOL CHEM, V269, P15827; Yasuda J, 1999, MOL CELL BIOL, V19, P7245; Zeitlmann L, 1998, J BIOL CHEM, V273, P15445, DOI 10.1074/jbc.273.25.15445; Zhu Y, 1998, ARTERIOSCL THROM VAS, V18, P473, DOI 10.1161/01.ATV.18.3.473; Zhuo M, 2000, J NEUROSCI, V20, P542, DOI 10.1523/JNEUROSCI.20-02-00542.2000	65	56	57	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					43143	43151		10.1074/jbc.M204426200	http://dx.doi.org/10.1074/jbc.M204426200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12193592	hybrid			2022-12-27	WOS:000179081200095
J	Abad, MC; Binderup, K; Rios-Steiner, J; Arni, RK; Preiss, J; Geiger, JH				Abad, MC; Binderup, K; Rios-Steiner, J; Arni, RK; Preiss, J; Geiger, JH			The X-ray crystallographic structure of Escherichia coli branching enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC ALPHA-AMYLASE; MAIZE ENDOSPERM; CYCLODEXTRIN GLYCOSYLTRANSFERASE; ANGSTROM RESOLUTION; AMYLOLYTIC ENZYMES; MUTAGENESIS; SPECIFICITY; STABILITY; MECHANISM; RESIDUES	Branching enzyme catalyzes the formation of alpha-1,6 branch points in either glycogen or starch. We report the 2.3-Angstrom crystal structure of glycogen branching enzyme from Escherichia coli. The enzyme consists of three major domains, an NH2-terminal seven-stranded beta-sandwich domain, a COOH-terminal domain, and a central alpha/beta-barrel domain containing the enzyme active site. While the central domain is similar to that of all the other amylase family enzymes, branching enzyme shares the structure of all three domains only with isoamylase. Oligosaccharide binding was modeled or branching enzyme using the enzyme-oligosaccharide complex structures of various alpha-amylases and cyclodextrin glucanotransferase and residues were implicated in oligosaccharide binding. While most of the oligosaccharides modeled well in the branching enzyme structure, an approximate 50degrees rotation between two of the glucose units was required to avoid steric clashes with Trp(298) of branching enzyme. A similar rotation was observed in the mammalian alpha-amylase structure caused by an equivalent tryptophan residue in this structure. It appears that there are two binding modes for oligosaccharides in these structures depending on the identity and location of this aromatic residue.	Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA; Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; Univ Puerto Rico, Dept Chem, Mayaguez, PR 00681 USA; UNESP, IBILCE, Dept Phys, BR-15054400 Sao Jose Dos Campos, SP, Brazil	Michigan State University; Michigan State University; University of Puerto Rico; University of Puerto Rico Mayaguez; Universidade Estadual Paulista	Geiger, JH (corresponding author), Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA.	preiss@pilot.msu.edu; geiger@cem.msu.edu	Arni, Raghuvir K/N-9338-2018; Arni, Raghuvir K/B-2222-2013	Arni, Raghuvir K/0000-0003-2460-1145; Arni, Raghuvir K/0000-0003-2460-1145; Geiger, James/0000-0002-9443-4488				Abad MC, 2002, ACTA CRYSTALLOGR D, V58, P359, DOI 10.1107/S090744490102073X; BABA T, 1991, BIOCHEM BIOPH RES CO, V181, P87, DOI 10.1016/S0006-291X(05)81385-3; Bao Y, 1996, J CLIN INVEST, V97, P941, DOI 10.1172/JCI118517; Binderup K, 1998, BIOCHEMISTRY-US, V37, P9033, DOI 10.1021/bi980199g; Binderup K, 2000, ARCH BIOCHEM BIOPHYS, V377, P366, DOI 10.1006/abbi.2000.1815; Binderup K, 2000, ARCH BIOCHEM BIOPHYS, V374, P73, DOI 10.1006/abbi.1999.1580; Binderup M, 2002, ARCH BIOCHEM BIOPHYS, V397, P279, DOI 10.1006/abbi.2001.2544; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brzozowski AM, 1997, BIOCHEMISTRY-US, V36, P10837, DOI 10.1021/bi970539i; BUISSON G, 1987, EMBO J, V6, P3909, DOI 10.1002/j.1460-2075.1987.tb02731.x; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240; CHEN YT, 1995, METABOLIC MOL BASES, V1, P935; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DIMAURO S, 1994, MYOLOGY, V2, P1554; Funane K, 1998, J PROTEIN CHEM, V17, P579, DOI 10.1007/BF02780959; GUAN HP, 1993, PLANT PHYSIOL, V102, P1269, DOI 10.1104/pp.102.4.1269; Guan HP, 1997, ARCH BIOCHEM BIOPHYS, V342, P92, DOI 10.1006/abbi.1997.0115; Harata K, 1996, ACTA CRYSTALLOGR D, V52, P1136, DOI 10.1107/S0907444996008438; Hong SJ, 2001, ARCH BIOCHEM BIOPHYS, V386, P62, DOI 10.1006/abbi.2000.2179; JESPERSEN HM, 1991, BIOCHEM J, V280, P51, DOI 10.1042/bj2800051; JESPERSEN HM, 1993, J PROTEIN CHEM, V12, P791, DOI 10.1007/BF01024938; Katsuya Y, 1998, J MOL BIOL, V281, P885, DOI 10.1006/jmbi.1998.1992; KLEIN C, 1991, J MOL BIOL, V217, P737, DOI 10.1016/0022-2836(91)90530-J; Kuriki T, 1996, J PROTEIN CHEM, V15, P305, DOI 10.1007/BF01887119; Kuriki T, 1997, J BIOL CHEM, V272, P28999, DOI 10.1074/jbc.272.46.28999; Libessart N, 1998, ARCH BIOCHEM BIOPHYS, V360, P135, DOI 10.1006/abbi.1998.0960; MATSUURA Y, 1984, J BIOCHEM-TOKYO, V95, P697, DOI 10.1093/oxfordjournals.jbchem.a134659; Mikkelsen R, 2001, ARCH BIOCHEM BIOPHYS, V385, P372, DOI 10.1006/abbi.2000.2164; NICHOLLS A, 1993, BIOPHYS J, V64, pA166; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Qian MX, 2001, BIOCHEMISTRY-US, V40, P7700, DOI 10.1021/bi0102050; ROMEO T, 1988, GENE, V70, P363, DOI 10.1016/0378-1119(88)90208-9; SCHRODER JM, 1993, ACTA NEUROPATHOL, V85, P419, DOI 10.1007/BF00334454; SVENSSON B, 1994, PLANT MOL BIOL, V25, P141, DOI 10.1007/BF00023233; TAKEDA Y, 1993, CARBOHYD RES, V240, P253, DOI 10.1016/0008-6215(93)84188-C; TAO BY, 1989, BIOCHIM BIOPHYS ACTA, V995, P214, DOI 10.1016/0167-4838(89)90038-1; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Uitdehaag JCM, 1999, NAT STRUCT BIOL, V6, P432, DOI 10.1038/8235; Uitdehaag JCM, 2000, BIOCHEMISTRY-US, V39, P7772, DOI 10.1021/bi000340x	39	99	104	2	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					42164	42170		10.1074/jbc.M205746200	http://dx.doi.org/10.1074/jbc.M205746200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12196524	hybrid			2022-12-27	WOS:000178985300109
J	Ranalli, TA; Tom, S; Bambara, RA				Ranalli, TA; Tom, S; Bambara, RA			AP endonuclease 1 coordinates flap endonuclease 1 and DNA ligase I activity in long patch base excision repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL NUCLEAR ANTIGEN; HUMAN APURINIC ENDONUCLEASE; DEOXYRIBOSE-PHOSPHATE RESIDUES; COLI EXONUCLEASE-III; POLYMERASE-BETA; APYRIMIDINIC ENDONUCLEASE; MAMMALIAN-CELLS; REPLICATION FORK; ABASIC SITES; CDNA	Base loss is common in cellular DNA, resulting from spontaneous degradation and enzymatic removal of damaged bases. Apurinic/apyrimidinic (AP) endonucleases recognize and cleave abasic (AP) sites during base excision repair (BER). APE1 (REF1, HAP1) is the predominant AP endonuclease in mammalian cells. Here we analyzed the influences of APEI on the human BER pathway. Specifically, APE1 enhanced the enzymatic activity of both flap endonuclease1 (FEN1) and DNA ligase I. FEN1 was stimulated on all tested substrates, regardless of flap length. Interestingly, we have found that APE1 can also inhibit the activities of both enzymes on substrates with a tetrahydrofuran (THF) residue on the 5'-downstream primer of a nick, simulating a reduced abasic site. However once the THF residue was displaced at least a single nucleotide, stimulation of FEN1 activity by APE1 resumes. Stimulation of DNA ligase I required the traditional nicked substrate. Furthermore, APE1 was able to enhance overall product formation in reconstitution of BER steps involving FEN1 cleavage followed by ligation. Overall, APE1 both stimulated downstream components of BER and prevented a futile cleavage and ligation cycle, indicating a far-reaching role in BER.	Univ Rochester, Med Ctr, Dept Biochem & Biophys, Sch Med & Dent, Rochester, NY 14642 USA	University of Rochester	Bambara, RA (corresponding author), Univ Rochester, Med Ctr, Dept Biochem & Biophys, Sch Med & Dent, 601 Elmwood Ave,Box 712, Rochester, NY 14642 USA.	robert_bambara@urmc.rochester.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM024441] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM24441] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bambara RA, 1997, J BIOL CHEM, V272, P4647, DOI 10.1074/jbc.272.8.4647; Bennett RAO, 1997, P NATL ACAD SCI USA, V94, P7166, DOI 10.1073/pnas.94.14.7166; Biade S, 1998, J BIOL CHEM, V273, P898, DOI 10.1074/jbc.273.2.898; Bornarth CJ, 1999, BIOCHEMISTRY-US, V38, P13347, DOI 10.1021/bi991321u; DeMott MS, 1996, J BIOL CHEM, V271, P30068, DOI 10.1074/jbc.271.47.30068; DeMott MS, 1998, J BIOL CHEM, V273, P27492, DOI 10.1074/jbc.273.42.27492; DEMPLE B, 1991, P NATL ACAD SCI USA, V88, P11450, DOI 10.1073/pnas.88.24.11450; DIANOV G, 1994, NUCLEIC ACIDS RES, V22, P993, DOI 10.1093/nar/22.6.993; DIANOV G, 1992, MOL CELL BIOL, V12, P1605, DOI 10.1128/MCB.12.4.1605; Dianov G, 1998, J BIOL CHEM, V273, P33811, DOI 10.1074/jbc.273.50.33811; Dianov GL, 1999, BIOCHEMISTRY-US, V38, P11021, DOI 10.1021/bi9908890; Dianova II, 2001, BIOCHEMISTRY-US, V40, P12639, DOI 10.1021/bi011117i; Fortini P, 1998, BIOCHEMISTRY-US, V37, P3575, DOI 10.1021/bi972999h; Frosina G, 1996, J BIOL CHEM, V271, P9573, DOI 10.1074/jbc.271.16.9573; Gary R, 1999, J BIOL CHEM, V274, P4354, DOI 10.1074/jbc.274.7.4354; Jonsson ZO, 1998, EMBO J, V17, P2412, DOI 10.1093/emboj/17.8.2412; KANE CM, 1981, J BIOL CHEM, V256, P3405; Kao KI, 2002, J BIOL CHEM, V277, P14379, DOI 10.1074/jbc.M110662200; Kim K, 1998, J BIOL CHEM, V273, P8842, DOI 10.1074/jbc.273.15.8842; Krokan HE, 2000, FEBS LETT, V476, P73, DOI 10.1016/S0014-5793(00)01674-4; Krokan HE, 1997, BIOCHEM J, V325, P1; KURIYAN J, 1993, J MOL BIOL, V234, P915, DOI 10.1006/jmbi.1993.1644; LI XY, 1995, J BIOL CHEM, V270, P22109, DOI 10.1074/jbc.270.38.22109; MATSUMOTO Y, 1995, SCIENCE, V269, P699, DOI 10.1126/science.7624801; Mol CD, 2000, NATURE, V403, P451, DOI 10.1038/35000249; Montecucco A, 1998, EMBO J, V17, P3786, DOI 10.1093/emboj/17.13.3786; Murante RS, 1995, J BIOL CHEM, V270, P30377, DOI 10.1074/jbc.270.51.30377; Otterlei M, 1999, EMBO J, V18, P3834, DOI 10.1093/emboj/18.13.3834; Parikh SS, 1998, EMBO J, V17, P5214, DOI 10.1093/emboj/17.17.5214; Parikh Sudip S., 1999, Current Opinion in Structural Biology, V9, P37, DOI 10.1016/S0959-440X(99)80006-2; Podlutsky AJ, 2001, EMBO J, V20, P1477, DOI 10.1093/emboj/20.6.1477; Ranalli TA, 2002, J BIOL CHEM, V277, P1719, DOI 10.1074/jbc.M109053200; ROBSON CN, 1991, NUCLEIC ACIDS RES, V19, P5519, DOI 10.1093/nar/19.20.5519; SEKI S, 1991, J BIOL CHEM, V266, P20797; SEKI S, 1992, BIOCHIM BIOPHYS ACTA, V1131, P287, DOI 10.1016/0167-4781(92)90027-W; SEKI S, 1991, BIOCHIM BIOPHYS ACTA, V1079, P57, DOI 10.1016/0167-4838(91)90024-T; SINGHAL RK, 1995, J BIOL CHEM, V270, P949, DOI 10.1074/jbc.270.2.949; Stucki M, 1998, ONCOGENE, V17, P835, DOI 10.1038/sj.onc.1202001; TERAOKA H, 1993, J BIOL CHEM, V268, P24156; Timson DJ, 2000, MUTAT RES-DNA REPAIR, V460, P301, DOI 10.1016/S0921-8777(00)00033-1; Tom S, 2001, J BIOL CHEM, V276, P48781, DOI 10.1074/jbc.M109626200; Tom S, 2001, J BIOL CHEM, V276, P24817, DOI 10.1074/jbc.M101673200; Tom S, 2000, J BIOL CHEM, V275, P10498, DOI 10.1074/jbc.275.14.10498; TOMKINSON AE, 1990, J BIOL CHEM, V265, P12611; Tomkinson AE, 1998, MUTAT RES-DNA REPAIR, V407, P1, DOI 10.1016/S0921-8777(97)00050-5; Tomkinson AE, 1997, BIOESSAYS, V19, P893, DOI 10.1002/bies.950191009; Waters TR, 1999, J BIOL CHEM, V274, P67, DOI 10.1074/jbc.274.1.67; WILSON DM, 1995, J BIOL CHEM, V270, P16002, DOI 10.1074/jbc.270.27.16002; Wilson DM, 1997, NUCLEIC ACIDS RES, V25, P933, DOI 10.1093/nar/25.5.933; Wu XT, 1996, NUCLEIC ACIDS RES, V24, P2036, DOI 10.1093/nar/24.11.2036	50	58	63	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					41715	41724		10.1074/jbc.M207207200	http://dx.doi.org/10.1074/jbc.M207207200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12200445	hybrid			2022-12-27	WOS:000178985300054
J	Yamaguchi, H; Wang, HG				Yamaguchi, H; Wang, HG			Bcl-XL protects BimEL-induced Bax conformational change and cytochrome c release independent of interacting with Bax or BimEL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL OUTER-MEMBRANE; DEPENDENT ANION CHANNEL; FAMILY MEMBER BIM; CELL-DEATH; PROMOTES APOPTOSIS; MOLECULAR-CLONING; BH3-ONLY PROTEINS; ENDONUCLEASE-G; BH4 DOMAIN; SURVIVAL	The Bcl-2 homology (BH) 3-only pro-apoptotic Bcl-2 family protein Bim plays an essential role in the mitochondrial pathway of apoptosis through activation of the BH1-3 multidomain protein Bax or Bak. To further understand how the BH3-only protein activates Bax, we provide evidence here that BimEL induces Bax conformational change and apoptosis through a Bcl-XL-suppressible but heterodimerization-independent mechanism. Substitution of the conserved leucine residue in the BH3 domain of BimEL for alanine (M1) inhibits the interaction of BimEL with Bcl-XL but does not abolish the ability of BimEL to induce Bax conformational change and apoptosis. However, removal of the C-terminal hydrophobic region from the M1 mutant (M1DeltaC) abolishes its ability to activate Bax and to induce apoptosis, although deletion of the C-terminal domain (DeltaC) alone has little if any effect on the pro-apoptotic activity of BimEL. Subcellular fractionation experiments show that the Bim mutant M1DeltaC is localized in the cytosol, indicating that both the C-terminal hydrophobic region and the BH3 domain are required for the mitochondrial targeting and pro-apoptotic activity of BimEL. Moreover, the Bcl-XL mutant (mt1), which is unable to interact with Bax and BimEL, blocks Bax conformational change and cytochrome c release induced by BimEL in intact cells and isolated mitochondria. BimEL or BakBH3 peptide induces Bax conformational change in vitro only under the presence of mitochondria, and the outer mitochondrial membrane fraction is sufficient for induction of Bax conformational change. Interestingly, native Bax is attached loosely on the surface of isolated mitochondria, which undergoes conformational change and insertion into mitochondrial membrane upon stimulation by BimEL, Bak-BH3 peptide, or freeze/thaw damage. Taken together, these findings indicate that BimEL may activate Bax by damaging the mitochondrial membrane structure directly, in addition to its binding and antagonizing Bcl-2/Bcl-XL function.	H Lee Moffitt Canc Ctr & Res Inst, Drug Discovery Program, Tampa, FL 33612 USA; Univ S Florida, Coll Med, Dept Pharmacol & Therapeut, Tampa, FL 33612 USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Wang, HG (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Drug Discovery Program, 12902 Magnolia Dr, Tampa, FL 33612 USA.	wanghg@moffitt.usf.edu			NCI NIH HHS [CA82197] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA082197] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Antonsson B, 2000, BIOCHEM J, V345, P271, DOI 10.1042/0264-6021:3450271; Antonsson B, 2001, J BIOL CHEM, V276, P11615, DOI 10.1074/jbc.M010810200; Aoki H, 2002, J BIOL CHEM, V277, P10244, DOI 10.1074/jbc.M112355200; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Bouillet P, 2002, NATURE, V415, P922, DOI 10.1038/415922a; Cheng EHY, 1996, NATURE, V379, P554, DOI 10.1038/379554a0; Cuddeback SM, 2001, J BIOL CHEM, V276, P20559, DOI 10.1074/jbc.M101527200; Desagher S, 2000, TRENDS CELL BIOL, V10, P369, DOI 10.1016/S0962-8924(00)01803-1; Desagher S, 1999, J CELL BIOL, V144, P891, DOI 10.1083/jcb.144.5.891; Dijkers PF, 2000, CURR BIOL, V10, P1201, DOI 10.1016/S0960-9822(00)00728-4; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Ellerby HM, 1999, NAT MED, V5, P1032, DOI 10.1038/12469; Eskes R, 2000, MOL CELL BIOL, V20, P929, DOI 10.1128/MCB.20.3.929-935.2000; Esposti MD, 2001, MOL CELL BIOL, V21, P7268, DOI 10.1128/MCB.21.21.7268-7276.2001; Ghafourifar P, 1999, J BIOL CHEM, V274, P6080, DOI 10.1074/jbc.274.10.6080; Goping IS, 1998, J CELL BIOL, V143, P207, DOI 10.1083/jcb.143.1.207; Green DR, 2002, CANCER CELL, V1, P19, DOI 10.1016/S1535-6108(02)00024-7; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Gross A, 1998, EMBO J, V17, P3878, DOI 10.1093/emboj/17.14.3878; Gross A, 1999, J BIOL CHEM, V274, P1156, DOI 10.1074/jbc.274.2.1156; Hegde R, 2002, J BIOL CHEM, V277, P432, DOI 10.1074/jbc.M109721200; Hsu YT, 1997, P NATL ACAD SCI USA, V94, P3668, DOI 10.1073/pnas.94.8.3668; Hsu YT, 1997, J BIOL CHEM, V272, P13829, DOI 10.1074/jbc.272.21.13829; Huang DCS, 2000, CELL, V103, P839, DOI 10.1016/S0092-8674(00)00187-2; Huang DCS, 1998, EMBO J, V17, P1029, DOI 10.1093/emboj/17.4.1029; Kudla G, 2000, J BIOL CHEM, V275, P22713, DOI 10.1074/jbc.M003807200; Lan L, 2000, BIOCHEM J, V349, P611, DOI 10.1042/0264-6021:3490611; Li H, 2000, SCIENCE, V289, P1159, DOI 10.1126/science.289.5482.1159; Li LY, 2001, NATURE, V412, P95, DOI 10.1038/35083620; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Lutter M, 2000, NAT CELL BIOL, V2, P754, DOI 10.1038/35036395; Lutter M, 2001, BMC CELL BIOL, V2, DOI 10.1186/1471-2121-2-22; Marani M, 2002, MOL CELL BIOL, V22, P3577, DOI 10.1128/MCB.22.11.3577-3589.2002; Martinou JC, 2001, NAT REV MOL CELL BIO, V2, P63, DOI 10.1038/35048069; Martins LM, 2002, J BIOL CHEM, V277, P439, DOI 10.1074/jbc.M109784200; Marzo I, 1998, SCIENCE, V281, P2027, DOI 10.1126/science.281.5385.2027; Matsko CM, 2001, BIOCHEM BIOPH RES CO, V287, P1112, DOI 10.1006/bbrc.2001.5696; Mikhailov V, 2001, J BIOL CHEM, V276, P18361, DOI 10.1074/jbc.M100655200; Miyashita MUT, 2001, FEBS LETT, V509, P135, DOI 10.1016/S0014-5793(01)03145-3; Murphy KM, 2000, J BIOL CHEM, V275, P17225, DOI 10.1074/jbc.C900590199; Nechushtan A, 2001, J CELL BIOL, V153, P1265, DOI 10.1083/jcb.153.6.1265; O'Connor L, 1998, EMBO J, V17, P384, DOI 10.1093/emboj/17.2.384; O'Reilly LA, 2000, AM J PATHOL, V157, P449, DOI 10.1016/S0002-9440(10)64557-9; Oda K, 2000, CELL, V102, P849, DOI 10.1016/S0092-8674(00)00073-8; Parrish J, 2001, NATURE, V412, P90, DOI 10.1038/35083608; Putcha GV, 2001, NEURON, V29, P615, DOI 10.1016/S0896-6273(01)00238-0; Puthalakath H, 2002, CELL DEATH DIFFER, V9, P505, DOI 10.1038/sj.cdd.4400998; Puthalakath H, 1999, MOL CELL, V3, P287, DOI 10.1016/S1097-2765(00)80456-6; Rathmell JC, 2002, CELL, V109, pS97, DOI 10.1016/S0092-8674(02)00704-3; Reed JC, 2001, TRENDS MOL MED, V7, P314, DOI 10.1016/S1471-4914(01)02026-3; Ruffolo SC, 2000, CELL DEATH DIFFER, V7, P1101, DOI 10.1038/sj.cdd.4400739; Saito M, 2000, NAT CELL BIOL, V2, P553, DOI 10.1038/35019596; Schimmer AD, 2001, CELL DEATH DIFFER, V8, P725, DOI 10.1038/sj.cdd.4400870; Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959; Shimizu S, 2000, P NATL ACAD SCI USA, V97, P3100, DOI 10.1073/pnas.97.7.3100; Shimizu S, 2001, J CELL BIOL, V152, P237, DOI 10.1083/jcb.152.2.237; Shinjyo T, 2001, MOL CELL BIOL, V21, P854, DOI 10.1128/MCB.21.3.854-864.2001; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Suzuki M, 2000, CELL, V103, P645, DOI 10.1016/S0092-8674(00)00167-7; Suzuki Y, 2001, MOL CELL, V8, P613, DOI 10.1016/S1097-2765(01)00341-0; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Verhagen AM, 2002, J BIOL CHEM, V277, P445, DOI 10.1074/jbc.M109891200; Wang HG, 1998, HISTOL HISTOPATHOL, V13, P521, DOI 10.14670/HH-13.521; Wang K, 1996, GENE DEV, V10, P2859, DOI 10.1101/gad.10.22.2859; Wang XD, 2001, GENE DEV, V15, P2922; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Whitfield J, 2001, NEURON, V29, P629, DOI 10.1016/S0896-6273(01)00239-2; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Yamaguchi H, 2001, ONCOGENE, V20, P7779, DOI 10.1038/sj.onc.1204984; Yamaguchi H, 2002, CANCER RES, V62, P466; Zhai DY, 2001, EUR J BIOCHEM, V268, P48, DOI 10.1046/j.1432-1327.2001.01841.x; Zong WX, 2001, GENE DEV, V15, P1481, DOI 10.1101/gad.897601	74	81	98	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					41604	41612		10.1074/jbc.M207516200	http://dx.doi.org/10.1074/jbc.M207516200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12198137	hybrid			2022-12-27	WOS:000178985300040
J	Zambotti, A; Makhluf, H; Shen, JH; Ducy, P				Zambotti, A; Makhluf, H; Shen, JH; Ducy, P			Characterization of an osteoblast-specific enhancer element in the CBFA1 gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR FACTOR-I; CARTILAGE MATRIX PROTEIN; TRANSCRIPTION FACTOR; BONE-FORMATION; CHONDROCYTE DIFFERENTIATION; PARATHYROID-HORMONE; POTENTIAL ROLE; EXPRESSION; PROMOTER; MOUSE	Cbfa1 is a critical regulator of cell differentiation expressed only in the osteochondrogenic lineage. To define the molecular basis of this cell-specific expression we analyzed the murine Cbfa1 promoter. Here we show that the first 976 bp of this promoter are specifically active in osteoblastic cells. Within this region DNase I footprinting delineated a 40-bp area (CE1) protected differently by nuclear extracts from osteoblastic cells and from non-osteoblastic cells. When multimerized, CE1 conferred an osteoblast-specific activity to a heterologous promoter in DNA transfection experiments; this enhancing ability was conserved between mouse, rat, and human CE1 present in the respective Cbfa1 promoters. CE1 site-specific mutagenesis determined that it binds NF1- and AP1-like activities. Further analyses revealed that the NF1 site acts as a repressor in non-osteoblastic cells due to the binding of NF1-A, a NF1 isoform not expressed in osteoblastic cells. In contrast, the AP1 site mediates an osteoblast-specific activation caused by the preferential binding of FosB to CE1 in osteoblastic cells. In summary, this study identified an osteoblast-specific enhancer in the Cbfa1 promoter whose activity is achieved by the combination of an inhibitory and an activatory mechanism.	Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Med, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Ducy, P (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, 1 Baylor Plaza,Rm S911, Houston, TX 77030 USA.				NIAMS NIH HHS [AR46487] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR046487] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Aslam F, 1999, ENDOCRINOLOGY, V140, P63, DOI 10.1210/en.140.1.63; AUSUBEL FM, 1995, SONS; Bidder M, 2000, BIOCHEMISTRY-US, V39, P8917, DOI 10.1021/bi000343+; Chaudhry AZ, 1997, DEV DYNAM, V208, P313; CHEN Q, 1995, DEV BIOL, V172, P293, DOI 10.1006/dbio.1995.0024; Cooke DW, 1999, J BIOL CHEM, V274, P12917, DOI 10.1074/jbc.274.18.12917; das Neves L, 1999, P NATL ACAD SCI USA, V96, P11946, DOI 10.1073/pnas.96.21.11946; Drissi H, 2000, J CELL PHYSIOL, V184, P341, DOI 10.1002/1097-4652(200009)184:3<341::AID-JCP8>3.0.CO;2-Z; DUCY P, 1995, MOL CELL BIOL, V15, P1858; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Ducy P, 1999, GENE DEV, V13, P1025, DOI 10.1101/gad.13.8.1025; Ducy P, 2000, DEV DYNAM, V219, P461, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1074>3.0.CO;2-C; FORREST SM, 1985, CALCIFIED TISSUE INT, V37, P51, DOI 10.1007/BF02557679; Gao YH, 1998, BIOCHEM BIOPH RES CO, V252, P697, DOI 10.1006/bbrc.1998.9643; Geoffroy V, 1998, MAMM GENOME, V9, P54, DOI 10.1007/s003359900679; Gronostajski RM, 2000, GENE, V249, P31, DOI 10.1016/S0378-1119(00)00140-2; GRONOSTAJSKI RM, 1986, NUCLEIC ACIDS RES, V14, P9117, DOI 10.1093/nar/14.22.9117; Jochum W, 2000, NAT MED, V6, P980, DOI 10.1038/79676; KAGOSHIMA H, 1993, TRENDS GENET, V9, P338, DOI 10.1016/0168-9525(93)90026-E; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Karsenty G, 1999, GENE DEV, V13, P3037, DOI 10.1101/gad.13.23.3037; Kern B, 2001, J BIOL CHEM, V276, P7101, DOI 10.1074/jbc.M006215200; KLEEREKOPER M, 1998, METABOLIC BONE DIS; Liu WG, 2001, J CELL BIOL, V155, P157, DOI 10.1083/jcb.200105052; MAJESKA RJ, 1980, ENDOCRINOLOGY, V107, P1494, DOI 10.1210/endo-107-5-1494; McCabe LR, 1996, ENDOCRINOLOGY, V137, P4398, DOI 10.1210/en.137.10.4398; Mukhopadhyay SS, 2001, MOL CELL BIOL, V21, P6859, DOI 10.1128/MCB.21.20.6859-6869.2001; Olsen BR, 2000, ANNU REV CELL DEV BI, V16, P191, DOI 10.1146/annurev.cellbio.16.1.191; Osada S, 1997, BIOCHEM BIOPH RES CO, V238, P744, DOI 10.1006/bbrc.1997.7382; Passegue E, 2000, EMBO J, V19, P2969, DOI 10.1093/emboj/19.12.2969; Rajas F, 1998, BIOCHEM J, V333, P77, DOI 10.1042/bj3330077; ROSENFELD PJ, 1986, J BIOL CHEM, V261, P1398; Sabatakos G, 2000, NAT MED, V6, P985, DOI 10.1038/79683; SCHUUR ER, 1995, CELL GROWTH DIFFER, V6, P219; SZABO P, 1995, J BIOL CHEM, V270, P10212, DOI 10.1074/jbc.270.17.10212; Takeda S, 2001, GENE DEV, V15, P467, DOI 10.1101/gad.845101; Tou LQ, 2001, MOL CELL ENDOCRINOL, V183, P71, DOI 10.1016/S0303-7207(01)00594-9; Xiao ZS, 1998, GENE, V214, P187, DOI 10.1016/S0378-1119(98)00227-3; Xiao ZS, 2001, J CELL BIOCHEM, V82, P647, DOI 10.1002/jcb.1192; Yamauchi M, 1996, MATRIX BIOL, V15, P119, DOI 10.1016/S0945-053X(96)90153-5	40	51	54	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					41497	41506		10.1074/jbc.M204271200	http://dx.doi.org/10.1074/jbc.M204271200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12186862	hybrid			2022-12-27	WOS:000178985300027
J	da Silva, EF; Mandal, SS; Reha-Krantz, LJ				da Silva, EF; Mandal, SS; Reha-Krantz, LJ			Using 2-aminopurine fluorescence to measure incorporation of incorrect nucleotides by wild type and mutant bacteriophage T4 DNA Polymerases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEOXYRIBONUCLEIC ACID POLYMERASES; REPLICATION FIDELITY; KINETIC MECHANISM; BIOCHEMICAL BASIS; 3'->5'-EXONUCLEASE ACTIVITY; AMINO-ACID; I KLENOW; MUTATOR; ANTIMUTATOR; SELECTION	The ability of wild type and mutant T4 DNA polymerases to discriminate in the utilization of the base analog 2-aminopurine (2AP) and the fluorescence of 2AP were used to determine how DNA polymerases distinguish between correct and incorrect nucleotides. Because T4 DNA polymerase incorporates dTMP opposite 2AP under single-turnover conditions, it was possible to compare directly the kinetic parameters for incorporation of dTMP opposite template 2AP to the parameters for incorporation of dTMP opposite template A without the complication of enzyme dissociation. The most significant difference detected was in the K-d for dTTP, which was 10-fold higher for incorporation of dTMP opposite template 2AP (similar to367 mum) than for incorporation of dTMP opposite template A (similar to31 mum). In contrast, the dTMP incorporation rate was reduced only about 2-fold from about 318 s(-1) with template A to about 165 s(-1) for template 2AP. Discrimination is due to the high selectivity in the initial nucleotide-binding step. T4 DNA polymerase binding to DNA with 2AP in the template position induces formation of a nucleotide binding pocket that is preshaped to bind dTTP and to exclude other nucleotides. If nucleotide binding is hindered, initiation of the proofreading pathway acts as an error avoidance mechanism to prevent incorporation of incorrect nucleotides.	Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada	University of Alberta	Reha-Krantz, LJ (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada.		Reha-Krantz, Linda/A-3748-2014	Reha-Krantz, Linda/0000-0003-4497-423X; Mandal, Subhrangsu/0000-0001-8495-9881; Fidalgo da Silva, Elizabeth/0000-0003-3540-9335				Baker RP, 1998, P NATL ACAD SCI USA, V95, P3507, DOI 10.1073/pnas.95.7.3507; Beard WA, 2002, J BIOL CHEM, V277, P8235, DOI 10.1074/jbc.M107286200; BLOOM LB, 1994, BIOCHEMISTRY-US, V33, P7576, DOI 10.1021/bi00190a010; BRUTLAG D, 1972, J BIOL CHEM, V247, P241; CAPSON TL, 1992, BIOCHEMISTRY-US, V31, P10984, DOI 10.1021/bi00160a007; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; ECHOLS H, 1991, ANNU REV BIOCHEM, V60, P477, DOI 10.1146/annurev.biochem.60.1.477; Franklin MC, 2001, CELL, V105, P657, DOI 10.1016/S0092-8674(01)00367-1; FREY MW, 1995, BIOCHEMISTRY-US, V34, P9185, DOI 10.1021/bi00028a031; GOODMAN M, 1999, Patent No. 5945312; GOODMAN MF, 1993, CRIT REV BIOCHEM MOL, V28, P83, DOI 10.3109/10409239309086792; Goodman MF, 1997, P NATL ACAD SCI USA, V94, P10493, DOI 10.1073/pnas.94.20.10493; HOPKINS R, 1979, J MOL BIOL, V135, P1, DOI 10.1016/0022-2836(79)90337-1; Kiefer JR, 1998, NATURE, V391, P304, DOI 10.1038/34693; KUCHTA RD, 1987, BIOCHEMISTRY-US, V26, P8410, DOI 10.1021/bi00399a057; KUCHTA RD, 1988, BIOCHEMISTRY-US, V27, P6716, DOI 10.1021/bi00418a012; KUNKEL TA, 1988, J BIOL CHEM, V263, P14784; LO KY, 1976, J BIOL CHEM, V251, P2475; LOEB LA, 1982, ANNU REV BIOCHEM, V52, P429; Mandal SS, 2002, BIOCHEMISTRY-US, V41, P4399, DOI 10.1021/bi015723p; Marquez LA, 1996, J BIOL CHEM, V271, P28903, DOI 10.1074/jbc.271.46.28903; MATHEWS CK, 1972, J BIOL CHEM, V247, P7430; Moran S, 1997, P NATL ACAD SCI USA, V94, P10506, DOI 10.1073/pnas.94.20.10506; MUZYCZKA N, 1972, J BIOL CHEM, V247, P7116; Patel PH, 2001, J BIOL CHEM, V276, P5044, DOI 10.1074/jbc.M008701200; PELLETIER H, 1994, SCIENCE, V264, P1891, DOI 10.1126/science.7516580; PETRUSKA J, 1988, P NATL ACAD SCI USA, V85, P6252, DOI 10.1073/pnas.85.17.6252; PLESS RC, 1983, BIOCHEMISTRY-US, V22, P4905, DOI 10.1021/bi00290a006; Rachofsky EL, 2001, BIOCHEMISTRY-US, V40, P946, DOI 10.1021/bi001664o; REDDY MK, 1992, J BIOL CHEM, V267, P14157; Reha-Krantz LJ, 1998, J BIOL CHEM, V273, P22969, DOI 10.1074/jbc.273.36.22969; REHAKRANTZ LJ, 1993, J BIOL CHEM, V268, P27100; REHAKRANTZ LJ, 1993, J VIROL, V67, P60, DOI 10.1128/JVI.67.1.60-66.1993; REHAKRANTZ LJ, 1981, J MOL BIOL, V145, P677, DOI 10.1016/0022-2836(81)90309-0; REHAKRANTZ LJ, 1994, J BIOL CHEM, V269, P5635; Shah AM, 2001, J BIOL CHEM, V276, P10824, DOI 10.1074/jbc.M008680200; Shamoo Y, 1999, CELL, V99, P155, DOI 10.1016/S0092-8674(00)81647-5; SLOANE DL, 1988, NUCLEIC ACIDS RES, V16, P6465, DOI 10.1093/nar/16.14.6465; STOCKI SA, 1995, J MOL BIOL, V254, P15, DOI 10.1006/jmbi.1995.0595; TSUJIKAWA L, 2000, THESIS U ALBERTA EDM; WARD DC, 1969, J BIOL CHEM, V244, P1228; Washington MT, 2001, CELL, V107, P917, DOI 10.1016/S0092-8674(01)00613-4; WATANABE SM, 1982, P NATL ACAD SCI-BIOL, V79, P6429, DOI 10.1073/pnas.79.21.6429; WONG I, 1991, BIOCHEMISTRY-US, V30, P526, DOI 10.1021/bi00216a030; Yang GW, 2002, BIOCHEMISTRY-US, V41, P2526, DOI 10.1021/bi0119924	45	57	60	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 25	2002	277	43					40640	40649		10.1074/jbc.M203315200	http://dx.doi.org/10.1074/jbc.M203315200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	607KU	12189135	hybrid			2022-12-27	WOS:000178791400063
J	Greenhalgh, CJ; Metcalf, D; Thaus, AL; Corbin, JE; Uren, R; Morgan, PO; Fabri, LJ; Zhang, JG; Martin, HM; Willson, TA; Billestrup, N; Nicola, NA; Baca, M; Alexander, WS; Hilton, DJ				Greenhalgh, CJ; Metcalf, D; Thaus, AL; Corbin, JE; Uren, R; Morgan, PO; Fabri, LJ; Zhang, JG; Martin, HM; Willson, TA; Billestrup, N; Nicola, NA; Baca, M; Alexander, WS; Hilton, DJ			Biological evidence that SOCS-2 can act either as an enhancer or suppressor of growth hormone signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMARY-GLAND DEVELOPMENT; MICE LACKING SUPPRESSOR; NEGATIVE REGULATION; TRANSGENIC MICE; CYTOKINE; RECEPTOR; EXPRESSION; INHIBITION; STAT5B; TRANSDUCTION	Suppressor of cytokine signaling (SOCS)-2 is a member of a family of intracellular proteins implicated in the negative regulation of cytokine signaling. The generation of SOCS-2-deficient mice, which grow to one and a half times the size of their wild-type littermates, suggests that SOCS-2 may attenuate growth hormone (GH) signaling. In vitro studies indicate that, while SOCS-2 can inhibit GH action at low concentrations, at higher concentrations it may potentiate signaling. To determine whether a similar enhancement of signaling is observed in vivo or alternatively whether increased SOCS-2 levels repress growth in vivo, we generated and analyzed transgenic mice that overexpress SOCS-2 from a human ubiquitin C promoter. These mice are not growth-deficient and are, in fact, significantly larger than wild-type mice. The overexpressed SOCS-2 was found to bind to endogenous GH receptors in a number of mouse organs, while phosphopeptide binding studies with recombinant SOCS-2 defined phosphorylated tyrosine 595 on the GH receptor as the site of interaction. Together, the data implicate SOCS-2 as having dual effects on GH signaling in vivo.	PO Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia; PO Royal Melbourne Hosp, Cooperat Res Cellular Growth Factors, Melbourne, Vic 3050, Australia; AMRAD Operat Ltd, Richmond 3121, Australia; Steno Diabet Ctr, DK-2820 Gentofte, Denmark	Royal Melbourne Hospital; Walter & Eliza Hall Institute; Royal Melbourne Hospital; Steno Diabetes Center	Greenhalgh, CJ (corresponding author), PO Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia.		Nicola, Nicos/D-2989-2011; Hilton, Douglas J/C-7250-2013	Nicola, Nicos/0000-0003-1054-7889; Hilton, Douglas J/0000-0002-7698-2392; fabri, louis/0000-0003-4033-3304; Uren, Rachel/0000-0001-7456-478X; Billestrup, Nils/0000-0002-4968-8067	NATIONAL CANCER INSTITUTE [R37CA022556, R01CA022556] Funding Source: NIH RePORTER; NCI NIH HHS [CA 22556] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adams TE, 1998, J BIOL CHEM, V273, P1285, DOI 10.1074/jbc.273.3.1285; Alexander WS, 1996, BLOOD, V87, P2162, DOI 10.1182/blood.V87.6.2162.bloodjournal8762162; Alexander WS, 1999, CELL, V98, P597, DOI 10.1016/S0092-8674(00)80047-1; Dif F, 2001, ENDOCRINOLOGY, V142, P5286, DOI 10.1210/en.142.12.5286; Favre H, 1999, FEBS LETT, V453, P63, DOI 10.1016/S0014-5793(99)00681-X; Greenhalgh CJ, 2001, J LEUKOCYTE BIOL, V70, P348; Greenhalgh CJ, 2002, MOL ENDOCRINOL, V16, P1394, DOI 10.1210/me.16.6.1394; Hansen JA, 1999, MOL ENDOCRINOL, V13, P1832, DOI 10.1210/me.13.11.1832; Horvat S, 2001, GENOMICS, V72, P209, DOI 10.1006/geno.2000.6441; Kile BT, 2001, MOL CELL BIOL, V21, P6189, DOI 10.1128/MCB.21.18.6189-6197.2001; Krebs DL, 2000, J CELL SCI, V113, P2813; Lindeman GJ, 2001, GENE DEV, V15, P1631, DOI 10.1101/gad.880801; Liu XW, 1997, GENE DEV, V11, P179, DOI 10.1101/gad.11.2.179; Marine JC, 1999, CELL, V98, P609, DOI 10.1016/S0092-8674(00)80048-3; MATHEWS LS, 1988, ENDOCRINOLOGY, V123, P2827, DOI 10.1210/endo-123-6-2827; Matsumoto A, 1999, MOL CELL BIOL, V19, P6396; Metcalf D, 2000, NATURE, V405, P1069, DOI 10.1038/35016611; Nicholson SE, 1999, EMBO J, V18, P375, DOI 10.1093/emboj/18.2.375; PALMITER RD, 1983, SCIENCE, V222, P809, DOI 10.1126/science.6356363; Pezet A, 1999, J BIOL CHEM, V274, P24497, DOI 10.1074/jbc.274.35.24497; Ram PA, 1999, J BIOL CHEM, V274, P35553, DOI 10.1074/jbc.274.50.35553; Ram PK, 2000, J BIOL CHEM, V275, P39487, DOI 10.1074/jbc.M004755200; Roberts AW, 2001, P NATL ACAD SCI USA, V98, P9324, DOI 10.1073/pnas.161271798; Schultheis B, 2002, BLOOD, V99, P1766, DOI 10.1182/blood.V99.5.1766; Stofega MR, 2000, MOL ENDOCRINOL, V14, P1338, DOI 10.1210/me.14.9.1338; Teglund S, 1998, CELL, V93, P841, DOI 10.1016/S0092-8674(00)81444-0; Tollet-Egnell P, 1999, ENDOCRINOLOGY, V140, P3693, DOI 10.1210/en.140.8.3693; Udy GB, 1997, P NATL ACAD SCI USA, V94, P7239, DOI 10.1073/pnas.94.14.7239; Yasukawa H, 2000, ANNU REV IMMUNOL, V18, P143, DOI 10.1146/annurev.immunol.18.1.143	29	136	147	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 25	2002	277	43					40181	40184		10.1074/jbc.C200450200	http://dx.doi.org/10.1074/jbc.C200450200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	607KU	12208853	hybrid			2022-12-27	WOS:000178791400004
J	Shalom-Barak, T; Knaus, UG				Shalom-Barak, T; Knaus, UG			A p21-activated kinase-controlled metabolic switch up-regulates phagocyte NADPH oxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTP-BINDING PROTEIN; PHOSPHOGLYCERATE MUTASE; HUMAN NEUTROPHILS; ACTIVATION; PHOSPHORYLATION; PURIFICATION; SERINE-303; GTPASES; RAC-2; CELLS	Chemoattractant-stimulated phagocytes increase their glucose uptake and divert energy production from glycolysis to the pentose phosphate pathway to generate NADPH. NADPH is a required cofactor for the NADPH oxidase to produce reactive oxygen metabolites, an important microbicidal tool in host defense. p21-Activated kinases (Paks) are regulated by the GTPases Rac and Cdc42 and control actin dynamics and phosphorylation of the oxidase component p47(phox). Here we report the interaction of Pak with phosphoglycerate mutase (PGAM)-B, an enzyme of the glycolytic pathway. Activated Pak1 inhibits glycolysis by association of its catalytic domain with PGAM-B and subsequent phosphorylation of the enzyme on serine residues 23 and 118, thereby abolishing PGAM activity. Leukocyte activation through chemoattractant receptors leads to Pak activation and transient inhibition of endogenous PGAM-B activity. Consistent with these observations, treatment of neutrophils with phosphoglycolic acid, a competitive PGAM-B inhibitor, increases upstream intermediates, thereby amplifying the respiratory burst. These results demonstrate that Rho GTPases regulate the glycolytic pathway through Pak and suggest a link between chemoattractant signaling and metabolic responses to enhance host defense.	Scripps Res Inst, Dept Immunol IMM28, La Jolla, CA 92037 USA; Jackson Lab, Bar Harbor, ME 04609 USA	Scripps Research Institute; Jackson Laboratory	Knaus, UG (corresponding author), Scripps Res Inst, Dept Immunol IMM28, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	uknaus@scripps.edu			NCRR NIH HHS [M01 RR 00833] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000833] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		ABO A, 1991, NATURE, V353, P668, DOI 10.1038/353668a0; Ago T, 1999, J BIOL CHEM, V274, P33644, DOI 10.1074/jbc.274.47.33644; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Beutler E., 1984, GLUTATHIONE RED CELL; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; BURCHILL BR, 1978, J CELL BIOL, V76, P439, DOI 10.1083/jcb.76.2.439; Daub H, 2001, J BIOL CHEM, V276, P1677, DOI 10.1074/jbc.C000635200; Dharmawardhane S, 1999, J LEUKOCYTE BIOL, V66, P521, DOI 10.1002/jlb.66.3.521; Hagi Akifumi, 2000, Journal of Medical Investigation, V47, P19; Hall A, 1999, BRIT J CANCER, V80, P25; Huang RY, 1998, MOL CELL BIOL, V18, P7130, DOI 10.1128/MCB.18.12.7130; Inanami O, 1998, J BIOL CHEM, V273, P9539, DOI 10.1074/jbc.273.16.9539; King CC, 2000, METHOD ENZYMOL, V325, P155; KNAUS UG, 1991, SCIENCE, V254, P1512, DOI 10.1126/science.1660188; KNAUS UG, 1992, J BIOL CHEM, V267, P23575; KNAUS UG, 1995, SCIENCE, V269, P221, DOI 10.1126/science.7618083; Merkulova T, 1997, BIOCHEM J, V323, P791, DOI 10.1042/bj3230791; Mira JP, 2000, P NATL ACAD SCI USA, V97, P185, DOI 10.1073/pnas.97.1.185; QUINN MT, 1993, J BIOL CHEM, V268, P20983; Rigden DJ, 1998, J MOL BIOL, V276, P449, DOI 10.1006/jmbi.1997.1554; SASAKI R, 1971, BIOCHIM BIOPHYS ACTA, V227, P595, DOI 10.1016/0005-2744(71)90010-6; SBARRA AJ, 1959, J BIOL CHEM, V234, P1355; Sells MA, 1997, CURR BIOL, V7, P202, DOI 10.1016/S0960-9822(97)70091-5; STJERNHOLM RL, 1980, RETICULOENDOTHELIAL, V2, P73; UCHIDA K, 1995, CLIN CHIM ACTA, V237, P43, DOI 10.1016/0009-8981(95)06063-J; VOLKER KW, 1995, COMP BIOCHEM PHYS B, V112, P503, DOI 10.1016/0305-0491(95)00096-8; WHITE MF, 1993, BIOCHEM J, V295, P743, DOI 10.1042/bj2950743; ZATTI M, 1965, BIOCHIM BIOPHYS ACTA, V99, P557, DOI 10.1016/S0926-6593(65)80213-2; Zenke FT, 1999, J BIOL CHEM, V274, P32565, DOI 10.1074/jbc.274.46.32565	29	51	54	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2002	277	43					40659	40665		10.1074/jbc.M206650200	http://dx.doi.org/10.1074/jbc.M206650200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	607KU	12189148	hybrid			2022-12-27	WOS:000178791400065
J	Lee, CG				Lee, CG			RH70, a bidirectional RNA helicase, co-purifies with U1snRNP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; SPLICING FACTORS; DNA; PROTEINS; SPLICEOSOME; CYCLOPHILIN; HYDROLYSIS; COMPLEX; DUPLEX; SNRNPS	In this report, I describe the co-purification of a novel 70-kDa RNA helicase (RH70) and U1snRNP through six column steps. Peptide sequence analysis by mass spectrometry and Edman degradation revealed that RH70 is the previously reported DDX17. Biochemical characterization of RH70, obtained by partial separation from U1snRNP, yielded the following results. (a) RH70 mediates the unwinding of duplex RNA but not DNA in an ATP-dependent manner. W Both the RNA-dependent ATPase and RNA helicase activities of RH70 are highly specific for ATP, exhibiting an apparent K-m of 0.5 mm. (c) RH70 catalyzes the unwinding of duplex RNA containing single-stranded regions at either the 5'- or W-end. Its association with U1snRNP and ATP specificity suggest a role for RH70 in pre-mRNA splicing, in particular, at the early stages of the splicing reaction involving U1snRNP.	Univ Med & Dent New Jersey, Grad Sch Biomed Sci, Dept Biochem & Mol Biol, Newark, NJ 07103 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Lee, CG (corresponding author), Univ Med & Dent New Jersey, Grad Sch Biomed Sci, Dept Biochem & Mol Biol, 185 S Orange Ave, Newark, NJ 07103 USA.							Ali JA, 1997, SCIENCE, V275, P377, DOI 10.1126/science.275.5298.377; Arenas JE, 1997, P NATL ACAD SCI USA, V94, P11798, DOI 10.1073/pnas.94.22.11798; Campodonico E, 2002, GENETICS, V160, P407; DEAN FB, 1991, J BIOL CHEM, V266, P5062; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Fuller-Pace Frances V., 1994, Trends in Cell Biology, V4, P271, DOI 10.1016/0962-8924(94)90210-0; GOETZ GS, 1988, J BIOL CHEM, V263, P383; GUI JF, 1994, NATURE, V369, P678, DOI 10.1038/369678a0; GUI JF, 1994, P NATL ACAD SCI USA, V91, P10824, DOI 10.1073/pnas.91.23.10824; Horowitz DS, 1997, RNA, V3, P1374; Huang YL, 2002, J BIOL CHEM, V277, P12810, DOI 10.1074/jbc.M200182200; Jankowsky E, 2000, NATURE, V403, P447, DOI 10.1038/35000239; Kim JL, 1998, STRUCTURE, V6, P89, DOI 10.1016/S0969-2126(98)00010-0; KIM SH, 1992, EMBO J, V11, P2319, DOI 10.1002/j.1460-2075.1992.tb05291.x; Korolev S, 1997, CELL, V90, P635, DOI 10.1016/S0092-8674(00)80525-5; Kramer A, 1996, ANNU REV BIOCHEM, V65, P367, DOI 10.1146/annurev.biochem.65.1.367; Lamm GM, 1996, NUCLEIC ACIDS RES, V24, P3739, DOI 10.1093/nar/24.19.3739; Lee CG, 1997, EMBO J, V16, P2671, DOI 10.1093/emboj/16.10.2671; LEE CG, 1992, J BIOL CHEM, V267, P4338; Liu ZR, 1998, MOL CELL BIOL, V18, P6910, DOI 10.1128/MCB.18.12.6910; Lohman TM, 1996, ANNU REV BIOCHEM, V65, P169, DOI 10.1146/annurev.bi.65.070196.001125; Martin A, 2002, J BIOL CHEM, V277, P17743, DOI 10.1074/jbc.M200762200; Mechanic LE, 1999, J BIOL CHEM, V274, P12488, DOI 10.1074/jbc.274.18.12488; Patel SS, 2000, ANNU REV BIOCHEM, V69, P651, DOI 10.1146/annurev.biochem.69.1.651; Py B, 1996, NATURE, V381, P169, DOI 10.1038/381169a0; ROSEN F, 1990, MOL CELL BIOL, V10, P1134; SCHWER B, 1992, EMBO J, V11, P5033, DOI 10.1002/j.1460-2075.1992.tb05610.x; Schwer B, 2001, NAT STRUCT BIOL, V8, P113, DOI 10.1038/84091; Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5; Tanner NK, 2001, MOL CELL, V8, P251, DOI 10.1016/S1097-2765(01)00329-X; Teigelkamp S, 1998, RNA, V4, P127; WASSARMAN DA, 1991, NATURE, V349, P463, DOI 10.1038/349463a0; WOPPMANN A, 1993, NUCLEIC ACIDS RES, V21, P2815, DOI 10.1093/nar/21.12.2815; ZHANG SS, 1994, BIOCHEMISTRY-US, V33, P3906, DOI 10.1021/bi00179a016	34	40	40	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 18	2002	277	42					39679	39683		10.1074/jbc.C200337200	http://dx.doi.org/10.1074/jbc.C200337200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	605EA	12193588	hybrid			2022-12-27	WOS:000178662500081
J	Osaki, T; Okino, N; Tokunaga, F; Iwanaga, S; Kawabata, S				Osaki, T; Okino, N; Tokunaga, F; Iwanaga, S; Kawabata, S			Proline-rich cell surface antigens of horseshoe crab hemocytes are substrates for protein cross-linking with a clotting protein coagulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-SEQUENCE; TACHYPLEUS-TRIDENTATUS; CLOTTABLE PROTEIN; MOLECULAR-BASIS; PURIFICATION; COMPONENTS; HOMOLOG; PLASMA	Monoclonal antibodies were raised against hemocytes of the horseshoe crab Tachypleus tridentatus. All of the antibodies obtained reacted with the same protein bands on SDS-PAGE of hemocyte lysate. Flow cytometry and biotinylation of surface substances on the hemocytes indicated that the antigens are major peripheral proteins of hemocytes. The antigens were purified from hemocyte lysate and were good substrates for the horseshoe crab hemocyte transglutaminase (HcTGase). Transglutaminases play an important role during the final stage of blood coagulation in mammals and crustaceans. Although HcTGase did not intermolecularly cross-link a clottable protein coagulogen or its proteolytic product coagulin, HcTGase promoted the cross-linking of coagulin with the surface antigens, resulting in the formation of a stable polymer. We determined the nucleotide sequences for two isoproteins of the antigens. The two proteins containing 271 and 284 residues (66% identity) were composed of tandem repeats of proline-rich segments. We named them proxins-1 and -2 after proline-rich proteins for protein cross-linking. Proxins may form a stable physical barrier against invading pathogens in cooperation with hemolymph coagulation at injured sites.	Kyushu Univ, Fac Sci, Dept Biol, Fukuoka 8128581, Japan	Kyushu University	Kawabata, S (corresponding author), Kyushu Univ, Fac Sci, Dept Biol, Fukuoka 8128581, Japan.	skawascb@mbox.nc.kyushu-u.ac.jp	Okino, Nozomu/AAY-2635-2021	Tokunaga, Fuminori/0000-0003-3626-9119; Osaki, Tsukasa/0000-0002-9487-3253				Ashida Masaaki, 1998, P135; Austin SJ, 1996, J BIOL CHEM, V271, P3737, DOI 10.1074/jbc.271.7.3737; Bergner A, 1996, EMBO J, V15, P6789, DOI 10.1002/j.1460-2075.1996.tb01070.x; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CROSS GAM, 1990, ANNU REV CELL BIOL, V6, P1, DOI 10.1146/annurev.cb.06.110190.000245; DAVIE EW, 1991, BIOCHEMISTRY-US, V30, P10363, DOI 10.1021/bi00107a001; DOOLITTLE RF, 1990, BIOCHEM BIOPH RES CO, V167, P16, DOI 10.1016/0006-291X(90)91723-6; DOOLITTLE RF, 1984, PLASMA PROTEINS, V10, P421; FURIE B, 1988, CELL, V53, P505, DOI 10.1016/0092-8674(88)90567-3; Iwanaga S, 2002, CURR OPIN IMMUNOL, V14, P87, DOI 10.1016/S0952-7915(01)00302-8; Iwanaga S, 1998, J BIOCHEM, V123, P1; Kawasaki H, 2000, J BIOL CHEM, V275, P35297, DOI 10.1074/jbc.M006856200; KOPACEK P, 1993, EUR J BIOCHEM, V213, P591, DOI 10.1111/j.1432-1033.1993.tb17798.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEGENDRE N, 1989, PRACTICAL GUIDE TO PROTEIN AND PEPTIDE PURIFICATION FOR MICROSEQUENCING, P49; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; LORAND L, 1981, METHOD ENZYMOL, V80, P333; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; NAKAMURA S, 1976, J BIOCHEM, V80, P1011, DOI 10.1093/oxfordjournals.jbchem.a131357; NAKAMURA S, 1976, BIOCHEM BIOPH RES CO, V72, P902, DOI 10.1016/S0006-291X(76)80217-3; Okino N, 1995, J BIOL CHEM, V270, P31008, DOI 10.1074/jbc.270.52.31008; Robinson NA, 1997, J BIOL CHEM, V272, P12035, DOI 10.1074/jbc.272.18.12035; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Soderhall K, 1998, CURR OPIN IMMUNOL, V10, P23, DOI 10.1016/S0952-7915(98)80026-5; STEINERT PM, 1995, J BIOL CHEM, V270, P17702, DOI 10.1074/jbc.270.30.17702; TAKAGI T, 1984, J BIOCHEM-TOKYO, V95, P1445, DOI 10.1093/oxfordjournals.jbchem.a134752; TOH Y, 1991, CELL TISSUE RES, V266, P137, DOI 10.1007/BF00678720; TOKUNAGA F, 1993, J BIOL CHEM, V268, P252; WILSON J, 1992, BIOCHEM BIOPH RES CO, V188, P655, DOI 10.1016/0006-291X(92)91106-Z	29	52	54	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2002	277	42					40084	40090		10.1074/jbc.M206773200	http://dx.doi.org/10.1074/jbc.M206773200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	605EA	12189150	hybrid			2022-12-27	WOS:000178662500129
J	Bocharov, EV; Korzhnev, DM; Blommers, MJJ; Arvinte, T; Orekhov, VY; Billeter, M; Arseniev, AS				Bocharov, EV; Korzhnev, DM; Blommers, MJJ; Arvinte, T; Orekhov, VY; Billeter, M; Arseniev, AS			Dynamics-modulated biological activity of transforming growth factor beta 3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MODEL-FREE APPROACH; GROWTH-FACTOR-BETA; MAGNETIC-RESONANCE RELAXATION; TGF-BETA; CRYSTAL-STRUCTURE; BACKBONE DYNAMICS; ORDER PARAMETERS; RECEPTOR; BINDING; MACROMOLECULES	Transforming growth factor beta3 (TGF-beta3) is an important mediator of growth, maintenance, and repair processes in human cells. Internal dynamic properties have been derived from N-15 NMR relaxation data and mapped onto the spatial structure of TGF-beta3. The pattern of internal dynamics in the structure identifies potential "hot spots" of binding free energy and reveals the importance of conformational entropy in the interaction of TGF-beta3 with the receptors. The observed internal dynamics set TGF-beta3 apart from other TGF-beta isoforms, with which it shares the same fold. These findings may explain functional differences among the various TGF-beta isoforms and thus prove essential in the search for related therapeutic agents.	Novartis Pharma AG, CH-4002 Basel, Switzerland; Russian Acad Sci, Shemyakin Ovchinnikow Inst Bioorgan Chem, Moscow, Russia; Univ Gothenburg, Swedish NMR Ctr, S-40530 Gothenburg, Sweden; Univ Gothenburg, Lundberg Lab, S-40530 Gothenburg, Sweden	Novartis; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; University of Gothenburg; University of Gothenburg	Blommers, MJJ (corresponding author), Novartis Pharma AG, CH-4002 Basel, Switzerland.	marcel_jj.blommers@pharma.novartis.com	Billeter, Martin/A-8293-2010; Orekhov, Vladislav/AAD-8464-2019	Orekhov, Vladislav/0000-0002-7892-6896				BARBATO G, 1992, BIOCHEMISTRY-US, V31, P5269, DOI 10.1021/bi00138a005; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Bocharov EV, 2000, J BIOMOL NMR, V16, P179, DOI 10.1023/A:1008315600134; Burmester JK, 1998, GROWTH FACTORS, V15, P231, DOI 10.3109/08977199809002119; CERLETTI N, 1995, Patent No. 9603433; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; CLORE GM, 1990, J AM CHEM SOC, V112, P4989, DOI 10.1021/ja00168a070; DAOPIN S, 1992, SCIENCE, V257, P369, DOI 10.1126/science.1631557; De Crescenzo G, 2001, J BIOL CHEM, V276, P29632, DOI 10.1074/jbc.M009765200; DELATORRE JG, 1981, Q REV BIOPHYS, V14, P81, DOI 10.1017/S0033583500002080; Derynck R, 1997, BIOCHIM BIOPHYS ACTA, V1333, P105; Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0; Eketjall S, 1999, EMBO J, V18, P5901, DOI 10.1093/emboj/18.21.5901; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; FARROW NA, 1994, J BIOMOL NMR, V4, P727, DOI 10.1007/BF00404280; Gray PC, 2000, J BIOL CHEM, V275, P3206, DOI 10.1074/jbc.275.5.3206; Hart PJ, 2002, NAT STRUCT BIOL, V9, P203, DOI 10.1038/nsb766; Hinck AP, 1996, BIOCHEMISTRY-US, V35, P8517, DOI 10.1021/bi9604946; Hofsteenge J, 1999, J BIOL CHEM, V274, P32786, DOI 10.1074/jbc.274.46.32786; Huang SS, 1999, J BIOL CHEM, V274, P27754, DOI 10.1074/jbc.274.39.27754; Kirsch T, 2000, EMBO J, V19, P3314, DOI 10.1093/emboj/19.13.3314; Kirsch T, 2000, NAT STRUCT BIOL, V7, P492; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Korzhnev DM, 2000, J BIOMOL NMR, V17, P231, DOI 10.1023/A:1008348827208; Korzhnev DM, 2001, PROG NUCL MAG RES SP, V38, P197, DOI 10.1016/S0079-6565(00)00028-5; Korzhnev DM, 2001, FEBS LETT, V495, P52, DOI 10.1016/S0014-5793(01)02363-8; Krasagakis K, 1998, BRIT J CANCER, V77, P1492, DOI 10.1038/bjc.1998.245; LIN HY, 1995, J BIOL CHEM, V270, P2747, DOI 10.1074/jbc.270.6.2747; LIPARI G, 1982, J AM CHEM SOC, V104, P4559, DOI 10.1021/ja00381a010; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Mittl PRE, 1996, PROTEIN SCI, V5, P1261, DOI 10.1002/pro.5560050705; Mostov K, 1997, SCIENCE, V276, P219, DOI 10.1126/science.276.5310.219; Murphy-Ullrich JE, 2000, CYTOKINE GROWTH F R, V11, P59, DOI 10.1016/S1359-6101(99)00029-5; Nesbitt SA, 1997, SCIENCE, V276, P266, DOI 10.1126/science.276.5310.266; Orekhov VY, 1995, APPL MAGN RESON, V9, P581, DOI 10.1007/BF03162365; Palmer AG, 2001, ANNU REV BIOPH BIOM, V30, P129, DOI 10.1146/annurev.biophys.30.1.129; Pellaud J, 1999, J BIOL CHEM, V274, P7699, DOI 10.1074/jbc.274.12.7699; Phan IQH, 1996, J BIOMOL NMR, V8, P369, DOI 10.1007/BF00228140; POWERS R, 1993, J MAGN RESON SER B, V101, P325, DOI 10.1006/jmrb.1993.1051; PRESS WH, 1997, NUMERICAL RECIPES C, P689; Salo J, 1997, SCIENCE, V276, P270, DOI 10.1126/science.276.5310.270; WEBER G, 1993, J PHYS CHEM-US, V97, P7108, DOI 10.1021/j100129a031; WOESSNER DE, 1962, J CHEM PHYS, V37, P647, DOI 10.1063/1.1701390; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; Yang DW, 1996, J MOL BIOL, V263, P369, DOI 10.1006/jmbi.1996.0581; 2002, Patent No. 6057430; 9502718	48	33	34	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2002	277	48					46273	46279		10.1074/jbc.M206274200	http://dx.doi.org/10.1074/jbc.M206274200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620JB	12221089	hybrid			2022-12-27	WOS:000179529300076
J	Nakamura, Y; Haines, N; Chen, JH; Okajima, T; Furukawa, K; Urano, T; Stanley, P; Irvine, KD; Furukawa, K				Nakamura, Y; Haines, N; Chen, JH; Okajima, T; Furukawa, K; Urano, T; Stanley, P; Irvine, KD; Furukawa, K			Identification of a Drosophila gene encoding xylosylprotein 84-galactosyltransferase that is essential for the synthesis of glycosaminoglycans and for morphogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN LINKAGE REGION; CAENORHABDITIS-ELEGANS; HEPARAN-SULFATE; GALACTOSYLTRANSFERASE-I; UDP-GALACTOSE; MOLECULAR-CLONING; EPITHELIAL INVAGINATION; STRUCTURAL-ANALYSIS; FIBROBLAST GROWTH; TOUT-VELU	In mammals, the xylosylprotein beta4-galactosyltransferase termed beta4GalT7 (XgaIT-1, EC 2.4.1.133) participates in proteoglycan biosynthesis through the transfer of galactose to the xylose that initiates each glycosaminoglycan chain. A Drosophila cDNA homologous to mammalian beta4-galactosyltransferases was identified using a human beta4GalT7 cDNA as a probe in a BLAST analysis of expressed sequence tags. The Drosophila cDNA encodes a type 11 membrane protein with 322 amino acids and shows 49% identity to human beta4GalT7. Extracts from L cells transfected with the cDNA exhibited marked galactosyltransferase activity specific for a xylopyranoside acceptor. Moreover, transfection with the cloned cDNA restored glycosaminoglycan synthesis in beta4GalT7-deficient Chinese hamster ovary cells. In transfectant lysates the properties of Drosophila and human beta4GalT7 resembled each other, except that Drosophila beta4GalT7 showed a less restricted specificity and was active at a wider range of temperatures. Drosophila beta4GalT7 is expressed throughout development, with higher expression levels in adults. Reduction of Drosophila beta4GalT7 levels using expressed RNA interference (RNAi) in imaginal discs resulted in an abnormal wing and leg morphology similar to that of flies with defective Hedgehog and Decapentaplegic signaling, which are known to depend on intact proteoglycan biosynthesis. Immimohistochemical analysis of tissues confirmed that both heparan sulfate and chondroitin sulfate biosynthesis were impaired. Our results demonstrate that Drosophila beta4GalT7 has the in vitro and in vivo properties predicted for an ortholog of human beta4GalT7 and is essential for normal animal development through its role in proteoglycan biosynthesis.	Nagoya Univ, Dept Biochem 2, Sch Med, Showa Ku, Nagoya, Aichi 4660065, Japan; Rutgers State Univ, Howard Hughes Med Inst, Waksman Inst, Piscataway, NJ 08854 USA; Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA; Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA	Nagoya University; Howard Hughes Medical Institute; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Yeshiva University; Albert Einstein College of Medicine	Furukawa, K (corresponding author), Nagoya Univ, Dept Biochem 2, Sch Med, Showa Ku, 65 Tsurumai, Nagoya, Aichi 4660065, Japan.	koichi@med.nagoya-u.ac.jp	Okajima, Tetsuya/I-7332-2014	Okajima, Tetsuya/0000-0002-3677-648X; Urano, Takeshi/0000-0003-3383-3554; Stanley, Pamela/0000-0001-5704-3747	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054594] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01-GM54594] Funding Source: Medline; PHS HHS [P01-13330, R01-36434] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Almeida R, 1999, J BIOL CHEM, V274, P26165, DOI 10.1074/jbc.274.37.26165; Almeida R, 1997, J BIOL CHEM, V272, P31979, DOI 10.1074/jbc.272.51.31979; Amado M, 1999, BBA-GEN SUBJECTS, V1473, P35, DOI 10.1016/S0304-4165(99)00168-3; Baeg GH, 2000, CURR OPIN CELL BIOL, V12, P575, DOI 10.1016/S0955-0674(00)00134-4; Bai XM, 2001, J BIOL CHEM, V276, P48189, DOI 10.1074/jbc.M107339200; Berninsone P, 2001, P NATL ACAD SCI USA, V98, P3738, DOI 10.1073/pnas.061593098; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brook WJ, 1996, ANNU REV CELL DEV BI, V12, P161, DOI 10.1146/annurev.cellbio.12.1.161; Bulik DA, 2000, P NATL ACAD SCI USA, V97, P10838, DOI 10.1073/pnas.97.20.10838; Calleja M, 1996, SCIENCE, V274, P252, DOI 10.1126/science.274.5285.252; ESKO JD, 1987, J BIOL CHEM, V262, P12189; Gastinel LN, 1999, EMBO J, V18, P3546, DOI 10.1093/emboj/18.13.3546; Goto S, 2001, NAT CELL BIOL, V3, P816, DOI 10.1038/ncb0901-816; Gotting C, 2000, J MOL BIOL, V304, P517, DOI 10.1006/jmbi.2000.4261; HELTING T, 1969, J BIOL CHEM, V244, P2790; Herman T, 1999, P NATL ACAD SCI USA, V96, P968, DOI 10.1073/pnas.96.3.968; Herman T, 1999, P NATL ACAD SCI USA, V96, P974, DOI 10.1073/pnas.96.3.974; Kennerdell JR, 2000, NAT BIOTECHNOL, V18, P896, DOI 10.1038/78531; Kennerdell JR, 1998, CELL, V95, P1017, DOI 10.1016/S0092-8674(00)81725-0; Kitagawa H, 1998, J BIOL CHEM, V273, P6615, DOI 10.1074/jbc.273.12.6615; Klein T, 1997, DEV BIOL, V189, P123, DOI 10.1006/dbio.1997.8564; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; Kuroiwa A, 2000, CYTOGENET CELL GENET, V89, P8, DOI 10.1159/000015578; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lo NW, 1998, GLYCOBIOLOGY, V8, P517, DOI 10.1093/glycob/8.5.517; Lugemwa FN, 1996, J BIOL CHEM, V271, P19159, DOI 10.1074/jbc.271.32.19159; MASRI KA, 1988, BIOCHEM BIOPH RES CO, V157, P657, DOI 10.1016/S0006-291X(88)80300-0; NAGATA Y, 1992, J BIOL CHEM, V267, P12082; Nomura T, 1998, J BIOL CHEM, V273, P13570, DOI 10.1074/jbc.273.22.13570; NURCOMBE V, 1993, SCIENCE, V260, P103, DOI 10.1126/science.7682010; Okajima T, 1999, J BIOL CHEM, V274, P22915, DOI 10.1074/jbc.274.33.22915; Okajima T, 1999, J BIOL CHEM, V274, P28841, DOI 10.1074/jbc.274.41.28841; POWELL JT, 1976, J BIOL CHEM, V251, P3645; QUENTIN E, 1990, P NATL ACAD SCI USA, V87, P1342, DOI 10.1073/pnas.87.4.1342; RAPRAEGER AC, 1991, SCIENCE, V252, P1705, DOI 10.1126/science.1646484; Roden L., 1980, BIOCH GLYCOPROTEINS, P267; SanchezHerrero E, 1996, MECH DEVELOP, V55, P159, DOI 10.1016/0925-4773(96)00498-4; Sato T, 1998, P NATL ACAD SCI USA, V95, P472, DOI 10.1073/pnas.95.2.472; SCHWARTZ NB, 1975, J BIOL CHEM, V250, P5200; Schwientek T, 1998, J BIOL CHEM, V273, P29331, DOI 10.1074/jbc.273.45.29331; Selleck SB, 2000, TRENDS GENET, V16, P206, DOI 10.1016/S0168-9525(00)01997-1; Selva EM, 2001, NAT CELL BIOL, V3, P809, DOI 10.1038/ncb0901-809; Seppo A, 2000, EUR J BIOCHEM, V267, P3549, DOI 10.1046/j.1432-1327.2000.01383.x; SPEICHER SA, 1994, DEVELOPMENT, V120, P535; Strigini M, 1997, DEVELOPMENT, V124, P4697; THAMPOE IJ, 1989, CANCER RES, V49, P6258; Toyoda H, 2000, J BIOL CHEM, V275, P2269, DOI 10.1074/jbc.275.4.2269; Toyoda H, 2000, J BIOL CHEM, V275, P21856, DOI 10.1074/jbc.M003540200; Vervoort M, 1999, CURR BIOL, V9, P632, DOI 10.1016/S0960-9822(99)80285-1; Wei G, 1999, J BIOL CHEM, V274, P7857, DOI 10.1074/jbc.274.12.7857; Wight Thomas N., 1992, Current Opinion in Cell Biology, V4, P793, DOI 10.1016/0955-0674(92)90102-I; WODARZ A, 1995, CELL, V82, P67, DOI 10.1016/0092-8674(95)90053-5; YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W	53	35	36	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2002	277	48					46280	46288		10.1074/jbc.M203873200	http://dx.doi.org/10.1074/jbc.M203873200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620JB	12215432	hybrid			2022-12-27	WOS:000179529300077
J	Armstrong, AP; Tometsko, ME; Glaccum, M; Sutherland, CL; Cosman, D; Dougall, WC				Armstrong, AP; Tometsko, ME; Glaccum, M; Sutherland, CL; Cosman, D; Dougall, WC			A RANK/TRAF6-dependent signal transduction pathway is essential for osteoclast cytoskeletal organization and resorptive function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; OSTEOPROTEGERIN LIGAND; RECEPTOR ACTIVATOR; DEFECTIVE INTERLEUKIN-1; BONE-RESORPTION; KEY REGULATOR; MICE LACKING; TRAF FAMILY; C-SRC; RANK	Signaling through receptor activator of nuclear factor-kappaB (RANK) is essential for the differentiation and activation of osteoclasts, the cell principally responsible for bone resorption. Animals genetically deficient in RANK or the cognate RANK ligand are profoundly osteopetrotic because of the lack of bone resorption and remodeling. RANK provokes biochemical signaling via the recruitment of intracellular tumor necrosis factor receptor-associated factors (TRAFs) after ligand binding and receptor oligomerization. To understand the RANK-mediated signal transduction mechanism in osteoclastogenesis, we have designed a system to recapitulate osteoclast differentiation and activation in vitro by transfer of the RANK cDNA into hematopoietic precursors genetically deficient in RANK. Gene transfer of RANK constructs that are selectively incapable of binding different TRAF proteins revealed that TRAF pathways downstream of RANK that affect osteoclast differentiation are functionally redundant. In contrast, the interaction of RANK with TRAF6 is absolutely required for the proper formation of cytoskeletal structures and functional resorptive activity of osteoclasts. Moreover, signaling via the interleukin-1 receptor, which also utilizes TRAF6, rescues the osteoclast activation defects observed in the absence of RANK/TRAF6 interactions. These studies are the first to define the functional domains of the RANK cytoplasmic tail that control specific differentiation and activation pathways in osteoclasts.	Immunex Corp, Dept Mol Biol, Seattle, WA 98101 USA; Immunex Corp, Dept Mol Immunol, Seattle, WA 98101 USA	Immunex Corporation; Immunex Corporation	Dougall, WC (corresponding author), Amgen Inc, Dept Canc Biol, 51 Univ St, Seattle, WA 98101 USA.	dougallw@amgen.com		Dougall, William/0000-0001-9487-251X				Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; Azuma Y, 2000, J BIOL CHEM, V275, P4858, DOI 10.1074/jbc.275.7.4858; BOYCE BF, 1992, J CLIN INVEST, V90, P1622, DOI 10.1172/JCI116032; Burgess TL, 1999, J CELL BIOL, V145, P527, DOI 10.1083/jcb.145.3.527; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; Darnay BG, 1998, J BIOL CHEM, V273, P20551, DOI 10.1074/jbc.273.32.20551; Darnay BG, 1999, J BIOL CHEM, V274, P7724, DOI 10.1074/jbc.274.12.7724; Dougall WC, 1999, GENE DEV, V13, P2412, DOI 10.1101/gad.13.18.2412; Fanslow W C, 1994, Semin Immunol, V6, P267, DOI 10.1006/smim.1994.1035; Franzoso G, 1997, GENE DEV, V11, P3482, DOI 10.1101/gad.11.24.3482; Fuller K, 1998, J EXP MED, V188, P997, DOI 10.1084/jem.188.5.997; Galibert L, 1998, J BIOL CHEM, V273, P34120, DOI 10.1074/jbc.273.51.34120; Goldring SR, 2000, CURR OPIN RHEUMATOL, V12, P195, DOI 10.1097/00002281-200005000-00006; GRIGORIADIS AE, 1994, SCIENCE, V266, P443, DOI 10.1126/science.7939685; Hofbauer LC, 2000, J BONE MINER RES, V15, P2, DOI 10.1359/jbmr.2000.15.1.2; HORNE WC, 1992, J CELL BIOL, V119, P1003, DOI 10.1083/jcb.119.4.1003; Inoue J, 2000, EXP CELL RES, V254, P14, DOI 10.1006/excr.1999.4733; Iotsova V, 1997, NAT MED, V3, P1285, DOI 10.1038/nm1197-1285; Jimi E, 1998, J BIOL CHEM, V273, P8799, DOI 10.1074/jbc.273.15.8799; Jimi E, 1999, EXP CELL RES, V247, P84, DOI 10.1006/excr.1998.4320; Kinsella TM, 1996, HUM GENE THER, V7, P1405, DOI 10.1089/hum.1996.7.12-1405; Kobayashi K, 2000, J EXP MED, V191, P275, DOI 10.1084/jem.191.2.275; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Lacey DL, 2000, AM J PATHOL, V157, P435, DOI 10.1016/S0002-9440(10)64556-7; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lakkakorpi PT, 1996, MICROSC RES TECHNIQ, V33, P171, DOI 10.1002/(SICI)1097-0029(19960201)33:2<171::AID-JEMT7>3.0.CO;2-W; Li J, 2000, P NATL ACAD SCI USA, V97, P1566, DOI 10.1073/pnas.97.4.1566; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; Lorenzo JA, 1998, ENDOCRINOLOGY, V139, P3022, DOI 10.1210/en.139.6.3022; Matsumoto M, 2000, J BIOL CHEM, V275, P31155, DOI 10.1074/jbc.M001229200; Merkel KD, 1999, AM J PATHOL, V154, P203, DOI 10.1016/S0002-9440(10)65266-2; Naito A, 1999, GENES CELLS, V4, P353, DOI 10.1046/j.1365-2443.1999.00265.x; Riggs BL, 2000, J BONE MINER RES, V15, P2293; Sanjay A, 2001, J CELL BIOL, V152, P181, DOI 10.1083/jcb.152.1.181; Schwartzberg PL, 1997, GENE DEV, V11, P2835, DOI 10.1101/gad.11.21.2835; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; Tanaka S, 1996, NATURE, V383, P528, DOI 10.1038/383528a0; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Wong BR, 1999, MOL CELL, V4, P1041, DOI 10.1016/S1097-2765(00)80232-4; Wong BR, 1998, J BIOL CHEM, V273, P28355, DOI 10.1074/jbc.273.43.28355; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; YOSHIDA H, 1990, NATURE, V345, P442, DOI 10.1038/345442a0; Zhang YH, 2001, J BIOL CHEM, V276, P563, DOI 10.1074/jbc.M008198200	43	184	206	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2002	277	46					44347	44356		10.1074/jbc.M202009200	http://dx.doi.org/10.1074/jbc.M202009200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	615XE	12185073	hybrid			2022-12-27	WOS:000179272000106
J	Hall, JM; Korach, KS				Hall, JM; Korach, KS			Analysis of the molecular mechanisms of human estrogen receptors alpha and beta reveals differential specificity in target promoter regulation by xenoestrogens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL ACTIVITY; RESPONSE ELEMENTS; ER-ALPHA; ANTIESTROGENS; PHYTOESTROGENS; COREGULATORS; CONFORMATION; RECRUITMENT; XENOBIOTICS; CONTEXT	Most of the currently available information on the transcriptional activities of endocrine-disrupting chemicals (xenoestrogens) through estrogen receptors a (ERalpha) and beta (ERbeta) has been derived from transactivation studies on synthetic estrogen-responsive reporters. Thus, the ability of the xenoestrogen-liganded ERs to regulate endogenous estrogen-responsive gene expression has not been well characterized. Here, we have evaluated the activities of xenoestrogens through ERalpha and ERbeta on the vitellogenin A2 estrogen-response element (ERE) and the human pS2, lactoferrin, and complement 3 physiological target gene promoters. Using mammalian cell transient transfection assays, we found that the activities of xenoestrogens were mediated in a promoter-specific manner. For example, when bound to all ligands examined, ERa displayed high levels of transcription on the vitellogenin ERE and the lactoferrin promoter, but substantially lower activity on the complement 3 and pS2 promoters. However, one of the most important observations was that there were significant differences in the relative transcriptional activities of xenoestrogen-bound ERalpha and ERbeta on different promoters, suggesting that ERalpha and ERbeta make unique contributions to xenoestrogen action in target cells. When probing the molecular mechanism of the promoter-specific activities observed, we found that the transcriptional activity of the ERs correlated with the ability of each receptor to assume an active conformation on specific promoters. Taken together, the results indicate that the transcriptional activities of xenoestrogens are mediated in a promoter-specific manner and that estrogen-responsive promoters communicate differently with ERalpha and ERbeta by influencing their structures in a distinct manner that leads to diversity in their transcriptional responses.	NIEHS, Receptor Biol Sect, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Hall, JM (corresponding author), NIEHS, Receptor Biol Sect, Bldg 101,Rm E460,MD E4-01,111 TW Alexander Dr,POB, Res Triangle Pk, NC 27709 USA.		Jansen, Heiko T./A-5770-2008	Jansen, Heiko T./0000-0003-0178-396X; Korach, Kenneth/0000-0002-7765-418X				An JP, 2001, J BIOL CHEM, V276, P17808, DOI 10.1074/jbc.M100953200; BERRY M, 1990, EMBO J, V9, P2811, DOI 10.1002/j.1460-2075.1990.tb07469.x; CARSON R, 1994, SILENT SPRING; Colburn Theo, 1996, OUR STOLEN FUTURE; Couse JF, 1999, SCIENCE, V286, P2328, DOI 10.1126/science.286.5448.2328; Couse JF, 1999, ENDOCR REV, V20, P358, DOI 10.1210/er.20.3.358; DANA SL, 1994, MOL ENDOCRINOL, V8, P1193, DOI 10.1210/me.8.9.1193; Giguere V, 1998, STEROIDS, V63, P335, DOI 10.1016/S0039-128X(98)00024-5; Hall JM, 1999, ENDOCRINOLOGY, V140, P5566, DOI 10.1210/en.140.12.5566; Hall JM, 2002, MOL ENDOCRINOL, V16, P469, DOI 10.1210/me.16.3.469; Hall JM, 2001, J BIOL CHEM, V276, P36869, DOI 10.1074/jbc.R100029200; Hall JM, 2000, MOL ENDOCRINOL, V14, P2010, DOI 10.1210/me.14.12.2010; Klinge CM, 2001, NUCLEIC ACIDS RES, V29, P2905, DOI 10.1093/nar/29.14.2905; Klinge CM, 2001, MOL CELL ENDOCRINOL, V174, P151, DOI 10.1016/S0303-7207(01)00382-3; Kuiper GGJM, 1998, ENDOCRINOLOGY, V139, P4252, DOI 10.1210/en.139.10.4252; Kuiper GGJM, 1997, ENDOCRINOLOGY, V138, P863, DOI 10.1210/en.138.3.863; Kushner PJ, 2000, J STEROID BIOCHEM, V74, P311, DOI 10.1016/S0960-0760(00)00108-4; LIU YH, 1993, MOL CELL BIOL, V13, P1836, DOI 10.1128/MCB.13.3.1836; LIU YH, 1991, J BIOL CHEM, V266, P21880; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; MCDONNELL DP, 1995, MOL ENDOCRINOL, V9, P659, DOI 10.1210/me.9.6.659; McKenna NJ, 1999, ENDOCR REV, V20, P321, DOI 10.1210/er.20.3.321; MCLACHLAN JA, 1993, ENVIRON HEALTH PERSP, V101, P386, DOI 10.2307/3431891; Norris JD, 1996, MOL ENDOCRINOL, V10, P1605, DOI 10.1210/mend.10.12.8961270; NUNEZ AM, 1989, EMBO J, V8, P823, DOI 10.1002/j.1460-2075.1989.tb03443.x; Paige LA, 1999, P NATL ACAD SCI USA, V96, P3999, DOI 10.1073/pnas.96.7.3999; Pearce D, 1998, J BIOL CHEM, V273, P30081, DOI 10.1074/jbc.273.46.30081; Petit F, 1997, J MOL ENDOCRINOL, V19, P321, DOI 10.1677/jme.0.0190321; Routledge EJ, 2000, J BIOL CHEM, V275, P35986, DOI 10.1074/jbc.M006777200; SCHULE R, 1988, SCIENCE, V242, P1418, DOI 10.1126/science.3201230; TZUKERMAN MT, 1994, MOL ENDOCRINOL, V8, P21, DOI 10.1210/me.8.1.21; Wijayaratne AL, 1999, ENDOCRINOLOGY, V140, P5828, DOI 10.1210/en.140.12.5828; Wood JR, 2001, MOL ENDOCRINOL, V15, P1114, DOI 10.1210/me.15.7.1114	33	79	80	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	2002	277	46					44455	44461		10.1074/jbc.M200849200	http://dx.doi.org/10.1074/jbc.M200849200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	615XE	12200415	hybrid			2022-12-27	WOS:000179272000117
J	Korichneva, I; Hoyos, B; Chua, R; Levi, E; Hammerling, U				Korichneva, I; Hoyos, B; Chua, R; Levi, E; Hammerling, U			Zinc release from protein kinase C as the common event during activation by lipid second messenger or reactive oxygen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHORBOL ESTER BINDING; CYSTEINE-RICH DOMAIN; REDOX SWITCH; CHAPERONE; RAS	Zinc is a structural component of many regulatory molecules including transcription factors and signaling molecules. We report that two alternate signaling pathways of protein kinase C (PKC) activation involving either the lipid second messengers (diacylglycerol and its mimetics, the phorbol esters) or reactive oxygen converge at the zinc finger of the regulatory domain. They all trigger the release of zinc ions. An increase in intracellular free Zn2+ was observed by confocal microscopy in intact cells treated with phorbol ester or by mild oxidation. The source of liberated Zn2+ was traced to PKC and particularly the zinc finger domains. The activated form of native PKCalpha contained significantly less Zn2+ than the resting form. Furthermore, purified recombinant PKC protein fragments shed stoichiometric amounts of Zn2+ upon reaction with diacylglycerol, phorbol ester, or reactive oxygen in vitro. Our results offer new insight into the regulation of PKC. Far from cementing rigid structures, zinc actually is the linchpin that orchestrates dynamic changes in response to specific signals, allowing kinase activity to be turned on or off.	Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Korichneva, I (corresponding author), Mem Sloan Kettering Canc Ctr, Program Immunol, 1275 York Ave,Box 382, New York, NY 10021 USA.				NATIONAL CANCER INSTITUTE [R01CA049933, R01CA089362] Funding Source: NIH RePORTER; NCI NIH HHS [CA 49933, CA 89362] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AHMED S, 1991, BIOCHEM J, V280, P233, DOI 10.1042/bj2800233; Barbirz S, 2000, J BIOL CHEM, V275, P18759, DOI 10.1074/jbc.M001089200; BURNS DJ, 1991, J BIOL CHEM, V266, P18330; GHOSH SJ, 1994, J BIOL CHEM, V269, P10000; GOPALAKRISHNA R, 1989, P NATL ACAD SCI USA, V86, P6758, DOI 10.1073/pnas.86.17.6758; Hoyos B, 2000, J EXP MED, V192, P835, DOI 10.1084/jem.192.6.835; HUNT JB, 1984, J BIOL CHEM, V259, P4793; Hurley JH, 1997, CURR OPIN STRUC BIOL, V7, P557, DOI 10.1016/S0959-440X(97)80122-4; Hurley JH, 1997, PROTEIN SCI, V6, P477; Imam A, 2001, FASEB J, V15, P28; Jakob U, 1999, CELL, V96, P341, DOI 10.1016/S0092-8674(00)80547-4; Jakob U, 2000, J BIOL CHEM, V275, P38302, DOI 10.1074/jbc.M005957200; KAZANIETZ MG, 1994, J BIOL CHEM, V269, P11590; KAZANIETZ MG, 1993, MOL PHARMACOL, V44, P298; Knapp LT, 2000, J BIOL CHEM, V275, P24136, DOI 10.1074/jbc.M002043200; Konishi H, 1997, P NATL ACAD SCI USA, V94, P11233, DOI 10.1073/pnas.94.21.11233; Mochly-Rosen D, 1998, FASEB J, V12, P35; Mott HR, 1996, P NATL ACAD SCI USA, V93, P8312, DOI 10.1073/pnas.93.16.8312; NEWTON AC, 1993, ANNU REV BIOPH BIOM, V22, P1, DOI 10.1146/annurev.bb.22.060193.000245; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; NISHIZUKA Y, 1995, FASEB J, V9, P484, DOI 10.1096/fasebj.9.7.7737456; ONO Y, 1989, P NATL ACAD SCI USA, V86, P4868, DOI 10.1073/pnas.86.13.4868; Velazquez RA, 1999, J NEUROSCI, V19, P2288; ZHANG GG, 1995, CELL, V81, P917, DOI 10.1016/0092-8674(95)90011-X	24	138	141	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	2002	277	46					44327	44331		10.1074/jbc.M205634200	http://dx.doi.org/10.1074/jbc.M205634200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	615XE	12213816	hybrid			2022-12-27	WOS:000179272000103
J	Wang, XK; Xu, L; Wang, H; Young, PR; Gaestel, M; Feuerstein, GZ				Wang, XK; Xu, L; Wang, H; Young, PR; Gaestel, M; Feuerstein, GZ			Mitogen-activated protein kinase-activated protein (MAPKAP) kinase 2 deficiency protects brain from ischemic injury in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL CEREBRAL-ISCHEMIA; EXPRESSION; RAT; BIOSYNTHESIS; INHIBITOR; CASCADE; DAMAGE; STROKE; STRESS; MRI	Mitogen-activated protein (MAP) kinase-activated protein kinase 2 (MK2) is one of several kinases directly regulated by p38 MAP kinase. A role of p38 MAP kinase in ischemic brain injury has been previously suggested by pharmacological means. In the present study, we provide evidence for a role of MK2 in cerebral ischemic injury using MM-deficient (MK2(-/-)) mice. MM2(-/-) mice subjected to focal ischemia markedly reduced infarct size by 64 and 76% after transient and permanent ischemia, respectively, compared with wild-type mice. Furthermore, MK2(-/-) mice had significant reduction in neurological deficits. Real-time PCR analysis identified a significantly lower expression in interleukin-1beta mRNA (53% reduction) but not in tumor necrosis factor-a mRNA in MK2(-/-) mice over wild-type animals after ischemic injury. The significant reduction in interleukin-1beta was also confirmed in MK2(-/-) mice by enzyme-linked immunosorbent assay. The marked neuroprotection from ischemic brain injury in MK2(-/-) mice was not associated with the alteration of hemodynamic or systemic variables, activation of caspase-3, or apoptosis. Our data provide new evidence for the involvement of MAP kinase pathway in focal ischemic brain injury and suggest that this effect might be associated with the expression of interleukin-1beta in the ischemic brain tissue.	Bristol Myers Squibb Co, Dept Cardiovasc Sci, Expt Stn, Wilmington, DE 19880 USA; Hannover Med Sch, Inst Biochem, D-30625 Hannover, Germany	Bristol-Myers Squibb; DuPont; Hannover Medical School	Wang, XK (corresponding author), Bristol Myers Squibb Co, Dept Cardiovasc Sci, Expt Stn, E400-3418, Wilmington, DE 19880 USA.		Gaestel, Matthias/A-6560-2013	Gaestel, Matthias/0000-0002-4944-4652				Alessandrini A, 1999, P NATL ACAD SCI USA, V96, P12866, DOI 10.1073/pnas.96.22.12866; BARONE FC, 1991, BRAIN RES BULL, V26, P285, DOI 10.1016/0361-9230(91)90240-K; Barone FC, 2001, J PHARMACOL EXP THER, V296, P312; Basu A, 2002, J NEUROSCI, V22, P6071; BEDERSON JB, 1986, STROKE, V17, P1304, DOI 10.1161/01.STR.17.6.1304; CANO E, 1995, TRENDS BIOCHEM SCI, V20, P117, DOI 10.1016/S0968-0004(00)88978-1; del Zoppo G, 2000, BRAIN PATHOL, V10, P95; *DHHS DHEW NIH, 1996, PUBL NIH DHHS DHEW, V8523; Floyd RA, 1992, ANN NEUROL, V32, P22; Graham SH, 2001, J CEREBR BLOOD F MET, V21, P99, DOI 10.1097/00004647-200102000-00001; Huang CK, 1997, J BIOL CHEM, V272, P17, DOI 10.1074/jbc.272.1.17; Irving EA, 2000, MOL BRAIN RES, V77, P65, DOI 10.1016/S0169-328X(00)00043-7; Kotlyarov A, 1999, NAT CELL BIOL, V1, P94, DOI 10.1038/10061; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Lin SP, 2001, STROKE, V32, P925, DOI 10.1161/01.STR.32.4.925; Loddick SA, 1996, J CEREBR BLOOD F MET, V16, P932, DOI 10.1097/00004647-199609000-00017; MINEMATSU K, 1992, NEUROLOGY, V42, P235, DOI 10.1212/WNL.42.1.235; Rothwell NJ, 2000, TRENDS NEUROSCI, V23, P618, DOI 10.1016/S0166-2236(00)01661-1; ROUSE J, 1994, CELL, V78, P1027, DOI 10.1016/0092-8674(94)90277-1; Sugino T, 2000, J NEUROSCI, V20, P4506, DOI 10.1523/JNEUROSCI.20-12-04506.2000; Thomas G, 1997, EUR J BIOCHEM, V247, P1180, DOI 10.1111/j.1432-1033.1997.01180.x; Wang H, 2001, BIOCHEM BIOPH RES CO, V286, P869, DOI 10.1006/bbrc.2001.5482; Wang H, 2001, STROKE, V32, P1020, DOI 10.1161/01.STR.32.4.1020; Wang XK, 2000, J NEUROSCI RES, V59, P238, DOI 10.1002/(SICI)1097-4547(20000115)59:2<238::AID-JNR10>3.0.CO;2-G; Wang XK, 2000, DRUG NEWS PERSPECT, V13, P133, DOI 10.1358/dnp.2000.13.3.657283; Werz O, 2002, J BIOL CHEM, V277, P14793, DOI 10.1074/jbc.M111945200; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Young PR, 1997, J BIOL CHEM, V272, P12116, DOI 10.1074/jbc.272.18.12116; Zhang RL, 1997, BRAIN RES, V766, P83, DOI 10.1016/S0006-8993(97)00580-5	29	47	54	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	2002	277	46					43968	43972		10.1074/jbc.M206837200	http://dx.doi.org/10.1074/jbc.M206837200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	615XE	12215446	hybrid			2022-12-27	WOS:000179272000057
J	Brickley, DR; Mikosz, CA; Hagan, CR; Conzen, SD				Brickley, DR; Mikosz, CA; Hagan, CR; Conzen, SD			Ubiquitin modification of serum and glucocorticoid-induced protein kinase-1 (SGK-1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLINOSITOL 3-PHOSPHATE; SIGNALING PATHWAY; CELLS; ACTIVATION; DOMAIN; GENE	The serum and glucocorticoid-induced protein kinase gene (sgk-1) encodes a multifunctional kinase that can be phosphorylated and activated through a phosphatidylinositol 3-kinase-dependent signaling pathway. In many cell types, endogenous SGK-1 steady-state protein levels are very low but can be acutely up-regulated after glucocorticoid receptor-mediated transcriptional activation; in breast epithelial and cancer cell lines, this up-regulation is associated with promotion of cell survival. We and others have noted that ectopically introduced full-length SGK-1 is poorly expressed, although SGK-1 lacking the first 60 amino acids (Delta60SGK-1) is expressed at much higher-fold protein levels than wildtype SGK-1 in both human embryonic kidney 293T and MCF10A mammary epithelial cells. In this report, we demonstrate for the first time that the low steady-state expression level of SGK-1 is due to polyubiquitination and subsequent degradation by the 26S proteasome. Deletion of the amino-terminal 60 amino acids of SGK-1 results in a mutant SGK-1 protein that is neither efficiently polyubiquitinated nor degraded by the 26S proteasome, accounting for the higher steady-state levels of the truncated protein. We also demonstrate that a subset of SGK-1 localizes to the plasma membrane and that the polyubiquitin-modified SGK-1 localizes to a membrane-associated fraction of the cell. Taken together, these data suggest that a significant fraction of SGK-1 is membrane-associated and ubiquitinated. These findings are consistent with the recently described role of SGK-1 in phosphorylating the membrane-associated protein Nedd4-2 and the integral membrane Na+/H+ exchanger isoform 3 (NHE3) and suggest a novel mechanism of regulation of SGK-1.	Univ Chicago, Dept Med, Hematol Oncol Sect, Chicago, IL 60637 USA	University of Chicago	Conzen, SD (corresponding author), Univ Chicago, Dept Med, Hematol Oncol Sect, 5841 S Maryland Ave,MC 2115, Chicago, IL 60637 USA.	sconzen@medicine.bsd.uchicago.edu			NCI NIH HHS [K08 CA90459, CA14599-25] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA014599, K08CA090459] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Andjelkovic M, 1997, J BIOL CHEM, V272, P31515, DOI 10.1074/jbc.272.50.31515; Bravo J, 2001, MOL CELL, V8, P829, DOI 10.1016/S1097-2765(01)00372-0; Brunet A, 2001, MOL CELL BIOL, V21, P952, DOI 10.1128/MCB.21.3.952-965.2001; Buse P, 1999, J BIOL CHEM, V274, P7253, DOI 10.1074/jbc.274.11.7253; Debonneville C, 2001, EMBO J, V20, P7052, DOI 10.1093/emboj/20.24.7052; Echarri A, 2001, CURR BIOL, V11, P1759, DOI 10.1016/S0960-9822(01)00538-3; Evans-Storms RB, 2000, ENDOCRINOLOGY, V141, P1854, DOI 10.1210/en.141.5.1854; FENTEANY G, 1995, SCIENCE, V268, P726, DOI 10.1126/science.7732382; Kandel ES, 1999, EXP CELL RES, V253, P210, DOI 10.1006/excr.1999.4690; Kennedy SG, 1997, GENE DEV, V11, P701, DOI 10.1101/gad.11.6.701; Kobayashi T, 1999, BIOCHEM J, V344, P189, DOI 10.1042/0264-6021:3440189; Lang F, 2001, SCI STKE, V2001; Lu ZM, 2002, MOL CELL, V9, P945, DOI 10.1016/S1097-2765(02)00519-1; Mikosz CA, 2001, J BIOL CHEM, V276, P16649, DOI 10.1074/jbc.M010842200; Moran TJ, 2000, CANCER RES, V60, P867; Okuda H, 2001, J BIOL CHEM, V276, P43611, DOI 10.1074/jbc.M107880200; Park J, 1999, EMBO J, V18, P3024, DOI 10.1093/emboj/18.11.3024; Pickart CM, 2001, MOL CELL, V8, P499, DOI 10.1016/S1097-2765(01)00347-1; Shelly C, 2002, J CELL SCI, V115, P1985; Snyder PM, 2002, J BIOL CHEM, V277, P5, DOI 10.1074/jbc.C100623200; Virbasius JV, 2001, P NATL ACAD SCI USA, V98, P12908, DOI 10.1073/pnas.221352898; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; WEBSTER MK, 1993, MOL CELL BIOL, V13, P2031, DOI 10.1128/MCB.13.4.2031; Xu JS, 2001, J CELL BIOL, V154, P1069, DOI 10.1083/jcb.200103111; Yun CC, 2002, J BIOL CHEM, V277, P7676, DOI 10.1074/jbc.M107768200	25	76	82	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					43064	43070		10.1074/jbc.M207604200	http://dx.doi.org/10.1074/jbc.M207604200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12218062	hybrid			2022-12-27	WOS:000179081200084
J	Grosfeld, A; Andre, J; Hauguel-de-Mouzon, S; Berra, E; Pouyssegur, J; Guerre-Millo, M				Grosfeld, A; Andre, J; Hauguel-de-Mouzon, S; Berra, E; Pouyssegur, J; Guerre-Millo, M			Hypoxia-inducible factor 1 transactivates the human leptin gene promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; ANGIOGENIC FACTOR; FACTOR 1-ALPHA; SKIN REPAIR; HIF-ALPHA; OB GENE; HYDROXYLATION; TRANSCRIPTION; PREECLAMPSIA; EXPRESSION	Increased placental leptin has been demonstrated in preeclampsia, a pregnancy disorder associated with placental hypoxia. This suggests that leptin gene expression is enhanced in response to oxygen deficiency in this organ. In support of this hypothesis, we have previously shown that hypoxia activates the leptin promoter in trophoblast-derived BeWo cells. Hypoxia-inducible factor 1 (HIF-1) is a heterodimeric HIF-1alpha/HIF-1beta complex that regulates the transcription of hypoxia-responsive genes. To test whether this factor is involved in hypoxia-induced leptin promoter activation, BeWo cells were transiently transfected with a HIF-1alpha expression vector. Exogenous HIF-1alpha markedly increased luciferase reporter activity driven by the leptin promoter when HIF-1beta was co-expressed in the same cells. This effect was similar to that elicited by CoCl2, an agent known to stabilize endogenous HIF-1alpha. These data suggest that HIF-1alpha/HIF-1beta dimers are involved in the effect of CoCl2 to activate the leptin promoter. To confirm the implication of HIF-1, the cells were transfected with a dominant negative form of HIF-1alpha producing transcriptionally inactive HIF-1beta/HIF-1alpha dimers. This mutant HIF-1alpha protein abolished CoCl2 activation of the leptin promoter, providing direct evidence that the effect of CoCl2 is mediated by endogenous HIF-1alpha. Deletion analysis and site-specific mutagenesis demonstrated that a HIF-1 consensus binding site (HRE) spanning -120 to -116 bp relative to the start site was required for CoCl2 and exogenous HIF-1a induction of leptin promoter activity. Electrophoretic mobility shift assays performed with in vitro-translated HIF-1alpha and HIF-1beta proteins demonstrated binding to this HRE and not to mutated sequences only when both subunits were used together. These data demonstrate that leptin is a new hypoxia-inducible gene, which is stimulated in a placental cell line through HIF-1 interaction with a consensus HRE site located at -116 in the proximal promoter.	Univ Paris 06, Ctr Rech Cordeliers, U465, INSERM, F-75006 Paris, France; Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA; CNRS, UMR 6543, F-06189 Nice, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Case Western Reserve University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur	Guerre-Millo, M (corresponding author), Univ Paris 06, Ctr Rech Cordeliers, U465, INSERM, 15 Rue Ecole Med, F-75006 Paris, France.		Guerre-Millo, Michele/G-7253-2017; Grosfeld, Alexandra/R-1404-2017; Grosfeld, Alexandra/AAH-3510-2020; Berra, Edurne/F-9692-2011	Grosfeld, Alexandra/0000-0002-9508-036X; Berra, Edurne/0000-0002-3820-5744				Ahima RS, 2000, ANNU REV PHYSIOL, V62, P413, DOI 10.1146/annurev.physiol.62.1.413; Bado A, 1998, NATURE, V394, P790, DOI 10.1038/29547; Benyo DF, 1997, J CLIN ENDOCR METAB, V82, P1582, DOI 10.1210/jc.82.5.1582; Bouloumie A, 1998, CIRC RES, V83, P1059, DOI 10.1161/01.RES.83.10.1059; Brahimi-Horn C, 2001, TRENDS CELL BIOL, V11, pS32, DOI 10.1016/S0962-8924(01)02126-2; CLAFFEY KP, 1992, J BIOL CHEM, V267, P16317; DEMOUZON SH, 2001, DIABETES S2, V50, pA4; Frank S, 2000, J CLIN INVEST, V106, P501, DOI 10.1172/JCI9148; Grosfeld A, 2002, DIABETOLOGIA, V45, P527, DOI 10.1007/s00125-002-0804-y; Grosfeld A, 2001, FEBS LETT, V502, P122, DOI 10.1016/S0014-5793(01)02673-4; Hellwig-Burgel T, 1999, BLOOD, V94, P1561, DOI 10.1182/blood.V94.5.1561.417a06_1561_1567; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Konturek PC, 2001, EUR J PHARMACOL, V414, P87, DOI 10.1016/S0014-2999(01)00748-8; Konturek PC, 1999, J PHYSIOL PHARMACOL, V50, P587; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Miller SG, 1996, P NATL ACAD SCI USA, V93, P5507, DOI 10.1073/pnas.93.11.5507; Mise H, 1998, J CLIN ENDOCR METAB, V83, P3225, DOI 10.1210/jc.83.9.3225; REDMAN CWG, 1991, PLACENTA, V12, P301, DOI 10.1016/0143-4004(91)90339-H; Richard DE, 2000, J BIOL CHEM, V275, P26765; Richard DE, 1999, J BIOL CHEM, V274, P32631, DOI 10.1074/jbc.274.46.32631; Sierra-Honigmann MR, 1998, SCIENCE, V281, P1683, DOI 10.1126/science.281.5383.1683; SILVERMAN KJ, 1988, BIOCHEM BIOPH RES CO, V153, P347, DOI 10.1016/S0006-291X(88)81229-4; Spinella F, 2002, J BIOL CHEM, V277, P27850, DOI 10.1074/jbc.M202421200; Stallmeyer B, 2001, J INVEST DERMATOL, V117, P98, DOI 10.1046/j.0022-202x.2001.01387.x; Stiehl DP, 2002, FEBS LETT, V512, P157, DOI 10.1016/S0014-5793(02)02247-0; Thornton RD, 2000, BIOCHEM J, V350, P307, DOI 10.1042/0264-6021:3500307; Wilczynski JR, 2002, MEDIAT INFLAMM, V11, P105, DOI 10.1080/09629350220131962; Zelzer E, 1998, EMBO J, V17, P5085, DOI 10.1093/emboj/17.17.5085; Zhang QX, 1997, J SURG RES, V67, P147, DOI 10.1006/jsre.1996.4983	30	210	233	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					42953	42957		10.1074/jbc.M206775200	http://dx.doi.org/10.1074/jbc.M206775200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12215445	hybrid			2022-12-27	WOS:000179081200069
J	Jenkins, GM; Cowart, LA; Signorelli, P; Pettus, BJ; Chalfant, CE; Hannun, YA				Jenkins, GM; Cowart, LA; Signorelli, P; Pettus, BJ; Chalfant, CE; Hannun, YA			Acute activation of de novo sphingolipid biosynthesis upon heat shock causes an accumulation of ceramide and subsequent dephosphorylation of SR proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; SERINE PALMITOYLTRANSFERASE; INDUCED APOPTOSIS; CELL APOPTOSIS; STRESS; GENERATION; DIFFERENTIATION; TRANSCRIPTION; INVOLVEMENT; INHIBITION	Recent studies are beginning to implicate sphingolipids in the heat stress response. In the yeast Saccharomyces cerevisiae, heat stress has been shown to activate de novo biosynthesis of sphingolipids, whereas in mammalian cells the sphingolipid ceramide has been implicated in the heat shock responses. In the current study, we found an increase in the ceramide mass of Molt-4 cells in response to heat shock, corroborating findings in HL-60 cells. Increased ceramide was determined to be from de novo biosynthesis by two major lines of evidence. First, the accumulation of ceramide was dependent upon the activities of both ceramide synthase and serine palmitoyltransferase. Second, pulse labeling studies demonstrated increased production of ceramide through the de novo biosynthetic pathway. Significantly, the de novo sphingolipid biosynthetic pathway was acutely induced upon heat shock, which resulted in a 2-fold increased flux in newly made ceramides within 1-2 min of exposure to 42.5 degreesC. Functionally, heat shock induced the dephosphorylation of the SR proteins, and this effect was demonstrated to be dependent upon the accumulation of de novo-produced ceramides. Thus, these studies disclose an evolutionary conserved activation of the de novo pathway in response to heat shock. Moreover, SR dephosphorylation is emerging as a specific downstream target of accumulation of newly made ceramides in mammalian cells.	Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; Univ Milan, Dept Patol Gen, I-20157 Milan, Italy	Medical University of South Carolina; University of Milan	Hannun, YA (corresponding author), Med Univ S Carolina, Dept Biochem & Mol Biol, Rm 501,Basic Sci Bldg,173 Ashley Ave,POB 250509, Charleston, SC 29425 USA.			signorelli, paola/0000-0003-2368-2393	NATIONAL CANCER INSTITUTE [R01CA087584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM043825, R01GM043825] Funding Source: NIH RePORTER; NCI NIH HHS [CA 87584] Funding Source: Medline; NIGMS NIH HHS [GM 43825] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Chalfant CE, 2001, J BIOL CHEM, V276, P44848, DOI 10.1074/jbc.M106291200; Chang Y, 1995, P NATL ACAD SCI USA, V92, P12275, DOI 10.1073/pnas.92.26.12275; Charles AG, 2001, CANCER CHEMOTH PHARM, V47, P444, DOI 10.1007/s002800000265; Chung N, 2000, J BIOL CHEM, V275, P17229, DOI 10.1074/jbc.C000229200; Dickson RC, 2000, METHOD ENZYMOL, V311, P3; Dickson RC, 1998, ANNU REV BIOCHEM, V67, P27, DOI 10.1146/annurev.biochem.67.1.27; GEORGOPOULOS C, 1993, ANNU REV CELL BIOL, V9, P601, DOI 10.1146/annurev.cb.09.110193.003125; Hannun YA, 1996, SCIENCE, V274, P1855, DOI 10.1126/science.274.5294.1855; Jenkins GM, 1997, J BIOL CHEM, V272, P32566, DOI 10.1074/jbc.272.51.32566; Jenkins GM, 2001, J BIOL CHEM, V276, P8574, DOI 10.1074/jbc.M007425200; Kondo T, 2000, J BIOL CHEM, V275, P7668, DOI 10.1074/jbc.275.11.7668; Kondo T, 2000, J BIOL CHEM, V275, P8872, DOI 10.1074/jbc.275.12.8872; Kroesen BJ, 2001, J BIOL CHEM, V276, P13606, DOI 10.1074/jbc.M009517200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Liu B, 1997, J BIOL CHEM, V272, P16281, DOI 10.1074/jbc.272.26.16281; MERRILL AH, 1988, ANAL BIOCHEM, V171, P373, DOI 10.1016/0003-2697(88)90500-3; Nagata Y, 1999, BLOOD, V94, P853, DOI 10.1182/blood.V94.3.853.415a12_853_863; OBEID LM, 1993, SCIENCE, V259, P1769, DOI 10.1126/science.8456305; Perry DK, 2000, J BIOL CHEM, V275, P9078, DOI 10.1074/jbc.275.12.9078; Pirkkala L, 2001, FASEB J, V15, P1118, DOI 10.1096/fj00-0294rev; TANAKA H, 1982, BIOCHEM J, V204, P713, DOI 10.1042/bj2040713; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Venable ME, 1995, J BIOL CHEM, V270, P30701, DOI 10.1074/jbc.270.51.30701; Wang E, 2000, METHOD ENZYMOL, V311, P15; Wang HT, 2001, CANCER RES, V61, P5102; Wells GB, 1998, J BIOL CHEM, V273, P7235, DOI 10.1074/jbc.273.13.7235	28	65	67	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					42572	42578		10.1074/jbc.M207346200	http://dx.doi.org/10.1074/jbc.M207346200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12200446	hybrid			2022-12-27	WOS:000179081200020
J	Wang, YD; Dziegielewski, J; Chang, AY; Dervan, PB; Beerman, TA				Wang, YD; Dziegielewski, J; Chang, AY; Dervan, PB; Beerman, TA			Cell-free and cellular activities of a DNA sequence selective hairpin polyamide-CBI conjugate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PYRROLE-IMIDAZOLE POLYAMIDES; SIMIAN VIRUS-40 DNA; MINOR-GROOVE; SIMIAN-VIRUS-40 DNA; BSC-1 CELLS; MAMMALIAN-CELLS; DRUG ADOZELESIN; GENE-EXPRESSION; SMALL MOLECULES; SV40 DNA	Alkylating agents are generally highly reactive with DNA but demonstrate limited DNA sequence selectivity. In contrast, synthetic pyrrole-imidazole polyamides recognize specific DNA sequences with high affinity but are unable to permanently damage DNA. An eight-ring hairpin polyamide conjugated to the alkylating moiety cyclopropylpyrroloindole, related to the natural product CC-1065, affords a conjugate 1-CBI (polyamide 1-CBI (1-(chloromethyl)-5-hydroxyl-1,2-dihydro-3H-benz[e]indole) conjugate), which binds to specific sequences in the minor groove of DNA and alkylates a single adenine flanking the polyamide binding site. In this study, we show that 1-CBI alkylates DNA in both plasmid and intracellular minichromosomal form and inhibits DNA replication under both cell-free and cellular conditions. In addition, it inhibits cell growth and arrests cells in the G(2)/M phase of the cell cycle.	Roswell Pk Canc Inst, Dept Pharmacol & Therapeut, Buffalo, NY 14263 USA; CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA	Roswell Park Cancer Institute; California Institute of Technology	Beerman, TA (corresponding author), Roswell Pk Canc Inst, Dept Pharmacol & Therapeut, Elm & Carlton St, Buffalo, NY 14263 USA.		Wang, Yong-Dong/K-3563-2013		NCI NIH HHS [CA80939, CA16056] Funding Source: Medline; NIGMS NIH HHS [GM27681] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA016056, R01CA080939] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM027681, R37GM027681] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arad U, 1998, BIOTECHNIQUES, V24, P760, DOI 10.2144/98245bm14; Belitsky JM, 2002, BIOORGAN MED CHEM, V10, P3313, DOI 10.1016/S0968-0896(02)00204-3; BHUYAN BK, 1983, CANCER RES, V43, P4227; Chang AY, 2000, J AM CHEM SOC, V122, P4856, DOI 10.1021/ja994345x; Chiang SY, 2000, J BIOL CHEM, V275, P24246, DOI 10.1074/jbc.M000820200; Cobuzzi RJ, 1996, J BIOL CHEM, V271, P19852, DOI 10.1074/jbc.271.33.19852; Dervan PB, 2001, BIOORGAN MED CHEM, V9, P2215, DOI 10.1016/S0968-0896(01)00262-0; Dickinson LA, 1998, P NATL ACAD SCI USA, V95, P12890, DOI 10.1073/pnas.95.22.12890; Dziegielewski J, 2001, BIOCHEMISTRY-US, V40, P704, DOI 10.1021/bi002181n; Gottesfeld JM, 1997, NATURE, V387, P202, DOI 10.1038/387202a0; Gottesfeld JM, 2000, GENE EXPRESSION, V9, P77; GRIMWADE JE, 1986, MOL PHARMACOL, V30, P358; Herzig MCS, 2002, BIOCHEMISTRY-US, V41, P1545, DOI 10.1021/bi011907s; Leonessa F, 1996, BRIT J CANCER, V73, P154, DOI 10.1038/bjc.1996.29; Liu JS, 2000, J BIOL CHEM, V275, P1391, DOI 10.1074/jbc.275.2.1391; MCHUGH MM, 1994, BIOCHEMISTRY-US, V33, P9158, DOI 10.1021/bi00197a019; MCHUGH MM, 1995, BIOCHEMISTRY-US, V34, P1805, DOI 10.1021/bi00005a038; McHugh MM, 1999, BIOCHEMISTRY-US, V38, P11508, DOI 10.1021/bi990598r; REYNOLDS VL, 1986, J ANTIBIOT, V39, P319, DOI 10.7164/antibiotics.39.319; REYNOLDS VL, 1985, BIOCHEMISTRY-US, V24, P6228, DOI 10.1021/bi00343a029; SCOTT WA, 1978, CELL, V15, P1511, DOI 10.1016/0092-8674(78)90073-9; STILLMAN BW, 1985, MOL CELL BIOL, V5, P2051, DOI 10.1128/MCB.5.8.2051; SUN D, 1992, BIOCHEMISTRY-US, V31, P2822, DOI 10.1021/bi00125a025; Wang YZ, 2001, CANCER RES, V61, P3787; WARPEHOSKI MA, 1992, BIOCHEMISTRY-US, V31, P2502, DOI 10.1021/bi00124a009; White S, 1997, J AM CHEM SOC, V119, P8756, DOI 10.1021/ja971569b; White S, 1996, BIOCHEMISTRY-US, V35, P12532, DOI 10.1021/bi960744i; Woynarowski JM, 1999, BBA-GENE STRUCT EXPR, V1444, P201, DOI 10.1016/S0167-4781(99)00002-0; WOYNAROWSKI JM, 1995, BIOCHEMISTRY-US, V34, P13042, DOI 10.1021/bi00040a015; Woynarowski JM, 1997, BBA-GENE STRUCT EXPR, V1353, P50, DOI 10.1016/S0167-4781(97)00046-8; ZSIDO TJ, 1992, BIOCHEM PHARMACOL, V43, P1817, DOI 10.1016/0006-2952(92)90715-U; ZSIDO TJ, 1991, BIOCHEMISTRY-US, V30, P3733, DOI 10.1021/bi00229a021	32	26	27	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					42431	42437		10.1074/jbc.M207179200	http://dx.doi.org/10.1074/jbc.M207179200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12196541	hybrid, Green Accepted			2022-12-27	WOS:000179081200003
J	Babini, E; Paukert, M; Geisler, HS; Grunder, S				Babini, E; Paukert, M; Geisler, HS; Grunder, S			Alternative splicing and interaction with di- and polyvalent cations control the dynamic range of acid-sensing ion channel 1 (ASIC1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR CALCIUM; SODIUM-CHANNEL; POTASSIUM CHANGES; NEURONS; RECEPTOR; ISCHEMIA; POTENTIATION; POLYAMINES; SENSATION; RELEASE	Homomeric acid-sensing ion channel 1 (ASIC1) can be activated by extracellular H+ in the physiological pH range and may, therefore, contribute to neurotransmission and peripheral pain perception. ASIC1a and ASIC1b are alternative splice products of the ASIC1 gene. Here we show that both splice variants show steady-state inactivation when exposed to slightly decreased pH, limiting their operational range. Compared with ASIC1a, steady-state inactivation and pH activation of ASIC1b are shifted to more acidic values by 0.25 and 0.7 pH units, respectively, extending the dynamic range of ASIC1. Shifts of inactivation and activation are intimately linked; only two amino acids in the ectodomain, which are exchanged by alternative splicing, control both properties. Moreover, we show that extracellular, divalent cations like Ca2+ and Mg2+ as well as the polyvalent cation spermine shift the steady-state inactivation of ASIC1a and ASIC1b to more acidic values. This leads to a potentiation of the channel response and is due to a stabilization of the resting state. Our results indicate that ASIC1b is an effective sensor of transient H+ signals during slight acidosis and that, in addition to alternative splicing, interaction with di- and polyvalent cations extends the dynamic range of ASIC H+ sensors.	Res Grp Sensory Physiol, Dept Otolaryngol, D-72076 Tubingen, Germany		Grunder, S (corresponding author), Res Grp Sensory Physiol, Dept Otolaryngol, D-72076 Tubingen, Germany.		Gründer, Stefan/I-2495-2019	Gründer, Stefan/0000-0002-7635-9883				Baron A, 2001, J BIOL CHEM, V276, P35361, DOI 10.1074/jbc.M105208200; Bassler EL, 2001, J BIOL CHEM, V276, P33782, DOI 10.1074/jbc.M104030200; BENNINGER C, 1980, BRAIN RES, V187, P165, DOI 10.1016/0006-8993(80)90502-8; Benson CJ, 1999, CIRC RES, V84, P921; Benson CJ, 2002, P NATL ACAD SCI USA, V99, P2338, DOI 10.1073/pnas.032678399; BROWN EM, 1993, NATURE, V366, P575, DOI 10.1038/366575a0; Chen CC, 1998, P NATL ACAD SCI USA, V95, P10240, DOI 10.1073/pnas.95.17.10240; Cook SP, 1998, J NEUROSCI, V18, P9238; Coscoy S, 1998, J BIOL CHEM, V273, P8317, DOI 10.1074/jbc.273.14.8317; de la Rosa DA, 2002, P NATL ACAD SCI USA, V99, P2326, DOI 10.1073/pnas.042688199; FAGE D, 1992, J NEUROCHEM, V58, P2170, DOI 10.1111/j.1471-4159.1992.tb10960.x; Firsov D, 1998, EMBO J, V17, P344, DOI 10.1093/emboj/17.2.344; Grunder S, 2000, NEUROREPORT, V11, P1607; HEBERT SC, 1995, CURR OPIN CELL BIOL, V7, P484, DOI 10.1016/0955-0674(95)80004-2; Hofer AM, 2000, NAT CELL BIOL, V2, P392, DOI 10.1038/35017020; Immke DC, 2001, NAT NEUROSCI, V4, P869, DOI 10.1038/nn0901-869; KROIGAARD M, 1992, ACTA PHYSIOL SCAND, V146, P233, DOI 10.1111/j.1748-1716.1992.tb09412.x; Kubo Y, 1998, SCIENCE, V279, P1722, DOI 10.1126/science.279.5357.1722; Madeja M, 1995, J NEUROSCI METH, V63, P211, DOI 10.1016/0165-0270(95)00094-1; MENON GK, 1985, J INVEST DERMATOL, V84, P508, DOI 10.1111/1523-1747.ep12273485; MULLE C, 1992, NEURON, V8, P937, DOI 10.1016/0896-6273(92)90208-U; NICHOLSON C, 1977, P NATL ACAD SCI USA, V74, P1287, DOI 10.1073/pnas.74.3.1287; Olson TH, 1998, NEUROREPORT, V9, P1109, DOI 10.1097/00001756-199804200-00028; PAOLETTI P, 1995, NEURON, V15, P1109, DOI 10.1016/0896-6273(95)90099-3; PASCHEN W, 1992, NEUROSCI LETT, V135, P121, DOI 10.1016/0304-3940(92)90150-6; Price MP, 2000, NATURE, V407, P1007, DOI 10.1038/35039512; Price MP, 2001, NEURON, V32, P1071, DOI 10.1016/S0896-6273(01)00547-5; PUMAIN R, 1985, J NEUROPHYSIOL, V53, P1; Sutherland SP, 2001, P NATL ACAD SCI USA, V98, P711, DOI 10.1073/pnas.011404498; Voilley N, 2001, J NEUROSCI, V21, P8026, DOI 10.1523/JNEUROSCI.21-20-08026.2001; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Waldmann R, 1998, CURR OPIN NEUROBIOL, V8, P418, DOI 10.1016/S0959-4388(98)80070-6	32	167	172	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					41597	41603		10.1074/jbc.M205877200	http://dx.doi.org/10.1074/jbc.M205877200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12198124	hybrid			2022-12-27	WOS:000178985300039
J	Hartenstine, MJ; Goodman, MF; Petruska, J				Hartenstine, MJ; Goodman, MF; Petruska, J			Weak strand displacement activity enables human DNA polymerase beta to expand CAG/CTG triplet repeats at strand breaks	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE-EXCISION-REPAIR; HEREDITARY-DISEASE GENES; IN-VITRO; ESCHERICHIA-COLI; TRINUCLEOTIDE REPEATS; REPLICATION; INSTABILITY; SLIPPAGE; YEAST; RECONSTITUTION	Using synthetic DNA constructs in vitro, we find that human DNA polymerase beta effectively catalyzes CAG/ CTG triplet repeat expansions by slippage initiated at nicks or 1-base gaps within short (14 triplet) repeat tracts in DNA duplexes under physiological conditions. In the same constructs, Escherichia coli DNA polymerase I Klenow Fragment exo(-) is much less effective in expanding repeats, because its much stronger strand displacement activity inhibits slippage by enabling rapid extension through two downstream repeats into flanking non-repeat sequence. Polymerase beta expansions of CAG/CTG repeats, observed over a 32-min period at rates of similar to1 triplet added per min, reveal significant effects of break type (nick versus gap), strand composition (CTG versus CAG), and dNTP substrate concentration, on repeat expansions at strand breaks. At physiological substrate concentrations (1-10 mum of each dNTP), polymerase beta expands triplet repeats with the help of weak strand displacement limited to the two downstream triplet repeats in our constructs. Such weak strand displacement activity in DNA repair at strand breaks may enable short tracts of repeats to be converted into longer, increasingly mutable ones associated with neurological diseases.	Univ So Calif, Dept Biol Sci, Hedco Mol Biol Labs, Los Angeles, CA 90089 USA	University of Southern California	Goodman, MF (corresponding author), Univ So Calif, Dept Biol Sci, Hedco Mol Biol Labs, SHS Room 172,Univ Pk, Los Angeles, CA 90089 USA.				NIA NIH HHS [AG17179] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P01AG017179] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ABBOTTS J, 1988, BIOCHEMISTRY-US, V27, P901, DOI 10.1021/bi00403a010; Ausubel FM, 1987, CURRENT PROTOCOLS MO, V1-5; BERGER SL, 1987, METHOD ENZYMOL, V152, P100; Bowater RP, 2001, PROG NUCLEIC ACID RE, V66, P159; Canceill D, 1999, J BIOL CHEM, V274, P27481, DOI 10.1074/jbc.274.39.27481; da Silva EF, 2000, J BIOL CHEM, V275, P31528, DOI 10.1074/jbc.M004594200; DARLOW JM, 1995, GENETICS, V141, P825; DERBYSHIRE V, 1988, SCIENCE, V240, P199, DOI 10.1126/science.2832946; GACY AM, 1995, CELL, V81, P533; Garcia-Diaz M, 2002, J BIOL CHEM, V277, P13184, DOI 10.1074/jbc.M111601200; Gellibolian R, 1998, GENETIC INSTABILITIES AND HEREDITARY NEUROLOGICAL DISEASES, P561; Gordenin DA, 1997, NAT GENET, V16, P116, DOI 10.1038/ng0697-116; Hartenstine MJ, 2000, J BIOL CHEM, V275, P18382, DOI 10.1074/jbc.275.24.18382; Henricksen LA, 2002, J BIOL CHEM, V277, P22361, DOI 10.1074/jbc.M201765200; Intano GW, 2001, NUCLEIC ACIDS RES, V29, P1366, DOI 10.1093/nar/29.6.1366; Jankowski C, 2000, P NATL ACAD SCI USA, V97, P2134, DOI 10.1073/pnas.040460297; Ji JP, 1996, NUCLEIC ACIDS RES, V24, P2835, DOI 10.1093/nar/24.14.2835; Jin YH, 2001, P NATL ACAD SCI USA, V98, P5122, DOI 10.1073/pnas.091095198; KANG SM, 1995, J BIOL CHEM, V270, P27014, DOI 10.1074/jbc.270.45.27014; Klungland A, 1997, EMBO J, V16, P3341, DOI 10.1093/emboj/16.11.3341; Kovtun IV, 2001, NAT GENET, V27, P407, DOI 10.1038/86906; Kroutil LC, 1999, NUCLEIC ACIDS RES, V27, P3481, DOI 10.1093/nar/27.17.3481; Kubota Y, 1996, EMBO J, V15, P6662, DOI 10.1002/j.1460-2075.1996.tb01056.x; MITAS M, 1995, NUCLEIC ACIDS RES, V23, P1050, DOI 10.1093/nar/23.6.1050; MITCHELL JB, 1985, MUTAT RES, V146, P295, DOI 10.1016/0167-8817(85)90071-9; Moore H, 1999, P NATL ACAD SCI USA, V96, P1504, DOI 10.1073/pnas.96.4.1504; Morel P, 1998, P NATL ACAD SCI USA, V95, P10003, DOI 10.1073/pnas.95.17.10003; Ohshima K, 1997, J BIOL CHEM, V272, P16798, DOI 10.1074/jbc.272.27.16798; Petruska J, 1998, J BIOL CHEM, V273, P5204, DOI 10.1074/jbc.273.9.5204; Petruska J, 1996, NUCLEIC ACIDS RES, V24, P1992, DOI 10.1093/nar/24.11.1992; Prasad R, 2001, J BIOL CHEM, V276, P32411, DOI 10.1074/jbc.C100292200; RANDAHL H, 1988, J BIOL CHEM, V263, P12228; RICHARDS RI, 1992, NAT GENET, V1, P257, DOI 10.1038/ng0792-257; Sakamoto N, 1999, MOL CELL, V3, P465, DOI 10.1016/S1097-2765(00)80474-8; Schweitzer JK, 1998, HUM MOL GENET, V7, P69, DOI 10.1093/hmg/7.1.69; SINGHAL RK, 1993, J BIOL CHEM, V268, P15906; Sobol RW, 1996, NATURE, V379, P183, DOI 10.1038/379183a0; SWEASY JB, 1992, J BIOL CHEM, V267, P1407; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; WANG TSF, 1980, BIOCHEMISTRY-US, V19, P1782, DOI 10.1021/bi00550a009	40	26	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					41379	41389		10.1074/jbc.M207013200	http://dx.doi.org/10.1074/jbc.M207013200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12196536	hybrid			2022-12-27	WOS:000178985300013
J	Li, L; von Bergen, M; Mandelkow, EM; Mandelkow, E				Li, L; von Bergen, M; Mandelkow, EM; Mandelkow, E			Structure, stability, and aggregation of paired helical filaments from tau protein and FTDP-17 mutants probed by tryptophan scanning mutagenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROTUBULE-BINDING REGION; IN-VITRO POLYMERIZATION; ALZHEIMERS-DISEASE; NEUROFIBRILLARY TANGLES; FRONTOTEMPORAL DEMENTIA; BETA-STRUCTURE; AMYLOID-BETA; FLUORESCENCE; PEPTIDES; ISOFORMS	By using tryptophan scanning mutagenesis, we observed the kinetics and structure of the polymerization of tau into paired helical filaments (PHFs) independently of exogenous reporter dyes. The fluorescence exhibits pronounced blue shifts due to burial of the residue inside PHFs, depending on Trp position. The effect is greatest near the center of the repeat domain, showing that the packing is tightest near the beta-structure inducing hexapeptide motifs. The tryptophan response allows measurement of PHF stability made by different tau isoforms and mutants. Unexpectedly, the stability of PHFs is quite low (denaturation half-points similar to1.0 M GdnHCl), implying that incipient aggregation should be reversible and that the observed high stability of Alzheimer PHFs is due to other factors. The stability increases with the number of repeats and with tau mutants promoting beta-structure, arguing for a gain of toxic function in frontotemporal dementias. Fluorescence resonance energy transfer (FRET) was used to analyze the distances of Tyr(310) to tryptophans in different positions. The degree of FRET in the soluble protein was position-dependent, with highest signals within the second and third repeats but low or no signals further away. In PHFs most mutants showed FRET, indicating that tight packing results from assembly of tau into PHFs.	Max Planck Unit Struct Mol Biol, D-22607 Hamburg, Germany	Max Planck Society	Mandelkow, E (corresponding author), Max Planck Unit Struct Mol Biol, Notkestr 85, D-22607 Hamburg, Germany.		von Bergen, Martin/D-7960-2011	von Bergen, Martin/0000-0003-2732-2977				Abraha A, 2000, J CELL SCI, V113, P3737; Barghorn S, 2000, BIOCHEMISTRY-US, V39, P11714, DOI 10.1021/bi000850r; BIERNAT J, 1992, EMBO J, V11, P1593, DOI 10.1002/j.1460-2075.1992.tb05204.x; BUTNER KA, 1991, J CELL BIOL, V115, P717, DOI 10.1083/jcb.115.3.717; BYLER DM, 1986, BIOPOLYMERS, V25, P469, DOI 10.1002/bip.360250307; Carmel G, 1996, J BIOL CHEM, V271, P32789, DOI 10.1074/jbc.271.51.32789; CHIU HC, 1977, BIOPOLYMERS, V16, P277, DOI 10.1002/bip.1977.360160205; CLEVELAND DW, 1977, J MOL BIOL, V116, P227, DOI 10.1016/0022-2836(77)90214-5; DeTure MA, 1996, J BIOL CHEM, V271, P32702, DOI 10.1074/jbc.271.51.32702; EISINGER J, 1969, BIOCHEMISTRY-US, V8, P3902, DOI 10.1021/bi00838a004; FRASER PE, 1994, J MOL BIOL, V244, P64, DOI 10.1006/jmbi.1994.1704; Friedhoff P, 1998, P NATL ACAD SCI USA, V95, P15712, DOI 10.1073/pnas.95.26.15712; Friedhoff P, 1998, BIOCHEMISTRY-US, V37, P10223, DOI 10.1021/bi980537d; Gamblin TC, 2000, BIOCHEMISTRY-US, V39, P6136, DOI 10.1021/bi000201f; Garzon-Rodriguez W, 2000, J BIOL CHEM, V275, P22645, DOI 10.1074/jbc.M000756200; Gasymov OK, 2001, BIOCHEMISTRY-US, V40, P14754, DOI 10.1021/bi0110342; Goedert M, 1999, FEBS LETT, V450, P306, DOI 10.1016/S0014-5793(99)00508-6; GOEDERT M, 1989, EMBO J, V8, P393, DOI 10.1002/j.1460-2075.1989.tb03390.x; Goedert M, 1998, PROG BRAIN RES, V117, P287; Goedert M, 1996, NATURE, V383, P550, DOI 10.1038/383550a0; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; GOODE BL, 1994, J CELL BIOL, V124, P769, DOI 10.1083/jcb.124.5.769; GUSTKE N, 1994, BIOCHEMISTRY-US, V33, P9511, DOI 10.1021/bi00198a017; Hong M, 1998, SCIENCE, V282, P1914, DOI 10.1126/science.282.5395.1914; Hyman BT, 2001, ANN NEUROL, V49, P808, DOI 10.1002/ana.1061; JAKES R, 1991, EMBO J, V10, P2725, DOI 10.1002/j.1460-2075.1991.tb07820.x; Jicha GA, 1997, J NEUROSCI RES, V48, P128, DOI 10.1002/(SICI)1097-4547(19970415)48:2<128::AID-JNR5>3.0.CO;2-E; Johnson Gail V. W., 1998, Alzheimer's Disease Review, V3, P125; Kampers T, 1996, FEBS LETT, V399, P344, DOI 10.1016/S0014-5793(96)01386-5; King ME, 1999, BIOCHEMISTRY-US, V38, P14851, DOI 10.1021/bi9911839; KIRSCHNER DA, 1987, P NATL ACAD SCI USA, V84, P6953, DOI 10.1073/pnas.84.19.6953; KOSIK KS, 1988, NEURON, V1, P817, DOI 10.1016/0896-6273(88)90129-8; KSIEZAKREDING H, 1991, NEURON, V6, P717, DOI 10.1016/0896-6273(91)90169-Z; Lansbury PT, 1997, NEURON, V19, P1151, DOI 10.1016/S0896-6273(00)80406-7; LEDESMA MD, 1994, J BIOL CHEM, V269, P21614; LEE G, 1988, SCIENCE, V239, P285, DOI 10.1126/science.3122323; LICHTENBERGKRAAG B, 1992, P NATL ACAD SCI USA, V89, P5384, DOI 10.1073/pnas.89.12.5384; Mandelkow EM, 1998, TRENDS CELL BIOL, V8, P425, DOI 10.1016/S0962-8924(98)01368-3; Perez M, 1996, J NEUROCHEM, V67, P1183; PERRY G, 1991, J NEUROSCI, V11, P3679; PIKE CJ, 1995, J NEUROCHEM, V64, P253, DOI 10.1046/j.1471-4159.1995.64010253.x; Rapoport M, 2002, P NATL ACAD SCI USA, V99, P6364, DOI 10.1073/pnas.092136199; Rizzu P, 1999, AM J HUM GENET, V64, P414, DOI 10.1086/302256; Ropson IJ, 1997, BIOCHEMISTRY-US, V36, P8594, DOI 10.1021/bi962983b; SCHWEERS O, 1995, P NATL ACAD SCI USA, V92, P8463, DOI 10.1073/pnas.92.18.8463; SCHWEERS O, 1994, J BIOL CHEM, V269, P24290; SUSI H, 1983, BIOCHEM BIOPH RES CO, V115, P391, DOI 10.1016/0006-291X(83)91016-1; Takano K, 2001, EUR J BIOCHEM, V268, P155, DOI 10.1046/j.1432-1327.2001.01863.x; von Bergen M, 2001, J BIOL CHEM, V276, P48165, DOI 10.1074/jbc.M105196200; von Bergen M, 2000, P NATL ACAD SCI USA, V97, P5129, DOI 10.1073/pnas.97.10.5129; WILLE H, 1992, J CELL BIOL, V118, P573, DOI 10.1083/jcb.118.3.573; WILSON DM, 1995, J BIOL CHEM, V270, P24306, DOI 10.1074/jbc.270.41.24306; Wilson DM, 1997, AM J PATHOL, V150, P2181; WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4884, DOI 10.1073/pnas.85.13.4884	54	65	67	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					41390	41400		10.1074/jbc.M206334200	http://dx.doi.org/10.1074/jbc.M206334200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12198126	hybrid			2022-12-27	WOS:000178985300014
J	Vogen, S; Gidalevitz, T; Biswas, C; Simen, BB; Stein, E; Gulmen, F; Argon, Y				Vogen, S; Gidalevitz, T; Biswas, C; Simen, BB; Stein, E; Gulmen, F; Argon, Y			Radicicol-sensitive peptide binding to the N-terminal portion of GRP94	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HSP90 MOLECULAR CHAPERONE; HEAT-SHOCK PROTEINS; ENDOPLASMIC-RETICULUM; IN-VITRO; CRYSTAL-STRUCTURE; ATPASE ACTIVITY; GP96 GRP94; DOMAIN; ANTIGEN; BIP	GRP94 is a molecular chaperone that carries immuno-logically relevant peptides from cell to cell, transferring them to major histocompatibility proteins for presentation to T cells. Here we examine the binding of several peptides to recombinant GRP94 and study the regulation and site of peptide binding. We show that GRP94 contains a peptide-binding site in its N-terminal 355 amino acids. A number of peptides bind to this site with low on- and off-rates and with specificity that is distinct from that of another endoplasmic reticulum chaperone, BiP/GRP78. Binding to the N-terminal fragment is sufficient to account for the peptide binding activity of the entire molecule. Peptide binding is inhibited by radicicol, a known inhibitor of the chaperone activities of HSP90-family proteins. However, the peptide-binding site is distinct from the radicicol-binding pocket, because both can bind to the N-terminal fragment simultaneously. Furthermore, peptide binding does not cause the same conformational change as does binding of radicicol. When the latter binds to the N-terminal domain, it induces a conformational change in the downstream, acidic domain of GRP94, as measured by altered gel mobility and loss of an antibody epitope. These results relate the peptide-binding activity of GRP94 to its other function as a chaperone.	Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; Univ Chicago, Comm Cell Physiol, Chicago, IL 60637 USA; Univ Chicago, Comm Immunol, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	Argon, Y (corresponding author), Univ Chicago, Dept Pathol, 5841 S Maryland Ave,MC 1089, Chicago, IL 60637 USA.		Gidalevitz, Tali/C-9217-2009; Simen, Birgitte/A-3574-2010	Gidalevitz, Tali/0000-0002-9178-6648; Simen, Birgitte/0000-0003-0503-0973	NCI NIH HHS [CA 74182] Funding Source: Medline; NHLBI NIH HHS [HL 07237] Funding Source: Medline; NIDDK NIH HHS [DK 07074] Funding Source: Medline; NIGMS NIH HHS [GM 07183] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA074182] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007183] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Basu S, 2001, IMMUNITY, V14, P303, DOI 10.1016/S1074-7613(01)00111-X; Berwin B, 2002, J IMMUNOL, V168, P4282, DOI 10.4049/jimmunol.168.9.4282; BLACHERE NE, 1993, J IMMUNOTHER, V14, P352, DOI 10.1097/00002371-199311000-00016; Blachere NE, 1995, SEMIN CANCER BIOL, V6, P349, DOI 10.1016/1044-579X(95)90004-7; Blachere NE, 1997, J EXP MED, V186, P1315, DOI 10.1084/jem.186.8.1315; BLONDELGUINDI S, 1993, J BIOL CHEM, V268, P12730; BLONDELGUINDI S, 1993, CELL, V75, P717, DOI 10.1016/0092-8674(93)90492-9; Chen SY, 1998, CELL STRESS CHAPERON, V3, P118, DOI 10.1379/1466-1268(1998)003<0118:DIOPAT>2.3.CO;2; Davis DP, 1999, J IMMUNOL, V163, P3842; EDWARDS DP, 1984, BIOCHEMISTRY-US, V23, P4427, DOI 10.1021/bi00314a029; FREEMAN BC, 1995, EMBO J, V14, P2281, DOI 10.1002/j.1460-2075.1995.tb07222.x; FREIDEN PJ, 1992, EMBO J, V11, P63, DOI 10.1002/j.1460-2075.1992.tb05028.x; Linderoth NA, 2001, J BIOL CHEM, V276, P11049, DOI 10.1074/jbc.M010059200; Linderoth NA, 2001, BIOCHEMISTRY-US, V40, P1483, DOI 10.1021/bi0016218; Linderoth NA, 2000, J BIOL CHEM, V275, P5472, DOI 10.1074/jbc.275.8.5472; Loo MA, 1998, EMBO J, V17, P6879, DOI 10.1093/emboj/17.23.6879; Maruya M, 1999, J MOL BIOL, V285, P903, DOI 10.1006/jmbi.1998.2349; MAZZARELLA RA, 1987, J BIOL CHEM, V262, P8875; MELNICK J, 1994, NATURE, V370, P373, DOI 10.1038/370373a0; MELNICK J, 1995, THESIS DULE U DURHAM; Nair S, 1999, J IMMUNOL, V162, P6426; Nemoto TK, 2001, EUR J BIOCHEM, V268, P5258, DOI 10.1046/j.0014-2956.2001.02457.x; Nieland TJF, 1996, P NATL ACAD SCI USA, V93, P6135, DOI 10.1073/pnas.93.12.6135; Pearl LH, 2000, CURR OPIN STRUC BIOL, V10, P46, DOI 10.1016/S0959-440X(99)00047-0; Pirkl F, 2001, J MOL BIOL, V308, P795, DOI 10.1006/jmbi.2001.4595; Prodromou C, 1997, CELL, V90, P65, DOI 10.1016/S0092-8674(00)80314-1; Prodromou C, 1997, NAT STRUCT BIOL, V4, P477, DOI 10.1038/nsb0697-477; Roe SM, 1999, J MED CHEM, V42, P260, DOI 10.1021/jm980403y; SARGAN DR, 1986, BIOCHEMISTRY-US, V25, P6252, DOI 10.1021/bi00368a062; Sastry S, 1999, J BIOL CHEM, V274, P12023, DOI 10.1074/jbc.274.17.12023; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; Scheibel T, 1998, BIOCHEM PHARMACOL, V56, P675, DOI 10.1016/S0006-2952(98)00120-8; Scheibel T, 1998, P NATL ACAD SCI USA, V95, P1495, DOI 10.1073/pnas.95.4.1495; Schulte TW, 1999, MOL ENDOCRINOL, V13, P1435, DOI 10.1210/me.13.9.1435; Schulte TW, 1998, CELL STRESS CHAPERON, V3, P100, DOI 10.1379/1466-1268(1998)003<0100:ARBTTN>2.3.CO;2; Spee P, 1999, BIOCHEMISTRY-US, V38, P10559, DOI 10.1021/bi990321r; Spee P, 1997, EUR J IMMUNOL, V27, P2441, DOI 10.1002/eji.1830270944; SRIVASTAVA PK, 1986, P NATL ACAD SCI USA, V83, P3407, DOI 10.1073/pnas.83.10.3407; SRIVASTAVA PK, 1993, ADV CANCER RES, V62, P153, DOI 10.1016/S0065-230X(08)60318-8; SRIVASTAVA PK, 1994, IMMUNOGENETICS, V39, P93; Stebbins CE, 1997, CELL, V89, P239, DOI 10.1016/S0092-8674(00)80203-2; SUTO R, 1995, SCIENCE, V269, P1585, DOI 10.1126/science.7545313; TAKEDA S, 1996, COLD SPRING HARB SYM, P289; Tamura Y, 1997, SCIENCE, V278, P117, DOI 10.1126/science.278.5335.117; Tanaka E, 2001, EUR J BIOCHEM, V268, P5270, DOI 10.1046/j.0014-2956.2001.02458.x; Wassenberg JJ, 2000, J BIOL CHEM, V275, P22806, DOI 10.1074/jbc.M001476200; Wearsch PA, 1998, BIOCHEMISTRY-US, V37, P5709, DOI 10.1021/bi9801006; Wearsch PA, 1996, PROTEIN EXPRES PURIF, V7, P114, DOI 10.1006/prep.1996.0015; Wearsch PA, 1996, BIOCHEMISTRY-US, V35, P16760, DOI 10.1021/bi962068q; Wearsch PA, 1997, J BIOL CHEM, V272, P5152, DOI 10.1074/jbc.272.8.5152; WEI JY, 1995, J BIOL CHEM, V270, P26677, DOI 10.1074/jbc.270.44.26677; Young JC, 1997, FEBS LETT, V418, P139, DOI 10.1016/S0014-5793(97)01363-X	52	56	65	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 25	2002	277	43					40742	40750		10.1074/jbc.M205323200	http://dx.doi.org/10.1074/jbc.M205323200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	607KU	12189140	hybrid			2022-12-27	WOS:000178791400076
J	Kun, E; Kirsten, E; Ordahl, CP				Kun, E; Kirsten, E; Ordahl, CP			Coenzymatic activity of randomly broken or intact double-stranded DNAs in auto and histone H-1 trans-poly(ADP-ribosylation), catalyzed by poly(ADP-ribose) polymerase (PARP I)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCLE-SPECIFIC TRANSCRIPTION; CAT BINDING-FACTOR; MOLECULAR-INTERACTIONS; SECONDARY STRUCTURE; TOPOISOMERASE-I; TEF-1; IDENTIFICATION; ELEMENTS; ASSOCIATION; TRANSFERASE	The enzymatic transfer of ADP-ribose from NAD to histone H, (defined as trans-poly(ADP-ribosylation)) or to PARP I (defined as auto-poly(ADP-ribosylation)) was studied with respect to the nature of the DNA required as a coenzyme. Linear double-stranded DNA (dsDNA) containing the MCAT core motif was compared with DNA containing random nicks (discontinuous or dcDNA). The dsDNAs activated trans-poly(ADP-ribosylation) about 5 times more effectively than dcDNA as measured by V-max. Activation of auto-poly(ADP-ribosylation) by dcDNA was 10 times greater than by dsDNA. The affinity of PARP I toward dcDNA or dsDNA in the auto-poly(ADP-ribosylation) was at least 100-fold lower than in trans-poly(ADP-ribosylation) (K-alpha = 1400 versus 3-15, respectively). Mg2+ inhibited trans-poly(ADP-ribosylation) and so did dcDNA at concentrations required to maximally activate auto-poly(ADP-ribosylation). Mg2+ activated auto-poly(ADP-ribosylation) of PARP I. These results for the first time demonstrate that physiologically occurring dsDNAs can serve as coenzymes for PARP I and catalyze preferentially trans-poly(ADP-ribosylation), thereby opening the possibility to study the physiologic function of PARP I.	Univ Calif San Francisco, Sch Med, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Sch Med, Dept Cellular Mol Pharmacol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Ordahl, CP (corresponding author), Univ Calif San Francisco, Sch Med, Dept Anat, San Francisco, CA 94143 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL035561, R01HL059693] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-59693, HL-35561] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Althaus F R, 1987, Mol Biol Biochem Biophys, V37, P1; Azakie A, 1996, J BIOL CHEM, V271, P8260, DOI 10.1074/jbc.271.14.8260; Bauer PI, 2000, INT J MOL MED, V5, P533; BAUER PI, 1990, BIOCHEM J, V270, P17, DOI 10.1042/bj2700017; Bauer PI, 1996, INT J ONCOL, V8, P239; Bauer PI, 2001, INT J MOL MED, V8, P691; Bauer PI, 2001, FEBS LETT, V506, P239, DOI 10.1016/S0014-5793(01)02919-2; BAUER PI, 1990, FEBS LETT, V273, P6, DOI 10.1016/0014-5793(90)81038-P; BUKI KG, 1995, J BIOL CHEM, V270, P3370, DOI 10.1074/jbc.270.7.3370; Butler AJ, 1999, MOL CELL BIOL, V19, P296; DeMurcia G., 2000, DNA DAMAGE STRESS SI; Farrance IKG, 1996, J BIOL CHEM, V271, P8266, DOI 10.1074/jbc.271.14.8266; FARRANCE IKG, 1992, J BIOL CHEM, V267, P17234; FARZANEH F, 1979, DEV BIOL, V72, P254, DOI 10.1016/0012-1606(79)90116-7; HAKAM A, 1987, FEBS LETT, V212, P73, DOI 10.1016/0014-5793(87)81559-4; Kun E, 1998, INT J MOL MED, V2, P131; Larkin SB, 1996, MOL CELL BIOL, V16, P3742; MAR JH, 1988, P NATL ACAD SCI USA, V85, P6404, DOI 10.1073/pnas.85.17.6404; MAR JH, 1990, MOL CELL BIOL, V10, P4271, DOI 10.1128/MCB.10.8.4271; MENDOZAALVAREZ H, 1993, J BIOL CHEM, V268, P22575; MINAGA T, 1983, J BIOL CHEM, V258, P725; MINAGA T, 1979, J BIOL CHEM, V254, P9663; PANZETER PL, 1994, BIOCHEMISTRY-US, V33, P9600, DOI 10.1021/bi00198a028; SASTRY SS, 1989, BIOCHEMISTRY-US, V28, P5670, DOI 10.1021/bi00439a050; SASTRY SS, 1988, J BIOL CHEM, V263, P1505; SASTRY SS, 1990, BIOCHEM BIOPH RES CO, V167, P842, DOI 10.1016/0006-291X(90)92102-6; STEWART AFR, 1994, J BIOL CHEM, V269, P3147; Yao N, 2000, J BIOL CHEM, V275, P1421, DOI 10.1074/jbc.275.2.1421	28	65	66	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 18	2002	277	42					39066	39069		10.1074/jbc.C200410200	http://dx.doi.org/10.1074/jbc.C200410200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	605EA	12205080	hybrid			2022-12-27	WOS:000178662500003
J	Govindarajan, R; Zhao, S; Song, XH; Guo, RJ; Wheelock, M; Johnson, KR; Mehta, PP				Govindarajan, R; Zhao, S; Song, XH; Guo, RJ; Wheelock, M; Johnson, KR; Mehta, PP			Impaired trafficking of connexins in androgen-independent human prostate cancer cell lines and its mitigation by alpha-catenin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAP-JUNCTIONAL COMMUNICATION; C6 GLIOMA-CELLS; E-CADHERIN; TRANSFORMED-CELLS; INTERCELLULAR COMMUNICATION; INTRACELLULAR-TRANSPORT; PROTEIN INTERACTIONS; CHANNEL PROTEIN; MOLECULAR-BASIS; P-CADHERIN	Gap junctions, composed of connexins, provide a pathway of direct intercellular communication for the diffusion of small molecules between cells. Evidence suggests that connexins act as tumor suppressors. We showed previously that expression of connexin-43 and connexin-32 in an indolent prostate cancer cell line, LNCaP, resulted in gap junction formation and growth inhibition. To elucidate the role of connexins in the progression of prostate cancer from a hormone-dependent to -independent state, we introduced connexin-43 and connexin-32 into an invasive, androgen-independent cell line, PC-3. Expression of these proteins in PC-3 cells resulted in intracellular accumulation. Western blot analysis revealed a lack of Triton-insoluble, plaque-assembled connexins. In contrast to LNCaP cells, connexins could not be cell surface-biotinylated and did not reside in the cell surface derived endocytic vesicles, in PC-3 cells, suggesting impaired trafficking to the cell surface. Intracellular accumulation of connexins was observed in several androgen-independent prostate cancer cell lines. Transient expression of a-catenin facilitated the trafficking of both connexins to the cell surface and induced gap junction assembly. Our results suggest that impaired trafficking, and not the inability to form gap junctions, is the major cause of communication deficiency in human prostate cancer cell lines.	Univ Nebraska, Med Ctr, Dept Biochem & Mol Biol, Dept Oral Biol, Omaha, NE 68182 USA; Univ Nebraska, Med Ctr, Eppley Inst Res Canc, Omaha, NE 68182 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Mehta, PP (corresponding author), Univ Nebraska, Med Ctr, Dept Biochem & Mol Biol, Dept Oral Biol, Omaha, NE 68182 USA.	pmehta@unmc.edu			NATIONAL CANCER INSTITUTE [R01CA073769] Funding Source: NIH RePORTER; NCI NIH HHS [CA 73769] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abate-Shen C, 2000, GENE DEV, V14, P2410, DOI 10.1101/gad.819500; Aberle H, 1996, J CELL BIOCHEM, V61, P514, DOI 10.1002/(SICI)1097-4644(19960616)61:4<514::AID-JCB4>3.0.CO;2-R; Barth AI, 1997, CURR OPIN CELL BIOL, V9, P683, DOI 10.1016/S0955-0674(97)80122-6; BERTHOUD VM, 2001, METHODS COMPANION ME, V20, P180; Bruzzone R, 1996, EUR J BIOCHEM, V238, P1, DOI 10.1111/j.1432-1033.1996.0001q.x; CHEN SC, 1995, CELL GROWTH DIFFER, V6, P681; Chen TS, 1999, CANCER RES, V59, P213; Deschenes SM, 1997, J NEUROSCI, V17, P9077; ELFOULY MH, 1987, EXP CELL RES, V168, P422, DOI 10.1016/0014-4827(87)90014-0; EWING CM, 1995, CANCER RES, V55, P4813; Frenzel EM, 1996, DEV BIOL, V179, P1, DOI 10.1006/dbio.1996.0237; Fukata M, 2001, NAT REV MOL CELL BIO, V2, P887, DOI 10.1038/35103068; Garrod D, 1996, CURR OPIN CELL BIOL, V8, P670, DOI 10.1016/S0955-0674(96)80108-6; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Goodenough DA, 1996, ANNU REV BIOCHEM, V65, P475, DOI 10.1146/annurev.bi.65.070196.002355; GOODENOUGH DA, 1988, J CELL BIOL, V107, P1817, DOI 10.1083/jcb.107.5.1817; Gumbiner BM, 2000, J CELL BIOL, V148, P399, DOI 10.1083/jcb.148.3.399; Habermann H, 2002, J UROLOGY, V167, P655, DOI 10.1016/S0022-5347(01)69118-3; Habermann H, 2001, ENDOCRINOLOGY, V142, P359, DOI 10.1210/en.142.1.359; Hegarty NJ, 1999, PROSTATE, V40, P261, DOI 10.1002/(SICI)1097-0045(19990901)40:4<261::AID-PROS8>3.0.CO;2-H; Hernandez-Blazquez FJ, 2001, EXP CELL RES, V270, P235, DOI 10.1006/excr.2001.5342; HSIEH JT, 1995, CANCER RES, V55, P190; Isaacs JT, 1997, AM J PATHOL, V150, P1511; Isaacs JT, 1999, UROL CLIN N AM, V26, P263, DOI 10.1016/S0094-0143(05)70066-5; ISAACS WB, 1994, SEMIN ONCOL, V21, P514; Jarrard DF, 1997, CLIN CANCER RES, V3, P2121; JOHNSON KR, 1993, EXP CELL RES, V207, P252, DOI 10.1006/excr.1993.1191; JONGEN WMF, 1991, J CELL BIOL, V114, P545, DOI 10.1083/jcb.114.3.545; Kelsell DP, 2001, TRENDS CELL BIOL, V11, P2, DOI 10.1016/S0962-8924(00)01866-3; Kelsell DP, 2001, AM J HUM GENET, V68, P559, DOI 10.1086/318803; KEMLER R, 1993, TRENDS GENET, V9, P317, DOI 10.1016/0168-9525(93)90250-L; Kim JB, 2000, J CELL BIOL, V151, P1193, DOI 10.1083/jcb.151.6.1193; KLEINERMAN DI, 1995, CANCER RES, V55, P1215; KLIEN KA, 1997, NAT GENET, V3, P402; Krutovskikh V, 2000, MUTAT RES-REV MUTAT, V462, P197, DOI 10.1016/S1383-5742(00)00037-5; Kumar NM, 1996, CELL, V84, P381, DOI 10.1016/S0092-8674(00)81282-9; KUMAR NM, 1995, J CELL SCI, V108, P3725; LAIRD DW, 1995, J CELL BIOL, V131, P1193, DOI 10.1083/jcb.131.5.1193; Lampe PD, 2000, ARCH BIOCHEM BIOPHYS, V384, P205, DOI 10.1006/abbi.2000.2131; LAMPE PD, 1994, J CELL BIOL, V127, P1895, DOI 10.1083/jcb.127.6.1895; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Loewenstein W R, 1992, Semin Cell Biol, V3, P59; Martin PEM, 2001, J CELL SCI, V114, P3845; Mehta P, 1999, DEV GENET, V24, P91, DOI 10.1002/(SICI)1520-6408(1999)24:1/2<91::AID-DVG10>3.0.CO;2-#; Mehta PP, 1996, MOL CARCINOGEN, V15, P18, DOI 10.1002/(SICI)1098-2744(199601)15:1<18::AID-MC4>3.0.CO;2-O; MEHTA PP, 1986, CELL, V44, P187, DOI 10.1016/0092-8674(86)90497-6; MEHTA PP, 1992, MOL BIOL CELL, V3, P839, DOI 10.1091/mbc.3.8.839; MEHTA PP, 1991, J MEMBRANE BIOL, V124, P207, DOI 10.1007/BF01994355; MESNIL M, 1995, CANCER RES, V55, P629; MEYER RA, 1992, J CELL BIOL, V119, P179, DOI 10.1083/jcb.119.1.179; MILLER AD, 1989, BIOTECHNIQUES, V7, P980; MORTON RA, 1993, CANCER RES, V53, P3585; MUSIL LS, 1991, J CELL BIOL, V115, P1357, DOI 10.1083/jcb.115.5.1357; MUSIL LS, 1990, J CELL BIOL, V111, P2077, DOI 10.1083/jcb.111.5.2077; MUSIL LS, 1993, CELL, V74, P1065, DOI 10.1016/0092-8674(93)90728-9; Nagafuchi A, 2001, CURR OPIN CELL BIOL, V13, P600, DOI 10.1016/S0955-0674(00)00257-X; NAUS CCG, 1993, EXP CELL RES, V206, P72, DOI 10.1006/excr.1993.1122; Paulson AF, 2000, J CELL SCI, V113, P3037; Provost E, 1999, CURR OPIN CELL BIOL, V11, P567, DOI 10.1016/S0955-0674(99)00015-0; Statuto M, 1997, J BIOL CHEM, V272, P24710, DOI 10.1074/jbc.272.39.24710; Stevenson BR, 1998, ANNU REV CELL DEV BI, V14, P89, DOI 10.1146/annurev.cellbio.14.1.89; Temme A, 1997, CURR BIOL, V7, P713, DOI 10.1016/S0960-9822(06)00302-2; Tomita K, 2000, BIOCHEM BIOPH RES CO, V267, P870, DOI 10.1006/bbrc.1999.2040; Toyofuku T, 1998, J BIOL CHEM, V273, P12725, DOI 10.1074/jbc.273.21.12725; Toyofuku T, 2001, J BIOL CHEM, V276, P1780, DOI 10.1074/jbc.M005826200; Tran NL, 1999, AM J PATHOL, V155, P787, DOI 10.1016/S0002-9440(10)65177-2; Trosko James E., 1998, Frontiers in Bioscience, V3, pD208; Tsukita S, 1999, CURR OPIN CELL BIOL, V11, P628, DOI 10.1016/S0955-0674(99)00016-2; Umbas R, 1997, INT J CANCER, V74, P374, DOI 10.1002/(SICI)1097-0215(19970822)74:4<374::AID-IJC2>3.0.CO;2-S; VanSlyke JK, 2000, METHODS, V20, P156, DOI 10.1006/meth.1999.0933; Vasioukhin V, 2001, CELL, V104, P605, DOI 10.1016/S0092-8674(01)00246-X; Wang YJ, 1997, J CELL SCI, V110, P301; Yamasaki H, 1996, CARCINOGENESIS, V17, P1199, DOI 10.1093/carcin/17.6.1199; Yap AS, 1997, ANNU REV CELL DEV BI, V13, P119, DOI 10.1146/annurev.cellbio.13.1.119; Zhou L, 1999, J CELL BIOL, V144, P1033, DOI 10.1083/jcb.144.5.1033; ZHU D, 1991, P NATL ACAD SCI USA, V88, P1883, DOI 10.1073/pnas.88.5.1883	76	68	73	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2002	277	51					50087	50097		10.1074/jbc.M202652200	http://dx.doi.org/10.1074/jbc.M202652200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	629AU	12205082	hybrid			2022-12-27	WOS:000180028900128
J	Zerbe, K; Pylypenko, O; Vitali, F; Zhang, WW; Rouse, S; Heck, M; Vrijbloed, JW; Bischoff, D; Bister, B; Sussmuth, RD; Pelzer, S; Wohlleben, W; Robinson, JA; Schlichting, I				Zerbe, K; Pylypenko, O; Vitali, F; Zhang, WW; Rouse, S; Heck, M; Vrijbloed, JW; Bischoff, D; Bister, B; Sussmuth, RD; Pelzer, S; Wohlleben, W; Robinson, JA; Schlichting, I			Crystal structure of OxyB, a cytochrome P450 implicated in an oxidative phenol coupling reaction during vancomycin biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOPEPTIDE ANTIBIOTICS; AMINO-ACID; HETEROLOGOUS EXPRESSION; PEPTIDE SYNTHETASE; MOLECULAR-CLONING; CRYSTALLOGRAPHY; CHLOROEREMOMYCIN; MOLSCRIPT; SYNTHASE; PROGRAM	Gene-inactivation studies point to the involvement of OxyB in catalyzing the first oxidative phenol coupling reaction during glycopeptide antibiotic biosynthesis. The oxyB gene has been cloned and sequenced from the vancomycin producer Amycolatopsis orientalis, and the hemoprotein has been produced in Escherichia coli, crystallized, and its structure determined to 1.7-Angstrom resolution. OxyB gave UV-visible spectra characteristic of a P450-like hemoprotein in the low spin ferric state. After reduction to the ferrous state by dithionite or by spinach ferredoxin and ferredoxin reductase, the CO-ligated form gave a 450-nm peak in a UV-difference spectrum. Addition of putative heptapeptide substrates to resting OxyB produced type I changes to the UV spectrum, but no turnover was observed in the presence of ferredoxin and ferredoxin reductase, showing that either the peptides or the reduction system, or both, are insufficient to support a full catalytic cycle. OxyB exhibits the typical P450-fold, with helix L containing the signature sequence FGHGXHXCLG and Cys(347) being the proximal axial thiolate ligand of the heme iron. The structural similarity of OxyB is highest to P450nor, P450terp, CYP119, and P450eryF. In OxyB, the F and G helices are rotated out of the active site compared with P450nor, resulting in a much more open active site, consistent with the larger size of the presumed heptapeptide substrate.	Univ Zurich, Inst Organ Chem, CH-8057 Zurich, Switzerland; Max Planck Inst Mol Physiol, Dept Phys Biochem, D-44227 Heidelberg, Germany; Max Planck Inst Med Res, Dept Biomol Mech, D-69120 Heidelberg, Germany; Univ Tubingen, Inst Organ Chem, D-72076 Tubingen, Germany; Univ Tubingen, Lehrstuhl Mikrobiol Biotechnol, D-72076 Tubingen, Germany	University of Zurich; Max Planck Society; Max Planck Society; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen	Robinson, JA (corresponding author), Univ Zurich, Inst Organ Chem, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	robinson@oci.unizh.ch	Schlichting, Ilme/I-1339-2013	Pylypenko, Olena/0000-0001-7073-5238; Sussmuth, Roderich/0000-0001-7027-2069; Heck, Markus/0000-0003-1954-1635				BACON D, 1988, J MOL GRAPHICS, V6, P219, DOI 10.1016/S0263-7855(98)80030-1; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bischoff D, 2001, ANGEW CHEM INT EDIT, V40, P4688, DOI 10.1002/1521-3773(20011217)40:24<4688::AID-ANIE4688>3.0.CO;2-M; Bischoff D, 2001, ANGEW CHEM INT EDIT, V40, P1693, DOI 10.1002/1521-3773(20010504)40:9<1693::AID-ANIE16930>3.0.CO;2-8; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen H, 2002, CHEM BIOL, V9, P103, DOI 10.1016/S1074-5521(02)00090-X; Chen HW, 2000, P NATL ACAD SCI USA, V97, P11942, DOI 10.1073/pnas.210395097; Chen HW, 2001, CHEM BIOL, V8, P301, DOI 10.1016/S1074-5521(01)00009-6; Chiu HT, 2001, P NATL ACAD SCI USA, V98, P8548, DOI 10.1073/pnas.151246498; Choroba OW, 2000, J AM CHEM SOC, V122, P5389, DOI 10.1021/ja000076v; CUPPVICKERY JR, 1995, NAT STRUCT BIOL, V2, P144, DOI 10.1038/nsb0295-144; de Montellano PR Ortiz, 1995, CYTOCHROME P450 STRU; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; GOTOH O, 1992, J BIOL CHEM, V267, P83; Haines DC, 2001, BIOCHEMISTRY-US, V40, P13456, DOI 10.1021/bi011197q; HASEMANN CA, 1995, STRUCTURE, V3, P41, DOI 10.1016/S0969-2126(01)00134-4; HASEMANN CA, 1994, J MOL BIOL, V236, P1169, DOI 10.1016/0022-2836(94)90019-1; Hubbard BK, 2000, CHEM BIOL, V7, P931, DOI 10.1016/S1074-5521(00)00043-0; IMAI M, 1989, P NATL ACAD SCI USA, V86, P7823, DOI 10.1073/pnas.86.20.7823; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; KIMATA Y, 1995, BIOCHEM BIOPH RES CO, V208, P96, DOI 10.1006/bbrc.1995.1310; Kirkpatrick PN, 2000, CHEM COMMUN, P1565, DOI 10.1039/b004463f; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KRAUS PFX, 1995, P NATL ACAD SCI USA, V92, P2071, DOI 10.1073/pnas.92.6.2071; Losey HC, 2001, BIOCHEMISTRY-US, V40, P4745, DOI 10.1021/bi010050w; MARTINIS SA, 1989, J AM CHEM SOC, V111, P9252, DOI 10.1021/ja00208a031; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; O'Brien DP, 2000, CHEM COMMUN, P103, DOI 10.1039/a907953j; OMURA T, 1964, J BIOL CHEM, V239, P2370; Park SY, 1997, NAT STRUCT BIOL, V4, P827, DOI 10.1038/nsb1097-827; Pelzer S, 1999, ANTIMICROB AGENTS CH, V43, P1565, DOI 10.1128/AAC.43.7.1565; Peterson Julian A., 1995, P151; Pfeifer V, 2001, J BIOL CHEM, V276, P38370, DOI 10.1074/jbc.M106580200; POULOS TL, 1987, J MOL BIOL, V195, P687, DOI 10.1016/0022-2836(87)90190-2; POULOS TL, 1992, FASEB J, V6, P674, DOI 10.1096/fasebj.6.2.1537455; POULOS TL, 1985, J BIOL CHEM, V260, P6122; Puk O, 2002, CHEM BIOL, V9, P225, DOI 10.1016/S1074-5521(02)00101-1; RAVICHANDRAN KG, 1993, SCIENCE, V261, P731, DOI 10.1126/science.8342039; Recktenwald J, 2002, MICROBIOL-SGM, V148, P1105, DOI 10.1099/00221287-148-4-1105; Sandercock AM, 2001, CHEM COMMUN, P1252, DOI 10.1039/b103668h; Sevrioukova IF, 1999, P NATL ACAD SCI USA, V96, P1863, DOI 10.1073/pnas.96.5.1863; Solenberg PJ, 1997, CHEM BIOL, V4, P195, DOI 10.1016/S1074-5521(97)90288-X; Sosio M, 2000, ANTON LEEUW INT J G, V78, P379, DOI 10.1023/A:1010239717396; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Sussmuth RD, 1999, ANGEW CHEM INT EDIT, V38, P1976, DOI 10.1002/(SICI)1521-3773(19990712)38:13/14<1976::AID-ANIE1976>3.0.CO;2-3; Trauger JW, 2000, P NATL ACAD SCI USA, V97, P3112, DOI 10.1073/pnas.040560597; van Wageningen AMA, 1998, CHEM BIOL, V5, P155, DOI 10.1016/S1074-5521(98)90060-6; Vidakovic M, 1998, BIOCHEMISTRY-US, V37, P9211, DOI 10.1021/bi980189f; Williams DH, 1999, ANGEW CHEM INT EDIT, V38, P1173, DOI 10.1002/(SICI)1521-3773(19990503)38:9<1172::AID-ANIE1172>3.0.CO;2-C; Yano JK, 2000, J BIOL CHEM, V275, P31086, DOI 10.1074/jbc.M004281200	52	108	111	3	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2002	277	49					47476	47485		10.1074/jbc.M206342200	http://dx.doi.org/10.1074/jbc.M206342200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622TT	12207020	hybrid			2022-12-27	WOS:000179663700084
J	Shimamura, T; Ibuka, A; Fushinobu, S; Wakagi, T; Ishiguro, M; Ishii, Y; Matsuzawa, H				Shimamura, T; Ibuka, A; Fushinobu, S; Wakagi, T; Ishiguro, M; Ishii, Y; Matsuzawa, H			Acyl-intermediate structures of the extended-spectrum class A beta-lactamase, Toho-1, in complex with cefotaxime, cephalothin, and benzylpenicillin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PENICILLIN-BINDING PROTEIN; SITE-DIRECTED MUTAGENESIS; SUBSTRATE-SPECIFICITY; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; ENZYME INTERMEDIATE; ANGSTROM RESOLUTION; E166A MUTANT; ACTIVE-SITE; RESISTANCE	Bacterial resistance to beta-lactam antibiotics is a serious problem limiting current clinical therapy. The most common form of resistance is the production of beta-lactamases that inactivate beta-lactam antibiotics. Toho-1 is an extended-spectrum beta-lactamase that has acquired efficient activity not only to penicillins but also to cephalosporins including the expanded-spectrum cephalosporins that were developed to be stable in former beta-lactamases. We present the acyl-intermediate structures of Toho-1 in complex with cefotaxime (expanded-spectrum cephalosporin), cephalothin (non-expanded-spectrum cephalosporin), and benzylpenicillin at 1.8-, 2.0-, and 2.1-Angstrom resolutions, respectively. These structures reveal distinct features that can explain the ability of Toho-1 to hydrolyze expanded-spectrum cephalosporins. First, the Omega-loop of Toho-1 is displaced to avoid the steric contacts with the bulky side chain of cefotaxime. Second, the conserved residues Asn(104) and Asp(240) form unique interactions with the bulky side chain of cefotaxime to fix it tightly. Finally, the unique interaction between the conserved Ser(237) and cephalosporins probably helps to bring the beta-lactam carbonyl group to the suitable position in the oxyanion hole, thus increasing the cephalosporinase activity.	Univ London Imperial Coll Sci Technol & Med, Div Biomed Sci, London SW7 2AY, England; Univ Tokyo, Dept Biotechnol, Bunkyo Ku, Tokyo 1138657, Japan; Univ Shizuoka, Dept Food Sci & Nutr, Shizuoka 4228526, Japan; Suntory Inst Bioorgan Res, Osaka 6188503, Japan; Toho Univ, Sch Med, Dept Microbiol, Ota Ku, Tokyo 1438540, Japan	Imperial College London; University of Tokyo; University of Shizuoka; Suntory Holdings Ltd	Shimamura, T (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Biomed Sci, London SW7 2AY, England.		Fushinobu, Shinya/E-4987-2011; Wakagi, Takayoshi/AAJ-4145-2021	Fushinobu, Shinya/0000-0003-1346-6435; SHIMIZU-IBUKA, Akiko/0000-0002-5310-9216				ADACHI H, 1991, J BIOL CHEM, V266, P3186; Banerjee S, 1998, BIOCHEMISTRY-US, V37, P3286, DOI 10.1021/bi972127f; Beadle BM, 2002, STRUCTURE, V10, P413, DOI 10.1016/S0969-2126(02)00725-6; Blazquez J, 1998, ANTIMICROB AGENTS CH, V42, P1042, DOI 10.1128/AAC.42.5.1042; Bouthors AT, 1999, PROTEIN ENG, V12, P313, DOI 10.1093/protein/12.4.313; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cantu C, 1997, J BIOL CHEM, V272, P29144, DOI 10.1074/jbc.272.46.29144; Chen CCH, 2001, BIOCHEMISTRY-US, V40, P2351, DOI 10.1021/bi002277h; Crichlow GV, 1999, BIOCHEMISTRY-US, V38, P10256, DOI 10.1021/bi9908787; DELAIRE M, 1992, J BIOL CHEM, V267, P20600; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; Fonze E, 2002, BIOCHEMISTRY-US, V41, P1877, DOI 10.1021/bi015789k; Gazouli M, 1998, ANTIMICROB AGENTS CH, V42, P1259, DOI 10.1128/AAC.42.5.1259; Giakkoupi P, 2001, FEMS MICROBIOL LETT, V201, P37, DOI 10.1111/j.1574-6968.2001.tb10729.x; HERZBERG O, 1991, J MOL BIOL, V217, P701, DOI 10.1016/0022-2836(91)90527-D; Herzberg O, 1991, CURR OPIN STRUC BIOL, V1, P946, DOI 10.1016/0959-440X(91)90090-G; Ibuka A, 1999, J MOL BIOL, V285, P2079, DOI 10.1006/jmbi.1998.2432; ISHII Y, 1995, ANTIMICROB AGENTS CH, V39, P2269, DOI 10.1128/AAC.39.10.2269; JACOB F, 1990, PROTEIN ENG, V4, P79, DOI 10.1093/protein/4.1.79; JELSCH C, 1993, PROTEINS, V16, P364, DOI 10.1002/prot.340160406; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KNOX JR, 1995, ANTIMICROB AGENTS CH, V39, P2593, DOI 10.1128/AAC.39.12.2593; KNOX JR, 1991, J MOL BIOL, V220, P435, DOI 10.1016/0022-2836(91)90023-Y; KNOX JR, 1993, PROTEIN ENG, V6, P11, DOI 10.1093/protein/6.1.11; Knox JR, 1996, CHEM BIOL, V3, P937, DOI 10.1016/S1074-5521(96)90182-9; KUZIN AP, 1995, BIOCHEMISTRY-US, V34, P9532, DOI 10.1021/bi00029a030; Kuzin AP, 1999, BIOCHEMISTRY-US, V38, P5720, DOI 10.1021/bi990136d; Matagne A, 1998, BIOCHEM J, V330, P581, DOI 10.1042/bj3300581; Mouz N, 1999, J BIOL CHEM, V274, P19175, DOI 10.1074/jbc.274.27.19175; Orencia MC, 2001, NAT STRUCT BIOL, V8, P238, DOI 10.1038/84981; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PETIT A, 1995, BIOCHEM J, V305, P33, DOI 10.1042/bj3050033; Powers RA, 2001, BIOCHEMISTRY-US, V40, P9207, DOI 10.1021/bi0109358; RAQUET X, 1994, J MOL BIOL, V244, P625, DOI 10.1006/jmbi.1994.1756; SEOANE A, 1991, J GEN MICROBIOL, V137, P141, DOI 10.1099/00221287-137-1-141; STRYNADKA NCJ, 1992, NATURE, V359, P700, DOI 10.1038/359700a0; Swaren P, 1998, J BIOL CHEM, V273, P26714, DOI 10.1074/jbc.273.41.26714; TaibiTronche P, 1996, J AM CHEM SOC, V118, P7441, DOI 10.1021/ja9529753; TAMAKI M, 1994, BIOCHEMISTRY-US, V33, P10200, DOI 10.1021/bi00199a049; Tranier S, 2000, J BIOL CHEM, V275, P28075; Tzouvelekis LS, 2000, INT J ANTIMICROB AG, V14, P137, DOI 10.1016/S0924-8579(99)00165-X; Vakulenko SB, 1999, J BIOL CHEM, V274, P23052, DOI 10.1074/jbc.274.33.23052; Wang XJ, 2002, J MOL BIOL, V320, P85, DOI 10.1016/S0022-2836(02)00400-X; ZAFARALLA G, 1992, BIOCHEMISTRY-US, V31, P3847, DOI 10.1021/bi00130a016	44	94	96	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 29	2002	277	48					46601	46608		10.1074/jbc.M207884200	http://dx.doi.org/10.1074/jbc.M207884200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620JB	12221102	hybrid			2022-12-27	WOS:000179529300116
J	Stamos, J; Sliwkowski, MX; Eigenbrot, C				Stamos, J; Sliwkowski, MX; Eigenbrot, C			Structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE; CRYSTAL-STRUCTURE; EGF RECEPTOR; CANCER; ACTIVATION; SUBSTRATE; ONCOGENE; REVEALS; TARGET; REGION	The crystal structure of the kinase domain from the epidermal growth factor receptor (EGFRK) including forty amino acids from the carboxyl-terminal tail has been determined to 2.6-Angstrom resolution, both with and without an EGFRK-specific inhibitor currently in Phase III clinical trials as an anti-cancer agent, erlotinib (OSI-774, CP-358,774, Tarceva(TM)). The EGFR family members are distinguished from all other known receptor tyrosine kinases in possessing constitutive kinase activity without a phosphorylation event within their kinase domains. Despite its lack of phosphorylation, we find that the EGFRK activation loop adopts a conformation similar to that of the phosphorylated active form of the kinase domain from the insulin receptor., Surprisingly, key residues of a putative dimerization motif lying between the EGFRK domain and carboxyl-terminal substrate docking sites are found in close contact with the kinase domain. Significant intermolecular contacts involving the carboxyl-terminal tail are discussed with respect to receptor oligomerization.	Genentech Inc, Dept Prot Engn, San Francisco, CA 94080 USA; Genentech Inc, Dept Mol Oncol, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech	Eigenbrot, C (corresponding author), 1 DNA Way, San Francisco, CA 94080 USA.	eigenbrot.c@gene.com						Arteaga CL, 2001, J CLIN ONCOL, V19, p32S; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BASU M, 1986, J BIOL CHEM, V261, P2879; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bridges AJ, 2001, CHEM REV, V101, P2541, DOI 10.1021/cr000250y; CHANTRY A, 1995, J BIOL CHEM, V270, P3068; CHEN WS, 1989, CELL, V59, P33, DOI 10.1016/0092-8674(89)90867-2; Cho HS, 2002, SCIENCE, V297, P1330, DOI 10.1126/science.1074611; Druker BJ, 2001, NEW ENGL J MED, V344, P1038, DOI 10.1056/NEJM200104053441402; Garcia-Echeverria C, 2000, MED RES REV, V20, P28, DOI 10.1002/(SICI)1098-1128(200001)20:1<28::AID-MED2>3.3.CO;2-U; Garrett TPJ, 2002, CELL, V110, P763, DOI 10.1016/S0092-8674(02)00940-6; GOTOH N, 1992, BIOCHEM BIOPH RES CO, V186, P768, DOI 10.1016/0006-291X(92)90812-Y; GUY PM, 1994, P NATL ACAD SCI USA, V91, P8132, DOI 10.1073/pnas.91.17.8132; Hubbard SR, 2000, ANNU REV BIOCHEM, V69, P373, DOI 10.1146/annurev.biochem.69.1.373; Hubbard SR, 1997, EMBO J, V16, P5572, DOI 10.1093/emboj/16.18.5572; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; Jones JT, 1999, FEBS LETT, V447, P227, DOI 10.1016/S0014-5793(99)00283-5; Karunagaran D, 1996, EMBO J, V15, P254, DOI 10.1002/j.1460-2075.1996.tb00356.x; Kelloff GJ, 1996, CANCER EPIDEM BIOMAR, V5, P657; KHAZAIE K, 1993, CANCER METAST REV, V12, P255, DOI 10.1007/BF00665957; Kobe B, 1996, EMBO J, V15, P6810, DOI 10.1002/j.1460-2075.1996.tb01072.x; Mcree D.E., 1999, PRACTICAL PROTEIN CR, V2nd ed., P91; Mohammadi M, 1996, CELL, V86, P577, DOI 10.1016/S0092-8674(00)80131-2; Moriki T, 2001, J MOL BIOL, V311, P1011, DOI 10.1006/jmbi.2001.4923; Ogawa A, 2002, J BIOL CHEM, V277, P14351, DOI 10.1074/jbc.C200086200; OSIGO H, 2002, CELL, V110, P775; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; OWEN DJ, 1995, STRUCTURE, V3, P467, DOI 10.1016/S0969-2126(01)00180-0; Palmer BD, 1997, J MED CHEM, V40, P1519, DOI 10.1021/jm960789h; Penuel E, 2002, J BIOL CHEM, V277, P28468, DOI 10.1074/jbc.M202510200; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; REWCASTLE GW, 1995, J MED CHEM, V38, P3482, DOI 10.1021/jm00018a008; Ross JS, 1998, STEM CELLS, V16, P413, DOI 10.1002/stem.160413; Schaefer G, 1999, J BIOL CHEM, V274, P859, DOI 10.1074/jbc.274.2.859; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; SCHLESSINGER J, 1992, NEURON, V9, P383, DOI 10.1016/0896-6273(92)90177-F; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Shawver LK, 2002, CANCER CELL, V1, P117, DOI 10.1016/S1535-6108(02)00039-9; Shewchuk L, 2000, J MED CHEM, V43, P133, DOI 10.1021/jm990401t; SLIWKOWSKI MX, 1994, J BIOL CHEM, V269, P14661; TIMMS JF, 1995, BIOCHEM J, V308, P219, DOI 10.1042/bj3080219; ULLRICH A, 1984, NATURE, V309, P418, DOI 10.1038/309418a0; WELLS A, 1990, SCIENCE, V247, P962, DOI 10.1126/science.2305263; Wissner A, 2000, J MED CHEM, V43, P3244, DOI 10.1021/jm000206a; Woodburn JR, 1999, PHARMACOL THERAPEUT, V82, P241, DOI 10.1016/S0163-7258(98)00045-X; XU RM, 1995, EMBO J, V14, P1015, DOI 10.1002/j.1460-2075.1995.tb07082.x; Yamaguchi H, 1996, NATURE, V384, P484, DOI 10.1038/384484a0; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073	48	967	1014	3	75	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2002	277	48					46265	46272		10.1074/jbc.M207135200	http://dx.doi.org/10.1074/jbc.M207135200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620JB	12196540	hybrid			2022-12-27	WOS:000179529300075
J	Babenko, AP; Bryan, J				Babenko, AP; Bryan, J			SUR-dependent modulation of K-ATP channels by an N-terminal K(IR)6.2 peptide - Defining intersubunit gating interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECTIFYING POTASSIUM CHANNEL; CASSETTE ABC TRANSPORTERS; PORE-FORMING SUBUNIT; SULFONYLUREA RECEPTOR; NUCLEOTIDE SENSITIVITY; INTRACELLULAR DOMAINS; MEMBRANE TOPOLOGY; TOLBUTAMIDE SITE; MOLECULAR-BASIS; BETA-SUBUNIT	Ntp and Ctp, synthetic peptides based on the N- and C-terminal sequences of K(IR)6.0, respectively, were used to probe gating of K(IR)6.0/SUR K-ATP channels. Micromolar Ntp dose-dependently increased the mean open channel probability in ligand-free solution (P-O(max)) and attenuated the ATP inhibition of K(IR)6.2/SUR1, but had no effect on homomeric K(IR)6.2 channels. Ntp (up to similar to10(-4) M) did not affect significantly the mean open or "fast," K+ driving force-dependent, intraburst closed times, verifying that Ntp selectively modulates the ratio of mean burst to interburst times. Ctp and Rnp, a randomized Ntp, had no effect, indicating that the effects of Ntp are structure specific. Ntp opened K(IR)6.1/SUR1 channels normally silent in the absence of stimulatory Mg- nucleotide(s) and attenuated the coupling of high-affinity sulfonylurea binding with KATp pore closure. These effects resemble those seen with N-terminal deletions (DeltaN) of K(IR)6.0, and application of Ntp to DeltaNK(ATP) channels decreased their P-O(max) and apparent IC50 for ATP in the absence of Mg2+. The results are consistent with a competition between Ntp and the endogenous N terminus for a site of interaction on the cytoplasmic face of the channel or with partial replacement of the deleted N terminus by Ntp, respectively. The K-IR N terminus and the TMD0-L0 segment of SUR1 are known to control the P-O(max). The L0 linker has been reported to be required for glibenclamide binding, and DeltaNK(IR)6.2/SUR1 channels exhibit reduced labeling of KIR with I-125-azidoglibenclamide, implying that the KIR N terminus and L0 of SUR1 are in proximity. We hypothesize that L0 interacts with the KIR N terminus in ligand-inhibited K-ATP channels and put forward a model, based on the architecture of BtuCD, MsbA, and the KcsA channel, in which TMD0-L0 links the MDR-like core of SUR with the K-IR pore.	Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Baylor College of Medicine	Babenko, AP (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, 1 Baylor Plaza,112C, Houston, TX 77030 USA.	ababenko@bcm.tme.edu			PHS HHS [44311] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		AGUILARBRYAN L, 1995, SCIENCE, V268, P423, DOI 10.1126/science.7716547; Ashfield R, 1999, DIABETES, V48, P1341, DOI 10.2337/diabetes.48.6.1341; Babenko AP, 1998, ANNU REV PHYSIOL, V60, P667, DOI 10.1146/annurev.physiol.60.1.667; Babenko AP, 1999, J BIOL CHEM, V274, P11587, DOI 10.1074/jbc.274.17.11587; Babenko AP, 1999, FEBS LETT, V445, P131, DOI 10.1016/S0014-5793(99)00102-7; Babenko AP, 2001, J BIOL CHEM, V276, P49083, DOI 10.1074/jbc.M108763200; Babenko AP, 1999, BIOCHEM BIOPH RES CO, V255, P231, DOI 10.1006/bbrc.1999.0172; Babenko AP, 2001, BIOPHYS J, V80, p625A; Babenko AP, 2000, J BIOL CHEM, V275, P717, DOI 10.1074/jbc.275.2.717; Babenko AP, 1999, FEBS LETT, V459, P367, DOI 10.1016/S0014-5793(99)01215-6; BABENKO AP, 2002, PHARMACOLOGIST, V44, pA189; Bakos E, 2000, J CELL SCI, V113, P4451; Chang G, 2001, SCIENCE, V293, P1793, DOI 10.1126/science.293.5536.1793; Clement JP, 1997, NEURON, V18, P827, DOI 10.1016/S0896-6273(00)80321-9; Conti LR, 2001, J BIOL CHEM, V276, P41270, DOI 10.1074/jbc.M106555200; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Drain P, 1998, P NATL ACAD SCI USA, V95, P13953, DOI 10.1073/pnas.95.23.13953; Giblin JP, 1999, J BIOL CHEM, V274, P22652, DOI 10.1074/jbc.274.32.22652; GILLIS KD, 1989, AM J PHYSIOL, V257, pC1119, DOI 10.1152/ajpcell.1989.257.6.C1119; Gulbis JM, 2000, SCIENCE, V289, P123, DOI 10.1126/science.289.5476.123; Hilgemann DW, 1996, SCIENCE, V273, P956, DOI 10.1126/science.273.5277.956; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Jones PA, 2001, FEBS LETT, V508, P85, DOI 10.1016/S0014-5793(01)03023-X; Karplus K, 1999, PROTEINS, P121; Kondo C, 1998, RECEPTOR CHANNEL, V6, P129; Koster JC, 1999, J PHYSIOL-LONDON, V515, P19, DOI 10.1111/j.1469-7793.1999.019ad.x; Li LH, 2000, BIOPHYS J, V79, P841, DOI 10.1016/S0006-3495(00)76340-5; Li LH, 2002, J GEN PHYSIOL, V119, P105, DOI 10.1085/jgp.119.1.105; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; Loussouarn G, 2000, J BIOL CHEM, V275, P1137, DOI 10.1074/jbc.275.2.1137; Matsuo M, 1999, J BIOL CHEM, V274, P37479, DOI 10.1074/jbc.274.52.37479; Mikhailov MV, 2001, FEBS LETT, V499, P154, DOI 10.1016/S0014-5793(01)02538-8; Proks P, 1999, J PHYSIOL-LONDON, V514, P19, DOI 10.1111/j.1469-7793.1999.019af.x; Raab-Graham KF, 1999, J BIOL CHEM, V274, P29122, DOI 10.1074/jbc.274.41.29122; Rosenberg MF, 2001, J BIOL CHEM, V276, P16076, DOI 10.1074/jbc.M100176200; ROST B, 1994, COMPUT APPL BIOSCI, V10, P53; Sakura H, 1999, J PHYSIOL-LONDON, V521, P337, DOI 10.1111/j.1469-7793.1999.00337.x; Schwappach B, 2000, NEURON, V26, P155, DOI 10.1016/S0896-6273(00)81146-0; Sharma N, 1999, J BIOL CHEM, V274, P20628, DOI 10.1074/jbc.274.29.20628; Shyng SL, 1998, SCIENCE, V282, P1138, DOI 10.1126/science.282.5391.1138; Takano M, 1998, J PHYSIOL-LONDON, V512, P395, DOI 10.1111/j.1469-7793.1998.395be.x; TRUBE G, 1984, PFLUG ARCH EUR J PHY, V401, P178, DOI 10.1007/BF00583879; Tucker SJ, 1997, NATURE, V387, P179, DOI 10.1038/387179a0; Tucker SJ, 1999, J BIOL CHEM, V274, P33393, DOI 10.1074/jbc.274.47.33393; Tusnady GE, 1997, FEBS LETT, V402, P1, DOI 10.1016/S0014-5793(96)01478-0; Uhde I, 1999, J BIOL CHEM, V274, P28079, DOI 10.1074/jbc.274.40.28079; Wissmann R, 1999, J BIOL CHEM, V274, P35521, DOI 10.1074/jbc.274.50.35521; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4; ZILBERTER Y, 1988, PFLUG ARCH EUR J PHY, V411, P584, DOI 10.1007/BF00582382	49	55	56	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2002	277	46					43997	44004		10.1074/jbc.M208085200	http://dx.doi.org/10.1074/jbc.M208085200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	615XE	12213829	hybrid			2022-12-27	WOS:000179272000061
J	Barylko, B; Wlodarski, P; Binns, DD; Gerber, SH; Earnest, S; Sudhof, TC; Grichine, N; Albanesi, JP				Barylko, B; Wlodarski, P; Binns, DD; Gerber, SH; Earnest, S; Sudhof, TC; Grichine, N; Albanesi, JP			Analysis of the catalytic domain of phosphatidylinositol 4-kinase type II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; LIPID KINASE; SACCHAROMYCES-CEREVISIAE; INOSITOL LIPIDS; CLONING; PURIFICATION; MEMBRANE; YEAST; PHOSPHOINOSITIDES; FAMILY	Phosphatidylinositol (PtdIns) 4-kinases catalyze the conversion of PtdIns to PtdIns 4-phosphate, the major precursor of phosphoinositides that regulates a vast array of cellular processes. Based on enzymatic differences, two classes of PtdIns 4-kinase have been distinguished termed Types 11 and Ill. Type III kinases, which belong to the phosphatidylinositol (PI) 3/4-kinase family, have been extensively characterized. In contrast, little is known about the Type 11 enzymes (PI4KIIs), which have been cloned and sequenced very recently. PI4KIIs bear essentially no sequence similarity to other protein or lipid kinases; hence, they represent a novel and distinct branch of the kinase superfamily. Here we define the minimal catalytic domain of a rat PI4KII isoform, PI4KIIalpha, and identify conserved amino acid residues required for catalysis. We further show that the catalytic domain by itself determines targeting of the kinase to membrane rafts. To verify that the PI4KII family extends beyond mammalian sources, we expressed and characterized Drosophila PI4KII and its catalytic domain. Depletion of PI4KII from Drosophila cells resulted in a severe reduction of PtdIns 4-kinase activity, suggesting the in vivo importance of this enzyme.	Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Mol Genet, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Ctr Basic Neurosci, Dallas, TX 75390 USA; Med Univ Warsaw, Dept Histol & Embryol, Ctr Biostruct Res, PL-02004 Warsaw, Poland	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Medical University of Warsaw	Albanesi, JP (corresponding author), Univ Texas, SW Med Ctr, Dept Pharmacol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	jalban@mednet.swmed.edu		Wlodarski, Pawel/0000-0002-0683-1791	NIGMS NIH HHS [GM55562] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055562] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Balla A, 2002, J BIOL CHEM, V277, P20041, DOI 10.1074/jbc.M111807200; Balla T, 1998, BBA-MOL CELL BIOL L, V1436, P69, DOI 10.1016/S0005-2760(98)00134-9; Balla T, 1997, J BIOL CHEM, V272, P18358, DOI 10.1074/jbc.272.29.18358; Barylko B, 2001, J BIOL CHEM, V276, P7705, DOI 10.1074/jbc.C000861200; Bondeva T, 1998, SCIENCE, V282, P293, DOI 10.1126/science.282.5387.293; Brill JA, 2000, DEVELOPMENT, V127, P3855; CARPENTER CL, 1990, BIOCHEMISTRY-US, V29, P11147, DOI 10.1021/bi00503a001; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; Cockcroft S, 2001, J MEMBRANE BIOL, V180, P187, DOI 10.1007/s002320010069; ENDEMANN GC, 1991, BIOCHEM J, V273, P63, DOI 10.1042/bj2730063; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; FLANAGAN CA, 1993, SCIENCE, V262, P1444, DOI 10.1126/science.8248783; FLANAGAN CA, 1992, J BIOL CHEM, V267, P24117; Gehrmann T, 1998, EUR J BIOCHEM, V253, P357, DOI 10.1046/j.1432-1327.1998.2530357.x; Gehrmann T, 1996, BBA-MOL CELL RES, V1311, P53, DOI 10.1016/0167-4889(95)00180-8; GIBBS CS, 1991, J BIOL CHEM, V266, P8923; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; HUNTER T, 1995, CELL, V83, P1, DOI 10.1016/0092-8674(95)90225-2; HUSEBYE ES, 1990, BIOCHIM BIOPHYS ACTA, V1042, P330, DOI 10.1016/0005-2760(90)90161-P; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Melkonian KA, 1999, J BIOL CHEM, V274, P3910, DOI 10.1074/jbc.274.6.3910; Meyers R, 1997, J BIOL CHEM, V272, P4384, DOI 10.1074/jbc.272.7.4384; Minogue S, 2001, J BIOL CHEM, V276, P16635, DOI 10.1074/jbc.M100982200; Nakagawa T, 1996, J BIOL CHEM, V271, P12088, DOI 10.1074/jbc.271.20.12088; Nakagawa T, 1996, BIOCHEM J, V320, P643, DOI 10.1042/bj3200643; OREILLY DR, 1992, BACULOVIRUS EXPRESSI, P124; Payrastre B, 2001, CELL SIGNAL, V13, P377, DOI 10.1016/S0898-6568(01)00158-9; PETERSON GL, 1979, ANAL BIOCHEM, V100, P201, DOI 10.1016/0003-2697(79)90222-7; Pike LJ, 1998, J BIOL CHEM, V273, P22298, DOI 10.1074/jbc.273.35.22298; Pirola L, 2001, J BIOL CHEM, V276, P21544, DOI 10.1074/jbc.M011330200; PORTER FD, 1988, J BIOL CHEM, V263, P8989; Rao VD, 1998, CELL, V94, P829, DOI 10.1016/S0092-8674(00)81741-9; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Simonsen A, 2001, CURR OPIN CELL BIOL, V13, P485, DOI 10.1016/S0955-0674(00)00240-4; Song KS, 1996, J BIOL CHEM, V271, P9690, DOI 10.1074/jbc.271.16.9690; STACK JH, 1994, J BIOL CHEM, V269, P31552; Steinbacher S, 1999, EMBO J, V18, P2923, DOI 10.1093/emboj/18.11.2923; Takenawa T, 2001, BBA-MOL CELL BIOL L, V1533, P190, DOI 10.1016/S1388-1981(01)00165-2; Tatusova TA, 1999, FEMS MICROBIOL LETT, V174, P247, DOI 10.1016/S0378-1097(99)00149-4; TAYLOR SS, 1993, TRENDS BIOCHEM SCI, V18, P84, DOI 10.1016/0968-0004(93)80001-R; Taylor SS, 1999, PHARMACOL THERAPEUT, V82, P133, DOI 10.1016/S0163-7258(99)00007-8; Toker A, 2002, CELL MOL LIFE SCI, V59, P761, DOI 10.1007/s00018-002-8465-z; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; WALKER DH, 1988, BIOCHEMISTRY-US, V27, P6504, DOI 10.1021/bi00417a046; Walker EH, 1999, NATURE, V402, P313, DOI 10.1038/46319; Waugh MG, 1998, J BIOL CHEM, V273, P17115, DOI 10.1074/jbc.273.27.17115; WETZKER R, 1991, EUR J BIOCHEM, V200, P179, DOI 10.1111/j.1432-1033.1991.tb21065.x; WONG K, 1994, J BIOL CHEM, V269, P28878; YOSHIDA S, 1994, J BIOL CHEM, V269, P1166; Zajchowski LD, 2002, EUR J BIOCHEM, V269, P737, DOI 10.1046/j.0014-2956.2001.02715.x	55	32	32	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2002	277	46					44366	44375		10.1074/jbc.M203241200	http://dx.doi.org/10.1074/jbc.M203241200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	615XE	12215430	hybrid			2022-12-27	WOS:000179272000108
J	Cabiscol, E; Belli, G; Tamarit, J; Echave, P; Herrero, E; Ros, J				Cabiscol, E; Belli, G; Tamarit, J; Echave, P; Herrero, E; Ros, J			Mitochondrial Hsp60, resistance to oxidative stress, and the labile iron pool are closely connected in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEINS; DNA-DAMAGE; STATIONARY-PHASE; CELL-DEATH; IN-VIVO; OXYGEN; CHAPERONE; GROEL; IDENTIFICATION; REQUIREMENT	In the present study, we have analyzed the role of the molecular chaperone Hsp60 in protection of Saccharomyces cerevisiae against oxidative damage. We constructed mutant strains in which the levels of Hsp60 protein, compared with wild-type cells, were four times greater, and the addition of doxycycline gradually reduces them to 20% of wild-type. Under oxidative-stress conditions, the progressive decrease in Hsp60 levels in these mutants resulted in reduced cell viability and an increase in both cell peroxide species and protein carbonyl content. Protection of Fe/S-containing enzymes from oxidative inactivation was found to be dose-dependent with respect to Hsp60 levels. As these enzymes release their iron ions under oxidative-stress conditions, the intracellular labile iron pool, monitored with calcein, was higher in cells with reduced Hsp60 levels. Consistently, the iron chelator deferoxamine protected low Hsp60-expressing cells from both oxidant-induced death and protein oxidation. These results indicate that the role of Hsp60 in oxidative-stress defense is explained by protection of several Fe/S proteins, which prevent the release of iron ions and thereby avert further damage.	Univ Lleida, Dept Ciencies Med Basiques, Fac Med, Lleida 25198, Spain	Universitat de Lleida	Ros, J (corresponding author), Univ Lleida, Dept Ciencies Med Basiques, Fac Med, Av Rovira Roure 44, Lleida 25198, Spain.	joaquim.ros@cmb.udl.es	Bellí, Gemma/AAD-5325-2019; Herrero, Enrique/B-5592-2009; Ros, Joaquim/A-7507-2010; Tamarit, Jordi/C-6316-2008; Cabiscol, Elisa/A-4584-2009; belli, gemma/A-7424-2011; ROS, Joaquim/ABG-7487-2020	Bellí, Gemma/0000-0002-4161-3204; Herrero, Enrique/0000-0002-6763-111X; Tamarit, Jordi/0000-0003-3227-6928; Cabiscol, Elisa/0000-0003-2795-7999; belli, gemma/0000-0002-4161-3204; ROS, Joaquim/0000-0003-0901-8648				Baumann F, 2000, FEBS LETT, V487, P307, DOI 10.1016/S0014-5793(00)02364-4; BOHEN SP, 1995, SCIENCE, V268, P1303, DOI 10.1126/science.7761850; BREUER W, 1995, AM J PHYSIOL-CELL PH, V268, pC1354, DOI 10.1152/ajpcell.1995.268.6.C1354; BREUER W, 1995, J BIOL CHEM, V270, P24209, DOI 10.1074/jbc.270.41.24209; BRIONES P, 1997, J INHERIT METAB DIS, V20, P469; Cabiscol E, 2000, J BIOL CHEM, V275, P27393; CABISCOL E, 1995, J BIOL CHEM, V270, P14742, DOI 10.1074/jbc.270.24.14742; CADENAS E, 1989, ANNU REV BIOCHEM, V58, P79, DOI 10.1146/annurev.bi.58.070189.000455; CHENG MY, 1989, NATURE, V337, P620, DOI 10.1038/337620a0; COLLINSON LP, 1992, J GEN MICROBIOL, V138, P329, DOI 10.1099/00221287-138-2-329; Craig EA, 1999, BIOL CHEM, V380, P1167, DOI 10.1515/BC.1999.148; Davidson JF, 1996, P NATL ACAD SCI USA, V93, P5116, DOI 10.1073/pnas.93.10.5116; Davidson JF, 2001, J BACTERIOL, V183, P4580, DOI 10.1128/JB.183.15.4580-4587.2001; Dubaquie Y, 1997, P NATL ACAD SCI USA, V94, P9011, DOI 10.1073/pnas.94.17.9011; Dubaquie Y, 1998, EMBO J, V17, P5868, DOI 10.1093/emboj/17.20.5868; Echave P, 2002, P NATL ACAD SCI USA, V99, P4626, DOI 10.1073/pnas.072504199; Fansler B., 1969, METHODS ENZYMOL, V13, P26; FENTON WA, 1994, NATURE, V371, P614, DOI 10.1038/371614a0; FISH WW, 1988, METHOD ENZYMOL, V158, P357, DOI 10.1016/0076-6879(88)58067-9; GALEY JP, 1997, ANTIOXIDANTS DIS MEC, P147; Gallego C, 1997, EMBO J, V16, P7196, DOI 10.1093/emboj/16.23.7196; GARDNER PR, 1991, J BIOL CHEM, V266, P1478; Gari E, 1997, YEAST, V13, P837, DOI 10.1002/(SICI)1097-0061(199707)13:9<837::AID-YEA145>3.0.CO;2-T; Gething MJ., 1997, GUIDEBOOK MOL CHAPER; Godon C, 1998, J BIOL CHEM, V273, P22480, DOI 10.1074/jbc.273.35.22480; Gosslau A, 2001, J BIOL CHEM, V276, P1814, DOI 10.1074/jbc.M008280200; HALLBERG EM, 1993, MOL CELL BIOL, V13, P3050, DOI 10.1128/MCB.13.5.3050; HALLIWELL B, 1990, METHOD ENZYMOL, V186, P1; Hansen JJ, 2002, AM J HUM GENET, V70, P1328, DOI 10.1086/339935; HENDRICK JP, 1993, ANNU REV BIOCHEM, V62, P349, DOI 10.1146/annurev.bi.62.070193.002025; Henle ES, 1997, J BIOL CHEM, V272, P19095, DOI 10.1074/jbc.272.31.19095; Huang J, 1996, BRAIN RES, V711, P184, DOI 10.1016/0006-8993(95)01376-8; HUCKRIEDE A, 1995, VIRCHOWS ARCH, V427, P159; HUCKRIEDE A, 1994, BBA-MOL BASIS DIS, V1227, P200, DOI 10.1016/0925-4439(94)90096-5; IMLAY JA, 1988, SCIENCE, V240, P1302, DOI 10.1126/science.3287616; JAATTELA M, 1993, J EXP MED, V177, P231, DOI 10.1084/jem.177.1.231; Jakob U, 1999, CELL, V96, P341, DOI 10.1016/S0092-8674(00)80547-4; Jamieson DJ, 1998, YEAST, V14, P1511, DOI 10.1002/(SICI)1097-0061(199812)14:16<1511::AID-YEA356>3.3.CO;2-J; JAMIESON DJ, 1994, MICROBIOL-UK, V140, P3277, DOI 10.1099/13500872-140-12-3277; KANG PJ, 1990, NATURE, V348, P137, DOI 10.1038/348137a0; Kaufman BA, 2000, P NATL ACAD SCI USA, V97, P7772, DOI 10.1073/pnas.140063197; Keyer K, 1996, P NATL ACAD SCI USA, V93, P13635, DOI 10.1073/pnas.93.24.13635; Kowaltowski AJ, 1999, FREE RADICAL BIO MED, V26, P463, DOI 10.1016/S0891-5849(98)00216-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laun P, 2001, MOL MICROBIOL, V39, P1166, DOI 10.1046/j.1365-2958.2001.02317.x; LEVINE RL, 1994, METHOD ENZYMOL, V233, P346; Lill R, 2000, TRENDS BIOCHEM SCI, V25, P352, DOI 10.1016/S0968-0004(00)01589-9; Lin KM, 2001, CIRCULATION, V103, P1787, DOI 10.1161/01.CIR.103.13.1787; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Liu HD, 1996, GENE DEV, V10, P592; Llorca O, 1998, J BIOL CHEM, V273, P32587, DOI 10.1074/jbc.273.49.32587; Longo VD, 1996, J BIOL CHEM, V271, P12275, DOI 10.1074/jbc.271.21.12275; Lutz T, 2001, J MOL BIOL, V307, P815, DOI 10.1006/jmbi.2001.4527; Madeo F, 1999, J CELL BIOL, V145, P757, DOI 10.1083/jcb.145.4.757; MARTIN J, 1992, SCIENCE, V258, P995, DOI 10.1126/science.1359644; MARTIN J, 1993, NATURE, V366, P228, DOI 10.1038/366228a0; MISRA TK, 1979, J BIOL CHEM, V254, P1154; MUNUJOS P, 1993, ANAL BIOCHEM, V212, P506, DOI 10.1006/abio.1993.1360; Nulton-Persson AC, 2001, J BIOL CHEM, V276, P23357, DOI 10.1074/jbc.M100320200; Ovelgonne JH, 1996, J MOL CELL CARDIOL, V28, P1617, DOI 10.1006/jmcc.1996.0152; Parsell D.A., 1994, BIOL HEAT SHOCK PROT, P457; PETIT MA, 1994, J BIOL CHEM, V269, P23824; READING DS, 1989, NATURE, V337, P655, DOI 10.1038/337655a0; Robinson JB., 1987, MITOCHONDRIA PRACTIC, P153, DOI DOI 10.1016/J.BBRC.2005.02.135; Rodriguez-Manzaneque MT, 1999, MOL CELL BIOL, V19, P8180; Rodriguez-Manzaneque MT, 2002, MOL BIOL CELL, V13, P1109, DOI 10.1091/mbc.01-10-0517; Schulz JB, 1996, J NEUROSCI, V16, P4696; SHACTER E, 1994, FREE RADICAL BIO MED, V17, P429, DOI 10.1016/0891-5849(94)90169-4; Sigler PB, 1998, ANNU REV BIOCHEM, V67, P581, DOI 10.1146/annurev.biochem.67.1.581; SLURZ LA, 2001, J BIOL CHEM, V276, P38084; Snoeckx LHEH, 2001, PHYSIOL REV, V81, P1461, DOI 10.1152/physrev.2001.81.4.1461; STOHS SJ, 1995, FREE RADICAL BIO MED, V18, P321, DOI 10.1016/0891-5849(94)00159-H; Tamarit J, 1998, J BIOL CHEM, V273, P3027, DOI 10.1074/jbc.273.5.3027; TANGERAS A, 1980, BIOCHIM BIOPHYS ACTA, V589, P162, DOI 10.1016/0005-2728(80)90035-3; Vasquez-Vivar J, 2000, J BIOL CHEM, V275, P14064, DOI 10.1074/jbc.275.19.14064; Voisine C, 2000, MOL CELL BIOL, V20, P3677, DOI 10.1128/MCB.20.10.3677-3684.2000; Vollgraf U, 1999, J NEUROCHEM, V73, P2501, DOI 10.1046/j.1471-4159.1999.0732501.x; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; WernerWashburne M, 1996, MOL MICROBIOL, V19, P1159, DOI 10.1111/j.1365-2958.1996.tb02461.x; Wong A, 1999, HUM MOL GENET, V8, P425, DOI 10.1093/hmg/8.3.425; Yan LJ, 1997, P NATL ACAD SCI USA, V94, P11168, DOI 10.1073/pnas.94.21.11168; Yun CW, 2000, J BIOL CHEM, V275, P10709, DOI 10.1074/jbc.275.14.10709	82	116	118	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2002	277	46					44531	44538		10.1074/jbc.M206525200	http://dx.doi.org/10.1074/jbc.M206525200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	615XE	12200437	hybrid, Green Published			2022-12-27	WOS:000179272000125
J	Crean, JKG; Finlay, D; Murphy, M; Moss, C; Godson, C; Martin, F; Brady, HR				Crean, JKG; Finlay, D; Murphy, M; Moss, C; Godson, C; Martin, F; Brady, HR			The role of p42/44 MAPK and protein kinase B in connective tissue growth factor induced extracellular matrix protein production, cell migration, and actin cytoskeletal rearrangement in human mesangial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING-PROTEIN; FACTOR-BETA; GENE-EXPRESSION; RHO FAMILY; PHOSPHATIDYLINOSITOL 3-KINASE; TYROSINE PHOSPHORYLATION; IN-VITRO; IIB-IIIA; INTEGRIN; ADHESION	Connective tissue growth factor (CTGF) is a member of an emerging family of immediate-early gene products that coordinate complex biological processes during differentiation and tissue repair. Here we describe the role of CTGF in integrin-mediated adhesive signaling and the production of extracellular matrix components in human mesangial cells. The addition of CTGF to primary mesangial cells induced fibronectin production, cell migration, and cytoskeletal rearrangement. These functional responses were associated with recruitment of Src and phosphorylation of p42/44 MAPK and protein kinase B. The inhibition of CTGF-induced p42/44 MAPK or phosphatidylinositol 3-kinase (PI3K)/protein kinase B pathway activities abrogated the induction of fibronectin expression. In addition, anti-beta(3) integrin antibodies attenuated the activation of both the p42/44 MAPK and protein kinase B and the increase in fibronectin levels. CTGF also induced mesangial cell migration via a beta(3) integrin-dependent mechanism that was similarly sensitive to the inhibition of the p42/44 MAPK and PI3K pathways, and it promoted the adhesion of the mesangial cells to type I collagen via up-regulation of a, integrin. Transient actin cytoskeletal disassembly was observed following treatment with the ligand over the course of a 24-h period. CTGF induced the loss of focal adhesions from the mesangial cell as evidenced by the loss of punctate vinculin. However, these processes are p42/44 MAPK and PI3K pathway-independent. Our data support the hypothesis that CTGF mediates a number of its biological effects by the induction of signaling processes via beta(3) integrin. However, others such as actin cytoskeleton disassembly are modulated in a beta(3), integrin/MALPK/PI3K-independent manner, indicating that CTGF is a complex pleiotropic factor with the potential to amplify primary pathophysiological responses.	Natl Univ Ireland Univ Coll Dublin, Mater Misericordiae Hosp, Dept Med & Therapeut, Conway Inst Biomol & Biomed Res, Dublin 7, Ireland; Natl Univ Ireland Univ Coll Dublin, Mater Misericordiae Hosp, Dept Pharmacol, Conway Inst Biomol & Biomed Res, Dublin 7, Ireland; Dublin Mol Med Ctr, Dublin 4, Ireland	Mater Misericordiae University Hospital; University College Dublin; Mater Misericordiae University Hospital; University College Dublin; Trinity College Dublin; University College Dublin	Crean, JKG (corresponding author), Natl Univ Ireland Univ Coll Dublin, Mater Misericordiae Hosp, Dept Med & Therapeut, Conway Inst Biomol & Biomed Res, 41 Eccles St, Dublin 7, Ireland.	john.crean@ucd.ie		/0000-0002-4337-6177; Godson, Catherine/0000-0003-0655-1041				Akiyama S K, 1996, Hum Cell, V9, P181; ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Babic AM, 1999, MOL CELL BIOL, V19, P2958; BOCKHOLT SM, 1995, CELL ADHES COMMUN, V3, P91, DOI 10.3109/15419069509081279; BORDER WA, 1990, NATURE, V346, P371, DOI 10.1038/346371a0; BORDER WA, 1992, NATURE, V360, P361, DOI 10.1038/360361a0; BORK P, 1993, FEBS LETT, V327, P125, DOI 10.1016/0014-5793(93)80155-N; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRADHAM DM, 1991, J CELL BIOL, V114, P1285, DOI 10.1083/jcb.114.6.1285; BRADY HR, 1992, KIDNEY INT, V42, P480, DOI 10.1038/ki.1992.312; Brigstock DR, 1999, ENDOCR REV, V20, P189, DOI 10.1210/er.20.2.189; Brill S, 1996, MOL CELL BIOL, V16, P4869; CARVER W, 1995, J CELL PHYSIOL, V165, P425, DOI 10.1002/jcp.1041650224; Chen CC, 2001, J BIOL CHEM, V276, P10443, DOI 10.1074/jbc.M008087200; CHENG HC, 1992, J BIOL CHEM, V267, P9248; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Clark EA, 1998, J CELL BIOL, V142, P573, DOI 10.1083/jcb.142.2.573; Cortes P, 2000, KIDNEY INT, V58, P2452, DOI 10.1046/j.1523-1755.2000.00428.x; Crean John KG, 2001, Expert Opin Ther Targets, V5, P519; Critchley DR, 2000, CURR OPIN CELL BIOL, V12, P133, DOI 10.1016/S0955-0674(99)00067-8; Delehedde M, 2001, EUR J BIOCHEM, V268, P4423, DOI 10.1046/j.1432-1327.2001.02363.x; Dogic D, 1998, J CELL SCI, V111, P793; FERRELL JE, 1989, P NATL ACAD SCI USA, V86, P2234, DOI 10.1073/pnas.86.7.2234; Finlay D, 2000, CELL DEATH DIFFER, V7, P302, DOI 10.1038/sj.cdd.4400652; FOX JEB, 1993, J BIOL CHEM, V268, P25973; Gilmore AP, 1996, STRUCTURE, V4, P647, DOI 10.1016/S0969-2126(96)00069-X; GOLDEN A, 1989, P NATL ACAD SCI USA, V86, P901, DOI 10.1073/pnas.86.3.901; Grotendorst Gary R., 1997, Cytokine and Growth Factor Reviews, V8, P171, DOI 10.1016/S1359-6101(97)00010-5; Grotendorst GR, 1996, CELL GROWTH DIFFER, V7, P469; Gupta S, 2000, KIDNEY INT, V58, P1389, DOI 10.1046/j.1523-1755.2000.00301.x; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Hapke S, 2001, J BIOL CHEM, V276, P26340, DOI 10.1074/jbc.M100181200; Hashimoto Y, 1998, J EXP MED, V187, P289, DOI 10.1084/jem.187.3.289; Honore S, 2000, HISTOCHEM CELL BIOL, V114, P323; HORWITZ A, 1986, NATURE, V320, P531, DOI 10.1038/320531a0; IGARASHI A, 1993, MOL BIOL CELL, V4, P637, DOI 10.1091/mbc.4.6.637; Ito Y, 2001, J AM SOC NEPHROL, V12, P472, DOI 10.1681/ASN.V123472; Ito Y, 1998, KIDNEY INT, V53, P853, DOI 10.1046/j.1523-1755.1998.00820.x; Jedsadayanmata A, 1999, J BIOL CHEM, V274, P24321, DOI 10.1074/jbc.274.34.24321; Johnson JL, 1996, J BIOL CHEM, V271, P21574, DOI 10.1074/jbc.271.35.20981; Jones PL, 1997, J CELL BIOL, V139, P279, DOI 10.1083/jcb.139.1.279; Kagami S, 2001, EXP CELL RES, V268, P274, DOI 10.1006/excr.2001.5279; Kaibuchi K, 1999, ANNU REV BIOCHEM, V68, P459, DOI 10.1146/annurev.biochem.68.1.459; King WG, 1997, MOL CELL BIOL, V17, P4406, DOI 10.1128/MCB.17.8.4406; Knezevic I, 1996, J BIOL CHEM, V271, P16416, DOI 10.1074/jbc.271.27.16416; Koya D, 1997, J CLIN INVEST, V100, P115, DOI 10.1172/JCI119503; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lau LF, 1999, EXP CELL RES, V248, P44, DOI 10.1006/excr.1999.4456; LEWIS JM, 1995, MOL BIOL CELL, V6, P151, DOI 10.1091/mbc.6.2.151; LIPFERT L, 1992, J CELL BIOL, V119, P905, DOI 10.1083/jcb.119.4.905; Liu WL, 2001, ENDOCRINOLOGY, V142, P1710, DOI 10.1210/en.142.5.1710; Loeser RF, 1997, ARTHRITIS RHEUM, V40, P270, DOI 10.1002/art.1780400211; Miller LA, 1999, EUR J IMMUNOL, V29, P1426, DOI 10.1002/(SICI)1521-4141(199905)29:05<1426::AID-IMMU1426>3.0.CO;2-J; Miyamoto S, 1996, J CELL BIOL, V135, P1633, DOI 10.1083/jcb.135.6.1633; MIYAMOTO S, 1995, SCIENCE, V267, P883, DOI 10.1126/science.7846531; Murphy M, 1999, J BIOL CHEM, V274, P5830, DOI 10.1074/jbc.274.9.5830; Nakanishi T, 2000, ENDOCRINOLOGY, V141, P264, DOI 10.1210/endo.141.1.7267; Nishida T, 1998, BIOCHEM BIOPH RES CO, V247, P905, DOI 10.1006/bbrc.1998.8895; PELLETIER AJ, 1995, J BIOL CHEM, V270, P18133, DOI 10.1074/jbc.270.30.18133; PLOPPER GE, 1995, MOL BIOL CELL, V6, P1349, DOI 10.1091/mbc.6.10.1349; Price LS, 1998, MOL BIOL CELL, V9, P1863, DOI 10.1091/mbc.9.7.1863; Riser BL, 2001, RENAL FAILURE, V23, P459, DOI 10.1081/JDI-100104729; Riser BL, 2000, J AM SOC NEPHROL, V11, P25, DOI 10.1681/ASN.V11125; Schwartz MA, 2002, NAT CELL BIOL, V4, pE65, DOI 10.1038/ncb0402-e65; Sondermann H, 1999, CELL ADHES COMMUN, V7, P43, DOI 10.3109/15419069909034391; STUDER RK, 1993, DIABETES, V42, P118, DOI 10.2337/diabetes.42.1.118; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Wahab NA, 2001, BIOCHEM J, V359, P77, DOI 10.1042/0264-6021:3590077; Wennerberg K, 2000, MOL CELL BIOL, V20, P5758, DOI 10.1128/MCB.20.15.5758-5765.2000; Westwick JK, 1997, MOL CELL BIOL, V17, P1324, DOI 10.1128/MCB.17.3.1324; Xu WM, 1998, J CELL SCI, V111, P1535; Yokoi H, 2001, AM J KIDNEY DIS, V38, pS134, DOI 10.1053/ajkd.2001.27422; Zhang R, 1998, MOL CELL BIOL, V18, P6131, DOI 10.1128/MCB.18.10.6131; Zhang X, 1999, P NATL ACAD SCI USA, V96, P9021, DOI 10.1073/pnas.96.16.9021; ZHOU XP, 1995, LAB INVEST, V73, P372; Zhou XP, 1997, KIDNEY INT, V51, P1797, DOI 10.1038/ki.1997.247	77	131	158	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2002	277	46					44187	44194		10.1074/jbc.M203715200	http://dx.doi.org/10.1074/jbc.M203715200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	615XE	12218048	hybrid			2022-12-27	WOS:000179272000085
J	Marvaud, JC; Stiles, BG; Chenal, A; Gillet, D; Gibert, M; Smith, LA; Popoff, MR				Marvaud, JC; Stiles, BG; Chenal, A; Gillet, D; Gibert, M; Smith, LA; Popoff, MR			Clostridium perfringens iota toxin - Mapping of the Ia domain involved in docking with Ib and cellular internalization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOTULINUM C2 TOXIN; RIBOSYLATING C3 EXOENZYME; LIPID BILAYER-MEMBRANES; ADP-RIBOSYLTRANSFERASE; LETHAL FACTOR; CRYSTAL-STRUCTURE; BINARY TOXIN; CHANNEL FUNCTION; COMPONENT C2II; BINDING	Clostridium perfringens iota toxin consists of two unlinked proteins. The binding component (Ib) is required to internalize into cells an enzymatic component (Ia) that ADP-ribosylates G-actin. To characterize the Ia domain that interacts with Ib, fusion proteins were constructed between the C. botulinum C3 enzyme, which ADP-ribosylates Rho, and various truncated versions of Ia. These chimeric molecules retained the wild type ADP-ribosyltransferase activity specific for Rho and were recognized by antibodies against C3 enzyme and Ia. Internalization of each chimera into Vero cells was assessed by measuring the disorganization of the actin cytoskeleton and intracellular ADP-ribosylation of Rho. Fusion proteins containing C3 linked to the C terminus of Ia were transported most efficiently into cells like wild type Ia in an Ib-dependent manner that was blocked by bafilomycin A1. The minimal Ia fragment that promoted translocation of Ia-C3 chimeras into cells consisted of 128 central residues (129-257). These findings revealed that iota toxin is a suitable system for mediating the entry of heterologous proteins such as C3 into cells.	Inst Pasteur, CNR Anaerobies, F-75724 Paris 15, France; USA, Med Res Inst Infect Dis, Toxinol Div, Ft Detrick, MD 21702 USA; CEA Saclay, Dept Ingenierie & Etud Prot, F-91191 Gif Sur Yvette, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; CEA; UDICE-French Research Universities; Universite Paris Saclay	Popoff, MR (corresponding author), Inst Pasteur, CNR Anaerobies, 28 Rue Dr Roux, F-75724 Paris 15, France.	mpopoff@pasteur.fr	Gillet, Daniel/C-5592-2008; Chenal, Alexandre/C-2240-2009	Gillet, Daniel/0000-0003-0477-3599; Chenal, Alexandre/0000-0002-4959-1003				Adler A J, 1973, Methods Enzymol, V27, P675; AKTORIES K, 1986, NATURE, V322, P390, DOI 10.1038/322390a0; ARORA N, 1993, J BIOL CHEM, V268, P3334; ARORA N, 1994, J BIOL CHEM, V269, P26165; AULLO P, 1993, EMBO J, V12, P921, DOI 10.1002/j.1460-2075.1993.tb05733.x; Bachmeyer C, 2001, FASEB J, V15, P1658, DOI 10.1096/fj.00-0671fje; Barth H, 2000, J BIOL CHEM, V275, P18704, DOI 10.1074/jbc.M000596200; Barth H, 2002, J BIOL CHEM, V277, P5074, DOI 10.1074/jbc.M109167200; Barth H, 1998, INFECT IMMUN, V66, P1364, DOI 10.1128/IAI.66.4.1364-1369.1998; Blocker D, 2000, INFECT IMMUN, V68, P4566, DOI 10.1128/IAI.68.8.4566-4573.2000; Blocker D, 2001, INFECT IMMUN, V69, P2980, DOI 10.1128/IAI.69.5.2980-2987.2001; BRAGG TS, 1989, GENE, V81, P45, DOI 10.1016/0378-1119(89)90335-1; CHARDIN P, 1989, EMBO J, V8, P1087, DOI 10.1002/j.1460-2075.1989.tb03477.x; Chenal A, 2002, PROTEIN ENG, V15, P383, DOI 10.1093/protein/15.5.383; Coligan JE, 1995, CURRENT PROTOCOLS PR; CONSIDINE RV, 1991, TOXICON, V29, P913, DOI 10.1016/0041-0101(91)90076-4; Gibert M, 2000, INFECT IMMUN, V68, P3848, DOI 10.1128/IAI.68.7.3848-3853.2000; Gill D., 1978, BACTERIAL TOXINS CEL, P291; Han S, 1999, NAT STRUCT BIOL, V6, P932, DOI 10.1038/13300; Han SI, 2001, J MOL BIOL, V305, P95, DOI 10.1006/jmbi.2000.4292; Lacy DB, 2002, J BIOL CHEM, V277, P3006, DOI 10.1074/jbc.M109997200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leppla S. H., 1995, Bacterial toxins and virulence factors in disease., P543; LEPPLA SH, 1999, COMPREHENSIVE SOURCE, P243; Marvaud JC, 2001, INFECT IMMUN, V69, P2435, DOI 10.1128/IAI.69.4.2435-2441.2001; MAUSS S, 1990, EUR J BIOCHEM, V194, P237, DOI 10.1111/j.1432-1033.1990.tb19448.x; Menetrey J, 2002, J BIOL CHEM, V277, P30950, DOI 10.1074/jbc.M201844200; MILNE JC, 1995, MOL MICROBIOL, V15, P661, DOI 10.1111/j.1365-2958.1995.tb02375.x; Miyaoka T, 1996, J BIOCHEM-TOKYO, V119, P200; OLSNES S, 1999, COMPREHENSIVE SOURCE, P73; Pannifer AD, 2001, NATURE, V414, P229, DOI 10.1038/n35101998; PASTAN I, 1992, ANNU REV BIOCHEM, V61, P331, DOI 10.1146/annurev.bi.61.070192.001555; Perelle S, 1997, INFECT IMMUN, V65, P1402, DOI 10.1128/IAI.65.4.1402-1407.1997; PERELLE S, 1995, INFECT IMMUN, V63, P4967, DOI 10.1128/IAI.63.12.4967-4967.1995; Perelle S, 1996, FEBS LETT, V395, P191, DOI 10.1016/0014-5793(96)01035-6; PERELLE S, 1993, INFECT IMMUN, V61, P5147, DOI 10.1128/IAI.61.12.5147-5156.1993; PERELLE S, 1997, FEMS MICROBIOL LETT, V146, P117; Petosa C, 1997, NATURE, V385, P833, DOI 10.1038/385833a0; Popoff MR, 2000, HANDB EXP PHARM, V145, P275; POPOFF MR, 1988, INFECT IMMUN, V56, P2299, DOI 10.1128/IAI.56.9.2299-2306.1988; POPOFF MR, 1991, INFECT IMMUN, V59, P3673, DOI 10.1128/IAI.59.10.3673-3679.1991; Popoff MR, 1996, J BIOL CHEM, V271, P10217, DOI 10.1074/jbc.271.17.10217; POPOFF MR, 1989, INFECT IMMUN, V57, P2462, DOI 10.1128/IAI.57.8.2462-2469.1989; Richard JF, 2002, MOL MICROBIOL, V43, P907, DOI 10.1046/j.1365-2958.2002.02806.x; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SCHMID A, 1994, J BIOL CHEM, V269, P16706; SIMPSON LI, 1989, J PHARMACOL EXP THER, V251, P1223; Stiles BG, 2000, INFECT IMMUN, V68, P3475, DOI 10.1128/IAI.68.6.3475-3484.2000; VANDEKERCKHOVE J, 1987, FEBS LETT, V225, P48, DOI 10.1016/0014-5793(87)81129-8; VANDERSPECK JC, 1999, COMPREHENSIVE SOURCE, P682; Warren G.W., 1996, Patent Coop. Treaty, Patent No. [WO96/ 10083, 9610083, WO 96/10083 A1]; Wilde C, 2001, TOXICON, V39, P1647, DOI 10.1016/S0041-0101(01)00152-0	52	35	38	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2002	277	46					43659	43666		10.1074/jbc.M207828200	http://dx.doi.org/10.1074/jbc.M207828200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	615XE	12221101	hybrid			2022-12-27	WOS:000179272000017
J	Zang, XX; Taylor, P; Wang, JM; Meyer, DJ; Scott, AL; Walkinshaw, MD; Maizels, RM				Zang, XX; Taylor, P; Wang, JM; Meyer, DJ; Scott, AL; Walkinshaw, MD; Maizels, RM			Homologues of human macrophage migration inhibitory factor from a parasitic nematode - Gene cloning, protein activity, and crystal structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN LYMPHATIC FILARIASIS; BRUGIA-MALAYI; FACTOR MIF; IMMUNE EVASION; PHENYLPYRUVATE TAUTOMERASE; CYTOKINE MIF; MODULATION; RESPONSES; MICROFILARIAE; PURIFICATION	Cytokines are the molecular messengers of the vertebrate immune system, coordinating the local and systemic immune responses to infective organisms. We report here functional and structural data on cytokine-like proteins from a eukaryotic pathogen. Two homologues of the human cytokine macrophage migration inhibitory factor (MIF) have been isolated from the parasitic nematode Brugia malayi. Both molecules (Bm-MIF-1 and Bm-MIF-2) show parallel functions to human MIF. They are chemotactic for human monocytes and activate them to produce IL-8, TNF-alpha, and endogenous MIF. The human and nematode MIF homologues share a tautomerase enzyme activity, which is in each case abolished by the mutation of the N-terminal proline residue. The crystal structure of Bm-MIF-2 at 1.8-Angstrom resolution has been determined, revealing a trimeric assembly with an inner pore created by beta-stranded sheets from each subunit. Both biological activity and crystal structure reveal remarkable conservation between a human cytokine and its parasite counterpart despite the considerable phylogenetic divide among these organisms. The strength of the similarity implies that MIF-mediated pathways play an important role in nematode immune evasion strategies.	Univ Edinburgh, Inst Cell Anim & Populat Biol, Edinburgh EH9 3JT, Midlothian, Scotland; Univ Edinburgh, Inst Cell & Mol Biol, Edinburgh EH9 3JT, Midlothian, Scotland; NCI, Frederick Canc Res & Dev Ctr, Mol Immunoregulat Lab, Frederick, MD 21702 USA; Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1E 7HT, England; Johns Hopkins Univ, Sch Hyg & Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA	University of Edinburgh; University of Edinburgh; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; University of London; London School of Hygiene & Tropical Medicine; Johns Hopkins University	Zang, XX (corresponding author), Univ Edinburgh, Inst Cell Anim & Populat Biol, W Mains Rd, Edinburgh EH9 3JT, Midlothian, Scotland.		walkinshaw, malcolm/AAB-7497-2019	walkinshaw, malcolm/0000-0001-5955-9325; Zang, Xingxing/0000-0001-5380-1942				Alcami A, 2000, IMMUNOL TODAY, V21, P447, DOI 10.1016/S0167-5699(00)01699-6; BERNHAGEN J, 1993, NATURE, V365, P756, DOI 10.1038/365756a0; Blaxter M, 1999, PARASITOLOGY, V118, pS39, DOI 10.1017/S0031182099004060; BLOOM BR, 1966, SCIENCE, V153, P80, DOI 10.1126/science.153.3731.80; Bozza M, 1999, J EXP MED, V189, P341, DOI 10.1084/jem.189.2.341; Bucala R, 2000, NATURE, V408, P146, DOI 10.1038/35041654; Calandra T, 2000, NAT MED, V6, P164, DOI 10.1038/72262; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; DAVID JR, 1966, P NATL ACAD SCI USA, V56, P72, DOI 10.1073/pnas.56.1.72; de Jong YP, 2001, NAT IMMUNOL, V2, P1061, DOI 10.1038/ni720; Donnelly SC, 1997, NAT MED, V3, P320, DOI 10.1038/nm0397-320; Falcone FH, 2001, J IMMUNOL, V167, P5348, DOI 10.4049/jimmunol.167.9.5348; GALAT A, 1993, FEBS LETT, V319, P233, DOI 10.1016/0014-5793(93)80553-7; Goerdt S, 1999, IMMUNITY, V10, P137, DOI 10.1016/S1074-7613(00)80014-X; Gomez-Escobar N, 2000, INFECT IMMUN, V68, P6402, DOI 10.1128/IAI.68.11.6402-6410.2000; Gregory WF, 1997, MOL BIOCHEM PARASIT, V87, P85, DOI 10.1016/S0166-6851(97)00050-9; KING CL, 1993, J CLIN INVEST, V92, P1667, DOI 10.1172/JCI116752; Kleemann R, 2000, NATURE, V408, P211, DOI 10.1038/35041591; Lawrence RA, 1996, PARASITOL TODAY, V12, P267, DOI 10.1016/0169-4758(96)10025-9; Liu SG, 1997, CLIN BIOCHEM, V30, P455, DOI 10.1016/S0009-9120(97)00049-0; Loke P, 2000, EUR J IMMUNOL, V30, P2669, DOI 10.1002/1521-4141(200009)30:9&lt;2669::AID-IMMU2669&gt;3.0.CO;2-1; LoVerde PT, 1998, PARASITOL TODAY, V14, P284, DOI 10.1016/S0169-4758(98)01261-7; Lubetsky JB, 1999, BIOCHEMISTRY-US, V38, P7346, DOI 10.1021/bi990306m; MacDonald AS, 1998, J IMMUNOL, V160, P4124; MAIZELS RM, 1991, PARASITOL TODAY, V7, P271, DOI 10.1016/0169-4758(91)90093-4; MAIZELS RM, 1993, NATURE, V365, P797, DOI 10.1038/365797a0; MAIZELS RM, 1995, PARASITOL TODAY, V11, P50, DOI 10.1016/0169-4758(95)80116-2; Maizels RM, 2001, INT J PARASITOL, V31, P889, DOI 10.1016/S0020-7519(01)00213-2; Manoury B, 2001, CURR BIOL, V11, P447, DOI 10.1016/S0960-9822(01)00118-X; Marson AL, 2001, GENE, V278, P53, DOI 10.1016/S0378-1119(01)00706-5; Matsunaga J, 1999, J BIOL CHEM, V274, P3268, DOI 10.1074/jbc.274.6.3268; Metz CN, 1997, ADV IMMUNOL, V66, P197, DOI 10.1016/S0065-2776(08)60598-2; Michael E, 1996, PARASITOLOGY, V112, P409, DOI 10.1017/S0031182000066646; Mitchell RA, 2000, SEMIN CANCER BIOL, V10, P359, DOI 10.1006/scbi.2000.0328; MozeticFrancky B, 1997, PROTEIN EXPRES PURIF, V9, P115, DOI 10.1006/prep.1996.0641; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pastrana DV, 1998, INFECT IMMUN, V66, P5955, DOI 10.1128/IAI.66.12.5955-5963.1998; Pennock JL, 1998, BIOCHEM J, V331, P905, DOI 10.1042/bj3310905; Ploegh HL, 1998, SCIENCE, V280, P248, DOI 10.1126/science.280.5361.248; Roger T, 2001, NATURE, V414, P920, DOI 10.1038/414920a; Rosengren E, 1997, FEBS LETT, V417, P85, DOI 10.1016/S0014-5793(97)01261-1; Schonemeyer A, 2001, J IMMUNOL, V167, P3207, DOI 10.4049/jimmunol.167.6.3207; Su SB, 1999, J EXP MED, V189, P395, DOI 10.1084/jem.189.2.395; Sun HW, 1996, P NATL ACAD SCI USA, V93, P5191, DOI 10.1073/pnas.93.11.5191; Suzuki M, 1996, NAT STRUCT BIOL, V3, P259, DOI 10.1038/nsb0396-259; Swope M, 1998, EMBO J, V17, P3534, DOI 10.1093/emboj/17.13.3534; Tan THP, 2001, BIOCHEM J, V357, P373, DOI 10.1042/0264-6021:3570373; Tang L, 1996, EXP PARASITOL, V82, P329, DOI 10.1006/expr.1996.0041; Taylor AB, 1999, BIOCHEMISTRY-US, V38, P7444, DOI 10.1021/bi9904048; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; WEISER WY, 1989, P NATL ACAD SCI USA, V86, P7522, DOI 10.1073/pnas.86.19.7522; Williams SA, 2000, INT J PARASITOL, V30, P411, DOI 10.1016/S0020-7519(00)00014-X; Wray GA, 1996, SCIENCE, V274, P568, DOI 10.1126/science.274.5287.568; Zang XX, 2000, J IMMUNOL, V165, P5161, DOI 10.4049/jimmunol.165.9.5161; Zang XX, 1999, BLOOD, V94, P1418, DOI 10.1182/blood.V94.4.1418.416k03_1418_1428; Zang XX, 2001, TRENDS BIOCHEM SCI, V26, P191, DOI 10.1016/S0968-0004(00)01761-8	56	93	102	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	2002	277	46					44261	44267		10.1074/jbc.M204655200	http://dx.doi.org/10.1074/jbc.M204655200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	615XE	12221083	hybrid			2022-12-27	WOS:000179272000095
J	Krempler, A; Henry, MD; Triplett, AA; Wagner, KU				Krempler, A; Henry, MD; Triplett, AA; Wagner, KU			Targeted deletion of the Tsg101 gene results in cell cycle arrest at G(1)/S and p53-independent cell death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN BREAST-CANCER; TRANSCRIPTIONAL ACTIVATION; EMBRYONIC LETHALITY; TUMOR-SUPPRESSOR; A GENE; PROTEIN; P53; CHROMOSOME-11; ABNORMALITIES; EXPRESSION	The tumor susceptibility gene 101 (Tsg101) was originally discovered in a screen for potential tumor suppressors using insertional mutagenesis in immortalized fibroblasts. To investigate essential functions of this gene in cell growth and neoplastic transformation, we derived primary mouse embryonic fibroblasts from Tsg101 conditional knockout mice. Expression of Cre recombinase from a retroviral vector efficiently down-regulated Tsg101. The deletion of Tsg101 caused growth arrest and cell death but did not result in increased proliferation and cellular transformation. Inactivation of p53 had no influence on the deleterious phenotype, but Tsg101(-/-) cells were rescued through expression of exogenous Tsg101. Fluorescence-activated cell sorting, proliferation assays, and Western blot analysis of crucial regulators of the cell cycle revealed that Tsg101 deficiency resulted in growth arrest at the G(1)/S transition through inactivation of cyclin-dependent kinase 2. As a consequence, DNA replication was not initiated in Tsg101-deficient cells. Our results clearly demonstrate that Tsg101 is not a primary tumor suppressor in mouse embryonic fibroblasts. However, the protein is crucial for cell proliferation and cell survival.	Univ Nebraska, Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center	Wagner, KU (corresponding author), Univ Nebraska, Med Ctr, Eppley Inst Res Canc & Allied Dis, 986805 Nebraska Med Ctr,Rm 8009, Omaha, NE 68198 USA.		Wagner, Kay-Uwe/B-6044-2009	Wagner, Kay-Uwe/0000-0002-5081-0226	NCI NIH HHS [R01CA93797, R01 CA093797] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA093797] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALI IU, 1987, SCIENCE, V238, P185, DOI 10.1126/science.3659909; Bishop N, 2002, J CELL BIOL, V157, P91, DOI 10.1083/jcb.200112080; DEOCALUNA R, 1995, NATURE, V0378; EL DW, 1993, CELL, V75, P817; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Feng GH, 2000, CANCER RES, V60, P1736; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; Gayther SA, 1997, ONCOGENE, V15, P2119, DOI 10.1038/sj.onc.1201591; HENGLEIN B, 1994, P NATL ACAD SCI USA, V91, P5490, DOI 10.1073/pnas.91.12.5490; Hittelman AB, 1999, EMBO J, V18, P5380, DOI 10.1093/emboj/18.19.5380; JONES SN, 1995, NATURE, V378, P206, DOI 10.1038/378206a0; Koonin EV, 1997, NAT GENET, V16, P330, DOI 10.1038/ng0897-330; Lee MP, 1997, CANCER RES, V57, P3131; Li LM, 1996, CELL, V85, P319, DOI 10.1016/S0092-8674(00)81111-3; Li LM, 1997, CELL, V88, P143, DOI 10.1016/S0092-8674(00)81866-8; Li LM, 2001, P NATL ACAD SCI USA, V98, P1619, DOI 10.1073/pnas.98.4.1619; Nasmyth K, 1996, SCIENCE, V274, P1643, DOI 10.1126/science.274.5293.1643; Oh H, 2002, P NATL ACAD SCI USA, V99, P5430, DOI 10.1073/pnas.082123999; OHTSUBO M, 1995, MOL CELL BIOL, V15, P2612; Pham CTN, 1996, P NATL ACAD SCI USA, V93, P13090, DOI 10.1073/pnas.93.23.13090; Ponting CP, 1997, J MOL MED-JMM, V75, P467; REEVE AE, 1989, MOL CELL BIOL, V9, P1799, DOI 10.1128/MCB.9.4.1799; Robertson KD, 1998, MOL CELL BIOL, V18, P6457, DOI 10.1128/MCB.18.11.6457; Ruland J, 2001, P NATL ACAD SCI USA, V98, P1859, DOI 10.1073/pnas.98.4.1859; Sever-Chroneos Z, 2001, MOL CELL BIOL, V21, P4032, DOI 10.1128/MCB.21.12.4032-4045.2001; Sherr CJ, 1998, GENE DEV, V12, P2984, DOI 10.1101/gad.12.19.2984; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; SOBEL A, 1991, TRENDS BIOCHEM SCI, V16, P301, DOI 10.1016/0968-0004(91)90123-D; Steiner P, 1997, NAT GENET, V16, P332, DOI 10.1038/ng0897-332; Stott FJ, 1998, EMBO J, V17, P5001, DOI 10.1093/emboj/17.17.5001; Sun ZJ, 1997, ONCOGENE, V15, P3121, DOI 10.1038/sj.onc.1201521; TELFORD WG, 1991, CELL PROLIFERAT, V24, P447, DOI 10.1111/j.1365-2184.1991.tb01173.x; TOMMASINO M, 1995, BIOESSAYS, V17, P509, DOI 10.1002/bies.950170607; VANDELOOSDRECHT AA, 1994, J IMMUNOL METHODS, V174, P311, DOI 10.1016/0022-1759(94)90034-5; Waga S, 1998, ANNU REV BIOCHEM, V67, P721, DOI 10.1146/annurev.biochem.67.1.721; Wagner KU, 1998, ONCOGENE, V17, P2761, DOI 10.1038/sj.onc.1202529; Wang Q, 1998, ONCOGENE, V16, P677, DOI 10.1038/sj.onc.1201563; Watanabe M, 1998, BIOCHEM BIOPH RES CO, V245, P900, DOI 10.1006/bbrc.1998.8547; Wu CL, 2001, CANCER RES, V61, P7325; XIANG Y, 1993, NATURE, V366, P701; Xie WQ, 1998, P NATL ACAD SCI USA, V95, P1595, DOI 10.1073/pnas.95.4.1595; ZerfassThome K, 1997, MOL CELL BIOL, V17, P407, DOI 10.1128/MCB.17.1.407; Zhong Q, 1998, CANCER RES, V58, P2699	43	75	84	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					43216	43223		10.1074/jbc.M207662200	http://dx.doi.org/10.1074/jbc.M207662200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12205095	hybrid, Green Accepted			2022-12-27	WOS:000179081200103
J	Mahnke-Zizelman, DK; Sabina, RL				Mahnke-Zizelman, DK; Sabina, RL			N-terminal sequence and distal histidine residues are responsible for pH-regulated cytoplasmic membrane binding of human AMP deaminase isoform E	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE; PHOSPHATIDATE BILAYERS; RAT; CLONING; EXPRESSION; NEOMYCIN; HEART; GENE; CDNA; PURIFICATION	Mammalian AMP deaminase 3 (AMPD3) enzymes reportedly bind to intracellular membranes, plasma lipid vesicles, and artificial lipid bilayers with associated alterations in enzyme conformation and function. However, proteolytic sensitivity of AMPD polypeptides makes it likely that prior studies were performed with N-truncated enzymes. This study uses erythrocyte ghosts to characterize the reversible cytoplasmic membrane association of human full-sized recombinant isoform E (AMPD3). Membrane-bound isoform E exhibits diminished catalytic activity whereas low micromolar concentrations of the cationic antibiotic, neomycin, disrupt this protein-lipid interaction and relieve catalytic inhibition. The cytoplasmic membrane association of isoform E also displays an inverse correlation with pH in the physiological range. Diethyl pyrocarbonate (DEPC) modification of isoform E nearly abolishes its cytoplasmic membrane binding capacity, and this effect can be reversed by hydroxylamine. Difference spectra reveal that 18 of 29 histidine residues in each isoform E subunit are N-carbethoxylated by DEPC. These combined data demonstrate that protonated imidazole rings of histidine residues mediate a pH-responsive association of isoform E with anionic charges on the surface of the cytoplasmic membrane, possibly phosphatidylinositol 4,5-bisphosphate, a pure noncompetitive inhibitor of the enzyme. Finally, AMPD1 and a series of N-truncated AMPD3 enzymes are used to show that these behaviors are specific to isoform. E and require up to 48 N-terminal amino acids, even though this stretch of sequence contains no histidine residues. The pH-responsive cytosol-membrane partitioning of isoform E may be an important mechanism for branch point regulation of adenylate catabolism.	Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA	Medical College of Wisconsin	Sabina, RL (corresponding author), Med Coll Wisconsin, Dept Biochem, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK050902] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-50902] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Arbuzova A, 2000, BBA-BIOMEMBRANES, V1464, P35, DOI 10.1016/S0005-2736(99)00243-6; ASHBY B, 1981, J BIOL CHEM, V256, P519; ASKARI A, 1963, SCIENCE, V141, P44, DOI 10.1126/science.141.3575.44; BAUSCHJURKEN MT, 1992, J BIOL CHEM, V267, P22407; BURSTEIN Y, 1974, BIOCHEMISTRY-US, V13, P205, DOI 10.1021/bi00698a030; Chilson OP, 1997, COMP BIOCHEM PHYS B, V116, P371, DOI 10.1016/S0305-0491(96)00270-2; DUDLEY GA, 1985, AM J PHYSIOL, V248, pC43, DOI 10.1152/ajpcell.1985.248.1.C43; GABEV E, 1989, BIOCHIM BIOPHYS ACTA, V979, P105, DOI 10.1016/0005-2736(89)90529-4; Hohl AM, 1999, MOL CELL BIOCHEM, V201, P151, DOI 10.1023/A:1007083000564; IWATA S, 1995, NATURE, V376, P660, DOI 10.1038/376660a0; KALMAR GB, 1990, P NATL ACAD SCI USA, V87, P6029, DOI 10.1073/pnas.87.16.6029; Knecht K, 2001, J NEUROSCI RES, V66, P941, DOI 10.1002/jnr.10059; KOCHAN Z, 1994, J MOL CELL CARDIOL, V26, P1497, DOI 10.1006/jmcc.1994.1168; Lemmon MA, 2000, BIOCHEM J, V350, P1, DOI 10.1042/0264-6021:3500001; Mahnke-Zizelman DK, 2001, BIOCHEM BIOPH RES CO, V285, P489, DOI 10.1006/bbrc.2001.5180; Mahnke-Zizelman DK, 1998, J BIOL CHEM, V273, P35118, DOI 10.1074/jbc.273.52.35118; MahnkeZizelman DK, 1996, BBA-GENE STRUCT EXPR, V1306, P75, DOI 10.1016/0167-4781(95)00231-6; MahnkeZizelman DK, 1996, BBA-GENE STRUCT EXPR, V1308, P122, DOI 10.1016/0167-4781(96)00089-9; MahnkeZizelman DK, 1997, BIOCHEM J, V326, P521, DOI 10.1042/bj3260521; MAHNKEZIZELMAN DK, 1992, J BIOL CHEM, V267, P20866; MARQUETANT R, 1989, BIOCHEMISTRY-US, V28, P8744, DOI 10.1021/bi00448a010; MEGHJI P, 1988, BIOCHEM J, V249, P695, DOI 10.1042/bj2490695; MINEO I, 1990, MOL CELL BIOL, V10, P5271, DOI 10.1128/MCB.10.10.5271; MORISAKI T, 1990, J BIOL CHEM, V265, P11482; Norman B, 2001, J APPL PHYSIOL, V91, P258, DOI 10.1152/jappl.2001.91.1.258; OGASAWARA N, 1982, BIOCHIM BIOPHYS ACTA, V714, P298; OVADI J, 1967, Acta Biochimica et Biophysica Academiae Scientiarum Hungaricae, V2, P455; PIPOLY GM, 1979, J CLIN INVEST, V63, P1066, DOI 10.1172/JCI109376; PRENTKI M, 1986, FEBS LETT, V197, P285, DOI 10.1016/0014-5793(86)80343-X; RANIERIRAGGI M, 1980, BIOCHEM J, V189, P367, DOI 10.1042/bj1890367; RUNDELL KW, 1992, AM J PHYSIOL, V263, pC287, DOI 10.1152/ajpcell.1992.263.2.C287; RUNDELL KW, 1992, AM J PHYSIOL, V263, pC294, DOI 10.1152/ajpcell.1992.263.2.C294; SABINA RL, 1984, J CLIN INVEST, V73, P720, DOI 10.1172/JCI111265; SABINA RL, 1992, NEUROLOGY, V42, P170, DOI 10.1212/WNL.42.1.170; SABINA RL, 1990, J BIOL CHEM, V265, P9423; SABINA RL, 1987, J BIOL CHEM, V262, P12397; SAKANE F, 1991, J BIOL CHEM, V266, P7096; SARKADI B, 1992, J BIOL CHEM, V267, P4854; SCHACHT J, 1976, J NEUROCHEM, V27, P1119, DOI 10.1111/j.1471-4159.1976.tb00318.x; SCHACHT J, 1978, J LIPID RES, V19, P1063; Sermsuvitayawong K, 1997, MAMM GENOME, V8, P767, DOI 10.1007/s003359900562; Sims B, 1999, J BIOL CHEM, V274, P25701, DOI 10.1074/jbc.274.36.25701; SINKELER SPT, 1987, CLIN SCI, V72, P475, DOI 10.1042/cs0720475; STANKIEWICZ A, 1981, INT J BIOCHEM, V13, P1177, DOI 10.1016/0020-711X(81)90211-1; Steck T L, 1974, Methods Enzymol, V31, P172; SWAIN JL, 1982, AM J PHYSIOL, V242, P818; Tanfani F, 1998, MOL GENET METAB, V65, P51, DOI 10.1006/mgme.1998.2740; TANFANI F, 1993, BIOCHEM J, V291, P921, DOI 10.1042/bj2910921; TAVENIER M, 1995, BBA-GEN SUBJECTS, V1244, P351, DOI 10.1016/0304-4165(95)98595-C; VANDENBERGH F, 1995, BIOCHEM J, V312, P401, DOI 10.1042/bj3120401; VONKUPPEVELT TH, 1994, J HISTOCHEM CYTOCHEM, V42, P861; WOZNIAK M, 1988, BIOCHEM J, V255, P977; YAMADA Y, 1992, BIOCHIM BIOPHYS ACTA, V1171, P125, DOI 10.1016/0167-4781(92)90153-Q; YUN SL, 1978, J BIOL CHEM, V253, P404	54	8	10	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					42654	42662		10.1074/jbc.M203473200	http://dx.doi.org/10.1074/jbc.M203473200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12213808	hybrid			2022-12-27	WOS:000179081200030
J	Thomas, JL; Mason, JI; Brandt, S; Spencer, BR; Norris, W				Thomas, JL; Mason, JI; Brandt, S; Spencer, BR; Norris, W			Structure/function relationships responsible for the kinetic differences between human type 1 and type 2 3 beta-hydroxysteroid dehydrogenase and for the catalysis of the type 1 activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLACENTAL 3-BETA-HYDROXY-5-ENE-STEROID DEHYDROGENASE; RADIOLABELING IDENTIFIES PEPTIDES; SITE-DIRECTED MUTAGENESIS; CANCER CELL-LINES; 3-ALPHA-HYDROXYSTEROID DEHYDROGENASE; STEROID 5->4-ENE-ISOMERASE; EPITHELIAL-CELLS; ISOMERASE; EXPRESSION; PURIFICATION	Two distinct genes encode the 93% homologous type 1 (placenta, peripheral tissues) and type 2 (adrenals, gonads) 3beta-hydroxysteroid dehydrogenase/isomerase (3beta-HSD/isomerase) in humans. Mutagenesis studies using the type 1 enzyme have produced the Y154F and K158Q mutant enzymes in the Y-154-P-H-156-S-K-158 motif as well as the Y269S and K273Q mutants from a second Motif, Y-269-T-L-S-K-273, both of which are present in the primary structure of the human type I 3beta-HSD/isomerase. In addition, the H156Y mutant of the type 1 enzyme has created a chimera of the type 2 enzyme Motif (Y-154-P-Y-156-S-K-158) in the type 1 enzyme. The mutant and wild-type enzymes have been expressed and purified. The K. value of dehydroepiandrosterone is 13-fold greater, and the maximal turnover rate (K-cat) is 2-fold greater for wild-type 2 3beta-HSD compared with the wild-type 1 3beta-HSD activity. The H156Y mutant of the type 1 enzyme has substrate kinetic constants for 3beta-HSD activity that are very similar to those of the wild-type 2 enzyme. Dixon analysis shows that epostane inhibits the 3beta-HSD activity of the wildtype 1 enzyme with 14-17-fold greater affinity compared with the wild-type 2 and H156Y enzymes. The Y154F and K158Q mutants exhibit no 3beta-HSD activity, have substantial isomerase activity, and utilize substrate with K-m values similar to those of wild-type 1 isomerase. The Y269S and K273Q mutants have low, pH-dependent 3beta-HSD activity, exhibit only 5% of the maximal isomerase activity, and utilize the isomerase substrate very poorly. From these studies, a structural basis for the profound differences in the substrate and inhibition kinetics of the wildtype 1 and 2 3beta-HSD, plus a catalytic role for the Tyr(154) and Lys(158) residues in the 3beta-HSD reaction have been identified. These advances in our understanding of the structure/function of human type 1 and 2 3beta-HSD/isomerase may lead to the design of selective inhibitors of the type 1 enzyme not only in placenta to control the onset of labor but also in hormone-sensitive breast, prostate, and choriocarcinoma tumors to slow their growth.	Mercer Univ, Sch Med, Div Basic Med Sci, Macon, GA 31207 USA; Univ Edinburgh, Dept Reprod & Dev Sci Clin Biochem, Sch Med, Edinburgh EH16 4SB, Midlothian, Scotland	Mercer University; University of Edinburgh	Thomas, JL (corresponding author), Mercer Univ, Sch Med, Div Basic Med Sci, 1550 Coll St, Macon, GA 31207 USA.	Thomas_J@Mercer.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD020055] Funding Source: NIH RePORTER; NICHD NIH HHS [HD20055, R01 HD020055] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHEN Z, 1993, BIOCHEMISTRY-US, V32, P3342, DOI 10.1021/bi00064a017; GELDOF AA, 1995, ANTICANCER RES, V15, P1349; Gingras S, 1999, MOL ENDOCRINOL, V13, P66, DOI 10.1210/me.13.1.66; Gingras S, 1999, ENDOCRINOLOGY, V140, P4573, DOI 10.1210/en.140.10.4573; Jiang SW, 1997, DNA CELL BIOL, V16, P969, DOI 10.1089/dna.1997.16.969; KACSOH B, 2000, ENDOCRINE PHYSL, P566; Labrie F, 1997, STEROIDS, V62, P148, DOI 10.1016/S0039-128X(96)00174-2; Liao DJ, 2002, J STEROID BIOCHEM, V80, P175, DOI 10.1016/S0960-0760(01)00185-6; Mason JI, 1998, ENDOCR RES, V24, P549, DOI 10.3109/07435809809032644; MILEWICH L, 1993, J STEROID BIOCHEM, V45, P525, DOI 10.1016/0960-0760(93)90169-W; NASH WE, 1994, J STEROID BIOCHEM, V50, P235, DOI 10.1016/0960-0760(94)90127-9; Penning TM, 1997, STEROIDS, V62, P101, DOI 10.1016/S0039-128X(96)00167-5; Puranen T, 1997, MOL ENDOCRINOL, V11, P77, DOI 10.1210/me.11.1.77; Rainey WE, 2002, TRENDS ENDOCRIN MET, V13, P234, DOI 10.1016/S1043-2760(02)00609-4; RHEAUME E, 1991, MOL ENDOCRINOL, V5, P1147, DOI 10.1210/mend-5-8-1147; Schlegel BP, 1998, BIOCHEMISTRY-US, V37, P3538, DOI 10.1021/bi9723055; SEGEL IH, 1975, ENZYME KINETICS, P109; Tanabe T, 1998, J BIOCHEM, V124, P634, DOI 10.1093/oxfordjournals.jbchem.a022159; THE VL, 1989, MOL ENDOCRINOL, V3, P1310, DOI 10.1210/mend-3-8-1310; THOMAS JL, 1988, J STEROID BIOCHEM, V31, P785, DOI 10.1016/0022-4731(88)90287-7; Thomas JL, 1998, J STEROID BIOCHEM, V66, P327, DOI 10.1016/S0960-0760(98)00058-2; THOMAS JL, 1993, J BIOL CHEM, V268, P18507; THOMAS JL, 1989, J STEROID BIOCHEM, V33, P209, DOI 10.1016/0022-4731(89)90296-3; Thomas JL, 1997, BIOCHEMISTRY-US, V36, P9029, DOI 10.1021/bi9710378; THOMAS JL, 1994, J SOC GYNECOL INVEST, V1, P155, DOI 10.1177/107155769400100211; THOMAS JL, 1995, J BIOL CHEM, V270, P21003, DOI 10.1074/jbc.270.36.21003; Thomas JL, 2001, J MOL ENDOCRINOL, V27, P77, DOI 10.1677/jme.0.0270077	28	64	66	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					42795	42801		10.1074/jbc.M208537200	http://dx.doi.org/10.1074/jbc.M208537200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12205101	hybrid			2022-12-27	WOS:000179081200050
J	Barnakov, AN; Barnakova, LA; Hazelbauer, GL				Barnakov, AN; Barnakova, LA; Hazelbauer, GL			Allosteric enhancement of adaptational demethylation by a carboxyl-terminal sequence on chemoreceptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-ABUNDANCE CHEMORECEPTOR; BACTERIAL CHEMOTAXIS; ESCHERICHIA-COLI; SIGNAL-TRANSDUCTION; SENSORY TRANSDUCER; REGULATORY DOMAIN; COVALENT MODIFICATION; METHYLESTERASE CHEB; DOCKING SITE; GENE-PRODUCT	Sensory adaptation in bacterial chemotaxis is mediated by covalent modification of chemoreceptors. Specific glutamyl residues are methylated and demethylated in reactions catalyzed by methyltransferase CheR and methylesterase CheB. In Escherichia coli and Salmonella enterica serovar typhimurium, efficient adaptational modification by either enzyme is dependent on a conserved pentapeptide sequence at the chemoreceptor carboxyl terminus, a position distant from the sites of modification. For CheR-catalyzed methylation, previous work demonstrated that this sequence acts as a high affinity docking site, enhancing methylation by increasing enzyme concentration near methyl-accepting glutamates. We investigated pentapeptide-mediated enhancement of CheB-catalyzed demethylation and found it occurred by a distinctly different mechanism. Assays of binding between CheB and the pentapeptide sequence showed that it was too weak to have a significant effect on local enzyme concentration. Kinetic analyses revealed that interaction of the sequence and the methylesterase enhanced the rate constant of demethylation not the Michaelis constant. This allosteric activation occurred if the sequence was attached to chemoreceptor, but hardly at all if it was present as an isolated peptide. In addition, free peptide inhibited demethylation of the native receptor carrying the pentapeptide sequence at its carboxyl terminus. These observations imply that the allosteric change is transmitted through the protein substrate, not the enzyme.	Washington State Univ, Pullman, WA 99164 USA; Univ Missouri, Dept Biochem, Columbia, MO 65211 USA	Washington State University; University of Missouri System; University of Missouri Columbia	Hazelbauer, GL (corresponding author), Washington State Univ, Pullman, WA 99164 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029963, R37GM029963] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM29963] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anand GS, 1998, BIOCHEMISTRY-US, V37, P14038, DOI 10.1021/bi980865d; Anand GS, 2002, BIOCHEMISTRY-US, V41, P6752, DOI 10.1021/bi012102n; BARAK R, 1992, BIOCHEMISTRY-US, V31, P1821, DOI 10.1021/bi00121a034; Barnakov AN, 1998, J BACTERIOL, V180, P6713, DOI 10.1128/JB.180.24.6713-6718.1998; Barnakov AN, 1999, P NATL ACAD SCI USA, V96, P10667, DOI 10.1073/pnas.96.19.10667; Barnakov AN, 2001, J BIOL CHEM, V276, P32984, DOI 10.1074/jbc.M105925200; BORCZUK A, 1986, BIOCHEM BIOPH RES CO, V141, P918, DOI 10.1016/S0006-291X(86)80130-9; BORKOVICH KA, 1992, P NATL ACAD SCI USA, V89, P6756, DOI 10.1073/pnas.89.15.6756; BORKOVICH KA, 1989, P NATL ACAD SCI USA, V86, P1208, DOI 10.1073/pnas.86.4.1208; CLARKE S, 1979, J BIOL CHEM, V254, P9695; Djordjevic S, 1998, P NATL ACAD SCI USA, V95, P1381, DOI 10.1073/pnas.95.4.1381; Falke JJ, 2001, TRENDS BIOCHEM SCI, V26, P257, DOI 10.1016/S0968-0004(00)01770-9; Falke JJ, 1997, ANNU REV CELL DEV BI, V13, P457, DOI 10.1146/annurev.cellbio.13.1.457; Feng XH, 1999, J BACTERIOL, V181, P3164, DOI 10.1128/JB.181.10.3164-3171.1999; Feng XH, 1997, J BACTERIOL, V179, P6714, DOI 10.1128/jb.179.21.6714-6720.1997; GEGNER JA, 1992, CELL, V70, P975, DOI 10.1016/0092-8674(92)90247-A; HAZELBAUER GL, 1981, J BACTERIOL, V145, P43, DOI 10.1128/JB.145.1.43-49.1981; HAZELBAUER GL, 1980, NATURE, V283, P98, DOI 10.1038/283098a0; HAZELBAUER GL, 1999, ENCY NEUROSCIENCE, P181; HESS JF, 1988, CELL, V53, P79, DOI 10.1016/0092-8674(88)90489-8; KEHRY MR, 1984, J BIOL CHEM, V259, P1828; KEHRY MR, 1983, P NATL ACAD SCI-BIOL, V80, P3599, DOI 10.1073/pnas.80.12.3599; Kim C, 2001, J MOL BIOL, V307, P119, DOI 10.1006/jmbi.2000.4389; Kim KK, 1999, NATURE, V400, P787, DOI 10.1038/23512; LeMoual H, 1997, BIOCHEMISTRY-US, V36, P13441, DOI 10.1021/bi9713207; Levin MD, 2002, BIOPHYS J, V82, P1809, DOI 10.1016/S0006-3495(02)75531-8; Li JY, 1997, BIOCHEMISTRY-US, V36, P11851, DOI 10.1021/bi971510h; LI JY, 1995, BIOCHEMISTRY-US, V34, P14626, DOI 10.1021/bi00045a003; LUPAS A, 1989, J BIOL CHEM, V264, P17337; MESIBOV R, 1973, J GEN PHYSIOL, V62, P203, DOI 10.1085/jgp.62.2.203; NOWLIN DM, 1988, PROTEINS, V3, P102, DOI 10.1002/prot.340030205; NOWLIN DM, 1987, J BIOL CHEM, V262, P6039; Okumura H, 1998, J BACTERIOL, V180, P1862, DOI 10.1128/JB.180.7.1862-1868.1998; RICE MS, 1991, J BIOL CHEM, V266, P9746; RUSSELL CB, 1989, J BACTERIOL, V171, P3609, DOI 10.1128/jb.171.7.3609-3618.1989; SEGALL JE, 1986, P NATL ACAD SCI USA, V83, P8987, DOI 10.1073/pnas.83.23.8987; SHAPIRO MJ, 1995, P NATL ACAD SCI USA, V92, P1053, DOI 10.1073/pnas.92.4.1053; SIMMS SA, 1987, J BIOL CHEM, V262, P8537; SORBER HA, 1968, HDB BIOCH; Sourjik V, 2002, P NATL ACAD SCI USA, V99, P123, DOI 10.1073/pnas.011589998; SPRINGER MS, 1979, NATURE, V280, P279, DOI 10.1038/280279a0; SPRINGER WR, 1977, P NATL ACAD SCI USA, V74, P533, DOI 10.1073/pnas.74.2.533; STOCK JB, 1978, P NATL ACAD SCI USA, V75, P3659, DOI 10.1073/pnas.75.8.3659; STOCK JB, 1981, J BIOL CHEM, V256, P826; TERWILLIGER TC, 1986, J BIOL CHEM, V261, P814; Weerasuriya S, 1998, J BACTERIOL, V180, P914, DOI 10.1128/JB.180.4.914-920.1998; WELCH M, 1993, P NATL ACAD SCI USA, V90, P8787, DOI 10.1073/pnas.90.19.8787; WEST AH, 1995, PROTEINS, V21, P345, DOI 10.1002/prot.340210407; Wu JG, 1996, BIOCHEMISTRY-US, V35, P4984, DOI 10.1021/bi9530189; YAMAMOTO K, 1990, J BACTERIOL, V172, P383, DOI 10.1128/JB.172.1.383-388.1990	50	24	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					42151	42156		10.1074/jbc.M206245200	http://dx.doi.org/10.1074/jbc.M206245200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12196531	hybrid			2022-12-27	WOS:000178985300107
J	Lu, H; Xu, TL				Lu, H; Xu, TL			The general anesthetic pentobarbital slows desensitization and deactivation of the glycine receptor in the rat spinal dorsal horn neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FROG SENSORY NEURONS; GATED ION CHANNELS; GABA(A) RECEPTORS; HIPPOCAMPAL-NEURONS; COMMISSURAL NEURONS; SYNAPTIC TRANSMISSION; IN-VITRO; CORD; ACTIVATION; BRAIN	Although many general anesthetics have been found to produce anesthetic and analgesic effects by augmenting GABA(A) receptor (GABA(A)R) function, the role of the glycine receptor (GlyR) in this process is not fully understood at the neuronal level in the spinal cord. We investigated the effects of a barbiturate general anesthetic, pentobarbital (PB), on the glycinergic miniature inhibitory postsynaptic currents (mIPSCs) and the responses to exogenously applied glycine, or taurine, a low affinity GlyR agonist, by using the whole-cell patch-clamp technique in the rat spinal dorsal horn neurons isolated using a novel mechanical method. Bath application of 30 mum PB significantly prolonged the decay time constant of the spontaneous glycinergic mIPSC without changing its amplitude and frequency. Co-application of 0.3 mm PB reduced the peak amplitude, affected the macroscopic desensitization and deactivation of the response to externally applied Gly in a concentration-dependent manner. In addition, the recovery of Gly response from desensitization was also prolonged by PB. However, PB did not change the desensitization and deactivation kinetics of the taurine-induced response. The GABA(A)R antagonist bicuculline (10 mum) did not affect the effect of PB on the Gly response. Thus, PB prolonged the spinal glycinergic mIPSCs by slowing desensitization and deactivation of GlyR. Two other structurally different intravenous anesthetics, i.e. propofol (10 mum) and etomidate (3 mum), prolonged the duration of the glycinergic mIPSC in the rat spinal dorsal horn neurons. In conclusion, on GlyR-Cl- channel complexes there may exist action site(s) of intravenous general anesthetics. GlyR and glycinergic neurotransmission may play an important role in the modulation of general anesthesia in the mammalian spinal cord.	Univ Sci & Technol China, Det Neurobiol & Biophys, Sch Life Sci, Lab Receptor Pharmacol, Hefei 230027, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS	Xu, TL (corresponding author), Univ Sci & Technol China, Det Neurobiol & Biophys, Sch Life Sci, Lab Receptor Pharmacol, POB 4, Hefei 230027, Peoples R China.	xutianle@ustc.edu.cn	Lu, Hui/K-2322-2013					AKAIKE N, 1985, J PHYSIOL-LONDON, V360, P367, DOI 10.1113/jphysiol.1985.sp015622; AKAIKE N, 1987, J PHYSIOL-LONDON, V394, P85, DOI 10.1113/jphysiol.1987.sp016861; AKAIKE N, 1990, AM J PHYSIOL, V258, pC452, DOI 10.1152/ajpcell.1990.258.3.C452; Akk G, 2000, BRIT J PHARMACOL, V130, P249, DOI 10.1038/sj.bjp.0703335; ANTOGNINI JF, 1993, ANESTHESIOLOGY, V79, P1244, DOI 10.1097/00000542-199312000-00015; Antognini JF, 1997, ANESTHESIOLOGY, V87, pA292, DOI 10.1097/00000542-199709001-00292; Antognini JF, 1998, TOXICOL LETT, V101, P51, DOI 10.1016/S0378-4274(98)00164-7; Bai DL, 1999, J NEUROSCI, V19, P10635, DOI 10.1523/JNEUROSCI.19-24-10635.1999; Beckstead MJ, 2001, J BIOL CHEM, V276, P24959, DOI 10.1074/jbc.M011627200; Belelli D, 1999, TRENDS PHARMACOL SCI, V20, P496, DOI 10.1016/S0165-6147(99)01405-4; BETZ H, 1990, NEURON, V5, P383, DOI 10.1016/0896-6273(90)90077-S; Cheng G, 2002, BRIT J PHARMACOL, V136, P673, DOI 10.1038/sj.bjp.0704760; COLLINS JG, 1995, TRENDS NEUROSCI, V18, P549, DOI 10.1016/0166-2236(95)98377-B; Dalziel JE, 1999, EUR J PHARMACOL, V385, P283, DOI 10.1016/S0014-2999(99)00710-4; Downie DL, 1996, BRIT J PHARMACOL, V118, P493, DOI 10.1111/j.1476-5381.1996.tb15430.x; Jonas P, 1998, SCIENCE, V281, P419, DOI 10.1126/science.281.5375.419; Jones MV, 1996, TRENDS NEUROSCI, V19, P96, DOI 10.1016/S0166-2236(96)80037-3; JONES MV, 1995, NEURON, V15, P181, DOI 10.1016/0896-6273(95)90075-6; Jones MV, 1998, J NEUROSCI, V18, P8590; KENDIG JJ, 1993, ANESTHESIOLOGY, V79, P1161; Krasowski MD, 1999, CELL MOL LIFE SCI, V55, P1278, DOI 10.1007/s000180050371; Lan JY, 2001, NAT NEUROSCI, V4, P382, DOI 10.1038/86028; Lei SB, 2001, J NEUROPHYSIOL, V85, P2030, DOI 10.1152/jn.2001.85.5.2030; Li XS, 2000, J NEUROSCI, V20, P899, DOI 10.1523/JNEUROSCI.20-03-00899.2000; Li Y, 2002, NEUROREPORT, V13, P223, DOI 10.1097/00001756-200202110-00010; Li YX, 1997, DEV BRAIN RES, V102, P261, DOI 10.1016/S0165-3806(97)00102-8; MACONOCHIE DJ, 1994, NEURON, V12, P61, DOI 10.1016/0896-6273(94)90152-X; ORSER BA, 1994, J NEUROSCI, V14, P7747; Pang ZP, 1998, ACTA PHARMACOL SIN, V19, P327; Rajendra S, 1997, PHARMACOL THERAPEUT, V73, P121, DOI 10.1016/S0163-7258(96)00163-5; RAMPIL IJ, 1993, ANESTHESIOLOGY, V78, P707, DOI 10.1097/00000542-199304000-00014; RAMPIL IJ, 1994, ANESTHESIOLOGY, V80, P606, DOI 10.1097/00000542-199403000-00017; Rho JM, 1996, J PHYSIOL-LONDON, V497, P509, DOI 10.1113/jphysiol.1996.sp021784; SCHMIEDEN V, 1993, SCIENCE, V262, P256, DOI 10.1126/science.8211147; Serafini R, 2000, J PHYSIOL-LONDON, V524, P649, DOI 10.1111/j.1469-7793.2000.00649.x; Shen WX, 2000, J NEUROSCI, V20, P3571, DOI 10.1523/JNEUROSCI.20-10-03571.2000; Wang ZM, 2001, J NEUROSCI, V21, P2983, DOI 10.1523/JNEUROSCI.21-09-02983.2001; WU J, 1994, BRAIN RES, V645, P303, DOI 10.1016/0006-8993(94)91664-0; Wu LJ, 2002, NEUROREPORT, V13, P977, DOI 10.1097/00001756-200205240-00016; Wu LJ, 2001, J NEUROSCI METH, V108, P199, DOI 10.1016/S0165-0270(01)00404-6; Xu TL, 1998, BRIT J PHARMACOL, V124, P779, DOI 10.1038/sj.bjp.0701896; Xu TL, 1999, J AUTONOM NERV SYST, V75, P156, DOI 10.1016/S0165-1838(98)00187-8; Xu TL, 1996, J PHYSIOL-LONDON, V496, P491, DOI 10.1113/jphysiol.1996.sp021701; Zhu WJ, 1997, J NEUROSCI, V17, P4022	44	23	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					41369	41378		10.1074/jbc.M206768200	http://dx.doi.org/10.1074/jbc.M206768200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12196533	hybrid			2022-12-27	WOS:000178985300012
J	Muroi, M; Ohnishi, T; Tanamoto, K				Muroi, M; Ohnishi, T; Tanamoto, K			Regions of the mouse CD14 molecule required for Toll-like receptor 2-and 4-mediated activation of NF-kappa B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CUTTING EDGE; LIPOPOLYSACCHARIDE LPS; CELLULAR-RESPONSES; BINDING; TLR4; MICE; IDENTIFICATION; ENDOTOXIN; MD-2; RESPONSIVENESS	Regions of mouse CD14 required for Toll-like receptor 2 (TLR2)- and TLR4-mediated activation of NF-kappaB were studied in transiently transfected 293 cells. Wild-type CD14 enhanced lipopolysaccharide (LPS)-induced NF-kappaB-dependent reporter activity in cells expressing TLR4/MD-2, and deletion of amino acid regions 35-44, 144-153, 235-243, and 270-275 impaired the TLR4-mediated activation. Unlike human CD14, mouse CD14 truncated at amino acid 151 lost the activity. Deletion of amino acids 35-44 or 235-243 also abrogated TLR2-mediated activation of NF-kappaB, whereas mutants lacking 144-153 and 270-275 retained the activity. Deletion and alanine substitution experiments revealed that amino acids 151-153 and 273-275 were required for the TLR4-mediated activation. Both deletion mutants lacking amino acids 35-44 and 235-243 and alanine substitution mutants in regions 151-153 and 273-275 were expressed on the cell surface and retained the ability to associate with TLR4. A cross-linking study with photoreactive LPS showed that the labeling intensities to CD14 mutants/TLR4/MD-2 were paralleled by the ability of CD14 mutants to increase TLR4-mediated activation. These results indicate that different regions of mouse CD14 are required for TLR4- and TLR2-mediated activation of NF-kappaB and suggest that amino acids 35- 44, 151-153, 235243, and 273-275 of mouse CD14 play an important role in LPS binding and its transfer to TLR4/MD-2.	Natl Inst Hlth Sci, Div Microbiol, Tokyo 1588501, Japan	National Institute of Health Sciences - Japan	Tanamoto, K (corresponding author), Natl Inst Hlth Sci, Div Microbiol, 1-18-1 Kamiyoga, Tokyo 1588501, Japan.	tanamoto@nihs.go.jp						Aliprantis AO, 1999, SCIENCE, V285, P736, DOI 10.1126/science.285.5428.736; Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; Correia JD, 2001, J BIOL CHEM, V276, P21129, DOI 10.1074/jbc.M009164200; Cunningham MD, 2000, J IMMUNOL, V164, P3255, DOI 10.4049/jimmunol.164.6.3255; DELUDE RL, 1995, P NATL ACAD SCI USA, V92, P9288, DOI 10.1073/pnas.92.20.9288; Dziarski R, 2001, J IMMUNOL, V166, P1938, DOI 10.4049/jimmunol.166.3.1938; Gupta D, 1996, J BIOL CHEM, V271, P23310, DOI 10.1074/jbc.271.38.23310; HAILMAN E, 1994, J EXP MED, V179, P269, DOI 10.1084/jem.179.1.269; Hatada EN, 2000, CURR OPIN IMMUNOL, V12, P52, DOI 10.1016/S0952-7915(99)00050-3; Heine H, 1999, J IMMUNOL, V162, P6971; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; Hoshino K, 1999, J IMMUNOL, V162, P3749; Jiang QQ, 2000, J IMMUNOL, V165, P3541, DOI 10.4049/jimmunol.165.7.3541; JUAN TSC, 1995, J BIOL CHEM, V270, P1382, DOI 10.1074/jbc.270.3.1382; JUAN TSC, 1995, J BIOL CHEM, V270, P17237, DOI 10.1074/jbc.270.29.17237; JUAN TSC, 1995, J BIOL CHEM, V270, P5219, DOI 10.1074/jbc.270.10.5219; Kirschning CJ, 1998, J EXP MED, V188, P2091, DOI 10.1084/jem.188.11.2091; LEE JD, 1993, P NATL ACAD SCI USA, V90, P9930, DOI 10.1073/pnas.90.21.9930; Lien E, 1999, J BIOL CHEM, V274, P33419, DOI 10.1074/jbc.274.47.33419; Means TK, 1999, J IMMUNOL, V163, P6748; MUROI M, 1995, J ENDOTOXIN RES, V2, P337, DOI 10.1177/096805199500200504; Muzio M, 1998, J EXP MED, V187, P2097, DOI 10.1084/jem.187.12.2097; Ohnishi T, 2001, J IMMUNOL, V167, P3354, DOI 10.4049/jimmunol.167.6.3354; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Qureshi ST, 1999, J EXP MED, V189, P615, DOI 10.1084/jem.189.4.615; Schletter J, 1995, ARCH MICROBIOL, V164, P383, DOI 10.1007/BF02529735; Schwandner R, 1999, J BIOL CHEM, V274, P17406, DOI 10.1074/jbc.274.25.17406; Shapiro RA, 1997, INFECT IMMUN, V65, P293, DOI 10.1128/IAI.65.1.293-297.1997; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Stelter F, 1997, EUR J BIOCHEM, V243, P100, DOI 10.1111/j.1432-1033.1997.00100.x; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Tanamoto K, 2000, J IMMUNOL, V164, P3149, DOI 10.4049/jimmunol.164.6.3149; Tapping RI, 2000, J IMMUNOL, V165, P5780, DOI 10.4049/jimmunol.165.10.5780; ULEVITCH RJ, 1995, ANNU REV IMMUNOL, V13, P437, DOI 10.1146/annurev.iy.13.040195.002253; ULMER AJ, 1990, ENDOTOXIN HLTH DIS, P463; Viriyakosol S, 2000, J BIOL CHEM, V275, P3144, DOI 10.1074/jbc.275.5.3144; VIRIYAKOSOL S, 1995, J BIOL CHEM, V270, P361, DOI 10.1074/jbc.270.1.361; Viriyakosol S, 1996, INFECT IMMUN, V64, P653, DOI 10.1128/IAI.64.2.653-656.1996; Vogel SN, 1999, J IMMUNOL, V162, P5666; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Yang RB, 1998, NATURE, V395, P284, DOI 10.1038/26239	41	67	71	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					42372	42379		10.1074/jbc.M205966200	http://dx.doi.org/10.1074/jbc.M205966200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12196527	hybrid			2022-12-27	WOS:000178985300134
J	Donovan, N; Becker, EBE; Konishi, Y; Bonni, A				Donovan, N; Becker, EBE; Konishi, Y; Bonni, A			JNK phosphorylation and activation of BAD couples the stress-activated signaling pathway to the cell death machinery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL KINASE; C-JUN; INDUCED APOPTOSIS; BCL-2 FAMILY; NEURONAL APOPTOSIS; PROTEIN-KINASES; SURVIVAL SIGNAL; MAP KINASES; AGONIST BAD; MITOCHONDRIA	The c-Jun N-terminal kinase (JNK) signaling pathway plays a critical role in mediating apoptosis in the developing and mature organism. The JNK signaling pathway is thought to induce apoptosis via transcription-dependent and transcription-independent mechanisms that remain to be elucidated. In this study, we report a novel mechanism by which the JNK signaling pathway directly activates a component of the cell death machinery. We have found that JNK catalyzes the phosphorylation of the BH3-only protein BAD at the distinct site of serine 128 in vitro. Activation of the JNK signaling pathway induces the BAD serine 128 phosphorylation in vivo, including in primary granule neurons of the developing rat cerebellum. The JNK-induced BAD serine 128 phosphorylation promotes the apoptotic effect of BAD in primary neurons by antagonizing the ability of growth factors to inhibit BAD-mediated apoptosis. These findings indicate that BAD is a novel substrate of JNK that links the stress-activated signaling pathway to the cell death machinery.	Harvard Univ, Sch Med, Program Biol & Biomed Sci, Dept Pathol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Bonni, A (corresponding author), Harvard Univ, Sch Med, Program Biol & Biomed Sci, Dept Pathol, Boston, MA 02115 USA.			Becker, Esther B E/0000-0002-5238-4902	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041021] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS 41021-01] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Behrens A, 1999, NAT GENET, V21, P326, DOI 10.1038/6854; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Blume-Jensen P, 1998, CURR BIOL, V8, P779, DOI 10.1016/S0960-9822(98)70302-1; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Chao DT, 1998, ANNU REV IMMUNOL, V16, P395, DOI 10.1146/annurev.immunol.16.1.395; Choi DW, 1996, CURR OPIN NEUROBIOL, V6, P667, DOI 10.1016/S0959-4388(96)80101-2; Cotman CW, 1998, NEUROBIOL AGING, V19, pS29, DOI 10.1016/S0197-4580(98)00042-6; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; DEL PL, 1997, SCIENCE, V278, P687; ESTUS S, 1994, J CELL BIOL, V127, P1717, DOI 10.1083/jcb.127.6.1717; Fan MY, 2000, J BIOL CHEM, V275, P29980, DOI 10.1074/jbc.M003776200; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Harada H, 2001, P NATL ACAD SCI USA, V98, P9666, DOI 10.1073/pnas.171301998; Harada H, 1999, MOL CELL, V3, P413, DOI 10.1016/S1097-2765(00)80469-4; Huang DCS, 2000, CELL, V103, P839, DOI 10.1016/S0092-8674(00)00187-2; Ito T, 1997, J BIOL CHEM, V272, P11671, DOI 10.1074/jbc.272.18.11671; Konishi Y, 2002, MOL CELL, V9, P1005, DOI 10.1016/S1097-2765(02)00524-5; Kuan CY, 1999, NEURON, V22, P667, DOI 10.1016/S0896-6273(00)80727-8; Le-Niculescu H, 1999, MOL CELL BIOL, V19, P751; Lewin GR, 1996, ANNU REV NEUROSCI, V19, P289, DOI 10.1146/annurev.ne.19.030196.001445; LOWENSTEIN DH, 1991, EPILEPSY RES, V10, P49, DOI 10.1016/0920-1211(91)90094-V; Maundrell K, 1997, J BIOL CHEM, V272, P25238, DOI 10.1074/jbc.272.40.25238; Reed J C, 1997, Adv Pharmacol, V41, P501, DOI 10.1016/S1054-3589(08)61070-4; Sabapathy K, 1999, MECH DEVELOP, V89, P115, DOI 10.1016/S0925-4773(99)00213-0; Schurmann A, 2000, MOL CELL BIOL, V20, P453, DOI 10.1128/MCB.20.2.453-461.2000; See RH, 2001, J BIOL CHEM, V276, P16310, DOI 10.1074/jbc.M008113200; Shimamura A, 2000, CURR BIOL, V10, P127, DOI 10.1016/S0960-9822(00)00310-9; Srivastava RK, 1999, P NATL ACAD SCI USA, V96, P3775, DOI 10.1073/pnas.96.7.3775; Stemmann O, 2001, CELL, V107, P715, DOI 10.1016/S0092-8674(01)00603-1; Tan Y, 1999, J BIOL CHEM, V274, P34859, DOI 10.1074/jbc.274.49.34859; THOMPSON CB, 1995, SCIENCE, V267; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; Watson A, 1998, J NEUROSCI, V18, P751; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yamamoto K, 1999, MOL CELL BIOL, V19, P8469; Yang DD, 1997, NATURE, V389, P865, DOI 10.1038/39899; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3	40	197	199	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 25	2002	277	43					40944	40949		10.1074/jbc.M206113200	http://dx.doi.org/10.1074/jbc.M206113200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	607KU	12189144	hybrid			2022-12-27	WOS:000178791400101
J	Muscat, GEO; Wagner, BL; Hou, JZ; Tangirala, RK; Bischoff, ED; Rohde, P; Petrowski, M; Li, JL; Shao, G; Macondray, G; Schulman, IG				Muscat, GEO; Wagner, BL; Hou, JZ; Tangirala, RK; Bischoff, ED; Rohde, P; Petrowski, M; Li, JL; Shao, G; Macondray, G; Schulman, IG			Regulation of cholesterol homeostasis and lipid metabolism in skeletal muscle by liver X receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TANGIER-DISEASE; GENE-EXPRESSION; DIETARY-CHOLESTEROL; LXR; EFFLUX; ABCA1; ATHEROSCLEROSIS; MUTATIONS; ALPHA; IDENTIFICATION	Recent studies have identified the liver X receptors (LXRalpha and LXRbeta) as important regulators of cholesterol and lipid metabolism. Although originally identified as liver-enriched transcription factors, LXRs are also expressed in skeletal muscle, a tissue that accounts for similar to40% of human total body weight and is the major site of glucose utilization and fatty acid oxidation. Nevertheless, no studies have yet addressed the functional role of LXRs in muscle. In this work we utilize a combination of in vivo and in vitro analysis to demonstrate that LXRs can functionally regulate genes involved in cholesterol metabolism in skeletal muscle. Furthermore we show that treatment of muscle cells in vitro with synthetic agonists of LXR increases the efflux of intracellular cholesterol to extracellular acceptors such as high density lipoprotein, thus identifying this tissue as a potential important regulator of reverse cholesterol transport and high density lipoprotein levels. Additionally we demonstrate that LXRa and a subset of LXR target genes are induced during myogenesis, suggesting a role for LXR-dependent signaling in the differentiation process.	X Ceptor Therapeut Inc, San Diego, CA 92121 USA; Univ Queensland, Ritchie Res Labs, Ctr Cellular & Mol Biol, Inst Mol Biosci, St Lucia, Qld 4072, Australia	University of Queensland	Muscat, GEO (corresponding author), X Ceptor Therapeut Inc, San Diego, CA 92121 USA.	g.muscat@imb.uq.edu.au; ischulman@x-ceptor.com	Muscat, George/A-6401-2017	Muscat, George/0000-0002-5829-5695				Attie AD, 2001, J LIPID RES, V42, P1717; BAINS W, 1984, MOL CELL BIOL, V4, P1449, DOI 10.1128/MCB.4.8.1449; Berge KE, 2000, SCIENCE, V290, P1771, DOI 10.1126/science.290.5497.1771; Bodzioch M, 1999, NAT GENET, V22, P347, DOI 10.1038/11914; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; Chawla A, 2001, MOL CELL, V7, P161, DOI 10.1016/S1097-2765(01)00164-2; Costet P, 2000, J BIOL CHEM, V275, P28240; Ducluzeau PH, 2001, DIABETES, V50, P1134, DOI 10.2337/diabetes.50.5.1134; Edwards PA, 2002, J LIPID RES, V43, P2; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; Hayden MR, 2000, CURR OPIN LIPIDOL, V11, P117, DOI 10.1097/00041433-200004000-00003; Hobbs HH, 1999, J CLIN INVEST, V104, P1015, DOI 10.1172/JCI8509; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; Joseph SB, 2002, J BIOL CHEM, V277, P11019, DOI 10.1074/jbc.M111041200; Joyce CW, 2002, P NATL ACAD SCI USA, V99, P407, DOI 10.1073/pnas.012587699; Kelley DE, 2001, DIABETES CARE, V24, P933, DOI 10.2337/diacare.24.5.933; Kohro T, 2000, J Atheroscler Thromb, V7, P145; Kraegen EW, 2001, EXP CLIN ENDOCR DIAB, V109, pS516; Laffitte BA, 2001, MOL CELL BIOL, V21, P7558, DOI 10.1128/MCB.21.22.7558-7568.2001; Laffitte BA, 2001, P NATL ACAD SCI USA, V98, P507, DOI 10.1073/pnas.021488798; Lawn RM, 1999, J CLIN INVEST, V104, pR25, DOI 10.1172/JCI8119; Lee MH, 2001, NAT GENET, V27, P79, DOI 10.1038/83799; Li AC, 2000, J CLIN INVEST, V106, P523, DOI 10.1172/JCI10370; Oliver WR, 2001, P NATL ACAD SCI USA, V98, P5306, DOI 10.1073/pnas.091021198; Oram JF, 2001, J LIPID RES, V42, P1173; Ou JF, 2001, P NATL ACAD SCI USA, V98, P6027, DOI 10.1073/pnas.111138698; Peet DJ, 1998, CELL, V93, P693, DOI 10.1016/S0092-8674(00)81432-4; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Repa JJ, 2000, SCIENCE, V289, P1524, DOI 10.1126/science.289.5484.1524; Rust S, 1999, NAT GENET, V22, P352, DOI 10.1038/11921; Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400; Schwartz K, 2000, BIOCHEM BIOPH RES CO, V274, P794, DOI 10.1006/bbrc.2000.3243; Tall AR, 2000, J CLIN INVEST, V106, P1205, DOI 10.1172/JCI11538; Vaisman BL, 2001, J CLIN INVEST, V108, P303; Venkateswaran A, 2000, P NATL ACAD SCI USA, V97, P12097, DOI 10.1073/pnas.200367697; Whitney KD, 2001, J BIOL CHEM, V276, P43509, DOI 10.1074/jbc.M106155200; Yoshikawa T, 2001, MOL CELL BIOL, V21, P2991, DOI 10.1128/MCB.21.9.2991-3000.2001	38	81	86	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2002	277	43					40722	40728		10.1074/jbc.M206681200	http://dx.doi.org/10.1074/jbc.M206681200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	607KU	12193599	hybrid			2022-12-27	WOS:000178791400073
J	Virkki, LV; Franke, C; Somieski, P; Boron, WF				Virkki, LV; Franke, C; Somieski, P; Boron, WF			Cloning and functional characterization of a novel aquaporin from Xenopus laevis oocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; NEUTRAL SOLUTE CHANNEL; MOLECULAR CHARACTERIZATION; WATER CHANNEL; TRANSPORT; EXPRESSION; GLYCEROL; LENS; MIP; PERMEABILITY	We have cloned a novel aquaporin (AQP) from Xenopus laevis oocytes, which we have provisionally named AQPxlo. The predicted protein showed highest homology (39-50%) to aquaglyceroporins. Northern blot analysis showed strong hybridization to an similar to1.4-kb transcript in X. laevis fat body and oocytes, whereas a weaker signal was obtained in kidney. We injected in vitro transcribed cRNA encoding AQPxlo into Xenopus oocytes for functional characterization. AQPxlo expression increased osmotic water permeability (P-f), as well as the uptake of glycerol and urea. However, AQPxlo excluded larger polyols and thiourea. An alkaline extracellular pH (pH(o)) increased P-f and to a lesser extent urea uptake but not glycerol uptake. Remarkably, low HgCl2, concentrations (0.3-10 mum) reduced P-f and urea uptake, whereas high concentrations (300-1000 mum) reversed the inhibition. We propose that AQPxlo is a new AQP paralogue unknown in mammals.	Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA	Yale University	Virkki, LV (corresponding author), Yale Univ, Sch Med, Dept Cellular & Mol Physiol, 333 Cedar St,POB 208026, New Haven, CT 06520 USA.		Boron, Walter/ABI-1564-2020	Boron, Walter/0000-0003-4741-7287				Chandy G, 1997, J MEMBRANE BIOL, V159, P29, DOI 10.1007/s002329900266; Estevez R, 1998, FASEB J, V12, P1319, DOI 10.1096/fasebj.12.13.1319; Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481; Ishibashi K, 2002, BBA-GENE STRUCT EXPR, V1576, P335, DOI 10.1016/S0167-4781(02)00393-7; Ishibashi K, 1997, J BIOL CHEM, V272, P20782, DOI 10.1074/jbc.272.33.20782; KARNISKI LP, 1992, J BIOL CHEM, V267, P19218; KUSHMERICK C, 1995, EXP EYE RES, V61, P351, DOI 10.1016/S0014-4835(05)80129-0; Kushmerick C, 1998, J MEMBRANE BIOL, V161, P9, DOI 10.1007/s002329900310; Nemeth-Cahalan KL, 2000, J BIOL CHEM, V275, P6777, DOI 10.1074/jbc.275.10.6777; Palacin M, 2001, CURR OPIN GENET DEV, V11, P328, DOI 10.1016/S0959-437X(00)00198-2; PRESTON GM, 1993, J BIOL CHEM, V268, P17; Romero MF, 1997, NATURE, V387, P409, DOI 10.1038/387409a0; Romero MF, 1998, AM J PHYSIOL-RENAL, V274, pF425, DOI 10.1152/ajprenal.1998.274.2.F425; Schreiber R, 1997, PFLUG ARCH EUR J PHY, V434, P841, DOI 10.1007/s004240050473; Schreiber R, 2000, FEBS LETT, V475, P291, DOI 10.1016/S0014-5793(00)01689-6; SIEBENS AW, 1987, J GEN PHYSIOL, V90, P799, DOI 10.1085/jgp.90.6.799; Tsukaguchi H, 1998, J BIOL CHEM, V273, P24737, DOI 10.1074/jbc.273.38.24737; Tsukaguchi H, 1999, AM J PHYSIOL-RENAL, V277, pF685, DOI 10.1152/ajprenal.1999.277.5.F685; TZOUNOPOULOS T, 1995, BIOPHYS J, V69, P904, DOI 10.1016/S0006-3495(95)79964-7; Varadaraj K, 1999, J MEMBRANE BIOL, V170, P191, DOI 10.1007/s002329900549; Virkki LV, 2002, AM J PHYSIOL-CELL PH, V282, pC1278, DOI 10.1152/ajpcell.00589.2001; Virkki LV, 2001, AM J PHYSIOL-REG I, V281, pR1994, DOI 10.1152/ajpregu.2001.281.6.R1994; Weber WM, 1999, J MEMBRANE BIOL, V170, P1, DOI 10.1007/s002329900532; Yasui M, 1999, NATURE, V402, P184, DOI 10.1038/46045; Zeuthen T, 1999, J BIOL CHEM, V274, P21631, DOI 10.1074/jbc.274.31.21631; ZHANG R, 1990, J BIOL CHEM, V265, P15375	26	39	43	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 25	2002	277	43					40610	40616		10.1074/jbc.M206157200	http://dx.doi.org/10.1074/jbc.M206157200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	607KU	12192003	hybrid			2022-12-27	WOS:000178791400059
J	Borza, DB; Bondar, O; Todd, P; Sundaramoorthy, M; Sado, Y; Ninomiya, Y; Hudson, BG				Borza, DB; Bondar, O; Todd, P; Sundaramoorthy, M; Sado, Y; Ninomiya, Y; Hudson, BG			Quaternary organization of the goodpasture autoantigen, the alpha 3(IV) collagen chain - Sequestration of two cryptic autoepitopes by intraprotomer interactions with the alpha 4 and alpha 5 NC1 domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASEMENT-MEMBRANE COLLAGEN; LINKED ALPORT SYNDROME; IV COLLAGEN; DIFFERENTIAL EXPRESSION; NONCOLLAGENOUS DOMAIN; MONOCLONAL-ANTIBODIES; IDENTIFICATION; NETWORK; ANTIGEN; EPITOPE	Goodpasture's (GP) disease is caused by autoantibodies that target the alpha3(IV) collagen chain in the glomerular basement membrane (GBM). Goodpasture autoantibodies bind two conformational epitopes (E-A and E-B) located within the non-collagenous (NC1) domain of this chain, which are sequestered within the NC1 hexamer of the type IV collagen network containing the alpha3(IV), alpha4(IV)l and alpha5(IV) chains. In this study, the quaternary organization of these chains and the molecular basis for the sequestration of the epitopes were investigated. This was accomplished by physicochemical and immunochemical characterization of the NC1 hexamers using chain-specific antibodies. The hexamers were found to have a molecular composition of (alpha3)(2)(alpha4)(2)(alpha5)(2) and to contain cross-linked alpha3-alpha5 heterodimers and alpha4-alpha4 homodimers. Together with association studies of individual NC1 domains, these findings indicate that the alpha3, alpha4, and alpha5 chains occur together in the same triple-helical protomer. In the GBM, this protomer dimerizes through NC1-NC1 domain interactions such that the alpha3, alpha4, and alpha5 chains of one protomer connect with the alpha5, alpha4, and alpha3 chains of the opposite protomer, respectively. The immunodominant Goodpasture autoepitope, located within the E-A region, is sequestered within the alpha3alpha4alpha5 protomer near the triple-helical junction, at the interface between the alpha3NC1 and alpha5NC1 domains, whereas the E-B epitope is sequestered at the interface between the alpha3NC1 and alpha4NC1 domains. The results also reveal the network distribution of the six chains of collagen IV in the renal glomerulus and provide a molecular explanation for the absence of the alpha3, alpha4, alpha5, and alpha6 chains in Alport syndrome.	Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN 37232 USA; Shigei Med Res Inst, Div Immunol, Okayama 701, Japan; Okayama Univ, Sch Med, Dept Mol Biol & Biochem, Okayama 700, Japan	Vanderbilt University; Okayama University	Borza, DB (corresponding author), Vanderbilt Univ, Med Ctr, Dept Med, 221 Kirkland Hall, Nashville, TN 37232 USA.		Borza, Dorin-Bogdan/AAF-2156-2020	Borza, Dorin-Bogdan/0000-0003-4568-279X; Hudson, Billy/0000-0002-5420-4100	NIDDK NIH HHS [P01 DK53763, R37 DK18381, R01 DK63925] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK053763, R37DK018381] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Borza DB, 2000, J BIOL CHEM, V275, P6030, DOI 10.1074/jbc.275.8.6030; Borza DB, 2001, J BIOL CHEM, V276, P28532, DOI 10.1074/jbc.M103690200; Boutaud A, 2000, J BIOL CHEM, V275, P30716, DOI 10.1074/jbc.M004569200; David M, 2001, J BIOL CHEM, V276, P6370, DOI 10.1074/jbc.M008956200; DOLZ R, 1988, EUR J BIOCHEM, V178, P357, DOI 10.1111/j.1432-1033.1988.tb14458.x; GUBLER MC, 1995, KIDNEY INT, V47, P1142, DOI 10.1038/ki.1995.163; GUNWAR S, 1990, J BIOL CHEM, V265, P5466; Gunwar S, 1998, J BIOL CHEM, V273, P8767, DOI 10.1074/jbc.273.15.8767; Heidet L, 2000, AM J PATHOL, V156, P1901, DOI 10.1016/S0002-9440(10)65063-8; Hellmark T, 1999, J BIOL CHEM, V274, P25862, DOI 10.1074/jbc.274.36.25862; JOHANSSON C, 1992, J BIOL CHEM, V267, P24533; Kalluri R, 1996, J BIOL CHEM, V271, P9062, DOI 10.1074/jbc.271.15.9062; Kashtan C E, 1996, Contrib Nephrol, V117, P142; KLEPPEL MM, 1992, J BIOL CHEM, V267, P4137; LANGEVELD JPM, 1988, J BIOL CHEM, V263, P10481; Nakanishi K, 1996, J AM SOC NEPHROL, V7, P938; Netzer KO, 1999, J BIOL CHEM, V274, P11267, DOI 10.1074/jbc.274.16.11267; Netzer KO, 1998, PROTEIN SCI, V7, P1340, DOI 10.1002/pro.5560070610; NINOMIYA Y, 1995, J CELL BIOL, V130, P1219, DOI 10.1083/jcb.130.5.1219; Nomura S, 1998, Am J Kidney Dis, V31, pE4; PEISSEL B, 1995, J CLIN INVEST, V96, P1948, DOI 10.1172/JCI118241; SADO Y, 1995, HISTOCHEM CELL BIOL, V104, P267, DOI 10.1007/BF01464322; Sado Y, 1998, KIDNEY INT, V53, P664, DOI 10.1046/j.1523-1755.1998.00795.x; SAUS J, 1988, J BIOL CHEM, V263, P13374; Seki T, 1998, HISTOCHEM CELL BIOL, V110, P359, DOI 10.1007/s004180050296; Sundaramoorthy M, 2002, J BIOL CHEM, V277, P31142, DOI 10.1074/jbc.M201740200; Than ME, 2002, P NATL ACAD SCI USA, V99, P6607, DOI 10.1073/pnas.062183499; TIMONEDA J, 1990, CONNECT TISSUE RES, V24, P169, DOI 10.3109/03008209009152147; TIMPL R, 1981, EUR J BIOCHEM, V120, P203, DOI 10.1111/j.1432-1033.1981.tb05690.x; WEBER S, 1988, EUR J BIOCHEM, V175, P229, DOI 10.1111/j.1432-1033.1988.tb14188.x; WIESLANDER J, 1985, J BIOL CHEM, V260, P8564; WIESLANDER J, 1987, CLIN EXP IMMUNOL, V69, P332; WILSON CB, 2002, MOL PATHOLOGY AUTOIM, P981; YURCHENCO PD, 1984, BIOCHEMISTRY-US, V23, P1839, DOI 10.1021/bi00303a040	34	64	73	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 18	2002	277	42					40075	40083		10.1074/jbc.M207769200	http://dx.doi.org/10.1074/jbc.M207769200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	605EA	12193605	hybrid			2022-12-27	WOS:000178662500128
J	Nieswandt, B; Schulte, V; Zywietz, A; Gratacap, MP; Offermanns, S				Nieswandt, B; Schulte, V; Zywietz, A; Gratacap, MP; Offermanns, S			Costimulation of G(i)- and G(12)/G(13)-mediated signaling pathways induces integrin alpha(IIb)beta(3) activation in platelets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SHAPE CHANGE; ANTITHROMBOTIC DRUGS; INDUCED AGGREGATION; COUPLED RECEPTORS; P2Y(1) RECEPTOR; GLYCOPROTEIN-VI; G-PROTEIN; COLLAGEN; KINASE; MICE	Platelet activation is a complex process induced by a variety of stimuli, which act in concert to ensure the rapid formation of a platelet plug at places of vascular injury. We show here that fibrillar collagen, which initiates platelet activation at the damaged vessel wall, activates only a small fraction of platelets in suspension directly, whereas the majority of platelets becomes activated by mediators released from collagen-activated platelets. In Galpha(q)-deficient platelets that do not respond with activation of integrin alpha(IIb)beta(3) to a variety of mediators like thromboxane A(2) (TXA(2)), thrombin, or ADP, collagen at high concentrations was able to induce aggregation, an effect that could be blocked by antagonists of the TXA(2) or P2Y(12) receptors. The activation of TXA(2) or P2Y(12) receptors alone, which in Galpha(q)-deficient platelets couple to G(12)/G(13) and G(i), respectively, did not induce platelet integrin activation or aggregation. However, concomitant activation of both receptors resulted in irreversible integrin alpha(IIb)beta(3)-mediated aggregation of Galpha(q)-deficient platelets. Thus, the activation of G(12)/G(13)- and G(i)-mediated signaling pathways is sufficient to induce integrin alpha(IIb)beta(3) activation. Although G(q)-mediated signaling plays an important role in platelet activation, it is not strictly required for the activation of integrin alpha(IIb)beta(3). This indicates that the efficient induction of platelet aggregation through G-protein-coupled receptors is an integrated response mediated by various converging G-protein-mediated signaling pathways involving G(q) and G(i) as well as G(12)/G(13).	Univ Wurzburg, Rudolf Virchow Ctr Exptl Biomed, D-97078 Wurzburg, Germany; Univ Heidelberg, Inst Pharmacol, D-69120 Heidelberg, Germany	University of Wurzburg; Ruprecht Karls University Heidelberg	Nieswandt, B (corresponding author), Univ Wurzburg, Rudolf Virchow Ctr Exptl Biomed, Versbacher Str 9, D-97078 Wurzburg, Germany.		; Offermanns, Stefan/L-3313-2017	Gratacap, Marie-Pierre/0000-0003-4362-6401; Offermanns, Stefan/0000-0001-8676-6805				Bauer M, 1999, BLOOD, V94, P1665, DOI 10.1182/blood.V94.5.1665.417k33_1665_1672; Bergmeier W, 2002, CYTOMETRY, V48, P80, DOI 10.1002/cyto.10114; Fabre JE, 1999, NAT MED, V5, P1199, DOI 10.1038/13522; Foster CJ, 2001, J CLIN INVEST, V107, P1591, DOI 10.1172/JCI12242; Gachet C, 2001, THROMB HAEMOSTASIS, V86, P222; Hechler B, 1998, BLOOD, V92, P152, DOI 10.1182/blood.V92.1.152.413k27_152_159; HEDBERG A, 1988, J PHARMACOL EXP THER, V245, P786; Hollopeter G, 2001, NATURE, V409, P202, DOI 10.1038/35051599; Ishizaki T, 2000, MOL PHARMACOL, V57, P976; Jin JG, 1998, P NATL ACAD SCI USA, V95, P8070, DOI 10.1073/pnas.95.14.8070; Klages B, 1999, J CELL BIOL, V144, P745, DOI 10.1083/jcb.144.4.745; LANZA F, 1985, THROMB HAEMOSTASIS, V54, P402; Leon C, 1999, J CLIN INVEST, V104, P1731, DOI 10.1172/JCI8399; Nieswandt B, 2001, BLOOD, V97, P3829, DOI 10.1182/blood.V97.12.3829; Nieswandt B, 2001, EMBO J, V20, P2120, DOI 10.1093/emboj/20.9.2120; OFFERMANNS S, 1994, P NATL ACAD SCI USA, V91, P504, DOI 10.1073/pnas.91.2.504; Offermanns S, 1997, NATURE, V389, P183, DOI 10.1038/38284; Ohkubo S, 1996, BRIT J PHARMACOL, V117, P1095, DOI 10.1111/j.1476-5381.1996.tb16702.x; Ohlmann P, 2000, BLOOD, V96, P2134, DOI 10.1182/blood.V96.6.2134.h8002134_2134_2139; Paul BZS, 1999, J BIOL CHEM, V274, P29108, DOI 10.1074/jbc.274.41.29108; Paul BZS, 1999, J BIOL CHEM, V274, P28293, DOI 10.1074/jbc.274.40.28293; Savi P, 1998, FEBS LETT, V422, P291, DOI 10.1016/S0014-5793(98)00025-8; SIMPSON AWM, 1986, FEBS LETT, V201, P301, DOI 10.1016/0014-5793(86)80628-7; Watson SP, 1998, IMMUNOL TODAY, V19, P260, DOI 10.1016/S0167-5699(98)01267-5; Yang J, 2000, P NATL ACAD SCI USA, V97, P9984, DOI 10.1073/pnas.180194597	25	103	104	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 18	2002	277	42					39493	39498		10.1074/jbc.M207256200	http://dx.doi.org/10.1074/jbc.M207256200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	605EA	12183468	hybrid			2022-12-27	WOS:000178662500057
J	Steiner, H; Winkler, E; Edbauer, D; Prokop, S; Basset, G; Yamasaki, A; Kostka, M; Haass, C				Steiner, H; Winkler, E; Edbauer, D; Prokop, S; Basset, G; Yamasaki, A; Kostka, M; Haass, C			PEN-2 is an integral component of the gamma-secretase complex required for coordinated expression of presenilin and nicastrin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISEASE-ASSOCIATED PRESENILIN-1; AMYLOID PRECURSOR PROTEIN; IN-VIVO; PROTEOLYTIC FRAGMENTS; ENDOPROTEOLYSIS; DEFICIENCY; MUTATION; INHIBITORS; PROTEASES; STATE	The Alzheimer disease-associated presenilin (PS) proteins apparently provide the active site of gamma-secretase, an unusual intramembrane-cleaving aspartyl protease. PSs principally occur as high molecular weight protein complexes that contain nicastrin (Nct) and additional so far unidentified components. Recently, PEN-2 has been implicated in gamma-secretase function. Here we identify PEN-2 as a critical component of PS1/gamma-secretase and PS2/gamma-secretase complexes. Strikingly, in the absence of PS1 and PS1/PS2, PEN-2 levels are strongly reduced. Similarly, PEN-2 levels are reduced upon RNA interference-mediated down-regulation of Nct. On the other side, down-regulation of PEN-2 by RNA interference is associated with reduced PS levels, impaired Nct maturation, and deficient gamma-secretase complex formation. We conclude that PEN-2 is an integral gamma-secretase complex component and that gamma-secretase complex components are expressed in a coordinated manner.	Univ Munich, Adolf Butenandt Inst, Dept Biochem, Lab Alzheimers & Parkinsons Dis Res, D-80336 Munich, Germany; Boehringer Ingelheim Pharma KG, Dept CNS Res, D-88397 Biberach, Germany	University of Munich; Boehringer Ingelheim	Steiner, H (corresponding author), Univ Munich, Adolf Butenandt Inst, Dept Biochem, Lab Alzheimers & Parkinsons Dis Res, Schillerstr 44, D-80336 Munich, Germany.		Prokop, Stefan/Y-1257-2019; Edbauer, Dieter/M-9906-2019	Prokop, Stefan/0000-0002-5633-2149; Edbauer, Dieter/0000-0002-7186-4653				Capell A, 1998, J BIOL CHEM, V273, P3205, DOI 10.1074/jbc.273.6.3205; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Edbauer D, 2002, P NATL ACAD SCI USA, V99, P8666, DOI 10.1073/pnas.132277899; Esler WP, 2002, P NATL ACAD SCI USA, V99, P2720, DOI 10.1073/pnas.052436599; Esler WP, 2000, NAT CELL BIOL, V2, P428, DOI 10.1038/35017062; Francis R, 2002, DEV CELL, V3, P85, DOI 10.1016/S1534-5807(02)00189-2; Goutte C, 2002, P NATL ACAD SCI USA, V99, P775, DOI 10.1073/pnas.022523499; Herreman A, 2000, NAT CELL BIOL, V2, P461, DOI 10.1038/35017105; Herreman A, 1999, P NATL ACAD SCI USA, V96, P11872, DOI 10.1073/pnas.96.21.11872; Hu Y, 2002, DEV CELL, V2, P69, DOI 10.1016/S1534-5807(01)00105-8; LaPointe CF, 2000, J BIOL CHEM, V275, P1502, DOI 10.1074/jbc.275.2.1502; Leem JY, 2002, J BIOL CHEM, V277, P19236, DOI 10.1074/jbc.C200148200; Li YM, 2000, P NATL ACAD SCI USA, V97, P6138, DOI 10.1073/pnas.110126897; Li YM, 2000, NATURE, V405, P689, DOI 10.1038/35015085; Mumm JS, 2000, DEV BIOL, V228, P151, DOI 10.1006/dbio.2000.9960; Naruse S, 1998, NEURON, V21, P1213, DOI 10.1016/S0896-6273(00)80637-6; Ponting CP, 2002, HUM MOL GENET, V11, P1037, DOI 10.1093/hmg/11.9.1037; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Steiner H, 2000, NAT REV MOL CELL BIO, V1, P217, DOI 10.1038/35043065; Steiner H, 2000, NAT CELL BIOL, V2, P848, DOI 10.1038/35041097; Steiner H, 1999, BIOCHEMISTRY-US, V38, P14600, DOI 10.1021/bi9914210; Steiner H, 1999, J BIOL CHEM, V274, P7615, DOI 10.1074/jbc.274.12.7615; Steiner H, 1998, J BIOL CHEM, V273, P32322, DOI 10.1074/jbc.273.48.32322; Steiner H, 1999, J BIOL CHEM, V274, P28669, DOI 10.1074/jbc.274.40.28669; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Walter J, 1998, BIOCHEMISTRY-US, V37, P5961, DOI 10.1021/bi971763a; Walter J, 1997, P NATL ACAD SCI USA, V94, P5349, DOI 10.1073/pnas.94.10.5349; Weihofen A, 2002, SCIENCE, V296, P2215, DOI 10.1126/science.1070925; Wolfe MS, 2001, J BIOL CHEM, V276, P5413, DOI 10.1074/jbc.R000026200; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Yu G, 2000, NATURE, V407, P48, DOI 10.1038/35024009; Yu G, 1998, J BIOL CHEM, V273, P16470, DOI 10.1074/jbc.273.26.16470; Zhang ZH, 2000, NAT CELL BIOL, V2, P463, DOI 10.1038/35017108	34	240	254	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 18	2002	277	42					39062	39065		10.1074/jbc.C200469200	http://dx.doi.org/10.1074/jbc.C200469200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	605EA	12198112	hybrid			2022-12-27	WOS:000178662500002
J	Arnt, CR; Chiorean, MV; Heldebrant, MV; Gores, GJ; Kaufmann, SH				Arnt, CR; Chiorean, MV; Heldebrant, MV; Gores, GJ; Kaufmann, SH			Synthetic Smac/DIABLO peptides enhance the effects of chemotherapeutic agents by binding XIAP and cIAP1 in situ	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOPTOSIS INHIBITORY PROTEIN; CELL-DEATH; STRUCTURAL BASIS; BACULOVIRAL-INHIBITOR; ACTIVE CASPASES; CYTOCHROME-C; LINKED IAP; FAMILY; GENE; DROSOPHILA	Inhibitor of apoptosis proteins (IAPs) interact with and inhibit caspases-3, -7, and -9. This interaction can be inhibited by Smac/DIABLO, a polypeptide released from mitochondria upon initiation of the apoptotic signaling process. Here we demonstrate that the first 4-8 N-terminal amino acids of Smac/DIABLO fused to the Drosophila antennapaedia penetratin sequence, a carrier peptide, enhance the induction of apoptosis and long term antiproliferative effects of diverse antineoplastic agents including paclitaxel, etoposide, 7-ethyl-10-hydroxycamptothecin (SN-38), and doxorubicin in MCF-7 breast cancer cells. Similar effects were observed in additional breast cancer and immortalized cholangiocyte cell lines. Further analysis demonstrated that the Smac-penetratin fusion peptide crossed the cellular membrane, bound XIAP and cIAP1, displaced caspase-3 from cytoplasmic aggregates, and enhanced drug-induced caspase action in situ. These studies demonstrate that inhibition of LAP proteins can modulate the efficacy of antineoplastic agents.	Mayo Clin & Mayo Fdn, Div Oncol Res, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, GI Basic Res Ctr, Rochester, MN 55905 USA; Mayo Clin & Mayo Grad Sch Med, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN 55901 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Kaufmann, SH (corresponding author), Mayo Clin & Mayo Fdn, Div Oncol Res, 200 1st St SW,Guggenheim 1342C,200 1st St SW, Rochester, MN 55905 USA.	Kaufmann.scott@mayo.edu	Chiorean, Michael/AAZ-5305-2021	Kaufmann, Scott/0000-0002-4900-7145	NCI NIH HHS [CA73709, R01 CA069008, R01 CA69008] Funding Source: Medline; NIDDK NIH HHS [DK41876] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adrain C, 2001, EMBO J, V20, P6627, DOI 10.1093/emboj/20.23.6627; ARENDS MJ, 1991, INT REV EXP PATHOL, V32, P223; Asselin E, 2001, CANCER RES, V61, P1862; Bangs P, 2000, CELL DEATH DIFFER, V7, P1027, DOI 10.1038/sj.cdd.4400754; BIRNBAUM MJ, 1994, J VIROL, V68, P2521, DOI 10.1128/JVI.68.4.2521-2528.1994; Blagosklonny MV, 1999, INT J CANCER, V83, P151, DOI 10.1002/(SICI)1097-0215(19991008)83:2<151::AID-IJC1>3.0.CO;2-5; Brunet CL, 1998, CELL DEATH DIFFER, V5, P107, DOI 10.1038/sj.cdd.4400334; Chai JJ, 2001, CELL, V104, P769, DOI 10.1016/S0092-8674(02)02034-2; Christich A, 2002, CURR BIOL, V12, P137, DOI 10.1016/S0960-9822(01)00658-3; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; CROOK NE, 1993, J VIROL, V67, P2168, DOI 10.1128/JVI.67.4.2168-2174.1993; Cryns V, 1998, GENE DEV, V12, P1551, DOI 10.1101/gad.12.11.1551; Derossi D, 1998, TRENDS CELL BIOL, V8, P84, DOI 10.1016/S0962-8924(97)01214-2; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Deveraux QL, 1998, EMBO J, V17, P2215, DOI 10.1093/emboj/17.8.2215; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Duckett CS, 1996, EMBO J, V15, P2685, DOI 10.1002/j.1460-2075.1996.tb00629.x; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; Fraser AG, 1999, CURR BIOL, V9, P292, DOI 10.1016/S0960-9822(99)80137-7; Fulda S, 2002, NAT MED, V8, P808, DOI 10.1038/nm735; Guo F, 2002, BLOOD, V99, P3419, DOI 10.1182/blood.V99.9.3419; Hay BA, 1995, CELL, V83, P1253, DOI 10.1016/0092-8674(95)90150-7; Hegde R, 2002, J BIOL CHEM, V277, P432, DOI 10.1074/jbc.M109721200; Hinds MG, 1999, NAT STRUCT BIOL, V6, P648; Holley CL, 2002, NAT CELL BIOL, V4, P439, DOI 10.1038/ncb798; Huang HK, 2000, J BIOL CHEM, V275, P26661; Huang YH, 2001, CELL, V104, P781, DOI 10.1016/S0092-8674(01)00273-2; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; KAUFMANN SH, 1991, CANCER RES, V51, P3534; Kaufmann SH, 2001, ANAL BIOCHEM, V296, P283, DOI 10.1006/abio.2001.5313; KAUFMANN SH, 1989, J BIOL CHEM, V264, P13946; Kidd VJ, 1998, ANNU REV PHYSIOL, V60, P533, DOI 10.1146/annurev.physiol.60.1.533; Kottke TJ, 2002, J BIOL CHEM, V277, P804, DOI 10.1074/jbc.M108419200; Kottke TJ, 1999, J BIOL CHEM, V274, P15927, DOI 10.1074/jbc.274.22.15927; Liston P, 1996, NATURE, V379, P349, DOI 10.1038/379349a0; Liu ZH, 2000, NATURE, V408, P1004, DOI 10.1038/35050006; MacFarlane M, 2000, J CELL BIOL, V148, P1239, DOI 10.1083/jcb.148.6.1239; Mano Y, 1998, LAB INVEST, V78, P1467; Martins LM, 2002, J BIOL CHEM, V277, P439, DOI 10.1074/jbc.M109784200; Miller LK, 1999, TRENDS CELL BIOL, V9, P323, DOI 10.1016/S0962-8924(99)01609-8; Nicholson DW, 2001, NATURE, V410, P33, DOI 10.1038/35065201; Notarbartolo M, 2002, CANCER LETT, V180, P91, DOI 10.1016/S0304-3835(01)00834-5; Okada H, 2002, MOL CELL BIOL, V22, P3509, DOI 10.1128/MCB.22.10.3509-3517.2002; Prochiantz A, 1996, CURR OPIN NEUROBIOL, V6, P629, DOI 10.1016/S0959-4388(96)80095-X; Riedl SJ, 2001, CELL, V104, P791, DOI 10.1016/S0092-8674(02)02036-6; Rothe M, 1995, CELL, V83, P1243, DOI 10.1016/0092-8674(95)90149-3; Roy N, 1997, EMBO J, V16, P6914, DOI 10.1093/emboj/16.23.6914; ROY N, 1995, CELL, V80, P167, DOI 10.1016/0092-8674(95)90461-1; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Salvesen GS, 1997, CELL, V91, P443, DOI 10.1016/S0092-8674(00)80430-4; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Silke J, 2002, J CELL BIOL, V157, P115, DOI 10.1083/jcb.200108085; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Song ZW, 2000, MOL CELL BIOL, V20, P2907, DOI 10.1128/MCB.20.8.2907-2914.2000; Srinivasula SM, 2000, J BIOL CHEM, V275, P36152, DOI 10.1074/jbc.C000533200; Srinivasula SM, 2001, NATURE, V410, P112, DOI 10.1038/35065125; Srinivasula SM, 2002, CURR BIOL, V12, P125, DOI 10.1016/S0960-9822(01)00657-1; Stehlik C, 1998, J EXP MED, V188, P211, DOI 10.1084/jem.188.1.211; Sun CH, 1999, NATURE, V401, P818, DOI 10.1038/44617; Suzuki Y, 2001, MOL CELL, V8, P613, DOI 10.1016/S1097-2765(01)00341-0; Tamm I, 2000, CLIN CANCER RES, V6, P1796; Thoren PEG, 2000, FEBS LETT, V482, P265, DOI 10.1016/S0014-5793(00)02072-X; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Uren AG, 1999, P NATL ACAD SCI USA, V96, P10170, DOI 10.1073/pnas.96.18.10170; Uren AG, 1996, P NATL ACAD SCI USA, V93, P4974, DOI 10.1073/pnas.93.10.4974; van den Hoff M J, 1995, Methods Mol Biol, V48, P185; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Verhagen AM, 2002, J BIOL CHEM, V277, P445, DOI 10.1074/jbc.M109891200; Vucic D, 2002, J BIOL CHEM, V277, P12275, DOI 10.1074/jbc.M112045200; Wing JP, 2002, CURR BIOL, V12, P131, DOI 10.1016/S0960-9822(01)00664-9; Wright CW, 2002, J BIOL CHEM, V277, P2454, DOI 10.1074/jbc.M110500200; Wyllie A H, 1980, Int Rev Cytol, V68, P251	74	231	268	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2002	277	46					44236	44243		10.1074/jbc.M207578200	http://dx.doi.org/10.1074/jbc.M207578200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	615XE	12218061	hybrid			2022-12-27	WOS:000179272000092
J	Berthold, DA; Voevodskaya, N; Stenmark, P; Graslund, A; Nordlund, P				Berthold, DA; Voevodskaya, N; Stenmark, P; Graslund, A; Nordlund, P			EPR studies of the mitochondrial alternative oxidase - Evidence for a diiron carboxylate center	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHYLOSINUS-TRICHOSPORIUM OB3B; CYANIDE-RESISTANT RESPIRATION; SITE-DIRECTED MUTAGENESIS; HIGHER PLANT-MITOCHONDRIA; HERPES-SIMPLEX-VIRUS; NONHEME IRON PROTEIN; METHANE MONOOXYGENASE; PARTIAL-PURIFICATION; ACTIVE-SITE; RIBONUCLEOTIDE REDUCTASE	The alternative oxidase (AOX) is a ubiquinol oxidase found in the mitochondrial respiratory chain of plants as well as some fungi and protists. It has been predicted to contain a coupled diiron center on the basis of a conserved sequence motif consisting of the proposed iron ligands, four glutamate and two histidine residues. However, this prediction has not been experimentally verified. Here we report the high level expression of the Arabidopsis thaliana alternative oxidase AOX1a as a maltose-binding protein fusion in Escherichia coli. Reduction and reoxidation of a sample of isolated E. coli membranes containing the alternative oxidase generated an EPR signal characteristic of a mixed-valent Fe(II)/Fe(III) binuclear iron center. The high anisotropy of the signal, the low value of the g-average tensor, and a small exchange coupling (-J) suggest that the iron center is hydroxo-bridged. A reduced membrane preparation yielded a parallel mode EPR signal with a g-value of about 15. In AOX containing a mutation of a putative glutamate ligand of the diiron center (E222A or E273A) the EPR signals are absent. These data provide evidence for an antiferromagnetic-coupled binuclear iron center, and together with the conserved sequence motif, identify the alternative oxidase as belonging to the growing family of diiron carboxylate proteins. The alternative oxidase is the first integral membrane protein in this family, and adds a new catalytic activity (ubiquinol oxidation) to this group of enzymatically diverse proteins.	Stockholm Univ, Dept Biochem & Biophys, S-10691 Stockholm, Sweden	Stockholm University	Berthold, DA (corresponding author), Stockholm Univ, Dept Biochem & Biophys, Svante Arrhenius Vag 12, S-10691 Stockholm, Sweden.	berthold@dbb.su.se		Stenmark, Pal/0000-0003-4777-3417				Ajayi WU, 2002, J BIOL CHEM, V277, P8187, DOI 10.1074/jbc.M111477200; ANDERSSON KK, 1990, ADV INORG CHEM, V43, P359; Andersson ME, 1999, FEBS LETT, V449, P17, DOI 10.1016/S0014-5793(99)00376-2; Atta M, 1996, J BIOL INORG CHEM, V1, P210, DOI 10.1007/s007750050045; ATTA M, 1994, J AM CHEM SOC, V116, P6429, DOI 10.1021/ja00093a051; Berthold DA, 2000, BBA-BIOENERGETICS, V1460, P241, DOI 10.1016/S0005-2728(00)00149-3; BERTHOLD DA, 1993, PLANT PHYSIOL, V101, P113, DOI 10.1104/pp.101.1.113; Berthold DA, 1998, BBA-BIOENERGETICS, V1364, P73, DOI 10.1016/S0005-2728(98)00015-2; BERTHOLD DA, 2002, IN PRESS PROTEIN SCI; BONNER WD, 1986, PLANT PHYSIOL, V80, P838, DOI 10.1104/pp.80.4.838; Carol P, 1999, PLANT CELL, V11, P57, DOI 10.1105/tpc.11.1.57; CHAUDHURI M, 1995, J EUKARYOT MICROBIOL, V42, P467, DOI 10.1111/j.1550-7408.1995.tb05892.x; Davydov RM, 1997, BIOCHEMISTRY-US, V36, P9093, DOI 10.1021/bi9700375; Davydov RM, 1999, J BIOL INORG CHEM, V4, P292, DOI 10.1007/s007750050315; DAY EP, 1988, J BIOL CHEM, V263, P15561; DEWITT JG, 1991, J AM CHEM SOC, V113, P9219, DOI 10.1021/ja00024a031; Dinant M, 2001, CURR GENET, V39, P101, DOI 10.1007/s002940000183; Djajanegara I, 1999, FEBS LETT, V454, P220, DOI 10.1016/S0014-5793(99)00808-X; DUTTON PL, 1971, BIOCHIM BIOPHYS ACTA, V226, P63, DOI 10.1016/0005-2728(71)90178-2; ELTHON TE, 1989, PLANT PHYSIOL, V89, P1311, DOI 10.1104/pp.89.4.1311; ELTHON TE, 1987, P NATL ACAD SCI USA, V84, P8399, DOI 10.1073/pnas.84.23.8399; FOX BG, 1989, J BIOL CHEM, V264, P10023; FOX BG, 1991, J BIOL CHEM, V266, P540; HENDRICH MP, 1990, J AM CHEM SOC, V112, P5861, DOI 10.1021/ja00171a029; HENRY MF, 1975, SUB-CELL BIOCHEM, V4, P1; Hoefnagel MHN, 1998, ARCH BIOCHEM BIOPHYS, V355, P262, DOI 10.1006/abbi.1998.0737; HUQ S, 1978, FEBS LETT, V95, P217, DOI 10.1016/0014-5793(78)80997-1; KUMAR AM, 1992, P NATL ACAD SCI USA, V89, P10842, DOI 10.1073/pnas.89.22.10842; Maxwell DP, 1999, P NATL ACAD SCI USA, V96, P8271, DOI 10.1073/pnas.96.14.8271; MCCORMICK JM, 1991, J AM CHEM SOC, V113, P9066, DOI 10.1021/ja00024a007; MEEUSE BJD, 1975, ANNU REV PLANT PHYS, V26, P117, DOI 10.1146/annurev.pp.26.060175.001001; MINAGAWA N, 1990, FEBS LETT, V267, P114, DOI 10.1016/0014-5793(90)80302-Y; Moller IM, 2001, ANNU REV PLANT PHYS, V52, P561, DOI 10.1146/annurev.arplant.52.1.561; OHNISHI T, 1976, J BIOL CHEM, V251, P2105; OHNISHI T, 1975, BIOCHIM BIOPHYS ACTA, V387, P475, DOI 10.1016/0005-2728(75)90087-0; OHNISHI T, 1976, J BIOL CHEM, V251, P2094; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; RAVI N, 1993, BIOCHEMISTRY-US, V32, P8487, DOI 10.1021/bi00084a013; RHOADS DM, 1991, P NATL ACAD SCI USA, V88, P2122, DOI 10.1073/pnas.88.6.2122; RICH PR, 1978, FEBS LETT, V96, P252, DOI 10.1016/0014-5793(78)80412-8; RICH PR, 1978, BIOCHIM BIOPHYS ACTA, V501, P381, DOI 10.1016/0005-2728(78)90106-8; RICH PR, 1977, BIOCHIM BIOPHYS ACTA, V462, P501, DOI 10.1016/0005-2728(77)90097-4; RICH PR, 1978, BIOCHIM BIOPHYS ACTA, V504, P345, DOI 10.1016/0005-2728(78)90059-2; SCHONBAUM GR, 1971, PLANT PHYSIOL, V47, P124, DOI 10.1104/pp.47.1.124; SIEDOW JN, 1995, FEBS LETT, V362, P10, DOI 10.1016/0014-5793(95)00196-G; Siedow JN, 2000, BBA-BIOENERGETICS, V1459, P432, DOI 10.1016/S0005-2728(00)00181-X; Solomon EI, 2000, CHEM REV, V100, P235, DOI 10.1021/cr9900275; Stenmark P, 2001, J BIOL CHEM, V276, P33297, DOI 10.1074/jbc.C100346200; Vanlerberghe GC, 1997, ANNU REV PLANT PHYS, V48, P703, DOI 10.1146/annurev.arplant.48.1.703; Veiga A, 2000, FEMS MICROBIOL LETT, V190, P93, DOI 10.1111/j.1574-6968.2000.tb09268.x; WOODLAND MP, 1986, BIOCHIM BIOPHYS ACTA, V873, P237, DOI 10.1016/0167-4838(86)90050-6; Yang YS, 1997, J AM CHEM SOC, V119, P11832, DOI 10.1021/ja971896j; Yao Z, 1992, PCR Methods Appl, V1, P205; YIM MB, 1982, J MAGN RESON, V46, P247, DOI 10.1016/0022-2364(82)90140-8; Zhang QS, 1996, PHYSIOL PLANTARUM, V96, P551, DOI 10.1111/j.1399-3054.1996.tb00226.x	55	63	70	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2002	277	46					43608	43614		10.1074/jbc.M206724200	http://dx.doi.org/10.1074/jbc.M206724200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	615XE	12215444	hybrid			2022-12-27	WOS:000179272000011
J	Eyles, JL; Metcalf, D; Grusby, MJ; Hilton, DJ; Starr, R				Eyles, JL; Metcalf, D; Grusby, MJ; Hilton, DJ; Starr, R			Negative regulation of interleukin-12 signaling by suppressor of cytokine signaling-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL STIMULATORY FACTOR; INTERFERON-GAMMA-PRODUCTION; MOUSE IL-12 RECEPTOR; NATURAL-KILLER; T-CELLS; IMMUNE-RESPONSES; IFN-GAMMA; NK CELLS; IN-VIVO; TYROSINE PHOSPHORYLATION	Suppressor of cytokine signaling-1 (SOCS-1) is an inhibitory protein that regulates responses to cytokines. Previously, we have shown SOCS-1 to be a key inhibitor of interferon gamma (IFNgamma). Recent data suggest that SOCS-1 may regulate other cytokines in vivo, in addition to IFNgamma. Uncontrolled responses to interleukin-12 (IL-12), an inflammatory cytokine, could contribute to increased IFNgamma production and the development of inflammatory disease in SOCS-1(-/-) mice. Here, we assess responses of SOCS-1-deficient cells to IL-12. Both IL-12-induced T cell proliferation and NK cytotoxic activity are enhanced in SOCS-1-deficient cells, relative to controls. To examine the contribution of continued IL-12 signaling to the SOCS-1(-/-) disease, we generated mice lacking both SOCS-1 and signal transducer and activator of transcription 4 (STAT4), an essential component of the IL-12 signaling pathway. SOCS-1(-/-) STAT4(-/-)mice have improved survival relative to SOCS-1(-/-) mice, but die between 1 and 2 months of age. We conclude that, in addition to IFNgamma, SOCS-1 regulates responses to IL-12.	Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia; Cooperat Res Ctr Cellular Growth Factors, Melbourne, Vic 3050, Australia; Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA	Walter & Eliza Hall Institute; Harvard University; Harvard T.H. Chan School of Public Health	Starr, R (corresponding author), Walter & Eliza Hall Inst Med Res, PO Royal Melbourne Hosp, Melbourne, Vic 3050, Australia.		Hilton, Douglas J/C-7250-2013	Hilton, Douglas J/0000-0002-7698-2392	NATIONAL CANCER INSTITUTE [R37CA022556, R01CA022556] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040171, R21AI040171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062135] Funding Source: NIH RePORTER; NCI NIH HHS [CA-22556] Funding Source: Medline; NIAID NIH HHS [AI40171] Funding Source: Medline; NIGMS NIH HHS [GM62135] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alexander WS, 1996, BLOOD, V87, P2162, DOI 10.1182/blood.V87.6.2162.bloodjournal8762162; Alexander WS, 1999, CELL, V98, P597, DOI 10.1016/S0092-8674(00)80047-1; BACON CM, 1995, J EXP MED, V181, P399, DOI 10.1084/jem.181.1.399; Brysha M, 2001, J BIOL CHEM, V276, P22086, DOI 10.1074/jbc.M102737200; Bullen DVR, 2001, IMMUNOLOGY, V104, P92, DOI 10.1046/j.1365-2567.2001.01294.x; Chakir H, 2000, J IMMUNOL, V165, P4985, DOI 10.4049/jimmunol.165.9.4985; CHAN SH, 1992, J IMMUNOL, V148, P92; CHAN SH, 1991, J EXP MED, V173, P869, DOI 10.1084/jem.173.4.869; Chang JT, 1999, J EXP MED, V189, P969, DOI 10.1084/jem.189.6.969; CHUA AO, 1995, J IMMUNOL, V155, P4286; DANDREA A, 1993, J EXP MED, V178, P1041, DOI 10.1084/jem.178.3.1041; DANDREA A, 1992, J EXP MED, V176, P1387, DOI 10.1084/jem.176.5.1387; Davidson NJ, 1998, J IMMUNOL, V161, P3143; Endo TA, 1997, NATURE, V387, P921, DOI 10.1038/43213; Ertel W, 1997, BLOOD, V89, P1612, DOI 10.1182/blood.V89.5.1612.1612_1612_1620; GATELY MK, 1991, J IMMUNOL, V147, P874; Gately MK, 1998, ANNU REV IMMUNOL, V16, P495, DOI 10.1146/annurev.immunol.16.1.495; HEINZEL FP, 1993, J EXP MED, V177, P1505, DOI 10.1084/jem.177.5.1505; Hilton DJ, 1998, P NATL ACAD SCI USA, V95, P114, DOI 10.1073/pnas.95.1.114; Howard M, 1994, GUIDEBOOK CYTOKINES; HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338; JACOBSON NG, 1995, J EXP MED, V181, P1755, DOI 10.1084/jem.181.5.1755; Kaplan MH, 1996, NATURE, V382, P174, DOI 10.1038/382174a0; KOBAYASHI M, 1989, J EXP MED, V170, P827, DOI 10.1084/jem.170.3.827; Losman JA, 1999, J IMMUNOL, V162, P3770; MANETTI R, 1993, J EXP MED, V177, P1199, DOI 10.1084/jem.177.4.1199; Marine JC, 1999, CELL, V98, P609, DOI 10.1016/S0092-8674(00)80048-3; MCKNIGHT AJ, 1994, J IMMUNOL, V152, P2172; MEHROTRA PT, 1993, J IMMUNOL, V151, P2444; Metcalf D, 2000, P NATL ACAD SCI USA, V97, P9174, DOI 10.1073/pnas.160255197; Metcalf D, 2002, P NATL ACAD SCI USA, V99, P943, DOI 10.1073/pnas.022628499; Naka T, 1997, NATURE, V387, P924, DOI 10.1038/43219; Naka T, 1998, P NATL ACAD SCI USA, V95, P15577, DOI 10.1073/pnas.95.26.15577; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Parrello T, 2000, J IMMUNOL, V165, P7234, DOI 10.4049/jimmunol.165.12.7234; PERUSSIA B, 1992, J IMMUNOL, V149, P3495; Presky DH, 1996, P NATL ACAD SCI USA, V93, P14002, DOI 10.1073/pnas.93.24.14002; ROBERTSON MJ, 1992, J EXP MED, V175, P779, DOI 10.1084/jem.175.3.779; Romani L, 1997, J IMMUNOL, V158, P5349; Sakamoto H, 1998, BLOOD, V92, P1668, DOI 10.1182/blood.V92.5.1668.417k09_1668_1676; SCHOENHAUT DS, 1992, J IMMUNOL, V148, P3433; Simpson SJ, 1998, J EXP MED, V187, P1225, DOI 10.1084/jem.187.8.1225; Sporri B, 2001, BLOOD, V97, P221, DOI 10.1182/blood.V97.1.221; Starr R, 1998, P NATL ACAD SCI USA, V95, P14395, DOI 10.1073/pnas.95.24.14395; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; SYPEK JP, 1993, J EXP MED, V177, P1797, DOI 10.1084/jem.177.6.1797; Takenaka H, 1997, J LEUKOCYTE BIOL, V61, P80, DOI 10.1002/jlb.61.1.80; Thierfelder WE, 1996, NATURE, V382, P171, DOI 10.1038/382171a0; Wu CY, 1997, J IMMUNOL, V159, P1658; Zhang JG, 2001, P NATL ACAD SCI USA, V98, P13261, DOI 10.1073/pnas.231486498	50	83	88	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	2002	277	46					43735	43740		10.1074/jbc.M208586200	http://dx.doi.org/10.1074/jbc.M208586200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	615XE	12221108	hybrid			2022-12-27	WOS:000179272000027
J	Cornet, PB; Picquet, C; Lemoine, P; Osteen, KG; Bruner-Tran, KL; Tabibzadeh, S; Courtoy, PJ; Eeckhout, Y; Marbaix, E; Henriet, P				Cornet, PB; Picquet, C; Lemoine, P; Osteen, KG; Bruner-Tran, KL; Tabibzadeh, S; Courtoy, PJ; Eeckhout, Y; Marbaix, E; Henriet, P			Regulation and function of LEFTY-A/EBAF in the human endometrium mRNA - Expression during the menstrual cycle, control by progesterone, and effect on matrix metalloproteinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER RIBONUCLEIC-ACIDS; FACTOR-BETA SUPERFAMILY; GROWTH-FACTORS; GELATINASE-B; IN-VITRO; COLLAGENASE; BREAKDOWN; RECEPTOR; LEVONORGESTREL; QUANTITATION	The human endometrium is a unique tissue that is periodically shed during menstruation. Although overall triggered by ovarian steroids withdrawal, menstrual induction of matrix metalloproteinases (MMPs) and resulting tissue breakdown are focal responses, pointing to additional local modulators. LEFTY-A, a novel member of the transforming growth factor-beta family identified originally as an endometrial bleeding-associated factor (EBAF), is a candidate for this local control. We measured LEFTY-A and beta-ACTIN mRNA concentration during the menstrual cycle in vivo and found that their ratio was dramatically (similar to100-fold) increased at the perimenstrual phase. A similar increase was seen when proliferative explants were cultured for 24 h in the absence of ovarian steroids; this was followed by spontaneous production of proMMP-1, -3, and -9. Both responses were inhibited by progesterone. Moreover, addition of recombinant LEFTY-A to proliferative explants was sufficient to stimulate the expression of proMMP-3 and -7; this response was also blocked by ovarian steroids. Collectively, these data indicate that LEFTY-A may provide a crucial signal for endometrial breakdown and bleeding by triggering expression of several MMPs. Progesterone appears to exert a dual block, upstream by inhibiting LEFTY-A expression and downstream by suppressing its stimulatory effect on MMPs.	Univ Catholique Louvain, Christian De Duve Inst Cellular Pathol, Cell Biol Unit, B-1200 Brussels, Belgium; Vanderbilt Univ, Sch Med, Dept Obstet Gynecol, Nashville, TN 37232 USA; SUNY Stony Brook, Dept Obstet & Gynecol & Reprod Med, Stony Brook, NY 11794 USA	Universite Catholique Louvain; Vanderbilt University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Marbaix, E (corresponding author), Clin Univ St Luc, Dept Pathol, Ave Hippocrate 10, B-1200 Brussels, Belgium.			Henriet, Patrick/0000-0003-4602-8888	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U54HD037321] Funding Source: NIH RePORTER; NCI NIH HHS [CA8466] Funding Source: Medline; NICHD NIH HHS [U54-HD-37321] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		AMMALA M, 1995, FERTIL STERIL, V63, P773; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRUNER KL, 1995, P NATL ACAD SCI USA, V92, P7362, DOI 10.1073/pnas.92.16.7362; Casslen B, 1998, BIOL REPROD, V58, P1343, DOI 10.1095/biolreprod58.6.1343; Chegini N, 1999, AM J REPROD IMMUNOL, V42, P297; Galant C, 2000, J CLIN ENDOCR METAB, V85, P4827, DOI 10.1210/jc.85.12.4827; GILLILAND G, 1990, P NATL ACAD SCI USA, V87, P2725, DOI 10.1073/pnas.87.7.2725; GIUDICE LC, 1993, J CLIN ENDOCR METAB, V76, P1115, DOI 10.1210/jc.76.5.1115; HAMPTON AL, 1994, J ENDOCRINOL, V141, pR1, DOI 10.1677/joe.0.141R001; Henriet P, 2000, P NATL ACAD SCI USA, V97, P10026, DOI 10.1073/pnas.170290997; Henriet P, 2002, ANN NY ACAD SCI, V955, P119, DOI 10.1111/j.1749-6632.2002.tb02773.x; Inoue T, 1996, J CLIN ENDOCR METAB, V81, P1502, DOI 10.1210/jc.81.4.1502; Jeziorska M, 1996, J REPROD FERTIL, V107, P43; KOJIMA K, 1994, BIOL REPROD, V50, P882, DOI 10.1095/biolreprod50.4.882; Kokorine I, 1996, J CELL SCI, V109, P2151; Kosaki K, 1999, AM J HUM GENET, V64, P712, DOI 10.1086/302289; Kothapalli R, 1997, J CLIN INVEST, V99, P2342, DOI 10.1172/JCI119415; Lukashev ME, 1998, TRENDS CELL BIOL, V8, P437, DOI 10.1016/S0962-8924(98)01362-2; MARBAIX E, 1992, P NATL ACAD SCI USA, V89, P11789, DOI 10.1073/pnas.89.24.11789; Marbaix E, 1996, P NATL ACAD SCI USA, V93, P9120, DOI 10.1073/pnas.93.17.9120; Marbaix E, 2000, HUM REPROD, V15, P120, DOI 10.1093/humrep/15.suppl_3.120; Mason JM, 2002, J BIOL CHEM, V277, P407, DOI 10.1074/jbc.M108103200; NOYES RW, 1950, FERTIL STERIL, V1, P3, DOI 10.1016/s0015-0282(16)30062-0; Osteen KG, 1999, GYNECOL OBSTET INVES, V48, P2, DOI 10.1159/000052863; OSTEEN KG, 1994, P NATL ACAD SCI USA, V91, P10129, DOI 10.1073/pnas.91.21.10129; Oulad-Abdelghani M, 1998, INT J DEV BIOL, V42, P23; Rigot V, 2001, BIOCHEM J, V358, P275, DOI 10.1042/0264-6021:3580275; RODGERS WH, 1993, AM J OBSTET GYNECOL, V168, P253, DOI 10.1016/S0002-9378(12)90922-9; RODGERS WH, 1994, J CLIN INVEST, V94, P946, DOI 10.1172/JCI117461; Roy RN, 1999, MOL CELL ENDOCRINOL, V153, P19, DOI 10.1016/S0303-7207(99)00092-1; Rudolph-Owen LA, 1998, BIOL REPROD, V59, P1349, DOI 10.1095/biolreprod59.6.1349; Salamonsen LA, 1999, CLIN EXP PHARMACOL P, V26, P154, DOI 10.1046/j.1440-1681.1999.03012.x; Singer CF, 1997, P NATL ACAD SCI USA, V94, P10341, DOI 10.1073/pnas.94.19.10341; Skinner JL, 1999, HUM REPROD, V14, P793, DOI 10.1093/humrep/14.3.793; Tabibzadeh S, 1998, MOL HUM REPROD, V4, P595, DOI 10.1093/molehr/4.6.595; Tabibzadeh S, 2000, J CLIN ENDOCR METAB, V85, P2526, DOI 10.1210/jc.85.7.2526; Tabibzadeh Siamak, 1997, Frontiers in Bioscience (online), V2, pA18; Ulloa L, 2001, J BIOL CHEM, V276, P21397, DOI 10.1074/jbc.M010783200; Ulloa L, 2001, J BIOL CHEM, V276, P21387, DOI 10.1074/jbc.M006933200; von Wolff M, 2000, MOL HUM REPROD, V6, P627; WELCH DR, 1990, P NATL ACAD SCI USA, V87, P7678, DOI 10.1073/pnas.87.19.7678	41	71	74	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					42496	42504		10.1074/jbc.M201793200	http://dx.doi.org/10.1074/jbc.M201793200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12215426	hybrid			2022-12-27	WOS:000179081200011
J	Kavanagh, KL; Klimacek, M; Nidetzky, B; Wilson, DK				Kavanagh, KL; Klimacek, M; Nidetzky, B; Wilson, DK			Crystal structure of Pseudomonas fluorescens mannitol 2-dehydrogenase binary and ternary complexes - Specificity and catalytic mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-SEQUENCE; DEHYDROGENASE GENE; PROTEIN; PURIFICATION; LOCATION; ALCOHOLS; REVEALS; PROGRAM; CLONING; ENZYME	Long-chain mannitol dehydrogenases are secondary alcohol dehydrogenases that are of wide interest because of their involvement in metabolism and potential applications in agriculture, medicine, and industry. They differ from other alcohol and polyol dehydrogenases because they do not contain a conserved tyrosine and are not dependent on Zn2+ or other metal cofactors. The structures of the long-chain mannitol 2-dehydrogenase (54 kDa) from Pseudomonas fluorescens in a binary complex with NAD(+) and ternary complex with NAD(+) and D-mannitol have been determined to resolutions of 1.7 and 1.8 Angstrom and R-factors of 0.171 and 0.176, respectively. These results show an N-terminal domain that includes a typical Rossmann fold. The C-terminal domain is primarily alpha-helical and mediates mannitol binding. The electron lone pair of Lys-295 is steered by hydrogen-bonding interactions with the amide oxygen of Asn-300 and the main-chain carbonyl oxygen of Val-229 to act as the general base. Asn-191 and Asn-300 are involved in a web of hydrogen bonding, which precisely orients the mannitol O2 proton for abstraction. These residues also aid in stabilizing a negative charge in the intermediate state and in preventing the formation of nonproductive complexes with the substrate. The catalytic lysine may be returned to its unprotonated state using a rectifying proton tunnel driven by Glu-292 oscillating among different environments. Despite low sequence homology, the closest structural neighbors are glycerol-3-phosphate dehydrogenase, N-(1-D-carboxylethyl)-L-norvaline dehydrogenase, UDP-glucose dehydrogenase, and 6-phosphogluconate dehydrogenase, indicating a possible evolutionary relationship among these enzymes.	Univ Calif Davis, Sect Mol & Cellular Biol, Davis, CA 95616 USA; Graz Univ Technol, Inst Biotechnol, A-8010 Graz, Austria	University of California System; University of California Davis; Graz University of Technology	Wilson, DK (corresponding author), Univ Calif Davis, Mol Biol Sect, 1 Shields Ave, Davis, CA 95616 USA.	dave@alanine.ucdavis.edu		Nidetzky, Bernd/0000-0002-5030-2643				ADAMS MJ, 1994, STRUCTURE, V2, P651, DOI 10.1016/S0969-2126(00)00066-6; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Britton KL, 1998, NAT STRUCT BIOL, V5, P593, DOI 10.1038/854; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunker P, 1997, BBA-GENE STRUCT EXPR, V1351, P157, DOI 10.1016/S0167-4781(96)00189-3; Campbell RE, 2000, BIOCHEMISTRY-US, V39, P7012, DOI 10.1021/bi000181h; DIAMANDIS EP, 1992, CLIN BIOCHEM, V25, P457, DOI 10.1016/0009-9120(92)90120-H; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; Horer S, 2001, J BIOL CHEM, V276, P27555, DOI 10.1074/jbc.M102850200; Jennings DB, 1998, P NATL ACAD SCI USA, V95, P15129, DOI 10.1073/pnas.95.25.15129; JENNINGS DH, 1984, ADV MICROB PHYSIOL, V25, P149; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kissinger CR, 1999, ACTA CRYSTALLOGR D, V55, P484, DOI 10.1107/S0907444998012517; Klimacek M, 2002, BIOCHEMISTRY-US, V41, P10158, DOI 10.1021/bi025517x; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; NIEHAUS WG, 1982, J BACTERIOL, V151, P243, DOI 10.1128/JB.151.1.243-250.1982; NOVOTNY MJ, 1984, J BACTERIOL, V159, P986, DOI 10.1128/JB.159.3.986-990.1984; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Schmatz DM, 1997, PARASITOLOGY, V114, pS81; SCHNEIDER KH, 1993, J GEN MICROBIOL, V139, P2475, DOI 10.1099/00221287-139-10-2475; Shen B, 1999, PLANT PHYSIOL, V121, P45, DOI 10.1104/pp.121.1.45; Slatner M, 1998, BIOCATAL BIOTRANSFOR, V16, P351, DOI 10.3109/10242429809003628; Slatner M, 1999, BIOCHEMISTRY-US, V38, P10489, DOI 10.1021/bi990327g; STOOP JMH, 1992, ARCH BIOCHEM BIOPHYS, V298, P612, DOI 10.1016/0003-9861(92)90456-7; Suresh S, 2000, STRUCT FOLD DES, V8, P541, DOI 10.1016/S0969-2126(00)00135-0; Suvarna K, 2000, MICROBIOL-SGM, V146, P2705, DOI 10.1099/00221287-146-10-2705; TARCZYNSKI MC, 1993, SCIENCE, V259, P508, DOI 10.1126/science.259.5094.508; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; WILLIAMSON JD, 1995, P NATL ACAD SCI USA, V92, P7148, DOI 10.1073/pnas.92.16.7148	36	34	35	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					43433	43442		10.1074/jbc.M206914200	http://dx.doi.org/10.1074/jbc.M206914200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12196534	hybrid			2022-12-27	WOS:000179081200128
J	Medvedev, AV; Robidoux, J; Bai, X; Cao, WH; Floering, LM; Daniel, KW; Collins, S				Medvedev, AV; Robidoux, J; Bai, X; Cao, WH; Floering, LM; Daniel, KW; Collins, S			Regulation of the uncoupling protein-2 gene in INS-1 13-cells by oleic acid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STIMULATED INSULIN-SECRETION; ELEMENT-BINDING PROTEINS; TRANSCRIPTION FACTOR; GLUCOSE REGULATION; SYNTHASE PROMOTER; ADIPOSE-TISSUE; RECEPTOR-GAMMA; FATTY-ACIDS; IN-VIVO; E-BOX	Current evidence suggests that uncoupling protein-2 (UCP2) is a regulator of insulin secretion. It is also known that chronic exposure of pancreatic islets to free fatty acids (FFAs) blunts glucose-stimulated insulin secretion and is accompanied by elevated levels of UCP2. However, the mechanisms regulating expression of UCP2 in beta-cells are unknown. Here, we show that UCP2 mRNA and protein levels were increased after a 48-h exposure of INS-1(832/13) beta-cells to oleic acid (0.5 mm) by activation of the UCP2 promoter. Furthermore, progressive deletions of the mouse UCP2 promoter (from -7.3 kb to +12 bp) indicated that an enhancer region (-86/-44) was responsible for both basal and FFA-stimulated UCP2 gene transcription. This enhancer contains tightly clustered Sp1, sterol regulatory element (SRE), and double E-Box elements. While all three sequence motifs were required for basal activity of the UCP2 promoter, the mutations in either the SRE or the E-Box elements eliminated the response to FFAs. The SRE and sterol regulatory element binding protein-1 (SREBP1) appear to be crucial for the response of the UCP2 gene to FFAs, since overexpression of the nuclear forms of the SREBPs increased UCP2 promoter activity by 7-10-fold and restored the ability of E-Box mutants to respond to oleic acid. These data support a model in which SREBP is the major modulator of UCP2 gene transcription by FFA, while E-Box binding factors play a supportive role.	Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA	Duke University; Duke University	Collins, S (corresponding author), Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Box 3557, Durham, NC 27710 USA.			Medvedev, Alexander/0000-0001-6983-1687; Robidoux, JAcques/0000-0002-4809-4734	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054024] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01-DK54024] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Boss O, 1997, FEBS LETT, V412, P111, DOI 10.1016/S0014-5793(97)00755-2; BRIGGS MR, 1993, J BIOL CHEM, V268, P14490; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Casado M, 1999, J BIOL CHEM, V274, P2009, DOI 10.1074/jbc.274.4.2009; Chan CB, 2001, DIABETES, V50, P1302, DOI 10.2337/diabetes.50.6.1302; Chan CB, 1999, DIABETES, V48, P1482, DOI 10.2337/diabetes.48.7.1482; COLLINS S, 1994, MOL ENDOCRINOL, V8, P518, DOI 10.1210/me.8.4.518; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dulloo AG, 2001, BRIT J NUTR, V86, P123, DOI 10.1079/BJN2001412; Fleury C, 1997, NAT GENET, V15, P269, DOI 10.1038/ng0397-269; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Jackson SM, 1998, J LIPID RES, V39, P767; JACKSON SM, 1995, J BIOL CHEM, V270, P21445, DOI 10.1074/jbc.270.37.21445; Kakuma T, 2000, P NATL ACAD SCI USA, V97, P8536, DOI 10.1073/pnas.97.15.8536; KIM JB, 1995, MOL CELL BIOL, V15, P2582; Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318; Koo SH, 2000, J BIOL CHEM, V275, P5200, DOI 10.1074/jbc.275.7.5200; Lameloise N, 2001, DIABETES, V50, P803, DOI 10.2337/diabetes.50.4.803; Li LX, 2002, ENDOCRINOLOGY, V143, P1371, DOI 10.1210/en.143.4.1371; McGarry JD, 1999, DIABETOLOGIA, V42, P128, DOI 10.1007/s001250051130; Medvedev AV, 2001, J BIOL CHEM, V276, P10817, DOI 10.1074/jbc.M010587200; Millet L, 1997, J CLIN INVEST, V100, P2665, DOI 10.1172/JCI119811; Pecqueur C, 2001, J BIOL CHEM, V276, P8705, DOI 10.1074/jbc.M006938200; Rufo C, 2001, J BIOL CHEM, V276, P21969, DOI 10.1074/jbc.M100461200; Saleh MC, 2002, DIABETOLOGIA, V45, P174, DOI 10.1007/s00125-001-0737-x; Samec S, 1998, FASEB J, V12, P715, DOI 10.1096/fasebj.12.9.715; SANCHEZ HB, 1995, J BIOL CHEM, V270, P1161, DOI 10.1074/jbc.270.3.1161; Shimano H, 2001, PROG LIPID RES, V40, P439, DOI 10.1016/S0163-7827(01)00010-8; Shimomura I, 1997, J CLIN INVEST, V99, P838, DOI 10.1172/JCI119247; Soeder KJ, 1999, J BIOL CHEM, V274, P12017, DOI 10.1074/jbc.274.17.12017; Sul HS, 1998, ANNU REV NUTR, V18, P331, DOI 10.1146/annurev.nutr.18.1.331; Surwit RS, 1998, P NATL ACAD SCI USA, V95, P4061, DOI 10.1073/pnas.95.7.4061; THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201; TONTONOZ P, 1993, MOL CELL BIOL, V13, P4753, DOI 10.1128/MCB.13.8.4753; Tordjman K, 2002, J LIPID RES, V43, P936; Vaulont S, 2000, J BIOL CHEM, V275, P31555, DOI 10.1074/jbc.R000016200; WANG D, 1995, J BIOL CHEM, V270, P28716, DOI 10.1074/jbc.270.48.28716; Wang D, 1997, J BIOL CHEM, V272, P26367, DOI 10.1074/jbc.272.42.26367; Zhang CY, 2001, CELL, V105, P745, DOI 10.1016/S0092-8674(01)00378-6	40	102	103	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					42639	42644		10.1074/jbc.M208645200	http://dx.doi.org/10.1074/jbc.M208645200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12205102	hybrid			2022-12-27	WOS:000179081200028
J	Miles, LA; Dy, CY; Nielsen, J; Barnham, KJ; Hinds, MG; Olivera, BM; Bulaj, G; Norton, RS				Miles, LA; Dy, CY; Nielsen, J; Barnham, KJ; Hinds, MG; Olivera, BM; Bulaj, G; Norton, RS			Structure of a novel P-superfamily spasmodic conotoxin reveals an inhibitory cystine knot motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3-DIMENSIONAL SOLUTION STRUCTURE; NUCLEAR MAGNETIC-RESONANCE; NMR STRUCTURE CALCULATION; SPIN COUPLING-CONSTANTS; MUSCLE SODIUM-CHANNELS; BIOLOGICAL MACROMOLECULES; GLYCINE RECEPTOR; PEPTIDES; SPECTROSCOPY; PROTEINS	Conotoxin gm9a, a putative 27-residue polypeptide encoded by Conus gloriamaris, was recently identified as a homologue of the "spasmodic peptide", tx9a, isolated from the venom of the mollusk-hunting cone shell Conus textile (Lirazan, M. B., Hooper, D., Corpuz, G. P., Ramilo, C. A., Bandyopadhyay, P., Cruz, L. J., and Olivera, B. M. (2000) Biochemistry 39, 1583-1588). The C. gloriamaris spasmodic peptide has been synthesized, and the refolded polypeptide was shown to be biologically active using a mouse bioassay. The chemically synthesized gm9a elicited the same symptomatology described previously for natively folded tx9a, and gm9a and tx9a were of similar potency, implying that neither the two gamma-carboxyglutamate (Gla) residues found in tx9a (Ser(8) and Ala(13) in gm9a) nor Gly(1) (Ser(1) in gm9a) are crucial for biological activity. We have determined the three-dimensional structure of gm9a in aqueous solution and demonstrated that the molecule adopts the well known inhibitory cystine knot motif constrained by three disulfide bonds involving Cys(2)-Cys(16), Cys(6)-Cys(18) and Cys(12)-Cys(23). Based on the gm9a structure, the sites of Gla substitution in tx9a are in loops located on one surface of the molecule, which is unlikely to be involved directly in receptor binding. Because this is the first structure reported for a member of the newly defined P-superfamily conotoxins, a comparison has been made with structurally related conotoxins. This shows that the structural scaffold that characterizes the P-conotoxins has the greatest potential for exhibiting structural diversity among the robust inhibitory cystine knot-containing conotoxins, a finding that has implications for functional epitope mimicry and protein engineering.	NMR Lab, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia; Biomol Res Inst, Parkville, Vic 3052, Australia; Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; Univ Philippines, Inst Marine Sci, Quezon City 1101, Philippines; Cognetix Incorp, Salt Lake City, UT 84108 USA; Univ Melbourne, Dept Pathol, Parkville, Vic 3010, Australia	Walter & Eliza Hall Institute; Utah System of Higher Education; University of Utah; University of the Philippines System; University of the Philippines Diliman; University of Melbourne	Norton, RS (corresponding author), NMR Lab, Walter & Eliza Hall Inst Med Res, 381 Royal Parade, Parkville, Vic 3052, Australia.		Dy, Catherine/D-7215-2013; Hinds, Mark Gavin/AAD-3653-2020; Miles, Luke/C-5363-2009	Dy, Catherine/0000-0003-3414-1613; Hinds, Mark Gavin/0000-0002-2856-5375; Miles, Luke Anthony/0000-0003-2412-3171; Norton, Raymond/0000-0001-8893-0584	NIGMS NIH HHS [GM48677] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Balaji RA, 2000, J BIOL CHEM, V275, P39516, DOI 10.1074/jbc.M006354200; BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; Baxter NJ, 1997, J BIOMOL NMR, V9, P359, DOI 10.1023/A:1018334207887; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; *BMRB, BIOMAGRESBANK; BRAUNSCHWEILER L, 1983, J MAGN RESON, V53, P521, DOI 10.1016/0022-2364(83)90226-3; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BUNDI A, 1979, BIOPOLYMERS, V18, P285, DOI 10.1002/bip.1979.360180206; GRAY WR, 1993, PROTEIN SCI, V2, P1732, DOI 10.1002/pro.5560021017; GRIESINGER C, 1987, J MAGN RESON, V75, P474, DOI 10.1016/0022-2364(87)90102-8; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Hill JM, 1997, STRUCTURE, V5, P571, DOI 10.1016/S0969-2126(97)00212-8; Hill JM, 2000, EUR J BIOCHEM, V267, P4649, DOI 10.1046/j.1432-1327.2000.01507.x; Hill JM, 1996, BIOCHEMISTRY-US, V35, P8824, DOI 10.1021/bi960073o; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KEIM P, 1973, J BIOL CHEM, V248, P7811; KUMAR A, 1980, BIOCHEM BIOPH RES CO, V95, P1, DOI 10.1016/0006-291X(80)90695-6; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; LEVITT MH, 1983, ADV MAGN RESON, V11, P47; Linge JP, 1999, J BIOMOL NMR, V13, P51, DOI 10.1023/A:1008365802830; Lirazan MB, 2000, BIOCHEMISTRY-US, V39, P1583, DOI 10.1021/bi9923712; MARION D, 1983, BIOCHEM BIOPH RES CO, V113, P967, DOI 10.1016/0006-291X(83)91093-8; Mitchell SS, 1998, BIOCHEMISTRY-US, V37, P1215, DOI 10.1021/bi972186t; Mourier G, 2000, PROTEIN ENG, V13, P217, DOI 10.1093/protein/13.3.217; Nielsen KJ, 1996, J MOL BIOL, V263, P297, DOI 10.1006/jmbi.1996.0576; Norton RS, 1999, DRUG DEVELOP RES, V46, P206, DOI 10.1002/(SICI)1098-2299(199903/04)46:3/4<206::AID-DDR6>3.3.CO;2-W; Norton RS, 2002, PERSPECTIVES IN MOLECULAR TOXINOLOGY, P159; Norton RS, 1998, TOXICON, V36, P1573, DOI 10.1016/S0041-0101(98)00149-4; Pallaghy PK, 2000, BIOPOLYMERS, V54, P173, DOI 10.1002/1097-0282(200009)54:3<173::AID-BIP30>3.3.CO;2-1; PALLAGHY PK, 1994, PROTEIN SCI, V3, P1833, DOI 10.1002/pro.5560031022; Pallaghy PK, 1999, J PEPT RES, V53, P343, DOI 10.1034/j.1399-3011.1999.00040.x; PERUTZ MF, 1985, J MOL BIOL, V183, P491, DOI 10.1016/0022-2836(85)90016-6; Prorok M, 1996, BIOCHEMISTRY-US, V35, P16528, DOI 10.1021/bi9621122; RANCE M, 1983, BIOCHEM BIOPH RES CO, V117, P479, DOI 10.1016/0006-291X(83)91225-1; RYAN SG, 1994, NAT GENET, V7, P131, DOI 10.1038/ng0694-131; SATO K, 1991, J BIOL CHEM, V266, P16989; SAUL B, 1994, FEBS LETT, V350, P71, DOI 10.1016/0014-5793(94)00736-5; Savarin P, 1998, BIOCHEMISTRY-US, V37, P5407, DOI 10.1021/bi9730341; SEAVEY B R, 1991, Journal of Biomolecular NMR, V1, P217, DOI 10.1007/BF01875516; SHIRE SJ, 1974, BIOCHEMISTRY-US, V13, P2967, DOI 10.1021/bi00711a028; SKLENAR V, 1993, J MAGN RESON SER A, V102, P241, DOI 10.1006/jmra.1993.1098; TANOKURA M, 1976, BIOPOLYMERS, V15, P393, DOI 10.1002/bip.1976.360150215; Vita C, 1999, P NATL ACAD SCI USA, V96, P13091, DOI 10.1073/pnas.96.23.13091; WAKAMATSU K, 1992, BIOCHEMISTRY-US, V31, P12577, DOI 10.1021/bi00165a006; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777	45	35	39	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					43033	43040		10.1074/jbc.M206690200	http://dx.doi.org/10.1074/jbc.M206690200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12193600	hybrid			2022-12-27	WOS:000179081200080
J	Nebl, T; Pestonjamasp, KN; Leszyk, JD; Crowley, JL; Oh, SW; Luna, EJ				Nebl, T; Pestonjamasp, KN; Leszyk, JD; Crowley, JL; Oh, SW; Luna, EJ			Proteomic analysis of a detergent-resistant membrane skeleton from neutrophil plasma membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							FC-EPSILON-RI; ACTIN-BINDING PROTEIN; GPI-ANCHORED PROTEINS; LIPID RAFTS; POLYMORPHONUCLEAR LEUKOCYTE; PEPTIDE RECEPTORS; GROWTH-FACTOR; MICRODOMAINS; DOMAINS; LOCALIZATION	Plasma membranes are organized into functional domains both by liquid-ordered packing into "lipid rafts," structures that resist Triton extraction, and by attachments to underlying cytoskeletal proteins in assemblies called "membrane skeletons." Although the actin cytoskeleton is implicated in many lipid raft-mediated signaling processes, little is known about the biochemical basis for actin involvement. We show here that a subset of plasma membrane skeleton proteins from bovine neutrophils co-isolates with cholesterol-rich, detergent-resistant membrane fragments (DRMs) that exhibit a relatively high buoyant density in sucrose (DRM-H; d similar to 1.16 g/ml). By using matrix-assisted laser desorption/ionization time of flight and tandem mass spectrometry, we identified 19 major DRM-H proteins. Membrane skeleton proteins include fodrin (nonerythroid spectrin), myosin-IIA, myosin-IG, alpha-actinin 1, alpha-actinin 4, vimentin and the F-actin-binding protein, supervillin. Other DRM-H components include lipid raft-associated integral membrane proteins (stomatin, flotillin 1, and flotillin 2), extracellular surface-bound and glycophosphatidylinositol-anchored proteins (IgM, membrane-type 6 matrix metalloproteinase), and intracellular dually acylated signaling proteins (Lyn kinase, Galpha(i-2)). Consistent with cytoskeletal association, most DRM-H-associated flotillin 2, Lyn, and Galpha(i)-2 also resist extraction with 0.1 m octyl glucoside. Supervillin, myosin-IG, and myosin-IIA resist extraction with 0.1 m sodium carbonate, a treatment that removes all detectable actin, suggesting that these cytoskeletal proteins are proximal to the DRM-H bilayer. Binding of supervillin to the DRM-H fragments is confirmed by co-immunoaffinity purification. In spreading neutrophils, supervillin localizes with F-actin in cell extensions and in discrete basal puncta that partially overlap with Galpha(i) staining. We suggest that the DRM-H fraction represents a membrane skeleton-associated subset of leukocyte signaling domains.	Univ Massachusetts, Sch Med, Dept Cell Biol, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Proteom Mass Spectrometry Lab, Shrewsbury, MA 01545 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System	Luna, EJ (corresponding author), Univ Massachusetts, Sch Med, Dept Cell Biol, Biotech 4,Ste 306,377 Plantat St, Worcester, MA 01605 USA.	Elizabeth.Luna@umassmed.edu	Nebl, Thomas/N-1620-2017; Luna, Elizabeth/B-4364-2012	Nebl, Thomas/0000-0003-4003-9340; Pestonjamasp, Kersi/0000-0001-8586-303X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033048] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM33048, R01 GM033048] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; Benting J, 1999, FEBS LETT, V462, P47, DOI 10.1016/S0014-5793(99)01501-X; Bickel PE, 1997, J BIOL CHEM, V272, P13793, DOI 10.1074/jbc.272.21.13793; BICKEL PE, 2001, AM J PHYSIOL, V282, pE1; Bloch RJ, 1997, SOC GEN PHY, V52, P177; BOYLES J, 1979, J CELL BIOL, V82, P347, DOI 10.1083/jcb.82.2.347; BOYLES J, 1981, CELL, V24, P905, DOI 10.1016/0092-8674(81)90116-1; Bremer A, 1998, CELL BIOLOGY - A LABORATORY HANDBOOK, 2ND EDITION, VOL 3, P277; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; BYERS TJ, 1985, P NATL ACAD SCI USA, V82, P6153, DOI 10.1073/pnas.82.18.6153; CARBONI JM, 1987, AM J PATHOL, V129, P589; CHANG WJ, 1994, J CELL BIOL, V126, P127, DOI 10.1083/jcb.126.1.127; DELBUONO BJ, 1989, J CELL PHYSIOL, V141, P636, DOI 10.1002/jcp.1041410323; DELLANGELICA E, 2000, CURRENT PROTOCOLS CE, V1; DENHAAN JMM, 1995, SCIENCE, V268, P1476, DOI 10.1126/science.7539551; Dobrowsky RT, 2000, CELL SIGNAL, V12, P81, DOI 10.1016/S0898-6568(99)00072-8; Dykstra M, 2001, J LEUKOCYTE BIOL, V70, P699; Eberle HB, 2002, J CELL SCI, V115, P827; FEINSTEIN A, 1969, NATURE, V224, P1307, DOI 10.1038/2241307a0; FIEDLER K, 1993, BIOCHEMISTRY-US, V32, P6365, DOI 10.1021/bi00076a009; FIELD KA, 1995, P NATL ACAD SCI USA, V92, P9201, DOI 10.1073/pnas.92.20.9201; Friedrichson T, 1998, NATURE, V394, P802, DOI 10.1038/29570; FUJIMOTO T, 1990, J CELL SCI, V96, P477; FUJIMOTO T, 1992, J CELL BIOL, V119, P1507, DOI 10.1083/jcb.119.6.1507; Galbiati F, 2001, CELL, V106, P403, DOI 10.1016/S0092-8674(01)00472-X; Geiger B, 2001, CURR OPIN CELL BIOL, V13, P584, DOI 10.1016/S0955-0674(00)00255-6; Gharahdaghi F, 1999, ELECTROPHORESIS, V20, P601, DOI 10.1002/(SICI)1522-2683(19990301)20:3<601::AID-ELPS601>3.0.CO;2-6; Godaly G, 2001, J LEUKOCYTE BIOL, V69, P899; Gomez-Mouton C, 2001, P NATL ACAD SCI USA, V98, P9642, DOI 10.1073/pnas.171160298; GOODLOEHOLLAND CM, 1987, METHOD CELL BIOL, V28, P103; GREWAL AS, 1978, INT ARCH ALLER A IMM, V56, P289, DOI 10.1159/000232034; HARTWIG JH, 1989, J CELL BIOL, V108, P467, DOI 10.1083/jcb.108.2.467; Holowka D, 2000, J CELL SCI, V113, P1009; Holowka D, 2001, SEMIN IMMUNOL, V13, P99, DOI 10.1006/smim.2000.0301; JESAITIS AJ, 1988, J CELL BIOL, V107, P921, DOI 10.1083/jcb.107.3.921; JESAITIS AJ, 1984, J CELL BIOL, V98, P1378, DOI 10.1083/jcb.98.4.1378; JESAITIS AJ, 1989, J CELL BIOL, V109, P2783, DOI 10.1083/jcb.109.6.2783; Jones GE, 2000, J LEUKOCYTE BIOL, V68, P593; Jonkman MF, 1999, J DERMATOL SCI, V20, P103, DOI 10.1016/S0923-1811(99)00017-1; Kim M, 2001, EMBO J, V20, P6347, DOI 10.1093/emboj/20.22.6347; KLOTZ KN, 1994, BIOESSAYS, V16, P193, DOI 10.1002/bies.950160310; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lange K, 2002, AM J PHYSIOL-CELL PH, V282, pC1, DOI 10.1152/ajpcell.2002.282.1.C1; LANGLEY RC, 1987, CELL MOTIL CYTOSKEL, V8, P165, DOI 10.1002/cm.970080208; LISANTI MP, 1994, J CELL BIOL, V126, P111, DOI 10.1083/jcb.126.1.111; London E, 2000, BBA-BIOMEMBRANES, V1508, P182, DOI 10.1016/S0304-4157(00)00007-1; Luna EJ, 1997, SOC GEN PHY, V52, P3; LUNA EJ, 1992, SCIENCE, V258, P955, DOI 10.1126/science.1439807; Manes S, 1999, EMBO J, V18, P6211, DOI 10.1093/emboj/18.22.6211; McMillan JR, 2001, J DERMATOL, V28, P291, DOI 10.1111/j.1346-8138.2001.tb00136.x; Melkonian KA, 1999, J BIOL CHEM, V274, P3910, DOI 10.1074/jbc.274.6.3910; Melkonian KA, 1995, BIOCHEMISTRY-US, V34, P16161, DOI 10.1021/bi00049a031; Moffett S, 2000, J BIOL CHEM, V275, P2191, DOI 10.1074/jbc.275.3.2191; Morozumi T, 2001, J PERIODONTAL RES, V36, P160, DOI 10.1034/j.1600-0765.2001.360304.x; MOTTOLA C, 1980, EUR J BIOCHEM, V111, P341, DOI 10.1111/j.1432-1033.1980.tb04947.x; Mukherjee S, 2000, TRAFFIC, V1, P203, DOI 10.1034/j.1600-0854.2000.010302.x; Nabi IR, 1999, J CELL SCI, V112, P1803; Nagafuchi A, 2001, CURR OPIN CELL BIOL, V13, P600, DOI 10.1016/S0955-0674(00)00257-X; NAKAMURA T, 1993, J IMMUNOL, V151, P6933; NELSON WJ, 1989, J CELL BIOL, V108, P893, DOI 10.1083/jcb.108.3.893; Oh P, 2001, MOL BIOL CELL, V12, P685, DOI 10.1091/mbc.12.3.685; OHNO T, 1990, J EXP MED, V172, P1165, DOI 10.1084/jem.172.4.1165; Pappin D J, 1997, Methods Mol Biol, V64, P165; PESTONJAMASP K, 1995, MOL BIOL CELL, V6, P247, DOI 10.1091/mbc.6.3.247; Pestonjamasp KN, 1997, J CELL BIOL, V139, P1255, DOI 10.1083/jcb.139.5.1255; PETERSON MD, 1992, J CELL SCI, V102, P581; Pierce RA, 2001, J IMMUNOL, V167, P3223, DOI 10.4049/jimmunol.167.6.3223; Pike LJ, 2002, BIOCHEMISTRY-US, V41, P2075, DOI 10.1021/bi0156557; Pope RK, 1998, GENOMICS, V52, P342, DOI 10.1006/geno.1998.5466; Pralle A, 2000, J CELL BIOL, V148, P997, DOI 10.1083/jcb.148.5.997; QUINN MT, 1989, BIOCHIM BIOPHYS ACTA, V987, P83, DOI 10.1016/0005-2736(89)90458-6; Rietveld A, 1998, BBA-REV BIOMEMBRANES, V1376, P467, DOI 10.1016/S0304-4157(98)00019-7; Rodgers W, 2001, EXP CELL RES, V267, P173, DOI 10.1006/excr.2001.5253; Runembert I, 2002, J CELL SCI, V115, P713; RUPPERT C, 1995, J CELL SCI, V108, P3775; SALGAR SK, 1994, AM J VET RES, V55, P803; Salzer U, 2001, BLOOD, V97, P1141, DOI 10.1182/blood.V97.4.1141; Sarndahl E, 1996, J BIOL CHEM, V271, P15267; SCHNITZER JE, 1995, SCIENCE, V269, P1435, DOI 10.1126/science.7660128; Schulte T, 1997, DEVELOPMENT, V124, P577; SENGELOV H, 1994, BIOCHEM J, V299, P473, DOI 10.1042/bj2990473; Seveau S, 2001, MOL BIOL CELL, V12, P3550, DOI 10.1091/mbc.12.11.3550; SHEETZ MP, 1979, BIOCHIM BIOPHYS ACTA, V557, P122, DOI 10.1016/0005-2736(79)90095-6; Shibuya A, 2000, NAT IMMUNOL, V1, P441, DOI 10.1038/80886; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; SMART EJ, 1995, P NATL ACAD SCI USA, V92, P10104, DOI 10.1073/pnas.92.22.10104; Song KS, 1996, J BIOL CHEM, V271, P9690, DOI 10.1074/jbc.271.16.9690; STEVENSON KB, 1989, BLOOD, V74, P2136; STOSSEL TP, 1994, SCI AM, V271, P54, DOI 10.1038/scientificamerican0994-54; STOSSEL TP, 1985, BLOOD PRINCIPLES PRA, P575; THOMAS JL, 1994, J CELL BIOL, V125, P795, DOI 10.1083/jcb.125.4.795; Valensin S, 2002, EUR J IMMUNOL, V32, P435, DOI 10.1002/1521-4141(200202)32:2<435::AID-IMMU435>3.0.CO;2-H; VALERIUS NH, 1981, CELL, V24, P195, DOI 10.1016/0092-8674(81)90515-8; Varma R, 1998, NATURE, V394, P798, DOI 10.1038/29563; Villalba M, 2001, J CELL BIOL, V155, P331, DOI 10.1083/jcb.200107080; von Haller PD, 2001, PROTEOMICS, V1, P1010; Waugh MG, 1999, BIOCHEM J, V337, P591, DOI 10.1042/0264-6021:3370591; WILLIAMS MR, 1982, RES VET SCI, V33, P47, DOI 10.1016/S0034-5288(18)32358-0; Wilson BS, 2000, J CELL BIOL, V149, P1131, DOI 10.1083/jcb.149.5.1131; WORKU M, 1994, AM J VET RES, V55, P221; Wulfkuhle JD, 1999, J CELL SCI, V112, P2125; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	102	250	263	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					43399	43409		10.1074/jbc.M205386200	http://dx.doi.org/10.1074/jbc.M205386200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12202484	hybrid			2022-12-27	WOS:000179081200124
J	Shi, JX; Radic, Z; Taylor, P				Shi, JX; Radic, Z; Taylor, P			Inhibitors of different structure induce distinguishing conformations in the omega loop, Cys(69)-Cys(96), of mouse acetylcholinesterase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERIPHERAL SITE LIGANDS; CRYSTAL-STRUCTURE; BINDING; COMPLEX; FASCICULIN; CHOLINESTERASES; PURIFICATION; SPECIFICITY; EXPRESSION; CHIRALITY	We have shown previously that association of reversible active site ligands induces a conformational change in an omega loop (Omega loop), Cys(69)-Cys(96), of acetylcholinesterase. The fluorophore acrylodan, site-specifically incorporated at positions 76, 81, and 84, on the external portion of the loop not lining the active site gorge, shows changes in its fluorescence spectrum that reflect the fluorescent side chain moving from a hydrophobic environment to become more solvent-exposed. This appears to result from a movement of the Omega loop accompanying ligand binding. We show here that the loop is indeed flexible and responds to conformational changes induced by both active center and peripheral site inhihitors (gallamine and fasciculin). Moreover, phosphorylation and carbamoylation of the active center serine shows distinctive changes in acrylodan fluorescence spectra at the Omega loop sites, depending on the chirality and steric dimensions of the covalently conjugated ligand. Capping of the gorge with fasciculin, although it does not displace the bound ligand, dominates in inducing a conformational change in the loop. Hence, the ligand-induced conformational changes are distinctive and suggest multiple loop conformations accompany conjugation at the active center serine. The fluorescence changes induced by the modified enzyme may prove useful in the detection of organophosphates or exposure to cholinesterase inhibitors.	Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Taylor, P (corresponding author), Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA.				NIEHS NIH HHS [ES10337] Funding Source: Medline; NIGMS NIH HHS [GM07752, GM-R37-18360] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES010337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM018360] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aldridge W. N., 1972, ENZYME INHIBITORS SU; Ariel N, 1998, BIOCHEM J, V335, P95, DOI 10.1042/bj3350095; AUGUSTINSSON KB, 1948, ACTA PHYSL SCAND S, V52, P1; Bar-On P, 2002, BIOCHEMISTRY-US, V41, P3555, DOI 10.1021/bi020016x; BELLEAU B, 1970, J AM CHEM SOC, V92, P6320, DOI 10.1021/ja00724a035; BERMAN HA, 1978, BIOCHEMISTRY-US, V17, P1704, DOI 10.1021/bi00602a019; BERMAN HA, 1989, J BIOL CHEM, V264, P3942; BERMAN JD, 1971, P NATL ACAD SCI USA, V68, P395, DOI 10.1073/pnas.68.2.395; Bourne Y, 1999, J BIOL CHEM, V274, P2963, DOI 10.1074/jbc.274.5.2963; BOURNE Y, 1995, CELL, V83, P503, DOI 10.1016/0092-8674(95)90128-0; BOURNE Y, 2002, 11 INT S CHOL MECH S, P39; Boyd AE, 2000, J BIOL CHEM, V275, P22401, DOI 10.1074/jbc.M000606200; CHANGEUX JP, 1966, MOL PHARMACOL, V2, P369; DELAHOZ D, 1986, LIFE SCI, V39, P195, DOI 10.1016/0024-3205(86)90530-8; Faerman C, 1996, FEBS LETT, V386, P65, DOI 10.1016/0014-5793(96)00374-2; HAREL M, 1993, P NATL ACAD SCI USA, V90, P9031, DOI 10.1073/pnas.90.19.9031; HOSEA NA, 1995, BIOCHEMISTRY-US, V34, P11528, DOI 10.1021/bi00036a028; KOELLE GB, 1994, J APPL TOXICOL, V14, P105, DOI 10.1002/jat.2550140211; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Lew J, 1997, J BIOL CHEM, V272, P1507, DOI 10.1074/jbc.272.3.1507; Mallender WD, 1999, J BIOL CHEM, V274, P8491, DOI 10.1074/jbc.274.13.8491; Marchot P, 1996, PROTEIN SCI, V5, P672; MARCHOT P, 1993, J BIOL CHEM, V268, P12458; MILLARD CB, 1995, J NEUROCHEM, V64, P1909, DOI 10.1046/j.1471-4159.1995.64051909.x; Millard CB, 1999, BIOCHEMISTRY-US, V38, P7032, DOI 10.1021/bi982678l; Morel N, 1999, MOL PHARMACOL, V55, P982, DOI 10.1124/mol.55.6.982; PRENDERGAST FG, 1983, J BIOL CHEM, V258, P7541; QUINN DM, 1987, CHEM REV, V87, P955, DOI 10.1021/cr00081a005; RADIC Z, 1992, BIOCHEMISTRY-US, V31, P9760, DOI 10.1021/bi00155a032; Radic Z, 2001, J BIOL CHEM, V276, P4622, DOI 10.1074/jbc.M006855200; Raves ML, 1997, NAT STRUCT BIOL, V4, P57, DOI 10.1038/nsb0197-57; ROSENBERRY TL, 1975, ADV ENZYMOL RAMB, V43, P103; Shi JX, 2001, J BIOL CHEM, V276, P42196, DOI 10.1074/jbc.M106896200; SUSSMAN JL, 1991, SCIENCE, V253, P872, DOI 10.1126/science.1678899; Szegletes T, 1999, BIOCHEMISTRY-US, V38, P122, DOI 10.1021/bi9813577; Szegletes T, 1998, BIOCHEMISTRY-US, V37, P4206, DOI 10.1021/bi972158a; TAYLOR P, 1994, ANNU REV PHARMACOL, V34, P281, DOI 10.1146/annurev.pa.34.040194.001433; TAYLOR P, 1975, BIOCHEMISTRY-US, V14, P1989, DOI 10.1021/bi00680a029; TAYLOR P, 1974, MOL PHARMACOL, V10, P93; TAYLOR P, 2001, GOODMAN GILMANS PHAR, P161; Velan B, 1996, FEBS LETT, V395, P22, DOI 10.1016/0014-5793(96)00995-7; Wilson I. B., 1960, ENZYMES, V4, P501; Wong L, 2000, BIOCHEMISTRY-US, V39, P5750, DOI 10.1021/bi992906r	43	25	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					43301	43308		10.1074/jbc.M204391200	http://dx.doi.org/10.1074/jbc.M204391200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12196517	hybrid			2022-12-27	WOS:000179081200113
J	Kosoy, A; Pagans, S; Espinas, ML; Azorin, F; Bernues, J				Kosoy, A; Pagans, S; Espinas, ML; Azorin, F; Bernues, J			GAGA factor down-regulates its own promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYCOMB RESPONSE ELEMENT; GLUTAMINE-RICH DOMAIN; DNA-BINDING; IN-VITRO; TRANSCRIPTION FACTOR; CHROMATIN-STRUCTURE; DROSOPHILA; REQUIRES; MAINTENANCE; ESTABLISHMENT	GAGA factor is involved in many nuclear transactions, notably in transcription as an activator in Drosophila. The genomic region corresponding to the Trl promoter has been obtained, and a minimal version of a fully active Trl promoter has been defined using transient transfection. assays in S2 cells. DNase I footprinting analysis has shown that this region contains multiple GAGA binding sites, suggesting a potential regulatory role of GAGA on its own promoter. The study shows that GAGA down-regulates Trl expression. The repression does not depend on the GAGA isoform, but binding to DNA is absolutely required. A fragment of the Trl promoter can mediate repression to a heterologous promoter only upon GAGA overexpression in transiently transfected S2 cells. Chromatin immunoprecipitation analysis of S2 cells confirmed that GAGA factors are bound to the Trl promoter over a region of 1.4 kbp. Using a double-stranded RNA interference approach, we show that endogenous GAGA factors limit Trl expression in S2 cells. Our results open the possibility of observing similar GAGA repressive effects on other promoters.	CSIC, Inst Mol Biol, Dept Mol & Cellular Biol, ES-08034 Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB)	Bernues, J (corresponding author), CSIC, Inst Mol Biol, Dept Mol & Cellular Biol, Jordi Girona 18-26, ES-08034 Barcelona, Spain.	jbmbmc@ibmb.csic.es	Bernues, Jordi/ABE-8360-2021; Pagans, Sara/G-3407-2015; Azorin, Fernando/N-4388-2014	Bernues, Jordi/0000-0001-6218-8254; Pagans, Sara/0000-0003-0772-6982; Azorin, Fernando/0000-0002-8426-7858; Espinas, M Lluisa/0000-0003-3914-2228				Agianian B, 1999, J MOL BIOL, V285, P527, DOI 10.1006/jmbi.1998.2355; Benyajati C, 1997, NUCLEIC ACIDS RES, V25, P3345, DOI 10.1093/nar/25.16.3345; Bhat KM, 1996, DEVELOPMENT, V122, P1113; BIGGIN MD, 1988, CELL, V53, P699, DOI 10.1016/0092-8674(88)90088-8; Busturia A, 2001, DEVELOPMENT, V128, P2163; Cavalli G, 1999, PRACT APPROACH SER, P20; Deuring R, 2000, MOL CELL, V5, P355, DOI 10.1016/S1097-2765(00)80430-X; Dubnicoff T, 1997, GENE DEV, V11, P2952, DOI 10.1101/gad.11.22.2952; EMAMI KH, 1995, MOL CELL BIOL, V15, P5906; Espinas ML, 2000, EMBO REP, V1, P253, DOI 10.1093/embo-reports/kvd046; Espinas ML, 1999, J BIOL CHEM, V274, P16461, DOI 10.1074/jbc.274.23.16461; FARKAS G, 1994, NATURE, V371, P806, DOI 10.1038/371806a0; GRANOK H, 1995, CURR BIOL, V5, P238, DOI 10.1016/S0960-9822(95)00048-0; Greenberg AJ, 2001, MOL CELL BIOL, V21, P8565, DOI 10.1128/MCB.21.24.8565-8574.2001; Horard B, 2000, MOL CELL BIOL, V20, P3187, DOI 10.1128/MCB.20.9.3187-3197.2000; Jimenez-Garcia E, 1998, J BIOL CHEM, V273, P24640, DOI 10.1074/jbc.273.38.24640; JONES KA, 1984, EMBO J, V3, P3247, DOI 10.1002/j.1460-2075.1984.tb02286.x; Katsani KR, 1999, EMBO J, V18, P698, DOI 10.1093/emboj/18.3.698; Lintermann KG, 1998, DEV GENES EVOL, V208, P447, DOI 10.1007/s004270050202; Mishra RK, 2001, MOL CELL BIOL, V21, P1311, DOI 10.1128/MCB.21.4.1311-1318.2001; Okada M, 1998, MOL CELL BIOL, V18, P2455, DOI 10.1128/MCB.18.5.2455; Omichinski JG, 1997, NAT STRUCT BIOL, V4, P122, DOI 10.1038/nsb0297-122; Orlando V, 1997, METHODS, V11, P205, DOI 10.1006/meth.1996.0407; Pedone PV, 1996, P NATL ACAD SCI USA, V93, P2822, DOI 10.1073/pnas.93.7.2822; Pile LA, 2000, J BIOL CHEM, V275, P1398, DOI 10.1074/jbc.275.2.1398; Platero JS, 1998, J CELL BIOL, V140, P1297; Poux S, 2001, GENE DEV, V15, P2509, DOI 10.1101/gad.208901; RAFF JW, 1994, EMBO J, V13, P5977, DOI 10.1002/j.1460-2075.1994.tb06943.x; READ D, 1990, MOL CELL BIOL, V10, P4334, DOI 10.1128/MCB.10.8.4334; RIO DC, 1983, CELL, V32, P1227, DOI 10.1016/0092-8674(83)90305-7; SOELLER WC, 1988, GENE DEV, V2, P68, DOI 10.1101/gad.2.1.68; SOELLER WC, 1993, MOL CELL BIOL, V13, P7961, DOI 10.1128/MCB.13.12.7961; Strutt H, 1997, EMBO J, V16, P3621, DOI 10.1093/emboj/16.12.3621; TSUKIYAMA T, 1994, NATURE, V367, P525, DOI 10.1038/367525a0; Tsukiyama T, 1996, METHOD ENZYMOL, V274, P291; Valentine SA, 1998, MOL CELL BIOL, V18, P6584, DOI 10.1128/MCB.18.11.6584; Vaquero A, 2000, J BIOL CHEM, V275, P19461, DOI 10.1074/jbc.M000967200; VAQUERO A, 2000, THESIS U BARCELONA; Weber JA, 1997, MOL CELL BIOL, V17, P3799, DOI 10.1128/MCB.17.7.3799; Wilkins RC, 1998, NUCLEIC ACIDS RES, V26, P2672, DOI 10.1093/nar/26.11.2672; Wilkins RC, 1999, J MOL BIOL, V285, P515, DOI 10.1006/jmbi.1998.2356; Wilkins RC, 1997, NUCLEIC ACIDS RES, V25, P3963, DOI 10.1093/nar/25.20.3963	42	15	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					42280	42288		10.1074/jbc.M207505200	http://dx.doi.org/10.1074/jbc.M207505200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12200449	hybrid			2022-12-27	WOS:000178985300123
J	Lin, L; Jeanclos, EM; Treuil, M; Braunewell, KH; Gundelfinger, ED; Anand, R				Lin, L; Jeanclos, EM; Treuil, M; Braunewell, KH; Gundelfinger, ED; Anand, R			The calcium sensor protein visinin-like protein-1 modulates the surface expression and agonist sensitivity of the alpha 4 beta 2 nicotinic acetylcholine receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C6 GLIOMA-CELLS; CA2+-BINDING PROTEIN; MOLECULAR-CLONING; CHRONIC EXPOSURE; DRUG-ADDICTION; CA2+ CHANNELS; UP-REGULATION; HUMAN-BRAIN; BINDING; INACTIVATION	The calcium sensor protein visinin-like protein-1 (VILIP-1) was isolated from a brain cDNA yeast two-hybrid library using the large cytoplasmic domain of the alpha4 subunit as a bait. VILIP-1 is a myristoylated calcium sensor protein that contains three functional calcium binding EF-hand motifs. The alpha4 subunit residues 302-339 were found to be essential for the interaction with VILIP-1. VILIP-1 coimmunopurified with detergent-solubilized recombinant alpha4beta2 acetylcholine receptors (AChRs) expressed in tsA201 cells and with native alpha4 AChRs isolated from brain. Coexpression of VILIP-1 with recombinant alpha4beta2 AChRs up-regulated their surface expression levels similar to2-fold and increased their agonist sensitivity to acetylcholine similar to3-fold. The modulation of the recombinant alpha4beta2 AChRs by VILIP-1 was attenuated in VILIP-1 mutants that lacked the ability to be myristoylated or to bind calcium. Collectively, these results suggest that VILIP-1 represents a novel modulator of alpha4beta2 AChRs that increases their surface expression levels and agonist sensitivity in response to changes in the intracellular levels of calcium.	Louisiana State Univ, Hlth Sci Ctr, Neurosci Ctr Excellence, New Orleans, LA 70112 USA; Louisiana State Univ, Hlth Sci Ctr, Dept Neurol, New Orleans, LA 70112 USA; Leibniz Inst Neurobiol, D-39118 Magdeburg, Germany; Humboldt Univ, Charite, Neurosci Res Ctr, Signal Transduct Res Grp, D-10117 Berlin, Germany	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Leibniz Institut fur Neurobiologie (LIN); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Anand, R (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Neurosci Ctr Excellence, Suite D,2020 Gravier St, New Orleans, LA 70112 USA.			Jeanclos, Elisabeth/0000-0001-5934-5490				Ames JB, 1996, CURR OPIN STRUC BIOL, V6, P432, DOI 10.1016/S0959-440X(96)80106-0; Ames JB, 1997, NATURE, V389, P198, DOI 10.1038/38310; An WF, 2000, NATURE, V403, P553, DOI 10.1038/35000592; Anand R, 1998, J PHARMACOL EXP THER, V287, P469; BENWELL MEM, 1988, J NEUROCHEM, V50, P1243, DOI 10.1111/j.1471-4159.1988.tb10600.x; Braunewell KH, 1997, J NEUROCHEM, V68, P2129; Braunewell KH, 1999, CELL TISSUE RES, V295, P1, DOI 10.1007/s004410051207; Braunewell KH, 1997, NEUROSCI LETT, V234, P139, DOI 10.1016/S0304-3940(97)00696-4; Buisson B, 2001, J NEUROSCI, V21, P1819, DOI 10.1523/JNEUROSCI.21-06-01819.2001; Cooper ST, 1999, J BIOL CHEM, V274, P27145, DOI 10.1074/jbc.274.38.27145; DeMaria CD, 2001, NATURE, V411, P484, DOI 10.1038/35078091; DIDIER M, 1995, MOL BRAIN RES, V30, P17, DOI 10.1016/0169-328X(94)00266-H; Ehlers MD, 1996, CELL, V84, P745, DOI 10.1016/S0092-8674(00)81052-1; Fenster CP, 1999, J NEUROSCI, V19, P4804; FLORES CM, 1992, MOL PHARMACOL, V41, P31; Gopalakrishnan M, 1997, MOL PHARMACOL, V52, P524, DOI 10.1124/mol.52.3.524; Guo WN, 2002, J BIOL CHEM, V277, P26436, DOI 10.1074/jbc.M201431200; Hsu YN, 1997, J NEUROCHEM, V69, P2427; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Ibanez-Tallon I, 2002, NEURON, V33, P893, DOI 10.1016/S0896-6273(02)00632-3; IMREDY JP, 1994, NEURON, V12, P1301, DOI 10.1016/0896-6273(94)90446-4; Jeanclos EM, 2001, J BIOL CHEM, V276, P28281, DOI 10.1074/jbc.M011549200; KAJIMOTO Y, 1993, J NEUROCHEM, V61, P1091, DOI 10.1111/j.1471-4159.1993.tb03624.x; Kato M, 1998, BIOCHEM J, V331, P871, DOI 10.1042/bj3310871; KOBAYASHI M, 1994, BBA-MOL CELL RES, V1222, P515, DOI 10.1016/0167-4889(94)90062-0; KOOB GF, 1992, TRENDS PHARMACOL SCI, V13, P177, DOI 10.1016/0165-6147(92)90060-J; Koob GF, 1997, J NEUROPSYCH CLIN N, V9, P482; Koob GF, 1996, NEURON, V16, P893, DOI 10.1016/S0896-6273(00)80109-9; KUNO T, 1992, BIOCHEM BIOPH RES CO, V184, P1219, DOI 10.1016/S0006-291X(05)80012-9; Lenz SE, 1996, CELL TISSUE RES, V283, P413, DOI 10.1007/s004410050552; Lin L, 2002, BIOCHEM BIOPH RES CO, V296, P827, DOI 10.1016/S0006-291X(02)00943-9; Lindstrom J, 1996, Ion Channels, V4, P377; MARKS MJ, 1992, J NEUROSCI, V12, P2765; Nakamura TY, 2001, P NATL ACAD SCI USA, V98, P12808, DOI 10.1073/pnas.221168498; Pauly JR, 1996, J PHARMACOL EXP THER, V278, P361; PENG X, 1994, MOL PHARMACOL, V46, P523; POLYMEROPOULOS MH, 1995, GENOMICS, V29, P273, DOI 10.1006/geno.1995.1244; SARGENT PB, 1993, ANNU REV NEUROSCI, V16, P403, DOI 10.1146/annurev.ne.16.030193.002155; Weiss JL, 2000, J BIOL CHEM, V275, P40082, DOI 10.1074/jbc.M008603200; Zhang S, 1998, NEURON, V21, P443, DOI 10.1016/S0896-6273(00)80553-X	40	92	97	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					41872	41878		10.1074/jbc.M206857200	http://dx.doi.org/10.1074/jbc.M206857200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12202488	hybrid			2022-12-27	WOS:000178985300074
J	Otten, LG; Sio, CF; Vrielink, J; Cool, RH; Quax, WJ				Otten, LG; Sio, CF; Vrielink, J; Cool, RH; Quax, WJ			Altering the substrate specificity of cephalosporin acylase by directed evolution of the beta-subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PENICILLIN-G ACYLASE; ESCHERICHIA-COLI; ACID ACYLASE; PSEUDOMONAS STRAIN; CRYSTAL-STRUCTURE; CLONING; EXPRESSION; GENES; ENZYMES; AMIDASE	Using directed evolution, we have selected an adipyl acylase enzyme that can be used for a one-step bioconversion of adipyl-7-aminodesacetoxycephalosporanic acid (adipyl-7-ADCA) to 7-ADCA an important compound for the synthesis of semisynthetic cephalosporins. The starting point for the directed evolution was the glutaryl acylase from Pseudomonas SY-77. The gene fragment encoding the beta-subunit was divided into five overlapping parts that were mutagenized separately using error-prone PCR. Mutants were selected in a leucine-deficient host using adipyl-leucine as the sole leucine source. In total, 24 out of 41 plate-selected mutants were found to have a significantly improved ratio of adipyl-7-ADCA versus glutaryl-7-ACA hydrolysis. Several mutations around the substrate-binding site were isolated, especially in two hot spot positions: residues Phe-375 and Asn-266. Five mutants were further characterized by determination of their Michaelis-Menten parameters. Strikingly, mutant SY-77(N266H) shows a nearly 10-fold improved catalytic efficiency (k(cat)/K-m) on adipyl-7-ADCA, resulting from a 50% increase in k(cat) and a 6-fold decrease in K-m, without decreasing the catalytic efficiency on glutaryl-7-ACA. In contrast, the improved adipyl/glutaryl activity ratio of mutant SY-77(F375L) mainly is a consequence of a decreased catalytic efficiency toward glutaryl-7-ACA. These results are discussed in the light of a structural model of SY-77 glutaryl acylase.	Univ Groningen, Univ Ctr Pharm, Dept Pharmaceut Biol, NL-9713 AV Groningen, Netherlands	University of Groningen	Quax, WJ (corresponding author), Univ Groningen, Univ Ctr Pharm, Dept Pharmaceut Biol, Antonius Deusinglaan 1, NL-9713 AV Groningen, Netherlands.		Quax, Wim/K-2802-2012; Quax, Wim/O-2875-2019; Otten, Linda/A-4802-2010	Quax, Wim/0000-0002-5162-9947; Quax, Wim/0000-0002-5162-9947; Cool, Robbert/0000-0002-9845-2202; Sio, Charles/0000-0002-1504-9101				ARAMORI I, 1991, J FERMENT BIOENG, V72, P232, DOI 10.1016/0922-338X(91)90155-A; ARAMORI I, 1991, J BACTERIOL, V173, P7848, DOI 10.1128/jb.173.24.7848-7855.1991; Armisen P, 1999, J CHROMATOGR A, V848, P61, DOI 10.1016/S0021-9673(99)00489-6; Arnold FH, 2001, TRENDS BIOCHEM SCI, V26, P100, DOI 10.1016/S0968-0004(00)01755-2; Bruggink A, 1998, ORG PROCESS RES DEV, V2, P128, DOI 10.1021/op9700643; CADWELL RC, 1994, PCR METH APPL, V3, P136; CRAWFORD L, 1995, BIO-TECHNOL, V13, P58, DOI 10.1038/nbt0195-58; FORNEY LJ, 1989, APPL ENVIRON MICROB, V55, P2556, DOI 10.1128/AEM.55.10.2556-2560.1989; FORNEY LJ, 1989, APPL ENVIRON MICROB, V55, P2550, DOI 10.1128/AEM.55.10.2550-2555.1989; Fritz-Wolf K, 2002, PROTEIN SCI, V11, P92, DOI 10.1110/ps.ps.27502; GARCIA JL, 1986, J BIOTECHNOL, V3, P187, DOI 10.1016/0168-1656(86)90001-5; Griffiths AD, 2000, CURR OPIN BIOTECH, V11, P338, DOI 10.1016/S0958-1669(00)00109-9; ISHII Y, 1994, J FERMENT BIOENG, V77, P591, DOI 10.1016/0922-338X(94)90138-4; ISHIYE M, 1992, BIOCHIM BIOPHYS ACTA, V1132, P233, DOI 10.1016/0167-4781(92)90155-S; Kim Y, 2001, CHEM BIOL, V8, P1253, DOI 10.1016/S1074-5521(01)00092-8; Kim Y, 2000, STRUCTURE, V8, P1059, DOI 10.1016/S0969-2126(00)00505-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leung DW, 1989, TECHNIQUE, V1, P11; Li Y, 1998, PROTEIN EXPRES PURIF, V12, P233, DOI 10.1006/prep.1997.0823; MATSUDA A, 1987, J BACTERIOL, V169, P5815, DOI 10.1128/jb.169.12.5815-5820.1987; McDonough MA, 1999, PROTEIN SCI, V8, P1971, DOI 10.1110/ps.8.10.1971; Monti D, 2000, BIOTECHNOL BIOENG, V70, P239, DOI 10.1002/1097-0290(20001020)70:2<239::AID-BIT13>3.0.CO;2-I; REYES F, 1989, J PHARM PHARMACOL, V41, P136, DOI 10.1111/j.2042-7158.1989.tb06412.x; Sambrook J., 2002, MOL CLONING LAB MANU; Schroen CGPH, 2000, BIOTECHNOL BIOENG, V70, P654, DOI 10.1002/1097-0290(20001220)70:6<654::AID-BIT7>3.0.CO;2-3; SHIBUYA Y, 1981, AGR BIOL CHEM TOKYO, V45, P1561, DOI 10.1080/00021369.1981.10864767; Sio CF, 2002, EUR J BIOCHEM, V269, P4495, DOI 10.1046/j.1432-1033.2002.03143.x; ZHANG QJ, 1993, ARCH MICROBIOL, V159, P392, DOI 10.1007/BF00290923; Zhao HM, 2002, CURR OPIN BIOTECH, V13, P104, DOI 10.1016/S0958-1669(02)00291-4	29	51	57	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					42121	42127		10.1074/jbc.M208317200	http://dx.doi.org/10.1074/jbc.M208317200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12198140	Green Published, hybrid			2022-12-27	WOS:000178985300103
J	Chandra, V; Jasti, J; Kaur, P; Dey, S; Perbandt, M; Srinivasan, A; Betzel, C; Singh, TP				Chandra, V; Jasti, J; Kaur, P; Dey, S; Perbandt, M; Srinivasan, A; Betzel, C; Singh, TP			Crystal structure of a complex formed between a snake venom phospholipase A(2) and a potent peptide inhibitor Phe-Leu-Ser-Tyr-Lys at 1.8 A resolution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DABOIA-RUSSELLI-PULCHELLA; TRANSITION-STATE ANALOG; RHEUMATOID-ARTHRITIS; ANGSTROM RESOLUTION; SEPTIC SHOCK; PURIFICATION; CRYSTALLOGRAPHY; ASSOCIATION; MOLSCRIPT; BINDING	Phospholipase A(2) is an important enzyme involved in the production of prostaglandins and their related compounds causing inflammatory disorders. Among the several peptides tested, the peptide Phe-Leu-Ser-Tyr-Lys (FLSYK) showed the highest inhibition. The dissociation constant (K-d) for this peptide was calculated to be 3.57 +/- 0.05 x 10(-9) m. In order to further improve the degree of inhibition of phospholipase A(2), a complex between Russells viper snake venom phospholipase A(2) and a peptide inhibitor FLSYK was crystallized, and its structure was determined by crystallographic methods and refined to an R-factor of 0.205 at 1.8 Angstrom resolution. The structure contains two crystallographically independent molecules of phospholipase A(2) (molecules A and B) and a peptide molecule specifically bound to molecule A only. The two molecules formed an asymmetric dimer. The dimerization caused a modification in the binding site of molecule A. The overall conformations of molecules A and B were found to be generally similar except three regions i.e. the Trp-31-containing loop (residues 25-34), the beta-wing consisting of two antiparallel beta-strands (residues 74-85) and the C-terminal region (residues 119-133). Out of the above three, the most striking difference pertains to the conformation of Trp-31 in the two molecules. The orientation of Trp-31 in molecule A was suitable for the binding of FLSYK, while it disallowed the binding of peptide to molecule B. The structure of the complex clearly shows that the peptide is so placed in the binding site of molecule A that the side chain of its lysine residue interacted extensively with the enzyme and formed several hydrogen bonds in addition to a strong electrostatic interaction with critical Asp-49. The C-terminal carboxylic group of the peptide interacted with the catalytic residue His-48.	All India Inst Med Sci, Dept Biophys, New Delhi 110029, India; DESY, UKE, Inst Med Biochem & Mol Biol, D-22603 Hamburg, Germany	All India Institute of Medical Sciences (AIIMS) New Delhi; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); University of Hamburg; University Medical Center Hamburg-Eppendorf	Singh, TP (corresponding author), All India Inst Med Sci, Dept Biophys, New Delhi 110029, India.		Perbandt, Markus/K-7603-2018; Betzel, Christian/G-8105-2018; Hu, Ruogu/B-2203-2008	Betzel, Christian/0000-0002-3879-5019; 				Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cha SS, 1996, J MED CHEM, V39, P3878, DOI 10.1021/jm960502g; Chandra V, 2002, J MOL BIOL, V320, P215, DOI 10.1016/S0022-2836(02)00473-4; Chandra V, 1999, ACTA CRYSTALLOGR D, V55, P925, DOI 10.1107/S090744499900058X; Chandra V, 2001, ACTA CRYSTALLOGR D, V57, P1793, DOI 10.1107/S0907444901014524; Chandra V, 2002, BIOCHEMISTRY-US, V41, P10914, DOI 10.1021/bi0258593; Chandra V, 2000, J MOL BIOL, V296, P1117, DOI 10.1006/jmbi.2000.3537; CHANDRA V, 2002, IN PRESS ACTA CRYSTA; Church WB, 2001, J BIOL CHEM, V276, P33156, DOI 10.1074/jbc.M101272200; Cruickshank D.W.J, 1996, P CCP4 STUD WEEK, P11; DAHNEKE BE, 1983, MEASUREMENT SUSPENDE, P199; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; GELB MH, 1995, ANNU REV BIOCHEM, V64, P653; GREEN JA, 1991, INFLAMMATION, V15, P355, DOI 10.1007/BF00917352; Jamal OS, 1998, ANN RHEUM DIS, V57, P550, DOI 10.1136/ard.57.9.550; JAYANTHI GP, 1989, TOXICON, V27, P875, DOI 10.1016/0041-0101(89)90099-8; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KASTURI S, 1989, TOXICON, V27, P229, DOI 10.1016/0041-0101(89)90136-0; KINI RM, 1997, VENOM PHOSPHOLIPASES, P146; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KUDO I, 1993, BIOCHIM BIOPHYS ACTA, V117, P217; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LASKOWSKI RA, 1994, P CCP4 STUD WEEK 1 M, P149; Lio YC, 1998, BBA-LIPID LIPID MET, V1392, P320, DOI 10.1016/S0005-2760(98)00049-6; MAKKER J, 2002, THESIS ALL INDIA I M; MERITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869; Murshudov G.N., 1997, CCP4 NEWSLETTER, V33, P31; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; ONO T, 1988, J BIOL CHEM, V263, P5732; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pan YH, 2001, BIOCHEMISTRY-US, V40, P609, DOI 10.1021/bi002514g; Perbandt M, 1997, FEBS LETT, V412, P573, DOI 10.1016/S0014-5793(97)00853-3; PRUZANSKI W, 1988, J RHEUMATOL, V15, P1351; Ramachandran G N, 1968, Adv Protein Chem, V23, P283, DOI 10.1016/S0065-3233(08)60402-7; SCHEVITZ RW, 1995, NAT STRUCT BIOL, V2, P458, DOI 10.1038/nsb0695-458; Schmitz K. S., 1990, INTRO DYNAMIC LIGHT; SCHULZE T, 1996, THESIS U HAMBURG HAM; SCOTT DL, 1990, SCIENCE, V250, P1541, DOI 10.1126/science.2274785; SCOTT DL, 1991, SCIENCE, V254, P1007, DOI 10.1126/science.1948070; SCOTT DL, 1990, SCIENCE, V250, P1563, DOI 10.1126/science.2274788; Sekar K, 1997, BIOCHEMISTRY-US, V36, P14186, DOI 10.1021/bi971370b; SMITH GM, 1992, BRIT J RHEUMATOL, V31, P175; THUNNISSEN MMGM, 1990, NATURE, V347, P689, DOI 10.1038/347689a0; TOMOO K, 1994, PROTEINS, V19, P330, DOI 10.1002/prot.340190408; Tseng A, 1996, J BIOL CHEM, V271, P23992, DOI 10.1074/jbc.271.39.23992; VADAS P, 1984, J LAB CLIN MED, V104, P873; Waite M, 1987, HDB LIPID RES, V5, P155; WHITE SP, 1990, SCIENCE, V250, P1560, DOI 10.1126/science.2274787; YUAN W, 1990, BIOCHEMISTRY-US, V29, P6082, DOI 10.1021/bi00477a028	49	36	42	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 25	2002	277	43					41079	41085		10.1074/jbc.M206130200	http://dx.doi.org/10.1074/jbc.M206130200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	607KU	12186870	hybrid			2022-12-27	WOS:000178791400117
J	Rochdi, MD; Watier, V; La Madeleine, C; Nakata, H; Kozasa, T; Parent, JL				Rochdi, MD; Watier, V; La Madeleine, C; Nakata, H; Kozasa, T; Parent, JL			Regulation of GTP-binding protein alpha(q) (G alpha(q)) signaling by the ezrin-radixin-moesin-binding phosphoprotein-50 (EBP50)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; DOMAIN-MEDIATED INTERACTION; PHOSPHOLIPASE-C ISOZYMES; COUPLED RECEPTOR KINASE; RECOMBINANT-GQ-ALPHA; BETA-GAMMA-SUBUNITS; PDZ-DOMAIN; NA+/H+ EXCHANGER; THROMBOXANE A(2); NHE-RF	Although ezrin-radixin-moesin-binding phosphoprotein 50 (EBP50) is a PDZ domain-containing protein known to bind to various channels, receptors, cytoskeletal elements, and cytoplasmic proteins, there is still very little evidence for a role of EBP50 in the regulation of receptor signal transduction. In this report, we show that EBP50 inhibits the phospholipase C (PLC)-beta-mediated inositol phosphate production of a Galpha(q)-coupled receptor as well as PLC-A activation by the constitutively active Galpha(q)-R183C mutant. Coinimunoprecipitation experiments revealed that EBP50 interacts with Galpha(q) and to a greater extent with Galpha(q)-R183C. Agonist stimulation of the thromboxane A(2) receptor (TP receptor) resulted in an increased interaction between EBP50 and Galpha(q), suggesting that EBP50 preferentially interacts with activated Galpha(q). We also demonstrate that EBP50 inhibits Galpha(q) signaling by preventing the interaction between Galpha(q) and the TP receptor and between activated Galpha(q) and PLC-beta1. Investigation of the EBP50 regions involved in Gaq binding indicated that its two PDZ domains are responsible for this interaction. This study constitutes the first demonstration of an interaction between a G protein alpha subunit and another protein through a PDZ domain, with broad implications in the regulation of diverse physiological systems.	Univ Sherbrooke, Fac Med, Serv Rhumatol, Sherbrooke, PQ J1H 5N4, Canada; Univ Sherbrooke, CHUS, Ctr Rech Clin, Sherbrooke, PQ J1H 5N4, Canada; Univ Illinois, Dept Pharmacol, Chicago, IL 60612 USA	University of Sherbrooke; University of Sherbrooke; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Parent, JL (corresponding author), Univ Sherbrooke, Fac Med, Serv Rhumatol, 3001 12e Ave Nord, Fleurimont, PQ J1H 5N4, Canada.							Breton S, 2000, J BIOL CHEM, V275, P18219, DOI 10.1074/jbc.M909857199; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; Carman CV, 1999, J BIOL CHEM, V274, P34483, DOI 10.1074/jbc.274.48.34483; Chidiac P, 1999, J BIOL CHEM, V274, P19639, DOI 10.1074/jbc.274.28.19639; CONKLIN BR, 1992, J BIOL CHEM, V267, P31; Gisler SM, 2001, J BIOL CHEM, V276, P9206, DOI 10.1074/jbc.M008745200; Hall RA, 1999, J BIOL CHEM, V274, P24328, DOI 10.1074/jbc.274.34.24328; Hall RA, 1998, P NATL ACAD SCI USA, V95, P8496, DOI 10.1073/pnas.95.15.8496; HEPLER JR, 1993, J BIOL CHEM, V268, P14367; HIRATA M, 1991, NATURE, V349, P617, DOI 10.1038/349617a0; Hwang JI, 2000, J BIOL CHEM, V275, P16632, DOI 10.1074/jbc.M001410200; Ingi T, 1998, J NEUROSCI, V18, P7178; Kinsella BT, 2001, BIOCHEM SOC T, V29, P641, DOI 10.1042/BST0290641; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; Lau AG, 2001, BIOCHEMISTRY-US, V40, P8572, DOI 10.1021/bi0103516; Maudsley S, 2000, MOL CELL BIOL, V20, P8352, DOI 10.1128/MCB.20.22.8352-8363.2000; Mohler PJ, 1999, J CELL BIOL, V147, P879, DOI 10.1083/jcb.147.4.879; Moyer BD, 1999, J CLIN INVEST, V104, P1353, DOI 10.1172/JCI7453; Moyer BD, 2000, J BIOL CHEM, V275, P27069; Murthy A, 1998, J BIOL CHEM, V273, P1273, DOI 10.1074/jbc.273.3.1273; Narumiya S, 1999, PHYSIOL REV, V79, P1193, DOI 10.1152/physrev.1999.79.4.1193; Parent JL, 2001, J BIOL CHEM, V276, P7079, DOI 10.1074/jbc.M009375200; Parent JL, 1999, J BIOL CHEM, V274, P8941, DOI 10.1074/jbc.274.13.8941; Poulat F, 1997, J BIOL CHEM, V272, P7167, DOI 10.1074/jbc.272.11.7167; Raghuram V, 2001, P NATL ACAD SCI USA, V98, P1300, DOI 10.1073/pnas.031538898; RAYCHOWDHURY MK, 1994, J BIOL CHEM, V269, P19256; Reczek D, 2001, J CELL BIOL, V153, P191, DOI 10.1083/jcb.153.1.191; Reczek D, 1997, J CELL BIOL, V139, P169, DOI 10.1083/jcb.139.1.169; Singer AU, 2002, NAT STRUCT BIOL, V9, P32, DOI 10.1038/nsb731; SMRCKA AV, 1993, J BIOL CHEM, V268, P9667; Tang Y, 2000, J BIOL CHEM, V275, P37559, DOI 10.1074/jbc.M006635200; Wang T, 1999, P NATL ACAD SCI USA, V96, P7843, DOI 10.1073/pnas.96.14.7843; WEINMAN EJ, 1995, J CLIN INVEST, V95, P2143, DOI 10.1172/JCI117903; Weinman EJ, 2000, AM J PHYSIOL-RENAL, V279, pF393, DOI 10.1152/ajprenal.2000.279.3.F393; Xu X, 1999, J BIOL CHEM, V274, P3549, DOI 10.1074/jbc.274.6.3549; Yun CHC, 1997, P NATL ACAD SCI USA, V94, P3010, DOI 10.1073/pnas.94.7.3010	36	46	48	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 25	2002	277	43					40751	40759		10.1074/jbc.M207910200	http://dx.doi.org/10.1074/jbc.M207910200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	607KU	12193606	hybrid			2022-12-27	WOS:000178791400077
J	Gonzalez, E; Kou, R; Lin, AJ; Golan, DE; Michel, T				Gonzalez, E; Kou, R; Lin, AJ; Golan, DE; Michel, T			Subcellular targeting and agonist-induced site-specific phosphorylation of endothelial nitric-oxide synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DUAL ACYLATION; ACTIVATION; AKT; TRANSLOCATION; PALMITOYLATION; DOMAIN; GOLGI; CELLS	The endothelial isoform of nitric-oxide synthase (eNOS) undergoes a complex pattern of covalent modifications, including acylation with the fatty acids myristate and palmitate as well as phosphorylation on multiple sites. eNOS acylation is a key determinant for the reversible subcellular targeting of the enzyme to plasmalemmal caveolae. We transfected a series of hemagglutinin epitope-tagged eNOS mutant cDNAs deficient in palmitoylation (palm(-)) and/or myristoylation (myr(-)) into bovine aortic endothelial cells; after treatment with the eNOS agonists sphingosine 1-phosphate or vascular endothelial growth factor, the recombinant eNOS was immunoprecipitated using an antibody directed against the epitope tag, and patterns of eNOS phosphorylation were analyzed in immunoblots probed with phosphorylation state-specific eNOS antibodies. The wild-type eNOS underwent agonist-induced phosphorylation at serine 1179 (a putative site for phosphorylation by kinase Akt), but phosphorylation of the myr(-) eNOS at this residue was nearly abrogated; the palm- eNOS exhibited an intermediate phenotype. The addition of the CD8 transmembrane domain to the amino terminus of eNOS acylation-deficient mutants rescued the wild-type phenotype of robust agonist-induced serine 1179 phosphorylation. Thus, membrane targeting, but not necessarily acylation, is the critical determinant for agonist-promoted eNOS phosphorylation at serine 1179. In striking contrast to serine 1179, phosphorylation of eNOS at serine 116 was enhanced in the myr- eNOS mutant and was markedly attenuated in the CD8-eNOS membrane-targeted fusion protein. We conclude that eNOS targeting differentially affects eNOS phosphorylation at distinct sites in the protein and suggest that the inter-relationships of eNOS acylation and phosphorylation may modulate eNOS localization and activity and thereby influence NO signaling pathways in the vessel wall.	Harvard Univ, Div Cardiovasc, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA; Harvard Univ, Div Hematol, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA; Harvard Univ, Dept Biol Chem & Mol Pharmacol, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA; Vet Affairs Boston Healthcare Syst, Boston, MA 02132 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System	Michel, T (corresponding author), Harvard Univ, Div Cardiovasc, Brigham & Womens Hosp, Sch Med, 75 Francis St, Boston, MA 02115 USA.	dgolan@hms.harvard.edu; michel@calvin.bwh.harvard.edu	Mordwinkin, Nicholas M/A-4347-2010		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL032854, R37HL032854, R01HL046457, R29HL046457, P60HL015157] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007155] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036259, R37GM036259] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL32854, HL15157, HL46457] Funding Source: Medline; NIEHS NIH HHS [T32ES07155] Funding Source: Medline; NIGMS NIH HHS [GM36259] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Astoul E, 1999, J CELL BIOL, V145, P1511, DOI 10.1083/jcb.145.7.1511; Bernier SG, 2000, J BIOL CHEM, V275, P30707, DOI 10.1074/jbc.M005116200; Brazil DP, 2001, TRENDS BIOCHEM SCI, V26, P657, DOI 10.1016/S0968-0004(01)01958-2; BUSCONI L, 1993, J BIOL CHEM, V268, P8410; Butt E, 2000, J BIOL CHEM, V275, P5179, DOI 10.1074/jbc.275.7.5179; Chen ZP, 1999, FEBS LETT, V443, P285, DOI 10.1016/S0014-5793(98)01705-0; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Feron O, 1998, BIOCHEMISTRY-US, V37, P193, DOI 10.1021/bi972307p; Fleming I, 2001, CIRC RES, V88, pE68, DOI 10.1161/hh1101.092677; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Fulton D, 2002, J BIOL CHEM, V277, P4277, DOI 10.1074/jbc.M106302200; Gallis B, 1999, J BIOL CHEM, V274, P30101, DOI 10.1074/jbc.274.42.30101; Ghosh S, 1998, J BIOL CHEM, V273, P22267, DOI 10.1074/jbc.273.35.22267; Goetz RM, 1999, P NATL ACAD SCI USA, V96, P2788, DOI 10.1073/pnas.96.6.2788; Harris MB, 2001, J BIOL CHEM, V276, P16587, DOI 10.1074/jbc.M100229200; Hisamoto K, 2001, J BIOL CHEM, V276, P3459, DOI 10.1074/jbc.M005036200; Igarashi J, 2001, J BIOL CHEM, V276, P12420, DOI 10.1074/jbc.M008375200; Kandel ES, 1999, EXP CELL RES, V253, P210, DOI 10.1006/excr.1999.4690; Kantor DB, 1996, SCIENCE, V274, P1744, DOI 10.1126/science.274.5293.1744; Klauck TM, 1996, SCIENCE, V271, P1589, DOI 10.1126/science.271.5255.1589; Kou RQ, 2002, J BIOL CHEM, V277, P29669, DOI 10.1074/jbc.M204519200; Kou RQ, 2002, BIOCHEMISTRY-US, V41, P4982, DOI 10.1021/bi016017r; Lee H, 2000, AM J PHYSIOL-CELL PH, V278, pC612, DOI 10.1152/ajpcell.2000.278.3.C612; Liu JW, 1997, J CELL BIOL, V137, P1525, DOI 10.1083/jcb.137.7.1525; LOSCALZO J, 1995, PROG CARDIOVASC DIS, V38, P87, DOI 10.1016/S0033-0620(05)80001-5; Meier R, 1997, J BIOL CHEM, V272, P30491, DOI 10.1074/jbc.272.48.30491; Michel T, 1997, J CLIN INVEST, V100, P2146, DOI 10.1172/JCI119750; MICHEL T, 1993, P NATL ACAD SCI USA, V90, P6252, DOI 10.1073/pnas.90.13.6252; Michell BJ, 1999, CURR BIOL, V9, P845, DOI 10.1016/S0960-9822(99)80371-6; MONCADA S, 1993, NEW ENGL J MED, V329, P2002; Montagnani M, 2001, J BIOL CHEM, V276, P30392, DOI 10.1074/jbc.M103702200; Prabhakar P, 2000, J BIOL CHEM, V275, P19416, DOI 10.1074/jbc.M001952200; Prabhakar P, 1998, J BIOL CHEM, V273, P27383, DOI 10.1074/jbc.273.42.27383; ROBINSON LJ, 1995, P NATL ACAD SCI USA, V92, P11776, DOI 10.1073/pnas.92.25.11776; ROBINSON LJ, 1995, J BIOL CHEM, V270, P995, DOI 10.1074/jbc.270.3.995; Shaul PW, 1998, AM J PHYSIOL-LUNG C, V275, pL843, DOI 10.1152/ajplung.1998.275.5.L843; Shaul PW, 1996, J BIOL CHEM, V271, P6518, DOI 10.1074/jbc.271.11.6518; Sim ATR, 1999, CELL CALCIUM, V26, P209, DOI 10.1054/ceca.1999.0072; Vanhaesebroeck B, 2000, BIOCHEM J, V346, P561, DOI 10.1042/0264-6021:3460561	39	76	77	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2002	277	42					39554	39560		10.1074/jbc.M207299200	http://dx.doi.org/10.1074/jbc.M207299200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	605EA	12189156	hybrid			2022-12-27	WOS:000178662500065
J	Guo, FS; Maurizi, MR; Esser, L; Xia, D				Guo, FS; Maurizi, MR; Esser, L; Xia, D			Crystal structure of ClpA, an Hsp100 chaperone and regulator of ClpAP protease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONFORMATIONAL-CHANGES; AAA-ATPASE; COMPLEX; PROTEOLYSIS; DOMAIN; UBIQUITIN; HOMOLOGY; RUVB; NSF	Escherichia coli ClpA, an Hsp100/Clp chaperone and an integral component of the ATP-dependent ClpAP protease, participates in regulatory protein degradation and the dissolution and degradation of protein aggregates. The crystal structure of the ClpA subunit reveals an N-terminal domain with pseudo-twofold symmetry and two AAA(+) modules (D1 and D2) each consisting of a large and a small sub-domain with ADP bound in the sub-domain junction. The N-terminal domain interacts with the D1 domain in a manner similar to adaptor-binding domains of other AAA(+) proteins. D1 and D2 are connected head-to-tail consistent with a cooperative and vectorial translocation of protein substrates. In a planar hexamer model of ClpA, built by assembling ClpA D1 and D2 into homohexameric rings of known structures of AAA(+) modules, the differences in D1-D1 and D2-D2 interfaces correlate with their respective contributions to hexamer stability and ATPase activity.	NCI, Cell Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Xia, D (corresponding author), 37 Convent Dr,Bldg 37,Rm 1B22, Bethesda, MD 20892 USA.	dixia@helix.hih.gov						BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beuron F, 1998, J STRUCT BIOL, V123, P248, DOI 10.1006/jsbi.1998.4039; BLOCK MR, 1988, P NATL ACAD SCI USA, V85, P7852, DOI 10.1073/pnas.85.21.7852; Bochtler M, 2000, NATURE, V403, P800, DOI 10.1038/35001629; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cowtan KD, 1996, ACTA CRYSTALLOGR D, V52, P43, DOI 10.1107/S090744499500761X; Dai RM, 2001, NAT CELL BIOL, V3, P740, DOI 10.1038/35087056; Dougan DA, 2002, MOL CELL, V9, P673, DOI 10.1016/S1097-2765(02)00485-9; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; Gottesman S, 1998, GENE DEV, V12, P1338, DOI 10.1101/gad.12.9.1338; Grimaud R, 1998, J BIOL CHEM, V273, P12476, DOI 10.1074/jbc.273.20.12476; Guenther B, 1997, CELL, V91, P335, DOI 10.1016/S0092-8674(00)80417-1; Hanson PI, 1997, CELL, V90, P523, DOI 10.1016/S0092-8674(00)80512-7; Hattendorf DA, 2002, EMBO J, V21, P12, DOI 10.1093/emboj/21.1.12; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Hoskins JR, 1998, P NATL ACAD SCI USA, V95, P12135, DOI 10.1073/pnas.95.21.12135; Ishikawa T, 2001, P NATL ACAD SCI USA, V98, P4328, DOI 10.1073/pnas.081543698; Jeruzalmi D, 2001, CELL, V106, P429, DOI 10.1016/S0092-8674(01)00463-9; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Karata K, 1999, J BIOL CHEM, V274, P26225, DOI 10.1074/jbc.274.37.26225; KESSEL M, 1995, J MOL BIOL, V250, P587, DOI 10.1006/jmbi.1995.0400; Kim YI, 2001, NAT STRUCT BIOL, V8, P230, DOI 10.1038/84967; Kondo H, 1997, NATURE, V388, P75, DOI 10.1038/40411; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Lenzen CU, 1998, CELL, V94, P525, DOI 10.1016/S0092-8674(00)81593-7; Liu JY, 2000, MOL CELL, V6, P637, DOI 10.1016/S1097-2765(00)00062-9; MAURIZI MR, 1994, METHOD ENZYMOL, V244, P314; Meyer HH, 2000, EMBO J, V19, P2181, DOI 10.1093/emboj/19.10.2181; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAGIEC EE, 1995, J BIOL CHEM, V270, P29182, DOI 10.1074/jbc.270.49.29182; Neuwald AF, 1999, GENOME RES, V9, P27; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Otwinowski Z., 1991, ISOMORPHOUS REPLACEM, P80; PARSELL DA, 1991, NATURE, V353, P270, DOI 10.1038/353270a0; Putnam CD, 2001, J MOL BIOL, V311, P297, DOI 10.1006/jmbi.2001.4852; Rabouille C, 1998, CELL, V92, P603, DOI 10.1016/S0092-8674(00)81128-9; Schirmer EC, 1998, J BIOL CHEM, V273, P15546, DOI 10.1074/jbc.273.25.15546; SEOL JH, 1995, BIOCHEM BIOPH RES CO, V217, P41, DOI 10.1006/bbrc.1995.2743; SINGH SK, 1994, J BIOL CHEM, V269, P29537; Singh SK, 2001, J BIOL CHEM, V276, P29420, DOI 10.1074/jbc.M103489200; Sousa MC, 2000, CELL, V103, P633, DOI 10.1016/S0092-8674(00)00166-5; Wang J, 2001, STRUCTURE, V9, P177, DOI 10.1016/S0969-2126(01)00570-6; Wang J, 2001, STRUCTURE, V9, P1107, DOI 10.1016/S0969-2126(01)00670-0; Wickner S, 1999, SCIENCE, V286, P1888, DOI 10.1126/science.286.5446.1888; WICKNER S, 1994, P NATL ACAD SCI USA, V91, P12218, DOI 10.1073/pnas.91.25.12218; Wilson AJC, 1942, NATURE, V150, P151, DOI 10.1038/150152a0; Yamada K, 2001, P NATL ACAD SCI USA, V98, P1442, DOI 10.1073/pnas.031470598; Yu RC, 1998, NAT STRUCT BIOL, V5, P803, DOI 10.1038/1843; Zhang XD, 2000, MOL CELL, V6, P1473, DOI 10.1016/S1097-2765(00)00143-X	52	168	171	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2002	277	48					46743	46752		10.1074/jbc.M207796200	http://dx.doi.org/10.1074/jbc.M207796200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620JB	12205096	hybrid			2022-12-27	WOS:000179529300134
J	Netzel-Arnett, S; Mitola, DJ; Yamada, SS; Chrysovergis, K; Holmbeck, K; Birkedal-Hansen, H; Bugge, TH				Netzel-Arnett, S; Mitola, DJ; Yamada, SS; Chrysovergis, K; Holmbeck, K; Birkedal-Hansen, H; Bugge, TH			Collagen dissolution by keratinocytes requires cell surface plasminogen activation and matrix metalloproteinase activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-BOUND UROKINASE; SMOOTH-MUSCLE-CELLS; INTERSTITIAL COLLAGENASE; DEGRADING PROTEASES; IV COLLAGENASE; GROWTH-FACTOR; IN-VIVO; SYSTEM; INHIBITION; MECHANISM	Matrix metalloproteinase-14 is required for degradation of fibrillar collagen by mesenchymal cells. Here we show that keratinocytes use an alternative plasminogen and matrix metalloproteinase-13-dependent pathway for dissolution of collagen fibrils. Primary keratinocytes displayed an absolute requirement for serum to dissolve collagen. Dissolution of collagen was abolished in plasminogen-depleted serum and could be restored by the exogenous addition of plasminogen. Both plasminogen activator inhibitor-1 and tissue inhibitor of metalloproteinase blocked collagen dissolution, demonstrating the requirement of both plasminogen activation and matrix metalloproteinase activity for degradation. Cell surface plasmin activity was critical for the degradation process as aprotinin, but not alpha(2)-antiplasmin, prevented collagen dissolution. Keratinocytes with single deficiencies in either urokinase or tissue plasminogen activator retained the ability to dissolve collagen. However, collagen fibril dissolution was abolished in keratinocytes with a combined deficiency in both urokinase and tissue plasminogen activator. Combined, but not single, urokinase and tissue plasminogen activator deficiency also completely blocked the activation of the fibrillar collagenase, matrix metalloproteinase-13, by keratinocytes. The activation of matrix metalloproteinase-13 in normal keratinocytes was prevented by plasminogen activator inhibitor-1 and aprotinin but not by tissue inhibitor of metalloproteinase-1 and -2, suggesting that plasmin activates matrix metalloproteinase-13 directly. We propose that plasminogen activation facilitates keratinocyte-mediated collagen breakdown via the direct activation of matrix metalloproteinase-13 and possibly other fibrillar collagenases.	NIDCR, Matrix Metalloprot Unit, NIH, Bethesda, MD 20892 USA; NIDCR, Proteases & Tissue Remodeling Unit, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Birkedal-Hansen, H (corresponding author), NIDCR, Matrix Metalloprot Unit, NIH, Rm 30-132,30 Convent Dr, Bethesda, MD 20892 USA.	netzelars@usa.redcross.org; Henning.Birkedal-Hansen@nih.gov		Holmbeck, Kenn/0000-0002-4472-3257				AIMES RT, 1995, J BIOL CHEM, V270, P5872, DOI 10.1074/jbc.270.11.5872; Andreasen PA, 1997, INT J CANCER, V72, P1, DOI 10.1002/(SICI)1097-0215(19970703)72:1<1::AID-IJC1>3.0.CO;2-Z; Andreasen PA, 2000, CELL MOL LIFE SCI, V57, P25, DOI 10.1007/s000180050497; BAKER MS, 1990, CANCER RES, V50, P4676; Balbin M, 2001, J BIOL CHEM, V276, P10253, DOI 10.1074/jbc.M009586200; BELIN D, 1985, EUR J BIOCHEM, V148, P225, DOI 10.1111/j.1432-1033.1985.tb08829.x; Benbow U, 1999, J BIOL CHEM, V274, P25371, DOI 10.1074/jbc.274.36.25371; Bezerra JA, 2001, AM J PATHOL, V158, P921, DOI 10.1016/S0002-9440(10)64039-4; BIRKEDALHANSEN H, 1987, METHOD ENZYMOL, V144, P140; BIRKEDALHANSEN H, 1993, CRIT REV ORAL BIOL M, V4, P197, DOI 10.1177/10454411930040020401; Blavier L, 2001, MOL BIOL CELL, V12, P1457, DOI 10.1091/mbc.12.5.1457; Bugge TH, 1996, P NATL ACAD SCI USA, V93, P5899, DOI 10.1073/pnas.93.12.5899; BUGGE TH, 1995, J BIOL CHEM, V270, P16886, DOI 10.1074/jbc.270.28.16886; CARMELIET P, 1994, NATURE, V368, P419, DOI 10.1038/368419a0; Carmeliet P, 1998, J CELL BIOL, V140, P233, DOI 10.1083/jcb.140.1.233; Carmeliet P, 1997, NAT GENET, V17, P439, DOI 10.1038/ng1297-439; COLLEN D, 1994, MOL BASIS BLOOD DIS, P725; Coussens LM, 1999, GENE DEV, V13, P1382, DOI 10.1101/gad.13.11.1382; CUBELLIS MV, 1989, P NATL ACAD SCI USA, V86, P4828, DOI 10.1073/pnas.86.13.4828; Dano K, 1999, APMIS, V107, P120, DOI 10.1111/j.1699-0463.1999.tb01534.x; DANO K, 1985, ADV CANCER RES, V44, P139, DOI 10.1016/S0065-230X(08)60028-7; Davis GE, 2001, J CELL SCI, V114, P917; DEUTSCH DG, 1970, SCIENCE, V170, P1095, DOI 10.1126/science.170.3962.1095; Drew AF, 1998, BLOOD, V91, P1616, DOI 10.1182/blood.V91.5.1616.1616_1616_1624; ELLIS V, 1991, J BIOL CHEM, V266, P12752; ELLIS V, 1990, J BIOL CHEM, V265, P9904; Gelb BD, 1996, SCIENCE, V273, P1236, DOI 10.1126/science.273.5279.1236; Gingrich MB, 2000, TRENDS NEUROSCI, V23, P399, DOI 10.1016/S0166-2236(00)01617-9; Hajjar KA, 2000, ANN NY ACAD SCI, V902, P265; HALL SW, 1991, J BIOL CHEM, V266, P12329; Havemose-Poulsen A, 1998, J PERIODONTAL RES, V33, P280, DOI 10.1111/j.1600-0765.1998.tb02201.x; Hay ED., 1991, CELL BIOL EXTRACELLU, P7; HENRIET P, 1992, FEBS LETT, V310, P175, DOI 10.1016/0014-5793(92)81323-E; Holmbeck K, 1999, CELL, V99, P81, DOI 10.1016/S0092-8674(00)80064-1; Hotary K, 2000, J CELL BIOL, V149, P1309, DOI 10.1083/jcb.149.6.1309; Kitching AR, 1997, J EXP MED, V185, P963, DOI 10.1084/jem.185.5.963; Knauper V, 1996, J BIOL CHEM, V271, P17124, DOI 10.1074/jbc.271.29.17124; Knauper V, 1996, J BIOL CHEM, V271, P1544, DOI 10.1074/jbc.271.3.1544; KOBAYASHI H, 1991, J BIOL CHEM, V266, P5147; KRISTENSEN P, 1991, J CELL BIOL, V115, P1763, DOI 10.1083/jcb.115.6.1763; Lee SL, 2000, J BIOL CHEM, V275, P36720, DOI 10.1074/jbc.M007802200; Lijnen HR, 1998, ARTERIOSCL THROM VAS, V18, P1035, DOI 10.1161/01.ATV.18.7.1035; List K, 2000, BIOCHEMISTRY-US, V39, P508, DOI 10.1021/bi991701f; Longstaff C, 1999, BLOOD, V93, P3839, DOI 10.1182/blood.V93.11.3839.411k08_3839_3846; Lund LR, 1999, EMBO J, V18, P4645, DOI 10.1093/emboj/18.17.4645; Luttun A, 2000, Curr Atheroscler Rep, V2, P407, DOI 10.1007/s11883-000-0079-z; Mazzieri R, 1997, EMBO J, V16, P2319, DOI 10.1093/emboj/16.9.2319; McCawley LJ, 2000, MOL MED TODAY, V6, P149, DOI 10.1016/S1357-4310(00)01686-5; McCawley LJ, 2001, CURR OPIN CELL BIOL, V13, P534, DOI 10.1016/S0955-0674(00)00248-9; MOOKHTIAR KA, 1990, BIOCHEMISTRY-US, V29, P10620, DOI 10.1021/bi00499a007; Moons L, 1998, J CLIN INVEST, V102, P1788, DOI 10.1172/JCI3316; Mukhina S, 2000, J BIOL CHEM, V275, P16450, DOI 10.1074/jbc.M909080199; Nicole O, 2001, NAT MED, V7, P59, DOI 10.1038/83358; Ohuchi E, 1997, J BIOL CHEM, V272, P2446, DOI 10.1074/jbc.272.4.2446; PEI DQ, 1995, NATURE, V375, P244, DOI 10.1038/375244a0; PENTLAND AP, 1986, J CLIN INVEST, V77, P246, DOI 10.1172/JCI112283; Pilcher BK, 1997, J CELL BIOL, V137, P1445, DOI 10.1083/jcb.137.6.1445; PLOW EF, 1986, J CELL BIOL, V103, P2411, DOI 10.1083/jcb.103.6.2411; Ramos-DeSimone N, 1999, J BIOL CHEM, V274, P13066, DOI 10.1074/jbc.274.19.13066; Romisch J, 1999, HAEMOSTASIS, V29, P292; Saftig P, 1998, P NATL ACAD SCI USA, V95, P13453, DOI 10.1073/pnas.95.23.13453; SAWAYA R, 1988, J NEUROSURG, V68, P73, DOI 10.3171/jns.1988.68.1.0073; Seandel M, 2001, BLOOD, V97, P2323, DOI 10.1182/blood.V97.8.2323; Segal G, 2001, J CELL SCI, V114, P119; Stathakis P, 1999, J BIOL CHEM, V274, P8910, DOI 10.1074/jbc.274.13.8910; STRONGIN AY, 1995, J BIOL CHEM, V270, P5331, DOI 10.1074/jbc.270.10.5331; Takeuchi T, 2000, J BIOL CHEM, V275, P26333, DOI 10.1074/jbc.M002941200; Tsirka SE, 1997, P NATL ACAD SCI USA, V94, P9779, DOI 10.1073/pnas.94.18.9779; VANDERREST M, 1991, FASEB J, V5, P2814, DOI 10.1096/fasebj.5.13.1916105; VANWART HE, 1990, P NATL ACAD SCI USA, V87, P5578, DOI 10.1073/pnas.87.14.5578; Werb Z, 1997, CELL, V91, P439, DOI 10.1016/S0092-8674(00)80429-8; Werb Z, 1999, APMIS, V107, P11, DOI 10.1111/j.1699-0463.1999.tb01521.x; WERB Z, 1977, NEW ENGL J MED, V296, P1017, DOI 10.1056/NEJM197705052961801; Werner F, 1999, J BIOL CHEM, V274, P21555, DOI 10.1074/jbc.274.31.21555; Windsor L. J, 2002, MATRIX METALLOPROTEI, DOI DOI 10.8.6-10.8.7; WOESSNER JF, 1996, MATRIX METALLOPROTEI; YUSPA SH, 1985, METHODS SKIN RES, P213	77	67	69	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2002	277	47					45154	45161		10.1074/jbc.M206354200	http://dx.doi.org/10.1074/jbc.M206354200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	618EE	12192005	hybrid			2022-12-27	WOS:000179404800073
J	Day, KC; McCabe, MT; Zhao, X; Wang, YH; Davis, JN; Phillips, J; Von Geldern, M; Ried, T; KuKuruga, MA; Cunha, GR; Hayward, SW; Day, ML				Day, KC; McCabe, MT; Zhao, X; Wang, YH; Davis, JN; Phillips, J; Von Geldern, M; Ried, T; KuKuruga, MA; Cunha, GR; Hayward, SW; Day, ML			Rescue of embryonic epithelium reveals that the homozygous deletion of the retinoblastoma gene confers growth factor independence and immortality but does not influence epithelial differentiation or tissue morphogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR; CELL-CYCLE; MALIGNANT TRANSFORMATION; CHROMOSOMAL-ABERRATIONS; TARGETED DISRUPTION; PROSTATE-CANCER; CARCINOMA-CELLS; VIRAL ONCOGENES; KINASE-ACTIVITY; G(1) CONTROL	The ability to rescue viable prostate precursor tissue from retinoblastoma-deficient (Rb-/-) fetal mice has allowed for the isolation and characterization of the first Rb-/- prostate epithelial cell line. This cell line, designated Rb-/-PrE, was utilized for experiments examining the consequences of Rb loss on an epithelial population. These findings demonstrated that Rb deletion has no discernible effect on prostatic histodifferentiation in Rb-/-PrE cultures. When Rb-/-PrE cells were recombined with embryonic rat urogenital mesenchyme and implanted into athymic male, nude mouse hosts, the recombinants developed into fully differentiated and morphologically normal prostate tissue. The Rb-/-PrE phenotype was characterized by serum independence in culture and immortality in vivo, when compared with wild type controls. Cell cycle analysis revealed elevated S phase DNA content accompanied by increased expression of cyclin El and proliferating cell nuclear antigen. Rb-/-PrE cultures also exhibited a diminished ability to growth arrest under high density culture conditions. We believe that the development of Rb-/- prostate tissue and cell lines has provided a unique experimental platform with which to investigate the consequences of Rb deletion in epithelial cells under various physiological conditions. Additionally, the development of this technology will allow similar studies in other tissues and cell populations rescued from Rb-/- fetuses.	Univ Michigan, Dept Urol, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; NCI, Urol Oncol Branch, Genet Sect, NIH, Bethesda, MD 20892 USA; Vanderbilt Univ, Med Ctr, Dept Canc Biol, Vanderbilt Ingram Comprehens Canc Ctr, Nashville, TN 37232 USA; Vanderbilt Univ, Med Ctr, Dept Urol Surg, Vanderbilt Ingram Comprehens Canc Ctr, Nashville, TN 37232 USA	University of Michigan System; University of Michigan; University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Vanderbilt University; Vanderbilt University	Day, ML (corresponding author), Univ Michigan, Dept Urol, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA.			Wang, Yuzhuo/0000-0002-9749-8591; Hayward, Simon/0000-0002-6059-6550	NATIONAL CANCER INSTITUTE [U01CA096403, P50CA069568] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056137] Funding Source: NIH RePORTER; NCI NIH HHS [P50 CA69568, CA96403] Funding Source: Medline; NIDDK NIH HHS [DK56137] Funding Source: Medline; PHS HHS [F005952, F005192] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Abate-Shen C, 2000, GENE DEV, V14, P2410, DOI 10.1101/gad.819500; Blagosklonny MV, 1997, CANCER RES, V57, P320; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; BOOKSTEIN R, 1990, SCIENCE, V247, P712, DOI 10.1126/science.2300823; Brehm A, 1999, TRENDS BIOCHEM SCI, V24, P142, DOI 10.1016/S0968-0004(99)01368-7; CHELLAPPAN SP, 1991, CELL, V65, P1053, DOI 10.1016/0092-8674(91)90557-F; CHEN PL, 1989, CELL, V58, P1193, DOI 10.1016/0092-8674(89)90517-5; Chen Y, 1996, CELL GROWTH DIFFER, V7, P1571; CLARKE AR, 1992, NATURE, V359, P328, DOI 10.1038/359328a0; COBRINIK D, 1992, TRENDS BIOCHEM SCI, V17, P312, DOI 10.1016/0968-0004(92)90443-D; Cottage A, 2001, GENE CHROMOSOME CANC, V30, P72, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1060>3.0.CO;2-X; CUNHA GR, 1984, STAIN TECHNOL, V59, P7, DOI 10.3109/10520298409113823; DANIELSEN HE, 1991, CARCINOGENESIS, V12, P1777, DOI 10.1093/carcin/12.10.1777; Dannenberg JH, 2000, GENE DEV, V14, P3051, DOI 10.1101/gad.847700; Day ML, 1997, J BIOL CHEM, V272, P8125, DOI 10.1074/jbc.272.13.8125; DECAPRIO JA, 1988, CELL, V54, P275, DOI 10.1016/0092-8674(88)90559-4; DEGREGORI J, 1995, GENE DEV, V9, P2873, DOI 10.1101/gad.9.23.2873; DEKLERK DP, 1978, INVEST UROL, V16, P240; Difilippantonio MJ, 2000, NATURE, V404, P510, DOI 10.1038/35006670; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Harbour JW, 2001, CURR TOP MICROBIOL, V254, P137; Hayward SW, 1999, PROSTATE, V39, P205; Hayward SW, 2001, CANCER RES, V61, P8135; HINDS PW, 1992, CELL, V70, P993, DOI 10.1016/0092-8674(92)90249-C; JACKS T, 1992, NATURE, V359, P295, DOI 10.1038/359295a0; Jiang Z, 1997, ONCOGENE, V14, P1789, DOI 10.1038/sj.onc.1201014; Knudsen KE, 1998, J BIOL CHEM, V273, P20213, DOI 10.1074/jbc.273.32.20213; KRAEMER PM, 1987, CANCER GENET CYTOGEN, V27, P273, DOI 10.1016/0165-4608(87)90010-0; KUBBIES M, 1986, CYTOMETRY, V7, P551, DOI 10.1002/cyto.990070609; LASSAR AB, 1994, CURR OPIN CELL BIOL, V6, P788, DOI 10.1016/0955-0674(94)90046-9; LEE EYHP, 1992, NATURE, V359, P288, DOI 10.1038/359288a0; Lee MH, 1996, GENE DEV, V10, P1621, DOI 10.1101/gad.10.13.1621; Lipinski MM, 1999, ONCOGENE, V18, P7873, DOI 10.1038/sj.onc.1203244; Liyanage M, 1996, NAT GENET, V14, P312, DOI 10.1038/ng1196-312; LORKE DE, 1994, ACTA ANAT, V150, P159; Mulligan G, 1998, TRENDS GENET, V14, P223, DOI 10.1016/S0168-9525(98)01470-X; Nevins JR, 1998, CELL GROWTH DIFFER, V9, P585; Niculescu AB, 1998, MOL CELL BIOL, V18, P629, DOI 10.1128/MCB.18.1.629; NORMAN JT, 1986, PROSTATE, V8, P209, DOI 10.1002/pros.2990080302; Ozer H L, 2000, Prog Mol Subcell Biol, V24, P121; Phillips JL, 2001, CANCER RES, V61, P8143; Robinson GW, 2001, ONCOGENE, V20, P7115, DOI 10.1038/sj.onc.1204888; Sage J, 2000, GENE DEV, V14, P3037, DOI 10.1101/gad.843200; Signoretti S, 2000, AM J PATHOL, V157, P1769, DOI 10.1016/S0002-9440(10)64814-6; Thompson JB, 2000, PETROLOGY+, V8, P303; Tsao SW, 2001, CANCER GENET CYTOGEN, V130, P141, DOI 10.1016/S0165-4608(01)00473-3; Wagner M, 2001, DEV DYNAM, V220, P198, DOI 10.1002/1097-0177(20010301)220:3<198::AID-DVDY1103>3.0.CO;2-T; Wan TSK, 1997, CANCER GENET CYTOGEN, V95, P166, DOI 10.1016/S0165-4608(96)00245-2; Wang YH, 2000, CANCER RES, V60, P6008; Watanabe G, 1998, MOL CELL BIOL, V18, P3212, DOI 10.1128/MCB.18.6.3212; Weaver ZA, 1999, GENE CHROMOSOME CANC, V25, P251, DOI 10.1002/(SICI)1098-2264(199907)25:3<251::AID-GCC7>3.0.CO;2-3; Weber JD, 2000, GENE DEV, V14, P2358, DOI 10.1101/gad.827300; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; WILLIAMS BO, 1994, EMBO J, V13, P4251, DOI 10.1002/j.1460-2075.1994.tb06745.x; Yang F, 2000, CHROMOSOME RES, V8, P219, DOI 10.1023/A:1009200912436; YEE AS, 1998, FRONT BIOSCI, V3, P532; Yeh SY, 1998, BIOCHEM BIOPH RES CO, V248, P361, DOI 10.1006/bbrc.1998.8974; Zhao X, 1997, J BIOL CHEM, V272, P22751, DOI 10.1074/jbc.272.36.22751; Zheng L, 2001, EXP CELL RES, V264, P2, DOI 10.1006/excr.2000.5129; ZHU L, 1993, GENE DEV, V7, P1111, DOI 10.1101/gad.7.7a.1111; Zwerschke W, 2000, ADV CANCER RES, V78, P1	61	24	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	2002	277	46					44475	44484		10.1074/jbc.M205361200	http://dx.doi.org/10.1074/jbc.M205361200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	615XE	12191999	hybrid			2022-12-27	WOS:000179272000119
J	Franek, WR; Chowdary, YC; Lin, XC; Hu, MW; Miller, EJ; Kazzaz, JA; Razzano, P; Romashko, J; Davis, JM; Narula, P; Horowitz, S; Scott, W; Mantell, LL				Franek, WR; Chowdary, YC; Lin, XC; Hu, MW; Miller, EJ; Kazzaz, JA; Razzano, P; Romashko, J; Davis, JM; Narula, P; Horowitz, S; Scott, W; Mantell, LL			Suppression of nuclear Factor-kappa B activity by nitric oxide and hyperoxia in oxygen-resistant cells*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED APOPTOSIS; DNA-BINDING; OXIDATIVE STRESS; INHIBITION; ACTIVATION; INDUCTION; ALPHA; TRANSLOCATION; INFLAMMATION; EXPRESSION	Inhaled nitric oxide (iNO) is used clinically to treat pulmonary hypertension in newborns, often in conjunction with hyperoxia (NO/O-2). Prolonged exposure to NO/O-2, causes synergistic lung injury and death of lung epithelial cells. To explore the mechanisms involved, oxygen-resistant HeLa-80 cells were exposed to NO +/- O-2. Exposure to NO and O-2 induced a synergistic cytotoxicity, accompanied with apoptotic characteristics, including elevated caspase-3-like activity, Annexin V incorporation, and nuclear condensation. This apoptosis was associated with a synergistic suppression of NF-kappaB activity. Cells lacking functional NF-kappaB p65 subunit were more sensitive to NO/O-2, than their wild type counterparts. This injury was partially rescued by transfection with a p65 expression construct, suggesting an inverse relationship between NF-kappaB and susceptibility to the cytotoxicity of NO/O-2. Despite the reduced NF-kappaB activity in cells exposed to NO +/- O-2, IkappaBalpha was degraded, suggesting that pathways regulating the steady-state levels of IkappaB were not involved. However, exposure to NO/O-2 caused a marked reduction in nuclear localization and an increase in protein carbonyl formation of NF-kappaB p65 subunit. These results suggest that NO/O-2-induced apoptosis occurs by suppressing NF-kappaB activity.	NYU, Sch Med, N Shore Long Isl Jewish Hlth Syst, Dept Surg,Cardiac Res Lab, Manhasset, NY 11030 USA; SUNY Stony Brook, Winthrop Univ Hosp, Sch Med, Dept Cardiovasc Thorac Surg, Mineola, NY 11501 USA; SUNY Stony Brook, Winthrop Univ Hosp, Sch Med, Dept Pediat, Mineola, NY 11501 USA; SUNY Stony Brook, Winthrop Univ Hosp, Sch Med, Dept Med, Mineola, NY 11501 USA; Univ Louisville, Jewish Hosp Hearth & Lung Inst, Dept Med, Louisville, KY 40202 USA; Univ Louisville, Jewish Hosp Hearth & Lung Inst, Dept Pharmacol & Toxicol, Louisville, KY 40202 USA	New York University; Northwell Health; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Winthrop University Hospital; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Winthrop University Hospital; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Winthrop University Hospital; University of Louisville; University of Louisville	Mantell, LL (corresponding author), NYU, Sch Med, N Shore Long Isl Jewish Hlth Syst, Dept Surg,Cardiac Res Lab, 350 Community Dr, Manhasset, NY 11030 USA.		Mordwinkin, Nicholas M/A-4347-2010					Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; Bogdan C, 2001, TRENDS CELL BIOL, V11, P66, DOI 10.1016/S0962-8924(00)01900-0; BONFOCO E, 1995, P NATL ACAD SCI USA, V92, P7162, DOI 10.1073/pnas.92.16.7162; CARMICHAEL J, 1987, CANCER RES, V47, P943; Connelly L, 2001, J IMMUNOL, V166, P3873, DOI 10.4049/jimmunol.166.6.3873; D'Acquisto F, 2001, CELL DEATH DIFFER, V8, P144, DOI 10.1038/sj.cdd.4400784; Davies KJA, 1999, IUBMB LIFE, V48, P41, DOI 10.1080/152165499307404; Deora AA, 1998, J BIOL CHEM, V273, P29923, DOI 10.1074/jbc.273.45.29923; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Ekekezie II, 2000, BIOL NEONATE, V77, P37, DOI 10.1159/000014193; Fortenberry JD, 1998, AM J RESP CELL MOL, V18, P421, DOI 10.1165/ajrcmb.18.3.2875; Franek WR, 2001, J BIOL CHEM, V276, P569, DOI 10.1074/jbc.M004716200; Ibe W, 2001, CELL PHYSIOL BIOCHEM, V11, P231, DOI 10.1159/000047808; JOENJE H, 1985, LAB INVEST, V52, P420; JOENJE H, 1997, OXYGEN EXPRESSION CE, P67; Marshall HE, 2001, BIOCHEMISTRY-US, V40, P1688, DOI 10.1021/bi002239y; Marshall HE, 1999, AM J RESP CELL MOL, V21, P296, DOI 10.1165/ajrcmb.21.3.f164; MARTIN SJ, 1995, J EXP MED, V182, P1545, DOI 10.1084/jem.182.5.1545; Matthews JR, 1996, NUCLEIC ACIDS RES, V24, P2236, DOI 10.1093/nar/24.12.2236; Mattson MP, 1997, J NEUROSCI RES, V49, P681, DOI 10.1002/(SICI)1097-4547(19970915)49:6<681::AID-JNR3>3.0.CO;2-3; Mattson MP, 2000, J NEUROCHEM, V74, P443, DOI 10.1046/j.1471-4159.2000.740443.x; Michelakis E, 2002, CIRCULATION, V105, P2398, DOI 10.1161/01.CIR.0000016641.12984.DC; Nader ND, 1999, ANESTHESIOLOGY, V91, P741, DOI 10.1097/00000542-199909000-00027; Nakshatri H, 1997, MOL CELL BIOL, V17, P3629, DOI 10.1128/MCB.17.7.3629; Narula P, 1998, AM J PHYSIOL-LUNG C, V274, pL411, DOI 10.1152/ajplung.1998.274.3.L411; PENG HB, 1995, J BIOL CHEM, V270, P14214, DOI 10.1074/jbc.270.23.14214; Popov S, 1996, P NATL ACAD SCI USA, V93, P11859, DOI 10.1073/pnas.93.21.11859; Raziuddin A, 1997, J BIOL CHEM, V272, P15715, DOI 10.1074/jbc.272.25.15715; ROBBINS CG, 1995, AM J PHYSIOL, V269, P545; Roman J, 2000, J BIOL CHEM, V275, P14684, DOI 10.1074/jbc.275.19.14684; ShattuckBrandt RL, 1997, CANCER RES, V57, P3032; Spiecker M, 1997, J BIOL CHEM, V272, P30969, DOI 10.1074/jbc.272.49.30969; STAMLER JS, 1992, P NATL ACAD SCI USA, V89, P7674, DOI 10.1073/pnas.89.16.7674; Stork E, 1997, NEW ENGL J MED, V336, P597; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Umansky V, 1998, EUR J IMMUNOL, V28, P2276, DOI 10.1002/(SICI)1521-4141(199808)28:08<2276::AID-IMMU2276>3.0.CO;2-H; XIE QW, 1994, J BIOL CHEM, V269, P4705; Yamamoto Y, 2001, J CLIN INVEST, V107, P135, DOI 10.1172/JCI11914	39	25	25	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					42694	42700		10.1074/jbc.M202623200	http://dx.doi.org/10.1074/jbc.M202623200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12215428	hybrid			2022-12-27	WOS:000179081200035
J	Philipps, B; Glockshuber, R				Philipps, B; Glockshuber, R			Randomization of the entire active-site helix alpha 1 of the thiol-disulfide oxidoreductase DsbA from Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOND FORMATION INVIVO; FORMATION IN-VIVO; REDOX PROPERTIES; ELECTROSTATIC INTERACTIONS; EFFICIENT CATALYSIS; CYSTEINE RESIDUES; ISOMERASE DSBA; PROTEIN; THIOREDOXIN; SEQUENCE	DsbA from Escherichia coli is the most oxidizing member of the thiol-disulfide oxidoreductase family (E-o' = -122 mV) and is required for efficient disulfide bond formation in the periplasm. The reactivity of the catalytic disulfide bond (Cys(30)-Pro(31)-His(32)-Cys(33)) is primarily due to an extremely low pK(alpha) value (3.4) Of Cys(30), which is stabilized by the partial positive dipole charge of the active-site helix alpha1 (residues 30-37). We have randomized all non-cysteine residues of helix alpha1 (residues 31, 32, and 34-37) and found that two-thirds of the resulting variants complement DsbA deficiency in a dsbA deletion strain. Sequencing of 98 variants revealed a large number of non-conservative replacements in active variants, even at well conserved positions. This indicates that tertiary structure context strongly determines a-helical secondary structure formation of the randomized sequence. A subset of active and inactive variants was further characterized. All these variants were more reducing than wild type DsbA, but the redox potentials of active variants did not drop below -210 mV. All inactive variants had redox potentials lower than -210 mV, although some of the inactive proteins were still re-oxidized by DsbB. This demonstrates that efficient oxidation of substrate polypeptides is the crucial property of DsbA in vivo.	ETH Honggerberg, Inst Molekularbiol & Biophys, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Glockshuber, R (corresponding author), ETH Honggerberg, Inst Molekularbiol & Biophys, CH-8093 Zurich, Switzerland.							Axe DD, 1996, P NATL ACAD SCI USA, V93, P5590, DOI 10.1073/pnas.93.11.5590; Bader M, 1998, J BIOL CHEM, V273, P10302, DOI 10.1074/jbc.273.17.10302; Bader M, 1999, CELL, V98, P217, DOI 10.1016/S0092-8674(00)81016-8; BARDWELL JCA, 1991, CELL, V67, P581, DOI 10.1016/0092-8674(91)90532-4; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Chivers PT, 1996, EMBO J, V15, P2659, DOI 10.1002/j.1460-2075.1996.tb00626.x; DAILEY FE, 1993, P NATL ACAD SCI USA, V90, P1043, DOI 10.1073/pnas.90.3.1043; DARBY NJ, 1995, BIOCHEMISTRY-US, V34, P3576, DOI 10.1021/bi00011a012; DeGrado WF, 1999, ANNU REV BIOCHEM, V68, P779, DOI 10.1146/annurev.biochem.68.1.779; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; GRAUSCHOPF U, 1995, CELL, V83, P947, DOI 10.1016/0092-8674(95)90210-4; Guddat LW, 1998, STRUCT FOLD DES, V6, P757, DOI 10.1016/S0969-2126(98)00077-X; Gustafsson C, 2001, J MOL RECOGNIT, V14, P308, DOI 10.1002/jmr.543; Hennecke J, 1997, BIOCHEMISTRY-US, V36, P6391, DOI 10.1021/bi963017w; Hennecke J, 1999, J MOL BIOL, V286, P1197, DOI 10.1006/jmbi.1998.2531; Hennecke J, 1997, J BIOL CHEM, V272, P189; HOL WGJ, 1985, PROG BIOPHYS MOL BIO, V45, P149, DOI 10.1016/0079-6107(85)90001-X; Holst B, 1997, J CELL BIOL, V138, P1229, DOI 10.1083/jcb.138.6.1229; Huber-Wunderlich M, 1998, FOLD DES, V3, P161, DOI 10.1016/S1359-0278(98)00024-8; Jacobi A, 1997, J BIOL CHEM, V272, P21692, DOI 10.1074/jbc.272.35.21692; Jonda S, 1999, EMBO J, V18, P3271, DOI 10.1093/emboj/18.12.3271; KAMITANI S, 1992, EMBO J, V11, P57, DOI 10.1002/j.1460-2075.1992.tb05027.x; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; KORTEMME T, 1995, J MOL BIOL, V253, P799, DOI 10.1006/jmbi.1995.0592; Kortemme T, 1996, BIOCHEMISTRY-US, V35, P14503, DOI 10.1021/bi9617724; KRAUSE G, 1991, J BIOL CHEM, V266, P9494; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LIN TY, 1989, BIOCHEMISTRY-US, V28, P5282, DOI 10.1021/bi00438a054; MARTIN JL, 1995, STRUCTURE, V3, P245, DOI 10.1016/S0969-2126(01)00154-X; MARTIN JL, 1993, NATURE, V365, P464, DOI 10.1038/365464a0; Matthews BW, 1996, FASEB J, V10, P35, DOI 10.1096/fasebj.10.1.8566545; Minor DL, 1996, NATURE, V380, P730, DOI 10.1038/380730a0; Mossner E, 1998, PROTEIN SCI, V7, P1233; Mossner E, 2000, FEBS LETT, V477, P21, DOI 10.1016/S0014-5793(00)01738-5; NELSON JW, 1994, BIOCHEMISTRY-US, V33, P5974, DOI 10.1021/bi00185a039; Riddle DS, 1997, NAT STRUCT BIOL, V4, P805, DOI 10.1038/nsb1097-805; ROST N, 1964, NATURE, V201, P185; Schirra HJ, 1998, BIOCHEMISTRY-US, V37, P6263, DOI 10.1021/bi980136y; Sillen A, 1999, PROTEINS, V37, P253, DOI 10.1002/(SICI)1097-0134(19991101)37:2<253::AID-PROT10>3.0.CO;2-J; SZAJEWSKI RP, 1980, J AM CHEM SOC, V102, P2011, DOI 10.1021/ja00526a042; WUNDERLICH M, 1993, PROTEIN SCI, V2, P717, DOI 10.1002/pro.5560020503; WUNDERLICH M, 1993, J MOL BIOL, V233, P559, DOI 10.1006/jmbi.1993.1535; WUNDERLICH M, 1993, BIOCHEMISTRY-US, V32, P12251, DOI 10.1021/bi00096a039; WUNDERLICH M, 1995, J MOL BIOL, V247, P28, DOI 10.1006/jmbi.1995.0119; ZAPUN A, 1994, BIOCHEMISTRY-US, V33, P5202, DOI 10.1021/bi00183a025; ZAPUN A, 1993, BIOCHEMISTRY-US, V32, P5083, DOI 10.1021/bi00070a016	47	13	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					43050	43057		10.1074/jbc.M207638200	http://dx.doi.org/10.1074/jbc.M207638200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12193604	hybrid			2022-12-27	WOS:000179081200082
J	Li, YH; Knisely, JM; Lu, WY; McCormick, LM; Wang, JY; Henkin, J; Schwartz, AL; Bu, GJ				Li, YH; Knisely, JM; Lu, WY; McCormick, LM; Wang, JY; Henkin, J; Schwartz, AL; Bu, GJ			Low density lipoprotein (LDL) receptor-related protein 1B impairs urokinase receptor regeneration on the cell surface and inhibits cell migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-CHAIN UROKINASE; PLASMINOGEN-ACTIVATOR; ALPHA(2)-MACROGLOBULIN RECEPTOR; EXPRESSION; FAMILY; COMPLEXES; SYSTEM; GENE; INTERNALIZATION; ASTROCYTOMAS	The low density lipoprotein (LDL) receptor-related protein 1B (LRP1B) is a newly identified member of the LDL receptor family and is closely related to LRP. It was discovered as a putative tumor suppressor and is frequently inactivated in lung cancer cells. In the present study, we used an LRP1B minireceptor (mLRP1B4), which mimics the function and trafficking of LRP1B, to explore the roles of LRP1B on the plasminogen activation system. We found that mLRP1B4 and urokinase plasminogen activator receptor (uPAR) form immuno-precipitable complexes on the cell surface in the presence of complexes of uPA and its inhibitor, plasminogen activator inhibitor type-1 (PAI-1). However, compared with cells expressing the analogous LRP minireceptor (mLRP4), cells expressing mLRPIB4 display a substantially slower rate of uPA.PAI-1 complex internalization. Expression of mLRP1B4, or an mLRP4 mutant deficient in endocytosis, leads to an accumulation of uPAR at the cell surface and increased cell-associated uPA and PAI-1 when compared with cells expressing mLRP4. In addition, we found that expression of mLRP1B or the mLRP4 endocytosis mutant impairs the regeneration of unoccupied uPAR on the cell surface and that this correlates with a diminished rate of cell migration. Taken together, these results demonstrate that LRP1B can function as a negative regulator of uPAR regeneration and cell migration.	Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; St Louis Childrens Hosp, St Louis, MO 63110 USA; Abbott Labs, Abbott Pk, IL 60064 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); St. Louis Children's Hospital; Washington University (WUSTL); Abbott Laboratories	Bu, GJ (corresponding author), Washington Univ, Sch Med, Dept Pediat, Box 8208,660 S Euclid Ave, St Louis, MO 63110 USA.							Andreasen PA, 1997, INT J CANCER, V72, P1, DOI 10.1002/(SICI)1097-0215(19970703)72:1<1::AID-IJC1>3.0.CO;2-Z; BARNATHAN ES, 1990, J BIOL CHEM, V265, P2865; Blasi F, 1999, THROMB HAEMOSTASIS, V82, P298; BU GJ, 1995, EMBO J, V14, P2269, DOI 10.1002/j.1460-2075.1995.tb07221.x; Chapman HA, 1999, THROMB HAEMOSTASIS, V82, P291; Chazaud B, 2002, AM J PATHOL, V160, P237, DOI 10.1016/S0002-9440(10)64367-2; Collen D, 1999, THROMB HAEMOSTASIS, V82, P259; CONESE M, 1994, J BIOL CHEM, V269, P17886; CONESE M, 1995, J CELL BIOL, V131, P1609, DOI 10.1083/jcb.131.6.1609; Czekay RP, 2001, MOL BIOL CELL, V12, P1467, DOI 10.1091/mbc.12.5.1467; deVries TJ, 1996, CANCER RES, V56, P1432; Fowler B, 1998, THROMB HAEMOSTASIS, V80, P148, DOI 10.1055/s-0037-1615154; Gotthardt M, 2000, J BIOL CHEM, V275, P25616, DOI 10.1074/jbc.M000955200; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; Higazi AAR, 1996, BLOOD, V87, P3545, DOI 10.1182/blood.V87.9.3545.bloodjournal8793545; Huang HT, 2000, CANCER RES, V60, P6868; JENSEN PH, 1990, CELL REGUL, V1, P1043, DOI 10.1091/mbc.1.13.1043; Koshelnick Y, 1999, THROMB HAEMOSTASIS, V82, P305, DOI 10.1055/s-0037-1615847; Langbein S, 2002, LAB INVEST, V82, P639, DOI 10.1038/labinvest.3780458; LI Y, 1999, INVAS METAST, V18, P240; Li YH, 2001, MOL NEUROBIOL, V23, P53; Li YH, 2001, J BIOL CHEM, V276, P18000, DOI 10.1074/jbc.M101589200; Li YH, 2001, MOL CELL BIOL, V21, P1185, DOI 10.1128/MCB.21.4.1185-1195.2001; Li YS, 2000, J BIOL CHEM, V275, P37187, DOI 10.1074/jbc.M000490200; Liu CX, 2000, CANCER RES, V60, P1961; Liu CX, 2001, J BIOL CHEM, V276, P28889, DOI 10.1074/jbc.M102727200; LOPES MBS, 1994, FEBS LETT, V338, P301, DOI 10.1016/0014-5793(94)80288-2; Maletinska L, 2000, CANCER RES, V60, P2300; MAZAR AP, 1995, FIBRINOLYSIS S1, V6, P49; McGarvey T, 1996, PROSTATE, V28, P311; Nykjaer A, 1997, EMBO J, V16, P2610, DOI 10.1093/emboj/16.10.2610; NYKJAER A, 1992, J BIOL CHEM, V267, P14543; Ossowski L, 2000, CURR OPIN CELL BIOL, V12, P613, DOI 10.1016/S0955-0674(00)00140-X; Stockinger W, 2000, J BIOL CHEM, V275, P25625, DOI 10.1074/jbc.M004119200; Wang JY, 1997, EUR J BIOCHEM, V247, P256, DOI 10.1111/j.1432-1033.1997.00256.x; Yamamoto M, 1997, CANCER RES, V57, P2799; Zhang JC, 1998, J BIOL CHEM, V273, P32273, DOI 10.1074/jbc.273.48.32273	37	58	60	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					42366	42371		10.1074/jbc.M207705200	http://dx.doi.org/10.1074/jbc.M207705200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12194987	hybrid			2022-12-27	WOS:000178985300133
J	Lin, S; Sahai, A; Chugh, SS; Pan, XM; Wallner, EI; Danesh, FR; Lomasney, JW; Kanwar, YS				Lin, S; Sahai, A; Chugh, SS; Pan, XM; Wallner, EI; Danesh, FR; Lomasney, JW; Kanwar, YS			RETRACTED: High glucose stimulates synthesis of fibronectin via a novel protein kinase C, Rap1b, and B-Raf signaling pathway (Retracted article. See vol. 294, pg. 10381, 2019)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Retracted Publication							SMOOTH-MUSCLE-CELLS; GLYCATION END-PRODUCTS; GROWTH-FACTOR-BETA; EXTRACELLULAR-MATRIX; MESANGIAL CELLS; EXCHANGE FACTOR; BINDING PROTEIN; GTPASE RAP1; MAP KINASE; DB/DB MICE	The molecular mechanism(s) by which high glucose induces fibronectin expression via G-protein activation in the kidney are largely unknown. This investigation describes the effect of high glucose (HG) on a small GTP-binding protein, Rap1b, expression and activation, and the relevance of protein kinase C (PKC) and Raf pathways in fibronectin synthesis in cultured renal glomerular mesangial cells (Mcs). In vivo experiments revealed a dose-dependent increase in Rap1b expression in glomeruli of diabetic rat kidneys. Similarly, in vitro exposure of MCs to HG led to an up-regulation of Rap1b with concomitant increase in fibronectin (FN) mRNA and protein expression. The up-regulation of Rap1b mRNA was mitigated by the PKC inhibitors, calphostin C, and bisindolymaleimide, while also reducing HG-induced FN expression in non-transfected MCs. Overexpression of Rap1b by transfection with pcDNA 3.1/Rap1b in MCs resulted in the stimulation of FN synthesis; however, the PKC inhibitors had no significant effect in reducing FN expression in Rap1b-transfected MCs. Transfection of Rap1b mutants S17N (Ser --> Asn) or T61R (Thr --> Arg) in MCs inhibited the HG-induced increased FN synthesis. B-Raf and Raf-1 expression was investigated to assess whether Rap1b effects are mediated via the Raf pathway. B-Raf, and not Raf-1, expression was increased in MCs transfected with Rap1b. HG also caused activation of Rap1b, which was largely unaffected by antiplatelet-derived growth factor (PDGF) antibodies. HG-induced activation of Rap1b was specific, since Rap2b activation and expression of Rap2a and Rap2b were unaffected by HG. These findings indicate that hyperglycemia and HG cause an activation and up-regulation of Rap1b in renal glomeruli and in cultured MCs, which then stimulates FN synthesis. This effect appears to be PKC-dependent and PDGF-independent, but involves B-Raf, suggesting a novel PKC-Rap1b-B-Raf pathway responsible for HG-induced increased mesangial matrix synthesis, a hallmark of diabetic nephropathy.	Northwestern Univ, Sch Med, Dept Pathol, Chicago, IL 60611 USA; Northwestern Univ, Sch Med, Dept Med, Chicago, IL 60611 USA	Northwestern University; Northwestern University	Kanwar, YS (corresponding author), Northwestern Univ, Sch Med, Dept Pathol, 303 E Chicago Ave, Chicago, IL 60611 USA.	y-kanwar@northwestern.edu		Danesh, Farhad/0000-0001-6849-5239	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063407] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060635, R37DK028492, R01DK028492] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL063407] Funding Source: Medline; NIDDK NIH HHS [DK28492, DK60635] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Arai A, 2001, J BIOL CHEM, V276, P10453, DOI 10.1074/jbc.M004627200; BARNETT RL, 1995, AM J PHYSIOL-CELL PH, V268, pC376, DOI 10.1152/ajpcell.1995.268.2.C376; Bos JL, 1998, EMBO J, V17, P6776, DOI 10.1093/emboj/17.23.6776; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; CAGLIERO E, 1991, J BIOL CHEM, V266, P14244; Chen S, 2000, KIDNEY INT, V58, pS40, DOI 10.1046/j.1523-1755.2000.07707.x; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COSIO FG, 1995, J AM SOC NEPHROL, V5, P1600; CULINE S, 1989, INT J CANCER, V44, P990; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; DiPaolo S, 1996, AM J PATHOL, V149, P2095; Evans T, 1991, CURR OPIN CELL BIOL, V3, P185, DOI 10.1016/0955-0674(91)90137-N; Feliers D, 2001, KIDNEY INT, V60, P495, DOI 10.1046/j.1523-1755.2001.060002495.x; Franke B, 2000, MOL CELL BIOL, V20, P779, DOI 10.1128/MCB.20.3.779-785.2000; Franke B, 1997, EMBO J, V16, P252, DOI 10.1093/emboj/16.2.252; Garvey WT, 1997, DIABETES, V46, P444, DOI 10.2337/diabetes.46.3.444; Grewal SS, 2000, J BIOL CHEM, V275, P3722, DOI 10.1074/jbc.275.5.3722; Ha H, 2001, KIDNEY INT, V59, P463, DOI 10.1046/j.1523-1755.2001.059002463.x; Ha HJ, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V134894; Ha HJ, 2000, KIDNEY INT, V58, pS19, DOI 10.1046/j.1523-1755.2000.07704.x; Hagemann C, 1999, EXP CELL RES, V253, P34, DOI 10.1006/excr.1999.4689; Herrmann C, 1996, J BIOL CHEM, V271, P6794, DOI 10.1074/jbc.271.12.6794; Hu CD, 1997, J BIOL CHEM, V272, P11702, DOI 10.1074/jbc.272.18.11702; Igarashi M, 1999, J CLIN INVEST, V103, P185, DOI 10.1172/JCI3326; Isono M, 2000, J AM SOC NEPHROL, V11, P2222, DOI 10.1681/ASN.V11122222; Kanwar YS, 1999, P NATL ACAD SCI USA, V96, P11323, DOI 10.1073/pnas.96.20.11323; Kao SC, 2001, J BIOL CHEM, V276, P18169, DOI 10.1074/jbc.M008870200; Kim SI, 2000, KIDNEY INT, V58, pS88, DOI 10.1046/j.1523-1755.2000.07714.x; KITAYAMA H, 1989, CELL, V56, P77, DOI 10.1016/0092-8674(89)90985-9; Koya D, 2000, FASEB J, V14, P439, DOI 10.1096/fasebj.14.3.439; KREISBERG JI, 1994, KIDNEY INT, V46, P105, DOI 10.1038/ki.1994.249; KREISBERG JI, 1978, KIDNEY INT, V14, P21, DOI 10.1038/ki.1978.86; Ladeda V, 2001, BIOCHEM BIOPH RES CO, V283, P854, DOI 10.1006/bbrc.2001.4845; LEROSEY I, 1991, BIOCHEM BIOPH RES CO, V175, P430, DOI 10.1016/0006-291X(91)91582-W; MAGUIRE J, 1994, SCIENCE, V265, P241, DOI 10.1126/science.7912851; Marshall CJ, 1998, NATURE, V392, P553, DOI 10.1038/33293; McLeod SJ, 1998, J BIOL CHEM, V273, P29218, DOI 10.1074/jbc.273.44.29218; Mene P, 1999, J AM SOC NEPHROL, V10, P1478; Mochizuki N, 2001, NATURE, V411, P1065, DOI 10.1038/35082594; Nakagawa H, 2000, DIABETES RES CLIN PR, V48, P87, DOI 10.1016/S0168-8227(99)00144-8; Natarajan R, 1999, HYPERTENSION, V33, P378, DOI 10.1161/01.HYP.33.1.378; Noh H, 2002, NEPHRON, V90, P78, DOI 10.1159/000046318; OHMSTEDE CA, 1990, P NATL ACAD SCI USA, V87, P6527, DOI 10.1073/pnas.87.17.6527; Ohtsuka T, 1996, J BIOL CHEM, V271, P1258, DOI 10.1074/jbc.271.3.1258; PENNINGTON SR, 1987, NATURE, V327, P188, DOI 10.1038/327188a0; Pietruck F, 1998, DIABETOLOGIA, V41, P94, DOI 10.1007/s001250050872; Pizon V, 1996, EUR J CELL BIOL, V69, P224; PRICE RG, 1987, RENAL BASEMENT MEMBR, P1; PUGLIESE G, 1994, DIABETES, V43, P478, DOI 10.2337/diabetes.43.3.478; QUARCK R, 1994, FEBS LETT, V342, P159, DOI 10.1016/0014-5793(94)80492-3; Quarck R, 1996, EUR J CELL BIOL, V70, P269; Reddy MA, 2002, J BIOL CHEM, V277, P9920, DOI 10.1074/jbc.M111305200; REYNET C, 1993, SCIENCE, V262, P1441, DOI 10.1126/science.8248782; ROMBERGER DJ, 1999, INT J BIOCHEM CELL B, V29, P939; Schiffer M, 2000, KIDNEY INT, V58, pS45, DOI 10.1046/j.1523-1755.2000.07708.x; Schmidt M, 2001, NAT CELL BIOL, V3, P1020, DOI 10.1038/ncb1101-1020; Schmitt JM, 2000, J BIOL CHEM, V275, P25342, DOI 10.1074/jbc.M003213200; Schwarzbauer JE, 1999, CURR OPIN CELL BIOL, V11, P622, DOI 10.1016/S0955-0674(99)00017-4; Seastone DJ, 1999, MOL BIOL CELL, V10, P393, DOI 10.1091/mbc.10.2.393; Singh LP, 2001, DIABETES, V50, P2355, DOI 10.2337/diabetes.50.10.2355; Sodhi CP, 2001, AM J PHYSIOL-RENAL, V280, pF667, DOI 10.1152/ajprenal.2001.280.4.F667; SUN L, 2001, KIDNEY INT, V60, P2129; TAHER MM, 1993, ARCH BIOCHEM BIOPHYS, V303, P260, DOI 10.1006/abbi.1993.1281; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Tanji N, 2000, J AM SOC NEPHROL, V11, P1656, DOI 10.1681/ASN.V1191656; THROCKMORTON DC, 1995, KIDNEY INT, V48, P111, DOI 10.1038/ki.1995.274; Tsiani E, 2002, AM J PHYSIOL-ENDOC M, V282, pE161, DOI 10.1152/ajpendo.2002.282.1.E161; van den Berghe N, 1999, J BIOL CHEM, V274, P11078, DOI 10.1074/jbc.274.16.11078; Van Triest M, 2001, METHOD ENZYMOL, V333, P343; vandenBerghe N, 1997, ONCOGENE, V15, P845, DOI 10.1038/sj.onc.1201407; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; Voziyan PA, 2002, J BIOL CHEM, V277, P3397, DOI 10.1074/jbc.M109935200; Weng GZ, 1999, SCIENCE, V284, P92, DOI 10.1126/science.284.5411.92; WILLIAMS NG, 1994, CANCER METAST REV, V13, P105, DOI 10.1007/BF00690421; Wolf G, 1999, KIDNEY INT, V56, P393, DOI 10.1046/j.1523-1755.1999.00590.x; York RD, 1998, NATURE, V392, P622, DOI 10.1038/33451; Ziyadeh FN, 1995, J DIABETES COMPLICAT, V9, P255, DOI 10.1016/1056-8727(95)80016-8; Zwartkruis FJT, 1999, EXP CELL RES, V253, P157, DOI 10.1006/excr.1999.4695; Zwartkruis FJT, 1998, EMBO J, V17, P5905, DOI 10.1093/emboj/17.20.5905	80	40	47	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					41725	41735		10.1074/jbc.M203957200	http://dx.doi.org/10.1074/jbc.M203957200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12196513	hybrid			2022-12-27	WOS:000178985300055
J	Fong, A; Zhang, MY; Neely, J; Sun, SC				Fong, A; Zhang, MY; Neely, J; Sun, SC			S9, a 19 S proteasome subunit interacting with ubiquitinated NF-kappa B2/p100	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; 26S PROTEASOME; DEATH DOMAIN; IKK-ALPHA; P50; PROTEOLYSIS; INVOLVEMENT; ACTIVATION; PATHWAY; KINASE	Proteasome-mediated processing of the nfkappab2 gene product p100 is a regulated event that generates the NF-kappaB subunit p52. This event can be induced through p100 phosphorylation by a signaling pathway involving the nuclear factor-kappaB-inducing kinase (NIK). The C-terminal region of p100, which contains its phosphorylation site and a death domain, plays a pivotal role in regulating the processing of p100. To understand the biochemical mechanism of p100 processing, we searched for cellular factors interacting with the C-terminal regulatory region of p100 using the yeast two-hybrid system. This led to the identification of S9, a non-ATPase subunit of the 19 S proteasome with no known functions. Interestingly, the S9/p100 interaction could be induced by NIK but not by a catalytically inactive NIK mutant. This inducible molecular interaction required p100 ubiquitination and was dependent on the intact death domain. We further demonstrated that the death domain is essential for NIK-induced post-translational processing of p100, thus providing a functional link between the S9 binding and the processing of p100. Finally, we provide genetic evidence for the essential role of S9 in the inducible processing of p100.	Penn State Univ, Coll Med, Dept Microbiol & Immunol, Hershey, PA 17033 USA; Penn State Univ, Coll Med, Dept Pediat, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Sun, SC (corresponding author), Penn State Univ, Coll Med, Dept Microbiol & Immunol, 500 Univ Dr, Hershey, PA 17033 USA.				NIAID NIH HHS [1R01 AI 45045] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045045] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Barkett M, 1999, ONCOGENE, V18, P6910, DOI 10.1038/sj.onc.1203238; Berglund H, 2000, J MOL BIOL, V302, P171, DOI 10.1006/jmbi.2000.4011; Caplen NJ, 2002, TRENDS BIOTECHNOL, V20, P49, DOI 10.1016/S0167-7799(01)01900-X; Ciechanover A, 2000, BIOESSAYS, V22, P442, DOI 10.1002/(SICI)1521-1878(200005)22:5<442::AID-BIES6>3.0.CO;2-Q; FAN CM, 1991, NATURE, V354, P395, DOI 10.1038/354395a0; Fong A, 2002, J BIOL CHEM, V277, P22111, DOI 10.1074/jbc.C200151200; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Harhaj EW, 1999, J BIOL CHEM, V274, P22911, DOI 10.1074/jbc.274.33.22911; Hoffman L, 1997, FEBS LETT, V404, P179, DOI 10.1016/S0014-5793(97)00126-9; HOLBROOK NJ, 1987, VIROLOGY, V157, P211, DOI 10.1016/0042-6822(87)90330-8; Huang BH, 1996, NATURE, V384, P638, DOI 10.1038/384638a0; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Lin L, 1998, CELL, V92, P819, DOI 10.1016/S0092-8674(00)81409-9; NERI A, 1991, CELL, V67, P1075, DOI 10.1016/0092-8674(91)90285-7; Neri A, 1996, LEUKEMIA LYMPHOMA, V23, P43, DOI 10.3109/10428199609054800; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; SIEBENLIST U, 1994, ANNU REV CELL BIOL, V10, P405, DOI 10.1146/annurev.cb.10.110194.002201; Silverman N, 2001, GENE DEV, V15, P2321, DOI 10.1101/gad.909001; SUN SC, 1994, P NATL ACAD SCI USA, V91, P1346, DOI 10.1073/pnas.91.4.1346; Uhlik M, 1998, J BIOL CHEM, V273, P21132, DOI 10.1074/jbc.273.33.21132; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; Xiao GT, 2001, MOL CELL, V7, P401, DOI 10.1016/S1097-2765(01)00187-3; Xiao GT, 2001, EMBO J, V20, P6805, DOI 10.1093/emboj/20.23.6805	24	19	19	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 25	2002	277	43					40697	40702		10.1074/jbc.M205330200	http://dx.doi.org/10.1074/jbc.M205330200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	607KU	12185077	hybrid			2022-12-27	WOS:000178791400069
J	Khreiss, T; Jozsef, L; Hossain, S; Chan, JSD; Potempa, LA; Filep, JG				Khreiss, T; Jozsef, L; Hossain, S; Chan, JSD; Potempa, LA; Filep, JG			Loss of pentameric symmetry of C-reactive protein is associated with delayed apoptosis of human neutrophils	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-REGULATED KINASE; PROGRAMMED CELL-DEATH; NEOANTIGEN NEO-CRP; FC-GAMMA-RIII; HUMAN MONOCYTES; AGING NEUTROPHILS; ENDOTHELIAL-CELLS; NITRIC-OXIDE; DNA-SEQUENCE; ANNEXIN-V	Human neutrophil granulocytes die rapidly, and their survival is contingent upon rescue from programmed cell death by signals from the environment. Here we report that a novel signal for delaying neutrophil apoptosis is the classic acute phase reactant, C-reactive protein (CRP). However, this anti-apoptotic activity is expressed only when the cyclic pentameric structure of CRP is lost, resulting in formation of modified or monomeric CRP (mCRP), which may be formed in inflamed tissues. By contrast, native pentameric CRP and CRP peptides 77-82, 174-185, and 201-206 failed to affect neutrophil apoptosis. The apoptosis delaying action of mCRP was markedly attenuated by an antibody against the low affinity IgG immune complex receptor (CD16) but not by an anti-CD32 antibody. mCRP evoked a transient concurrent activation of the extracellular signal-regulated kinase (ERK) and phosphatidylinositol 3-kinase/A-kt signaling pathways, leading to inhibition of caspase-3 and consequently to delaying apoptosis. Consistently, pharmacological inhibition of either ERK or Akt reversed the anti-apoptotic action of mCRP; however, they did not produce additive inhibition. Thus, mCRP, but not pentameric CRP or peptides derived from CRP, promotes neutrophil survival and may therefore contribute to amplification of the inflammatory response.	Maisonneuve Rosemont Hosp, Res Ctr, Montreal, PQ H1T 2M4, Canada; Univ Montreal, Dept Med, Montreal, PQ H1T 2M4, Canada; Univ Montreal, Ctr Hosp Univ Montreal Hotel Dieu, Ctr Rech, Quebec City, PQ H2W 1T8, Canada; NextEra Therapeut, Vernon Hills, IL 60061 USA	Universite de Montreal; Universite de Montreal; Universite de Montreal	Filep, JG (corresponding author), Maisonneuve Rosemont Hosp, Res Ctr, 5415 Blvd Assompt, Montreal, PQ H1T 2M4, Canada.	janos.g.filep@umontreal.ca						BALLOU SP, 1992, CYTOKINE, V4, P361, DOI 10.1016/1043-4666(92)90079-7; Bharadwaj D, 1999, J EXP MED, V190, P585, DOI 10.1084/jem.190.4.585; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; COLOTTA F, 1992, BLOOD, V80, P2012; Diehl EE, 2000, AM J MED SCI, V319, P79, DOI 10.1097/00000441-200002000-00002; DONG AC, 1994, J BIOL CHEM, V269, P6424; Dong Q, 1996, J IMMUNOL, V156, P4815; DRANSFIELD I, 1994, J IMMUNOL, V153, P1254; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Fehsel K, 1997, NITRIC OXIDE-BIOL CH, V1, P254, DOI 10.1006/niox.1997.0124; FILEP J, 1989, LIFE SCI, V44, P517, DOI 10.1016/0024-3205(89)90613-9; Filep JG, 1996, BLOOD, V87, P5136, DOI 10.1182/blood.V87.12.5136.bloodjournal87125136; Frasch SC, 1998, J BIOL CHEM, V273, P8389, DOI 10.1074/jbc.273.14.8389; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Gershov D, 2000, J EXP MED, V192, P1353, DOI 10.1084/jem.192.9.1353; Gould JM, 2001, INFECT IMMUN, V69, P1747, DOI 10.1128/IAI.69.3.1747-1754.2001; Heuertz RM, 1997, MOL MED TODAY, V3, P539, DOI 10.1016/S1357-4310(97)01145-3; HOMBURG CHE, 1995, BLOOD, V85, P532; KauffmanZeh A, 1997, NATURE, V385, P544, DOI 10.1038/385544a0; KINOSHITA CM, 1989, BIOCHEMISTRY-US, V28, P9840, DOI 10.1021/bi00451a044; Klein JB, 2000, J IMMUNOL, V164, P4286, DOI 10.4049/jimmunol.164.8.4286; KOLBBACHOFEN V, 1995, GLYCOCONJUGATE J, V12, P122, DOI 10.1007/BF00731355; KUSHNER I, 1988, METHOD ENZYMOL, V163, P373; LEE A, 1993, J LEUKOCYTE BIOL, V54, P283, DOI 10.1002/jlb.54.4.283; LEI KJ, 1985, J BIOL CHEM, V260, P3377; LILES WC, 1995, BLOOD, V86, P3181; MARNELL LL, 1995, J IMMUNOL, V155, P2185; MOLD C, 1981, J EXP MED, V154, P1703, DOI 10.1084/jem.154.5.1703; Motie M, 1996, J IMMUNOL, V156, P4435; MURPHY TM, 1991, J EXP MED, V173, P495, DOI 10.1084/jem.173.2.495; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; PARK JR, 1994, BLOOD, V84, P440; POTEMPA LA, 1987, MOL IMMUNOL, V24, P531, DOI 10.1016/0161-5890(87)90028-9; Potempa LA, 1999, US Patent, Patent No. 5874238; REES RF, 1988, CLIN IMMUNOL IMMUNOP, V48, P95, DOI 10.1016/0090-1229(88)90160-2; ROBEY FA, 1987, J BIOL CHEM, V262, P7053; Sanchez-Mejorada G, 1998, J LEUKOCYTE BIOL, V63, P521, DOI 10.1002/jlb.63.5.521; SAVILL JS, 1989, J CLIN INVEST, V83, P865, DOI 10.1172/JCI113970; SHEPHARD EG, 1990, J IMMUNOL, V145, P1469; SHIELDS MJ, 1991, J IMMUNOL METHODS, V141, P253, DOI 10.1016/0022-1759(91)90152-6; Shrive AK, 1996, NAT STRUCT BIOL, V3, P346, DOI 10.1038/nsb0496-346; SIEGEL J, 1974, J EXP MED, V140, P631, DOI 10.1084/jem.140.3.631; SREERAMA N, 1993, ANAL BIOCHEM, V209, P32, DOI 10.1006/abio.1993.1079; Stein MP, 2000, J CLIN INVEST, V105, P369, DOI 10.1172/JCI7817; Tilton B, 1997, J BIOL CHEM, V272, P28096, DOI 10.1074/jbc.272.44.28096; Tudan C, 2000, J IMMUNOL, V165, P5798, DOI 10.4049/jimmunol.165.10.5798; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Wang HW, 2001, BIOCHEM BIOPH RES CO, V288, P75, DOI 10.1006/bbrc.2001.5733; WHYTE MKB, 1993, J IMMUNOL, V150, P5124; WOO P, 1985, J BIOL CHEM, V260, P3384; Xia DY, 1997, P NATL ACAD SCI USA, V94, P2575, DOI 10.1073/pnas.94.6.2575; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; YAO RJ, 1995, SCIENCE, V267, P2003, DOI 10.1126/science.7701324; YING SC, 1989, J IMMUNOL, V143, P221; Zouki C, 1997, J CLIN INVEST, V100, P522, DOI 10.1172/JCI119561; Zouki C, 2001, J IMMUNOL, V167, P5355, DOI 10.4049/jimmunol.167.9.5355; Zouki C, 2001, FASEB J, V15, P25	58	133	143	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2002	277	43					40775	40781		10.1074/jbc.M205378200	http://dx.doi.org/10.1074/jbc.M205378200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	607KU	12198121	hybrid			2022-12-27	WOS:000178791400080
J	Takebe, G; Yarimizu, J; Saito, Y; Hayashi, T; Nakamura, H; Yodoi, J; Nagasawa, S; Takahashi, K				Takebe, G; Yarimizu, J; Saito, Y; Hayashi, T; Nakamura, H; Yodoi, J; Nagasawa, S; Takahashi, K			A comparative study on the hydroperoxide and thiol specificity of the glutathione peroxidase family and selenoprotein P	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-PLASMA; THIOREDOXIN REDUCTASE; PHOSPHOLIPID HYDROPEROXIDES; SPERM MATURATION; PURIFICATION; SELENOENZYME; PHOSPHATIDYLCHOLINE; PROTEINS; ASSAY; CELLS	Glutathione peroxidase catalyzes the reduction of hydrogen peroxide and organic hydroperoxide by glutathione and functions in the protection of cells against oxidative damage. Glutathione peroxidase exists in several forms that differ in their primary structure and localization. We have also shown that selenoprotein P exhibits a glutathione peroxidase-like activity (Saito, Y., Hayashi, T., Tanaka, A., Watanabe, Y., Suzuki, M., Saito, E., and Takahashi, K. (1999) J. Biol Chem. 274, 28662871). To understand the physiological significance of the diversity among these enzymes, a comparative study on the peroxide substrate specificity of three types of ubiquitous glutathione peroxidase (cellular glutathione peroxidase, phospholipid hydroperoxide glutathione peroxidase, and extracellular glutathione peroxidase) and of selenoprotein P purified from human origins was done. The specific activities and kinetic parameters against two hydroperoxides (hydrogen peroxide and phosphatidylcholine hydroperoxide) were determined. We next examined the thiol specificity and found that thioredoxin is the preferred electron donor for selenoprotein P. These four enzymes exhibit different peroxide and thiol specificities and collaborate to protect biological molecules from oxidative stress both inside and outside the cells.	Hokkaido Univ, Grad Sch Pharmaceut Sci, Dept Hyg Chem, Kita Ku, Sapporo, Hokkaido 0600812, Japan; Hokkaido Inst Publ Hlth, Kita Ku, Sapporo, Hokkaido 060, Japan; Kyoto Univ, Inst Virus Res, Dept Biol Responses, Sakyo Ku, Kyoto 6068507, Japan	Hokkaido University; Kyoto University	Takahashi, K (corresponding author), Hokkaido Univ, Grad Sch Pharmaceut Sci, Dept Hyg Chem, Kita Ku, Kita 12 Nishi 6, Sapporo, Hokkaido 0600812, Japan.	kazu@pharm.hokudai.ac.jp	Saito, Yoshiro/H-4597-2019	Saito, Yoshiro/0000-0002-0559-5889				Arner ESJ, 1999, METHOD ENZYMOL, V300, P226; Arteel GE, 1998, BIOL CHEM, V379, P1201; AVISSAR N, 1994, AM J PHYSIOL, V267, pE68, DOI 10.1152/ajpendo.1994.267.1.E68; AWASTHI YC, 1975, J BIOL CHEM, V250, P5144; BAO YP, 1995, ANAL BIOCHEM, V224, P395, DOI 10.1006/abio.1995.1056; Bao YP, 1997, FEBS LETT, V410, P210, DOI 10.1016/S0014-5793(97)00591-7; BJORNSTEDT M, 1994, J BIOL CHEM, V269, P29382; Brigelius-Flohe R, 1999, FREE RADICAL BIO MED, V27, P951, DOI 10.1016/S0891-5849(99)00173-2; BURK RF, 1973, P SOC EXP BIOL MED, V143, P719, DOI 10.3181/00379727-143-37399; BURK RF, 1994, J NUTR, V124, P1891, DOI 10.1093/jn/124.10.1891; Burk RF, 1997, HISTOCHEM CELL BIOL, V108, P11, DOI 10.1007/s004180050141; BURK RF, 1993, ANNU REV NUTR, V13, P65, DOI 10.1146/annurev.nu.13.070193.000433; BURK RF, 1995, HEPATOLOGY, V21, P561; CHU FF, 1993, J BIOL CHEM, V268, P2571; DALZIEL K, 1957, ACTA CHEM SCAND, V11, P1706, DOI 10.3891/acta.chem.scand.11-1706; EPP O, 1983, EUR J BIOCHEM, V133, P51, DOI 10.1111/j.1432-1033.1983.tb07429.x; ESWORTHY RS, 1993, ARCH BIOCHEM BIOPHYS, V307, P29, DOI 10.1006/abbi.1993.1555; FLOHE L, 1972, H-S Z PHYSIOL CHEM, V353, P987, DOI 10.1515/bchm2.1972.353.1.987; FLOHE L, 1973, FEBS LETT, V32, P132, DOI 10.1016/0014-5793(73)80755-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MAIORINO M, 1990, METHOD ENZYMOL, V186, P448; MAIORINO M, 1995, BIOL CHEM H-S, V376, P651, DOI 10.1515/bchm3.1995.376.11.651; MITSUI A, 1992, BIOCHEM BIOPH RES CO, V186, P1220, DOI 10.1016/S0006-291X(05)81536-0; OBLONG JE, 1993, BIOCHEMISTRY-US, V32, P7271, DOI 10.1021/bi00079a025; Pfeifer H, 2001, FASEB J, V15, P1236, DOI 10.1096/fj.00-0655fje; ROVERI A, 1994, BBA-PROTEIN STRUCT M, V1208, P211, DOI 10.1016/0167-4838(94)90106-6; Saito Y, 1999, J BIOL CHEM, V274, P2866, DOI 10.1074/jbc.274.5.2866; SATTLER W, 1994, ARCH BIOCHEM BIOPHYS, V309, P214, DOI 10.1006/abbi.1994.1105; Soderberg A, 2000, CANCER RES, V60, P2281; Sztajer H, 2001, J BIOL CHEM, V276, P7397, DOI 10.1074/jbc.M008631200; TAKAHASHI K, 1990, J BIOCHEM-TOKYO, V108, P145, DOI 10.1093/oxfordjournals.jbchem.a123172; TAKAHASHI K, 1987, ARCH BIOCHEM BIOPHYS, V256, P677, DOI 10.1016/0003-9861(87)90624-2; Ursini F, 1999, SCIENCE, V285, P1393, DOI 10.1126/science.285.5432.1393; URSINI F, 1982, BIOCHIM BIOPHYS ACTA, V710, P197, DOI 10.1016/0005-2760(82)90150-3; URSINI F, 1985, BIOCHIM BIOPHYS ACTA, V839, P62, DOI 10.1016/0304-4165(85)90182-5; URSINI F, 1995, METHOD ENZYMOL, V252, P38; WAKASUGI N, 1990, P NATL ACAD SCI USA, V87, P8282, DOI 10.1073/pnas.87.21.8282; Wollman EE, 1997, BIOCHEM BIOPH RES CO, V230, P602, DOI 10.1006/bbrc.1996.6015; YAMAMOTO Y, 1993, ARCH BIOCHEM BIOPHYS, V305, P541, DOI 10.1006/abbi.1993.1458; Yarimizu J, 2000, ANTIOXID REDOX SIGN, V2, P643, DOI 10.1089/ars.2000.2.4-643	40	228	245	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2002	277	43					41254	41258		10.1074/jbc.M202773200	http://dx.doi.org/10.1074/jbc.M202773200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	607KU	12185074	hybrid			2022-12-27	WOS:000178791400137
J	Arunkumar, AI; Srisailam, S; Krishnaswamy, T; Kumar, S; Kathir, KM; Chi, YH; Wang, HM; Chang, GG; Chiu, IM; Yu, C				Arunkumar, AI; Srisailam, S; Krishnaswamy, T; Kumar, S; Kathir, KM; Chi, YH; Wang, HM; Chang, GG; Chiu, IM; Yu, C			Structure and stability of an acidic fibroblast growth factor from Notophthalmus viridescens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-STRUCTURE DETERMINATION; FGF RECEPTOR DIMERIZATION; CRYSTAL-STRUCTURE; SUCROSE OCTASULFATE; DIRECT REFINEMENT; CHEMICAL-SHIFTS; RIBONUCLEASE-S; HEPARIN; BINDING; OLIGOMERIZATION	The three-dimensional solution structure of an acidic fibroblast growth factor (nFGF-1) from the newt (Notophthalmus viridescens) is determined using multidimensional NMR techniques. Complete assignment of all the atoms (H-1, N-15, and C-13) has been achieved using a variety of triple resonance experiments. 50 structures were calculated using hybrid distance geometry-dynamical simulated annealing technique with a total of 1359 constraints. The atomic root mean square distribution for the backbone atoms in the structured region is 0.60 Angstrom. The secondary structural elements include 12 beta-strands arranged antiparallely into a beta-barrel structure. The protein (nFGF-1) exists in a monomeric state upon binding to the ligand, sucrose octa sulfate (SOS), in a stoichiometric ratio of 1:1. The SOS binding site consists of a dense cluster of positively charged residues located at the C-terminal end of the molecule. The conformational stabilities of nFGF-1 and its structural and functional homologue from the human source (hFGF-1) are drastically different. The differential stabilities of nFGF-1 and hFGF-1 are attributed to the differences in the number of hydrogen bonds and the presence of solvent inaccessible cavities in the two proteins.	Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA; Natl Tsing Hua Univ, Dept Chem, Hsinchu 30013, Taiwan; Natl Def Med Ctr, Dept Biochem, Taipei 10764, Taiwan	University System of Ohio; Ohio State University; National Tsing Hua University; National Defense Medical Center	Chiu, IM (corresponding author), Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA.	chiu.1@osu.edu; cyu@mx.nthu.edu.tw	KUMAR, P. SURESH/AAT-8951-2020; Chiu, Ing-Ming/B-1534-2008; Kumar, Suresh Thallapuranam/R-5606-2016; Chi, Ya-Hui/B-1080-2010; Kumar, Dr Suresh/HHZ-2615-2022; Chi, Ya-Hui/ABE-8550-2020	KUMAR, P. SURESH/0000-0003-3222-2604; Kumar, Suresh Thallapuranam/0000-0001-7262-1373; Kumar, Dr Suresh/0000-0002-2539-6553; Chi, Ya-Hui/0000-0002-9216-0938; Alphonse Ignatius, Arun/0000-0002-7342-044X				Arrington CB, 2000, METHOD ENZYMOL, V323, P104; Arunkumar AI, 2000, J BIOMOL NMR, V17, P279, DOI 10.1023/A:1008339701691; Arunkumar AI, 2002, PROTEIN SCI, V11, P1050, DOI 10.1110/ps.2270102; AVIEZER D, 1994, CELL, V79, P1005, DOI 10.1016/0092-8674(94)90031-0; Bai YW, 1996, PROTEINS, V24, P145, DOI 10.1002/(SICI)1097-0134(199602)24:2<145::AID-PROT1>3.0.CO;2-I; Bai YW, 1995, METHOD ENZYMOL, V259, P344; BAIRD A, 1990, PEPTIDE GROWTH FACTO; BASILICO C, 1992, ADV CANCER RES, V59, P115, DOI 10.1016/S0065-230X(08)60305-X; BAX A, 1993, ACCOUNTS CHEM RES, V26, P131, DOI 10.1021/ar00028a001; BELLOT F, 1991, EMBO J, V10, P2849, DOI 10.1002/j.1460-2075.1991.tb07834.x; Blaber M, 1996, BIOCHEMISTRY-US, V35, P2086, DOI 10.1021/bi9521755; BRUNGER AT, 1992, XPLOR SOFTWARE MANUA; BURGESS WH, 1989, ANNU REV BIOCHEM, V58, P575, DOI 10.1146/annurev.bi.58.070189.003043; Chi YH, 2002, J BIOL CHEM, V277, P34941, DOI 10.1074/jbc.M205446200; Chi YH, 2000, J BIOL CHEM, V275, P39444, DOI 10.1074/jbc.M007205200; CLORE GM, 1991, PROTEIN SCI, V3, P379; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DABORA JM, 1991, J BIOL CHEM, V266, P23637; DAVIES J, 1999, BIOCHEM J, V341, P611; DiGabriele AD, 1998, NATURE, V393, P812, DOI 10.1038/31741; DILL KA, 1990, BIOCHEMISTRY-US, V29, P7133, DOI 10.1021/bi00483a001; FOLKMAN J, 1990, SCIENCE, V238, P442; Gardner KH, 1998, ANNU REV BIOPH BIOM, V27, P357, DOI 10.1146/annurev.biophys.27.1.357; GILSON MK, 1988, PROTEINS, V3, P32, DOI 10.1002/prot.340030104; KIM EE, 1992, BIOCHEMISTRY-US, V31, P12304, DOI 10.1021/bi00164a004; KUSZEWSKI J, 1995, J MAGN RESON SER B, V107, P293, DOI 10.1006/jmrb.1995.1093; KUSZEWSKI J, 1995, J MAGN RESON SER B, V106, P92, DOI 10.1006/jmrb.1995.1017; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; LEE B, 1991, BIOPOLYMERS, V31, P993, DOI 10.1002/bip.360310809; LEE W, 1994, FEBS LETT, V350, P87, DOI 10.1016/0014-5793(94)00740-3; LEMMON MA, 1994, TRENDS BIOCHEM SCI, V19, P459, DOI 10.1016/0968-0004(94)90130-9; Liang J, 1998, PROTEIN SCI, V7, P1884, DOI 10.1002/pro.5560070905; MACH H, 1993, BIOCHEMISTRY-US, V32, P5480, DOI 10.1021/bi00071a026; Markley JL, 1998, EUR J BIOCHEM, V256, P1, DOI 10.1046/j.1432-1327.1998.2560001.x; MOSCATELLI D, 1992, J BIOL CHEM, V267, P25803; NILGES M, 1988, PROTEIN ENG, V2, P27, DOI 10.1093/protein/2.1.27; Ogura K, 1999, J BIOMOL NMR, V13, P11, DOI 10.1023/A:1008330622467; Ornitz DM, 2000, BIOESSAYS, V22, P108, DOI 10.1002/(SICI)1521-1878(200002)22:2<108::AID-BIES2>3.0.CO;2-M; ORNITZ DM, 1992, MOL CELL BIOL, V12, P240, DOI 10.1128/MCB.12.1.240; ORNITZ DM, 1995, SCIENCE, V268, P432, DOI 10.1126/science.7536345; Patrie KM, 1997, GROWTH FACTORS, V14, P39, DOI 10.3109/08977199709021509; Patrie KM, 1999, BIOCHEMISTRY-US, V38, P9264, DOI 10.1021/bi9903345; PinedaLucena A, 1996, J MOL BIOL, V264, P162, DOI 10.1006/jmbi.1996.0631; PINEDALUCENA A, 1994, J MOL BIOL, V242, P81, DOI 10.1006/jmbi.1994.1558; Plotnikov AN, 1999, CELL, V98, P641, DOI 10.1016/S0092-8674(00)80051-3; Plotnikov AN, 2000, CELL, V101, P413, DOI 10.1016/S0092-8674(00)80851-X; POULIN ML, 1994, BBA-MOL CELL RES, V1220, P209, DOI 10.1016/0167-4889(94)90137-6; Ratnaparkhi GS, 2000, BIOCHEMISTRY-US, V39, P12365, DOI 10.1021/bi000775k; Ricciardi A, 2000, J BIOL CHEM, V275, P18302, DOI 10.1074/jbc.275.24.18302; RICHARDS FM, 1974, J MOL BIOL, V82, P1, DOI 10.1016/0022-2836(74)90570-1; ROGHANI M, 1994, J BIOL CHEM, V269, P3976; Romero A, 1996, EUR J BIOCHEM, V241, P453, DOI 10.1111/j.1432-1033.1996.00453.x; Samuel D, 2000, J BIOL CHEM, V275, P34968, DOI 10.1074/jbc.M005147200; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Sivaraman T, 2000, BIOCHEMISTRY-US, V39, P8705, DOI 10.1021/bi992867j; SPIVAKKROIZMAN T, 1994, CELL, V79, P1015, DOI 10.1016/0092-8674(94)90032-9; SPRINGER BA, 1994, J BIOL CHEM, V269, P26879; Stauber DJ, 2000, P NATL ACAD SCI USA, V97, P49, DOI 10.1073/pnas.97.1.49; VARADARAJAN R, 1992, BIOCHEMISTRY-US, V31, P1421, DOI 10.1021/bi00120a019; Venkataraman G, 1999, P NATL ACAD SCI USA, V96, P1892, DOI 10.1073/pnas.96.5.1892; VOLKIN DB, 1993, BIOCHIM BIOPHYS ACTA, V1203, P18, DOI 10.1016/0167-4838(93)90031-L; WUTHRICH K, 1982, J MOL BIOL, V155, P311, DOI 10.1016/0022-2836(82)90007-9; ZHU XT, 1993, STRUCTURE, V1, P27, DOI 10.1016/0969-2126(93)90006-3	63	23	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2002	277	48					46424	46432		10.1074/jbc.M207814200	http://dx.doi.org/10.1074/jbc.M207814200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620JB	12205097	hybrid			2022-12-27	WOS:000179529300094
J	Han, DC; Shen, TL; Miao, H; Wang, BC; Guan, JL				Han, DC; Shen, TL; Miao, H; Wang, BC; Guan, JL			EphB1 associates with Grb7 and regulates cell migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL-ADHESION-KINASE; R-RAS; TRANSMEMBRANE LIGANDS; INTEGRIN ACTIVATION; NEURAL DEVELOPMENT; TYROSINE KINASES; BINDING PROTEINS; EPHRIN LIGANDS; RECEPTOR; FAMILY	EphB1 is a member of the Eph family of receptor tyrosine kinases that play important roles in diverse biological processes including nervous system development, angiogenesis, and neural synapsis formation and maturation. Grb7 is an adaptor molecule implicated in the regulation of cell migration. Here we report identification of an interaction between Grb7 and the cytoplasmic domain of EphB1 by using Grb7 as a "bait" in a yeast two-hybrid screening. Co-immunoprecipitation was used to confirm the interaction of Grb7 with the cytoplasmic domain of EphB1 as well as the full-length receptor in intact cells. This interaction is mediated by the SH2 domain of Grb7 and requires tyrosine autophosphorylation of EphB1. Furthermore, Tyr-928 of EphB1 was identified as the primary binding site for Grb7. Stimulation of endogenous EphB1 in embryonal carcinoma P19 cells with its ligand ephrinB1 increased its association with Grb7, which is consistent with a role for the autophosphorylation of EphB1. We also found that EphB1 could phosphorylate Grb7 and mutation of either Tyr-928 or Tyr-594 to Phe decreased this activity. Finally, we show that EphB1 could stimulate fibroblast motility on extracellular matrix in a kinase-dependent manner, which also correlated with its association with Grb7. Consistent with this, co-expression of Grb7 with EphB1 further enhanced cell motility, whereas co-expression of the Grb7 SH2 domain abolished EphB1-stimulated cell migration. Together, our results identified a novel interaction between EphB1 with the adaptor molecule Grb7 and suggested that this interaction may play a role in the regulation of cell migration by EphB1.	Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA; Korea Res Inst Biosci & Biotechnol, Taejon 305600, South Korea; Case Western Reserve Univ, Sch Med, Rammelkamp Ctr Res, Cleveland, OH 44109 USA	Cornell University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Case Western Reserve University; MetroHealth System	Guan, JL (corresponding author), Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA.		Shen, Tang-Long/C-7460-2011	Shen, Tang-Long/0000-0001-6264-3608	NATIONAL CANCER INSTITUTE [R01CA096533] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK057933] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052890] Funding Source: NIH RePORTER; NCI NIH HHS [CA96533] Funding Source: Medline; NIDDK NIH HHS [DK57933] Funding Source: Medline; NIGMS NIH HHS [GM52890, GM48050] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams RH, 2000, TRENDS CARDIOVAS MED, V10, P183, DOI 10.1016/S1050-1738(00)00046-3; Binns KL, 2000, MOL CELL BIOL, V20, P4791, DOI 10.1128/MCB.20.13.4791-4805.2000; Bohme B, 1996, J BIOL CHEM, V271, P24747, DOI 10.1074/jbc.271.40.24747; BOYD AW, 2001, SCI STKE, pRE20; Bruckner K, 1997, SCIENCE, V275, P1640, DOI 10.1126/science.275.5306.1640; Cary LA, 1996, J CELL SCI, V109, P1787; CARY LA, 1999, FRONT BIOSCI, V4, P102; Choi S, 1999, ONCOGENE, V18, P5413, DOI 10.1038/sj.onc.1202917; Cowan CA, 2001, NATURE, V413, P174, DOI 10.1038/35093123; Daly RJ, 1998, CELL SIGNAL, V10, P613, DOI 10.1016/S0898-6568(98)00022-9; Dodelet VC, 2000, ONCOGENE, V19, P5614, DOI 10.1038/sj.onc.1203856; Fiddes RJ, 1998, J BIOL CHEM, V273, P7717, DOI 10.1074/jbc.273.13.7717; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Gale NW, 1997, CELL TISSUE RES, V290, P227, DOI 10.1007/s004410050927; Gu C, 2001, MOL CELL BIOL, V21, P4579, DOI 10.1128/MCB.21.14.4579-4597.2001; Han DC, 2000, J BIOL CHEM, V275, P28911, DOI 10.1074/jbc.M001997200; Han DC, 1999, J BIOL CHEM, V274, P24425, DOI 10.1074/jbc.274.34.24425; Han DC, 2001, ONCOGENE, V20, P6315, DOI 10.1038/sj.onc.1204775; Hanks SK, 1997, BIOESSAYS, V19, P137, DOI 10.1002/bies.950190208; HANNON GJ, 1993, GENE DEV, V7, P2378, DOI 10.1101/gad.7.12a.2378; Hattori M, 2000, SCIENCE, V289, P1360, DOI 10.1126/science.289.5483.1360; Holland SJ, 1996, NATURE, V383, P722, DOI 10.1038/383722a0; Holland SJ, 1998, CURR OPIN NEUROBIOL, V8, P117, DOI 10.1016/S0959-4388(98)80015-9; Holmberg J, 2000, NATURE, V408, P203, DOI 10.1038/35041577; Huynh-Do U, 1999, EMBO J, V18, P2165, DOI 10.1093/emboj/18.8.2165; Knoll B, 2002, TRENDS NEUROSCI, V25, P145, DOI 10.1016/S0166-2236(00)02093-2; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lawrenson ID, 2002, J CELL SCI, V115, P1059; Lu Q, 2001, CELL, V105, P69, DOI 10.1016/S0092-8674(01)00297-5; MANSER J, 1990, DEV GENET, V11, P49, DOI 10.1002/dvg.1020110107; MARGOLIS B, 1992, P NATL ACAD SCI USA, V89, P8894, DOI 10.1073/pnas.89.19.8894; Miao H, 2000, NAT CELL BIOL, V2, P62, DOI 10.1038/35000008; Morrione A, 1997, J BIOL CHEM, V272, P26382, DOI 10.1074/jbc.272.42.26382; Murai KK, 2002, NEURON, V33, P159, DOI 10.1016/S0896-6273(02)00565-2; OOI J, 1995, ONCOGENE, V10, P1621; Parsons JT, 1996, CURR OPIN CELL BIOL, V8, P146, DOI 10.1016/S0955-0674(96)80059-7; Schlaepfer DD, 1999, PROG BIOPHYS MOL BIO, V71, P435, DOI 10.1016/S0079-6107(98)00052-2; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; Shen TL, 2002, J BIOL CHEM, V277, P29069, DOI 10.1074/jbc.M203085200; Stein E, 1998, J BIOL CHEM, V273, P1303, DOI 10.1074/jbc.273.3.1303; Stein E, 1996, J BIOL CHEM, V271, P23588, DOI 10.1074/jbc.271.38.23588; Stein E, 1998, GENE DEV, V12, P667, DOI 10.1101/gad.12.5.667; Tanaka S, 2000, J CELL PHYSIOL, V183, P411, DOI 10.1002/(SICI)1097-4652(200006)183:3<411::AID-JCP14>3.0.CO;2-Z; Wang BC, 2000, J BIOL CHEM, V275, P5222, DOI 10.1074/jbc.275.7.5222; Wang J, 1999, MOL CELL BIOL, V19, P6217; Wilkinson DG, 2001, NAT REV NEUROSCI, V2, P155, DOI 10.1038/35058515; Yue Y, 1999, J NEUROSCI, V19, P2090; Zhang ZH, 1996, CELL, V85, P61, DOI 10.1016/S0092-8674(00)81082-X; ZHOU S, 1995, J BIOL CHEM, V270, P14863; Zisch AH, 2000, ONCOGENE, V19, P177, DOI 10.1038/sj.onc.1203304; Zou JX, 1999, P NATL ACAD SCI USA, V96, P13813, DOI 10.1073/pnas.96.24.13813	51	67	71	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 22	2002	277	47					45655	45661		10.1074/jbc.M203165200	http://dx.doi.org/10.1074/jbc.M203165200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	618EE	12223469	hybrid			2022-12-27	WOS:000179404800132
J	Thoden, JB; Kim, J; Raushel, FM; Holden, HM				Thoden, JB; Kim, J; Raushel, FM; Holden, HM			Structural and kinetic studies of sugar binding to galactose mutarotase from Lactococcus lactis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; PROTEIN STRUCTURES; CLONING; PROGRAM; GENES	Galactose mutarotase catalyzes the conversion of beta-D-galactose to a-D-galactose in the Leloir pathway for galactose metabolism. The high resolution x-ray structure of the dimeric enzyme from Lactococcus lactis was recently solved and shown to be topologically similar to the 18-stranded, anti-parallel beta-motif observed for domain 5 of beta-galactosidase. In addition to determining the overall molecular fold of galactose mutarotase, this initial investigation also provided a detailed description of the electrostatic interactions between the enzyme and its physiologically relevant substrate, galactose. Specifically, the side chains of His-96 and His-170 were shown to be located within hydrogen bonding distance to the C-5 oxygen of the substrate, while the carboxylate of Glu-304 was positioned near the C-1 hydroxyl group of the sugar. On the basis of this initial study, a possible role for Glu-304 as the general acid/base group in catalysis was put forth. Here we describe the combined x-ray crystallographic and kinetic analyses of L. lactis galactose mutarotase complexed with D-glucose, D-fucose, D-quinovose, L-arabinose, or D-xylose. These investigations have revealed that there are several distinct binding modes for these sugars, which are dependent upon the spatial orientation of the C-4 hydroxyl group. In those sugars with the same C-4 hydroxyl group orientation as galactose, their C-1 hydroxyl groups are invariably located near Glu-304. For those sugars, which have the same C-4 hydroxyl group configuration as glucose, the C-1 hydroxyls are typically located near Asp-243. These different binding modes correlate with both the observed kinetic parameters and the presence or absence of a hydrogen bond between the guanidinium group of Arg-71 and the C-4 hydroxyl group of the sugar ligand.	Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; Texas A&M Univ, Dept Chem, College Stn, TX 77842 USA	University of Wisconsin System; University of Wisconsin Madison; Texas A&M University System; Texas A&M University College Station	Thoden, JB (corresponding author), Univ Wisconsin, Dept Biochem, 443 Babcock Dr, Madison, WI 53706 USA.		Kim, Jungwook/AAP-1322-2020; Raushel, Frank/B-7125-2015	Kim, Jungwook/0000-0001-5213-9299; Raushel, Frank/0000-0002-5918-3089	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047814, R01DK030343, R56DK030343, R56DK047814] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK47814, DK30343] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BAILEY JM, 1969, J BIOL CHEM, V244, P781; BAILEY JM, 1967, J BIOL CHEM, V242, P4263; BENTLEY R, 1960, J BIOL CHEM, V235, P1219; BENTLEY R, 1960, J BIOL CHEM, V235, P1225; BOUFFARD GG, 1994, J MOL BIOL, V244, P269, DOI 10.1006/jmbi.1994.1728; Egloff MP, 2001, STRUCTURE, V9, P689, DOI 10.1016/S0969-2126(01)00626-8; Erlandson KA, 2001, APPL ENVIRON MICROB, V67, P1445, DOI 10.1128/AEM.67.4.1445-1452.2001; Fethiere J, 1999, J MOL BIOL, V288, P635, DOI 10.1006/jmbi.1999.2698; GATZ C, 1986, J BACTERIOL, V168, P31, DOI 10.1128/jb.168.1.31-39.1986; HUCHO F, 1971, EUR J BIOCHEM, V23, P489, DOI 10.1111/j.1432-1033.1971.tb01645.x; JACOBSON RH, 1994, NATURE, V369, P761, DOI 10.1038/369761a0; KESTON AS, 1954, SCIENCE, V120, P355, DOI 10.1126/science.120.3113.355-a; KESTON AS, 1963, ARCH BIOCHEM BIOPHYS, V102, P306, DOI 10.1016/0003-9861(63)90184-X; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LAPEDES SL, 1968, BIOCHEM BIOPH RES CO, V31, P967, DOI 10.1016/0006-291X(68)90547-0; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; LI LK, 1965, ARCH BIOCHEM BIOPHYS, V110, P156, DOI 10.1016/0003-9861(65)90167-0; Li SL, 2000, EMBO J, V19, P1228, DOI 10.1093/emboj/19.6.1228; MASKELL DJ, 1992, MOL MICROBIOL, V6, P3051, DOI 10.1111/j.1365-2958.1992.tb01763.x; MOLLET B, 1991, J BACTERIOL, V173, P4464, DOI 10.1128/JB.173.14.4464-4473.1991; PARSONS MR, 1995, STRUCTURE, V3, P1171, DOI 10.1016/S0969-2126(01)00253-2; POOLMAN B, 1990, J BACTERIOL, V172, P4037, DOI 10.1128/jb.172.7.4037-4047.1990; Roussel A, 1990, ACTA CRYSTALLOGR A, V46, pC66; Thoden JB, 2002, J BIOL CHEM, V277, P20854, DOI 10.1074/jbc.M201415200; TRONRUD DE, 1987, ACTA CRYSTALLOGR A, V43, P489, DOI 10.1107/S0108767387099124; WALLENFELS K, 1965, BIOCHEM Z, V343, P294	26	32	32	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 22	2002	277	47					45458	45465		10.1074/jbc.M208395200	http://dx.doi.org/10.1074/jbc.M208395200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	618EE	12218067	hybrid			2022-12-27	WOS:000179404800110
J	He, GC; Gupta, S; Yi, M; Michaely, P; Hobbs, HH; Cohen, JC				He, GC; Gupta, S; Yi, M; Michaely, P; Hobbs, HH; Cohen, JC			ARH is a modular adaptor protein that interacts with the LDL receptor, clathrin, and AP-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUTOSOMAL RECESSIVE HYPERCHOLESTEROLEMIA; BETA-ARRESTIN; INTERNALIZATION; RECOGNITION; BINDING; DOMAIN; MOTIF; IDENTIFICATION; ENDOCYTOSIS; MUTATIONS	Mutations in the phosphotyrosine binding domain protein ARH cause autosomal recessive hypercholesterolemia, a disorder caused by defective internalization of low density lipoprotein receptors (LDLR) in the liver. To examine the function of ARH, we used pull-down experiments to test for interactions between ARH, the LDLR, and proteins involved in clathrin-mediated endocytosis. The phosphotyrosine binding domain of ARH interacted with the internalization sequence (NPVY) in the cytoplasmic tail of LDLR in a sequence-specific manner. Mutations in the NPVY sequence that were previously shown to decrease LDLR internalization abolished in vitro binding to ARH. Recombinant ARH bound purified bovine clathrin with high affinity (K-D, similar to44 nm). The interaction between ARH and clathrin was mapped to a canonical clathrin box sequence (LLDLE) in ARH and to the N-terminal domain of the clathrin heavy chain. A highly conserved 20-amino acid sequence in the C-terminal region of ARH bound the beta(2)-adaptin subunit of AP-2. Mutation of a glutamic acid residue in the appendage domain of beta(2)-adaptin that is required for interaction with the adapter protein beta-arrestin markedly reduced binding to ARH. These data are consistent with the hypothesis that ARH functions as an adaptor protein that couples LDLR to the endocytic machinery.	Univ Texas, SW Med Ctr, Ctr Human Nutr, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Cell Biol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Mol Genet, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, McDermott Ctr Human Growth & Dev, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Cohen, JC (corresponding author), Univ Texas, SW Med Ctr, Ctr Human Nutr, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	jonathan.cohen@utsouthwestern.edu			NHLBI NIH HHS [HL20948, HL53917] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948, R01HL053917] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Arca M, 2002, LANCET, V359, P841, DOI 10.1016/S0140-6736(02)07955-2; BANSAL A, 1991, CELL, V67, P1195, DOI 10.1016/0092-8674(91)90295-A; Bohn LM, 1999, SCIENCE, V286, P2495, DOI 10.1126/science.286.5449.2495; Boll W, 2002, TRAFFIC, V3, P590, DOI 10.1034/j.1600-0854.2002.30808.x; Boll W, 1996, EMBO J, V15, P5789, DOI 10.1002/j.1460-2075.1996.tb00965.x; CHEN WJ, 1990, J BIOL CHEM, V265, P3116; Claing A, 2002, PROG NEUROBIOL, V66, P61, DOI 10.1016/S0301-0082(01)00023-5; DAVIS CG, 1986, CELL, V45, P15, DOI 10.1016/0092-8674(86)90533-7; DAVIS CG, 1987, J BIOL CHEM, V262, P4075; Dell'Angelica EC, 2001, TRENDS CELL BIOL, V11, P315, DOI 10.1016/S0962-8924(01)02043-8; Esnouf RM, 1999, ACTA CRYSTALLOGR D, V55, P938, DOI 10.1107/S0907444998017363; Forman-Kay JD, 1999, CURR OPIN STRUC BIOL, V9, P690, DOI 10.1016/S0959-440X(99)00031-7; Garcia CK, 2001, SCIENCE, V292, P1394, DOI 10.1126/science.1060458; Goldstein JL, 2001, METABOLIC MOL BASES, V8th, P2863; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; Guy GR, 2002, CELL SIGNAL, V14, P11, DOI 10.1016/S0898-6568(01)00227-3; HAVEL RJ, 1988, HEPATOLOGY, V8, P1689, DOI 10.1002/hep.1840080637; Hirst J, 1998, BBA-MOL CELL RES, V1404, P173, DOI 10.1016/S0167-4889(98)00056-1; INNERARITY TL, 1990, J LIPID RES, V31, P1337; Kibbey RG, 1998, J CELL BIOL, V142, P59, DOI 10.1083/jcb.142.1.59; Kim Y. B., 2002, J BIOL CHEM; Kirchhausen T, 2002, CELL, V109, P413, DOI 10.1016/S0092-8674(02)00751-1; Laporte SA, 2000, J BIOL CHEM, V275, P23120, DOI 10.1074/jbc.M002581200; Laporte SA, 2002, J BIOL CHEM, V277, P9247, DOI 10.1074/jbc.M108490200; Michaely P, 1999, J BIOL CHEM, V274, P35908, DOI 10.1074/jbc.274.50.35908; Norman D, 1999, J CLIN INVEST, V104, P619, DOI 10.1172/JCI6677; Owen DJ, 2000, EMBO J, V19, P4216, DOI 10.1093/emboj/19.16.4216; PATHAK RK, 1990, J CELL BIOL, V111, P347, DOI 10.1083/jcb.111.2.347; SCHRODER S, 1991, J BIOL CHEM, V266, P7910; ter Haar E, 2000, P NATL ACAD SCI USA, V97, P1096, DOI 10.1073/pnas.97.3.1096; Zhang ZT, 1997, EMBO J, V16, P6141, DOI 10.1093/emboj/16.20.6141; Zuliani G, 1999, ARTERIOSCL THROM VAS, V19, P802, DOI 10.1161/01.ATV.19.3.802	33	174	180	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2002	277	46					44044	44049		10.1074/jbc.M208539200	http://dx.doi.org/10.1074/jbc.M208539200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	615XE	12221107	hybrid			2022-12-27	WOS:000179272000067
J	Eto, K; Kimura, H				Eto, K; Kimura, H			A novel enhancing mechanism for hydrogen sulfide-producing activity of cystathionine beta-synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE; SODIUM-NITROPRUSSIDE; S-ADENOSYLMETHIONINE; SMOOTH-MUSCLE; BRAIN-TISSUE; MUTATIONS; CYSTEINE; DOMAIN	H2S is produced from cysteine by cystathionine beta-synthase (CBS) in the brain and functions as a neuromodulator. Although the production of H2S is regulated by Ca2+ and calmodulin in response to neuronal excitation, little is known about the molecular mechanism for the regulation in CBS activity. Here we show that four cysteine residues of CBS are involved in the regulation of its activity in the presence of Ca2+ and calmodulin. Sodium nitroprusside (SNP), a modifying agent for cysteine residues, enhances CBS activity, whereas N-ethylmaleimide, an alkylating agent for cysteine residues, completely abolished the effect of SNP. Site-directed mutagenesis of the 13 cysteine residues of CBS identified four cysteine residues that are involved in the regulation of CBS activity by SNP, and two of the four residues are involved in the regulation of the basal CBS activity. The enhancement of CBS activity by SNP is independent of nitric oxide production. In the presence of Staphylococcus aureus alpha-hemolysin, which permeabilizes the cell membrane, exogenously applied SNP enhances the activity of CBS in intact cells. The present study demonstrates a novel mechanism for the regulation of CBS activity and provides a possible therapeutic application of SNP for the diseases in which CBS activity is deficient.	Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Tokyo 1878551, Japan	National Center for Neurology & Psychiatry - Japan	Kimura, H (corresponding author), Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, 4-1-1 Ogawahigashi, Tokyo 1878551, Japan.	kimura@ncnp.go.jp	Kimura, Hideo/J-6811-2016					Abe K, 1996, J NEUROSCI, V16, P1066; BOTTIGLIERI T, 1994, DRUGS, V48, P137, DOI 10.2165/00003495-199448020-00002; Clarke R, 1998, ARCH NEUROL-CHICAGO, V55, P1449, DOI 10.1001/archneur.55.11.1449; Dello Russo C, 2000, J NEUROENDOCRINOL, V12, P225; Eto K, 2002, BIOCHEM BIOPH RES CO, V293, P1485, DOI 10.1016/S0006-291X(02)00422-9; Eto K, 2002, J NEUROSCI, V22, P3386; FINK D, 1989, CELL SIGNAL, V1, P387, DOI 10.1016/0898-6568(89)90057-0; FINKELSTEIN JD, 1975, BIOCHEM BIOPH RES CO, V66, P81, DOI 10.1016/S0006-291X(75)80297-X; GARRY MG, 1994, J NEUROSCI, V14, P4329; GEORGES RJ, 1970, CLIN CHIM ACTA, V30, P737, DOI 10.1016/0009-8981(70)90268-8; GOODWIN LR, 1989, J ANAL TOXICOL, V13, P105, DOI 10.1093/jat/13.2.105; GRIFFITH OW, 1987, METHOD ENZYMOL, V143, P366; GRUETTER CA, 1981, J PHARMACOL EXP THER, V219, P181; Hosoki R, 1997, BIOCHEM BIOPH RES CO, V237, P527, DOI 10.1006/bbrc.1997.6878; HU FL, 1993, HUM MOL GENET, V2, P1857, DOI 10.1093/hmg/2.11.1857; KNOWLES RG, 1990, BIOCHEM J, V269, P207, DOI 10.1042/bj2690207; Kraus JP, 1999, HUM MUTAT, V13, P362; LEEUWENKAMP OR, 1984, PHARM WEEKBLAD, V6, P195, DOI 10.1007/BF01999942; Morrison LD, 1996, J NEUROCHEM, V67, P1328; Mudd Sh, 1989, METABOLIC BASIS INHE, V1, P693; Ogita K, 1998, NEUROCHEM INT, V33, P1, DOI 10.1016/S0197-0186(05)80002-6; Ojha S, 2002, BIOCHEMISTRY-US, V41, P4649, DOI 10.1021/bi011827o; SAVAGE JC, 1990, J CHROMATOGR-BIOMED, V526, P540, DOI 10.1016/S0378-4347(00)82537-2; Shan XY, 2001, HUM MOL GENET, V10, P635, DOI 10.1093/hmg/10.6.635; SHIH VE, 1995, AM J HUM GENET, V57, P34; STIPANUK MH, 1982, BIOCHEM J, V206, P267, DOI 10.1042/bj2060267; Taoka S, 1998, J BIOL CHEM, V273, P25179, DOI 10.1074/jbc.273.39.25179; VANRHEENEN DL, 1968, J CHROMATOGR, V37, P341, DOI 10.1016/S0021-9673(01)99120-4; WARENYCIA MW, 1989, BIOCHEM PHARMACOL, V38, P973, DOI 10.1016/0006-2952(89)90288-8; Zhao WM, 2001, EMBO J, V20, P6008, DOI 10.1093/emboj/20.21.6008	30	68	76	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					42680	42685		10.1074/jbc.M205835200	http://dx.doi.org/10.1074/jbc.M205835200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12213817	hybrid			2022-12-27	WOS:000179081200033
J	Suzuki, H; Kumagai, H				Suzuki, H; Kumagai, H			Autocatalytic processing of gamma-glutamyltranspeptidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTAMYL-TRANSFERASE TRANSPEPTIDASE; ESCHERICHIA-COLI K-12; MOLECULAR-CLONING; BACILLUS-SUBTILIS; PRECURSOR FORM; INTRAMOLECULAR AUTOPROTEOLYSIS; NUCLEOTIDE-SEQUENCE; DNA-SEQUENCE; GENE; SUBUNIT	g-Glutamyltranspeptidase is the key enzyme in glutathione metabolism, and we previously presented evidence suggesting that it belongs to the N-terminal nucleophile hydrolase superfamily. Enzymatically active gamma-glutamyltranspeptidase, which consists of one large subunit and one small subunit, is generated from an inactive common precursor through post-translational proteolytic processing. The processing mechanism for gamma-glutamyltranspeptidase of Escherichia coli K-12 has been analyzed by means of in vitro studies using purified precursors. Here we show that the processing of a precursor of gamma-glutamyltranspeptidase is an intramolecular autocatalytic event and that the catalytic nucleophile for the processing reaction is the oxygen atom of the side chain of Thr-391 (N-terminal residue of the small (beta) subunit), which is also the nucleophile for the enzymatic reaction.	Kyoto Univ, Grad Sch Biostudies, Div Integrated Life Sci, Sakyo Ku, Kyoto 6068502, Japan	Kyoto University	Suzuki, H (corresponding author), Kyoto Univ, Grad Sch Biostudies, Div Integrated Life Sci, Sakyo Ku, Kyoto 6068502, Japan.	hideyuki@lif.kyoto-u.ac.jp						BAROUKI R, 1984, J BIOL CHEM, V259, P7970; BRANNIGAN JA, 1995, NATURE, V378, P416, DOI 10.1038/378416a0; Bruice TC, 1966, BIOORGANIC MECH, V1, P259; CAPRARO MA, 1983, FEBS LETT, V157, P139, DOI 10.1016/0014-5793(83)81132-6; Carter BZ, 1998, J BIOL CHEM, V273, P28277, DOI 10.1074/jbc.273.43.28277; Chong SR, 1996, J BIOL CHEM, V271, P22159, DOI 10.1074/jbc.271.36.22159; CLAUDIO JO, 1991, J FERMENT BIOENG, V72, P125, DOI 10.1016/0922-338X(91)90322-8; COLOMA J, 1986, NUCLEIC ACIDS RES, V14, P1393, DOI 10.1093/nar/14.3.1393; Ditzel L, 1998, J MOL BIOL, V279, P1187, DOI 10.1006/jmbi.1998.1818; FINIDORI J, 1984, J BIOL CHEM, V259, P4687; GOODSPEED DC, 1989, GENE, V76, P1, DOI 10.1016/0378-1119(89)90002-4; Guan C, 1998, J BIOL CHEM, V273, P9695, DOI 10.1074/jbc.273.16.9695; Guan CD, 1996, J BIOL CHEM, V271, P1732, DOI 10.1074/jbc.271.3.1732; HAHIMOTO W, 1995, J BIOCH, V118, P1216; HASHIMOTO W, 1995, J BIOCHEM-TOKYO, V118, P75, DOI 10.1093/oxfordjournals.jbchem.a124894; HASHIMOTO W, 1992, BIOCHEM BIOPH RES CO, V189, P173, DOI 10.1016/0006-291X(92)91540-7; Heinemeyer W, 1997, J BIOL CHEM, V272, P25200, DOI 10.1074/jbc.272.40.25200; HEISTERKAMP N, 1991, P NATL ACAD SCI USA, V88, P6303, DOI 10.1073/pnas.88.14.6303; Hewitt L, 2000, J MOL BIOL, V302, P887, DOI 10.1006/jmbi.2000.4105; HUGHEY RP, 1976, J BIOL CHEM, V251, P7863; Ikeda Y, 1996, J BIOCHEM-TOKYO, V119, P1166; Inoue M, 2000, BIOCHEMISTRY-US, V39, P7764, DOI 10.1021/bi000220p; ISHIYE M, 1993, BIOTECHNOL PROGR, V9, P323, DOI 10.1021/bp00021a012; JOYCE CM, 1984, J BACTERIOL, V158, P636, DOI 10.1128/JB.158.2.636-643.1984; Kasche V, 1999, BBA-PROTEIN STRUCT M, V1433, P76, DOI 10.1016/S0167-4838(99)00155-7; Katayama T, 2000, APPL ENVIRON MICROB, V66, P4764, DOI 10.1128/AEM.66.11.4764-4771.2000; Kim S, 2001, J BIOL CHEM, V276, P48376, DOI 10.1074/jbc.M109603200; Kim Y, 2002, J BIOL CHEM, V277, P2823, DOI 10.1074/jbc.M108888200; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; KUNO T, 1983, BIOCHEM BIOPH RES CO, V114, P889, DOI 10.1016/0006-291X(83)90864-1; KUNO T, 1984, BIOCHEM INT, V8, P581; LAPERCHE Y, 1986, P NATL ACAD SCI USA, V83, P937, DOI 10.1073/pnas.83.4.937; Lee YS, 1998, J BACTERIOL, V180, P4576, DOI 10.1128/JB.180.17.4576-4582.1998; Li ST, 1999, J BACTERIOL, V181, P1403, DOI 10.1128/JB.181.5.1403-1408.1999; Li Y, 1999, EUR J BIOCHEM, V262, P713, DOI 10.1046/j.1432-1327.1999.00417.x; MATSUDA Y, 1983, J BIOCHEM-TOKYO, V94, P755, DOI 10.1093/oxfordjournals.jbchem.a134416; MATSUDA Y, 1980, J BIOCHEM, V87, P1243; MATSUDA Y, 1983, J BIOCHEM-TOKYO, V93, P1427, DOI 10.1093/oxfordjournals.jbchem.a134278; NASH B, 1984, J BIOL CHEM, V259, P678; NASH B, 1982, J BIOL CHEM, V257, P585; Ogawa Y, 1997, BIOSCI BIOTECH BIOCH, V61, P1596, DOI 10.1271/bbb.61.1596; Paetzel M, 1997, TRENDS BIOCHEM SCI, V22, P28, DOI 10.1016/S0968-0004(96)10065-7; PAPANDRIKOPOULOU A, 1989, EUR J BIOCHEM, V183, P693, DOI 10.1111/j.1432-1033.1989.tb21100.x; Potdar PD, 1997, AM J PHYSIOL-LUNG C, V273, pL1082, DOI 10.1152/ajplung.1997.273.5.L1082; RAJPERTDEMEYTS E, 1988, P NATL ACAD SCI USA, V85, P8840, DOI 10.1073/pnas.85.23.8840; Sakai H, 1996, J BIOCHEM, V120, P26, DOI 10.1093/oxfordjournals.jbchem.a021388; SAKAMURO D, 1988, GENE, V73, P1; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Schmidtke G, 1996, EMBO J, V15, P6887, DOI 10.1002/j.1460-2075.1996.tb01081.x; SEEMULLER E, 1995, FEBS LETT, V359, P173, DOI 10.1016/0014-5793(95)00036-9; Shao Y, 1996, BIOCHEMISTRY-US, V35, P3810, DOI 10.1021/bi952592h; SUZUKI H, 1988, BIOCHEM BIOPH RES CO, V150, P33, DOI 10.1016/0006-291X(88)90482-2; Suzuki H, 1999, J MOL CATAL B-ENZYM, V6, P175, DOI 10.1016/S1381-1177(98)00116-7; SUZUKI H, 1989, J BACTERIOL, V171, P5169, DOI 10.1128/jb.171.9.5169-5172.1989; SUZUKI H, 1986, J BACTERIOL, V168, P1332, DOI 10.1128/jb.168.3.1332-1335.1986; SUZUKI H, 1986, J BACTERIOL, V168, P1325, DOI 10.1128/jb.168.3.1325-1331.1986; SUZUKI H, 1987, J BACTERIOL, V169, P3926, DOI 10.1128/jb.169.9.3926-3931.1987; SUZUKI H, 1993, J BACTERIOL, V175, P6038, DOI 10.1128/JB.175.18.6038-6040.1993; Taniguchi N, 1998, ADV ENZYMOL RAMB, V72, P239; TATE SS, 1981, MOL CELL BIOCHEM, V39, P357, DOI 10.1007/BF00232585; TATE SS, 1976, P NATL ACAD SCI USA, V73, P2599, DOI 10.1073/pnas.73.8.2599; UCHIDA I, 1993, MOL MICROBIOL, V9, P487, DOI 10.1111/j.1365-2958.1993.tb01710.x; VIEIRA J, 1987, METHOD ENZYMOL, V153, P3; Xu K, 1996, J BACTERIOL, V178, P4319, DOI 10.1128/jb.178.14.4319-4322.1996; Xu MQ, 1996, EMBO J, V15, P5146, DOI 10.1002/j.1460-2075.1996.tb00898.x; Xu QA, 1999, CELL, V98, P651, DOI 10.1016/S0092-8674(00)80052-5; YOKOSAWA N, 1983, ONCODEV BIOL MED, V4, pC71	67	115	117	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					43536	43543		10.1074/jbc.M207680200	http://dx.doi.org/10.1074/jbc.M207680200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12207027	hybrid			2022-12-27	WOS:000179081200139
J	Cabezon, E; Butler, PJG; Runswick, MJ; Carbajo, RJ; Walker, JE				Cabezon, E; Butler, PJG; Runswick, MJ; Carbajo, RJ; Walker, JE			Homologous and heterologous inhibitory effects of ATPase inhibitor proteins on F-ATPases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE HEART-MITOCHONDRIA; BINDING; IF1; PURIFICATION; F1F0-ATPASE; F-1-ATPASE; PH	In Saccharomyces cerevisiae, at least three proteins (IF1, STF1, and STF2) appear to be involved in the regulation of ATP synthase. Both IF1 and STF1 inhibit F-1, whereas the proposed function for STF2 is to facilitate the binding of IF1 and STF1 to F-1. The oligomerization properties of yeast IF1 and STF1 have been investigated by sedimentation equilibrium analytical ultracentrifugation and by covalent cross-linking. Both techniques confirm that IF1 and STF1 oligomerize in opposite directions in relation to pH, suggesting that both proteins might regulate yeast F1F0-ATPase under different conditions. Their effects on bovine F-ATPases are also described. Whereas bovine IF1 inhibits yeast F-1-ATPase even better than yeast IF1 or STF1, the capability of yeast IF1 to inhibit the bovine enzyme is very low and decreases with time. Such an effect is also observed in the study of the homologous inhibition of yeast F-1-ATPase. Yeast inhibitors are not as effective as their bovine counterpart, and the complex seems to dissociate gradually.	MRC, Dunn Human Nutr Unit, Cambridge CB2 2XY, England; MRC, Mol Biol Lab, Cambridge CB2 2QH, England	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research; MRC Laboratory Molecular Biology	Walker, JE (corresponding author), MRC, Dunn Human Nutr Unit, Hills Rd, Cambridge CB2 2XY, England.		Cabezon, Elena/K-5874-2014	Walker, John/0000-0001-7929-2162; Cabezon, Elena/0000-0002-6177-5016				Cabezon E, 2000, J BIOL CHEM, V275, P28353, DOI 10.1074/jbc.C000427200; Cabezon E, 2000, J BIOL CHEM, V275, P25460, DOI 10.1074/jbc.M003859200; Cabezon E, 2001, EMBO J, V20, P6990, DOI 10.1093/emboj/20.24.6990; CASASSA EF, 1964, ADV PROTEIN CHEM, V19, P287, DOI 10.1016/S0065-3233(08)60191-6; CINTRON NM, 1979, J BIOL CHEM, V254, P3439; Eisenberg H, 1976, BIOL MACROMOLECULES; Gordon-Smith DJ, 2001, J MOL BIOL, V308, P325, DOI 10.1006/jmbi.2001.4570; HASHIMOTO T, 1990, J BIOENERG BIOMEMBR, V22, P27, DOI 10.1007/BF00762843; HASHIMOTO T, 1987, J BIOCHEM-TOKYO, V102, P685, DOI 10.1093/oxfordjournals.jbchem.a122106; HASHIMOTO T, 1990, J BIOCHEM-TOKYO, V108, P17, DOI 10.1093/oxfordjournals.jbchem.a123154; HASHIMOTO T, 1981, J BIOCHEM-TOKYO, V90, P1151, DOI 10.1093/oxfordjournals.jbchem.a133567; Johnson M.L., 1994, MODERN ANAL ULTRACEN, P37; Kratky O, 1973, Methods Enzymol, V27, P98; LUTTER R, 1993, J MOL BIOL, V229, P787, DOI 10.1006/jmbi.1993.1081; NORLING B, 1990, EUR J BIOCHEM, V188, P247, DOI 10.1111/j.1432-1033.1990.tb15396.x; PANCHENKO MV, 1985, FEBS LETT, V184, P226, DOI 10.1016/0014-5793(85)80611-6; PULLMAN ME, 1963, J BIOL CHEM, V238, P3762; TAUSSKY HH, 1953, J BIOL CHEM, V202, P675; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tsunoda SP, 2001, P NATL ACAD SCI USA, V98, P6560, DOI 10.1073/pnas.111128098; VANHOLDE KE, 1958, J PHYS CHEM-US, V62, P734, DOI 10.1021/j150564a025; vanRaaij MJ, 1996, BIOCHEMISTRY-US, V35, P15618, DOI 10.1021/bi960628f; WAY M, 1990, EMBO J, V9, P4103, DOI 10.1002/j.1460-2075.1990.tb07632.x	23	40	44	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					41334	41341		10.1074/jbc.M207169200	http://dx.doi.org/10.1074/jbc.M207169200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12186878	hybrid			2022-12-27	WOS:000178985300008
J	Fischer, M; Romisch, W; Schiffmann, S; Kelly, M; Oschkinat, H; Steinbacher, S; Huber, R; Eisenreich, W; Richter, G; Bacher, A				Fischer, M; Romisch, W; Schiffmann, S; Kelly, M; Oschkinat, H; Steinbacher, S; Huber, R; Eisenreich, W; Richter, G; Bacher, A			Biosynthesis of riboflavin in archaea studies on the mechanism of 3,4-dihydroxy-2-butanone-4-phosphate synthase of Methanococcus jannaschii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; BACTERIAL BIOLUMINESCENCE; 4-PHOSPHATE SYNTHASE; BACILLUS-SUBTILIS; METHANOBACTERIUM-THERMOAUTOTROPHICUM; 4-CARBON PRECURSOR; CYCLOHYDROLASE-II; DEAMINASE; PROTEIN; 6,7-DIMETHYL-8-RIBITYLLUMAZINE	The hypothetical protein predicted by the open reading frame MJ0055 of Methanococcus jannaschii was expressed in a recombinant Escherichia coli strain under the control of a synthetic gene optimized for translation in an eubacterial host. The recombinant protein catalyzes the formation of the riboflavin precursor 3,4-dihydroxy-2-butanone 4-phosphate from ribulose 5-phosphate at a rate of 174 nmol mg(-1) min(-1) at 37 degreesC. The homodimeric 51.6-kDa protein requires divalent metal ions, preferentially magnesium, for activity. The reaction involves an intramolecular skeletal rearrangement as shown by C-13 NMR spectroscopy using [U-C-13(5)]ribulose 5-phosphate as substrate. A cluster of charged amino acid residues comprising arginine 25, glutamates 26 and 28, and aspartates 21 and 30 is essential for catalytic activity. Histidine 164 and glutamate 185 were also shown to be essential for catalytic activity.	Tech Univ Munich, Inst Organ Chem & Biochem, D-85747 Garching, Germany; Max Planck Inst Biochem, Dept Prot Crystallog, D-82512 Martinsried, Germany; Forschungsinst Mol Pharmakol, D-13125 Berlin, Germany	Technical University of Munich; Max Planck Society	Fischer, M (corresponding author), Tech Univ Munich, Inst Organ Chem & Biochem, Lichtenbergstr 4, D-85747 Garching, Germany.		Fischer, Markus/AFT-1856-2022; Fischer, Markus J./G-9477-2012; Eisenreich, Wolfgang/A-1258-2013; Richter, Gerald/F-3642-2011	Fischer, Markus/0000-0001-7243-4199; Eisenreich, Wolfgang/0000-0002-9832-8279; Oschkinat, Hartmut/0000-0002-4384-9544; Schiffmann, Susanne/0000-0001-5035-2504				BACHER A, 1986, METHOD ENZYMOL, V122, P192; Bacher A, 2001, VITAM HORM, V61, P1; Bacher A, 2000, ANNU REV NUTR, V20, P153, DOI 10.1146/annurev.nutr.20.1.153; BACHER A, 1996, ESCHERICHIA COLI SAL, V2, P657; Briggs WR, 1999, ANNU REV CELL DEV BI, V15, P33, DOI 10.1146/annurev.cellbio.15.1.33; BULLOCK WO, 1987, BIOTECHNIQUES, V5, P376; BURROWS RB, 1978, J BACTERIOL, V136, P657, DOI 10.1128/JB.136.2.657-667.1978; Eberhardt S, 1997, J BACTERIOL, V179, P2938, DOI 10.1128/jb.179.9.2938-2943.1997; EISENREICH W, 1991, J BIOL CHEM, V266, P9622; FOOR F, 1975, J BIOL CHEM, V250, P3545; HARZER G, 1978, BIOCHIM BIOPHYS ACTA, V540, P48, DOI 10.1016/0304-4165(78)90433-6; HOLLANDER I, 1979, BIOCHEM BIOPH RES CO, V89, P759, DOI 10.1016/0006-291X(79)90694-6; Kelly MJS, 2001, P NATL ACAD SCI USA, V98, P13025, DOI 10.1073/pnas.231323598; KIS K, 1995, BIOCHEMISTRY-US, V34, P2883, DOI 10.1021/bi00009a019; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Lee, 1991, CHEM BIOCH FLAVOENZY, V2, P109; Lee J., 1985, CHEM BIOLUMINESCENCE, P401; Liao DI, 2002, BIOCHEMISTRY-US, V41, P1795, DOI 10.1021/bi015652u; Liao DI, 2001, STRUCTURE, V9, P11, DOI 10.1016/S0969-2126(00)00550-5; MANN M, 1995, TRENDS BIOCHEM SCI, V20, P219, DOI 10.1016/S0968-0004(00)89019-2; MEIGHEN EA, 1993, FASEB J, V7, P1016, DOI 10.1096/fasebj.7.11.8370470; MEIGHEN EA, 1991, MICROBIOL REV, V55, P123, DOI 10.1128/MMBR.55.1.123-142.1991; Mortl S, 1996, J BIOL CHEM, V271, P33201, DOI 10.1074/jbc.271.52.33201; MULLER F, 1992, CHEM BIOCH FLAVOENZY, V3; NEUBERGER G, 1986, BIOCHEM BIOPH RES CO, V139, P1111, DOI 10.1016/S0006-291X(86)80292-3; NIELSEN P, 1981, BIOCHIM BIOPHYS ACTA, V662, P312, DOI 10.1016/0005-2744(81)90044-9; OKANE DJ, 1992, MOL MICROBIOL, V6, P443, DOI 10.1111/j.1365-2958.1992.tb01488.x; Plaut G.W, 1960, J BIOL CHEM, V235, P41; PLAUT GWE, 1974, ANNU REV BIOCHEM, V43, P899, DOI 10.1146/annurev.bi.43.070174.004343; Plaut GWE, 1971, METHODS ENZYMOL B, V18, P515; READ SM, 1981, ANAL BIOCHEM, V116, P53, DOI 10.1016/0003-2697(81)90321-3; REUKE B, 1992, J BACTERIOL, V174, P4042, DOI 10.1128/jb.174.12.4042-4049.1992; Richter G, 1999, EUR J BIOCHEM, V261, P57, DOI 10.1046/j.1432-1327.1999.00211.x; RICHTER G, 1993, J BACTERIOL, V175, P4045, DOI 10.1128/JB.175.13.4045-4051.1993; Richter G, 1997, J BACTERIOL, V179, P2022, DOI 10.1128/jb.179.6.2022-2028.1997; Richter G, 1997, METHOD ENZYMOL, V280, P374; Salomon M, 2001, P NATL ACAD SCI USA, V98, P12357, DOI 10.1073/pnas.221455298; SANCAR A, 1994, BIOCHEMISTRY-US, V33, P2, DOI 10.1021/bi00167a001; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SEDLMAIER H, 1987, Z NATURFORSCH C, V42, P425; STUBER D, 1990, IMMUNOLOGICAL METHOD, V4, P121; VOLK R, 1990, J BIOL CHEM, V265, P19479; VOLK R, 1988, J AM CHEM SOC, V110, P3651, DOI 10.1021/ja00219a047; VOLK R, 1991, J BIOL CHEM, V266, P20610; WACKER H, 1964, J BIOL CHEM, V239, P3493; YOUNG DW, 1986, NAT PROD REP, V3, P395, DOI 10.1039/np9860300395	47	26	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					41410	41416		10.1074/jbc.M206863200	http://dx.doi.org/10.1074/jbc.M206863200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12200440	hybrid			2022-12-27	WOS:000178985300016
J	Greene, NDE; Leung, KY; Wait, R; Begum, S; Dunn, MJ; Copp, AJ				Greene, NDE; Leung, KY; Wait, R; Begum, S; Dunn, MJ; Copp, AJ			Differential protein expression at the stage of neural tube closure in the mouse embryo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; KINASE-C; 2-DIMENSIONAL ELECTROPHORESIS; HEAT-SHOCK; PROTEOMICS; INDUCTION; FILAMENTS; ELEMENTS; NUCLEAR; GENOMES	Analysis of the protein complement of a biological system through proteomics provides the opportunity to directly monitor the functional readout of gene expression. In this study, proteomics was applied to the mouse embryo to investigate the molecular events underlying the processes occurring at the stage of neural tube closure. Protein profiles of embryos between embryonic days 8.5 and 10.5 exhibited a number of stage-specific changes. Identification of developmentally regulated proteins by mass spectrometry revealed several groups of functionally related proteins including circulatory, cytoskeletal, and stress proteins. Additional proteins of unknown function were identified, such as Copine 1 and PICOT, whose developmental regulation was previously unsuspected.	UCL, Inst Child Hlth, Neural Dev Unit, London WC1N 1EH, England; Harefield Hosp, Imperial Coll Sch Med, Heart Sci Ctr, Natl Heart & Lung Inst, Harefield VB9 6JH, Middx, England; Univ London Imperial Coll Sci Technol & Med, Fac Med, Kennedy Inst Rheumatol Div, London W6 8LH, England	University of London; University College London; Imperial College London; Royal Brompton & Harefield NHS Foundation Trust; Harefield Hospital; Imperial College London; University of Oxford	Greene, NDE (corresponding author), UCL, Inst Child Hlth, Neural Dev Unit, Guilford St, London WC1N 1EH, England.	n.greene@ich.ucl.ac.uk	Copp, Andrew/C-4174-2008	Copp, Andrew/0000-0002-2544-9117; Greene, Nicholas D.E./0000-0002-4170-5248				Agashe VR, 2000, SEMIN CELL DEV BIOL, V11, P15, DOI 10.1006/scdb.1999.0347; Anderson L, 1997, ELECTROPHORESIS, V18, P533, DOI 10.1002/elps.1150180333; Awad MM, 2000, CELL GROWTH DIFFER, V11, P325; Barnes JA, 2000, ANAT EMBRYOL, V202, P67, DOI 10.1007/s004290000090; BENDAVID Y, 1991, EMBO J, V10, P317, DOI 10.1002/j.1460-2075.1991.tb07952.x; Cockroft DL, 1990, POSTIMPLANTATION MAM, P15; Cooper JA, 2000, CURR OPIN CELL BIOL, V12, P97, DOI 10.1016/S0955-0674(99)00062-9; COPP AJ, 1992, DEV BIOL, V153, P312, DOI 10.1016/0012-1606(92)90116-X; Creutz CE, 1998, J BIOL CHEM, V273, P1393, DOI 10.1074/jbc.273.3.1393; de Bruijn MFTR, 2000, EMBO J, V19, P2465, DOI 10.1093/emboj/19.11.2465; DUNCAN PI, 1995, J BIOL CHEM, V270, P21524, DOI 10.1074/jbc.270.37.21524; DZIADEK M, 1978, J EMBRYOL EXP MORPH, V46, P135; Gorg A, 2000, ELECTROPHORESIS, V21, P1037, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1037::AID-ELPS1037>3.0.CO;2-V; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Gygi SP, 2000, P NATL ACAD SCI USA, V97, P9390, DOI 10.1073/pnas.160270797; Hatayama T, 1997, CELL STRUCT FUNCT, V22, P517, DOI 10.1247/csf.22.517; Hegardt FG, 1999, BIOCHEM J, V338, P569, DOI 10.1042/0264-6021:3380569; Herrmann H, 2000, CURR OPIN CELL BIOL, V12, P79, DOI 10.1016/S0955-0674(99)00060-5; HOULE J, 1983, DEV BRAIN RES, V9, P189, DOI 10.1016/0165-3806(83)90051-2; JACKSON BW, 1981, DIFFERENTIATION, V20, P203, DOI 10.1111/j.1432-0436.1981.tb01177.x; Jones EA, 2001, J ANAT, V198, P555, DOI 10.1046/j.1469-7580.2001.19850555.x; KOVACH JS, 1967, J MOL BIOL, V25, P131, DOI 10.1016/0022-2836(67)90284-7; LATHAM KE, 1993, MOL REPROD DEV, V35, P140, DOI 10.1002/mrd.1080350207; Lee AS, 2001, TRENDS BIOCHEM SCI, V26, P504, DOI 10.1016/S0968-0004(01)01908-9; Leung KY, 2001, PROTEOMICS, V1, P787; Loones MT, 1997, CELL MOL LIFE SCI, V53, P179, DOI 10.1007/PL00000590; Lopez MF, 2002, CIRC RES, V90, P380, DOI 10.1161/hh0402.105757; Mohsen AA, 1998, BIOCHEMISTRY-US, V37, P10325, DOI 10.1021/bi973096r; MURACH KF, 1990, J CELL BIOCHEM, V44, P19, DOI 10.1002/jcb.240440103; Pandey A, 2000, NATURE, V405, P837, DOI 10.1038/35015709; Poyton RO, 1996, ANNU REV BIOCHEM, V65, P563, DOI 10.1146/annurev.bi.65.070196.003023; Rendon-Huerta E, 1999, BIOCHEM J, V344, P469, DOI 10.1042/0264-6021:3440469; Tomsig JL, 2000, BIOCHEMISTRY-US, V39, P16163, DOI 10.1021/bi0019949; Vizzard MA, 2000, DEV BRAIN RES, V119, P217, DOI 10.1016/S0165-3806(99)00174-1; Walsh D, 1997, CELL MOL LIFE SCI, V53, P198, DOI 10.1007/PL00000592; Wilda M, 2001, MECH DEVELOP, V103, P197, DOI 10.1016/S0925-4773(01)00357-4; WILKINSON DG, 1987, DEVELOPMENT, V99, P493; Witte S, 2000, J BIOL CHEM, V275, P1902, DOI 10.1074/jbc.275.3.1902	38	25	29	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					41645	41651		10.1074/jbc.M203607200	http://dx.doi.org/10.1074/jbc.M203607200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12200422	hybrid			2022-12-27	WOS:000178985300045
J	Sato, S; Tatebayashi, Y; Akagi, T; Chui, DH; Murayama, M; Miyasaka, T; Planel, E; Tanemura, K; Sun, XY; Hashikawa, T; Yoshioka, K; Ishiguro, K; Takashima, A				Sato, S; Tatebayashi, Y; Akagi, T; Chui, DH; Murayama, M; Miyasaka, T; Planel, E; Tanemura, K; Sun, XY; Hashikawa, T; Yoshioka, K; Ishiguro, K; Takashima, A			Aberrant tau phosphorylation by glycogen synthase kinase-3 beta and JNK3 induces oligomeric tau fibrils in COS-7 cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAIRED HELICAL FILAMENTS; N-TERMINAL KINASE; ACTIVATED PROTEIN-KINASES; ALZHEIMERS-DISEASE; NEUROFIBRILLARY TANGLES; IN-VITRO; ABNORMAL PHOSPHORYLATION; HIPPOCAMPAL-NEURONS; OXIDATIVE STRESS; NERVOUS-SYSTEM	Neurofibrillary tangles (NFTs) are found in a wide range of neurodegenerative disorders, including Alzheimer's disease. The major component of NFTs is aberrantly hyperphosphorylated microtubule-associated protein tau. Because appropriate in vivo models have been lacking, the role of tau phosphorylation in NFTs formation has remained elusive. Here, we describe a new model in which adenovirus-mediated gene expression of tau, DeltaMEKK, JNK3, and GSK-3beta in COS-7 cells produces most of the pathological phosphorylation epitopes of tau including AT100. Furthermore, this co-expression resulted in the formation of tau aggregates having short fibrils that were detergent-insoluble and Thioflavin-S-reactive. These results suggest that aberrant tau phosphorylation by the combination of these kinases may be involved in "pretangle," oligomeric tau fibril formation in vivo.	RIKEN, Brain Sci Inst, Lab Alzheimers Dis, Wako, Saitama 3510198, Japan; RIKEN, Brain Sci Inst, Lab Neural Architecture, Wako, Saitama 3510198, Japan; Kanazawa Univ, Canc Res Inst, Div Cell Cycle Regulat, Kanazawa, Ishikawa 9200934, Japan; Mitsubishi Kasei Corp, Inst Life Sci, Tokyo 1948511, Japan	RIKEN; RIKEN; Kanazawa University	Takashima, A (corresponding author), RIKEN, Brain Sci Inst, Lab Alzheimers Dis, Wako, Saitama 3510198, Japan.			Planel, Emmanuel/0000-0001-5128-0565				Alonso AD, 2001, P NATL ACAD SCI USA, V98, P6923, DOI 10.1073/pnas.121119298; Behl C, 1999, PROG NEUROBIOL, V57, P301, DOI 10.1016/S0301-0082(98)00055-0; BINDER LI, 1985, J CELL BIOL, V101, P1371, DOI 10.1083/jcb.101.4.1371; Chui DH, 1998, J NEUROSCI RES, V53, P99; Chui DH, 1999, NAT MED, V5, P560, DOI 10.1038/8438; Goedert M, 1997, FEBS LETT, V409, P57, DOI 10.1016/S0014-5793(97)00483-3; GOEDERT M, 1995, NEUROSCI LETT, V189, P167, DOI 10.1016/0304-3940(95)11484-E; GOEDERT M, 1994, BIOCHEM J, V301, P871, DOI 10.1042/bj3010871; Goedert M, 1996, NATURE, V383, P550, DOI 10.1038/383550a0; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; HASEGAWA M, 1992, J BIOL CHEM, V267, P17047; IHARA Y, 1986, J BIOCHEM-TOKYO, V99, P1807, DOI 10.1093/oxfordjournals.jbchem.a135662; Ishiguro K, 1995, NEUROSCI LETT, V202, P81, DOI 10.1016/0304-3940(95)12206-0; Ito M, 1999, MOL CELL BIOL, V19, P7539; Kampers T, 1996, FEBS LETT, V399, P344, DOI 10.1016/S0014-5793(96)01386-5; KANEGAE Y, 1994, JPN J MED SCI BIOL, V47, P157, DOI 10.7883/yoken1952.47.157; Lee VMY, 1999, NEURON, V24, P507, DOI 10.1016/S0896-6273(00)81106-X; LeVine H, 1999, METHOD ENZYMOL, V309, P274; LIN AN, 1995, SCIENCE, V268, P286, DOI 10.1126/science.7716521; MATSUO ES, 1994, NEURON, V13, P989, DOI 10.1016/0896-6273(94)90264-X; MINDEN A, 1994, SCIENCE, V266, P1719, DOI 10.1126/science.7992057; Miyake S, 1996, P NATL ACAD SCI USA, V93, P1320, DOI 10.1073/pnas.93.3.1320; MOHIT AA, 1995, NEURON, V14, P67, DOI 10.1016/0896-6273(95)90241-4; Morishima Y, 2001, J NEUROSCI, V21, P7551, DOI 10.1523/JNEUROSCI.21-19-07551.2001; MORISHIMAKAWASHIMA M, 1995, J BIOL CHEM, V270, P823, DOI 10.1074/jbc.270.2.823; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Nunomura A, 1999, J NEUROSCI, V19, P1959; Nunomura A, 2001, J NEUROPATH EXP NEUR, V60, P759, DOI 10.1093/jnen/60.8.759; Perez M, 1996, J NEUROCHEM, V67, P1183; Perez M, 2000, FEBS LETT, V486, P270, DOI 10.1016/S0014-5793(00)02323-1; Perry G, 1999, NEUROREPORT, V10, P2411, DOI 10.1097/00001756-199908020-00035; Perry G, 2000, FREE RADICAL BIO MED, V28, P831, DOI 10.1016/S0891-5849(00)00158-1; Reynolds CH, 2000, J NEUROCHEM, V74, P1587, DOI 10.1046/j.1471-4159.2000.0741587.x; Reynolds CH, 1997, J NEUROCHEM, V68, P1736; SAITO I, 1985, J VIROL, V54, P711, DOI 10.1128/JVI.54.3.711-719.1985; Sayre LM, 2000, J NEUROCHEM, V74, P270, DOI 10.1046/j.1471-4159.2000.0740270.x; SCHWEERS O, 1995, P NATL ACAD SCI USA, V92, P8463, DOI 10.1073/pnas.92.18.8463; Shiurba RA, 1996, BRAIN RES, V737, P119, DOI 10.1016/0006-8993(96)00717-2; SZENDREI GI, 1993, J NEUROSCI RES, V34, P243, DOI 10.1002/jnr.490340212; TAKASHIMA A, 1995, NEUROSCI LETT, V198, P83, DOI 10.1016/0304-3940(95)11964-X; TAKASHIMA A, 1993, P NATL ACAD SCI USA, V90, P7789, DOI 10.1073/pnas.90.16.7789; Takashima A, 1998, NEUROSCI RES, V31, P317, DOI 10.1016/S0168-0102(98)00061-3; Takashima A, 1998, P NATL ACAD SCI USA, V95, P9637, DOI 10.1073/pnas.95.16.9637; Troy CM, 2001, J NEUROCHEM, V77, P157, DOI 10.1046/j.1471-4159.2001.00218.x; WILLE H, 1992, J CELL BIOL, V118, P573, DOI 10.1083/jcb.118.3.573; Wilson DM, 1997, AM J PATHOL, V150, P2181; WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4506, DOI 10.1073/pnas.85.12.4506; Xia Y, 1998, GENE DEV, V12, P3369, DOI 10.1101/gad.12.21.3369; Yamaguchi H, 1996, ACTA NEUROPATHOL, V92, P232, DOI 10.1007/s004010050513; YAN MH, 1994, NATURE, V372, P798; Zheng-Fischhofer QY, 1998, EUR J BIOCHEM, V252, P542, DOI 10.1046/j.1432-1327.1998.2520542.x; Zhu XW, 2001, J NEUROCHEM, V76, P435, DOI 10.1046/j.1471-4159.2001.00046.x	52	111	120	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					42060	42065		10.1074/jbc.M202241200	http://dx.doi.org/10.1074/jbc.M202241200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12191990	hybrid			2022-12-27	WOS:000178985300095
J	Kim, OS; Park, EJ; Joe, EH; Jou, I				Kim, OS; Park, EJ; Joe, EH; Jou, I			JAK-STAT signaling mediates gangliosides-induced inflammatory responses in brain microglial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; GAMMA-ACTIVATED SITE; IFN-GAMMA; INTERFERON-GAMMA; CEREBROSPINAL-FLUID; GENE-EXPRESSION; KINASE; ALPHA; BETA; PHOSPHORYLATION	Neuronal cell membranes are particularly rich in gangliosides, which play important roles in brain physiology and pathology. Previously, we reported that gangliosides could act as microglial activators and are thus likely to participate in many neuronal diseases. In the present study we provide evidence that JAK-STAT inflammatory signaling mediates gangliosides-stimulated microglial activation. Both in rat primary microglia and murine BV2 microglial cells, gangliosides stimulated nuclear factor binding to GAS/ISRE elements, which are known to be STAT-binding sites. Consistent with this, gangliosides rapidly activated JAK1 and JAK2 and induced phosphoryIation of STAT1 and STAT3. In addition, gangliosides increased transcription of the inflammation-associated genes inducible nitric-oxide synthase, ICAM-1, and MCP-1, which are reported to contain STAT-binding elements in their promoter regions. AG490, a JAK inhibitor, reduced induction of these genes, nuclear factor binding activity, and activation of STAT1 and -3 in gangliosides-treated microglia. AG490 also inhibited gangliosides-induced release of nitric oxide, an inflammation hallmark. Furthermore, AG490 markedly reduced activation of ERK1/2 MAPK, indicating that ERKs act downstream of JAK-STAT signaling during microglial activation. However, AG490 did not affect activation of p38 MAPK. We also report that the sialic acid residues present on gangliosides may be one of the essential components in activation of JAK-STAT signaling. The present study indicates that JAK-STAT signaling is an early event in gangliosides-induced brain inflammatory responses.	Ajou Univ, Sch Med, Dept Pharmacol, Suwon 442721, South Korea	Ajou University	Jou, I (corresponding author), Ajou Univ, Sch Med, Dept Pharmacol, Suwon 442721, South Korea.	jouilo@madang.ajou.ac.kr						BACON CM, 1995, J EXP MED, V181, P399, DOI 10.1084/jem.181.1.399; Bhat NR, 1998, J NEUROSCI, V18, P1633; BLENNOW K, 1991, ARCH NEUROL-CHICAGO, V48, P1032, DOI 10.1001/archneur.1991.00530220048018; DANIAL NN, 1995, SCIENCE, V269, P1875, DOI 10.1126/science.7569929; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; DAVID M, 1995, SCIENCE, V269, P1721, DOI 10.1126/science.7569900; DERRY DM, 1967, SCIENCE, V158, P1450, DOI 10.1126/science.158.3807.1450; Dreyfus H, 1997, ANAL BIOCHEM, V249, P67, DOI 10.1006/abio.1997.2143; Ehret GB, 2001, J BIOL CHEM, V276, P6675, DOI 10.1074/jbc.M001748200; Fischer HG, 2001, J IMMUNOL, V166, P2717, DOI 10.4049/jimmunol.166.4.2717; FU XY, 1990, P NATL ACAD SCI USA, V87, P8555, DOI 10.1073/pnas.87.21.8555; Ganster RW, 2001, P NATL ACAD SCI USA, V98, P8638, DOI 10.1073/pnas.151239498; Ganster RW, 2000, NITRIC OXIDE BIOL PA, P129; Gao JJ, 1997, J BIOL CHEM, V272, P1226, DOI 10.1074/jbc.272.2.1226; Garofalo T, 1998, J BIOL CHEM, V273, P35153, DOI 10.1074/jbc.273.52.35153; Gisslen M, 1997, J NEUROVIROL, V3, P148, DOI 10.3109/13550289709015804; Gouni-Berthold L, 2001, HYPERTENSION, V38, P1030, DOI 10.1161/hy1101.093104; GOUY H, 1994, J IMMUNOL, V152, P3271; HADER T, 1999, EUR J IMMUNOL, V29, P556; HAKOMORI SI, 1990, J BIOL CHEM, V265, P18713; Igaz P, 2001, INFLAMM RES, V50, P435, DOI 10.1007/PL00000267; Imada K, 2000, MOL IMMUNOL, V37, P1, DOI 10.1016/S0161-5890(00)00018-3; Iwabuchi K, 1998, J BIOL CHEM, V273, P9130, DOI 10.1074/jbc.273.15.9130; Jiang H, 2000, J ALLERGY CLIN IMMUN, V105, P1063, DOI 10.1067/mai.2000.107604; JOHNSTON JA, 1994, NATURE, V370, P151, DOI 10.1038/370151a0; Kanda N, 2001, J IMMUNOL, V166, P72, DOI 10.4049/jimmunol.166.1.72; Kantakamalakul W, 1999, J IMMUNOL, V162, P7417; Kasahara K, 1997, J BIOL CHEM, V272, P29947, DOI 10.1074/jbc.272.47.29947; KESSLER DS, 1990, GENE DEV, V4, P1753, DOI 10.1101/gad.4.10.1753; KIELCZYNSKI W, 1991, P NATL ACAD SCI USA, V88, P1991, DOI 10.1073/pnas.88.5.1991; KISHIMOTO T, 1994, CELL, V76, P253, DOI 10.1016/0092-8674(94)90333-6; Kopitz J, 1998, J BIOL CHEM, V273, P11205, DOI 10.1074/jbc.273.18.11205; Kovarik P, 1998, EMBO J, V17, P3660, DOI 10.1093/emboj/17.13.3660; Kovarik P, 2001, EMBO J, V20, P91, DOI 10.1093/emboj/20.1.91; LASKIN DL, 1995, ANNU REV PHARMACOL, V35, P655, DOI 10.1146/annurev.pharmtox.35.1.655; Ledesma MD, 2000, EMBO REP, V1, P530; McLaurin J, 1998, J BIOL CHEM, V273, P4506, DOI 10.1074/jbc.273.8.4506; Meuillet E, 1996, GLIA, V17, P206, DOI 10.1002/(SICI)1098-1136(199607)17:3<206::AID-GLIA3>3.0.CO;2-Z; Michikawa M, 2001, J NEUROSCI, V21, P7226, DOI 10.1523/JNEUROSCI.21-18-07226.2001; Mitsuda T, 2002, J BIOL CHEM, V277, P11239, DOI 10.1074/jbc.M107756200; Nelms K, 1999, ANNU REV IMMUNOL, V17, P701, DOI 10.1146/annurev.immunol.17.1.701; OShea JJ, 1997, IMMUNITY, V7, P1, DOI 10.1016/S1074-7613(00)80505-1; Park C, 1998, METHODS, V15, P175, DOI 10.1006/meth.1998.0622; Prinetti A, 1999, J BIOL CHEM, V274, P20916, DOI 10.1074/jbc.274.30.20916; Pyo H, 1999, J BIOL CHEM, V274, P34584, DOI 10.1074/jbc.274.49.34584; RODDEN FA, 1991, J NEUROSURG, V74, P606, DOI 10.3171/jns.1991.74.4.0606; SAITO M, 1979, J BIOL CHEM, V254, P7845; Schindler C, 1999, EXP CELL RES, V253, P7, DOI 10.1006/excr.1999.4670; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Streit WJ, 1999, PROG NEUROBIOL, V57, P563, DOI 10.1016/S0301-0082(98)00069-0; Takaoka A, 1999, EMBO J, V18, P2480, DOI 10.1093/emboj/18.9.2480; Takaoka A, 2000, SCIENCE, V288, P2357, DOI 10.1126/science.288.5475.2357; Tessitore A, 1998, EUR J BIOCHEM, V258, P968, DOI 10.1046/j.1432-1327.1998.2580968.x; Wang SSS, 2001, J BIOL CHEM, V276, P42027, DOI 10.1074/jbc.M102834200; WANG XY, 1995, J BIOL CHEM, V270, P27999; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Xuan YT, 2001, P NATL ACAD SCI USA, V98, P9050, DOI 10.1073/pnas.161283798; YANAGISAWA K, 1995, NAT MED, V1, P1062, DOI 10.1038/nm1095-1062; Yang MS, 2002, GLIA, V38, P273, DOI 10.1002/glia.10057; Zhou ZHL, 1998, J IMMUNOL, V160, P3908	61	145	156	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2002	277	43					40594	40601		10.1074/jbc.M203885200	http://dx.doi.org/10.1074/jbc.M203885200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	607KU	12191995	Green Published, hybrid			2022-12-27	WOS:000178791400057
J	Miranda, FF; Teigen, K; Thorolfsson, M; Svebak, RM; Knappskog, PM; Flatmark, T; Martinez, A				Miranda, FF; Teigen, K; Thorolfsson, M; Svebak, RM; Knappskog, PM; Flatmark, T; Martinez, A			Phosphorylation and mutations of Ser(16) in human phenylalanine hydroxylase - Kinetic and structural effects	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAMP-DEPENDENT PHOSPHORYLATION; AMINO-ACID HYDROXYLASES; INFRARED-SPECTROSCOPY; FUSION PROTEIN; STABILITY; PHENYLKETONURIA; ACTIVATION; EXPRESSION; ENZYME; SEQUENCE	Phosphorylation of phenylalanine hydroxylase (PAH) at Ser(16) by cyclic AMP-dependent protein kinase is a post-translational modification that increases its basal activity and facilitates its activation by the substrate L-Phe. So far there is no structural information on the flexible N-terminal tail (residues 1-18), including the phosphorylation site. To get further insight into the molecular basis for the effects of phosphorylation on the catalytic efficiency and enzyme stability, molecular modeling was performed using the crystal structure of the recombinant rat enzyme. The most probable conformation and orientation of the N-terminal tail thus obtained indicates that phosphorylation of Ser(16) induces a local conformational change as a result of an electrostatic interaction between the phosphate group and Arg(13) as well as a repulsion by Glu(280) in the loop at the entrance of the active site crevice structure. The modeled reorientation of the N-terminal tail residues (Met(1)-Leu(15)) on phosphorylation is in agreement with the observed conformational change and increased accessibility of the substrate to the active site, as indicated by circular dichroism spectroscopy and the enzyme kinetic data for the full-length phosphorylated and nonphosphorylated human PAH. To further validate the model we have prepared and characterized mutants substituting Ser(16) with a negatively charged residue and found that S16E largely mimics the effects of phosphorylation of human PAH. Both the phosphorylated enzyme and the mutants with acidic side chains instead of Ser(16) revealed an increased resistance toward limited tryptic proteolysis and, as indicated by circular dichroism spectroscopy, an increased content of alpha-helical structure. In agreement with the modeled structure, the formation of an Arg(13) to Ser(16) phosphate salt bridge and the conformational change of the N-terminal tail also explain the higher stability toward limited tryptic proteolysis of the phosphorylated enzyme. The results obtained with the mutant R13A and E381A further support the model proposed for the molecular mechanism for the activation of the enzyme by phosphorylation.	Univ Bergen, Dept Biochem & Mol Biol, N-5009 Bergen, Norway; Univ Bergen, Haukleland Hosp, Dept Med Genet, N-5009 Bergen, Norway	University of Bergen; University of Bergen; Haukeland University Hospital	Martinez, A (corresponding author), Univ Bergen, Dept Biochem & Mol Biol, Arstadveien 19, N-5009 Bergen, Norway.	aurora.martinez@ibmb.uib.no	Teigen, Knut/K-3934-2012; Martinez, Aurora/M-3088-2019; Miranda, Frederico/A-8946-2015	Teigen, Knut/0000-0002-7031-9215; Martinez, Aurora/0000-0003-1643-6506; 				ABITA JP, 1976, J BIOL CHEM, V251, P5310; BENOREPARSONS M, 1989, ARCH BIOCHEM BIOPHYS, V272, P274, DOI 10.1016/0003-9861(89)90220-8; Bjorgo E, 1998, EUR J BIOCHEM, V257, P1, DOI 10.1046/j.1432-1327.1998.2570001.x; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; Brushia Robert J., 1999, Frontiers in Bioscience, V4, pd618, DOI 10.2741/Brushia; Chehin R, 1998, FEBS LETT, V422, P225, DOI 10.1016/S0014-5793(97)01596-2; CITRON BA, 1994, BIOCHEM BIOPH RES CO, V198, P174, DOI 10.1006/bbrc.1994.1025; DICKSON PW, 1994, J BIOL CHEM, V269, P20369; Doskeland AP, 1996, BIOCHEM J, V313, P409, DOI 10.1042/bj3130409; DOSKELAND AP, 1984, J BIOL CHEM, V259, P1242; DOSKELAND AP, 1992, EUR J BIOCHEM, V206, P161, DOI 10.1111/j.1432-1033.1992.tb16913.x; Eiken HG, 1996, HUM MUTAT, V7, P228, DOI 10.1002/(SICI)1098-1004(1996)7:3<228::AID-HUMU7>3.0.CO;2-6; Erlandsen H, 1997, NAT STRUCT BIOL, V4, P995, DOI 10.1038/nsb1297-995; Erlandsen H, 1999, MOL GENET METAB, V68, P103, DOI 10.1006/mgme.1999.2922; FERGUSON KA, 1964, METABOLISM, V13, P985, DOI 10.1016/S0026-0495(64)80018-4; FERRIN TE, 1988, J MOL GRAPHICS, V6, P13, DOI 10.1016/0263-7855(88)80054-7; Flatmark T, 1999, CHEM REV, V99, P2137, DOI 10.1021/cr980450y; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Fuchs SY, 2000, J BIOL CHEM, V275, P12560, DOI 10.1074/jbc.275.17.12560; Fusetti F, 1998, J BIOL CHEM, V273, P16962, DOI 10.1074/jbc.273.27.16962; Gjetting T, 2001, MOL GENET METAB, V72, P132, DOI 10.1006/mgme.2000.3118; HEDRICK JL, 1968, ARCH BIOCHEM BIOPHYS, V126, P155, DOI 10.1016/0003-9861(68)90569-9; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ishida N, 2000, J BIOL CHEM, V275, P25146, DOI 10.1074/jbc.M001144200; IWAKI M, 1986, J BIOL CHEM, V261, P2051; Jennings IG, 2001, FEBS LETT, V488, P196, DOI 10.1016/S0014-5793(00)02426-1; Kappock TJ, 1996, CHEM REV, V96, P2659, DOI 10.1021/cr9402034; KAUFMAN S, 1993, ADV ENZYMOL RAMB, V67, P77; KAUFMAN S, 1986, ADV ENZYME REGUL, V25, P37, DOI 10.1016/0065-2571(86)90007-5; KNAPPSKOG PM, 1993, ADV EXP MED BIOL, V338, P59; Knappskog PM, 1996, HUM MUTAT, V8, P236, DOI 10.1002/(SICI)1098-1004(1996)8:3<236::AID-HUMU7>3.0.CO;2-7; Kobe B, 1999, NAT STRUCT BIOL, V6, P442, DOI 10.1038/8247; KOWLESSUR D, 1995, P NATL ACAD SCI USA, V92, P4743, DOI 10.1073/pnas.92.11.4743; LEACH AR, 1992, J COMPUT CHEM, V13, P730, DOI 10.1002/jcc.540130608; Li M, 1998, BIOCHEMISTRY-US, V37, P7869, DOI 10.1021/bi9801053; MARTINEZ A, 1995, BIOCHEM J, V306, P589, DOI 10.1042/bj3060589; Martinez A, 1996, J BIOL CHEM, V271, P19737, DOI 10.1074/jbc.271.33.19737; MENG EC, 1992, J COMPUT CHEM, V13, P505, DOI 10.1002/jcc.540130412; PHILLIPS RS, 1984, J BIOL CHEM, V259, P2474; PULLEN K, 1995, PROTEIN SCI, V4, P2478, DOI 10.1002/pro.5560041204; SCRIVER CR, 1996, ANNU REV GENET, V28, P141; Smart JL, 1999, BIOPOLYMERS, V49, P225, DOI 10.1002/(SICI)1097-0282(199903)49:3<225::AID-BIP4>3.0.CO;2-B; SMITH SC, 1984, J BIOL CHEM, V259, P1284; Solstad T, 2000, EUR J BIOCHEM, V267, P6302, DOI 10.1046/j.1432-1327.2000.01715.x; Stemmer C, 2002, J BIOL CHEM, V277, P1092, DOI 10.1074/jbc.M109503200; TANI K, 1988, P NATL ACAD SCI USA, V85, P1792, DOI 10.1073/pnas.85.6.1792; Teigen K, 1999, J MOL BIOL, V294, P807, DOI 10.1006/jmbi.1999.3288; TIPPER J, 1992, J BIOL CHEM, V267, P889; Wang GA, 2001, P NATL ACAD SCI USA, V98, P1537, DOI 10.1073/pnas.031561698; WRETBORN M, 1980, BIOCHEM BIOPH RES CO, V93, P403, DOI 10.1016/0006-291X(80)91091-8	50	43	46	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2002	277	43					40937	40943		10.1074/jbc.M112197200	http://dx.doi.org/10.1074/jbc.M112197200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	607KU	12185072	Green Submitted, hybrid			2022-12-27	WOS:000178791400100
J	Maur, AAD; Zahnd, C; Fischer, F; Spinelli, S; Honegger, A; Cambillau, C; Escher, D; Pluckthun, A; Barberis, A				Maur, AAD; Zahnd, C; Fischer, F; Spinelli, S; Honegger, A; Cambillau, C; Escher, D; Pluckthun, A; Barberis, A			Direct in vivo screening of intrabody libraries constructed on a highly stable single-chain framework	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMERASE-II HOLOENZYME; IN-VITRO; ANTIBODY FRAGMENT; VARIABLE DOMAINS; FV-FRAGMENTS; INTRACELLULAR EXPRESSION; BINDING PROTEINS; ESCHERICHIA-COLI; GENE ACTIVATION; LEUCINE ZIPPER	Single-chain Fv antibody fragments (scFv) represent a convenient antibody format for intracellular expression in eukaryotic or prokaryotic cells. These so-called intrabodies have great potential in functional genomics as a tool to study the function of newly identified proteins in vivo, for example by binding-induced modulation of their activity or by blocking interactions with other proteins. However, the intracellular expression and activity of many single-chain Fvs are limited by their instability and folding efficiency in the reducing intracellular environment, where the highly conserved intrachain disulfide bonds do not form. In the present work, we used an in vivo selection system to isolate novel antigen-binding intrabodies. We screened two intrabody libraries carrying a randomized third hypervariable loop onto the heavy chain of a stable framework, which had been further optimized by random mutagenesis for better behavior in the selection system, and we biophysically characterized the selected variants to interpret the outcome of the selection. Our results show that single-framework intrabody libraries can be directly screened in vivo to rapidly select antigen-specific intrabodies.	ESBATech AG, CH-8952 Zurich, Switzerland; Univ Zurich, Inst Biochem, CH-8057 Zurich, Switzerland; CNRS, F-13402 Marseille, France	University of Zurich; Centre National de la Recherche Scientifique (CNRS)	Barberis, A (corresponding author), ESBATech AG, Wagistr 21, CH-8952 Zurich, Switzerland.		Plückthun, Andreas/C-2746-2009	Plückthun, Andreas/0000-0003-4191-5306; Honegger, Annemarie/0000-0002-3378-3967				Aramburu J, 1999, SCIENCE, V285, P2129, DOI 10.1126/science.285.5436.2129; BARBERIS A, 1995, CELL, V81, P359, DOI 10.1016/0092-8674(95)90389-5; Barstead R, 2001, CURR OPIN CHEM BIOL, V5, P63, DOI 10.1016/S1367-5931(00)00173-3; BENVENUTO E, 1995, TRENDS MICROBIOL, V3, P272, DOI 10.1016/S0966-842X(00)88943-X; BIOCCA S, 1993, BIOCHEM BIOPH RES CO, V197, P422, DOI 10.1006/bbrc.1993.2496; BIOCCA S, 1995, BIO-TECHNOL, V13, P1110, DOI 10.1038/nbt1095-1110; BIRD RE, 1988, SCIENCE, V242, P423, DOI 10.1126/science.3140379; CATTANEO A, 1997, INTRACELLULAR ANTIBO; Chattopadhyaya R, 2000, J BIOMOL STRUCT DYN, V18, P181, DOI 10.1080/07391102.2000.10506657; CHEN HZ, 1983, METHOD ENZYMOL, V101, P674; CHOTHIA C, 1987, J MOL BIOL, V196, P901, DOI 10.1016/0022-2836(87)90412-8; CHOTHIA C, 1985, J MOL BIOL, V186, P651, DOI 10.1016/0022-2836(85)90137-8; Cochet O, 1998, CANCER RES, V58, P1170; der Maur AA, 2001, FEBS LETT, V508, P407, DOI 10.1016/S0014-5793(01)03101-5; Dumoulin M, 2002, PROTEIN SCI, V11, P500, DOI 10.1110/ps.34602; Escher D, 2000, MOL CELL BIOL, V20, P2774, DOI 10.1128/MCB.20.8.2774-2782.2000; Farrell S, 1996, GENE DEV, V10, P2359, DOI 10.1101/gad.10.18.2359; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Ge L, 1995, ANTIBODY ENG, P229; Giles RV, 2000, CURR OPIN MOL THER, V2, P238; GLOCKSHUBER R, 1992, BIOCHEMISTRY-US, V31, P1270, DOI 10.1021/bi00120a002; GLOCKSHUBER R, 1990, BIOCHEMISTRY-US, V29, P1362, DOI 10.1021/bi00458a002; Hanes J, 1998, P NATL ACAD SCI USA, V95, P14130, DOI 10.1073/pnas.95.24.14130; Harris S, 2000, Pharmacogenomics, V1, P433, DOI 10.1517/14622416.1.4.433; Hassanzadeh G, 1998, FEBS LETT, V437, P75, DOI 10.1016/S0014-5793(98)01204-6; Honegger A, 2001, J MOL BIOL, V309, P657, DOI 10.1006/jmbi.2001.4662; HUSTON JS, 1988, P NATL ACAD SCI USA, V85, P5879, DOI 10.1073/pnas.85.16.5879; Jermutus L, 2001, P NATL ACAD SCI USA, V98, P75, DOI 10.1073/pnas.011311398; Jung S, 1997, PROTEIN ENG, V10, P959, DOI 10.1093/protein/10.8.959; Kaiser C, 1994, METHODS YEAST GENETI, P169; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; Lener M, 2000, EUR J BIOCHEM, V267, P1196, DOI 10.1046/j.1432-1327.2000.01125.x; Martineau P, 1998, J MOL BIOL, V280, P117, DOI 10.1006/jmbi.1998.1840; Maynard J, 2000, ANNU REV BIOMED ENG, V2, P339, DOI 10.1146/annurev.bioeng.2.1.339; Mossner E, 2001, J MOL BIOL, V308, P115, DOI 10.1006/jmbi.2001.4575; OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029; PADLAN EA, 1994, MOL IMMUNOL, V31, P169, DOI 10.1016/0161-5890(94)90001-9; Pluckthun A, 1996, ANTIBODY ENG PRACTIC, P203; POKROVSKAYA ID, 1994, ANAL BIOCHEM, V220, P420, DOI 10.1006/abio.1994.1360; Portner-Taliana A, 2000, J IMMUNOL METHODS, V238, P161, DOI 10.1016/S0022-1759(00)00145-9; Rondon IJ, 1997, ANNU REV MICROBIOL, V51, P257, DOI 10.1146/annurev.micro.51.1.257; Sambrook J., 1989, MOL CLONING; SELLERS JW, 1989, NATURE, V341, P74, DOI 10.1038/341074a0; SIBANDA BL, 1985, NATURE, V316, P170, DOI 10.1038/316170a0; SIBANDA BL, 1989, J MOL BIOL, V206, P759, DOI 10.1016/0022-2836(89)90583-4; TAVLADORAKI P, 1993, NATURE, V366, P469, DOI 10.1038/366469a0; Tse E, 2002, J MOL BIOL, V317, P85, DOI 10.1006/jmbi.2002.5403; Verma R, 1998, J IMMUNOL METHODS, V216, P165, DOI 10.1016/S0022-1759(98)00077-5; Visintin M, 1999, P NATL ACAD SCI USA, V96, P11723, DOI 10.1073/pnas.96.21.11723; Visintin M, 2002, J MOL BIOL, V317, P73, DOI 10.1006/jmbi.2002.5392; Worn A, 2000, J BIOL CHEM, V275, P2795, DOI 10.1074/jbc.275.4.2795; Worn A, 1998, BIOCHEMISTRY-US, V37, P13120, DOI 10.1021/bi980712q	53	58	81	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 22	2002	277	47					45075	45085		10.1074/jbc.M205264200	http://dx.doi.org/10.1074/jbc.M205264200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	618EE	12215438	hybrid			2022-12-27	WOS:000179404800063
J	Krippner-Heidenreich, A; Tubing, F; Bryde, S; Willi, S; Zimmermann, G; Scheurich, P				Krippner-Heidenreich, A; Tubing, F; Bryde, S; Willi, S; Zimmermann, G; Scheurich, P			Control of receptor-induced signaling complex formation by the kinetics of ligand/receptor interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; CELL-AFFECTING AGENTS; TNF-RECEPTOR; LIGAND; DEATH; CD95; INTERNALIZATION; APOPTOSIS; PATHWAYS; DOMAIN	Tumor necrosis factor (TNF) exists both as a membrane-integrated type 11 precursor protein and a soluble cytokine that have different bioactivities on TNFR2 (CD120b) but not on TNFR1 (CD120a). To identify the molecular basis of this disparity, we have investigated receptor chimeras comprising the cytoplasmic part of Fas (CD95) and the extracellular domains of the two TNF receptors. The membrane form of TNF, but not its soluble form, was capable of inducing apoptosis as well as activation of c-Jun N-terminal kinase and NF-kappaB via the TNFR2-derived chimera. In contrast, the TNFR1-Fas chimera displayed strong responsiveness to both TNF forms. This pattern of responsiveness is identical to that of wild type TNF receptors, demonstrating that the underlying mechanisms are independent of the particular type of the intracellular signaling machinery and rather are controlled upstream of the intracellular domain. We further demonstrate that the signaling strength induced by a given ligand/receptor interaction is regulated at the level of adaptor protein recruitment, as shown for FADD, caspase-8, and TRAF2. Since both incidents, strong signaling and robust adapter protein recruitment, are paralleled by a high stability of individual ligand-receptor complexes, we propose that half-lives of individual ligand-receptor complexes control signaling at the level of adaptor protein recruitment.	Univ Stuttgart, Inst Cell Biol & Immunol, D-70569 Stuttgart, Germany	University of Stuttgart	Scheurich, P (corresponding author), Univ Stuttgart, Inst Cell Biol & Immunol, Allmandring 31, D-70569 Stuttgart, Germany.							Ahn JH, 2001, J BIOL CHEM, V276, P47100, DOI 10.1074/jbc.M107385200; Algeciras-Schimnich A, 2002, MOL CELL BIOL, V22, P207, DOI 10.1128/MCB.22.1.207-220.2002; BROCKHAUS M, 1990, P NATL ACAD SCI USA, V87, P3127, DOI 10.1073/pnas.87.8.3127; Chan FKM, 2000, SCIENCE, V288, P2351, DOI 10.1126/science.288.5475.2351; Deak JC, 1998, P NATL ACAD SCI USA, V95, P5595, DOI 10.1073/pnas.95.10.5595; DECLERCQ W, 1995, CYTOKINE, V7, P701, DOI 10.1006/cyto.1995.0082; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dri P, 2000, J IMMUNOL, V165, P2165, DOI 10.4049/jimmunol.165.4.2165; EVANS TJ, 1994, J EXP MED, V180, P2173, DOI 10.1084/jem.180.6.2173; Fotin-Mleczek M, 2002, J CELL SCI, V115, P2757; Grassme H, 2002, J IMMUNOL, V168, P298, DOI 10.4049/jimmunol.168.1.298; Grassme H, 2001, BIOCHEM BIOPH RES CO, V284, P1016, DOI 10.1006/bbrc.2001.5045; Grassme H, 2001, J BIOL CHEM, V276, P20589, DOI 10.1074/jbc.M101207200; Grell M, 1998, P NATL ACAD SCI USA, V95, P570, DOI 10.1073/pnas.95.2.570; GRELL M, 1995, CELL, V83, P793, DOI 10.1016/0092-8674(95)90192-2; GRELL M, 1993, LYMPHOKINE CYTOK RES, V12, P143; GRELL M, 1997, GROWTH FACTORS CYTOK, P669; HIGUCHI M, 1994, J IMMUNOL, V152, P3550; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; Huang DCS, 1997, ONCOGENE, V14, P405, DOI 10.1038/sj.onc.1200848; Lenczowski JM, 1997, MOL CELL BIOL, V17, P170, DOI 10.1128/MCB.17.1.170; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; LOETSCHER H, 1993, J BIOL CHEM, V268, P26350; Muhlenbeck F, 1998, J BIOL CHEM, V273, P33091, DOI 10.1074/jbc.273.49.33091; NAISMITH JH, 1995, J BIOL CHEM, V270, P13303, DOI 10.1074/jbc.270.22.13303; PARCE JW, 1990, ANN BIOL CLIN-PARIS, V48, P639; PARCE JW, 1989, SCIENCE, V246, P243, DOI 10.1126/science.2799384; Park YC, 2000, CELL, V101, P777, DOI 10.1016/S0092-8674(00)80889-2; PENNICA D, 1992, J BIOL CHEM, V267, P21172; Pound JD, 1999, INT IMMUNOL, V11, P11, DOI 10.1093/intimm/11.1.11; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Schneider P, 1998, J EXP MED, V187, P1205, DOI 10.1084/jem.187.8.1205; Schutze S, 1999, J BIOL CHEM, V274, P10203, DOI 10.1074/jbc.274.15.10203; Siegel RM, 1998, J CELL BIOL, V141, P1243, DOI 10.1083/jcb.141.5.1243; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; THOMA B, 1990, J EXP MED, V172, P1019, DOI 10.1084/jem.172.4.1019; Wajant H, 2001, ONCOGENE, V20, P4101, DOI 10.1038/sj.onc.1204558; Wajant H, 2001, INT J BIOCHEM CELL B, V33, P19, DOI 10.1016/S1357-2725(00)00064-9; Weiss T, 1998, J IMMUNOL, V161, P3136; Weiss T, 1997, J IMMUNOL, V158, P2398; Ye H, 1999, MOL CELL, V4, P321, DOI 10.1016/S1097-2765(00)80334-2	41	61	63	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	2002	277	46					44155	44163		10.1074/jbc.M207399200	http://dx.doi.org/10.1074/jbc.M207399200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	615XE	12215450	hybrid			2022-12-27	WOS:000179272000081
J	Pedram, A; Razandi, M; Levin, ER				Pedram, A; Razandi, M; Levin, ER			Deciphering vascular endothelial cell growth factor/vascular permeability factor signaling to vascular permeability - Inhibition by atrial natriuretic peptide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOINOSITIDE 3-OH KINASE; NITRIC-OXIDE PRODUCTION; PROTEIN-KINASE; TIGHT JUNCTION; PHOSPHATIDYLINOSITOL 3-KINASE; MICROVASCULAR PERMEABILITY; TRANSDUCTION PATHWAYS; ACTIN REORGANIZATION; DIABETIC-RETINOPATHY; INDUCED ANGIOGENESIS	Vascular endothelial cell growth factor (VEGF) was originally described as a potent vascular permeability factor (VPF) that importantly contributes to Vascular pathobiology. The signaling pathways that underlie VEGF/VPF-induced permeability are not well defined. Furthermore, endogenous vascular peptides that regulate this important VPF function are currently unknown. We report here that VPF significantly enhances permeability in aortic endothelial cells via a linked signaling pathway, sequentially involving Src, ERK, JNK, and phosphatidylinositol 3-kinase/AKT. This leads to the serine/threonine phosphorylation and redistribution of actin and the tight junction (TJ) proteins, zona occludens-1 and occludin, and the loss of the endothelial cell barrier architecture. Atrial natriuretic peptide (ANP) inhibited VPF signaling, TJ protein phosphorylation and localization, and VPF-induced permeability. This involved both guanylate cyclase and natriuretic peptide clearance receptors. In vivo, transgenic mice that overexpress ANP showed significantly less VPF-induced kinase activation and vascular permeability compared with non-transgenic littermates. Thus, ANP acts as an anti-permeability factor by inhibiting the signaling functions of VPF that we define here and by preserving the endothelial cell TJ functional morphology.	Vet Affairs Med Ctr, Med Serv, Div Endocrinol, Long Beach, CA 90822 USA; Univ Calif Irvine, Dept Med, Irvine, CA 92717 USA; Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92717 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Long Beach Healthcare System; University of California System; University of California Irvine; University of California System; University of California Irvine	Levin, ER (corresponding author), Vet Affairs Med Ctr, Med Serv, Div Endocrinol, 11-111-I,5901 E 7th St, Long Beach, CA 90822 USA.	ellis.levin@med.va.gov			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059890] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-59890] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; Andreeva AY, 2001, J BIOL CHEM, V276, P38480, DOI 10.1074/jbc.M104923200; Antonetti DA, 1999, J BIOL CHEM, V274, P23463, DOI 10.1074/jbc.274.33.23463; BACALLAO R, 1994, J CELL SCI, V107, P3301; Basu S, 2001, NAT MED, V7, P569, DOI 10.1038/87895; Bazzoni G, 2000, J BIOL CHEM, V275, P20520, DOI 10.1074/jbc.M905251199; Blum MS, 1997, AM J PHYSIOL-HEART C, V273, pH286, DOI 10.1152/ajpheart.1997.273.1.H286; CAO L, 1995, HYPERTENSION, V25, P227, DOI 10.1161/01.HYP.25.2.227; CHANG M, 1989, NATURE, V341, P68, DOI 10.1038/341068a0; CHINKERS M, 1989, NATURE, V338, P78, DOI 10.1038/338078a0; Clancy RM, 1997, J CLIN INVEST, V100, P1789, DOI 10.1172/JCI119706; Coniglio SJ, 2001, J BIOL CHEM, V276, P28113, DOI 10.1074/jbc.M102299200; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; Dayanir V, 2001, J BIOL CHEM, V276, P17686, DOI 10.1074/jbc.M009128200; Denker BM, 1998, AM J PHYSIOL-RENAL, V274, pF1, DOI 10.1152/ajprenal.1998.274.1.F1; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; Eliceiri BP, 1999, MOL CELL, V4, P915, DOI 10.1016/S1097-2765(00)80221-X; Encinas M, 2001, J NEUROSCI, V21, P1464, DOI 10.1523/JNEUROSCI.21-05-01464.2001; Fanning AS, 1998, J BIOL CHEM, V273, P29745, DOI 10.1074/jbc.273.45.29745; Feng D, 1997, J PHYSIOL-LONDON, V504, P747, DOI 10.1111/j.1469-7793.1997.747bd.x; Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4; FERRARA N, 1993, TRENDS CARDIOVAS MED, V3, P244, DOI 10.1016/1050-1738(93)90046-9; FIELD LJ, 1991, AM J PHYSIOL, V260, pR1, DOI 10.1152/ajpregu.1991.260.1.R1; Fukumura D, 2001, P NATL ACAD SCI USA, V98, P2604, DOI 10.1073/pnas.041359198; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; GELFAND RA, 1991, AM J PHYSIOL, V261, pE183, DOI 10.1152/ajpendo.1991.261.2.E183; Gerber HP, 1998, J BIOL CHEM, V273, P30336, DOI 10.1074/jbc.273.46.30336; Gossmann A, 2000, AM J OBSTET GYNECOL, V183, P956, DOI 10.1067/mob.2000.107092; Gratton JP, 2001, J BIOL CHEM, V276, P30359, DOI 10.1074/jbc.M009698200; GUO DQ, 1995, J BIOL CHEM, V270, P6729, DOI 10.1074/jbc.270.12.6729; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; He H, 1999, J BIOL CHEM, V274, P25130, DOI 10.1074/jbc.274.35.25130; Hirase T, 2001, J BIOL CHEM, V276, P10423, DOI 10.1074/jbc.M007136200; Isono M, 1998, KIDNEY INT, V53, P1133, DOI 10.1046/j.1523-1755.1998.00869.x; ITOH H, 1992, HYPERTENSION, V19, P758, DOI 10.1161/01.HYP.19.6.758; Kevil CG, 2000, AM J PHYSIOL-CELL PH, V279, pC21, DOI 10.1152/ajpcell.2000.279.1.C21; Kevil CG, 1998, J BIOL CHEM, V273, P15099, DOI 10.1074/jbc.273.24.15099; Khwaja A, 1997, EMBO J, V16, P2783, DOI 10.1093/emboj/16.10.2783; Komalavilas P, 1999, J BIOL CHEM, V274, P34301, DOI 10.1074/jbc.274.48.34301; Kong M, 2000, J BIOL CHEM, V275, P36035, DOI 10.1074/jbc.M005621200; Kroll J, 1997, J BIOL CHEM, V272, P32521, DOI 10.1074/jbc.272.51.32521; Larson DM, 1988, ENDOTHELIAL CELLS, VIII, P75; Levin ER, 1998, NEW ENGL J MED, V339, P321; Levin ER, 1998, J CLIN INVEST, V102, P1978, DOI 10.1172/JCI4814; Logan SK, 1997, MOL CELL BIOL, V17, P5784, DOI 10.1128/MCB.17.10.5784; Luttrell LM, 1996, J BIOL CHEM, V271, P19443, DOI 10.1074/jbc.271.32.19443; MAACK T, 1987, SCIENCE, V238, P675, DOI 10.1126/science.2823385; Martin-Padura I, 1998, J CELL BIOL, V142, P117, DOI 10.1083/jcb.142.1.117; MILES AA, 1952, J PHYSIOL-LONDON, V118, P228, DOI 10.1113/jphysiol.1952.sp004789; MILLAUER B, 1993, CELL, V72, P835, DOI 10.1016/0092-8674(93)90573-9; MILLAUER B, 1994, NATURE, V367, P576, DOI 10.1038/367576a0; MILTON SG, 1990, J CELL PHYSIOL, V144, P498, DOI 10.1002/jcp.1041440318; Morales-Ruiz M, 2000, CIRC RES, V86, P892, DOI 10.1161/01.RES.86.8.892; MORISHITA Y, 1992, EUR J PHARM-MOLEC PH, V225, P203, DOI 10.1016/0922-4106(92)90021-M; Morita K, 1999, P NATL ACAD SCI USA, V96, P511, DOI 10.1073/pnas.96.2.511; Murohara T, 1998, CIRCULATION, V97, P99, DOI 10.1161/01.CIR.97.1.99; Oliver PM, 1997, P NATL ACAD SCI USA, V94, P14730, DOI 10.1073/pnas.94.26.14730; Papapetropoulos A, 1997, J CLIN INVEST, V100, P3131, DOI 10.1172/JCI119868; Parenti A, 1998, J BIOL CHEM, V273, P4220, DOI 10.1074/jbc.273.7.4220; Paul R, 2001, NAT MED, V7, P222, DOI 10.1038/84675; Pedram A, 1997, J BIOL CHEM, V272, P17097, DOI 10.1074/jbc.272.27.17097; Pedram A, 2001, ENDOCRINOLOGY, V142, P1578, DOI 10.1210/en.142.4.1578; Pedram A, 1998, J BIOL CHEM, V273, P26722, DOI 10.1074/jbc.273.41.26722; Radisavljevic Z, 2000, J BIOL CHEM, V275, P20770, DOI 10.1074/jbc.M002448200; Razandi M, 2000, J BIOL CHEM, V275, P38540, DOI 10.1074/jbc.M007555200; ROBERTS WG, 1995, J CELL SCI, V108, P2369; RodriguezViciana P, 1997, CELL, V89, P457, DOI 10.1016/S0092-8674(00)80226-3; Rousseau S, 2000, J BIOL CHEM, V275, P10661, DOI 10.1074/jbc.275.14.10661; Rousseau S, 1997, ONCOGENE, V15, P2169, DOI 10.1038/sj.onc.1201380; SALZMAN AL, 1995, AM J PHYSIOL-GASTR L, V268, pG361, DOI 10.1152/ajpgi.1995.268.2.G361; SENGER DR, 1983, SCIENCE, V219, P983, DOI 10.1126/science.6823562; Shen BQ, 1999, J BIOL CHEM, V274, P33057, DOI 10.1074/jbc.274.46.33057; Shono T, 2001, EXP CELL RES, V264, P275, DOI 10.1006/excr.2001.5154; Simonson MS, 1996, J BIOL CHEM, V271, P77, DOI 10.1074/jbc.271.1.77; SINGH S, 1988, NATURE, V334, P708, DOI 10.1038/334708a0; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Stacker SA, 1999, J BIOL CHEM, V274, P34884, DOI 10.1074/jbc.274.49.34884; STEINHELPER ME, 1990, HYPERTENSION, V16, P301, DOI 10.1161/01.HYP.16.3.301; Tanno S, 2001, CANCER RES, V61, P589; Timokhina I, 1998, EMBO J, V17, P6250, DOI 10.1093/emboj/17.21.6250; van Bruggen N, 1999, J CLIN INVEST, V104, P1613, DOI 10.1172/JCI8218; WALTENBERGER J, 1994, J BIOL CHEM, V269, P26988; Wang W, 2001, AM J PHYSIOL-HEART C, V280, pH434, DOI 10.1152/ajpheart.2001.280.1.H434; WEI CM, 1993, CIRCULATION, V88, P1004, DOI 10.1161/01.CIR.88.3.1004; Wittchen ES, 1999, J BIOL CHEM, V274, P35179, DOI 10.1074/jbc.274.49.35179; Wu HM, 1999, AM J PHYSIOL-HEART C, V276, pH535, DOI 10.1152/ajpheart.1999.276.2.H535	86	104	108	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2002	277	46					44385	44398		10.1074/jbc.M202391200	http://dx.doi.org/10.1074/jbc.M202391200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	615XE	12213803	hybrid			2022-12-27	WOS:000179272000110
J	Tran, N; Proenza, C; Macri, V; Petigara, F; Sloan, E; Samler, S; Accili, EA				Tran, N; Proenza, C; Macri, V; Petigara, F; Sloan, E; Samler, S; Accili, EA			A conserved domain in the NH2 terminus important for assembly and functional expression of pacemaker channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC-NUCLEOTIDE; TETRAMERIZATION DOMAIN; COILED-COILS; HCN1; MODULATION; VOLTAGE; FAMILY; T1	Pacemaker channels are formed by co-assembly of hyperpolarization-activated cyclic nucleotide-gated (HCN) subunits. Previously, we suggested that the NH2 termini of the mouse HCN2 isoform were important for subunit co-assembly and functional channel expression. Using an alignment strategy together with yeast two-hybrid assays, patch clamp electrophysiology, and confocal imaging, we have now identified a domain within the NH2 terminus of the HCN2 subunit that is responsible for interactions between NH2 termini and promoting the trafficking of functional channels to the plasma membrane. This domain is composed of 52 amino acids, is located adjacent to the putative first transmembrane segment, and is highly conserved among the mammalian HCN isoforms. This conserved domain, but not the remaining unconserved NH2-terminal regions of HCN2, specifically interacted with itself in yeast two-hybrid assays. Moreover, the conserved domain was important for expression of currents. Whereas relatively normal whole cell HCN2 currents were produced by channels containing only the conserved domain, further deletion of this region, leaving only a more polar and putative coiled-coil segment, eliminated HCN2 currents and resulted in proteins that localized predominantly in perinuclear compartments. Thus, we suggest that this conserved domain is the critical NH2-terminal determinant of subunit co-assembly and trafficking of pacemaker channels.	Simon Fraser Univ, Sch Kinesiol, Ion Channel Lab, Burnaby, BC V5A 1S6, Canada	Simon Fraser University	Accili, EA (corresponding author), Simon Fraser Univ, Sch Kinesiol, Ion Channel Lab, Burnaby, BC V5A 1S6, Canada.			Macri, Vincenzo/0000-0003-3463-2877; Proenza, Catherine/0000-0003-4324-6206				Accili EA, 2002, NEWS PHYSIOL SCI, V17, P32, DOI 10.1152/physiologyonline.2002.17.1.32; Chen C, 2001, J GEN PHYSIOL, V117, P491, DOI 10.1085/jgp.117.5.491; Grabner M, 1998, P NATL ACAD SCI USA, V95, P1903, DOI 10.1073/pnas.95.4.1903; Ishii TM, 1999, J BIOL CHEM, V274, P12835, DOI 10.1074/jbc.274.18.12835; Kaupp UB, 2001, ANNU REV PHYSIOL, V63, P235, DOI 10.1146/annurev.physiol.63.1.235; Kobertz WR, 1999, NAT STRUCT BIOL, V6, P1122; Lu JL, 2001, BIOCHEMISTRY-US, V40, P10934, DOI 10.1021/bi010763e; Ludwig A, 1998, NATURE, V393, P587, DOI 10.1038/31255; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Ma DK, 2001, SCIENCE, V291, P316, DOI 10.1126/science.291.5502.316; Minor DL, 2000, CELL, V102, P657, DOI 10.1016/S0092-8674(00)00088-X; Monteggia LM, 2000, MOL BRAIN RES, V81, P129, DOI 10.1016/S0169-328X(00)00155-8; Moosmang S, 2001, EUR J BIOCHEM, V268, P1646, DOI 10.1046/j.1432-1327.2001.02036.x; Moroni A, 2001, J BIOL CHEM, V276, P29233, DOI 10.1074/jbc.M100830200; PARRY DAD, 1982, BIOSCIENCE REP, V2, P1017, DOI 10.1007/BF01122170; Proenza C, 2000, J BIOL CHEM, V275, P23169, DOI 10.1074/jbc.M003389200; Proenza C, 2002, J BIOL CHEM, V277, P29634, DOI 10.1074/jbc.M200504200; Proenza C, 2002, J BIOL CHEM, V277, P5101, DOI 10.1074/jbc.M106974200; Santoro B, 1998, CELL, V93, P717, DOI 10.1016/S0092-8674(00)81434-8; Santoro B, 2000, J NEUROSCI, V20, P5264, DOI 10.1523/JNEUROSCI.20-14-05264.2000; Stevens DR, 2001, NATURE, V413, P631, DOI 10.1038/35098087; Ulens C, 2001, J BIOL CHEM, V276, P6069, DOI 10.1074/jbc.C000738200; Viscomi C, 2001, J BIOL CHEM, V276, P29930, DOI 10.1074/jbc.M103971200; Wang J, 2001, J GEN PHYSIOL, V118, P237, DOI 10.1085/jgp.118.3.237; Zerangue N, 2000, P NATL ACAD SCI USA, V97, P3591, DOI 10.1073/pnas.060016797	25	30	31	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	2002	277	46					43588	43592		10.1074/jbc.M208477200	http://dx.doi.org/10.1074/jbc.M208477200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	615XE	12193608	hybrid			2022-12-27	WOS:000179272000008
J	Zhang, H; Shi, XQ; Zhang, QJ; Hampong, M; Paddon, H; Wahyuningsih, D; Pelech, S				Zhang, H; Shi, XQ; Zhang, QJ; Hampong, M; Paddon, H; Wahyuningsih, D; Pelech, S			Nocodazole-induced p53-dependent c-Jun N-terminal kinase activation reduces apoptosis in human colon carcinoma HCT116 cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRESS-INDUCED ACTIVATION; HUMAN CANCER-CELLS; PROTEIN-KINASE; MICROTUBULE DISRUPTION; ULTRAVIOLET-RADIATION; SIGNAL-TRANSDUCTION; P53; TUMOR; PHOSPHORYLATION; GROWTH	Microtubule-interfering agents are widely used in cancer chemotherapy, and prognostic results vary significantly from tumor to tumor, depending on the p53 status. In preliminary experiments, we compared the expression and phosphorylation profiles of more than 100 protein kinases and protein phosphatases in human colorectal carcinoma cell line HCT116 between p53+/+ and p53-/- cells in response to short term nocodazole treatment through application of Kinetworks(TM) immunoblotting screens. Among the proteins tracked, the regulation of the phosphorylation of c-Jun N-terminal kinase (JN-K)1/2 at Thr-183tryr-185 was the major difference between p53+/+ and p53-/- cells. With the loss of the p,53 gene, the levels of phosphorylation of Ser-63 of c-Jun and Thr-183/Tyr-185 of JNK1/2 in p53-/- cells did not increase as markedly as in p53+/+ cells in response to a 1-h treatment with nocodazole or other microtubule-disrupting drugs such as vinblastine and colchicine. Similar observations were also made in MCF-7 and A549 tumor cells, which were rendered p53-deficient by E6 oncoprotein expression. However, arsenate-induced JNK activation in p53-/- cells was preserved. Inhibition of p53 expression by its antisense oligonucleotide also attenuated nocodazole-induced JNK activation in p53+/+ cells. Surprisingly, cotransfection of p53+/+ cells with dominant negative mutants of JNK isoforms and treatment of p53+/+ cells with the JNK inhibitor SP600125 actually further enhanced apoptosis in p53+/+ cells by up to 2-fold in response to nocodazole. These findings indicate that inhibition of p53-mediated JNK1/2 activity in certain tumor cells could serve to enhance the apoptosis-inducing actions of cancer chemotherapeutic agents that disrupt mitotic spindle function.	Univ British Columbia, Dept Med, Brain Res Ctr, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Biomed Res Ctr, Vancouver, BC V6T 1Z3, Canada; Kinexus Bioinformat Corp, Vancouver, BC V6T 1Z4, Canada	University of British Columbia; University of British Columbia	Pelech, S (corresponding author), Univ British Columbia, Dept Med, Brain Res Ctr, 1st Floor,Koerner Pavil,2211 Wesbrook Mall, Vancouver, BC V6T 1Z3, Canada.							Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bunz F, 1999, J CLIN INVEST, V104, P263, DOI 10.1172/JCI6863; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Buschmann T, 2001, MOL CELL BIOL, V21, P2743, DOI 10.1128/MCB.21.8.2743-2754.2001; Butterfield L, 1997, J BIOL CHEM, V272, P10110; Chen YR, 1999, MOL PHARMACOL, V56, P1271, DOI 10.1124/mol.56.6.1271; Chen YR, 1996, J BIOL CHEM, V271, P31929, DOI 10.1074/jbc.271.50.31929; El-Deiry WS, 1998, CURR TOP MICROBIOL, V227, P121; Gundersen GG, 1999, CURR OPIN CELL BIOL, V11, P81, DOI 10.1016/S0955-0674(99)80010-6; Hirota Y, 1996, JPN J CANCER RES, V87, P735, DOI 10.1111/j.1349-7006.1996.tb00286.x; Hu MCT, 1997, ONCOGENE, V15, P2277, DOI 10.1038/sj.onc.1201401; Huang CS, 2000, J BIOL CHEM, V275, P32516, DOI 10.1074/jbc.M005366200; Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9; KALLUNKI T, 1994, GENE DEV, V8, P2996, DOI 10.1101/gad.8.24.2996; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Kyriakis JM, 1995, ANN NY ACAD SCI, V766, P303, DOI 10.1111/j.1749-6632.1995.tb26683.x; Lee LF, 1998, J BIOL CHEM, V273, P28253, DOI 10.1074/jbc.273.43.28253; Meek DW, 1998, CELL SIGNAL, V10, P159, DOI 10.1016/S0898-6568(97)00119-8; MILNE DM, 1995, J BIOL CHEM, V270, P5511, DOI 10.1074/jbc.270.10.5511; MIYASHITA T, 1995, CELL, V80, P293; OConnor PM, 1997, CANCER RES, V57, P4285; Potapova O, 2000, MOL CELL BIOL, V20, P1713, DOI 10.1128/MCB.20.5.1713-1722.2000; Ryan KM, 2001, CURR OPIN CELL BIOL, V13, P332, DOI 10.1016/S0955-0674(00)00216-7; Sablina AA, 2001, ONCOGENE, V20, P899, DOI 10.1038/sj.onc.1204156; Sayed M, 2000, J BIOL CHEM, V275, P16569, DOI 10.1074/jbc.M000312200; Sayed M, 2001, ONCOGENE, V20, P6994, DOI 10.1038/sj.onc.1204894; Stewart ZA, 2001, ONCOGENE, V20, P113, DOI 10.1038/sj.onc.1204060; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; Vousden KH, 2000, CELL, V103, P691, DOI 10.1016/S0092-8674(00)00171-9; WALDMAN T, 1995, CANCER RES, V55, P5187; Wang TH, 1998, J BIOL CHEM, V273, P4928, DOI 10.1074/jbc.273.9.4928; Wang TH, 1999, J BIOL CHEM, V274, P8208, DOI 10.1074/jbc.274.12.8208; Wu GS, 1996, NAT MED, V2, P255, DOI 10.1038/nm0396-255a; Yujiri T, 1998, SCIENCE, V282, P1911, DOI 10.1126/science.282.5395.1911; Zhang H, 2001, J BIOL CHEM, V276, P6905, DOI 10.1074/jbc.C000917200	36	55	58	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	2002	277	46					43648	43658		10.1074/jbc.M203214200	http://dx.doi.org/10.1074/jbc.M203214200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	615XE	12221076	hybrid			2022-12-27	WOS:000179272000016
J	Bowden, MG; Visai, L; Longshaw, CM; Holland, KT; Speziale, P; Hook, M				Bowden, MG; Visai, L; Longshaw, CM; Holland, KT; Speziale, P; Hook, M			Is the GehD lipase from Staphylococcus epidermidis a collagen binding adhesin?	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COAGULASE-NEGATIVE STAPHYLOCOCCI; CAPSULAR POLYSACCHARIDE ADHESIN; AUREUS STRAINS; STREPTOCOCCUS-PNEUMONIAE; LIPOLYTIC-ACTIVITY; MATRIX MOLECULES; ALPHA-ENOLASE; PROTEIN; IDENTIFICATION; FIBRONECTIN	The opportunistic human pathogen Staphylococcus epidermidis is the major cause of nosocomial biomaterial infections. S. epidermidis has the ability to attach to indwelling materials coated with extracellular matrix proteins such as fibrinogen, fibronectin, vitronectin, and collagen. To identify the proteins necessary for S. epidermidis attachment to collagen, we screened an expression library using digoxigenin-labeled collagen as well as two monoclonal antibodies generated against the Staphylococcus aureus collagen-adhesin, Cna, as probes. These monoclonal antibodies recognize collagen binding epitopes on the surface of S. aureus and S. epidermidis cells. Using this approach, we identified GehD, the extracellular lipase originally found in S. epidermidis 9, as a collagen-binding protein. Despite the monoclonal antibody cross-reactivity, the GehD amino acid sequence and predicted structure are radically different from those of Cna. The mature GehD circular dichroism spectra differs from that of Cna but strongly resembles that of a mammalian cell-surface collagen binding receptor, known as the a, integrin I domain, suggesting that they have similar secondary structures. The GehD protein is translated as a preproenzyme, secreted, and post-translationally processed into mature lipase. GehD does not have the conserved LPXTG C-terminal motif present in cell wall-anchored proteins, but it can be detected in lysostaphin cell wall extracts. A recombinant version of mature GehD binds to collagens type 1, II, and IV adsorbed onto microtiter plates in a dose-dependent saturable manner. Recombinant, mature GehD protein and anti-GehD antibodies can inhibit the attachment of S. epidermidis to immobilized collagen. These results provide evidence that GehD may be a bi-functional molecule, acting not only as a lipase but also as a cell surface-associated collagen adhesin.	Texas A&M Univ, Inst Biosci & Technol, Syst Hlth Sci Ctr, Houston, TX 77030 USA; Univ Pavia, Dept Biochem, I-27100 Pavia, Italy; Univ Leeds, Div Microbiol, Sch Biochem & Mol Biol, Leeds LS2 9JT, W Yorkshire, England	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Pavia; University of Leeds	Hook, M (corresponding author), Texas A&M Univ, Inst Biosci & Technol, Syst Hlth Sci Ctr, 2121 W Holcombe Blvd, Houston, TX 77030 USA.	mhook@ibt.tamu.edu	Visai, Livia/R-7397-2017; Longshaw, Christopher/H-2871-2013	Visai, Livia/0000-0003-1181-3632; Longshaw, Christopher/0000-0002-5586-7256	NIAID NIH HHS [AI 10629] Funding Source: Medline; NIAMS NIH HHS [AR44415] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044415] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Bergmann S, 2001, MOL MICROBIOL, V40, P1273, DOI 10.1046/j.1365-2958.2001.02448.x; Courtney HS, 1996, INFECT IMMUN, V64, P2415, DOI 10.1128/IAI.64.7.2415-2419.1996; Davis SL, 2001, J BIOL CHEM, V276, P27799, DOI 10.1074/jbc.M103873200; de Silva GDI, 2001, CLIN INFECT DIS, V33, P1520, DOI 10.1086/323338; Fagan PK, 2001, INFECT IMMUN, V69, P4851, DOI 10.1128/IAI.69.8.4851-4857.2001; Fontan PA, 2000, J INFECT DIS, V182, P1712, DOI 10.1086/317604; Garrett DO, 1999, INFECT CONT HOSP EP, V20, P167, DOI 10.1086/501605; Gotz F, 1998, CHEM PHYS LIPIDS, V93, P15, DOI 10.1016/S0009-3084(98)00025-5; GRIBBON EM, 1993, J GEN MICROBIOL, V139, P1745, DOI 10.1099/00221287-139-8-1745; HEDSTROM SA, 1983, ACTA PATH MICRO IM B, V91, P169; HEDSTROM SA, 1975, ACTA PATH MICRO IM B, V83, P285; Heilmann C, 1997, MOL MICROBIOL, V24, P1013, DOI 10.1046/j.1365-2958.1997.4101774.x; HERRMANN M, 1988, J INFECT DIS, V158, P693, DOI 10.1093/infdis/158.4.693; HOGT AH, 1986, J BIOMED MATER RES, V20, P533, DOI 10.1002/jbm.820200409; Holmes AR, 2001, MOL MICROBIOL, V41, P1395, DOI 10.1046/j.1365-2958.2001.02610.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIEBL W, 1986, MOL GEN GENET, V204, P166, DOI 10.1007/BF00330205; Longshaw CM, 2000, MICROBIOL-UK, V146, P1419, DOI 10.1099/00221287-146-6-1419; Lowe AM, 1998, MOL MICROBIOL, V27, P967, DOI 10.1046/j.1365-2958.1998.00741.x; Lu CF, 2001, P NATL ACAD SCI USA, V98, P2387, DOI 10.1073/pnas.041606398; MULLER E, 1993, INFECT IMMUN, V61, P551, DOI 10.1128/IAI.61.2.551-558.1993; Nilsson M, 1998, INFECT IMMUN, V66, P2666, DOI 10.1128/IAI.66.6.2666-2673.1998; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Pancholi V, 1997, J EXP MED, V186, P1633, DOI 10.1084/jem.186.10.1633; PASCUAL A, 1986, EUR J CLIN MICROBIOL, V5, P518, DOI 10.1007/BF02017694; Reinscheid DJ, 2001, J BACTERIOL, V183, P1175, DOI 10.1128/JB.183.4.1175-1183.2001; Rich RL, 1999, J BIOL CHEM, V274, P24906, DOI 10.1074/jbc.274.35.24906; ROLLOF J, 1987, ACTA PATH MICRO IM B, V95, P109; Rosenstein R, 2000, BIOCHIMIE, V82, P1005, DOI 10.1016/S0300-9084(00)01180-9; Simons JWFA, 1998, CHEM PHYS LIPIDS, V93, P27, DOI 10.1016/S0009-3084(98)00026-7; Symersky J, 1997, NAT STRUCT BIOL, V4, P833, DOI 10.1038/nsb1097-833; TOJO M, 1988, J INFECT DIS, V157, P713, DOI 10.1093/infdis/157.4.713; Visai L, 2000, J BIOL CHEM, V275, P39837, DOI 10.1074/jbc.M005297200; Xu Y, 2000, J BIOL CHEM, V275, P38981, DOI 10.1074/jbc.M007668200; YU J, 1994, BIOMATERIALS, V15, P805, DOI 10.1016/0142-9612(94)90035-3	35	80	86	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					43017	43023		10.1074/jbc.M207921200	http://dx.doi.org/10.1074/jbc.M207921200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12218064	hybrid			2022-12-27	WOS:000179081200078
J	Panzenboeck, U; Balazs, Z; Sovic, A; Hrzenjak, A; Levak-Frank, S; Wintersperger, A; Malle, E; Sattler, W				Panzenboeck, U; Balazs, Z; Sovic, A; Hrzenjak, A; Levak-Frank, S; Wintersperger, A; Malle, E; Sattler, W			ABCA1 and scavenger receptor class B, type I, are modulators of reverse sterol transport at an in Vitro blood-brain barrier constituted of porcine brain capillary endothelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOLIPOPROTEIN-A-I; DENSITY-LIPOPROTEIN RECEPTOR; CHOLESTEROL HOMEOSTASIS; ALPHA-TOCOPHEROL; 24S-HYDROXYCHOLESTEROL CEREBROSTEROL; POLARIZED CHOLESTEROL; ALZHEIMERS-DISEASE; APOA-I; SR-BI; EXPRESSION	The objective of the present study was to investigate the involvement of key players in reverse cholesterol/24(S)OH-cholesterol transport in primary porcine brain capillary endothelial cells (pBCEC) that constitute the BBB. We identified that, in addition to scavenger receptor class B, type I (SR-BI), pBCEC express ABCA1 and apolipoprotein A-I (apoA-I) mRNA and protein. Studies on the regulation of ABCA1 by the liver X receptor agonist 24(S)OH-cholesterol revealed increased ABCA1 expression and apoA-I-dependent [H-3]cholesterol efflux from pBCEC. In unpolarized pBCEC, high density lipoprotein, subclass 3 (HDL3)-dependent [H-3]cholesterol efflux, was unaffected by 24(S)OH-cholesterol treatment but was enhanced 5-fold in SR-BI overexpressing pBCEC. Efflux of cellular 24(S)-[H-3]OH-cholesterol was highly efficient, independent of ABCA1, and correlated with SR-BI expression. Polarized pBCEC were cultured on porous membrane filters that allow separate access to the apical and the basolateral compartment. Addition of cholesterol acceptors to the apical compartment resulted in preferential [H-3]cholesterol efflux to the basolateral compartment. HDL3 was a better promoter of basolateral [H-3]cholesterol efflux than lipid-free apoA-I. Basolateral pretreatment with 24(S)OH-cholesterol enhanced apoA-I-dependent basolateral cholesterol efflux up to 2-fold along with the induction of ABCA1 at the basolateral membrane. Secretion of apoA-I also occurred preferentially to the basolateral compartment, where the majority of apoA-I was recovered in an HDL-like density range. In contrast, 24(S)-[H-3]OH-cholesterol was mobilized efficiently to the apical compartment of the in vitro BBB by HDL3, low density lipoprotein, and serum. These results suggest the existence of an autoregulatory mechanism for removal of potentially neurotoxic 24(S)OH-cholesterol. In conclusion, the apoA-I/ABCA1- and HDL/SR-BI-dependent pathways modulate polarized sterol mobilization at the BBB.	Graz Univ, Inst Med Biochem & Med Mol Biol, A-8010 Graz, Austria	University of Graz	Sattler, W (corresponding author), Graz Univ, Inst Med Biochem & Med Mol Biol, Harrachgasse 21, A-8010 Graz, Austria.	wolfgang.sattler@kfunigraz.ac.at	Malle, Ernst/D-3071-2013	Panzenbock, Ute/0000-0002-0545-6758				Babiker A, 1997, J BIOL CHEM, V272, P26253, DOI 10.1074/jbc.272.42.26253; Babiker A, 1998, BBA-LIPID LIPID MET, V1392, P333, DOI 10.1016/S0005-2760(98)00047-2; Bergt C, 2000, BIOCHEM J, V346, P345, DOI 10.1042/0264-6021:3460345; Bjorkhem I, 2001, J BIOL CHEM, V276, P37004, DOI 10.1074/jbc.M103828200; Bodzioch M, 1999, NAT GENET, V22, P347, DOI 10.1038/11914; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; Cao GP, 1997, J BIOL CHEM, V272, P33068, DOI 10.1074/jbc.272.52.33068; Chisholm JW, 2002, J LIPID RES, V43, P36; Costet P, 2000, J BIOL CHEM, V275, P28240; Dietschy JM, 2001, CURR OPIN LIPIDOL, V12, P105, DOI 10.1097/00041433-200104000-00003; Fassbender K, 2001, P NATL ACAD SCI USA, V98, P5856, DOI 10.1073/pnas.081620098; FIELDING CJ, 1995, J LIPID RES, V36, P211; Goti D, 2000, J NEUROCHEM, V74, P1374, DOI 10.1046/j.1471-4159.2000.0741374.x; Goti D, 2002, J BIOL CHEM, V277, P28537, DOI 10.1074/jbc.M203989200; Goti D, 2001, J NEUROCHEM, V76, P498, DOI 10.1046/j.1471-4159.2001.00100.x; Harris IR, 1998, J LIPID RES, V39, P412; Janowski BA, 1999, P NATL ACAD SCI USA, V96, P266, DOI 10.1073/pnas.96.1.266; Ji Y, 1997, J BIOL CHEM, V272, P20982, DOI 10.1074/jbc.272.34.20982; Jick H, 2000, LANCET, V356, P1627, DOI 10.1016/S0140-6736(00)03155-X; Kellner-Weibel G, 2000, BIOCHEMISTRY-US, V39, P221, DOI 10.1021/bi991666c; Kolsch H, 2001, J NEURAL TRANSM, V108, P475, DOI 10.1007/s007020170068; Krieger M, 1999, ANNU REV BIOCHEM, V68, P523, DOI 10.1146/annurev.biochem.68.1.523; Lawn RM, 1999, J CLIN INVEST, V104, pR25, DOI 10.1172/JCI8119; Lee J, 2002, BIOCHEM J, V364, P475, DOI 10.1042/BJ20011493; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu TT, 2001, J BIOL CHEM, V276, P37735, DOI 10.1074/jbc.R100035200; Lund EG, 1999, P NATL ACAD SCI USA, V96, P7238, DOI 10.1073/pnas.96.13.7238; Lutjohann D, 2000, J LIPID RES, V41, P195; Lutjohann D, 1996, P NATL ACAD SCI USA, V93, P9799, DOI 10.1073/pnas.93.18.9799; Mardones P, 2002, J NUTR, V132, P443, DOI 10.1093/jn/132.3.443; Marmorstein AD, 1998, CELL BIOLOGY - A LABOARATORY HANDBOOK, 2ND EDITION, VOL 4, P341; Merched A, 2000, NEUROBIOL AGING, V21, P27, DOI 10.1016/S0197-4580(99)00103-7; MOCKEL B, 1994, J NEUROCHEM, V62, P788; Murthy S, 2002, J LIPID RES, V43, P1054, DOI 10.1194/jlr.M100358-JLR200; Ohama T, 2002, BIOCHEM BIOPH RES CO, V296, P625, DOI 10.1016/S0006-291X(02)00853-7; Panzenbock U, 2000, J BIOL CHEM, V275, P19536, DOI 10.1074/jbc.M000458200; Papassotiropoulos A, 2002, J PSYCHIAT RES, V36, P27, DOI 10.1016/S0022-3956(01)00050-4; Puglielli L, 2001, NAT CELL BIOL, V3, P905, DOI 10.1038/ncb1001-905; Repa JJ, 2000, SCIENCE, V289, P1524, DOI 10.1126/science.289.5484.1524; Rigotti A, 1997, P NATL ACAD SCI USA, V94, P12610, DOI 10.1073/pnas.94.23.12610; Ritter M, 2002, GENOMICS, V79, P693, DOI 10.1006/geno.2002.6761; Santamarina-Fojo S, 2001, J LIPID RES, V42, P1339; SATTLER W, 1994, METHOD ENZYMOL, V233, P469; Schmitz G, 2001, CURR OPIN LIPIDOL, V12, P129, DOI 10.1097/00041433-200104000-00006; Schwartz K, 2000, BIOCHEM BIOPH RES CO, V274, P794, DOI 10.1006/bbrc.2000.3243; Silver DL, 2001, J BIOL CHEM, V276, P25287, DOI 10.1074/jbc.M101726200; Sparks DL, 2000, MICROSC RES TECHNIQ, V50, P287, DOI 10.1002/1097-0029(20000815)50:4<287::AID-JEMT7>3.0.CO;2-L; Sun Y, 1999, J LIPID RES, V40, P1799; Tewes B, 1997, DRUG TRANSPORT ACROSS THE BLOOD-BRAIN BARRIER, P91; Trigatti BL, 2000, BBA-MOL CELL BIOL L, V1529, P276, DOI 10.1016/S1388-1981(00)00154-2; Tsuruoka H, 2002, J BIOL CHEM, V277, P2916, DOI 10.1074/jbc.M106445200; Turley SD, 1998, AM J PHYSIOL-ENDOC M, V274, pE1099, DOI 10.1152/ajpendo.1998.274.6.E1099; Venkateswaran A, 2000, P NATL ACAD SCI USA, V97, P12097, DOI 10.1073/pnas.200367697; Wang N, 1996, J BIOL CHEM, V271, P21001, DOI 10.1074/jbc.271.35.21001; Wolozin B, 2001, P NATL ACAD SCI USA, V98, P5371, DOI 10.1073/pnas.101123198; Xie CL, 1999, P NATL ACAD SCI USA, V96, P11992, DOI 10.1073/pnas.96.21.11992	56	149	156	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					42781	42789		10.1074/jbc.M207601200	http://dx.doi.org/10.1074/jbc.M207601200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12202492	hybrid			2022-12-27	WOS:000179081200048
J	Wu, JM; Janknecht, R				Wu, JM; Janknecht, R			Regulation of the ETS transcription factor ER81 by the 90-kDa ribosomal S6 kinase 1 and protein kinase A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; MAP KINASE; COACTIVATOR CBP; GENE-REGULATION; PEA3 SUBFAMILY; PHOSPHORYLATION; ACTIVATION; GROWTH; CAMP; CREB	The ETS transcription factor ER81 is activated in response to many signals via mitogen-activated protein kinases (MAPKs). However, ER81 is not only phosphorylated on MAPK sites but also at other sites that impact on its transactivation potential. Here we describe that the 90-kDa ribosomal S6 kinase 1 (RSK1), a protein kinase downstream of the extracellular signal-regulated kinase (ERK) subclass of MAPKs, binds to ER81, phosphorylates it, and enhances ER81-dependent transcription. Two in vivo RSK1 phosphorylation sites within ER81, Ser(191) and Ser(216), were identified, whose mutation to alanine reduces ER81 activity upon ERK-MAPK stimulation. Furthermore, RSK1 activates the ER81 cofactor CREB-binding protein and may thereby augment ER81-dependent transcription. Similar to RSK1, the cAMP-dependent protein kinase A (PKA) phosphorylates ER81 on Ser(191)/Ser(216). Additionally, PKA targets ER81 on Ser(334) in vivo. Surprisingly, phosphorylation of Ser(334) severely reduces the DNA-binding ability of ER81 but also enhances the transactivation potential of ER81. These counteractive effects of PKA phosphorylation on ER81-dependent transcription may cause the selective up-regulation of promoters with high but not low affinity for ER81. Collectively, we have identified mechanisms for how two distinct signaling pathways with different effector protein kinases, RSK1 and PKA, converge on ER81, which may regulate ER81 function during development and tumorigenesis.	Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA	Mayo Clinic	Janknecht, R (corresponding author), Mayo Clin, Dept Biochem & Mol Biol, 200 First St SW, Rochester, MN 55905 USA.			Janknecht, Ralf/0000-0003-1741-1562	NCI NIH HHS [R01 CA085257] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Arber S, 2000, CELL, V101, P485, DOI 10.1016/S0092-8674(00)80859-4; BADING H, 1991, SCIENCE, V253, P912, DOI 10.1126/science.1715095; Baert JL, 2002, J BIOL CHEM, V277, P1002, DOI 10.1074/jbc.M107139200; Baert JL, 1997, INT J CANCER, V70, P590, DOI 10.1002/(SICI)1097-0215(19970304)70:5<590::AID-IJC17>3.0.CO;2-H; Block C, 1996, NAT STRUCT BIOL, V3, P244, DOI 10.1038/nsb0396-244; Bosc DG, 2002, J CELL BIOCHEM, V86, P174, DOI 10.1002/jcb.10205; Bosc DG, 2001, ONCOGENE, V20, P6215, DOI 10.1038/sj.onc.1204820; BROWN TA, 1992, GENE DEV, V6, P2502, DOI 10.1101/gad.6.12b.2502; BRUDER JT, 1992, GENE DEV, V6, P545, DOI 10.1101/gad.6.4.545; Buck M, 2001, MOL CELL, V8, P807, DOI 10.1016/S1097-2765(01)00374-4; BURGERING BMT, 1993, EMBO J, V12, P4211, DOI 10.1002/j.1460-2075.1993.tb06105.x; Cassoni P, 1997, INT J CANCER, V72, P340, DOI 10.1002/(SICI)1097-0215(19970717)72:2<340::AID-IJC23>3.0.CO;2-I; Chawla S, 1998, SCIENCE, V281, P1505, DOI 10.1126/science.281.5382.1505; CHEN RH, 1993, P NATL ACAD SCI USA, V90, P10952, DOI 10.1073/pnas.90.23.10952; ChoChung YS, 1995, CRIT REV ONCOL HEMAT, V21, P33, DOI 10.1016/1040-8428(94)00166-9; Chotteau-Lelievre A, 2001, MECH DEVELOP, V108, P191, DOI 10.1016/S0925-4773(01)00480-4; ChotteauLelievre A, 1997, ONCOGENE, V15, P937, DOI 10.1038/sj.onc.1201261; COOK SJ, 1993, SCIENCE, V262, P1069, DOI 10.1126/science.7694367; Coutte L, 1999, ONCOGENE, V18, P6278, DOI 10.1038/sj.onc.1203020; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; Crawford HC, 2001, MOL CELL BIOL, V21, P1370, DOI 10.1128/MCB.21.4.1370-1383.2001; Dalby KN, 1998, J BIOL CHEM, V273, P1496, DOI 10.1074/jbc.273.3.1496; Daniel PB, 1998, ANNU REV NUTR, V18, P353, DOI 10.1146/annurev.nutr.18.1.353; FAURE M, 1994, J BIOL CHEM, V269, P7851; Frodin M, 2000, EMBO J, V19, P2924, DOI 10.1093/emboj/19.12.2924; Frodin M, 1999, MOL CELL ENDOCRINOL, V151, P65, DOI 10.1016/S0303-7207(99)00061-1; FRODIN M, 1994, J BIOL CHEM, V269, P6207; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Goodman RH, 2000, GENE DEV, V14, P1553; Graves BJ, 1998, ADV CANCER RES, V75, P1, DOI 10.1016/S0065-230X(08)60738-1; GRAVES LM, 1993, P NATL ACAD SCI USA, V90, P10300, DOI 10.1073/pnas.90.21.10300; Hung MC, 1999, SEMIN ONCOL, V26, P51; HYNES NE, 1994, BBA-REV CANCER, V1198, P165, DOI 10.1016/0304-419X(94)90012-4; Janknecht R, 1996, MOL CELL BIOL, V16, P1550; JANKNECHT R, 1993, BIOCHIM BIOPHYS ACTA, V1155, P346, DOI 10.1016/0304-419X(93)90014-4; Janknecht R, 2002, HISTOL HISTOPATHOL, V17, P657, DOI 10.14670/HH-17.657; Janknecht R, 1996, ONCOGENE, V12, P1961; Janknecht R, 2001, J BIOL CHEM, V276, P41856, DOI 10.1074/jbc.M106630200; Janknecht R, 1996, BIOCHEM BIOPH RES CO, V228, P831, DOI 10.1006/bbrc.1996.1740; Jensen CJ, 1999, J BIOL CHEM, V274, P27168, DOI 10.1074/jbc.274.38.27168; Joel PB, 1998, MOL CELL BIOL, V18, P1978, DOI 10.1128/MCB.18.4.1978; KENNELLY PJ, 1991, J BIOL CHEM, V266, P15555; LEIGHTON IA, 1995, FEBS LETT, V375, P289, DOI 10.1016/0014-5793(95)01170-J; Lin JH, 1998, CELL, V95, P393, DOI 10.1016/S0092-8674(00)81770-5; Liu SL, 2000, ONCOGENE, V19, P3352, DOI 10.1038/sj.onc.1203675; MONTE D, 1995, ONCOGENE, V11, P771; Nakajima T, 1996, CELL, V86, P465, DOI 10.1016/S0092-8674(00)80119-1; Papoutsopoulou S, 2000, MOL CELL BIOL, V20, P7300, DOI 10.1128/MCB.20.19.7300-7310.2000; Pearson KL, 1999, BBA-GENE STRUCT EXPR, V1489, P354, DOI 10.1016/S0167-4781(99)00166-9; RAO VN, 1992, ONCOGENE, V7, P65; Richards SA, 2001, MOL CELL BIOL, V21, P7470, DOI 10.1128/MCB.21.21.7470-7480.2001; ROSEN LB, 1994, NEURON, V12, P1207, DOI 10.1016/0896-6273(94)90438-3; Rusanescu G, 1995, NEURON, V15, P1415, DOI 10.1016/0896-6273(95)90019-5; Sassone-Corsi P, 1999, SCIENCE, V285, P886, DOI 10.1126/science.285.5429.886; SEVETSON BR, 1993, P NATL ACAD SCI USA, V90, P10305, DOI 10.1073/pnas.90.21.10305; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Shepherd TG, 2001, CURR BIOL, V11, P1739, DOI 10.1016/S0960-9822(01)00536-X; Stork PJS, 2002, TRENDS CELL BIOL, V12, P258, DOI 10.1016/S0962-8924(02)02294-8; URNESS LD, 1990, CELL, V63, P47, DOI 10.1016/0092-8674(90)90287-O; VANDERGEER P, 1994, ELECTROPHORESIS, V15, P544, DOI 10.1002/elps.1150150173; Viollet B, 1997, MOL CELL BIOL, V17, P4208, DOI 10.1128/MCB.17.8.4208; WU J, 1993, SCIENCE, V262, P1065, DOI 10.1126/science.7694366; Xing J, 1998, MOL CELL BIOL, V18, P1946, DOI 10.1128/MCB.18.4.1946; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959	65	79	89	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					42669	42679		10.1074/jbc.M205501200	http://dx.doi.org/10.1074/jbc.M205501200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12213813	hybrid			2022-12-27	WOS:000179081200032
J	Blagoev, B; Kratchmarova, I; Nielsen, MM; Fernandez, MM; Voldby, J; Andersen, JS; Kristiansen, K; Pandey, A; Mann, M				Blagoev, B; Kratchmarova, I; Nielsen, MM; Fernandez, MM; Voldby, J; Andersen, JS; Kristiansen, K; Pandey, A; Mann, M			Inhibition of adipocyte differentiation by resistin-like molecule alpha - Biochemical characterization of its oligomeric nature	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPOSE-TISSUE; 3T3-L1 ADIPOCYTES; ACTIVIN-A; PROTEIN; EXPRESSION; RECEPTORS; AFFINITY; OBESITY; FAMILY; LIGAND	A novel family of cysteine-rich secreted proteins with unique tissue distribution has recently been identified. One of the members, resistin (for "resistance to insulin"), also called FIZZ3, was identified in a screen for molecules that are down-regulated in mature adipocytes upon administration of thiazolidinediones. The prototypical member of this family was originally identified from bronchoalveolar lavage fluid of inflamed lungs and designated FIZZ1 ("found in inflammatory zone"). This molecule was also found to be highly expressed in adipose tissue and was named resistin-like molecule a (RELMalpha). Here we demonstrate that RELMalpha inhibits the differentiation of 3T3-L1 preadipocytes into adipocytes. RELMalpha has no effect on proliferation of 3T3-L1 preadipocytes. Pretreatment of 3T3-L1 preadipocytes with RELMalpha does not affect insulin- or platelet-derived growth factor-induced mitogenesis. IRS-1 phosphorylation and glucose transport stimulated by insulin in mature adipocytes were also unaffected by RELMalpha. We show that RELMalpha forms disulfide-linked homooligomers based on results from electrophoresis under reducing and nonreducing conditions, coimmunoprecipitation experiments as well as by mass spectrometry. In addition, RELMalpha is able to form heterooligomers with resistin but not RELMbeta. Since RELMa is expressed by adipose tissue and it is a secreted factor, our findings suggest that RELMalpha may be involved in the control of the adipogenesis as well as in the process of muscle differentiation.	Univ So Denmark, Ctr Expt Bioinformat, DK-5230 Odense M, Denmark	University of Southern Denmark	Mann, M (corresponding author), Univ So Denmark, Ctr Expt Bioinformat, DK-5230 Odense M, Denmark.		Mann, Matthias/A-3454-2013; Andersen, Jens S/L-2100-2015; Pandey, Akhilesh/B-4127-2009; Kristiansen, Karsten/J-5148-2014	Mann, Matthias/0000-0003-1292-4799; Andersen, Jens S/0000-0002-6091-140X; Pandey, Akhilesh/0000-0001-9943-6127; Kristiansen, Karsten/0000-0002-6024-0917; Blagoev, Blagoy/0000-0002-3596-0066; Kratchmarova, Irina/0000-0001-6613-7315	NATIONAL CANCER INSTITUTE [K01CA075447] Funding Source: NIH RePORTER; NCI NIH HHS [K01 CA75447] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ahima RS, 2000, TRENDS ENDOCRIN MET, V11, P327, DOI 10.1016/S1043-2760(00)00301-5; Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Fruebis J, 2001, P NATL ACAD SCI USA, V98, P2005, DOI 10.1073/pnas.041591798; GRAY AM, 1990, SCIENCE, V247, P1328, DOI 10.1126/science.2315700; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Guo DQ, 1996, J BIOL CHEM, V271, P615, DOI 10.1074/jbc.271.2.615; Halvorsen Y D, 2000, Pharmacogenomics, V1, P179, DOI 10.1517/14622416.1.2.179; Hansen JB, 1999, J BIOL CHEM, V274, P2386, DOI 10.1074/jbc.274.4.2386; HAUNER H, 1995, EUR J CLIN INVEST, V25, P90, DOI 10.1111/j.1365-2362.1995.tb01532.x; Holcomb IN, 2000, EMBO J, V19, P4046, DOI 10.1093/emboj/19.15.4046; HUSKENHINDI P, 1994, J BIOL CHEM, V269, P19380; Ishibashi K, 2001, J CLIN INVEST, V107, P1193, DOI 10.1172/JCI11753; Kim KH, 2001, J BIOL CHEM, V276, P11252, DOI 10.1074/jbc.C100028200; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; MACDOUGALD OA, 1994, J BIOL CHEM, V269, P19041; MACDOUGALD OA, 1995, ANNU REV BIOCHEM, V64, P345, DOI 10.1146/annurev.bi.64.070195.002021; Olefsky JM, 2000, TRENDS ENDOCRIN MET, V11, P362, DOI 10.1016/S1043-2760(00)00306-4; Pandey A, 2000, P NATL ACAD SCI USA, V97, P179, DOI 10.1073/pnas.97.1.179; PETRUSCHKE T, 1994, INT J OBESITY, V18, P532; Procopio WN, 1999, J BIOL CHEM, V274, P30196, DOI 10.1074/jbc.274.42.30196; Rosen ED, 2000, ANNU REV CELL DEV BI, V16, P145, DOI 10.1146/annurev.cellbio.16.1.145; RUBIN CS, 1978, J BIOL CHEM, V253, P7570; Saltiel AR, 2001, CELL, V104, P517, DOI 10.1016/S0092-8674(01)00239-2; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Steppan CM, 2001, P NATL ACAD SCI USA, V98, P502, DOI 10.1073/pnas.98.2.502; Wilm M, 1996, ANAL CHEM, V68, P1, DOI 10.1021/ac9509519	29	54	59	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					42011	42016		10.1074/jbc.M206975200	http://dx.doi.org/10.1074/jbc.M206975200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12189153	hybrid			2022-12-27	WOS:000178985300090
J	Geiben-Lynn, R; Brown, N; Walker, BD; Luster, AD				Geiben-Lynn, R; Brown, N; Walker, BD; Luster, AD			Purification of a modified form of bovine antithrombin III as an HIV-1CD8(+) T-cell antiviral factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; MACROPHAGE-DERIVED CHEMOKINE; REVERSE TRANSCRIPTION; HEPARIN-BINDING; HIV-1 INFECTION; MEDIATED SUPPRESSION; SERPIN ANTITHROMBIN; BETA-CHEMOKINES; GENE-EXPRESSION; CD8(+) CELLS	CD8(+) T-cells secrete soluble factor(s) capable of inhibiting both R5- and X4-tropic strains of human immunodeficiency virus type 1 (HIV-1). CCR5 chemokine ligands, released from activated CD8(+) T-cells, contribute to the antiviral activity of these cells. These CC-chemokines, however, do not account for all CD8(+) T-cell antiviral factor(s) (CAF) released from these cells, particularly because the elusive CAF can inhibit the replication of X4 HIV-1 strains that use CXCR4 and not CCR5 as a coreceptor. Here we demonstrate that activated CD8(+) T-cells of HIV-1-seropositive individuals modify serum bovine antithrombin III into an HIV-1 inhibitory factor capable of suppressing the replication of X4 HIV-1. These data indicate that antithrombin III may play a role in the progression of HIV-1 disease.	Massachusetts Gen Hosp, Div Rheumatol Allergy & Immunol, Boston, MA 02129 USA; Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Partners AIDS Res Ctr, Boston, MA 02129 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Luster, AD (corresponding author), Massachusetts Gen Hosp, Bldg 149,13th St, Charlestown, MA 02129 USA.		Luster, Andrew/ABE-6504-2020	Luster, Andrew/0000-0001-9679-7912	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI030914, R01AI028568, R01AI046999, R37AI028568] Funding Source: NIH RePORTER; NIAID NIH HHS [AI46999, AI30914, AI28568] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		CARRELL RW, 1991, NATURE, V353, P576, DOI 10.1038/353576a0; CHEN CH, 1993, AIDS RES HUM RETROV, V9, P1079, DOI 10.1089/aid.1993.9.1079; COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811; Dunzendorfer S, 2001, BLOOD, V97, P1079, DOI 10.1182/blood.V97.4.1079; EUHUS DM, 1990, INT J CANCER, V45, P1065, DOI 10.1002/ijc.2910450615; EVANS DL, 1992, BIOCHEMISTRY-US, V31, P12629, DOI 10.1021/bi00165a013; Garzino-Demo A, 1999, P NATL ACAD SCI USA, V96, P11986, DOI 10.1073/pnas.96.21.11986; Geiben-Lynn R, 2001, J VIROL, V75, P8306, DOI 10.1128/JVI.75.17.8306-8316.2001; Hocini H, 2000, CLIN DIAGN LAB IMMUN, V7, P515, DOI 10.1128/CDLI.7.3.515-518.2000; Horuk R, 1998, NATURE, V393, P524, DOI 10.1038/31116; Kaneider NC, 2001, BIOCHEM BIOPH RES CO, V287, P42, DOI 10.1006/bbrc.2001.5534; Konopka K, 1999, J DENT RES, V78, P1773, DOI 10.1177/00220345990780120201; Larsson H, 2001, J BIOL CHEM, V276, P11996, DOI 10.1074/jbc.M010170200; Le Borgne S, 2000, J VIROL, V74, P4456, DOI 10.1128/JVI.74.10.4456-4464.2000; Leith JG, 1997, AIDS, V11, P575, DOI 10.1097/00002030-199705000-00004; Levy JA, 1996, IMMUNOL TODAY, V17, P217, DOI 10.1016/0167-5699(96)10011-6; LIU CS, 1987, EUR J BIOCHEM, V167, P247, DOI 10.1111/j.1432-1033.1987.tb13330.x; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Mackewicz CE, 2000, J GEN VIROL, V81, P1261, DOI 10.1099/0022-1317-81-5-1261; MACKEWICZ CE, 1995, P NATL ACAD SCI USA, V92, P2308, DOI 10.1073/pnas.92.6.2308; McNeely TB, 1997, BLOOD, V90, P1141, DOI 10.1182/blood.V90.3.1141.1141_1141_1149; MOUREY L, 1993, J MOL BIOL, V232, P223, DOI 10.1006/jmbi.1993.1378; O'Reilly MS, 1999, SCIENCE, V285, P1926, DOI 10.1126/science.285.5435.1926; Oelschlager C, 2002, BLOOD, V99, P4015, DOI 10.1182/blood.V99.11.4015; Pal R, 1997, SCIENCE, V278, P695, DOI 10.1126/science.278.5338.695; Proost P, 2000, BLOOD, V96, P1674, DOI 10.1182/blood.V96.5.1674.h8001674a_1674_1680; Proost P, 1999, J BIOL CHEM, V274, P3988, DOI 10.1074/jbc.274.7.3988; Saif MW, 2001, AIDS PATIENT CARE ST, V15, P15, DOI 10.1089/108729101460065; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; Saphire ACS, 2001, J VIROL, V75, P9187, DOI 10.1128/JVI.75.19.9187-9200.2001; Scarlatti G, 1997, NAT MED, V3, P1259, DOI 10.1038/nm1197-1259; SCCHREUDER HA, 1994, NAT STRUCT BIOL, V1, P48; Shapiro L, 2001, FASEB J, V15, P115, DOI 10.1096/fj.00-0311com; Shugars D C, 1997, Oral Dis, V3 Suppl 1, pS70; Souter PJ, 2001, CRIT CARE MED, V29, P134, DOI 10.1097/00003246-200101000-00027; Struyf S, 1998, J IMMUNOL, V161, P2672; Tomaras GD, 2000, P NATL ACAD SCI USA, V97, P3503, DOI 10.1073/pnas.070521097; Tseng CC, 2000, FEBS LETT, V475, P232, DOI 10.1016/S0014-5793(00)01700-2; Valenzuela-Fernandez A, 2001, J BIOL CHEM, V276, P26550, DOI 10.1074/jbc.M100411200; Van Patten SM, 1999, J BIOL CHEM, V274, P10268, DOI 10.1074/jbc.274.15.10268; Wahl SM, 1997, ORAL DIS S1, V3, pS64; WALKER CM, 1986, SCIENCE, V234, P1563, DOI 10.1126/science.2431484; Wardell MR, 1997, BIOCHEMISTRY-US, V36, P13133, DOI 10.1021/bi970664u; Yang OO, 1997, J VIROL, V71, P3120, DOI 10.1128/JVI.71.4.3120-3128.1997	44	31	38	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					42352	42357		10.1074/jbc.M207079200	http://dx.doi.org/10.1074/jbc.M207079200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12192009	hybrid			2022-12-27	WOS:000178985300131
J	Gong, DM; Zhang, CQ; Chen, XY; Gong, ZZ; Zhu, JK				Gong, DM; Zhang, CQ; Chen, XY; Gong, ZZ; Zhu, JK			Constitutive activation and transgenic evaluation of the function of an Arabidopsis PKS protein kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SALT TOLERANCE; SIGNAL-TRANSDUCTION; GENE; TRANSCRIPTION; REDUCTASE; HOMOLOG; ENCODES; TOBACCO; BINDING; SOS1	A novel family of SOS2 (salt overly sensitive 2)-like protein kinase genes (designated PKSes) have been recently identified in Arabidopsis. The biochemical characteristics as well as in vivo roles of most of the PKSes are unclear at present. In this work, we isolated and characterized one of the PKSes, PKS18. PKS18 was expressed in leaves of mature Arabidopsis plants. The glutathione S-transferase (GST)-PKS18 fusion protein was inactive by itself in substrate phosphorylation. An activation loop Thr(169) to Asp mutation, however, highly activated this kinase in vitro (designated PKS18T/D). Kinase activity of the PKS18T/D preferred Mn2+ to Mg2+. The activated kinase showed a substrate specificity, and high catalytic efficiency for a peptide substrate p3 and for ATP. Interestingly, PYKS18T/D transgenic plants were hypersensitive to the phytohormone abscisic acid (ABA) in seed germination and seedling growth, whereas silencing the kinase gene by RNA interference (RNAi) conferred ABA-insensitivity, indicating the involvement of PKS18 in plant ABA signaling.	Univ Arizona, Dept Plant Sci, Tucson, AZ 85721 USA	University of Arizona	Zhu, JK (corresponding author), Univ Arizona, Dept Plant Sci, Tucson, AZ 85721 USA.	jkzhu@ag.arizona.edu	Zhang, Changqing/C-7872-2012; Gong, Zhizhong/AAS-4796-2021; Zhu, Jian-Kang/F-7658-2011	Zhang, Changqing/0000-0002-0130-4378; Zhu, Jian-Kang/0000-0001-5134-731X; chen, xiuyin/0000-0002-1734-3267	NIGMS NIH HHS [R01GM59138] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059138] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; Ball KL, 1995, FEBS LETT, V377, P189, DOI 10.1016/0014-5793(95)01343-1; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; DALE S, 1995, FEBS LETT, V361, P191, DOI 10.1016/0014-5793(95)00172-6; Finkelstein RR, 2000, PLANT CELL, V12, P599, DOI 10.1105/tpc.12.4.599; Gomez-Cadenas A, 1999, P NATL ACAD SCI USA, V96, P1767, DOI 10.1073/pnas.96.4.1767; Guo Y, 2001, PLANT CELL, V13, P1383, DOI 10.1105/tpc.13.6.1383; Halfter U, 2000, P NATL ACAD SCI USA, V97, P3735, DOI 10.1073/pnas.040577697; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Ishitani M, 2000, PLANT CELL, V12, P1667, DOI 10.1105/tpc.12.9.1667; Kang JY, 2002, PLANT CELL, V14, P343, DOI 10.1105/tpc.010362; KEMP RG, 1967, BIOCHEMISTRY-US, V6, P423, DOI 10.1021/bi00854a009; Koornneef M, 1998, PLANT PHYSIOL BIOCH, V36, P83, DOI 10.1016/S0981-9428(98)80093-4; KREIS M, 2000, PLANT PROTEIN KINASE, P1; Leung J, 1998, ANNU REV PLANT PHYS, V49, P199, DOI 10.1146/annurev.arplant.49.1.199; Li JX, 2000, SCIENCE, V287, P300, DOI 10.1126/science.287.5451.300; Liu JP, 2000, P NATL ACAD SCI USA, V97, P3730, DOI 10.1073/pnas.060034197; Liu JP, 1998, SCIENCE, V280, P1943, DOI 10.1126/science.280.5371.1943; Lopez-Molina L, 2001, P NATL ACAD SCI USA, V98, P4782, DOI 10.1073/pnas.081594298; MacRobbie EAC, 2000, P NATL ACAD SCI USA, V97, P12361, DOI 10.1073/pnas.220417197; McCartney RR, 2001, J BIOL CHEM, V276, P36460, DOI 10.1074/jbc.M104418200; McCourt P, 1999, ANNU REV PLANT PHYS, V50, P219, DOI 10.1146/annurev.arplant.50.1.219; MURANAKA T, 1994, MOL CELL BIOL, V14, P2958, DOI 10.1128/MCB.14.5.2958; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Narasimhulu SB, 1996, PLANT CELL, V8, P873, DOI 10.1105/tpc.8.5.873; Qiu QS, 2002, P NATL ACAD SCI USA, V99, P8436, DOI 10.1073/pnas.122224699; Quintero FJ, 2002, P NATL ACAD SCI USA, V99, P9061, DOI 10.1073/pnas.132092099; Roberts DM, 1993, CURR OPIN CELL BIOL, V5, P242, DOI 10.1016/0955-0674(93)90110-C; Shen W, 2001, PLANT PHYSIOL, V125, P1429, DOI 10.1104/pp.125.3.1429; Shi HZ, 2000, P NATL ACAD SCI USA, V97, P6896, DOI 10.1073/pnas.120170197; STONE JM, 1994, SCIENCE, V266, P793, DOI 10.1126/science.7973632; Sturany S, 2001, J BIOL CHEM, V276, P3310, DOI 10.1074/jbc.M008719200; Su JY, 1996, J BIOL CHEM, V271, P14430, DOI 10.1074/jbc.271.24.14430; Sugden C, 1999, PLANT PHYSIOL, V120, P257, DOI 10.1104/pp.120.1.257; Sun GQ, 1997, BIOCHEMISTRY-US, V36, P2139, DOI 10.1021/bi962291n; Toroser D, 2000, PLANT PHYSIOL, V123, P403, DOI 10.1104/pp.123.1.403; Tuininga JE, 1999, J BIOL CHEM, V274, P21023, DOI 10.1074/jbc.274.30.21023; Uno Y, 2000, P NATL ACAD SCI USA, V97, P11632, DOI 10.1073/pnas.190309197; Waldron RT, 2001, J BIOL CHEM, V276, P32606, DOI 10.1074/jbc.M101648200; Wu SJ, 1996, PLANT CELL, V8, P617, DOI 10.1105/tpc.8.4.617; ZHAO Y, 1994, BIOCHEMISTRY-US, V33, P3714, DOI 10.1021/bi00178a031; ZHENG RL, 1992, J BIOL CHEM, V267, P23640; Zhu JK, 1998, PLANT CELL, V10, P1181, DOI 10.1105/tpc.10.7.1181	44	58	79	0	17	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					42088	42096		10.1074/jbc.M205504200	http://dx.doi.org/10.1074/jbc.M205504200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12198122	hybrid			2022-12-27	WOS:000178985300099
J	Mizuta, B; Mizuta, M; Araki, S; Kitamura, D				Mizuta, B; Mizuta, M; Araki, S; Kitamura, D			RAG2 is down-regulated by cytoplasmic sequestration and ubiquitin-dependent degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							V(D)J RECOMBINATION; CELL-CYCLE; P27(KIP1); REPAIR; PATHWAYS; KINASE; GENE	Periodic accumulation and degradation of RAG2 (recombination-activating gene 2) protein controls the cell-cycle-dependent V(D)J recombination of lymphocyte antigen receptor genes. Here we show the molecular mechanism of RAG2 degradation. The RAG2 protein is translocated from the nucleus to the cytoplasm and degraded through the ubiquitin/proteasome system. RAG2 translocation is mediated by the Thr-490 phosphorylation of RAG2. Inhibition of this phosphorylation by p27Kip1 stabilizes the RAG2 protein in the nucleus. These results suggest that RAG2 sequestration in the cytoplasm and its subsequent degradation by the ubiquitin/proteasome system upon entering the S phase is an integral part of G0/G1-specific V(D)J recombination.	Sci Univ Tokyo, Res Inst Biol Sci, Noda, Chiba 2780022, Japan	Tokyo University of Science	Mizuta, B (corresponding author), Sci Univ Tokyo, Res Inst Biol Sci, 2669 Yamazaki, Noda, Chiba 2780022, Japan.		Araki, Shinsuke/M-3983-2018	Araki, Shinsuke/0000-0002-9936-1417				Ciechanover A, 1998, EMBO J, V17, P7151, DOI 10.1093/emboj/17.24.7151; Desiderio S, 1996, CURR TOP MICROBIOL, V217, P45; FENTEANY G, 1995, SCIENCE, V268, P726, DOI 10.1126/science.7732382; Gellert M, 1997, ADV IMMUNOL, V64, P39, DOI 10.1016/S0065-2776(08)60886-X; GERACE L, 1995, CELL, V82, P341, DOI 10.1016/0092-8674(95)90420-4; Hershko A, 2000, NAT MED, V6, P1073, DOI 10.1038/80384; Hesslein DGT, 2001, ADV IMMUNOL, V78, P169, DOI 10.1016/S0065-2776(01)78004-2; Kirch SA, 1998, EMBO J, V17, P4881, DOI 10.1093/emboj/17.16.4881; Lee J, 1999, IMMUNITY, V11, P771, DOI 10.1016/S1074-7613(00)80151-X; LEWIS SM, 1994, ADV IMMUNOL, V56, P27, DOI 10.1016/S0065-2776(08)60450-2; Lieber MR, 1999, GENES CELLS, V4, P77, DOI 10.1046/j.1365-2443.1999.00245.x; Malek NP, 2001, NATURE, V413, P323, DOI 10.1038/35095083; Mizuta R, 1997, INT IMMUNOL, V9, P1607, DOI 10.1093/intimm/9.10.1607; Morimura T, 2000, J BIOL CHEM, V275, P36523, DOI 10.1074/jbc.M006415200; OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047; Rubinfeld B, 1997, SCIENCE, V275, P1790, DOI 10.1126/science.275.5307.1790; SADOFSKY MJ, 1994, NUCLEIC ACIDS RES, V22, P1805, DOI 10.1093/nar/22.10.1805; SCHATZ DG, 1989, CELL, V59, P1035, DOI 10.1016/0092-8674(89)90760-5; Smith GCM, 1999, GENE DEV, V13, P916, DOI 10.1101/gad.13.8.916; Takata M, 1998, EMBO J, V17, P5497, DOI 10.1093/emboj/17.18.5497; Tomoda K, 1999, NATURE, V398, P160, DOI 10.1038/18230; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; Tsvetkov LM, 1999, CURR BIOL, V9, P661, DOI 10.1016/S0960-9822(99)80290-5	23	33	33	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					41423	41427		10.1074/jbc.M206605200	http://dx.doi.org/10.1074/jbc.M206605200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12205088	hybrid			2022-12-27	WOS:000178985300018
J	Raghuraman, G; Lapinski, PE; Raghavan, M				Raghuraman, G; Lapinski, PE; Raghavan, M			Tapasin interacts with the membrane-spanning domains of both TAP subunits and enhances the structural stability of TAP1 center dot TAP2 complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MHC CLASS-I; ANTIGEN-PROCESSING TAP; PEPTIDE-BINDING; TRANSPORT COMPLEX; LOADING COMPLEX; INSECT CELLS; MOLECULES; TRANSLOCATION; EXPRESSION; SUBSTRATE	The transporter associated with antigen processing (TAP) proteins are involved in transport of peptides from the cytosol into the endoplasmic reticulum. Two subunits, TAP1 and TAP2, are necessary and sufficient for peptide binding and peptide translocation across the endoplasmic reticulum. membrane. TAP1. and TAP2 contain an N-terminal hydrophobic membrane-spanning region and a C-terminal nucleotide binding domain. Tapasin is an endoplasmic reticulum resident protein that has been found associated with the TAP subunits and shown to increase expression levels of TAP. Here we investigated TAP-tapasin interactions and their effects on TAP function in insect cells. We show tapasin binding to both TAP1 and TAP2 and to the corresponding nucleotide binding domain-exchanged chimeras as well as to a truncated TAP1.TAP2 complex containing just the membrane-spanning regions of TAP1 and TAP2. However, tapasin interactions with either the truncated TAP construct containing just the nucleotide binding domain are not observed. Tapasin is not required for high affinity peptide binding to TAP1.TAP2 complexes, and in fact, the presence of tapasin slightly reduces the affinity of TAP complexes for peptides. However, at near physiological temperatures, both tapasin and nucleotides stabilize the peptide binding site of TAP1-TAP2 complexes against inactivation, and enhanced thermostability of both TAP subunits is observed in the presence of tapasin. The enhanced structural stability of TAP1.TAP2 complexes in the presence of tapasin might explain the observations that tapasin increases TAP protein expression levels in mammalian cells.	Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Raghavan, M (corresponding author), Univ Michigan, Sch Med, Dept Microbiol & Immunol, 5641 Med Sci Bldg 2, Ann Arbor, MI 48109 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI044115, R01AI044115] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048310] Funding Source: NIH RePORTER; NIAID NIH HHS [AI44115-03, R01 AI044115] Funding Source: Medline; NIAMS NIH HHS [AR48310-02] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Abele R, 1999, BBA-BIOMEMBRANES, V1461, P405, DOI 10.1016/S0005-2736(99)00171-6; ANDROLEWICZ MJ, 1994, IMMUNITY, V1, P7, DOI 10.1016/1074-7613(94)90004-3; ANDROLEWICZ MJ, 1993, P NATL ACAD SCI USA, V90, P9130, DOI 10.1073/pnas.90.19.9130; Antoniou AN, 2002, IMMUNOLOGY, V106, P182, DOI 10.1046/j.1365-2567.2002.01415.x; Arora S, 2001, P NATL ACAD SCI USA, V98, P7241, DOI 10.1073/pnas.131132198; Bangia N, 1999, EUR J IMMUNOL, V29, P1858, DOI 10.1002/(SICI)1521-4141(199906)29:06<1858::AID-IMMU1858>3.0.CO;2-C; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Cresswell P, 1999, IMMUNOL REV, V172, P21, DOI 10.1111/j.1600-065X.1999.tb01353.x; Grandea AG, 2001, TRENDS IMMUNOL, V22, P194, DOI 10.1016/S1471-4906(01)01861-0; Grandea AG, 2000, IMMUNITY, V13, P213, DOI 10.1016/S1074-7613(00)00021-2; Lapinski PE, 2000, J BIOL CHEM, V275, P6831, DOI 10.1074/jbc.275.10.6831; Lapinski PE, 2001, J BIOL CHEM, V276, P7526, DOI 10.1074/jbc.M009448200; Lauvau G, 1999, J BIOL CHEM, V274, P31349, DOI 10.1074/jbc.274.44.31349; Lehner PJ, 1998, IMMUNITY, V8, P221, DOI 10.1016/S1074-7613(00)80474-4; Li SL, 1997, P NATL ACAD SCI USA, V94, P8708, DOI 10.1073/pnas.94.16.8708; Li SL, 2000, J BIOL CHEM, V275, P1581, DOI 10.1074/jbc.275.3.1581; MEYER TH, 1994, FEBS LETT, V351, P443, DOI 10.1016/0014-5793(94)00908-2; Momburg F, 2002, MOL IMMUNOL, V39, P217, DOI 10.1016/S0161-5890(02)00103-7; Momburg F, 1998, ADV IMMUNOL, V68, P191, DOI 10.1016/S0065-2776(08)60560-X; NEEFJES JJ, 1993, SCIENCE, V261, P769, DOI 10.1126/science.8342042; Neumann L, 1999, J MOL BIOL, V294, P1203, DOI 10.1006/jmbi.1999.3329; Ortmann B, 1997, SCIENCE, V277, P1306, DOI 10.1126/science.277.5330.1306; Pamer E, 1998, ANNU REV IMMUNOL, V16, P323, DOI 10.1146/annurev.immunol.16.1.323; Powis SJ, 1997, EUR J IMMUNOL, V27, P2744, DOI 10.1002/eji.1830271040; Sadasivan B, 1996, IMMUNITY, V5, P103, DOI 10.1016/S1074-7613(00)80487-2; Saveanu L, 2001, J BIOL CHEM, V276, P22107, DOI 10.1074/jbc.M011221200; Schoenhals GJ, 1999, EMBO J, V18, P743, DOI 10.1093/emboj/18.3.743; van Endert PM, 1999, J BIOL CHEM, V274, P14632, DOI 10.1074/jbc.274.21.14632; VANENDERT PM, 1994, IMMUNITY, V1, P491, DOI 10.1016/1074-7613(94)90091-4; Vos JC, 1999, J IMMUNOL, V163, P6679	30	46	46	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					41786	41794		10.1074/jbc.M207128200	http://dx.doi.org/10.1074/jbc.M207128200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12213826	hybrid			2022-12-27	WOS:000178985300063
J	Rosado, JA; Brownlow, SL; Sage, SO				Rosado, JA; Brownlow, SL; Sage, SO			Endogenously expressed Trp1 is involved in store-mediated Ca2+ entry by conformational coupling in human platelets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAPACITATIVE CALCIUM-ENTRY; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; FURA-2-LOADED HUMAN-PLATELETS; OPERATED HTRP3 CHANNELS; ACTIN CYTOSKELETON; HUMAN HOMOLOG; FUNCTIONAL EXPRESSION; IP3 RECEPTOR; MECHANISM; DEPLETION	Physical interaction between transient receptor potential (Trp) channels and inositol 1,4,5-trisphosphate receptors (IP(3)Rs) has been presented as a candidate mechanism for the activation of store-mediated Ca2+ entry. The role of a human homologue of Drosophila transient receptor potential channel, hTrp1, in the conduction of store-mediated Ca2+ entry was examined in human platelets. Incubation of platelets with a specific antibody, which recognizes the extracellular amino acid sequence 557-571 of hTrp1, inhibited both store depletion-induced Ca2+ and Mn2+ entry in a concentration-dependent manner. Stimulation of platelets with the physiological agonist thrombin activated coupling between the IP3 receptor type II and endogenously expressed hTrp1. This event was reversed by refilling of the internal Ca2+ stores but maintained after removal of the agonist if the stores were not allowed to refill. Inhibition of IP3 recycling using Li+ or inhibition of IP(3)Rs with xestospongin C or treatment with jasplakinolide, to stabilize the cortical actin filament network, abolished thrombin-induced coupling between hTrp1 and IP3R type II. Incubation with the anti-hTrp1 antibody inhibited thrombin-evoked Ca2+ entry without affecting Ca2+ release from intracellular stores. These results provide evidence for the involvement of hTrp1 in the activation of store-mediated Ca2+ entry by coupling to IP3R type II in normal human cells.	Univ Cambridge, Dept Physiol, Cambridge CB2 3EG, England	University of Cambridge	Sage, SO (corresponding author), Univ Cambridge, Dept Physiol, Downing St, Cambridge CB2 3EG, England.		Rosado, Juan A/H-3488-2015	Rosado, Juan A/0000-0002-9749-2325; Sage, Stewart/0000-0001-8578-3558				BERRIDGE MJ, 1995, BIOCHEM J, V312, P1, DOI 10.1042/bj3120001; Birnbaumer L, 2000, RECENT PROG HORM RES, V55, P127; Boulay G, 1999, P NATL ACAD SCI USA, V96, P14955, DOI 10.1073/pnas.96.26.14955; Boyum A, 1968, Scand J Clin Lab Invest Suppl, V97, P9; den Dekker E, 2001, BBA-MOL CELL RES, V1539, P243, DOI 10.1016/S0167-4889(01)00112-4; GRAF E, 1982, BIOCHEMISTRY-US, V21, P4511, DOI 10.1021/bi00261a049; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; IRVINE RF, 1990, FEBS LETT, V263, P5, DOI 10.1016/0014-5793(90)80692-C; KIMURA M, 1993, J PHYSIOL-LONDON, V464, P1; Kiselyov K, 1998, NATURE, V396, P478, DOI 10.1038/24890; Kiselyov K, 1999, MOL CELL, V4, P423, DOI 10.1016/S1097-2765(00)80344-5; Liu XB, 2000, J BIOL CHEM, V275, P3403, DOI 10.1074/jbc.275.5.3403; Lockwich TP, 2000, J BIOL CHEM, V275, P11934, DOI 10.1074/jbc.275.16.11934; Ma HT, 2000, SCIENCE, V287, P1647, DOI 10.1126/science.287.5458.1647; Mori Y, 2002, J EXP MED, V195, P673, DOI 10.1084/jem.20011758; Parekh AB, 1997, PHYSIOL REV, V77, P901, DOI 10.1152/physrev.1997.77.4.901; Patterson RL, 1999, CELL, V98, P487, DOI 10.1016/S0092-8674(00)81977-7; Putney JW, 1999, P NATL ACAD SCI USA, V96, P14669, DOI 10.1073/pnas.96.26.14669; PUTNEY JW, 1990, CELL CALCIUM, V11, P611, DOI 10.1016/0143-4160(90)90016-N; RINK TJ, 1990, ANNU REV PHYSIOL, V52, P431, DOI 10.1146/annurev.ph.52.030190.002243; RINK TJ, 1987, J PHYSIOL-LONDON, V393, P513, DOI 10.1113/jphysiol.1987.sp016837; Rosado JA, 2000, BIOCHEM J, V351, P429, DOI 10.1042/0264-6021:3510429; Rosado JA, 2000, J PHYSIOL-LONDON, V526, P221, DOI 10.1111/j.1469-7793.2000.t01-2-00221.x; Rosado JA, 2000, J BIOL CHEM, V275, P7527, DOI 10.1074/jbc.275.11.7527; Rosado JA, 2000, BIOCHEM J, V350, P631, DOI 10.1042/0264-6021:3500631; Rosado JA, 2001, BIOCHEM J, V356, P191, DOI 10.1042/0264-6021:3560191; Rosado JA, 2000, J PHYSIOL-LONDON, V529, P159, DOI 10.1111/j.1469-7793.2000.00159.x; SAGE SO, 1989, BIOCHEM J, V258, P923, DOI 10.1042/bj2580923; Sage SO, 1997, EXP PHYSIOL, V82, P807, DOI 10.1113/expphysiol.1997.sp004066; SARGEANT P, 1994, EXP PHYSIOL, V79, P269, DOI 10.1113/expphysiol.1994.sp003762; Sinkins WG, 1998, BIOCHEM J, V331, P331, DOI 10.1042/bj3310331; SWEENEY M, AM J PHYSL, V283, pL144; Wang WC, 1999, AM J PHYSIOL-CELL PH, V276, pC969, DOI 10.1152/ajpcell.1999.276.4.C969; WES PD, 1995, P NATL ACAD SCI USA, V92, P9652, DOI 10.1073/pnas.92.21.9652; Xu SZ, 2001, CIRC RES, V88, P84, DOI 10.1161/01.RES.88.1.84; ZHU X, 1995, FEBS LETT, V373, P193, DOI 10.1016/0014-5793(95)01038-G; Zhu X, 1996, CELL, V85, P661, DOI 10.1016/S0092-8674(00)81233-7; Zitt C, 1996, NEURON, V16, P1189, DOI 10.1016/S0896-6273(00)80145-2	38	127	132	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					42157	42163		10.1074/jbc.M207320200	http://dx.doi.org/10.1074/jbc.M207320200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12196544	hybrid			2022-12-27	WOS:000178985300108
J	Wong, GW; Foster, PS; Yasuda, S; Qi, JC; Mahalingam, S; Mellor, EA; Katsoulotos, G; Li, LX; Boyce, JA; Krilis, SA; Stevens, RL				Wong, GW; Foster, PS; Yasuda, S; Qi, JC; Mahalingam, S; Mellor, EA; Katsoulotos, G; Li, LX; Boyce, JA; Krilis, SA; Stevens, RL			Biochemical and functional characterization of human transmembrane tryptase (TMT)/tryptase gamma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAST-CELL TRYPTASE; RECEPTOR-ALPHA CHAIN; IL-13 MESSENGER-RNA; AIRWAYS HYPERREACTIVITY; INTERLEUKIN-13 RECEPTOR; COMPLEMENTARY-DNA; SERINE PROTEASES; BINDING SUBUNIT; ALLERGIC-ASTHMA; DEFICIENT MICE	Transmembrane tryptase (TMT)/tryptase gamma is a membrane-bound serine protease stored in the secretory granules of human and mouse lung mast cells (MCs). We now show that TMT reaches the external face of the plasma membrane when MCs are induced to degranulate. Analysis of purified recombinant TMT revealed that it is a two-chain neutral protease. Thus, TMT is the only MC protease identified so far which retains its 18-residue propeptide when proteolytically activated. The genes that encode TMT and tryptase 131 reside on human chromosome 16p13.3. However, substrate specificity studies revealed that TMT and tryptase 61 are functionally distinct even though they are similar to50% identical. Although TMT is rapidly inactivated by the human plasma serpin alpha(1)-antitrypsin in vitro, administration of recombinant TMT (but not recombinant tryptase PI) into the trachea of mice leads to airway hyperresponsiveness (AHR) and increased expression of interleukin (IL) 13. T cells also increase their expression of IL-13 mRNA when exposed to TMT in vitro. TMT is therefore a novel exocytosed surface mediator that can stimulate those cell types that are in close proximity. TMT induces AHR in normal mice but not in transgenic mice that lack signal transducer and activator of transcription (STAT) 6 or the alpha-chain of the cytokine receptor that recognizes both IL-4 and IL-13. Based on these data, we conclude that TMT is an exocytosed MC neutral protease that induces AHR in lungs primarily by activating an IL-13/IL-4Ralpha/STAT6-dependent pathway.	Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; St George Hosp, Dept Immunol Allergy & Infect Dis, Kogarah, NSW 2217, Australia; Univ New S Wales, Dept Med, Kogarah, NSW 2217, Australia; Australian Natl Univ, John Curtin Sch Med Res, Div Biochem & Mol Biol, Canberra, ACT 0200, Australia	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; St George Hospital; University of New South Wales Sydney; Australian National University; John Curtin School of Medical Research	Stevens, RL (corresponding author), Brigham & Womens Hosp, Dept Med, Smith Bldg,Rm 616B,1 Jimmy Fund Way, Boston, MA 02115 USA.	rstevens@rics.bwh.harvard.edu	Yasuda, Shinsuke/A-4369-2012; Foster, Paul/G-5057-2013	Wong, G. William/0000-0002-5286-6506	NHLBI NIH HHS [HL-36110, HL-63284] Funding Source: Medline; NIAID NIH HHS [AI-31599, AI-48802, AI-23483, AI-52353] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL036110, R01HL063284] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052353, U01AI031599, U19AI031599, R56AI052353, R01AI048802, R01AI023483] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aman MJ, 1996, J BIOL CHEM, V271, P29265, DOI 10.1074/jbc.271.46.29265; BURD PR, 1995, J EXP MED, V181, P1373, DOI 10.1084/jem.181.4.1373; Castells MC, 2001, NAT IMMUNOL, V2, P436, DOI 10.1038/87749; Caughey GH, 2000, J IMMUNOL, V164, P6566, DOI 10.4049/jimmunol.164.12.6566; Chan H, 1999, PROTEIN EXPRES PURIF, V15, P251, DOI 10.1006/prep.1998.1025; Daniels SE, 1996, NATURE, V383, P247, DOI 10.1038/383247a0; De Sanctis GT, 1999, AM J PHYSIOL-LUNG C, V277, pL1118, DOI 10.1152/ajplung.1999.277.6.L1118; DESANCTIS GT, 1995, NAT GENET, V11, P150, DOI 10.1038/ng1095-150; Echtenacher B, 1996, NATURE, V381, P75, DOI 10.1038/381075a0; Eriksson S, 1996, CHEST, V110, pS237, DOI 10.1378/chest.110.6_Supplement.237S; Fang KC, 1999, J IMMUNOL, V162, P5528; Fath MA, 1998, J BIOL CHEM, V273, P13563, DOI 10.1074/jbc.273.22.13563; Foster PS, 1996, J EXP MED, V183, P195, DOI 10.1084/jem.183.1.195; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; GURISH MF, 1994, MAMM GENOME, V5, P656, DOI 10.1007/BF00411467; GURISH MF, 1993, J BIOL CHEM, V268, P11372; Hamelmann E, 1997, AM J RESP CRIT CARE, V156, P766, DOI 10.1164/ajrccm.156.3.9606031; Hershey GKK, 1997, NEW ENGL J MED, V337, P1720, DOI 10.1056/NEJM199712113372403; Hilton DJ, 1996, P NATL ACAD SCI USA, V93, P497, DOI 10.1073/pnas.93.1.497; Hogan SP, 1998, J IMMUNOL, V161, P1501; Hooper JD, 1999, CANCER RES, V59, P3199; Huang CF, 1997, J BIOL CHEM, V272, P31885, DOI 10.1074/jbc.272.50.31885; Huang CF, 1998, J IMMUNOL, V160, P1910; Huang CF, 1999, J BIOL CHEM, V274, P19670, DOI 10.1074/jbc.274.28.19670; Huang CF, 2001, J BIOL CHEM, V276, P26276, DOI 10.1074/jbc.M102356200; Humbert M, 1997, J ALLERGY CLIN IMMUN, V99, P657, DOI 10.1016/S0091-6749(97)70028-9; Inoue M, 1999, BIOCHEM BIOPH RES CO, V266, P564, DOI 10.1006/bbrc.1999.1870; IRANI AA, 1986, P NATL ACAD SCI USA, V83, P4464, DOI 10.1073/pnas.83.12.4464; Jaffe JS, 1996, AM J RESP CELL MOL, V15, P473, DOI 10.1165/ajrcmb.15.4.8879181; Kotsimbos TC, 1996, P ASSOC AM PHYSICIAN, V108, P368; Kotsimbos TC, 1998, J ALLERGY CLIN IMMUN, V102, P859, DOI 10.1016/S0091-6749(98)70029-6; LAGUNOFF D, 1976, ARCH BIOCHEM BIOPHYS, V173, P554, DOI 10.1016/0003-9861(76)90292-7; Lee JH, 2001, AM J RESP CELL MOL, V25, P474, DOI 10.1165/ajrcmb.25.4.4522; LEVISCHAFFER F, 1987, J IMMUNOL, V139, P3431; Li HM, 1996, J IMMUNOL, V156, P4833; Li L, 1999, J IMMUNOL, V162, P2477; Li LX, 1998, J IMMUNOL, V161, P5079; LI LX, 1995, J BIOL CHEM, V270, P2258, DOI 10.1074/jbc.270.5.2258; Mahalingam S, 1999, J VIROL, V73, P1479, DOI 10.1128/JVI.73.2.1479-1491.1999; Mahalingam S, 2001, J BIOL CHEM, V276, P7568, DOI 10.1074/jbc.M005773200; Malaviya R, 1996, NATURE, V381, P77, DOI 10.1038/381077a0; MALAVIYA R, 1994, J IMMUNOL, V152, P1907; Marquardt U, 2002, J MOL BIOL, V321, P491, DOI 10.1016/S0022-2836(02)00625-3; Marsh DG, 1997, NAT GENET, V15, P389; MARTIN TR, 1993, J CLIN INVEST, V91, P1176, DOI 10.1172/JCI116277; Mattes J, 2001, J IMMUNOL, V167, P1683, DOI 10.4049/jimmunol.167.3.1683; MCKENZIE ANJ, 1993, P NATL ACAD SCI USA, V90, P3735, DOI 10.1073/pnas.90.8.3735; Mekori YA, 1999, J ALLERGY CLIN IMMUN, V104, P517, DOI 10.1016/S0091-6749(99)70316-7; MILLER JS, 1990, J CLIN INVEST, V86, P864, DOI 10.1172/JCI114786; MILLER JS, 1989, J CLIN INVEST, V84, P1188, DOI 10.1172/JCI114284; MINTY A, 1993, NATURE, V362, P248, DOI 10.1038/362248a0; Mitsuyasu H, 1998, NAT GENET, V19, P119, DOI 10.1038/472; Murata T, 1996, J IMMUNOL, V156, P2972; Naseer T, 1997, AM J RESP CRIT CARE, V155, P845, DOI 10.1164/ajrccm.155.3.9117015; NobenTrauth N, 1997, P NATL ACAD SCI USA, V94, P10838, DOI 10.1073/pnas.94.20.10838; Ochi H, 1999, J EXP MED, V190, P267, DOI 10.1084/jem.190.2.267; Pallaoro M, 1999, J BIOL CHEM, V274, P3355, DOI 10.1074/jbc.274.6.3355; Pereira PJB, 1998, NATURE, V392, P306, DOI 10.1038/32703; POSTMA DS, 1995, NEW ENGL J MED, V333, P894, DOI 10.1056/NEJM199510053331402; Prodeus AP, 1997, NATURE, V390, P172, DOI 10.1038/36586; REYNOLDS DS, 1990, P NATL ACAD SCI USA, V87, P3230, DOI 10.1073/pnas.87.8.3230; Schmid-Grendelmeier P, 2002, J IMMUNOL, V169, P1021, DOI 10.4049/jimmunol.169.2.1021; SCHWARTZ LB, 1987, J IMMUNOL, V138, P2611; Silverman GA, 2001, J BIOL CHEM, V276, P33293, DOI 10.1074/jbc.R100016200; Skokos D, 2001, J IMMUNOL, V166, P868, DOI 10.4049/jimmunol.166.2.868; Takeda K, 1996, NATURE, V380, P627, DOI 10.1038/380627a0; Tekkanat KK, 2001, J IMMUNOL, V166, P3542, DOI 10.4049/jimmunol.166.5.3542; Toru H, 1998, J ALLERGY CLIN IMMUN, V102, P491, DOI 10.1016/S0091-6749(98)70140-X; VANDERSLICE P, 1990, P NATL ACAD SCI USA, V87, P3811, DOI 10.1073/pnas.87.10.3811; Wang HW, 2000, FASEB J, V14, pA1239; Wang ZM, 1998, BIOL CHEM, V379, P167, DOI 10.1515/bchm.1998.379.2.167; Webb DC, 2000, J IMMUNOL, V165, P108, DOI 10.4049/jimmunol.165.1.108; WELHAM MJ, 1995, J BIOL CHEM, V270, P12286, DOI 10.1074/jbc.270.20.12286; Wills-Karp M, 2001, J ALLERGY CLIN IMMUN, V107, P9, DOI 10.1067/mai.2001.112265; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Wong GW, 2001, J BIOL CHEM, V276, P49169, DOI 10.1074/jbc.M108677200; Wong GW, 2001, J BIOL CHEM, V276, P20648, DOI 10.1074/jbc.M010422200; Wong UW, 1999, J BIOL CHEM, V274, P30784, DOI 10.1074/jbc.274.43.30784; Yang M, 2001, AM J RESP CELL MOL, V25, P522, DOI 10.1165/ajrcmb.25.4.4620; Zheng T, 2000, J CLIN INVEST, V106, P1081, DOI 10.1172/JCI10458; Zhou Z, 1999, J CLIN INVEST, V103, P779, DOI 10.1172/JCI5909; ZURAWSKI SM, 1995, J BIOL CHEM, V270, P13869, DOI 10.1074/jbc.270.23.13869	82	61	61	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					41906	41915		10.1074/jbc.M205868200	http://dx.doi.org/10.1074/jbc.M205868200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12194977	hybrid			2022-12-27	WOS:000178985300078
J	Gallina, A; Hanley, TM; Mandel, R; Trahey, M; Broder, CC; Viglianti, GA; Ryser, HJP				Gallina, A; Hanley, TM; Mandel, R; Trahey, M; Broder, CC; Viglianti, GA; Ryser, HJP			Inhibitors of protein-disulfide isomerase prevent cleavage of disulfide bonds in receptor-bound glycoprotein 120 and prevent HIV-1 entry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS TYPE-1 ENVELOPE; GLYCOSYLATION SITES; SECRETORY PROTEINS; ESCHERICHIA-COLI; CELL-LINE; SURFACE; BINDING; GP120; FUSION; MEMBRANE	We previously reported that monoclonal antibodies to protein-disulfide isomerase (PDI) and other membrane-impermeant PDI inhibitors prevented HIV-1 infection. PDI is present at the surface of HIV-1 target cells and reduces disulfide bonds in a model peptide attached to the cell membrane. Here we show that soluble PDI cleaves disulfide bonds in recombinant envelope glycoprotein gp120 and that gp120 bound to the surface receptor CD4 undergoes a disulfide reduction that is prevented by PDI inhibitors. Concentrations of inhibitors that prevent this reduction and inhibit the cleavage of surface-bound disulfide conjugate prevent infection at the level of HIV-1 entry. The entry of HIV-1 strains differing in their coreceptor specificities is similarly inhibited, and so is the reduction of gp120 bound to CD4 of coreceptor-negative cells. PDI inhibitors also prevent HIV envelope-mediated cell-cell fusion but have no effect on the entry of HIV-1 pseudo-typed with murine leukemia virus envelope. Importantly, PDI coprecipitates with both soluble and cellular CD4. We propose that a PDI-CD4 association at the cell surface enables PDI to reach CD4-bound virus and to reduce disulfide bonds present in the domain of gp120 that binds to CD4. Conformational changes resulting from the opening of gp120-disulfide loops may drive the processes of virus-cell and cell-cell fusion. The biochemical events described identify new potential targets for anti-HIV agents.	Boston Univ, Sch Med, Dept Pathol, Boston, MA 02118 USA; Univ Montana, Montana Biotechnol Ctr, Missoula, MT 59812 USA; Uniformed Serv Univ Hlth Sci, Dept Microbiol & Immunol, Bethesda, MD 20814 USA	Boston University; University of Montana System; University of Montana; Uniformed Services University of the Health Sciences - USA	Ryser, HJP (corresponding author), Boston Univ, Sch Med, Dept Pathol, Boston, MA 02118 USA.		Hanley, Timothy/AAG-7547-2020; Broder, Christopher/E-1169-2013	Viglianti, Gregory/0000-0002-0244-8293; Hanley, Timothy/0000-0002-6253-6850	NATIONAL CANCER INSTITUTE [R01CA014551] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL057882] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043885, R21AI043885, R21AI044312, R01AI041758, R01AI044669] Funding Source: NIH RePORTER; NCI NIH HHS [CA14551] Funding Source: Medline; NHLBI NIH HHS [HLB57882] Funding Source: Medline; NIAID NIH HHS [AI44669, AI41758, AI44312, AI43885] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Barbeau B, 1998, J VIROL, V72, P7125, DOI 10.1128/JVI.72.9.7125-7136.1998; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chan DC, 1998, CELL, V93, P681, DOI 10.1016/S0092-8674(00)81430-0; CHENG SY, 1986, P NATL ACAD SCI USA, V83, P947, DOI 10.1073/pnas.83.4.947; CIMINALE V, 1990, AIDS RES HUM RETROV, V6, P1281, DOI 10.1089/aid.1990.6.1281; CLAVEL F, 1994, J VIROL, V68, P1179, DOI 10.1128/JVI.68.2.1179-1185.1994; CLEMENTS GJ, 1991, AIDS RES HUM RETROV, V7, P3, DOI 10.1089/aid.1991.7.3; Couet J, 1996, BIOCHEMISTRY-US, V35, P14800, DOI 10.1021/bi961359w; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Donoghue N, 2000, PROTEIN SCI, V9, P2436, DOI 10.1110/ps.9.12.2436; Donzella GA, 1998, NAT MED, V4, P72, DOI 10.1038/nm0198-072; Dumonceaux J, 1998, J VIROL, V72, P512, DOI 10.1128/JVI.72.1.512-519.1998; EARL PL, 1994, J VIROL, V68, P3015, DOI 10.1128/JVI.68.5.3015-3026.1994; EDMAN JC, 1985, NATURE, V317, P267, DOI 10.1038/317267a0; FEENER EP, 1990, J BIOL CHEM, V265, P18780; Fenouillet E, 2001, J INFECT DIS, V183, P744, DOI 10.1086/318823; Frand AR, 2000, TRENDS CELL BIOL, V10, P203, DOI 10.1016/S0962-8924(00)01745-1; FREEDMAN RB, 1988, BIOCHEM SOC T, V16, P96, DOI 10.1042/bst0160096; FREEDMAN RB, 1989, CELL, V57, P1069, DOI 10.1016/0092-8674(89)90043-3; Guthapfel R, 1996, EUR J BIOCHEM, V242, P315, DOI 10.1111/j.1432-1033.1996.0315r.x; HARRIS RJ, 1990, EUR J BIOCHEM, V188, P291, DOI 10.1111/j.1432-1033.1990.tb15402.x; HAWLEY RG, 1994, GENE THER, V1, P136; Hoffman TL, 1999, P NATL ACAD SCI USA, V96, P6359, DOI 10.1073/pnas.96.11.6359; Hotchkiss KA, 1998, BBA-PROTEIN STRUCT M, V1388, P478, DOI 10.1016/S0167-4838(98)00211-8; JENG MF, 1995, BIOCHEMISTRY-US, V34, P10101, DOI 10.1021/bi00032a001; Jiang XM, 1999, J BIOL CHEM, V274, P2416, DOI 10.1074/jbc.274.4.2416; KAETZEL CS, 1987, BIOCHEM J, V241, P39, DOI 10.1042/bj2410039; KALEF E, 1994, METHOD ENZYMOL, V233, P395; KIM JS, 1993, PROTEIN SCI, V2, P348; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; LEONARD CK, 1990, J BIOL CHEM, V265, P10373; MADDON PJ, 1985, CELL, V42, P93, DOI 10.1016/S0092-8674(85)80105-7; Maerz AL, 2001, J VIROL, V75, P6635, DOI 10.1128/JVI.75.14.6635-6644.2001; MANDEL R, 1993, P NATL ACAD SCI USA, V90, P4112, DOI 10.1073/pnas.90.9.4112; Matthias LJ, 2002, NAT IMMUNOL, V3, P727, DOI 10.1038/ni815; PAGE KA, 1990, J VIROL, V64, P5270, DOI 10.1128/JVI.64.11.5270-5276.1990; Ramachandran N, 2001, P NATL ACAD SCI USA, V98, P9539, DOI 10.1073/pnas.171180998; RIVERA A, 1997, THESIS BOSTON U BOST; Rizzuto CD, 1998, SCIENCE, V280, P1949, DOI 10.1126/science.280.5371.1949; RYSER HJP, 1994, P NATL ACAD SCI USA, V91, P4559, DOI 10.1073/pnas.91.10.4559; RYSER HJP, 1999, PLASMA MEMBRANE REDA, P229; RYSER HJP, 1997, PROLYL HYDROXYLASE P, P425; Salzwedel K, 2000, J VIROL, V74, P326, DOI 10.1128/JVI.74.1.326-333.2000; SATTENTAU QJ, 1993, J VIROL, V67, P7383, DOI 10.1128/JVI.67.12.7383-7393.1993; STEVENSON KJ, 1978, BIOCHEMISTRY-US, V17, P2189, DOI 10.1021/bi00604a026; Tager M, 1997, EXP HEMATOL, V25, P601; TERADA K, 1995, J BIOL CHEM, V270, P20410, DOI 10.1074/jbc.270.35.20410; THALI M, 1993, J VIROL, V67, P3978, DOI 10.1128/JVI.67.7.3978-3988.1993; TSCHACHLER E, 1990, J VIROL, V64, P2250, DOI 10.1128/JVI.64.5.2250-2259.1990; Ugolini S, 1997, J EXP MED, V186, P1287, DOI 10.1084/jem.186.8.1287; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Wu LJ, 1996, NATURE, V384, P179, DOI 10.1038/384179a0; YOSHIMORI T, 1990, J BIOL CHEM, V265, P15984; Zai A, 1999, J CLIN INVEST, V103, P393, DOI 10.1172/JCI4890	55	162	170	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 27	2002	277	52					50579	50588		10.1074/jbc.M204547200	http://dx.doi.org/10.1074/jbc.M204547200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	631QD	12218051	hybrid			2022-12-27	WOS:000180177700052
J	McLean, BW; Boraston, AB; Brouwer, D; Sanaie, N; Fyfe, CA; Warren, RAJ; Kilburn, DG; Haynes, CA				McLean, BW; Boraston, AB; Brouwer, D; Sanaie, N; Fyfe, CA; Warren, RAJ; Kilburn, DG; Haynes, CA			Carbohydrate-binding modules recognize fine substructures of cellulose	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRYPTOPHAN RESIDUES; FIMI CENC; CRYSTALLINE CELLULOSE; BACTERIAL CELLULASE; NMR-SPECTROSCOPY; XYLANASE 10A; PROTEIN-A; DOMAIN; SPECIFICITY; EXOGLUCANASE	Competition isotherms are used to identify the set of cellulose substructures to which cellulose binding modules (CBMs) from families 2a, 3, 4, 9, and 17 bind. The experiments are based on coupling a unique fluorescent tag to each CBM in a manner that does not alter the natural binding properties of the CBM and therefore allows the surface and solution concentrations of each CBM to be monitored as a function of time and composition. Adsorption and surface exchange of like or competing CBMs are monitored using a range of cellulose preparations varying in both crystallinity and provenance. CBMs from families 2a, 3,4,9, and 17 are shown to recognize different physical forms of prepared cellulose. The demonstration of the very fine binding specificity of cellulose-specific CBMs implies that the polysaccharide targets of CBMs extend down to the resolution of cellulose microstructures.	PENCE Inc, Natl Business Ctr, Prot Engn Network Ctr Excellence, Edmonton, AB T6G 2S2, Canada; Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z4, Canada; Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z4, Canada; Univ British Columbia, Biotechnol Lab, Vancouver, BC V6T 1Z4, Canada; Univ British Columbia, Dept Biol & Chem Engn, Vancouver, BC V6T 1Z4, Canada	University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia	Haynes, CA (corresponding author), Univ British Columbia, Biotechnol Lab, 237-6174 Univ Blvd, Vancouver, BC V6T 1Z3, Canada.	israels@chml.ubc.ca		Boraston, Alisdair/0000-0001-6417-0592				Abou Hachem M, 2000, BIOCHEM J, V345, P53, DOI 10.1042/0264-6021:3450053; Atalla RH, 1999, SOLID STATE NUCL MAG, V15, P1, DOI 10.1016/S0926-2040(99)00042-9; ATALLA RH, 1999, COMPREHENSIVE NATURA, V3, P529; Boraston AB, 2001, BIOCHEMISTRY-US, V40, P6240, DOI 10.1021/bi0101695; Boraston AB, 2000, BIOCHEMISTRY-US, V39, P11129, DOI 10.1021/bi0007728; Boraston AB, 1999, ROY SOC CH, P202; Bray MR, 1996, PROTEIN SCI, V5, P2311, DOI 10.1002/pro.5560051117; Carrard G, 2000, P NATL ACAD SCI USA, V97, P10342, DOI 10.1073/pnas.160216697; Creagh AL, 1996, P NATL ACAD SCI USA, V93, P12229, DOI 10.1073/pnas.93.22.12229; DIN N, 1991, BIO-TECHNOL, V9, P1096, DOI 10.1038/nbt1191-1096; DIN N, 1994, MOL MICROBIOL, V11, P747, DOI 10.1111/j.1365-2958.1994.tb00352.x; GILKES NR, 1992, J BIOL CHEM, V267, P6743; GOLDSTEIN MA, 1993, J BACTERIOL, V175, P5762, DOI 10.1128/JB.175.18.5762-5768.1993; GOLDSTEIN MA, 1994, J BACTERIOL, V176, P7328, DOI 10.1128/JB.176.23.7328-7334.1994; HAYNES CA, 1994, COLLOID SURFACE B, V2, P517, DOI 10.1016/0927-7765(94)80066-9; Hestrin S., 1963, METHODS CARBOHYDRATE, V3, P4; Jervis EJ, 1997, J BIOL CHEM, V272, P24016, DOI 10.1074/jbc.272.38.24016; Johnson PE, 1996, BIOCHEMISTRY-US, V35, P14381, DOI 10.1021/bi961612s; Johnson PE, 1996, BIOCHEMISTRY-US, V35, P13895, DOI 10.1021/bi961186a; KNOWLES J, 1987, TRENDS BIOTECHNOL, V5, P255, DOI 10.1016/0167-7799(87)90102-8; KULSHRESHTHA AK, 1973, J POLYM SCI POL PHYS, V11, P487, DOI 10.1002/pol.1973.180110307; Linder M, 1997, J BIOTECHNOL, V57, P15, DOI 10.1016/S0168-1656(97)00087-4; McLean BW, 2000, PROTEIN ENG, V13, P801, DOI 10.1093/protein/13.11.801; MILLWARDSADLER SJ, 1994, MOL MICROBIOL, V11, P375, DOI 10.1111/j.1365-2958.1994.tb00317.x; Mundy JN., 1983, SOLID STATE NUCL MET; Notenboom V, 2001, J MOL BIOL, V314, P797, DOI 10.1006/jmbi.2001.5153; Notenboom V, 2001, BIOCHEMISTRY-US, V40, P6248, DOI 10.1021/bi0101704; ONG E, 1993, BIOTECHNOL BIOENG, V42, P401, DOI 10.1002/bit.260420402; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; POOLE DM, 1993, FEMS MICROBIOL LETT, V106, P77, DOI 10.1016/0378-1097(93)90059-B; Simpson PJ, 1999, STRUCTURE, V7, P853, DOI 10.1016/S0969-2126(99)80108-7; Tomme P, 1996, J BACTERIOL, V178, P4216, DOI 10.1128/jb.178.14.4216-4223.1996; Tomme P, 1996, BIOCHEMISTRY-US, V35, P13885, DOI 10.1021/bi961185i; Tormo J, 1996, EMBO J, V15, P5739, DOI 10.1002/j.1460-2075.1996.tb00960.x; WOOD TM, 1988, METHOD ENZYMOL, V160, P19; XU GY, 1995, BIOCHEMISTRY-US, V34, P6993, DOI 10.1021/bi00021a011	36	76	76	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2002	277	52					50245	50254		10.1074/jbc.M204433200	http://dx.doi.org/10.1074/jbc.M204433200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	631QD	12191997	hybrid			2022-12-27	WOS:000180177700007
J	Gao, N; Jiang, BH; Leonard, SS; Corum, L; Zhang, Z; Roberts, JR; Antonini, J; Zheng, JZ; Flynn, DC; Castranova, V; Shi, XL				Gao, N; Jiang, BH; Leonard, SS; Corum, L; Zhang, Z; Roberts, JR; Antonini, J; Zheng, JZ; Flynn, DC; Castranova, V; Shi, XL			p38 signaling-mediated hypoxia-inducible factor 1 alpha and vascular endothelial growth factor induction by Cr(VI) in DU145 human prostate carcinoma cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CR(VI)-INDUCED P53 ACTIVATION; UBIQUITIN-PROTEASOME PATHWAY; HYDROXYL RADICAL FORMATION; FACTOR GENE-EXPRESSION; FACTOR-KAPPA-B; TUMOR ANGIOGENESIS; NUCLEAR FACTOR; SOLID TUMORS; TRANSCRIPTION; INHIBITION	Chromium(VI) (Cr(VI)) is widely used in industry and is a potent inducer of tumors in animals. The present study demonstrates that Cr(VI) induces hypoxia-inducible factor 1 (HIF-1) activity through the specific expression of HIF-1alpha but not HIF-1beta subunit and increases the level of vascular endothelial growth factor (VEGF) expression in DU145 human prostate carcinoma cells. To dissect the signaling pathways involved in Cr(VI)-induced HIF-1 expression, we found that p38 mitogen-activated protein kinase signaling was required for HIF-1alpha expression induced by Cr(VI). Neither phosphatidylinositol 3-kinase nor extracellular signal-regulated kinase activity was required for Cr(VI)-induced HIF-1 expression. Cr(VI) induced expression of HIF-1 and VEGF through the production of reactive oxygen species in DU145 cells. The major species of reactive oxygen species responsible for the induction of HIF-1 and VEGF expression is H2O2. These results suggest that the expression of HIF-1 and VEGF induced by Cr(VI) may be an important signaling pathway in the Cr(VI)induced carcinogenesis.	W Virginia Univ, Dept Microbiol Immunol & Cell Biol, Dept Microbiol, Mary Babb Randolph Canc Ctr, Morgantown, WV 26506 USA; NIOSH, Hlth Effects Lab Div, Morgantown, WV 26505 USA	West Virginia University; Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH)	Shi, XL (corresponding author), W Virginia Univ, Dept Microbiol Immunol & Cell Biol, Dept Microbiol, Mary Babb Randolph Canc Ctr, Morgantown, WV 26506 USA.		Shi, Xianglin/B-8588-2012; Zhang, Zhuo/B-8601-2012	Jiang, Bing-Hua/0000-0003-4526-2031	NATIONAL CANCER INSTITUTE [R29CA060731, R01CA060731] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016440] Funding Source: NIH RePORTER; NCI NIH HHS [CA60731] Funding Source: Medline; NCRR NIH HHS [RR16440] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		An WG, 1998, NATURE, V392, P405, DOI 10.1038/32925; Angelov L, 1999, CANCER RES, V59, P5536; Arbiser JL, 1997, P NATL ACAD SCI USA, V94, P861, DOI 10.1073/pnas.94.3.861; Blagosklonny MV, 2001, ONCOGENE, V20, P395, DOI 10.1038/sj.onc.1204055; Borgstrom P, 1996, CANCER RES, V56, P4032; BRITIGAN BE, 1986, J BIOL CHEM, V261, P7026; Bunn HF, 1996, PHYSIOL REV, V76, P839, DOI 10.1152/physrev.1996.76.3.839; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200; Chandel NS, 1998, P NATL ACAD SCI USA, V95, P11715, DOI 10.1073/pnas.95.20.11715; Chen RF, 2000, RARE METALS, V19, P231; Cheng SY, 1996, P NATL ACAD SCI USA, V93, P8502, DOI 10.1073/pnas.93.16.8502; Ding M, 2001, J BIOL CHEM, V276, P9108, DOI 10.1074/jbc.M007666200; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Folkman J, 1995, NEW ENGL J MED, V333, P1757, DOI 10.1056/NEJM199512283332608; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Gao N, 2002, J BIOL CHEM, V277, P31963, DOI 10.1074/jbc.M200082200; Halterman MW, 1999, J NEUROSCI, V19, P6818, DOI 10.1523/JNEUROSCI.19-16-06818.1999; HOFFMAN EC, 1991, SCIENCE, V252, P954, DOI 10.1126/science.1852076; Huang CS, 2001, J BIOL CHEM, V276, P22397, DOI 10.1074/jbc.M010828200; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jiang BH, 2001, CELL GROWTH DIFFER, V12, P363; Jiang BH, 1997, CANCER RES, V57, P5328; Jiang BH, 1996, J BIOL CHEM, V271, P17771, DOI 10.1074/jbc.271.30.17771; Jiang BH, 1996, AM J PHYSIOL-CELL PH, V271, pC1172, DOI 10.1152/ajpcell.1996.271.4.C1172; Kallio PJ, 1999, J BIOL CHEM, V274, P6519, DOI 10.1074/jbc.274.10.6519; KIM KJ, 1993, NATURE, V362, P841, DOI 10.1038/362841a0; Konishi T, 2000, INT J ONCOL, V16, P501; LIU YX, 1995, CIRC RES, V77, P638, DOI 10.1161/01.RES.77.3.638; Maxwell PH, 1997, P NATL ACAD SCI USA, V94, P8104, DOI 10.1073/pnas.94.15.8104; Mazure NM, 1997, BLOOD, V90, P3322, DOI 10.1182/blood.V90.9.3322; Pavco PA, 2000, CLIN CANCER RES, V6, P2094; Presta LG, 1997, CANCER RES, V57, P4593; Ravi R, 2000, GENE DEV, V14, P34; Rojas E, 1999, MUTAT RES-GEN TOX EN, V443, P157, DOI 10.1016/S1383-5742(99)00018-6; Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005; Salceda S, 1997, J BIOL CHEM, V272, P22642, DOI 10.1074/jbc.272.36.22642; Saleh M, 1996, CANCER RES, V56, P393; Salnikow K, 2000, CANCER RES, V60, P3375; Semenza GL, 2000, CRIT REV BIOCHEM MOL, V35, P71, DOI 10.1080/10409230091169186; SHI XL, 1994, ENVIRON HEALTH PERSP, V102, P231, DOI 10.2307/3431792; Shi XL, 1999, MOL CELL BIOCHEM, V194, P63, DOI 10.1023/A:1006904904514; SHI XL, 1989, BIOCHEM BIOPH RES CO, V163, P627, DOI 10.1016/0006-291X(89)92183-9; SHI XL, 1990, ARCH BIOCHEM BIOPHYS, V281, P90, DOI 10.1016/0003-9861(90)90417-W; SHI XL, 1992, ARCH BIOCHEM BIOPHYS, V292, P323, DOI 10.1016/0003-9861(92)90085-B; Shi XL, 1999, J INORG BIOCHEM, V75, P37, DOI 10.1016/S0162-0134(99)00030-6; SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0; SHWEIKI D, 1995, P NATL ACAD SCI USA, V92, P768, DOI 10.1073/pnas.92.3.768; Vallyathan Val, 1997, Environmental Health Perspectives, V105, P165, DOI 10.2307/3433405; Volpert OV, 1997, ONCOGENE, V14, P1495, DOI 10.1038/sj.onc.1200977; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wang SW, 2001, CARCINOGENESIS, V22, P757, DOI 10.1093/carcin/22.5.757; Wang SW, 2000, AM J PHYSIOL-CELL PH, V279, pC868, DOI 10.1152/ajpcell.2000.279.3.C868; WARREN RS, 1995, J CLIN INVEST, V95, P1789, DOI 10.1172/JCI117857; Ye JP, 1999, J BIOL CHEM, V274, P34974, DOI 10.1074/jbc.274.49.34974; YE JP, 1995, CARCINOGENESIS, V16, P2401, DOI 10.1093/carcin/16.10.2401; Zhong H, 1999, CANCER RES, V59, P5830; Zhong H, 2000, CANCER RES, V60, P1541	60	102	112	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 22	2002	277	47					45041	45048		10.1074/jbc.M202775200	http://dx.doi.org/10.1074/jbc.M202775200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	618EE	12213806	hybrid			2022-12-27	WOS:000179404800059
J	Gueydan, C; Wauquier, C; De Mees, C; Huez, G; Kruys, W				Gueydan, C; Wauquier, C; De Mees, C; Huez, G; Kruys, W			Identification of ribosomal proteins specific to higher eukaryotic organisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AU-RICH ELEMENT; ANGSTROM-RESOLUTION; SUBUNIT; RNA; BINDING; PURIFICATION; SEQUENCES; EXPRESSION; GENES	This report describes the identification of a novel protein named PS1D (Genbank(TM) accession number AJ272345), which is composed of an S1-like RNA-binding domain, a (cysteine)x3-(histidine) CCCH-zinc finger, and a very basic carboxyl domain. PS1D is expressed as two isoforms, probably resulting from the alternative splicing of mRNA. The long PS1D isoform differs from the short one by the presence of 48 additional amino acids at its amino-terminal extremity. Analysis of PS1D subcellular distribution by cell fractionation reveals that this protein belongs to the core of the eukaryotic 60S ribosomal subunit. Interestingly, PS1D protein is a highly conserved protein among mammalians as murine, human, and simian PS1D homologues share more than 95% identity. In contrast, no homologous protein is found in lower eukaryotes such as yeast and Caenorhabditis elegans. These observations indicate that PS1D is the first eukaryotic ribosomal protein that is specific to higher eukaryotes.	Free Univ Brussels, Inst Biol & Med Mol, Chim Biol Lab, B-6041 Gosselies, Belgium; Free Univ Brussels, Inst Biol & Med Mol, Lab Biol Dev, B-6041 Gosselies, Belgium		Gueydan, C (corresponding author), Free Univ Brussels, Inst Biol & Med Mol, Chim Biol Lab, 12 Rue Profs Jeener & Brachet, B-6041 Gosselies, Belgium.		Kruys, Veronique I/N-6613-2018	Kruys, Veronique/0000-0002-3144-5403; Gueydan, Cyril/0000-0003-3097-7667				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Arnold RJ, 1999, J BIOL CHEM, V274, P37035, DOI 10.1074/jbc.274.52.37035; Ban N, 1999, NATURE, V400, P841, DOI 10.1038/23641; Bottger EC, 2001, EMBO REP, V2, P318, DOI 10.1093/embo-reports/kve062; Bycroft M, 1997, CELL, V88, P235, DOI 10.1016/S0092-8674(00)81844-9; CELIS JE, 1994, CELL BIOL LAB HDB, P657; Christophe-Hobertus C, 1999, EUR J BIOCHEM, V265, P491, DOI 10.1046/j.1432-1327.1999.00796.x; DINGWALL C, 1991, TRENDS BIOCHEM SCI, V16, P478, DOI 10.1016/0968-0004(91)90184-W; FISHER EMC, 1990, CELL, V63, P1205, DOI 10.1016/0092-8674(90)90416-C; Gueydan C, 1999, J BIOL CHEM, V274, P2322, DOI 10.1074/jbc.274.4.2322; HASSOUNA N, 1984, NUCLEIC ACIDS RES, V12, P3563, DOI 10.1093/nar/12.8.3563; Lafontaine DLJ, 2001, NAT REV MOL CELL BIO, V2, P514, DOI 10.1038/35080045; Mager WH, 1997, NUCLEIC ACIDS RES, V25, P4872, DOI 10.1093/nar/25.24.4872; Mewes HW, 2000, NUCLEIC ACIDS RES, V28, P37, DOI 10.1093/nar/28.1.37; Nadano D, 2000, JPN J CANCER RES, V91, P802, DOI 10.1111/j.1349-7006.2000.tb01017.x; Olson MOJ, 2000, TRENDS CELL BIOL, V10, P189, DOI 10.1016/S0962-8924(00)01738-4; Schluenzen F, 2000, CELL, V102, P615, DOI 10.1016/S0092-8674(00)00084-2; SHERTON CC, 1972, J BIOL CHEM, V247, P4460; Siomi MC, 1996, MOL CELL BIOL, V16, P3825; SUBRAMANIAN AR, 1983, PROG NUCLEIC ACID RE, V28, P101, DOI 10.1016/S0079-6603(08)60085-9; TSURUGI K, 1977, J BIOL CHEM, V252, P3961; TSURUGI K, 1976, J BIOL CHEM, V251, P7940; Williamson NA, 1997, EUR J BIOCHEM, V246, P786, DOI 10.1111/j.1432-1033.1997.00786.x; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Wool IG, 1995, BIOCHEM CELL BIOL, V73, P933, DOI 10.1139/o95-101; XU L, 1994, NUCLEIC ACIDS RES, V22, P646, DOI 10.1093/nar/22.4.646; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; ZHANG W, 1993, MOL CELL BIOL, V13, P7652, DOI 10.1128/MCB.13.12.7652; ZINN AR, 1994, MOL CELL BIOL, V14, P2485, DOI 10.1128/MCB.14.4.2485	30	9	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 22	2002	277	47					45034	45040		10.1074/jbc.M208551200	http://dx.doi.org/10.1074/jbc.M208551200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	618EE	12202495	hybrid			2022-12-27	WOS:000179404800058
J	Howe, AG; Zaremberg, V; McMaster, CR				Howe, AG; Zaremberg, V; McMaster, CR			Cessation of growth to prevent cell death due to inhibition of phosphatidylcholine synthesis is impaired at 37 degrees C in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CTP-PHOSPHOCHOLINE CYTIDYLYLTRANSFERASE; CDP-CHOLINE PATHWAY; ENCODING CHOLINEPHOSPHATE CYTIDYLYLTRANSFERASE; PHOSPHOLIPID TRANSFER PROTEIN; YEAST GOLGI-COMPLEX; ESCHERICHIA-COLI; CKI GENE; BIOSYNTHESIS; EXPRESSION; CLONING	Phosphatidylcholine is the most abundant phospholipid in eukaryotic cells, comprising 50% of total cellular phospholipid, and thus plays a major role in cellular and organellar biogenesis. In this study, we have used both nutritional deprivation as well as a conditional temperature sensitive allele of PCT1 (CTP:phosphocholine cytidylyltransferase) coupled with an inactivated phosphatidylethanolamine methylation pathway to determine how cells respond to inactivation of phosphatidylcholine synthesis. Metabolic studies determined that phosphatidylcholine biosynthesis decreased to negligible levels within 1 h upon shift to the nonpermissive temperature for the temperature-sensitive PCT1 allele. Phosphatidylcholine mass decreased to negligible levels upon removal of choline from the medium or growth at the nonpermissive temperature, with the levels of the other major phospholipids increasing slightly. Cell growth rate visibly slowed upon cessation of phosphatidylcholine synthesis. Cells remained viable for 7-8 h after phosphatidylcholine synthesis was prevented; however, at time points beyond 8 h, viability was significantly reduced but only if the cells had been previously grown at 37 degreesC and not 25 degreesC. The inhibition of phosphatidylcholine synthesis at 37 degreesC did not alter Golgi-derived vesicle transport to the vacuole as monitored by carboxypeptidase Y processing or to the plasma membrane as determined by invertase secretion. Immunofluorescence microscopy localized Pct1p to the nucleus and nuclear membrane. Pct1p activity is regulated by Sec14p, a cytoplasm/Golgi localized phosphatidylcholine/phosphatidylinositol binding protein that regulates Golgi-derived vesicle transport partially through its ligand-dependent regulation of PCT1 derived enzyme activity. Our nuclear localization of Pct1p indicates that the regulation of Pct1p by Sec14p is indirect.	Dalhousie Univ, Atlantic Res Ctr, IWK Hlth Ctr, Dept Pediat, Halifax, NS B3H 4H7, Canada; Dalhousie Univ, Atlantic Res Ctr, IWK Hlth Ctr, Dept Biochem, Halifax, NS B3H 4H7, Canada; Dalhousie Univ, Atlantic Res Ctr, IWK Hlth Ctr, Dept Mol Biol, Halifax, NS B3H 4H7, Canada	Dalhousie University; Dalhousie University; Dalhousie University	McMaster, CR (corresponding author), Dalhousie Univ, Atlantic Res Ctr, IWK Hlth Ctr, Dept Pediat, Halifax, NS B3H 4H7, Canada.			McMaster, Christopher/0000-0003-0822-5776				AMES BN, 1960, J BIOL CHEM, V235, P769; Attard GS, 2000, P NATL ACAD SCI USA, V97, P9032, DOI 10.1073/pnas.160260697; BANKAITIS VA, 1990, NATURE, V347, P561, DOI 10.1038/347561a0; CHRISTIANSON TW, 1992, GENE, V110, P112; CLEVES AE, 1989, J CELL BIOL, V109, P2939, DOI 10.1083/jcb.109.6.2939; CLEVES AE, 1991, CELL, V64, P789, DOI 10.1016/0092-8674(91)90508-V; Cornell RB, 2000, TRENDS BIOCHEM SCI, V25, P441, DOI 10.1016/S0968-0004(00)01625-X; CUI Z, 1993, J BIOL CHEM, V268, P16655; Dowd SR, 2001, J BIOL CHEM, V276, P3756, DOI 10.1074/jbc.M003694200; Goldstein A, 1975, Methods Enzymol, V42, P504; Griac P, 1996, J BIOL CHEM, V271, P25692, DOI 10.1074/jbc.271.41.25692; Henneberry AL, 2001, MOL BIOL CELL, V12, P511, DOI 10.1091/mbc.12.3.511; HJELMSTAD RH, 1991, J BIOL CHEM, V266, P4357; HOSAKA K, 1989, J BIOL CHEM, V264, P2053; Howe AG, 2001, BBA-MOL CELL BIOL L, V1534, P65, DOI 10.1016/S1388-1981(01)00181-0; JOHNSON JE, 1992, BIOCHEM J, V285, P815, DOI 10.1042/bj2850815; Kaiser C., 1994, METHODS YEAST GENETI; Kearns BG, 1997, NATURE, V387, P101, DOI 10.1038/387101a0; KENT C, 1995, ANNU REV BIOCHEM, V64, P315, DOI 10.1146/annurev.bi.64.070195.001531; Kim KH, 1998, J BIOL CHEM, V273, P6844, DOI 10.1074/jbc.273.12.6844; KODAKI T, 1987, J BIOL CHEM, V262, P15428; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lykidis A, 2001, BIOCHEMISTRY-US, V40, P494, DOI 10.1021/bi002140r; MCGEE TP, 1994, J CELL BIOL, V124, P273, DOI 10.1083/jcb.124.3.273; MCGRAW P, 1989, GENETICS, V122, P317; MCMASTER CR, 1994, J BIOL CHEM, V269, P14776; MCMASTER CR, 1994, J BIOL CHEM, V269, P28010; PREISS J, 1986, J BIOL CHEM, V261, P8597; SKINNER HB, 1995, P NATL ACAD SCI USA, V92, P112, DOI 10.1073/pnas.92.1.112; TSUKAGOSHI Y, 1987, EUR J BIOCHEM, V169, P477, DOI 10.1111/j.1432-1033.1987.tb13635.x; TSUKAGOSHI Y, 1991, J BACTERIOL, V173, P2134, DOI 10.1128/jb.173.6.2134-2136.1991; Walkey CJ, 1998, J BIOL CHEM, V273, P27043, DOI 10.1074/jbc.273.42.27043; Williams JG, 1998, J BIOL CHEM, V273, P13482, DOI 10.1074/jbc.273.22.13482; Xie ZG, 1998, P NATL ACAD SCI USA, V95, P12346, DOI 10.1073/pnas.95.21.12346; Xie ZH, 2001, MOL BIOL CELL, V12, P1117, DOI 10.1091/mbc.12.4.1117	35	30	30	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	2002	277	46					44100	44107		10.1074/jbc.M206643200	http://dx.doi.org/10.1074/jbc.M206643200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	615XE	12200438	hybrid			2022-12-27	WOS:000179272000074
J	Nauze, M; Gonin, L; Chaminade, B; Peres, C; Hullin-Matsuda, F; Perret, B; Chap, H; Gassama-Diagne, A				Nauze, M; Gonin, L; Chaminade, B; Peres, C; Hullin-Matsuda, F; Perret, B; Chap, H; Gassama-Diagne, A			Guinea pig phospholipase B, identification of the catalytic serine and the proregion involved in its processing and enzymatic activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BRUSH-BORDER MEMBRANE; SUCRASE-ISOMALTASE; PRO REGION; PROTEIN; INTESTINE; B/LIPASE; A(2); PURIFICATION; EXPRESSION; PROPEPTIDE	Guinea pig phospholipase B (GPPLB) is a glycosylated ectoenzyme of intestinal brush border membrane. It displays a broad substrate specificity and is activated by trypsin cleavage. The primary sequence contains four tandem repeat domains (I to IV) and several serines in lipase consensus sequences. We used site-directed mutagenesis to demonstrate that only the serine 399 present in repeat II is responsible for the various enzymatic activities of GPPLB. Furthermore, we characterized for the first time the retinyl esterase activity of the enzyme. We also constructed and expressed in COS-7 cells, an NH2-terminal repeat I deletion mutant which was detected at a very low level by immunoblot. However, confocal microscopy study showed a strong intracellular accumulation with a weak membrane expression of the mutated protein, indicating a role of the NH2-terminal repeat I in the processing of GPPLB. Nevertheless, the Western blot-detected protein presented a glycosylation and trypsin sensitivity patterns similar to wild type PLB. The mutant is also fully active without trypsin treatment, in contrast to native enzyme. Thus, we propose a structural model for GPPLB, in which the repeat I constitutes a lid covering the active site and impairing enzymatic activity, its removal by trypsin leading to an active protein.	Hop Purpan, Inst Federatif Rech Immunol Cellulaire & Mol, INSERM,Dept Lipoprot & Mediateurs Lipid, Unite 563,Ctr Physiopathol Toulouse Purpan, F-31059 Toulouse, France	CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm)	Gassama-Diagne, A (corresponding author), Hop Purpan, Inst Federatif Rech Immunol Cellulaire & Mol, INSERM,Dept Lipoprot & Mediateurs Lipid, Unite 563,Ctr Physiopathol Toulouse Purpan, F-31059 Toulouse, France.		Peres, Carlos Augusto/N-8275-2019; Peres, Carlos A./ABE-8361-2020; Peres, Carlos A./B-1276-2013; Hullin-Matsuda, Françoise/N-3880-2017	Peres, Carlos A./0000-0002-1588-8765; Peres, Carlos A./0000-0002-1588-8765; Hullin-Matsuda, Françoise/0000-0002-6042-2841; Bertrand, PERRET/0000-0001-7568-445X				ACKERMANN EJ, 1995, BBA-LIPID LIPID MET, V1259, P125, DOI 10.1016/0005-2760(95)00143-Z; Beer HD, 1996, BIOCHEM J, V319, P351, DOI 10.1042/bj3190351; BOLL W, 1993, J BIOL CHEM, V268, P12901; Boudreau F, 2001, J BIOL CHEM, V276, P32122, DOI 10.1074/jbc.M102002200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; Chaminade B, 1999, LIPIDS, V34, pS49, DOI 10.1007/BF02562228; Delagebeaudeuf C, 1998, J BIOL CHEM, V273, P13407, DOI 10.1074/jbc.273.22.13407; Delagebeaudeuf C, 1996, BBA-LIPID LIPID MET, V1303, P119, DOI 10.1016/0005-2760(96)00090-2; DELEENHEER AP, 1979, J CHROMATOGR, V162, P408, DOI 10.1016/S0378-4347(00)81528-5; Dessen A, 1999, CELL, V97, P349, DOI 10.1016/S0092-8674(00)80744-8; DIAGNE A, 1987, LIPIDS, V22, P33, DOI 10.1007/BF02534872; DUGI KA, 1992, J BIOL CHEM, V267, P25086; Fairlie WD, 2001, J BIOL CHEM, V276, P16911, DOI 10.1074/jbc.M010000200; GASSAMADIAGNE A, 1992, J BIOL CHEM, V267, P13418; GASSAMADIAGNE A, 1989, J BIOL CHEM, V264, P9470; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; Ghannoum MA, 2000, CLIN MICROBIOL REV, V13, P122, DOI 10.1128/CMR.13.1.122-143.2000; Harrison EH, 2001, J NUTR, V131, P1405, DOI 10.1093/jn/131.5.1405; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Hidaka Y, 2000, J BIOL CHEM, V275, P25155, DOI 10.1074/jbc.M000543200; HURTLEY SM, 1989, ANNU REV CELL BIOL, V5, P277, DOI 10.1146/annurev.cb.05.110189.001425; Jacob R, 2002, J BIOL CHEM, V277, P8217, DOI 10.1074/jbc.M111500200; KIM DK, 1994, FEBS LETT, V343, P213, DOI 10.1016/0014-5793(94)80566-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lu T, 2001, BIOCHEMISTRY-US, V40, P7133, DOI 10.1021/bi010237n; MATSUDA H, 1979, BIOCHIM BIOPHYS ACTA, V573, P155, DOI 10.1016/0005-2760(79)90182-6; Moolenaar CEC, 1997, J CELL SCI, V110, P557; NAIM HY, 1994, J BIOL CHEM, V269, P26933; Ouwendijk J, 1996, J CLIN INVEST, V97, P633, DOI 10.1172/JCI118459; RIGTRUP KM, 1994, BIOCHEMISTRY-US, V33, P2661, DOI 10.1021/bi00175a039; Schrag JD, 1997, METHOD ENZYMOL, V284, P85; Shen H, 2001, ADV DRUG DELIVER REV, V50, pS103, DOI 10.1016/S0169-409X(01)00181-8; Shinde UP, 1997, NATURE, V389, P520, DOI 10.1038/39097; Takemori H, 1998, J BIOL CHEM, V273, P2222, DOI 10.1074/jbc.273.4.2222; Taylor JK, 1997, DNA CELL BIOL, V16, P1419, DOI 10.1089/dna.1997.16.1419; Tchoua U, 2000, BBA-MOL CELL BIOL L, V1487, P255, DOI 10.1016/S1388-1981(00)00101-3; Tojo H, 1998, J BIOL CHEM, V273, P2214, DOI 10.1074/jbc.273.4.2214; UPTON C, 1995, TRENDS BIOCHEM SCI, V20, P178, DOI 10.1016/S0968-0004(00)89002-7; Wacker H, 1997, BIOCHEMISTRY-US, V36, P3336, DOI 10.1021/bi962398a; Waite M, 1987, HDB LIPID RES, V5, P155; WEISSMAN JS, 1992, CELL, V71, P841, DOI 10.1016/0092-8674(92)90559-U; Yabuta Y, 2001, J BIOL CHEM, V276, P44427, DOI 10.1074/jbc.M107573200; ZHANG ZZ, 2000, BIOCHEM J, V350, P71	44	9	9	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	2002	277	46					44093	44099		10.1074/jbc.M205761200	http://dx.doi.org/10.1074/jbc.M205761200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	615XE	12194976	hybrid			2022-12-27	WOS:000179272000073
J	Zheng, YF; Schlondorff, J; Blobel, CP				Zheng, YF; Schlondorff, J; Blobel, CP			Evidence for regulation of the tumor necrosis factor alpha-convertase (TACE) by protein-tyrosine phosphatase PTPH1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METALLOPROTEASE-DISINTEGRIN MDC9; CYTOSKELETAL-ASSOCIATED PROTEINS; AMYLOID PRECURSOR PROTEIN; GROWTH-FACTOR; INTRACELLULAR MATURATION; TRANSMEMBRANE PROTEINS; SECRETASE CLEAVAGE; DOMAIN-STRUCTURE; CELL-SURFACE; MEMBRANE	Tumor necrosis factor a-convertase (TACE) is a metalloprotease-disintegrin involved in the ectodomain shedding of several proteins and is critical for proper murine development. TACE-mediated ectodomain shedding is regulated, and the cytoplasmic domain of TACE contains several potential signaling motifs, suggesting that this domain may play a role in regulating the metalloprotease activity. Here we report that the protein-tyrosine phosphatase PTPH1, which contains both a band 4.1 domain and a single PDZ domain, can interact with the cytoplasmic domain of TACE. The interaction was initially observed in a yeast two-hybrid screen and was confirmed using an in vitro binding assay and coimmunoprecipitations from eukaryotic cell extracts. The interaction is mediated via binding of the PDZ domain of PTPH1 to the COOH terminus of TACE. The latter represents a novel group I PDZ binding sequence characterized by a terminal cysteine residue. In co-expression experiments, significantly lower levels of TACE were observed in the presence of catalytically active forms of PTPH1 compared with catalytically inactive forms of PTPH1. Furthermore, phorbol ester-stimulated shedding of the TACE substrate tumor necrosis factor-alpha was decreased in cells expressing catalytically active PTPH1 compared with inactive PTPH1. Taken together, these results suggest that PTPH1 may be a negative regulator of TACE levels and function, and thus provide the first evidence for the regulation of TACE through a cytoplasmic protein.	Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Cellular Biochem & Biophys Program, New York, NY 10021 USA; Cornell Univ, Weill Grad Sch Med Sci, Grad Program Physiol Biophys & Mol Med, New York, NY 10021 USA; Cornell Univ, Rockefeller Univ, Mem Sloan Kettering Canc Ctr, Tri Inst,Training Program, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Cornell University; Cornell University; Memorial Sloan Kettering Cancer Center; Rockefeller University	Blobel, CP (corresponding author), Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Cellular Biochem & Biophys Program, Box 368,1275 York Ave, New York, NY 10021 USA.		Zheng, Yufang/F-1091-2011	Zheng, Yufang/0000-0002-0488-2624; Schlondorff, Johannes/0000-0002-9973-9731	NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058668, T32GM007739] Funding Source: NIH RePORTER; NCI NIH HHS [P30-CA-08748] Funding Source: Medline; NIGMS NIH HHS [R01 GM58668, 5T32GM07739-17] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AITKEN A, 1995, BIOCHEM SOC T, V23, P605, DOI 10.1042/bst0230605; ARIMURA Y, 1992, TUMOR BIOL, V13, P180, DOI 10.1159/000217763; Arribas J, 1997, J BIOL CHEM, V272, P17160, DOI 10.1074/jbc.272.27.17160; Arribas J, 1996, J BIOL CHEM, V271, P11376, DOI 10.1074/jbc.271.19.11376; Asakura M, 2002, NAT MED, V8, P35, DOI 10.1038/nm0102-35; Baldin V, 2000, Prog Cell Cycle Res, V4, P49; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Black RA, 1998, CURR OPIN CELL BIOL, V10, P654, DOI 10.1016/S0955-0674(98)80042-2; Blobel CP, 2000, CURR OPIN CELL BIOL, V12, P606, DOI 10.1016/S0955-0674(00)00139-3; BRAKEBUSCH C, 1992, EMBO J, V11, P943, DOI 10.1002/j.1460-2075.1992.tb05133.x; BRAKEBUSCH C, 1994, J BIOL CHEM, V269, P32488; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; BURBELO PD, 1995, CURR BIOL, V5, P95, DOI 10.1016/S0960-9822(95)00022-4; Buxbaum JD, 1998, J BIOL CHEM, V273, P27765, DOI 10.1074/jbc.273.43.27765; BUXBAUM JD, 1992, P NATL ACAD SCI USA, V89, P10075, DOI 10.1073/pnas.89.21.10075; CHENG HJ, 1994, MOL BIOL CELL, V5, P943, DOI 10.1091/mbc.5.9.943; Doedens JR, 2000, J BIOL CHEM, V275, P14598, DOI 10.1074/jbc.275.19.14598; EHLERS MRW, 1991, BIOCHEMISTRY-US, V30, P10065, DOI 10.1021/bi00106a001; Fan HZ, 1999, EMBO J, V18, P6962, DOI 10.1093/emboj/18.24.6962; Fitzgerald ML, 2000, J CELL BIOL, V148, P811, DOI 10.1083/jcb.148.4.811; Gechtman Z, 1999, J BIOL CHEM, V274, P28828, DOI 10.1074/jbc.274.40.28828; Gjorloff-Wingren A, 2000, EUR J IMMUNOL, V30, P2412, DOI 10.1002/1521-4141(2000)30:8<2412::AID-IMMU2412>3.0.CO;2-J; Gutwein P, 2000, J BIOL CHEM, V275, P15490, DOI 10.1074/jbc.275.20.15490; Hattori M, 2000, SCIENCE, V289, P1360, DOI 10.1126/science.289.5483.1360; Hooper NM, 1997, BIOCHEM J, V321, P265, DOI 10.1042/bj3210265; Howard L, 1999, J BIOL CHEM, V274, P31693, DOI 10.1074/jbc.274.44.31693; Hung AY, 2002, J BIOL CHEM, V277, P5699, DOI 10.1074/jbc.R100065200; ITOH F, 1993, INT J CANCER, V55, P947, DOI 10.1002/ijc.2910550612; Izumi Y, 1998, EMBO J, V17, P7260, DOI 10.1093/emboj/17.24.7260; Kratzschmar J, 1996, J BIOL CHEM, V271, P4593; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; Lemjabbar H, 2002, NAT MED, V8, P41, DOI 10.1038/nm0102-41; Lum L, 1998, J BIOL CHEM, V273, P26236, DOI 10.1074/jbc.273.40.26236; MASSAGUE J, 1993, ANNU REV BIOCHEM, V62, P515, DOI 10.1146/annurev.bi.62.070193.002503; Merlos-Suarez A, 2001, J BIOL CHEM, V276, P48510, DOI 10.1074/jbc.M103488200; Moss ML, 1997, NATURE, V385, P733, DOI 10.1038/385733a0; Nelson KK, 1999, BIOCHEM J, V343, P673, DOI 10.1042/0264-6021:3430673; Pan DJ, 1997, CELL, V90, P271, DOI 10.1016/S0092-8674(00)80335-9; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Primakoff P, 2000, TRENDS GENET, V16, P83, DOI 10.1016/S0168-9525(99)01926-5; Qi HL, 1999, SCIENCE, V283, P91, DOI 10.1126/science.283.5398.91; Reddy P, 2000, J BIOL CHEM, V275, P14608, DOI 10.1074/jbc.275.19.14608; Rio C, 2000, J BIOL CHEM, V275, P10379, DOI 10.1074/jbc.275.14.10379; Roghani M, 1999, J BIOL CHEM, V274, P3531, DOI 10.1074/jbc.274.6.3531; Schlondorff J, 1999, J CELL SCI, V112, P3603; Shirakabe K, 2001, J BIOL CHEM, V276, P9352, DOI 10.1074/jbc.M007913200; Solomon KA, 1999, J IMMUNOL, V163, P4105; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Weskamp G, 2002, MOL CELL BIOL, V22, P1537, DOI 10.1128/MCB.22.5.1537-1544.2002; YANG Q, 1991, P NATL ACAD SCI USA, V88, P5949, DOI 10.1073/pnas.88.14.5949; Zhang SH, 1999, J BIOL CHEM, V274, P17806, DOI 10.1074/jbc.274.25.17806; Zhang SH, 1997, J BIOL CHEM, V272, P27281, DOI 10.1074/jbc.272.43.27281	53	98	101	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					42463	42470		10.1074/jbc.M207459200	http://dx.doi.org/10.1074/jbc.M207459200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12207026	hybrid			2022-12-27	WOS:000179081200007
J	Kobayashi, M; Taniura, H; Yoshikawa, K				Kobayashi, M; Taniura, H; Yoshikawa, K			Ectopic expression of necdin induces differentiation of mouse neuroblastoma cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRADER-WILLI-SYNDROME; NEURONAL GROWTH SUPPRESSOR; TRANSCRIPTION FACTOR E2F1; POSTMITOTIC NEURONS; NUCLEAR-PROTEIN; FAMILY PROTEINS; MESSENGER-RNA; GENE; APOPTOSIS; DNA	Needin is expressed predominantly in postmitotic neurons, and ectopic expression of this protein strongly suppresses cell growth. Necdin has been implicated in the pathogenesis of Prader-Willi syndrome, a human neurodevelopmental disorder associated with genomic imprinting. Here we demonstrate that ectopic expression of needin induces a neuronal phenotype in neuroblastoma cells. Necdin was undetectable in mouse neuroblastoma N1E-115 cells under undifferentiated and differentiated conditions. N1E-115 cells transfected with necdin cDNA showed morphological differentiation such as neurite outgrowth and expression of the synaptic marker proteins synaptotagmin and synaptophysin. In addition, Western blot analysis of the retinoblastoma protein (Rb) family members Rb, p130, and p107 revealed that necdin cDNA transfectants contained an increased level of p130 and a reduced level of p107, a pattern seen in differentiated G(O) cells. The transcription factors E2F1 and E2F4 physically interacted with necdin via their carboxyl-terminal transactivation domains, but only E2F1 abrogated necdin-induced growth arrest and neurite outgrowth of neuroblastoma cells. Overexpression of E2F1 in differentiated N1E-115 cells induced apoptosis, which was antagonized by co-expression of needin. These results suggest that needin promotes the differentiation and survival of neurons through its antagonistic interactions with E2F1.	Osaka Univ, Inst Prot Res, Div Regulat Macromol Funct, Suita, Osaka 5650871, Japan	Osaka University	Yoshikawa, K (corresponding author), Osaka Univ, Inst Prot Res, Div Regulat Macromol Funct, Yamadaoka 3-2, Suita, Osaka 5650871, Japan.							AIZAWA T, 1992, DEV BRAIN RES, V68, P265, DOI 10.1016/0165-3806(92)90069-9; Azuma-Hara N, 1999, EXP CELL RES, V251, P442, DOI 10.1006/excr.1999.4593; Callaghan DA, 1999, DEV BIOL, V207, P257, DOI 10.1006/dbio.1998.9162; De Laurenzi V, 2000, J BIOL CHEM, V275, P15226, DOI 10.1074/jbc.275.20.15226; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Eizenberg O, 1996, MOL CELL BIOL, V16, P5178; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Gerard M, 1999, NAT GENET, V23, P199, DOI 10.1038/13828; Gill RM, 2000, J CELL BIOL, V148, P1187, DOI 10.1083/jcb.148.6.1187; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; HAYASHI Y, 1995, BIOCHEM BIOPH RES CO, V213, P317, DOI 10.1006/bbrc.1995.2132; Hou ST, 2000, J NEUROCHEM, V75, P91, DOI 10.1046/j.1471-4159.2000.0750091.x; Izumi M, 2000, BBA-GENE STRUCT EXPR, V1492, P341, DOI 10.1016/S0167-4781(00)00117-2; Jay P, 1997, NAT GENET, V17, P357, DOI 10.1038/ng1197-357; KOWALIK TF, 1995, J VIROL, V69, P2491, DOI 10.1128/JVI.69.4.2491-2500.1995; KRANENBURG O, 1995, J CELL BIOL, V131, P227, DOI 10.1083/jcb.131.1.227; LeCouter JE, 1996, ONCOGENE, V12, P1433; Lipinski MM, 1999, ONCOGENE, V18, P7873, DOI 10.1038/sj.onc.1203244; MacDonald HR, 1997, HUM MOL GENET, V6, P1873, DOI 10.1093/hmg/6.11.1873; MARUYAMA K, 1991, BIOCHEM BIOPH RES CO, V178, P291, DOI 10.1016/0006-291X(91)91812-Q; Muscatelli F, 2000, HUM MOL GENET, V9, P3101, DOI 10.1093/hmg/9.20.3101; Nakada Y, 1998, GENE, V213, P65, DOI 10.1016/S0378-1119(98)00206-6; Niinobe M, 2000, DEV NEUROSCI-BASEL, V22, P310, DOI 10.1159/000017455; Nishimura I, 1998, J NEUROSCI, V18, P2387, DOI 10.1523/jneurosci.18-07-02387.1998; Persengiev SP, 1999, MOL CELL BIOL, V19, P6048; Raschella G, 1998, CELL DEATH DIFFER, V5, P401, DOI 10.1038/sj.cdd.4400359; SLACK RS, 1995, J CELL BIOL, V129, P779, DOI 10.1083/jcb.129.3.779; Smith EJ, 1996, MOL CELL BIOL, V16, P6965; Sutcliffe JS, 1997, LANCET, V350, P1520, DOI 10.1016/S0140-6736(05)63943-8; Takazaki R, 2002, EXP CELL RES, V277, P220, DOI 10.1006/excr.2002.5558; Taniguchi N, 2000, J BIOL CHEM, V275, P31674, DOI 10.1074/jbc.M005103200; Taniura H, 1999, J BIOL CHEM, V274, P16242, DOI 10.1074/jbc.274.23.16242; Taniura H, 1998, J BIOL CHEM, V273, P720, DOI 10.1074/jbc.273.2.720; Taniura H, 2002, J CELL BIOCHEM, V84, P545, DOI 10.1002/jcb.10047.abs; Uetsuki T, 1996, J BIOL CHEM, V271, P918, DOI 10.1074/jbc.271.2.918; Wang ZM, 1998, P NATL ACAD SCI USA, V95, P15583, DOI 10.1073/pnas.95.26.15583; Yoshikawa K, 2000, NEUROSCI RES, V37, P1, DOI 10.1016/S0168-0102(00)00101-2	37	59	63	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					42128	42135		10.1074/jbc.M205024200	http://dx.doi.org/10.1074/jbc.M205024200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12198120	hybrid			2022-12-27	WOS:000178985300104
J	Schauvliege, R; Vanrobaeys, J; Schotte, P; Beyaert, R				Schauvliege, R; Vanrobaeys, J; Schotte, P; Beyaert, R			Caspase-11 gene expression in response to lipopolysaccharide and interferon-gamma requires nuclear factor-kappa B and signal transducer and activator of transcription (STAT) 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICE DEFICIENT; PROTEASE; IDENTIFICATION; APOPTOSIS; IMMUNITY; CLONING; FAMILY; ENZYME	Murine caspase-11, together with caspase-1, is essential for the production of IL-1beta in response to lipopolysaccharide (LPS). In most cells, caspase-11 is only expressed upon induction with pro-inflammatory stimuli. To understand how caspase-11 expression is transcriptionally regulated, we isolated the caspase-11 gene promoter by genome walking and investigated the mechanisms regulating caspase-11 gene expression in macrophages that are treated with LPS and interferon-gamma. Transient transfections with caspase-11 promoter-luciferase reporter constructs and deletion/mutation analysis revealed an essential role for NF-KB binding in the up-regulation of caspase-11 in response to LPS. In the case of interferon-gamma stimulation, signal transducer and activator of transcription 1 binding to the caspase-11 promoter could be shown to be required for caspase-11 expression.	State Univ Ghent VIB, Unit Mol Signal Transduct Inflammat, Dept Mol Biomed Res, B-9000 Ghent, Belgium	Flanders Institute for Biotechnology (VIB); Ghent University	Beyaert, R (corresponding author), State Univ Ghent VIB, Unit Mol Signal Transduct Inflammat, Dept Mol Biomed Res, KL Ledeganckstr 35, B-9000 Ghent, Belgium.	rudi.beyaert@dmb.rug.ac.be	Beyaert, Rudi/B-2589-2009	Beyaert, Rudi/0000-0002-5704-582X				Aaronson DS, 2002, SCIENCE, V296, P1653, DOI 10.1126/science.1071545; Alexander C, 2001, J ENDOTOXIN RES, V7, P167, DOI 10.1179/096805101101532675; CERRETTI DP, 1992, SCIENCE, V256, P97, DOI 10.1126/science.1373520; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Cryns V, 1998, GENE DEV, V12, P1551, DOI 10.1101/gad.12.11.1551; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Desmedt M, 1998, J IMMUNOL, V160, P5300; Dinarello CA, 1999, METHODS, V19, P121, DOI 10.1006/meth.1999.0837; Ghayur T, 1997, NATURE, V386, P619, DOI 10.1038/386619a0; Gu Y, 1997, SCIENCE, V275, P206, DOI 10.1126/science.275.5297.206; Harrison DC, 2001, MOL BRAIN RES, V89, P133, DOI 10.1016/S0169-328X(01)00058-4; Hawiger J, 2001, IMMUNOL RES, V23, P99, DOI 10.1385/IR:23:2-3:099; Hisahara S, 2001, J EXP MED, V193, P111, DOI 10.1084/jem.193.1.111; Hur J, 2001, FEBS LETT, V507, P157, DOI 10.1016/S0014-5793(01)02975-1; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Kamada S, 1997, ONCOGENE, V15, P285, DOI 10.1038/sj.onc.1201192; Kang SJ, 2000, J CELL BIOL, V149, P613, DOI 10.1083/jcb.149.3.613; Kano A, 1999, BIOCHEM BIOPH RES CO, V257, P672, DOI 10.1006/bbrc.1999.0276; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; Lee CK, 2000, J IMMUNOL, V164, P1286, DOI 10.4049/jimmunol.164.3.1286; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; Lin XY, 2000, J BIOL CHEM, V275, P39920, DOI 10.1074/jbc.M007255200; Liu WF, 2002, J BIOL CHEM, V277, P8273, DOI 10.1074/jbc.M110768200; Mackman N, 2000, IMMUNOL RES, V21, P247, DOI 10.1385/IR:21:2-3:247; Nishiyama J, 2001, BIOCHEM J, V360, P49, DOI 10.1042/0264-6021:3600049; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Salvesen GS, 1997, CELL, V91, P443, DOI 10.1016/S0092-8674(00)80430-4; Schotte P, 2001, J BIOL CHEM, V276, P21153, DOI 10.1074/jbc.M102239200; Sharp FR, 2001, ADV EXP MED BIOL, V502, P273; Shibata M, 2000, J CLIN INVEST, V106, P643, DOI 10.1172/JCI10203; Stennicke HR, 1999, J BIOL CHEM, V274, P8359, DOI 10.1074/jbc.274.13.8359; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; Van de Craen M, 1997, FEBS LETT, V403, P61, DOI 10.1016/S0014-5793(97)00026-4; van der Meer JWM, 1998, ANN NY ACAD SCI, V856, P243, DOI 10.1111/j.1749-6632.1998.tb08331.x; Wang SY, 1996, J BIOL CHEM, V271, P20580, DOI 10.1074/jbc.271.34.20580; Wang SY, 1998, CELL, V92, P501, DOI 10.1016/S0092-8674(00)80943-5; WINGENDER E, 1994, J BIOTECHNOL, V35, P273, DOI 10.1016/0168-1656(94)90041-8	37	117	124	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					41624	41630		10.1074/jbc.M207852200	http://dx.doi.org/10.1074/jbc.M207852200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12198138	hybrid			2022-12-27	WOS:000178985300042
J	Uchiumi, T; Honma, S; Endo, Y; Hachimori, A				Uchiumi, T; Honma, S; Endo, Y; Hachimori, A			Ribosomal proteins at the stalk region modulate functional rRNA structures in the GTPase center	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-GLYCOSIDASE ACTIVITY; ALPHA-SARCIN CLEAVAGE; ELONGATION-FACTOR-G; COLI 70S RIBOSOME; RICIN A-CHAIN; ESCHERICHIA-COLI; ANGSTROM RESOLUTION; BINDING-SITES; CRYSTAL-STRUCTURE; EF-G	Replacement of the L10.L7/L12 protein complex and L11 in Escherichia coli ribosomes with the respective rat counterparts P0-P1/P2 and eukaryotic L12 causes conversion of ribosomal specificity for elongation factors from prokaryotic elongation factor (EF)-Tu/EF-G to eukaryotic EF (eEF)-1alpha/eEF-2. Here we have investigated the effects of protein replacement on the structure and function of two rRNA domains around positions 1070 and 2660 (sarcin/ricin loop) of 23 S rRNA. Protein replacement at the 1070 region in E. coli 50 S subunits was demonstrated by chemical probing analysis. Binding of rat proteins to the 1070 region caused increased accessibility of the 2660 and 1070 regions to ligands for eukaryotic ribosomes: the ribotoxin pepocin for the 2660 region (E. coli numbering), anti-28 S autoantibody for the 1070 region, and eEF-2 for both regions. Moreover, binding of the E. coli L10-L7/L12 complex and L11 to the 1070 region was shown to be responsible for E. coli ribosomal accessibility to another ribotoxin, gypsophilin. Ribosomal proteins at the 1070 region appear to modulate the structures and functions of the 2660 and 1070 RNA regions in slightly different modes in prokaryotes and eukaryotes.	Shinshu Univ, Fac Text Sci & Technol, Inst High Polymer Res, Ueda, Nagano 3868567, Japan; Ehime Univ, Fac Engn, Dept Appl Chem, Matsuyama, Ehime 7908577, Japan	Shinshu University; Ehime University	Uchiumi, T (corresponding author), Shinshu Univ, Fac Text Sci & Technol, Inst High Polymer Res, Ueda, Nagano 3868567, Japan.							Agrawal RK, 1998, P NATL ACAD SCI USA, V95, P6134, DOI 10.1073/pnas.95.11.6134; Agrawal RK, 2001, J MOL BIOL, V311, P777, DOI 10.1006/jmbi.2001.4907; ARAI KI, 1974, J BIOCHEM-TOKYO, V76, P283, DOI 10.1093/oxfordjournals.jbchem.a130570; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; BEAUCLERK AAD, 1984, J BIOL CHEM, V259, P6559; CHU JL, 1991, J EXP MED, V174, P507, DOI 10.1084/jem.174.3.507; Conn GL, 1999, SCIENCE, V284, P1171, DOI 10.1126/science.284.5417.1171; Correll CC, 1999, J MOL BIOL, V292, P275, DOI 10.1006/jmbi.1999.3072; Correll CC, 1998, P NATL ACAD SCI USA, V95, P13436, DOI 10.1073/pnas.95.23.13436; Cundliffe E., 1986, STRUCTURE FUNCTION G, P586; DABBS ER, 1979, J BACTERIOL, V140, P734, DOI 10.1128/JB.140.2.734-737.1979; DIJK J, 1979, NUCLEIC ACIDS RES, V6, P2717, DOI 10.1093/nar/6.8.2717; Draper DE, 2000, RIBOSOME: STRUCTURE, FUNCTION, ANTIBIOTICS, AND CELLULAR INTERACTIONS, P105; EGEBJERG J, 1989, EMBO J, V8, P607, DOI 10.1002/j.1460-2075.1989.tb03415.x; EGEBJERG J, 1990, J MOL BIOL, V213, P275, DOI 10.1016/S0022-2836(05)80190-1; ENDO Y, 1988, J BIOL CHEM, V263, P8735; ENDO Y, 1987, J BIOL CHEM, V262, P8128; ENDO Y, 1982, J BIOL CHEM, V257, P9054; Gabashvili IS, 2000, CELL, V100, P537, DOI 10.1016/S0092-8674(00)80690-X; GUDKOV AT, 1978, FEBS LETT, V93, P215, DOI 10.1016/0014-5793(78)81106-5; GUTELL RR, 1993, NUCLEIC ACIDS RES, V21, P3055, DOI 10.1093/nar/21.13.3055; HAMEL E, 1972, J BIOL CHEM, V247, P805; HAUSNER TP, 1987, BIOCHIMIE, V69, P911, DOI 10.1016/0300-9084(87)90225-2; Holmberg L, 1999, J MOL BIOL, V289, P223, DOI 10.1006/jmbi.1999.2706; Iwasaki K, 1979, Methods Enzymol, V60, P657; KAZIRO Y, 1972, J BIOCHEM, V72, P853, DOI 10.1093/oxfordjournals.jbchem.a129980; LILJAS A, 1987, BIOCHIMIE, V69, P1043, DOI 10.1016/0300-9084(87)90004-6; MILLER SP, 1991, NUCLEIC ACIDS RES, V19, P1657, DOI 10.1093/nar/19.7.1657; MOAZED D, 1988, NATURE, V334, P362, DOI 10.1038/334362a0; MOAZED D, 1986, CELL, V47, P985, DOI 10.1016/0092-8674(86)90813-5; MOLLER W, 1983, J MOL BIOL, V163, P553, DOI 10.1016/0022-2836(83)90112-2; Moller W., 1974, RIBOSOMES, P711; Munishkin A, 1997, P NATL ACAD SCI USA, V94, P12280, DOI 10.1073/pnas.94.23.12280; NATHANS D, 1961, P NATL ACAD SCI USA, V47, P497, DOI 10.1073/pnas.47.4.497; PETTERSSON I, 1979, NUCLEIC ACIDS RES, V6, P2637, DOI 10.1093/nar/6.7.2637; PETTERSSON I, 1976, FEBS LETT, V64, P135, DOI 10.1016/0014-5793(76)80267-0; RANDI R, 1962, J BIOL CHEM, V237, P3707; Remacha M, 1995, BIOCHEM CELL BIOL, V73, P959, DOI 10.1139/o95-103; REMACHA M, 1988, J BIOL CHEM, V263, P9094; RICH BE, 1987, MOL CELL BIOL, V7, P4065, DOI 10.1128/MCB.7.11.4065; ROSENDAHL G, 1993, J MOL BIOL, V234, P1013, DOI 10.1006/jmbi.1993.1655; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Seggerson K, 1998, RNA, V4, P1203, DOI 10.1017/S1355838298980773; Stark H, 1997, NATURE, V389, P403, DOI 10.1038/38770; Stelzl U, 2000, P NATL ACAD SCI USA, V97, P4597, DOI 10.1073/pnas.090009297; SZEWCZAK AA, 1993, P NATL ACAD SCI USA, V90, P9581, DOI 10.1073/pnas.90.20.9581; TOKIMATSU H, 1981, J MOL BIOL, V152, P397, DOI 10.1016/0022-2836(81)90250-3; Traut RR, 1995, BIOCHEM CELL BIOL, V73, P949, DOI 10.1139/o95-102; UCHIUMI T, 1995, J BIOL CHEM, V270, P29889; Uchiumi T, 1999, J BIOL CHEM, V274, P27578, DOI 10.1074/jbc.274.39.27578; Uchiumi T, 1999, J BIOL CHEM, V274, P681, DOI 10.1074/jbc.274.2.681; UCHIUMI T, 1987, P NATL ACAD SCI USA, V84, P5580, DOI 10.1073/pnas.84.16.5580; UCHIUMI T, 1991, J BIOL CHEM, V266, P2054; Uchiumi T, 1997, J BIOL CHEM, V272, P3302, DOI 10.1074/jbc.272.6.3302; Uchiumi T, 2002, J BIOL CHEM, V277, P3857, DOI 10.1074/jbc.M107730200; Wimberly BT, 1999, CELL, V97, P491, DOI 10.1016/S0092-8674(00)80759-X; WOOL IG, 1992, TRENDS BIOCHEM SCI, V17, P266, DOI 10.1016/0968-0004(92)90407-Z; Wool IG, 1995, BIOCHEM CELL BIOL, V73, P933, DOI 10.1139/o95-101; Xing YY, 1996, BIOCHEMISTRY-US, V35, P1581, DOI 10.1021/bi952132o; Yoshinari S, 1996, EUR J BIOCHEM, V242, P585, DOI 10.1111/j.1432-1033.1996.0585r.x; Yoshinari S, 1997, BIOSCI BIOTECH BIOCH, V61, P324, DOI 10.1271/bbb.61.324; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089	62	24	25	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					41401	41409		10.1074/jbc.M207424200	http://dx.doi.org/10.1074/jbc.M207424200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12198134	hybrid			2022-12-27	WOS:000178985300015
J	Avdi, NJ; Malcolm, KC; Nick, JA; Worthen, GS				Avdi, NJ; Malcolm, KC; Nick, JA; Worthen, GS			A role for protein phosphatase-2A in p38 mitogen-activated protein kinase-mediated regulation of the c-Jun NH2-terminal kinase pathway in human Neutrophils	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; DUAL-SPECIFICITY PHOSPHATASES; MAP KINASE; SIGNAL-TRANSDUCTION; MEK KINASE-1; CROSS-TALK; IN-VITRO; SYNERGISTIC ACTIVATION; TYROSINE PHOSPHATASES; CELLULAR STRESSES	Human neutrophil accumulation in inflammatory foci is essential for the effective control of microbial infections. Although exposure of neutrophils to cytokines such as tumor necrosis factor-alpha (TNFalpha), generated at sites of inflammation, leads to activation of MAPK pathways, mechanisms responsible for the fine regulation of specific MAPK modules remain unknown. We have previously demonstrated activation of a TNFalpha-mediated JNK pathway module, leading to apoptosis in adherent human neutrophils (Avdi, N. J., Nick, J. A., Whitlock, B. B., Billstrom, M. A., Henson, P. M., Johnson, G. L., and Worthen, G. S. (2001) J. Biol. Chem. 276, 2189-2199). Herein, evidence is presented linking regulation of the JNK pathway to p38 MAPK and the Ser/Thr protein phosphatase-2A (PP2A). Inhibition of p38 MAPK by SB 203580 and M 39 resulted in significant augmentation of TNFalpha-induced JNK and MKK4 (but not MKK7 or MEKK1) activation, whereas prior exposure to a p38-activating agent (platelet-activating factor) diminished the TNFalpha-induced JNK response. TNFa-induced apoptosis was also greatly enhanced upon p38 inhibition. Studies with a reconstituted cell-free system indicated the absence of a direct inhibitory effect of p38 MAPK on the JNK module. Neutrophil exposure to the Ser/Thr phosphatase inhibitors okadaic acid and calyculin A induced JNK activation. Increased phosphatase activity following TNFa stimulation was shown to be PP2A-associated and p38-dependent. Furthermore, PP2A-induced dephosphorylation of MKK4 resulted in its inactivation. Thus, in neutrophils, p38 MAPK, through a PP2A-mediated mechanism, regulates the JNK pathway, thus determining the extent and nature of subsequent responses such as apoptosis.	Natl Jewish & Med Res Ctr, Dept Med, Denver, CO 80206 USA; Natl Jewish & Med Res Ctr, Dept Pediat, Div Cell Biol, Denver, CO 80206 USA; Univ Colorado, Sch Med, Dept Med, Denver, CO 80206 USA	National Jewish Health; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Avdi, NJ (corresponding author), Natl Jewish & Med Res Ctr, Dept Med, 1400 Jackson St,D403, Denver, CO 80206 USA.			BRIONES, NATALIE/0000-0002-8342-9552	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061407] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 61407-04] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Alonso A, 2001, J BIOL CHEM, V276, P4766, DOI 10.1074/jbc.M006497200; Alsayed Y, 2001, J BIOL CHEM, V276, P4012, DOI 10.1074/jbc.M007431200; Avdi NJ, 1996, J BIOL CHEM, V271, P33598, DOI 10.1074/jbc.271.52.33598; Avdi NJ, 2001, J BIOL CHEM, V276, P2189, DOI 10.1074/jbc.M007527200; BUSCHER M, 1988, ONCOGENE, V3, P301; Camps M, 2000, FASEB J, V14, P6, DOI 10.1096/fasebj.14.1.6; CANO E, 1995, TRENDS BIOCHEM SCI, V20, P117, DOI 10.1016/S0968-0004(00)88978-1; COHEN PTW, 1990, FEBS LETT, V268, P355, DOI 10.1016/0014-5793(90)81285-V; Cohen PTW, 1997, TRENDS BIOCHEM SCI, V22, P245, DOI 10.1016/S0968-0004(97)01060-8; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; De Windt LJ, 2000, J BIOL CHEM, V275, P13571, DOI 10.1074/jbc.275.18.13571; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; Dumont JE, 2001, CELL SIGNAL, V13, P457, DOI 10.1016/S0898-6568(01)00168-1; ERREDE B, 1995, MOL REPROD DEV, V42, P477, DOI 10.1002/mrd.1080420416; Eyers PA, 1999, FEBS LETT, V451, P191, DOI 10.1016/S0014-5793(99)00552-9; Fleming Y, 2000, BIOCHEM J, V352, P145, DOI 10.1042/0264-6021:3520145; Frasch SC, 1998, J BIOL CHEM, V273, P8389, DOI 10.1074/jbc.273.14.8389; Gerwins P, 1997, J BIOL CHEM, V272, P8288, DOI 10.1074/jbc.272.13.8288; Goedert M, 1997, EMBO J, V16, P3563, DOI 10.1093/emboj/16.12.3563; Gotz J, 1998, P NATL ACAD SCI USA, V95, P12370, DOI 10.1073/pnas.95.21.12370; GUY GR, 1992, J BIOL CHEM, V267, P1846; GUY GR, 1993, J BIOL CHEM, V268, P2141; Hall-Jackson CA, 1999, ONCOGENE, V18, P2047, DOI 10.1038/sj.onc.1202603; Hazzalin CA, 1997, ONCOGENE, V15, P2321, DOI 10.1038/sj.onc.1201403; HERSKOWITZ I, 1995, CELL, V80, P187, DOI 10.1016/0092-8674(95)90402-6; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; Keyse SM, 2000, CURR OPIN CELL BIOL, V12, P186, DOI 10.1016/S0955-0674(99)00075-7; King AG, 1995, ONCOGENE, V11, P2553; Kinoshita K, 1996, GENES CELLS, V1, P29, DOI 10.1046/j.1365-2443.1996.02002.x; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; Lawler S, 1998, CURR BIOL, V8, P1387, DOI 10.1016/S0960-9822(98)00019-0; Lisnock J, 2000, BIOCHEMISTRY-US, V39, P3141, DOI 10.1021/bi992410+; Liverton NJ, 1999, J MED CHEM, V42, P2180, DOI 10.1021/jm9805236; Masuda K, 2001, J BIOL CHEM, V276, P39002, DOI 10.1074/jbc.M104600200; Matsuguchi T, 2001, MOL CELL BIOL, V21, P6999, DOI 10.1128/MCB.21.20.6999-7009.2001; Minamino T, 1999, P NATL ACAD SCI USA, V96, P15127, DOI 10.1073/pnas.96.26.15127; Muda M, 1996, J BIOL CHEM, V271, P27205, DOI 10.1074/jbc.271.44.27205; Neel BG, 1997, CURR OPIN CELL BIOL, V9, P193, DOI 10.1016/S0955-0674(97)80063-4; Nick JA, 1997, J CLIN INVEST, V99, P975, DOI 10.1172/JCI119263; Nick JA, 1996, J IMMUNOL, V156, P4867; Nick JA, 2000, J IMMUNOL, V164, P2151, DOI 10.4049/jimmunol.164.4.2151; O'Rourke SM, 1998, GENE DEV, V12, P2874, DOI 10.1101/gad.12.18.2874; Robinson CJM, 2001, CELL SIGNAL, V13, P29, DOI 10.1016/S0898-6568(00)00121-2; Rosenberger SF, 1999, ONCOGENE, V18, P3626, DOI 10.1038/sj.onc.1202695; Sanchez-Perez I, 2000, ONCOGENE, V19, P5142, DOI 10.1038/sj.onc.1203887; Schlesinger Thomas K., 1998, Frontiers in Bioscience, V3, pD1181; Schuringa JJ, 2000, BIOCHEM J, V347, P89, DOI 10.1042/0264-6021:3470089; Shanley TP, 2001, J IMMUNOL, V166, P966, DOI 10.4049/jimmunol.166.2.966; Sheikh-Hamad D, 1998, J BIOL CHEM, V273, P1832, DOI 10.1074/jbc.273.3.1832; Shen Y, 2001, P NATL ACAD SCI USA, V98, P13613, DOI 10.1073/pnas.231499098; SHERMAN ML, 1990, P NATL ACAD SCI USA, V87, P5663, DOI 10.1073/pnas.87.15.5663; Singh RP, 1999, J BIOL CHEM, V274, P19593, DOI 10.1074/jbc.274.28.19593; Sontag E, 2001, CELL SIGNAL, V13, P7, DOI 10.1016/S0898-6568(00)00123-6; Takekawa M, 1998, EMBO J, V17, P4744, DOI 10.1093/emboj/17.16.4744; Tonks NK, 2001, CURR OPIN CELL BIOL, V13, P182, DOI 10.1016/S0955-0674(00)00196-4; Uh ST, 2000, J BIOL CHEM, V275, P793, DOI 10.1074/jbc.275.2.793; Wang XN, 2000, EXP CELL RES, V258, P425, DOI 10.1006/excr.2000.4939; Westermarck J, 2001, MOL CELL BIOL, V21, P2373, DOI 10.1128/MCB.21.7.2373-2383.2001; Xia Y, 2000, P NATL ACAD SCI USA, V97, P5243, DOI 10.1073/pnas.97.10.5243; Yang D, 1997, P NATL ACAD SCI USA, V94, P3004, DOI 10.1073/pnas.94.7.3004; Yu R, 2000, J BIOL CHEM, V275, P2322, DOI 10.1074/jbc.275.4.2322; Yujiri T, 2000, P NATL ACAD SCI USA, V97, P7272, DOI 10.1073/pnas.130176697; Yujiri T, 1999, J BIOL CHEM, V274, P12605, DOI 10.1074/jbc.274.18.12605; Yujiri T, 1998, SCIENCE, V282, P1911, DOI 10.1126/science.282.5395.1911; ZHENG CF, 1994, EMBO J, V13, P1123, DOI 10.1002/j.1460-2075.1994.tb06361.x; Zhou GS, 2002, J BIOL CHEM, V277, P6391, DOI 10.1074/jbc.M107014200	67	80	85	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 25	2002	277	43					40687	40696		10.1074/jbc.M204455200	http://dx.doi.org/10.1074/jbc.M204455200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	607KU	12186863	hybrid			2022-12-27	WOS:000178791400068
J	Edberg, JC; Qin, HW; Gibson, AW; Yee, AMF; Redecha, PB; Indik, ZK; Schreiber, AD; Kimberly, RP				Edberg, JC; Qin, HW; Gibson, AW; Yee, AMF; Redecha, PB; Indik, ZK; Schreiber, AD; Kimberly, RP			The CY domain of the Fc gamma RIa alpha-chain (CD64) alters gamma-chain tyrosine-based signaling and phagocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-MEDIATED PHAGOCYTOSIS; IMMUNOGLOBULIN-G; PROTEIN-KINASE; BETA-SUBUNIT; EPSILON-RI; PSEUDOPOD EXTENSION; BISPECIFIC ANTIBODY; CYTOPLASMIC DOMAIN; MAST-CELLS; IGG-FC	Although the cytoplasmic domain of the human FcgammaRIa alpha-chain lacks tyrosine-based phosphorylation motifs, it modulates receptor cycling and receptor-specific cytokine production. The cytoplasmic domain of FcgammaRIa is constitutively phosphorylated, and the inhibition of dephosphorylation with okadaic acid, an inhibitor of type 1 and type 2A protein serine/threonine phosphatase, inhibits both receptor-induced activation of the early tyrosine phosphorylation cascade and receptor-specific phagocytosis. To explore the basis for these effects of the cytoplasmic domain of FcgammaRIa, we developed a series of human FcgammaRIa molecular variants, expressed in the murine macrophage cell line P388D1, and demonstrate that serine phosphorylation of the cytoplasmic domain is an important regulatory mechanism. Truncation of the cytoplasmic domain and mutation of the cytoplasmic domain serine residues to alanine abolish the okadaic acid inhibition of phagocytic function. In contrast, the serine mutants did not recapitulate the selective effects of cytoplasmic domain truncation on cytokine production. These results demonstrate for the first time a direct functional role for serine phosphorylation in the a-chain of FcgammaRIa and suggest that the cytoplasmic domain of FcgammaRI regulates the different functional capacities of the FcgammaRIa-receptor complex.	Univ Alabama, Dept Med, Birmingham, AL 35294 USA; Univ Alabama, Dept Microbiol, Birmingham, AL 35294 USA; Cornell Univ, Hosp Special Surg, Dept Med, New York, NY 10021 USA; Cornell Univ, Weill Med Coll, New York, NY 10021 USA; Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Cornell University; Cornell University; University of Pennsylvania	Edberg, JC (corresponding author), Univ Alabama, Dept Med, 1530 3rd Ave S,THT433A, Birmingham, AL 35294 USA.			Kimberly, Robert/0000-0002-5330-3086	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI022193, R01AI022193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR042476, R01AR033062, P60AR020614] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 22193] Funding Source: Medline; NIAMS NIH HHS [R01 AR 33062, R01 AR 42476, P60 AR 20614] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Barford D, 1998, ANNU REV BIOPH BIOM, V27, P133, DOI 10.1146/annurev.biophys.27.1.133; CAMBIER JC, 1995, J IMMUNOL, V155, P3281; Cox D, 1999, J BIOL CHEM, V274, P1240, DOI 10.1074/jbc.274.3.1240; DAVIS W, 1995, EMBO J, V14, P432, DOI 10.1002/j.1460-2075.1995.tb07019.x; Deo YM, 1997, IMMUNOL TODAY, V18, P127, DOI 10.1016/S0167-5699(97)01007-4; Dombrowicz D, 1997, J CLIN INVEST, V99, P915, DOI 10.1172/JCI119256; Donnadieu E, 2000, IMMUNITY, V12, P515, DOI 10.1016/S1074-7613(00)80203-4; DURDEN DL, 1994, BIOCHEM J, V299, P569, DOI 10.1042/bj2990569; DURDEN DL, 1995, J IMMUNOL, V154, P4039; Edberg JC, 1997, EXP CLIN IMMUNOGENET, V14, P183; Edberg JC, 1999, J BIOL CHEM, V274, P30328, DOI 10.1074/jbc.274.42.30328; EDBERG JC, 1995, J BIOL CHEM, V270, P22301, DOI 10.1074/jbc.270.38.22301; EDBERG JC, 1994, J IMMUNOL, V152, P5826; GIBSON AW, 1999, LUPUS MOL CELLULAR P, P557; Graziano RF, 1997, CANCER IMMUNOL IMMUN, V45, P124, DOI 10.1007/s002620050413; GUYRE PM, 1989, J IMMUNOL, V143, P1650; Hiraoka S, 1999, INT IMMUNOL, V11, P199, DOI 10.1093/intimm/11.2.199; INDIK Z, 1992, IMMUNOBIOLOGY, V185, P183, DOI 10.1016/S0171-2985(11)80640-6; INDIK ZK, 1994, EXP HEMATOL, V22, P599; Karimi K, 1999, J LEUKOCYTE BIOL, V65, P854, DOI 10.1002/jlb.65.6.854; Keler T, 1997, CANCER RES, V57, P4008; KIMBERLY RP, 1995, ARTHRITIS RHEUM, V38, P306, DOI 10.1002/art.1780380303; Kinet JP, 1999, ANNU REV IMMUNOL, V17, P931, DOI 10.1146/annurev.immunol.17.1.931; KUROSAKI T, 1992, J EXP MED, V175, P447, DOI 10.1084/jem.175.2.447; Larsen EC, 2000, J IMMUNOL, V165, P2809, DOI 10.4049/jimmunol.165.5.2809; Lin SQ, 1996, CELL, V85, P985, DOI 10.1016/S0092-8674(00)81300-8; Liu CL, 1996, J CLIN INVEST, V98, P2001, DOI 10.1172/JCI119004; Lowry MB, 1998, J EXP MED, V187, P161, DOI 10.1084/jem.187.2.161; Lowry MB, 1998, J BIOL CHEM, V273, P24513, DOI 10.1074/jbc.273.38.24513; Mansfield PJ, 2000, BLOOD, V95, P2407, DOI 10.1182/blood.V95.7.2407.007k02_2407_2412; McKenzie S E, 1998, Curr Opin Hematol, V5, P16, DOI 10.1097/00062752-199801000-00003; Melendez AJ, 1998, P NATL ACAD SCI USA, V95, P2169, DOI 10.1073/pnas.95.5.2169; Miller KL, 1996, J EXP MED, V183, P2227, DOI 10.1084/jem.183.5.2227; NISHIWAKI S, 1990, CARCINOGENESIS, V11, P1837, DOI 10.1093/carcin/11.10.1837; OHTA Y, 1991, CELL, V67, P275, DOI 10.1016/0092-8674(91)90179-3; PAOLINI R, 1991, NATURE, V353, P855, DOI 10.1038/353855a0; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; PFEFFERKORN LC, 1995, J BIOL CHEM, V270, P8164, DOI 10.1074/jbc.270.14.8164; Posey JA, 1999, J IMMUNOTHER, V22, P371, DOI 10.1097/00002371-199907000-00011; Pullarkat V, 1999, CANCER IMMUNOL IMMUN, V48, P9, DOI 10.1007/s002620050543; QUILLIAM AL, 1993, IMMUNOLOGY, V78, P358; Raman C, 1998, J BIOL CHEM, V273, P19183, DOI 10.1074/jbc.273.30.19183; Ravetch JV, 1997, CURR OPIN IMMUNOL, V9, P121, DOI 10.1016/S0952-7915(97)80168-9; Repp R, 1995, J Hematother, V4, P415, DOI 10.1089/scd.1.1995.4.415; SALMON JE, 1995, J CLIN INVEST, V95, P2877, DOI 10.1172/JCI117994; Salmon JE, 1996, J CLIN INVEST, V97, P1348, DOI 10.1172/JCI118552; Somasundaram Chezian, 1999, Human Antibodies, V9, P47; Suzuki T, 2000, J IMMUNOL, V165, P473, DOI 10.4049/jimmunol.165.1.473; Tilton B, 1997, J BIOL CHEM, V272, P28096, DOI 10.1074/jbc.272.44.28096; Tridandapani S, 2000, J BIOL CHEM, V275, P20480, DOI 10.1074/jbc.M909462199; van der Pol WL, 1998, IMMUNOGENETICS, V48, P222, DOI 10.1007/s002510050426; van Vugt MJ, 1999, BLOOD, V94, P808, DOI 10.1182/blood.V94.2.808.414k31_808_817; WANG AVT, 1994, J EXP MED, V180, P1165, DOI 10.1084/jem.180.3.1165; Wang J, 1999, J BIOL CHEM, V274, P24349, DOI 10.1074/jbc.274.34.24349; Wu JM, 1997, J CLIN INVEST, V100, P1059, DOI 10.1172/JCI119616	55	21	22	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 25	2002	277	43					41287	41293		10.1074/jbc.M207835200	http://dx.doi.org/10.1074/jbc.M207835200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	607KU	12200451	hybrid			2022-12-27	WOS:000178791400142
J	Paarmann, I; Spangenberg, O; Lavie, A; Konrad, M				Paarmann, I; Spangenberg, O; Lavie, A; Konrad, M			Formation of complexes between Ca2+center dot calmodulin and the synapse-associated protein SAP97 requires the SH3 domain-guanylate kinase domain-connecting HOOK region	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LARGE TUMOR-SUPPRESSOR; HUMAN HOMOLOG; PDZ DOMAINS; INTRAMOLECULAR INTERACTION; POSTSYNAPTIC DENSITY; PLASMA-MEMBRANE; CALMODULIN; FAMILY; CALCIUM; CHANNEL	Mammalian synapse-associated protein SAP97, a structural and functional homolog of Drosophila Dlg, is a membrane-associated guanylate kinase (MAGUK) that is present at pre- and postsynaptic sites as well as in epithelial cell-cell contact sites. It is a multidomain scaffolding protein that shares with other members of the MAGUK protein family a characteristic modular organization composed of three sequential protein interaction motifs known as PDZ domains, followed by an Sre homology 3 (SH3) domain, and an enzymatically inactive guanylate kinase (GK)-like domain. Specific binding partners are known for each domain, and different modes of intramolecular interactions have been proposed that particularly involve the SH3 and GK domains and the so-called HOOK region located between these two domains. We identified the HOOK region as a specific site for calmodulin binding and studied the dynamics of complex formation of recombinant calmodulin and SAP97 by surface plasmon resonance spectroscopy. Binding of various SAP97 deletion constructs to immobilized calmodulin was strictly calcium-dependent. From the rate constants of association and dissociation we determined an equilibrium dissociation constant K-d of 122 nM for the association of calcium-saturated calmodulin and a SAP97 fragment, which encompassed the entire SH3-HOOK-GK module. Comparative structure-based sequence analysis of calmodulin binding regions from various target proteins predicts variable affinities for the interaction of calmodulin with members of the MAGUK protein family. Our findings suggest that calmodulin could regulate the intramolecular interaction between the SH3, HOOK, and GK domains of SAP97.	Max Planck Inst Biophys Chem, Dept Mol Genet, D-37070 Gottingen, Germany; Univ Illinois, Dept Biochem & Mol Biol, Chicago, IL 60607 USA	Max Planck Society; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Konrad, M (corresponding author), Max Planck Inst Biophys Chem, Dept Mol Genet, D-37070 Gottingen, Germany.		Lavie, Arnon/H-4927-2012	Lavie, Arnon/0000-0001-5591-8722				Brenman JE, 1998, J NEUROSCI, V18, P8805; Brundiers R, 1999, J BIOL CHEM, V274, P35289, DOI 10.1074/jbc.274.50.35289; BURNS NR, 1985, BIOCHEMISTRY-US, V24, P3070, DOI 10.1021/bi00333a040; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Deguchi M, 1998, J BIOL CHEM, V273, P26269, DOI 10.1074/jbc.273.41.26269; DeMarco SJ, 2001, J BIOL CHEM, V276, P21594, DOI 10.1074/jbc.M101448200; Evenas J, 1998, CURR OPIN CHEM BIOL, V2, P293, DOI 10.1016/S1367-5931(98)80072-0; Fanning AS, 1998, CURR TOP MICROBIOL, V228, P209; Garcia EP, 1998, NEURON, V21, P727, DOI 10.1016/S0896-6273(00)80590-5; Garner CC, 2000, TRENDS CELL BIOL, V10, P274, DOI 10.1016/S0962-8924(00)01783-9; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Gilli R, 1998, BIOCHEMISTRY-US, V37, P5450, DOI 10.1021/bi972083a; Hanada T, 2000, J BIOL CHEM, V275, P28774, DOI 10.1074/jbc.M000715200; Hata Y, 1998, NEUROSCI RES, V32, P1, DOI 10.1016/S0168-0102(98)00069-8; Hibino H, 2000, EMBO J, V19, P78, DOI 10.1093/emboj/19.1.78; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Jurado LA, 1999, PHYSIOL REV, V79, P661, DOI 10.1152/physrev.1999.79.3.661; Karlsson R, 1997, J IMMUNOL METHODS, V200, P121, DOI 10.1016/S0022-1759(96)00195-0; Kim E, 1997, J CELL BIOL, V136, P669, DOI 10.1083/jcb.136.3.669; Kuhlendahl S, 1998, EUR J BIOCHEM, V252, P305, DOI 10.1046/j.1432-1327.1998.2520305.x; Lee SH, 2000, CURR OPIN NEUROBIOL, V10, P125, DOI 10.1016/S0959-4388(99)00046-X; Li YH, 2002, J BIOL CHEM, V277, P4159, DOI 10.1074/jbc.M110792200; Lisman JE, 2001, NEURON, V31, P191, DOI 10.1016/S0896-6273(01)00364-6; LUE RA, 1994, P NATL ACAD SCI USA, V91, P9818, DOI 10.1073/pnas.91.21.9818; Marfatia SM, 2000, J BIOL CHEM, V275, P13759, DOI 10.1074/jbc.275.18.13759; Masuko N, 1999, J BIOL CHEM, V274, P5782, DOI 10.1074/jbc.274.9.5782; McGee AW, 2001, MOL CELL, V8, P1291, DOI 10.1016/S1097-2765(01)00411-7; McGee AW, 1999, J BIOL CHEM, V274, P17431, DOI 10.1074/jbc.274.25.17431; Moarefi I, 1997, NATURE, V385, P650, DOI 10.1038/385650a0; MULLER BM, 1995, J NEUROSCI, V15, P2354, DOI 10.1523/JNEUROSCI.15-03-02354.1995; Nix SL, 2000, J BIOL CHEM, V275, P41192, DOI 10.1074/jbc.M002078200; O'Brien RJ, 1998, CURR OPIN NEUROBIOL, V8, P364, DOI 10.1016/S0959-4388(98)80062-7; ONEIL KT, 1990, TRENDS BIOCHEM SCI, V15, P59, DOI 10.1016/0968-0004(90)90177-D; Persechini A, 1999, J BIOL CHEM, V274, P6827, DOI 10.1074/jbc.274.11.6827; Persechini A, 1996, J BIOL CHEM, V271, P32217, DOI 10.1074/jbc.271.50.32217; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Sans N, 2001, J NEUROSCI, V21, P7506, DOI 10.1523/JNEUROSCI.21-19-07506.2001; Satoh K, 1997, GENES CELLS, V2, P415, DOI 10.1046/j.1365-2443.1997.1310329.x; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Shin HW, 2000, J NEUROSCI, V20, P3580, DOI 10.1523/JNEUROSCI.20-10-03580.2000; SMITH CWJ, 1987, J BIOL CHEM, V262, P116; STRYNADKA NCJ, 1990, PROTEINS, V7, P234, DOI 10.1002/prot.340070305; Takeuchi M, 1997, J BIOL CHEM, V272, P11943, DOI 10.1074/jbc.272.18.11943; Tavares GA, 2001, MOL CELL, V8, P1313, DOI 10.1016/S1097-2765(01)00416-6; Valtschanoff JG, 2000, EUR J NEUROSCI, V12, P3605, DOI 10.1046/j.1460-9568.2000.00256.x; Woods DF, 1996, J CELL BIOL, V134, P1469, DOI 10.1083/jcb.134.6.1469; Wu HJ, 2000, EMBO J, V19, P5740, DOI 10.1093/emboj/19.21.5740; Wu HJ, 1998, J CELL SCI, V111, P2365; Yoshimura Y, 2002, BIOCHEM BIOPH RES CO, V290, P948, DOI 10.1006/bbrc.2001.6320; 1998, BIATECHNOLOGY HDB VE	50	31	31	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 25	2002	277	43					40832	40838		10.1074/jbc.M205618200	http://dx.doi.org/10.1074/jbc.M205618200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	607KU	12189141	hybrid			2022-12-27	WOS:000178791400087
J	Wadehra, M; Iyer, R; Goodglick, L; Braun, J				Wadehra, M; Iyer, R; Goodglick, L; Braun, J			The tetraspan protein epithelial membrane protein-2 interacts with beta 1 integrins and regulates adhesion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ADHESION; DEPENDENT REGULATION; BINDING-SPECIFICITY; SUPERFAMILY; COMPLEXES; GROWTH; CD151; CD63; CD81; ALPHA-3-BETA-1	The growth arrest-specific-3 (GAS3)/PMP22 proteins are members of the four-transmembrane (tetraspan) superfamily. Although the function of these proteins is poorly understood, GAS3/PMP22 proteins have been implicated in the control of growth and progression of certain cancers. Epithelial membrane protein-2 (EMP2), a GAS3/PMP22 family member, was recently identified as a putative tumor suppressor gene. Here, we addressed the normal function of EMP2 by testing the prediction that it influences integrin-related cell functions. We observed that EMP2 associates with the beta(1) integrin subunit. Co-immunoprecipitation and immunodepletion experiments indicated that similar to60% of beta(1) integrins and EMP2 can be isolated in common protein complexes. Whereas this association between EMP2 and beta(1) integrin may be direct or indirect, it has features of integrin heterodimer selectivity. Thus, by laser confocal microscopy, EMP2 colocalized with alpha(6)beta(1), but not alpha(5)beta(1) integrin. Increased expression of EMP2 also influenced the integrin heterodimer repertoire present on the plasma membrane. EMP2 specifically increased the surface expression of the alpha(6)beta(1) integrin while decreasing that of the alpha(5)beta(1) protein. Reciprocally, reduction in EMP2 expression using a specific ribozyme decreased surface expression of alpha(6)beta(1), integrin. Accordingly, these EMP2-mediated changes resulted in a dramatic alteration in cellular adhesion to extracellular matrix proteins. This study demonstrates for the first time the interaction of a GAS3/PMP22 family member with an integrin protein and suggests that such interactions and their functional consequences are a physiologic role of GAS3/PMP22 proteins.	Univ Calif Los Angeles, David Geffen Sch, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch, Inst Mol Biol, Los Angeles, CA 90095 USA; Jonsson Comprehens Canc Ctr, Los Angeles, CA 90034 USA; Dept Pathol & Lab, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center	Braun, J (corresponding author), Univ Calif Los Angeles, David Geffen Sch, Dept Pathol & Lab Med, CHS 13-222,10833 Le Conte Ave, Los Angeles, CA 90095 USA.			Braun, Jonathan/0000-0003-1646-2974	NCI NIH HHS [5T32 CA 009120-27] Funding Source: Medline; NIAID NIH HHS [AI 28697] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI028697] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Amarzguioui M, 1998, CELL MOL LIFE SCI, V54, P1175, DOI 10.1007/s000180050247; Aplin AE, 1999, J BIOL CHEM, V274, P31223, DOI 10.1074/jbc.274.44.31223; Aplin AE, 1999, CURR OPIN CELL BIOL, V11, P737, DOI 10.1016/S0955-0674(99)00045-9; Attardi LD, 2000, GENE DEV, V14, P704; Belkin AM, 2000, MICROSC RES TECHNIQ, V51, P280, DOI 10.1002/1097-0029(20001101)51:3<280::AID-JEMT7>3.0.CO;2-O; BenPorath I, 1996, GENE, V183, P69, DOI 10.1016/S0378-1119(96)00475-1; Berditchevski F, 1997, J BIOL CHEM, V272, P2595, DOI 10.1074/jbc.272.5.2595; Berditchevski F, 1999, J CELL BIOL, V146, P477, DOI 10.1083/jcb.146.2.477; BERDITCHEVSKI F, 1995, J BIOL CHEM, V270, P17784, DOI 10.1074/jbc.270.30.17784; Brancolini C, 1999, MOL BIOL CELL, V10, P2441, DOI 10.1091/mbc.10.7.2441; CHRISTOPHEHOBER.C, 2001, GENOMICS, V2, P3; Claas C, 2001, J BIOL CHEM, V276, P7974, DOI 10.1074/jbc.M008650200; Dackovic J, 2001, EUR J NEUROL, V8, P689, DOI 10.1046/j.1468-1331.2001.00306.x; Dedhar S, 1999, Curr Opin Hematol, V6, P37, DOI 10.1097/00062752-199901000-00007; FABBRETTI E, 1995, GENE DEV, V9, P1846, DOI 10.1101/gad.9.15.1846; Fitter S, 1999, BIOCHEM J, V338, P61, DOI 10.1042/0264-6021:3380061; GUADAGNO TM, 1991, J CELL BIOL, V115, P1419, DOI 10.1083/jcb.115.5.1419; Keely P, 1998, TRENDS CELL BIOL, V8, P101, DOI 10.1016/S0962-8924(97)01219-1; Kern A, 1998, J CELL PHYSIOL, V176, P634, DOI 10.1002/(SICI)1097-4652(199809)176:3<634::AID-JCP20>3.3.CO;2-J; Kikkawa Y, 2000, J CELL SCI, V113, P869; Luetterforst R, 1999, J CELL BIOL, V145, P1443, DOI 10.1083/jcb.145.7.1443; Maecker HT, 1997, FASEB J, V11, P428, DOI 10.1096/fasebj.11.6.9194523; Mannion BA, 1996, J IMMUNOL, V157, P2039; MCCALL MJ, 1992, P NATL ACAD SCI USA, V89, P5710, DOI 10.1073/pnas.89.13.5710; Meredith JE, 1999, J BIOL CHEM, V274, P8111, DOI 10.1074/jbc.274.12.8111; Naef R, 1998, MICROSC RES TECHNIQ, V41, P359, DOI 10.1002/(SICI)1097-0029(19980601)41:5<359::AID-JEMT3>3.0.CO;2-L; Penas PF, 2000, J INVEST DERMATOL, V114, P1126, DOI 10.1046/j.1523-1747.2000.00998.x; Rubinstein E, 1996, EUR J IMMUNOL, V26, P2657, DOI 10.1002/eji.1830261117; Serru V, 1999, BIOCHEM J, V340, P103, DOI 10.1042/0264-6021:3400103; Shimizu Y, 1996, Hum Cell, V9, P175; SNIPES GJ, 1993, J NEUROCHEM, V61, P1961, DOI 10.1111/j.1471-4159.1993.tb09840.x; Sterk LMT, 2000, J CELL BIOL, V149, P969, DOI 10.1083/jcb.149.4.969; Stipp CS, 2001, J BIOL CHEM, V276, P4853, DOI 10.1074/jbc.M009859200; Sugiura T, 1999, J CELL BIOL, V146, P1375, DOI 10.1083/jcb.146.6.1375; Taylor V, 1996, GENE, V175, P115, DOI 10.1016/0378-1119(96)00134-5; Testa JE, 1999, CANCER RES, V59, P3812; VARNER JA, 1995, MOL BIOL CELL, V6, P725, DOI 10.1091/mbc.6.6.725; Wang CX, 2001, BLOOD, V97, P3890, DOI 10.1182/blood.V97.12.3890; WEITZMAN JB, 1993, J BIOL CHEM, V268, P8651; Won WJ, 2002, J IMMUNOL, V168, P5605, DOI 10.4049/jimmunol.168.11.5605; Yanez-Mo M, 1998, J CELL BIOL, V141, P791, DOI 10.1083/jcb.141.3.791; Yauch RL, 2000, J BIOL CHEM, V275, P9230, DOI 10.1074/jbc.275.13.9230; Yauch RL, 1998, MOL BIOL CELL, V9, P2751, DOI 10.1091/mbc.9.10.2751	43	56	66	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 25	2002	277	43					41094	41100		10.1074/jbc.M206868200	http://dx.doi.org/10.1074/jbc.M206868200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	607KU	12189152	hybrid			2022-12-27	WOS:000178791400119
J	Wang, XQ; Sun, P; Paller, AS				Wang, XQ; Sun, P; Paller, AS			Ganglioside modulation regulates epithelial cell adhesion and spreading via ganglioside-specific effects on signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; GROWTH-FACTOR RECEPTOR; PHOSPHATIDYLINOSITOL 3-KINASE; ACTIVATION; FIBRONECTIN; EXPRESSION; KERATINOCYTES; BINDING; DIFFERENTIATION; TRANSDUCTION	Gangliosides are implicated in regulating cell adhesion and migration on fibronectin by binding with the a, subunit of alpha(5)beta(1) integrin. However, the effects of gangliosides on cell spreading and related signaling pathways are unknown. Increases in gangliosides GT1b and GD3 inhibited spreading on fibronectin, concurrent with inhibition of Src and focal adhesion kinase. Although antibody blockade of GT1b or GD3 function and gene-modulated ganglioside depletion stimulated spreading and activated Src and focal adhesion kinase, the augmented spreading by disruption of GT1b function, but not by disruption of GD3 function, was inhibited by blockade of Src and focal adhesion kinase activation. In contrast, inhibitors of protein kinase C prevented the stimulation of spreading by GD3 functional inhibition, but not by GT1b functional blockade. Modulation of either GT1b or GD3 content affected phosphoinositol 3-kinase activation, and inhibition of this activation reversed the stimulation of cell spreading by anti-GD3 antibody, anti-GT1b antibody, and ganglioside depletion, suggesting that phosphoinositol 3-kinase is an intermediate in both the FAK/Src and protein kinase C pathways that lead to cell spreading. These studies demonstrate that epithelial cell ganglioside GT1b modulates cell spreading through alpha(5)beta(1)/FAK and phosphoinositol 3-kinase signaling, whereas GD3-modulated spreading appears to involve phosphoinositol 3-kinase-dependent protein kinase C signaling.	Northwestern Univ, Sch Med, Childrens Mem Inst Educ & Res, Dept Pediat, Chicago, IL 60614 USA; Northwestern Univ, Sch Med, Childrens Mem Inst Educ & Res, Dept Dermatol, Chicago, IL 60614 USA	Northwestern University; Northwestern University	Paller, AS (corresponding author), Childrens Mem Hosp, Div Dermatol 107, 2300 Childrens Plaza, Chicago, IL 60614 USA.			Paller, Amy/0000-0001-6187-6549	NIAMS NIH HHS [R01 AR 44619] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044619] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Balciunaite E, 2001, BIOCHEM J, V358, P281, DOI 10.1042/0264-6021:3580281; Danilkovitch A, 1999, EXP CELL RES, V248, P575, DOI 10.1006/excr.1999.4429; Disatnik MH, 2002, J CELL SCI, V115, P2151; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Hakomori S, 2002, P NATL ACAD SCI USA, V99, P225, DOI 10.1073/pnas.012540899; Iwabuchi K, 1998, J BIOL CHEM, V273, P9130, DOI 10.1074/jbc.273.15.9130; KIM HH, 1994, J BIOL CHEM, V269, P24747; Kim MS, 2001, CANCER LETT, V171, P79, DOI 10.1016/S0304-3835(01)00505-5; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li RX, 2001, J BIOL CHEM, V276, P42782, DOI 10.1074/jbc.M101481200; MassonGadais B, 1997, EXP CELL RES, V236, P238, DOI 10.1006/excr.1997.3721; Miranti CK, 1999, J BIOL CHEM, V274, P10571, DOI 10.1074/jbc.274.15.10571; NAGATA Y, 1992, J BIOL CHEM, V267, P12082; OKEEFE EJ, 1985, J INVEST DERMATOL, V85, P125, DOI 10.1111/1523-1747.ep12276531; PALLER AS, 1995, J INVEST DERMATOL, V105, P237, DOI 10.1111/1523-1747.ep12317572; PALLER AS, 1995, EXP CELL RES, V217, P118, DOI 10.1006/excr.1995.1070; PALLER AS, 1993, J INVEST DERMATOL, V100, P841, DOI 10.1111/1523-1747.ep12476755; ROYAL I, 1995, J BIOL CHEM, V270, P27780, DOI 10.1074/jbc.270.46.27780; Schlaepfer DD, 1997, J BIOL CHEM, V272, P13189, DOI 10.1074/jbc.272.20.13189; Sun P, 2002, J INVEST DERMATOL, V119, P107, DOI 10.1046/j.1523-1747.2002.01802.x; Sung CC, 1998, EXP CELL RES, V239, P311, DOI 10.1006/excr.1997.3897; Sung Ching-Ching, 1997, Journal of Investigative Dermatology, V108, P662; VUORI K, 1993, J BIOL CHEM, V268, P21459; Vyas KA, 2001, BIOL CHEM, V382, P241, DOI 10.1515/BC.2001.031; Wada T, 1999, BIOCHEM BIOPH RES CO, V261, P21, DOI 10.1006/bbrc.1999.0973; Wang XQ, 2001, J INVEST DERMATOL, V116, P69, DOI 10.1046/j.1523-1747.2001.00222.x; Wang XQ, 2001, GLYCOBIOLOGY, V11, P515, DOI 10.1093/glycob/11.7.515; Wang XQ, 2001, J BIOL CHEM, V276, P44504, DOI 10.1074/jbc.M106563200; Wang XQ, 2001, J BIOL CHEM, V276, P8436, DOI 10.1074/jbc.M006097200; Wang YL, 1999, METHOD ENZYMOL, V306, P281; WANG YL, 1994, P NATL ACAD SCI USA, V91, P8180, DOI 10.1073/pnas.91.17.8180; WHITNEY GS, 1993, DNA CELL BIOL, V12, P823, DOI 10.1089/dna.1993.12.823; ZHENG MZ, 1993, J BIOL CHEM, V268, P2217	33	25	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 25	2002	277	43					40410	40419		10.1074/jbc.M207117200	http://dx.doi.org/10.1074/jbc.M207117200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	607KU	12183467	hybrid			2022-12-27	WOS:000178791400034
J	Garvie, CW; Pufall, MA; Graves, BJ; Wolberger, C				Garvie, CW; Pufall, MA; Graves, BJ; Wolberger, C			Structural analysis of the autoinhibition of Ets-1 and its role in protein partnerships	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR; DNA-BINDING; AUTO-INHIBITION; DOMAIN; FAMILY; PHOSPHORYLATION; PEA3	The DNA-binding activity of the eukaryotic transcription factor Ets-1 (E26 avian erythroblastosis virus oncogene-E twenty-six) is negatively regulated by inhibitory regions that flank the ETS domain. Based on the results of solution studies, these N- and C-terminal inhibitory regions have been proposed to pack against the ETS domain and form an autoinhibitory module whose N terminus partially unfolds upon binding of Ets-1 to DNA. Mutations that disrupt autoinhibition of DNA binding also cause a structural change in the inhibitory region. We report here a crystallographic study of fragments of Ets-1 that provide structural details of the inhibitory module and the structural transition that accompanies DNA binding. The structures of free and DNA-bound Ets-1 fragments containing the ETS domain and the inhibitory regions confirm that the N-terminal inhibitory region contains two a-helices one of which unfolds upon Ets-1 binding to DNA. The observations from the crystal structure, coupled with mutagenesis experiments, allow us to propose a model for the inhibited form of Ets-1 and lend insight into the flexible interaction between Ets-1 and the acute myeloid leukemia 1 protein, AML1 (RUNX1).	Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; Univ Utah, Dept Oncol Sci, Huntsman Canc Inst, Salt Lake City, UT 84112 USA	Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah	Wolberger, C (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, 725 N Wolfe St, Baltimore, MD 21205 USA.	ewolberg@jhmi.edu		Pufall, Miles/0000-0002-7022-6916; Wolberger, Cynthia/0000-0001-8578-2969	NATIONAL CANCER INSTITUTE [T32CA093247, P30CA042014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008537, R01GM038663] Funding Source: NIH RePORTER; NCI NIH HHS [T32-CA93247] Funding Source: Medline; NIGMS NIH HHS [T32-GM08537, R01 GM38663] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Batchelor AH, 1998, SCIENCE, V279, P1037, DOI 10.1126/science.279.5353.1037; BENNETT MJ, 1994, P NATL ACAD SCI USA, V91, P3127, DOI 10.1073/pnas.91.8.3127; Bojovic BB, 2001, J BIOL CHEM, V276, P4509, DOI 10.1074/jbc.M005509200; Bradford AP, 1997, MOL CELL BIOL, V17, P1065, DOI 10.1128/MCB.17.3.1065; Bravo J, 2001, NAT STRUCT BIOL, V8, P371, DOI 10.1038/86264; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cowley DO, 2000, GENE DEV, V14, P366; DALTON S, 1992, CELL, V68, P597, DOI 10.1016/0092-8674(92)90194-H; Fitzsimmons D, 1996, GENE DEV, V10, P2198, DOI 10.1101/gad.10.17.2198; Garvie CW, 2001, MOL CELL, V8, P1267, DOI 10.1016/S1097-2765(01)00410-5; GIOVANE A, 1994, GENE DEV, V8, P1502, DOI 10.1101/gad.8.13.1502; Goetz TL, 2000, MOL CELL BIOL, V20, P81, DOI 10.1128/MCB.20.1.81-90.2000; Graves BJ, 1998, COLD SPRING HARB SYM, V63, P621, DOI 10.1101/sqb.1998.63.621; Graves BJ, 1998, ADV CANCER RES, V75, P1, DOI 10.1016/S0065-230X(08)60738-1; Greenall A, 2001, J BIOL CHEM, V276, P16207, DOI 10.1074/jbc.M011582200; Gu TL, 2000, MOL CELL BIOL, V20, P91, DOI 10.1128/MCB.20.1.91-103.2000; JANKNECHT R, 1994, ONCOGENE, V9, P1273; Johnson PR, 1998, CELL, V94, P217, DOI 10.1016/S0092-8674(00)81421-X; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Jonsen MD, 1996, MOL CELL BIOL, V16, P2065; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kim WY, 1999, EMBO J, V18, P1609, DOI 10.1093/emboj/18.6.1609; LOPEZ M, 1994, MOL CELL BIOL, V14, P3292, DOI 10.1128/MCB.14.5.3292; NYE JA, 1992, GENE DEV, V6, P975, DOI 10.1101/gad.6.6.975; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PETERSEN JM, 1995, SCIENCE, V269, P1866, DOI 10.1126/science.7569926; Pufall MA, 2002, ANNU REV CELL DEV BI, V18, P421, DOI 10.1146/annurev.cellbio.18.031502.133614; Schymkowitz JWH, 2001, NAT STRUCT BIOL, V8, P888, DOI 10.1038/nsb1001-888; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; Sieweke MH, 1998, EMBO J, V17, P1728, DOI 10.1093/emboj/17.6.1728; Sieweke Michael H., 1997, Leukemia (Basingstoke), V11, P486; Skalicky JJ, 1996, PROTEIN SCI, V5, P296; Vielhaber EL, 2001, J BIOL CHEM, V276, P45921, DOI 10.1074/jbc.M107726200; Wang H, 2002, J BIOL CHEM, V277, P2225, DOI 10.1074/jbc.M109430200	35	72	73	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2002	277	47					45529	45536		10.1074/jbc.M206327200	http://dx.doi.org/10.1074/jbc.M206327200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	618EE	12221090	hybrid			2022-12-27	WOS:000179404800118
J	Melzner, I; Scott, V; Dorsch, K; Fischer, P; Wabitsch, M; Bruderlein, S; Hasel, C; Moller, P				Melzner, I; Scott, V; Dorsch, K; Fischer, P; Wabitsch, M; Bruderlein, S; Hasel, C; Moller, P			Leptin gene expression in human preadipocytes is switched on by maturation-induced demethylation of distinct CpGs in its proximal promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENHANCER-BINDING-PROTEIN; DNA METHYLATION; ADIPOCYTE DIFFERENTIATION; TRANSCRIPTION FACTOR; CYTOSINE METHYLATION; 3T3-L1 CELLS; OB GENE; ALPHA; ACTIVATION; MECP2	The peptide hormone leptin plays a major role in the regulation of energy intake and expenditure and is predominantly expressed in mature adipocytes but not in preadipocytes. Using bisulfite genomic sequencing, we found that 32 CpGs, distributed within a 317-bp sequence of the proximal leptin promoter, were highly methylated in human preadipocytes (73.4% +/- 9.0%). During maturation toward terminally differentiated adipocytes, this promoter region was extremely demethylated (9.4% +/- 4.4%). CpG methylation-dependent transcriptional activity of the promoter fragment was determined in transfection experiments using a set of 5'-truneated mock-, HhaI-, and SssI-methylated promoter-reporter constructs. Whereas the methylated CpG within the CCAAT/enhancer-binding protein a recognition site down-regulated reporter expression, methylated CpGs proximal to the TATA motif and/or in a further upstream region abrogated promoter activity completely. These distinct promoter CpG sequences were found unmethylated in leptin-expressing mature adipocytes. As evidenced by electrophoretic mobility shift assays, nuclear protein complexes were specifically formed on methylated oligonucleotide probes corresponding to the dedicated promoter sequences, indicating that methyl-CpG binding proteins participate in transcriptional repression and regulation of the human leptin gene.	Univ Ulm, Dept Pathol, D-89081 Ulm, Germany; Univ Ulm, Dept Pediat, D-89081 Ulm, Germany	Ulm University; Ulm University	Moller, P (corresponding author), Univ Ulm, Dept Pathol, Albert Einstein Allee 11, D-89081 Ulm, Germany.	peter.moeller@medizin.uni-ulm.de						Bartolomei MS, 1997, ANNU REV GENET, V31, P493, DOI 10.1146/annurev.genet.31.1.493; Campanero MR, 2000, P NATL ACAD SCI USA, V97, P6481, DOI 10.1073/pnas.100340697; Campfield LA, 2000, FRONT HORM RES, V26, P12; Cao YX, 2000, BIOCHEM J, V350, P883, DOI 10.1042/0264-6021:3500883; CEDAR H, 1988, CELL, V53, P3, DOI 10.1016/0092-8674(88)90479-5; Chehab FF, 2000, TRENDS PHARMACOL SCI, V21, P309, DOI 10.1016/S0165-6147(00)01514-5; CHRISTY RJ, 1989, GENE DEV, V3, P1323, DOI 10.1101/gad.3.9.1323; Cohen P, 2002, SCIENCE, V297, P240, DOI 10.1126/science.1071527; COMB M, 1990, NUCLEIC ACIDS RES, V18, P3975, DOI 10.1093/nar/18.13.3975; CORNELIUS P, 1994, ANNU REV NUTR, V14, P99, DOI 10.1146/annurev.nu.14.070194.000531; De Smet C, 1999, MOL CELL BIOL, V19, P7327; DIGNAM JD, 1990, METHOD ENZYMOL, V182, P194; EDEN S, 1994, CURR OPIN GENET DEV, V4, P255, DOI 10.1016/S0959-437X(05)80052-8; Feng Q, 2001, GENE DEV, V15, P827; Free A, 2001, J BIOL CHEM, V276, P3353, DOI 10.1074/jbc.M007224200; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Gainsford T, 1996, P NATL ACAD SCI USA, V93, P14564, DOI 10.1073/pnas.93.25.14564; Gong DW, 1996, J BIOL CHEM, V271, P3971; HARRINGTON MA, 1988, P NATL ACAD SCI USA, V85, P2066, DOI 10.1073/pnas.85.7.2066; HAUNER H, 1989, J CLIN INVEST, V84, P1663, DOI 10.1172/JCI114345; Haynes WG, 1997, J CLIN INVEST, V100, P270, DOI 10.1172/JCI119532; HOLLER M, 1988, GENE DEV, V2, P1127, DOI 10.1101/gad.2.9.1127; Huntriss J, 1997, BIOCHEM BIOPH RES CO, V235, P730, DOI 10.1006/bbrc.1997.6876; Hwang CS, 1997, ANNU REV CELL DEV BI, V13, P231, DOI 10.1146/annurev.cellbio.13.1.231; Hwang CS, 1996, P NATL ACAD SCI USA, V93, P873, DOI 10.1073/pnas.93.2.873; IGUCHIARIGA SMM, 1989, GENE DEV, V3, P612, DOI 10.1101/gad.3.5.612; KAESTNER KH, 1990, P NATL ACAD SCI USA, V87, P251, DOI 10.1073/pnas.87.1.251; Kaludov NK, 2000, NUCLEIC ACIDS RES, V28, P1921, DOI 10.1093/nar/28.9.1921; Kitazawa S, 1999, J BIOL CHEM, V274, P28787, DOI 10.1074/jbc.274.40.28787; Lane MD, 1999, BIOCHEM BIOPH RES CO, V266, P677, DOI 10.1006/bbrc.1999.1885; LEWIS JD, 1992, CELL, V69, P905, DOI 10.1016/0092-8674(92)90610-O; LIN FT, 1994, P NATL ACAD SCI USA, V91, P8757, DOI 10.1073/pnas.91.19.8757; Lord GM, 1998, NATURE, V394, P897, DOI 10.1038/29795; Lu S, 1997, P NATL ACAD SCI USA, V94, P4692, DOI 10.1073/pnas.94.9.4692; MACDOUGALD OA, 1995, J BIOL CHEM, V270, P647, DOI 10.1074/jbc.270.2.647; Mason MM, 1998, ENDOCRINOLOGY, V139, P1013, DOI 10.1210/en.139.3.1013; MEEHAN RR, 1989, CELL, V58, P499, DOI 10.1016/0092-8674(89)90430-3; Miller SG, 1996, P NATL ACAD SCI USA, V93, P5507, DOI 10.1073/pnas.93.11.5507; Nan XS, 1996, MOL CELL BIOL, V16, P414; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; NAVEHMANY T, 1981, P NATL ACAD SCI-BIOL, V78, P4246, DOI 10.1073/pnas.78.7.4246; PARK EA, 1990, MOL CELL BIOL, V10, P6264, DOI 10.1128/MCB.10.12.6264; PRENDERGAST GC, 1991, CELL, V65, P395, DOI 10.1016/0092-8674(91)90457-A; Prokhortchouk A, 2001, GENE DEV, V15, P1613, DOI 10.1101/gad.198501; Razin A, 1998, EMBO J, V17, P4905, DOI 10.1093/emboj/17.17.4905; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; RIGGS AD, 1992, TRENDS GENET, V8, P169, DOI 10.1016/0168-9525(92)90219-T; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; Rosen ED, 2000, ANNU REV CELL DEV BI, V16, P145, DOI 10.1146/annurev.cellbio.16.1.145; SCHMIDT W, 1990, J BIOL CHEM, V265, P15489; SCOTT RE, 1982, J CELL BIOL, V94, P400, DOI 10.1083/jcb.94.2.400; Shao DL, 1997, J BIOL CHEM, V272, P21473, DOI 10.1074/jbc.272.34.21473; Sierra-Honigmann MR, 1998, SCIENCE, V281, P1683, DOI 10.1126/science.281.5383.1683; TAYLOR SM, 1985, INT J OBESITY, V9, P15; TAYLOR SM, 1979, CELL, V17, P771, DOI 10.1016/0092-8674(79)90317-9; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; UMEK RM, 1991, SCIENCE, V251, P288, DOI 10.1126/science.1987644; Wabitsch M, 2000, INT J CANCER, V88, P889, DOI 10.1002/1097-0215(20001215)88:6<889::AID-IJC8>3.0.CO;2-N; Yokomori N, 1999, DIABETES, V48, P685, DOI 10.2337/diabetes.48.4.685; Yokomori N, 2002, DIABETOLOGIA, V45, P140, DOI 10.1007/s125-002-8255-4; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924	61	145	153	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2002	277	47					45420	45427		10.1074/jbc.M208511200	http://dx.doi.org/10.1074/jbc.M208511200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	618EE	12213831	hybrid			2022-12-27	WOS:000179404800105
J	Pender, C; Goldfine, ID; Manchem, VP; Evans, JL; Spevak, WR; Shi, SY; Rao, S; Bajjalieh, S; Maddux, BA; Youngren, JF				Pender, C; Goldfine, ID; Manchem, VP; Evans, JL; Spevak, WR; Shi, SY; Rao, S; Bajjalieh, S; Maddux, BA; Youngren, JF			Regulation of insulin receptor function by a small molecule insulin receptor activator	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISCOVERY; RESISTANCE; MECHANISMS; PROTEIN	In type 2 diabetes mellitus, impaired insulin signaling leads to hyperglycemia and other metabolic abnormalities. TLK19780, a non-peptide small molecule, is a new member of a novel class of anti-diabetic agents that function as activators of the insulin receptor (IR) beta-subunit tyrosine kinase. In HTC-IR cells, 20 muM TLK19780 enhanced maximal insulin-stimulated IR autophosphorylation 2-fold and increased insulin sensitivity 2-3-fold. In contrast, TLK19780 did not potentiate the action of insulin-like growth factor-1, indicating the selectivity of TLK19780 toward the IR. The predominant effect of TLK19780 was to increase the number of IR that underwent autophosphorylation. Kinetic studies indicated that TLK19780 acted very rapidly, with a maximal effect observed 2 min after addition to insulin-stimulated cells. In 3T3-L1 adipocytes, 5 mum TLK19780 enhanced insulin-stimulated glucose transport, increasing both the sensitivity and maximal responsiveness to insulin. These studies indicate that at low micromolar levels small IR activator molecules can enhance insulin action in various cultured cells and suggest that this effect is mediated by increasing the number of IR that are tyrosine-phosphorylated in response to insulin. These studies suggest that these types of molecules could be developed to treat type 2 diabetes and other clinical conditions associated with insulin resistance.	Univ Calif San Francisco, Mt Zion Med Ctr, San Francisco, CA 94143 USA; Telik Inc, San Francisco, CA 94080 USA	University of California System; University of California San Francisco; UCSF Medical Center; UCSF Medical Center at Mount Zion	Youngren, JF (corresponding author), Univ Calif San Francisco, Mt Zion Med Ctr, Box 1616, San Francisco, CA 94143 USA.	drjack@itsa.ucsf.edu	Evans, Joseph L./N-4501-2013	Evans, Joseph L./0000-0002-9334-1650				FORSAYETH JR, 1987, P NATL ACAD SCI USA, V84, P3448, DOI 10.1073/pnas.84.10.3448; GOLDFINE ID, 1987, ENDOCR REV, V8, P235, DOI 10.1210/edrv-8-3-235; Goldfine ID, 1999, J LAB CLIN MED, V134, P100, DOI 10.1016/S0022-2143(99)90112-9; KAHN CR, 1994, DIABETES, V43, P1066, DOI 10.2337/diab.43.8.1066; KAHN CR, 1988, J CLIN INVEST, V82, P1151, DOI 10.1172/JCI113711; Li M, 2001, DIABETES, V50, P2323, DOI 10.2337/diabetes.50.10.2323; Liu K, 2000, J MED CHEM, V43, P3487, DOI 10.1021/jm000285q; Luo RZT, 1999, SCIENCE, V285, P1077, DOI 10.1126/science.285.5430.1077; MADDUX BA, 1995, NATURE, V373, P448, DOI 10.1038/373448a0; Manchem VP, 2001, DIABETES, V50, pA125; Manchem VP, 2001, DIABETES, V50, P824, DOI 10.2337/diabetes.50.4.824; MOLLER DE, 1991, NEW ENGL J MED, V325, P938; Salituro GM, 2001, RECENT PROG HORM RES, V56, P107, DOI 10.1210/rp.56.1.107; SBRACCIA P, 1990, J BIOL CHEM, V265, P4902; SUNG CK, 1994, MOL ENDOCRINOL, V8, P315, DOI 10.1210/me.8.3.315; THIES RS, 1990, DIABETES, V39, P250, DOI 10.2337/diabetes.39.2.250; Virkamaki A, 1999, J CLIN INVEST, V103, P931, DOI 10.1172/JCI6609; White MF, 1998, RECENT PROG HORM RES, V53, P119; Youngren JF, 1999, AM J PHYSIOL-ENDOC M, V276, pE990, DOI 10.1152/ajpendo.1999.276.5.E990; Zhang B, 1999, SCIENCE, V284, P974, DOI 10.1126/science.284.5416.974; Zhang BB, 2000, CURR OPIN CHEM BIOL, V4, P461, DOI 10.1016/S1367-5931(00)00103-4; ZhangSun G, 1996, ENDOCRINOLOGY, V137, P2649, DOI 10.1210/en.137.7.2649	22	30	37	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2002	277	46					43565	43571		10.1074/jbc.M202426200	http://dx.doi.org/10.1074/jbc.M202426200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	615XE	12213804	hybrid			2022-12-27	WOS:000179272000005
J	Gouaze, V; Andrieu-Abadie, N; Cuvillier, O; Malagarie-Cazenave, S; Frisach, MF; Mirault, ME; Levade, T				Gouaze, V; Andrieu-Abadie, N; Cuvillier, O; Malagarie-Cazenave, S; Frisach, MF; Mirault, ME; Levade, T			Glutathione peroxidase-1 protects from CD95-induced apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CARCINOMA CELLS; FAS-INDUCED APOPTOSIS; DOXORUBICIN-INDUCED APOPTOSIS; APO-1/FAS LIGAND EXPRESSION; OXIDATIVE STRESS; NECROSIS-FACTOR; CYTOCHROME-C; T-CELLS; CD95(FAS/APO-1)-MEDIATED APOPTOSIS; MEDIATED APOPTOSIS	Through the induction of apoptosis, CD95 plays a crucial role in the immune response and the elimination of cancer cells. Ligation of CD95 receptor activates a complex signaling network that appears to implicate the generation of reactive oxygen species (ROS). This study investigated the place of ROS production in CD95-mediated apoptosis and the role of the antioxidant enzyme glutathione peroxidase-1 (GPx1). Anti-CD95 antibodies triggered an early generation of ROS in human breast cancer T47D cells that was blocked by overexpression of GPx1 and inhibition of initiator caspase activation. Enforced expression of GPxl also resulted in inhibition of CD95-induced effector caspase activation, DNA fragmentation, and apoptotic cell death. Resistance to CD95-mediated apoptosis was not due to an increased expression of anti-apoptotic molecules and could be reversed by glutathione-depleting agents. In addition, whereas the anti-apoptotic protein Bcl-xL prevented CD95-induced apoptosis in MCF-7 cells, it did not inhibit the early ROS production. Moreover, Bcl-xL but not GPx1 overexpression could suppress the staurosporine-induced late generation of ROS and subsequent cell death. Altogether, these findings suggest that GPx1 functions upstream of the mitochondrial events to inhibit the early ROS production and apoptosis induced by CD95 ligation. Finally, transgenic mice overexpressing GPx1 were partially protected from the lethal effect of antiCD95, underlying the importance of peroxide formation (and GPx1) in CD95-triggered apoptosis.	CHU Rangueil, INSERM, U466, Lab Biochim Med, F-31059 Toulouse 9, France; CHU Laval, Res Ctr, Unit Hlth & Environm, Ste Foy, PQ G1V 4G2, Canada	CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Laval University	Levade, T (corresponding author), CHU Rangueil, INSERM, U466, Lab Biochim Med, 1 Ave Jean Pulhes,TSA 50032, F-31059 Toulouse 9, France.	levade@toulouse.inserm.fr	CUVILLIER, Olivier/B-2567-2009; Andrieu-Abadie, Nathalie/N-6793-2013; Gouaze-Andersson, Valerie/O-9180-2014; CUVILLIER, Olivier/S-1631-2019; Levade, Thierry/O-8948-2014	CUVILLIER, Olivier/0000-0003-3346-375X; Andrieu-Abadie, Nathalie/0000-0003-2698-1970; Gouaze-Andersson, Valerie/0000-0002-1797-515X; CUVILLIER, Olivier/0000-0003-3346-375X; malagarie-cazenave, sophie/0000-0001-8380-5223				Andrieu-Abadie N, 1999, FASEB J, V13, P1501, DOI 10.1096/fasebj.13.12.1501; Armstrong RC, 1996, J BIOL CHEM, V271, P16850, DOI 10.1074/jbc.271.28.16850; Banki K, 1996, J BIOL CHEM, V271, P32994, DOI 10.1074/jbc.271.51.32994; Banki K, 1999, J IMMUNOL, V162, P1466; Bauer MKA, 1998, J BIOL CHEM, V273, P8048, DOI 10.1074/jbc.273.14.8048; Brigelius-Flohe R, 1999, FREE RADICAL BIO MED, V27, P951, DOI 10.1016/S0891-5849(99)00173-2; BUTTKE TM, 1994, IMMUNOL TODAY, V15, P7, DOI 10.1016/0167-5699(94)90018-3; Chandra J, 2000, FREE RADICAL BIO MED, V29, P323, DOI 10.1016/S0891-5849(00)00302-6; Chiba T, 1996, EUR J IMMUNOL, V26, P1164, DOI 10.1002/eji.1830260530; Cuvillier O, 2001, CELL DEATH DIFFER, V8, P162, DOI 10.1038/sj.cdd.4400793; Deas O, 1997, INT IMMUNOL, V9, P117, DOI 10.1093/intimm/9.1.117; DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6; Garcia-Calvo M, 1998, J BIOL CHEM, V273, P32608, DOI 10.1074/jbc.273.49.32608; Gouaze V, 2001, MOL PHARMACOL, V60, P488; Gulbins E, 1996, IMMUNOLOGY, V89, P205, DOI 10.1046/j.1365-2567.1996.d01-743.x; Haouzi D, 2001, HEPATOLOGY, V33, P1181, DOI 10.1053/jhep.2001.24235; Hentze H, 2002, J BIOL CHEM, V277, P5588, DOI 10.1074/jbc.M110766200; Holmstrom TH, 1998, J IMMUNOL, V160, P2626; JAATTELA M, 1995, ONCOGENE, V10, P2297; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Jayanthi S, 1999, MOL BRAIN RES, V72, P158, DOI 10.1016/S0169-328X(99)00216-8; Juo P, 1998, CURR BIOL, V8, P1001, DOI 10.1016/S0960-9822(07)00420-4; Kasahara Y, 1997, BLOOD, V89, P1748, DOI 10.1182/blood.V89.5.1748.1748_1748_1753; Keane MM, 1996, CANCER RES, V56, P4791; Kiningham KK, 1999, FASEB J, V13, P1601, DOI 10.1096/fasebj.13.12.1601; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Kohno T, 1996, J IMMUNOL, V156, P4722; Krammer PH, 2000, NATURE, V407, P789, DOI 10.1038/35037728; Kruman I, 1998, J NEUROSCI RES, V51, P293, DOI 10.1002/(SICI)1097-4547(19980201)51:3<293::AID-JNR3>3.0.CO;2-B; Kwon D, 2001, J NEUROIMMUNOL, V113, P1, DOI 10.1016/S0165-5728(00)00321-0; Laouar A, 1999, J BIOL CHEM, V274, P23526, DOI 10.1074/jbc.274.33.23526; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Malassagne B, 2001, GASTROENTEROLOGY, V121, P1451, DOI 10.1053/gast.2001.29590; MATSUDA M, 1991, J IMMUNOL, V147, P3837; Medema JP, 1998, J BIOL CHEM, V273, P3388, DOI 10.1074/jbc.273.6.3388; MIRAULT ME, 1991, J BIOL CHEM, V266, P20752; MIRAULT ME, 1994, ANN NY ACAD SCI, V738, P104; NAGATA S, 1995, SCIENCE, V267, P1449, DOI 10.1126/science.7533326; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; Nomura K, 1999, J BIOL CHEM, V274, P29294, DOI 10.1074/jbc.274.41.29294; OGASAWARA J, 1993, NATURE, V364, P806, DOI 10.1038/364806a0; Rasper DM, 1998, CELL DEATH DIFFER, V5, P271, DOI 10.1038/sj.cdd.4400370; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Srinivasan A, 1998, J BIOL CHEM, V273, P4523, DOI 10.1074/jbc.273.8.4523; Sun XM, 1999, J BIOL CHEM, V274, P5053, DOI 10.1074/jbc.274.8.5053; Suzuki Y, 1998, FEBS LETT, V425, P209, DOI 10.1016/S0014-5793(98)00228-2; Um HD, 1996, J IMMUNOL, V156, P3469; vandenDobbelsteen DJ, 1996, J BIOL CHEM, V271, P15420, DOI 10.1074/jbc.271.26.15420; Vogt M, 1998, FEBS LETT, V429, P67, DOI 10.1016/S0014-5793(98)00562-6; Wedi B, 1999, BLOOD, V94, P2365, DOI 10.1182/blood.V94.7.2365.419k08_2365_2373; William R, 1997, BLOOD, V89, P4175, DOI 10.1182/blood.V89.11.4175; Williams MS, 1996, J IMMUNOL, V157, P2395; Wilson DJ, 1999, CELL IMMUNOL, V194, P67, DOI 10.1006/cimm.1999.1486; Xiang JL, 1996, P NATL ACAD SCI USA, V93, P14559, DOI 10.1073/pnas.93.25.14559; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; ZAMZAMI N, 1995, J EXP MED, V182, P367, DOI 10.1084/jem.182.2.367; Zamzami N, 1997, J BIOENERG BIOMEMBR, V29, P185, DOI 10.1023/A:1022694131572; Zhang P, 1997, J BIOL CHEM, V272, P30615, DOI 10.1074/jbc.272.49.30615	58	73	75	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					42867	42874		10.1074/jbc.M203067200	http://dx.doi.org/10.1074/jbc.M203067200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12221075	hybrid			2022-12-27	WOS:000179081200059
J	Hua, QX; Chu, YC; Jia, WH; Phillips, NFB; Wang, RY; Katsoyannis, PG; Weiss, MA				Hua, QX; Chu, YC; Jia, WH; Phillips, NFB; Wang, RY; Katsoyannis, PG; Weiss, MA			Mechanism of insulin chain combination - Asymmetric roles of A-chain alpha-helices in disulfide pairing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH FACTOR-I; RECEPTOR-BINDING; BIOLOGICAL-ACTIVITY; FOLDING PATHWAY; PHOTO-CIDNP; IGF-I; PROTEIN; PEPTIDE; ASSIGNMENT; DYNAMICS	The A and B chains of insulin combine to form native disulfide bridges without detectable isomers. The fidelity of chain combination thus recapitulates the folding of proinsulin, a precursor protein in which the two chains are tethered by a disordered connecting peptide. We have recently shown that chain combination is blocked by seemingly conservative substitutions in the C-terminal alpha-helix of the A chain. Such analogs, once formed, nevertheless retain high biological activity. By contrast, we demonstrate here that chain combination is robust to non-conservative substitutions in the N-terminal alpha-helix. Introduction of multiple glycine substitutions into the N-terminal segment of the A chain (residues A1-A5) yields analogs that are less stable than native insulin and essentially without biological activity. H-1 NMR studies of a representative analog lacking invariant side chains Ile(A2) and Val(A3) (A chain sequence GGGEQCCTSICSLYQLENYCN. substitutions are italicized and cysteines are underlined) demonstrate local unfolding of the A1-A5 segment in an otherwise native-like structure. That this and related partial folds retain efficient disulfide pairing suggests that the native N-terminal alpha-helix does not participate in the transition state of the reaction. Implications for the hierarchical folding mechanisms of proinsulin and insulin-like growth factors are discussed.	NYU, Mt Sinai Sch Med, Dept Pharmacol & Biol Chem, New York, NY 10029 USA; Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA	Icahn School of Medicine at Mount Sinai; New York University; Case Western Reserve University	Katsoyannis, PG (corresponding author), NYU, Mt Sinai Sch Med, Dept Pharmacol & Biol Chem, New York, NY 10029 USA.							BAKER EN, 1988, PHILOS T ROY SOC B, V319, P369, DOI 10.1098/rstb.1988.0058; Baldwin RL, 1999, TRENDS BIOCHEM SCI, V24, P77, DOI 10.1016/S0968-0004(98)01345-0; Baldwin RL, 1999, TRENDS BIOCHEM SCI, V24, P26, DOI 10.1016/S0968-0004(98)01346-2; BREMS DN, 1992, PROTEIN ENG, V5, P519, DOI 10.1093/protein/5.6.519; CARA JF, 1990, J BIOL CHEM, V265, P17820; Chance R. E., 1981, PEPTIDES SYNTHESIS S, P721; CHANCE RE, 1993, DIABETES CARE, V16, P133, DOI 10.2337/diacare.16.3.133; CHU YC, 1987, BIOCHEMISTRY-US, V26, P6975, DOI 10.1021/bi00396a018; CHU YC, 1994, BIOCHEMISTRY-US, V33, P11278, DOI 10.1021/bi00203a025; DEREWENDA U, 1991, J MOL BIOL, V220, P425, DOI 10.1016/0022-2836(91)90022-X; Dodson G, 1998, CURR OPIN STRUC BIOL, V8, P189, DOI 10.1016/S0959-440X(98)80037-7; Grantcharova VP, 1998, NAT STRUCT BIOL, V5, P714, DOI 10.1038/1412; Guo ZY, 2002, BIOCHEMISTRY-US, V41, P1556, DOI 10.1021/bi011166v; Guo ZY, 2001, BIOL CHEM, V382, P443, DOI 10.1515/BC.2001.054; HOBER S, 1992, BIOCHEMISTRY-US, V31, P1749, DOI 10.1021/bi00121a024; HU SQ, 1993, BIOCHEMISTRY-US, V32, P2631, DOI 10.1021/bi00061a022; Hua QX, 1996, J MOL BIOL, V259, P297, DOI 10.1006/jmbi.1996.0320; HUA QX, 1991, BIOCHEMISTRY-US, V30, P5505, DOI 10.1021/bi00236a025; HUA QX, 1995, NAT STRUCT BIOL, V2, P129, DOI 10.1038/nsb0295-129; Hua QX, 1996, J MOL BIOL, V264, P390, DOI 10.1006/jmbi.1996.0648; HUA QX, 1991, NATURE, V354, P238, DOI 10.1038/354238a0; Hua QX, 2001, BIOCHEMISTRY-US, V40, P12299, DOI 10.1021/bi011021o; HUA QX, 1990, BIOCHEMISTRY-US, V29, P10545, DOI 10.1021/bi00498a018; Jacoby E, 1996, J MOL BIOL, V258, P136, DOI 10.1006/jmbi.1996.0239; KATSOYAN.PG, 1966, P NATL ACAD SCI USA, V55, P1554, DOI 10.1073/pnas.55.6.1554; KLINE AD, 1990, BIOCHEMISTRY-US, V29, P2906, DOI 10.1021/bi00464a003; KOBAYASHI M, 1986, BIOCHEM BIOPH RES CO, V137, P250, DOI 10.1016/0006-291X(86)91203-9; Kristensen C, 1997, J BIOL CHEM, V272, P12978, DOI 10.1074/jbc.272.20.12978; Luo YZ, 2001, BIOCHEMISTRY-US, V40, P5283, DOI 10.1021/bi010122j; MARSHALL RN, 1974, J CLIN ENDOCR METAB, V39, P283, DOI 10.1210/jcem-39-2-283; MERRIFIELD RB, 1982, BIOCHEMISTRY-US, V21, P5020, DOI 10.1021/bi00263a028; MILLER JA, 1993, BIOCHEMISTRY-US, V32, P5203, DOI 10.1021/bi00070a032; NAKAGAWA SH, 1992, BIOCHEMISTRY-US, V31, P3204, DOI 10.1021/bi00127a023; NARHI LO, 1993, BIOCHEMISTRY-US, V32, P5214, DOI 10.1021/bi00070a033; Olsen HB, 1996, BIOCHEMISTRY-US, V35, P8836, DOI 10.1021/bi960292+; Olsen HB, 1998, J MOL BIOL, V284, P477, DOI 10.1006/jmbi.1998.2175; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; POCKER Y, 1980, BIOCHEMISTRY-US, V19, P5043, DOI 10.1021/bi00563a017; Qiao ZS, 2001, BIOCHEMISTRY-US, V40, P2662, DOI 10.1021/bi001613r; Ron D, 2002, J CLIN INVEST, V109, P443, DOI 10.1172/JC1200215020; Shakhnovich EI, 1999, NAT STRUCT BIOL, V6, P99, DOI 10.1038/5785; Shakhnovich EI, 1998, FOLD DES, V3, pR108, DOI 10.1016/S1359-0278(98)00056-X; SHOELSON SE, 1992, BIOCHEMISTRY-US, V31, P1757, DOI 10.1021/bi00121a025; SIEBER P, 1978, H-S Z PHYSIOL CHEM, V359, P113; Slieker LJ, 1997, DIABETOLOGIA, V40, pS54, DOI 10.1007/s001250051402; Sosnick TR, 2000, METHOD ENZYMOL, V317, P393; STEINER DF, 1988, HORM METAB RES, V20, P443, DOI 10.1055/s-2007-1010855; STEINER DF, 1967, T NEW YORK ACAD SCI, V30, P60, DOI 10.1111/j.2164-0947.1967.tb02452.x; STEINER DF, 1968, P NATL ACAD SCI USA, V60, P622, DOI 10.1073/pnas.60.2.622; TANG JG, 1990, BIOCHEM J, V268, P429, DOI 10.1042/bj2680429; WEISS MA, 1990, BIOCHEMISTRY-US, V29, P8389, DOI 10.1021/bi00488a028; Weiss MA, 2002, BIOCHEMISTRY-US, V41, P809, DOI 10.1021/bi011839+; WEISS MA, 1984, P NATL ACAD SCI-BIOL, V81, P6019, DOI 10.1073/pnas.81.19.6019; Weiss MA, 2000, BIOCHEMISTRY-US, V39, P15429, DOI 10.1021/bi001905s; WEISS MA, 1989, BIOCHEMISTRY-US, V28, P9855, DOI 10.1021/bi00451a046; WEISS MA, 1991, BIOCHEMISTRY-US, V30, P7373, DOI 10.1021/bi00244a004; Winter J, 2002, J BIOL CHEM, V277, P310, DOI 10.1074/jbc.M107832200; Xu B, 2002, J MOL BIOL, V316, P435, DOI 10.1006/jmbi.2001.5377; Xu B, 2002, PROTEIN SCI, V11, P104, DOI 10.1110/ps.ps.32102; Zhang JX, 1997, PROTEIN SCI, V6, P1563, DOI 10.1002/pro.5560060720	60	61	66	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					43443	43453		10.1074/jbc.M206107200	http://dx.doi.org/10.1074/jbc.M206107200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12196530	hybrid			2022-12-27	WOS:000179081200129
J	Young, NM; Brisson, JR; Kelly, J; Watson, DC; Tessier, L; Lanthier, PH; Jarrell, HC; Cadotte, N; Michael, FS; Aberg, E; Szymanski, CM				Young, NM; Brisson, JR; Kelly, J; Watson, DC; Tessier, L; Lanthier, PH; Jarrell, HC; Cadotte, N; Michael, FS; Aberg, E; Szymanski, CM			Structure of the N-linked glycan present on multiple glycoproteins in the gram-negative bacterium, Campylobacter jejuni	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSTTRANSLATIONAL MODIFICATION; NEISSERIA-MENINGITIDIS; PILIN GLYCOSYLATION; MYCOBACTERIUM-TUBERCULOSIS; IDENTIFICATION; FLAGELLIN; PROTEINS; POLYSACCHARIDES; SPECTROSCOPY; PURIFICATION	Mass spectrometry investigations of partially purified Campylobacter jejuni protein PEB3 showed it to be partially modified with an Asn-linked glycan with a mass of 1406 Da and composed of one hexose, five N-acetylhexosamines and a species of mass 228 Da, consistent with a trideoxydiacetamidohexose. By means of soybean lectin affinity chromatography, a mixture of glycoproteins was obtained from a glycine extract, and two-dimensional gel proteomics analysis led to the identification of at least 22 glycoproteins, predominantly annotated as periplasmic proteins. Glycopeptides were prepared from the glycoprotein mixture by Pronase digestion and gel filtration. The structure of the glycan was determined by using nano-NMR techniques to beGaINAc-alpha1,4-GaINAc-alpha1,4-[Glcbeta1,3-]GaINAc-alpha1,4-GaINAc-alpha1,4-GaINAc-alpha1,3-Bac- beta1,N-Asn-Xaa, where Bac is bacillosamine, 2,4-diacetamido-2,4,6-trideoxyglucopyranose. Protein glycosylation was abolished when the pglB gene was mutated, providing further evidence that the enzyme encoded by this gene is responsible for formation of the glycopeptide N-linkage. Comparison of the pgl locus with that of Neisseria meningitidis suggested that most of the homologous genes are probably involved in the biosynthesis of bacillosamine.	Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada	National Research Council Canada	Young, NM (corresponding author), Natl Res Council Canada, Inst Biol Sci, 100 Sussex Dr, Ottawa, ON K1A 0R6, Canada.							Angata T, 2002, CHEM REV, V102, P439, DOI 10.1021/cr000407m; BAUMANN H, 1992, BIOCHEMISTRY-US, V31, P4081, DOI 10.1021/bi00131a026; Bedouet L, 1998, MICROBIOS, V94, P183; Benz I, 2001, MOL MICROBIOL, V40, P1403, DOI 10.1046/j.1365-2958.2001.02487.x; Brimer CD, 1998, J BACTERIOL, V180, P3209, DOI 10.1128/JB.180.12.3209-3217.1998; Doig P, 1996, MOL MICROBIOL, V19, P379, DOI 10.1046/j.1365-2958.1996.370890.x; Gallego RG, 2001, J BIOL CHEM, V276, P30834, DOI 10.1074/jbc.M101013200; Ge YG, 1998, J BACTERIOL, V180, P2418, DOI 10.1128/JB.180.9.2418-2425.1998; Gemmill TR, 1999, BBA-GEN SUBJECTS, V1426, P227, DOI 10.1016/S0304-4165(98)00126-3; Gharahdaghi F, 1999, ELECTROPHORESIS, V20, P601, DOI 10.1002/(SICI)1522-2683(19990301)20:3<601::AID-ELPS601>3.0.CO;2-6; Guerry P, 1996, MOL MICROBIOL, V19, P369, DOI 10.1046/j.1365-2958.1996.369895.x; GUERRY P, 1994, METHOD ENZYMOL, V235, P474; Herrmann JL, 2000, FEBS LETT, V473, P358, DOI 10.1016/S0014-5793(00)01553-2; Horn C, 1999, J BIOL CHEM, V274, P32023, DOI 10.1074/jbc.274.45.32023; JANSSON PE, 1989, CARBOHYD RES, V188, P169, DOI 10.1016/0008-6215(89)84069-8; Jennings MP, 1998, MOL MICROBIOL, V29, P975, DOI 10.1046/j.1365-2958.1998.00962.x; Kahler CM, 2001, INFECT IMMUN, V69, P3597, DOI 10.1128/IAI.69.6.3597-3604.2001; Kupce E, 2001, J MAGN RESON, V148, P115, DOI 10.1006/jmre.2000.2224; Kupce E, 1998, J MAGN RESON, V135, P361, DOI 10.1006/jmre.1998.1607; LABIGNEROUSSEL A, 1988, J BACTERIOL, V170, P1704, DOI 10.1128/jb.170.4.1704-1708.1988; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEGENDRE N, 1988, BIOTECHNIQUES, V6, P154; Linton D, 2002, MOL MICROBIOL, V43, P497, DOI 10.1046/j.1365-2958.2002.02762.x; LOGAN SM, 1983, INFECT IMMUN, V42, P675, DOI 10.1128/IAI.42.2.675-682.1983; Lu JY, 1996, CARBOHYD RES, V296, P1, DOI 10.1016/S0008-6215(96)00240-6; Marceau M, 1999, J BACTERIOL, V181, P656, DOI 10.1128/JB.181.2.656-661.1999; Moens S, 1997, ARCH MICROBIOL, V168, P169, DOI 10.1007/s002030050484; Molinaro A, 2002, CARBOHYD RES, V337, P467, DOI 10.1016/S0008-6215(02)00004-6; PARGE HE, 1995, NATURE, V378, P32, DOI 10.1038/378032a0; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; PEI ZH, 1991, J BIOL CHEM, V266, P16363; Piotto M, 2001, J MAGN RESON, V149, P114, DOI 10.1006/jmre.2001.2287; Power PM, 2000, MICROBIOL-UK, V146, P967, DOI 10.1099/00221287-146-4-967; Rademaker GJ, 1998, ANAL BIOCHEM, V257, P149, DOI 10.1006/abio.1997.2548; Romain F, 1999, INFECT IMMUN, V67, P5567, DOI 10.1128/IAI.67.11.5567-5572.1999; Schaffer C, 2001, EUR J BIOCHEM, V268, P857, DOI 10.1046/j.1432-1327.2001.01961.x; Schaffer C, 2001, PROTEOMICS, V1, P248; STIMSON E, 1995, MOL MICROBIOL, V17, P1201, DOI 10.1111/j.1365-2958.1995.mmi_17061201.x; Szymanski CM, 1999, MOL MICROBIOL, V32, P1022, DOI 10.1046/j.1365-2958.1999.01415.x; Szymanski CM, 2002, INFECT IMMUN, V70, P2242, DOI 10.1128/IAI.70.4.2242-2244.2002; Thibault P, 2001, J BIOL CHEM, V276, P34862, DOI 10.1074/jbc.M104529200; Uhrin D, 2000, NMR IN MICROBIOLOGY: THEORY AND APPLICATIONS, P165; UHRIN D, 1997, J MAGN RESON, V126, P148; VINOGRADOV EV, 1992, EUR J BIOCHEM, V210, P491, DOI 10.1111/j.1432-1033.1992.tb17447.x; Wacker M., 2001, IJMM International Journal of Medical Microbiology, V291, P81; Wyss C, 1998, INFECT IMMUN, V66, P5751, DOI 10.1128/IAI.66.12.5751-5754.1998; YAO RJ, 1994, MOL MICROBIOL, V14, P883, DOI 10.1111/j.1365-2958.1994.tb01324.x; YOUNG NM, 1990, MOL IMMUNOL, V27, P1083, DOI 10.1016/0161-5890(90)90096-I	48	352	380	1	52	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					42530	42539		10.1074/jbc.M206114200	http://dx.doi.org/10.1074/jbc.M206114200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12186869	hybrid			2022-12-27	WOS:000179081200015
J	De Antoni, A; Schmitzova, J; Trepte, HH; Gallwitz, D; Albert, S				De Antoni, A; Schmitzova, J; Trepte, HH; Gallwitz, D; Albert, S			Significance of GTP hydrolysis in Ypt1p-regulated endoplasmic reticulum to Golgi transport revealed by the analysis of two novel Ypt1-GAPs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATING PROTEIN; BIOCHEMICAL-CHARACTERIZATION; VESICULAR TRANSPORT; YEAST SUGGESTS; RAB GTPASE; GAP; FUSION; YPT1; IDENTIFICATION; EXPRESSION	We here report on the identification and detailed biochemical characterization of two novel GTPase-activating proteins, Gyp5p and Gyp8p, whose efficient substrate is Ypt1p, a Ypt/Rab-GTPase essential for endoplasmic reticulum-to-Golgi trafficking in yeast. Gyp5p, accelerated the intrinsic GTPase activity of Ypt1p 4.2 X 10(4)-fold and, surprisingly, the 40-fold reduced GTP hydrolysis rate of Ypt1 (Q67L)p 1.5 x 10(4)-fold. At steady state, the two newly discovered GTPase-activating proteins (GAPs) as well as the previously described Gyp1p, which also uses Ypt1p as the preferred substrate, display different sulicellular localization. To add to an understanding of the significance of Ypt1p-bound GTP hydrolysis in vivo, yeast strains expressing the GTPase-deficient Ypt1(Q67L)p and having different Ypt1-GAP genes deleted were created. Depending on the genetic background, different mutants exhibited growth defects at low temperature and, already at permissive temperature, various morphological alterations resembling autophagy. Transport of proteins was not significantly impaired. Growth defects of Ypt1(Q67L)expressing cells could be suppressed on high expression of all three Ypt1-GAPs. We propose that permanently active Ypt1p leads to increased vesicle fusion, which might induce previously unnoticed autophagic degradation of exaggerated membrane-enclosed structures. The data indicate that hydrolysis of Ypt1p-bound GTP is a prerequisite for a balanced vesicle flow between endoplasmic reticulum and Golgi compartments.	Max Planck Inst Biophys Chem, Dept Mol Genet, D-37070 Gottingen, Germany	Max Planck Society	Gallwitz, D (corresponding author), Max Planck Inst Biophys Chem, Dept Mol Genet, D-37070 Gottingen, Germany.	dgallwi1@gwdg.de		De Antoni, Anna/0000-0003-4908-1684				Ahmadian MR, 1997, NAT STRUCT BIOL, V4, P686, DOI 10.1038/nsb0997-686; Albert S, 1999, EMBO J, V18, P5216, DOI 10.1093/emboj/18.19.5216; Albert S, 1999, J BIOL CHEM, V274, P33186, DOI 10.1074/jbc.274.47.33186; Albert S, 2000, BIOL CHEM, V381, P453, DOI 10.1515/BC.2000.059; BALCH WE, 1994, CELL, V76, P841, DOI 10.1016/0092-8674(94)90359-X; Bannykh SI, 1998, TRENDS CELL BIOL, V8, P21, DOI 10.1016/S0962-8924(97)01184-7; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BECKER J, 1991, EMBO J, V10, P785, DOI 10.1002/j.1460-2075.1991.tb08010.x; Benli M, 1996, EMBO J, V15, P6460, DOI 10.1002/j.1460-2075.1996.tb01037.x; Bon E, 2000, YEAST, V16, P1229, DOI 10.1002/1097-0061(20000930)16:13<1229::AID-YEA618>3.0.CO;2-Q; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; BROWNBRIDGE GG, 1993, J BIOL CHEM, V268, P10914; Cao XC, 2000, J CELL BIOL, V149, P55, DOI 10.1083/jcb.149.1.55; Cao XC, 1998, EMBO J, V17, P2156, DOI 10.1093/emboj/17.8.2156; Casanova JE, 1999, MOL BIOL CELL, V10, P47, DOI 10.1091/mbc.10.1.47; De Antoni A, 2000, GENE, V246, P179, DOI 10.1016/S0378-1119(00)00083-4; Du LL, 1998, J BIOL CHEM, V273, P3253, DOI 10.1074/jbc.273.6.3253; Du LL, 2001, MOL BIOL CELL, V12, P1215, DOI 10.1091/mbc.12.5.1215; DUGGLEBY RG, 1991, BIOCHIM BIOPHYS ACTA, V1080, P231, DOI 10.1016/0167-4838(91)90007-M; FRECH M, 1994, BIOCHEMISTRY-US, V33, P3237, DOI 10.1021/bi00177a014; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Guo W, 2000, TRENDS CELL BIOL, V10, P251, DOI 10.1016/S0962-8924(00)01754-2; KAISER CA, 1990, CELL, V61, P723, DOI 10.1016/0092-8674(90)90483-U; Klionsky DT, 1999, ANNU REV CELL DEV BI, V15, P1, DOI 10.1146/annurev.cellbio.15.1.1; KRENGEL U, 1990, CELL, V62, P539, DOI 10.1016/0092-8674(90)90018-A; Lang T, 1998, EMBO J, V17, P3597, DOI 10.1093/emboj/17.13.3597; Lazar T, 1997, TRENDS BIOCHEM SCI, V22, P468, DOI 10.1016/S0968-0004(97)01150-X; Li BJ, 1998, YEAST, V14, P915, DOI 10.1002/(SICI)1097-0061(199807)14:10<915::AID-YEA291>3.3.CO;2-P; Mellman I, 2000, CELL, V100, P99, DOI 10.1016/S0092-8674(00)81687-6; Muller O, 2000, J CELL BIOL, V151, P519, DOI 10.1083/jcb.151.3.519; Neuwald AF, 1997, TRENDS BIOCHEM SCI, V22, P243, DOI 10.1016/S0968-0004(97)01073-6; Niedenthal RK, 1996, YEAST, V12, P773, DOI 10.1002/(SICI)1097-0061(19960630)12:8<773::AID-YEA972>3.3.CO;2-C; Pfeffer SR, 1999, NAT CELL BIOL, V1, pE17, DOI 10.1038/8967; Rak A, 2000, EMBO J, V19, P5105, DOI 10.1093/emboj/19.19.5105; Richardson CJ, 1998, MOL CELL BIOL, V18, P827, DOI 10.1128/MCB.18.2.827; Rybin V, 1996, NATURE, V383, P266, DOI 10.1038/383266a0; Sakai Y, 1998, J CELL BIOL, V141, P625, DOI 10.1083/jcb.141.3.625; Schlumpberger M, 1997, J BACTERIOL, V179, P1068, DOI 10.1128/jb.179.4.1068-1076.1997; SCHMITT HD, 1988, CELL, V53, P635, DOI 10.1016/0092-8674(88)90579-X; Schweins T, 1996, BIOCHEMISTRY-US, V35, P14225, DOI 10.1021/bi961118o; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; STROM M, 1993, NATURE, V361, P736, DOI 10.1038/361736a0; Tong AHY, 2002, SCIENCE, V295, P321, DOI 10.1126/science.1064987; VOLLMER P, 1995, METHOD ENZYMOL, V257, P118; Vollmer P, 1999, EUR J BIOCHEM, V260, P284, DOI 10.1046/j.1432-1327.1999.00192.x; WAGNER P, 1992, METHOD ENZYMOL, V219, P369; WALWORTH NC, 1992, MOL CELL BIOL, V12, P2017, DOI 10.1128/MCB.12.5.2017; Wickner W, 2000, ANNU REV BIOCHEM, V69, P247, DOI 10.1146/annurev.biochem.69.1.247; Will E, 2001, METHOD ENZYMOL, V329, P50; Will E, 2001, J BIOL CHEM, V276, P12135, DOI 10.1074/jbc.M011451200; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	51	65	70	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2002	277	43					41023	41031		10.1074/jbc.M205783200	http://dx.doi.org/10.1074/jbc.M205783200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	607KU	12189143	Green Published, hybrid			2022-12-27	WOS:000178791400111
J	Feng, W; Fan, JS; Jiang, M; Shi, YW; Zhang, M				Feng, W; Fan, JS; Jiang, M; Shi, YW; Zhang, M			PDZ7 of glutamate receptor interacting protein binds to its target via a novel hydrophobic surface area	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMPA RECEPTORS; DOMAIN; NMR; RECOGNITION; MEMBRANE; COMPLEX; PROGRAM; ASSOCIATION; LIGANDS; PEPTIDE	Glutamate receptor interacting protein 1 (GRIP1) is a scaffold protein composed of seven PDZ (Postsynaptic synaptic density-95/Discs large Zona occludens-1) domains. The protein plays important roles in the synaptic targeting of alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA) receptors. The interaction between GRIP1 PDZ7 and a Ras guanine nucleotide exchange factor, GRASP-1, regulates synaptic distribution of AMPA receptors. Here, we describe the three-dimensional structure of GRIP1 PDZ7 determined by NMR spectroscopy. GRIP1 PDZ7 contains a closed carboxyl group-binding pocket and a narrow alphaB/betaB-groove that is not likely to bind to classical PDZ ligands. Unexpectedly, GRIP1 PDZ7 contains a large solvent-exposed hydrophobic surface at a site distinct from the conventional ligand-binding alphaB/betaB-groove. NMR titration experiments show that GRIP1 PDZ7 binds to GRASP-1 via this hydrophobic surface. Our data uncover a novel PDZ domain-mediated protein interaction mode that may be responsible for multimerization of other PDZ domain-containing scaffold proteins.	Hong Kong Univ Sci & Technol, Dept Biochem, Kowloon, Hong Kong, Peoples R China	Hong Kong University of Science & Technology	Zhang, M (corresponding author), Hong Kong Univ Sci & Technol, Dept Biochem, Kowloon, Hong Kong, Peoples R China.	mzhang@ust.hk	FENG, WEI/C-8966-2012	Feng, Wei/0000-0001-9738-9398; Zhang, Mingjie/0000-0001-9404-0190				BAX A, 1993, ACCOUNTS CHEM RES, V26, P131, DOI 10.1021/ar00028a001; Bladt F, 2002, P NATL ACAD SCI USA, V99, P6816, DOI 10.1073/pnas.092130099; Bruckner K, 1999, NEURON, V22, P511, DOI 10.1016/S0896-6273(00)80706-0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cabral JHM, 1996, NATURE, V382, P649, DOI 10.1038/382649a0; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Craven SE, 1998, CELL, V93, P495, DOI 10.1016/S0092-8674(00)81179-4; Daniels DL, 1998, NAT STRUCT BIOL, V5, P317, DOI 10.1038/nsb0498-317; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Dong HL, 1999, J NEUROSCI, V19, P6930, DOI 10.1523/JNEUROSCI.19-16-06930.1999; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Fouassier L, 2001, HEPATOLOGY, V33, P166, DOI 10.1053/jhep.2001.21143; GARRETT DS, 1991, J MAGN RESON, V95, P214, DOI 10.1016/0022-2364(91)90341-P; Harris BZ, 2001, J CELL SCI, V114, P3219; Hillier BJ, 1999, SCIENCE, V284, P812, DOI 10.1126/science.284.5415.812; Kay LE, 1997, CURR OPIN STRUC BIOL, V7, P722, DOI 10.1016/S0959-440X(97)80084-X; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lau AG, 2001, BIOCHEMISTRY-US, V40, P8572, DOI 10.1021/bi0103516; Lin D, 1999, J BIOL CHEM, V274, P3726, DOI 10.1074/jbc.274.6.3726; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Nicholls A., 1992, GRASP GRAPHICAL REPR; Schultz J, 2000, NUCLEIC ACIDS RES, V28, P231, DOI 10.1093/nar/28.1.231; Schultz J, 1998, NAT STRUCT BIOL, V5, P19, DOI 10.1038/nsb0198-19; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Srivastava S, 1998, NEURON, V21, P581, DOI 10.1016/S0896-6273(00)80568-1; Tochio H, 2000, J MOL BIOL, V303, P359, DOI 10.1006/jmbi.2000.4148; Tochio H, 1999, NAT STRUCT BIOL, V6, P417; Torres R, 1998, NEURON, V21, P1453, DOI 10.1016/S0896-6273(00)80663-7; Vallenius T, 2000, J BIOL CHEM, V275, P11100, DOI 10.1074/jbc.275.15.11100; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Wyszynski M, 1999, J NEUROSCI, V19, P6528; Xu XZS, 1998, J CELL BIOL, V142, P545, DOI 10.1083/jcb.142.2.545; Ye B, 2000, NEURON, V26, P603, DOI 10.1016/S0896-6273(00)81198-8; Zhang Q, 2001, J BIOL CHEM, V276, P43216, DOI 10.1074/jbc.M105996200	39	31	32	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2002	277	43					41140	41146		10.1074/jbc.M207206200	http://dx.doi.org/10.1074/jbc.M207206200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	607KU	12196542	hybrid			2022-12-27	WOS:000178791400124
J	Li, X; Massa, PE; Hanidu, A; Peet, GW; Aro, P; Savitt, A; Mische, S; Li, J; Marcu, KB				Li, X; Massa, PE; Hanidu, A; Peet, GW; Aro, P; Savitt, A; Mische, S; Li, J; Marcu, KB			IKK alpha, IKK beta, and NEMO/IKK gamma are each required for the NF-kappa B-mediated inflammatory response program	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							NECROSIS-FACTOR-ALPHA; PROTOONCOGENE BCL-3 ENCODES; SEVERE LIVER DEGENERATION; EPIDERMAL-GROWTH-FACTOR; GENE-EXPRESSION; KINASE-ALPHA; MICE LACKING; DEPENDENT TRANSCRIPTION; MOLECULAR-CLONING; DNA-BINDING	The IKKbeta and NEMO/IKKgamma subunits of the NF-kappaB-activating signalsome complex are known to be essential for activating NF-kappaB by inflammatory and other stress-like stimuli. However, the IKKalpha subunit is believed to be dispensable for the latter responses and instead functions as an in vivo mediator of other novel NF-kappaB-dependent and -independent functions. In contrast to this generally accepted view of IKKalpha's physiological functions, we demonstrate in mouse embryonic fibroblasts (NMFs) that, akin to IKKbeta and NEMO/IKKgamma, IKKalpha is also a global regulator of tumor necrosis factor alpha- and IL-1-responsive IKK signalsome-dependent target genes including many known NF-kappaB targets such as serum amyloid A3, C3, interleukin (IL)-6, IL-11, IL-1 receptor antagonist, vascular endothelial growth factor, Ptx3, beta(2)-microglobulin, IL-1alpha, Mcp-1 and -3, RANTES (regulated on activation normal T cell expressed and secreted), Fas antigen, Jun-B, c-Fos, macrophage colony-stimulating factor, and granulocyte-macrophage colony-stimulating factor. Only a small number of NF-kappaB-dependent target genes were preferentially dependent on IKKa or IKKbeta. Constitutive expression of a trans-dominant IkappaBalpha superrepressor (IkappaBalphaSR) in wild type MEFs confirmed that these signalsome-dependent target genes were also dependent on NF-kappaB. A subset of NF-kappaB target genes were IKK-dependent in the absence of exogenous stimuli, suggesting that the signalsome was also required to regulate basal levels of activated NF-kappaB in established MEFs. Overall, a sizable number of novel NF-kappaP/IKK-dependent genes were identified including Secreted Frizzled, cadherin 13, protocadherin 7, CCAAT/enhancer-binding protein-beta and -6, osteoprotegerin, FOXC2 and FOXF2, BMP-2, p75 neurotrophin receptor, caspase-11, guanylate-binding proteins 1 and 2, ApoJ/clusterin, interferon (a and 13) receptor 2, decorin, osteoglycin, epiregulin, proliferins 2 and 3, stromal cell-derived factor, and cathepsins B, F, and Z. SOCS-3, a negative effector of STAT3 signaling, was found to be an NF-kappaB/IKK-induced gene, suggesting that IKK-mediated NF-kappaB activation can coordinately illicit negative effects on STAT signaling.	Boehringer Ingelheim Pharmaceut, Dept Biol, Ridgefield, CT 06877 USA; SUNY Stony Brook, Genet Grad Program, Stony Brook, NY 11794 USA; SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; SUNY Stony Brook, Dept Microbiol, Stony Brook, NY 11794 USA; S Orsola Univ Hosp, Ctr Appl Biomed Res, I-40138 Bologna, Italy	Boehringer Ingelheim; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; IRCCS Azienda Ospedaliero-Universitaria di Bologna	Li, J (corresponding author), Boehringer Ingelheim Pharmaceut, Dept Biol, Ridgefield, CT 06877 USA.	jli@rdg.boehringer-ingelheim.com; kmarcu@ms.ce.sunysb.edu		Mische, Sheenah/0000-0002-6055-5564	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057555] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026939] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI057555] Funding Source: Medline; NIGMS NIH HHS [GM26939] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALDRED AR, 1987, J BIOL CHEM, V262, P2875; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Barkett M, 1999, ONCOGENE, V18, P6910, DOI 10.1038/sj.onc.1203238; Baud V, 1999, GENE DEV, V13, P1297, DOI 10.1101/gad.13.10.1297; Beadling C, 1999, J IMMUNOL, V162, P2677; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Bergmann M, 1998, J BIOL CHEM, V273, P6607, DOI 10.1074/jbc.273.12.6607; Berlato C, 2002, J IMMUNOL, V168, P6404, DOI 10.4049/jimmunol.168.12.6404; Bettuzzi S, 2002, ONCOGENE, V21, P4328, DOI 10.1038/sj.onc.1205594; Bleul CC, 1996, J EXP MED, V184, P1101, DOI 10.1084/jem.184.3.1101; Boehm U, 1998, J IMMUNOL, V161, P6715; Bono F, 1999, FEBS LETT, V457, P93, DOI 10.1016/S0014-5793(99)01006-6; BOURS V, 1993, CELL, V72, P729, DOI 10.1016/0092-8674(93)90401-B; BROWN AM, 1994, MOL CELL BIOL, V14, P2926, DOI 10.1128/MCB.14.5.2926; Caivano M, 2001, J BIOL CHEM, V276, P48693, DOI 10.1074/jbc.M108282200; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Cao YX, 2001, CELL, V107, P763, DOI 10.1016/S0092-8674(01)00599-2; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Davis RE, 2001, J EXP MED, V194, P1861, DOI 10.1084/jem.194.12.1861; Dechend R, 1999, ONCOGENE, V18, P3316, DOI 10.1038/sj.onc.1202717; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; DINAUER MC, 1990, J CLIN INVEST, V86, P1729, DOI 10.1172/JCI114898; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fang JM, 2000, AM J HUM GENET, V67, P1382, DOI 10.1086/316915; FUJITA T, 1993, GENE DEV, V7, P1354, DOI 10.1101/gad.7.7b.1354; Gerritsen ME, 1997, P NATL ACAD SCI USA, V94, P2927, DOI 10.1073/pnas.94.7.2927; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Groskopf JC, 1997, ENDOCRINOLOGY, V138, P2835, DOI 10.1210/en.138.7.2835; Gustin JA, 2001, J BIOL CHEM, V276, P27740, DOI 10.1074/jbc.M102559200; Hatada EN, 2000, CURR OPIN IMMUNOL, V12, P52, DOI 10.1016/S0952-7915(99)00050-3; HATADA EN, 1993, EMBO J, V12, P2781, DOI 10.1002/j.1460-2075.1993.tb05939.x; Hay E, 2001, J BIOL CHEM, V276, P29028, DOI 10.1074/jbc.M011265200; Heissmeyer V, 1999, EMBO J, V18, P4766, DOI 10.1093/emboj/18.17.4766; Heissmeyer V, 2001, MOL CELL BIOL, V21, P1024, DOI 10.1128/MCB.21.4.1024-1035.2001; Hinz M, 2001, BLOOD, V97, P2798, DOI 10.1182/blood.V97.9.2798; Hirano F, 1998, MOL CELL BIOL, V18, P1266, DOI 10.1128/MCB.18.3.1266; Hu YL, 2001, NATURE, V410, P710, DOI 10.1038/35070605; Hu YL, 1999, SCIENCE, V284, P316, DOI 10.1126/science.284.5412.316; Kaisho T, 2001, J EXP MED, V193, P417, DOI 10.1084/jem.193.4.417; KANG SM, 1992, SCIENCE, V256, P1452, DOI 10.1126/science.1604322; Karin M, 1999, ONCOGENE, V18, P6867, DOI 10.1038/sj.onc.1203219; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Klomp LWJ, 1996, J CLIN INVEST, V98, P207, DOI 10.1172/JCI118768; Kordes U, 2000, LEUKEMIA, V14, P399, DOI 10.1038/sj.leu.2401705; Koul D, 2001, J BIOL CHEM, V276, P11402, DOI 10.1074/jbc.M007806200; Krappmann D, 2000, J BIOL CHEM, V275, P29779, DOI 10.1074/jbc.M003902200; Kurland JF, 2001, J BIOL CHEM, V276, P45380, DOI 10.1074/jbc.M108294200; LEGOUY E, 1987, EMBO J, V6, P3359, DOI 10.1002/j.1460-2075.1987.tb02657.x; Li J, 2001, J BIOL CHEM, V276, P18579, DOI 10.1074/jbc.M100846200; Li QT, 1999, SCIENCE, V284, P321, DOI 10.1126/science.284.5412.321; Li QT, 1999, GENE DEV, V13, P1322, DOI 10.1101/gad.13.10.1322; Li X, 2000, BRAIN RES PROTOC, V5, P211, DOI 10.1016/S1385-299X(00)00015-5; Li XH, 2001, J BIOL CHEM, V276, P4494, DOI 10.1074/jbc.M008353200; Li ZW, 1999, J EXP MED, V189, P1839, DOI 10.1084/jem.189.11.1839; LIOU HC, 1992, EMBO J, V11, P3003, DOI 10.1002/j.1460-2075.1992.tb05370.x; LIOU HC, 1994, MOL CELL BIOL, V14, P5349, DOI 10.1128/MCB.14.8.5349; Liu YJ, 1997, P NATL ACAD SCI USA, V94, P8138, DOI 10.1073/pnas.94.15.8138; LIVAK KJ, 1995, PCR METH APPL, V4, P357; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; Lund EG, 1998, J BIOL CHEM, V273, P34316, DOI 10.1074/jbc.273.51.34316; Madrid LV, 2000, MOL CELL BIOL, V20, P1626, DOI 10.1128/MCB.20.5.1626-1638.2000; Madrid LV, 2001, J BIOL CHEM, V276, P18934, DOI 10.1074/jbc.M101103200; Mahadevappa M, 1999, NAT BIOTECHNOL, V17, P1134, DOI 10.1038/15124; Makris C, 2000, MOL CELL, V5, P969, DOI 10.1016/S1097-2765(00)80262-2; Martin AG, 2000, J BIOL CHEM, V275, P24383, DOI 10.1074/jbc.M909396199; Martin AG, 2001, J BIOL CHEM, V276, P15840, DOI 10.1074/jbc.M011313200; Matsushima A, 2001, J EXP MED, V193, P631, DOI 10.1084/jem.193.5.631; Matsushima N, 2000, PROTEINS, V38, P210, DOI 10.1002/(SICI)1097-0134(20000201)38:2<210::AID-PROT9>3.0.CO;2-1; Mattson MP, 2000, J NEUROCHEM, V74, P443, DOI 10.1046/j.1471-4159.2000.740443.x; May MJ, 1998, IMMUNOL TODAY, V19, P80, DOI 10.1016/S0167-5699(97)01197-3; May MJ, 2000, SCIENCE, V289, P1550, DOI 10.1126/science.289.5484.1550; Mayo MW, 2002, J BIOL CHEM, V277, P11116, DOI 10.1074/jbc.M108670200; McKenzie FR, 2000, MOL CELL BIOL, V20, P2635, DOI 10.1128/MCB.20.8.2635-2649.2000; Mercurio F, 1999, ONCOGENE, V18, P6163, DOI 10.1038/sj.onc.1203174; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Miura N, 1998, GENOMICS, V50, P346, DOI 10.1006/geno.1998.5288; NOLAN GP, 1993, MOL CELL BIOL, V13, P3557, DOI 10.1128/MCB.13.6.3557; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; PAN JL, 1995, J BIOL CHEM, V270, P23077, DOI 10.1074/jbc.270.39.23077; Panetta R, 1999, BIOCHEM BIOPH RES CO, V259, P550, DOI 10.1006/bbrc.1999.0817; PARKOS CA, 1988, P NATL ACAD SCI USA, V85, P3319, DOI 10.1073/pnas.85.10.3319; Perini G, 2002, J EXP MED, V195, P907, DOI 10.1084/jem.20011797; Perkins ND, 1997, SCIENCE, V275, P523, DOI 10.1126/science.275.5299.523; PLAKSIN D, 1993, J EXP MED, V177, P1651, DOI 10.1084/jem.177.6.1651; Qian W, 1999, J INF STOR PROC SYST, V1, P159; Rattner A, 1997, P NATL ACAD SCI USA, V94, P2859, DOI 10.1073/pnas.94.7.2859; Rosenberg ME, 2002, MOL CELL BIOL, V22, P1893, DOI 10.1128/MCB.22.6.1893-1902.2002; ROSENBERG ME, 1995, INT J BIOCHEM CELL B, V27, P633, DOI 10.1016/1357-2725(95)00027-M; Rothermel B, 2000, J BIOL CHEM, V275, P8719, DOI 10.1074/jbc.275.12.8719; Rudolph D, 2000, GENE DEV, V14, P854; Sakurai H, 1999, J BIOL CHEM, V274, P30353, DOI 10.1074/jbc.274.43.30353; Santamaria I, 1999, J BIOL CHEM, V274, P13800, DOI 10.1074/jbc.274.20.13800; Santamaria I, 1998, J BIOL CHEM, V273, P16816, DOI 10.1074/jbc.273.27.16816; Schmidt-Supprian M, 2000, MOL CELL, V5, P981, DOI 10.1016/S1097-2765(00)80263-4; Schwarz DA, 1998, IMMUNITY, V9, P657, DOI 10.1016/S1074-7613(00)80663-9; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Shimizu N, 2000, J VIROL, V74, P619, DOI 10.1128/JVI.74.2.619-626.2000; Shirakata Y, 2000, J BIOL CHEM, V275, P5748, DOI 10.1074/jbc.275.8.5748; SILKENSEN JR, 1994, BIOCHEM CELL BIOL, V72, P483, DOI 10.1139/o94-065; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Sizemore N, 1999, MOL CELL BIOL, V19, P4798; Sizemore N, 2002, J BIOL CHEM, V277, P3863, DOI 10.1074/jbc.M110572200; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; Takeda K, 1999, SCIENCE, V284, P313, DOI 10.1126/science.284.5412.313; Takeuchi T, 2000, J NEUROCHEM, V74, P1489, DOI 10.1046/j.1471-4159.2000.0741489.x; Tanaka M, 1999, BLOOD, V93, P804, DOI 10.1182/blood.V93.3.804.403a16_804_815; Tanaka M, 1999, IMMUNITY, V10, P421, DOI 10.1016/S1074-7613(00)80042-4; Tessitore A, 2000, HUM GENET, V107, P568, DOI 10.1007/s004390000429; Toft DJ, 2001, P NATL ACAD SCI USA, V98, P13055, DOI 10.1073/pnas.231364798; UZE G, 1992, P NATL ACAD SCI USA, V89, P4774, DOI 10.1073/pnas.89.10.4774; Vanden Berghe W, 1998, J BIOL CHEM, V273, P3285, DOI 10.1074/jbc.273.6.3285; Wang D, 1998, J BIOL CHEM, V273, P29411, DOI 10.1074/jbc.273.45.29411; Wang SY, 1996, J BIOL CHEM, V271, P20580, DOI 10.1074/jbc.271.34.20580; Wang SY, 1998, CELL, V92, P501, DOI 10.1016/S0092-8674(00)80943-5; Wang Y, 2001, BMC Dev Biol, V1, P9, DOI 10.1186/1471-213X-1-9; WULCZYN FG, 1992, NATURE, V358, P597, DOI 10.1038/358597a0; WYNN TA, 1991, J IMMUNOL, V147, P4384; Yagi T, 2000, GENE DEV, V14, P1169; Yamamoto Y, 2001, J BIOL CHEM, V276, P36327, DOI 10.1074/jbc.M104090200; Yoshida K, 1998, GENOMICS, V49, P458, DOI 10.1006/geno.1998.5271; Zanocco-Marani T, 1999, CANCER RES, V59, P5331; Zhong HH, 1997, CELL, V89, P413, DOI 10.1016/S0092-8674(00)80222-6; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0	125	191	205	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2002	277	47					45129	45140		10.1074/jbc.M205165200	http://dx.doi.org/10.1074/jbc.M205165200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	618EE	12221085	Green Accepted, hybrid			2022-12-27	WOS:000179404800070
J	Rush, JS; Cho, SK; Jiang, SM; Hofmann, SL; Waechter, CJ				Rush, JS; Cho, SK; Jiang, SM; Hofmann, SL; Waechter, CJ			Identification and characterization of a cDNA encoding a dolichyl pyrophosphate phosphatase located in the endoplasmic reticulum of mammalian cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIS-ISOPRENYLTRANSFERASE ACTIVITY; PALMITOYL-PROTEIN THIOESTERASE; SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; RAT-LIVER; PIG BRAIN; DIPHOSPHATE PHOSPHATASE; LINKED OLIGOSACCHARIDES; DEVELOPMENTAL-CHANGE; N-GLYCOSYLATION	The CWH8 gene in Saccharomyces cerevisiae has been shown recently (Fernandez, F., Rush, J. S., Toke, D. A., Han, G., Quinn, J. E., Carman, G. M., Choi, J.-Y., Voelker, D. R., Aebi, M., and Waechter, C. J. (2001) J. Biol. Chem. 276, 41455-41464) to encode a dolichyl pyrophosphate (Dol-P-P) phosphatase associated with crude microsomal fractions. Mutations in CWH8 result in the accumulation of Dol-P-P, deficiency in lipid intermediate synthesis, defective protein N-glycosylation, and a reduced growth rate. A cDNA (DOLPP1, GenBank(TM) accession number AB030189) from mouse brain encoding a homologue of the yeast CWH8 gene is now shown to complement the defects in growth and protein N-glycosylation, and to correct the accumulation of Dol-P-P in the cwh8Delta yeast mutant. Northern blot analyses demonstrate a wide distribution of the DOLPP1 mRNA in mouse tissues. Overexpression of Dolpp1p in yeast, COS, and Sf9 cells produces substantial increases in Dol-P-P phosphatase activity but not in dolichyl monophosphate or phosphatidic acid phosphatase activities in microsomal fractions. Subcellular fractionation and immunofluorescence studies localize the enzyme encoded by DOLPP1 to the endoplasmic reticulum of COS cells. The results of protease sensitivity studies with microsomal vesicles from the lpp1Delta/dpp1Delta yeast mutant expressing DOLPP1 are consistent with Dolpp1p having a luminally oriented active site. The sequence of the DOLPP1 cDNA predicts a polypeptide with 238 amino acids, and a new polypeptide corresponding to 27 kDa is observed when DOLPP1 is expressed in yeast, COS, and Sf9 cells. This study is the first identification and characterization of a cDNA clone encoding an essential component of a mammalian lipid pyrophosphate phosphatase that is highly specific for Dol-P-P. The specificity, subcellular location, and topological orientation of the active site described in the current study strongly support a role for Dolpp1p in the recycling of Dol-P-P discharged during protein N-glycosylation reactions on the luminal leaflet of the endoplasmic reticulum in mammalian cells.	Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA; Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Hamon Ctr Therapeut Oncol Res, Dallas, TX 75390 USA	University of Kentucky; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Waechter, CJ (corresponding author), Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA.			Cho, Steve Kyungrae/0000-0001-8547-8430	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035323] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM36035] Funding Source: Medline; NINDS NIH HHS [NS35323] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADAIR WL, 1989, CHEM PHYS LIPIDS, V51, P279, DOI 10.1016/0009-3084(89)90015-7; Aebi M, 1996, GLYCOBIOLOGY, V6, P439, DOI 10.1093/glycob/6.4.439; ALLEN CM, 1978, BIOCHEMISTRY-US, V17, P5020, DOI 10.1021/bi00616a025; APPELKVIST EL, 1981, J BIOCHEM BIOPH METH, V5, P203, DOI 10.1016/0165-022X(81)90045-2; BARTLETT GR, 1959, J BIOL CHEM, V234, P466; BELOCOPITOW E, 1982, EUR J BIOCHEM, V125, P167, DOI 10.1111/j.1432-1033.1982.tb06664.x; Brindley DN, 1996, CHEM PHYS LIPIDS, V80, P45, DOI 10.1016/0009-3084(96)02545-5; Burda P, 1999, BBA-GEN SUBJECTS, V1426, P239, DOI 10.1016/S0304-4165(98)00127-5; BURTON WA, 1979, J BIOL CHEM, V254, P7129; CAMP LA, 1994, J BIOL CHEM, V269, P23212; Carman GM, 1997, BBA-LIPID LIPID MET, V1348, P45, DOI 10.1016/S0005-2760(97)00095-7; CARSON DD, 1981, J BIOL CHEM, V256, P1552; Cha JH, 2000, J BIOL CHEM, V275, P6901, DOI 10.1074/jbc.275.10.6901; CRICK DC, 1994, J BIOL CHEM, V269, P10559; CRICK DC, 1994, J NEUROCHEM, V62, P247; DANILOV LL, 1989, CHEM PHYS LIPIDS, V51, P191, DOI 10.1016/0009-3084(89)90006-6; DUNPHY PJ, 1967, BIOCHIM BIOPHYS ACTA, V136, P136, DOI 10.1016/0304-4165(67)90329-7; Faulkner A, 1999, J BIOL CHEM, V274, P14831, DOI 10.1074/jbc.274.21.14831; Fernandez F, 2001, J BIOL CHEM, V276, P41455, DOI 10.1074/jbc.M105544200; Frank DW, 1998, J BIOL CHEM, V273, P11791, DOI 10.1074/jbc.273.19.11791; Freeze HH, 2001, BIOCHIMIE, V83, P791, DOI 10.1016/S0300-9084(01)01292-5; Freeze HH, 2001, SEMIN LIVER DIS, V21, P501, DOI 10.1055/s-2001-19031; FREEZE HH, 2001, GLYCOBIOLOGY, V11, pR1; Gupta P, 2001, P NATL ACAD SCI USA, V98, P13566, DOI 10.1073/pnas.251485198; HARFORD JB, 1980, BIOCHEM J, V188, P481, DOI 10.1042/bj1880481; HARFORD JB, 1977, BIOCHEM BIOPH RES CO, V76, P1036, DOI 10.1016/0006-291X(77)90960-3; HERSCOVICS A, 1993, FASEB J, V7, P540, DOI 10.1096/fasebj.7.6.8472892; HILL JE, 1986, YEAST, V2, P163, DOI 10.1002/yea.320020304; HOSAKA K, 1984, BIOCHIM BIOPHYS ACTA, V796, P102; HUBBARD SC, 1980, J BIOL CHEM, V255, P1782; IDOYAGAVARGAS V, 1980, FEBS LETT, V112, P63, DOI 10.1016/0014-5793(80)80128-1; Inoue S, 2000, BIOCHEM BIOPH RES CO, V268, P553, DOI 10.1006/bbrc.2000.2170; LUCAS JJ, 1977, J BIOL CHEM, V252, P4330; MORLOCK KR, 1991, J BIOL CHEM, V266, P3586; OReilly D.R., 1992, BACULOVIRUS EXPRESSI; RICKWOOD D, 1982, ANAL BIOCHEM, V123, P23, DOI 10.1016/0003-2697(82)90618-2; RIP JW, 1981, J BIOL CHEM, V256, P1929; RODRIGUEZVICO F, 1989, ANAL BIOCHEM, V183, P275, DOI 10.1016/0003-2697(89)90479-X; ROSENWALD AG, 1990, J BIOL CHEM, V265, P14544; Rush JS, 1998, GLYCOBIOLOGY, V8, P1207, DOI 10.1093/glycob/8.12.1207; RUSH JS, 2000, GLYCOBIOLOGY, V94, P1067; Sambrook J., 2002, MOL CLONING LAB MANU; Schenk B, 2001, GLYCOBIOLOGY, V11, p61R, DOI 10.1093/glycob/11.5.61R; SCHER MG, 1984, ARCH BIOCHEM BIOPHYS, V231, P293, DOI 10.1016/0003-9861(84)90391-6; SCHER MG, 1984, J BIOL CHEM, V259, P4580; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Silberstein S, 1996, FASEB J, V10, P849, DOI 10.1096/fasebj.10.8.8666161; SPIRO MJ, 1986, J BIOL CHEM, V261, P4725; Stukey J, 1997, PROTEIN SCI, V6, P469; Toke DA, 1998, J BIOL CHEM, V273, P3278, DOI 10.1074/jbc.273.6.3278; Toke DA, 1998, J BIOL CHEM, V273, P14331, DOI 10.1074/jbc.273.23.14331; van Berkel MAA, 1999, GLYCOBIOLOGY, V9, P243, DOI 10.1093/glycob/9.3.243; Verkruyse LA, 1996, J BIOL CHEM, V271, P15831, DOI 10.1074/jbc.271.26.15831; WEDGWOOD JF, 1980, J BIOL CHEM, V255, P1120; WOLF M J, 1991, Glycobiology, V1, P405, DOI 10.1093/glycob/1.4.405; [No title captured]	56	38	39	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 22	2002	277	47					45226	45234		10.1074/jbc.M207076200	http://dx.doi.org/10.1074/jbc.M207076200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	618EE	12198133	hybrid			2022-12-27	WOS:000179404800082
J	Grun, F; Venkatesan, RN; Tabb, MM; Zhou, CC; Cao, JR; Hemmati, D; Blumberg, B				Grun, F; Venkatesan, RN; Tabb, MM; Zhou, CC; Cao, JR; Hemmati, D; Blumberg, B			Benzoate X receptors alpha and beta are pharmacologically distinct and do not function as xenobiotic receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORPHAN NUCLEAR RECEPTORS; SIGNALING PATHWAY; XENOPUS; SXR; PHYSIOLOGY; INHIBITOR; DEFINES; LIGANDS; BXR	The Xenopus benzoate nuclear hormone receptors, BXRalpha and BXRbeta, share 82% identity within their ligand-binding domains and are classified as members of the NR1I2 subfamily that includes the mammalian steroid and xenobiotic receptor, SXP/PXR. Although alkyl benzoates have been identified as endogenous ligands, the exact role of the benzoate receptors in amphibian physiology has not been established. In this report, we show that BXRalpha and BXRbeta are pharmacologically distinct from each other: BXRa is more promiscuous than BXRbeta with respect to both ligand specificity and co-activator recruitment. BXRalpha can be transactivated by a number of benzoate derivatives including 4-amino-butylbenzoate (4-ABB), 4-hydroxy-butylbenzoate (4-HBB), 3-hydroxy ethyl benzoate (3-HEB), and benzyl benzoate, but only 4-HBB acts as an agonist for both receptors. Furthermore, BXRalpha-specific agonists such as 4-ABB, chlorpyrifos, and trifluralin act as antagonists on BXRbeta. BXRs are widely distributed in adult tissues but do not show any enrichment in liver and intestine, major sites of SXR/PXR expression that are critical in xenobiotic metabolism. Neither BXR shows the broad specificity toward steroids or xenobiotics exhibited by SXR/PXR. Therefore, we conclude that the BXRs are pharmacologically distinct from each other and unlikely to serve as xenobiotic sensors.	Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA	University of California System; University of California Irvine	Blumberg, B (corresponding author), Univ Calif Irvine, Dept Dev & Cell Biol, 5205 McGaugh Hall,Rm 5205, Irvine, CA 92697 USA.		Grun, Felix/C-8271-2011; Cao, Junran/E-7354-2013	Zhou, Changcheng/0000-0001-7649-0710	NIGMS NIH HHS [GM60572] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060572] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ausubel FM., 1987, CURRENT PROTOCOLS MO, DOI 10.1002/mrd.1080010210; Bertilsson G, 1998, P NATL ACAD SCI USA, V95, P12208, DOI 10.1073/pnas.95.21.12208; Blumberg B, 1998, GENE DEV, V12, P3195, DOI 10.1101/gad.12.20.3195; Blumberg B, 1998, GENE DEV, V12, P1269, DOI 10.1101/gad.12.9.1269; Blumberg B, 1998, GENE DEV, V12, P3149, DOI 10.1101/gad.12.20.3149; BUCK J, 1993, J EXP MED, V178, P675, DOI 10.1084/jem.178.2.675; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; Dussault I, 2001, J BIOL CHEM, V276, P33309, DOI 10.1074/jbc.C100375200; FORMAN BM, 1995, CELL, V81, P541, DOI 10.1016/0092-8674(95)90075-6; Heasman J, 2000, DEV BIOL, V222, P124, DOI 10.1006/dbio.2000.9720; HUGHES MK, 1993, MOL BIOL EVOL, V10, P1360; Kliewer SA, 1998, CELL, V92, P73, DOI 10.1016/S0092-8674(00)80900-9; Kliewer SA, 1999, SCIENCE, V284, P757, DOI 10.1126/science.284.5415.757; Koide T, 2001, GENE DEV, V15, P2111, DOI 10.1101/gad.908801; Lehmann JM, 1998, J CLIN INVEST, V102, P1016, DOI 10.1172/JCI3703; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Moore LB, 2002, MOL ENDOCRINOL, V16, P977, DOI 10.1210/me.16.5.977; Nishikawa J, 2000, BIOCHEM BIOPH RES CO, V277, P209, DOI 10.1006/bbrc.2000.3649; SMITH DP, 1994, NUCLEIC ACIDS RES, V22, P66, DOI 10.1093/nar/22.1.66; Synold TW, 2001, NAT MED, V7, P584, DOI 10.1038/87912; WILLY PJ, 1998, HORMONES SIGNALING, V1, P307; Xie W, 2001, J BIOL CHEM, V276, P37739, DOI 10.1074/jbc.R100033200; 1999, NUCL RECEPTOR NOMENC, V97, P161	25	32	32	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	2002	277	46					43691	43697		10.1074/jbc.M206553200	http://dx.doi.org/10.1074/jbc.M206553200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	615XE	12198127	hybrid			2022-12-27	WOS:000179272000021
J	Piiper, A; Dikic, I; Lutz, MP; Leser, J; Kronenberger, B; Elez, R; Cramer, H; Muller-Esterl, W; Zeuzem, S				Piiper, A; Dikic, I; Lutz, MP; Leser, J; Kronenberger, B; Elez, R; Cramer, H; Muller-Esterl, W; Zeuzem, S			Cyclic AMP induces transactivation of the receptors for epidermal growth factor and nerve growth factor, thereby modulating activation of MAP kinase, Akt, and neurite outgrowth in PC12 cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; NUCLEOTIDE-EXCHANGE FACTOR; EGF RECEPTOR; B-RAF; NEURONAL DIFFERENTIATION; DEPENDENT ACTIVATION; SIGNAL-TRANSDUCTION; TRK RECEPTORS; PHOSPHATIDYLINOSITOL 3-KINASE; NEUROTROPHIN RECEPTORS	In PC12 cells, a well studied model for neuronal differentiation, an elevation in the intracellular cAMP level increases cell survival, stimulates neurite outgrowth, and causes activation of extracellular signal-regulated protein kinase 1 and 2 (ERK1/2). Here we show that an increase in the intracellular cAMP concentration induces tyrosine phosphorylation of two receptor tyrosine kinases, i.e. the epidermal growth factor (EGF) receptor and the high affinity receptor for nerve growth factor (NGF), also termed TrkA. cAMP-induced tyrosine phosphorylation of the EGF receptor is rapid and correlates with ERK1/2 activation. It occurs also in Panc-1, but not in human mesangial cells. cAMP-induced tyrosine phosphorylation of the NGF receptor is slower and correlates with Akt activation. Inhibition of EGF receptor tyrosine phosphorylation, but not of the NGF receptor, reduces cAMP-induced neurite outgrowth. Expression of dominant-negative Akt does not abolish cAMP-induced survival in serum-free media, but. increases cAMP-induced ERK1/2 activation and neurite outgrowth. Together, our results demonstrate that cAMP induces dual signaling in PC12 cells: transactivation of the EGF receptor triggering the ERK1/2 pathway and neurite outgrowth; and transactivation of the NGF receptor promoting Akt activation and thereby modulating ERK1/2 activation and neurite outgrowth.	Univ Frankfurt, Dept Internal Med, D-60590 Frankfurt, Germany; Univ Frankfurt, Inst Biochem 2, D-60590 Frankfurt, Germany; Ludwig Inst Canc Res, S-75124 Uppsala, Sweden; Univ Ulm, Dept Internal Med 1, D-89070 Ulm, Germany; Aventis Pharma Deutschland GmbH, D-65812 Bad Soden, Germany	Goethe University Frankfurt; Goethe University Frankfurt; Ludwig Institute for Cancer Research; Ulm University; Sanofi-Aventis	Piiper, A (corresponding author), Univ Frankfurt, Dept Med 2, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.		Zeuzem, Stefan/AAE-7435-2019; Dikic, Ivan/O-4650-2015	Dikic, Ivan/0000-0001-8156-9511				ALTSCHULER DL, 1995, J BIOL CHEM, V270, P10373, DOI 10.1074/jbc.270.18.10373; Asakura M, 2002, NAT MED, V8, P35, DOI 10.1038/nm0102-35; Bang OS, 2001, J CELL SCI, V114, P81; Bos JL, 1998, EMBO J, V17, P6776, DOI 10.1093/emboj/17.23.6776; BURGERING BMT, 1993, EMBO J, V12, P4211, DOI 10.1002/j.1460-2075.1993.tb06105.x; Busca R, 2000, EMBO J, V19, P2900, DOI 10.1093/emboj/19.12.2900; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; CRESPO P, 1995, J BIOL CHEM, V270, P25259, DOI 10.1074/jbc.270.42.25259; Crowder RJ, 1999, J NEUROCHEM, V73, P466, DOI 10.1046/j.1471-4159.1999.0730466.x; Crowder RJ, 1998, J NEUROSCI, V18, P2933; Daub H, 1996, NATURE, V379, P557, DOI 10.1038/379557a0; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; Downward J, 1998, CURR OPIN CELL BIOL, V10, P262, DOI 10.1016/S0955-0674(98)80149-X; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Dugan LL, 1999, J BIOL CHEM, V274, P25842, DOI 10.1074/jbc.274.36.25842; English JD, 1996, J BIOL CHEM, V271, P24329, DOI 10.1074/jbc.271.40.24329; ERHARDT P, 1995, MOL CELL BIOL, V15, P5524; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; Filippa N, 1999, MOL CELL BIOL, V19, P4989; FRODIN M, 1994, J BIOL CHEM, V269, P6207; Fujita T, 2002, J BIOL CHEM, V277, P22191, DOI 10.1074/jbc.M110364200; Guan KL, 2000, J BIOL CHEM, V275, P27354; Gutkind J. S., 2000, SCI STKE, pre1, DOI DOI 10.1126/STKE.2000.40.RE1; Hanson MG, 1998, J NEUROSCI, V18, P7361; Harada H, 1999, MOL CELL, V3, P413, DOI 10.1016/S1097-2765(00)80469-4; HATA Y, 1991, J BIOL CHEM, V266, P6571; HEIDEMANN SR, 1985, J CELL BIOL, V100, P916, DOI 10.1083/jcb.100.3.916; Huang NK, 2001, J BIOL CHEM, V276, P13838, DOI 10.1074/jbc.M008589200; Iida N, 2001, J NEUROSCI, V21, P6459, DOI 10.1523/JNEUROSCI.21-17-06459.2001; Impey S, 1998, NAT NEUROSCI, V1, P595, DOI 10.1038/2830; Ivankovic-Dikic I, 2000, NAT CELL BIOL, V2, P574, DOI 10.1038/35023515; Kaplan DR, 1997, CURR OPIN CELL BIOL, V9, P213, DOI 10.1016/S0955-0674(97)80065-8; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; Klinger M, 2002, J BIOL CHEM, V277, P32490, DOI 10.1074/jbc.M200556200; Korhonen JM, 1999, J BIOL CHEM, V274, P37307, DOI 10.1074/jbc.274.52.37307; Lee FS, 2002, J BIOL CHEM, V277, P9096, DOI 10.1074/jbc.M107421200; Lee FS, 2001, P NATL ACAD SCI USA, V98, P3555, DOI 10.1073/pnas.061020198; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; Leserer M, 2000, IUBMB LIFE, V49, P405; Li MT, 2000, MOL CELL BIOL, V20, P9356, DOI 10.1128/MCB.20.24.9356-9363.2000; Luttrell LM, 1999, CURR OPIN CELL BIOL, V11, P177, DOI 10.1016/S0955-0674(99)80023-4; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; MacInnis BL, 2002, SCIENCE, V295, P1536, DOI 10.1126/science.1064913; Martin KC, 1997, NEURON, V18, P899, DOI 10.1016/S0896-6273(00)80330-X; Maudsley S, 2000, J BIOL CHEM, V275, P9572, DOI 10.1074/jbc.275.13.9572; MEYERFRANKE A, 1995, NEURON, V15, P805, DOI 10.1016/0896-6273(95)90172-8; Mondorf UF, 2000, FEBS LETT, V472, P129, DOI 10.1016/S0014-5793(00)01433-2; Moro L, 1998, EMBO J, V17, P6622, DOI 10.1093/emboj/17.22.6622; NAKAFUKU M, 1993, FEBS LETT, V315, P227, DOI 10.1016/0014-5793(93)81169-Z; OBERMEIER A, 1994, EMBO J, V13, P1585, DOI 10.1002/j.1460-2075.1994.tb06421.x; Ohtsuka T, 1996, J BIOL CHEM, V271, P1258, DOI 10.1074/jbc.271.3.1258; Okada T, 1999, MOL CELL BIOL, V19, P6057; Patapoutian A, 2001, CURR OPIN NEUROBIOL, V11, P272, DOI 10.1016/S0959-4388(00)00208-7; Patterson SL, 2001, NEURON, V32, P123, DOI 10.1016/S0896-6273(01)00443-3; Piiper A, 2000, MOL PHARMACOL, V58, P608, DOI 10.1124/mol.58.3.608; Piiper A, 1997, AM J PHYSIOL-GASTR L, V272, pG1276, DOI 10.1152/ajpgi.1997.272.5.G1276; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Qiu WS, 2000, J BIOL CHEM, V275, P31921, DOI 10.1074/jbc.M003327200; Rosen LB, 1996, P NATL ACAD SCI USA, V93, P1113, DOI 10.1073/pnas.93.3.1113; RUKENSTEIN A, 1991, J NEUROSCI, V11, P2552; RYDEL RE, 1988, P NATL ACAD SCI USA, V85, P1257, DOI 10.1073/pnas.85.4.1257; Sable CL, 1997, FEBS LETT, V409, P253, DOI 10.1016/S0014-5793(97)00518-8; Sibilia M, 1998, EMBO J, V17, P719, DOI 10.1093/emboj/17.3.719; STEPHENS RM, 1994, NEURON, V12, P691, DOI 10.1016/0896-6273(94)90223-2; Toker A, 1997, NATURE, V387, P673, DOI 10.1038/42648; TRAVERSE S, 1994, CURR BIOL, V4, P694, DOI 10.1016/S0960-9822(00)00154-8; Virdee K, 2000, CURR BIOL, V10, P1151, DOI 10.1016/S0960-9822(00)00702-8; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; Wan Y, 1998, J BIOL CHEM, V273, P14533, DOI 10.1074/jbc.273.23.14533; Wei J, 1998, NEURON, V21, P495, DOI 10.1016/S0896-6273(00)80561-9; WU J, 1993, SCIENCE, V262, P1066; Yamashita S, 2000, J BIOL CHEM, V275, P25488, DOI 10.1074/jbc.M003414200; Yamauchi T, 1997, NATURE, V390, P91, DOI 10.1038/36369; YAO RJ, 1995, SCIENCE, V267, P2003, DOI 10.1126/science.7701324; YOUNG SW, 1994, FEBS LETT, V338, P212, DOI 10.1016/0014-5793(94)80367-6; Zhang YZ, 2000, J NEUROSCI, V20, P5671, DOI 10.1523/JNEUROSCI.20-15-05671.2000; Zimmermann S, 1999, SCIENCE, V286, P1741, DOI 10.1126/science.286.5445.1741; Zwartkruis FJT, 1998, EMBO J, V17, P5905, DOI 10.1093/emboj/17.20.5905	78	79	82	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	2002	277	46					43623	43630		10.1074/jbc.M203926200	http://dx.doi.org/10.1074/jbc.M203926200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	615XE	12218049	hybrid			2022-12-27	WOS:000179272000013
J	Arthur, WT; Ellerbroek, SM; Der, CJ; Burridge, K; Wennerberg, K				Arthur, WT; Ellerbroek, SM; Der, CJ; Burridge, K; Wennerberg, K			XPLN, a guanine nucleotide exchange factor for RhoA and RhoB, but not RhoC	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN STRESS FIBERS; BINDING PROTEIN-RHO; MEMBRANE PROTRUSION; RAS TRANSFORMATION; GTPASES; FAMILY; ACTIVATION; GROWTH; CDC42; CELLS	Rho proteins cycle between an inactive, GDP-bound state and an active, GTP-bound state. Activation of these GTPases is mediated by guanine nucleotide exchange factors (GEFs), which promote GDP to GTP exchange. In this study we have characterized XPLN, a Rho family GEF. Like other Rho GEFs, XPLN contains a tandem Dbl homology and pleckstrin homology domain topography, but lacks homology with other known functional domains or motifs. XPLN protein is expressed in the brain, skeletal muscle, heart, kidney, platelets, and macrophage and neuronal cell lines. In vitro, XPLN stimulates guanine nucleotide exchange on RhoA and RhoB, but not RhoC, RhoG, Rac1, or Cdc42. Consistent with these data, XPLN preferentially associates with RhoA and RhoB. The specificity of XPLN for RhoA and RhoB, but not RhoC, is surprising given that they share over 85% sequence identity. We determined that the inability of XPLN to exchange RhoC is mediated by isoleucine 43 in RhoC, a position occupied by valine in RhoA and RhoB. When expressed in cells, XPLN activates RhoA and RhoB, but not RhoC, and stimulates the assembly of stress fibers and focal adhesions in a Rho kinase-dependent manner. We also found that XPLN possesses transforming activity, as determined by focus formation assays. In conclusion, here we describe a Rho family GEF that can discriminate between the closely related RhoA, Rholl, and RhoC, possibly giving insight to the divergent functions of these three proteins.	Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA; Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Pharmacol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Arthur, WT (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Cell & Dev Biol, CB 7295, Chapel Hill, NC 27599 USA.		Wennerberg, Krister/AFM-0539-2022; Wennerberg, Krister/AAH-2919-2022	Wennerberg, Krister/0000-0002-1352-4220; Wennerberg, Krister/0000-0002-1352-4220; Der, Channing/0000-0002-7751-2747	NATIONAL CANCER INSTITUTE [R01CA092240, R01CA063071] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL045100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029860] Funding Source: NIH RePORTER; NCI NIH HHS [CA63071, CA92240] Funding Source: Medline; NHLBI NIH HHS [HL45100] Funding Source: Medline; NIGMS NIH HHS [GM29860] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abe K, 2000, J BIOL CHEM, V275, P10141, DOI 10.1074/jbc.275.14.10141; ADAMSON P, 1992, J CELL BIOL, V119, P617, DOI 10.1083/jcb.119.3.617; Alberts AS, 1998, EMBO J, V17, P4075, DOI 10.1093/emboj/17.14.4075; Allen WE, 1998, J CELL BIOL, V141, P1147, DOI 10.1083/jcb.141.5.1147; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Arthur WT, 2001, MOL BIOL CELL, V12, P2711, DOI 10.1091/mbc.12.9.2711; Banyard J, 2000, ONCOGENE, V19, P580, DOI 10.1038/sj.onc.1203338; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Blomquist A, 2000, BIOCHEM J, V352, P319, DOI 10.1042/0264-6021:3520319; Caron E, 1998, SCIENCE, V282, P1717, DOI 10.1126/science.282.5394.1717; Chan AML, 1996, ONCOGENE, V12, P1259; CHEN SY, 1994, ONCOGENE, V9, P2691; Chen Z, 2000, J BIOL CHEM, V275, P17974, DOI 10.1074/jbc.C000145200; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; CLARK GJ, 1995, METHOD ENZYMOL, V255, P395; Cox EA, 2001, MOL BIOL CELL, V12, P265, DOI 10.1091/mbc.12.2.265; Crompton AM, 2000, J BIOL CHEM, V275, P25751, DOI 10.1074/jbc.M002050200; Gamblin SJ, 1998, CURR OPIN STRUC BIOL, V8, P195, DOI 10.1016/S0959-440X(98)80038-9; Hussain NK, 2001, NAT CELL BIOL, V3, P927, DOI 10.1038/ncb1001-927; Karnoub AE, 2001, NAT STRUCT BIOL, V8, P1037, DOI 10.1038/nsb719; KHOSRAVIFAR R, 1995, MOL CELL BIOL, V15, P6443; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Kleer CG, 2002, AM J PATHOL, V160, P579, DOI 10.1016/S0002-9440(10)64877-8; KOZMA R, 1995, MOL CELL BIOL, V15, P1942; LEONARD DA, 1994, BIOCHEMISTRY-US, V33, P12323, DOI 10.1021/bi00206a040; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; MICHIELS F, 1995, NATURE, V375, P338, DOI 10.1038/375338a0; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Prendergast GC, 2001, NAT REV CANCER, V1, P162, DOI 10.1038/35101096; Pruitt K, 2001, CANCER LETT, V171, P1, DOI 10.1016/S0304-3835(01)00528-6; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Reuther GW, 2001, J BIOL CHEM, V276, P27145, DOI 10.1074/jbc.M103565200; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Rumenapp U, 1999, FEBS LETT, V459, P313, DOI 10.1016/S0014-5793(99)01270-3; Sahai E, 2002, NAT CELL BIOL, V4, P408, DOI 10.1038/ncb796; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Schmidt A, 2002, J BIOL CHEM, V277, P14581, DOI 10.1074/jbc.M111108200; Schoenwaelder SM, 2002, J BIOL CHEM, V277, P14738, DOI 10.1074/jbc.M200661200; Shen X, 2001, J BIOL CHEM, V276, P15362, DOI 10.1074/jbc.M009534200; Snyder JT, 2002, NAT STRUCT BIOL, V9, P468, DOI 10.1038/nsb796; Stam JC, 1998, EMBO J, V17, P4066, DOI 10.1093/emboj/17.14.4066; Thiesen S, 2000, BIOCHEM BIOPH RES CO, V273, P364, DOI 10.1006/bbrc.2000.2925; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; van Golen KL, 2000, CANCER RES, V60, P5832; Watanabe N, 1999, NAT CELL BIOL, V1, P136, DOI 10.1038/11056	46	99	102	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					42964	42972		10.1074/jbc.M207401200	http://dx.doi.org/10.1074/jbc.M207401200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12221096	hybrid			2022-12-27	WOS:000179081200071
J	Du, J; Stankiewicz, MJ; Liu, Y; Xi, Q; Schmitz, JE; Lekstrom-Himes, JA; Ackerman, SJ				Du, J; Stankiewicz, MJ; Liu, Y; Xi, Q; Schmitz, JE; Lekstrom-Himes, JA; Ackerman, SJ			Novel combinatorial interactions of GATA-1, PU.1, and C/EBP epsilon isoforms regulate transcription of the gene encoding eosinophil granule major basic protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							ENHANCER-BINDING-PROTEIN; DNA-BINDING; LINEAGE COMMITMENT; GRANULOCYTIC DIFFERENTIATION; ERYTHROID-DIFFERENTIATION; RESTRICTED EXPRESSION; TARGETED DISRUPTION; MYELOID DEVELOPMENT; INHIBITOR DOMAIN; CELL-LINES	GATA-1 and the ets factor PU.1 have been reported to functionally antagonize one another in the regulation of erythroid versus myeloid gene transcription and development. The CCAAT enhancer binding protein epsilon (C/EBPepsilon) is expressed as multiple isoforms and has been shown to be essential to myeloid (granulocyte) terminal differentiation. We have defined a novel synergistic, as opposed to antagonistic, combinatorial interaction between GATA-1 and PU.1, and a unique repressor role for certain C/EBPepsilon isoforms in the transcriptional regulation of a model eosinophil granulocyte gene, the major basic protein (MBP). The eosinophil-specific P2 promoter of the MBP gene contains GATA-1, C/EBP, and PU.1 consensus sites that bind these factors in nuclear extracts of the eosinophil myelocyte cell line, AML14.3D10. The promoter is transactivated by GATA-1 alone but is synergistically transactivated by low levels of PU.1 in the context of optimal levels of GATA-1. The C/EBPepsilon(27) isoform strongly represses GATA-1 activity and completely blocks GATA-1/PU.1 synergy. In vitro mutational analyses of the MBP-P2 promoter showed that both the GATA-1/PU.1 synergy, and repressor activity of C/EBPepsilon(27) are mediated via protein-protein interactions through the C/EBP and/or GATA-binding sites but not the PU.1 sites. Co-immunoprecipitations using lysates of AML14.3D10 eosinophils show that both C/EBPepsilon(32/30) and epsilon(27) physically interact in vivo with PU.1 and GATA-1, demonstrating functional interactions among these factors in eosinophil progenitors. Our findings identify novel combinatorial protein-protein interactions for GATA-1, PU.1, and C/EBPepsilon isoforms in eosinophil gene transcription that include GATA-1/PU.1 synergy and repressor activity for C/EBPepsilon(27).	Univ Illinois, Coll Med, Dept Biochem & Mol Biol, Chicago, IL 60612 USA; NIH, Host Def Lab, Bethesda, MD 20892 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; National Institutes of Health (NIH) - USA	Ackerman, SJ (corresponding author), Univ Illinois, Coll Med W, Dept Biochem & Mol Biol, MC536,A-312,1819 W Polk St, Chicago, IL 60612 USA.	sackerma@uic.edu			NIAID NIH HHS [AI33043] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033043] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ackerman SJ, 2000, RESP MED, V94, P1135, DOI 10.1053/rmed.2000.0913; ACKERMAN SJ, 1983, J IMMUNOL, V131, P2977; ACKERMAN SJ, 1983, J EXP MED, V158, P946, DOI 10.1084/jem.158.3.946; AKIRA S, 1990, EMBO J, V9, P1897, DOI 10.1002/j.1460-2075.1990.tb08316.x; Anderson KL, 1998, BLOOD, V91, P3702, DOI 10.1182/blood.V91.10.3702; Anderson KL, 1998, BLOOD, V92, P1576, DOI 10.1182/blood.V92.5.1576.417k29_1576_1585; Angerer ND, 1999, J BIOL CHEM, V274, P4147, DOI 10.1074/jbc.274.7.4147; ANTONSON P, 1995, BIOCHEM BIOPH RES CO, V215, P106, DOI 10.1006/bbrc.1995.2439; Antonson P, 1996, GENOMICS, V35, P30, DOI 10.1006/geno.1996.0319; Baltus B, 1999, J LEUKOCYTE BIOL, V66, P683, DOI 10.1002/jlb.66.4.683; Baumann MA, 1998, STEM CELLS, V16, P16, DOI 10.1002/stem.160016; Bellon T, 1997, BLOOD, V90, P1828, DOI 10.1182/blood.V90.5.1828; BIRKENMEIER EH, 1989, GENE DEV, V3, P1146, DOI 10.1101/gad.3.8.1146; BROWN HJ, 1995, EMBO J, V14, P124, DOI 10.1002/j.1460-2075.1995.tb06982.x; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; Celada A, 1996, J EXP MED, V184, P61, DOI 10.1084/jem.184.1.61; Chumakov AM, 1997, MOL CELL BIOL, V17, P1375, DOI 10.1128/MCB.17.3.1375; DeKoter RP, 1998, EMBO J, V17, P4456, DOI 10.1093/emboj/17.15.4456; DeKoter RP, 2000, SCIENCE, V288, P1439, DOI 10.1126/science.288.5470.1439; Dennig J, 1996, EMBO J, V15, P5659, DOI 10.1002/j.1460-2075.1996.tb00950.x; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Du J, 2000, J BIOL CHEM, V275, P33167, DOI 10.1074/jbc.M003655200; EVANS T, 1991, MOL CELL BIOL, V11, P843, DOI 10.1128/MCB.11.2.843; Fisher RC, 1998, STEM CELLS, V16, P25, DOI 10.1002/stem.160025; Flodby P, 1996, J BIOL CHEM, V271, P24753, DOI 10.1074/jbc.271.40.24753; FRIEDMAN AD, 1990, GENE DEV, V4, P1416, DOI 10.1101/gad.4.8.1416; FRIEDMAN AD, 1989, GENE DEV, V3, P1314, DOI 10.1101/gad.3.9.1314; Ghirlando R, 2000, J BIOL CHEM, V275, P28152; Gombart AF, 2001, BLOOD, V97, P2561, DOI 10.1182/blood.V97.9.2561; GRUART V, 1992, BLOOD, V79, P2592; HANNON R, 1991, P NATL ACAD SCI USA, V88, P3004, DOI 10.1073/pnas.88.8.3004; Himmelmann A, 1997, BLOOD, V90, P3984, DOI 10.1182/blood.V90.10.3984; HOHAUS S, 1995, MOL CELL BIOL, V15, P5830; HROMAS R, 1993, BLOOD, V82, P2998; KLEMSZ MJ, 1990, CELL, V61, P113, DOI 10.1016/0092-8674(90)90219-5; KULESSA H, 1995, GENE DEV, V9, P1250, DOI 10.1101/gad.9.10.1250; Lekstrom-Himes J, 1998, J BIOL CHEM, V273, P28545, DOI 10.1074/jbc.273.44.28545; Lekstrom-Himes JA, 2001, STEM CELLS, V19, P125, DOI 10.1634/stemcells.19-2-125; Lekstrom-Himes JA, 1999, J EXP MED, V189, P1847, DOI 10.1084/jem.189.11.1847; LI MS, 1995, BIOCHEM J, V305, P921, DOI 10.1042/bj3050921; MARTIN DIK, 1990, GENE DEV, V4, P1886, DOI 10.1101/gad.4.11.1886; McKercher SR, 1996, EMBO J, V15, P5647, DOI 10.1002/j.1460-2075.1996.tb00949.x; McNagny KM, 1998, EMBO J, V17, P3669, DOI 10.1093/emboj/17.13.3669; Muller C, 1995, EMBO J, V14, P6127, DOI 10.1002/j.1460-2075.1995.tb00303.x; NAGULAPALLI S, 1995, J IMMUNOL, V155, P4330; Nerlov C, 2000, BLOOD, V95, P2543, DOI 10.1182/blood.V95.8.2543.008k19_2543_2551; Nerlov C, 1998, GENE DEV, V12, P2413, DOI 10.1101/gad.12.15.2413; Nerlov C, 1998, GENE DEV, V12, P2403, DOI 10.1101/gad.12.15.2403; Onodera K, 1997, J BIOCHEM, V121, P251; ORKIN SH, 1992, BLOOD, V80, P575; Osada S, 1996, J BIOL CHEM, V271, P3891; PAHL HL, 1993, J BIOL CHEM, V268, P5014; Paul CC, 1997, AM J HEMATOL, V56, P79, DOI 10.1002/(SICI)1096-8652(199710)56:2<79::AID-AJH2>3.0.CO;2-Y; PAUL CC, 1995, BLOOD, V86, P3737, DOI 10.1182/blood.V86.10.3737.bloodjournal86103737; PEREZ C, 1994, MOL CELL BIOL, V14, P5023, DOI 10.1128/MCB.14.8.5023; Petrovick HS, 1998, MOL CELL BIOL, V18, P3915, DOI 10.1128/MCB.18.7.3915; PEVNY L, 1991, NATURE, V349, P257, DOI 10.1038/349257a0; POLI V, 1990, CELL, V63, P643, DOI 10.1016/0092-8674(90)90459-R; Querfurth E, 2000, GENE DEV, V14, P2515, DOI 10.1101/gad.177200; Rekhtman N, 1999, GENE DEV, V13, P1398, DOI 10.1101/gad.13.11.1398; ROSMARIN AG, 1995, J BIOL CHEM, V270, P23627, DOI 10.1074/jbc.270.40.23627; Rosmarin AG, 1998, J BIOL CHEM, V273, P13097, DOI 10.1074/jbc.273.21.13097; Scott EW, 1997, IMMUNITY, V6, P437, DOI 10.1016/S1074-7613(00)80287-3; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; SCREPANTI I, 1995, EMBO J, V14, P1932, DOI 10.1002/j.1460-2075.1995.tb07185.x; Shivdasani RA, 1996, BLOOD, V87, P4025, DOI 10.1182/blood.V87.10.4025.bloodjournal87104025; Simon MC, 1996, CURR TOP MICROBIOL, V211, P113; Smith LT, 1996, BLOOD, V88, P1234, DOI 10.1182/blood.V88.4.1234.bloodjournal8841234; SPOSI NM, 1992, P NATL ACAD SCI USA, V89, P6353, DOI 10.1073/pnas.89.14.6353; Sun Z, 1996, CURR TOP MICROBIOL, V211, P173; SUN ZJ, 1995, J BIOL CHEM, V270, P1462, DOI 10.1074/jbc.270.3.1462; TANAKA T, 1995, CELL, V80, P353, DOI 10.1016/0092-8674(95)90418-2; Tang JG, 2001, J BIOL CHEM, V276, P17739, DOI 10.1074/jbc.M011546200; Tenen DG, 1997, BLOOD, V90, P489, DOI 10.1182/blood.V90.2.489.489_489_519; Trainor CD, 2000, J BIOL CHEM, V275, P28157; Trainor CD, 1996, MOL CELL BIOL, V16, P2238; TSAI SF, 1991, GENE DEV, V5, P919, DOI 10.1101/gad.5.6.919; UDDIN S, 1995, J BIOL CHEM, V270, P15938, DOI 10.1074/jbc.270.27.15938; UMEK RM, 1991, SCIENCE, V251, P288, DOI 10.1126/science.1987644; van Dijk TB, 1998, BLOOD, V91, P2126, DOI 10.1182/blood.V91.6.2126.2126_2126_2132; VOSO MT, 1994, P NATL ACAD SCI USA, V91, P7932, DOI 10.1073/pnas.91.17.7932; Vyas P, 1999, BLOOD, V93, P2867; WANG ND, 1995, SCIENCE, V269, P1108, DOI 10.1126/science.7652557; WASMOEN TL, 1989, J EXP MED, V170, P2051, DOI 10.1084/jem.170.6.2051; WASMOEN TL, 1987, P NATL ACAD SCI USA, V84, P3029, DOI 10.1073/pnas.84.9.3029; WILLIAMS SC, 1995, EMBO J, V14, P3170, DOI 10.1002/j.1460-2075.1995.tb07319.x; Williams SC, 1998, J BIOL CHEM, V273, P13493, DOI 10.1074/jbc.273.22.13493; WILLIAMS SC, 1991, GENE DEV, V5, P1553, DOI 10.1101/gad.5.9.1553; Williamson EA, 1998, J BIOL CHEM, V273, P14796, DOI 10.1074/jbc.273.24.14796; Yamaguchi Y, 1999, BLOOD, V94, P1429, DOI 10.1182/blood.V94.4.1429.416k13_1429_1439; Yamaguchi Y, 1998, BLOOD, V91, P3447, DOI 10.1182/blood.V91.9.3447.3447_3447_3458; YAMAGUCHI Y, 1994, J BIOL CHEM, V269, P19410; Yamanaka R, 1998, INT J MOL MED, V1, P213; Yamanaka R, 1997, P NATL ACAD SCI USA, V94, P6462, DOI 10.1073/pnas.94.12.6462; Yamanaka R, 1997, P NATL ACAD SCI USA, V94, P13187, DOI 10.1073/pnas.94.24.13187; Yang D, 2000, J BIOL CHEM, V275, P9425, DOI 10.1074/jbc.275.13.9425; Zhang DE, 1996, CURR TOP MICROBIOL, V211, P137; ZHANG DE, 1994, J IMMUNOL, V153, P3276; Zhang DE, 1997, P NATL ACAD SCI USA, V94, P569, DOI 10.1073/pnas.94.2.569; Zhang DE, 1996, MOL CELL BIOL, V16, P1231; Zhang P, 2000, BLOOD, V96, P2641; Zhang P, 1998, J EXP MED, V188, P1173, DOI 10.1084/jem.188.6.1173; Zhang P, 1999, P NATL ACAD SCI USA, V96, P8705, DOI 10.1073/pnas.96.15.8705; Zimmermann N, 2000, J IMMUNOL, V164, P1055, DOI 10.4049/jimmunol.164.2.1055; ZON LI, 1991, P NATL ACAD SCI USA, V88, P10642, DOI 10.1073/pnas.88.23.10642; ZON LI, 1993, BLOOD, V81, P3234	106	96	98	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					43481	43494		10.1074/jbc.M204777200	http://dx.doi.org/10.1074/jbc.M204777200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12202480	hybrid			2022-12-27	WOS:000179081200133
J	Martin, D; Salinas, M; Fujita, N; Tsuruo, T; Cuadrado, A				Martin, D; Salinas, M; Fujita, N; Tsuruo, T; Cuadrado, A			Ceramide and reactive oxygen species generated by H2O2 induce caspase-3-independent degradation of Akt/protein kinase B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAGNESIUM-DEPENDENT SPHINGOMYELINASE; BREAST-CARCINOMA CELLS; NEUTRAL SPHINGOMYELINASE; PROTEIN-KINASE; PC12 CELLS; IONIZING-RADIATION; INDUCED APOPTOSIS; HEAT-SHOCK; AKT KINASE; DEATH	This study was designed to elucidate the mechanisms leading to down-regulation of the Akt/protein kinase B (PKB) survival pathway during H2O2-induced cell death. H2O2 produced early activation of Akt/PKB and also DNA damage that was followed by stabilization of p53 levels, formation of reactive oxygen species (ROS), and generation of ceramide through activation of a glutathione-sensitive neutral sphingomyelinase. These events correlated with long term dephosphorylation and subsequent degradation of Akt. A membrane-targeted active Akt version attenuated apoptosis but not necrosis induced by H2O2 and was more resistant to dephosphorylation and proteolysis induced by apoptotic concentrations of H2O2. Proteolysis of Akt was prevented by exogenous addition of glutathione, indicating a role of ROS and ceramide in Akt degradation. However, Akt was degraded similarly in cells transfected with wild type and dominant negative p53 mutant, indicating that degradation of Akt under oxidative injury may be p53-independent. Specific inhibitors of caspase groups I and III prevented proteolysis of Akt/PKB and poly(ADP-ribose) polymerase in cells submitted to apoptotic but not necrotic H2O2 concentrations. Surprisingly, in caspase-3-deficient MCF-7 cells Akt was more sensitive to H2O2-induced degradation than the caspase-3 substrate poly(ADP-ribose) polymerase. Moreover, the Akt/PKB double mutant Akt(D108A,D119A), which is not cleaved by caspase-3, and a triple mutant (D453A,D455A,D456A), which lacks the consensus sequence for caspase-3 cleavage, were also degraded in H2O2-treated cells. Our results suggest that strong oxidants generate intracellular ROS and ceramide which in term lead to down-regulation of Akt by dephosphorylation and caspase-3-independent proteolysis.	Univ Autonoma Madrid, Dept Bioquim, Fac Med, Madrid 28029, Spain; Univ Autonoma Madrid, Inst Invest Biomed Alberto Sols, Fac Med, Madrid 28029, Spain; Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo 1138654, Japan	Autonomous University of Madrid; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); University of Tokyo	Cuadrado, A (corresponding author), Univ Autonoma Madrid, Dept Bioquim, Fac Med, Arzobispo Morcillo 4, Madrid 28029, Spain.	antonio.cuadrado@uam.es	Fujita, Naoya/A-7349-2010	Fujita, Naoya/0000-0002-9631-9264; Cuadrado, Antonio/0000-0002-3444-9012; Cuadrado, Antonio/0000-0002-4039-7140				Anderson ME, 1998, CHEM-BIOL INTERACT, V112, P1; Andrieu-Abadie N, 2001, FREE RADICAL BIO MED, V31, P717, DOI 10.1016/S0891-5849(01)00655-4; Bachelder RE, 2001, J BIOL CHEM, V276, P34702, DOI 10.1074/jbc.M102806200; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Bezombes C, 2001, FASEB J, V15, P1583, DOI 10.1096/fj.00-0787fje; Bindokas VP, 1996, J NEUROSCI, V16, P1324; Brazil DP, 2001, TRENDS BIOCHEM SCI, V26, P657, DOI 10.1016/S0968-0004(01)01958-2; Brunet A, 2001, CURR OPIN NEUROBIOL, V11, P297, DOI 10.1016/S0959-4388(00)00211-7; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Collins AR, 1997, MUTAT RES-FUND MOL M, V375, P183, DOI 10.1016/S0027-5107(97)00013-4; Dbaibo GS, 2001, FEBS LETT, V503, P7, DOI 10.1016/S0014-5793(01)02625-4; Dobrowsky RT, 2001, METHOD CELL BIOL, V66, P135; Fensome AC, 2000, J BIOL CHEM, V275, P1128, DOI 10.1074/jbc.275.2.1128; FRIDOVICH I, 1997, ANN NY ACAD SCI, V893, P13; Goldkorn T, 1998, J CELL SCI, V111, P3209; Goldshmit Y, 2001, J BIOL CHEM, V276, P46379, DOI 10.1074/jbc.M105637200; Gouaze V, 2001, MOL PHARMACOL, V60, P488; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Hannun YA, 1996, SCIENCE, V274, P1855, DOI 10.1126/science.274.5294.1855; Hannun YA, 2000, TRENDS CELL BIOL, V10, P73, DOI 10.1016/S0962-8924(99)01694-3; HANSEN MB, 1989, J IMMUNOL METHODS, V119, P203, DOI 10.1016/0022-1759(89)90397-9; Hasper HJ, 2000, CYTOMETRY, V40, P167, DOI 10.1002/(SICI)1097-0320(20000601)40:2<167::AID-CYTO11>3.3.CO;2-T; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Ikeyama S, 2002, FASEB J, V16, pA1163, DOI 10.1096/fj.01-0409fje; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Janicke RU, 2001, ONCOGENE, V20, P5043, DOI 10.1038/sj.onc.1204659; Kim SJ, 2002, J BIOL CHEM, V277, P33501, DOI 10.1074/jbc.M202862200; Konishi H, 1997, FEBS LETT, V410, P493, DOI 10.1016/S0014-5793(97)00541-3; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; Liu B, 1997, J BIOL CHEM, V272, P16281, DOI 10.1074/jbc.272.26.16281; Liu B, 1998, J BIOL CHEM, V273, P11313, DOI 10.1074/jbc.273.18.11313; Martin D, 2001, J NEUROCHEM, V78, P1000, DOI 10.1046/j.1471-4159.2001.00472.x; Miller FD, 2001, CELL MOL LIFE SCI, V58, P1045, DOI 10.1007/PL00000919; Perry DK, 2000, METHOD ENZYMOL, V312, P22; Pettmann B, 1998, NEURON, V20, P633, DOI 10.1016/S0896-6273(00)81004-1; Poot M, 1999, CYTOMETRY, V36, P359, DOI 10.1002/(SICI)1097-0320(19990801)36:4<359::AID-CYTO12>3.0.CO;2-V; Rimpler MM, 1999, BIOCHEM J, V340, P291, DOI 10.1042/0264-6021:3400291; Rokudai S, 2000, J CELL PHYSIOL, V182, P290, DOI 10.1002/(SICI)1097-4652(200002)182:2<290::AID-JCP18>3.0.CO;2-8; Salinas M, 2000, MOL CELL NEUROSCI, V15, P156, DOI 10.1006/mcne.1999.0813; Salinas M, 2001, MOL CELL NEUROSCI, V17, P67, DOI 10.1006/mcne.2000.0921; Sanchez-Prieto R, 2000, CANCER RES, V60, P2464; Sawada M, 2001, ONCOGENE, V20, P1368, DOI 10.1038/sj.onc.1204207; Serrano M, 2001, CURR OPIN CELL BIOL, V13, P748, DOI 10.1016/S0955-0674(00)00278-7; Shaw M, 1998, BIOCHEM J, V336, P241, DOI 10.1042/bj3360241; Spiegel S, 1996, FASEB J, V10, P1388, DOI 10.1096/fasebj.10.12.8903509; Summers SA, 1998, MOL CELL BIOL, V18, P5457, DOI 10.1128/MCB.18.9.5457; Tang D, 2001, J BIOL CHEM, V276, P30461, DOI 10.1074/jbc.M102045200; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; Wang XT, 2000, J BIOL CHEM, V275, P14624, DOI 10.1074/jbc.275.19.14624; Widmann C, 1998, J BIOL CHEM, V273, P7141, DOI 10.1074/jbc.273.12.7141; Yoshimura S, 1999, J NEUROCHEM, V73, P675, DOI 10.1046/j.1471-4159.1999.0730675.x; Yoshimura S, 1998, J BIOL CHEM, V273, P6921, DOI 10.1074/jbc.273.12.6921; Zhou HL, 1998, J BIOL CHEM, V273, P16568, DOI 10.1074/jbc.273.26.16568	53	159	164	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					42943	42952		10.1074/jbc.M201070200	http://dx.doi.org/10.1074/jbc.M201070200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12213802	hybrid			2022-12-27	WOS:000179081200068
J	Muller, YA; Heiring, C; Misselwitz, R; Welfle, K; Welfle, H				Muller, YA; Heiring, C; Misselwitz, R; Welfle, K; Welfle, H			The cystine knot promotes folding and not thermodynamic stability in vascular endothelial growth factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; ANGSTROM RESOLUTION; DISULFIDE BONDS; VEGF; COMPLEX; BINDING; DENATURATION; PROTEINS; MUTANTS; PROGRAM	Cystine knots consist of three intertwined disulfide bridges and are considered major determinants of protein stability in proteins in which they occur. We questioned this function and observed that removal of individual disulfide bridges in human vascular endothelial growth factor (VEGF) does not reduce its thermodynamic stability but reduces its unexpected high thermal stability of 108 degreesC by up to 40 degreesC. In wild-type VEGF (DeltaG(u,25)(0) = 5.1 kcal(.)mol(-1)), the knot is responsible for a large entropic stabilization of TDeltaS(u,25)(0) = -39.3 kcal mol(-1), which is compensated for by a DeltaH(u,25)(0) of -34.2 kcal mol(-1). In the disulfide-deficient mutants, this entropic stabilization disappears, but instead of a decrease, we observe an increase in the thermodynamic stability by about 2 kcal-mol(-1). A detailed crystallographic analysis of the mutant structures suggests a role of the cystine knot motif in protein folding rather than in the stabilization of the folded state. When assuming that the sequential order of the disulfide bridge formation is conserved between VIEGF and glycoprotein alpha-subunit, the crystal structure of the mutant C61A-C104A, which deviates by a root mean square deviation of more than 2.2 Angstrom from wild-type VEGF, identifies a true folding intermediate of VEGF.	Max Delbruck Ctr Mol Med, Forsch Grp Kristallog, D-13092 Berlin, Germany; Univ Sussex, Sch Biol Sci, Brighton BN1 9QG, E Sussex, England; Free Univ Berlin, Fachbereich Biol, Grad Sch, D-14195 Berlin, Germany; Max Delbruck Ctr Mol Med, Arbeitsgrp Biopolymerspekroskopie, D-13092 Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Sussex; Free University of Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Muller, YA (corresponding author), Max Delbruck Ctr Mol Med, Forsch Grp Kristallog, D-13092 Berlin, Germany.	y.muller@sussex.ac.uk	Muller, Yves A/R-5397-2016	Muller, Yves A/0000-0003-0519-8928				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BECKTEL WJ, 1987, BIOPOLYMERS, V26, P1859, DOI 10.1002/bip.360261104; BETZ SF, 1993, PROTEIN SCI, V2, P1551, DOI 10.1002/pro.5560021002; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Craik DJ, 1999, J MOL BIOL, V294, P1327, DOI 10.1006/jmbi.1999.3383; Darby N, 1995, Methods Mol Biol, V40, P219; Darling RJ, 2000, J BIOL CHEM, V275, P15413, DOI 10.1074/jbc.275.20.15413; Darling RJ, 2001, BIOCHEMISTRY-US, V40, P577, DOI 10.1021/bi002046a; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Heiring C, 2001, PROTEIN ENG, V14, P183, DOI 10.1093/protein/14.3.183; Hymowitz SG, 2001, EMBO J, V20, P5332, DOI 10.1093/emboj/20.19.5332; ISAACS NW, 1995, CURR OPIN STRUC BIOL, V5, P391, DOI 10.1016/0959-440X(95)80102-2; Johnson CM, 1997, J MOL BIOL, V268, P198, DOI 10.1006/jmbi.1997.0928; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Joukov V, 1998, J BIOL CHEM, V273, P6599, DOI 10.1074/jbc.273.12.6599; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903; Keyt BA, 1996, J BIOL CHEM, V271, P5638, DOI 10.1074/jbc.271.10.5638; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LUMRY R, 1966, BIOPOLYMERS, V4, P917, DOI 10.1002/bip.1966.360040808; LUMRY R, 1970, BIOPOLYMERS, V9, P1125, DOI 10.1002/bip.1970.360091002; McCrary BS, 1996, J MOL BIOL, V264, P784, DOI 10.1006/jmbi.1996.0677; Merritt EA, 1999, ACTA CRYSTALLOGR D, V55, P1109, DOI 10.1107/S0907444999003789; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Muller YA, 1997, STRUCTURE, V5, P1325, DOI 10.1016/S0969-2126(97)00284-0; Muller YA, 1997, P NATL ACAD SCI USA, V94, P7192, DOI 10.1073/pnas.94.14.7192; Muller YA, 1998, STRUCTURE, V6, P1153, DOI 10.1016/S0969-2126(98)00116-6; MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020; OSHEA EK, 1992, CELL, V68, P699, DOI 10.1016/0092-8674(92)90145-3; Pace C. N., 1997, PROTEIN STRUCTURE PR, V2, P299; Pace CN, 1998, J MOL BIOL, V279, P271, DOI 10.1006/jmbi.1998.1760; PALLAGHY PK, 1994, PROTEIN SCI, V3, P1833, DOI 10.1002/pro.5560031022; Perl D, 2000, NAT STRUCT BIOL, V7, P380; PERRAKIS A, 1997, ACTA CRYSTALLOGR D, V49, P129; POTGENS AJG, 1994, J BIOL CHEM, V269, P32879; Price-Carter M, 1998, BIOCHEMISTRY-US, V37, P9851, DOI 10.1021/bi9803978; PRIVALOV PL, 1988, ADV PROTEIN CHEM, V39, P191; Tanford C, 1968, Adv Protein Chem, V23, P121, DOI 10.1016/S0065-3233(08)60401-5; Vitt UA, 2001, MOL ENDOCRINOL, V15, P681, DOI 10.1210/me.15.5.681; Wiesmann C, 1998, BIOCHEMISTRY-US, V37, P17765, DOI 10.1021/bi9819327; Wiesmann C, 2000, NAT STRUCT BIOL, V7, P440; Wiesmann C, 1997, CELL, V91, P695, DOI 10.1016/S0092-8674(00)80456-0	42	42	44	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					43410	43416		10.1074/jbc.M206438200	http://dx.doi.org/10.1074/jbc.M206438200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12207021	hybrid			2022-12-27	WOS:000179081200125
J	Ranganathan, G; Phan, D; Pokrovskaya, ID; McEwen, JE; Li, CL; Kern, PA				Ranganathan, G; Phan, D; Pokrovskaya, ID; McEwen, JE; Li, CL; Kern, PA			The translational regulation of lipoprotein lipase by epinephrine involves an RNA binding complex including the catalytic subunit of protein kinase A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORMONE-SENSITIVE LIPASE; ISOLATED RAT ADIPOCYTES; HUMAN ADIPOSE-TISSUE; MESSENGER-RNA; 3'-UNTRANSLATED REGION; CYCLIC-AMP; ANCHOR PROTEIN; GENE-EXPRESSION; RICH DOMAIN; GERM-CELLS	The balance of lipid flux in adipocytes is controlled by the opposing actions of lipolysis and lipogenesis, which are controlled primarily by hormone-sensitive lipase and lipoprotein lipase (LPL), respectively. Catecholamines stimulate adipocyte lipolysis through reversible phosphorylation of hormone-sensitive lipase, and simultaneously inhibit LPL activity. However, LPL regulation is complex and previous studies have described translational regulation of LPL in response to catecholamines because of an RNA-binding protein that interacts with the W-untranslated region of LPL mRNA. In this study, we identified several protein components of an LPL RNA binding complex. Using an LPL RNA affinity column, we identified two of the RNA-binding proteins as the catalytic (C) subunit of cAMP-dependent protein kinase (PKA), and A kinase anchoring protein (AKAP) 121/149, one of the PKA anchoring proteins, which has known RNA binding activity. To determine whether the C subunit was involved in LPL translation inhibition, the C subunit was depleted from the cytoplasmic extract of epinephrine-stimulated adipocytes by immunoprecipitation. This resulted in the loss of LPL translation inhibition activity of the extract, along with decreased RNA binding activity in a gel shift assay. To demonstrate the importance of the AKAPs, inhibition of PKA-AKAP binding with a peptide competitor (HT31) prevented epinephrine-mediated inhibition of LPL translation. C subunit kinase activity was necessary for LPL RNA binding and translation inhibition, suggesting that the phosphorylation of AKAP121/149 or other proteins was an important part of RNA binding complex formation. The hormonal activation of PKA results in the reversible phosphorylation of hormone-sensitive lipase, which is the primary mediator of adipocyte lipolysis. These studies demonstrate a dual role for PKA to simultaneously inhibit LPL-mediated lipogenesis through inhibition of LPL translation.	Univ Arkansas Med Sci, Cent Arkansas vet Healthcare Syst, Little Rock, AR 72205 USA; Univ Arkansas Med Sci, Dept Med, Div Endocrinol, Little Rock, AR 72205 USA; Univ Arkansas Med Sci, Dept Geriatr, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences; US Department of Veterans Affairs; Veterans Health Administration (VHA); Central Arkansas Veterans Healthcare System; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences	Kern, PA (corresponding author), Univ Arkansas Med Sci, Cent Arkansas vet Healthcare Syst, 4300 W 7th St, Little Rock, AR 72205 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK039176, R37DK039176, R01DK039176] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 39176] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ASHLEY CT, 1996, SCIENCE, V262, P563; BILEZIKIAN JP, 1983, ENDOCR REV, V4, P378, DOI 10.1210/edrv-4-4-378; CARR DW, 1992, J BIOL CHEM, V267, P13376; Chen Q, 1997, J BIOL CHEM, V272, P15247, DOI 10.1074/jbc.272.24.15247; CHIJIWA T, 1990, J BIOL CHEM, V265, P5267; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHRIST B, 1991, BIOCHEM BIOPH RES CO, V177, P1273, DOI 10.1016/0006-291X(91)90679-2; Diviani D, 2001, J CELL SCI, V114, P1431; DOOLITTLE MH, 1990, J BIOL CHEM, V265, P4570; ECKEL RH, 1987, LIPOPROTEIN LIPASE, P79; Feliciello A, 1998, J BIOL CHEM, V273, P23361, DOI 10.1074/jbc.273.36.23361; Feliciello A, 2001, J MOL BIOL, V308, P99, DOI 10.1006/jmbi.2001.4585; Francis SH, 1999, CRIT REV CL LAB SCI, V36, P275, DOI 10.1080/10408369991239213; Furusawa M, 2001, J BIOL CHEM, V276, P36647, DOI 10.1074/jbc.M103885200; GOERS JWF, 1987, ANAL BIOCHEM, V166, P27, DOI 10.1016/0003-2697(87)90541-0; Goldberg IJ, 1996, J LIPID RES, V37, P693; HAUSKEN ZE, 1997, PROTEIN TARGETING PR, P47; HOD Y, 1988, J BIOL CHEM, V263, P7747; Holm C, 1997, METHOD ENZYMOL, V286, P45; KELLEY DE, 1994, J CLIN INVEST, V94, P2349, DOI 10.1172/JCI117600; Kern PA, 1996, J LIPID RES, V37, P2332; LIN RY, 1995, J BIOL CHEM, V270, P27804, DOI 10.1074/jbc.270.46.27804; Londos C, 1999, ANN NY ACAD SCI, V892, P155, DOI 10.1111/j.1749-6632.1999.tb07794.x; McKnight GS, 1998, RECENT PROG HORM RES, V53, P139; ONG JM, 1989, J CLIN INVEST, V84, P305, DOI 10.1172/JCI114155; ONG JM, 1988, J BIOL CHEM, V263, P12933; ONG JM, 1989, J BIOL CHEM, V264, P3177; ONG JM, 1992, ENDOCRINOLOGY, V130, P2310, DOI 10.1210/en.130.4.2310; ONG JM, 1992, MOL ENDOCRINOL, V6, P61, DOI 10.1210/me.6.1.61; Osuga J, 2000, P NATL ACAD SCI USA, V97, P787, DOI 10.1073/pnas.97.2.787; PENG H, 1995, J BIOL CHEM, V270, P23996, DOI 10.1074/jbc.270.41.23996; Ramsay TG, 1996, ENDOCRIN METAB CLIN, V25, P847, DOI 10.1016/S0889-8529(05)70358-3; Ranganathan G, 1997, J BIOL CHEM, V272, P2515; Ranganathan G, 1999, J BIOL CHEM, V274, P9122, DOI 10.1074/jbc.274.13.9122; Ranganathan G, 2000, J BIOL CHEM, V275, P40986, DOI 10.1074/jbc.M008775200; SIMSOLO RB, 1992, J LIPID RES, V33, P89; STEPHENS JM, 1992, J BIOL CHEM, V267, P8336; STRALFORS P, 1984, P NATL ACAD SCI-BIOL, V81, P3317, DOI 10.1073/pnas.81.11.3317; TAVANGAR K, 1992, J CLIN INVEST, V90, P1672, DOI 10.1172/JCI116039; Tian D, 1998, J BIOL CHEM, V273, P28454, DOI 10.1074/jbc.273.43.28454; Trendelenburg G, 1996, BIOCHEM BIOPH RES CO, V225, P313, DOI 10.1006/bbrc.1996.1172; TSO JY, 1985, NUCLEIC ACIDS RES, V13, P2485, DOI 10.1093/nar/13.7.2485; UNGER RH, 1995, DIABETES, V44, P863, DOI 10.2337/diabetes.44.8.863; WALSH DA, 1968, J BIOL CHEM, V243, P3763; WION KL, 1987, SCIENCE, V235, P1638, DOI 10.1126/science.3823907; Xie GF, 2001, AM J PHYSIOL-GASTR L, V281, pG1051, DOI 10.1152/ajpgi.2001.281.4.G1051; YUKHT A, 1995, J CLIN INVEST, V96, P2438, DOI 10.1172/JCI118301	47	37	38	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					43281	43287		10.1074/jbc.M202560200	http://dx.doi.org/10.1074/jbc.M202560200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12218046	hybrid			2022-12-27	WOS:000179081200111
J	Rodriguez-Cuenca, S; Pujol, E; Justo, R; Frontera, M; Oliver, J; Gianotti, M; Roca, P				Rodriguez-Cuenca, S; Pujol, E; Justo, R; Frontera, M; Oliver, J; Gianotti, M; Roca, P			Sex-dependent thermogenesis, differences in mitochondrial morphology and function, and adrenergic response in brown adipose tissue	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNCOUPLING PROTEIN THERMOGENIN; FAT-CELLS; BETA-ADRENOCEPTOR; BINDING-SITES; MESSENGER-RNA; RATS; EXPRESSION; LIPOLYSIS; RECEPTOR; TESTOSTERONE	Gender-related differences in brown adipose tissue (BAT) thermogenesis of 110-day-old rats were studied by determining the morphological and functional features of BAT. The adrenergic control was assessed by studying the levels of beta(3)- and alpha(2A)-adrenergic receptors (AR) and by determining the lipolytic response to norepinephrine (beta(1)-,beta(2)-beta(3)-, and alpha(2)-AR agonist), isoprenaline (beta(1)-, beta(2)-, and beta(3)-AR agonist), and CGP12177A (selective partial beta(3)-AR agonist but beta(1)- and beta(2)-AR antagonist) together with post-receptor agents, forskolin and dibutyryl cyclic AMP. The female rats that had greater oxygen consumption showed higher UCP1 content, a higher multilocular arrangement, and both longer cristae and higher cristae dense mitochondria in BAT indicating heightened thermogenic capacity and activity; this picture is accompanied by a more sensitive beta(3)-AR to norepinephrine signal (EC50 10-fold lower for CGP12177A) and a lower expression of alpha(2A)-AR than male rats. Taken together, our results support the idea that the BAT hormonal environment could be involved in the control of different elements of lipolytic and thermogenic adrenergic pathways. Gender dimorphism is both at receptor (changing a2A-AR density and beta(3)-AR affinity) and post-receptor (modulating the links involved in the adrenergic signal transduction) levels. These changes in adrenergic control could be responsible, at least in part, both for the important mitochondrial recruitment differences and functional and morphological features of BAT in female rats under usual rodent housing temperatures.	Univ Illes Balears, Dept Biol Fonamental & Ciencias Salut, E-07071 Palma de Mallorca, Spain	Universitat de les Illes Balears	Roca, P (corresponding author), Univ Illes Balears, Dept Biol Fonamental & Ciencias Salut, Cra Valldemossa Km 7-5, E-07071 Palma de Mallorca, Spain.	pilar.roca@uib.es	Rodriguez-Cuenca, Sergio/C-5901-2011; Gianotti, Magdalena/H-7725-2015; Roca, Pilar/L-7578-2014; Oliver, Jordi/H-8073-2013	Gianotti, Magdalena/0000-0002-5225-9079; Roca, Pilar/0000-0003-3878-5424; Oliver, Jordi/0000-0002-5702-7306; Frontera Borrueco, Marga/0000-0001-8670-9106				Abelenda M, 1999, EUR J ENDOCRINOL, V141, P630, DOI 10.1530/eje.0.1410630; Atgie C, 1997, AM J PHYSIOL-CELL PH, V273, pC1136, DOI 10.1152/ajpcell.1997.273.4.C1136; Bengtsson T, 2000, BIOCHEM J, V347, P643, DOI 10.1042/0264-6021:3470643; BOULOUMIE A, 1994, EUR J PHARM-MOLEC PH, V269, P95, DOI 10.1016/0922-4106(94)90031-0; BRONNIKOV G, 1992, J BIOL CHEM, V267, P2006; CERVANTESOLIVIER P, 1985, BIOCHEMISTRY-US, V24, P3765, DOI 10.1021/bi00335a052; Chaudhry A, 1999, AM J PHYSIOL-REG I, V277, pR147, DOI 10.1152/ajpregu.1999.277.1.R147; Cinti S, 2001, P NUTR SOC, V60, P319, DOI 10.1079/PNS200192; DEPERGOLA G, 1990, ACTA ENDOCRINOL-COP, V123, P61, DOI 10.1530/acta.0.1230061; FOLCH J, 1957, J BIOL CHEM, V226, P497; Germack R, 1997, BRIT J PHARMACOL, V120, P201, DOI 10.1038/sj.bjp.0700885; GHADIALLY F.N., 1988, ULTRASTRUCT PATHOL, P194; GIUDICELLI Y, 1993, PROSTAG LEUKOTR ESS, V48, P91, DOI 10.1016/0952-3278(93)90015-O; Gomez-Ambrosi J, 2001, INT J MOL MED, V8, P103; HERRON D, 1990, FEBS LETT, V268, P296, DOI 10.1016/0014-5793(90)81031-I; HIMMSHAGEN J, 1991, FRONT NEUROENDOCRIN, V12, P38; HIMMSHAGEN J, 1990, FASEB J, V4, P2890, DOI 10.1096/fasebj.4.11.2199286; LACASA D, 1991, ENDOCRINOLOGY, V128, P747, DOI 10.1210/endo-128-2-747; LACASA D, 1994, BBA-MOL CELL RES, V1224, P527, DOI 10.1016/0167-4889(94)90290-9; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lafontan M., 1997, Human Reproduction (Oxford), V12, P6; LAFONTAN M, 1995, ENDOCR REV, V16, P716, DOI 10.1210/er.16.6.716; Lanni A, 1996, INT J BIOCHEM CELL B, V28, P337, DOI 10.1016/1357-2725(95)00137-9; Llado I, 2002, OBES RES, V10, P296, DOI 10.1038/oby.2002.41; LONCAR D, 1988, J ULTRA MOL STRUCT R, V101, P199, DOI 10.1016/0889-1605(88)90010-9; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Malo A, 2001, EUR J ENDOCRINOL, V145, P87, DOI 10.1530/eje.0.1450087; Matthias A, 2000, J BIOL CHEM, V275, P25073, DOI 10.1074/jbc.M000547200; MAURIEGE P, 1987, EUR J CLIN INVEST, V17, P156, DOI 10.1111/j.1365-2362.1987.tb02395.x; MCBENNET SM, 1993, OBESITY EUROPE, P399; McDonald RB, 1999, J BIOENERG BIOMEMBR, V31, P507, DOI 10.1023/A:1005404708710; MCDONALD RB, 1993, P SOC EXP BIOL MED, V204, P117; MORRONI M, 1995, INT J OBESITY, V19, P126; NAVA MP, 1994, PFLUG ARCH EUR J PHY, V426, P40, DOI 10.1007/BF00374668; NECHAD M, 1987, AM J PHYSIOL, V253, pC889, DOI 10.1152/ajpcell.1987.253.6.C889; Nedergaard J, 2001, BBA-BIOENERGETICS, V1504, P82, DOI 10.1016/S0005-2728(00)00247-4; ODONNELL ME, 1982, AM J PHYSIOL, V242, pC46, DOI 10.1152/ajpcell.1982.242.1.C46; PECQUERY R, 1995, BIOCHEM BIOPH RES CO, V206, P112, DOI 10.1006/bbrc.1995.1016; PECQUERY R, 1990, ENDOCRINOLOGY, V126, P241, DOI 10.1210/endo-126-1-241; Pedersen SB, 2001, BIOCHEM BIOPH RES CO, V288, P191, DOI 10.1006/bbrc.2001.5763; PUERTA M, 1993, CAN J PHYSIOL PHARM, V71, P858, DOI 10.1139/y93-129; PUIGSERVER P, 1991, BIOCHEM J, V279, P575, DOI 10.1042/bj2790575; Quevedo S, 1998, PFLUG ARCH EUR J PHY, V436, P689, DOI 10.1007/s004240050690; REHNMARK S, 1990, J BIOL CHEM, V265, P16464; Ricquier D, 2000, J PHYSIOL-LONDON, V529, P3, DOI 10.1111/j.1469-7793.2000.00003.x; Roca P, 1999, PFLUG ARCH EUR J PHY, V438, P628, DOI 10.1007/s004240051086; Rodriguez E, 2001, PFLUG ARCH EUR J PHY, V442, P396, DOI 10.1007/s004240100556; THOMAS PS, 1978, ANAL BIOCHEM, V89, P35, DOI 10.1016/0003-2697(78)90724-8; Valet P, 2000, J BIOL CHEM, V275, P34797, DOI 10.1074/jbc.M005210200; Valladares A, 2000, J CELL PHYSIOL, V185, P324, DOI 10.1002/1097-4652(200012)185:3<324::AID-JCP2>3.0.CO;2-Q; Wharton DC., 1967, METHOD ENZYMOL, P245; XU XF, 1993, ENDOCRINOLOGY, V132, P1651, DOI 10.1210/en.132.4.1651; XU XF, 1991, ENDOCRINOLOGY, V128, P379, DOI 10.1210/endo-128-1-379; YOSHIDA T, 1987, METABOLISM, V36, P1, DOI 10.1016/0026-0495(87)90054-0; Zhao J, 1998, AM J PHYSIOL-REG I, V275, pR2002, DOI 10.1152/ajpregu.1998.275.6.R2002	55	152	155	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					42958	42963		10.1074/jbc.M207229200	http://dx.doi.org/10.1074/jbc.M207229200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12215449	hybrid			2022-12-27	WOS:000179081200070
J	Shum, JKS; Melendez, JA; Jeffrey, JJ				Shum, JKS; Melendez, JA; Jeffrey, JJ			Serotonin-induced MMP-13 production is mediated via phospholipase C, protein kinase C, and ERK1/2 in rat uterine smooth muscle cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLLAGENASE GENE-EXPRESSION; 5-HT2 BINDING CHARACTERISTICS; RECEPTOR SIGNAL-TRANSDUCTION; N-TERMINAL KINASE; FACTOR-KAPPA-B; MATRIX-METALLOPROTEINASE; PHORBOL ESTER; PHOSPHOINOSITIDE TURNOVER; EPITHELIAL-CELLS; DIFFERENTIAL REGULATION	Serotonin (5-hydroxytryptamine; 5-HT), acting via the 5-HT2A receptor, up-regulates the transcription and production of interstitial collagenase (matrix metalloproteinase-13; MMP-13), a critical enzyme responsible for maintaining the integrity of the uterus, after parturition. Serotonin treatment of rat uterine myometrial smooth muscle cells induced inositol phosphate (IP) turnover, which was abolished by the 5-HT2A receptor-specific antagonists ketanserin and spiperone. The phospholipase C (PLC) inhibitors U73122 and D609 attenuated serotonin-mediated-IP turnover with a corresponding inhibition of MMP-13 protein production. Subsequent recovery of both MMP-13 protein expression and IP generation was seen following the removal of D609. Protein kinase C (PKC) activators, the diacylglycerol analogue 1,2-dioctanoyl-sn-glycerol and phorbol myristate acetate (PMA), mimicked the effect of serotonin on MMP-13 protein expression; prolonged PMA treatment (which down-regulates PKC) lowered MMP-13 protein levels. The PKC-specific inhibitors bisindolylmaleimide I, calphostin C, CGP 41251, and the PKCdelta-selective inhibitor rottlerin were able to suppress serotonin up-regulation of MMP-13. Furthermore, the mitogen-activated protein kinase kinase (MEK) inhibitor PD98059 blocked serotonin-dependent activation of p44/42 MAPK (pERK1/2), a downstream effector of PKC and also down-regulated MMP-13 protein expression. Similarly, calphostin C and rottlerin depressed activation of p44/42 MAPK. From these studies, serotonin, binding through the 5-HT2A receptor, initiates a signaling cascade whereby stimulation of PLC leads to the activation of PKC and subsequently the ERK1/2 pathway, which ultimately results in MMP-13 production.	Albany Med Coll, Ctr Immunol & Microbial Dis, Albany, NY 12208 USA; Albany Med Coll, Ctr Cell Biol & Canc Res, Albany, NY 12208 USA	Albany Medical College; Albany Medical College	Melendez, JA (corresponding author), Albany Med Coll, Ctr Immunol & Microbial Dis, MC-151, Albany, NY 12208 USA.	melenda@mail.amc.edu		Melendez, Juan/0000-0001-8021-3097				Amtmann E, 1996, DRUG EXP CLIN RES, V22, P287; APUD JA, 1991, PHARMACOL RES, V23, P217, DOI 10.1016/S1043-6618(05)80081-7; BERRIDGE MJ, 1982, BIOCHEM J, V206, P587, DOI 10.1042/bj2060587; BLAIR HC, 1986, J CELL PHYSIOL, V129, P111, DOI 10.1002/jcp.1041290116; BOULTON TG, 1991, BIOCHEMISTRY-US, V30, P278, DOI 10.1021/bi00215a038; BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J; BRINCKERHOFF CE, 1979, ARTHRITIS RHEUM, V22, P1109, DOI 10.1002/art.1780221010; BURGESON RE, 1988, ANNU REV CELL BIOL, V4, P551, DOI 10.1146/annurev.cb.04.110188.003003; COHEN ML, 1987, J CARDIOVASC PHARM, V10, P176, DOI 10.1097/00005344-198708000-00007; CONKLIN BR, 1992, J BIOL CHEM, V267, P31; CONN PJ, 1985, J PHARMACOL EXP THER, V234, P195; CONN PJ, 1984, NEUROPHARMACOLOGY, V23, P993, DOI 10.1016/0028-3908(84)90017-0; Eude I, 2000, BIOL REPROD, V63, P1567, DOI 10.1095/biolreprod63.5.1567; Florian JA, 1998, J PHARMACOL EXP THER, V284, P346; Frey MR, 2001, BIOCHEM PHARMACOL, V61, P1093, DOI 10.1016/S0006-2952(01)00596-2; GLENNON RA, 1986, J MED CHEM, V29, P2375, DOI 10.1021/jm00161a038; GLENNON RA, 1986, J MED CHEM, V29, P194, DOI 10.1021/jm00152a005; Gliki G, 2001, BIOCHEM J, V353, P503, DOI 10.1042/0264-6021:3530503; Greene EL, 2000, AM J PHYSIOL-RENAL, V278, pF650, DOI 10.1152/ajprenal.2000.278.4.F650; HALME J, 1980, ARCH BIOCHEM BIOPHYS, V199, P51, DOI 10.1016/0003-9861(80)90255-6; Han ZN, 2001, J CLIN INVEST, V108, P73, DOI 10.1172/JCI12466; HARKNESS MLR, 1954, J PHYSIOL-LONDON, V123, P492, DOI 10.1113/jphysiol.1954.sp005066; HARKNESS RD, 1956, J PHYSIOL-LONDON, V132, P502, DOI 10.1113/jphysiol.1956.sp005543; Hsu HY, 2002, J BIOL CHEM, V277, P22131, DOI 10.1074/jbc.M111883200; Huang CC, 1998, MOL CELL ENDOCRINOL, V139, P79, DOI 10.1016/S0303-7207(98)00071-9; JEFFREY JJ, 1991, J CELL PHYSIOL, V146, P399, DOI 10.1002/jcp.1041460310; JEFFREY JJ, 1970, BIOCHEMISTRY-US, V9, P268, DOI 10.1021/bi00804a012; Jiang TR, 1996, CIRC RES, V78, P553, DOI 10.1161/01.RES.78.4.553; Jiang Y, 2002, CANCER RES, V62, P1910; Johansson N, 2000, J CELL SCI, V113, P227; JOHNSON JA, 1995, LIFE SCI, V57, P1027, DOI 10.1016/0024-3205(95)02048-N; KISS Z, 1995, BBA-LIPID LIPID MET, V1259, P105, DOI 10.1016/0005-2760(95)00148-6; LEYSEN JE, 1982, MOL PHARMACOL, V21, P301; Li WQ, 2001, J IMMUNOL, V166, P3491, DOI 10.4049/jimmunol.166.5.3491; Liacini A, 2002, MATRIX BIOL, V21, P251, DOI 10.1016/S0945-053X(02)00007-0; Liedtke CM, 2002, BBA-MOL CELL RES, V1589, P77, DOI 10.1016/S0167-4889(01)00189-6; Liu EB, 2000, CANCER RES, V60, P2361; Mengshol JA, 2000, ARTHRITIS RHEUM, V43, P801, DOI 10.1002/1529-0131(200004)43:4<801::AID-ANR10>3.0.CO;2-4; MORT JS, 1993, MATRIX, V13, P95, DOI 10.1016/S0934-8832(11)80068-5; MOSIOR M, 1995, J BIOL CHEM, V270, P25526, DOI 10.1074/jbc.270.43.25526; MULLERDECKER K, 1989, BIOCHEM BIOPH RES CO, V162, P198, DOI 10.1016/0006-291X(89)91981-5; NAKAKI T, 1985, J PHARMACOL EXP THER, V234, P442; Naze S, 1997, J PHARMACOL EXP THER, V281, P15; Onodera S, 2002, J BIOL CHEM, V277, P7865, DOI 10.1074/jbc.M106020200; Passaretti TV, 1996, MOL CELL ENDOCRINOL, V120, P125, DOI 10.1016/0303-7207(96)03827-0; PAYNE DM, 1991, EMBO J, V10, P885, DOI 10.1002/j.1460-2075.1991.tb08021.x; PEROUTKA SJ, 1979, MOL PHARMACOL, V16, P687; Ravanti L, 1999, J BIOL CHEM, V274, P2446, DOI 10.1074/jbc.274.4.2446; Reunanen N, 2002, J BIOL CHEM, V277, P32360, DOI 10.1074/jbc.M204296200; ROSS R, 1971, J CELL BIOL, V50, P159, DOI 10.1083/jcb.50.1.159; ROSWIT WT, 1988, ARCH BIOCHEM BIOPHYS, V262, P67, DOI 10.1016/0003-9861(88)90169-5; ROTH BL, 1986, J PHARMACOL EXP THER, V238, P480; RYDELEKFITZGERALD L, 1993, MOL CELL ENDOCRINOL, V91, P67, DOI 10.1016/0303-7207(93)90256-J; SAKO T, 1988, TOHOKU J EXP MED, V156, P229, DOI 10.1620/tjem.156.229; SCHATZ F, 1983, ENDOCRINOLOGY, V113, P1274, DOI 10.1210/endo-113-4-1274; STRICKLIN GP, 1977, BIOCHEMISTRY-US, V16, P1607, DOI 10.1021/bi00627a013; SZALLASI Z, 1994, J BIOL CHEM, V269, P2118; Takahashi C, 1998, P NATL ACAD SCI USA, V95, P13221, DOI 10.1073/pnas.95.22.13221; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Ueda Y, 1996, J BIOL CHEM, V271, P23512, DOI 10.1074/jbc.271.38.23512; Undie AS, 1999, BRAIN RES, V816, P286, DOI 10.1016/S0006-8993(98)01076-2; vanDijk MCM, 1997, J BIOL CHEM, V272, P11011; VINCENTI MP, 1994, NUCLEIC ACIDS RES, V22, P4818, DOI 10.1093/nar/22.22.4818; WATTS SW, 1994, J PHARMACOL EXP THER, V271, P832; Watts SW, 1998, ANN NY ACAD SCI, V861, P162; Westermarck J, 2001, MOL CELL BIOL, V21, P2373, DOI 10.1128/MCB.21.7.2373-2383.2001; WHITHAM SE, 1986, BIOCHEM J, V240, P913, DOI 10.1042/bj2400913; WILCOX BD, 1994, MOL CELL ENDOCRINOL, V101, P67, DOI 10.1016/0303-7207(94)90220-8; WILCOX BD, 1994, J BIOL CHEM, V269, P29658; WILCOX BD, 1992, J BIOL CHEM, V267, P20752; Wilcox CB, 2000, MOL CELL ENDOCRINOL, V170, P41, DOI 10.1016/S0303-7207(00)00327-0	71	41	42	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					42830	42840		10.1074/jbc.M205094200	http://dx.doi.org/10.1074/jbc.M205094200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12213812	hybrid			2022-12-27	WOS:000179081200055
J	Tang, NY; Lin, TM; Ostap, EM				Tang, NY; Lin, TM; Ostap, EM			Dynamics of Myo1c (Myosin-I beta) lipid binding and dissociation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; BRUSH-BORDER; LOCALIZATION; ASSOCIATION; DOMAIN; SH3; SITES; TAIL	Myosin-I is the single-headed member of the myosin superfamily that associates with lipid membranes. Biochemical experiments have shown that myosin-I membrane binding is the result of electrostatic interactions between the basic tail domain and acidic phospholipids. To better understand the dynamics of myosin-I membrane association, we measured the rates of association and dissociation of a recombinant myo1c tail domain (which includes three IQ domains and bound calmodulins) to and from large unilamellar vesicles using fluorescence resonance energy transfer. The apparent second-order rate constant for lipid-tail association in the absence of calcium is fast with nearly every lipid-tail collision resulting in binding. The rate of binding is decreased in the presence of calcium. Time courses of myo1c-tail dissociation are best fit by two exponential rates: a fast component that has a rate that depends on the ratio of acidic phospholipid to myo1c-tail (phosphatidylserine (PS)/tail) and a slow component that predominates at high PS/tail ratios. The dissociation rate of the slow component is slower than the myo1c ATPase rate, suggesting that myo1c is able to stay associated with the lipid membrane during multiple catalytic cycles of the motor. Calcium significantly increases the lifetimes of the membrane-bound state, resulting in dissociation rates much less than 0.001 s(-1).	Univ Penn, Sch Med, Dept Physiol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Penn Muscle Inst, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Ostap, EM (corresponding author), Univ Penn, Sch Med, Dept Physiol, B400 Richards Bldg, Philadelphia, PA 19104 USA.	ostap@mail.med.upenn.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057247] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM57247] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anderson BL, 1998, J CELL BIOL, V141, P1357, DOI 10.1083/jcb.141.6.1357; Anderson RGW, 2002, SCIENCE, V296, P1821, DOI 10.1126/science.1068886; Balish MF, 1999, ARCH BIOCHEM BIOPHYS, V370, P285, DOI 10.1006/abbi.1999.1409; BAZZI MD, 1991, BIOCHEMISTRY-US, V30, P7970, DOI 10.1021/bi00246a014; BAZZI MD, 1987, BIOCHEMISTRY-US, V26, P115, DOI 10.1021/bi00375a017; BERG HC, 1977, BIOPHYS J, V20, P193, DOI 10.1016/S0006-3495(77)85544-6; BERG OG, 1985, ANNU REV BIOPHYS BIO, V14, P131, DOI 10.1146/annurev.biophys.14.1.131; Cyr JL, 2002, J NEUROSCI, V22, P2487, DOI 10.1523/JNEUROSCI.22-07-02487.2002; Diakonova M, 2002, MOL BIOL CELL, V13, P402, DOI 10.1091/mbc.01-05-0273; DOBERSTEIN SK, 1992, J CELL BIOL, V117, P1241, DOI 10.1083/jcb.117.6.1241; Evangelista M, 2000, J CELL BIOL, V148, P353, DOI 10.1083/jcb.148.2.353; FANNING AS, 1994, CELL MOTIL CYTOSKEL, V29, P29, DOI 10.1002/cm.970290104; Gillespie PG, 1999, J BIOL CHEM, V274, P31373, DOI 10.1074/jbc.274.44.31373; HAYDEN SM, 1990, J CELL BIOL, V111, P443, DOI 10.1083/jcb.111.2.443; Holt JR, 2002, CELL, V108, P371, DOI 10.1016/S0092-8674(02)00629-3; Jung G, 2001, J CELL BIOL, V153, P1479, DOI 10.1083/jcb.153.7.1479; Lechler T, 2000, J CELL BIOL, V148, P363, DOI 10.1083/jcb.148.2.363; Nelsestuen GL, 1999, CURR OPIN STRUC BIOL, V9, P433, DOI 10.1016/S0959-440X(99)80060-8; RUPPERT C, 1995, J CELL SCI, V108, P3775; Sokac AM, 2000, INT REV CYTOL, V200, P197, DOI 10.1016/S0074-7696(00)00005-X; SWANLJUNGCOLLINS H, 1992, J BIOL CHEM, V267, P3445; Tang NY, 2001, CURR BIOL, V11, P1131, DOI 10.1016/S0960-9822(01)00320-7; Tyska MJ, 2002, BIOPHYS J, V82, P1869, DOI 10.1016/S0006-3495(02)75537-9; Wang FS, 1996, SCIENCE, V273, P660, DOI 10.1126/science.273.5275.660; XU CJ, 1992, BIOCHIM BIOPHYS ACTA, V1120, P49, DOI 10.1016/0167-4838(92)90423-B; Xu P, 1997, P NATL ACAD SCI USA, V94, P3685, DOI 10.1073/pnas.94.8.3685; ZOT HG, 1992, J CELL BIOL, V116, P367, DOI 10.1083/jcb.116.2.367	27	54	54	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					42763	42768		10.1074/jbc.M206388200	http://dx.doi.org/10.1074/jbc.M206388200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12221091	hybrid			2022-12-27	WOS:000179081200045
J	Welch, JS; Escoubet-Lozach, L; Sykes, DB; Liddiard, K; Greaves, DR; Glass, CK				Welch, JS; Escoubet-Lozach, L; Sykes, DB; Liddiard, K; Greaves, DR; Glass, CK			T(H)2 cytokines and allergic challenge induce YM1 expression in macrophages by a STAT6-dependent mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERFERON-GAMMA; AIRWAY HYPERRESPONSIVENESS; EOSINOPHIL INFILTRATION; SIGNAL-TRANSDUCTION; PERITONEAL-CAVITY; GENE-EXPRESSION; HUMAN MONOCYTES; GROWTH-FACTOR; CELL-LINES; MICE	The diverse functions of macrophages as participants in innate and acquired immune responses are regulated by the specific milieu of environmental factors, cytokines, and other signaling molecules that are encountered at sites of inflammation. Microarray analysis of the transcriptional response of mouse peritoneal macrophages to the T(H)2 cytokine interleukin-4 (IL-4) identified Ym1 and arginase as the most highly up-regulated genes, exhibiting more than 68- and 88-fold induction, respectively. Molecular characterization of the Ym1 promoter in transfected epithelial and macrophage cell lines revealed the presence of multiple signal transducers and activators of transcription 6 (STAT6) response elements that function in a combinatorial manner to mediate transcriptional responses to IL-4. The participation of STAT6 as an obligate component of protein complexes binding to these sites was established by analysis of nuclear extracts derived from STAT6-deficient macrophages. Macrophage expression of Ym1 was highly induced in vivo by an IL-4- and STAT6-dependent mechanism during the evolution of allergic peritonitis, supporting the biological relevance of the IL-4-dependent pathway characterized ex vivo in peritoneal macrophages. These studies establish Ym1 as a highly inducible STAT6-dependent transcript in T(H)2-biased inflammation and define Cis-active elements in the Ym1 promoter that are required for this transcriptional response.	Dept Cellular & Mol Med, La Jolla, CA 92093 USA; Dept Med, La Jolla, CA 92093 USA; Med Sci Training Program, La Jolla, CA 92093 USA; Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	University of Oxford	Glass, CK (corresponding author), Dept Cellular & Mol Med, La Jolla, CA 92093 USA.		Glass, Christopher/AAI-3933-2021	Glass, Christopher/0000-0003-4344-3592; Greaves, David/0000-0003-2856-9410	NHLBI NIH HHS [HL59694] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059694] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Akimoto T, 1998, J EXP MED, V187, P1537, DOI 10.1084/jem.187.9.1537; AUSUBEL FM, 2001, CURRENT PROTOCOLS MO; BOGDAN C, 1993, ANN NY ACAD SCI, V685, P713, DOI 10.1111/j.1749-6632.1993.tb35934.x; CELADA A, 1984, J EXP MED, V160, P55, DOI 10.1084/jem.160.1.55; Chang NCA, 2001, J BIOL CHEM, V276, P17497, DOI 10.1074/jbc.M010417200; CHOMARAT P, 1998, CYTOKINE HDB, P149; Conrad DJ, 2000, AM J RESP CELL MOL, V22, P226, DOI 10.1165/ajrcmb.22.2.3786; Das AM, 1999, CLIN EXP IMMUNOL, V117, P223, DOI 10.1046/j.1365-2249.1999.00978.x; de Vries JE, 1998, J ALLERGY CLIN IMMUN, V102, P165, DOI 10.1016/S0091-6749(98)70080-6; Dickensheets HL, 1999, J LEUKOCYTE BIOL, V65, P307, DOI 10.1002/jlb.65.3.307; Ehrt S, 2001, J EXP MED, V194, P1123, DOI 10.1084/jem.194.8.1123; Falcone FH, 2001, J IMMUNOL, V167, P5348, DOI 10.4049/jimmunol.167.9.5348; Finkelman FD, 2001, J ALLERGY CLIN IMMUN, V107, P772, DOI 10.1067/mai.2001.114989; Goerdt S, 1999, PATHOBIOLOGY, V67, P222, DOI 10.1159/000028096; Goerdt S, 1999, IMMUNITY, V10, P137, DOI 10.1016/S1074-7613(00)80014-X; Gordon S, 1998, RES IMMUNOL, V149, P685, DOI 10.1016/S0923-2494(99)80039-X; Guidez F, 1998, MOL CELL BIOL, V18, P3851, DOI 10.1128/MCB.18.7.3851; Guo L, 2000, J BIOL CHEM, V275, P8032, DOI 10.1074/jbc.275.11.8032; Harbord M, 2002, J BIOL CHEM, V277, P5468, DOI 10.1074/jbc.M110635200; Hart PH, 1999, J LEUKOCYTE BIOL, V66, P575, DOI 10.1002/jlb.66.4.575; HEINZEL FP, 1989, J EXP MED, V169, P59, DOI 10.1084/jem.169.1.59; Ihn H, 2002, J IMMUNOL, V168, P1895, DOI 10.4049/jimmunol.168.4.1895; IVASHKIV LB, 1995, IMMUNITY, V3, P1, DOI 10.1016/1074-7613(95)90152-3; Jin HM, 1998, GENOMICS, V54, P316, DOI 10.1006/geno.1998.5593; Kuperman D, 1998, J EXP MED, V187, P939, DOI 10.1084/jem.187.6.939; MAEYER ED, 1998, CYTOKINE HDB, P491; Mills CD, 2000, J IMMUNOL, V164, P6166, DOI 10.4049/jimmunol.164.12.6166; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; Munder M, 1999, J IMMUNOL, V163, P3771; Nau GJ, 2002, P NATL ACAD SCI USA, V99, P1503, DOI 10.1073/pnas.022649799; Newman SL, 1999, TRENDS MICROBIOL, V7, P67, DOI 10.1016/S0966-842X(98)01431-0; Owhashi M, 2000, J BIOL CHEM, V275, P1279, DOI 10.1074/jbc.275.2.1279; Paludan SR, 1998, SCAND J IMMUNOL, V48, P459; Patel BKR, 1996, J BIOL CHEM, V271, P22175, DOI 10.1074/jbc.271.36.22175; Patel BKR, 1998, P NATL ACAD SCI USA, V95, P172, DOI 10.1073/pnas.95.1.172; Raes G, 2002, J LEUKOCYTE BIOL, V71, P597; Raveh D, 1998, J LEUKOCYTE BIOL, V64, P108, DOI 10.1002/jlb.64.1.108; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Rutschman R, 2001, J IMMUNOL, V166, P2173, DOI 10.4049/jimmunol.166.4.2173; SCOTT P, 1988, J EXP MED, V168, P1675, DOI 10.1084/jem.168.5.1675; Sherman MA, 2001, IMMUNOL REV, V179, P48, DOI 10.1034/j.1600-065X.2001.790105.x; Sykes DB, 2001, BLOOD, V98, P2308, DOI 10.1182/blood.V98.8.2308; Tomkinson A, 2001, J IMMUNOL, V166, P5792, DOI 10.4049/jimmunol.166.9.5792; Walker C, 1998, J IMMUNOL, V161, P1962; Ward JM, 2001, AM J PATHOL, V158, P323, DOI 10.1016/S0002-9440(10)63972-7; Webb DC, 2000, J IMMUNOL, V165, P108, DOI 10.4049/jimmunol.165.1.108; Webb DC, 2001, J BIOL CHEM, V276, P41969, DOI 10.1074/jbc.M106223200; ZuanyAmorim C, 1996, J IMMUNOL, V157, P377; ZUANYAMORIM C, 1993, BRIT J PHARMACOL, V110, P917, DOI 10.1111/j.1476-5381.1993.tb13900.x; ZUANYAMORIM C, 1994, ANN NY ACAD SCI, V725, P34, DOI 10.1111/j.1749-6632.1994.tb39787.x	50	184	193	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					42821	42829		10.1074/jbc.M205873200	http://dx.doi.org/10.1074/jbc.M205873200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12215441	hybrid, Green Published			2022-12-27	WOS:000179081200054
J	Bian, X; Opipari, AW; Ratanaproeksa, AB; Boitano, AE; Lucas, PC; Castle, VP				Bian, X; Opipari, AW; Ratanaproeksa, AB; Boitano, AE; Lucas, PC; Castle, VP			Constitutively active NF kappa B is required for the survival of S-type neuroblastoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-LINES; TRANSCRIPTION FACTOR; GENE-EXPRESSION; ACTIVATION; ALPHA; GROWTH; TUMOR; PROTEIN; DEATH; IKK	The NFkappaB transcription factors can both promote cell survival and induce apoptosis depending on cell type and context. Neuroblastoma (NB) cells display two predominant culture phenotypes identified as N- and S-types. Malignant S-type cells express neither high levels of MYCN nor Bcl-2, suggesting that other survival mechanisms are important. We characterized NFkappaB activity in S-type cells and determined its role in their survival. S-type lines (SH-EP1 and SK-N-AS) were treated with pyrrolidine dithiocarbamate (PDTC), a NFkappaB inhibitor, or L-1-tosylamido-2-phenylethyl chloromethyl ketone (TPCK), a serine protease inhibitor that blocks IkappaBalpha degradation. Both agents induced cell death, suggesting that constitutive NFkappaB activity is required for survival. The transient expression of a super-repressor IkappaBalpha mutant killed S-type cells. The inhibition of NFkappaB produced an apoptotic response characterized by the collapse of the mitochondrial transmembrane electrochemical gradient, caspase-9 activation, and apoptotic DNA changes. Constitutive NFkappaB DNA binding activity specifically involving p65 and p50 was demonstrated in S- but not N-type cells by electromobility supershift and gene reporter assays. This study demonstrates a role for NFkappaB in the survival of S-type NB tumor cells and suggests that NFkappaB activity and function differ according to NB tumor cell phenotype.	Univ Michigan, Ctr Comprehens Canc, Dept Pediat, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Obstet & Gynecol, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Castle, VP (corresponding author), Univ Michigan, Ctr Comprehens Canc, Dept Pediat, Rm 4302,1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	vcastle@umich.edu		Lucas, Peter/0000-0003-4880-7172	NCI NIH HHS [CA697276-04] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; BAEUERLE PA, 1988, CELL, V53, P211, DOI 10.1016/0092-8674(88)90382-0; Barker V, 2001, NAT NEUROSCI, V4, P1194, DOI 10.1038/nn755; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; Bian X, 2001, J BIOL CHEM, V276, P48921, DOI 10.1074/jbc.M108674200; Biedler J L, 1988, Prog Clin Biol Res, V271, P265; BIEDLER JL, 1973, CANCER RES, V33, P2643; BOLIVAR R, 1980, CANCER, V46, P1555, DOI 10.1002/1097-0142(19801001)46:7<1555::AID-CNCR2820460710>3.0.CO;2-4; BOURS V, 1994, BIOCHEM PHARMACOL, V47, P145, DOI 10.1016/0006-2952(94)90448-0; BROWN K, 1995, SCIENCE, V267, P1485, DOI 10.1126/science.7878466; Bui NT, 2001, J CELL BIOL, V152, P753, DOI 10.1083/jcb.152.4.753; Chen SH, 2000, AM J PATHOL, V156, P1085, DOI 10.1016/S0002-9440(10)64976-0; Chu ZL, 1998, J BIOL CHEM, V273, P15891, DOI 10.1074/jbc.273.26.15891; Davis RE, 2001, J EXP MED, V194, P1861, DOI 10.1084/jem.194.12.1861; Dejardin E, 1999, ONCOGENE, V18, P2567, DOI 10.1038/sj.onc.1202599; Devalaraja MN, 1999, CANCER RES, V59, P1372; Doi TS, 1999, P NATL ACAD SCI USA, V96, P2994, DOI 10.1073/pnas.96.6.2994; DOLE MG, 1995, CANCER RES, V55, P2576; Frappaz D, 2000, J CLIN ONCOL, V18, P468, DOI 10.1200/JCO.2000.18.3.468; Gasparian AV, 2002, J CELL SCI, V115, P141; Gilmore TD, 1999, ONCOGENE, V18, P6925, DOI 10.1038/sj.onc.1203222; Herrmann JL, 1997, EXP CELL RES, V237, P101, DOI 10.1006/excr.1997.3737; Inohara N, 1997, P NATL ACAD SCI USA, V94, P10717, DOI 10.1073/pnas.94.20.10717; ITO CY, 1994, NUCLEIC ACIDS RES, V22, P3787, DOI 10.1093/nar/22.18.3787; JANET T, 1995, J NEUROSCI RES, V40, P707, DOI 10.1002/jnr.490400602; Jasty R, 2001, NEOPLASIA, V3, P304, DOI 10.1038/sj.neo.7900171; Karin M, 1999, J BIOL CHEM, V274, P27339, DOI 10.1074/jbc.274.39.27339; Kim DW, 2000, CARCINOGENESIS, V21, P871, DOI 10.1093/carcin/21.5.871; KUMAR S, 1995, FEBS LETT, V375, P169, DOI 10.1016/0014-5793(95)01186-I; Li NX, 1998, P NATL ACAD SCI USA, V95, P13012, DOI 10.1073/pnas.95.22.13012; May MJ, 1998, IMMUNOL TODAY, V19, P80, DOI 10.1016/S0167-5699(97)01197-3; Mora J, 2001, CANCER RES, V61, P6892; OGITA S, 1988, ONCOLOGY, V45, P117, DOI 10.1159/000226544; OPIPARI AW, 1992, J BIOL CHEM, V267, P12424; OSBORN L, 1989, P NATL ACAD SCI USA, V86, P2336, DOI 10.1073/pnas.86.7.2336; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; Piacentini M, 1996, J PATHOL, V180, P415, DOI 10.1002/(SICI)1096-9896(199612)180:4<415::AID-PATH684>3.0.CO;2-A; Rayet B, 1999, ONCOGENE, V18, P6938, DOI 10.1038/sj.onc.1203221; REDDY UR, 1991, J NEUROCHEM, V56, P67, DOI 10.1111/j.1471-4159.1991.tb02563.x; ROSS RA, 1995, CELL GROWTH DIFFER, V6, P449; Ryan KM, 2000, NATURE, V404, P892, DOI 10.1038/35009130; SAXEN L, 1960, CANCER, V13, P899, DOI 10.1002/1097-0142(196009/10)13:5<899::AID-CNCR2820130506>3.0.CO;2-U; Schafer H, 1998, FEBS LETT, V436, P139, DOI 10.1016/S0014-5793(98)01109-0; Schmidt ML, 2000, J CLIN ONCOL, V18, P1260, DOI 10.1200/JCO.2000.18.6.1260; SCHRECK R, 1992, J EXP MED, V175, P1181, DOI 10.1084/jem.175.5.1181; Shimada H, 2000, NEUROBLASTOMA, P341; Visconti R, 1997, ONCOGENE, V15, P1987, DOI 10.1038/sj.onc.1201373; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Wu M, 1996, EMBO J, V15, P4682, DOI 10.1002/j.1460-2075.1996.tb00845.x; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	50	60	64	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					42144	42150		10.1074/jbc.M203891200	http://dx.doi.org/10.1074/jbc.M203891200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12198114	hybrid			2022-12-27	WOS:000178985300106
J	Gajate, C; An, FY; Mollinedo, F				Gajate, C; An, FY; Mollinedo, F			Differential cytostatic and apoptotic effects of ecteinascidin-743 in cancer cells - Transcription-dependent cell cycle arrest and transcription-independent JNK and mitochondrial mediated apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL KINASE; PERFORMANCE LIQUID-CHROMATOGRAPHY; HUMAN LEUKEMIC-CELLS; ANTITUMOR-ACTIVITY; MINOR-GROOVE; SELECTIVE INDUCTION; ANTICANCER DRUG; TOPOISOMERASE-I; HUMAN PLASMA; DNA	We have found that ecteinascidin-743 (ET-743) inhibited cell proliferation at 1-10 ng/ml, leading to S and G(2)/M arrest and subsequent apoptosis, and induced early apoptosis without previous cell cycle arrest at 10-100 ng/ml in cancer cells. ET-743-mediated apoptosis, did not involve Fas/CD95. ET-743 induced c-Jun NH2-terminal kinase (JNK) and caspase-3 activation, and JNK and caspase inhibition prevented ET-743-induced apoptosis. ET-743 failed to promote apoptosis in caspase-3-deficient MCF-7 cells, further implicating caspase-3 in its proapoptotic action. Overexpression of bcl-2 by gene transfer abrogated ET-743-induced apoptosis, but cells underwent cell cycle arrest. ET-743 triggered cytochrome c release from mitochondria that was inhibited by Bcl-2 overexpression. Inhibition of transcription or protein synthesis did not prevent ET-743-induced apoptosis, but abrogated ET-743-induced cell cycle arrest. Microarray analyses revealed changes in the expression of a small number of cell cycle-related genes (p21, GADD45A, cyclin G2, MCM5, and histones) that suggested their putative involvement in ET-743-induced cell cycle arrest. These data indicate that ET-743 is a very potent anticancer drug showing dose-dependent cytostatic and proapoptotic effects through activation of two different signaling pathways, namely a transcription-dependent pathway leading to cell cycle arrest and a transcription-independent route leading to rapid apoptosis that involves mitochondria, JNK, and caspase-3.	Univ Salamanca, Consejo Super Invest, Inst Biol Mol & Celular Canc, Ctr Invest Canc, E-37007 Salamanca, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion del Cancer (CIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca	Mollinedo, F (corresponding author), Univ Salamanca, Consejo Super Invest, Inst Biol Mol & Celular Canc, Ctr Invest Canc, Campus Miguel Unamuno, E-37007 Salamanca, Spain.			Gajate, Consuelo/0000-0003-0604-6459				Ando T, 2001, J BIOL CHEM, V276, P42971, DOI 10.1074/jbc.M106460200; Anto RJ, 2002, CARCINOGENESIS, V23, P143, DOI 10.1093/carcin/23.1.143; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bonfanti M, 1999, ANTI-CANCER DRUG DES, V14, P179; Bush JA, 2001, EXP CELL RES, V271, P305, DOI 10.1006/excr.2001.5381; Chen YR, 1999, MOL PHARMACOL, V56, P1271, DOI 10.1124/mol.56.6.1271; Chen YR, 1996, J BIOL CHEM, V271, P31929, DOI 10.1074/jbc.271.50.31929; Chen YR, 1998, ONCOGENE, V17, P173, DOI 10.1038/sj.onc.1201941; Choudhuri T, 2002, FEBS LETT, V512, P334, DOI 10.1016/S0014-5793(02)02292-5; Crosio C, 2002, MOL CELL BIOL, V22, P874, DOI 10.1128/MCB.22.3.874-885.2002; Erba E, 2001, EUR J CANCER, V37, P97, DOI 10.1016/S0959-8049(00)00357-9; Friesen C, 1996, NAT MED, V2, P574, DOI 10.1038/nm0596-574; Gajate C, 2000, INT J CANCER, V85, P674, DOI 10.1002/(SICI)1097-0215(20000301)85:5<674::AID-IJC13>3.0.CO;2-Z; Gajate C, 2000, CANCER RES, V60, P2651; Gajate C, 2000, INT J CANCER, V86, P208, DOI 10.1002/(SICI)1097-0215(20000415)86:2<208::AID-IJC10>3.0.CO;2-E; Gajate C, 1998, MOL PHARMACOL, V53, P602, DOI 10.1124/mol.53.4.602; GarciaRocha M, 1996, BRIT J CANCER, V73, P875, DOI 10.1038/bjc.1996.176; Green D, 1998, TRENDS CELL BIOL, V8, P267, DOI 10.1016/S0962-8924(98)01273-2; Hendriks HR, 1999, ANN ONCOL, V10, P1233, DOI 10.1023/A:1008364727071; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; Horne MC, 1997, J BIOL CHEM, V272, P12650, DOI 10.1074/jbc.272.19.12650; Horne MC, 1996, J BIOL CHEM, V271, P6050, DOI 10.1074/jbc.271.11.6050; Ishikawa Y, 2000, KIDNEY INT, V58, P1078, DOI 10.1046/j.1523-1755.2000.00265.x; Izbicka E, 1998, ANN ONCOL, V9, P981, DOI 10.1023/A:1008224322396; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Jimeno Jose M., 1996, Drugs of the Future, V21, P1155; Jin S, 2000, P NATL ACAD SCI USA, V97, P6775, DOI 10.1073/pnas.97.12.6775; Lei K, 2002, MOL CELL BIOL, V22, P4929, DOI 10.1128/MCB.22.13.4929-4942.2002; Li WW, 2001, CLIN CANCER RES, V7, P2908; Liang DT, 1999, J CELL SCI, V112, P559; Martinez EJ, 2001, CHEM BIOL, V8, P1151, DOI 10.1016/S1074-5521(01)00082-5; Martinez EJ, 1999, P NATL ACAD SCI USA, V96, P3496, DOI 10.1073/pnas.96.7.3496; Minuzzo M, 2000, P NATL ACAD SCI USA, V97, P6780, DOI 10.1073/pnas.97.12.6780; Mollinedo F, 1997, CANCER RES, V57, P1320; Mollinedo F, 1998, ANIMAL CELL CULTURE TECHNIQUES, P264; MOLLINEDO F, 1993, BIOCHEM BIOPH RES CO, V192, P603, DOI 10.1006/bbrc.1993.1458; Moore BM, 1997, J AM CHEM SOC, V119, P5475, DOI 10.1021/ja9704500; Moragoda L, 2001, ANTICANCER RES, V21, P873; Morin D, 2001, FEBS LETT, V495, P131, DOI 10.1016/S0014-5793(01)02376-6; Mukhopadhyay A, 2001, ONCOGENE, V20, P7597, DOI 10.1038/sj.onc.1204997; Nicholson DW, 1997, TRENDS BIOCHEM SCI, V22, P299, DOI 10.1016/S0968-0004(97)01085-2; PEREZSALA D, 1995, J BIOL CHEM, V270, P6235, DOI 10.1074/jbc.270.11.6235; Pique M, 2000, FEBS LETT, V480, P193, DOI 10.1016/S0014-5793(00)01922-0; Piwocka K, 2001, FREE RADICAL BIO MED, V31, P670, DOI 10.1016/S0891-5849(01)00629-3; Pommier Y, 1996, BIOCHEMISTRY-US, V35, P13303, DOI 10.1021/bi960306b; RINEHART KL, 1990, J ORG CHEM, V55, P4512, DOI 10.1021/jo00302a007; Rosing H, 1998, J CHROMATOGR B, V710, P183, DOI 10.1016/S0378-4347(98)00143-1; Rosing H, 1998, J MASS SPECTROM, V33, P1134, DOI 10.1002/(SICI)1096-9888(1998110)33:11<1134::AID-JMS730>3.0.CO;2-S; Takahashi N, 2001, CLIN CANCER RES, V7, P3251; Takebayashi Y, 1999, P NATL ACAD SCI USA, V96, P7196, DOI 10.1073/pnas.96.13.7196; Takebayashi Y, 2001, CLIN CANCER RES, V7, P185; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; Valoti G, 1998, CLIN CANCER RES, V4, P1977; Yang Q, 2000, J BIOL CHEM, V275, P36892, DOI 10.1074/jbc.M005319200; Zewail-Foote M, 1999, J MED CHEM, V42, P2493, DOI 10.1021/jm990241l	55	74	79	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					41580	41589		10.1074/jbc.M204644200	http://dx.doi.org/10.1074/jbc.M204644200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12198119	hybrid, Green Published			2022-12-27	WOS:000178985300037
J	Hibino, T; Waditee, R; Araki, E; Ishikawa, H; Aoki, K; Tanaka, Y; Takabe, T				Hibino, T; Waditee, R; Araki, E; Ishikawa, H; Aoki, K; Tanaka, Y; Takabe, T			Functional characterization of choline monooxygenase, an enzyme for betaine synthesis in plants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCINE BETAINE; ALDEHYDE DEHYDROGENASE; ENHANCED TOLERANCE; ESCHERICHIA-COLI; STRESS TOLERANCE; SALT STRESS; GENE; IDENTIFICATION; OXIDASE; OVEREXPRESSION	In plants, the first step in betaine synthesis was shown to be catalyzed by a novel Rieske-type iron-sulfur enzyme, choline monooxygenase (CMO). Although CMO so far has been found only in Chenopodiaceae and Amaranthaceae, the recent genome sequence suggests the presence of a CMO-Iike gene in Arabidopsis, a betaine non-accumulating plant. Here, we examined the functional properties of CMO expressed in Escherichia coli, cyanobacterium, and Arabidopsis thaliana. We found that E. coli cells in which choline dehydrogenase (CDH) was replaced with spinach CMO accumulate betaine and complement the salt-sensitive phenotype of the CDH-deleted E. coli mutant. Changes of Cys-181 in spinach CMO to Ser, Thr, and Ala and His-287 to Gly, Val, and Ala abolished the accumulation of betaine. The Arabidopsis CMO-like gene was transcribed in Arabidopsis, but its protein was not detected. When the Arabidopsis CMO-like gene was expressed in E. coli, the protein was detected but was found not to promote betaine sysnthesis. Overexpression of spinach CMO in E. coli, Synechococcus sp. PCC7942, and Arabidopsis conferred resistance to abiotic stress. These facts clearly indicate that CMO, but not the CMO-Iike protein, could oxidize choline and that Cys-181 and His-287 are involved in the binding of Fe-S cluster and Fe, respectively.	Meijo Univ, Inst Res, Tenpaku Ku, Nagoya, Aichi 4688502, Japan; Meijo Univ, Grad Sch Environm & Human Sci, Nagoya, Aichi 4688502, Japan	Meijo University; Meijo University	Takabe, T (corresponding author), Meijo Univ, Inst Res, Tenpaku Ku, Nagoya, Aichi 4688502, Japan.	takabe@ccmfs.meijo-u.ac.jp						Boch J, 1996, J BACTERIOL, V178, P5121, DOI 10.1128/jb.178.17.5121-5129.1996; BURNET M, 1995, PLANT PHYSIOL, V108, P581, DOI 10.1104/pp.108.2.581; Butler CS, 1997, ADV MICROB PHYSIOL, V38, P47; Carredano E, 2000, J MOL BIOL, V296, P701, DOI 10.1006/jmbi.1999.3462; CHERN MK, 1995, BIOCHEM BIOPH RES CO, V213, P561, DOI 10.1006/bbrc.1995.2168; Deshnium P, 1995, PLANT MOL BIOL, V29, P897, DOI 10.1007/BF00014964; FALKENBERG P, 1990, BIOCHIM BIOPHYS ACTA, V1034, P253, DOI 10.1016/0304-4165(90)90046-Y; Hayashi H, 1997, PLANT J, V12, P133, DOI 10.1046/j.1365-313X.1997.12010133.x; Hibino T, 2001, PLANT MOL BIOL, V45, P353, DOI 10.1023/A:1006497113323; Holmstrom KO, 2000, J EXP BOT, V51, P177, DOI 10.1093/jexbot/51.343.177; Hoshida H, 2000, PLANT MOL BIOL, V43, P103, DOI 10.1023/A:1006408712416; Huang J, 2000, PLANT PHYSIOL, V122, P747, DOI 10.1104/pp.122.3.747; Incharoensakdi A, 2000, EUR J BIOCHEM, V267, P7015, DOI 10.1046/j.1432-1327.2000.01797.x; Kempf B, 1998, ARCH MICROBIOL, V170, P319, DOI 10.1007/s002030050649; LAMARK T, 1991, MOL MICROBIOL, V5, P1049, DOI 10.1111/j.1365-2958.1991.tb01877.x; Lee BH, 1997, PLANT MOL BIOL, V35, P763, DOI 10.1023/A:1005867420619; Lilius G, 1996, BIO-TECHNOL, V14, P177, DOI 10.1038/nbt0296-177; McNeil SD, 2000, PLANT PHYSIOL, V124, P153, DOI 10.1104/pp.124.1.153; Morimoto K, 2002, FEBS LETT, V519, P123, DOI 10.1016/S0014-5793(02)02736-9; Nakamura T, 1997, PLANT J, V11, P1115, DOI 10.1046/j.1365-313X.1997.11051115.x; NOMURA M, 1995, PLANT PHYSIOL, V107, P703, DOI 10.1104/pp.107.3.703; Nuccio ML, 2000, METAB ENG, V2, P300, DOI 10.1006/mben.2000.0158; Nuccio ML, 1998, PLANT J, V16, P487, DOI 10.1046/j.1365-313x.1998.00316.x; Ollagnier-de-Choudens S, 2001, J BIOL CHEM, V276, P22604, DOI 10.1074/jbc.M102902200; Rathinasabapathi B, 1997, P NATL ACAD SCI USA, V94, P3454, DOI 10.1073/pnas.94.7.3454; RHODES D, 1987, PLANT PHYSIOL, V84, P781, DOI 10.1104/pp.84.3.781; RHODES D, 1993, ANNU REV PLANT PHYS, V44, P357, DOI 10.1146/annurev.pp.44.060193.002041; Russell BL, 1998, PLANT PHYSIOL, V116, P859, DOI 10.1104/pp.116.2.859; TA DT, 1992, J BIOL CHEM, V267, P11120; Takabe T, 1998, STRESS RESPONSES OF PHOTOSYNTHETIC ORGANISMS, P115; Waditee R, 2002, P NATL ACAD SCI USA, V99, P4109, DOI 10.1073/pnas.052576899; Wang YM, 1999, PLANT CELL PHYSIOL, V40, P668, DOI 10.1093/oxfordjournals.pcp.a029591; WERETILNYK EA, 1990, P NATL ACAD SCI USA, V87, P2745, DOI 10.1073/pnas.87.7.2745; Wolfe MD, 2001, J BIOL CHEM, V276, P1945, DOI 10.1074/jbc.M007795200; YAMADA H, 1979, AGR BIOL CHEM TOKYO, V43, P2173, DOI 10.1080/00021369.1979.10863769; Zheng LM, 1998, J BIOL CHEM, V273, P13264, DOI 10.1074/jbc.273.21.13264	36	58	61	0	15	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					41352	41360		10.1074/jbc.M205965200	http://dx.doi.org/10.1074/jbc.M205965200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12192001	hybrid			2022-12-27	WOS:000178985300010
J	Johnston, AJ; Hoogenraad, J; Dougan, DA; Truscott, KN; Yano, M; Mori, M; Hoogenraad, NJ; Ryan, MT				Johnston, AJ; Hoogenraad, J; Dougan, DA; Truscott, KN; Yano, M; Mori, M; Hoogenraad, NJ; Ryan, MT			Insertion and assembly of human Tom7 into the preprotein translocase complex of the outer mitochondrial membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN IMPORT RECEPTOR; FUNCTIONAL-ANALYSIS; BIOGENESIS; PRECURSOR; CHANNEL; COMPONENT; PATHWAY; PORE; ELECTROPHORESIS; IDENTIFICATION	Tom7 is a component of the translocase of the outer mitochondrial membrane (TOM) and assembles into a general import pore complex that translocates preproteins into mitochondria. We have identified the human Tom7 homolog and characterized its import and assembly into the mammalian TOM complex. Tom7 is imported into mitochondria in a nucleotide-independent manner and is anchored to the outer membrane with its C terminus facing the intermembrane space. Unlike studies in fungi, we found that human Tom7 assembles into an similar to120-kDa import intermediate in HeLa cell mitochondria. To detect subunits within this complex, we employed a novel supershift analysis whereby mitochondria containing newly imported Tom7 were incubated with antibodies specific for individual TOM components prior to separation by blue native electrophoresis. We found that the 120-kDa complex contains Tom40 and lacks receptor components. This intermediate can be chased to the stable similar to380-kDa mammalian TOM complex that additionally contains Tom22. Overexpression of Tom22 in HeLa cells results in the rapid assembly of Tom7 into the 380-kDa complex indicating that Tom22 is rate-limiting for TOM complex formation. These results indicate that the levels of Tom22 within mitochondria dictate the assembly of TOM complexes and hence may regulate its biogenesis.	La Trobe Univ, Dept Biochem, Melbourne, Vic 3086, Australia; Kumamoto Univ, Sch Med, Dept Mol Genet, Kumamoto 8600811, Japan	La Trobe University; Kumamoto University	Ryan, MT (corresponding author), La Trobe Univ, Dept Biochem, Melbourne, Vic 3086, Australia.	M.Ryan@latrobe.edu.au	dougan, david/B-3359-2010; Hoogenraad, Nicholas J/C-7505-2011; Ryan, Michael/X-2152-2019; Ryan, Michael T/C-6673-2011; Truscott, Kaye/D-3362-2012	dougan, david/0000-0001-9313-1904; Ryan, Michael/0000-0003-2586-8829; Ryan, Michael T/0000-0003-2586-8829; Johnston, Amelia/0000-0003-4289-3516; Truscott, Kaye/0000-0002-5352-9835				Abdul KM, 2000, BIOCHEM BIOPH RES CO, V276, P1028, DOI 10.1006/bbrc.2000.3589; Abe Y, 2000, CELL, V100, P551, DOI 10.1016/S0092-8674(00)80691-1; ALCONADA A, 1995, MOL CELL BIOL, V15, P6196; Allen R, 2002, FEBS LETT, V514, P347, DOI 10.1016/S0014-5793(02)02433-X; ARGAN C, 1983, J BIOL CHEM, V258, P6667; Armstrong LC, 1997, J BIOL CHEM, V272, P6510, DOI 10.1074/jbc.272.10.6510; Brix J, 1997, J BIOL CHEM, V272, P20730, DOI 10.1074/jbc.272.33.20730; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; DAUM G, 1982, J BIOL CHEM, V257, P3028; Dekker PJT, 1998, MOL CELL BIOL, V18, P6515, DOI 10.1128/MCB.18.11.6515; Dembowski M, 2001, J BIOL CHEM, V276, P17679, DOI 10.1074/jbc.M009653200; Dietmeier K, 1997, NATURE, V388, P195, DOI 10.1038/40663; Fritz S, 2001, J CELL BIOL, V152, P683, DOI 10.1083/jcb.152.4.683; GOPING IS, 1995, FEBS LETT, V373, P45; GRATZER S, 1995, J CELL BIOL, V129, P25, DOI 10.1083/jcb.129.1.25; HACHIYA N, 1994, EMBO J, V13, P5146, DOI 10.1002/j.1460-2075.1994.tb06844.x; Hanson B, 1996, EUR J BIOCHEM, V235, P750, DOI 10.1111/j.1432-1033.1996.t01-1-00750.x; HARLOW E, 1999, USING ANTIBODIES LAB, P286; Hill K, 1998, NATURE, V395, P516, DOI 10.1038/26780; HONLINGER A, 1995, MOL CELL BIOL, V15, P3382; Honlinger A, 1996, EMBO J, V15, P2125, DOI 10.1002/j.1460-2075.1996.tb00566.x; Hoogenraad NJ, 2001, IUBMB LIFE, V51, P345; Jansch L, 1998, J BIOL CHEM, V273, P17251, DOI 10.1074/jbc.273.27.17251; KEIL P, 1993, J BIOL CHEM, V268, P19177; KIEBLER M, 1993, CELL, V74, P483, DOI 10.1016/0092-8674(93)80050-O; Koehler CM, 2000, FEBS LETT, V476, P27, DOI 10.1016/S0014-5793(00)01664-1; Komiya T, 1996, J BIOL CHEM, V271, P22105, DOI 10.1074/jbc.271.36.22105; Kunkele KP, 1998, J BIOL CHEM, V273, P31032, DOI 10.1074/jbc.273.47.31032; Kunkele KP, 1998, CELL, V93, P1009, DOI 10.1016/S0092-8674(00)81206-4; Kurz M, 1999, MOL BIOL CELL, V10, P2461, DOI 10.1091/mbc.10.7.2461; LITHGOW T, 1994, P NATL ACAD SCI USA, V91, P11973, DOI 10.1073/pnas.91.25.11973; Meisinger C, 2001, MOL CELL BIOL, V21, P2337, DOI 10.1128/MCB.21.7.2337-2348.2001; Model K, 2001, NAT STRUCT BIOL, V8, P361, DOI 10.1038/86253; Mori M, 1998, BBA-MOL CELL RES, V1403, P12, DOI 10.1016/S0167-4889(98)00021-4; Neupert W, 1997, ANNU REV BIOCHEM, V66, P863, DOI 10.1146/annurev.biochem.66.1.863; Nuttall SD, 1997, DNA CELL BIOL, V16, P1067, DOI 10.1089/dna.1997.16.1067; PERALTA D, 1993, EUR J BIOCHEM, V211, P881, DOI 10.1111/j.1432-1033.1993.tb17621.x; Pfanner N, 2001, NAT REV MOL CELL BIO, V2, P339, DOI 10.1038/35073006; Rapaport D, 1999, J CELL BIOL, V146, P321, DOI 10.1083/jcb.146.2.321; Rapaport D, 2002, TRENDS BIOCHEM SCI, V27, P191, DOI 10.1016/S0968-0004(02)02065-0; Ryan MT, 2002, ADV PROTEIN CHEM, V59, P223; Ryan MT, 2001, METHOD CELL BIOL, V65, P189, DOI 10.1016/S0091-679X(01)65012-X; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; SEKI N, 1995, FEBS LETT, V375, P307, DOI 10.1016/0014-5793(95)01229-8; SIKORSKI RS, 1989, GENETICS, V122, P19; Suzuki H, 2002, J CELL SCI, V115, P1895; Suzuki H, 2000, J BIOL CHEM, V275, P37930, DOI 10.1074/jbc.M006558200; Terada K, 1996, MOL CELL BIOL, V16, P6103; van Wilpe S, 1999, NATURE, V401, P485, DOI 10.1038/46802; Voos W, 1999, BBA-REV BIOMEMBRANES, V1422, P235, DOI 10.1016/S0304-4157(99)00007-6; Yano M, 2000, MOL CELL BIOL, V20, P7205, DOI 10.1128/MCB.20.19.7205-7213.2000	52	101	105	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					42197	42204		10.1074/jbc.M205613200	http://dx.doi.org/10.1074/jbc.M205613200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12198123	hybrid			2022-12-27	WOS:000178985300113
J	Kloek, C; Haq, AK; Dunn, SL; Lavery, HJ; Banks, AS; Myers, MG				Kloek, C; Haq, AK; Dunn, SL; Lavery, HJ; Banks, AS; Myers, MG			Regulation of Jak kinases by intracellular leptin receptor sequences	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL TRANSDUCER GP130; OB-R; ERYTHROPOIETIN RECEPTOR; CYTOPLASMIC DOMAINS; CYTOKINE RECEPTORS; ALPHA-INTERFERON; ACTIVATION; INTERLEUKIN-6; EXPRESSION; NEURONS	Leptin signals the status of body energy stores via the leptin receptor (LR), a member of the Type I cytokine receptor family. Type I cytokine receptors mediate intracellular signaling via the activation of associated Jak family tyrosine kinases. Although their COOH-terminal sequences vary, alternatively spliced LR isoforms (LRa-LRd) share common NH2-terminal sequences, including the first 29 intracellular amino acids. The so-called long form LR (LRb) activates Jak-dependent signaling and is required for the physiologic actions of leptin. In this study, we have analyzed Jak activation by intracellular LR sequences under the control of the extracellular erythropoeitin (Epo) (Epo receptor/LRb chimeras). We show that Jak2 is the requisite Jak kinase for signaling by the LRb intracellular domain and confirm the requirement for the Box 1 motif for Jak2 activation. A minimal LRb intracellular domain for Jak2 activation includes intracellular amino acids 31-48. Although the sequence requirements for intracellular amino acids 37-48 are flexible, intracellular amino acids 31-36 of LRb play a critical role in Jak2 activation and contain a loose homology motif found in other Jak2-activating cytokine receptors. The failure of short form sequences to function in Jak2 activation reflects the absence of this motif.	Joslin Diabet Ctr, Div Res, Sect Obes, Boston, MA 02215 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02215 USA	Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School	Myers, MG (corresponding author), Joslin Diabet Ctr, Div Res, Sect Obes, 1 Joslin Pl, Boston, MA 02215 USA.		Banks, Alexander/B-4832-2012	Banks, Alexander/0000-0003-1787-6925	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK056731, R01DK056731] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK56731] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bahrenberg G, 2002, MOL ENDOCRINOL, V16, P859, DOI 10.1210/me.16.4.859; Banks AS, 2000, J BIOL CHEM, V275, P14563, DOI 10.1074/jbc.275.19.14563; BAUMANN H, 1994, MOL CELL BIOL, V14, P138, DOI 10.1128/MCB.14.1.138; Baumann H, 1996, P NATL ACAD SCI USA, V93, P8374, DOI 10.1073/pnas.93.16.8374; Bjorbaek C, 1997, J BIOL CHEM, V272, P32686, DOI 10.1074/jbc.272.51.32686; Bjorbaek C, 2000, J BIOL CHEM, V275, P40649, DOI 10.1074/jbc.M007577200; Bjorbaek C, 2001, J BIOL CHEM, V276, P4747, DOI 10.1074/jbc.M007439200; Carpenter LR, 1998, P NATL ACAD SCI USA, V95, P6061, DOI 10.1073/pnas.95.11.6061; Chua SC, 1997, GENOMICS, V45, P264, DOI 10.1006/geno.1997.4962; Chua SC, 1996, SCIENCE, V271, P994, DOI 10.1126/science.271.5251.994; Constantinescu SN, 1999, TRENDS ENDOCRIN MET, V10, P18, DOI 10.1016/S1043-2760(98)00101-5; Constantinescu SN, 2001, MOL CELL, V7, P377, DOI 10.1016/S1097-2765(01)00185-X; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; Devos R, 1997, J BIOL CHEM, V272, P18304, DOI 10.1074/jbc.272.29.18304; Elmquist JK, 1999, NEURON, V22, P221, DOI 10.1016/S0896-6273(00)81084-3; Flier JS, 1997, P NATL ACAD SCI USA, V94, P4242, DOI 10.1073/pnas.94.9.4242; Gadina M, 2001, CURR OPIN IMMUNOL, V13, P363, DOI 10.1016/S0952-7915(00)00228-4; GUSCHIN D, 1995, EMBO J, V14, P1421, DOI 10.1002/j.1460-2075.1995.tb07128.x; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Huang LJS, 2001, MOL CELL, V8, P1327, DOI 10.1016/S1097-2765(01)00401-4; IHLE JN, 1995, TRENDS GENET, V11, P69, DOI 10.1016/S0168-9525(00)89000-9; KISHIMOTO T, 1994, CELL, V76, P253, DOI 10.1016/0092-8674(94)90333-6; Kohlhuber F, 1997, MOL CELL BIOL, V17, P695, DOI 10.1128/MCB.17.2.695; Nakashima K, 1997, FEBS LETT, V403, P79, DOI 10.1016/S0014-5793(97)00013-6; NARAZAKI M, 1994, P NATL ACAD SCI USA, V91, P2285, DOI 10.1073/pnas.91.6.2285; Niswender KD, 2001, NATURE, V413, P794, DOI 10.1038/35101657; Spanswick D, 1997, NATURE, V390, P521, DOI 10.1038/37379; Taga T, 1997, ANNU REV IMMUNOL, V15, P797, DOI 10.1146/annurev.immunol.15.1.797; Tartaglia LA, 1997, J BIOL CHEM, V272, P6093, DOI 10.1074/jbc.272.10.6093; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; White DW, 1997, J BIOL CHEM, V272, P4065, DOI 10.1074/jbc.272.7.4065; Yan H, 1996, MOL CELL BIOL, V16, P2074; Zhu YX, 1997, J BIOL CHEM, V272, P21334, DOI 10.1074/jbc.272.34.21334	33	170	182	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					41547	41555		10.1074/jbc.M205148200	http://dx.doi.org/10.1074/jbc.M205148200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12196522	hybrid			2022-12-27	WOS:000178985300033
J	Warner, JB; Thalhauser, C; Tao, K; Sahagian, GG				Warner, JB; Thalhauser, C; Tao, K; Sahagian, GG			Role of N-linked oligosaccharide flexibility in mannose phosphorylation of lysosomal enzyme cathepsin L	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN RECOGNITION DETERMINANTS; LYSINE-BASED STRUCTURE; PROCATHEPSIN-D; DNASE-I; N-ACETYLGLUCOSAMINE-1-PHOSPHOTRANSFERASE; IDENTIFICATION; CELLS; PROREGION; RESIDUES; SUBUNIT	Mannose phosphorylation of N-linked oligosaccharides by UDP-GlcNAc:lysosomal enzyme N-acetylglucosamine-1-phosphotransferase is a key step in the targeting of lysosomal enzymes in mammalian cells and tissues. The selectivity of this process is determined by lysine-based phosphorylation signals shared by lysosomal enzymes of diverse structure and function. By introducing new glycosylation sites at several locations on the surface of mouse procathepsin L and modeling oligosaccharide conformations for sites that are phosphorylated, it was shown that the inherent flexibility of N-linked oligosaccharides can account for the specificity of the transferase for oligosaccharides at different locations on the protein. By using this approach, the physical relationship between the lysine-based signal and the site of phosphorylation of mannose residues was determined. The analysis also revealed the existence of additional independent lysine-based phosphorylation signals on procathepsin L, which account for the low level of phosphorylation observed when the primary Lys-54/Lys-99 signal is ablated. Mutagenesis of residues that surround Lys-54 and Lys-99 and demonstration of mannose phosphorylation of a glycosylated derivative of green fluorescent protein provide strong evidence that the cathepsin L phosphorylation signal is a simple structure composed of as few as two well placed lysine residues.	Tufts Univ, Sch Med, Dept Physiol, Boston, MA 02111 USA	Tufts University	Sahagian, GG (corresponding author), Tufts Univ, Sch Med, Dept Physiol, 136 Harrison Ave, Boston, MA 02111 USA.				NCI NIH HHS [CA66575] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA066575] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bao M, 1996, J BIOL CHEM, V271, P31437, DOI 10.1074/jbc.271.49.31437; Bao M, 1996, J BIOL CHEM, V271, P31446, DOI 10.1074/jbc.271.49.31446; BARANSKI TJ, 1991, J BIOL CHEM, V266, P23365; BARANSKI TJ, 1992, J BIOL CHEM, V267, P23342; BARANSKI TJ, 1990, CELL, V63, P281, DOI 10.1016/0092-8674(90)90161-7; Bush CA, 1999, ANNU REV BIOPH BIOM, V28, P269, DOI 10.1146/annurev.biophys.28.1.269; CANTOR AB, 1992, J BIOL CHEM, V267, P23349; CUMMING DA, 1987, BIOCHEMISTRY-US, V26, P6664, DOI 10.1021/bi00395a016; CUOZZO JW, 1994, J BIOL CHEM, V269, P14490; Cuozzo JW, 1998, J BIOL CHEM, V273, P21067, DOI 10.1074/jbc.273.33.21067; CUOZZO JW, 1995, J BIOL CHEM, V270, P15611, DOI 10.1074/jbc.270.26.15611; DONG JM, 1989, J BIOL CHEM, V264, P7377; Gonzalez L, 2000, ARCH BIOCHEM BIOPHYS, V383, P17, DOI 10.1006/abbi.2000.2031; HASILIK A, 1981, EUR J BIOCHEM, V121, P125, DOI 10.1111/j.1432-1033.1981.tb06440.x; Jimenez-Barbero J, 1999, CURR OPIN STRUC BIOL, V9, P549, DOI 10.1016/S0959-440X(99)00004-4; KANE SE, 1993, J BIOL CHEM, V268, P11456; KAUFMAN RJ, 1991, NUCLEIC ACIDS RES, V19, P4485, DOI 10.1093/nar/19.16.4485; KORNFELD S, 1989, ANNU REV CELL BIOL, V5, P483, DOI 10.1146/annurev.cb.05.110189.002411; LANG L, 1984, J BIOL CHEM, V259, P4663; NATOWICZ M, 1982, J BIOL CHEM, V257, P4412; Nishikawa A, 1999, J BIOL CHEM, V274, P19309, DOI 10.1074/jbc.274.27.19309; Nishikawa A, 1997, J BIOL CHEM, V272, P19408, DOI 10.1074/jbc.272.31.19408; Raas-Rothschild A, 2000, J CLIN INVEST, V105, P673, DOI 10.1172/JCI5826; REITMAN ML, 1981, J BIOL CHEM, V256, P1977; STEARNS NA, 1990, ARCH BIOCHEM BIOPHYS, V283, P447, DOI 10.1016/0003-9861(90)90666-M; TAO K, 1994, ARCH BIOCHEM BIOPHYS, V311, P19, DOI 10.1006/abbi.1994.1203; Tikkanen R, 1997, EMBO J, V16, P6684, DOI 10.1093/emboj/16.22.6684; VARKI A, 1980, J BIOL CHEM, V255, P8398; VARKI A, 1980, J BIOL CHEM, V255, P847	29	19	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					41897	41905		10.1074/jbc.M203097200	http://dx.doi.org/10.1074/jbc.M203097200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12202476	hybrid			2022-12-27	WOS:000178985300077
J	Yin, XM; Luo, YM; Cao, GD; Bai, L; Pei, W; Kuharsky, DK; Chen, J				Yin, XM; Luo, YM; Cao, GD; Bai, L; Pei, W; Kuharsky, DK; Chen, J			Bid-mediated mitochondrial pathway is critical to ischemic neuronal apoptosis and focal cerebral ischemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C RELEASE; BCL-2 FAMILY PROTEINS; DELAYED CELL-DEATH; DNA FRAGMENTATION; ARTERY OCCLUSION; CEREBROVASCULAR ANATOMY; FOREBRAIN ISCHEMIA; MESSENGER-RNA; BRAIN-DAMAGE; FAS ANTIGEN	We have investigated the role of the BH3-only pro-death Bcl-2 family protein, Bid, in ischemic neuronal death in a murine focal cerebral ischemia model. Wildtype and bid-deficient mice of inbred C57BL/6 background were subjected to 90-min ischemia induced by left middle cerebral artery occlusion followed by 72-h reperfusion. The volume of ischemic infarct was significantly smaller in the bid-deficient brains than in the wild-type brains, suggesting that Bid participated in the ischemic neuronal death. Indeed, following the ischemic treatment there was a significant reduction of apoptosis in the ischemic areas, particularly in the inner infarct border zone (the penumbra), of the bid-deficient brains. In addition, activation of Bid in the wild-type brains could be readily detected at similar to3 h after ischemia, as evidenced by its proteolytic cleavage and translocation to the mitochondria as determined using Western blot analysis and immunofluorescence staining. Correspondingly, mitochondrial release of cytochrome c could be detected around the same time Bid was cleaved in the wild-type brains. However, no significant cytochrome c release was detected in the bid-deficient brains until 24 h later. This suggests that, although the mitochondrial apoptosis pathway might be activated by multiple mechanisms during focal cerebral ischemia, Bid is critical to its early activation. This notion was further supported by the finding that caspase-3 activation was severely impaired in the bid-deficient brains, whereas activation of caspase-8 was much less affected. Taken together, these data suggest that Bid is activated early in neuronal ischemia in a caspase-8-dependent fashion and that Bid is perhaps one of the earliest and most potent activators of the mitochondrial apoptosis pathway. Thus, the role of Bid in the induction of ischemic neuronal death may render this molecule an attractive target for future therapeutic intervention.	Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Yin, XM (corresponding author), Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15261 USA.			Chen, Jun/0000-0002-8077-3403	NATIONAL CANCER INSTITUTE [K01CA074885] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS035965, R01NS038560] Funding Source: NIH RePORTER; NCI NIH HHS [CA74885] Funding Source: Medline; NINDS NIH HHS [NS 35965, NS38560] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANKARCRONA M, 1995, NEURON, V15, P961, DOI 10.1016/0896-6273(95)90186-8; Araki T, 1998, BRAIN RES, V794, P239, DOI 10.1016/S0006-8993(98)00231-5; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Cao GD, 2001, J CEREBR BLOOD F MET, V21, P321, DOI 10.1097/00004647-200104000-00001; Cao GD, 2002, J CEREBR BLOOD F MET, V22, P534, DOI 10.1097/00004647-200205000-00005; Cao GD, 2001, J NEUROSCI, V21, P4678, DOI 10.1523/JNEUROSCI.21-13-04678.2001; Cheema ZF, 1999, J NEUROSCI, V19, P1754; Chen J, 1996, J CEREBR BLOOD F MET, V16, P566, DOI 10.1097/00004647-199607000-00006; Chen J, 1998, J NEUROSCI, V18, P4914; Chen J, 1997, J CEREBR BLOOD F MET, V17, P2, DOI 10.1097/00004647-199701000-00002; Du C, 1996, J CEREBR BLOOD F MET, V16, P195, DOI 10.1097/00004647-199603000-00003; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; Endres H, 1998, J CEREBR BLOOD F MET, V18, P238, DOI 10.1097/00004647-199803000-00002; Fink K, 1998, J CEREBR BLOOD F MET, V18, P1071, DOI 10.1097/00004647-199810000-00003; Fujii M, 1997, STROKE, V28, P1805, DOI 10.1161/01.STR.28.9.1805; Fujimura M, 1998, J CEREBR BLOOD F MET, V18, P1239, DOI 10.1097/00004647-199811000-00010; Fujimura M, 1999, J NEUROSCI, V19, P3414; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Gross A, 1999, J BIOL CHEM, V274, P1156, DOI 10.1074/jbc.274.2.1156; Hara H, 1997, P NATL ACAD SCI USA, V94, P2007, DOI 10.1073/pnas.94.5.2007; Heibein JA, 2000, J EXP MED, V192, P1391, DOI 10.1084/jem.192.10.1391; Jin KL, 2001, J CEREBR BLOOD F MET, V21, P1411, DOI 10.1097/00004647-200112000-00005; Kondo T, 1997, J NEUROSCI, V17, P4180; Krajewski S, 1999, P NATL ACAD SCI USA, V96, P5752, DOI 10.1073/pnas.96.10.5752; Leist M, 1997, J EXP MED, V185, P1481, DOI 10.1084/jem.185.8.1481; Li H, 2000, STROKE, V31, P176, DOI 10.1161/01.STR.31.1.176; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Li SC, 2002, J BIOL CHEM, V277, P26912, DOI 10.1074/jbc.M200726200; LI Y, 1995, AM J PATHOL, V146, P1045; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; Liu XS, 1997, CELL, V89, P175, DOI 10.1016/S0092-8674(00)80197-X; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Madesh M, 2002, J BIOL CHEM, V277, P5651, DOI 10.1074/jbc.M108171200; Maeda K, 1999, NEUROBIOL DIS, V6, P101, DOI 10.1006/nbdi.1998.0235; Maeda K, 1998, NEUROREPORT, V9, P1317, DOI 10.1097/00001756-199805110-00012; Martin-Villalba A, 2001, CELL DEATH DIFFER, V8, P679, DOI 10.1038/sj.cdd.4400882; Martin-Villalba A, 1999, J NEUROSCI, V19, P3809; MATSUYAMA T, 1995, MOL BRAIN RES, V34, P166, DOI 10.1016/0169-328X(95)00162-L; Morita-Fujimura Y, 2001, STROKE, V32, P2356, DOI 10.1161/hs1001.097241; Murakami K, 1998, J NEUROSCI, V18, P205; Nakashima K, 1999, J NEUROTRAUM, V16, P143, DOI 10.1089/neu.1999.16.143; Namura S, 1998, J NEUROSCI, V18, P3659; Ni BH, 1998, J CEREBR BLOOD F MET, V18, P248, DOI 10.1097/00004647-199803000-00003; Noshita N, 2001, J CEREBR BLOOD F MET, V21, P557, DOI 10.1097/00004647-200105000-00010; Park CH, 1998, BIOCHEM BIOPH RES CO, V252, P623, DOI 10.1006/bbrc.1998.9572; Plesnila N, 2001, P NATL ACAD SCI USA, V98, P15318, DOI 10.1073/pnas.261323298; Rosenbaum DM, 2000, J NEUROSCI RES, V61, P686, DOI 10.1002/1097-4547(20000915)61:6<686::AID-JNR12>3.0.CO;2-7; Schulz JB, 1999, ANN NEUROL, V45, P421, DOI 10.1002/1531-8249(199904)45:4<421::AID-ANA2>3.0.CO;2-Q; Slee EA, 2000, CELL DEATH DIFFER, V7, P556, DOI 10.1038/sj.cdd.4400689; Snider BJ, 1999, ANN NY ACAD SCI, V893, P243, DOI 10.1111/j.1749-6632.1999.tb07829.x; Susin SA, 1999, J EXP MED, V189, P381, DOI 10.1084/jem.189.2.381; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; Van Loo G, 2002, CELL DEATH DIFFER, V9, P301, DOI 10.1038/sj.cdd.4400966; Velier JJ, 1999, J NEUROSCI, V19, P5932, DOI 10.1523/JNEUROSCI.19-14-05932.1999; Wang K, 1996, GENE DEV, V10, P2859, DOI 10.1101/gad.10.22.2859; Yan CH, 2000, J CEREBR BLOOD F MET, V20, P620, DOI 10.1097/00004647-200003000-00020; YANG GY, 1994, STROKE, V25, P1658, DOI 10.1161/01.STR.25.8.1658; Yin XM, 1999, NATURE, V400, P886, DOI 10.1038/23730; Zamzami N, 2000, ONCOGENE, V19, P6342, DOI 10.1038/sj.onc.1204030; Zhao YG, 2001, J BIOL CHEM, V276, P27432, DOI 10.1074/jbc.M102465200	61	102	108	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					42074	42081		10.1074/jbc.M204991200	http://dx.doi.org/10.1074/jbc.M204991200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12200426	hybrid			2022-12-27	WOS:000178985300097
J	Erwert, RD; Winn, RK; Harlan, JM; Bannerman, DD				Erwert, RD; Winn, RK; Harlan, JM; Bannerman, DD			Shiga-like toxin inhibition of FLICE-like inhibitory protein expression sensitizes endothelial cells to bacterial lipopolysaccharide-induced apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMOLYTIC-UREMIC SYNDROME; TUMOR-NECROSIS-FACTOR; ESCHERICHIA-COLI O157-H7; MULTIPLE ORGAN FAILURE; FACTOR-ALPHA; LUNG INJURY; HEMORRHAGIC COLITIS; DEPENDENT PATHWAY; CASPASE INHIBITOR; GENE-EXPRESSION	Shiga-like toxin (SLT) has been implicated in the pathogenesis of hemolytic uremic syndrome and its attendant endothelial cell (EC) injury. Key serotypes of Escherichia coli produce SLT-1 in addition to another highly pro-inflammatory molecule, lipopolysaccharide (LPS). It has previously been established that SLT-1 induces EC apoptosis and that LPS enhances this effect. LPS alone has no affect on human EC viability, and the mechanism for this enhancement remains unknown. In the present report, we demonstrate that SLT-1 sensitizes EC to LPS-induced apoptosis. Pretreatment with SLT-1 sensitized EC to LPS-induced apoptosis, whereas pretreatment with LPS did not influence SLT-1-induced apoptosis. SLT-1 exposure resulted in decreased expression of FLICE-like inhibitory protein (FLIP), an antiapoptotic protein that has previously been shown to block LPS-induced apoptosis. This SLT-1-mediated decrease in FLIP expression preceded the onset of apoptosis elicited by SLT-1 alone or in combination with LPS. SLT-1-mediated decrements in FLIP expression correlated in a dose- and time-dependent manner with sensitization to LPS-induced apoptosis. Finally, transient or stable overexpression of FLIP protected against LPS enhancement of SLT-1-induced apoptosis, and this protection corresponded with sustained expression of FLIP. Together, these data suggest that SLT-1 sensitizes EC to LPS-induced apoptosis by inhibiting FLIP expression.	ARS, Immunol & Dis Resistance Lab, USDA, ANRI,BARC E, Beltsville, MD 20705 USA; Univ Washington, Sch Med, Dept Med, Seattle, WA 98104 USA; Univ Washington, Sch Med, Dept Surg, Seattle, WA 98104 USA	United States Department of Agriculture (USDA); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Bannerman, DD (corresponding author), ARS, Immunol & Dis Resistance Lab, USDA, ANRI,BARC E, Bldg 1040,Rm 2, Beltsville, MD 20705 USA.	dbanner@anri.barc.usda.gov			NHLBI NIH HHS [HL 03174, HL 18645] Funding Source: Medline; NIGMS NIH HHS [GM 42686, GM 07037] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL018645] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042686] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ackermann EJ, 1999, J BIOL CHEM, V274, P11245, DOI 10.1074/jbc.274.16.11245; ADES EW, 1992, J INVEST DERMATOL, V99, P683, DOI 10.1111/1523-1747.ep12613748; ARDITI M, 1993, INFECT IMMUN, V61, P3149, DOI 10.1128/IAI.61.8.3149-3156.1993; Armstrong RC, 1996, J BIOL CHEM, V271, P16850, DOI 10.1074/jbc.271.28.16850; Bannerman DD, 1999, LAB INVEST, V79, P1181; Bannerman DD, 2002, J BIOL CHEM, V277, P8048, DOI 10.1074/jbc.M111249200; Bannerman DD, 2001, J BIOL CHEM, V276, P14924, DOI 10.1074/jbc.M100819200; Bannerman DD, 1998, J BIOL CHEM, V273, P35371, DOI 10.1074/jbc.273.52.35371; BARRETT TJ, 1989, INFECT IMMUN, V57, P3434, DOI 10.1128/IAI.57.11.3434-3437.1989; BARRETT TJ, 1990, MICROB PATHOGENESIS, V9, P95, DOI 10.1016/0882-4010(90)90083-3; Bierhaus A, 2000, SEMIN THROMB HEMOST, V26, P571, DOI 10.1055/s-2000-13214; BITZAN M, 1991, J PEDIATR-US, V119, P380, DOI 10.1016/S0022-3476(05)82049-9; BRANDTZAEG P, 1989, J INFECT DIS, V159, P195, DOI 10.1093/infdis/159.2.195; BRIGHAM KL, 1986, AM REV RESPIR DIS, V133, P913; Choi KB, 1998, J BIOL CHEM, V273, P20185, DOI 10.1074/jbc.273.32.20185; COOPERSTOCK MS, 1974, ANTIMICROB AGENTS CH, V6, P422, DOI 10.1128/AAC.6.4.422; Eisenhauer PB, 2001, INFECT IMMUN, V69, P1889, DOI 10.1128/IAI.69.3.1889-1894.2001; Fenteany G, 1998, J BIOL CHEM, V273, P8545, DOI 10.1074/jbc.273.15.8545; FENTEANY G, 1995, SCIENCE, V268, P726, DOI 10.1126/science.7732382; Frey EA, 1998, MICROB PATHOGENESIS, V24, P101, DOI 10.1006/mpat.1997.0178; Fujita M, 1998, INT ARCH ALLERGY IMM, V117, P202, DOI 10.1159/000024011; Fukazawa T, 2001, ONCOGENE, V20, P5225, DOI 10.1038/sj.onc.1204673; Fulda S, 2000, CANCER RES, V60, P3947; GYLES CL, 1992, CAN J MICROBIOL, V38, P734, DOI 10.1139/m92-120; HaimovitzFriedman A, 1997, J EXP MED, V186, P1831, DOI 10.1084/jem.186.11.1831; HAREL Y, 1993, J CLIN INVEST, V92, P2110, DOI 10.1172/JCI116811; Hoyt DG, 1996, AM J PHYSIOL-LUNG C, V270, pL689, DOI 10.1152/ajplung.1996.270.4.L689; HOYT DG, 1995, AM J PHYSIOL-LUNG C, V269, pL171, DOI 10.1152/ajplung.1995.269.2.L171; Jacewicz MS, 1999, INFECT IMMUN, V67, P1439, DOI 10.1128/IAI.67.3.1439-1444.1999; Jones NL, 2000, AM J PHYSIOL-GASTR L, V278, pG811, DOI 10.1152/ajpgi.2000.278.5.G811; Kawasaki M, 2000, AM J PATHOL, V157, P597, DOI 10.1016/S0002-9440(10)64570-1; KAYE SA, 1993, INFECT IMMUN, V61, P3886, DOI 10.1128/IAI.61.9.3886-3891.1993; Keusch GT, 1996, J INFECT DIS, V173, P1164, DOI 10.1093/infdis/173.5.1164; Kim Y, 2002, J BIOL CHEM, V277, P22320, DOI 10.1074/jbc.M202458200; Kinoshita S, 1997, IMMUNITY, V6, P235, DOI 10.1016/S1074-7613(00)80326-X; Krueger A, 2001, MOL CELL BIOL, V21, P8247, DOI 10.1128/MCB.21.24.8247-8254.2001; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Li LW, 2000, J BIOL CHEM, V275, P23340, DOI 10.1074/jbc.M001950200; Lien E, 2000, J CLIN INVEST, V105, P497, DOI 10.1172/JCI8541; LOUISE CB, 1992, INFECT IMMUN, V60, P1536, DOI 10.1128/IAI.60.4.1536-1543.1992; LOUISE CB, 1991, INFECT IMMUN, V59, P4173, DOI 10.1128/IAI.59.11.4173-4179.1991; Medvedev AE, 2000, J IMMUNOL, V164, P5564, DOI 10.4049/jimmunol.164.11.5564; Miller D K, 1997, Semin Immunol, V9, P35, DOI 10.1006/smim.1996.0058; MORRISON DC, 1976, IMMUNOCHEMISTRY, V13, P813, DOI 10.1016/0019-2791(76)90181-6; O'Loughlin EV, 2001, MICROBES INFECT, V3, P493, DOI 10.1016/S1286-4579(01)01405-8; OBRIG TG, 1988, INFECT IMMUN, V56, P2373, DOI 10.1128/IAI.56.9.2373-2378.1988; OBRIG TG, 1993, J BIOL CHEM, V268, P15484; OGASAWARA T, 1988, MICROB PATHOGENESIS, V4, P127, DOI 10.1016/0882-4010(88)90054-X; OLSON NC, 1995, BRIT VET J, V151, P489, DOI 10.1016/S0007-1935(05)80023-5; Pammer J, 1999, BIOCHEM BIOPH RES CO, V264, P139, DOI 10.1006/bbrc.1999.1436; Pijpers AHJM, 2001, J AM SOC NEPHROL, V12, P767, DOI 10.1681/ASN.V124767; POHLMAN TH, 1989, CELL IMMUNOL, V119, P41, DOI 10.1016/0008-8749(89)90222-0; Proulx F, 1999, CLIN DIAGN LAB IMMUN, V6, P773, DOI 10.1128/CDLI.6.5.773-773.1999; Proulx F, 2001, PEDIATR RES, V50, P163, DOI 10.1203/00006450-200108000-00002; Ray PE, 2001, PEDIATR NEPHROL, V16, P823, DOI 10.1007/s004670100660; RICHARDSON SE, 1988, HUM PATHOL, V19, P1102, DOI 10.1016/S0046-8177(88)80093-5; RIETSCHEL ET, 1994, FASEB J, V8, P217, DOI 10.1096/fasebj.8.2.8119492; Sata M, 1998, J BIOL CHEM, V273, P33103, DOI 10.1074/jbc.273.50.33103; Scaffidi C, 1999, J BIOL CHEM, V274, P1541, DOI 10.1074/jbc.274.3.1541; Slee EA, 1996, BIOCHEM J, V315, P21, DOI 10.1042/bj3150021; Thijs LG, 1996, CURR TOP MICROBIOL, V216, P209; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Tschopp J, 1998, CURR OPIN IMMUNOL, V10, P552, DOI 10.1016/S0952-7915(98)80223-9; ULEVITCH RJ, 1975, J EXP MED, V142, P1570, DOI 10.1084/jem.142.6.1570; VIRCA GD, 1989, J BIOL CHEM, V264, P21951; West MA, 2002, CRIT CARE MED, V30, pS64, DOI 10.1097/00003246-200201001-00009; Widmann C, 1998, J BIOL CHEM, V273, P7141, DOI 10.1074/jbc.273.12.7141; Williams JM, 1997, TOXICOL LETT, V91, P121, DOI 10.1016/S0378-4274(97)03879-4; Williams JM, 1999, TOXICOL LETT, V105, P47, DOI 10.1016/S0378-4274(98)00383-X; Yoshida T, 1999, J INFECT DIS, V180, P2048, DOI 10.1086/315116; Zen K, 1999, J BIOL CHEM, V274, P28808, DOI 10.1074/jbc.274.40.28808; ZIEGLER EJ, 1982, NEW ENGL J MED, V307, P1225, DOI 10.1056/NEJM198211113072001	72	25	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2002	277	43					40567	40574		10.1074/jbc.M206351200	http://dx.doi.org/10.1074/jbc.M206351200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	607KU	12189147	hybrid			2022-12-27	WOS:000178791400054
J	Receveur, V; Czjzek, M; Schulein, M; Panine, P; Henrissat, B				Receveur, V; Czjzek, M; Schulein, M; Panine, P; Henrissat, B			Dimension, shape, and conformational flexibility of a two domain fungal cellulase in solution probed by small angle X-ray scattering	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELLOBIOHYDROLASE-I; TRICHODERMA-REESEI; BINDING DOMAINS; CELLULOMONAS-FIMI; BIOLOGICAL MACROMOLECULES; CRYSTALLINE CELLULOSE; GLYCOSYL HYDROLASES; LIMITED PROTEOLYSIS; BACTERIAL CELLULASE; FUNCTIONAL DOMAINS	Cellulase Ce145 from Humicola insolens has a modular structure with a catalytic module and a cellulose-binding module (CBM) separated by a 36 amino acid, glycosylated, linker peptide. The solution conformation of the entire two domain Ce145 protein as well as the effect of the length and flexibility of the linker on the spatial arrangement of the constitutive modules were studied by small angle x-ray scattering combined with the known three-dimensional structure of the individual modules. The measured dimensions of the enzyme show that the linker exhibits an extended conformation leading to a maximum extension between the two centers of mass of each module corresponding to about four cellobiose units on a cellulose chain. The glycosylation of the linker is the key factor defining its extended conformation, and a five proline stretch mutation on the linker was found to confer a higher rigidity to the enzyme. Our study shows that the respective positioning of the catalytic module and the CBM onto the insoluble substrate is most likely influenced by the linker structure and flexibility. Our results are consistent with a model where cellulases can move on the surface of cellulose with a caterpillar-like displacement with free energy restrictions.	CNRS, UMR 6098, F-13402 Marseille 20, France; Univ Aix Marseille 1, F-13402 Marseille 20, France; Univ Aix Marseille 2, F-13402 Marseille 20, France; Novozymes, DK-2800 Bagsvaerd, Denmark; European Synchrotron Radiat Facil, F-38043 Grenoble, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Novozymes; European Synchrotron Radiation Facility (ESRF)	Receveur, V (corresponding author), CNRS, UMR 6098, F-13402 Marseille 20, France.	receveur@afmb.cnrs-mrs.fr	Panine, Pierre/AAF-2506-2019; Henrissat, Bernard/J-2475-2012	Henrissat, Bernard/0000-0002-3434-8588; Receveur-Brechot, Veronique/0000-0002-7464-6192				ABUJA PM, 1988, EUR BIOPHYS J BIOPHY, V15, P339, DOI 10.1007/BF00254721; ABUJA PM, 1988, BIOCHEM BIOPH RES CO, V156, P180, DOI 10.1016/S0006-291X(88)80821-0; BOISSET C, 1995, FEBS LETT, V376, P49, DOI 10.1016/0014-5793(95)01244-0; Bolam DN, 1998, BIOCHEM J, V331, P775, DOI 10.1042/bj3310775; Boraston AB, 1999, ROY SOC CH, P202; Bourne Y, 2001, CURR OPIN STRUC BIOL, V11, P593, DOI 10.1016/S0959-440X(00)00253-0; CHRISTENSEN T, 1988, BIO-TECHNOL, V6, P1419, DOI 10.1038/nbt1288-1419; DAVIES GJ, 1993, NATURE, V365, P362, DOI 10.1038/365362a0; GILKES NR, 1992, J BIOL CHEM, V267, P6743; GILKES NR, 1991, MICROBIOL REV, V55, P303, DOI 10.1128/MMBR.55.2.303-315.1991; GILKES NR, 1988, J BIOL CHEM, V263, P10401; Glatter von O., 1982, SMALL ANGLE XRAY SCA, P167; Guinier A, 1955, SMALL ANGLE SCATERIN; Henrissat B, 1996, BIOCHEM J, V316, P695, DOI 10.1042/bj3160695; HENRISSAT B, 1993, BIOCHEM J, V293, P781, DOI 10.1042/bj2930781; Jervis EJ, 1997, J BIOL CHEM, V272, P24016, DOI 10.1074/jbc.272.38.24016; Kelly MA, 2001, BIOCHEMISTRY-US, V40, P14376, DOI 10.1021/bi011043a; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; KRAULIS PJ, 1989, BIOCHEMISTRY-US, V28, P7241, DOI 10.1021/bi00444a016; Linder M, 1997, J BIOTECHNOL, V57, P15, DOI 10.1016/S0168-1656(97)00087-4; MEINKE A, 1992, GLYCOBIOLOGY, V2, P321, DOI 10.1093/glycob/2.4.321; Peitsch MC, 1996, BIOCHEM SOC T, V24, P274, DOI 10.1042/bst0240274; PILZ I, 1990, BIOCHEM J, V271, P277, DOI 10.1042/bj2710277; Porod G., 1982, SMALL ANGLE XRAY SCA, P17, DOI DOI 10.1002/ACTP.1985.010360520; RASMUSSEN G, 1991, Patent No. 17243; Receveur V, 1998, FEBS LETT, V426, P57, DOI 10.1016/S0014-5793(98)00309-3; ROUSSEL A, 1989, SILICON GRAPHICS GEO, P77; Sakon J, 1997, NAT STRUCT BIOL, V4, P810, DOI 10.1038/nsb1097-810; SCHULEIN M, 1993, TRICHODERMA REESEI C, V8, P109; SHEN H, 1991, J BIOL CHEM, V266, P11335; SRISODSUK M, 1993, J BIOL CHEM, V268, P20756; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; TOMME P, 1988, EUR J BIOCHEM, V170, P575, DOI 10.1111/j.1432-1033.1988.tb13736.x; TOMME P, 1995, ENZYMATIC DEGRADATIO, V618, P142; VANTILBEURGH H, 1986, FEBS LETT, V204, P223, DOI 10.1016/0014-5793(86)80816-X; Wilkins DK, 1999, BIOCHEMISTRY-US, V38, P16424, DOI 10.1021/bi991765q; ZIMMERMAN SB, 1993, ANNU REV BIOPH BIOM, V22, P27, DOI 10.1146/annurev.bb.22.060193.000331	40	87	95	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2002	277	43					40887	40892		10.1074/jbc.M205404200	http://dx.doi.org/10.1074/jbc.M205404200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	607KU	12186865	hybrid			2022-12-27	WOS:000178791400094
J	Slevin, M; Kumar, S; Gaffney, J				Slevin, M; Kumar, S; Gaffney, J			Angiogenic oligosaccharides of hyaluronan induce multiple signaling pathways affecting vascular endothelial cell mitogenic and wound healing responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; TUMOR-DERIVED HYALURONIDASE; SMOOTH-MUSCLE-CELLS; FACTOR-KAPPA-B; GROWTH-FACTOR; PHOSPHOLIPASE-C; BINDING PROTEINS; CARCINOMA-CELLS; RECEPTOR RHAMM; ACID BINDING	Hyaluronan (HA) is a large nonsulfated glycosaminoglycan and an important regulator of angiogenesis, in particular, the growth and migration of vascular endothelial cells. We have identified some of the key intermediates responsible for induction of mitogenesis and wound recovery. Treatment of bovine aortic endothelial cells with oligosaccharides of hyaluronan (o-HA) resulted in rapid tyrosine phosphorylation and plasma membrane translocation of phospholipase Cgammal (PLCgammal). Cytoplasmic loading with inhibitory antibodies to PLCgammal, Gbeta, and Galpha(i/o/t/z) inhibited activation of extracellular-regulated kinase 1/2 (ERK1/2). Treatment with the Galpha(i/o) inhibitor, pertussis toxin, reduced o-HA-induced PLCgammal tyrosine phosphorylation, protein kinase C (PKC) alpha and beta1/2 membrane translocation, ERK1/2 activation, mitogenesis, and wound recovery, suggesting a mechanism for o-HA-induced angiogenesis through G-proteins, PLCgammal, and PKC. In particular, we demonstrated a possible role for PKCalpha in mitogenesis and PKCbeta1/2 in wound recovery. Using antisense oligonucleotides and the Ras farnesylation inhibitor FTI-277, we showed that o-HA-induced bovine aortic endothelial cell proliferation, wound recovery, and ERK1/2 activation were also partially dependent on Ras activation, and that o-HA-stimulated tyrosine phosphorylation of the adapter protein Shc, as well as its association with Sos1. Binding of Src to Shc was required for its activation and for Ras-dependent activation of ERK1/2, cell proliferation, and wound recovery. Neither Src nor Ras activation was inhibited by pertussis toxin, suggesting that their activation was independent of heterotrimeric G-proteins. However, the specific Src kinase inhibitor PP2 inhibited Gbeta subunit co-precipitation with PLCgammal, suggesting a possible role for Src in activation of PLCgammal and interaction between two distinct o-HA-induced signaling pathways.	Manchester Metropolitan Univ, Dept Biol Sci, Manchester M1 5GD, Lancs, England; Manchester Victoria Univ, Dept Pathol Sci, Manchester M1 5GD, Lancs, England	Manchester Metropolitan University; University of Manchester	Slevin, M (corresponding author), Manchester Metropolitan Univ, Dept Biol Sci, Manchester M1 5GD, Lancs, England.	m.a.slevin@mmu.ac.uk	Slevin, Mark/AFT-1420-2022; slevin, mark a/A-1593-2008	slevin, mark/0000-0003-3767-4861				AbdAlla S, 2000, NATURE, V407, P94, DOI 10.1038/35024095; Allen V, 1997, BIOCHEM J, V327, P545, DOI 10.1042/bj3270545; Bourguignon LYW, 2001, J BIOL CHEM, V276, P7327, DOI 10.1074/jbc.M006498200; Bourguignon LYW, 2001, J BIOL CHEM, V276, P48679, DOI 10.1074/jbc.M106759200; Brinck J, 1999, EXP CELL RES, V252, P342, DOI 10.1006/excr.1999.4645; Camenisch TD, 2000, AM J RESP CELL MOL, V23, P431, DOI 10.1165/ajrcmb.23.4.f201; COUSSENS L, 1986, SCIENCE, V233, P859, DOI 10.1126/science.3755548; DEED R, 1997, INT J CANCER, V71, P116; DELPECH B, 1990, INT J CANCER, V46, P388, DOI 10.1002/ijc.2910460309; FARESE RV, 1991, LIPID RELATED 2 MESS, P205; Fieber C, 1999, GENE, V226, P41, DOI 10.1016/S0378-1119(98)00566-6; Fitzgerald KA, 2000, J IMMUNOL, V164, P2053, DOI 10.4049/jimmunol.164.4.2053; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Garbay C, 2000, BIOCHEM PHARMACOL, V60, P1165, DOI 10.1016/S0006-2952(00)00428-7; Gschwendt M, 1996, FEBS LETT, V392, P77, DOI 10.1016/0014-5793(96)00785-5; Hall CL, 1996, ONCOGENE, V13, P2213; Hall CL, 2001, MATRIX BIOL, V20, P183, DOI 10.1016/S0945-053X(01)00133-0; Harrington EO, 2000, BIOCHEM BIOPH RES CO, V271, P499, DOI 10.1006/bbrc.2000.2655; Hodson EAM, 1999, BIOCHEM BIOPH RES CO, V258, P425, DOI 10.1006/bbrc.1999.0657; Jeay S, 2001, ENDOCRINOLOGY, V142, P147, DOI 10.1210/en.142.1.147; Kim CG, 1996, J BIOL CHEM, V271, P21187, DOI 10.1074/jbc.271.35.21187; Kim I, 2001, J BIOL CHEM, V276, P7614, DOI 10.1074/jbc.M009705200; KNUDSON W, 1984, P NATL ACAD SCI-BIOL, V81, P6767, DOI 10.1073/pnas.81.21.6767; KRUPINSKI J, 1994, STROKE, V25, P1794, DOI 10.1161/01.STR.25.9.1794; KUMAR S, 1994, NATO ADV SCI INST SE, V263, P219; Lauder H, 1997, BRIT J PHARMACOL, V122, P663, DOI 10.1038/sj.bjp.0701443; LERNER EC, 1995, J BIOL CHEM, V270, P26802, DOI 10.1074/jbc.270.45.26802; Liu DC, 1996, P NATL ACAD SCI USA, V93, P7832, DOI 10.1073/pnas.93.15.7832; Lokeshwar VB, 1996, J BIOL CHEM, V271, P23853, DOI 10.1074/jbc.271.39.23853; Lokeshwar VB, 1996, CANCER RES, V56, P651; Lokeshwar VB, 1999, CANCER RES, V59, P4464; Lokeshwar VB, 2000, J BIOL CHEM, V275, P27641; Luttrell LM, 1997, ADV SEC MESS PHOSPH, V31, P263; MARTIN JF, 1990, ENDOTHELIUM INTRO CU, P95; MCCAFFERY RE, 1989, ONCOGENE, V4, P1441; Montesano R, 1996, LAB INVEST, V75, P249; MUKAI H, 1992, J BIOL CHEM, V267, P16237; Nandi A, 2000, J BIOL CHEM, V275, P14939, DOI 10.1074/jbc.275.20.14939; NOH DY, 1995, BBA-REV CANCER, V1242, P99, DOI 10.1016/0304-419X(95)00006-0; Ohta S, 1997, INT J ONCOL, V10, P561; PAULI BU, 1988, HUM PATHOL, V19, P628, DOI 10.1016/S0046-8177(88)80168-0; Pham HT, 1997, CANCER RES, V57, P778; PONTING J, 2002, CURRENT PERSPECTIVES; Rao CM, 1996, BIOCHEM MOL BIOL INT, V40, P327; Roden L, 1989, CIBA F SYMP, P76; ROONEY P, 1993, DIFFERENTIATION, V54, P1; ROONEY P, 1995, INT J CANCER, V60, P632, DOI 10.1002/ijc.2910600511; SATOH T, 1992, J BIOL CHEM, V267, P24149; SATTAR A, 1994, J INVEST DERMATOL, V103, P576, DOI 10.1111/1523-1747.ep12396880; Savani RC, 2001, J BIOL CHEM, V276, P36770, DOI 10.1074/jbc.M102273200; Schwindinger WF, 2001, ONCOGENE, V20, P1653, DOI 10.1038/sj.onc.1204181; SCOTT JE, 1995, J ANAT, V187, P259; Serbulea M, 1999, INT J ONCOL, V14, P733; SHEA TB, 1991, J NEUROSCI, V11, P1685; Skubitz KM, 1998, FEBS LETT, V439, P97, DOI 10.1016/S0014-5793(98)01347-7; Slevin M, 1998, LAB INVEST, V78, P987; Szekeres CK, 2000, J BIOL CHEM, V275, P38831, DOI 10.1074/jbc.M002673200; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Thodeti CK, 2000, J BIOL CHEM, V275, P9849, DOI 10.1074/jbc.275.13.9849; Trochon V, 1996, INT J CANCER, V66, P664, DOI 10.1002/(SICI)1097-0215(19960529)66:5<664::AID-IJC14>3.0.CO;2-4; Tsifrina E, 1999, AM J PATHOL, V155, P1625, DOI 10.1016/S0002-9440(10)65478-8; VAINIKKA S, 1994, J BIOL CHEM, V269, P18320; vanBiesen T, 1996, J BIOL CHEM, V271, P1266, DOI 10.1074/jbc.271.3.1266; Vanderkuur JA, 1997, ENDOCRINOLOGY, V138, P4301, DOI 10.1210/en.138.10.4301; Volkov Y, 1998, J IMMUNOL, V161, P6487; Watanabe Michifumi, 1993, Nippon Ganka Gakkai Zasshi, V97, P1034; Wellner M, 1999, ARTERIOSCL THROM VAS, V19, P178, DOI 10.1161/01.ATV.19.1.178; WEST DC, 1989, EXP CELL RES, V183, P179, DOI 10.1016/0014-4827(89)90428-X; WEST DC, 1991, INT J RADIAT BIOL, V60, P55, DOI 10.1080/09553009114551541; WEST DC, 1989, CIBA F SYMP, V143, P187; WEST DC, 1988, LANCET, V1, P715; WEST DC, 1985, SCIENCE, V228, P1324, DOI 10.1126/science.2408340; Xia P, 1996, J CLIN INVEST, V98, P2018, DOI 10.1172/JCI119006; Yano KJ, 1999, ENDOCRINOLOGY, V140, P4622, DOI 10.1210/en.140.10.4622; Yassin RR, 1998, PEPTIDES, V19, P47, DOI 10.1016/S0196-9781(97)00276-3; Yasunari K, 2000, HYPERTENSION, V35, P1092, DOI 10.1161/01.HYP.35.5.1092; Yedovitzky M, 1997, J BIOL CHEM, V272, P1417, DOI 10.1074/jbc.272.3.1417; Zhang SW, 1998, J BIOL CHEM, V273, P11342, DOI 10.1074/jbc.273.18.11342	78	256	268	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2002	277	43					41046	41059		10.1074/jbc.M109443200	http://dx.doi.org/10.1074/jbc.M109443200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	607KU	12194965	Green Published, hybrid			2022-12-27	WOS:000178791400114
J	Chan, DA; Sutphin, PD; Denko, NC; Giaccia, AJ				Chan, DA; Sutphin, PD; Denko, NC; Giaccia, AJ			Role of prolyl hydroxylation in oncogenically stabilized hypoxia-inducible factor-1 alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; HIF-ALPHA; INDUCTION; PROTEIN; CELLS; ERYTHROPOIETIN; DESTRUCTION; HIF-1-ALPHA; EXPRESSION; BINDING	Stabilization of the hypoxia-inducible factor-1 (HIF-1) protein is essential for its role as a regulator of gene expression under low oxygen conditions. Here, employing a novel hydroxylation-specific antibody, we directly show that proline 564 of HIF-1alpha and proline 531 of HIF-2alpha are hydroxylated under normoxia. Importantly, HIF-1alpha Pro-564 and HIF-2alpha Pro-531 hydroxylation is diminished with the treatment of hypoxia, cobalt chloride, desferrioxamine, or dimethyloxalyglycine, regardless of the E3 ubiquitin ligase activity of the von Hippel-Lindau (VHL) tumor suppressor gene. Furthermore, in VHL-deficient cells, HIF-1alpha Pro-564 and HIF-2alpha Pro-531 had detectable amounts of hydroxylation following transition to hypoxia, indicating that the post-translational modification is not reversible. The introduction of v-Src or RasV12 oncogenes resulted in the stabilization of normoxic HIF-1alpha and the loss of hydroxylated Pro-564, demonstrating that oncogene-induced stabilization of HIF-1alpha is signaled through the inhibition of prolyl bydroxylation. Conversely, a constitutively active Akt oncogene stabilized HIF-1alpha under normoxia independently of prolyl hydroxylation, suggesting an alternative mechanism for HIF-1alpha stabilization. Thus, these results indicate distinct pathways for HIF-1alpha stabilization by different oncogenes. More importantly, these findings link oncogenesis with normoxic HIF-1alpha expression through prolyl hydroxylation.	Stanford Univ, Ctr Clin Sci Res, Dept Radiat Oncol, Program Canc Biol, Stanford, CA 94305 USA	Stanford University	Giaccia, AJ (corresponding author), Stanford Univ, Ctr Clin Sci Res, Dept Radiat Oncol, Program Canc Biol, 269 Campus Dr, Stanford, CA 94305 USA.		denko, nicholas/F-8444-2010		NCI NIH HHS [CA67166, CA09302] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA067166] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bunn HF, 1996, PHYSIOL REV, V76, P839, DOI 10.1152/physrev.1996.76.3.839; Chen EY, 1999, TERATOLOGY, V60, P215; Chun YS, 2001, BIOCHEM PHARMACOL, V61, P947, DOI 10.1016/S0006-2952(01)00564-0; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Graeber TG, 1996, NATURE, V379, P88, DOI 10.1038/379088a0; ILIOPOULOS O, 1995, NAT MED, V1, P822, DOI 10.1038/nm0895-822; Isaacs JS, 2002, J BIOL CHEM, V277, P29936, DOI 10.1074/jbc.M204733200; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jewell UR, 2001, FASEB J, V15, P1312, DOI 10.1096/fj.00-0732fje; Jiang BH, 1997, CANCER RES, V57, P5328; Katschinski DM, 2002, J BIOL CHEM, V277, P9262, DOI 10.1074/jbc.M110377200; Lando D, 2002, SCIENCE, V295, P858, DOI 10.1126/science.1068592; Masson N, 2001, EMBO J, V20, P5197, DOI 10.1093/emboj/20.18.5197; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Mazure NM, 1997, BLOOD, V90, P3322, DOI 10.1182/blood.V90.9.3322; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Ryan HE, 2000, CANCER RES, V60, P4010; Sato S, 2000, P NATL ACAD SCI USA, V97, P10832, DOI 10.1073/pnas.170276797; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; Sheta EA, 2001, ONCOGENE, V20, P7624, DOI 10.1038/sj.onc.1204972; Shibata T, 2000, GENE THER, V7, P493, DOI 10.1038/sj.gt.3301124; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Zundel W, 2000, GENE DEV, V14, P391	24	212	221	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 18	2002	277	42					40112	40117		10.1074/jbc.M206922200	http://dx.doi.org/10.1074/jbc.M206922200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	605EA	12186875	hybrid			2022-12-27	WOS:000178662500133
J	Foghsgaard, L; Lademann, U; Wissing, D; Poulsen, B; Jaattela, M				Foghsgaard, L; Lademann, U; Wissing, D; Poulsen, B; Jaattela, M			Cathepsin B mediates tumor necrosis factor-induced arachidonic acid release in tumor cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOSOLIC PHOSPHOLIPASE A(2); INDUCED APOPTOSIS; DEATH PATHWAY; FACTOR-ALPHA; ACTIVATION; INHIBITION; CASPASES; TNF; PROTEASE; RECEPTOR	Arachidonic acid (AA) generated by cytosolic phospholipase A(2) (cPLA(2)) has been suggested to function as a second messenger in tumor necrosis factor (TNF)-induced death signaling. Here, we show that cathepsin B-like proteases are required for the TNF-induced AA release in transformed cells. Pharmaceutical inhibitors of cathepsin B blocked TNF-induced AA release in human breast (MCF-7S1) and cervix (ME-180as) carcinoma as well as murine fibrosarcoma (WEHI-S) cells. Furthermore, TNF-induced AA release was significantly reduced in cathepsin B-deficient immortalized murine embryonic fibroblasts. Employing cPIA(2)-deficient MCF-7S1 cells expressing ectopic cPLA2 or cPLA(2)-deficient immortalized murine embryonic fibroblasts, we showed that cPLA(2) is dispensable for TNF-induced AA release and death in these cells. Furthermore, TNF-induced cathepsin B-dependent AA release could be dissociated from the cathepsin B-independent cell death in MCF-7S1 cells, whereas both events required cathepsin B activity in other cell lines tested. These data suggest that cathepsin B inhibitors may prove useful not only in the direct control of cell death but also in limiting the damage-associated inflammation.	Danish Canc Soc, Inst Canc Biol, Apoptosis Lab, DK-2100 Copenhagen, Denmark	Danish Cancer Society	Jaattela, M (corresponding author), Danish Canc Soc, Inst Canc Biol, Apoptosis Lab, Strandboulevarden 49, DK-2100 Copenhagen, Denmark.		Jäättelä, Marja/AAT-7932-2021	Jäättelä, Marja/0000-0001-5950-7111				Adam-Klages S, 1998, J IMMUNOL, V161, P5687; Ashkenazi A, 1999, CURR OPIN CELL BIOL, V11, P255, DOI 10.1016/S0955-0674(99)80034-9; Atsumi G, 2000, J BIOL CHEM, V275, P18248, DOI 10.1074/jbc.M000271200; Atsumi G, 1998, J BIOL CHEM, V273, P13870, DOI 10.1074/jbc.273.22.13870; Bonventre JV, 1997, NATURE, V390, P622, DOI 10.1038/37635; Capper EA, 2001, PROG LIPID RES, V40, P167, DOI 10.1016/S0163-7827(01)00002-9; Cummings BS, 2000, J PHARMACOL EXP THER, V294, P793; Deussing J, 1998, P NATL ACAD SCI USA, V95, P4516, DOI 10.1073/pnas.95.8.4516; Foghsgaard L, 2001, J CELL BIOL, V153, P999, DOI 10.1083/jcb.153.5.999; Foghsgaard L, 1997, J VIROL, V71, P7509, DOI 10.1128/JVI.71.10.7509-7517.1997; Gobeil S, 2001, CELL DEATH DIFFER, V8, P588, DOI 10.1038/sj.cdd.4400851; Gray J, 2001, J BIOL CHEM, V276, P32750, DOI 10.1074/jbc.M103150200; Guicciardi ME, 2000, J CLIN INVEST, V106, P1127, DOI 10.1172/JCI9914; Halangk W, 2000, J CLIN INVEST, V106, P773, DOI 10.1172/JCI9411; HAYAKAWA M, 1993, J BIOL CHEM, V268, P11290; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; JAATTELA M, 1995, ONCOGENE, V10, P2297; JAATTELA M, 1993, J IMMUNOL, V151, P4286; Jaattela M, 1998, EMBO J, V17, P6124, DOI 10.1093/emboj/17.21.6124; Katz E, 2001, J IMMUNOL, V166, P137, DOI 10.4049/jimmunol.166.1.137; Keppler D, 1996, ENZYME PROTEIN, V49, P94, DOI 10.1159/000468619; Khwaja A, 1999, J BIOL CHEM, V274, P36817, DOI 10.1074/jbc.274.51.36817; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; Leist M, 2001, NAT REV MOL CELL BIO, V2, P589, DOI 10.1038/35085008; Leist M, 2001, CELL DEATH DIFFER, V8, P324, DOI 10.1038/sj.cdd.4400859; Luschen S, 2000, J BIOL CHEM, V275, P24670, DOI 10.1074/jbc.M003280200; Mathiasen IS, 1999, CANCER RES, V59, P4848; Nakatani Y, 2000, J BIOL CHEM, V275, P1161, DOI 10.1074/jbc.275.2.1161; Nitatori T, 1996, ADV EXP MED BIOL, V389, P177; Pennacchio LA, 1998, NAT GENET, V20, P251, DOI 10.1038/3059; RashbaStep J, 1997, ARCH BIOCHEM BIOPHYS, V343, P44, DOI 10.1006/abbi.1997.0134; Sapirstein A, 1996, J BIOL CHEM, V271, P21505, DOI 10.1074/jbc.271.35.21505; Schotte P, 1998, BIOCHEM BIOPH RES CO, V251, P379, DOI 10.1006/bbrc.1998.9425; Scorrano L, 2001, J BIOL CHEM, V276, P12035, DOI 10.1074/jbc.M010603200; Stoka V, 2001, J BIOL CHEM, V276, P3149, DOI 10.1074/jbc.M008944200; Thorne TE, 1996, J VIROL, V70, P8502, DOI 10.1128/JVI.70.12.8502-8507.1996; Vancompernolle K, 1998, FEBS LETT, V438, P150, DOI 10.1016/S0014-5793(98)01275-7; Varfolomeev EE, 1998, IMMUNITY, V9, P267, DOI 10.1016/S1074-7613(00)80609-3; Vercammen D, 1998, J EXP MED, V187, P1477, DOI 10.1084/jem.187.9.1477; VoelkelJohnson C, 1996, J IMMUNOL, V156, P201; Wallach D, 1999, ANNU REV IMMUNOL, V17, P331, DOI 10.1146/annurev.immunol.17.1.331; Wissing D, 1997, P NATL ACAD SCI USA, V94, P5073, DOI 10.1073/pnas.94.10.5073	42	50	53	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 18	2002	277	42					39499	39506		10.1074/jbc.M206669200	http://dx.doi.org/10.1074/jbc.M206669200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	605EA	12185082	hybrid			2022-12-27	WOS:000178662500058
J	Yang, TB; Poovaiah, BW				Yang, TB; Poovaiah, BW			A calmodulin-binding/CGCG box DNA-binding protein family involved in multiple signaling pathways in plants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; TRANSCRIPTION FACTOR; AUXIN ACTION; CALCIUM; ETHYLENE; ARABIDOPSIS; TRANSDUCTION; CALCIUM/CALMODULIN; PERCEPTION; DEFENSE	We reported earlier that the tobacco early ethylene-responsive gene NtER1 encodes a calmodulin-binding protein (Yang, T., and Poovaiah, B. W. (2000) J. Biol. Chem. 275, 38467-38473). Here we demonstrate that there is one NtER1 homolog as well as five related genes in Arabidopsis. These six genes are rapidly and differentially induced by environmental signals such as temperature extremes, UVB, salt, and wounding;, hormones such as ethylene and abscisic acid; and signal molecules such as methyl jasmonate, H2O2, and salicylic acid. Hence, they were designated as AtSR1-6 ((A) under bar rabidopsts (t) under bar haliana (s) under bar ignal-(r) under bar esponsive genes). Ca2+/calmodulin binds to all AtSRs, and their calmodulin-binding regions are located on a conserved basic amphiphilic a-helical motif in the C terminus. AtSR1 targets the nucleus and specifically recognizes a novel 6-bp CGCG box (A/C/G)CGCG(G/T/C). The multiple CGCG cis-elements are found in promoters of genes such as those involved in ethylene signaling, abscisic acid signaling, and light signal perception. The DNA-binding domain in AtSR1 is located on the N-terminal 146 bp where all AtSR1-related proteins share high similarity but have no similarity to other known DNA-binding proteins. The calmodulin-binding nuclear proteins isolated from wounded leaves exhibit specific CGCG box DNA binding activities. These results suggest that the AtSR gene family encodes a family of calmodulin-binding/DNA-binding proteins involved in multiple signal transduction pathways in plants.	Washington State Univ, Dept Hort, Lab Plant Mol Biol & Physiol, Pullman, WA 99164 USA	Washington State University	Poovaiah, BW (corresponding author), Washington State Univ, Dept Hort, Lab Plant Mol Biol & Physiol, Pullman, WA 99164 USA.							Abel S, 1996, PLANT PHYSIOL, V111, P9, DOI 10.1104/pp.111.1.9; Bahler M, 2002, FEBS LETT, V513, P107, DOI 10.1016/S0014-5793(01)03239-2; Bergey DR, 1999, PLANT MOL BIOL, V40, P815, DOI 10.1023/A:1006247624823; Bleecker AB, 2000, ANNU REV CELL DEV BI, V16, P1, DOI 10.1146/annurev.cellbio.16.1.1; Bouche N, 2002, J BIOL CHEM, V277, P21851, DOI 10.1074/jbc.M200268200; Bowler C, 2000, TRENDS PLANT SCI, V5, P241, DOI 10.1016/S1360-1385(00)01628-9; BRAAM J, 1990, CELL, V60, P357, DOI 10.1016/0092-8674(90)90587-5; BRUCE WB, 1991, EMBO J, V10, P3015, DOI 10.1002/j.1460-2075.1991.tb07852.x; BUSH DS, 1995, ANNU REV PLANT PHYS, V46, P95, DOI 10.1146/annurev.pp.46.060195.000523; Chao QM, 1997, CELL, V89, P1133, DOI 10.1016/S0092-8674(00)80300-1; Christou P, 1995, METHOD CELL BIOL, V50, P375, DOI 10.1016/S0091-679X(08)61044-4; CORNELIUSSEN B, 1994, NATURE, V368, P760, DOI 10.1038/368760a0; Davis SJ, 1998, PLANT MOL BIOL, V36, P521, DOI 10.1023/A:1005991617182; Evans NH, 2001, CURR OPIN PLANT BIOL, V4, P415, DOI 10.1016/S1369-5266(00)00194-1; Fujimoto SY, 2000, PLANT CELL, V12, P393, DOI 10.1105/tpc.12.3.393; GIRAUDAT J, 1995, CURR OPIN CELL BIOL, V7, P232, DOI 10.1016/0955-0674(95)80033-6; GREEN PJ, 1987, EMBO J, V18, P4689; GREEN R, 1995, PLANT CELL, V7, P203, DOI 10.1105/tpc.7.2.203; JENA PK, 1989, P NATL ACAD SCI USA, V86, P3644, DOI 10.1073/pnas.86.10.3644; Klessig DF, 2000, P NATL ACAD SCI USA, V97, P8849, DOI 10.1073/pnas.97.16.8849; Larkindale J, 2002, PLANT PHYSIOL, V128, P682, DOI 10.1104/pp.010320; Leon J, 2001, J EXP BOT, V52, P1, DOI 10.1093/jexbot/52.354.1; LEVINE A, 1994, CELL, V79, P583, DOI 10.1016/0092-8674(94)90544-4; NATALIE C, 1989, ANNU REV BIOCHEM, V58, P951; ODonnell PJ, 1996, SCIENCE, V274, P1914, DOI 10.1126/science.274.5294.1914; ONEIL KT, 1990, TRENDS BIOCHEM SCI, V15, P59, DOI 10.1016/0968-0004(90)90177-D; Pauly N, 2000, NATURE, V405, P754, DOI 10.1038/35015671; Pei ZM, 2000, NATURE, V406, P731, DOI 10.1038/35021067; POOVAIAH BW, 1993, CRIT REV PLANT SCI, V12, P185, DOI 10.1080/713608046; POOVAIAH BW, 1987, CRC CR REV PLANT SCI, V6, P47, DOI 10.1080/07352688709382247; POOVAIAH BW, 2002, PLANT ROOTS HIDDEN H, P505; QUAIL PH, 1994, CURR OPIN GENET DEV, V4, P652, DOI 10.1016/0959-437X(94)90131-L; Reddy ASN, 2000, BIOCHEM BIOPH RES CO, V279, P762, DOI 10.1006/bbrc.2000.4032; Reddy ASN, 2001, PLANT SCI, V160, P381, DOI 10.1016/S0168-9452(00)00386-1; REINBOTHE S, 1994, PLANT CELL, V6, P1197, DOI 10.1105/tpc.6.9.1197; ROBERTS DM, 1992, ANNU REV PLANT PHYS, V43, P375, DOI 10.1146/annurev.pp.43.060192.002111; Schmittgen TD, 2000, ANAL BIOCHEM, V285, P194, DOI 10.1006/abio.2000.4753; Schwechheimer C, 1998, ANNU REV PLANT PHYS, V49, P127, DOI 10.1146/annurev.arplant.49.1.127; Sedgwick SG, 1999, TRENDS BIOCHEM SCI, V24, P311, DOI 10.1016/S0968-0004(99)01426-7; SILVA ODE, 1994, PLANT MOL BIOL, V25, P921, DOI 10.1007/BF00028887; Snedden WA, 2001, NEW PHYTOL, V151, P35, DOI 10.1046/j.1469-8137.2001.00154.x; Stepanova AN, 2000, CURR OPIN PLANT BIOL, V3, P353, DOI 10.1016/S1369-5266(00)00096-0; Szymanski DB, 1996, PLANT CELL, V8, P1069, DOI 10.1105/tpc.8.6.1069; Tabata S, 2000, NATURE, V408, P823, DOI 10.1038/35048507; TERZAGHI WB, 1995, ANNU REV PLANT PHYS, V46, P61445; Trewavas AJ, 1997, PLANT CELL, V9, P1181, DOI 10.1105/tpc.9.7.1181; van der Luit AH, 1999, PLANT PHYSIOL, V121, P705, DOI 10.1104/pp.121.3.705; Wang ZP, 1998, PLANT J, V16, P515, DOI 10.1046/j.1365-313x.1998.00311.x; Yang T, 2002, P NATL ACAD SCI USA, V99, P4097, DOI 10.1073/pnas.052564899; Yang TB, 2000, J BIOL CHEM, V275, P3137, DOI 10.1074/jbc.275.5.3137; Yang TB, 2000, J BIOL CHEM, V275, P38467, DOI 10.1074/jbc.M003566200; Zegzouti H, 1999, PLANT J, V18, P589, DOI 10.1046/j.1365-313x.1999.00483.x; Zhu JK, 2001, CURR OPIN PLANT BIOL, V4, P401, DOI 10.1016/S1369-5266(00)00192-8; Zielinski RE, 1998, ANNU REV PLANT PHYS, V49, P697, DOI 10.1146/annurev.arplant.49.1.697	54	257	301	2	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 22	2002	277	47					45049	45058		10.1074/jbc.M207941200	http://dx.doi.org/10.1074/jbc.M207941200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	618EE	12218065	hybrid			2022-12-27	WOS:000179404800060
J	Kauppi, M; Wohlfahrt, G; Olkkonen, VM				Kauppi, M; Wohlfahrt, G; Olkkonen, VM			Analysis of the Munc18b-syntaxin binding interface - Use of a mutant Munc18b to dissect the functions of syntaxins 2 and 3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STIMULATED GLUT4 TRANSLOCATION; APICAL PLASMA-MEMBRANE; CANINE KIDNEY-CELLS; EPITHELIAL-CELLS; 3-DIMENSIONAL STRUCTURE; VESICLE TRAFFICKING; 3T3-L1 ADIPOCYTES; INTESTINAL-CELLS; SNARE COMPLEX; PROTEINS	Munc18b is a mammalian Sec1-related protein that is abundant in epithelial cells and regulates vesicle transport to the apical plasma membrane. We constructed a homology model of Munc18b in complex with syntaxin 3 based on the crystal structure of the neuronal Sec1-syntaxin 1A complex. In this model we identified all residues in the interface between the two proteins that contribute directly to the interaction and mutagenized residues in Munc18b to alter its binding to syntaxins 1A, 2, and 3. The syntaxin-binding properties of the mutants were tested using an in vitro assay and by a co-immuno-precipitation approach employing Munc18b expressed in CHO-K1 cells. Three Munc18b variants, W28S, S42K, and E59K, were generated that are defective in binding to all three syntaxins. A fourth mutant protein, S48D, shows abolishment of syntaxin 3 interaction but binds syntaxin 2 at normal and syntaxin 1A at mildly reduced efficiency. Over-expression of Munc18b S48D inhibited transport of influenza hemagglutinin to the apical surface of Madin-Darby canine kidney II cells, which express syntaxin 2 abundantly, but not of Caco-2 cells, in which syntaxin 3 is the major apical target SNARE (soluble NSF (N-ethylmaleimide sensitive factor) attachment protein receptors). This suggests that, although syntaxin 3 is the main target SNARE operating in exocytic transport to the apical plasma membrane in certain epithelial cell types, syntaxin 2 may play an important role in this trafficking route in others.	Natl Publ Hlth Inst, Dept Mol Med, Biomedicum, FIN-00251 Helsinki, Finland; Univ Cologne, Inst Biochem, D-50674 Cologne, Germany	Finland National Institute for Health & Welfare; University of Cologne	Olkkonen, VM (corresponding author), Natl Publ Hlth Inst, Dept Mol Med, Biomedicum, POB 104, FIN-00251 Helsinki, Finland.			Wohlfahrt, Gerd/0000-0003-0530-2000; Olkkonen, Vesa/0000-0001-5553-7997				AALTO MK, 1992, CELL, V68, P181, DOI 10.1016/0092-8674(92)90462-L; BENNETT MK, 1993, CELL, V74, P863, DOI 10.1016/0092-8674(93)90466-4; Bock JB, 2001, NATURE, V409, P839, DOI 10.1038/35057024; Bower MJ, 1997, J MOL BIOL, V267, P1268, DOI 10.1006/jmbi.1997.0926; Breuza L, 2000, AM J PHYSIOL-CELL PH, V279, pC1239, DOI 10.1152/ajpcell.2000.279.4.C1239; CASE DA, 1997, AMBER 5; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; Collaborative Computational Project, 1994, ACTA CRYST D, V50, P760; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Coppola T, 2002, MOL BIOL CELL, V13, P1906, DOI 10.1091/mbc.02-02-0025; Delgrossi MH, 1997, J CELL SCI, V110, P2207; Dulubova I, 1999, EMBO J, V18, P4372, DOI 10.1093/emboj/18.16.4372; Fernandez I, 1998, CELL, V94, P841, DOI 10.1016/S0092-8674(00)81742-0; Fletcher AI, 1999, J BIOL CHEM, V274, P4027, DOI 10.1074/jbc.274.7.4027; Galli T, 1998, MOL BIOL CELL, V9, P1437, DOI 10.1091/mbc.9.6.1437; Grusovin J, 2000, BIOCHEM J, V350, P741, DOI 10.1042/0264-6021:3500741; Halachmi N, 1996, J NEUROCHEM, V66, P889; HATA Y, 1995, J BIOL CHEM, V270, P13022, DOI 10.1074/jbc.270.22.13022; Jahn R, 2000, NEURON, V27, P201, DOI 10.1016/S0896-6273(00)00029-5; Jahn R, 1999, ANNU REV BIOCHEM, V68, P863, DOI 10.1146/annurev.biochem.68.1.863; KATAGIRI H, 1995, J BIOL CHEM, V270, P4963, DOI 10.1074/jbc.270.10.4963; KEE Y, 1995, NEURON, V14, P991, DOI 10.1016/0896-6273(95)90337-2; Khan AH, 2001, J BIOL CHEM, V276, P4063, DOI 10.1074/jbc.M007419200; Lafont F, 1999, P NATL ACAD SCI USA, V96, P3734, DOI 10.1073/pnas.96.7.3734; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lehtonen S, 1999, KIDNEY INT, V56, P815, DOI 10.1046/j.1523-1755.1999.00625.x; Low SH, 1998, J CELL BIOL, V141, P1503, DOI 10.1083/jcb.141.7.1503; Low SH, 1996, MOL BIOL CELL, V7, P2007, DOI 10.1091/mbc.7.12.2007; Misura KMS, 2000, NATURE, V404, P355, DOI 10.1038/35006120; Naren AP, 1997, NATURE, V390, P302, DOI 10.1038/36882; Okamoto M, 1997, J BIOL CHEM, V272, P31459, DOI 10.1074/jbc.272.50.31459; Pevsner J, 1996, J NEUROSCI RES, V45, P89, DOI 10.1002/(SICI)1097-4547(19960715)45:2<89::AID-JNR1>3.3.CO;2-K; Poirier MA, 1998, NAT STRUCT BIOL, V5, P765, DOI 10.1038/1799; Quinones B, 1999, J CELL SCI, V112, P4291; Reed GL, 1999, BLOOD, V93, P2617, DOI 10.1182/blood.V93.8.2617.408k19_2617_2626; Riento K, 1996, EUR J BIOCHEM, V239, P638, DOI 10.1111/j.1432-1033.1996.0638u.x; Riento K, 2000, J BIOL CHEM, V275, P13476, DOI 10.1074/jbc.275.18.13476; Riento K, 1998, J CELL SCI, V111, P2681; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; Rowe J, 2001, J CELL SCI, V114, P3323; Rowe J, 1999, J CELL SCI, V112, P1865; SCHOMBURG D, 1988, J MOL GRAPHICS, V6, P161, DOI 10.1016/0263-7855(88)80069-9; SHETTY KT, 1995, J NEUROCHEM, V64, P1988; SUOMALAINEN M, 1994, J VIROL, V68, P4879, DOI 10.1128/JVI.68.8.4879-4889.1994; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Tamori Y, 1998, J BIOL CHEM, V273, P19740, DOI 10.1074/jbc.273.31.19740; Tellam JT, 1997, J BIOL CHEM, V272, P6179, DOI 10.1074/jbc.272.10.6179; TELLAM JT, 1995, J BIOL CHEM, V270, P5857, DOI 10.1074/jbc.270.11.5857; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thurmond DC, 2000, EMBO J, V19, P3565, DOI 10.1093/emboj/19.14.3565; Thurmond DC, 1998, J BIOL CHEM, V273, P33876, DOI 10.1074/jbc.273.50.33876; Ungermann C, 1998, NATURE, V396, P543, DOI 10.1038/25069; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Verhage M, 1997, NEURON, V18, P453, DOI 10.1016/S0896-6273(00)81245-3; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X	55	28	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	2002	277	46					43973	43979		10.1074/jbc.M208315200	http://dx.doi.org/10.1074/jbc.M208315200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	615XE	12198139	hybrid			2022-12-27	WOS:000179272000058
J	Shackleton, S; Hamer, I; Foti, M; Zumwald, N; Maeder, C; Carpentier, JL				Shackleton, S; Hamer, I; Foti, M; Zumwald, N; Maeder, C; Carpentier, JL			Role of two dileucine-like motifs in insulin receptor anchoring to microvilli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELECTIN GLYCOPROTEIN LIGAND-1; GROWTH-FACTOR RECEPTOR; AP-1 CLATHRIN ADAPTER; SURFACE REDISTRIBUTION; TYROSINE KINASE; HIV-1 NEF; BETA(2)-ADRENERGIC RECEPTOR; INTERNALIZATION SIGNALS; DIFFERENTIAL REGULATION; JUXTAMEMBRANE REGION	In the absence of ligand, the insulin receptor is maintained on microvilli on the cell surface. A dileucine-like motif (LL986-987) is necessary but not sufficient for this anchoring, which also required the presence of additional sequence(s) downstream of position 1000. The aim of the present study was to identify this (these) additional sequence(s). First, exons 16 or 17 were fused to the extracellular and transmembrane domains of complement receptor 1 and stably expressed in Chinese hamster ovary cells. Results obtained indicate that exon 17 is sufficient for anchoring to microvilli. Second, analysis of insulin receptor mutants truncated within exon 17 demonstrated that whereas receptors truncated at position 1000 showed no preferential association with microvilli, receptors truncated at position 1012 displayed a level of association identical to that of the full-length insulin receptor. Third, mutation of a diisoleucine motif (II1006-1007) present within this 12-amino acid stretch abrogated the preferential association of the receptor with microvilli. These results indicate that the domain required for association of insulin receptor with microvilli is contained within the region encoded by exon 17 and that, within this sequence, two dileucine-like motifs (LL986-987 and II1006-1007) play a crucial role.	Univ Geneva, Fac Med, Dept Morphol, CH-1211 Geneva 4, Switzerland	University of Geneva	Carpentier, JL (corresponding author), CMU, Fac Med, Dept Morphol, Rue Michel Servet 1, CH-1211 Geneva 4, Switzerland.			Foti, Michelangelo/0000-0001-7199-4135				Abitorabi MA, 1997, J CELL BIOL, V139, P563, DOI 10.1083/jcb.139.2.563; Accola MA, 1999, J VIROL, V73, P9992, DOI 10.1128/JVI.73.12.9992-9999.1999; AIKEN C, 1994, CELL, V76, P853, DOI 10.1016/0092-8674(94)90360-3; BACKER JM, 1992, J CELL BIOL, V118, P831, DOI 10.1083/jcb.118.4.831; BACKER JM, 1990, J BIOL CHEM, V265, P16450; BERLIN C, 1995, CELL, V80, P413, DOI 10.1016/0092-8674(95)90491-3; Bresnahan PA, 1998, CURR BIOL, V8, P1235, DOI 10.1016/S0960-9822(07)00517-9; BRETSCHER A, 1991, ANNU REV CELL BIOL, V7, P337, DOI 10.1146/annurev.cb.07.110191.002005; BROWN MS, 1983, CELL, V32, P663, DOI 10.1016/0092-8674(83)90052-1; Bruehl RE, 1997, J LEUKOCYTE BIOL, V61, P489, DOI 10.1002/jlb.61.4.489; CARPENTIER JL, 1993, HISTOCHEMISTRY, V100, P169, DOI 10.1007/BF00269090; CARPENTIER JL, 1992, P NATL ACAD SCI USA, V89, P162, DOI 10.1073/pnas.89.1.162; CARPENTIER JL, 1987, J CELL BIOL, V105, P2751, DOI 10.1083/jcb.105.6.2751; CARPENTIER JL, 1994, DIABETOLOGIA, V37, pS117, DOI 10.1007/BF00400835; CARPENTIER JL, 1981, J CELL BIOL, V91, P17, DOI 10.1083/jcb.91.1.17; CARPENTIER JL, 1995, J BIOL CHEM, V270, P5001, DOI 10.1074/jbc.270.10.5001; CARPENTIER JL, 1985, DIABETES, V34, P1002, DOI 10.2337/diabetes.34.10.1002; CARPENTIER JL, 1978, J CLIN INVEST, V61, P1056; CONDEELIS J, 1993, ANNU REV CELL BIOL, V9, P411, DOI 10.1146/annurev.cb.09.110193.002211; Craig HM, 2000, VIROLOGY, V271, P9, DOI 10.1006/viro.2000.0277; DEDIEGO JG, 1991, ENDOCRINOLOGY, V128, P2136, DOI 10.1210/endo-128-4-2136; DENHARTIGH JC, 1992, J CELL BIOL, V119, P349, DOI 10.1083/jcb.119.2.349; ERLANDSEN SL, 1993, J HISTOCHEM CYTOCHEM, V41, P327, DOI 10.1177/41.3.7679125; FAN JY, 1982, P NATL ACAD SCI-BIOL, V79, P7788, DOI 10.1073/pnas.79.24.7788; Foti M, 2002, P NATL ACAD SCI USA, V99, P2008, DOI 10.1073/pnas.042689099; Gabilondo AM, 1997, P NATL ACAD SCI USA, V94, P12285, DOI 10.1073/pnas.94.23.12285; Greenberg M, 1998, CURR BIOL, V8, P1239, DOI 10.1016/S0960-9822(07)00518-0; GUSTAFSON TA, 1995, MOL CELL BIOL, V15, P2500; HAFT CR, 1994, J BIOL CHEM, V269, P26286; Hamer I, 1997, J BIOL CHEM, V272, P21685, DOI 10.1074/jbc.272.35.21685; Hamer I, 2002, DIABETOLOGIA, V45, P657, DOI 10.1007/s00125-002-0798-5; Hamer I, 1998, BIOCHEM J, V329, P183, DOI 10.1042/bj3290183; Heilker R, 1996, EMBO J, V15, P2893, DOI 10.1002/j.1460-2075.1996.tb00650.x; Hubbard SR, 1997, EMBO J, V16, P5572, DOI 10.1093/emboj/16.18.5572; HUBBARD SR, 1994, NATURE, V372, P746, DOI 10.1038/372746a0; Kawakami K, 2001, J BIOL CHEM, V276, P25114, DOI 10.1074/jbc.M100936200; Kil SJ, 1999, J BIOL CHEM, V274, P3141, DOI 10.1074/jbc.274.5.3141; Kil SJ, 2000, J CELL PHYSIOL, V185, P47, DOI 10.1002/1097-4652(200010)185:1<47::AID-JCP4>3.3.CO;2-F; Kirchhausen T, 1997, CURR OPIN CELL BIOL, V9, P488, DOI 10.1016/S0955-0674(97)80024-5; Le Borgne R, 1998, BBA-MOL CELL RES, V1404, P195, DOI 10.1016/S0167-4889(98)00057-3; LETOURNEUR F, 1992, CELL, V69, P1143, DOI 10.1016/0092-8674(92)90636-Q; Louvard D, 1989, CURR OPIN CELL BIOL, V1, P51, DOI 10.1016/S0955-0674(89)80036-5; LUTON F, 1994, J IMMUNOL, V153, P63; MADI N, 1991, CLIN EXP IMMUNOL, V84, P9; MATTER K, 1994, J CELL BIOL, V126, P991, DOI 10.1083/jcb.126.4.991; McPherson PS, 2001, TRAFFIC, V2, P375, DOI 10.1034/j.1600-0854.2001.002006375.x; MOORE KL, 1995, J CELL BIOL, V128, P661, DOI 10.1083/jcb.128.4.661; OHNO H, 1995, SCIENCE, V269, P1872, DOI 10.1126/science.7569928; Orsini MJ, 1999, J BIOL CHEM, V274, P31076, DOI 10.1074/jbc.274.43.31076; PACCAUD JP, 1993, J BIOL CHEM, V268, P23191; PACCAUD JP, 1992, J BIOL CHEM, V267, P13101; PAVALKO FM, 1995, J CELL BIOL, V129, P1155, DOI 10.1083/jcb.129.4.1155; PICKER LJ, 1991, CELL, V66, P921, DOI 10.1016/0092-8674(91)90438-5; RAJAGOPALAN M, 1991, J BIOL CHEM, V266, P23068; Signoret N, 1998, J CELL SCI, V111, P2819; Subtil A, 1998, J BIOL CHEM, V273, P29424, DOI 10.1074/jbc.273.45.29424; TARTAREDECKERT S, 1995, J BIOL CHEM, V270, P23456, DOI 10.1074/jbc.270.40.23456; Tikkanen R, 2000, TRAFFIC, V1, P631, DOI 10.1034/j.1600-0854.2000.010807.x; Tsukita S, 1997, TRENDS BIOCHEM SCI, V22, P53, DOI 10.1016/S0968-0004(96)10071-2; Wu Z, 2001, J BIOL CHEM, V276, P5240, DOI 10.1074/jbc.M006684200; Wyss S, 2001, J VIROL, V75, P2982, DOI 10.1128/JVI.75.6.2982-2992.2001; YAMADA K, 1995, BIOCHEMISTRY-US, V34, P946, DOI 10.1021/bi00003a029; Zhang J, 1997, J BIOL CHEM, V272, P27005, DOI 10.1074/jbc.272.43.27005; Zhu YX, 2001, SCIENCE, V292, P1716, DOI 10.1126/science.1060896	64	6	6	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	2002	277	46					43631	43637		10.1074/jbc.M204036200	http://dx.doi.org/10.1074/jbc.M204036200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	615XE	12218050	hybrid			2022-12-27	WOS:000179272000014
J	Bebok, Z; Varga, K; Hicks, JK; Venglarik, CJ; Kovacs, T; Chen, L; Hardiman, KM; Collawn, JF; Sorscher, EJ; Matalon, S				Bebok, Z; Varga, K; Hicks, JK; Venglarik, CJ; Kovacs, T; Chen, L; Hardiman, KM; Collawn, JF; Sorscher, EJ; Matalon, S			Reactive oxygen nitrogen species decrease cystic fibrosis transmembrane conductance regulator expression and cAMP-mediated Cl- secretion in airway epithelia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SURFACTANT PROTEIN-A; RESPIRATORY-DISTRESS SYNDROME; EXHALED NITRIC-OXIDE; ACUTE LUNG INJURY; APICAL MEMBRANE; ALVEOLAR MACROPHAGES; TYROSINE NITRATION; CHLORIDE CHANNELS; SMOOTH-MUSCLE; CYCLIC-GMP	We investigated putative mechanisms by which nitric oxide modulates cystic fibrosis transmembrane conductance regulator (CFTR) expression and function in epithelial cells. Immunoprecipitation followed by Western blotting, as well as immunocytochemical and cell surface biotinylation measurements, showed that incubation of both stably transduced (HeLa) and endogenous CFTR expressing (16HBE14o-, Calu-3, and mouse tracheal epithelial) cells with 100 muM diethylenetriamine NONOate (DETA NONOate) for 24-96 h decreased both intracellular and apical CFTR levels. Calu-3 and mouse tracheal epithelial cells, incubated with DETA NONOate but not with 100 lim 8-bromo-cGMP for 96 h, exhibited reduced cAMP-activated short circuit currents when mounted in Ussing chambers. Exposure of Calu-3 cells to nitric oxide donors resulted in the nitration of a number of proteins including CFTR. Nitration was augmented by proteasome inhibition, suggesting a role for the proteasome in the degradation of nitrated proteins. Our studies demonstrate that levels of nitric oxide that are likely to be encountered in the vicinity of airway cells during inflammation may nitrate CFTR resulting in enhanced degradation and decreased function. Decreased levels and function of normal CFTR may account for some of the cystic fibrosis-like symptoms that occur in chronic inflammatory lung diseases associated with increased NO production.	Univ Alabama, Dept Anesthesiol, Birmingham, AL 35205 USA; Univ Alabama, Dept Med, Birmingham, AL 35233 USA; Univ Alabama, Dept Cell Biol, Birmingham, AL 35233 USA; Univ Alabama, Dept Environm Hlth Sci, Birmingham, AL 35233 USA; Univ Alabama, Dept Anesthesiol, Birmingham, AL 35233 USA; Univ Alabama, Gregory Fleming James Cyst Fibrosis Res Ctr, Birmingham, AL 35233 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Matalon, S (corresponding author), Univ Alabama, Dept Anesthesiol, 901 19th St S,BMR 2,Rm 224, Birmingham, AL 35205 USA.			Sorscher, Eric J./0000-0001-9341-3354; Collawn, James/0000-0002-2528-2759	NHLBI NIH HHS [HL31197, HL51173] Funding Source: Medline; NIDDK NIH HHS [P30 DK54781, P50 DK53090] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL031197, R01HL031197] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK054781, P50DK053090] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDERSON MP, 1992, AM J PHYSIOL, V263, pL1, DOI 10.1152/ajplung.1992.263.1.L1; Bebok Z, 1998, J BIOL CHEM, V273, P29873, DOI 10.1074/jbc.273.45.29873; BEBOK Z, 2002, AM J RESP CRIT CARE, V163, pA842; BEBOK Z, 1999, PED PULM S, V19; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; BECKMANN JS, 1994, BIOL CHEM H-S, V375, P81, DOI 10.1515/bchm3.1994.375.2.81; BOLOTINA VM, 1994, NATURE, V368, P850, DOI 10.1038/368850a0; BRUNNER F, 1995, FEBS LETT, V376, P262, DOI 10.1016/0014-5793(95)01297-X; Buchczyk DP, 2000, BIOL CHEM, V381, P121, DOI 10.1515/BC.2000.017; CLARKE LL, 1992, AM J PHYSIOL, V263, pL519, DOI 10.1152/ajplung.1992.263.5.L519; Davis PB, 1996, AM J RESP CRIT CARE, V154, P1229, DOI 10.1164/ajrccm.154.5.8912731; De Andrade JA, 2000, AM J RESP CRIT CARE, V161, P2035, DOI 10.1164/ajrccm.161.6.9907001; Eiserich JP, 1998, NATURE, V391, P393, DOI 10.1038/34923; Gaston B, 1999, BBA-BIOENERGETICS, V1411, P323, DOI 10.1016/S0005-2728(99)00023-7; Gole MD, 2000, AM J PHYSIOL-LUNG C, V278, pL961, DOI 10.1152/ajplung.2000.278.5.L961; Greis KD, 1996, ARCH BIOCHEM BIOPHYS, V335, P396, DOI 10.1006/abbi.1996.0522; Grune T, 1998, J BIOL CHEM, V273, P10857, DOI 10.1074/jbc.273.18.10857; Guo Y, 1998, AM J PHYSIOL-LUNG C, V274, pL369, DOI 10.1152/ajplung.1998.274.3.L369; GUPTA S, 1995, BRIT J PHARMACOL, V116, P2201, DOI 10.1111/j.1476-5381.1995.tb15054.x; HADDAD IY, 1994, J CLIN INVEST, V94, P2407, DOI 10.1172/JCI117607; Hickman-Davis J, 1999, P NATL ACAD SCI USA, V96, P4953, DOI 10.1073/pnas.96.9.4953; Hickman-Davis JM, 2002, AM J PHYSIOL-LUNG C, V282, pL944, DOI 10.1152/ajplung.00216.2001; HUSAIN M, 1994, CIRCULATION, V89, P2498, DOI 10.1161/01.CIR.89.6.2498; HYDE SC, 1990, NATURE, V346, P362, DOI 10.1038/346362a0; Ignarro LJ, 1999, J CARDIOVASC PHARM, V34, P879, DOI 10.1097/00005344-199912000-00016; Ischiropoulos H, 1998, ARCH BIOCHEM BIOPHYS, V356, P1, DOI 10.1006/abbi.1998.0755; ISCHIROPOULOS H, 1992, ARCH BIOCHEM BIOPHYS, V298, P446, DOI 10.1016/0003-9861(92)90433-W; Jain L, 1998, AM J PHYSIOL-LUNG C, V274, pL475, DOI 10.1152/ajplung.1998.274.4.L475; Jilling T, 1999, AM J PHYSIOL-LUNG C, V277, pL89, DOI 10.1152/ajplung.1999.277.1.L89; KNOWLES MR, 1983, SCIENCE, V221, P1067, DOI 10.1126/science.6308769; KOIVISTO A, 1993, PFLUG ARCH EUR J PHY, V425, P549, DOI 10.1007/BF00374884; Lei DC, 1996, GENE THER, V3, P427; LIGHT DB, 1990, NATURE, V344, P336, DOI 10.1038/344336a0; LIPTON SA, 1993, NATURE, V364, P626, DOI 10.1038/364626a0; MALINSKI T, 1993, J CEREBR BLOOD F MET, V13, P355, DOI 10.1038/jcbfm.1993.48; Meacham GC, 1999, EMBO J, V18, P1492, DOI 10.1093/emboj/18.6.1492; Meng QH, 2000, J PATHOL, V190, P126, DOI 10.1002/(SICI)1096-9896(200002)190:2<126::AID-PATH500>3.0.CO;2-#; MORENO JJ, 1992, CHEM RES TOXICOL, V5, P425, DOI 10.1021/tx00027a017; MORRIS AP, 1994, AM J PHYSIOL, V266, pC254, DOI 10.1152/ajpcell.1994.266.1.C254; Nielsen VG, 2000, AM J RESP CRIT CARE, V161, P1154, DOI 10.1164/ajrccm.161.4.9907033; Paxinou E, 2001, J NEUROSCI, V21, P8053, DOI 10.1523/JNEUROSCI.21-20-08053.2001; Pilewski Joseph M., 1999, Physiological Reviews, V79, pS215; PUNJABI CJ, 1994, AM J RESP CELL MOL, V11, P165, DOI 10.1165/ajrcmb.11.2.7519435; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; SCHWIEBERT EM, 1995, CELL, V81, P1063, DOI 10.1016/S0092-8674(05)80011-X; Sittipunt C, 2001, AM J RESP CRIT CARE, V163, P503, DOI 10.1164/ajrccm.163.2.2004187; Stamler J S, 1995, Curr Top Microbiol Immunol, V196, P19; STOOS BA, 1994, J AM SOC NEPHROL, V4, P1855; STUTTS MJ, 1995, SCIENCE, V269, P847, DOI 10.1126/science.7543698; vanderVliet A, 1997, J BIOL CHEM, V272, P7617, DOI 10.1074/jbc.272.12.7617; Weinberger B, 1999, PHARMACOL THERAPEUT, V84, P401, DOI 10.1016/S0163-7258(99)00044-3; WIZEMANN TM, 1994, J LEUKOCYTE BIOL, V56, P759, DOI 10.1002/jlb.56.6.759; Yates DH, 2001, IMMUNOL CELL BIOL, V79, P178, DOI 10.1046/j.1440-1711.2001.00990.x; Zhang YM, 2001, MOL BIOL CELL, V12, P1303, DOI 10.1091/mbc.12.5.1303; Zhu S, 2001, AM J RESP CRIT CARE, V163, P166, DOI 10.1164/ajrccm.163.1.2005068; Zhu S, 1998, AM J PHYSIOL-LUNG C, V275, pL1031, DOI 10.1152/ajplung.1998.275.6.L1031; Zhu S, 2000, AM J PHYSIOL-LUNG C, V278, pL1025, DOI 10.1152/ajplung.2000.278.5.L1025	58	72	74	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					43041	43049		10.1074/jbc.M203154200	http://dx.doi.org/10.1074/jbc.M203154200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12194970	hybrid			2022-12-27	WOS:000179081200081
J	Ceccarelli, C; Grodsky, NB; Ariyaratne, N; Colman, RF; Bahnson, BJ				Ceccarelli, C; Grodsky, NB; Ariyaratne, N; Colman, RF; Bahnson, BJ			Crystal structure of porcine mitochondrial NADP(+)-dependent isocitrate dehydrogenase complexed with Mn2+ and isocitrate - Insights into the enzyme mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PIG-HEART; BINDING-SITE; SUBSTRATE-SPECIFICITY; MAGNETIC-RESONANCE; SEQUENCE ALIGNMENT; MANGANOUS ION; ACTIVE-SITE; METAL-IONS; PROTEIN; PHOSPHORYLATION	The crystal structure of porcine heart mitochondrial NADP(+)-dependent isocitrate dehydrogenase (IDH) complexed with Mn2+ and isocitrate was solved to a resolution of 1.85 Angstrom. The enzyme was expressed in Escherichia coli, purified as a fusion protein with maltose binding protein, and cleaved with thrombin to yield homogeneous enzyme. The structure was determined by multi-wavelength anomalous diffraction phasing using selenium substitution in the form of selenomethionine as the anomalous scatterer. The porcine NADP(+)-IDH enzyme is structurally compared with the previously solved structures of IDH from E. coli and Bacillus subtilis that share 16 and 17% identity, respectively, with the mammalian enzyme. The porcine enzyme has a protein fold similar to the bacterial IDH structures with each monomer folding into two domains. However, considerable differences exist between the bacterial and mammalian forms of IDH in regions connecting core secondary structure. Based on the alignment of sequence and structure among the porcine, E. coli, and R subtilis IDH, a putative phosphorylation site has been identified for the mammalian enzyme. The active site, including the bound Mn2+-isocitrate complex, is highly ordered and, therefore, mechanistically informative. The consensus IDH mechanism predicts that the Mn2+-bound hydroxyl of isocitrate is deprotonated prior to its NADP(+)-dependent oxidation. The present crystal structure has an active site water that is well positioned to accept the proton and ultimately transfer the proton to solvent through an additional bound water.	Univ Delaware, Dept Chem & Biochem, Newark, DE 19716 USA	University of Delaware	Bahnson, BJ (corresponding author), Univ Delaware, Dept Chem & Biochem, Newark, DE 19716 USA.	bahnson@udel.edu			NHLBI NIH HHS [HL67774] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067774] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Allen F.H., 1993, CHEM DESIGN AUTOMATI, V8, P31; ALTSCHUL SF, 1991, J MOL BIOL, V219, P555, DOI 10.1016/0022-2836(91)90193-A; BAILEY JM, 1987, BIOCHEMISTRY-US, V26, P4893, DOI 10.1021/bi00389a042; BAILEY JM, 1985, BIOCHEMISTRY-US, V24, P5367, DOI 10.1021/bi00341a015; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARTON GJ, 1993, PROTEIN ENG, V6, P37, DOI 10.1093/protein/6.1.37; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cherbavaz DB, 2000, J MOL BIOL, V295, P377, DOI 10.1006/jmbi.1999.3195; COLMAN RF, 1973, J BIOL CHEM, V248, P8137; COLMAN RF, 1972, J BIOL CHEM, V247, P215; COLMAN RF, 1983, PEPTIDE PROTEIN REV, V1, P41; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Doyle SA, 2001, BIOCHEMISTRY-US, V40, P4234, DOI 10.1021/bi002533q; EHRLICH RS, 1990, BIOCHEMISTRY-US, V29, P5179, DOI 10.1021/bi00473a026; EHRLICH RS, 1983, J BIOL CHEM, V258, P7079; EHRLICH RS, 1981, J BIOL CHEM, V256, P1276; EHRLICH RS, 1982, J BIOL CHEM, V257, P4769; EHRLICH RS, 1989, BIOCHEMISTRY-US, V28, P2058, DOI 10.1021/bi00431a014; FinerMoore J, 1997, BIOCHEMISTRY-US, V36, P13890, DOI 10.1021/bi9711691; Grodsky NB, 2000, BIOCHEMISTRY-US, V39, P2193, DOI 10.1021/bi9919753; HASELBECK RJ, 1992, BIOCHEMISTRY-US, V31, P6219, DOI 10.1021/bi00142a007; HENDRICKSON WA, 1991, SCIENCE, V254, P51, DOI 10.1126/science.1925561; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Huang YC, 2002, BIOCHEMISTRY-US, V41, P5637, DOI 10.1021/bi0200716; HURLEY JH, 1989, P NATL ACAD SCI USA, V86, P8635, DOI 10.1073/pnas.86.22.8635; HURLEY JH, 1991, BIOCHEMISTRY-US, V30, P8671, DOI 10.1021/bi00099a026; Jo SH, 2001, J BIOL CHEM, V276, P16168, DOI 10.1074/jbc.M010120200; JOHANSON RA, 1981, ARCH BIOCHEM BIOPHYS, V207, P9, DOI 10.1016/0003-9861(81)90002-3; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; JONES TA, 1992, CCP4 STUDY WEEKEND 1, P91; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KELLERMANN OK, 1982, METHOD ENZYMOL, V90, P459; KELLY JH, 1981, J BIOL CHEM, V256, P330; Kleywegt GJ, 1997, STRUCTURE, V5, P1557, DOI 10.1016/S0969-2126(97)00305-5; Kleywegt GJ, 1997, METHOD ENZYMOL, V277, P208, DOI 10.1016/S0076-6879(97)77013-7; KLEYWEGT GJ, 1994, CCP4 P, P59; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Levitt DG, 2001, ACTA CRYSTALLOGR D, V57, P1013, DOI 10.1107/S0907444901006394; MAS MT, 1984, BIOCHEMISTRY-US, V23, P1675, DOI 10.1021/bi00303a015; NORTHROP DB, 1974, J BIOL CHEM, V249, P2928; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; RUSSELL RB, 1992, PROTEINS, V14, P309, DOI 10.1002/prot.340140216; Singh SK, 2002, J BIOL CHEM, V277, P7567, DOI 10.1074/jbc.M107908200; Singh SK, 2001, J BIOL CHEM, V276, P26154, DOI 10.1074/jbc.M101191200; Soundar S, 2000, J BIOL CHEM, V275, P5606, DOI 10.1074/jbc.275.8.5606; Soundar S, 1996, PROTEIN EXPRES PURIF, V8, P305, DOI 10.1006/prep.1996.0105; STODDARD BL, 1993, BIOCHEMISTRY-US, V32, P9310, DOI 10.1021/bi00087a008; STODDARD BL, 1993, BIOCHEMISTRY-US, V32, P9317, DOI 10.1021/bi00087a009; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P1872, DOI 10.1107/S090744499901029X; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; THORSNESS PE, 1987, J BIOL CHEM, V262, P10422; VANDERHELM D, 1968, ACTA CRYSTALL B-STRU, VB 24, P578, DOI 10.1107/S0567740868002864; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; VILLAFRANCA JJ, 1972, J BIOL CHEM, V247, P209	58	93	95	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					43454	43462		10.1074/jbc.M207306200	http://dx.doi.org/10.1074/jbc.M207306200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12207025	hybrid			2022-12-27	WOS:000179081200130
J	Huang, HC; Nguyen, T; Pickett, CB				Huang, HC; Nguyen, T; Pickett, CB			Phosphorylation of Nrf2 at Ser-40 by protein kinase C regulates antioxidant response element-mediated transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEME OXYGENASE-1 GENE; ARYL-HYDROCARBON RECEPTOR; HUMAN NEUROBLASTOMA-CELLS; YA-SUBUNIT GENE; INDUCIBLE EXPRESSION; PHOSPHATIDYLINOSITOL 3-KINASE; FUNCTIONAL-CHARACTERIZATION; NF-E2-RELATED FACTOR-2; TERT-BUTYLHYDROQUINONE; PHENOLIC ANTIOXIDANTS	Nrf2, a basic leucine zipper transcription factor, is an essential activator of the coordinated transcription of genes encoding antioxidant enzymes and phase 11 detoxifying enzymes through the regulatory sequence termed antioxidant response element (ARE). Recently we reported evidence for the involvement of protein kinase C (PKC) in phosphorylating Nrf2 and triggering its nuclear translocation in response to oxidative stress. We show here that phosphorylation of purified rat Nrf2 by the catalytic subunit of PKC was blocked by a synthetic peptide mimicking one of the potential PKC sites. Accordingly, Nrf2 bearing a Ser to Ala mutation at amino acid 40 (S40A) could not be phosphorylated by PKC. The S40A mutation did not affect in vitro binding of Nrf2/MafK to the ARE. However, it partially impaired Nrf2 activation of ARE-driven transcription in a reporter gene assay when Keap1 was overexpressed. In vitro transcribed/translated Keap1 could be coimmunoprecipitated with Nrf2. Phosphorylation of wild-type Nrf2 by PKC promoted its dissociation from Keap1, whereas the Nrf2-S40A mutant remained associated. These findings together with our prior studies suggest that the PKC-catalyzed phosphorylation. of Nrf2 at Ser-40 is a critical signaling event leading to ARE-mediated cellular antioxidant response.	Schering Plough Res Inst, Kenilworth, NJ 07033 USA	Merck & Company; Schering-Plough Research Institute	Pickett, CB (corresponding author), Schering Plough Res Inst, 2015 Galloping Hill Rd, Kenilworth, NJ 07033 USA.							Alam J, 2000, J BIOL CHEM, V275, P27694; Alam J, 1999, J BIOL CHEM, V274, P26071, DOI 10.1074/jbc.274.37.26071; Chen YH, 1996, J BIOL CHEM, V271, P26261, DOI 10.1074/jbc.271.42.26261; Dhakshinamoorthy S, 2001, ONCOGENE, V20, P3906, DOI 10.1038/sj.onc.1204506; Dhakshinamoorthy S, 2000, J BIOL CHEM, V275, P40134, DOI 10.1074/jbc.M003531200; FAVREAU LV, 1991, J BIOL CHEM, V266, P4556; FRILING RS, 1990, P NATL ACAD SCI USA, V87, P6258, DOI 10.1073/pnas.87.16.6258; GOPALAKRISHNA R, 1994, P NATL ACAD SCI USA, V91, P12233, DOI 10.1073/pnas.91.25.12233; Gopalakrishna R, 2000, FREE RADICAL BIO MED, V28, P1349, DOI 10.1016/S0891-5849(00)00221-5; He CH, 2001, J BIOL CHEM, V276, P20858, DOI 10.1074/jbc.M101198200; Huang HC, 2000, P NATL ACAD SCI USA, V97, P12475, DOI 10.1073/pnas.220418997; IGARASHI K, 1994, NATURE, V367, P568, DOI 10.1038/367568a0; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Jain N, 1999, J BIOL CHEM, V274, P24392, DOI 10.1074/jbc.274.34.24392; Kang KW, 2000, MOL PHARMACOL, V58, P1017, DOI 10.1124/mol.58.5.1017; Kang KW, 2001, MOL PHARMACOL, V59, P1147, DOI 10.1124/mol.59.5.1147; Katoh Y, 2001, GENES CELLS, V6, P857, DOI 10.1046/j.1365-2443.2001.00469.x; Kwak MK, 2001, MOL MED, V7, P135, DOI 10.1007/BF03401947; Lee JM, 2001, BIOCHEM BIOPH RES CO, V280, P286, DOI 10.1006/bbrc.2000.4106; Lee JM, 2001, J BIOL CHEM, V276, P20011, DOI 10.1074/jbc.M100734200; LI Y, 1992, J BIOL CHEM, V267, P15097; Long WP, 1999, J BIOL CHEM, V274, P12391, DOI 10.1074/jbc.274.18.12391; McMahon M, 2001, CANCER RES, V61, P3299; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; MOI P, 1994, P NATL ACAD SCI USA, V91, P9926, DOI 10.1073/pnas.91.21.9926; Montano MM, 2000, J BIOL CHEM, V275, P34306, DOI 10.1074/jbc.M003880200; Nguyen T, 2000, J BIOL CHEM, V275, P15466, DOI 10.1074/jbc.M000361200; RUSHMORE TH, 1990, J BIOL CHEM, V265, P14648; Sekhar KR, 2002, FREE RADICAL BIO MED, V32, P650, DOI 10.1016/S0891-5849(02)00755-4; Sun XG, 2000, J BIOL CHEM, V275, P7470, DOI 10.1074/jbc.275.11.7470; Wild AC, 1999, J BIOL CHEM, V274, P33627, DOI 10.1074/jbc.274.47.33627; Yu R, 1999, J BIOL CHEM, V274, P27545, DOI 10.1074/jbc.274.39.27545; Yu R, 2000, J BIOL CHEM, V275, P2322, DOI 10.1074/jbc.275.4.2322; Yu R, 2000, J BIOL CHEM, V275, P39907, DOI 10.1074/jbc.M004037200; Zhu M, 2001, BIOCHEM BIOPH RES CO, V289, P212, DOI 10.1006/bbrc.2001.5944; Zipper LM, 2000, BIOCHEM BIOPH RES CO, V278, P484, DOI 10.1006/bbrc.2000.3830	37	774	799	1	54	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					42769	42774		10.1074/jbc.M206911200	http://dx.doi.org/10.1074/jbc.M206911200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12198130	hybrid			2022-12-27	WOS:000179081200046
J	McCole, DF; Keely, SJ; Coffey, RJ; Barrett, KE				McCole, DF; Keely, SJ; Coffey, RJ; Barrett, KE			Transactivation of the epidermal growth factor receptor in colonic epithelial cells by carbachol requires extracellular release of transforming growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; DEPENDENT CHLORIDE SECRETION; MUSCARINIC ACETYLCHOLINE-RECEPTOR; EGF RECEPTOR; COUPLED RECEPTORS; FACTOR-ALPHA; T-84 CELLS; TGF-ALPHA; INHIBITION; TRANSPORT	We have shown previously that the muscarinic agonist, carbachol (CCh), transactivates the epidermal growth factor receptor (EGFr) via calmodulin, Pyk-2, and Src kinase activation. EGFr phosphorylation causes extracellular signal-regulated kinase (ERK) activation and inhibits CCh-stimulated chloride secretion across intestinal epithelial cells. Here we investigated whether CCh-stimulated EGFr transactivation involves EGFr ligand release. Pre-incubation of T-84 cell monolayers with a neutralizing antibody to the EGFr ligand binding domain decreased CCh-induced phosphorylation of EGFr and ERK. CCh-stimulated efflux of Rb-86(+) from T-84 cell monolayers, which parallels changes in chloride secretion, was potentiated by anti-EGFr pre-incubation. AntiEGFr did not reduce CCh-stimulated Pyk-2 phosphorylation. Co-incubation with the Src kinase inhibitor PP2 and anti-EGFr had an additive inhibitory effect on CCh-induced ERK phosphorylation greater than either inhibitor alone. CCh caused the basolateral release of transforming growth factor a (TGF-alpha) into T-84 cell bathing media. A metalloproteinase inhibitor, WAY171318, reduced CCh-induced phosphorylation of ERK and completely blocked EGFr phosphorylation and TGF-alpha release. We conclude that CCh-stimulated EGFr transactivation and subsequent ERK activation, a pathway that limits CCh-induced chloride secretion, is mediated by metalloproteinase-dependent extracellular release of TGF-a and intracellular Src activation. These findings have important implications for our understanding of the role of growth factors in regulating epithelial ion secretion.	Univ Calif San Diego, Med Ctr, Sch Med, Div Gastroenterol,Dept Med, San Diego, CA 92103 USA; Vanderbilt Univ, Med Ctr, Nashville, TN 37232 USA; Vet Affairs Med Ctr, Nashville, TN 37232 USA	University of California System; University of California San Diego; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Barrett, KE (corresponding author), Univ Calif San Diego, Med Ctr, Sch Med, Div Gastroenterol,Dept Med, 8414,200 W Arbor Dr, San Diego, CA 92103 USA.		McCole, Declan/AAL-2454-2020; Barrett, Kim/AAE-2794-2022; Barrett, Kim Elaine/AAE-7762-2019	Barrett, Kim Elaine/0000-0002-6704-998X; Keely, Stephen/0000-0002-6315-3587	NCI NIH HHS [CA46413] Funding Source: Medline; NIDDK NIH HHS [DK28305] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA046413] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK028305] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adomeit A, 1999, MOL CELL BIOL, V19, P5289; Babyatsky MW, 1996, GASTROENTEROLOGY, V110, P975, DOI 10.1053/gast.1996.v110.pm8613031; BARNARD JA, 1995, GASTROENTEROLOGY, V108, P564, DOI 10.1016/0016-5085(95)90087-X; Barrett K.E.., 1999, ELECTROLYTE SECRETIO; Barrett KE, 1998, AM J PHYSIOL-CELL PH, V274, pC958, DOI 10.1152/ajpcell.1998.274.4.C958; BERSCHNEIDER HM, 1988, FASEB J, V2, P2625, DOI 10.1096/fasebj.2.10.2838365; CARPENTER G, 2000, SCI STKE, V15, pPE1; CARTLIDGE SA, 1989, BRIT J CANCER, V60, P657, DOI 10.1038/bjc.1989.334; Chang N, 2001, AM J PHYSIOL-GASTR L, V281, pG129, DOI 10.1152/ajpgi.2001.281.1.G129; Chow JYC, 2000, J BIOL CHEM, V275, P21169, DOI 10.1074/jbc.M002160200; Cunnick JM, 1998, J BIOL CHEM, V273, P14468, DOI 10.1074/jbc.273.23.14468; Damstrup L, 1999, BRIT J CANCER, V80, P1012, DOI 10.1038/sj.bjc.6690456; Daub H, 1996, NATURE, V379, P557, DOI 10.1038/379557a0; DEMPSEY PJ, 1994, J BIOL CHEM, V269, P16878; DEVOR DC, 1992, AM J PHYSIOL, V263, pC780, DOI 10.1152/ajpcell.1992.263.4.C780; Dignass AU, 2001, EUR J GASTROEN HEPAT, V13, P763, DOI 10.1097/00042737-200107000-00002; Dong JY, 1999, P NATL ACAD SCI USA, V96, P6235, DOI 10.1073/pnas.96.11.6235; Fan HZ, 1999, EMBO J, V18, P6962, DOI 10.1093/emboj/18.24.6962; Gschwind A, 2001, ONCOGENE, V20, P1594, DOI 10.1038/sj.onc.1204192; Kalmes A, 2000, CIRC RES, V87, P92, DOI 10.1161/01.RES.87.2.92; Keely SJ, 1998, J BIOL CHEM, V273, P27111, DOI 10.1074/jbc.273.42.27111; Keely SJ, 2000, J BIOL CHEM, V275, P12619, DOI 10.1074/jbc.275.17.12619; Keely SJ, 1999, J BIOL CHEM, V274, P33449, DOI 10.1074/jbc.274.47.33449; Luttrell LM, 1999, CURR OPIN CELL BIOL, V11, P177, DOI 10.1016/S0955-0674(99)80023-4; Luttrell LM, 1997, J BIOL CHEM, V272, P4637, DOI 10.1074/jbc.272.7.4637; Maudsley S, 2000, J BIOL CHEM, V275, P9572, DOI 10.1074/jbc.275.13.9572; MIETTINEN PJ, 1989, PEDIATR RES, V26, P25, DOI 10.1203/00006450-198907000-00009; OLOUGHLIN EV, 1990, J PAEDIATR CHILD H, V26, P126, DOI 10.1111/j.1440-1754.1990.tb02408.x; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Pierce KL, 2001, J BIOL CHEM, V276, P23155, DOI 10.1074/jbc.M101303200; Pierce KL, 2000, P NATL ACAD SCI USA, V97, P1489, DOI 10.1073/pnas.97.4.1489; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Prenzel N, 2000, BREAST CANCER RES, V2, P184, DOI 10.1186/bcr52; SANDLE GI, 1990, GASTROENTEROLOGY, V99, P97, DOI 10.1016/0016-5085(90)91235-X; Schlondorff J, 1999, J CELL SCI, V112, P3603; Slack BE, 2000, BIOCHEM J, V348, P381, DOI 10.1042/0264-6021:3480381; STENSON WF, 1999, TXB GASTROENTEROLOGY, P123; Sunnarborg SW, 2002, J BIOL CHEM, V277, P12838, DOI 10.1074/jbc.M112050200; THOMAS DM, 1992, GUT, V33, P628, DOI 10.1136/gut.33.5.628; Tsai W, 1997, EMBO J, V16, P4597, DOI 10.1093/emboj/16.15.4597; Umata T, 2001, J BIOL CHEM, V276, P30475, DOI 10.1074/jbc.M103673200; Uribe JM, 1996, AM J PHYSIOL-CELL PH, V271, pC914, DOI 10.1152/ajpcell.1996.271.3.C914; Uribe JM, 1996, J BIOL CHEM, V271, P26588, DOI 10.1074/jbc.271.43.26588; VENGLARIK CJ, 1990, AM J PHYSIOL, V259, P358; WEYMER A, 1985, J CLIN INVEST, V76, P1828, DOI 10.1172/JCI112175; Zwick E, 1997, J BIOL CHEM, V272, P24767, DOI 10.1074/jbc.272.40.24767	46	98	100	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					42603	42612		10.1074/jbc.M206487200	http://dx.doi.org/10.1074/jbc.M206487200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12202486	hybrid			2022-12-27	WOS:000179081200024
J	Fourel, G; Miyake, T; Defossez, PA; Li, R; Gilson, E				Fourel, G; Miyake, T; Defossez, PA; Li, R; Gilson, E			General Regulatory Factors (GRFs) as genome partitioners	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMOSOMAL DNA-REPLICATION; C-TERMINAL DOMAINS; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTIONAL ACTIVATION; IN-VIVO; SUBTELOMERIC REGIONS; RIBOSOMAL-PROTEIN; BINDING DOMAIN; SIR PROTEINS; YEAST	Insulators are sequences that uncouple adjacent chromosome domains. Here we have shown that Saccharomyces cerevisiae Rap1p and Abf1p proteins are endowed with a potent insulating capacity. Insulating domains in Rap1p coincide with previously described transcription activation domains, whereas four adjacent subdomains spanning the whole of the Abf1p C terminus (440-731) were found to display autonomous insulating capacity. That both Rap1p and Abf1p silencing domains either contain or largely overlap with an insulating domain suggests that insulation conveys some undefined chromosome organization capacity that also contributes a function in silencing. Together with Reb1p and Tbf1p, previously involved in the activity of Saccharomyces cerevisiae subtelomeric insulators, insulating potential emerges as a supplementary common property of General Regulatory Factors (GRFs). Thus GRFs, which bind to sites scattered throughout the genome within promoters, would not only play a key role in regulating gene expression but also partition the genome in functionally independent domains.	Ecole Normale Super Lyon, CNRS ENSSL 5665, F-69364 Lyon, France; Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA	Ecole Normale Superieure de Lyon (ENS de LYON); University of Virginia	Fourel, G (corresponding author), Ecole Normale Super Lyon, CNRS ENSSL 5665, 46 Allee Italie, F-69364 Lyon, France.			Defossez, Pierre-Antoine/0000-0002-6463-9263				AMATI BB, 1988, CELL, V54, P967, DOI 10.1016/0092-8674(88)90111-0; Bi X, 1999, GENE DEV, V13, P1089, DOI 10.1101/gad.13.9.1089; BUCK SW, 1995, GENE DEV, V9, P370, DOI 10.1101/gad.9.3.370; Burns LG, 1997, MOL CELL BIOL, V17, P4811, DOI 10.1128/MCB.17.8.4811; Bussemaker HJ, 2001, NAT GENET, V27, P167, DOI 10.1038/84792; CHASMAN DI, 1990, GENE DEV, V4, P503, DOI 10.1101/gad.4.4.503; CHO GN, 1995, NUCLEIC ACIDS RES, V23, P2980, DOI 10.1093/nar/23.15.2980; Cohen BA, 2000, NAT GENET, V26, P183, DOI 10.1038/79896; de Bruin D, 2001, NATURE, V409, P109, DOI 10.1038/35051119; Deminoff SJ, 2001, GENETICS, V158, P133; Donze D, 2001, EMBO J, V20, P520, DOI 10.1093/emboj/20.3.520; Flanagan JF, 1999, NUCLEIC ACIDS RES, V27, P2022, DOI 10.1093/nar/27.9.2022; Fourel G, 2001, EMBO REP, V2, P124, DOI 10.1093/embo-reports/kve024; Fourel G, 1999, EMBO J, V18, P2522, DOI 10.1093/emboj/18.9.2522; Gabellini D, 2002, CELL, V110, P339, DOI 10.1016/S0092-8674(02)00826-7; Gartenberg MR, 2000, CURR OPIN MICROBIOL, V3, P132, DOI 10.1016/S1369-5274(00)00064-3; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Gerasimova TI, 2000, MOL CELL, V6, P1025, DOI 10.1016/S1097-2765(00)00101-5; Goncalves PM, 1996, MOL MICROBIOL, V19, P535, DOI 10.1046/j.1365-2958.1996.404939.x; Graham IR, 1999, MOL CELL BIOL, V19, P7481; HARDY CFJ, 1992, MOL CELL BIOL, V12, P1209, DOI 10.1128/MCB.12.3.1209; Heun P, 2001, SCIENCE, V294, P2181, DOI 10.1126/science.1065366; HOFFMAN JFX, 1989, CELL, V57, P725; Horard B, 2000, MOL CELL BIOL, V20, P3187, DOI 10.1128/MCB.20.9.3187-3197.2000; Hu YF, 1999, GENE DEV, V13, P637, DOI 10.1101/gad.13.6.637; Idrissi FZ, 2001, J BIOL CHEM, V276, P26090, DOI 10.1074/jbc.M101746200; Keaveney M, 1998, MOL CELL, V1, P917, DOI 10.1016/S1097-2765(00)80091-X; Kirkpatrick DT, 1999, GENETICS, V152, P101; Koering CE, 2000, NUCLEIC ACIDS RES, V28, P2519, DOI 10.1093/nar/28.13.2519; Lebrun E, 2001, GENETICS, V158, P167; Lercher MJ, 2002, NAT GENET, V31, P180, DOI 10.1038/ng887; Li BB, 2000, CELL, V101, P471, DOI 10.1016/S0092-8674(00)80858-2; Li R, 1998, MOL CELL BIOL, V18, P1296, DOI 10.1128/MCB.18.3.1296; Lieb JD, 2001, NAT GENET, V28, P327, DOI 10.1038/ng569; Lutz M, 2000, BIOCHEM SOC T, V28, P386, DOI 10.1042/0300-5127:0280386; Mencia M, 2002, MOL CELL, V9, P823, DOI 10.1016/S1097-2765(02)00490-2; Mirabella A, 1997, EMBO J, V16, P523, DOI 10.1093/emboj/16.3.523; Miyake T, 2000, J BIOL CHEM, V275, P40169, DOI 10.1074/jbc.M007138200; Miyake T, 2002, MOL CELL BIOL, V22, P505, DOI 10.1128/MCB.22.2.505-516.2002; MORETTI P, 1994, GENE DEV, V8, P2257, DOI 10.1101/gad.8.19.2257; Ohlsson R, 2001, TRENDS GENET, V17, P520, DOI 10.1016/S0168-9525(01)02366-6; Ohtsuki S, 1998, GENE DEV, V12, P3325, DOI 10.1101/gad.12.21.3325; Pilpel Y, 2001, NAT GENET, V29, P153, DOI 10.1038/ng724; Pryde FE, 1999, EMBO J, V18, P2538, DOI 10.1093/emboj/18.9.2538; Reed SH, 1999, GENE DEV, V13, P3052, DOI 10.1101/gad.13.23.3052; Reid JL, 2000, MOL CELL, V6, P1297, DOI 10.1016/S1097-2765(00)00128-3; Ryan MP, 2000, MOL CELL BIOL, V20, P5847, DOI 10.1128/MCB.20.16.5847-5857.2000; Sekinger EA, 1999, EMBO J, V18, P7041, DOI 10.1093/emboj/18.24.7041; Stenoien DL, 2000, J CELL BIOCHEM, P99; Sun FL, 1999, CELL, V99, P459, DOI 10.1016/S0092-8674(00)81534-2; Thomas MJ, 1999, GENE, V236, P197, DOI 10.1016/S0378-1119(99)00261-9; Valerius O, 2002, J BIOL CHEM, V277, P21440, DOI 10.1074/jbc.M201841200; Wiltshire S, 1997, NUCLEIC ACIDS RES, V25, P4250, DOI 10.1093/nar/25.21.4250; Yu LN, 1999, MOL CELL BIOL, V19, P5279	54	42	45	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					41736	41743		10.1074/jbc.M202578200	http://dx.doi.org/10.1074/jbc.M202578200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12200417	hybrid			2022-12-27	WOS:000178985300056
J	Strack, S				Strack, S			Overexpression of the protein phosphatase 2A regulatory subunit B gamma promotes neuronal differentiation by activating the MAP kinase (MAPK) cascade	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; NEURITE OUTGROWTH; OKADAIC ACID; SERINE/THREONINE PHOSPHATASES; SUBCELLULAR-LOCALIZATION; PC12 CELLS; CYCLIN-G; IDENTIFICATION; TYROSINE; FAMILY	Protein serine/threonine phosphatase 2A (PP2A) is a multifunctional regulator of cellular signaling. Variable regulatory subunits associate with a core dimer of scaffolding and catalytic subunits and are postulated to dictate substrate specificity and subcellular location of the heterotrimeric PP2A holoenzyme. The role of brain-specific, regulatory subunits in neuronal differentiation and signaling was investigated in the PC6-3 subline of PC12 cells. Endogenous Bbeta, Bgamma, and B'beta protein expression was induced during nerve growth factor (NGF)-mediated neuronal differentiation. Transient expression of Bgamma, but not other PP2A regulatory subunits, facilitated neurite outgrowth in the absence and presence of NGF. Tetracycline-inducible expression of Bgamma caused growth arrest and neurofilament expression, further evidence that PP2A/Bgamma can promote differentiation. In PC6-3 cells, but not non-neuronal cell lines, Bgamma specifically promoted long lasting activation of the mitogen-activated protein (MAP) kinase cascade, a key mediator of neuronal differentiation. Pharmacological and dominant-negative inhibition and kinase assays indicate that Bgamma promotes neuritogenesis by stimulating the MAP kinase cascade downstream of the TrkA NGF receptor but upstream or at the level of the B-Raf kinase. Mutational analyses demonstrate that the divergent N terminus is critical for Bgamma activity. These studies implicate PP2A/Bgamma as a positive regulator of MAP kinase signaling in neurons.	Univ Iowa, Coll Med, Dept Pharmacol, Iowa City, IA 52242 USA	University of Iowa	Strack, S (corresponding author), Univ Iowa, Coll Med, Dept Pharmacol, 2-432 BSB,51 Newton Rd, Iowa City, IA 52242 USA.	stefan-strack@uiowa.edu		Strack, Stefan/0000-0002-6175-7280	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK025295] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK25295] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abraham D, 2000, J BIOL CHEM, V275, P22300, DOI 10.1074/jbc.M003259200; ALESSI DR, 1995, METHOD ENZYMOL, V255, P279; ALESSI DR, 1995, CURR BIOL, V5, P283, DOI 10.1016/S0960-9822(95)00059-5; Bennin DA, 2002, J BIOL CHEM, V277, P27449, DOI 10.1074/jbc.M111693200; Campagne MV, 1999, MOL BRAIN RES, V64, P1; CHIOU JY, 1992, J NEUROCHEM, V59, P1963, DOI 10.1111/j.1471-4159.1992.tb11034.x; Chong H, 2001, EMBO J, V20, P3716, DOI 10.1093/emboj/20.14.3716; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; FIORE RS, 1993, NEUROSCIENCE, V55, P463, DOI 10.1016/0306-4522(93)90516-I; GAUSE KC, 1993, J BIOL CHEM, V268, P16124; Giasson BI, 1997, J NEUROBIOL, V32, P193, DOI 10.1002/(SICI)1097-4695(199702)32:2<193::AID-NEU4>3.0.CO;2-3; Gill JS, 1998, MOL BRAIN RES, V57, P123, DOI 10.1016/S0169-328X(98)00080-1; Green S. H., 1995, Methods (Orlando), V7, P222, DOI 10.1006/meth.1995.1028; GREENE LA, 1987, METHOD ENZYMOL, V147, P207; Hsu W, 1999, J BIOL CHEM, V274, P3439, DOI 10.1074/jbc.274.6.3439; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Kao SC, 2001, J BIOL CHEM, V276, P18169, DOI 10.1074/jbc.M008870200; Lin XH, 1998, P NATL ACAD SCI USA, V95, P14693, DOI 10.1073/pnas.95.25.14693; MAYER RE, 1991, BIOCHEMISTRY-US, V30, P3589, DOI 10.1021/bi00229a001; McCright B, 1996, J BIOL CHEM, V271, P22081, DOI 10.1074/jbc.271.36.22081; Merrick SE, 1997, J NEUROSCI, V17, P5726; Millward TA, 1999, TRENDS BIOCHEM SCI, V24, P186, DOI 10.1016/S0968-0004(99)01375-4; Morice C, 1999, EUR J NEUROSCI, V11, P1995, DOI 10.1046/j.1460-9568.1999.00609.x; Morrison DK, 1997, CURR OPIN CELL BIOL, V9, P174, DOI 10.1016/S0955-0674(97)80060-9; Okamoto K, 1996, MOL CELL BIOL, V16, P6593; Okamoto K, 2002, MOL CELL, V9, P761, DOI 10.1016/S1097-2765(02)00504-X; PALLAS DC, 1990, CELL, V60, P167, DOI 10.1016/0092-8674(90)90726-U; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; PITTMAN RN, 1993, J NEUROSCI, V13, P3669; QIU MS, 1992, NEURON, V9, P705, DOI 10.1016/0896-6273(92)90033-A; RAY LB, 1988, P NATL ACAD SCI USA, V85, P3753, DOI 10.1073/pnas.85.11.3753; Schipper HM, 1999, NEUROSCIENCE, V93, P585, DOI 10.1016/S0306-4522(99)00120-7; Seeling JM, 1999, SCIENCE, V283, P2089, DOI 10.1126/science.283.5410.2089; Segal RA, 1996, ANNU REV NEUROSCI, V19, P463, DOI 10.1146/annurev.ne.19.030196.002335; Sieburth DS, 1999, GENE DEV, V13, P2562, DOI 10.1101/gad.13.19.2562; Silverstein AM, 2002, P NATL ACAD SCI USA, V99, P4221, DOI 10.1073/pnas.072071699; Sonoda Y, 1997, J BIOL CHEM, V272, P15366, DOI 10.1074/jbc.272.24.15366; SONTAG E, 1995, J CELL BIOL, V128, P1131, DOI 10.1083/jcb.128.6.1131; Sontag E, 1996, NEURON, V17, P1201, DOI 10.1016/S0896-6273(00)80250-0; SONTAG E, 1993, CELL, V75, P887, DOI 10.1016/0092-8674(93)90533-V; Strack S, 1999, FEBS LETT, V460, P462, DOI 10.1016/S0014-5793(99)01377-0; Strack S, 2002, J BIOL CHEM, V277, P20750, DOI 10.1074/jbc.M202992200; Strack S, 1998, J COMP NEUROL, V392, P515; Sweatt JD, 2001, J NEUROCHEM, V76, P1, DOI 10.1046/j.1471-4159.2001.00054.x; TAPLEY P, 1992, ONCOGENE, V7, P371; Tehrani MA, 1996, J BIOL CHEM, V271, P5164; TOLEDOARAL JJ, 1995, NEURON, V14, P607, DOI 10.1016/0896-6273(95)90317-8; TRAVERSE S, 1992, BIOCHEM J, V288, P351, DOI 10.1042/bj2880351; Turowski P, 1999, MOL BIOL CELL, V10, P1997, DOI 10.1091/mbc.10.6.1997; Ugi S, 2002, MOL CELL BIOL, V22, P2375, DOI 10.1128/MCB.22.7.2375-2387.2002; Voorhoeve PM, 1999, ONCOGENE, V18, P515, DOI 10.1038/sj.onc.1202316; Voorhoeve PM, 1999, ONCOGENE, V18, P679, DOI 10.1038/sj.onc.1202289; Wassarman DA, 1996, GENE DEV, V10, P272, DOI 10.1101/gad.10.3.272; Wu CB, 2001, J NEUROSCI, V21, P5406, DOI 10.1523/JNEUROSCI.21-15-05406.2001; Xing HR, 2001, J BIOL CHEM, V276, P9733, DOI 10.1074/jbc.M008096200; Yan Z, 2000, MOL CELL BIOL, V20, P1021, DOI 10.1128/MCB.20.3.1021-1029.2000; YANG SI, 1991, MOL CELL BIOL, V11, P1988, DOI 10.1128/MCB.11.4.1988; York RD, 1998, NATURE, V392, P622, DOI 10.1038/33451; ZOLNIEROWICZ S, 1994, BIOCHEMISTRY-US, V33, P11858, DOI 10.1021/bi00205a023; Zwartkruis FJT, 1998, EMBO J, V17, P5905, DOI 10.1093/emboj/17.20.5905	61	68	69	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					41525	41532		10.1074/jbc.M203767200	http://dx.doi.org/10.1074/jbc.M203767200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12191994	hybrid			2022-12-27	WOS:000178985300030
J	Aslani, A; Olsson, M; Elias, P				Aslani, A; Olsson, M; Elias, P			ATP-dependent unwinding of a minimal origin of DNA replication by the origin-binding protein and the single-strand DNA-binding protein ICP8 from Herpes simplex virus type I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRAL ORIGIN; CRYSTAL-STRUCTURES; UL9 PROTEIN; HELICASE; DOMAIN; ORIS; COMPLEX; OLIGONUCLEOTIDE; SEQUENCE; CLONING	The Herpes simplex virus type I origin-binding protein, OBP, is encoded by the UL9 gene. OBP binds the origin of DNA replication, oriS, in a cooperative and sequence-specific manner. OBP is also an ATP-dependent DNA helicase. We have recently shown that single-stranded oriS folds into a unique and evolutionarily conserved conformation, oriS*, which is stably bound by OBP. OriS* contains a stable hairpin formed by complementary base pairing between box I and box III in oriS. Here we show that OBP, in the presence of the single-stranded DNA-binding protein ICP8, can convert an 80-base pair double-stranded minimal oriS fragment to oriS* and form an OBP-oriS* complex. The formation of an OBP-oriS* complex requires hydrolysable ATP. We also demonstrate that OBP in the presence of ICP8 and ATP promotes slow but specific and complete unwinding of duplex minimal oriS. The possibility that the OBP-oriS* complex may serve as an assembly site for the herpes virus replisome is discussed.	Univ Gothenburg, Dept Med Biochem, SE-40530 Gothenburg, Sweden	University of Gothenburg	Elias, P (corresponding author), Univ Gothenburg, Dept Med Biochem, Box 440, SE-40530 Gothenburg, Sweden.							ABBOTTS AP, 1995, J GEN VIROL, V76, P3125, DOI 10.1099/0022-1317-76-12-3125; Aslani A, 2000, J BIOL CHEM, V275, P5880, DOI 10.1074/jbc.275.8.5880; Aslani A, 2001, P NATL ACAD SCI USA, V98, P7194, DOI 10.1073/pnas.121177198; BOEHMER PE, 1993, P NATL ACAD SCI USA, V90, P8444, DOI 10.1073/pnas.90.18.8444; Boehmer PE, 1997, ANNU REV BIOCHEM, V66, P347, DOI 10.1146/annurev.biochem.66.1.347; BOROWIEC JA, 1990, CELL, V60, P181, DOI 10.1016/0092-8674(90)90730-3; Chen YM, 1996, VIROLOGY, V221, P281, DOI 10.1006/viro.1996.0377; ELIAS P, 1992, J BIOL CHEM, V267, P17424; ELIAS P, 1990, J BIOL CHEM, V265, P17167; ELIAS P, 1988, P NATL ACAD SCI USA, V85, P2959, DOI 10.1073/pnas.85.9.2959; GAO M, 1988, VIROLOGY, V163, P319, DOI 10.1016/0042-6822(88)90272-3; *GCG, 2000, WISC PACK VERS 10 1; GUSTAFSSON CM, 1994, P NATL ACAD SCI USA, V91, P4629, DOI 10.1073/pnas.91.11.4629; GUSTAFSSON CM, 1995, J BIOL CHEM, V270, P19028, DOI 10.1074/jbc.270.32.19028; Hammarsten O, 1997, NUCLEIC ACIDS RES, V25, P1753, DOI 10.1093/nar/25.9.1753; HAZUDA DJ, 1991, J BIOL CHEM, V266, P24621; HAZUDA DJ, 1992, J BIOL CHEM, V267, P14309; He XD, 2000, J VIROL, V74, P5726, DOI 10.1128/JVI.74.12.5726-5728.2000; He XD, 2001, P NATL ACAD SCI USA, V98, P3024, DOI 10.1073/pnas.061028298; HERNANDEZ TR, 1991, J VIROL, V65, P1649, DOI 10.1128/JVI.65.3.1649-1652.1991; Kim JL, 1998, STRUCTURE, V6, P89, DOI 10.1016/S0969-2126(98)00010-0; Kornberg A., 1992, DNA REPLICATION; Korolev S, 1997, CELL, V90, P635, DOI 10.1016/S0092-8674(00)80525-5; LOCKSHON D, 1986, J VIROL, V58, P513, DOI 10.1128/JVI.58.2.513-521.1986; LOCKSHON D, 1988, MOL CELL BIOL, V8, P4018, DOI 10.1128/MCB.8.10.4018; Makhov AM, 1996, EMBO J, V15, P1742, DOI 10.1002/j.1460-2075.1996.tb00520.x; Nurse P, 1999, J BIOL CHEM, V274, P25026, DOI 10.1074/jbc.274.35.25026; SantaLucia J, 1998, P NATL ACAD SCI USA, V95, P1460, DOI 10.1073/pnas.95.4.1460; Simonsson S, 1998, J BIOL CHEM, V273, P24633, DOI 10.1074/jbc.273.38.24633; STOW ND, 1983, VIROLOGY, V130, P427, DOI 10.1016/0042-6822(83)90097-1; Subramanya HS, 1996, NATURE, V384, P379, DOI 10.1038/384379a0; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; WEIR HM, 1990, J GEN VIROL, V71, P1379, DOI 10.1099/0022-1317-71-6-1379; WELLER SK, 1985, MOL CELL BIOL, V5, P930, DOI 10.1128/MCB.5.5.930; ZUKER M, 1989, SCIENCE, V244, P48, DOI 10.1126/science.2468181	35	27	31	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 25	2002	277	43					41204	41212		10.1074/jbc.M208270200	http://dx.doi.org/10.1074/jbc.M208270200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	607KU	12183471	hybrid			2022-12-27	WOS:000178791400131
J	Robinson, P; Mirza, M; Knott, A; Abdulrazzak, H; Willott, R; Marston, S; Watkins, H; Redwood, C				Robinson, P; Mirza, M; Knott, A; Abdulrazzak, H; Willott, R; Marston, S; Watkins, H; Redwood, C			Alterations in thin filament regulation induced by a human cardiac troponin T mutant that causes dilated cardiomyopathy are distinct from those induced by troponin T mutants that cause hypertrophic cardiomyopathy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCLE-CONTRACTION; HEART-FAILURE; DISEASE PATHOGENESIS; ALTERED REGULATION; TRANSGENIC MICE; MOTILITY ASSAY; MUTATIONS; PROTEIN; CALCIUM; GENETICS	We have compared the in vitro regulatory properties of recombinant human cardiac troponin reconstituted using wild type troponin T with troponin containing the DeltaLys-210 troponin T mutant that causes dilated cardiomyopathy (DCM) and the R92Q troponin T known to cause hypertrophic cardiomyopathy (HCM). Troponin containing DeltaLys-210 troponin T inhibited actin-tropomyosin-activated myosin subfragment-1 ATPase activity to the same extent as wild type at pCa8.5 (>80%) but produced substantially less enhancement of ATPase at pCa4.5. The Ca2+ sensitivity of ATPase activation was increased (DeltapCa(50) = +0.2 pCa units) and cooperativity of Ca2+ activation was virtually abolished. Equimolar mixtures of wild type and DeltaLys-210 troponin T gave a lower Ca2+ sensitivity than with wild type, while maintaining the diminished ATPase activation at pCa4.5 observed with 100% mutant. In contrast, R92Q troponin gave reduced inhibition at pCa8.5 but greater activation than wild type at pCa4.5; Ca2+ sensitivity was increased but there was no change in cooperativity. In vitro motility assay of reconstituted thin filaments confirmed the ATPase results and moreover indicated that the predominant effect of the DeltaLys-210 mutation was a reduced sliding speed. The functional consequences of this DCM mutation are qualitatively different from the R92Q or any other studied HCM troponin T mutation, suggesting that DCM and HCM may be triggered by distinct primary stimuli.	Univ Oxford, Wellcome Trust Ctr Human Genet, Dept Cardiovasc Med, Oxford OX3 7BN, England; Univ Oxford, Physiol Lab, Oxford OX3 7BN, England; Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Imperial College London	Redwood, C (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Dept Cardiovasc Med, Oxford OX3 7BN, England.	credwood@molbiol.ox.ac.uk		Abdulrazzak, Hassan/0000-0002-0654-7221; Watkins, Hugh/0000-0002-5287-9016				Bing W, 1997, BIOCHEM J, V327, P335, DOI 10.1042/bj3270335; Blair E, 2001, HUM MOL GENET, V10, P1215, DOI 10.1093/hmg/10.11.1215; Burton D, 2002, BIOCHEM J, V362, P443, DOI 10.1042/0264-6021:3620443; de Tombe PP, 1998, CARDIOVASC RES, V37, P367, DOI 10.1016/S0008-6363(97)00275-7; Elliott K, 2000, J BIOL CHEM, V275, P22069, DOI 10.1074/jbc.M002502200; Filatov VL, 1999, BIOCHEMISTRY-MOSCOW+, V64, P969; Franz WM, 2001, LANCET, V358, P1627, DOI 10.1016/S0140-6736(01)06657-0; GEEVES MA, 1994, BIOPHYS J, V67, P273, DOI 10.1016/S0006-3495(94)80478-3; Gerull B, 2002, NAT GENET, V30, P201, DOI 10.1038/ng815; Hajjar RJ, 2000, CIRCULATION, V101, P1679; HAJJAR RJ, 1992, BASIC RES CARDIOL, V87, P143; Hernandez OM, 2001, J APPL PHYSIOL, V90, P1125, DOI 10.1152/jappl.2001.90.3.1125; Kamisago M, 2000, NEW ENGL J MED, V343, P1688, DOI 10.1056/NEJM200012073432304; KEELING PJ, 1995, BRIT HEART J, V73, P417; Knollmann BC, 2001, TRENDS CARDIOVAS MED, V11, P206, DOI 10.1016/S1050-1738(01)00115-3; Knott A, 2002, J MOL CELL CARDIOL, V34, P469, DOI 10.1006/jmcc.2002.1528; KRON SJ, 1991, METHOD ENZYMOL, V196, P399; Li DX, 2001, CIRCULATION, V104, P2188, DOI 10.1161/hc4301.098285; Marston SB, 1996, J MUSCLE RES CELL M, V17, P497, DOI 10.1007/BF00123365; Marston SB, 2001, J MUSCLE RES CELL M, V22, P1, DOI 10.1023/A:1010355716511; MICHELS VV, 1992, NEW ENGL J MED, V326, P77, DOI 10.1056/NEJM199201093260201; Montgomery DE, 2001, J PHYSIOL-LONDON, V536, P583, DOI 10.1111/j.1469-7793.2001.0583c.xd; Morimoto S, 1998, AM J PHYSIOL-CELL PH, V275, pC200, DOI 10.1152/ajpcell.1998.275.1.C200; Morimoto S, 2002, P NATL ACAD SCI USA, V99, P913, DOI 10.1073/pnas.022628899; Oberst L, 1998, J CLIN INVEST, V102, P1498, DOI 10.1172/JCI4088; Olson TM, 2001, J MOL CELL CARDIOL, V33, P723, DOI 10.1006/jmcc.2000.1339; Olson TM, 1998, SCIENCE, V280, P750, DOI 10.1126/science.280.5364.750; Perez NG, 1999, CIRCULATION, V99, P1077, DOI 10.1161/01.CIR.99.8.1077; Perry SV, 1998, J MUSCLE RES CELL M, V19, P575; POTTER JD, 1995, J BIOL CHEM, V270, P2557, DOI 10.1074/jbc.270.6.2557; Purcell IF, 1999, CARDIOVASC RES, V43, P884, DOI 10.1016/S0008-6363(99)00123-6; Redwood C, 2000, CIRC RES, V86, P1146; Redwood CS, 1999, CARDIOVASC RES, V44, P20, DOI 10.1016/S0008-6363(99)00213-8; Ruf T, 1998, CARDIOVASC RES, V40, P580, DOI 10.1016/S0008-6363(98)00164-3; Schaertl S, 1995, BIOCHEMISTRY-US, V34, P15890, DOI 10.1021/bi00049a003; Schonberger J, 2001, AM J HUM GENET, V69, P249, DOI 10.1086/321978; Seidman JG, 2001, CELL, V104, P557, DOI 10.1016/S0092-8674(01)00242-2; Stefancsik R, 1998, P NATL ACAD SCI USA, V95, P957, DOI 10.1073/pnas.95.3.957; Sweeney HL, 1998, P NATL ACAD SCI USA, V95, P14406, DOI 10.1073/pnas.95.24.14406; Szczesna D, 2000, J BIOL CHEM, V275, P624, DOI 10.1074/jbc.275.1.624; Takeda S, 2002, BIOPHYS J, V82, p170A; Tardiff JC, 1999, J CLIN INVEST, V104, P469, DOI 10.1172/JCI6067; Tobacman LS, 1999, J BIOL CHEM, V274, P28363, DOI 10.1074/jbc.274.40.28363; van der Velden J, 2001, CIRCULATION, V104, P1140, DOI 10.1161/hc3501.095485; Watkins H, 2001, EUR HEART J SUPPL, V3, pL43, DOI 10.1016/S1520-765X(01)90064-1; Wolff MR, 1996, J CLIN INVEST, V98, P167, DOI 10.1172/JCI118762	46	107	110	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2002	277	43					40710	40716		10.1074/jbc.M203446200	http://dx.doi.org/10.1074/jbc.M203446200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	607KU	12186860	hybrid			2022-12-27	WOS:000178791400071
J	Zeng, ZZ; Yellaturu, CR; Neeli, I; Rao, GN				Zeng, ZZ; Yellaturu, CR; Neeli, I; Rao, GN			5(S)-hydroxyeicosatetraenoic acid stimulates DNA synthesis in human microvascular endothelial cells via activation of Jak/STAT and phosphatidylinositol 3-kinase/Akt signaling, leading to induction of expression of basic fibroblast growth factor 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOSOLIC PHOSPHOLIPASE A(2); GROWTH-FACTOR-I; ARACHIDONIC-ACID; 4E-BINDING PROTEIN-1; INITIATION; KINASE; METABOLITES; PHOSPHORYLATION; ANGIOGENESIS; 3-KINASE	To understand the role of eicosanoids in angiogenesis, we have studied the effect of lipoxygenase metabolites of arachidonic acid on human microvascular endothelial cell (HMVEC) DNA synthesis. Among the various lipoxygenase metabolites of arachidonic acid tested, 5(S)-hydroxyeicosatetraenoic acid (5(S)-HETE) induced DNA synthesis in HMVEC. 5(S)-HETE also stimulated Jak-2, STAT-1, and STAT-3 tyrosine phosphorylation and STAT-3-DNA binding activity. Tyrphostin AG490, a specific inhibitor of Jak-2, significantly reduced tyrosine phosphorylation and DNA binding activity of STAT-3 and DNA synthesis induced by 5(S)-HETE. In addition, 5(S)-HETE stimulated phosphatidylinositol 3-kinase (PI3-kinase) activity and phosphorylation of its downstream targets Akt, p70S6K, and 4E-BP1 and their effector molecules ribosomal. protein S6 and eIF4E. LY294002 and rapamycin, potent inhibitors of PI3-kinase and mTOR, respectively, also blocked the DNA synthesis induced by 5(S)-HETE. Interestingly, AG490 attenuated 5(S)-HETE-induced PI3-kinase activity and phosphorylation of Akt, p70S6K, ribosomal protein S6, 4E-BP1, and eIF4E. 5(S)-HETE induced the expression of basic fibroblast growth factor 2 (bFGF-2) in a Jak-2- and PI3-kinase-dependent manner. In addition, a neutralizing anti-bFGF-2 antibody completely blocked 5(S)HETE-induced DNA synthesis in HMVEC. Together these results suggest that 5(S)-HETE stimulates HMVEC growth via Jak-2- and PI3-kinase-dependent induction of expression of bFGF-2. These findings also reveal a cross-talk between Jak-2 and PI3-kinase in response to 5(S)-HETE in HMVEC.	Univ Tennessee, Ctr Hlth Sci, Dept Physiol, Memphis, TN 38163 USA; Univ Tennessee, Ctr Hlth Sci, Ctr Vasc Biol, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center	Rao, GN (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Physiol, 894 Union Ave, Memphis, TN 38163 USA.	grao@physio1.utmem.edu			NHLBI NIH HHS [HL 64165] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064165] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Blume-Jensen P, 1998, CURR BIOL, V8, P779, DOI 10.1016/S0960-9822(98)70302-1; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Chen JK, 2001, MOL CELL BIOL, V21, P6322, DOI 10.1128/MCB.21.18.6322-6331.2001; Constantino S, 2001, ONCOGENE, V20, P2080, DOI 10.1038/sj.onc.1204308; CUEVAS P, 1991, CIRC RES, V69, P360, DOI 10.1161/01.RES.69.2.360; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; DEL PL, 1997, SCIENCE, V278, P687; DETHLEFSEN SM, 1994, EXP CELL RES, V212, P262, DOI 10.1006/excr.1994.1142; Dormond O, 2001, NAT MED, V7, P1041, DOI 10.1038/nm0901-1041; Dufner A, 1999, MOL CELL BIOL, V19, P4525; FAFEUR V, 1991, J CELL PHYSIOL, V149, P277, DOI 10.1002/jcp.1041490214; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; GLASGOW WC, 1992, J BIOL CHEM, V267, P10771; GOLUBIC M, 1991, EMBO J, V10, P2897, DOI 10.1002/j.1460-2075.1991.tb07839.x; Graber MN, 1996, J BIOL CHEM, V271, P883, DOI 10.1074/jbc.271.2.883; GRONICH J, 1994, J CLIN INVEST, V93, P1224, DOI 10.1172/JCI117076; HAN JW, 1991, SCIENCE, V252, P576, DOI 10.1126/science.1902323; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; HARRIS RC, 1990, J CELL PHYSIOL, V144, P429, DOI 10.1002/jcp.1041440310; Herbert TP, 2000, J BIOL CHEM, V275, P11249, DOI 10.1074/jbc.275.15.11249; HORVATH CM, 1995, GENE DEV, V9, P984, DOI 10.1101/gad.9.8.984; Khaleghpour K, 1999, MOL CELL BIOL, V19, P4302; Klippel A, 1997, MOL CELL BIOL, V17, P338, DOI 10.1128/MCB.17.1.338; LIN L, 1994, CIRC RES, V74, P197, DOI 10.1161/01.RES.74.2.197; Macian F, 2001, ONCOGENE, V20, P2476, DOI 10.1038/sj.onc.1204386; Mezentsev A, 2002, J BIOL CHEM, V277, P18670, DOI 10.1074/jbc.M201143200; MYERS MG, 1994, J BIOL CHEM, V269, P28783; Nielsen M, 1997, P NATL ACAD SCI USA, V94, P6764, DOI 10.1073/pnas.94.13.6764; Nosaka T, 1999, EMBO J, V18, P4754, DOI 10.1093/emboj/18.17.4754; OBRIEN ER, 1994, AM J PATHOL, V145, P883; OWEN NE, 1986, AM J PHYSIOL, V250, pC584, DOI 10.1152/ajpcell.1986.250.4.C584; PALMBERG L, 1987, J CELL SCI, V88, P151; PEPPELENBOSCH MP, 1993, CELL, V74, P565, DOI 10.1016/0092-8674(93)80057-L; Piomelli D, 1993, CURR OPIN CELL BIOL, V5, P274, DOI 10.1016/0955-0674(93)90116-8; RALPH RK, 1990, CANCER LETT, V49, P181, DOI 10.1016/0304-3835(90)90156-R; RAO GN, 1994, BIOCHEM J, V299, P197, DOI 10.1042/bj2990197; RAO GN, 1994, J BIOL CHEM, V269, P32586; Rao GN, 1999, J BIOL CHEM, V274, P12925, DOI 10.1074/jbc.274.18.12925; Rao GN, 1999, J BIOL CHEM, V274, P6003, DOI 10.1074/jbc.274.9.6003; Romano M, 2001, FASEB J, V15, P2326, DOI 10.1096/fj.01-0150com; SELLMAYER A, 1991, J BIOL CHEM, V266, P3800; SETTY BNY, 1987, J BIOL CHEM, V262, P17613; SHIMAKURA S, 1992, CANCER RES, V52, P1744; SMITH WL, 1989, BIOCHEM J, V259, P315, DOI 10.1042/bj2590315; Tang DG, 1996, P NATL ACAD SCI USA, V93, P5241, DOI 10.1073/pnas.93.11.5241; TSAI MH, 1991, MOL CELL BIOL, V11, P2785, DOI 10.1128/MCB.11.5.2785; Vanhaesebroeck B, 2000, BIOCHEM J, V346, P561, DOI 10.1042/0264-6021:3460561; Wu YY, 2000, J BIOL CHEM, V275, P2147, DOI 10.1074/jbc.275.3.2147; Zong CS, 1998, J BIOL CHEM, V273, P28065, DOI 10.1074/jbc.273.43.28065	50	43	47	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2002	277	43					41213	41219		10.1074/jbc.M204508200	http://dx.doi.org/10.1074/jbc.M204508200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	607KU	12193593	hybrid			2022-12-27	WOS:000178791400132
J	Husted, LB; Sorensen, EB; Armstrong, PB; Quigley, JP; Kristensen, L; Sottrup-Jensen, L				Husted, LB; Sorensen, EB; Armstrong, PB; Quigley, JP; Kristensen, L; Sottrup-Jensen, L			Localization of carbohydrate attachment sites and disulfide bridges in Limulus alpha(2)-macroglobulin - Evidence for two forms differing primarily in their bait region sequences	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-BINDING DOMAIN; ALPHA-1-INHIBITOR-III MESSENGER-RNA; NATIVE HUMAN ALPHA(2)-MACROGLOBULIN; N-LINKED OLIGOSACCHARIDES; AMERICAN HORSESHOE-CRAB; AMINO-ACID-SEQUENCE; HUMAN ALPHA-2-MACROGLOBULIN; ALPHA-MACROGLOBULIN; 3-DIMENSIONAL STRUCTURE; HEMOLYTIC SYSTEM	The primary structure determination of the dimeric invertebrate alpha(2)-macroglobulin (a,M) from Limulus polyphemus has been completed by determining its sites of glycosylation and disulfide bridge pattern. Of seven potential glycosylation sites for N-linked glycosylation, six (Asn(275), Asn(307), Asn(866), Asn(896), Asn(1089), and Asn(1145)) carry common glucosamine-based carbohydrates groups, whereas one (Asn(80)) carries a carbohydrate chain containing both glucosamine and galactosamine. Nine disulfide bridges, which are homologues with bridges in human alpha(2)M, have been identified (Cys(228)-Cys(269), cys(456)-cys(580), cys(612)-cys(799) ,cys(657)-cys(707), cys(849)-Cys(176), Cys(874)-Cys(910), Cys(946)-Cys(1328), Cys(1104)-Cys(1155), and Cys(1362)-Cys(1475)). In addition to these bridges, Limulus a2M contains three unique bridges that connect Cys(361) and Cys(382), Cys(1370) and Cys(1374), respectively, and Cys(719) in one subunit with the same residue in the other subunit of the dimer. The latter bridge forms the only interchain disulfide bridge in Limulus alpha(2)M. The location of this bridge within the bait region is discussed and compared with other alpha-macroglobulins. Several peptides identified in the course of determining the disulfide bridge pattern provided evidence for the existence of two forms of Limulus alpha(2)M. The two forms have a high degree of sequence identity, but they differ extensively in large parts of their bait regions suggesting that they have different inhibitory spectra. The two forms (Limulus alpha(2)M-1 and -2) are most likely present in an similar to2:1 ratio in the hemolymph of each animal, and they can be partially separated on a Mono Q column at pH 7.4 by applying a shallow gradient of NaCl.	Aarhus Univ, Dept Mol Biol, Sci Pk Div, DK-8000 Aarhus C, Denmark; Marine Biol Lab, Woods Hole, MA 02543 USA; Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA; Scripps Res Inst, Dept Vasc Biol, La Jolla, CA 92037 USA	Aarhus University; Marine Biological Laboratory - Woods Hole; University of California System; University of California Davis; Scripps Research Institute	Sottrup-Jensen, L (corresponding author), Aarhus Univ, Dept Mol Biol, Sci Pk Div, Gustav Wieds Vej 10, DK-8000 Aarhus C, Denmark.	lsj@mb.au.dk		Armstrong, Peter/0000-0001-5197-1999; Sorensen, Esben Skipper/0000-0002-7050-3354				AIELLO LP, 1988, J BIOL CHEM, V263, P4013; ARMSTRONG PB, 1994, ANN NY ACAD SCI, V737, P188, DOI 10.1111/j.1749-6632.1994.tb44312.x; ARMSTRONG PB, 1991, J BIOL CHEM, V266, P2526; ARMSTRONG PB, 1987, BIOCHEM J, V248, P703, DOI 10.1042/bj2480703; BARRETT AJ, 1973, BIOCHEM J, V133, P709, DOI 10.1042/bj1330709; BENDIXEN E, 1992, BIOCHEMISTRY-US, V31, P3611, DOI 10.1021/bi00129a009; Bowen ME, 1998, J BIOL CHEM, V273, P1825, DOI 10.1074/jbc.273.3.1825; BRACIAK TA, 1988, J BIOL CHEM, V263, P3999; CRIMMINS DL, 1989, ANAL BIOCHEM, V176, P255, DOI 10.1016/0003-2697(89)90305-9; DOLMER K, 1993, FEBS LETT, V315, P85, DOI 10.1016/0014-5793(93)81139-Q; Dolmer K, 1996, FEBS LETT, V393, P37, DOI 10.1016/0014-5793(96)00852-6; ENGHILD JJ, 1990, BIOCHEMISTRY-US, V29, P10070, DOI 10.1021/bi00495a009; GETTINS PGW, 1995, J BIOL CHEM, V270, P14160, DOI 10.1074/jbc.270.23.14160; HARPEL PC, 1973, J EXP MED, V138, P508, DOI 10.1084/jem.138.3.508; Iwaki D, 1996, EUR J BIOCHEM, V242, P822, DOI 10.1111/j.1432-1033.1996.0822r.x; Jenner L, 1998, STRUCTURE, V6, P595, DOI 10.1016/S0969-2126(98)00061-6; JENSEN PEH, 1986, J BIOL CHEM, V261, P5863; Kolodziej SJ, 1996, J STRUCT BIOL, V116, P366, DOI 10.1006/jsbi.1996.0054; Kopacek P, 2000, EUR J BIOCHEM, V267, P465, DOI 10.1046/j.1432-1327.2000.01020.x; Manzella SM, 1996, J BIOL CHEM, V271, P12117, DOI 10.1074/jbc.271.21.12117; Mutsuro J, 2000, IMMUNOGENETICS, V51, P847, DOI 10.1007/s002510000216; Qazi U, 1998, J BIOL CHEM, V273, P8987, DOI 10.1074/jbc.273.15.8987; QUIGLEY JP, 1983, J BIOL CHEM, V258, P7903; QUIGLEY JP, 1985, J BIOL CHEM, V260, P2715; QUIGLEY JP, 1991, J BIOL CHEM, V266, P19426; SMITH PL, 1992, J BIOL CHEM, V267, P19140; SORENSEN ES, 1993, J DAIRY RES, V60, P535, DOI 10.1017/S0022029900027886; Sottrup-Jensen L., 1987, PLASMA PROTEINS, V5, P191; SOTTRUPJENSEN L, 1993, BIOCHEM MOL BIOL INT, V30, P789; SOTTRUPJENSEN L, 1995, ANAL BIOCHEM, V225, P187, DOI 10.1006/abio.1995.1137; SOTTRUPJENSEN L, 1989, J BIOL CHEM, V264, P15781; SOTTRUPJENSEN L, 1986, FEBS LETT, V205, P20, DOI 10.1016/0014-5793(86)80857-2; SOTTRUPJENSEN L, 1984, J BIOL CHEM, V259, P8318; SOTTRUPJENSEN L, 1990, J BIOL CHEM, V265, P17727; SOTTRUPJENSEN L, 1984, J BIOL CHEM, V259, P8293; SOTTRUPJENSEN L, 1994, ANN NY ACAD SCI, V737, P172, DOI 10.1111/j.1749-6632.1994.tb44311.x; SOTTRUPJENSEN L, 1990, COMP BIOCHEM PHYS B, V96, P621, DOI 10.1016/0305-0491(90)90066-3; SOTTRUPJENSEN L, 1989, J BIOL CHEM, V264, P11539; Swarnakar S, 2000, BIOCHEM J, V347, P679, DOI 10.1042/0264-6021:3470679; TANAKA N, 1992, J BIOCHEM-TOKYO, V112, P68, DOI 10.1093/oxfordjournals.jbchem.a123867; TOMIYA N, 1993, J BIOL CHEM, V268, P113; VANKUIK JA, 1987, EUR J BIOCHEM, V169, P399; VANLEUVEN F, 1986, J BIOL CHEM, V261, P1369	43	14	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2002	277	46					43698	43706		10.1074/jbc.M208236200	http://dx.doi.org/10.1074/jbc.M208236200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	615XE	12218066	Green Submitted, hybrid			2022-12-27	WOS:000179272000022
J	Jang, YJ; Ma, S; Terada, Y; Erikson, RL				Jang, YJ; Ma, S; Terada, Y; Erikson, RL			Phosphorylation of threonine 210 and the role of serine 137 in the regulation of mammalian polo-like kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE; PROTEIN-KINASE; 1 PLK1; SPINDLE; PLX1; PURIFICATION; PHOSPHATASE; ACTIVATION; CLONING; MUTANT	The mammalian polo-like kinase (Plk) plays a critical role in M-phase progression. Plk is phosphorylated and activated by an upstream kinase(s), which has not yet been identified in mammalian cells. Phosphopeptide mapping and phosphoamino acid analyses of Plk labeled in vivo and phosphorylated in vitro by Xenopus polo-like kinase kinase-1 (xPlkk1) or by lymphocyte-oriented kinase, its most closely related mammalian enzyme, indicate that Thr-210 is a major phosphorylation site in activated Plk from mitotic HeLa cells. Although the amino acid sequence surrounding Ser-137 is similar to that at Thr-210 and is conserved in Plk family members, Ser-137 is not detectably phosphorylated in mitotic mammalian cells or by xPlkk1 in vitro. Nevertheless, the substitution of either Thr-210 or Ser-137 with Asp (T210D or S137D) elevates the kinase activity of Plk. The kinase activity of the double mutant S137D/T210D is not significantly different from that of T210D or S137D, demonstrating that substitution of both residues does not have an additive effect on Plk activity. Expression of the S137D mutant construct arrested HeLa cells in early S-phase with slightly separated centrosomes, whereas cells expressing wild type and T210D were arrested or delayed in M-phase. These data indicate that the Ser-137 may have an unexpected and novel role in the function of Plk.	Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University	Erikson, RL (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	erikson@biosun.harvard.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059172] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM59172] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Descombes P, 1998, EMBO J, V17, P1328, DOI 10.1093/emboj/17.5.1328; Ellinger-Ziegelbauer H, 2000, GENES CELLS, V5, P491, DOI 10.1046/j.1365-2443.2000.00337.x; GAUTIER J, 1991, CELL, V67, P197, DOI 10.1016/0092-8674(91)90583-K; Glover DM, 1998, GENE DEV, V12, P3777, DOI 10.1101/gad.12.24.3777; HAMANAKA R, 1995, J BIOL CHEM, V270, P21086, DOI 10.1074/jbc.270.36.21086; HUANG WD, 1994, P NATL ACAD SCI USA, V91, P8960, DOI 10.1073/pnas.91.19.8960; Jang YJ, 2002, P NATL ACAD SCI USA, V99, P1984, DOI 10.1073/pnas.042689299; Jiang W, 1998, BIOTECHNIQUES, V24, P349; KAMPS MP, 1989, ANAL BIOCHEM, V176, P22, DOI 10.1016/0003-2697(89)90266-2; Kelm O, 2002, J BIOL CHEM, V277, P25247, DOI 10.1074/jbc.M202855200; KUMAGAI A, 1991, CELL, V64, P903, DOI 10.1016/0092-8674(91)90315-P; Kumagai A, 1996, SCIENCE, V273, P1377, DOI 10.1126/science.273.5280.1377; Kuramochi S, 1997, J BIOL CHEM, V272, P22679, DOI 10.1074/jbc.272.36.22679; Lane HA, 1996, J CELL BIOL, V135, P1701, DOI 10.1083/jcb.135.6.1701; LEE KS, 1995, MOL CELL BIOL, V15, P7143; Lee KS, 1997, MOL CELL BIOL, V17, P3408, DOI 10.1128/MCB.17.6.3408; LEE MS, 1992, MOL BIOL CELL, V3, P73, DOI 10.1091/mbc.3.1.73; Liu F, 1997, MOL CELL BIOL, V17, P571, DOI 10.1128/MCB.17.2.571; Liu XQ, 2002, P NATL ACAD SCI USA, V99, P8672, DOI 10.1073/pnas.132269599; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Mundt KE, 1997, BIOCHEM BIOPH RES CO, V239, P377, DOI 10.1006/bbrc.1997.7378; Nigg EA, 1998, CURR OPIN CELL BIOL, V10, P776, DOI 10.1016/S0955-0674(98)80121-X; NIGG EA, 1995, BIOESSAYS, V17, P471, DOI 10.1002/bies.950170603; OHKURA H, 1995, GENE DEV, V9, P1059, DOI 10.1101/gad.9.9.1059; PARKER LL, 1992, P NATL ACAD SCI USA, V89, P2917, DOI 10.1073/pnas.89.7.2917; Pestov DG, 1999, BIOTECHNIQUES, V26, P102, DOI 10.2144/99261st04; Qian YW, 1999, MOL CELL BIOL, V19, P8625; Qian YW, 1998, MOL CELL BIOL, V18, P4262, DOI 10.1128/MCB.18.7.4262; Qian YW, 1998, SCIENCE, V282, P1701, DOI 10.1126/science.282.5394.1701; Seong YS, 2002, J BIOL CHEM, V277, P32282, DOI 10.1074/jbc.M202602200; Shirayama M, 1998, EMBO J, V17, P1336, DOI 10.1093/emboj/17.5.1336; SUNKEL CE, 1988, J CELL SCI, V89, P25; Tavares AAM, 1996, EMBO J, V15, P4873, DOI 10.1002/j.1460-2075.1996.tb00868.x	34	171	178	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2002	277	46					44115	44120		10.1074/jbc.M202172200	http://dx.doi.org/10.1074/jbc.M202172200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	615XE	12207013	hybrid, Green Published			2022-12-27	WOS:000179272000076
J	Murata, T; Sato, K; Hori, M; Ozaki, H; Karaki, H				Murata, T; Sato, K; Hori, M; Ozaki, H; Karaki, H			Decreased endothelial nitric-oxide synthase (eNOS) activity resulting from abnormal interaction between eNOS and its regulatory proteins in hypoxia-induced pulmonary hypertension	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE CELLS; DEPENDENT RELAXATION; VASCULAR ENDOTHELIUM; ARTERY; EXPRESSION; DISEASE; LUNGS; RAT; PROLIFERATION; CALMODULIN	In the pulmonary artery isolated from 1-week hypoxia-induced pulmonary hypertensive rats, endothelial NO production stimulated by carbachol was decreased significantly in in situ visualization using diaminofluorescein-2 diacetate and also in cGMP content. This change was followed by the decrease in carbachol-induced endothelium-dependent relaxation. Protein expression of endothelial NO synthase (eNOS) and its regulatory proteins, caveolin-1 and heat shock protein 90, did not change in the hypoxic pulmonary artery, indicating that chronic hypoxia impairs eNOS activity at posttranslational level. In the hypoxic pulmonary artery, the increase in intracellular Ca2+ level stimulated by carbachol but not by ionomycin was reduced. We next focused on changes in Ca2+ sensitivity of the eNOS activation system. A morphological study revealed atrophy of endothelial cells and a peripheral condensation of eNOS in hypoxic endothelial cells preserving co-localization between eNOS and Golgi or plasma membranes. However, eNOS was tightly coupled with caveolin-1, and was dissociated from heat shock protein 90 or calmodulin in the hypoxic pulmonary artery in either the presence or absence of carbachol. Furthermore, eNOS Ser(1177) phosphorylation in both conditions significantly decreased without affecting Akt phosphorylation in the hypoxic artery. In conclusion, chronic hypoxia impairs endothelial Ca2+ metabolism and normal coupling between eNOS and caveolin-1 resulted in eNOS inactivity.	Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Dept Vet Pharmacol, Tokyo 1138657, Japan; Univ Tokyo, Grad Sch Agr & Life Sci, Dept Radio Isotope Ctr, Bunkyo Ku, Tokyo 1138657, Japan	University of Tokyo; University of Tokyo	Murata, T (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Dept Vet Pharmacol, Tokyo 1138657, Japan.			Murata, Takahisa/0000-0002-3328-0796				Barbera J A, 2000, Monaldi Arch Chest Dis, V55, P445; Broillet MC, 2001, FEBS LETT, V491, P227, DOI 10.1016/S0014-5793(01)02206-2; BUSSE R, 1990, FEBS LETT, V265, P133, DOI 10.1016/0014-5793(90)80902-U; Chen YF, 2000, AM J MED SCI, V320, P223, DOI 10.1097/00000441-200010000-00001; EDDAHIBI S, 1992, AM J PHYSIOL, V263, P194; Fleming I, 2001, CIRC RES, V88, pE68, DOI 10.1161/hh1101.092677; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Gaine S, 2000, JAMA-J AM MED ASSOC, V284, P3160, DOI 10.1001/jama.284.24.3160; GarciaCardena G, 1996, P NATL ACAD SCI USA, V93, P6448, DOI 10.1073/pnas.93.13.6448; GIAID A, 1995, NEW ENGL J MED, V333, P214, DOI 10.1056/NEJM199507273330403; Govers R, 2001, AM J PHYSIOL-RENAL, V280, pF193, DOI 10.1152/ajprenal.2001.280.2.F193; Gratton JP, 2000, J BIOL CHEM, V275, P22268, DOI 10.1074/jbc.M001644200; Hampl V, 2000, PHYSIOL REV, V80, P1337, DOI 10.1152/physrev.2000.80.4.1337; Jiang Z, 2001, J Extra Corpor Technol, V33, P23; Komai H, 2001, CARDIOVASC PATHOL, V10, P29, DOI 10.1016/S1054-8807(00)00063-6; LeCras TD, 1996, AM J PHYSIOL-LUNG C, V270, pL164, DOI 10.1152/ajplung.1996.270.1.L164; LUCKHOFF A, 1990, PFLUG ARCH EUR J PHY, V416, P305, DOI 10.1007/BF00392067; Maeda Y, 2000, J PHARMACOL EXP THER, V292, P387; Maier W, 2000, J CARDIOVASC PHARM, V35, P173, DOI 10.1097/00005344-200002000-00001; Mason NA, 1998, J PATHOL, V185, P313, DOI 10.1002/(SICI)1096-9896(199807)185:3<313::AID-PATH93>3.0.CO;2-8; Michel JB, 1997, J BIOL CHEM, V272, P15583, DOI 10.1074/jbc.272.25.15583; Murata T, 2001, LIFE SCI, V69, P2685, DOI 10.1016/S0024-3205(01)01352-2; Murata T, 2001, EUR J PHARMACOL, V421, P45, DOI 10.1016/S0014-2999(01)01015-9; Nakazawa H, 1999, BRIT J PHARMACOL, V128, P1098, DOI 10.1038/sj.bjp.0702878; Rabinovitch M, 2001, J CLIN INVEST, V108, P1109; RABINOVITCH M, 1986, LAB INVEST, V55, P632; Resta TC, 1997, AM J PHYSIOL-HEART C, V272, pH806, DOI 10.1152/ajpheart.1997.272.2.H806; Rudic RD, 1998, J CLIN INVEST, V101, P731, DOI 10.1172/JCI1699; SATO K, 1990, J PHARMACOL EXP THER, V255, P114; SESSA WC, 1995, J BIOL CHEM, V270, P17641, DOI 10.1074/jbc.270.30.17641; SHAUL PW, 1993, J CARDIOVASC PHARM, V22, P819, DOI 10.1097/00005344-199312000-00007; Sugimoto K, 2000, HISTOCHEM CELL BIOL, V113, P341; Tyler RC, 1999, AM J PHYSIOL-LUNG C, V276, pL297, DOI 10.1152/ajplung.1999.276.2.L297; Veyssier-Belot C, 1999, CARDIOVASC RES, V44, P274, DOI 10.1016/S0008-6363(99)00230-8; Voelkel NF, 2000, J CLIN INVEST, V106, P733, DOI 10.1172/JCI11144; Wang J, 1997, J CLIN INVEST, V100, P2347, DOI 10.1172/JCI119774; WANSTALL JC, 1992, BRIT J PHARMACOL, V107, P407, DOI 10.1111/j.1476-5381.1992.tb12759.x; XUE C, 1995, NEW ENGL J MED, V333, P1642; Xue C, 1996, HYPERTENSION, V28, P743, DOI 10.1161/01.HYP.28.5.743; XUE C, 1994, AM J PHYSIOL-LUNG C, V267, pL667, DOI 10.1152/ajplung.1994.267.6.L667	40	121	132	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	2002	277	46					44085	44092		10.1074/jbc.M205934200	http://dx.doi.org/10.1074/jbc.M205934200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	615XE	12185080	hybrid			2022-12-27	WOS:000179272000072
J	Panaretakis, T; Pokrovskaja, K; Shoshan, MC; Grander, D				Panaretakis, T; Pokrovskaja, K; Shoshan, MC; Grander, D			Activation of Bak, Bax, and BH3-only proteins in the apoptotic response to doxorubicin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C RELEASE; MITOCHONDRIAL DYSFUNCTION; BCL-2; CISPLATIN; CLEAVAGE; SURVIVAL; CALPAIN; CONFORMATION; DOMAIN; CELLS	The anthracyclin doxorubicin (DXR) is a major antitumor agent known to cause cellular damage via a number of mechanisms including free radical formation and inhibition of topoisomerase II. It is not clear, however, how the subsequent lesions may lead to the apoptotic death of the cell. We have here examined the effects of DXR on activation of pro-apoptotic members of the Bcl-2 family, all of which are connected to the mitochondrial events of apoptosis. In two human cell lines (lymphoma and myeloma), clinically relevant concentrations of DXR were found to induce apoptosis, first observed after 24 It of treatment. Apoptosis correlated with modulation of Bak and Bax to their active conformations. bax-as well as bak-deficient mouse embryo fibroblasts were resistant to DXR compared with wild-type mouse embryo fibroblasts further supporting a role for these proteins as main DXR-induced apoptosis regulators. Furthermore, using immunocytochemistry as well as chemical blocking of putative apical pathways we could demonstrate that Bak is activated prior to Bax. In the human cell lines, DXR was furthermore found to induce high protein levels of Bik, another BH3-only protein. DXR-induced apoptosis was completely blocked in Bcl-2-overexpressing U266 cells. Interestingly, in Bcl-2-transfected cells Bak activation was also blocked, while Bax was still partially active in agreement with differential regulation of these two proteins. Furthermore, co-incubation of the phosphatidylinositol 3-kinase (PI3K)-inhibitor LY294002 potentiated the apoptotic response to DXR. This enhanced apoptosis was preceded by enhanced Bak and Bax activation, and both responses as well as apoptosis were blocked in transfectants overexpressing Bcl-2. In summary, several pieces of evidence suggest that DXR induces apoptosis through a sequential and differential activation of Bak and Bax.	Karolinska Hosp & Inst, Canc Ctr Karolinska, Dept Pathol & Oncol, S-17176 Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital	Grander, D (corresponding author), Karolinska Hosp & Inst, Canc Ctr Karolinska, Dept Pathol & Oncol, S-17176 Stockholm, Sweden.	Dan.Grander@cck.ki.se		Panaretakis, Theocharis/0000-0001-5754-6950; Pokrovskaja Tamm, Katja/0000-0001-6359-1256				Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Cuvillier O, 2001, CELL DEATH DIFFER, V8, P162, DOI 10.1038/sj.cdd.4400793; Decaudin D, 1997, CANCER RES, V57, P62; Depowski PL, 2001, MODERN PATHOL, V14, P672, DOI 10.1038/modpathol.3880371; Desagher S, 2000, TRENDS CELL BIOL, V10, P369, DOI 10.1016/S0962-8924(00)01803-1; Desagher S, 1999, J CELL BIOL, V144, P891, DOI 10.1083/jcb.144.5.891; Dijkers PF, 2002, J CELL BIOL, V156, P531, DOI 10.1083/jcb.200108084; Finnegan NM, 2001, BRIT J CANCER, V85, P115, DOI 10.1054/bjoc.2001.1850; Gamen S, 2000, EXP CELL RES, V258, P223, DOI 10.1006/excr.2000.4924; Gao G, 2000, J CELL BIOCHEM, V80, P53; Gewirtz DA, 1999, BIOCHEM PHARMACOL, V57, P727, DOI 10.1016/S0006-2952(98)00307-4; Griffiths GJ, 1999, J CELL BIOL, V144, P903, DOI 10.1083/jcb.144.5.903; Kalivendi SV, 2001, J BIOL CHEM, V276, P47266, DOI 10.1074/jbc.M106829200; Kubbutat MHG, 1997, MOL CELL BIOL, V17, P460, DOI 10.1128/MCB.17.1.460; Loeffler M, 2000, EXP CELL RES, V256, P19, DOI 10.1006/excr.2000.4833; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Lutz RJ, 2000, BIOCHEM SOC T, V28, P51, DOI 10.1042/bst0280051; Mandic A, 2002, MOL CELL BIOL, V22, P3003, DOI 10.1128/MCB.22.9.3003-3013.2002; Mandic A, 2001, MOL CELL BIOL, V21, P3684, DOI 10.1128/MCB.21.11.3684-3691.2001; Marshansky V, 2001, J IMMUNOL, V166, P3130, DOI 10.4049/jimmunol.166.5.3130; Marzo I, 1998, SCIENCE, V281, P2027, DOI 10.1126/science.281.5385.2027; Nechushtan A, 1999, EMBO J, V18, P2330, DOI 10.1093/emboj/18.9.2330; O'Gorman DM, 2000, LEUKEMIA, V14, P602, DOI 10.1038/sj.leu.2401726; Perez-Tenorio G, 2002, BRIT J CANCER, V86, P540, DOI 10.1038/sj.bjc.6600126; Pillaire MJ, 2000, BIOCHEM BIOPH RES CO, V278, P724, DOI 10.1006/bbrc.2000.3877; Stahl M, 2002, J IMMUNOL, V168, P5024, DOI 10.4049/jimmunol.168.10.5024; Wang GQ, 2001, J BIOL CHEM, V276, P34307, DOI 10.1074/jbc.M103526200; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wei MC, 2000, GENE DEV, V14, P2060; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3	30	126	135	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2002	277	46					44317	44326		10.1074/jbc.M205273200	http://dx.doi.org/10.1074/jbc.M205273200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	615XE	12193597	hybrid			2022-12-27	WOS:000179272000102
J	Peck, JW; Oberst, M; Bouker, KB; Bowden, E; Burbelo, PD				Peck, JW; Oberst, M; Bouker, KB; Bowden, E; Burbelo, PD			The RhoA-binding protein, Rhophilin-2, regulates actin cytoskeleton organization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE-THREONINE KINASE; SMALL GTPASE RHO; STRESS FIBERS; TYROSINE PHOSPHORYLATION; PUTATIVE TARGET; SERINE/THREONINE KINASE; MAMMALIAN HOMOLOG; FOCAL ADHESIONS; CELL-ADHESION; IDENTIFICATION	The Rho GTPases regulate the actin cytoskeleton through interactions with various downstream effector molecules. Here we have identified a ubiquitously expressed human RhoA-binding protein, designated Rhophilin-2. Rhophilin-2 shows 40% amino acid similarity to human Rhophilin-1 and contains an N-terminal Rho-binding, a central Bro1-like, and a C-terminal PDZ domain. Glutathione S-transferase-capture experiments revealed that Rhophilin-1 and Rhophilin-2 interacted with both GDP- and GTP-bound RhoA in vitro. Despite the ability of Rhophilin-1 and Rhophilin-2 to interact with RhoA in a nucleotide-independent fashion, Rho-induced serum response element transcriptional activity was not altered by expression of either of these molecules. Although Rhophilin-2-expressing HeLa cells showed a loss of actin stress fibers, Rhophilin-1 expression had no noticeable effect on the actin cytoskeleton. Coexpression of Rhophilin-2 with a constitutively active Rho mutant reversed the disassembly phenotype, in which the coexpressing cells were more spread and less contracted than Rho alone-expressing cells. Expression of various Rhophilin-2 deletion and point mutants containing the N-terminal RhoA-binding domain but lacking other regions suggested that the disassembly of F-actin stress fibers was not simply caused by Rho sequestration. In addition, the Bro1 and PDZ domains of Rhophilin-2 were required for disassembly. RhoA activity assays also revealed that Rhophilin-2-expressing cells showed increased levels of RhoA-GTP suggesting that the Rhophilin-2-induced disassembly of stress fibers was not mediated by decreased RhoA activity. Based on the biochemical and biological activity, Rhophilin-2 may function normally in a Rho pathway to limit stress fiber formation and/or increase the turnover of F-actin structures in the absence of high levels of RhoA activity.	Georgetown Univ, Med Ctr, Vincent T Lombardi Canc Res Ctr, Washington, DC 20007 USA	Georgetown University	Burbelo, PD (corresponding author), Georgetown Univ, Med Ctr, Vincent T Lombardi Canc Res Ctr, Rm W210,New Res Bldg,3970 Reservoir Rd NW, Washington, DC 20007 USA.	burbelpd@georgetown.edu			NCI NIH HHS [R29 CA422142] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alberts AS, 2001, J BIOL CHEM, V276, P2824, DOI 10.1074/jbc.M006205200; Amano M, 1996, SCIENCE, V271, P648, DOI 10.1126/science.271.5249.648; Amano M, 1997, SCIENCE, V275, P1308, DOI 10.1126/science.275.5304.1308; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Borinstein SC, 2000, CELL SIGNAL, V12, P769, DOI 10.1016/S0898-6568(00)00129-7; Bourbon HM, 2002, MECH DEVELOP, V110, P71, DOI 10.1016/S0925-4773(01)00566-4; Brill S, 1996, MOL CELL BIOL, V16, P4869; Burbelo PD, 1999, P NATL ACAD SCI USA, V96, P9083, DOI 10.1073/pnas.96.16.9083; Cao LG, 1998, J BIOL CHEM, V273, P21077, DOI 10.1074/jbc.273.33.21077; Caron E, 1998, SCIENCE, V282, P1717, DOI 10.1126/science.282.5394.1717; Che SL, 1999, J BIOL CHEM, V274, P5522, DOI 10.1074/jbc.274.9.5522; Chen B, 2000, J BIOL CHEM, V275, P19275, DOI 10.1074/jbc.M908994199; ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403; Clark EA, 1998, J CELL BIOL, V142, P573, DOI 10.1083/jcb.142.2.573; Drechsel DN, 1997, CURR BIOL, V7, P12, DOI 10.1016/S0960-9822(06)00023-6; Fujita A, 2000, J CELL SCI, V113, P103; Fukuhara S, 1999, J BIOL CHEM, V274, P5868, DOI 10.1074/jbc.274.9.5868; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; HILL CS, 1995, CELL, V81, P1159, DOI 10.1016/S0092-8674(05)80020-0; Hotchin NA, 1995, J CELL BIOL, V131, P1857, DOI 10.1083/jcb.131.6.1857; Ishizaki T, 1997, FEBS LETT, V404, P118, DOI 10.1016/S0014-5793(97)00107-5; Jackson M, 2001, NATURE, V410, P89, DOI 10.1038/35065091; Kato T, 2001, J CELL SCI, V114, P775; KISHI K, 1993, J CELL BIOL, V120, P1187, DOI 10.1083/jcb.120.5.1187; Kosako H, 2000, ONCOGENE, V19, P6059, DOI 10.1038/sj.onc.1203987; KUMAGAI N, 1993, J BIOL CHEM, V268, P24535; LEUNG T, 1995, J BIOL CHEM, V270, P29051, DOI 10.1074/jbc.270.49.29051; Madaule P, 1998, NATURE, V394, P491, DOI 10.1038/28873; Matsui T, 1996, EMBO J, V15, P2208, DOI 10.1002/j.1460-2075.1996.tb00574.x; Missotten M, 1999, CELL DEATH DIFFER, V6, P124, DOI 10.1038/sj.cdd.4400456; Morissette MR, 2000, AM J PHYSIOL-HEART C, V278, pH1769, DOI 10.1152/ajpheart.2000.278.6.H1769; Muller JM, 2002, EMBO J, V21, P736, DOI 10.1093/emboj/21.4.736; NegreteUrtasun S, 1997, J BACTERIOL, V179, P1832, DOI 10.1128/jb.179.5.1832-1835.1997; Nickas ME, 1996, MOL CELL BIOL, V16, P2585; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; PATERSON HF, 1990, J CELL BIOL, V111, P1001, DOI 10.1083/jcb.111.3.1001; Patrie KM, 2002, J BIOL CHEM, V277, P30183, DOI 10.1074/jbc.M203072200; Pirone DM, 2000, J BIOL CHEM, V275, P22650, DOI 10.1074/jbc.M002832200; RANKIN S, 1994, FEBS LETT, V354, P315, DOI 10.1016/0014-5793(94)01148-6; Reid T, 1996, J BIOL CHEM, V271, P13556, DOI 10.1074/jbc.271.23.13556; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Ren XD, 2000, METHOD ENZYMOL, V325, P264; Ren XD, 1996, MOL BIOL CELL, V7, P435, DOI 10.1091/mbc.7.3.435; Reynaud C, 2000, J BIOL CHEM, V275, P33962, DOI 10.1074/jbc.M000465200; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Ridley AJ, 1999, NAT CELL BIOL, V1, pE64, DOI 10.1038/11034; Rottner K, 1999, CURR BIOL, V9, P640, DOI 10.1016/S0960-9822(99)80286-3; SATOH S, 2001, J BIOL CHEM, V16, P16; SECKL MJ, 1995, J BIOL CHEM, V270, P6984, DOI 10.1074/jbc.270.12.6984; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Springael JY, 2002, FEBS LETT, V517, P103, DOI 10.1016/S0014-5793(02)02586-3; TAKAISHI K, 1995, ONCOGENE, V11, P39; Tian DH, 2002, MOL CELL BIOL, V22, P2650, DOI 10.1128/MCB.22.8.2650-2662.2002; Tominaga T, 2000, MOL CELL, V5, P13, DOI 10.1016/S1097-2765(00)80399-8; Vincent S, 1997, MOL CELL BIOL, V17, P2247, DOI 10.1128/MCB.17.4.2247; Vito P, 1999, J BIOL CHEM, V274, P1533, DOI 10.1074/jbc.274.3.1533; Watanabe G, 1996, SCIENCE, V271, P645, DOI 10.1126/science.271.5249.645; Watanabe N, 1997, EMBO J, V16, P3044, DOI 10.1093/emboj/16.11.3044; Watanabe N, 1999, NAT CELL BIOL, V1, P136, DOI 10.1038/11056; Xu WJ, 2001, J BACTERIOL, V183, P6917, DOI 10.1128/JB.183.23.6917-6923.2001	62	60	62	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2002	277	46					43924	43932		10.1074/jbc.M203569200	http://dx.doi.org/10.1074/jbc.M203569200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	615XE	12221077	hybrid			2022-12-27	WOS:000179272000052
J	Tauchi-Sato, K; Ozeki, S; Houjou, T; Taguchi, R; Fujimoto, T				Tauchi-Sato, K; Ozeki, S; Houjou, T; Taguchi, R; Fujimoto, T			The surface of lipid droplets is a phospholipid monolayer with a unique fatty acid composition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THIN-LAYER-CHROMATOGRAPHY; GPI-ANCHORED PROTEINS; ELECTRON-MICROSCOPY; CHOLESTEROL; CAVEOLIN; CELLS; LIPOSOMES; BODIES	We found that caveolin-2 is targeted to the surface of lipid droplets (Fujimoto, T., Kogo, H., Ishiguro, K., Tauchi, K., and Nomura, R. (2001) J. Cell Biol. 152,1079-1085) and hypothesized that the lipid droplet surface is a kind of membrane. To elucidate the characteristics of the lipid droplet surface, we isolated lipid droplets from HepG2 cells and analyzed them by cryoelectron microscopy and by mass spectrometry. By use of cryoelectron microscopy at the stage temperature of 4.2 K, the lipid droplet surface was observed as a single line without any fixation or staining, indicating the presence of a single layer of phospholipids. This result appeared consistent with the hypothesis that the lipid droplet surface is derived from the cytoplasmic leaflet of the endoplasmic reticulum membrane and may be continuous to it. However, mass spectrometry revealed that the fatty acid composition of phosphatidylcholine and lysophosphatidylcholine in lipid droplets is different from that of the rough endoplasmic reticulum. The ample presence of free cholesterol in lipid droplets also suggests that their surface is differentiated from the bulk endoplasmic reticulum. membrane. On the other hand, although caveolin-2beta and adipose differentiation-related protein, both localizing in lipid droplets, were enriched in the low density floating fraction, the fatty acid composition of the fraction was distinct from lipid droplets. Collectively, the result indicates that the lipid droplet surface is a hemi-membrane or a phospholipid monolayer containing cholesterol but is compositionally different from the endoplasmic reticulum membrane or the sphingolipid/cholesterol-rich microdomain.	Nagoya Univ, Grad Sch Med, Dept Anat & Mol Cell Biol, Nagoya, Aichi 4668550, Japan; Nagoya City Univ, Dept Biol Mol, Grad Sch Pharmaceut Sci, Nagoya, Aichi 4678603, Japan	Nagoya University; Nagoya City University	Fujimoto, T (corresponding author), Nagoya Univ, Grad Sch Med, Dept Anat & Mol Cell Biol, 65 Tsurumai, Nagoya, Aichi 4668550, Japan.	tfujimot@med.nagoya-u.ac.jp	Fujimoto, Toyoshi/ABH-9058-2020	Fujimoto, Toyoshi/0000-0002-3601-7977				ADRIAN M, 1984, NATURE, V308, P32, DOI 10.1038/308032a0; BLANCHETTEMACKIE EJ, 1995, J LIPID RES, V36, P1211; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; Brown DA, 2001, CURR BIOL, V11, pR446, DOI 10.1016/S0960-9822(01)00257-3; CHANG CCY, 1995, J BIOL CHEM, V270, P29532; Cole NB, 2002, J BIOL CHEM, V277, P6344, DOI 10.1074/jbc.M108414200; Field KA, 1997, J BIOL CHEM, V272, P4276, DOI 10.1074/jbc.272.7.4276; Fiske CH, 1925, J BIOL CHEM, V66, P375; FUJIMOTO K, 1995, J CELL SCI, V108, P3443; Fujimoto T, 1997, J HISTOCHEM CYTOCHEM, V45, P595, DOI 10.1177/002215549704500411; Fujimoto T, 2001, J CELL BIOL, V152, P1079, DOI 10.1083/jcb.152.5.1079; FUJIYOSHI Y, 1980, ULTRAMICROSCOPY, V5, P459, DOI 10.1016/S0304-3991(80)80004-0; FUJIYOSHI Y, 1991, ULTRAMICROSCOPY, V38, P241, DOI 10.1016/0304-3991(91)90159-4; FUJIYOSHI Y, 1994, EMBO J, V13, P318, DOI 10.1002/j.1460-2075.1994.tb06264.x; GAMBLE W, 1978, J LIPID RES, V19, P1068; Kellner-Weibel G, 2001, J LIPID RES, V42, P768; LANGE Y, 1989, J BIOL CHEM, V264, P3786; Li SW, 1998, FEBS LETT, V434, P127, DOI 10.1016/S0014-5793(98)00945-4; MACALA LJ, 1983, J LIPID RES, V24, P1243; MCGOOKEY DJ, 1983, J CELL BIOL, V97, P1156, DOI 10.1083/jcb.97.4.1156; MORIMOTO T, 1998, CELLS LAB MANUAL, P1; Murphy DJ, 1999, TRENDS BIOCHEM SCI, V24, P109, DOI 10.1016/S0968-0004(98)01349-8; Ostermeyer AG, 2001, J CELL BIOL, V152, P1071, DOI 10.1083/jcb.152.5.1071; Parton RG, 1996, CURR OPIN CELL BIOL, V8, P542, DOI 10.1016/S0955-0674(96)80033-0; PEIXOTODEMENEZES A, 1979, LAB INVEST, V40, P545; Pol A, 2001, J CELL BIOL, V152, P1057, DOI 10.1083/jcb.152.5.1057; Prattes S, 2000, J CELL SCI, V113, P2977; ROUSER G, 1966, LIPIDS, V1, P85, DOI 10.1007/BF02668129; Sato C, 2001, NATURE, V409, P1047, DOI 10.1038/35059098; SCHROEDER R, 1994, P NATL ACAD SCI USA, V91, P12130, DOI 10.1073/pnas.91.25.12130; Shi ST, 2002, VIROLOGY, V292, P198, DOI 10.1006/viro.2001.1225; Song KS, 1996, J BIOL CHEM, V271, P9690, DOI 10.1074/jbc.271.16.9690; Stone SJ, 2000, J BIOL CHEM, V275, P34534, DOI 10.1074/jbc.M002865200; Taguchi R, 2000, J MASS SPECTROM, V35, P953, DOI 10.1002/1096-9888(200008)35:8<953::AID-JMS23>3.0.CO;2-4; TAHARA Y, 1994, MICRON, V25, P141, DOI 10.1016/0968-4328(94)90039-6; van Meer G, 2001, J CELL BIOL, V152, pF29, DOI 10.1083/jcb.152.5.F29; Yu WG, 1998, AM J PATHOL, V152, P759; Yu WG, 2000, BLOOD, V95, P1078, DOI 10.1182/blood.V95.3.1078.003k16_1078_1085; Zweytick D, 2000, BBA-REV BIOMEMBRANES, V1469, P101, DOI 10.1016/S0005-2736(00)00294-7	40	489	512	2	59	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2002	277	46					44507	44512		10.1074/jbc.M207712200	http://dx.doi.org/10.1074/jbc.M207712200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	615XE	12221100	hybrid			2022-12-27	WOS:000179272000122
J	Tsuboi, S; Kotani, Y; Ogawa, K; Hatanaka, T; Yatsushiro, S; Otsuka, M; Moriyama, Y				Tsuboi, S; Kotani, Y; Ogawa, K; Hatanaka, T; Yatsushiro, S; Otsuka, M; Moriyama, Y			An intramolecular disulfide bridge as a catalytic switch for serotonin N-acetyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; PINEAL-GLAND; MELATONIN SYNTHESIS; PROTEASOMAL PROTEOLYSIS; ANGSTROM RESOLUTION; HYDROGEN-PEROXIDE; MECHANISM; PROTEIN; ENZYME; TRANSCRIPTION	Serotonin N-acetyltransferase (EC. 2.3.1.87) (AA-NAT) is a melatonin rhythm-generating enzyme in pineal glands. To establish a melatonin rhythm, AA-NAT activity is precisely regulated through several signaling pathways. Here we show novel regulation of AA-NAT activity, in which an intramolecular disulfide bond may function as a switch for the catalysis. Recombinant AANAT activity was irreversibly inhibited by N-ethylmaleimide (NEM) in an acetyl-CoA-protected manner. Oxidized glutathione or dissolved oxygen reversibly inhibited AA-NAT in an acetyl-CoA-protected manner. To identify the cysteine residues responsible for the inhibition, AA-NAT was first oxidized with dissolved oxygen, treated with NEM, reduced with dithiothreitol, and then labeled with [C-14]NEM. CyS61 and Cys(177) were specifically labeled in an acetyl-CoA-protected manner. The AA-NAT with the Cys(61) to Ala and Cys(177) to Ala double substitutions (C61A/C177A-AA-NAT) was fully active but did not exhibit sensitivity to either oxidation or NEM, whereas the AA-NATs with only the single substitutions retained about 40% of these sensitivities. An intramolecular disulfide bond between Cys(61) and Cys(177) formed upon oxidation and cleaved upon reduction was identified. Furthermore, Cl61A/C177A-AA-NAT expressed in COS7 cells wag relatively insensitive to H2O2-evoked oxidative stress, whereas wild-type AA-NAT was strongly inhibited under the same conditions. These results indicate that the formation and cleavage of the disulfide bond between Cys(61) and Cys(177) produce the active and inactive states of AA-NAT. It is possible that intracellular redox conditions regulate AA-NAT activity through switching via an intramolecular disulfide bridge.	Okayama Univ, Fac Pharmaceut Sci, Dept Biochem, Okayama 7008530, Japan; Res Inst Biol Sci Okayama, Okayama 7161241, Japan	Okayama University	Moriyama, Y (corresponding author), Okayama Univ, Fac Pharmaceut Sci, Dept Biochem, Tsushima 1-1-1, Okayama 7008530, Japan.							ANGELIS JD, 1998, J BIOL CHEM, V273, P3045; Aslund F, 1999, P NATL ACAD SCI USA, V96, P6161, DOI 10.1073/pnas.96.11.6161; AXELROD J, 1974, SCIENCE, V184, P1341, DOI 10.1126/science.184.4144.1341; BORJIGIN J, 1995, NATURE, V378, P783, DOI 10.1038/378783a0; COON SL, 1995, SCIENCE, V270, P1681, DOI 10.1126/science.270.5242.1681; Coon SL, 2001, J BIOL CHEM, V276, P24097, DOI 10.1074/jbc.M011298200; Craft CM, 2000, MOL BRAIN RES, V75, P198, DOI 10.1016/S0169-328X(99)00278-8; De Wit R, 2001, FASEB J, V15, P306; Ferry G, 2000, J BIOL CHEM, V275, P8794, DOI 10.1074/jbc.275.12.8794; Foulkes NS, 1997, TRENDS NEUROSCI, V20, P487, DOI 10.1016/S0166-2236(97)01109-0; Ganguly S, 2001, P NATL ACAD SCI USA, V98, P8083, DOI 10.1073/pnas.141118798; Gastel JA, 1998, SCIENCE, V279, P1358, DOI 10.1126/science.279.5355.1358; Hickman AB, 1999, MOL CELL, V3, P23, DOI 10.1016/S1097-2765(00)80171-9; Hickman AB, 1999, CELL, V97, P361, DOI 10.1016/S0092-8674(00)80745-X; ITO W, 1991, GENE, V102, P67, DOI 10.1016/0378-1119(91)90539-N; Khalil EM, 1998, J BIOL CHEM, V273, P30321, DOI 10.1074/jbc.273.46.30321; Khalil EM, 1998, J AM CHEM SOC, V120, P6195, DOI 10.1021/ja981365a; Klein DC, 1997, RECENT PROG HORM RES, V52, P307; KOSOWER NS, 1983, FUNCTIONS GLUTATHION, P307; Maronde E, 1999, J PINEAL RES, V27, P170, DOI 10.1111/j.1600-079X.1999.tb00613.x; Maronde E, 1999, J NEUROSCI, V19, P3326; Moriyama Y, 2000, J EXP BIOL, V203, P117; MORIYAMA Y, 1987, J BIOL CHEM, V262, P14723; NAMBOODIRI MAA, 1981, SCIENCE, V213, P571, DOI 10.1126/science.7017937; NAMBOODIRI MAA, 1980, J BIOL CHEM, V255, P6032; Obsil T, 2001, CELL, V105, P257, DOI 10.1016/S0092-8674(01)00316-6; REITER RJ, 1991, ENDOCR REV, V12, P151, DOI 10.1210/edrv-12-2-151; ROSEBOOM PH, 1995, MOL PHARMACOL, V47, P439; Scheibner KA, 2002, J BIOL CHEM, V277, P18118, DOI 10.1074/jbc.M200595200; Schomerus C, 2000, J NEUROCHEM, V75, P2123, DOI 10.1046/j.1471-4159.2000.0752123.x; THOMAS KB, 1990, ANAL BIOCHEM, V184, P228, DOI 10.1016/0003-2697(90)90673-W; TOYOOKA T, 1983, J CHROMATOGR, V282, P495, DOI 10.1016/S0021-9673(00)91626-1; Toyooka T., 1988, ANAL CHIM ACTA, V205, P29; Zatz M, 2000, J NEUROCHEM, V74, P2315, DOI 10.1046/j.1471-4159.2000.0742315.x; Zhan-Poe XY, 1999, J PINEAL RES, V27, P49, DOI 10.1111/j.1600-079X.1999.tb00596.x	35	12	12	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	2002	277	46					44229	44235		10.1074/jbc.M203305200	http://dx.doi.org/10.1074/jbc.M203305200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	615XE	12215431	hybrid			2022-12-27	WOS:000179272000091
J	Garrigue-Antar, L; Hartigan, N; Kadler, KE				Garrigue-Antar, L; Hartigan, N; Kadler, KE			Post-translational modification of bone morphogenetic protein-1 is required for secretion and stability of the protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROCOLLAGEN C-PROTEINASE; N-LINKED OLIGOSACCHARIDES; QUALITY-CONTROL; MOLECULAR CHAPERONE; ANGSTROM RESOLUTION; SPERMADHESIN FAMILY; CRYSTAL-STRUCTURE; ENZYME-ACTIVITY; CUB DOMAIN; IN-VITRO	Bone morphogenetic protein (BMP)-1 is a glycosylated metalloproteinase that is fundamental to the synthesis of a normal extracellular matrix because it cleaves type I procollagen, as well as other precursor proteins. Sequence analysis suggests that BMP-1 has six potential N-linked glycosylation sites (i.e. NXS/T) namely: Asn(91) (prodomain), Asn(142) (metalloproteinase domain), Asn(332) and Asn(363) (CUB1 domain), Asn(599) (CUB3 domain), and Asn(726) in the C-terminal-specific domain. In this study we showed that all these sites are N-glycosylated with complex-type oligosaccharides containing sialic acid, except Asn(726) presumably because proline occurs immediately C-terminal of threonine in the consensus sequence. Recombinant BMP-1 molecules lacking all glycosylation sites or the three CUB-specific sites were not secreted. BMP-1 lacking CUB glycosylation was translocated to the proteasome for degradation. BMP-1 molecules lacking individual glycosylation sites were efficiently secreted and exhibited full procollagen C-proteinase activity, but N332Q and N599Q exhibited a slower rate of cleavage. BMP-1 molecules lacking any one of the CUB-specific glycosylation sites were sensitive to thermal denaturation. The study showed that the glycosylation sites in the CUB domains of BMP-1 are important for secretion and stability of the molecule.	Univ Manchester, Sch Biol Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England	University of Manchester	Garrigue-Antar, L (corresponding author), Univ Manchester, Sch Biol Sci, Wellcome Trust Ctr Cell Matrix Res, Stopford Bldg 2-205,Oxford Rd, Manchester M13 9PT, Lancs, England.	laure.garrigue-antar@man.ac.uk	KADLER, KARL/ABI-2403-2020	KADLER, KARL/0000-0003-4977-4683; Garrigue-Antar, Laure/0000-0001-6331-8882				Amano S, 2000, J BIOL CHEM, V275, P22728, DOI 10.1074/jbc.M002345200; BORK P, 1993, J MOL BIOL, V231, P539, DOI 10.1006/jmbi.1993.1305; Charlwood J, 2001, J BIOL CHEM, V276, P16739, DOI 10.1074/jbc.M009361200; Christensen LL, 2000, GLYCOBIOLOGY, V10, P931, DOI 10.1093/glycob/10.9.931; DUMERMUTH E, 1991, J BIOL CHEM, V266, P21381; ELBEIN AD, 1991, FASEB J, V5, P3055, DOI 10.1096/fasebj.5.15.1743438; ELBEIN AD, 1987, ANNU REV BIOCHEM, V56, P497, DOI 10.1146/annurev.biochem.56.1.497; Fenteany G, 1998, J BIOL CHEM, V273, P8545, DOI 10.1074/jbc.273.15.8545; FENTEANY G, 1995, SCIENCE, V268, P726, DOI 10.1126/science.7732382; FINELLI L, 1995, GENETICS, V141, P271; FUKAGAWA M, 1994, DEV BIOL, V163, P175, DOI 10.1006/dbio.1994.1133; Garrigue-Antar L, 2001, J BIOL CHEM, V276, P26237, DOI 10.1074/jbc.M010814200; GAVEL Y, 1990, PROTEIN ENG, V3, P433, DOI 10.1093/protein/3.5.433; Gelman MS, 2002, J BIOL CHEM, V277, P11709, DOI 10.1074/jbc.M111958200; HOJIMA Y, 1985, J BIOL CHEM, V260, P5996; Horton R M, 1993, Methods Mol Biol, V15, P251, DOI 10.1385/0-89603-244-2:251; HWANG SPL, 1994, DEVELOPMENT, V120, P559; Ihara Y, 1999, MOL CELL, V4, P331, DOI 10.1016/S1097-2765(00)80335-4; Imamura Y, 1998, J BIOL CHEM, V273, P27511, DOI 10.1074/jbc.273.42.27511; Imperiali B, 1999, CURR OPIN CHEM BIOL, V3, P643, DOI 10.1016/S1367-5931(99)00021-6; KADLER KE, 1987, J BIOL CHEM, V262, P15696; Kadowaki T, 2000, J BIOL CHEM, V275, P25577, DOI 10.1074/jbc.M003521200; Kessler E, 2001, J BIOL CHEM, V276, P27051, DOI 10.1074/jbc.M102921200; Kessler E, 1996, SCIENCE, V271, P360, DOI 10.1126/science.271.5247.360; KESSLER E, 1986, COLLAGEN REL RES, V6, P249; Kopito RR, 1997, CELL, V88, P427, DOI 10.1016/S0092-8674(00)81881-4; Lehrman MA, 2001, J BIOL CHEM, V276, P8623, DOI 10.1074/jbc.R100002200; Lin XL, 2000, P NATL ACAD SCI USA, V97, P1456, DOI 10.1073/pnas.97.4.1456; Liu Y, 1999, J BIOL CHEM, V274, P5861, DOI 10.1074/jbc.274.9.5861; MAENO M, 1993, GENE, V134, P257, DOI 10.1016/0378-1119(93)90103-A; Marques G, 1997, CELL, V91, P417, DOI 10.1016/S0092-8674(00)80425-0; MARSHALL RD, 1972, ANNU REV BIOCHEM, V41, P673, DOI 10.1146/annurev.bi.41.070172.003325; Martina JA, 1998, J BIOL CHEM, V273, P3725, DOI 10.1074/jbc.273.6.3725; MATSUI C, 1995, J BIOL CHEM, V270, P23496, DOI 10.1074/jbc.270.40.23496; Mimura Y, 2001, J BIOL CHEM, V276, P45539, DOI 10.1074/jbc.M107478200; Mullins MC, 1998, TRENDS GENET, V14, P127, DOI 10.1016/S0168-9525(98)01431-0; Nagai K, 1997, GLYCOBIOLOGY, V7, P769, DOI 10.1093/glycob/7.6.769; NGUYEN T, 1994, DEV BIOL, V166, P569, DOI 10.1006/dbio.1994.1338; Oka T, 2002, J BIOL CHEM, V277, P14724, DOI 10.1074/jbc.M110725200; Panchenko MV, 1996, J BIOL CHEM, V271, P7113, DOI 10.1074/jbc.271.12.7113; Rattenholl A, 2002, J BIOL CHEM, V277, P26372, DOI 10.1074/jbc.M203247200; Romao MJ, 1997, J MOL BIOL, V274, P650, DOI 10.1006/jmbi.1997.1423; Saito Y, 1999, EMBO J, V18, P6718, DOI 10.1093/emboj/18.23.6718; SARENEVA T, 1995, BIOCHEM J, V308, P9, DOI 10.1042/bj3080009; Scott IC, 1999, DEV BIOL, V213, P283, DOI 10.1006/dbio.1999.9383; Scott IC, 2000, J BIOL CHEM, V275, P30504, DOI 10.1074/jbc.M004846200; SHIMELL MJ, 1991, CELL, V67, P469, DOI 10.1016/0092-8674(91)90522-Z; Spiro RG, 2000, J BIOL CHEM, V275, P35657, DOI 10.1074/jbc.R000022200; STOCKER W, 1995, PROTEIN SCI, V4, P823; Suzuki N, 1996, DEVELOPMENT, V122, P3587; Tsukuba T, 1998, J BIOL CHEM, V273, P35260, DOI 10.1074/jbc.273.52.35260; Ujvari A, 2001, J BIOL CHEM, V276, P5924, DOI 10.1074/jbc.M009203200; Unsold C, 2002, J BIOL CHEM, V277, P5596, DOI 10.1074/jbc.M110003200; Varela PF, 1997, J MOL BIOL, V274, P635, DOI 10.1006/jmbi.1997.1424; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; Wang CQ, 1996, BIOCHEMISTRY-US, V35, P7299, DOI 10.1021/bi9517704; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; WYSS DF, 1995, SCIENCE, V269, P1273, DOI 10.1126/science.7544493; Yasuda Y, 1999, EUR J BIOCHEM, V266, P383, DOI 10.1046/j.1432-1327.1999.00863.x	59	40	43	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					43327	43334		10.1074/jbc.M207342200	http://dx.doi.org/10.1074/jbc.M207342200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12218058	hybrid			2022-12-27	WOS:000179081200116
J	Haapasalo, A; Sipola, L; Larsson, K; Akerman, KEO; Stoilov, P; Stamm, S; Wong, G; Castren, E				Haapasalo, A; Sipola, L; Larsson, K; Akerman, KEO; Stoilov, P; Stamm, S; Wong, G; Castren, E			Regulation of TRKB surface expression by brain-derived neurotrophic factor and truncated TRIM Isoforms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CULTURED HIPPOCAMPAL-NEURONS; NERVE GROWTH-FACTOR; TYROSINE KINASE RECEPTORS; AFFINITY NGF RECEPTOR; FULL-LENGTH; SYNAPTIC TRANSMISSION; SIGNAL-TRANSDUCTION; CORTICAL-NEURONS; DOWN-REGULATION; DIFFERENTIAL REGULATION	Brain-derived neurotrophic factor (BDNF) signaling through its receptor TRKB modulates survival, differentiation, and activity of neurons. BDNF activates TRKB on the cell surface, which leads to the initiation of intracellular signaling cascades and different biological responses in neurons. Neuronal activity has been shown to regulate TRKB levels on the plasma membrane of neurons, but little is known about other factors affecting TRKB surface expression levels. We report here that BDNF regulates the cell surface levels of transfected or endogenously expressed full-length TRKB, depending on the exposure time in neuroblastoma cells and primary hippocampal neurons. BDNF rapidly increases TRKB surface expression levels in seconds, whereas treatment of cells with BDNF for a longer time (minutes to hours) leads to decreased TRKB surface levels. Coexpression of the full-length TRKB together with the truncated TRKB.T1 isoform. results in decreased levels of full-length TRKB on the cell surface. This effect is specific to the T1 isoform, because coexpression of a kinase-dead TRKB mutant or another kinase domain-lacking TRKB form, truncated T-Shc, leads to increased TRKB surface levels. Our results suggest that regulation of TRKB surface expression levels by different factors is tightly controlled by complex mechanisms in active neurons.	Univ Kuopio, Dept Neurobiol, AI Virtanen Inst, Kuopio 70211, Finland; Univ Kuopio, Dept Psychiat, Kuopio 70211, Finland; Univ Erlangen Nurnberg, Inst Biochem, D-91054 Erlangen, Germany	University of Eastern Finland; University of Eastern Finland; University of Erlangen Nuremberg	Castren, E (corresponding author), Univ Kuopio, Dept Neurobiol, AI Virtanen Inst, POB 1627, Kuopio 70211, Finland.		Castrén, Eero/A-4618-2010	Castren, Eero/0000-0002-1402-2791; Haapasalo, Annakaisa/0000-0003-0959-2957				ARMANINI MP, 1995, EUR J NEUROSCI, V7, P1403, DOI 10.1111/j.1460-9568.1995.tb01132.x; Balkowiec A, 2000, J NEUROSCI, V20, P7417, DOI 10.1523/jneurosci.20-19-07417.2000; BARBACID M, 1994, J NEUROBIOL, V25, P1386, DOI 10.1002/neu.480251107; BECK KD, 1993, J NEUROSCI, V13, P4001; Bibel M, 1999, EMBO J, V18, P616, DOI 10.1093/emboj/18.3.616; BIFFO S, 1995, DEVELOPMENT, V121, P2461; Canossa M, 1997, P NATL ACAD SCI USA, V94, P13279, DOI 10.1073/pnas.94.24.13279; CARTER BD, 1995, J BIOL CHEM, V270, P21751, DOI 10.1074/jbc.270.37.21751; Drake CT, 1999, J NEUROSCI, V19, P8009; Du J, 2000, J CELL BIOL, V150, P1423, DOI 10.1083/jcb.150.6.1423; Eide FF, 1996, J NEUROSCI, V16, P3123; Frank L, 1997, EXP NEUROL, V145, P62, DOI 10.1006/exnr.1997.6440; FRISEN J, 1993, P NATL ACAD SCI USA, V90, P4971, DOI 10.1073/pnas.90.11.4971; Fryer RH, 1996, J COMP NEUROL, V374, P21, DOI 10.1002/(SICI)1096-9861(19961007)374:1<21::AID-CNE2>3.0.CO;2-P; Geerlings A, 2001, J BIOL CHEM, V276, P17584, DOI 10.1074/jbc.M010602200; Goodman LJ, 1996, MOL CELL NEUROSCI, V7, P222, DOI 10.1006/mcne.1996.0017; Haapasalo A, 1999, ONCOGENE, V18, P1285, DOI 10.1038/sj.onc.1202401; Haapasalo A, 2001, BIOCHEM BIOPH RES CO, V280, P1352, DOI 10.1006/bbrc.2001.4296; HAAPASALO A, 1999, BIOCHEMICA, V3, P20; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HANTZOPOULOS PA, 1994, NEURON, V13, P187, DOI 10.1016/0896-6273(94)90469-3; Hartmann M, 2001, EMBO J, V20, P5887, DOI 10.1093/emboj/20.21.5887; HEMPSTEAD BL, 1991, NATURE, V350, P678, DOI 10.1038/350678a0; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; JING SQ, 1992, NEURON, V9, P1067, DOI 10.1016/0896-6273(92)90066-M; Kafitz KW, 1999, NATURE, V401, P918, DOI 10.1038/44847; KANG HJ, 1995, SCIENCE, V267, P1658, DOI 10.1126/science.7886457; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; KLEIN R, 1991, CELL, V66, P395, DOI 10.1016/0092-8674(91)90628-C; KLEIN R, 1989, EMBO J, V8, P3701, DOI 10.1002/j.1460-2075.1989.tb08545.x; KLEIN R, 1990, CELL, V61, P647, DOI 10.1016/0092-8674(90)90476-U; Knusel B, 1997, NEUROSCIENCE, V78, P851, DOI 10.1016/S0306-4522(96)00616-1; KNUSEL B, 1992, J NEUROCHEM, V59, P1987; Kohara K, 2001, SCIENCE, V291, P2419, DOI 10.1126/science.1057415; Kojima M, 2001, J NEUROSCI RES, V64, P1, DOI 10.1002/jnr.1080; Kostyuk PG, 1999, NEUROSCIENCE, V92, P1157, DOI 10.1016/S0306-4522(99)00221-3; Kruttgen A, 1998, P NATL ACAD SCI USA, V95, P9614, DOI 10.1073/pnas.95.16.9614; Kryl D, 1999, J NEUROSCI, V19, P5823, DOI 10.1523/JNEUROSCI.19-14-05823.1999; LESSMANN V, 1994, NEUROREPORT, V6, P21; LEVINE ES, 1995, P NATL ACAD SCI USA, V92, P8074, DOI 10.1073/pnas.92.17.8074; Lewin GR, 1996, ANNU REV NEUROSCI, V19, P289, DOI 10.1146/annurev.ne.19.030196.001445; Li YX, 1998, P NATL ACAD SCI USA, V95, P10884, DOI 10.1073/pnas.95.18.10884; LOHOF AM, 1993, NATURE, V363, P350, DOI 10.1038/363350a0; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; Meyer-Franke A, 1998, NEURON, V21, P681, DOI 10.1016/S0896-6273(00)80586-3; MIDDLEMAS DS, 1991, MOL CELL BIOL, V11, P143, DOI 10.1128/MCB.11.1.143; Ninkina N, 1996, EMBO J, V15, P6385, DOI 10.1002/j.1460-2075.1996.tb01029.x; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Pozzo-Miller LD, 1999, J NEUROSCI, V19, P4972; Rubio N, 1997, EUR J NEUROSCI, V9, P1847, DOI 10.1111/j.1460-9568.1997.tb00751.x; Saarelainen T, 2001, CELL MOL NEUROBIOL, V21, P429, DOI 10.1023/A:1012775808253; SCHNEIDER R, 1991, ONCOGENE, V6, P1807; Sommerfeld MT, 2000, J BIOL CHEM, V275, P8982, DOI 10.1074/jbc.275.12.8982; SOPPET D, 1991, CELL, V65, P895, DOI 10.1016/0092-8674(91)90396-G; SQUINTO SP, 1991, CELL, V65, P885, DOI 10.1016/0092-8674(91)90395-F; Stoilov P, 2002, BIOCHEM BIOPH RES CO, V290, P1054, DOI 10.1006/bbrc.2001.6301; Takei N, 1997, J NEUROCHEM, V68, P370; Weible MW, 2001, CYTOMETRY, V43, P182, DOI 10.1002/1097-0320(20010301)43:3<182::AID-CYTO1047>3.0.CO;2-J; WIDMER HR, 1993, BRAIN RES, V614, P325, DOI 10.1016/0006-8993(93)91051-S; Xia ZG, 1996, J NEUROSCI, V16, P5425; Yacoubian TA, 2000, NAT NEUROSCI, V3, P342, DOI 10.1038/73911	61	118	125	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					43160	43167		10.1074/jbc.M205202200	http://dx.doi.org/10.1074/jbc.M205202200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12202482	hybrid			2022-12-27	WOS:000179081200097
J	Madhankumar, AB; Mintz, A; Debinski, W				Madhankumar, AB; Mintz, A; Debinski, W			Alanine-scanning mutagenesis of alpha-helix D segment of interleukin 13 reveals new functionally important residues of the cytokine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR; BINDING; CELLS; IL-13; EXPRESSION; COMPONENT; CLONING; SITES; IL4	We documented that a-helices A, C, and D in human interleukin-13 (IL13) participate in interaction with its respective receptors. We hypothesized that a-helix D is the site II of the cytokine that binds IL13Ralpha1, a component of the normal tissue heterodimeric signaling IL13/4 receptor (IL13/4R), and that a-helix D independently binds a monomeric IL13Ralpha2 receptor, which is a nonsignaling glioma-restricted receptor for IL13. Therefore, we alanine-scanned mutagenized helix D of IL13 to identify the residues involved in the respective receptors interaction. Recombinant muteins of IL13 were produced in Escherichia coli, and their structural integrity and identity were verified. The alanine mutants were tested in functional cellular assays, in which IL13 interaction with IL13Ralpha2 (glioma cells) or an ability to functionally stimulate IL13/4R (TF-1 cells) were examined, and also in binding assays. We found that residues 105, 106, and 109 of the D-helix of IL13 are responsible for interacting with the glioma-associated receptor. Moreover, glutamic acids at positions 92 and 110, and leucine at position 104 was found to be important for IL13/4R stimulation. Thus, alpha-helix D of IL13 is the primary site responsible for interaction with the IL13 binding proteins. We propose a model that illustrates the binding mode of IL13 with cancer-related IL13Ralpha2 and physiological IL13/4R.	Penn State Univ, Coll Med, Dept Surg, Neurosurg Sect, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Debinski, W (corresponding author), Penn State Univ, Coll Med, Dept Surg, Neurosurg Sect, 500 Univ Dr, Hershey, PA 17033 USA.	wdebinski@psu.edu			NCI NIH HHS [2R01-CA74145] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA074145] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALTENBACH C, 1990, SCIENCE, V248, P1088, DOI 10.1126/science.2160734; BALDWIN R L, 1991, Current Biology, V1, P218, DOI 10.1016/0960-9822(91)90061-Z; Caput D, 1996, J BIOL CHEM, V271, P16921, DOI 10.1074/jbc.271.28.16921; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; de Vries JE, 1998, J ALLERGY CLIN IMMUN, V102, P165, DOI 10.1016/S0091-6749(98)70080-6; Debinski W, 1998, CRIT REV ONCOGENESIS, V9, P255; Debinski W, 1998, NAT BIOTECHNOL, V16, P449, DOI 10.1038/nbt0598-449; DEBINSKI W, 1993, J BIOL CHEM, V268, P14065; Debinski W, 1995, CLIN CANCER RES, V1, P1253; Debinski W, 1996, J BIOL CHEM, V271, P22428, DOI 10.1074/jbc.271.37.22428; DEBINSKI W, 1995, J BIOL CHEM, V270, P16775, DOI 10.1074/jbc.270.28.16775; Debinski W, 1999, CLIN CANCER RES, V5, p3143S; Debinski W, 2000, MOL MED, V6, P440, DOI 10.1007/BF03401786; DENG WP, 1992, ANAL BIOCHEM, V200, P81, DOI 10.1016/0003-2697(92)90280-K; Eisenmesser EZ, 2001, J MOL BIOL, V310, P231, DOI 10.1006/jmbi.2001.4765; GOLDENBERG DP, 1989, NATURE, V338, P127, DOI 10.1038/338127a0; Hilton DJ, 1996, P NATL ACAD SCI USA, V93, P497, DOI 10.1073/pnas.93.1.497; HUANG SK, 1995, J IMMUNOL, V155, P2688; JUNG K, 1993, BIOCHEMISTRY-US, V32, P12273, DOI 10.1021/bi00097a001; KITAMURA T, 1989, J CELL PHYSIOL, V140, P323, DOI 10.1002/jcp.1041400219; KRUSE N, 1993, EMBO J, V12, P5121, DOI 10.1002/j.1460-2075.1993.tb06207.x; MCKENZIE ANJ, 1993, P NATL ACAD SCI USA, V90, P3735, DOI 10.1073/pnas.90.8.3735; Miloux B, 1997, FEBS LETT, V401, P163, DOI 10.1016/S0014-5793(96)01462-7; MINTY A, 1993, NATURE, V362, P248, DOI 10.1038/362248a0; Mintz A, 2002, NEOPLASIA, V4, P388, DOI 10.1038/sj.neo.7900234; Moy FJ, 2001, J MOL BIOL, V310, P219, DOI 10.1006/jmbi.2001.4764; Nash KT, 2001, CRIT REV ONCOL HEMAT, V39, P87, DOI 10.1016/S1040-8428(01)00124-X; SALACINSKI PRP, 1981, ANAL BIOCHEM, V117, P136, DOI 10.1016/0003-2697(81)90703-X; SCHULZ GE, 1979, PRINCIPLES PROTEIN S, P1; SPRANG SR, 1993, CURR OPIN STRUC BIOL, V3, P815, DOI 10.1016/0959-440X(93)90144-A; Thompson JP, 1999, J BIOL CHEM, V274, P29944, DOI 10.1074/jbc.274.42.29944; TONY HP, 1994, EUR J BIOCHEM, V225, P659, DOI 10.1111/j.1432-1033.1994.00659.x; WILLIAMS SC, 2000, RRD MOLEC CELL BIOL, V1, P19; ZURAWSKI SM, 1993, EMBO J, V12, P2663, DOI 10.1002/j.1460-2075.1993.tb05927.x	34	41	50	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					43194	43205		10.1074/jbc.M205047200	http://dx.doi.org/10.1074/jbc.M205047200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12189139	hybrid			2022-12-27	WOS:000179081200101
J	Sakane, F; Imai, S; Yamada, K; Murakami, T; Tsushima, S; Kanoh, H				Sakane, F; Imai, S; Yamada, K; Murakami, T; Tsushima, S; Kanoh, H			Alternative splicing of the human diacylglycerol kinase 8 gene generates two isoforms differing in their expression patterns and in regulatory functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLECKSTRIN HOMOLOGY DOMAIN; MOLECULAR-CLONING; ZETA; ALPHA; ACTIVATION; MECHANISM; RECEPTOR; ISOZYME; FAMILY; CELLS	Diacylglycerol kinase (DGK) plays an important role in signal transduction through modulating the balance between two signaling lipids, diacylglycerol and phosphatidic acid. DGKdelta (type II isozyme) contains a pleckstrin homology domain at the N terminus and a sterile a motif domain at the C terminus. We identified another DGKdelta isoform (DGKdelta2, 135 kDa) that shared the same sequence with DGKdelta previously cloned (DGKdelta1, 130 kDa) except for the 52 residues N-terminally extended. Analysis of panels of human normal and tumor tissue cDNAs revealed that DGKdelta2 was ubiquitously expressed in all normal and tumor tissues examined, whereas the transcript of DGKdelta1 was detected only in ovary and spleen, and in a limited set of tumor-derived cells. The expression of DGKdelta2 was induced by treating cells with epidermal growth factor and tumor-promoting phorbol ester. In contrast, the levels of mRNA and protein of DGKdelta1 were suppressed by phorbol ester treatment. It thus becomes clear that the two DGKdelta isoforms are expressed under distinct regulatory mechanisms. DGKdelta1 was translocated through its pleckstrin homology domain from the cytoplasm to the plasma membrane in response to phorbol ester stimulation, whereas DGKdelta2 remained in the cytoplasm even after stimulation. Further experiments showed that the delta2-specific N-terminal sequence blocks the phorbol ester-dependent translocation of this isoform. Co-immunoprecipitation analysis of differently tagged DGKdelta1 and DGKdelta2 proteins showed that they were able to form homo- as well as hetero-oligomers. Taken together, alternative splicing of the human DGKdelta gene generates at least two isoforms, differing in their expressions and regulatory functions.	Sapporo Med Univ, Sch Med, Dept Biochem, Chuo Ku, Sapporo, Hokkaido 0608556, Japan; Sapporo Med Univ, Sch Hlth Sci, Dept Liberal Arts & Sci, Chuo Ku, Sapporo, Hokkaido 0608556, Japan	Sapporo Medical University; Sapporo Medical University	Sakane, F (corresponding author), Sapporo Med Univ, Sch Med, Dept Biochem, Chuo Ku, South 1,West 17, Sapporo, Hokkaido 0608556, Japan.	sakane@sapmed.ac.jp	Sakane, Fumio/H-2693-2017	Sakane, Fumio/0000-0003-0857-0377				ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; Bunting M, 1996, J BIOL CHEM, V271, P10230, DOI 10.1074/jbc.271.17.10230; Caricasole A, 2002, J BIOL CHEM, V277, P4790, DOI 10.1074/jbc.M110249200; Ding L, 1998, J BIOL CHEM, V273, P32746, DOI 10.1074/jbc.273.49.32746; Ding L, 1997, P NATL ACAD SCI USA, V94, P5519, DOI 10.1073/pnas.94.11.5519; English D, 1996, CELL SIGNAL, V8, P341, DOI 10.1016/0898-6568(95)00076-3; EXTON JH, 1994, BBA-LIPID LIPID MET, V1212, P26, DOI 10.1016/0005-2760(94)90186-4; GOTO K, 1994, P NATL ACAD SCI USA, V91, P13042, DOI 10.1073/pnas.91.26.13042; GOTO K, 1993, P NATL ACAD SCI USA, V90, P7598, DOI 10.1073/pnas.90.16.7598; Houssa B, 1997, J BIOL CHEM, V272, P10422; Hurley JH, 1997, PROTEIN SCI, V6, P477; Imai S, 2002, J BIOL CHEM, V277, P35323, DOI 10.1074/jbc.M202035200; Isakoff SJ, 1998, EMBO J, V17, P5374, DOI 10.1093/emboj/17.18.5374; Jiang Y, 2000, J BIOL CHEM, V275, P34092, DOI 10.1074/jbc.M004914200; KAI M, 1994, J BIOL CHEM, V269, P18492; KANOH H, 1990, TRENDS BIOCHEM SCI, V15, P47, DOI 10.1016/0968-0004(90)90172-8; Kanoh H, 2002, J BIOCHEM, V131, P629, DOI 10.1093/oxfordjournals.jbchem.a003144; Klauck TM, 1996, J BIOL CHEM, V271, P19781, DOI 10.1074/jbc.271.33.19781; LEE W, 1987, CELL, V49, P741, DOI 10.1016/0092-8674(87)90612-X; Lemmon MA, 2000, BIOCHEM J, V350, P1, DOI 10.1042/0264-6021:3500001; Maffucci T, 2001, FEBS LETT, V506, P173, DOI 10.1016/S0014-5793(01)02909-X; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; Raddatz D, 1996, HEPATOLOGY, V24, P928; Ron D, 1999, FASEB J, V13, P1658, DOI 10.1096/fasebj.13.13.1658; Sakane F, 1997, INT J BIOCHEM CELL B, V29, P1139, DOI 10.1016/S1357-2725(97)00037-X; SAKANE F, 1990, NATURE, V344, P345, DOI 10.1038/344345a0; Sakane F, 1996, J BIOL CHEM, V271, P8394, DOI 10.1074/jbc.271.14.8394; Sanjuan MA, 2001, J CELL BIOL, V153, P207, DOI 10.1083/jcb.153.1.207; SCHAAP D, 1990, FEBS LETT, V275, P151, DOI 10.1016/0014-5793(90)81461-V; Shirai Y, 2000, J BIOL CHEM, V275, P24760, DOI 10.1074/jbc.M003151200; Takeuchi H, 1997, BBA-MOL CELL RES, V1359, P275, DOI 10.1016/S0167-4889(97)00109-2; Tang W, 1996, J BIOL CHEM, V271, P10237, DOI 10.1074/jbc.271.17.10237; Topham MK, 1999, J BIOL CHEM, V274, P11447, DOI 10.1074/jbc.274.17.11447; Topham MK, 1998, NATURE, V394, P697, DOI 10.1038/29337; Topham MK, 2001, J CELL BIOL, V152, P1135, DOI 10.1083/jcb.152.6.1135; van Blitterswijk WJ, 2000, CELL SIGNAL, V12, P595, DOI 10.1016/S0898-6568(00)00113-3	36	81	83	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					43519	43526		10.1074/jbc.M206895200	http://dx.doi.org/10.1074/jbc.M206895200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12200442	hybrid			2022-12-27	WOS:000179081200137
J	Badaut, C; Williams, R; Arluison, V; Bouffartigues, E; Robert, B; Buc, H; Rimsky, S				Badaut, C; Williams, R; Arluison, V; Bouffartigues, E; Robert, B; Buc, H; Rimsky, S			The degree of oligomerization of the H-NS nucleoid structuring protein is related to specific binding to DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI BGL PROMOTER; ESCHERICHIA-COLI; CURVED DNA; PROU OPERON; IN-VITRO; GENE-EXPRESSION; FUNCTIONAL-SIGNIFICANCE; STATIONARY-PHASE; RNA-POLYMERASE; TRANSCRIPTION	At several E. coli promoters, initiation of transcription is repressed by a tight nucleoprotein complex formed by the assembly of the H-NS protein. In order to characterize the relationship between the structure of H-NS oligomers in solution and on relevant DNA fragments, we have compared wild-type H-NS and several transdominant H-NS mutants using gel shift assays, DNase I footprinting, analytical ultracentrifugation, and reactivity toward a cross-linking reagent. In solution, oligomerization occurs through two protein interfaces, one necessary to construct a dimeric core (and involving residues 1-64) and the other required for subsequent assembly of these dimers. We show that, as well as region 64-95, residues present in the NH2-terminal coiled coil domain also participate in this second interface. Our results support the view that the same interacting interfaces are also involved on the DNA. We propose that the dimeric core recognizes specific motifs, with the second interface being critical for their correct head to tail assembly. The COOH-terminal domain of the protein contains the DNA binding motif essential for the discrimination of this specific functional assembly over competitive nonspecific H-NS polymers.	Inst Pasteur, CNRS, URA 1773, F-75724 Paris 15, France; Inst Gustave Roussy, F-94805 Villejuif, France; Inst Gustave Roussy, CNRS, Ecole Normale Super Cachan, UMR 8532, F-94805 Villejuif, France; Commissariat Energie Atom Saclay, CNRS, Sect Biophys Fonct Membranaires, DBJC CEA, F-91191 Gif Sur Yvette, France; Commissariat Energie Atom Saclay, CNRS, URA 2096, F-91191 Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UNICANCER; Gustave Roussy; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS)	Rimsky, S (corresponding author), Inst Gustave Roussy, 39 Rue Camille Desmoulins, F-94805 Villejuif, France.		Bouffartigues, Emeline/CAG-9939-2022; Robert, Bruno/D-1264-2012; Arluison, Veronique S/F-2714-2019	Bouffartigues, Emeline/0000-0003-2569-4961; Robert, Bruno/0000-0001-5999-4538; Arluison, Veronique S/0000-0003-4056-7282; Badaut, Cyril/0000-0002-0064-6384; Rimsky, Sylvie/0000-0003-2654-3014; Williams, Roy/0000-0002-5442-9166				Afflerbach H, 1998, MOL MICROBIOL, V28, P641, DOI 10.1046/j.1365-2958.1998.00829.x; Atlung T, 1997, MOL MICROBIOL, V24, P7, DOI 10.1046/j.1365-2958.1997.3151679.x; BARTH M, 1995, J BACTERIOL, V177, P3455, DOI 10.1128/jb.177.12.3455-3464.1995; Caramel A, 2000, MOL MICROBIOL, V36, P85, DOI 10.1046/j.1365-2958.2000.01827.x; Ceschini S, 2000, J BIOL CHEM, V275, P729, DOI 10.1074/jbc.275.2.729; Dame RT, 2000, NUCLEIC ACIDS RES, V28, P3504, DOI 10.1093/nar/28.18.3504; DERSCH P, 1993, MOL MICROBIOL, V8, P875, DOI 10.1111/j.1365-2958.1993.tb01634.x; DESANTIS P, 1988, BIOPHYS CHEM, V32, P305, DOI 10.1016/0301-4622(88)87016-9; FALCONI M, 1988, MOL MICROBIOL, V2, P323, DOI 10.1111/j.1365-2958.1988.tb00035.x; Falconi M, 1998, EMBO J, V17, P7033, DOI 10.1093/emboj/17.23.7033; Francetic O, 2000, MOL MICROBIOL, V35, P1506, DOI 10.1046/j.1365-2958.2000.01817.x; Free A, 2001, MOL MICROBIOL, V42, P903, DOI 10.1046/j.1365-2958.2001.02678.x; GOWRISHANKAR J, 1989, J BACTERIOL, V171, P1923, DOI 10.1128/jb.171.4.1923-1931.1989; GRABAREK Z, 1990, ANAL BIOCHEM, V185, P131, DOI 10.1016/0003-2697(90)90267-D; HIROTA Y, 1992, NUCL ACIDS S SER, V25, P151; Hommais F, 2001, MOL MICROBIOL, V40, P20, DOI 10.1046/j.1365-2958.2001.02358.x; Jordi BJAM, 1997, J BIOL CHEM, V272, P12083, DOI 10.1074/jbc.272.18.12083; Jordi JAM, 2000, J BIOL CHEM, V275, P12123, DOI 10.1074/jbc.275.16.12123; Levinthal M, 1996, RES MICROBIOL, V147, P333, DOI 10.1016/0923-2508(96)84708-5; LUCHT JM, 1994, J BIOL CHEM, V269, P6578; Mukerji M, 1997, MOL MICROBIOL, V24, P617, DOI 10.1046/j.1365-2958.1997.3621725.x; OWENHUGHES TA, 1992, CELL, V71, P255, DOI 10.1016/0092-8674(92)90354-F; Rajkumari K, 2001, J BACTERIOL, V183, P6543, DOI 10.1128/JB.183.22.6543-6550.2001; Rajkumari K, 1996, J BACTERIOL, V178, P4176, DOI 10.1128/jb.178.14.4176-4181.1996; Rimsky S, 2001, MOL MICROBIOL, V42, P1311, DOI 10.1046/j.1365-2958.2001.02706.x; Schneider R, 2001, NUCLEIC ACIDS RES, V29, P5107, DOI 10.1093/nar/29.24.5107; Schnetz K, 1996, NUCLEIC ACIDS RES, V24, P2422, DOI 10.1093/nar/24.12.2422; SCHNETZ K, 1995, EMBO J, V14, P2545, DOI 10.1002/j.1460-2075.1995.tb07252.x; Schroder O, 2000, J MOL BIOL, V298, P737, DOI 10.1006/jmbi.2000.3708; Shindo H, 1999, FEBS LETT, V455, P63, DOI 10.1016/S0014-5793(99)00862-5; Smyth CP, 2000, MOL MICROBIOL, V36, P962, DOI 10.1046/j.1365-2958.2000.01917.x; SPASSKY A, 1984, NUCLEIC ACIDS RES, V12, P5321, DOI 10.1093/nar/12.13.5321; Spurio R, 1997, EMBO J, V16, P1795, DOI 10.1093/emboj/16.7.1795; Stafford WF, 1997, CURR OPIN BIOTECH, V8, P14, DOI 10.1016/S0958-1669(97)80152-8; TANAKA K, 1994, BIOSCI BIOTECH BIOCH, V58, P1097, DOI 10.1271/bbb.58.1097; TANAKA K, 1991, MOL GEN GENET, V226, P367, DOI 10.1007/BF00260648; Timchenko T, 1996, EMBO J, V15, P3986, DOI 10.1002/j.1460-2075.1996.tb00772.x; TUPPER AE, 1994, EMBO J, V13, P258, DOI 10.1002/j.1460-2075.1994.tb06256.x; Ueguchi C, 1997, J MOL BIOL, V274, P145, DOI 10.1006/jmbi.1997.1381; Ueguchi C, 1996, J MOL BIOL, V263, P149, DOI 10.1006/jmbi.1996.0566; Williams RM, 1996, J BACTERIOL, V178, P4335, DOI 10.1128/jb.178.15.4335-4343.1996; Yarmolinsky M, 2000, CURR OPIN MICROBIOL, V3, P138, DOI 10.1016/S1369-5274(00)00065-5; Zhang AX, 1996, EMBO J, V15, P1340, DOI 10.1002/j.1460-2075.1996.tb00476.x	43	67	69	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					41657	41666		10.1074/jbc.M206037200	http://dx.doi.org/10.1074/jbc.M206037200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12200432	hybrid			2022-12-27	WOS:000178985300047
J	Guo, CY; Brautigan, DL; Larner, JM				Guo, CY; Brautigan, DL; Larner, JM			Ionizing radiation activates nuclear protein phosphatase-1 by ATM-dependent dephosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE CHECKPOINTS; ATAXIA-TELANGIECTASIA; SIGNAL-TRANSDUCTION; HISTONE H1; PHOSPHORYLATION; TYPE-1; ASSOCIATION; MUTATION; DAMAGE; IDENTIFICATION	Ionizing radiation (IR) is known to activate multiple signaling pathways, resulting in diverse stress responses including apoptosis, cell cycle arrest, and gene induction. IR-activated cell cycle checkpoints are regulated by Ser/Thr phosphorylation, so we tested to see if protein phosphatases were targets of an IR-activated damage-sensing pathway. Jurkat cells were subjected to IR or sham radiation followed by brief P-32 metabolic labeling. Nuclear extracts were subjected to microcystin affinity chromatography to recover phosphatases, and the proteins were analyzed by two-dimensional gel electrophoresis. Protein sequencing revealed that the microcystin-bound proteins with the greatest reduction in P-32 intensity following IR were the alpha and delta isoforms of protein phosphatase 1 (PP1). Both of these PP1 isoforms contain an Arg-Pro-Ile/Val-Thr-Pro-Pro-Arg sequence near the C terminus, a known site of phosphorylation by Cdc/Cdk kinases, and phosphorylation attenuates phosphatase activity. In wild-type Jurkat cells or ataxia telangiectasia (AT) cells that are stably transfected with full-length ATM kinase, IR resulted in net dephosphorylation of this site in PP1 and produced activation of PP1. However, in AT cells that are deficient in ATM, IR failed to induce dephosphorylation or activation of PP1. IR-induced PP1 activation in the nucleus may be a critical component in an ATM-mediated pathway controlling checkpoint activation.	Univ Virginia, Dept Radiat Oncol, Charlottesville, VA 22908 USA; Univ Virginia, Sch Med, Ctr Cell Signaling, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia	Larner, JM (corresponding author), Univ Virginia, Dept Radiat Oncol, Box 800383, Charlottesville, VA 22908 USA.				NCI NIH HHS [CA 72622, CA 40042] Funding Source: Medline; NIGMS NIH HHS [GM 56362] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R29CA072622] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056362] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Beamish H, 1996, J BIOL CHEM, V271, P20486, DOI 10.1074/jbc.271.34.20486; Berndt N, 1997, CURR BIOL, V7, P375, DOI 10.1016/S0960-9822(06)00185-0; Campos M, 1996, J BIOL CHEM, V271, P28478, DOI 10.1074/jbc.271.45.28478; Chung HY, 1999, BIOCHEMISTRY-US, V38, P10371, DOI 10.1021/bi990902g; CLARKE PR, 1993, MOL BIOL CELL, V4, P397, DOI 10.1091/mbc.4.4.397; Cohen PTW, 2002, J CELL SCI, V115, P241; DAnna JA, 1997, RADIAT RES, V148, P260, DOI 10.2307/3579611; DOHADWALA M, 1994, P NATL ACAD SCI USA, V91, P6408, DOI 10.1073/pnas.91.14.6408; DOONAN JH, 1991, J BIOL CHEM, V266, P18889; FERNANDEZ A, 1992, J CELL BIOL, V116, P1421, DOI 10.1083/jcb.116.6.1421; Gatei M, 2000, NAT GENET, V25, P115, DOI 10.1038/75508; Gatei M, 2001, J BIOL CHEM, V276, P17276, DOI 10.1074/jbc.M011681200; Guo CY, 1999, RADIAT RES, V151, P125, DOI 10.2307/3579762; Guo CY, 1999, J BIOL CHEM, V274, P18715, DOI 10.1074/jbc.274.26.18715; Guo CY, 2000, CANCER RES, V60, P5667; Guo CY, 2002, J BIOL CHEM, V277, P4839, DOI 10.1074/jbc.M110092200; Hughes M, 1996, EMBO J, V15, P4574, DOI 10.1002/j.1460-2075.1996.tb00835.x; Khanna KK, 1998, NAT GENET, V20, P398, DOI 10.1038/3882; Larner JM, 1997, CANCER SURV, V29, P25; Lavin MF, 1996, CURR OPIN IMMUNOL, V8, P459, DOI 10.1016/S0952-7915(96)80030-6; LIU VF, 1995, STEM CELLS, V13, P117; MARTIN BI, 1994, PROTEIN EXPRES PURIF, V5, P211, DOI 10.1006/prep.1994.1033; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; Murnion ME, 2001, J BIOL CHEM, V276, P26656, DOI 10.1074/jbc.M102288200; OHKURA H, 1989, CELL, V57, P997, DOI 10.1016/0092-8674(89)90338-3; Paulson JR, 1996, J CELL SCI, V109, P1437; Shafman T, 1997, NATURE, V387, P520, DOI 10.1038/387520a0; Thompson LJ, 1997, J BIOL CHEM, V272, P29693, DOI 10.1074/jbc.272.47.29693; Tournebize R, 1997, EMBO J, V16, P5537, DOI 10.1093/emboj/16.18.5537; Van Eynde A, 1995, J BIOL CHEM, V270, P28068, DOI 10.1074/jbc.270.47.28068; VANZYL W, 1992, MOL CELL BIOL, V12, P4946, DOI 10.1128/MCB.12.11.4946; VIRSHUP DM, 1992, MOL CELL BIOL, V12, P4883, DOI 10.1128/MCB.12.11.4883; Vulsteke V, 1997, J BIOL CHEM, V272, P32972, DOI 10.1074/jbc.272.52.32972; Waterman MJF, 1998, NAT GENET, V19, P175, DOI 10.1038/542; YAMANO H, 1994, EMBO J, V13, P5310, DOI 10.1002/j.1460-2075.1994.tb06865.x; ZIV Y, 1989, CANCER RES, V49, P2495; Ziv Y, 1997, ONCOGENE, V15, P159, DOI 10.1038/sj.onc.1201319	37	49	49	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					41756	41761		10.1074/jbc.M207519200	http://dx.doi.org/10.1074/jbc.M207519200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12202491	hybrid			2022-12-27	WOS:000178985300059
J	Jeyaretnam, B; Glushka, J; Kolli, VSK; Carlson, RW				Jeyaretnam, B; Glushka, J; Kolli, VSK; Carlson, RW			Characterization of a novel lipid-A from Rhizobium species Sin-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							27-HYDROXYOCTACOSANOIC ACID; LIPOPOLYSACCHARIDE LPS; INFECTION THREAD; LETHAL TOXICITY; LEGUMINOSARUM; BIOSYNTHESIS; COMPONENT; PHASEOLI; MUTANT; REGION	The structure of the lipid-A from Rhizobium species Sin-1, a nitrogen-fixing Gram-negative bacterial symbiont of Sesbania, was determined by composition, nuclear magnetic resonance spectroscopic, and mass spectrometric analyses. The lipid-A preparation consisted of a mixture of structures due to differences in fatty acylation and in the glycosyl backbone. There were two different disaccharide backbones. One disaccharide consisted of a distal glucosaminosyl residue beta-linked to position 6 of a proximal 2-aminoglucono-1,5-lactonosyl residue, and in the second disaccharide, the proximal residue was 2-amino-2,3-dideoxy-D-erythro-hex-2-enono-1,5-lactone. For both disaccharides, the distal glucosamine was acylated at C-2' primarily with beta-hydroxy-palmitate (beta-OHC16:0) which, in turn, was O-acylated with 27-hydroxyoctacosanoic acid. For some of the lipid-A molecules, the distal glucosaminosyl residue was also acylated at C-3' with beta-hydroxymyristate (beta-OHC14: 0), whereas other molecules were devoid of this acyl substituent. Both the 2-aminoglucono-1,5-lactonosyl and 2-amino-2,3-dideoxy-D-erythro-hex-2-enono-1,5-lactonosyl residues were acylated at C-2, primarily with beta-OHC16:0. Minor amounts of lipid-A molecules contained beta-OHC14:0 at C-3 and/or beta-hydroxystearate (beta-OHC18:0) or beta-hydroxyoctadecenoate (beta-OHC18:1) as the C-2 and C-2' N-acyl substituents.	Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Carlson, RW (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA.				NIGMS NIH HHS [GM61761, GM89583] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061761] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BHAT UR, 1991, J BACTERIOL, V173, P2155, DOI 10.1128/JB.173.7.2155-2159.1991; BHAT UR, 1994, J BIOL CHEM, V269, P14402; BHAT UR, 1991, INT J SYST BACTERIOL, V41, P213; Brozek KA, 1996, J BIOL CHEM, V271, P32112, DOI 10.1074/jbc.271.50.32119; CARLSON RW, 1987, J BACTERIOL, V169, P4923, DOI 10.1128/jb.169.11.4923-4928.1987; Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; CHRIST WJ, 1995, SCIENCE, V268, P80, DOI 10.1126/science.7701344; CHRIST WJ, 1993, Patent No. 536969; DEMAAGD RA, 1989, J BACTERIOL, V171, P1143, DOI 10.1128/jb.171.2.1143-1150.1989; Forsberg LS, 1998, J BIOL CHEM, V273, P2747, DOI 10.1074/jbc.273.5.2747; GOLENBOCK DT, 1991, J BIOL CHEM, V266, P19490; HOLLINGSWORTH RI, 1989, J BIOL CHEM, V264, P9300; Jarvis BW, 1997, INFECT IMMUN, V65, P3011, DOI 10.1128/IAI.65.8.3011-3016.1997; Kannenberg EL, 2001, MOL MICROBIOL, V39, P379, DOI 10.1046/j.1365-2958.2001.02225.x; Kawata T, 1999, BRIT J PHARMACOL, V127, P853, DOI 10.1038/sj.bjp.0702596; KIRIKAE T, 1994, FEMS IMMUNOL MED MIC, V9, P237, DOI 10.1111/j.1574-695X.1994.tb00499.x; KRAUSS JH, 1989, EUR J BIOCHEM, V180, P519, DOI 10.1111/j.1432-1033.1989.tb14677.x; KRAUSS JH, 1988, INT J SYST BACTERIOL, V38, P157, DOI 10.1099/00207713-38-2-157; Leaf TA, 1996, MICROBIOL-SGM, V142, P1169, DOI 10.1099/13500872-142-5-1169; Literacka E, 1999, FEBS LETT, V456, P227, DOI 10.1016/S0014-5793(99)00952-7; LOPPNOW H, 1990, INFECT IMMUN, V58, P3743, DOI 10.1128/IAI.58.11.3743-3750.1990; LOPPNOW H, 1990, ADV EXP MED BIOL, V256, P561; LYNN WA, 1992, IMMUNOL TODAY, V13, P271, DOI 10.1016/0167-5699(92)90009-V; MAYER H, 1989, ARCH MICROBIOL, V151, P111, DOI 10.1007/BF00414423; NOEL KD, 1986, J BACTERIOL, V168, P1392, DOI 10.1128/jb.168.3.1392-1401.1986; Pedron T, 2000, IMMUNOLOGY, V101, P262, DOI 10.1046/j.1365-2567.2000.00107.x; PEROTTO S, 1994, MOL PLANT MICROBE IN, V7, P99, DOI 10.1094/MPMI-7-0099; Plotz BM, 2000, J BIOL CHEM, V275, P11222, DOI 10.1074/jbc.275.15.11222; PRICE NPJ, 1995, P NATL ACAD SCI USA, V92, P7352, DOI 10.1073/pnas.92.16.7352; PRICE NPJ, 1994, J BACTERIOL, V176, P4646, DOI 10.1128/JB.176.15.4646-4655.1994; Que NLS, 2000, J BIOL CHEM, V275, P28006; Que NLS, 2000, J BIOL CHEM, V275, P28017; RAETZ CRH, 1990, ANNU REV BIOCHEM, V59, P129, DOI 10.1146/annurev.biochem.59.1.129; RANA D, 1995, FEMS MICROBIOL LETT, V134, P19, DOI 10.1111/j.1574-6968.1995.tb07908.x; REUHS BL, 1994, MOL PLANT MICROBE IN, V7, P240, DOI 10.1094/MPMI-7-0240; Rietschel E. T., 1992, BACTERIAL ENDOTOXIC, V1, P3; RUSSA R, 1985, ARCH MICROBIOL, V141, P284, DOI 10.1007/BF00428838; RUSSA R, 1995, ARCH MICROBIOL, V163, P345, DOI 10.1007/BF00404207; Russa R, 1996, ARCH MICROBIOL, V165, P26, DOI 10.1007/s002030050292; STACEY G, 1991, MOL PLANT MICROBE IN, V4, P332, DOI 10.1094/MPMI-4-332; Suda Y, 1997, J BIOCHEM-TOKYO, V121, P1129; TAKADA H, 1992, BACTERIAL ENDOTOXIC, V1, P107; TAKAYAMA K, 1989, INFECT IMMUN, V57, P1336, DOI 10.1128/IAI.57.4.1336-1338.1989; Urbanik-Sypniewska T, 2000, IMMUNOBIOLOGY, V202, P408, DOI 10.1016/S0171-2985(00)80043-1; URBANIKSYPNIEWSKA T, 1989, ARCH MICROBIOL, V152, P527, DOI 10.1007/BF00425481; Vandenplas ML, 2002, J BIOL CHEM, V277, P41811, DOI 10.1074/jbc.M205252200; WESTPHAL O., 1965, METHOD CARBOHYD CHEM, V5, P83; York WS, 1985, METHOD ENZYMOL, P3, DOI DOI 10.1016/0076-6879(86)18062-1	48	29	30	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					41802	41810		10.1074/jbc.M112140200	http://dx.doi.org/10.1074/jbc.M112140200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12193590	hybrid			2022-12-27	WOS:000178985300065
J	Pinkoski, MJ; Droin, NM; Green, DR				Pinkoski, MJ; Droin, NM; Green, DR			Tumor necrosis factor alpha up-regulates non-lymphoid Fas-ligand following superantigen-induced peripheral lymphocyte activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VERSUS-HOST-DISEASE; INFLAMMATORY BOWEL-DISEASE; CD4(+) T-CELLS; ULCERATIVE-COLITIS; SCID MICE; TNF-ALPHA; INDUCED APOPTOSIS; EPITHELIAL-CELLS; FACTOR RECEPTOR; CROHNS-DISEASE	Members of the tumor necrosis factor (TNF) and TNF receptor families play important roles in inducing apoptosis and mediating the inflammatory response. Activated T lymphocytes can trigger the expression of Fas-ligand on non-lymphoid tissue, such as intestinal epithelial cells (IEC), and this, in turn, can induce apoptosis in the T cells. Here, we examine the role of TNFalpha in this feedback regulation. Injection of TNFalpha into mice caused a rapid up-regulation of Fas-ligand mRNA in IEC. TNFalpha-induced activation of the Fas-ligand promoter in IEC requires NF-kappaB as this was blocked by an I-kappaBalphaM super-repressor and by mutation of an NF-kappaB site in the Fas-ligand promoter. Activation of T cells by antigen induced Fas-ligand expression in IEC in vivo in wild type, but not in TNFalpha-/- or TNFR1-/- mice. These results define a novel pathway wherein TNFa, produced by activated T cells in the intestine, induce Fas-ligand expression in IEC. This is the first observation that one member of the TNF superfamily mediates the regulation of another family member and represents a potential feedback mechanism controlling lymphocyte infiltration and inflammation in the small intestine.	La Jolla Inst Allergy & Immunol, Div Cellular Immunol, San Diego, CA 92121 USA	La Jolla Institute for Immunology	Pinkoski, MJ (corresponding author), La Jolla Inst Allergy & Immunol, Div Cellular Immunol, 10355 Sci Ctr Dr, San Diego, CA 92121 USA.		Droin, Nathalie M/Y-5506-2018; Green, Douglas R/N-8083-2018	Droin, Nathalie M/0000-0002-6099-5324; Green, Douglas R/0000-0002-7332-1417	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044828] Funding Source: NIH RePORTER; NIAID NIH HHS [AI44828-02] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Baud V, 2001, TRENDS CELL BIOL, V11, P372, DOI 10.1016/S0962-8924(01)02064-5; Bonfoco E, 1998, IMMUNITY, V9, P711, DOI 10.1016/S1074-7613(00)80668-8; Bregenholt S, 2001, IMMUNOL LETT, V78, P7, DOI 10.1016/S0165-2478(01)00240-1; Bregenholt S, 1998, EUR J IMMUNOL, V28, P379, DOI 10.1002/(SICI)1521-4141(199801)28:01<379::AID-IMMU379>3.0.CO;2-X; Chan FKM, 2000, IMMUNITY, V13, P419, DOI 10.1016/S1074-7613(00)00041-8; Chen JJ, 1998, SCIENCE, V282, P1714, DOI 10.1126/science.282.5394.1714; EIGENBRODT ML, 1990, AM J PATHOL, V137, P1065; Elzey BD, 2001, J IMMUNOL, V167, P3049, DOI 10.4049/jimmunol.167.6.3049; Giordano C, 1997, SCIENCE, V275, P960, DOI 10.1126/science.275.5302.960; GRIFFITH TS, 1995, SCIENCE, V270, P1189, DOI 10.1126/science.270.5239.1189; Griffith TS, 1996, IMMUNITY, V5, P7, DOI 10.1016/S1074-7613(00)80305-2; Inagaki-Ohara K, 2001, ONCOGENE, V20, P812, DOI 10.1038/sj.onc.1204172; Iwamoto M, 1996, J PATHOL, V180, P152; Kasibhatla S, 1998, MOL CELL, V1, P543, DOI 10.1016/S1097-2765(00)80054-4; Kasibhatla S, 1999, J BIOL CHEM, V274, P987, DOI 10.1074/jbc.274.2.987; KRAMER B, 1995, J INFLAMM, V45, P183; Lenardo M, 1999, ANNU REV IMMUNOL, V17, P221, DOI 10.1146/annurev.immunol.17.1.221; Lin TS, 1998, J CLIN INVEST, V101, P570, DOI 10.1172/JCI896; MACDONALD TT, 1988, J EXP MED, V167, P1341, DOI 10.1084/jem.167.4.1341; Masuda H, 1995, J Clin Lab Immunol, V46, P111; MURATA Y, 1995, J GASTROENTEROL, V30, P56; Nelson DP, 2000, J CLIN INVEST, V105, P1199, DOI 10.1172/JCI8212; Nikolic B, 2000, J CLIN INVEST, V105, P1289, DOI 10.1172/JCI7894; PIGUET PF, 1987, J EXP MED, V166, P1280, DOI 10.1084/jem.166.5.1280; Pinkoski MJ, 2000, AM J PHYSIOL-GASTR L, V278, pG354, DOI 10.1152/ajpgi.2000.278.3.G354; Pinkoski MJ, 1999, CELL DEATH DIFFER, V6, P1174, DOI 10.1038/sj.cdd.4400611; Pinkoski MJ, 2000, NAT IMMUNOL, V1, P461, DOI 10.1038/82701; Plevy SE, 1997, J IMMUNOL, V159, P6276; POWRIE F, 1994, IMMUNITY, V1, P553, DOI 10.1016/1074-7613(94)90045-0; Reimund JM, 1996, J CLIN IMMUNOL, V16, P144, DOI 10.1007/BF01540912; Rooney I, 2000, METHOD ENZYMOL, V322, P345; Siegel RM, 2000, NAT IMMUNOL, V1, P469, DOI 10.1038/82712; Speiser DE, 1996, EUR J IMMUNOL, V26, P3055, DOI 10.1002/eji.1830261235; Stassi G, 2000, NAT IMMUNOL, V1, P483, DOI 10.1038/82725; Sytwu HK, 1996, IMMUNITY, V5, P17, DOI 10.1016/S1074-7613(00)80306-4; Takeuchi T, 1999, J IMMUNOL, V162, P518; Trobonjaca Z, 2001, J IMMUNOL, V166, P3804, DOI 10.4049/jimmunol.166.6.3804; Ueyama H, 1998, GUT, V43, P48, DOI 10.1136/gut.43.1.48; VAN AD, 1996, SCIENCE, V274, P787; van den Brink MRM, 2000, TRANSPLANTATION, V70, P184; Wallach D, 1999, ANNU REV IMMUNOL, V17, P331, DOI 10.1146/annurev.immunol.17.1.331; Williams AM, 1999, CLIN EXP IMMUNOL, V116, P415; Zhang HG, 2000, J CLIN INVEST, V105, P813, DOI 10.1172/JCI8236; ZHENG LX, 1995, NATURE, V377, P348, DOI 10.1038/377348a0	44	25	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					42380	42385		10.1074/jbc.M208167200	http://dx.doi.org/10.1074/jbc.M208167200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12196549	hybrid			2022-12-27	WOS:000178985300135
J	Zaborowska, Z; Furste, JP; Erdmann, VA; Kurreck, J				Zaborowska, Z; Furste, JP; Erdmann, VA; Kurreck, J			Sequence requirements in the catalytic core of the "10-23" DNA enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HAMMERHEAD RIBOZYME; MESSENGER-RNA; CRYSTAL-STRUCTURE; CLEAVAGE; MECHANISM	A systematic mutagenesis study of the "10-23" DNA enzyme was performed to analyze the sequence requirements of its catalytic domain. Therefore, each of the 15 core nucleotides was substituted separately by the remaining three naturally occurring nucleotides. Changes at the borders of the catalytic domain led to a dramatic loss of enzymatic activity, whereas several nucleotides in between could be exchanged without severe effects. Thymidine at position 8 had the lowest degree of conservation and its substitution by any of the other three nucleotides caused only a minor loss of activity. In addition to the standard nucleotides (adenosine, guanosine, thymidine, or cytidine) modified nucleotides were used to gain further information about the role of individual functional groups. Again, thymidine at position 8 as well as some other nucleotides could be substituted by inosine without severe effects on the catalytic activity. For two positions, additional experiments with 2-aminopurine and deoxypurine, respectively, were performed to obtain information about the specific role of functional groups. In addition to sequence-function relationships of the DNA enzyme, this study provides information about suitable sites to introduce modified nucleotides for further functional studies or for internal stabilization of the DNA enzyme against endonucleolytic attack.	Free Univ Berlin, Inst Biochem, D-14195 Berlin, Germany	Free University of Berlin	Kurreck, J (corresponding author), Free Univ Berlin, Inst Biochem, Thielallee 63, D-14195 Berlin, Germany.		Kurreck, Jens/B-7785-2008	Kurreck, Jens/0000-0002-1469-0052				BEIGELMAN L, 1995, J BIOL CHEM, V270, P25702, DOI 10.1074/jbc.270.43.25702; HASELOFF J, 1988, NATURE, V334, P585, DOI 10.1038/334585a0; Iversen PO, 2001, AM J PHYSIOL-HEART C, V281, pH2211, DOI 10.1152/ajpheart.2001.281.5.H2211; Jen KY, 2000, STEM CELLS, V18, P307, DOI 10.1634/stemcells.18-5-307; Joyce GF, 2001, METHOD ENZYMOL, V341, P503, DOI 10.1016/S0076-6879(01)41173-6; Khachigian LM, 2002, J BIOL CHEM, V277, P22985, DOI 10.1074/jbc.M200977200; KUIMELIS RG, 1996, CATALYTIC RNA, P197; Kurreck J, 2002, J BIOL CHEM, V277, P7099, DOI 10.1074/jbc.M107206200; NG MMP, 1994, BIOCHEMISTRY-US, V33, P12119, DOI 10.1021/bi00206a015; Nowakowski J, 1999, ACTA CRYSTALLOGR D, V55, P1885, DOI 10.1107/S0907444999010550; Nowakowski J, 2000, J MOL BIOL, V300, P93, DOI 10.1006/jmbi.2000.3826; Nowakowski J, 1999, NAT STRUCT BIOL, V6, P151; PLEY HW, 1994, NATURE, V372, P68, DOI 10.1038/372068a0; RUFFNER DE, 1990, BIOCHEMISTRY-US, V29, P10695, DOI 10.1021/bi00499a018; Santiago FS, 1999, NAT MED, V5, P1264, DOI 10.1038/15215; Santoro SW, 1998, BIOCHEMISTRY-US, V37, P13330, DOI 10.1021/bi9812221; Santoro SW, 1997, P NATL ACAD SCI USA, V94, P4262, DOI 10.1073/pnas.94.9.4262; SCOTT WG, 1995, CELL, V81, P991, DOI 10.1016/S0092-8674(05)80004-2; SLIM G, 1992, BIOCHEM BIOPH RES CO, V183, P605, DOI 10.1016/0006-291X(92)90525-P; Sun LQ, 2000, PHARMACOL REV, V52, P325; TUSCHL T, 1993, BIOCHEMISTRY-US, V32, P11658, DOI 10.1021/bi00094a023; UHLENBECK OC, 1987, NATURE, V328, P596, DOI 10.1038/328596a0; Usman N, 2000, J CLIN INVEST, V106, P1197, DOI 10.1172/JCI11631	23	80	89	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 25	2002	277	43					40617	40622		10.1074/jbc.M207094200	http://dx.doi.org/10.1074/jbc.M207094200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	607KU	12192010	hybrid			2022-12-27	WOS:000178791400060
J	Fukuda, M				Fukuda, M			Synaptotagmin-like protein (Slp) homology domain 1 of Slac2-a/melanophilin is a critical determinant of GTP-dependent specific binding to Rab27A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYOSIN-VA; MELANOSOME TRANSPORT; PHOSPHOLIPID-BINDING; C2 DOMAINS; ASHEN MICE; FAMILY; EFFECTOR; GTPASES; MELANOCYTES; MOTIF	The N-terminal synaptotagmin-like protein (Slp) homology domain (SHD) of the Slp and Slac2 families has recently been identified as a specific Rab27A-binding domain (Kuroda, T. S., Fukuda, M., Ariga, H., and Mikoshiba, K. (2002) J. Biol. Chem. 277, 9212-9218; Fukuda, M., Kuroda, T. S., and Mikoshiba, K. (2002) J. BioL Chem. 277, 12432-12436). The SHD consists of two conserved a-helical regions (SHD1 and SHD2) that are often separated by two zinc finger motifs. However, the structural basis of Rab27A recognition by the SHD (i.e. involvement of each region (SHD1, zinc finger motifs, and SHD2) in Rab27A recognition and critical residue(s) for Rab27A/SHD interaction) had never been elucidated. In this study, systematic deletion analysis and Ala-based site-directed mutagenesis showed that SHD1 of Slac2-a/melanophilin alone is both necessary and sufficient for high affinity specific recognition of the GTP-bound form of Rab27A. By contrast, the zinc finger motifs and SHD2 are not an autonomous Rab27A-binding site and seem to be important for stabilization of the structure of the SHD or higher affinity Rab27A binding. In addition, chimeric analysis of Rab3A and Rab27A showed that the specific sequence of the switch 11 region of Rab27 isoforms (especially Leu-84, Phe-88, and Asp-91 of Rab27A), which is not conserved in the Rab3 or RabS isoforms, is essential for recognition by the Slac2-a SHD. Based on these findings, I propose that SHD1 of the Slp and Slac2 families be referred to as RBD27 (Rab-binding domain specific for Rab27 isoforms).	RIKEN, Inst Phys & Chem Res, Fukuda Initiat Res Unit, Wako, Saitama 3510198, Japan	RIKEN	Fukuda, M (corresponding author), RIKEN, Inst Phys & Chem Res, Fukuda Initiat Res Unit, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	mnfukuda@brain.riken.go.jp	Fukuda, MItsunori/I-1511-2015	Fukuda, MItsunori/0000-0002-8620-5853				Bahadoran P, 2001, J CELL BIOL, V152, P843, DOI 10.1083/jcb.152.4.843; Berkowitz JKM, 2001, J BIOL CHEM, V276, P18855, DOI 10.1074/jbc.M011167200; Bock JB, 2001, NATURE, V409, P839, DOI 10.1038/35057024; Burd CG, 1998, MOL CELL, V2, P157, DOI 10.1016/S1097-2765(00)80125-2; El-Amraoui A, 2002, EMBO REP, V3, P463, DOI 10.1093/embo-reports/kvf090; Fukuda M, 2001, J BIOL CHEM, V276, P40319, DOI 10.1074/jbc.M105356200; Fukuda M, 2000, J BIOL CHEM, V275, P28180; Fukuda M, 1999, J BIOL CHEM, V274, P31421, DOI 10.1074/jbc.274.44.31421; Fukuda M, 1999, J BIOL CHEM, V274, P31428, DOI 10.1074/jbc.274.44.31428; Fukuda M, 1996, J BIOL CHEM, V271, P8430, DOI 10.1074/jbc.271.14.8430; FUKUDA M, 1994, J BIOL CHEM, V269, P29206; FUKUDA M, 1995, J BIOL CHEM, V270, P26523, DOI 10.1074/jbc.270.44.26523; Fukuda M, 2002, BIOCHEM J, V366, P681, DOI 10.1042/BJ20020484; Fukuda M, 2002, J BIOL CHEM, V277, P12432, DOI 10.1074/jbc.C200005200; Fukuda M, 2001, J BIOL CHEM, V276, P41112, DOI 10.1074/jbc.M106209200; Fukuda M, 2001, BIOCHEM BIOPH RES CO, V283, P513, DOI 10.1006/bbrc.2001.4803; Fukuda M, 2001, BIOCHEM BIOPH RES CO, V281, P1226, DOI 10.1006/bbrc.2001.4512; Gaullier JM, 1998, NATURE, V394, P432, DOI 10.1038/28767; Haddad EK, 2001, J CELL BIOL, V152, P835, DOI 10.1083/jcb.152.4.835; Hume AN, 2002, TRAFFIC, V3, P193, DOI 10.1034/j.1600-0854.2002.030305.x; Hume AN, 2001, J CELL BIOL, V152, P795, DOI 10.1083/jcb.152.4.795; Kuroda TS, 2002, BIOCHEM BIOPH RES CO, V293, P899, DOI 10.1016/S0006-291X(02)00320-0; Kuroda TS, 2002, J BIOL CHEM, V277, P9212, DOI 10.1074/jbc.M112414200; Kutateladze TG, 1999, MOL CELL, V3, P805, DOI 10.1016/S1097-2765(01)80013-7; Matesic LE, 2001, P NATL ACAD SCI USA, V98, P10238, DOI 10.1073/pnas.181336698; Menasche G, 2000, NAT GENET, V25, P173, DOI 10.1038/76024; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; MU FT, 1995, J BIOL CHEM, V270, P13503, DOI 10.1074/jbc.270.22.13503; Ostermeier C, 1999, CELL, V96, P363, DOI 10.1016/S0092-8674(00)80549-8; Pereira-Leal JB, 2001, J MOL BIOL, V313, P889, DOI 10.1006/jmbi.2001.5072; Pereira-Leal JB, 2000, J MOL BIOL, V301, P1077, DOI 10.1006/jmbi.2000.4010; Pfeffer SR, 2001, TRENDS CELL BIOL, V11, P487, DOI 10.1016/S0962-8924(01)02147-X; Provance DW, 2002, TRAFFIC, V3, P124, DOI 10.1034/j.1600-0854.2002.030205.x; Seabra MC, 2002, TRENDS MOL MED, V8, P23, DOI 10.1016/S1471-4914(01)02227-4; Segev N, 2001, CURR OPIN CELL BIOL, V13, P500, DOI 10.1016/S0955-0674(00)00242-8; SHIRATAKI H, 1993, MOL CELL BIOL, V13, P2061, DOI 10.1128/MCB.13.4.2061; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; Stenmark H, 1996, J BIOL CHEM, V271, P24048, DOI 10.1074/jbc.271.39.24048; Stinchcombe JC, 2001, J CELL BIOL, V152, P825, DOI 10.1083/jcb.152.4.825; Strom M, 2002, J BIOL CHEM, V277, P25423, DOI 10.1074/jbc.M202574200; Sun L, 2001, J BIOL CHEM, V276, P12911, DOI 10.1074/jbc.M011110200; Wang J, 1999, J BIOL CHEM, V274, P28542, DOI 10.1074/jbc.274.40.28542; Wang XL, 2001, J BIOL CHEM, V276, P32480, DOI 10.1074/jbc.M103337200; Wilson SM, 2000, P NATL ACAD SCI USA, V97, P7933, DOI 10.1073/pnas.140212797; Wu XF, 2002, MOL BIOL CELL, V13, P1735, DOI 10.1091/mbc.01-12-0595; Wu XFS, 2002, NAT CELL BIOL, V4, P271, DOI 10.1038/ncb760; Yi Z, 2002, MOL CELL BIOL, V22, P1858, DOI 10.1128/MCB.22.6.1858-1867.2002; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	48	69	71	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2002	277	42					40118	40124		10.1074/jbc.M205765200	http://dx.doi.org/10.1074/jbc.M205765200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	605EA	12189142	hybrid			2022-12-27	WOS:000178662500134
J	Doucey, MA; Laurence, G; Naeher, D; Michielin, O; Baumgartner, P; Guillaume, P; Palmer, E; Luescher, IF				Doucey, MA; Laurence, G; Naeher, D; Michielin, O; Baumgartner, P; Guillaume, P; Palmer, E; Luescher, IF			CD3 delta establishes a functional link between the T cell receptor and CD8	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-BETA; POSITIVE SELECTION; CORECEPTOR FUNCTION; LIGAND INTERACTIONS; NEGATIVE SELECTION; CTL CLONES; ACTIVATION; CHAIN; TCR; LYMPHOCYTES	T cells expressing T cell receptor (TCR) complexes that lack CD3delta, either due to deletion of the CD3delta gene, or by replacement of the connecting peptide of the TCRalpha chain, exhibit severely impaired positive selection and TCR-mediated activation of CD8 single-positive T cells. Because the same defects have been observed in mice expressing no CD8beta or tailless CD8beta, we examined whether CD3delta serves to couple TCR-CD3 with CD8. To this end we used T cell hybridomas and transgenic mice expressing the T1 TCR, which recognizes a photoreactive derivative of the PbCS 252-260 peptide in the context of H-2K(d). We report that, in thymocytes and hybridomas expressing the T1 TCR-CD3 complex, CD8alphabeta associates with the TCR. This association was not observed on T1 hybridomas expressing only CD8alphaalpha or a CD3delta(-) variant of the T1 TCR. CD3delta was selectively coimmunoprecipitated with anti-CD8 antibodies, indicating an avid association of CD8 with CD3delta. Because CD8alphabeta is a raft constituent, due to this association a fraction of TCR-CD3 is raft-associated. Cross-linking of these TCR-CD8 adducts results in extensive TCR aggregate formation and intracellular calcium mobilization. Thus, CD3delta couples TCR-CD3 with raft-associated CD8, which is required for effective activation and positive selection of CD8(+) T cells.	Univ Lausanne, Lausanne Branch, Ludwig Inst Canc Res, CH-1066 Epalinges, Switzerland; Univ Lausanne, Inst Biochem, CH-1066 Epalinges, Switzerland; Univ Basel Hosp, Lab Transplantat Immunol & Nephrol, CH-4031 Basel, Switzerland	Ludwig Institute for Cancer Research; University of Lausanne; University of Lausanne; University of Basel	Luescher, IF (corresponding author), Univ Lausanne, Lausanne Branch, Ludwig Inst Canc Res, CH-1066 Epalinges, Switzerland.		Michielin, Olivier/ABE-7924-2020					Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Anel A, 1997, J IMMUNOL, V158, P19; Arcaro A, 2000, J IMMUNOL, V165, P2068, DOI 10.4049/jimmunol.165.4.2068; Arcaro A, 2001, J EXP MED, V194, P1485, DOI 10.1084/jem.194.10.1485; Backstrom BT, 1998, SCIENCE, V281, P835, DOI 10.1126/science.281.5378.835; Backstrom BT, 1996, IMMUNITY, V5, P437, DOI 10.1016/S1074-7613(00)80500-2; Basson MA, 2000, IMMUNOL TODAY, V21, P509, DOI 10.1016/S0167-5699(00)01711-4; Berger MA, 1997, J EXP MED, V186, P1461, DOI 10.1084/jem.186.9.1461; BEYERS AD, 1992, P NATL ACAD SCI USA, V89, P2945, DOI 10.1073/pnas.89.7.2945; Block MS, 2001, J IMMUNOL, V167, P821, DOI 10.4049/jimmunol.167.2.821; Borroto A, 1998, J BIOL CHEM, V273, P12807, DOI 10.1074/jbc.273.21.12807; Bosselut R, 1999, J EXP MED, V190, P1517, DOI 10.1084/jem.190.10.1517; Bosselut R, 2001, IMMUNITY, V14, P483, DOI 10.1016/S1074-7613(01)00128-5; CROOKS MEC, 1994, IMMUNITY, V1, P277; Daniels MA, 2000, J EXP MED, V191, P335, DOI 10.1084/jem.191.2.335; Dave VP, 1998, INT IMMUNOL, V10, P1481, DOI 10.1093/intimm/10.10.1481; Dave VP, 1997, EMBO J, V16, P1360, DOI 10.1093/emboj/16.6.1360; DeJarnette JB, 1998, P NATL ACAD SCI USA, V95, P14909, DOI 10.1073/pnas.95.25.14909; Delgado P, 2000, NATURE, V406, P426, DOI 10.1038/35019102; Doucey MA, 2001, EUR J IMMUNOL, V31, P1561, DOI 10.1002/1521-4141(200105)31:5&lt;1561::AID-IMMU1561&gt;3.0.CO;2-W; Drake DR, 2001, J IMMUNOL, V166, P7009, DOI 10.4049/jimmunol.166.12.7009; Drevot P, 2002, EMBO J, V21, P1899, DOI 10.1093/emboj/21.8.1899; Fernandez-Miguel G, 1999, P NATL ACAD SCI USA, V96, P1547, DOI 10.1073/pnas.96.4.1547; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Haks MC, 1998, EMBO J, V17, P1871, DOI 10.1093/emboj/17.7.1871; HONIG B, 1995, SCIENCE, V268, P1144, DOI 10.1126/science.7761829; Hudrisier D, 1998, J IMMUNOL, V161, P553; Irie HY, 1998, J IMMUNOL, V161, P183; ITANO A, 1994, IMMUNITY, V1, P287, DOI 10.1016/1074-7613(94)90080-9; KEARSE KP, 1995, IMMUNITY, V2, P391; Kessler B, 1998, J IMMUNOL, V161, P6939; LUESCHER IF, 1995, NATURE, V373, P353, DOI 10.1038/373353a0; LUESCHER IF, 1995, IMMUNITY, V3, P51, DOI 10.1016/1074-7613(95)90158-2; LUESCHER IF, 1994, J BIOL CHEM, V269, P5574; Naeher D, 2002, J IMMUNOL, V169, P2964, DOI 10.4049/jimmunol.169.6.2964; NAKAYAMA K, 1994, SCIENCE, V263, P1131, DOI 10.1126/science.8108731; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SHORES EW, 1994, SCIENCE, V266, P1047, DOI 10.1126/science.7526464; Stotz SH, 1999, J EXP MED, V189, P253, DOI 10.1084/jem.189.2.253; Sun ZYJ, 2001, CELL, V105, P913, DOI 10.1016/S0092-8674(01)00395-6; SUZUKI S, 1992, EUR J IMMUNOL, V22, P2475, DOI 10.1002/eji.1830221002; Trobridge PA, 2001, J IMMUNOL, V166, P809, DOI 10.4049/jimmunol.166.2.809; Ulivieri C, 2001, J BIOL CHEM, V276, P3574, DOI 10.1074/jbc.M008588200; Vignali DAA, 1996, J EXP MED, V183, P2097, DOI 10.1084/jem.183.5.2097; Wang BP, 1998, J EXP MED, V188, P1375, DOI 10.1084/jem.188.7.1375; Wang BP, 1999, J IMMUNOL, V162, P88; Werlen G, 2000, NATURE, V406, P422, DOI 10.1038/35019094; Xavier R, 1998, IMMUNITY, V8, P723, DOI 10.1016/S1074-7613(00)80577-4; Xu XN, 2001, IMMUNITY, V14, P591, DOI 10.1016/S1074-7613(01)00133-9; Zhang WG, 1998, IMMUNITY, V9, P239, DOI 10.1016/S1074-7613(00)80606-8	50	72	74	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 31	2003	278	5					3257	3264		10.1074/jbc.M208119200	http://dx.doi.org/10.1074/jbc.M208119200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644JW	12215456	hybrid			2022-12-27	WOS:000180915000063
J	Kumar, A; Chaudhry, I; Reid, MB; Boriek, AM				Kumar, A; Chaudhry, I; Reid, MB; Boriek, AM			Distinct signaling pathways are activated in response to mechanical stress applied axially and transversely to skeletal muscle fibers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NH2-TERMINAL KINASE-ACTIVITY; MAP-KINASE; PROTEIN-KINASES; PHOSPHOINOSITIDE 3-KINASE; ENDOTHELIAL-CELLS; REDOX REGULATION; SHEAR-STRESS; IN-VITRO; STRETCH; TRANSDUCTION	In the diaphragm muscle we tested the hypothesis that MAP kinase signaling pathways are activated by mechanical stress and such signaling pathways are dependent on the direction in which mechanical stress is applied. Although equal magnitudes of mechanical stress were applied axially and transversely a greater level of activation of ERK1/2, p38, Raf-1, p90 RSK, Elk-1, and the DNA binding activity of AP-1 transcription factor was produced when the muscle was stretched transversely than when stretched axially. A significant up-regulation in protein tyrosine phosphorylation was observed in axially or transversely loaded diaphragm muscles and the activation of ERK1/2 was completely inhibited by gemstein (protein-tyrosine kinase inhibitor). Pretreatment of muscles with wortmannin (phosphoinositide 3-kinase inhibitor), TMB-8 (antagonist of intracellular calcium release), GF109203X (PKC inhibitor), or PD98059 (NMK1/2 inhibitor) blocked the activation of ERK1/2 kinases in response to axial but not to transverse loading. On the other hand, pretreatment of muscles with protein kinase A inhibitors H-7 and KT5720 completely suppressed the activation of ERK1/2 in response to transverse loading only. Taken together with the alterations of MAP kinases and the findings of elevations of downstream transcription targets, our data are consistent with two distinct MAP kinase signal transduction pathways in response to mechanical stress.	Baylor Coll Med, Dept Med, Houston, TX 77030 USA	Baylor College of Medicine	Boriek, AM (corresponding author), Baylor Coll Med, Dept Med, Suite 520B,1 Baylor Plaza, Houston, TX 77030 USA.	boriek@bcm.tmc.edu		Kumar, Ashok/0000-0001-8571-2848	NHLBI NIH HHS [HL45721] Funding Source: Medline; PHS HHS [R01-46230, R01-63134] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL045721] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aaronson DS, 2002, SCIENCE, V296, P1653, DOI 10.1126/science.1071545; ABATE C, 1990, SCIENCE, V249, P1157, DOI 10.1126/science.2118682; ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Berk BC, 1995, J BIOMECH, V28, P1439, DOI 10.1016/0021-9290(95)00092-5; BOGOYEVITCH MA, 1995, J BIOL CHEM, V270, P29710; Bokemeyer D, 1996, KIDNEY INT, V49, P1187, DOI 10.1038/ki.1996.172; Boppart MD, 1999, J APPL PHYSIOL, V87, P1668, DOI 10.1152/jappl.1999.87.5.1668; Boppart MD, 2001, AM J PHYSIOL-CELL PH, V280, pC352, DOI 10.1152/ajpcell.2001.280.2.C352; BORIEK AM, 1994, J APPL PHYSIOL, V76, P223, DOI 10.1152/jappl.1994.76.1.223; BORIEK AM, 1994, J APPL PHYSIOL, V77, P2065, DOI 10.1152/jappl.1994.77.5.2065; Boriek AM, 1998, LUNG BIOL HEALTH DIS, V121, P181; Boriek AM, 2002, J APPL PHYSIOL, V92, P725, DOI 10.1152/jappl.2002.92.2.725; Boriek AM, 2001, AM J PHYSIOL-REG I, V280, pR156, DOI 10.1152/ajpregu.2001.280.1.R156; Boriek AM, 2001, AM J PHYSIOL-CELL PH, V280, pC46, DOI 10.1152/ajpcell.2001.280.1.C46; Carafoli E, 2002, P NATL ACAD SCI USA, V99, P1115, DOI 10.1073/pnas.032427999; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chen KD, 1999, J BIOL CHEM, V274, P18393, DOI 10.1074/jbc.274.26.18393; COBB MH, 1995, J BIOL CHEM, V270, P14843, DOI 10.1074/jbc.270.25.14843; Cobb MH, 2000, TRENDS BIOCHEM SCI, V25, P7, DOI 10.1016/S0968-0004(99)01508-X; Dimmeler S, 2000, CIRC RES, V86, P4, DOI 10.1161/01.RES.86.1.4; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; Ermak G, 2002, MOL IMMUNOL, V38, P713, DOI 10.1016/S0161-5890(01)00108-0; Frodin M, 1999, MOL CELL ENDOCRINOL, V151, P65, DOI 10.1016/S0303-7207(99)00061-1; GOLDSPINK DF, 1995, AM J PHYSIOL-ENDOC M, V268, pE288, DOI 10.1152/ajpendo.1995.268.2.E288; Hazzalin CA, 2002, NAT REV MOL CELL BIO, V3, P30, DOI 10.1038/nrm715; Ikeda M, 1999, BIOCHEM BIOPH RES CO, V257, P668, DOI 10.1006/bbrc.1999.0532; Ingber DE, 1998, BIOL BULL-US, V194, P323, DOI 10.2307/1543102; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Katso R, 2001, ANNU REV CELL DEV BI, V17, P615, DOI 10.1146/annurev.cellbio.17.1.615; Kawano Y, 2001, AM J PHYSIOL-ENDOC M, V281, pE1255, DOI 10.1152/ajpendo.2001.281.6.E1255; Kemp TJ, 2001, GENOMICS, V72, P260, DOI 10.1006/geno.2000.6461; Kippenberger S, 2000, J INVEST DERMATOL, V114, P408, DOI 10.1046/j.1523-1747.2000.00915.x; Kleinert H, 1996, MOL PHARMACOL, V49, P15; Kranenburg O, 2001, ONCOGENE, V20, P1540, DOI 10.1038/sj.onc.1204187; Kubota A, 1997, BIOCHEM BIOPH RES CO, V235, P171, DOI 10.1006/bbrc.1997.6743; Kumar A, 1999, METHOD ENZYMOL, V300, P339; Kumar A, 1998, J IMMUNOL, V161, P776; Kyriakis JM, 1999, BIOCHEM SOC SYMP, P29; Lowe DA, 1999, CELL TISSUE RES, V296, P531, DOI 10.1007/s004410051314; MacKenna DA, 1998, J CLIN INVEST, V101, P301, DOI 10.1172/JCI1026; Martineau LC, 2001, J APPL PHYSIOL, V91, P693, DOI 10.1152/jappl.2001.91.2.693; McKoy G, 1999, J PHYSIOL-LONDON, V516, P583, DOI 10.1111/j.1469-7793.1999.0583v.x; Mellor H, 1998, BIOCHEM J, V332, P281, DOI 10.1042/bj3320281; Mitchell P, 1999, J APPL PHYSIOL, V86, P313, DOI 10.1152/jappl.1999.86.1.313; NATHAN C, 1994, CELL, V78, P915, DOI 10.1016/0092-8674(94)90266-6; Nishioka N, 1995, FEBS LETT, V377, P393, DOI 10.1016/0014-5793(95)01382-2; Osman AA, 2001, J APPL PHYSIOL, V90, P454, DOI 10.1152/jappl.2001.90.2.454; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Peyssonnaux C, 2001, BIOL CELL, V93, P53, DOI 10.1016/S0248-4900(01)01125-X; Ruwhof C, 2000, CARDIOVASC RES, V47, P23, DOI 10.1016/S0008-6363(00)00076-6; Ryder JW, 2000, J BIOL CHEM, V275, P1457, DOI 10.1074/jbc.275.2.1457; Sen CK, 1996, FASEB J, V10, P709, DOI 10.1096/fasebj.10.7.8635688; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; Shepherd PR, 1998, BIOCHEM J, V333, P471, DOI 10.1042/bj3330471; Soderling TR, 2001, CHEM REV, V101, P2341, DOI 10.1021/cr0002386; Stork PJS, 2002, TRENDS CELL BIOL, V12, P258, DOI 10.1016/S0962-8924(02)02294-8; Stull JT, 2001, J BIOL CHEM, V276, P2311, DOI 10.1074/jbc.R000030200; Su B, 1996, CURR OPIN IMMUNOL, V8, P402, DOI 10.1016/S0952-7915(96)80131-2; Suzuma I, 2002, J BIOL CHEM, V277, P1047, DOI 10.1074/jbc.M105336200; Tidball JG, 1998, AM J PHYSIOL-CELL PH, V275, pC260, DOI 10.1152/ajpcell.1998.275.1.C260; Toker A, 2000, MOL PHARMACOL, V57, P652, DOI 10.1124/mol.57.4.652; Turner C H, 1998, J Orthop Sci, V3, P346, DOI 10.1007/s007760050064; VANDENBURGH H, 1979, SCIENCE, V203, P265, DOI 10.1126/science.569901; VANDENBURGH HH, 1995, J CELL PHYSIOL, V163, P285, DOI 10.1002/jcp.1041630209; Wang HB, 2001, P NATL ACAD SCI USA, V98, P11295, DOI 10.1073/pnas.201201198; WANG N, 1993, SCIENCE, V260, P1124, DOI 10.1126/science.7684161; Whitmarsh AJ, 1996, J MOL MED-JMM, V74, P589, DOI 10.1007/s001090050063; Wisdom R, 1999, EXP CELL RES, V253, P180, DOI 10.1006/excr.1999.4685; Wojtaszewski JFP, 1999, AM J PHYSIOL-ENDOC M, V277, pE724, DOI 10.1152/ajpendo.1999.277.4.E724; Wretman C, 2000, ACTA PHYSIOL SCAND, V170, P45; Wretman C, 2001, J PHYSIOL-LONDON, V535, P155, DOI 10.1111/j.1469-7793.2001.00155.x; Yang XH, 1997, BBA-GENE STRUCT EXPR, V1350, P287, DOI 10.1016/S0167-4781(96)00225-4; Zhi G, 1998, J BIOL CHEM, V273, P8951, DOI 10.1074/jbc.273.15.8951	73	75	78	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2002	277	48					46493	46503		10.1074/jbc.M203654200	http://dx.doi.org/10.1074/jbc.M203654200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620JB	12221078	hybrid			2022-12-27	WOS:000179529300103
J	Gentile, F; Amodeo, P; Febbraio, F; Picaro, F; Motta, A; Formisano, S; Nucci, R				Gentile, F; Amodeo, P; Febbraio, F; Picaro, F; Motta, A; Formisano, S; Nucci, R			SDS-resistant active and thermostable dimers are obtained from the dissociation of homotetrameric beta-glycosidase from hyperthermophilic Sulfolobus solfataricus in SDS - Stabilizing role of the A-C intermonomeric interface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYACRYLAMIDE-GEL ELECTROPHORESIS; DEPENDENT DIABETES-MELLITUS; CRYSTAL-STRUCTURE; NUCLEIC-ACIDS; SALT BRIDGES; FORCE-FIELD; MOLECULAR-DYNAMICS; ALZHEIMERS-DISEASE; THERMAL-STABILITY; APOLIPOPROTEIN-E	beta-Glycosidases are fundamental, widely conserved enzymes. Those from hyperthermophiles exhibit unusual stabilities toward various perturbants. Previous work with homotetrameric beta-glycosidase from hyperthermophilic Sulfolobus solfataricus (M-r 226,760) has shown that addition of 0.05-0.1% SDS was associated with minimal secondary structure perturbations and increased activity. This work addresses the effects of SDS on beta-glycosidase quaternary structure. In 0.1-1% SDS, the enzyme was dimeric, as determined by Ferguson analysis of transverse-gradient polyacrylamide gels. The catalytic activity of the beta-glycosidase dimer in SDS was determined by in-gel assay. A minor decrease of thermal stability in SDS was observed after exposure to temperatures up to 80 degreesC for 1 h. An analysis of beta-glycosidase crystal structure showed different changes in solvent-accessible surface area on going from the tetramer to the two possible dimers (A-C and A-D). Energy minimization and molecular dynamics calculations showed that the A-C dimer, exhibiting the lowest exposed surface area, was more stabilized by a network of polar interactions. The charge distribution around the A-C interface was characterized by a local short range anisotropy, resulting in an unfavorable interaction with SDS. This paper provides a detailed description of an SDS-resistant inter-monomeric interface, which may help understand similar interfaces involved in important biological processes.	CNR, Ist Biochim Prot, I-80125 Naples, Italy; Univ Federico II, Ist Endocrinol & Oncol Sperimentale, CNR, I-80131 Naples, Italy; Univ Federico II, Dipartimento Biol & Patol Cellular & Mol, I-80131 Naples, Italy; CNR, Ist Chim Biomol, I-80078 Naples, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); University of Naples Federico II; University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto di Chimica Biomolecolare (ICB-CNR)	Febbraio, F (corresponding author), CNR, Ist Biochim Prot, Via Marconi 10, I-80125 Naples, Italy.	febbraio@dafne.ibpe.na.cnr.it	Gentile, Fabrizio/K-2475-2012; Febbraio, Ferdinando/AAX-8255-2020; Amodeo, Pietro/P-1800-2015	Gentile, Fabrizio/0000-0002-6704-3115; Febbraio, Ferdinando/0000-0002-3653-9847; Amodeo, Pietro/0000-0002-6439-7575; Motta, Andrea/0000-0002-8643-658X				Aguilar CF, 1997, J MOL BIOL, V271, P789, DOI 10.1006/jmbi.1997.1215; Bentley NM, 2002, BIOCHEM J, V366, P273, DOI 10.1042/BJ20020207; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; BRYAN JK, 1977, ANAL BIOCHEM, V78, P513, DOI 10.1016/0003-2697(77)90111-7; CarrascoMarin E, 1996, J IMMUNOL, V156, P450; CHAN MK, 1995, SCIENCE, V267, P1463, DOI 10.1126/science.7878465; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; COZENS B, 1984, J BIOL CHEM, V259, P6248; DAuria S, 1997, BIOCHEM J, V323, P833, DOI 10.1042/bj3230833; Decker H, 2001, J BIOL CHEM, V276, P17796, DOI 10.1074/jbc.M010436200; DEHAEN C, 1987, ANAL BIOCHEM, V166, P235, DOI 10.1016/0003-2697(87)90570-7; Elcock AH, 1998, J MOL BIOL, V284, P489, DOI 10.1006/jmbi.1998.2159; Ettinger RA, 1998, J IMMUNOL, V161, P6439; Ettinger RA, 2000, J IMMUNOL, V165, P3232, DOI 10.4049/jimmunol.165.6.3232; FERGUSON KA, 1964, METABOLISM, V13, P985, DOI 10.1016/S0026-0495(64)80018-4; Gentile F, 1997, ANAL BIOCHEM, V244, P228, DOI 10.1006/abio.1996.9863; HEDRICK JL, 1968, ARCH BIOCHEM BIOPHYS, V126, P155, DOI 10.1016/0003-9861(68)90569-9; Henrissat B, 1998, BIOCHEM SOC T, V26, P153, DOI 10.1042/bst0260153; HOROVITZ A, 1990, J MOL BIOL, V216, P1031, DOI 10.1016/S0022-2836(99)80018-7; KELLY CA, 1993, BIOCHEMISTRY-US, V32, P3913, DOI 10.1021/bi00066a010; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; KORNDORFER I, 1995, J MOL BIOL, V246, P511, DOI 10.1006/jmbi.1994.0103; LADU MJ, 1995, J BIOL CHEM, V270, P9039, DOI 10.1074/jbc.270.16.9039; Lopez-Serrano D, 2002, PIGM CELL RES, V15, P104; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Munson GW, 2000, BIOCHEMISTRY-US, V39, P16119, DOI 10.1021/bi0017475; MUSAFIA B, 1995, J MOL BIOL, V254, P761, DOI 10.1006/jmbi.1995.0653; NEVILLE DM, 1971, J BIOL CHEM, V246, P6328; NUCCI R, 1993, BIOTECHNOL APPL BIOC, V17, P239; NUCCI R, 1995, BIOTECHNOL APPL BIOC, V21, P265; RODBARD D, 1970, P NATL ACAD SCI USA, V65, P970, DOI 10.1073/pnas.65.4.970; RODBARD D, 1971, ANAL BIOCHEM, V40, P95, DOI 10.1016/0003-2697(71)90086-8; Russo C, 1998, P NATL ACAD SCI USA, V95, P15598, DOI 10.1073/pnas.95.26.15598; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; SANJEEVI CB, 1995, TISSUE ANTIGENS, V45, P148, DOI 10.1111/j.1399-0039.1995.tb02434.x; Sanjeevi CB, 1997, TISSUE ANTIGENS, V50, P61, DOI 10.1111/j.1399-0039.1997.tb02836.x; Schiffmann R, 2002, DRUGS, V62, P733, DOI 10.2165/00003495-200262050-00002; SPASSOV VZ, 1995, PROTEIN SCI, V4, P1516, DOI 10.1002/pro.5560040809; TOMSCHY A, 1994, PROTEIN ENG, V7, P1471, DOI 10.1093/protein/7.12.1471; VANLITH HA, 1992, ANAL BIOCHEM, V201, P288, DOI 10.1016/0003-2697(92)90341-4; Vogt G, 1997, J MOL BIOL, V269, P631, DOI 10.1006/jmbi.1997.1042; WALKER JE, 1980, EUR J BIOCHEM, V108, P581, DOI 10.1111/j.1432-1033.1980.tb04753.x; WEBER K, 1969, J BIOL CHEM, V244, P4406; WEINER PK, 1981, J COMPUT CHEM, V2, P287, DOI 10.1002/jcc.540020311; WEINER SJ, 1986, J COMPUT CHEM, V7, P230, DOI 10.1002/jcc.540070216; WEINER SJ, 1984, J AM CHEM SOC, V106, P765, DOI 10.1021/ja00315a051; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6	48	41	45	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2002	277	46					44050	44060		10.1074/jbc.M206761200	http://dx.doi.org/10.1074/jbc.M206761200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	615XE	12213823	hybrid			2022-12-27	WOS:000179272000068
J	Hirota, T; Okano, T; Kokame, K; Shirotani-Ikejima, H; Miyata, T; Fukada, Y				Hirota, T; Okano, T; Kokame, K; Shirotani-Ikejima, H; Miyata, T; Fukada, Y			Glucose down-regulates Per1 and Per2 mRNA levels and induces circadian gene expression in cultured rat-1 fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTORS; MOLECULAR-MECHANISMS; PERIPHERAL-TISSUES; BRCA1 EXPRESSION; PHASE-SHIFTS; CLOCK; BINDING; LIGHT; MPER1; OSCILLATORS	In mammals, peripheral circadian clocks are present in most tissues, but little is known about how these clocks are synchronized with the ambient 24-h cycles. By using rat-1 fibroblasts, a model cell system of the peripheral clock, we found that an exchange of the culture medium triggered circadian gene expression that was preceded by slow down-regulation of Per1 and Per2 mRNA levels. This profile contrasts to the immediate up-regulation of these genes often observed for clock resetting. The screening of factor(s) responsible for the down-regulation revealed glucose as a key component triggering the circadian rhythm. The requirement of both glucose metabolism and RNA/protein synthesis for the down-regulation suggests the involvement of gene(s) immediately up-regulated by glucose metabolism. An analysis with high density oligonucleotide microarrays identified >100 glucose-regulated genes. We found among others immediately up-regulated genes encoding transcriptional regulators TIEG1, VDUP1, and HES1, in addition to cooperatively regulated genes that are associated with cholesterol biosynthesis and cell cycle. The immediate up-regulation of Tieg1 and Vdup1 expression was dependent on glucose metabolism but not on protein synthesis, suggesting that the transcriptional regulators mediate the glucose-induced down-regulation of Per1 and Per2 expression. These results illustrate a novel mode of peripheral clock resetting by external glucose, a major food metabolite.	Univ Tokyo, Grad Sch Sci, Dept Biochem & Biophys, Bunkyo Ku, Tokyo 1130033, Japan; Natl Cardiovasc Ctr, Res Inst, Suita, Osaka 5658565, Japan	University of Tokyo; National Cerebral & Cardiovascular Center - Japan	Fukada, Y (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biochem & Biophys, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.	sfukada@mail.ecc.u-tokyo.ac.jp	Hirota, Tsuyoshi/D-8158-2015; 吉孝, 深田/G-5090-2014	Hirota, Tsuyoshi/0000-0003-4876-3608; Okano, Toshiyuki/0000-0001-6740-6265; Kokame, Koichi/0000-0002-9654-6299				Akashi M, 2000, GENE DEV, V14, P645; Akiyama M, 1999, J NEUROSCI, V19, P1115; Balsalobre A, 2000, CURR BIOL, V10, P1291, DOI 10.1016/S0960-9822(00)00758-2; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Brown SA, 1999, CURR OPIN GENET DEV, V9, P588, DOI 10.1016/S0959-437X(99)00009-X; Cermakian N, 2000, NAT REV MOL CELL BIO, V1, P59, DOI 10.1038/35036078; Cook T, 2000, AM J PHYSIOL-GASTR L, V278, pG513, DOI 10.1152/ajpgi.2000.278.4.G513; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Ema M, 1999, EMBO J, V18, P1905, DOI 10.1093/emboj/18.7.1905; FUKUDA H, 1991, BIOCHIM BIOPHYS ACTA, V1086, P261, DOI 10.1016/0005-2760(91)90168-H; Grundschober C, 2001, J BIOL CHEM, V276, P46751, DOI 10.1074/jbc.M107499200; Hara R, 2001, GENES CELLS, V6, P269, DOI 10.1046/j.1365-2443.2001.00419.x; Hida A, 2000, GENOMICS, V65, P224, DOI 10.1006/geno.2000.6166; Hirota T, 2001, J BIOCHEM, V129, P51, DOI 10.1093/oxfordjournals.jbchem.a002836; Horikawa K, 2000, J NEUROSCI, V20, P5867, DOI 10.1523/JNEUROSCI.20-15-05867.2000; Ishida N, 1999, P NATL ACAD SCI USA, V96, P8819, DOI 10.1073/pnas.96.16.8819; Kageyama R, 2000, MOL CELLS, V10, P1, DOI 10.1007/s10059-000-0001-0; King DP, 2000, ANNU REV NEUROSCI, V23, P713, DOI 10.1146/annurev.neuro.23.1.713; KINLAW WB, 1987, ENDOCRINOLOGY, V120, P1563, DOI 10.1210/endo-120-4-1563; Maywood ES, 1999, P NATL ACAD SCI USA, V96, P15211, DOI 10.1073/pnas.96.26.15211; McNamara P, 2001, CELL, V105, P877, DOI 10.1016/S0092-8674(01)00401-9; Morris ME, 1998, SCIENCE, V279, P1544, DOI 10.1126/science.279.5356.1544; Nishiyama A, 2001, IUBMB LIFE, V52, P29, DOI 10.1080/15216540252774739; Nonaka H, 2001, CIRCULATION, V104, P1746, DOI 10.1161/hc4001.098048; Ohtani Kiyoshi, 1999, Frontiers in Bioscience, V4, pd793, DOI 10.2741/Ohtani; PINES J, 1989, CELL, V58, P833, DOI 10.1016/0092-8674(89)90936-7; PITTENDRIGH CS, 1993, ANNU REV PHYSIOL, V55, P16; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; Sakakura Y, 2001, BIOCHEM BIOPH RES CO, V286, P176, DOI 10.1006/bbrc.2001.5375; Shigeyoshi Y, 1997, CELL, V91, P1043, DOI 10.1016/S0092-8674(00)80494-8; Shimano H, 2001, PROG LIPID RES, V40, P439, DOI 10.1016/S0163-7827(01)00010-8; Stephan FK, 1998, PHYSIOL BEHAV, V65, P277, DOI 10.1016/S0031-9384(98)00166-8; Stephan FK, 1997, PHYSIOL BEHAV, V62, P995, DOI 10.1016/S0031-9384(97)00204-7; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Takahata S, 2000, GENES CELLS, V5, P739, DOI 10.1046/j.1365-2443.2000.00363.x; Towle HC, 2001, P NATL ACAD SCI USA, V98, P13476, DOI 10.1073/pnas.251530798; Vaughn JP, 1996, CELL GROWTH DIFFER, V7, P711; Wakamatsu H, 2001, NEUROREPORT, V12, P127, DOI 10.1097/00001756-200101220-00033; Wang A, 2000, J BIOL CHEM, V275, P4532, DOI 10.1074/jbc.275.6.4532; Yagita K, 2000, FEBS LETT, V465, P79, DOI 10.1016/S0014-5793(99)01724-X; Yagita K, 2001, SCIENCE, V292, P278, DOI 10.1126/science.1059542; YAMAMOTO H, 1987, CHRONOBIOL INT, V4, P483, DOI 10.3109/07420528709078539; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Yu R, 2000, MOL ENDOCRINOL, V14, P1137, DOI 10.1210/me.14.8.1137; Yu WJ, 2002, BIOCHEM BIOPH RES CO, V290, P933, DOI 10.1006/bbrc.2001.6300; Zylka MJ, 1998, NEURON, V20, P1103, DOI 10.1016/S0896-6273(00)80492-4	50	247	252	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2002	277	46					44244	44251		10.1074/jbc.M206233200	http://dx.doi.org/10.1074/jbc.M206233200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	615XE	12213820	hybrid			2022-12-27	WOS:000179272000093
J	Nishi, T; Shimizu, N; Hiramoto, M; Sato, L; Yamaguchi, Y; Hasegawa, M; Aizawa, S; Tanaka, H; Kataoka, K; Watanabe, H; Handa, H				Nishi, T; Shimizu, N; Hiramoto, M; Sato, L; Yamaguchi, Y; Hasegawa, M; Aizawa, S; Tanaka, H; Kataoka, K; Watanabe, H; Handa, H			Spatial redox regulation of a critical cysteine residue of NF-kappa B in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING ACTIVITY; TRANSCRIPTION FACTOR; CRYSTAL-STRUCTURE; S-NITROSYLATION; NITRIC-OXIDE; P50 SUBUNIT; IN-VIVO; THIOREDOXIN; PROTEIN; REF-1	Reduction-oxidation (redox) regulation has been implicated in the activation of the transcription factor NF-kappaB. However, the significance and mechanism of the redox regulation remain elusive, mainly due to the technical limitations caused by rapid proton transfer in redox reactions and by the presence of many redox molecules within cells. Here we establish versatile methods for measuring redox states of proteins and their individual cysteine residues in vitro and in vivo, involving thiol-modifying reagents and LC-MS analysis. Using these methods, we demonstrate that the redox state of NF-kappaB is spatially regulated by its subcellular localization. While the p65 subunit and most cysteine residues of the p50 subunit are reduced similarly in the cytoplasm and in the nucleus, Cys-62 of p50 is highly oxidized in the cytoplasm and strongly reduced in the nucleus. The reduced form of Cys-62 is essential for the DNA binding activity of NF-kappaB Several lines of evidence suggest that the redox factor Ref-1 is involved in Cys-62 reduction in the nucleus. We propose that the Ref-1-dependent reduction of p50 in the nucleus is a necessary step for NF-kappaB activation. This study also provides the first example of a drug that inhibits the redox reaction between two specific proteins.	Tokyo Inst Technol, Fac Biosci & Biotechnol, Midori Ku, Yokohama, Kanagawa 2268501, Japan; Tokyo Inst Technol, Frontier Collaborat Res Ctr, Midori Ku, Yokohama, Kanagawa 2268501, Japan; Nihon Univ, Sch Med, Dept Anat, Itabashi Ku, Tokyo 173, Japan; Univ Tokyo, Inst Med Sci, Minato Ku, Tokyo 1088639, Japan; Okazaki Natl Res Inst, Natl Inst Basic Biol, Okazaki, Aichi 4448585, Japan	Tokyo Institute of Technology; Tokyo Institute of Technology; Nihon University; University of Tokyo; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Okazaki Institute for Integrative Bioscience (OIIB)	Handa, H (corresponding author), Tokyo Inst Technol, Fac Biosci & Biotechnol, Midori Ku, 4259 Nagatsuta Cho, Yokohama, Kanagawa 2268501, Japan.		Watanabe, Hajime/S-8957-2019; WATANABE, Hajime/AAJ-8904-2021; Yamaguchi, Yuki/B-9390-2015	Yamaguchi, Yuki/0000-0002-0197-614X; Watanabe, Hajime/0000-0001-9657-6554				ABATE C, 1990, CELL GROWTH DIFFER, V1, P455; Bader M, 1999, CELL, V98, P217, DOI 10.1016/S0092-8674(00)81016-8; Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; Carrero P, 2000, MOL CELL BIOL, V20, P402, DOI 10.1128/MCB.20.1.402-415.2000; Chen FE, 1998, NATURE, V391, P410, DOI 10.1038/34956; Daily D, 2001, J BIOL CHEM, V276, P1335, DOI 10.1074/jbc.M008121200; DelaTorre A, 1997, BIOCHEM BIOPH RES CO, V238, P703, DOI 10.1006/bbrc.1997.7279; delaTorre A, 1999, J IMMUNOL, V162, P4101; Demple B, 1997, METHODS, V11, P267, DOI 10.1006/meth.1996.0421; DEMPLE B, 1991, P NATL ACAD SCI USA, V88, P11450, DOI 10.1073/pnas.88.24.11450; Ding HG, 1997, P NATL ACAD SCI USA, V94, P8445, DOI 10.1073/pnas.94.16.8445; Eu JP, 2000, CELL, V102, P499, DOI 10.1016/S0092-8674(00)00054-4; Gaiddon C, 1999, EMBO J, V18, P5609, DOI 10.1093/emboj/18.20.5609; GHOSH G, 1995, NATURE, V373, P303, DOI 10.1038/373303a0; HAYASHI T, 1993, J BIOL CHEM, V268, P11380; Hidalgo E, 1997, CELL, V88, P121, DOI 10.1016/S0092-8674(00)81864-4; Hiramoto M, 1998, J IMMUNOL, V160, P810; Hirota K, 1999, J BIOL CHEM, V274, P27891, DOI 10.1074/jbc.274.39.27891; Hirota K, 1997, P NATL ACAD SCI USA, V94, P3633, DOI 10.1073/pnas.94.8.3633; HOLMGREN A, 1995, METHOD ENZYMOL, V252, P199; Huxford T, 1998, CELL, V95, P759, DOI 10.1016/S0092-8674(00)81699-2; Jacobs MD, 1998, CELL, V95, P749, DOI 10.1016/S0092-8674(00)81698-0; Jakob U, 1999, CELL, V96, P341, DOI 10.1016/S0092-8674(00)80547-4; Jayaraman L, 1997, GENE DEV, V11, P558, DOI 10.1101/gad.11.5.558; Lando D, 2000, J BIOL CHEM, V275, P4618, DOI 10.1074/jbc.275.7.4618; Mannick JB, 1999, SCIENCE, V284, P651, DOI 10.1126/science.284.5414.651; MATTHEWS JR, 1993, NUCLEIC ACIDS RES, V21, P1727, DOI 10.1093/nar/21.8.1727; Matthews JR, 1996, NUCLEIC ACIDS RES, V24, P2236, DOI 10.1093/nar/24.12.2236; MATTHEWS JR, 1992, NUCLEIC ACIDS RES, V20, P3821, DOI 10.1093/nar/20.15.3821; MITOMO K, 1994, GENE, V145, P197; MULLER CW, 1995, NATURE, V373, P311, DOI 10.1038/373311a0; Park SK, 1997, BIOCHEM J, V322, P609, DOI 10.1042/bj3220609; RICHARD PH, 1998, HDB FLUORESCENT PROB, P47; ROBSON CN, 1991, NUCLEIC ACIDS RES, V19, P5519, DOI 10.1093/nar/19.20.5519; Shimizu N, 2000, NAT BIOTECHNOL, V18, P877, DOI 10.1038/78496; Takeuchi J, 2000, ANTIOXID REDOX SIGN, V2, P83, DOI 10.1089/ars.2000.2.1-83; TOLEDANO MB, 1993, MOL CELL BIOL, V13, P852, DOI 10.1128/MCB.13.2.852; TOLEDANO MB, 1991, P NATL ACAD SCI USA, V88, P4328, DOI 10.1073/pnas.88.10.4328; Tsai B, 2001, CELL, V104, P937, DOI 10.1016/S0092-8674(01)00289-6; Wei SJ, 2000, CANCER RES, V60, P6688; XANTHOUDAKIS S, 1992, EMBO J, V11, P3323, DOI 10.1002/j.1460-2075.1992.tb05411.x; XANTHOUDAKIS S, 1994, P NATL ACAD SCI USA, V91, P23, DOI 10.1073/pnas.91.1.23; Zheng M, 1998, SCIENCE, V279, P1718, DOI 10.1126/science.279.5357.1718	43	190	200	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	2002	277	46					44548	44556		10.1074/jbc.M202970200	http://dx.doi.org/10.1074/jbc.M202970200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	615XE	12213807	hybrid			2022-12-27	WOS:000179272000127
J	Shallom, D; Belakhov, V; Solomon, D; Shoham, G; Baasov, T; Shoham, Y				Shallom, D; Belakhov, V; Solomon, D; Shoham, G; Baasov, T; Shoham, Y			Detailed kinetic analysis and identification of the nucleophile in alpha-L-arabinofuranosidase from Geobacillus stearothermophilus T-6, a family 51 glycoside hydrolase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEQUENCE-BASED CLASSIFICATION; ACTIVE-SITE NUCLEOPHILE; MECHANISTIC CONSEQUENCES; PURIFICATION; RESIDUES; MUTAGENESIS; ARABINOFURANOHYDROLASE; GLUCOAMYLASE; HYDROLYSIS; MUTATION	alpha-L-Arabinofuranosidases cleave the L-arabinofuranoside side chains of different hemicelluloses and are key enzymes in the complete degradation of the plant cell wall. The alpha-L-arabinofuranosidase from Geobacillus stearothermophilus T-6, a family 51 glycoside hydrolase, was subjected to a detailed mechanistic study. Aryl-alpha-Larabinofuranosides with various leaving groups were synthesized and used to verify the catalytic mechanism and catalytic residues of the enzyme. The steady-state constants and the resulting Bronsted plots for the E175A mutant are consistent with the role of Glu-175 as the acid-base catalytic residue. The proposed nucleophile residue, Glu-294, was replaced to Ala by a double-base pairs substitution. The resulting E294A mutant, with 4-nitrophenyl alpha-L-arabinofuranoside as the substrate, exhibited eight orders of magnitude lower activity and a 10-fold higher K-m value compared with the wild type enzyme. Sodium azide accelerated by more than 40-fold the rate of the hydrolysis of 2',4',6'-trichlorophenyl alpha-L-arabinofuranoside by the E294A mutant. The glycosylazide product formed during this reaction was isolated and characterized as P-L-arabinofuranosyl-azide by H-1 NMR, C-13 NMR, mass spectrometry, and Fourier transform infrared analysis. The anomeric configuration of this product supports the assignment of Glu-294 as the catalytic nucleophile residue of the alpha-L-arabinofuranosidase T-6 and allows for the first time the unequivocal identification of this residue in glycoside hydrolases family 51.	Technion Israel Inst Technol, Dept Food Engn & Biotechnol, IL-32000 Haifa, Israel; Technion Israel Inst Technol, Dept Chem, IL-32000 Haifa, Israel; Technion Israel Inst Technol, Inst Catalysis Sci & Technol, IL-32000 Haifa, Israel; Hebrew Univ Jerusalem, Dept Inorgan Chem, IL-91904 Jerusalem, Israel; Hebrew Univ Jerusalem, Lab Struct Chem & Biol, IL-91904 Jerusalem, Israel	Technion Israel Institute of Technology; Technion Israel Institute of Technology; Technion Israel Institute of Technology; Hebrew University of Jerusalem; Hebrew University of Jerusalem	Shoham, Y (corresponding author), Technion Israel Inst Technol, Dept Food Engn & Biotechnol, IL-32000 Haifa, Israel.	yshoham@tx.technion.ac.il	Shoham, Yuval/M-4409-2013; Baasov, Timor/L-5173-2019	Baasov, Timor/0000-0002-1427-2619; Belakhov, Valery/0000-0003-1918-974X				Beylot MH, 2001, BIOCHEM J, V358, P607, DOI 10.1042/0264-6021:3580607; Biely P, 1997, J BIOTECHNOL, V57, P151, DOI 10.1016/S0168-1656(97)00096-5; BIELY P, 1985, TRENDS BIOTECHNOL, V3, P286, DOI 10.1016/0167-7799(85)90004-6; Davies G. J., 1998, INCOMPREHENSIVE BIOL, P119; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; de Vries RP, 2000, CARBOHYD RES, V327, P401, DOI 10.1016/S0008-6215(00)00066-5; Debeche T, 2002, PROTEIN ENG, V15, P21, DOI 10.1093/protein/15.1.21; Ferre H, 2000, EUR J BIOCHEM, V267, P6633, DOI 10.1046/j.1432-1327.2000.01758.x; Fort S, 2000, J AM CHEM SOC, V122, P5429, DOI 10.1021/ja9936520; GILEAD S, 1995, APPL ENVIRON MICROB, V61, P170, DOI 10.1128/AEM.61.1.170-174.1995; HARRIS EMS, 1993, BIOCHEMISTRY-US, V32, P1618, DOI 10.1021/bi00057a028; Hazlewood GP, 1998, PROG NUCLEIC ACID RE, V61, P211, DOI 10.1016/S0079-6603(08)60828-4; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; Henrissat B, 1996, BIOCHEM J, V316, P695, DOI 10.1042/bj3160695; Kaneko S, 1998, APPL ENVIRON MICROB, V64, P4021; KELLY MA, 1988, CARBOHYD RES, V181, P262, DOI 10.1016/0008-6215(88)84045-X; KELLY MA, 1987, BIOCHEM J, V245, P843, DOI 10.1042/bj2450843; Lawson SL, 1996, BIOCHEMISTRY-US, V35, P10110, DOI 10.1021/bi960586v; Leatherbarrow R. J, 2001, GRAFIT 5; Lee RC, 2001, BIOCHEM J, V356, P181, DOI 10.1042/0264-6021:3560181; Ly HD, 1999, ANNU REV BIOCHEM, V68, P487, DOI 10.1146/annurev.biochem.68.1.487; Mackenzie LF, 1998, J AM CHEM SOC, V120, P5583, DOI 10.1021/ja980833d; MacLeod AM, 1996, BIOCHEMISTRY-US, V35, P13165, DOI 10.1021/bi9610616; Malet C, 1998, FEBS LETT, V440, P208, DOI 10.1016/S0014-5793(98)01448-3; Matsuo N, 2000, BIOCHEM J, V346, P9, DOI 10.1042/0264-6021:3460009; McIntosh LP, 1996, BIOCHEMISTRY-US, V35, P9958, DOI 10.1021/bi9613234; MIKAMI B, 1994, BIOCHEMISTRY-US, V33, P7779, DOI 10.1021/bi00191a005; Moracci M, 1998, BIOCHEMISTRY-US, V37, P17262, DOI 10.1021/bi981855f; Notenboom V, 1998, NAT STRUCT BIOL, V5, P812, DOI 10.1038/1852; Palcic MM, 1999, CURR OPIN BIOTECH, V10, P616, DOI 10.1016/S0958-1669(99)00044-0; Pitson SM, 1996, FEBS LETT, V398, P7, DOI 10.1016/S0014-5793(96)01153-2; PLANAS P, 1998, CARBOHYDRASES TRICHO, P21; Saha Badal C., 2000, Biotechnology Advances, V18, P403, DOI 10.1016/S0734-9750(00)00044-6; SCHIMMEL P, 1989, ACCOUNTS CHEM RES, V22, P232, DOI 10.1021/ar00163a001; Shallom D, 2002, FEBS LETT, V514, P163, DOI 10.1016/S0014-5793(02)02343-8; SIERKS MR, 1990, PROTEIN ENG, V3, P193, DOI 10.1093/protein/3.3.193; SINNOTT ML, 1990, CHEM REV, V90, P1171, DOI 10.1021/cr00105a006; Sunna A, 1997, CRIT REV BIOTECHNOL, V17, P39, DOI 10.3109/07388559709146606; Suurnakki A, 1997, Adv Biochem Eng Biotechnol, V57, P261; TOTSUKA A, 1994, EUR J BIOCHEM, V221, P649, DOI 10.1111/j.1432-1033.1994.tb18777.x; Trincone A, 2000, BIOORG MED CHEM LETT, V10, P365, DOI 10.1016/S0960-894X(99)00700-3; VanLaere KMJ, 1997, APPL MICROBIOL BIOT, V47, P231; Viladot JL, 1998, BIOCHEMISTRY-US, V37, P11332, DOI 10.1021/bi980586q; WANG QP, 1994, J AM CHEM SOC, V116, P11594, DOI 10.1021/ja00104a060; WITHERS SG, 1992, BIOCHEMISTRY-US, V31, P9979, DOI 10.1021/bi00156a017; Wolfenden R, 1998, J AM CHEM SOC, V120, P6814, DOI 10.1021/ja9813055; WONG KKY, 1993, PORT PR R M, V4, P127; Zechel D. L., 1999, COMPREHENSIVE NATURA, V5, P279; Zechel DL, 2000, ACCOUNTS CHEM RES, V33, P11, DOI 10.1021/ar970172+; Zverlov VV, 1998, FEMS MICROBIOL LETT, V164, P337, DOI 10.1016/S0378-1097(98)00236-5	50	80	86	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2002	277	46					43667	43673		10.1074/jbc.M208285200	http://dx.doi.org/10.1074/jbc.M208285200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	615XE	12221104	hybrid			2022-12-27	WOS:000179272000018
J	Valjakka, J; Hemminki, A; Niemi, S; Soderlund, H; Takkinen, K; Rouvinen, J				Valjakka, J; Hemminki, A; Niemi, S; Soderlund, H; Takkinen, K; Rouvinen, J			Crystal structure of an in Vitro affinity- and specificity-matured anti-testosterone Fab in Comiplex with testosterone - Improved affinity results from small structural changes within the variable domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-CHAIN FV; RANDOM MUTAGENESIS; PHAGE DISPLAY; X-RAY; ANTIBODY; SELECTION; MATURATION; BINDING; EVOLUTION; FRAGMENT	A highly selective, high affinity recombinant anti-testosterone Fab fragment has been generated by stepwise optimization of the complementarity-determining regions (CDRs) by random mutagenesis and phage display selection of a monoclonal antibody (3-C4F5). The best mutant (77 Fab) was obtained by evaluating the additivity effects of different independently selected CDR mutations. The 77 Fab contains 20 mutations and has about 40-fold increased affinity (K-d = 3 x 10(-10) m) when compared with the wild-type (3-C4F5) Fab. To obtain structural insight into factors, which are needed to improve binding properties, we have determined the crystal structures of the mutant 77 Fab fragment with (2.15 Angstrom) and without testosterone (2.10 Angstrom) and compared these with previously determined wild-type structures. The overall testosterone binding of the 77 Fab is similar to that of the wild-type. The improved affinity and specificity of the 77 Fab fragment are due to more comprehensive packing of the testosterone with the protein, which is the result of small structural changes within the variable domains. Only one important binding site residue Glu-95 of the heavy chain CDR3 is mutated to alanine in the 77 Fab fragment. This mutation, originally selected from the phage library based on improved specificity, provides more free space for the testosterone D-ring. The light chain CDR1 of 77 Fab containing eight mutations has the most significant effect on the improved affinity, although it has no direct contact with the testosterone. The mutations of CDR-L1 cause a rearrangement in its conformation, leading to an overall fine reshaping of the binding site.	Univ Joensuu, Dept Chem, FIN-80101 Joensuu, Finland; Finnish Red Cross, Helsinki 00310, Finland; Orion Diagnost, Oulunsalo 90460, Finland; VTT Biotechnol, Espoo 02044, Finland	University of Eastern Finland; VTT Technical Research Center Finland	Valjakka, J (corresponding author), Univ Joensuu, Dept Chem, POB 111, FIN-80101 Joensuu, Finland.	jarkko.valjakka@joensuu.fi						AREVALO JH, 1993, NATURE, V365, P859, DOI 10.1038/365859a0; AREVALO JH, 1994, J MOL BIOL, V241, P663, DOI 10.1006/jmbi.1994.1543; BARBAS CF, 1991, P NATL ACAD SCI USA, V88, P7978, DOI 10.1073/pnas.88.18.7978; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Boder ET, 2000, P NATL ACAD SCI USA, V97, P10701, DOI 10.1073/pnas.170297297; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chames P, 1998, J IMMUNOL, V161, P5421; Chen Y, 1999, J MOL BIOL, V293, P865, DOI 10.1006/jmbi.1999.3192; Daugherty PS, 2000, P NATL ACAD SCI USA, V97, P2029, DOI 10.1073/pnas.030527597; EVANS SV, 1993, J MOL GRAPHICS, V11, P134, DOI 10.1016/0263-7855(93)87009-T; GRAM H, 1992, P NATL ACAD SCI USA, V89, P3576, DOI 10.1073/pnas.89.8.3576; Hanes J, 1998, P NATL ACAD SCI USA, V95, P14130, DOI 10.1073/pnas.95.24.14130; Hanes J, 1997, P NATL ACAD SCI USA, V94, P4937, DOI 10.1073/pnas.94.10.4937; HAWKINS RE, 1992, J MOL BIOL, V226, P889, DOI 10.1016/0022-2836(92)90639-2; Hemminki A, 1998, IMMUNOTECHNOLOGY, V4, P59, DOI 10.1016/S1380-2933(98)00002-5; Hemminki A, 1998, PROTEIN ENG, V11, P311, DOI 10.1093/protein/11.4.311; HERMES JD, 1989, GENE, V84, P143, DOI 10.1016/0378-1119(89)90148-0; HERMES JD, 1990, P NATL ACAD SCI USA, V87, P696, DOI 10.1073/pnas.87.2.696; Hoogenboom HR, 1997, TRENDS BIOTECHNOL, V15, P62, DOI 10.1016/S0167-7799(97)84205-9; Jermutus L, 2001, P NATL ACAD SCI USA, V98, P75, DOI 10.1073/pnas.011311398; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; JONSSON U, 1991, BIOTECHNIQUES, V11, P620; KABAT EA, 1991, SEQUENCES PROTEIN IM; KARLSSON R, 1991, J IMMUNOL METHODS, V145, P229, DOI 10.1016/0022-1759(91)90331-9; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lamminmaki U, 1999, J MOL BIOL, V291, P589, DOI 10.1006/jmbi.1999.2981; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; MCREE DE, 1999, XTALVIEW 4 0; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rader C, 1997, CURR OPIN BIOTECH, V8, P503, DOI 10.1016/S0958-1669(97)80075-4; Saviranta P, 1998, PROTEIN ENG, V11, P143, DOI 10.1093/protein/11.2.143; Schier R, 1996, J MOL BIOL, V263, P551, DOI 10.1006/jmbi.1996.0598; Short MK, 2002, J BIOL CHEM, V277, P16365, DOI 10.1074/jbc.M110444200; TAKKINEN K, 1991, PROTEIN ENG, V4, P837, DOI 10.1093/protein/4.7.837; Trinh CH, 1997, STRUCTURE, V5, P937, DOI 10.1016/S0969-2126(97)00247-5; Valjakka J, 2000, ACTA CRYSTALLOGR D, V56, P218, DOI 10.1107/S0907444999016224; Valjakka J, 2002, J BIOL CHEM, V277, P4183, DOI 10.1074/jbc.M105579200; WINTER G, 1994, ANNU REV IMMUNOL, V12, P433, DOI 10.1146/annurev.iy.12.040194.002245; Yang PL, 1999, J MOL BIOL, V294, P1191, DOI 10.1006/jmbi.1999.3197; YANG WP, 1995, J MOL BIOL, V254, P392, DOI 10.1006/jmbi.1995.0626	41	39	45	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2002	277	46					44021	44027		10.1074/jbc.M208392200	http://dx.doi.org/10.1074/jbc.M208392200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	615XE	12196551	hybrid			2022-12-27	WOS:000179272000064
J	Bottger, P; Pedersen, L				Bottger, P; Pedersen, L			Two highly conserved glutamate residues critical for type III sodium-dependent phosphate transport revealed by uncoupling transport function from retroviral receptor function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MURINE LEUKEMIA-VIRUS; CELL-SURFACE RECEPTOR; MOLECULAR-BASIS; GENE ENCODES; FELINE; CATION; ENTRY; IDENTIFICATION; COTRANSPORTER; CLONING	Type III sodium-dependent phosphate (NaPi) cotransporters, Pit1 and Pit2, have been assigned housekeeping Pi transport functions and suggested involved in chondroblastic and osteoblastic mineralization and ectopic calcification. Both proteins exhibit dual function, thus, besides being transporters, they also serve as receptors for several gammaretroviruses. We here show that it is possible to uncouple transport and receptor functions of a type III NaPi cotransporter and thus exploit the retroviral receptor function as a control for proper processing and folding of mutant proteins. Thus exchanging two putative transmembranic glutamate residues in human Pit2, Glu(55) and Glu(575), with glutamine or with lysine severely impaired or knocked out, respectively, P-i transport function, but left viral receptor function undisturbed. Both glutamates are conserved in type III NaPi cotransporters, in fungal NaPi cotransporters PHO-4 and Pho89, and in other known or putative phosphate permeases from a number of species and are the first residues shown to be critical for type III NaPi cotransport. Their putative transmembranic positions together with the presented data are consistent with Glu(55) and Glu(575) being parts of a cation liganding site or playing roles in conformational changes associated with substrate transport. Finally, the results also show that Pit2 retroviral receptor function per se is not dependent on Pit2 P-i transport function.	Aarhus Univ, Dept Mol Biol, DK-8000 Aarhus C, Denmark; Aarhus Univ, Inst Expt Clin Res, DK-8000 Aarhus C, Denmark	Aarhus University; Aarhus University	Pedersen, L (corresponding author), Aarhus Univ, Dept Mol Biol, CF Mollers Alle,Bldg 130, DK-8000 Aarhus C, Denmark.	LP@mb.au.dk	Pedersen, Lene/A-3673-2014	Pedersen, Lene/0000-0002-3396-1292				ALBRITTON LM, 1989, CELL, V57, P659, DOI 10.1016/0092-8674(89)90134-7; Beck GR, 2000, P NATL ACAD SCI USA, V97, P8352, DOI 10.1073/pnas.140021997; Boyer CJC, 1998, BBA-BIOMEMBRANES, V1368, P73, DOI 10.1016/S0005-2736(97)00159-4; Chien ML, 1998, VIROLOGY, V240, P109, DOI 10.1006/viro.1997.8933; Chien ML, 1997, J VIROL, V71, P4564, DOI 10.1128/JVI.71.6.4564-4570.1997; Dibrov P, 1998, FEBS LETT, V424, P1, DOI 10.1016/S0014-5793(98)00119-7; Dreyer K, 2000, J VIROL, V74, P2926, DOI 10.1128/JVI.74.6.2926-2929.2000; Eiden MV, 1996, J VIROL, V70, P1080, DOI 10.1128/JVI.70.2.1080-1085.1996; Giachelli CM, 1999, AM J PATHOL, V154, P671, DOI 10.1016/S0002-9440(10)65313-8; Griffith DA, 1999, BIOCHEMISTRY-US, V38, P7524, DOI 10.1021/bi990076b; JOHANN SV, 1992, J VIROL, V66, P1635, DOI 10.1128/JVI.66.3.1635-1640.1992; Jono S, 2000, CIRC RES, V87, pE10, DOI 10.1161/01.RES.87.7.e10; Kaim G, 1997, BIOCHEMISTRY-US, V36, P9185, DOI 10.1021/bi970831q; Kavanaugh MP, 1996, KIDNEY INT, V49, P959, DOI 10.1038/ki.1996.135; KAVANAUGH MP, 1994, P NATL ACAD SCI USA, V91, P7071, DOI 10.1073/pnas.91.15.7071; Leverett BD, 1998, J VIROL, V72, P4956, DOI 10.1128/JVI.72.6.4956-4961.1998; Lundorf MD, 1999, J VIROL, V73, P3169, DOI 10.1128/JVI.73.4.3169-3175.1999; Lundorf MD, 1998, J VIROL, V72, P4524, DOI 10.1128/JVI.72.5.4524-4527.1998; Martinez P, 1998, MOL GEN GENET, V258, P628, DOI 10.1007/s004380050776; MCLACHLIN JR, 1993, VIROLOGY, V195, P1, DOI 10.1006/viro.1993.1340; Miller AD, 1996, J VIROL, V70, P5564, DOI 10.1128/JVI.70.8.5564-5571.1996; MILLER AD, 1989, BIOTECHNIQUES, V7, P980; MILLER DG, 1994, J VIROL, V68, P8270, DOI 10.1128/JVI.68.12.8270-8276.1994; MILLER DG, 1994, P NATL ACAD SCI USA, V91, P78, DOI 10.1073/pnas.91.1.78; Nielsen LB, 2001, BONE, V28, P160, DOI 10.1016/S8756-3282(00)00418-X; OHARA B, 1990, CELL GROWTH DIFFER, V1, P119; OLAH Z, 1994, J BIOL CHEM, V269, P25426; Overbaugh J, 2001, MICROBIOL MOL BIOL R, V65, P371, DOI 10.1128/MMBR.65.3.371-389.2001; Palmer G, 1999, BONE, V24, P1, DOI 10.1016/S8756-3282(98)00151-3; PEDERSEN L, 1995, J VIROL, V69, P2401, DOI 10.1128/JVI.69.4.2401-2405.1995; Pedersen L, 1997, J VIROL, V71, P7619, DOI 10.1128/JVI.71.10.7619-7622.1997; Pedersen PA, 1997, FEBS LETT, V400, P206, DOI 10.1016/S0014-5793(96)01381-6; Poolman B, 1996, MOL MICROBIOL, V19, P911, DOI 10.1046/j.1365-2958.1996.397949.x; Rasko JEJ, 1999, P NATL ACAD SCI USA, V96, P2129, DOI 10.1073/pnas.96.5.2129; Rodrigues P, 1999, J VIROL, V73, P3789, DOI 10.1128/JVI.73.5.3789-3799.1999; Salaun C, 2002, J VIROL, V76, P4304, DOI 10.1128/JVI.76.9.4304-4311.2002; Sommerfelt MA, 1999, J GEN VIROL, V80, P3049, DOI 10.1099/0022-1317-80-12-3049; Tailor CS, 1999, J VIROL, V73, P6500, DOI 10.1128/JVI.73.8.6500-6505.1999; Tailor CS, 2000, J VIROL, V74, P237, DOI 10.1128/JVI.74.1.237-244.2000; Tailor CS, 1999, J VIROL, V73, P4470, DOI 10.1128/JVI.73.5.4470-4474.1999; TAKEUCHI Y, 1992, J VIROL, V66, P1219, DOI 10.1128/JVI.66.2.1219-1222.1992; Tatsumi S, 1998, ENDOCRINOLOGY, V139, P1692, DOI 10.1210/en.139.4.1692; Timmer RT, 2000, J GEN PHYSIOL, V116, P363, DOI 10.1085/jgp.116.3.363; Uckert W, 1998, HUM GENE THER, V9, P2619, DOI 10.1089/10430349850019454; VANZEIJL M, 1994, P NATL ACAD SCI USA, V91, P1168, DOI 10.1073/pnas.91.3.1168; VERSAW WK, 1995, P NATL ACAD SCI USA, V92, P3884, DOI 10.1073/pnas.92.9.3884; VILSEN B, 1995, BIOCHEMISTRY-US, V34, P1455, DOI 10.1021/bi00004a041; WANG H, 1994, VIROLOGY, V202, P1058, DOI 10.1006/viro.1994.1439; WILSON CA, 1995, J VIROL, V69, P534, DOI 10.1128/JVI.69.1.534-537.1995; WILSON CA, 1994, J VIROL, V68, P7697, DOI 10.1128/JVI.68.12.7697-7703.1994	50	46	47	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					42741	42747		10.1074/jbc.M207096200	http://dx.doi.org/10.1074/jbc.M207096200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12205090	hybrid			2022-12-27	WOS:000179081200042
J	Fontemaggi, G; Kela, I; Amariglio, N; Rechavi, G; Krishnamurthy, J; Strano, S; Sacchi, A; Givol, D; Blandino, G				Fontemaggi, G; Kela, I; Amariglio, N; Rechavi, G; Krishnamurthy, J; Strano, S; Sacchi, A; Givol, D; Blandino, G			Identification of direct p73 target genes combining DNA microarray and chromatin immunoprecipitation analyses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER CELL-LINE; KINASE C-ABL; TRANSCRIPTIONAL ACTIVITY; APOPTOTIC RESPONSE; SPONTANEOUS TUMORS; INDUCE APOPTOSIS; REGULATES P73; P53 MUTANTS; EXPRESSION; P63	The newly discovered p53 family member, p73, has a striking homology to p53 in both sequence and modular structure. Ectopic expression of p73 promotes transcription of p53 target genes and recapitulates the most characterized p53 biological effects such as growth arrest, apoptosis, and differentiation. Unlike p53-deficient mice that develop normally but are subject to spontaneous tumor formation, p73-deficient mice exhibit severe defects in the development of central nervous system and suffer from inflammation but are not prone to tumor development. These phenotypes suggest different biological activities mediated by p53 and p73 that might reflect activation of specific sets of target genes. Here, we have analyzed the gene expression profile of H1299 cells after p73alpha or p53 activation using oligonucleotide microarrays capable of detecting similar to11,000 mRNA species. Our results indicate that p73alpha and p53 activate both common and distinct groups of genes. We found 141 and 320 genes whose expression is modulated by p73alpha and p53, respectively. p73alpha up-regulates 85 genes, whereas p53 induces 153 genes, of which 27 are in common with p73alpha. Functional classification of these genes reveals that they are involved in many aspects of cell function ranging from cell cycle and apoptosis to DNA repair. Furthermore, we report that some of the up-regulated genes are directly activated by p73alpha or p53.	Regina Elena Inst Canc Res, Dept Expt Oncol, I-00158 Rome, Italy; Weizmann Inst Sci, Dept Phys Complex Syst, IL-76100 Rehovot, Israel; Tel Aviv Univ, Dept Pediat Hemato Oncol, Chaim Sheba Med Ctr, IL-69978 Tel Aviv, Israel; Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel; Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel	IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; Weizmann Institute of Science; Chaim Sheba Medical Center; Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine; Weizmann Institute of Science	Blandino, G (corresponding author), Regina Elena Inst Canc Res, Dept Expt Oncol, Via Messi Oro 156, I-00158 Rome, Italy.		strano, sabrina/B-6743-2013; Strano, Sabrina/K-9654-2016; Fontemaggi, Giulia/K-9702-2016; Blandino, Giovanni/B-1137-2013	strano, sabrina/0000-0002-6341-4230; Fontemaggi, Giulia/0000-0001-8332-8842; Blandino, Giovanni/0000-0002-6970-2241				Agami R, 1999, NATURE, V399, P809; ALMOG N, 1997, BIOCHIM BIOPHYS ACTA, V1333, P1; Bingle L, 1996, THORAX, V51, P1273, DOI 10.1136/thx.51.12.1273; Blatt M, 1996, PHYS REV LETT, V76, P3251, DOI 10.1103/PhysRevLett.76.3251; Costanzo A, 2002, MOL CELL, V9, P175, DOI 10.1016/S1097-2765(02)00431-8; De Laurenzi V, 2000, J BIOL CHEM, V275, P15226, DOI 10.1074/jbc.275.20.15226; De Laurenzi V, 1999, CELL DEATH DIFFER, V6, P389, DOI 10.1038/sj.cdd.4400521; De Laurenzi V, 1998, J EXP MED, V188, P1763, DOI 10.1084/jem.188.9.1763; Di Como CJ, 1999, MOL CELL BIOL, V19, P1438; Dobbelstein M, 1998, J GEN VIROL, V79, P3079, DOI 10.1099/0022-1317-79-12-3079; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Feng G, 2001, CANCER RES, V61, P7999; Flores ER, 2002, NATURE, V416, P560, DOI 10.1038/416560a; Fontemaggi G, 2001, MOL CELL BIOL, V21, P8461, DOI 10.1128/MCB.21.24.8461-8470.2001; Gaiddon C, 2001, MOL CELL BIOL, V21, P1874, DOI 10.1128/MCB.21.5.1874-1887.2001; Gong JG, 1999, NATURE, V399, P806; Hainaut P, 1997, NUCLEIC ACIDS RES, V25, P151, DOI 10.1093/nar/25.1.151; Hansen R, 1997, CURR OPIN GENET DEV, V7, P46, DOI 10.1016/S0959-437X(97)80108-6; Hermeking H, 1997, MOL CELL, V1, P3, DOI 10.1016/S1097-2765(00)80002-7; Hollstein M, 1997, Recent Results Cancer Res, V143, P369; Irwin MS, 2001, CELL GROWTH DIFFER, V12, P337; Janciauskiene S, 2001, BBA-MOL BASIS DIS, V1535, P221, DOI 10.1016/S0925-4439(01)00025-4; Jiang RL, 1998, GENE DEV, V12, P1046, DOI 10.1101/gad.12.7.1046; Jimenez GS, 2000, NAT GENET, V26, P37, DOI 10.1038/79152; Jost CA, 1997, NATURE, V389, P191, DOI 10.1038/38298; Kaghad M, 1997, CELL, V90, P809, DOI 10.1016/S0092-8674(00)80540-1; Kannan K, 2000, FEBS LETT, V470, P77, DOI 10.1016/S0014-5793(00)01291-6; Kannan K, 2001, ONCOGENE, V20, P3449, DOI 10.1038/sj.onc.1204446; Kannan K, 2001, ONCOGENE, V20, P2225, DOI 10.1038/sj.onc.1204319; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Marin MC, 2000, NAT GENET, V25, P47, DOI 10.1038/75586; Marin MC, 1998, MOL CELL BIOL, V18, P6316, DOI 10.1128/MCB.18.11.6316; Morena A, 2002, BLOOD, V100, P96, DOI 10.1182/blood.V100.1.96; Morgan K, 1997, INT J BIOCHEM CELL B, V29, P1501, DOI 10.1016/S1357-2725(97)00118-0; Moustakas A, 2001, J CELL SCI, V114, P4359; Oren M, 1999, J BIOL CHEM, V274, P36031, DOI 10.1074/jbc.274.51.36031; Pozniak CD, 2000, SCIENCE, V289, P304, DOI 10.1126/science.289.5477.304; Roth J, 1998, J VIROL, V72, P8510, DOI 10.1128/JVI.72.11.8510-8516.1998; Sasaki Y, 2002, J BIOL CHEM, V277, P719, DOI 10.1074/jbc.M108080200; Steegenga WT, 1999, MOL CELL BIOL, V19, P3885; Strano S, 2001, J BIOL CHEM, V276, P15164, DOI 10.1074/jbc.M010484200; Strano S, 2002, J BIOL CHEM, V277, P18817, DOI 10.1074/jbc.M201405200; Strano S, 2001, FEBS LETT, V490, P163, DOI 10.1016/S0014-5793(01)02119-6; Strano S, 2000, J BIOL CHEM, V275, P29503, DOI 10.1074/jbc.M003360200; Szak ST, 2001, MOL CELL BIOL, V21, P3375, DOI 10.1128/MCB.21.10.3375-3386.2001; Tan MJ, 2000, P NATL ACAD SCI USA, V97, P109, DOI 10.1073/pnas.97.1.109; URIST M, 2000, CANC CELLS, V1, P311; Valsecchi V, 1997, MECH DEVELOP, V69, P203, DOI 10.1016/S0925-4773(97)00146-9; van Bokhoven H, 2001, AM J HUM GENET, V69, P481, DOI 10.1086/323123; Vellucci VF, 1995, GENE, V166, P213, DOI 10.1016/0378-1119(95)00543-9; Vikhanskaya F, 2001, CANCER RES, V61, P935; Wang YC, 1998, ONCOGENE, V17, P1923, DOI 10.1038/sj.onc.1202113; Xia LQ, 1997, CANCER RES, V57, P3055; Yang A, 2002, TRENDS GENET, V18, P90, DOI 10.1016/S0168-9525(02)02595-7; Yang A, 2000, NATURE, V404, P99, DOI 10.1038/35003607; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Yu J, 1999, P NATL ACAD SCI USA, V96, P14517, DOI 10.1073/pnas.96.25.14517; Yuan ZM, 1999, NATURE, V399, P814, DOI 10.1038/21704; Zaika AI, 1999, CANCER RES, V59, P3257; Zhao RB, 2000, GENE DEV, V14, P981; Zhu Hong-Jian, 2001, Molecular Cell Biology Research Communications, V4, P321, DOI 10.1006/mcbr.2001.0301	61	118	123	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					43359	43368		10.1074/jbc.M205573200	http://dx.doi.org/10.1074/jbc.M205573200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12213815	hybrid			2022-12-27	WOS:000179081200120
J	Mu, ZM; Yin, XY; Prochownik, EV				Mu, ZM; Yin, XY; Prochownik, EV			Pag, a putative tumor suppressor, interacts with the Myc Box II domain of C-myc and selectively alters its biological function and target gene expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ABL TYROSINE KINASE; PHYSIOLOGICAL INHIBITOR; ESSENTIAL COFACTOR; ZIPPER PROTEIN; GROWTH-FACTORS; CELL-GROWTH; DNA-BINDING; MAX; TRANSFORMATION; APOPTOSIS	The highly conserved Myc Box II (MBII) domain of c-Myc is critically important for transformation and transcriptional regulation. A yeast two-hybrid screen identified Pag as a MBII-interacting protein. Pag, a member of the peroxiredoxin family, has been reported previously to bind to and inhibit the cytostatic properties of the c-Abl oncoprotein. We now show that Pag promotes increased cell size and confers a proapoptotic phenotype, two hallmark features of ectopic c-Myc overexpression. Pag and c-Myc also confer resistance to oxidative stress, a previously unrecognized property of the latter protein. In contrast, Pag inhibits tumorigenesis by c-Myc-overexpressing fibroblasts and causes a broad but selective loss of c-Myc target gene regulation. Pag is therefore an MBII-interacting protein that can either mimic or enhance some of the c-Myc properties while at the same inhibiting others. These features, along with the previously identified interaction with c-Abl, provide support for the idea that Pag functions as a tumor suppressor.	Childrens Hosp Pittsburgh, Sect Hematol, Pittsburgh, PA 15213 USA; Childrens Hosp Pittsburgh, Hematol Oncol Sect, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Ctr Med, Dept Mol Genet & Biochem, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Inst Canc, Program Mol Oncol, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Prochownik, EV (corresponding author), Childrens Hosp Pittsburgh, Sect Hematol, 3705 5th Ave, Pittsburgh, PA 15213 USA.	edward_prochownik@poplar.chp.edu			NATIONAL CANCER INSTITUTE [R01CA078259] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL033741] Funding Source: NIH RePORTER; NCI NIH HHS [CA78259] Funding Source: Medline; NHLBI NIH HHS [HL33741] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Alland L, 1997, NATURE, V387, P49, DOI 10.1038/387049a0; ASKEW DS, 1991, ONCOGENE, V6, P1915; AYER DE, 1995, CELL, V80, P767, DOI 10.1016/0092-8674(95)90355-0; AYER DE, 1993, CELL, V72, P211, DOI 10.1016/0092-8674(93)90661-9; AYER DE, 1993, GENE DEV, V7, P2110, DOI 10.1101/gad.7.11.2110; Baudino TA, 2001, MOL CELL BIOL, V21, P691, DOI 10.1128/MCB.21.3.691-702.2001; BELLOFERNANDEZ C, 1993, P NATL ACAD SCI USA, V90, P7804, DOI 10.1073/pnas.90.16.7804; BLACKWOOD EM, 1991, SCIENCE, V251, P1211, DOI 10.1126/science.2006410; CHAE HZ, 1994, P NATL ACAD SCI USA, V91, P7017, DOI 10.1073/pnas.91.15.7017; Claassen GF, 1999, ONCOGENE, V18, P2925, DOI 10.1038/sj.onc.1202747; Cole MD, 1999, ONCOGENE, V18, P2916, DOI 10.1038/sj.onc.1202748; DANG CV, 1988, MOL CELL BIOL, V8, P4048, DOI 10.1128/MCB.8.10.4048; Dang CV, 1999, MOL CELL BIOL, V19, P1; Eisenman RN, 2001, GENE DEV, V15, P2023, DOI 10.1101/gad928101; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; Facchini LM, 1998, FASEB J, V12, P633, DOI 10.1096/fasebj.12.9.633; Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653; Gupta K, 1998, ONCOGENE, V16, P1149, DOI 10.1038/sj.onc.1201634; Henriksson M, 1996, ADV CANCER RES, V68, P109, DOI 10.1016/S0065-230X(08)60353-X; HURLIN PJ, 1995, EMBO J, V14, P5646, DOI 10.1002/j.1460-2075.1995.tb00252.x; Hurlin PJ, 1995, ONCOGENE, V11, P2487; Iritani BM, 1999, P NATL ACAD SCI USA, V96, P13180, DOI 10.1073/pnas.96.23.13180; ISHII T, 1993, J BIOL CHEM, V268, P18633; Kang SW, 1998, J BIOL CHEM, V273, P6297, DOI 10.1074/jbc.273.11.6297; Kim S, 2000, P NATL ACAD SCI USA, V97, P11198, DOI 10.1073/pnas.200372597; KRETZNER L, 1992, NATURE, V359, P426, DOI 10.1038/359426a0; Laherty CD, 1997, CELL, V89, P349, DOI 10.1016/S0092-8674(00)80215-9; Landay M, 2000, CELL DEATH DIFFER, V7, P697, DOI 10.1038/sj.cdd.4400701; Langlands K, 1997, ANAL BIOCHEM, V249, P250, DOI 10.1006/abio.1997.2184; McMahon SB, 1998, CELL, V94, P363, DOI 10.1016/S0092-8674(00)81479-8; McMahon SB, 2000, MOL CELL BIOL, V20, P556, DOI 10.1128/MCB.20.2.556-562.2000; MITTELMAN F, 1994, CATALOG CHROMOSOMAL; Mori K, 1998, J BIOL CHEM, V273, P29794, DOI 10.1074/jbc.273.45.29794; NEMOTO Y, 1990, GENE, V91, P261, DOI 10.1016/0378-1119(90)90097-B; Nesbit CE, 1998, CELL GROWTH DIFFER, V9, P731; Nesbit CE, 1999, ONCOGENE, V18, P3004, DOI 10.1038/sj.onc.1202746; Nesbit CE, 2000, ONCOGENE, V19, P3200, DOI 10.1038/sj.onc.1203636; Obaya AJ, 1999, ONCOGENE, V18, P2934, DOI 10.1038/sj.onc.1202749; Prendergast GC, 1999, ONCOGENE, V18, P2967, DOI 10.1038/sj.onc.1202727; PRENDERGAST GC, 1991, CELL, V65, P395, DOI 10.1016/0092-8674(91)90457-A; PROCHOWNIK EV, 1986, NATURE, V322, P848, DOI 10.1038/322848a0; PROSPERI MT, 1993, J BIOL CHEM, V268, P11050; PROSPERI MT, 1994, GENOMICS, V19, P236, DOI 10.1006/geno.1994.1053; Prosperi MT, 1998, FEBS LETT, V423, P39, DOI 10.1016/S0014-5793(98)00057-X; Sakamuro D, 1996, NAT GENET, V14, P69, DOI 10.1038/ng0996-69; Sakamuro D, 1999, ONCOGENE, V18, P2942, DOI 10.1038/sj.onc.1202725; SAWYERS CL, 1992, CELL, V70, P901, DOI 10.1016/0092-8674(92)90241-4; Schmidt EV, 1999, ONCOGENE, V18, P2988, DOI 10.1038/sj.onc.1202751; SCHREIBERAGUS N, 1995, CELL, V80, P777, DOI 10.1016/0092-8674(95)90356-9; Spotts GD, 1997, MOL CELL BIOL, V17, P1459, DOI 10.1128/MCB.17.3.1459; STERN DF, 1986, MOL CELL BIOL, V6, P870, DOI 10.1128/MCB.6.3.870; STONE J, 1987, MOL CELL BIOL, V7, P1697, DOI 10.1128/MCB.7.5.1697; THANNICKAL VJ, 2000, AM J PHYSIOL, V279, pC1005; Wen ST, 1997, GENE DEV, V11, P2456, DOI 10.1101/gad.11.19.2456; Xiao QR, 1998, GENE DEV, V12, P3803, DOI 10.1101/gad.12.24.3803; Yanagawa T, 2000, CANCER LETT, V156, P27, DOI 10.1016/S0304-3835(00)00434-1; Yin XY, 1999, ONCOGENE, V18, P1177, DOI 10.1038/sj.onc.1202410; ZERVOS AS, 1993, CELL, V72, P223, DOI 10.1016/0092-8674(93)90662-A; Zhang H, 1997, J BIOL CHEM, V272, P17416, DOI 10.1074/jbc.272.28.17416	59	114	117	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					43175	43184		10.1074/jbc.M206066200	http://dx.doi.org/10.1074/jbc.M206066200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12196529	hybrid			2022-12-27	WOS:000179081200099
J	Orozco, IJ; Kim, SJ; Martinson, HG				Orozco, IJ; Kim, SJ; Martinson, HG			The Poly(A) signal, without the assistance of any downstream element, directs RNA polymerase II to pause in vivo and then to release stochastically from the template	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-COMPLEMENT GENES; ZINC-FINGER PROTEIN; ALPHA-2 GLOBIN GENE; MAJOR LATE PROMOTER; CCAAT BOX SEQUENCE; HEAT-SHOCK GENES; C-MYC GENE; TRANSCRIPTION TERMINATION; MESSENGER-RNA; IN-VITRO	Genes encoding polyadenylated mRNAs depend on their poly(A) signals for termination of transcription. Typically, transcription downstream of the poly(A) signal gradually declines to zero, but often there is a transient increase in polymerase density immediately preceding the decline. Special elements called pause sites are traditionally invoked to account for this increase. Using run-on transcription from the nuclei of transfected cells, we show that both the pause and the gradual decline that follow a poly(A) site are generated entirely by the poly(A) signal itself in a series of model constructs. We found no other elements to be involved and argue that the elements called pause sites do not function through pausing. Both the poly(A)-dependent pause and the subsequent decline occurred earlier for a stronger poly(A) signal than for a weaker one. Because the gradual decline resembles the abortive elongation that occurs downstream of many promoters, one model has proposed that the poly(A) signal flips the polymerase from the elongation mode to the abortive mode like a binary switch. We compared abortive elongators with poly(A) terminators and found a 4-fold difference in processivity. We conclude that poly(A) terminating polymerases do not merely revert to their prior state of low processivity but rather convert to a new termination-prone condition.	Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Martinson, HG (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 405 Hilgard Ave, Los Angeles, CA 90095 USA.				NIGMS NIH HHS [GM50863] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050863] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AFFOLTER M, 1986, J BIOL CHEM, V261, P1496; Andrulis ED, 2000, GENE DEV, V14, P2635, DOI 10.1101/gad.844200; ASHFIELD R, 1994, EMBO J, V13, P5656, DOI 10.1002/j.1460-2075.1994.tb06904.x; ASHFIELD R, 1991, EMBO J, V10, P4197, DOI 10.1002/j.1460-2075.1991.tb04998.x; BAKER CC, 1989, J VIROL, V63, P3529, DOI 10.1128/JVI.63.8.3529-3534.1989; Birse CE, 1997, EMBO J, V16, P3633, DOI 10.1093/emboj/16.12.3633; Blau J, 1996, MOL CELL BIOL, V16, P2044; BOSSONE SA, 1992, P NATL ACAD SCI USA, V89, P7452, DOI 10.1073/pnas.89.16.7452; Brackenridge S, 1997, NUCLEIC ACIDS RES, V25, P2326, DOI 10.1093/nar/25.12.2326; Burns CM, 1999, J BIOL CHEM, V274, P5245, DOI 10.1074/jbc.274.8.5245; CARSWELL S, 1989, MOL CELL BIOL, V9, P4248, DOI 10.1128/MCB.9.10.4248; Chao LC, 1999, MOL CELL BIOL, V19, P5588; CONNELLY S, 1989, CELL, V57, P561, DOI 10.1016/0092-8674(89)90126-8; CONNELLY S, 1988, GENE DEV, V2, P440, DOI 10.1101/gad.2.4.440; CONNELLY S, 1989, MOL CELL BIOL, V9, P5254, DOI 10.1128/MCB.9.11.5254; Davenport RJ, 2000, SCIENCE, V287, P2497, DOI 10.1126/science.287.5462.2497; DELUCIA AL, 1986, J VIROL, V57, P138, DOI 10.1128/JVI.57.1.138-144.1986; DREYER C, 1978, EUR J BIOCHEM, V86, P241, DOI 10.1111/j.1432-1033.1978.tb12305.x; Dye MJ, 2001, CELL, V105, P669, DOI 10.1016/S0092-8674(01)00372-5; EGGERMONT J, 1993, EMBO J, V12, P2539, DOI 10.1002/j.1460-2075.1993.tb05909.x; EICK D, 1994, ANAL BIOCHEM, V218, P347, DOI 10.1006/abio.1994.1190; ENRIQUEZHARRIS P, 1991, EMBO J, V10, P1833, DOI 10.1002/j.1460-2075.1991.tb07709.x; GIARDINA C, 1993, J BIOL CHEM, V268, P23806; Greger IH, 2000, P NATL ACAD SCI USA, V97, P8415, DOI 10.1073/pnas.140217697; HAGENBUCHLE O, 1984, CELL, V38, P737, DOI 10.1016/0092-8674(84)90269-1; Hans H, 2000, MOL CELL BIOL, V20, P2926, DOI 10.1128/MCB.20.8.2926-2932.2000; Hansen K, 1998, EMBO J, V17, P3066, DOI 10.1093/emboj/17.11.3066; Hirose Y, 1998, NATURE, V395, P93, DOI 10.1038/25786; IWAMOTO S, 1986, J VIROL, V59, P112, DOI 10.1128/JVI.59.1.112-119.1986; Izzo MW, 1999, J BIOL CHEM, V274, P19498, DOI 10.1074/jbc.274.27.19498; Kaplan CD, 2000, GENE DEV, V14, P2623, DOI 10.1101/gad.831900; Keene RG, 1999, NUCLEIC ACIDS RES, V27, P3173, DOI 10.1093/nar/27.15.3173; Kim YK, 2002, MOL CELL BIOL, V22, P4622, DOI 10.1128/MCB.22.13.4622-4637.2002; KRUMM A, 1992, GENE DEV, V6, P2201, DOI 10.1101/gad.6.11.2201; Lee TI, 2000, ANNU REV GENET, V34, P77, DOI 10.1146/annurev.genet.34.1.77; LOGAN J, 1987, P NATL ACAD SCI USA, V84, P8306, DOI 10.1073/pnas.84.23.8306; MAA MC, 1990, J BIOL CHEM, V265, P12513; MARSHALL NF, 1992, MOL CELL BIOL, V12, P2078, DOI 10.1128/MCB.12.5.2078; MEULIA T, 1993, MOL CELL BIOL, V13, P5647, DOI 10.1128/MCB.13.9.5647; Orphanides G, 2002, CELL, V108, P439, DOI 10.1016/S0092-8674(02)00655-4; OSBORNE BI, 1988, GENE DEV, V2, P766, DOI 10.1101/gad.2.6.766; Osheim YN, 1999, MOL CELL, V3, P379, DOI 10.1016/S1097-2765(00)80465-7; OWCZAREK CM, 1992, NUCLEIC ACIDS RES, V20, P851, DOI 10.1093/nar/20.4.851; Parks CL, 1997, J VIROL, V71, P9600, DOI 10.1128/JVI.71.12.9600-9607.1997; Pei Y, 2002, J BIOL CHEM, V277, P19639, DOI 10.1074/jbc.M200015200; PETERSON ML, 1989, MOL CELL BIOL, V9, P726, DOI 10.1128/MCB.9.2.726; Peterson ML, 2002, MOL CELL BIOL, V22, P5606, DOI 10.1128/MCB.22.15.5606-5615.2002; Ping YH, 2001, J BIOL CHEM, V276, P12951, DOI 10.1074/jbc.M006130200; PRIBYL TM, 1988, MOL CELL BIOL, V8, P5369, DOI 10.1128/MCB.8.12.5369; Price DH, 2000, MOL CELL BIOL, V20, P2629, DOI 10.1128/MCB.20.8.2629-2634.2000; PROUDFOOT NJ, 1989, TRENDS BIOCHEM SCI, V14, P105, DOI 10.1016/0968-0004(89)90132-1; Proudfoot NJ, 2002, CELL, V108, P501, DOI 10.1016/S0092-8674(02)00617-7; Renner DB, 2001, J BIOL CHEM, V276, P42601, DOI 10.1074/jbc.M104967200; Roberts GC, 1998, NUCLEIC ACIDS RES, V26, P5568, DOI 10.1093/nar/26.24.5568; ROBERTS S, 1992, EMBO J, V11, P1085, DOI 10.1002/j.1460-2075.1992.tb05147.x; ROUGVIE AE, 1988, CELL, V54, P795, DOI 10.1016/S0092-8674(88)91087-2; RUSSO P, 1995, YEAST, V11, P447, DOI 10.1002/yea.320110507; SPENCER CA, 1993, MOL CELL BIOL, V13, P1296, DOI 10.1128/MCB.13.2.1296; TANTRAVAHI J, 1993, MOL CELL BIOL, V13, P578, DOI 10.1128/MCB.13.1.578; Tran DP, 2001, MOL CELL BIOL, V21, P7495, DOI 10.1128/MCB.21.21.7495-7508.2001; Valerius O, 2002, J BIOL CHEM, V277, P21440, DOI 10.1074/jbc.M201841200; VANDENBERGH DJ, 1991, J MOL BIOL, V220, P255, DOI 10.1016/0022-2836(91)90011-T; WHITELAW E, 1986, EMBO J, V5, P2915, DOI 10.1002/j.1460-2075.1986.tb04587.x; XU M, 1986, J BIOL CHEM, V261, P3838; Yeung G, 1998, MOL CELL BIOL, V18, P276, DOI 10.1128/MCB.18.1.276; Yonaha M, 2000, EMBO J, V19, P3770, DOI 10.1093/emboj/19.14.3770; Yonaha M, 1999, MOL CELL, V3, P593, DOI 10.1016/S1097-2765(00)80352-4; Zhao J, 1999, MICROBIOL MOL BIOL R, V63, P405, DOI 10.1128/MMBR.63.2.405-445.1999; Zhu AQ, 1998, BIOCHEMISTRY-US, V37, P11202, DOI 10.1021/bi9729110	69	44	45	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					42899	42911		10.1074/jbc.M207415200	http://dx.doi.org/10.1074/jbc.M207415200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12196547	hybrid			2022-12-27	WOS:000179081200063
J	Deval, J; Selmi, B; Boretto, J; Egloff, MP; Guerreiro, C; Sarfati, S; Canard, B				Deval, J; Selmi, B; Boretto, J; Egloff, MP; Guerreiro, C; Sarfati, S; Canard, B			The molecular mechanism of multidrug resistance by the Q151M human immunodeficiency virus type 1 reverse transcriptase and its suppression using alpha-boranophosphate nucleotide analogues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POL GENE-MUTATIONS; COMBINATION THERAPY; DRUG-SENSITIVITY; ZIDOVUDINE AZT; HIV-1; KINETICS; STRAINS; FITNESS; PROGRAM; MUTANTS	Nucleoside analogues are currently used to treat human immunodeficiency virus infections. The appearance of up to five substitutions (A62V, V751, F77L, F116Y, and Q151M) in the viral reverse transcriptase promotes resistance to these drugs, and reduces efficiency of the antiretroviral chemotherapy. Using pre-steady state kinetics, we show that Q151M and A62V/V751I/F77L/F116Y/ Q151M substitutions confer to reverse transcriptase (RT) the ability to discriminate an analogue relative to its natural counterpart, and have no effect on repair of the analogue-terminated DNA primer. Discrimination results from a selective decrease of the catalytic rate constant k(pol): 18-fold (from 7 to 0.3 s(-1)), 13-fold (from 1.9 to 0.14 s(-1)), and 12-fold (from 13 to 1 s(-1)) in the case of ddATP, ddCTP, and 3'-azido-3'-deoxythymidine 5'- triphosphate (AZTTP), respectively. The binding affinities of the triphosphate analogues for RT remain unchanged. Molecular modeling explains drug resistance by a selective loss of electrostatic interactions between the analogue and RT. Resistance was overcome using a-boranophosphate nucleotide analogues. Using A62V/V75I/ F77L/F116Y/Q151M RT, k(pol) increases up to 70- and 13-fold using a-boranophosphate-ddATP and a-boranophosphate AZTTP, respectively. These results highlight the general capacity of such analogues to circumvent multidrug resistance when RT-mediated nucleotide resistance originates from the selective decrease of the catalytic rate constant k(pol).	CNRS, F-13288 Marseille 9, France; Univ Aix Marseille 1, UMR Architecture & Fonct Macromol Biol 6098, F-13288 Marseille, France; Univ Aix Marseille 2, UMR Architecture & Fonct Macromol Biol 6098, F-13288 Marseille 9, France; Inst Pasteur, Unite Chim Organ, F-75724 Paris 15, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Canard, B (corresponding author), CNRS, ESIL Case 925,163 Ave Luminy, F-13288 Marseille 9, France.			Canard, Bruno/0000-0003-4924-1991				Arion D, 1998, BIOCHEMISTRY-US, V37, P15908, DOI 10.1021/bi981200e; Boretto J, 2001, ANAL BIOCHEM, V292, P139, DOI 10.1006/abio.2001.5045; Brandis JW, 1996, BIOCHEMISTRY-US, V35, P2189, DOI 10.1021/bi951682j; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Feng JY, 1999, BIOCHEMISTRY-US, V38, P9440, DOI 10.1021/bi990709m; Garcia-Lerma JG, 2000, J VIROL, V74, P9339, DOI 10.1128/JVI.74.20.9339-9346.2000; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; Iversen AKN, 1996, J VIROL, V70, P1086, DOI 10.1128/JVI.70.2.1086-1090.1996; Kosalaraksa P, 1999, J VIROL, V73, P5356, DOI 10.1128/JVI.73.7.5356-5363.1999; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Krebs R, 1997, BIOCHEMISTRY-US, V36, P10292, DOI 10.1021/bi970512z; LARDER BA, 1989, SCIENCE, V243, P1731, DOI 10.1126/science.2467383; LARDER BA, 1989, SCIENCE, V246, P1155, DOI 10.1126/science.2479983; Lennerstrand J, 2001, J VIROL, V75, P7202, DOI 10.1128/JVI.75.15.7202-7205.2001; Maeda Y, 1998, J INFECT DIS, V177, P1207, DOI 10.1086/515282; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Meyer P, 2000, EMBO J, V19, P3520, DOI 10.1093/emboj/19.14.3520; Meyer PR, 1999, MOL CELL, V4, P35, DOI 10.1016/S1097-2765(00)80185-9; REARDON JE, 1992, BIOCHEMISTRY-US, V31, P4473, DOI 10.1021/bi00133a013; ROUSSEL A, 1991, SILICON GRAPHICS DIR, P97; SARAFIANOS SG, 1995, J BIOL CHEM, V270, P19729, DOI 10.1074/jbc.270.34.19729; Selmi B, 2001, J BIOL CHEM, V276, P13965, DOI 10.1074/jbc.M009837200; Selmi B, 2001, J BIOL CHEM, V276, P48466, DOI 10.1074/jbc.M107003200; SHAFER RW, 1994, J INFECT DIS, V169, P722, DOI 10.1093/infdis/169.4.722; SHAFER RW, 1995, J INFECT DIS, V172, P70, DOI 10.1093/infdis/172.1.70; SHIRASAKA T, 1995, P NATL ACAD SCI USA, V92, P2398, DOI 10.1073/pnas.92.6.2398; SHIRASAKA T, 1993, P NATL ACAD SCI USA, V90, P562, DOI 10.1073/pnas.90.2.562; Ueno T, 1997, BIOCHEMISTRY-US, V36, P1092, DOI 10.1021/bi962393d; UENO T, 1995, J BIOL CHEM, V270, P23605, DOI 10.1074/jbc.270.40.23605; Wainberg MA, 1999, ANTIVIR THER, V4, P87	30	87	91	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					42097	42104		10.1074/jbc.M206725200	http://dx.doi.org/10.1074/jbc.M206725200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12194983	hybrid			2022-12-27	WOS:000178985300100
J	Hsi, LC; Wilson, LC; Eling, TE				Hsi, LC; Wilson, LC; Eling, TE			Opposing effects of 15-lipoxygenase-1 and-2 metabolites on MAPK signaling in prostate - Alteration in peroxisome proliferator-activated receptor gamma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN BREAST-CANCER; GROWTH-FACTOR-I; KINASE-MEDIATED PHOSPHORYLATION; HUMAN COLORECTAL-CANCER; CELL-CYCLE ARREST; PPAR-GAMMA; PROTEIN-KINASE; PHOSPHATIDYLINOSITOL 3-KINASE; INHIBIT GROWTH; MAMMALIAN LIPOXYGENASES	Human prostate tumors have elevated levels of 15-lipoxygenase-1 (15-LOX-1) and data suggest that 15-LOX-1 may play a role in the development of prostate cancer. In contrast, 15-LOX-2 expression is higher in normal rather than in tumor prostate tissue and appears to suppress cancer development. We recently reported that 13-(S)-HODE, the 15-LOX-1 metabolite, up-regulates the MA-P kinase signaling pathway and subsequently down-regulates PPARgamma in human colorectal carcinoma cells. To determine whether this mechanism is applicable to prostate cancer and what the effects of 15-LOX-2 are, we investigated the effect of 15-LOX-1, 15-LOX-2, and their metabolites on epidermal growth factor (EGF)- and insulin-like growth factor (IGF)-1 signaling in prostate carcinoma cells. In PC3 cells, 13-(S)-HODE, a 15-LOX-1 metabolite, upregulated MAP kinase while in contrast 15-(S)-HETE, a 15-LOX-2 metabolite, down-regulated MAP kinase. As a result, 13-(S)-HODE increased PPARgamma phosphorylation while a subsequent decrease in PPARgamma phosphorylation was observed with 15-(S)-HETE. Thus, 15-LOX metabolites have opposing effects on the regulation of the MAP kinase signaling pathway and a downstream target of MAP kinase signaling like PPARgamma. In addition to the EGF signaling pathway, the IGF signaling pathway appears to be linked to prostate cancer. 13-(S)-HODE and 15-(S)-HETE up-regulate or down-regulate, respectively, both the MAPK and Akt pathways after activation with IGF-1. Thus, the effect of these lipid metabolites is not solely restricted to EGF signaling and not solely restricted to MAPK signaling. These results provide a plausible mechanism to explain the apparent opposing effects 15-LOX-1 and 15-LOX-2 play in prostate cancer.	NIEHS, Eicosanoid Biochem Sect, Mol Carcinogenesis Lab, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Eling, TE (corresponding author), NIEHS, Eicosanoid Biochem Sect, Mol Carcinogenesis Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.				NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES050144, Z01ES050144, Z01ES050143] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Adams M, 1997, J BIOL CHEM, V272, P5128, DOI 10.1074/jbc.272.8.5128; Alblas J, 1998, ONCOGENE, V16, P131, DOI 10.1038/sj.onc.1201485; Brash AR, 1997, P NATL ACAD SCI USA, V94, P6148, DOI 10.1073/pnas.94.12.6148; Brockman JA, 1998, GASTROENTEROLOGY, V115, P1049, DOI 10.1016/S0016-5085(98)70072-1; Butler R, 2000, CELL GROWTH DIFFER, V11, P49; Camp HS, 1997, J BIOL CHEM, V272, P10811; Chang TH, 2000, CANCER RES, V60, P1129; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; DiGiovanni J, 2000, CANCER RES, V60, P1561; DiGiovanni J, 2000, P NATL ACAD SCI USA, V97, P3455, DOI 10.1073/pnas.97.7.3455; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Dufourny B, 1997, J BIOL CHEM, V272, P31163, DOI 10.1074/jbc.272.49.31163; Elstner E, 1998, P NATL ACAD SCI USA, V95, P8806, DOI 10.1073/pnas.95.15.8806; Funk CD, 1996, BBA-LIPID LIPID MET, V1304, P65, DOI 10.1016/S0005-2760(96)00107-5; Guan You-Fei, 1999, Neoplasia (New York), V1, P330, DOI 10.1038/sj.neo.7900050; HENKE DC, 1984, ANAL BIOCHEM, V162, P156; Hill EM, 1998, AM J RESP CELL MOL, V18, P662, DOI 10.1165/ajrcmb.18.5.2985; Hsi LC, 2001, J BIOL CHEM, V276, P34545, DOI 10.1074/jbc.M100280200; Hu ED, 1996, SCIENCE, V274, P2100, DOI 10.1126/science.274.5295.2100; Huang JT, 1999, NATURE, V400, P378, DOI 10.1038/22572; Ikawa H, 1999, CANCER RES, V59, P360; Jiang BH, 1999, P NATL ACAD SCI USA, V96, P2077, DOI 10.1073/pnas.96.5.2077; Kelavkar UP, 2000, CARCINOGENESIS, V21, P1777; Kelavkar UP, 2001, CARCINOGENESIS, V22, P1765, DOI 10.1093/carcin/22.11.1765; Kulik G, 1997, MOL CELL BIOL, V17, P1595, DOI 10.1128/MCB.17.3.1595; Mueller E, 1998, MOL CELL, V1, P465, DOI 10.1016/S1097-2765(00)80047-7; Nagy L, 1998, CELL, V93, P229, DOI 10.1016/S0092-8674(00)81574-3; Ohta K, 2001, J CLIN ENDOCR METAB, V86, P2170, DOI 10.1210/jc.86.5.2170; Reginato MJ, 1998, J BIOL CHEM, V273, P1855, DOI 10.1074/jbc.273.4.1855; Sarraf P, 1998, NAT MED, V4, P1046, DOI 10.1038/2030; Schwarz EJ, 1997, MOL CELL BIOL, V17, P1552, DOI 10.1128/MCB.17.3.1552; Shappell SB, 1999, AM J PATHOL, V155, P235, DOI 10.1016/S0002-9440(10)65117-6; Shappell SB, 2001, CANCER RES, V61, P497; SIGAL E, 1990, J BIOL CHEM, V265, P5113; Takashima T, 2001, INT J ONCOL, V19, P465; Tang SH, 2002, J BIOL CHEM, V277, P16189, DOI 10.1074/jbc.M111936200; TOTONEZ P, 1994, NUCLEIC ACIDS RES, V22, P5623; Tsubouchi Y, 2000, BIOCHEM BIOPH RES CO, V270, P400, DOI 10.1006/bbrc.2000.2436; Ullrich V, 2001, BBA-MOL CELL BIOL L, V1532, P1, DOI 10.1016/S1388-1981(01)00126-3; Wolk A, 1998, J NATL CANCER I, V90, P911, DOI 10.1093/jnci/90.12.911; YAMAMOTO S, 1992, BIOCHIM BIOPHYS ACTA, V1128, P117, DOI 10.1016/0005-2760(92)90297-9; Zhang B, 1996, J BIOL CHEM, V271, P31771, DOI 10.1074/jbc.271.50.31771	42	131	138	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 25	2002	277	43					40549	40556		10.1074/jbc.M203522200	http://dx.doi.org/10.1074/jbc.M203522200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	607KU	12189136	hybrid			2022-12-27	WOS:000178791400052
J	Hanfrey, C; Franceschetti, M; Mayer, MJ; Illingworth, C; Michael, AJ				Hanfrey, C; Franceschetti, M; Mayer, MJ; Illingworth, C; Michael, AJ			Abrogation of upstream open reading frame-mediated translational control of a plant S-adenosylmethionine decarboxylase results in polyamine disruption and growth perturbations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENOSYL-L-METHIONINE; MESSENGER-RNA; ORNITHINE-DECARBOXYLASE; ARGININE DECARBOXYLASE; GENE; OVEREXPRESSION; IDENTIFICATION; BIOSYNTHESIS; METHYLATION; INHIBITION	S-Adenosylmethionine decarboxylase (AdoMetDC) is a key enzyme in polyamine biosynthesis. We show that the plant AdoMetDC activity is subject to post-transcriptional control by polyamines. A highly conserved small upstream open reading frame (uORF) in the AdoMetDC mRNA 5' leader is responsible for translational repression of a downstream p-glucuronidase reporter cistron in transgenic tobacco plants. Elimination of the small uORF from an AdoMetDC cDNA led to increased relative translational efficiency of the AdoMetDC proenzyme in transgenic plants. The resulting increased activity of AdoMetDC caused disruption to polyamine levels with depletion of putrescine, reduction of spermine levels, and a more than 400-fold increase in the level of decarboxylated S-adenosyhnethionine. These changes were associated with severe growth and developmental defects. The high level of decarboxylated S-adenosylmethionine was not associated with any change in 5'-methylcytosine content in genomic DNA and S-adenosylinethionine levels were more or less normal, indicating a highly efficient system for maintenance of S-adenosylmethionine levels in plants. This work demonstrates that uORF-mediated translational control of AdoMetDC is essential for polyamine homeostasis and for normal growth and development.	Inst Food Res, Div Food Safety Sci, Norwich NR4 7UA, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia	Michael, AJ (corresponding author), Inst Food Res, Div Food Safety Sci, Norwich Res Pk, Norwich NR4 7UA, Norfolk, England.	tony.michael@bbsrc.ac.uk						Balasundaram D, 1996, J BACTERIOL, V178, P2721, DOI 10.1128/jb.178.9.2721-2724.1996; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burtin D, 1997, BIOCHEM J, V325, P331, DOI 10.1042/bj3250331; BURTIN D, 1991, PLANT PHYSIOL, V95, P461, DOI 10.1104/pp.95.2.461; Chiang PK, 1996, FASEB J, V10, P471, DOI 10.1096/fasebj.10.4.8647346; Cohen S A, 1998, Guttmacher Rep Public Policy, V1, P1; Franceschetti M, 2001, BIOCHEM J, V353, P403, DOI 10.1042/0264-6021:3530403; Frostesjo L, 1997, J BIOL CHEM, V272, P4359, DOI 10.1074/jbc.272.7.4359; Geballe AP, 2000, COLD SPRING HARBOR M, V39, P595; Hanzawa Y, 2000, EMBO J, V19, P4248, DOI 10.1093/emboj/19.16.4248; Heby O, 1995, INT J DEV BIOL, V39, P737; HEBY O, 1988, PROGR POLYAMINE RES, P291; HIATT AC, 1986, J BIOL CHEM, V261, P1293; HILL JR, 1992, J BIOL CHEM, V267, P21886; Hinnebusch A.G., 1996, TRANSLATIONAL CONTRO, P199; Hinnebusch AG, 2000, COLD SPRING HARBOR M, V39, P185; Jones Jonathan D. G., 1992, Transgenic Research, V1, P285, DOI 10.1007/BF02525170; KAKUTANI T, 1995, NUCLEIC ACIDS RES, V23, P130, DOI 10.1093/nar/23.1.130; Kakutani T, 1996, P NATL ACAD SCI USA, V93, P12406, DOI 10.1073/pnas.93.22.12406; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KOZAK M, 1991, J CELL BIOL, V115, P887, DOI 10.1083/jcb.115.4.887; KRAMER D, 1995, J BIOL CHEM, V270, P2124, DOI 10.1074/jbc.270.5.2124; Law GL, 2001, J BIOL CHEM, V276, P38036; Malmberg RL, 1998, CRIT REV PLANT SCI, V17, P199, DOI 10.1016/S0735-2689(98)00358-X; MAMONT PS, 1982, EUR J BIOCHEM, V123, P499; Manni A, 2001, INT J ONCOL, V19, P317; Michael AJ, 1996, BIOCHEM J, V314, P241, DOI 10.1042/bj3140241; Morris DR, 2000, MOL CELL BIOL, V20, P8635, DOI 10.1128/MCB.20.23.8635-8642.2000; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nishimura K, 2002, GENES CELLS, V7, P41, DOI 10.1046/j.1356-9597.2001.00494.x; PEGG AE, 1982, BIOCHEM J, V202, P519, DOI 10.1042/bj2020519; PEGG AE, 1987, INHIBITION POLYAMINE, P33; Raney A, 2000, J BIOL CHEM, V275, P24444, DOI 10.1074/jbc.M003364200; Ravanel S, 1998, P NATL ACAD SCI USA, V95, P7805, DOI 10.1073/pnas.95.13.7805; Roberts SC, 2002, J BIOL CHEM, V277, P5902, DOI 10.1074/jbc.M110118200; Ruan HJ, 1996, J BIOL CHEM, V271, P29576, DOI 10.1074/jbc.271.47.29576; RUAN HJ, 1994, J BIOL CHEM, V269, P17905; Ryabova LA, 2000, GENE DEV, V14, P817; SHANTZ LM, 1994, BIOCHEM J, V302, P765, DOI 10.1042/bj3020765; Wang LJ, 2001, PLANT PHYSIOL, V125, P1380, DOI 10.1104/pp.125.3.1380; WHITE MW, 1990, BIOCHEM J, V268, P657, DOI 10.1042/bj2680657; Xiong HS, 1997, J BIOL CHEM, V272, P28342, DOI 10.1074/jbc.272.45.28342	42	100	115	3	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2002	277	46					44131	44139		10.1074/jbc.M206161200	http://dx.doi.org/10.1074/jbc.M206161200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	615XE	12205086	hybrid			2022-12-27	WOS:000179272000078
J	van Amsterdam, IMC; Ubbink, M; van den Bosch, M; Rotsaert, F; Sanders-Loehr, J; Canters, GW				van Amsterdam, IMC; Ubbink, M; van den Bosch, M; Rotsaert, F; Sanders-Loehr, J; Canters, GW			A new type 2 copper cysteinate azurin - Involvement of an engineered exposed cysteine in copper binding through internal rearrangement	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PSEUDOMONAS-AERUGINOSA AZURIN; RESONANCE RAMAN-SPECTROSCOPY; ZINC SUPEROXIDE-DISMUTASE; MEDIATED PROTEIN OXIDATION; SPERM WHALE MYOGLOBIN; EXOGENOUS LIGANDS; CRYSTAL-STRUCTURES; ELECTRON-TRANSFER; HIS117GLY AZURIN; PROXIMAL LIGAND	The double mutant H117G/N42C azurin exhibits tetragonal type 2 copper site characteristics with Cys(42) as one of the copper ligands as concluded from spectroscopic evidence (UV-visible, EPR, and resonance Raman). Analysis of the kinetics of copper uptake by the apoprotein by means of stopped flow spectroscopy suggests that the solvent-exposed CyS42 assists in binding the metal ion and carrying it over to the active site where it becomes coordinated by, among others, a second cysteine, Cys(112). A structure is proposed in which the loop from residue 36 to 47 has rearranged to form a tetragonal type 2 copper site with Cys(42) as one of the ligands. The process of copper uptake as observed for the double mutant may be relevant for a better understanding of the way copper chaperones accept and transfer metal ions in the living cell.	Leiden Univ, Inst Chem, Gorlaeus Labs, NL-2300 RA Leiden, Netherlands; Oregon Grad Inst Sci & Technol, Dept Biochem & Mol Biol, Beaverton, OR 97006 USA	Leiden University; Leiden University - Excl LUMC	Canters, GW (corresponding author), Leiden Univ, Inst Chem, Gorlaeus Labs, Einsteinweg 55,POB 9502, NL-2300 RA Leiden, Netherlands.	canters@chem.leidenuniv.nl	Ubbink, Marcellus/E-2158-2011	Ubbink, Marcellus/0000-0002-2615-6914	NIGMS NIH HHS [GM-18865] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alvarez ML, 2001, J AM CHEM SOC, V123, P576, DOI 10.1021/ja994322i; Andrew CR, 1996, ACCOUNTS CHEM RES, V29, P365, DOI 10.1021/ar950084u; Andrew CR, 1997, J BIOL INORG CHEM, V2, P98, DOI 10.1007/s007750050111; ANDREW CR, 1994, J AM CHEM SOC, V116, P11489, DOI 10.1021/ja00104a032; ANDREW CR, 1995, J AM CHEM SOC, V117, P10759, DOI 10.1021/ja00148a025; Andrew CR, 1996, J AM CHEM SOC, V118, P10436, DOI 10.1021/ja960969g; BARRICK D, 1995, CURR OPIN BIOTECH, V6, P411, DOI 10.1016/0958-1669(95)80070-0; BARRICK D, 1994, BIOCHEMISTRY-US, V33, P6546, DOI 10.1021/bi00187a023; Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313; BLASZAK JA, 1983, J BIOL CHEM, V258, P9886; Cabiscol Elisa, 2000, International Microbiology, V3, P3; CZERNUSZEWICZ RS, 1986, INORG CHEM, V25, P696, DOI 10.1021/ic00225a022; Das TK, 1999, INORG CHEM, V38, P1952, DOI 10.1021/ic990049+; Dean RT, 1997, BIOCHEM J, V324, P1; DENBLAAUWEN T, 1991, J AM CHEM SOC, V113, P5050, DOI 10.1021/ja00013a046; DENBLAAUWEN T, 1993, BIOCHEMISTRY-US, V32, P12455, DOI 10.1021/bi00097a025; DENBLAAUWEN T, 1993, J AM CHEM SOC, V115, P1121, DOI 10.1021/ja00056a042; DEPILLIS GD, 1994, J AM CHEM SOC, V116, P6981, DOI 10.1021/ja00094a081; Hammann C, 1997, J MOL BIOL, V266, P357, DOI 10.1006/jmbi.1996.0764; HAN J, 1993, J AM CHEM SOC, V115, P4256, DOI 10.1021/ja00063a048; HAN S, 1989, J AM CHEM SOC, V111, P3505, DOI 10.1021/ja00192a003; Harrison MD, 2000, TRENDS BIOCHEM SCI, V25, P29, DOI 10.1016/S0968-0004(99)01492-9; Harrison MD, 1999, J BIOL INORG CHEM, V4, P145, DOI 10.1007/s007750050297; Huffman DL, 2001, ANNU REV BIOCHEM, V70, P677, DOI 10.1146/annurev.biochem.70.1.677; JETER RM, 1984, ARCH MICROBIOL, V138, P124, DOI 10.1007/BF00413012; Jeuken LJC, 2000, J MOL BIOL, V299, P737, DOI 10.1006/jmbi.2000.3754; Jeuken LJC, 2000, J AM CHEM SOC, V122, P12186, DOI 10.1021/ja0006144; JEUKEN LJC, 2001, THESIS U LEIDEN LEID, P129; Konz JO, 1998, BIOTECHNOL PROGR, V14, P393, DOI 10.1021/bp980021l; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kroes SJ, 1996, J BIOL INORG CHEM, V1, P551, DOI 10.1007/s007750050091; Liu HB, 2000, BIOCHEMISTRY-US, V39, P8125, DOI 10.1021/bi000846f; Lu Y, 1996, INORG CHEM, V35, P1692, DOI 10.1021/ic9513189; LU Y, 1992, J AM CHEM SOC, V114, P3560, DOI 10.1021/ja00035a064; LU Y, 1993, P NATL ACAD SCI USA, V90, P11456, DOI 10.1073/pnas.90.24.11456; Mandal S, 1997, COORDIN CHEM REV, V160, P191, DOI 10.1016/S0010-8545(96)01342-2; MARET W, 1986, J AM CHEM SOC, V108, P6351, DOI 10.1021/ja00280a036; MARKS RHL, 1979, ARCH BIOCHEM BIOPHYS, V195, P103, DOI 10.1016/0003-9861(79)90331-X; MARTIN AE, 1990, P NATL ACAD SCI USA, V87, P598, DOI 10.1073/pnas.87.2.598; MCREE DE, 1994, P NATL ACAD SCI USA, V91, P12847, DOI 10.1073/pnas.91.26.12847; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Messerschmidt A, 1998, P NATL ACAD SCI USA, V95, P3443, DOI 10.1073/pnas.95.7.3443; NAR H, 1992, FEBS LETT, V306, P119, DOI 10.1016/0014-5793(92)80981-L; NAR H, 1991, J MOL BIOL, V221, P765, DOI 10.1016/0022-2836(91)80173-R; O'Halloran TV, 2000, J BIOL CHEM, V275, P25057, DOI 10.1074/jbc.R000006200; Rosenzweig AC, 2000, CURR OPIN CHEM BIOL, V4, P140, DOI 10.1016/S1367-5931(99)00066-6; Rosenzweig AC, 2001, ACCOUNTS CHEM RES, V34, P119, DOI 10.1021/ar000012p; Sandberg A, 2002, BIOCHEMISTRY-US, V41, P1060, DOI 10.1021/bi0157621; Schnepf R, 2001, J AM CHEM SOC, V123, P2186, DOI 10.1021/ja001880k; SOLOMON EI, 1992, CHEM REV, V92, P521, DOI 10.1021/cr00012a003; Stadtman ER, 1997, CHEM RES TOXICOL, V10, P485, DOI 10.1021/tx960133r; Valentine JS, 1998, CURR OPIN CHEM BIOL, V2, P253, DOI 10.1016/S1367-5931(98)80067-7; van Amsterdam IMC, 2001, CHEM-EUR J, V7, P2398, DOI 10.1002/1521-3765(20010601)7:11<2398::AID-CHEM23980>3.0.CO;2-L; VANDERSPOEL D, 1999, GROMACS USER MANUAL; VANGUNSTEREN WF, 1996, GRONINGEN MOL SIMULA; vanPouderoyen G, 1996, BIOCHEMISTRY-US, V35, P1397, DOI 10.1021/bi951604w; Wang XT, 1999, J AM CHEM SOC, V121, P2947, DOI 10.1021/ja982636k; YAMANAKA T, 1963, J BIOCHEM-TOKYO, V53, P256, DOI 10.1093/oxfordjournals.jbchem.a127689	59	17	17	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2002	277	46					44121	44130		10.1074/jbc.M202977200	http://dx.doi.org/10.1074/jbc.M202977200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	615XE	12186859	hybrid			2022-12-27	WOS:000179272000077
J	Abbey, SE; Potter, LR				Abbey, SE; Potter, LR			Vasopressin-dependent inhibition of the C-type natriuretic peptide receptor, NPR-B/GC-B, requires elevated intracellular calcium concentrations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; SMOOTH-MUSCLE CELLS; STIMULATED CGMP ACCUMULATION; CULTURED MOUSE ASTROCYTES; CYCLIC-GMP ACCUMULATION; HOMOLOGOUS DESENSITIZATION; ENDOTHELIAL-CELLS; DOWN-REGULATION; PHORBOL ESTER; CYCLASE	Natriuretic peptides bind their cognate cell surface guanylyl cyclase receptors and elevate intracellular cGMP concentrations. In vascular smooth muscle cells, this results in the activation of the type I cGMP-dependent protein kinase and vasorelaxation. In contrast, pressor hormones like arginine-vasopressin, angiotensin II, and endothelin bind serpentine receptors that interact with G(q) and activate phospholipase Cbeta The products of this enzyme, diacylglycerol and inositol trisphosphate, activate the conventional and novel forms of protein kinase C (PKC) and elevate intracellular calcium concentrations, respectively. The latter response results in vasoconstriction, which opposes the actions of natriuretic peptides. Previous reports have shown that pressor hormones inhibit natriuretic peptide receptors NPR-A or NPR-B in a variety of different cell types. Although the mechanism for this inhibition remains unknown, it has been universally accepted that PKC is an obligatory component of this pathway primarily because pharmacologic activators of PKC mimic the inhibitory effects of these hormones. Here, we show that in A10 vascular smooth muscle cells, neither chronic PKC down-regulation nor specific PKC inhibitors block the AVP-dependent desensitization of NPR-B even though both processes block PKC-dependent desensitization. In contrast, the cell-permeable calcium chelator, BAPTA-AM (1,2-bis(2-aminophenoxy)ethane-NNN',N'-tetraacetic acid, tetraacetoxymethyl ester), abrogates the AVP-dependent desensitization of NPR-B, and ionomycin, a calcium ionophore, mimics the AVP effect. These data show that the inositol trisphosphate/calcium. arm of the phospholipase C pathway mediates the desensitization of a natriuretic peptide receptor in A10 cells. In addition, we report that CNP attenuates AVP-dependent elevations in intracellular calcium concentrations. Together, these data reveal a dominant role for intracellular calcium in the reciprocal regulation of these two important vasoactive signaling systems.	Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Potter, LR (corresponding author), Univ Minnesota, Dept Biochem Mol Biol & Biophys, 6-155 Jackson,321 Church St SE, Minneapolis, MN 55455 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066397] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007612] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01HL66397, R01 HL066397] Funding Source: Medline; NIAMS NIH HHS [AR07612] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ASE K, 1988, FEBS LETT, V236, P396, DOI 10.1016/0014-5793(88)80064-4; BELLEMANN P, 1988, J RECEPTOR RES, V8, P407, DOI 10.3109/10799898809049001; Braunewell KH, 2001, J NEUROCHEM, V78, P1277, DOI 10.1046/j.1471-4159.2001.00506.x; Brown J, 1997, AM J PHYSIOL-HEART C, V272, pH2919, DOI 10.1152/ajpheart.1997.272.6.H2919; Bryan PM, 2002, J BIOL CHEM, V277, P16041, DOI 10.1074/jbc.M110626200; Centrella M, 2001, TRENDS ENDOCRIN MET, V12, P235, DOI 10.1016/S1043-2760(01)00431-3; CHRISMAN TD, 1993, J BIOL CHEM, V268, P3698; Chun TH, 1997, HYPERTENSION, V29, P1296, DOI 10.1161/01.HYP.29.6.1296; Chusho H, 2001, P NATL ACAD SCI USA, V98, P4016, DOI 10.1073/pnas.071389098; Crook RB, 1997, BIOCHEM J, V324, P49, DOI 10.1042/bj3240049; DREWETT JG, 1995, J BIOL CHEM, V270, P4668, DOI 10.1074/jbc.270.9.4668; FETHIERE J, 1993, MOL CELL BIOCHEM, V124, P11, DOI 10.1007/BF01096376; FETHIERE J, 1992, FEBS LETT, V305, P77, DOI 10.1016/0014-5793(92)80868-H; Fowkes RC, 2000, J ENDOCRINOL, V166, P195, DOI 10.1677/joe.0.1660195; FURUYA M, 1995, ANN NY ACAD SCI, V748, P517; FURUYA M, 1991, BIOCHEM BIOPH RES CO, V177, P927, DOI 10.1016/0006-291X(91)90627-J; Gekeler V, 1996, BRIT J CANCER, V74, P897, DOI 10.1038/bjc.1996.454; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HAGIWARA H, 1994, J BIOL CHEM, V269, P10729; Hagiwara H, 1996, AM J PHYSIOL-CELL PH, V270, pC1311, DOI 10.1152/ajpcell.1996.270.5.C1311; HANEDA M, 1991, KIDNEY INT, V40, P188, DOI 10.1038/ki.1991.199; HOLLIDAY LS, 1995, J BIOL CHEM, V270, P18983, DOI 10.1074/jbc.270.32.18983; JAISWAL RK, 1992, BIOCHEM BIOPH RES CO, V182, P395, DOI 10.1016/S0006-291X(05)80158-5; JAISWAL RK, 1988, FEBS LETT, V227, P47, DOI 10.1016/0014-5793(88)81411-X; Joubert S, 2001, BIOCHEMISTRY-US, V40, P11096, DOI 10.1021/bi010580s; KAWABE J, 1992, BIOCHIM BIOPHYS ACTA, V1175, P81, DOI 10.1016/0167-4889(92)90012-Z; KOLLER KJ, 1993, J BIOL CHEM, V268, P5997; KOLLER KJ, 1991, SCIENCE, V252, P120, DOI 10.1126/science.1672777; Levin ER, 1998, NEW ENGL J MED, V339, P321; Matsukawa N, 1999, P NATL ACAD SCI USA, V96, P7403, DOI 10.1073/pnas.96.13.7403; MCARDLE CA, 1993, ENDOCRINOLOGY, V132, P2065, DOI 10.1210/en.132.5.2065; MUKHOPADHYAY AK, 1989, ENDOCRINOLOGY, V125, P686, DOI 10.1210/endo-125-2-686; NAMBI P, 1986, P NATL ACAD SCI USA, V83, P8492, DOI 10.1073/pnas.83.22.8492; NAMBI P, 1987, BIOCHEM J, V244, P481, DOI 10.1042/bj2440481; OKAHARA K, 1995, FEBS LETT, V373, P108, DOI 10.1016/0014-5793(95)01027-C; Olshevskaya EV, 2002, MOL CELL BIOCHEM, V230, P139, DOI 10.1023/A:1014248208584; Paulding WR, 1996, AM J PHYSIOL-CELL PH, V270, pC740, DOI 10.1152/ajpcell.1996.270.3.C740; Pfeifer A, 1996, SCIENCE, V274, P2082, DOI 10.1126/science.274.5295.2082; Potter LR, 2000, J BIOL CHEM, V275, P31099, DOI 10.1074/jbc.M005506200; Potter LR, 1998, J BIOL CHEM, V273, P15533, DOI 10.1074/jbc.273.25.15533; POTTER LR, 1992, J BIOL CHEM, V267, P14531; Potter LR, 1998, BIOCHEMISTRY-US, V37, P2422, DOI 10.1021/bi972303k; POTTER LR, 1994, J BIOL CHEM, V269, P14636; Potter LR, 1999, MOL BIOL CELL, V10, P1811, DOI 10.1091/mbc.10.6.1811; Potter LR, 2001, J BIOL CHEM, V276, P6057, DOI 10.1074/jbc.R000033200; Potter LR, 1998, MOL CELL BIOL, V18, P2164, DOI 10.1128/MCB.18.4.2164; REYNOLDS EE, 1986, BIOCHEM BIOPH RES CO, V136, P927, DOI 10.1016/0006-291X(86)90421-3; Richards AM, 1996, HEART, V76, P36, DOI 10.1136/hrt.76.3_Suppl_3.36; Schulz S, 1999, VITAM HORM, V57, P123; SHINOMIYA M, 1994, BIOCHEM BIOPH RES CO, V205, P1051, DOI 10.1006/bbrc.1994.2772; Silberbach M, 2001, CELL SIGNAL, V13, P221, DOI 10.1016/S0898-6568(01)00139-5; SMITH JB, 1987, AM J PHYSIOL, V253, pC147, DOI 10.1152/ajpcell.1987.253.1.C147; Suda M, 1998, P NATL ACAD SCI USA, V95, P2337, DOI 10.1073/pnas.95.5.2337; SUDOH T, 1990, BIOCHEM BIOPH RES CO, V168, P863, DOI 10.1016/0006-291X(90)92401-K; SUGA S, 1992, J CLIN INVEST, V90, P1145, DOI 10.1172/JCI115933; SUGA SI, 1992, ENDOCRINOLOGY, V130, P229, DOI 10.1210/en.130.1.229; SUMNERS C, 1991, AM J PHYSIOL, V260, pC79, DOI 10.1152/ajpcell.1991.260.1.C79; Thibault G, 1996, LIFE SCI, V58, P2345, DOI 10.1016/0024-3205(96)00235-4; Tsang D, 1997, REGUL PEPTIDES, V70, P91, DOI 10.1016/S0167-0115(97)00013-X; Ueno H, 1997, CIRCULATION, V96, P2272; WEI CM, 1993, AM J PHYSIOL, V264, pH71, DOI 10.1152/ajpheart.1993.264.1.H71; Wilkins MR, 1997, LANCET, V349, P1307, DOI 10.1016/S0140-6736(96)07424-7; Yasoda A, 1998, J BIOL CHEM, V273, P11695, DOI 10.1074/jbc.273.19.11695; YASUNARI K, 1992, HYPERTENSION, V19, P314, DOI 10.1161/01.HYP.19.4.314; Yeung VTF, 1996, J NEUROSCI RES, V46, P686, DOI 10.1002/(SICI)1097-4547(19961215)46:6<686::AID-JNR6>3.0.CO;2-B; YEUNG VTF, 1992, FEBS LETT, V308, P301, DOI 10.1016/0014-5793(92)81298-Z; Zlock DW, 1997, HYPERTENSION, V29, P83, DOI 10.1161/01.HYP.29.1.83	67	46	53	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					42423	42430		10.1074/jbc.M206686200	http://dx.doi.org/10.1074/jbc.M206686200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12196532	hybrid			2022-12-27	WOS:000179081200002
J	Sandmark, J; Mann, S; Marquet, A; Schneider, G				Sandmark, J; Mann, S; Marquet, A; Schneider, G			Structural basis for the inhibition of the biosynthesis of biotin by the antibiotic amiclenomycin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DETHIOBIOTIN SYNTHETASE; 7,8-DIAMINOPELARGONIC ACID; CRYSTAL-STRUCTURE; 8-AMINO-7-OXOPELARGONATE SYNTHASE; 7-KETO-8-AMINOPELARGONIC ACID; ASPARTATE-AMINOTRANSFERASE; ENZYME; MECHANISM; SUBSTRATE; INTERMEDIATE	The antibiotic amiclenomycin blocks the biosynthesis of biotin by inhibiting the pyridoxal-phosphate-dependent enzyme diaminopelargonic acid synthase. Inactivation of the enzyme is stereoselective, i.e. the cis isomer of amiclenomycin is a potent inhibitor, whereas the trans isomer is much less reactive. The crystal structure of the complex of the holoenzyme and amiclenomycin at 1.8 Angstrom resolution reveals that the internal aldimine linkage between the cofactor and the side chain of the catalytic residue Lys-274 is broken. Instead, a covalent bond is formed between the 4-amino nitrogen of amiclenomycin and the C4' carbon atom of pyridoxal-phosphate. The electron density for the bound inhibitor suggests that aromatization of the cyclohexadiene ring has occurred upon formation of the covalent adduct. This process could be initiated by proton abstraction at the C4' carbon atom of the cyclohexadiene ring, possibly by the proximal side chain of Lys-274, leading to the tautomer Schiff base followed by the removal of the second allylic hydrogen. The carboxyl tail of the amiclenomycin moiety forms a salt link to the conserved residue Arg-391 in the substrate-binding site. Modeling suggests steric hindrance at the active site as the determinant of the weak inhibiting potency of the trans isomer.	Karolinska Inst, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden; Univ Paris 06, Lab Chim Organ Biol, CNRS, UMR 7613, F-75252 Paris 05, France	Karolinska Institutet; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Schneider, G (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Scheeles Vag 2, S-17177 Stockholm, Sweden.	gunter@alfa.mbb.ki.se		Schneider, Gunter/0000-0003-0622-5713				ALEXEEV D, 1995, STRUCTURE, V3, P1207, DOI 10.1016/S0969-2126(01)00256-8; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BAXTER RL, 1994, J CHEM SOC CHEM COMM, P759, DOI 10.1039/c39940000759; Eads JC, 1999, BIOCHEMISTRY-US, V38, P9840, DOI 10.1021/bi990018q; EISENBERG MA, 1973, ADV ENZYMOL RAMB, V38, P317; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; Fu MM, 1999, BIOORGAN MED CHEM, V7, P1581, DOI 10.1016/S0968-0896(99)00081-4; GEHRING H, 1984, BIOCHEMISTRY-US, V23, P6335, DOI 10.1021/bi00321a007; GIBSON KJ, 1995, BIOCHEMISTRY-US, V34, P10976, DOI 10.1021/bi00035a003; HAYASHI H, 1995, J BIOCHEM-TOKYO, V118, P463, DOI 10.1093/oxfordjournals.jbchem.a124931; Hennig M, 1997, P NATL ACAD SCI USA, V94, P4866, DOI 10.1073/pnas.94.10.4866; HOTTA K, 1975, J ANTIBIOT, V28, P222, DOI 10.7164/antibiotics.28.222; HUANG WJ, 1995, BIOCHEMISTRY-US, V34, P10985, DOI 10.1021/bi00035a004; IZUMI Y, 1973, AGR BIOL CHEM TOKYO, V37, P2683, DOI 10.1080/00021369.1973.10861063; Jansonius JN, 1998, CURR OPIN STRUC BIOL, V8, P759, DOI 10.1016/S0959-440X(98)80096-1; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; JULIN DA, 1989, BIOCHEMISTRY-US, V28, P3815, DOI 10.1021/bi00435a029; Kack H, 1998, P NATL ACAD SCI USA, V95, P5495, DOI 10.1073/pnas.95.10.5495; Kack H, 1999, J MOL BIOL, V291, P857, DOI 10.1006/jmbi.1999.2997; Kack H, 1998, ACTA CRYSTALLOGR D, V54, P1397, DOI 10.1107/S0907444998001954; KERN A, 1985, LIEBIGS ANN CHEM, P877; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LESLIE A, 1992, JOINT CCP4 ESF EACBM, V28; Mann S, 2002, CHEM-EUR J, V8, P439, DOI 10.1002/1521-3765(20020118)8:2<439::AID-CHEM439>3.0.CO;2-5; Marquet A, 2001, VITAM HORM, V61, P51; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; METZLER CM, 1991, J BIOL CHEM, V266, P9374; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; OKAMI Y, 1974, J ANTIBIOT, V27, P656, DOI 10.7164/antibiotics.27.656; OTSUKA AJ, 1988, J BIOL CHEM, V263, P19577; Ploux O, 1996, EUR J BIOCHEM, V236, P301, DOI 10.1111/j.1432-1033.1996.00301.x; Ploux O, 1999, EUR J BIOCHEM, V259, P63, DOI 10.1046/j.1432-1327.1999.00006.x; POETSCH M, 1985, J ANTIBIOT, V38, P312, DOI 10.7164/antibiotics.38.312; RANDO RR, 1977, BIOCHEMISTRY-US, V16, P4604, DOI 10.1021/bi00640a012; Rendina AR, 1999, PESTIC SCI, V55, P236, DOI 10.1002/(SICI)1096-9063(199903)55:3&lt;236::AID-PS888&gt;3.0.CO;2-0; Schneider G, 2001, FEBS LETT, V495, P7, DOI 10.1016/S0014-5793(01)02325-0; Schneider G, 2000, STRUCT FOLD DES, V8, pR1, DOI 10.1016/S0969-2126(00)00085-X; Shah SA, 1997, STRUCTURE, V5, P1067, DOI 10.1016/S0969-2126(97)00258-X; STONER GL, 1975, J BIOL CHEM, V250, P4037; STONER GL, 1975, J BIOL CHEM, V250, P4019; Webster SP, 2000, BIOCHEMISTRY-US, V39, P516, DOI 10.1021/bi991620j	43	35	42	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					43352	43358		10.1074/jbc.M207239200	http://dx.doi.org/10.1074/jbc.M207239200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12218056	hybrid			2022-12-27	WOS:000179081200119
J	Trowbridge, JM; Rudisill, JA; Ron, D; Gallo, RL				Trowbridge, JM; Rudisill, JA; Ron, D; Gallo, RL			Dermatan sulfate binds and potentiates activity of keratinocyte growth factor (FGF-7)*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARIN-COFACTOR-II; FIBROBLAST-GROWTH; HIGH-AFFINITY; CRYSTAL-STRUCTURE; FACTOR RECEPTORS; KGF RECEPTOR; DOMAIN; PROTEOGLYCANS; EXPRESSION; DIFFERENTIATION	FGF-7 is induced after injury and induces the proliferation of keratinocytes. Like most members of the FGF family, the activity of FGF-7 is strongly influenced by binding to heparin, but this glycosaminoglycan is absent on keratinocyte cell surfaces and minimally present in the wound environment. In this investigation we compared the relative activity of heparan sulfate and chondroitin sulfate B (dermatan sulfate), glycosaminoglycans that are present in wounds. A lymphoid cell line (BaF/KGFR) containing the FGF-7 receptor (FGFR2 IIIb) was treated with FGF-7 and with various glycosaminoglycans. FGF-7 did not support cell proliferation in the absence of glycosaminoglycan or with addition of heparan sulfate or chondroitin sulfate A/C but did stimulate BaF/KGFR division in the presence of dermatan sulfate or highly sulfated low molecular weight fractions of dermatan. Dermatan sulfate also enabled FGF7-dependent phosphorylation of mitogen-activated protein kinase and promoted binding of radiolabeled FGF-7 to FGFR2 IIIb. In addition, dermatan sulfate and FGF-7 stimulated growth of normal keratinocytes in culture. Thus, dermatan sulfate, the predominant glycosaminoglycan in skin, is the principle cofactor for FGF-7.	Univ Calif San Diego, Div Dermatol, Dept Med, San Diego, CA 92161 USA; Vet Affairs Med Ctr, La Jolla, CA 92161 USA; Technion Israel Inst Technol, Dept Biol, IL-32000 Haifa, Israel	University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); Technion Israel Institute of Technology	Gallo, RL (corresponding author), Univ Calif San Diego, Div Dermatol, Dept Med, 3350 La Jolla Village Dr, San Diego, CA 92161 USA.		Gallo, Richard L/A-8931-2009	Gallo, Richard L/0000-0002-1401-7861	NCI NIH HHS [5T32CA81211] Funding Source: Medline; NIAMS NIH HHS [AR45676] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA081211] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045676] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Berman B, 1999, J BIOL CHEM, V274, P36132, DOI 10.1074/jbc.274.51.36132; BonnehBarkay D, 1997, J BIOL CHEM, V272, P12415, DOI 10.1074/jbc.272.19.12415; BOTTARO DP, 1990, J BIOL CHEM, V265, P12767; BROWN CT, 1995, J CELL BIOCHEM, V59, P57, DOI 10.1002/jcb.240590108; CAMEJO EH, 1995, ARTERIOSCL THROM VAS, V15, P1456, DOI 10.1161/01.ATV.15.9.1456; CELLA G, 1992, ANGIOLOGY, V43, P59, DOI 10.1177/000331979204300107; DELEHEDDE M, 2002, J BIOL CHEM, V17, P17; DiGabriele AD, 1998, NATURE, V393, P812, DOI 10.1038/31741; Fernandez JA, 1999, THROMB HAEMOSTASIS, V82, P1462; FINCH PW, 1989, SCIENCE, V245, P752, DOI 10.1126/science.2475908; FRESHNEY IR, 2000, CULTURE ANIMAL CELLS, P345; Friedl A, 1997, AM J PATHOL, V150, P1443; Gallagher JT, 2001, J CLIN INVEST, V108, P357, DOI 10.1172/JCI13713; GUIMOND S, 1993, J BIOL CHEM, V268, P23906; Hsu YR, 1999, BIOCHEMISTRY-US, V38, P2523, DOI 10.1021/bi9821317; KAN MK, 1993, SCIENCE, V259, P1918, DOI 10.1126/science.8456318; KAWASHIMA H, 2002, J BIOL CHEM, V30, P30; KIM CW, 1994, MOL BIOL CELL, V5, P797, DOI 10.1091/mbc.5.7.797; KREUGER J, 2001, J BIOL CHEM, V13, P13; Kuschert GSV, 1999, BIOCHEMISTRY-US, V38, P12959, DOI 10.1021/bi990711d; LaRochelle WJ, 1999, BIOCHEMISTRY-US, V38, P1765, DOI 10.1021/bi982092z; Liaw PCY, 2001, J BIOL CHEM, V276, P20959, DOI 10.1074/jbc.M010584200; LORTAT-JACOB H, 1995, BIOCHEM J, V310, P497, DOI 10.1042/bj3100497; Lyon M, 1998, J BIOL CHEM, V273, P271, DOI 10.1074/jbc.273.1.271; Lyon M, 2002, J BIOL CHEM, V277, P1040, DOI 10.1074/jbc.M107506200; Maccarana M, 1996, J BIOL CHEM, V271, P17804, DOI 10.1074/jbc.271.30.17804; MAIMONE MM, 1990, J BIOL CHEM, V265, P18263; MARCHESE C, 1995, J EXP MED, V182, P1369, DOI 10.1084/jem.182.5.1369; MARCHESE C, 1990, J CELL PHYSIOL, V144, P326, DOI 10.1002/jcp.1041440219; Marchese C, 2001, J INVEST DERMATOL, V116, P623, DOI 10.1046/j.0022-202x.2001.01280.x; MASCELLANI G, 1993, BIOCHEM J, V296, P639, DOI 10.1042/bj2960639; MIKI T, 1991, SCIENCE, V251, P72, DOI 10.1126/science.1846048; Mongiat M, 2000, J BIOL CHEM, V275, P7095, DOI 10.1074/jbc.275.10.7095; OKSALA O, 1995, J HISTOCHEM CYTOCHEM, V43, P125, DOI 10.1177/43.2.7529785; Ornitz DM, 1996, J BIOL CHEM, V271, P15292, DOI 10.1074/jbc.271.25.15292; ORNITZ DM, 1992, MOL CELL BIOL, V12, P240, DOI 10.1128/MCB.12.1.240; Ostrovsky O, 2002, J BIOL CHEM, V277, P2444, DOI 10.1074/jbc.M108540200; Pellegrini L, 2000, NATURE, V407, P1029, DOI 10.1038/35039551; Penc SF, 1998, J BIOL CHEM, V273, P28116, DOI 10.1074/jbc.273.43.28116; PIERCE GF, 1994, J EXP MED, V179, P831, DOI 10.1084/jem.179.3.831; RAPRAEGER AC, 1994, METHOD ENZYMOL, V245, P219; RAPRAEGER AC, 1991, SCIENCE, V252, P1705, DOI 10.1126/science.1646484; REICHSLOTKY R, 1994, J BIOL CHEM, V269, P32279; RON D, 1993, J BIOL CHEM, V268, P2984; RON D, 1993, J BIOL CHEM, V268, P5388; RUBIN JS, 1989, P NATL ACAD SCI USA, V86, P802, DOI 10.1073/pnas.86.3.802; SAKSELA O, 1988, J CELL BIOL, V107, P743, DOI 10.1083/jcb.107.2.743; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; SHAOUL E, 1995, ONCOGENE, V10, P1553; STAIANOCOICO L, 1993, J EXP MED, V178, P865, DOI 10.1084/jem.178.3.865; Tumova S, 2000, INT J BIOCHEM CELL B, V32, P269, DOI 10.1016/S1357-2725(99)00116-8; VLODAVSKY I, 1991, TRENDS BIOCHEM SCI, V16, P268, DOI 10.1016/0968-0004(91)90102-2; Walker A, 1996, BIOCHEM J, V317, P871, DOI 10.1042/bj3170871; WERNER S, 1992, P NATL ACAD SCI USA, V89, P6896, DOI 10.1073/pnas.89.15.6896	54	82	91	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					42815	42820		10.1074/jbc.M204959200	http://dx.doi.org/10.1074/jbc.M204959200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12215437	hybrid			2022-12-27	WOS:000179081200053
J	Cornilescu, G; Lee, BR; Cornilescu, CC; Wang, GS; Peterkofsky, A; Clore, GM				Cornilescu, G; Lee, BR; Cornilescu, CC; Wang, GS; Peterkofsky, A; Clore, GM			Solution structure of the phosphoryl transfer complex between the cytoplasmic A domain of the mannitol transporter IIMannitol and HPr of the Escherichia coli phoshotransferase system	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PHOSPHOTRANSFERASE SYSTEM; PHOSPHOCARRIER PROTEIN HPR; HISTIDINE-CONTAINING PROTEIN; RESIDUAL DIPOLAR COUPLINGS; C-TERMINAL DOMAIN; ACTIVE-SITE; ENZYME-II; NMR-SPECTROSCOPY; BACTERIAL PHOSPHOENOLPYRUVATE; STAPHYLOCOCCUS-CARNOSUS	The solution structure of the complex between the cytoplasmic A domain (IIA(Mtl)) of the mannitol transporter IIMannitol and the histidine-containing phosphocarrier protein (HPr) of the Escherichia coli phosphotransferase system has been solved by NMR, including the use of conjoined rigid body/torsion angle dynamics, and residual dipolar couplings, coupled with cross-validation, to permit accurate orientation of the two proteins. A convex surface on HPr, formed by helices 1 and 2, interacts with a complementary concave depression on the surface of IIA(Mtl) formed by helix 3, portions of helices 2 and 4, and beta-strands 2 and 3. The majority of intermolecular contacts are hydrophobic, with a small number of electrostatic interactions at the periphery of the interface. The active site histidines, His-15 of HPr and His-65 of IIA(Mtl), are in close spatial proximity, and a pentacoordinate phosphoryl transition state can be readily accommodated with no change in protein-protein orientation and only minimal perturbations of the backbone immediately adjacent to the histidines. Comparison with two previously solved structures of complexes of HPr with partner proteins of the phosphotransferase system, the N-terminal domain of enzyme I (EIN) and enzyme IIA(Glucose) (IIA(Glc)), reveals a number of common features despite the fact that EIN, IIA(Glc), and IIA(Mtl) bear no structural resemblance to one another. Thus, entirely different underlying structural elements can form binding surfaces for HPr that are similar in terms of both shape and residue composition. These structural comparisons illustrate the roles of surface and residue complementarity, redundancy, incremental build-up of specificity and conformational side chain plasticity in the formation of transient specific protein-protein complexes in signal transduction pathways.	NIDDK, Chem Phys Lab, NIH, Bethesda, MD 20892 USA; NHLBI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA; NHLBI, Biophys Chem Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Clore, GM (corresponding author), NIDDK, Chem Phys Lab, NIH, Bldg 5,Rm B1-30I, Bethesda, MD 20892 USA.		Cornilescu, Claudia/K-1981-2015; Cornilescu, Gabriel/H-3113-2011; Cornilescu, Claudia/H-1959-2012; Clore, G Marius/L-2546-2018; Clore, G. Marius/A-3511-2008	Cornilescu, Claudia/0000-0002-2401-7806; Cornilescu, Gabriel/0000-0002-1204-8904; Clore, G Marius/0000-0003-3809-1027; Clore, G. Marius/0000-0003-3809-1027	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [Z01HL000151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK029023, Z01DK029023] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AB E, 1997, PROTEIN SCI, V6, P304; AB E, 2001, J MOL BIOL, V308, P993, DOI 10.1006/jmbi.2001.4623; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; ANDERSON JW, 1993, J BIOL CHEM, V268, P12325; BAX A, 1993, ACCOUNTS CHEM RES, V26, P131, DOI 10.1021/ar00028a001; Bax A, 2001, METHOD ENZYMOL, V339, P127, DOI 10.1016/S0076-6879(01)39313-8; BAX A, 1994, METHOD ENZYMOL, V239, P79; BEGLEY GS, 1982, BIOCHEMISTRY-US, V21, P5552, DOI 10.1021/bi00265a026; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240; Chou JJ, 2000, J BIOMOL NMR, V18, P101, DOI 10.1023/A:1008358318863; Clore GM, 2000, P NATL ACAD SCI USA, V97, P9021, DOI 10.1073/pnas.97.16.9021; Clore GM, 1998, J MAGN RESON, V131, P159, DOI 10.1006/jmre.1997.1345; Clore GM, 1999, J AM CHEM SOC, V121, P9008, DOI 10.1021/ja991789k; Clore GM, 2002, J MAGN RESON, V154, P329, DOI 10.1006/jmre.2001.2489; Clore GM, 2002, J AM CHEM SOC, V124, P2866, DOI 10.1021/ja017712p; Clore GM, 1998, TRENDS BIOTECHNOL, V16, P22, DOI 10.1016/S0167-7799(97)01135-9; Clore GM, 1998, J AM CHEM SOC, V120, P10571, DOI 10.1021/ja982592f; CLORE GM, 1991, SCIENCE, V252, P1390, DOI 10.1126/science.2047852; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Eberstadt M, 1996, BIOCHEMISTRY-US, V35, P11286, DOI 10.1021/bi960492l; FISCHER R, 1992, EUR J BIOCHEM, V204, P963, DOI 10.1111/j.1432-1033.1992.tb16717.x; Garrett DS, 1997, BIOCHEMISTRY-US, V36, P4393, DOI 10.1021/bi970221q; GARRETT DS, 1991, J MAGN RESON, V95, P214, DOI 10.1016/0022-2364(91)90341-P; Garrett DS, 1999, NAT STRUCT BIOL, V6, P166; HERZBERG O, 1994, CURR OPIN STRUC BIOL, V4, P814, DOI 10.1016/0959-440X(94)90262-3; Hu JS, 1997, J AM CHEM SOC, V119, P1803, DOI 10.1021/ja963625z; Hu JS, 1997, J BIOMOL NMR, V9, P323, DOI 10.1023/A:1018691228238; JACOBSON GR, 1979, J BIOL CHEM, V254, P249; JIA ZC, 1993, J BIOL CHEM, V268, P22490; KROON GJA, 1993, PROTEIN SCI, V2, P1331, DOI 10.1002/pro.5560020816; KRUSE R, 1993, PROTEIN ENG, V6, P417, DOI 10.1093/protein/6.4.417; KUNDIG W, 1964, P NATL ACAD SCI USA, V52, P1067, DOI 10.1073/pnas.52.4.1067; Kuszewski J, 1999, J AM CHEM SOC, V121, P2337, DOI 10.1021/ja9843730; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LAVALLIE ER, 1993, BIO-TECHNOL, V11, P187, DOI 10.1038/nbt0293-187; LEE CA, 1983, J BIOL CHEM, V258, P761; LIAO DI, 1991, BIOCHEMISTRY-US, V30, P9583, DOI 10.1021/bi00104a004; LOLKEMA JS, 1993, BIOCHEMISTRY-US, V32, P1396, DOI 10.1021/bi00057a002; Losonczi JA, 1999, J MAGN RESON, V138, P334, DOI 10.1006/jmre.1999.1754; MUELLER EG, 1990, BIOCHEMISTRY-US, V29, P6892, DOI 10.1021/bi00481a019; Napper S, 1996, BIOCHEMISTRY-US, V35, P11260, DOI 10.1021/bi9603480; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; NILGES M, 1988, PROTEIN ENG, V2, P27, DOI 10.1093/protein/2.1.27; Nunn RS, 1996, J MOL BIOL, V259, P502, DOI 10.1006/jmbi.1996.0335; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; PAS HH, 1988, BIOCHEMISTRY-US, V27, P5835, DOI 10.1021/bi00416a002; Postma P.W., 1996, ESCHERICHIA COLI SAL, P1149; Prestegard JH, 2001, CURR OPIN CHEM BIOL, V5, P584, DOI 10.1016/S1367-5931(00)00247-7; REDDY P, 1989, NUCLEIC ACIDS RES, V17, P10473, DOI 10.1093/nar/17.24.10473; Reddy P, 1991, Protein Expr Purif, V2, P179, DOI 10.1016/1046-5928(91)90069-U; Robillard GT, 1999, BBA-REV BIOMEMBRANES, V1422, P73, DOI 10.1016/S0304-4157(99)00002-7; Ruckert M, 2000, J AM CHEM SOC, V122, P7793, DOI 10.1021/ja001068h; Schauder S, 1998, J MOL BIOL, V276, P591, DOI 10.1006/jmbi.1997.1544; Schwieters CD, 2002, J BIOMOL NMR, V23, P221, DOI 10.1023/A:1019875223132; Schwieters CD, 2001, J MAGN RESON, V152, P288, DOI 10.1006/jmre.2001.2413; Schwieters CD, 2001, J MAGN RESON, V149, P239, DOI 10.1006/jmre.2001.2300; SCHWIETERS CD, 2002, IN PRESS J MAGN RESO; Sliz P, 1997, STRUCTURE, V5, P775, DOI 10.1016/S0969-2126(97)00232-3; Sondej M, 2002, BIOCHEMISTRY-US, V41, P5556, DOI 10.1021/bi011990j; STEPHAN MM, 1989, BIOCHEMISTRY-US, V28, P7941, DOI 10.1021/bi00445a058; Tchieu JH, 2001, J MOL MICROB BIOTECH, V3, P329; Tjandra N, 1997, SCIENCE, V278, P1111, DOI 10.1126/science.278.5340.1111; Tjandra N, 1997, NAT STRUCT BIOL, V4, P732, DOI 10.1038/nsb0997-732; van Montfort RLM, 1998, STRUCTURE, V6, P377, DOI 10.1016/S0969-2126(98)00039-2; VANDIJK AA, 1990, BIOCHEMISTRY-US, V29, P8164, DOI 10.1021/bi00487a026; VANDIJK AA, 1992, BIOCHEMISTRY-US, V31, P9063, DOI 10.1021/bi00152a050; vanMontfort RLM, 1997, STRUCTURE, V5, P217, DOI 10.1016/S0969-2126(97)00180-9; VANNULAND NAJ, 1993, FEBS LETT, V315, P11, DOI 10.1016/0014-5793(93)81122-G; VANWEEGHEL RP, 1991, BIOCHEMISTRY-US, V30, P9478, DOI 10.1021/bi00103a013; VANWEEGHEL RP, 1991, BIOCHEMISTRY-US, V30, P1774, DOI 10.1021/bi00221a007; VANWEEGHEL RP, 1991, BIOCHEMISTRY-US, V30, P1768, DOI 10.1021/bi00221a006; Wang GS, 2000, EMBO J, V19, P5635, DOI 10.1093/emboj/19.21.5635; WEIGEL N, 1982, J BIOL CHEM, V257, P4499; WHITE DW, 1990, J BACTERIOL, V172, P1509, DOI 10.1128/jb.172.3.1509-1515.1990; WORTHYLAKE D, 1991, P NATL ACAD SCI USA, V88, P10382, DOI 10.1073/pnas.88.23.10382; Zweckstetter M, 2000, J AM CHEM SOC, V122, P3791, DOI 10.1021/ja0000908; Zweckstetter M, 2002, J BIOMOL NMR, V23, P127, DOI 10.1023/A:1016316415261	78	60	61	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					42289	42298		10.1074/jbc.M207314200	http://dx.doi.org/10.1074/jbc.M207314200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12202490	hybrid			2022-12-27	WOS:000178985300124
J	Munshi, HG; Wu, YI; Ariztia, EV; Stack, MS				Munshi, HG; Wu, YI; Ariztia, EV; Stack, MS			Calcium regulation of matrix metalloproteinase-mediated migration in oral squamous cell carcinoma cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							2 GELATINASE-A; TISSUE INHIBITOR; IV COLLAGENASE; ENHANCED PRODUCTION; DIFFERENTIAL REGULATION; 72-KDA GELATINASE; COMPLEX-FORMATION; CATALYTIC DOMAIN; EPIDERMAL-CELLS; CONCANAVALIN-A	Activation of matrix metalloproteinase 2 (MMP-2) has been shown to play a significant role in the behavior of cancer cells, affecting both migration and invasion. The activation process requires multimolecular complex formation involving pro-MMP-2, membrane type 1-MMP (MT1-MMP), and tissue inhibitor of metalloproteinases-2 (TIMP-2). Because calcium is an important regulator of keratinocyte function, we evaluated the effect of calcium on AMP regulation in an oral squamous cell carcinoma line (SCC25). Increasing extracellular calcium (0.09-1.2 mm) resulted in a dose-dependent increase in MT1-MMP-dependent pro-MMP-2 activation. Despite the requirement for MT1-MMP in the activation process, no changes in MT1-MMP expression, cell surface localization, or endocytosis were apparent. However, increased generation of the catalytically inactive 43-kDa MT1-MMP autolysis product and decline in the TIMP-2 levels in conditioned media were observed. The decrease in TIMP-2 levels in the conditioned media was prevented by a broad spectrum MMP inhibitor, suggesting that calcium promotes recruitment of TIMP-2 to MT1-MMP on the cell surface. Despite the decline in soluble TIMP-2, no accumulation of TIMP-2 in cell lysates was seen. Blocking TIMP-2 degradation with bafilomycin A1 significantly increased cell-associated TIMP-2 levels in the presence of high calcium. These data suggest that the decline in TIMP-2 is because of increased calcium-mediated MT1-MMP-dependent degradation of TIMP-2. In functional studies, increasing calcium enhanced MMP-dependent cellular migration on laminin-5-rich matrix using an in vitro colony dispersion assay. Taken together, these results suggest that changes in extracellular calcium can regulate post-translational MMP dynamics and thus affect the cellular behavior of oral squamous cell carcinoma.	Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA; Northwestern Univ, Div Hematol Oncol, Dept Med, Chicago, IL 60611 USA; Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center	Stack, MS (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, 303 E Chicago Ave,Tarry 8-715, Chicago, IL 60611 USA.	mss130@northwestern.edu			NIDCR NIH HHS [P01 DE12328] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P01DE012328] Funding Source: NIH RePORTER	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Aznavoorian S, 2001, CANCER RES, V61, P6264; AZZAM HS, 1992, CANCER RES, V52, P4540; Baumann P, 2000, BRIT J CANCER, V83, P1387, DOI 10.1054/bjoc.2000.1454; Bikle DD, 2001, MOL CELL ENDOCRINOL, V177, P161, DOI 10.1016/S0303-7207(01)00452-X; BROWN PD, 1993, J NATL CANCER I, V85, P574, DOI 10.1093/jnci/85.7.574; Butler GS, 1998, J BIOL CHEM, V273, P871, DOI 10.1074/jbc.273.2.871; Crescimanno C, 1996, EXP CELL RES, V227, P240, DOI 10.1006/excr.1996.0273; Deryugina EI, 1997, J CELL SCI, V110, P2473; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Ellerbroek SM, 1999, CANCER RES, V59, P1635; Ellerbroek SM, 2001, J BIOL CHEM, V276, P24833, DOI 10.1074/jbc.M005631200; Forastiere A, 2001, NEW ENGL J MED, V345, P1890, DOI 10.1056/NEJMra001375; Giannelli G, 1997, SCIENCE, V277, P225, DOI 10.1126/science.277.5323.225; Gilles C, 1997, LAB INVEST, V76, P651; Gilles C, 1998, CANCER RES, V58, P5529; Gilles C, 2001, J CELL SCI, V114, P2967; Gospodarowicz D, 1984, METHODS PREPARATION, P275; Haas TL, 1998, J BIOL CHEM, V273, P3604, DOI 10.1074/jbc.273.6.3604; HENNINGS H, 1980, CELL, V19, P245, DOI 10.1016/0092-8674(80)90406-7; HENNINGS H, 1983, EXP CELL RES, V143, P127, DOI 10.1016/0014-4827(83)90115-5; HERNANDEZBARREN.S, 2002, SEMIN CANCER BIOL, V12, P1312; Itoh Y, 1998, J BIOL CHEM, V273, P24360, DOI 10.1074/jbc.273.38.24360; Itoh Y, 2001, EMBO J, V20, P4782, DOI 10.1093/emboj/20.17.4782; Jiang AX, 2001, P NATL ACAD SCI USA, V98, P13693, DOI 10.1073/pnas.241293698; Jo Y, 2000, BIOCHEM J, V345, P511, DOI 10.1042/bj3450511; Kawata R, 2002, ACTA OTO-LARYNGOL, V122, P101, DOI 10.1080/00016480252775823; Kobayashi T, 1998, DERMATOLOGY, V197, P1, DOI 10.1159/000017967; Kobayashi T, 2000, IUBMB LIFE, V50, P221; Kobayashi T, 2001, EMBO REP, V2, P604, DOI 10.1093/embo-reports/kve129; Koshikawa N, 2000, J CELL BIOL, V148, P615, DOI 10.1083/jcb.148.3.615; Kurahara S, 1999, HEAD NECK-J SCI SPEC, V21, P627, DOI 10.1002/(SICI)1097-0347(199910)21:7<627::AID-HED7>3.3.CO;2-U; Kurschat P, 1999, J BIOL CHEM, V274, P21056, DOI 10.1074/jbc.274.30.21056; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lehti K, 1998, BIOCHEM J, V334, P345, DOI 10.1042/bj3340345; Liabakk NB, 1996, CANCER RES, V56, P190; LIOTTA LA, 1980, NATURE, V284, P67, DOI 10.1038/284067a0; LOHI J, 1995, J BIOL CHEM, V270, P17602, DOI 10.1074/jbc.270.29.17602; Madlener M, 1998, EXP CELL RES, V242, P201, DOI 10.1006/excr.1998.4049; Makela M, 1999, EXP CELL RES, V251, P67, DOI 10.1006/excr.1999.4564; Maquoi E, 2000, J BIOL CHEM, V275, P11368, DOI 10.1074/jbc.275.15.11368; Maquoi E, 1998, FEBS LETT, V424, P262, DOI 10.1016/S0014-5793(98)00187-2; Maquoi E, 2000, EXP CELL RES, V261, P348, DOI 10.1006/excr.2000.5063; Mauro T, 1998, J INVEST DERMATOL, V111, P1198, DOI 10.1046/j.1523-1747.1998.00421.x; MENON GK, 1985, J INVEST DERMATOL, V84, P508, DOI 10.1111/1523-1747.ep12273485; MENON GK, 1994, J INVEST DERMATOL, V102, P789, DOI 10.1111/1523-1747.ep12377921; Munshi HG, 2002, METHOD CELL BIOL, V69, P195, DOI 10.1016/S0091-679X(02)69013-2; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Nagavarapu U, 2002, J INVEST DERMATOL, V118, P573, DOI 10.1046/j.1523-1747.2002.01713.x; Neuhaus EM, 2000, J CELL BIOL, V150, P1013, DOI 10.1083/jcb.150.5.1013; Nomura H, 1996, INT J CANCER, V69, P9, DOI 10.1002/(SICI)1097-0215(19960220)69:1<9::AID-IJC3>3.0.CO;2-8; Overall CM, 1999, J BIOL CHEM, V274, P4421, DOI 10.1074/jbc.274.7.4421; OVERALL CM, 1990, J BIOL CHEM, V265, P21141; Raby BN, 2001, INT J CANCER, V93, P644, DOI 10.1002/ijc.1380; Rozanov DV, 2001, J BIOL CHEM, V276, P25705, DOI 10.1074/jbc.M007921200; SATO H, 1994, NATURE, V370, P61, DOI 10.1038/370061a0; Sato H, 1996, FEBS LETT, V393, P101, DOI 10.1016/0014-5793(96)00861-7; SELTZER JL, 1994, EXP CELL RES, V213, P365, DOI 10.1006/excr.1994.1211; Shimada T, 2000, CLIN EXP METASTAS, V18, P179, DOI 10.1023/A:1006749501682; Shofuda K, 1998, J BIOCHEM-TOKYO, V124, P462, DOI 10.1093/oxfordjournals.jbchem.a022136; Simon C, 1998, CANCER RES, V58, P1135; Stanton H, 1998, J CELL SCI, V111, P2789; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; STRONGIN AY, 1995, J BIOL CHEM, V270, P5331, DOI 10.1074/jbc.270.10.5331; STRONGIN AY, 1993, J BIOL CHEM, V268, P14033; Takahashi K, 1999, INT J CANCER, V80, P387, DOI 10.1002/(SICI)1097-0215(19990129)80:3<387::AID-IJC9>3.3.CO;2-K; Toth M, 2002, J BIOL CHEM, V277, P26340, DOI 10.1074/jbc.M200655200; Toth M, 2000, J BIOL CHEM, V275, P41415, DOI 10.1074/jbc.M006871200; Uekita T, 2001, J CELL BIOL, V155, P1345, DOI 10.1083/jcb.200108112; Werb Z, 1997, CELL, V91, P439, DOI 10.1016/S0092-8674(00)80429-8; Will H, 1996, J BIOL CHEM, V271, P17119, DOI 10.1074/jbc.271.29.17119; Wong H, 2000, METH MOL B, V151, P305, DOI 10.1385/1-59259-046-2:305; Yamamoto M, 1998, J MED CHEM, V41, P1209, DOI 10.1021/jm970404a; Yana I, 2000, MOL BIOL CELL, V11, P2387, DOI 10.1091/mbc.11.7.2387; YU M, 1995, CANCER RES, V55, P3272; YUSPA SH, 1989, J CELL BIOL, V109, P1207, DOI 10.1083/jcb.109.3.1207; Zucker S, 1998, J BIOL CHEM, V273, P1216, DOI 10.1074/jbc.273.2.1216	76	47	53	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					41480	41488		10.1074/jbc.M207695200	http://dx.doi.org/10.1074/jbc.M207695200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12194986	hybrid			2022-12-27	WOS:000178985300025
J	Brackertz, M; Boeke, J; Zhang, R; Renkawitz, R				Brackertz, M; Boeke, J; Zhang, R; Renkawitz, R			Two highly related p66 proteins comprise a new family of potent transcriptional repressors interacting with MBD2 and MBD3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CPG-BINDING-PROTEIN; DNA METHYLTRANSFERASE GENE; HISTONE DEACETYLASE; METHYLATED DNA; IMMUNODEFICIENCY SYNDROME; FRAGILE-X; COMPLEX; CHROMATIN; MECP2; INSTABILITY	Methyl-CpG-binding domain proteins (MBD) mediate functional responses of methylated DNA. MBD2 and MBD3 are components of the MeCP1 protein complex, which contains the Mi-2/NuRD complex and includes 66 and 68-kDa polypeptides. Here we identified two highly related 66-kDa proteins in a yeast two-hybrid screen with MBD2b. Based on the high degree of sequence conservation to the previously identified Xenopus p66 subunit of the Mi-2/NuRD complex, we termed these proteins hp66alpha and hp66beta. hp66alpha is the human orthologue of Xenopus p66, whereas hp66beta, previously identified as a component of the human MeCP1 complex, is a second member of a p66 gene family. Coprecipitation of hp66alpha and MBD2 demonstrates their in vivo association. Furthermore, confocal microscopy shows a nuclear colocalization of hp66alpha with hp66beta and MBD2 in a speckled pattern. hp66alpha is a potent transcriptional repressor reducing gene activity about 100-fold and is ubiquitously coexpressed with hp66beta in cell lines and in fetal and adult tissues. We demonstrate direct binding of both p66 family members to MBD2 as well as MBD3. Interestingly, hp66alpha, which binds with a higher affinity than hp66beta, interacts via two interaction domains in contrast to a single interaction domain present in hp66beta. These results demonstrate that two highly related mammalian p66 proteins display overlapping functions and are involved in methylation dependent transcriptional repression.	Univ Giessen, Genet Inst, D-35392 Giessen, Germany	Justus Liebig University Giessen	Renkawitz, R (corresponding author), Univ Giessen, Genet Inst, Heinrich Buff Ring 58-62, D-35392 Giessen, Germany.							Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Ballestar E, 2001, EUR J BIOCHEM, V268, P5397, DOI 10.1046/j.0014-2956.2001.02480.x; Baylin SB, 1998, ADV CANCER RES, V72, P141; Bhattacharya SK, 1999, NATURE, V397, P579, DOI 10.1038/17533; Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9; Boeke J, 2000, J BIOL CHEM, V275, P34963, DOI 10.1074/jbc.M005929200; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Feng Q, 2002, MOL CELL BIOL, V22, P536, DOI 10.1128/MCB.22.2.536-546.2002; Feng Q, 2001, GENE DEV, V15, P827; Fujita N, 2000, MOL CELL BIOL, V20, P5107, DOI 10.1128/MCB.20.14.5107-5118.2000; Hansen RS, 1999, P NATL ACAD SCI USA, V96, P14412, DOI 10.1073/pnas.96.25.14412; Hassig CA, 1997, CELL, V89, P341, DOI 10.1016/S0092-8674(00)80214-7; Heard E, 1997, ANNU REV GENET, V31, P571, DOI 10.1146/annurev.genet.31.1.571; Heinzel T, 1997, NATURE, V387, P43, DOI 10.1038/387043a0; Hendrich B, 1998, MOL CELL BIOL, V18, P6538, DOI 10.1128/MCB.18.11.6538; Hendrich B, 2001, GENE DEV, V15, P710, DOI 10.1101/gad.194101; HOLLENBERG SM, 1995, MOL CELL BIOL, V15, P3813; Jaenisch R, 1997, TRENDS GENET, V13, P323, DOI 10.1016/S0168-9525(97)01180-3; Jones PA, 1999, NAT GENET, V21, P163, DOI 10.1038/5947; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Kaludov NK, 2000, NUCLEIC ACIDS RES, V28, P1921, DOI 10.1093/nar/28.9.1921; KREMER EJ, 1991, SCIENCE, V252, P1711, DOI 10.1126/science.1675488; Luo JY, 2000, NATURE, V408, P377, DOI 10.1038/35042612; Nakao M, 2001, GENE, V278, P25, DOI 10.1016/S0378-1119(01)00721-1; Nan XS, 1997, CELL, V88, P471, DOI 10.1016/S0092-8674(00)81887-5; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Sekimata M, 2001, J BIOL CHEM, V276, P42632, DOI 10.1074/jbc.M107048200; STANDKE GJR, 1994, MOL ENDOCRINOL, V8, P469, DOI 10.1210/me.8.4.469; Tatematsu K, 2000, GENES CELLS, V5, P677, DOI 10.1046/j.1365-2443.2000.00359.x; TOH Y, 1995, GENE, V159, P97, DOI 10.1016/0378-1119(94)00410-T; Tong JK, 1998, NATURE, V395, P917, DOI 10.1038/27699; Tsai RYL, 1997, BIOTECHNIQUES, V23, P794, DOI 10.2144/97235bm06; Wade PA, 1999, NAT GENET, V23, P62, DOI 10.1038/12664; Xu GL, 1999, NATURE, V402, P187, DOI 10.1038/46052; Xue YT, 1998, MOL CELL, V2, P851, DOI 10.1016/S1097-2765(00)80299-3; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924	38	67	71	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 25	2002	277	43					40958	40966		10.1074/jbc.M207467200	http://dx.doi.org/10.1074/jbc.M207467200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	607KU	12183469	hybrid			2022-12-27	WOS:000178791400103
J	Rosmann, S; Hahn, D; Lottaz, D; Kruse, MN; Stocker, W; Sterchi, EE				Rosmann, S; Hahn, D; Lottaz, D; Kruse, MN; Stocker, W; Sterchi, EE			Activation of human meprin-alpha in a cell culture model of colorectal cancer is triggered by the plasminogen-activating system	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINOBENZOIC ACID HYDROLASE; NON-PANCREATIC HYDROLYSIS; PLASMA-MEMBRANE PROTEINS; SINGLE-CHAIN UROKINASE; HUMAN SMALL-INTESTINE; HUMAN COLON-CANCER; EPITHELIAL-CELLS; PABA-PEPTIDE; BETA-SUBUNIT; CACO-2 CELLS	The activation of latent proenzymes is an important mechanism for the regulation of localized proteolytic activity. Human meprin-alpha, an astacin-like zinc metalloprotease expressed in normal colon epithelial cells, is secreted as a zymogen into the intestinal lumen. Here, meprin is activated after propeptide cleavage by trypsin. In contrast, colorectal cancer cells secrete meprin-a in a non-polarized way, leading to accumulation and increased activity of meprin-alpha in the tumor stroma. We have analyzed the activation mechanism of promeprin-alpha in colorectal cancer using a co-culture model of the intestinal mucosa composed of colorectal adenocarcinoma cells (Caco-2) cultivated on filter supports and intestinal fibroblasts grown in the companion dish. We provide evidence that meprin-a is activated by plasmin and show that the presence of plasminogen in the basolateral compartment of the co-cultures is sufficient for promeprin-alpha activation. Analysis of the plasminogen-activating system in the co-cultures revealed that plasminogen activators produced and secreted by fibroblasts converted plasminogen to active plasmin, which in turn generated active meprin-alpha. This activation mechanism offers an explanation for the observed meprin-a activity in the tumor stroma, a prerequisite for a potential role of this protease in colorectal cancer.	Univ Bern, Inst Biochem & Mol Biol, CH-3012 Bern, Switzerland; Univ Bern, Dept Pediat, CH-3012 Bern, Switzerland; Univ Munster, Inst Zoophysiol, D-48143 Munster, Germany	University of Bern; University of Bern; University of Munster	Sterchi, EE (corresponding author), Univ Bern, Inst Biochem & Mol Biol, Buhlstr 28, CH-3012 Bern, Switzerland.	erwin.sterchi@mci.unibe.ch	Stöcker, Walter/AAB-9704-2019	Stöcker, Walter/0000-0002-1515-6994				Andreasen PA, 1997, INT J CANCER, V72, P1, DOI 10.1002/(SICI)1097-0215(19970703)72:1<1::AID-IJC1>3.0.CO;2-Z; Andreasen PA, 2000, CELL MOL LIFE SCI, V57, P25, DOI 10.1007/s000180050497; Bertenshaw GP, 2001, J BIOL CHEM, V276, P13248, DOI 10.1074/jbc.M011414200; BEYNON RJ, 1981, BIOCHEM J, V199, P591, DOI 10.1042/bj1990591; BODE W, 1992, NATURE, V358, P164, DOI 10.1038/358164a0; BOND JS, 1995, PROTEIN SCI, V4, P1247, DOI 10.1002/pro.5560040701; BUO L, 1993, APMIS, V101, P235, DOI 10.1111/j.1699-0463.1993.tb00106.x; BURTIN P, 1985, INT J CANCER, V35, P307, DOI 10.1002/ijc.2910350305; Chestukhin A, 1997, J BIOL CHEM, V272, P3153, DOI 10.1074/jbc.272.6.3153; Choi NS, 2000, ANAL BIOCHEM, V281, P236, DOI 10.1006/abio.2000.4572; CUBELLIS MV, 1990, EMBO J, V9, P1079, DOI 10.1002/j.1460-2075.1990.tb08213.x; CZERNICHOW B, 1989, INT J CANCER, V44, P238, DOI 10.1002/ijc.2910440209; DAHLQVIST A, 1984, SCAND J CLIN LAB INV, V44, P169, DOI 10.3109/00365518409161400; Darmoul D, 2001, BRIT J CANCER, V85, P772, DOI 10.1054/bjoc.2001.1976; de Both NJ, 1999, BRIT J CANCER, V81, P934, DOI 10.1038/sj.bjc.6690790; Ducroc R, 2002, LIFE SCI, V70, P1359, DOI 10.1016/S0024-3205(01)01519-3; DUMERMUTH E, 1993, FEBS LETT, V335, P367, DOI 10.1016/0014-5793(93)80421-P; DUMERMUTH E, 1991, J BIOL CHEM, V266, P21381; Eldering JA, 1997, EUR J BIOCHEM, V247, P920, DOI 10.1111/j.1432-1033.1997.00920.x; Engle MJ, 1998, J CELL PHYSIOL, V174, P362, DOI 10.1002/(SICI)1097-4652(199803)174:3<362::AID-JCP10>3.0.CO;2-B; Ginestra A, 1997, J BIOL CHEM, V272, P17216, DOI 10.1074/jbc.272.27.17216; Goldfinger LE, 1998, J CELL BIOL, V141, P255, DOI 10.1083/jcb.141.1.255; GRONDAHLHANSEN J, 1991, AM J PATHOL, V138, P111; GRUNBERG J, 1993, FEBS LETT, V335, P376, DOI 10.1016/0014-5793(93)80422-Q; Hahn D, 1997, EUR J BIOCHEM, V247, P933, DOI 10.1111/j.1432-1033.1997.00933.x; Hansen TP, 1999, APMIS, V107, P689, DOI 10.1111/j.1699-0463.1999.tb01461.x; Harvey SR, 1999, AM J PATHOL, V155, P1115, DOI 10.1016/S0002-9440(10)65214-5; HE CS, 1989, P NATL ACAD SCI USA, V86, P2632, DOI 10.1073/pnas.86.8.2632; HIGAZI AA, 1995, J BIOL CHEM, V270, P17375, DOI 10.1074/jbc.270.29.17375; Ishmael FT, 2001, J BIOL CHEM, V276, P23207, DOI 10.1074/jbc.M102654200; JOHNSON GD, 1994, J BIOL CHEM, V269, P7682; Johnson GD, 1997, J BIOL CHEM, V272, P28126, DOI 10.1074/jbc.272.44.28126; KAUSHAL GP, 1994, J CELL BIOL, V126, P1319, DOI 10.1083/jcb.126.5.1319; KENNY AJ, 1987, BIOCHEM J, V245, P515, DOI 10.1042/bj2450515; Kohler D, 2000, FEBS LETT, V465, P2, DOI 10.1016/S0014-5793(99)01712-3; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEBIVIC A, 1990, J CELL BIOL, V111, P1351, DOI 10.1083/jcb.111.4.1351; Lottaz D, 1999, CANCER RES, V59, P1127; Lottaz D, 1999, EUR J BIOCHEM, V259, P496, DOI 10.1046/j.1432-1327.1999.00071.x; MACKAY AR, 1990, CANCER RES, V50, P5997; MARCHAND P, 1994, J BIOL CHEM, V269, P15388; MARCHAND P, 1995, J BIOL CHEM, V270, P5449, DOI 10.1074/jbc.270.10.5449; Mariadason JM, 2000, J CELL PHYSIOL, V183, P347, DOI 10.1002/(SICI)1097-4652(200006)183:3<347::AID-JCP7>3.0.CO;2-W; MATTER K, 1990, CELL, V60, P429, DOI 10.1016/0092-8674(90)90594-5; Matters GL, 1999, MOL CARCINOGEN, V25, P169, DOI 10.1002/(SICI)1098-2744(199907)25:3<169::AID-MC3>3.0.CO;2-Y; MIGNATTI P, 1993, PHYSIOL REV, V73, P161, DOI 10.1152/physrev.1993.73.1.161; Miller HRP, 2002, IMMUNOLOGY, V105, P375, DOI 10.1046/j.1365-2567.2002.01375.x; Pandrea IV, 2000, EXP MOL PATHOL, V69, P37, DOI 10.1006/exmp.2000.2309; PANNELL R, 1987, BLOOD, V69, P22; PETERSEN LC, 1988, J BIOL CHEM, V263, P11189; POLLANEN J, 1991, ADV CANCER RES, V57, P273; PYKE C, 1994, HISTOPATHOLOGY, V24, P131, DOI 10.1111/j.1365-2559.1994.tb01291.x; QUAX PHA, 1990, CANCER RES, V50, P1488; RAGNO P, 1992, EXP CELL RES, V203, P236, DOI 10.1016/0014-4827(92)90060-L; REAL FX, 1992, INT J CANCER, V51, P173, DOI 10.1002/ijc.2910510203; Rothen-Rutishauser B, 2000, PHARMACEUT RES, V17, P460, DOI 10.1023/A:1007585105753; Satomi S, 2001, BIOCHEM BIOPH RES CO, V287, P995, DOI 10.1006/bbrc.2001.5686; STERCHI EE, 1988, ARCH BIOCHEM BIOPHYS, V265, P105, DOI 10.1016/0003-9861(88)90376-1; STERCHI EE, 1983, J PEDIATR GASTR NUTR, V2, P539, DOI 10.1097/00005176-198302030-00024; STERCHI EE, 1982, CLIN SCI, V62, P557, DOI 10.1042/cs0620557; STOCKER W, 1995, PROTEIN SCI, V4, P823; STOPPELLI MP, 1986, CELL, V45, P675, DOI 10.1016/0092-8674(86)90782-8; VASSALLI JD, 1991, J CLIN INVEST, V88, P1067, DOI 10.1172/JCI115405; VOGEL LK, 1995, J BIOL CHEM, V270, P22933, DOI 10.1074/jbc.270.39.22933; Walker PD, 1998, KIDNEY INT, V53, P1673, DOI 10.1046/j.1523-1755.1998.00949.x; Williams SJ, 2001, INT J CANCER, V93, P67, DOI 10.1002/ijc.1304; Wilson AJ, 2000, GUT, V47, P105, DOI 10.1136/gut.47.1.105; Yang JL, 2000, INT J CANCER, V89, P431, DOI 10.1002/1097-0215(20000920)89:5<431::AID-IJC6>3.0.CO;2-V; ZWEIBAUM A, 1984, INT J CANCER, V34, P591, DOI 10.1002/ijc.2910340502; ZWEIBAUM A, 1983, INT J CANCER, V32, P407, DOI 10.1002/ijc.2910320403	70	48	50	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2002	277	43					40650	40658		10.1074/jbc.M206203200	http://dx.doi.org/10.1074/jbc.M206203200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	607KU	12189145	hybrid			2022-12-27	WOS:000178791400064
J	Santy, LC				Santy, LC			Characterization of a fast cycling ADP-ribosylation factor 6 mutant	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING PROTEINS; COP-COATED VESICLES; ACTIN CYTOSKELETON; EXCHANGE FACTOR; NUCLEOTIDE EXCHANGE; BINDING PROTEIN; PLASMA-MEMBRANE; ARF6 GTPASE; DOMAIN; ARNO	Studies of GTPase function often employ expression of dominant negative or constitutively active mutants. Dominant negative mutants cannot bind GTP and thus cannot be activated. Constitutively active mutants cannot hydrolyze GTP and therefore accumulate a large pool of GTP-bound GTPase. These mutations block the normal cycle of GTP binding, hydrolysis, and release. Therefore, although the GTPase-deficient mutants are in the active conformation, they do not fully imitate all the actions of the GTPase. This is particularly true for the ADP-ribosylation factors (ARFs), GTPases that regulate vesicular trafficking events. In Ras and Rho GTPases replacement of phenylalanine 28 with a leucine residue produces a "fast cycling" mutant that can undergo spontaneous GTP-GDP exchange and retains the ability to hydrolyze GTP. Unfortunately this phenylalanine residue is not conserved in the ARF family of GTPases. Here we report the design and characterization of a novel activated mutant of ARF6, ARF6 T157A. In vitro studies show that ARF6 T157A can spontaneously bind and release GTP more quickly than the wildtype protein suggesting that it is a fast cycling mutant. This mutant has enhanced activity in vivo and induces cortical actin rearrangements in HeLa cells and enhanced motility in Madin-Darby canine kidney cells.	Univ Virginia, Dept Cell Biol, Hlth Sci Ctr, Charlottesville, VA 22908 USA	University of Virginia	Santy, LC (corresponding author), Univ Virginia, Dept Cell Biol, Hlth Sci Ctr, POB 800732, Charlottesville, VA 22908 USA.			Santy, Lorraine/0000-0002-4795-0738	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI032991] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK009924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066251] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI 32991] Funding Source: Medline; NIDDK NIH HHS [F32 DK 09924] Funding Source: Medline; NIGMS NIH HHS [R01 GM 66251] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Altschuler Y, 1999, J CELL BIOL, V147, P7, DOI 10.1083/jcb.147.1.7; AMOR JC, 1994, NATURE, V372, P704, DOI 10.1038/372704a0; Boshans RL, 2000, MOL CELL BIOL, V20, P3685, DOI 10.1128/MCB.20.10.3685-3694.2000; Brown FD, 2001, J CELL BIOL, V154, P1007, DOI 10.1083/jcb.200103107; Campbell SL, 1998, ONCOGENE, V17, P1395, DOI 10.1038/sj.onc.1202174; Chardin P, 1996, NATURE, V384, P481, DOI 10.1038/384481a0; Chavrier P, 1999, CURR OPIN CELL BIOL, V11, P466, DOI 10.1016/S0955-0674(99)80067-2; D'Souza-Schorey C, 1997, EMBO J, V16, P5445, DOI 10.1093/emboj/16.17.5445; D'Souza-Schorey C, 1998, J CELL BIOL, V140, P603, DOI 10.1083/jcb.140.3.603; D'SOUZA-SCHOREY C, 1995, SCIENCE, V267, P1175, DOI 10.1126/science.7855600; DASCHER C, 1994, J BIOL CHEM, V269, P1437; DONALDSON JG, 1992, P NATL ACAD SCI USA, V89, P6408, DOI 10.1073/pnas.89.14.6408; Franco M, 1999, EMBO J, V18, P1480, DOI 10.1093/emboj/18.6.1480; Frank SR, 1998, MOL BIOL CELL, V9, P3133, DOI 10.1091/mbc.9.11.3133; GREASLEY SE, 1995, NAT STRUCT BIOL, V2, P797, DOI 10.1038/nsb0995-797; Jackson TR, 2000, J CELL BIOL, V151, P627, DOI 10.1083/jcb.151.3.627; KAHN RA, 1995, J BIOL CHEM, V270, P143, DOI 10.1074/jbc.270.1.143; Lin R, 1999, J BIOL CHEM, V274, P23633, DOI 10.1074/jbc.274.33.23633; Lin R, 1997, CURR BIOL, V7, P794, DOI 10.1016/S0960-9822(06)00338-1; PAI EF, 1989, NATURE, V341, P209, DOI 10.1038/341209a0; PETERS PJ, 1995, J CELL BIOL, V128, P1003, DOI 10.1083/jcb.128.6.1003; Radhakrishna H, 1996, J CELL BIOL, V134, P935, DOI 10.1083/jcb.134.4.935; Radhakrishna H, 1999, J CELL SCI, V112, P855; Radhakrishna H, 1997, J CELL BIOL, V139, P49, DOI 10.1083/jcb.139.1.49; Randazzo PA, 2001, METHOD ENZYMOL, V329, P343; REINSTEIN J, 1991, J BIOL CHEM, V266, P17700; Santy LC, 2001, J CELL BIOL, V154, P599, DOI 10.1083/jcb.200104019; Santy LC, 1999, CURR BIOL, V9, P1173, DOI 10.1016/S0960-9822(00)80019-6; SCHLICHTING I, 1990, BIOCHEMISTRY-US, V29, P504, DOI 10.1021/bi00454a026; SERAFINI T, 1991, CELL, V67, P239, DOI 10.1016/0092-8674(91)90176-Y; TANIGAWA G, 1993, J CELL BIOL, V123, P1365, DOI 10.1083/jcb.123.6.1365; ZHANG CJ, 1994, J CELL BIOL, V124, P289, DOI 10.1083/jcb.124.3.289; Zhang Q, 1999, MOL CELL BIOL, V19, P8158	33	46	46	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 25	2002	277	43					40185	40188		10.1074/jbc.C200481200	http://dx.doi.org/10.1074/jbc.C200481200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	607KU	12218044	hybrid			2022-12-27	WOS:000178791400005
J	Grant, GA; Hu, ZQ; Xu, XL				Grant, GA; Hu, ZQ; Xu, XL			Cofactor binding to Escherichia coli D-3-phosphoglycerate dehydrogenase induces multiple conformations which alter effector binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MODULATED ALLOSTERIC REGULATION; END PRODUCT INHIBITION; DOMAIN INTERFACE; SERINE BIOSYNTHESIS; SERA GENE; MECHANISM; COOPERATIVITY; PURIFICATION; NUCLEOTIDE; SEQUENCE	The inhibition of Escherichia coli D-3-phosphoglycerate dehydrogenase by L-serine is positively cooperative with a Hill coefficient of similar to2, whereas the binding of the inhibitor, L-serine, to the apoenzyme displays positive cooperativity in the binding of the first two serine molecules and negative cooperativity in the binding of the last two serine molecules. An earlier report demonstrated that the presence of phosphate appeared to lessen the degree of both the positive and negative cooperativity, but the cause of this effect was unknown. This study demonstrates that the presence of intrinsically bound NADH was responsible to a substantial degree for this effect. In addition, this study also provides evidence for negative cooperativity in NADH binding and for at least two NADH-induced conformational forms of the enzyme that bind the inhibitor in the physiological range. Successive binding of NADH to the enzyme resulted in an increase in the affinity for the first inhibitor ligand bound and a lessening of both the positive and negative cooperativity of inhibitor binding as compared with that seen in the absence of NADH. This effect was specific for NADH and was not observed in the presence of NAD(+) or the substrate alpha-ketoglutarate. Conversely, the binding Of L-serine did not have a significant effect on the stoichiometry of NADH binding, consistent with it being a V-type allosteric system. Thus, cofactor-related conditions were found in equilibrium binding experiments that significantly altered the cooperativity of inhibitor binding. Since the result of inhibitor binding is a reduction in the catalytic activity, the binding of inhibitor to these NADH-induced conformers must also induce additional conformations that lead to differential inhibition of catalytic activity.	Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Grant, GA (corresponding author), Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, Box 8103,660 S Euclid Ave, St Louis, MO 63110 USA.	ggrant@pcg.wustl.edu			NIGMS NIH HHS [GM 56676] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056676] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AlRabiee R, 1996, J BIOL CHEM, V271, P23235, DOI 10.1074/jbc.271.38.23235; AlRabiee R, 1996, J BIOL CHEM, V271, P13013, DOI 10.1074/jbc.271.22.13013; CONWAY A, 1968, BIOCHEMISTRY-US, V7, P4011, DOI 10.1021/bi00851a031; DUBROW R, 1977, J BIOL CHEM, V252, P1527; Grant GA, 2000, BIOCHEMISTRY-US, V39, P7316, DOI 10.1021/bi000218y; Grant GA, 1999, PROTEIN SCI, V8, P2501; Grant GA, 1996, PROTEIN SCI, V5, P34; Grant GA, 2001, J BIOL CHEM, V276, P17844, DOI 10.1074/jbc.M009957200; Grant GA, 1998, J BIOL CHEM, V273, P22389, DOI 10.1074/jbc.273.35.22389; Grant GA, 2001, J BIOL CHEM, V276, P1078, DOI 10.1074/jbc.M007512200; GRANT GA, BIOCHEMISTRY, V38, P16548; HORECKER BL, 1948, J BIOL CHEM, V175, P385; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; SCHULLER DJ, 1995, NAT STRUCT BIOL, V2, P69, DOI 10.1038/nsb0195-69; SCHULLER DJ, 1989, J BIOL CHEM, V264, P2645; SUGIMOTO E, 1968, J BIOL CHEM, V243, P2090; SUGIMOTO E, 1968, J BIOL CHEM, V243, P2081; TOBEY KL, 1986, J BIOL CHEM, V261, P2179; WINZOR DJ, 1995, QUANTITATIVE CHARACT, P31; Zhao GS, 1996, J BACTERIOL, V178, P232, DOI 10.1128/jb.178.1.232-239.1996	21	18	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2002	277	42					39548	39553		10.1074/jbc.M208019200	http://dx.doi.org/10.1074/jbc.M208019200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	605EA	12183470	hybrid			2022-12-27	WOS:000178662500064
J	Barazi, HO; Li, ZQ; Cashel, JA; Krutzsch, HC; Annis, DS; Mosher, DF; Roberts, DD				Barazi, HO; Li, ZQ; Cashel, JA; Krutzsch, HC; Annis, DS; Mosher, DF; Roberts, DD			Regulation of integrin function by CD47 ligands - Differential effects on alpha(v)beta(3) and alpha(4)beta(1) integrin-mediated adhesion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-BINDING DOMAIN; PROTEIN CD47; T-CELLS; ALPHA(3)BETA(1) INTEGRIN; SIGNALING PATHWAY; PLASMA-MEMBRANE; RECEPTOR; THROMBOSPONDIN-1; ACTIVATION; IDENTIFICATION	We examined the regulation of alpha(4)beta(1) integrin function in melanoma cells and T cells by ligands of CD47. A CD47 antibody (B6H12) that inhibited alpha(v)beta(3)-mediated adhesion of melanoma cells induced by CD47-binding peptides from thrombospondin-1 directly stimulated alpha(4)beta(1)-mediated adhesion of the same cells to vascular cell adhesion molecule-1 and N-terminal regions of thrombospondin-1 or thrombospondin-2. B6H12 also stimulated alpha(4)beta(1)- as well as alpha(2)beta(1)- and alpha(5)beta(1)-mediated adhesion of CD47-expressing T cells but not of CD47-deficient T cells. alpha(4)beta(1) and CD47 co-purified as a detergent-stable complex on a CD47 antibody affinity column. CD47-binding peptides based on C-terminal sequences of thrombospondin-1 also, specifically enhanced adhesion of melanoma cells and T cells to alpha(4)beta(1) ligands. Unexpectedly, activation of alpha(4)beta(1) function by the thrombospondin-1 CD47-hinding peptides also occurred in CD47-deficient T cells. CD47-independent activation of alpha(4)beta(1), required the Val-Val-Met (VVM) motif of the peptides and was sensitive to inhibition by pertussis toxin. These results indicate that activation of alpha(4)beta(1), by the CD47 antibody B6H12 and by VVM peptides occurs by different mechanisms. The antibody directly activates a CD47-alpha(4)beta(1) complex, whereas VVM peptides may target an unidentified G(i)-linked receptor that regulates alpha(4)beta(1).	NCI, Pathol Lab, NIH, Bethesda, MD 20892 USA; Univ Wisconsin, Dept Med, Madison, WI 53706 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Wisconsin System; University of Wisconsin Madison	Roberts, DD (corresponding author), NCI, Pathol Lab, NIH, Bldg 10,Rm 2A33,10 Ctr Dr,MSC 1500, Bethesda, MD 20892 USA.		Roberts, David D./A-9699-2008	Roberts, David D./0000-0002-2481-2981				Abitorabi MA, 1997, J CELL BIOL, V139, P563, DOI 10.1083/jcb.139.2.563; AKIYAMA SK, 1985, J BIOL CHEM, V260, P4492; Avice MN, 2000, J IMMUNOL, V165, P4624, DOI 10.4049/jimmunol.165.8.4624; Babic I, 2000, J IMMUNOL, V164, P3652, DOI 10.4049/jimmunol.164.7.3652; BEDNARCZYK JL, 1992, J BIOL CHEM, V267, P25274; BROWN E, 1990, J CELL BIOL, V111, P2785, DOI 10.1083/jcb.111.6.2785; Brown EJ, 2001, TRENDS CELL BIOL, V11, P130, DOI 10.1016/S0962-8924(00)01906-1; Chandrasekaran S, 1999, J BIOL CHEM, V274, P11408, DOI 10.1074/jbc.274.16.11408; Chung J, 1997, J BIOL CHEM, V272, P14740, DOI 10.1074/jbc.272.23.14740; Erb L, 2001, J CELL BIOL, V153, P491, DOI 10.1083/jcb.153.3.491; Frazier WA, 1999, J BIOL CHEM, V274, P8554, DOI 10.1074/jbc.274.13.8554; Gao AG, 1996, J BIOL CHEM, V271, P21, DOI 10.1074/jbc.271.1.21; Gao AG, 1996, J CELL BIOL, V135, P533, DOI 10.1083/jcb.135.2.533; GAO AG, 1994, J BIOL CHEM, V269, P29650; Green JM, 1999, J CELL BIOL, V146, P673, DOI 10.1083/jcb.146.3.673; Green JM, 1997, J CELL BIOL, V139, P1209, DOI 10.1083/jcb.139.5.1209; Han X, 2000, J BIOL CHEM, V275, P37984, DOI 10.1074/jbc.M002334200; Imhof BA, 1997, EUR J IMMUNOL, V27, P3242, DOI 10.1002/eji.1830271223; Keenan RM, 1997, J MED CHEM, V40, P2289, DOI 10.1021/jm970205r; KOSFELD MD, 1993, J BIOL CHEM, V268, P8808; Krutzsch HC, 1999, J BIOL CHEM, V274, P24080, DOI 10.1074/jbc.274.34.24080; Leitinger B, 2002, J CELL SCI, V115, P963; Li ZQ, 2002, J CELL BIOL, V157, P509, DOI 10.1083/jcb.200109098; Li ZQ, 2001, J IMMUNOL, V166, P2427, DOI 10.4049/jimmunol.166.4.2427; Lin KC, 1999, J MED CHEM, V42, P920, DOI 10.1021/jm980673g; Lindberg FP, 1996, J CELL BIOL, V134, P1313, DOI 10.1083/jcb.134.5.1313; Lindberg FP, 1996, SCIENCE, V274, P795, DOI 10.1126/science.274.5288.795; Liu Y, 2001, J BIOL CHEM, V276, P40156, DOI 10.1074/jbc.M104138200; Maile LA, 2002, J BIOL CHEM, V277, P1800, DOI 10.1074/jbc.M108380200; Misenheimer TM, 2000, J BIOL CHEM, V275, P40938, DOI 10.1074/jbc.M007022200; Mould AP, 1996, J BIOL CHEM, V271, P20365, DOI 10.1074/jbc.271.34.20365; Oldenborg PA, 2000, SCIENCE, V288, P2051, DOI 10.1126/science.288.5473.2051; Palecek SP, 1998, J CELL SCI, V111, P929; Palecek SP, 1997, NATURE, V385, P537, DOI 10.1038/385537a0; Pettersen RD, 1999, J IMMUNOL, V162, P7031; Rebres RA, 2001, J BIOL CHEM, V276, P7672, DOI 10.1074/jbc.M008858200; Reinhold MI, 1997, J EXP MED, V185, P1, DOI 10.1084/jem.185.1.1; Roberts David D., 1994, Journal of Tissue Culture Methods, V16, P217, DOI 10.1007/BF01540654; Rubinstein E, 1997, EUR J IMMUNOL, V27, P1919, DOI 10.1002/eji.1830270815; Seiffert M, 1999, BLOOD, V94, P3633, DOI 10.1182/blood.V94.11.3633.423k01_3633_3643; Seiffert M, 2001, BLOOD, V97, P2741, DOI 10.1182/blood.V97.9.2741; Sipes JM, 1999, J BIOL CHEM, V274, P22755, DOI 10.1074/jbc.274.32.22755; Ticchioni M, 1997, J IMMUNOL, V158, P677; Ticchioni M, 2001, FASEB J, V15, P341, DOI 10.1096/fj.99-0833com; Tulasne D, 2001, BLOOD, V98, P3346, DOI 10.1182/blood.V98.12.3346; VOGEL T, 1993, ARCH BIOCHEM BIOPHYS, V300, P501, DOI 10.1006/abbi.1993.1068; Waclavicek M, 1997, J IMMUNOL, V159, P5345; Wang XQ, 1999, J CELL BIOL, V147, P389, DOI 10.1083/jcb.147.2.389; Wang XQ, 1998, MOL BIOL CELL, V9, P865, DOI 10.1091/mbc.9.4.865; Wilson KE, 1999, J IMMUNOL, V163, P3621; Wu AL, 1999, MOL CELL, V4, P619, DOI 10.1016/S1097-2765(00)80212-9; Yauch RL, 2000, J BIOL CHEM, V275, P9230, DOI 10.1074/jbc.275.13.9230	52	65	69	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					42859	42866		10.1074/jbc.M206849200	http://dx.doi.org/10.1074/jbc.M206849200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12218055	hybrid			2022-12-27	WOS:000179081200058
J	Kayyali, US; Pennella, CM; Trujillo, C; Villa, O; Gaestel, M; Hassoun, PM				Kayyali, US; Pennella, CM; Trujillo, C; Villa, O; Gaestel, M; Hassoun, PM			Cytoskeletal changes in hypoxic pulmonary endothelial cells are dependent on MAPK-activated protein kinase MK2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEINS; ACTIN POLYMERIZATION; MOLECULAR MECHANISMS; MESSENGER-RNA; STRESS; PHOSPHORYLATION; EXPRESSION; PATHWAY; PROTEIN-KINASE-2; PERMEABILITY	Exposure to hypoxia causes structural changes in the endothelial cell layer that alter its permeability and its interaction with leukocytes and platelets. One of the well characterized cytoskeletal changes in response to stress involves the reorganization of the actin cytoskeleton and the formation of stress fibers. This report describes cytoskeletal changes in pulmonary microvascular endothelial cells in response to hypoxia and potential mechanisms involved in this process. The hypoxia-induced actin redistribution appears to be mediated by components downstream of MAPK p38, which is activated in pulmonary endothelial cells in response to hypoxia. Our results indicate that kinase MM, which is a substrate of p38, becomes activated by hypoxia, leading to the phosphorylation of one of its substrates, HSP27. Because HSP27 phosphorylation is known to alter actin distribution in response to other stimuli, we postulate that it also causes the actin redistribution observed in hypoxia. This notion is supported by the observations that similar actin redistribution occurs in cells overexpressing constitutively active MK2 or phosphomimicking HSP27 mutant. Overexpressing dominant negative MK2 blocks the effects of hypoxia on the actin cytoskeleton. Taken together these results indicate that hypoxia stimulates the p38-MK2-HSP27 pathway leading to significant alteration in the actin cytoskeleton.	Tufts New England Med Ctr, Div Pulm & Crit Care, Tupper Res Inst, Dept Med, Boston, MA 02111 USA; Tufts Univ, Sch Med, Boston, MA 02111 USA; Hannover Med Sch, Inst Biochem, D-30625 Hannover, Germany	Tufts Medical Center; Tufts University; Hannover Medical School	Kayyali, US (corresponding author), Tufts New England Med Ctr, Div Pulm & Crit Care, Tupper Res Inst, Dept Med, 750 Washington St,257, Boston, MA 02111 USA.		Gaestel, Matthias/A-6560-2013	Gaestel, Matthias/0000-0002-4944-4652	NHLBI NIH HHS [HL49441] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL049441, R29HL049441] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aufricht C, 1998, AM J PHYSIOL-RENAL, V274, pF215, DOI 10.1152/ajprenal.1998.274.1.F215; BADESCH DB, 1989, AM J RESP CELL MOL, V1, P489, DOI 10.1165/ajrcmb/1.6.489; BENNDORF R, 1994, J BIOL CHEM, V269, P20780; Carini R, 2001, HEPATOLOGY, V33, P131, DOI 10.1053/jhep.2001.21050; Conrad PW, 2000, CELL SIGNAL, V12, P463, DOI 10.1016/S0898-6568(00)00091-7; Conrad PW, 1999, J BIOL CHEM, V274, P23570, DOI 10.1074/jbc.274.33.23570; Cote CG, 1996, AM J PHYSIOL-LUNG C, V271, pL869, DOI 10.1152/ajplung.1996.271.5.L869; Das M, 2001, J BIOL CHEM, V276, P15631, DOI 10.1074/jbc.M010690200; Ehrnsperger M, 1997, EMBO J, V16, P221, DOI 10.1093/emboj/16.2.221; ENGEL K, 1995, J BIOL CHEM, V270, P27213, DOI 10.1074/jbc.270.45.27213; Erukhimov JA, 2000, AM J RESP CRIT CARE, V162, P288, DOI 10.1164/ajrccm.162.1.9806088; Guillemin K, 1997, CELL, V89, P9, DOI 10.1016/S0092-8674(00)80176-2; Herlaar E, 1999, MOL MED TODAY, V5, P439, DOI 10.1016/S1357-4310(99)01544-0; Huot J, 1997, CIRC RES, V80, P383, DOI 10.1161/01.RES.80.3.383; Ichikawa H, 1997, CIRC RES, V81, P922; JAKOB U, 1993, J BIOL CHEM, V268, P1517; Kacimi R, 2000, CARDIOVASC RES, V46, P139, DOI 10.1016/S0008-6363(00)00007-9; Kayyali US, 2001, J BIOL CHEM, V276, P14359, DOI 10.1074/jbc.M010100200; KLEMENZ R, 1993, J CELL BIOL, V120, P639, DOI 10.1083/jcb.120.3.639; Kotlyarov A, 2002, MOL CELL BIOL, V22, P4827, DOI 10.1128/MCB.22.13.4827-4835.2002; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee JC, 2000, IMMUNOPHARMACOLOGY, V47, P185, DOI 10.1016/S0162-3109(00)00206-X; Liao JK, 1995, J CLIN INVEST, V96, P2661, DOI 10.1172/JCI118332; Marais E, 2001, J MOL CELL CARDIOL, V33, P769, DOI 10.1006/jmcc.2001.1347; O'Rourke JF, 1997, ONCOL RES, V9, P327; OGAWA S, 1990, ADV EXP MED BIOL, V281, P303; OGAWA S, 1992, AM J PHYSIOL, V262, pC546, DOI 10.1152/ajpcell.1992.262.3.C546; OGAWA S, 1990, J CLIN INVEST, V85, P1090, DOI 10.1172/JCI114540; PARTRIDGE CA, 1995, AM J PHYSIOL-LUNG C, V269, pL52, DOI 10.1152/ajplung.1995.269.1.L52; Pinsky DJ, 1996, J CLIN INVEST, V97, P493, DOI 10.1172/JCI118440; Pitt BR, 2002, AM J RESP CELL MOL, V26, P6, DOI 10.1165/ajrcmb.26.1.f224; Rogalla T, 1999, J BIOL CHEM, V274, P18947, DOI 10.1074/jbc.274.27.18947; ROUSSEAU EPM, 1983, J BIOMECH, V16, P339, DOI 10.1016/0021-9290(83)90017-9; Schneider GB, 1998, J CELL PHYSIOL, V177, P575, DOI 10.1002/(SICI)1097-4652(199812)177:4<575::AID-JCP8>3.0.CO;2-1; Seko Y, 1997, BIOCHEM BIOPH RES CO, V239, P840, DOI 10.1006/bbrc.1997.7570; SHREENIWAS R, 1992, J CLIN INVEST, V90, P2333, DOI 10.1172/JCI116122; SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0; STELZNER TJ, 1988, J CLIN INVEST, V82, P1840, DOI 10.1172/JCI113800; Stenmark KR, 1997, ANNU REV PHYSIOL, V59, P89, DOI 10.1146/annurev.physiol.59.1.89; Wakayama T, 1998, CELL BIOL INT, V22, P295, DOI 10.1006/cbir.1998.0252; WANG GL, 1993, J BIOL CHEM, V268, P21513; Welsh DJ, 2001, AM J RESP CRIT CARE, V164, P282, DOI 10.1164/ajrccm.164.2.2008054; Winzen R, 1999, EMBO J, V18, P4969, DOI 10.1093/emboj/18.18.4969; Zulueta JJ, 2002, AM J RESP CELL MOL, V26, P22, DOI 10.1165/ajrcmb.26.1.4510	44	95	102	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					42596	42602		10.1074/jbc.M205863200	http://dx.doi.org/10.1074/jbc.M205863200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12202485	hybrid			2022-12-27	WOS:000179081200023
J	Deka, RK; Machius, M; Norgard, MV; Tomchick, DR				Deka, RK; Machius, M; Norgard, MV; Tomchick, DR			Crystal structure of the 47-kDa lipoprotein of Treponema pallidum reveals a novel penicillin-binding protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; ELECTROSPRAY MASS-SPECTROMETRY; SITE-DIRECTED MUTAGENESIS; A BETA-LACTAMASES; ESCHERICHIA-COLI; ACTIVE-SITE; CARBOXYPEPTIDASE ACTIVITY; MEMBRANE-PROTEINS; OUTER-MEMBRANE; SUBSP PALLIDUM	Syphilis is a complex sexually transmitted disease caused by the spirochetal bacterium Treponema pallidum. T. pallidum has remained exquisitely sensitive to penicillin, but the mode of action and lethal targets for beta-lactams are still unknown. We previously identified the T. pallidum 47-kDa lipoprotein (Tp47) as a penicillin-binding protein (PBP). Tp47 contains three hypothetical consensus motifs (SVTK, TEN, and KTG) that typically form the active center of other PBPs. Yet, in this study, mutations of key amino acids within these motifs failed to abolish the penicillin binding activity of Tp47. The crystal structure of Tp47 at a resolution of 1.95 A revealed a fold different from any other known PBP; Tp47 is predominantly beta-sheet, in contrast to the alpha/beta-fold common to other PBPs. It comprises four distinct domains: two complex beta-sheet-containing N-terminal domains and two C-terminal domains that adopt immunoglobulin-like folds. The three hypothetical PBP signature motifs do not come together to form a typical PBP active site. Furthermore, Tp47 is unusual in that it displays beta-lactamase activity (k(cat) for penicillin = 271 +/- 6 s(-1)), a feature that hindered attempts to identify the active site in Tp47 by co-crystallization and mass spectrometric techniques. Taken together, Tp47 does not fit the classical structural and mechanistic paradigms for PBPs, and thus Tp47 appears to represent a new class of PBP.	Univ Texas, SW Med Ctr, Dept Microbiol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Norgard, MV (corresponding author), Univ Texas, SW Med Ctr, Dept Microbiol, 6000 Harry Hines Blvd, Dallas, TX 75390 USA.		Tomchick, Diana/HGV-2018-2022	Tomchick, Diana/0000-0002-7529-4643	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI016692] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-16692] Funding Source: Medline; PHS HHS [I-0940] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHAMBERLAIN NR, 1989, INFECT IMMUN, V57, P2872, DOI 10.1128/IAI.57.9.2872-2877.1989; COX DL, 1992, INFECT IMMUN, V60, P1076, DOI 10.1128/IAI.60.3.1076-1083.1992; CUNNINGHAM TM, 1987, J BACTERIOL, V169, P5298, DOI 10.1128/jb.169.11.5298-5300.1987; Davies C, 2001, J BIOL CHEM, V276, P616, DOI 10.1074/jbc.M004471200; Esnouf RM, 1999, ACTA CRYSTALLOGR D, V55, P938, DOI 10.1107/S0907444998017363; Fraser CM, 1998, SCIENCE, V281, P375, DOI 10.1126/science.281.5375.375; Gardina PJ, 1997, MOL MICROBIOL, V23, P1181, DOI 10.1046/j.1365-2958.1997.3001661.x; GHUYSEN JM, 1991, ANNU REV MICROBIOL, V45, P37, DOI 10.1146/annurev.mi.45.100191.000345; GHUYSEN JM, 1988, REV INFECT DIS, V10, P726; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Goffin C, 1998, MICROBIOL MOL BIOL R, V62, P1079, DOI 10.1128/MMBR.62.4.1079-1093.1998; HADONOU AM, 1992, EUR J BIOCHEM, V207, P97, DOI 10.1111/j.1432-1033.1992.tb17025.x; Hagedorn HJ, 2002, J CLIN MICROBIOL, V40, P973, DOI 10.1128/JCM.40.3.973-978.2002; HAYASHI S, 1988, J BACTERIOL, V170, P5392, DOI 10.1128/jb.170.11.5392-5395.1988; HAYASHI S, 1990, J BIOENERG BIOMEMBR, V22, P451, DOI 10.1007/BF00763177; HAYES NS, 1977, INFECT IMMUN, V17, P174, DOI 10.1128/IAI.17.1.174-186.1977; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Janin J, 1995, PROTEINS, V23, P580, DOI 10.1002/prot.340230413; JONES SA, 1984, J EXP MED, V160, P1404, DOI 10.1084/jem.160.5.1404; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KELLY JA, 1986, SCIENCE, V231, P1429, DOI 10.1126/science.3082007; Kelly JA, 1998, CELL MOL LIFE SCI, V54, P353, DOI 10.1007/s000180050163; Kerfeld CA, 1998, BIOCHEMISTRY-US, V37, P13911, DOI 10.1021/bi9810252; Lu WP, 1999, BIOCHEMISTRY-US, V38, P6537, DOI 10.1021/bi990025e; Luthy L, 2002, J BIOL CHEM, V277, P10187, DOI 10.1074/jbc.M108993200; MALHOTRA KT, 1992, J BIOL CHEM, V267, P11386; Massova I, 1998, ANTIMICROB AGENTS CH, V42, P1; Matagne A, 1998, BIOCHEM J, V330, P581, DOI 10.1042/bj3300581; MCPHERSON A, 1990, EUR J BIOCHEM, V189, P1, DOI 10.1111/j.1432-1033.1990.tb15454.x; Nelson DE, 2001, J BACTERIOL, V183, P3055, DOI 10.1128/JB.183.10.3055-3064.2001; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; NORGARD MV, 1983, INFECT IMMUN, V42, P435, DOI 10.1128/IAI.42.2.435-445.1983; NORGARD MV, 1986, INFECT IMMUN, V54, P500, DOI 10.1128/IAI.54.2.500-506.1986; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Ponstingl H, 2000, PROTEINS, V41, P47; RADOLF JD, 1989, INFECT IMMUN, V57, P1248, DOI 10.1128/IAI.57.4.1248-1254.1989; RADOLF JD, 1988, INFECT IMMUN, V56, P490, DOI 10.1128/IAI.56.2.490-498.1988; RADOLF JD, 1995, MOL MICROBIOL, V16, P1067, DOI 10.1111/j.1365-2958.1995.tb02332.x; SPRATT BG, 1988, REV INFECT DIS, V10, P699; SPRATT BG, 1975, P NATL ACAD SCI USA, V72, P2999, DOI 10.1073/pnas.72.8.2999; Sun YP, 1998, J MASS SPECTROM, V33, P1009, DOI 10.1002/(SICI)1096-9888(1998100)33:10<1009::AID-JMS717>3.0.CO;2-4; Turk B, 1997, BIOL CHEM, V378, P141; van Oers NSC, 2000, NAT IMMUNOL, V1, P322, DOI 10.1038/79774; VANDERLINDEN MPG, 1994, BIOCHEM J, V303, P357, DOI 10.1042/bj3030357; WEIGEL LM, 1994, P NATL ACAD SCI USA, V91, P11611, DOI 10.1073/pnas.91.24.11611; WEIGEL LM, 1994, ANTIMICROB AGENTS CH, V38, P330, DOI 10.1128/AAC.38.2.330; WEIGEL LM, 1992, INFECT IMMUN, V60, P1568, DOI 10.1128/IAI.60.4.1568-1576.1992; WEIGEL LM, 1994, THESIS U TEXAS; Yang Y, 2000, J BIOL CHEM, V275, P26674; ZREIN M, 1995, J CLIN MICROBIOL, V33, P525, DOI 10.1128/JCM.33.3.525-527.1995	52	41	52	3	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					41857	41864		10.1074/jbc.M207402200	http://dx.doi.org/10.1074/jbc.M207402200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12196546	hybrid			2022-12-27	WOS:000178985300072
J	Digits, JA; Pyun, HJ; Coates, RM; Casey, PJ				Digits, JA; Pyun, HJ; Coates, RM; Casey, PJ			Stereospecificity and kinetic mechanism of human prenylcysteine lyase, an unusual thioether oxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURONAL CEROID-LIPOFUSCINOSIS; PALMITOYL-PROTEIN THIOESTERASE; REDUCTIVE HALF-REACTION; FARNESYLCYSTEINE ANALOGS; SUBSTRATE-SPECIFICITY; MONOAMINE-OXIDASE; INHIBITION; CELLS; PURIFICATION; ENDOPROTEASE	Prenylated proteins contain either a 15-carbon farnesyl or a 20-carbon geranylgeranyl isoprenoid covalently attached to cysteine residues at or near their C terminus. The cellular abundance of prenylated proteins, as well as the stability of the thioether bond, poses a metabolic challenge to cells. A lysosomal enzyme termed prenylcysteine lyase has been identified that degrades a variety of prenylcysteines. Prenylcysteine lyase is a FAD-dependent thioether oxidase that produces free cysteine, an isoprenoid aldehyde, and hydrogen peroxide as products of the reaction. Here we report initial studies of the kinetic mechanism and stereospecificity of this unusual enzyme. We utilized product and dead end inhibitors of prenylcysteine lyase to probe the kinetic mechanism of the multistep reaction. The results with these inhibitors, together with those of other experiments, suggest that the reaction catalyzed by prenylcysteine lyase proceeds through a sequential mechanism. The reaction catalyzed by the enzyme is stereospecific, in that the pro-S hydride of the farnesylcysteine is transferred to FAD to initiate the reaction. With (2R,1'S)-[1'-H-2(1)]farnesylcysteine as a substrate, a primary deuterium isotope effect of 2 was observed on the steady state rate. However, the absence of an isotope effect on an observed pre-steady-state burst of hydrogen peroxide formation implicates a partially rate-determining proton transfer after a relatively fast C-H (C-D) bond cleavage step. Furthermore, no pre-steady-state burst of cysteine was observed. The finding that the rate of cysteine formation was within 2-fold of the steady-state k(cat) value indicates that cysteine production is one of the primary rate-limiting steps in the reaction. These results provide substantial new information on the catalytic mechanism of prenylcysteine lyase.	Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; Univ Illinois, Dept Chem, Urbana, IL 61801 USA	Duke University; Duke University; University of Illinois System; University of Illinois Urbana-Champaign	Casey, PJ (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA.			Casey, Patrick/0000-0002-7366-9309	NCRR NIH HHS [RR 04648] Funding Source: Medline; NIGMS NIH HHS [GM 13956, GM 46372] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR004648] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046372] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BENSON TE, 1993, BIOCHEMISTRY-US, V32, P2024, DOI 10.1021/bi00059a019; Bright H.B., 1975, ENZYMES, V12B, P421; BROWN MJ, 1991, J AM CHEM SOC, V113, P3176, DOI 10.1021/ja00008a058; CASEY PJ, 1989, P NATL ACAD SCI USA, V86, P8232; CASHMAN JR, 1990, CHEM RES TOXICOL, V3, P344, DOI 10.1021/tx00016a012; CLELAND WW, 1963, BIOCHIM BIOPHYS ACTA, V67, P104, DOI 10.1016/0926-6569(63)90211-6; COOK P, 1991, ENZYME MECH ISOTOPE, P204; COREY EJ, 1972, TETRAHEDRON LETT, P4339; DAVISSON VJ, 1986, J ORG CHEM, V51, P4768, DOI 10.1021/jo00375a005; DEKANT W, 1989, DRUG METAB REV, V20, P43, DOI 10.3109/03602538908994144; DENU JM, 1994, BIOCHEMISTRY-US, V33, P4001, DOI 10.1021/bi00179a029; DERENZO EC, 1956, ADV ENZYMOL REL S BI, V17, P293; DIXON M, 1965, BIOCHIM BIOPHYS ACTA, V96, P368, DOI 10.1016/0005-2787(65)90557-5; Edelstein RL, 1998, J ORG CHEM, V63, P5298, DOI 10.1021/jo980304s; EPSTEIN WW, 1991, P NATL ACAD SCI USA, V88, P9668, DOI 10.1073/pnas.88.21.9668; GERLACH H, 1973, CHEM COMMUN, V48, P274; GHISLA S, 1989, EUR J BIOCHEM, V181, P1, DOI 10.1111/j.1432-1033.1989.tb14688.x; GIBSON QH, 1964, J BIOL CHEM, V239, P3927; GLOMSET JA, 1990, TRENDS BIOCHEM SCI, V15, P139, DOI 10.1016/0968-0004(90)90213-U; Haklai R, 1998, BIOCHEMISTRY-US, V37, P1306, DOI 10.1021/bi972032d; Heasley CJ, 1996, BIOCHEM BIOPH RES CO, V225, P6, DOI 10.1006/bbrc.1996.1122; JANG GF, 1993, BIOCHEMISTRY-US, V32, P9500, DOI 10.1021/bi00087a031; Kahn K, 1997, BIOCHEMISTRY-US, V36, P4731, DOI 10.1021/bi963184w; KOSTER JF, 1968, BIOCHIM BIOPHYS ACTA, V151, P11, DOI 10.1016/0005-2744(68)90156-3; Lambert J., 1987, INTRO ORGANIC SPECTR, P351; LOCKRIDGE O, 1972, J BIOL CHEM, V247, P8097; Lu JY, 1996, P NATL ACAD SCI USA, V93, P10046, DOI 10.1073/pnas.93.19.10046; MA YT, 1992, BIOCHEMISTRY-US, V31, P11772, DOI 10.1021/bi00162a014; Marcinkeviciene J, 2000, ARCH BIOCHEM BIOPHYS, V377, P178, DOI 10.1006/abbi.2000.1769; MASSEY V, 1967, J BIOL CHEM, V242, P1259; MASSEY V, 1964, FED PROC, V23, P18; MIDLAND MM, 1979, J AM CHEM SOC, V101, P2352, DOI 10.1021/ja00503a019; MILLER JR, 1995, J AM CHEM SOC, V117, P7830, DOI 10.1021/ja00134a038; NORTHROP DB, 1975, BIOCHEMISTRY-US, V14, P2644, DOI 10.1021/bi00683a013; OI S, 1971, ARCH BIOCHEM BIOPHYS, V145, P557, DOI 10.1016/S0003-9861(71)80015-2; Palmer G, 1968, BIOL OXIDATIONS, P263; Parish CA, 1997, BIOCHEMISTRY-US, V36, P2686, DOI 10.1021/bi961844r; PARK SB, 1994, CHEM RES TOXICOL, V7, P191, DOI 10.1021/tx00038a012; Perez-Sala D, 1998, FEBS LETT, V426, P319, DOI 10.1016/S0014-5793(98)00365-2; PEREZSALA D, 1992, BIOCHEM J, V284, P835, DOI 10.1042/bj2840835; POMPLIANO DL, 1992, BIOCHEMISTRY-US, V31, P3800, DOI 10.1021/bi00130a010; Ravn MM, 2000, ORG LETT, V2, P573, DOI 10.1021/ol991230p; RAYN MM, 2000, EUR J ORG CHEM, P1401; REISS Y, 1990, CELL, V62, P81, DOI 10.1016/0092-8674(90)90242-7; SAUSEN PJ, 1990, J BIOL CHEM, V265, P6139; SEGEL IH, 1975, ENZYME KINETICS, P506; SILVERMAN RB, 1995, ACCOUNTS CHEM RES, V28, P335, DOI 10.1021/ar00056a003; STILL WC, 1978, J ORG CHEM, V43, P2923, DOI 10.1021/jo00408a041; TIPTON KF, 1968, EUR J BIOCHEM, V5, P316, DOI 10.1111/j.1432-1033.1968.tb00372.x; Tschantz WR, 2001, J BIOL CHEM, V276, P2321, DOI 10.1074/jbc.C000616200; Tschantz WR, 1999, J BIOL CHEM, V274, P35802, DOI 10.1074/jbc.274.50.35802; VESA J, 1995, NATURE, V376, P584, DOI 10.1038/376584a0; WATSON JL, 1996, BIOCHEMISTRY-US, V35, P1342; Xu YJ, 1996, MOL PHARMACOL, V50, P1495; Yamashita M, 1998, PROTEIN ENG, V11, P1075, DOI 10.1093/protein/11.11.1075; Zhang FL, 1996, ANNU REV BIOCHEM, V65, P241, DOI 10.1146/annurev.bi.65.070196.001325; ZHANG L, 1994, J BIOL CHEM, V269, P15973; Zhang LL, 1997, J BIOL CHEM, V272, P23354, DOI 10.1074/jbc.272.37.23354; [No title captured]	59	16	16	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 25	2002	277	43					41086	41093		10.1074/jbc.M208069200	http://dx.doi.org/10.1074/jbc.M208069200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	607KU	12186880	hybrid			2022-12-27	WOS:000178791400118
J	Kontani, K; Tada, M; Ogawa, T; Okai, T; Saito, K; Araki, Y; Katada, T				Kontani, K; Tada, M; Ogawa, T; Okai, T; Saito, K; Araki, Y; Katada, T			Di-Ras, a distinct subgroup of Ras family GTPases with unique biochemical properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN CYTOSKELETON; PC12 CELLS; PROTEIN; RAP1; GENE; IDENTIFICATION; ACTIVATION; EFFECTORS; OVARIAN; R-RAS3	The small GTPase Ras family regulates a variety of cell functions including proliferation and differentiation. Here we have identified novel Ras members, human Di-Ras1 and Di-Ras2, belonging to a distinct branch of the GTPase family. Di-Ras1 and Di-Ras2 specifically expressed in heart and brain share 30 - 40% overall identity with other members of Ras family, however, they have the following characteristic substitutions at highly conserved regions among the Ras family. 1) Thr-63 and Ser-65 in Di-Ras are substituted for Ala-59 and Gln-61 positions in Ha-Ras, respectively, that are known to be critical for GTP hydrolysis. 2) Within the effector domains, Di-Ras has Ile at a position corresponding to Asp-33 in Ha-Ras, which is important for its interaction with the downstream effector Raf. As predicted by these substitutions, Di-Ras has only a quite low level of GTPase activity and exists predominantly as a GTP-bound form upon its expression in living cells. Moreover, Di-Ras fails to interact with the Ras-binding domain of Raf, resulting in no stimulation of mitogen-activated protein kinase. Interestingly, introduction of Di-Ras into HEK293T cells induces large cellular vacuolation. These findings raise the possibility that Di-Ras might regulate cell morphogenesis in a manner distinct from other members of Ras family.	Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Physiol Chem, Tokyo 1130033, Japan	University of Tokyo	Katada, T (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Physiol Chem, Tokyo 1130033, Japan.		Tada, Minoru/AHB-5933-2022	Tada, Minoru/0000-0003-4739-1259; Saito, Kota/0000-0003-2478-2687				BARSAGI D, 1986, SCIENCE, V233, P1061, DOI 10.1126/science.3090687; Bos JL, 1998, EMBO J, V17, P6776, DOI 10.1093/emboj/17.23.6776; Bos JL, 2001, NAT REV MOL CELL BIO, V2, P369, DOI 10.1038/35073073; BOS JL, 1997, BIOCHIM BIOPHYS ACTA, V1333, P19; Campbell SL, 1998, ONCOGENE, V17, P1395, DOI 10.1038/sj.onc.1202174; Chi SJ, 1999, ONCOGENE, V18, P2281, DOI 10.1038/sj.onc.1202538; CHUANG E, 1994, MOL CELL BIOL, V14, P5318, DOI 10.1128/MCB.14.8.5318; Ellis CA, 2002, P NATL ACAD SCI USA, V99, P9876, DOI 10.1073/pnas.142193799; Foster R, 1996, MOL CELL BIOL, V16, P2689; Guasch RM, 1998, MOL CELL BIOL, V18, P4761, DOI 10.1128/MCB.18.8.4761; HAN LM, 1995, MOL CELL BIOL, V15, P1318; IYENGAR R, 1982, P NATL ACAD SCI-BIOL, V79, P5179, DOI 10.1073/pnas.79.17.5179; JOHN J, 1988, J BIOL CHEM, V263, P11792; Katz ME, 1997, CURR OPIN GENET DEV, V7, P75, DOI 10.1016/S0959-437X(97)80112-8; Kimmelman A, 1997, ONCOGENE, V15, P2675, DOI 10.1038/sj.onc.1201674; Kimmelman AC, 2000, ONCOGENE, V19, P2014, DOI 10.1038/sj.onc.1203530; KITAYAMA H, 1989, CELL, V56, P77, DOI 10.1016/0092-8674(89)90985-9; Marshall CJ, 1996, CURR OPIN CELL BIOL, V8, P197, DOI 10.1016/S0955-0674(96)80066-4; Matsumoto K, 1997, ONCOGENE, V15, P2409, DOI 10.1038/sj.onc.1201416; Nobes CD, 1998, J CELL BIOL, V141, P187, DOI 10.1083/jcb.141.1.187; Ohba Y, 2000, MOL CELL BIOL, V20, P6074, DOI 10.1128/MCB.20.16.6074-6083.2000; Peng HQ, 2000, INT J CANCER, V86, P690, DOI 10.1002/(SICI)1097-0215(20000601)86:5<690::AID-IJC14>3.0.CO;2-K; PIZON V, 1988, ONCOGENE, V3, P201; Quilliam LA, 1999, J BIOL CHEM, V274, P23850, DOI 10.1074/jbc.274.34.23850; Saito K, 2002, J BIOL CHEM, V277, P3412, DOI 10.1074/jbc.M106276200; SATOH T, 1988, FEBS LETT, V236, P185, DOI 10.1016/0014-5793(88)80311-9; Tall GG, 2001, DEV CELL, V1, P73, DOI 10.1016/S1534-5807(01)00008-9; TRAHEY M, 1987, SCIENCE, V238, P542, DOI 10.1126/science.2821624; Yu YH, 1999, P NATL ACAD SCI USA, V96, P214, DOI 10.1073/pnas.96.1.214	29	49	53	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 25	2002	277	43					41070	41078		10.1074/jbc.M202150200	http://dx.doi.org/10.1074/jbc.M202150200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	607KU	12194967	hybrid			2022-12-27	WOS:000178791400116
J	McAlinden, A; Crouch, EC; Bann, JG; Zhang, PN; Sandell, LJ				McAlinden, A; Crouch, EC; Bann, JG; Zhang, PN; Sandell, LJ			Trimerization of the amino propeptide of type IIA procollagen using a 14-amino acid sequence derived from the coiled-coil neck domain of surfactant protein D	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOXYL-TERMINAL PROPEPTIDE; GCN4 LEUCINE-ZIPPER; OLIGOMERIZATION-STATE; TRIPLE-HELIX; I COLLAGEN; OSTEOGENESIS IMPERFECTA; PRO-ALPHA-1(I) CHAIN; EXPRESSION; STABILITY; POSITION	The folding of a collagen triple helix usually requires the presence of additional sequences that contribute to the association and correct alignment of the collagen chains. We recently reported that the C-terminal neck and lectin domains of a collagenous C-type lectin, rat pulmonary surfactant protein D (SP-D), are sufficient to drive the trimerization of a heterologous type IIA procollagen amino propeptide sequence. However, the conformation of the resulting trimeric IIA propeptide and the specific contributions of the SP-D sequence to trimerization were not elucidated. In the present study, we show that trimerization of the fusion protein is associated with correct folding of the collagen helix within the IIA propeptide domain (as assessed by circular dichroism) and that the constituent chains are hydroxylated. Chemical cross-linking and analytical ultracentrifugation showed that the IIA amino-propeptide retains its trimeric configuration even after proteolytic removal of the SP-D domains. By contrast, IIA amino-propeptides synthesized without fusion to the neck or lectin domains are assembled exclusively as monomers. To localize the trimerization sequence, mutant chimeric cDNA constructs were designed containing premature termination codons within the coiled-coil neck domain. A short, 14-amino acid sequence corresponding to the first two heptad repeats of the neck domain was sufficient to drive the trimeric association of the IIA amino-propeptide a-chains. However, deletion of the collagen domain resulted in the secretion of monomers. These studies demonstrate that two heptad repeats are sufficient for trimeric association of the propeptide but indicate that cooperative interactions between the coiled-coil and collagen domains are required for the formation of a stable helix.	Washington Univ, Barnes Jewish Hosp, Sch Med, Dept Orthopaed Surg, St Louis, MO 63110 USA; Washington Univ, Barnes Jewish Hosp, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; Washington Univ, Barnes Jewish Hosp, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA	Barnes-Jewish Hospital; Washington University (WUSTL); Barnes-Jewish Hospital; Washington University (WUSTL); Barnes-Jewish Hospital; Washington University (WUSTL)	Sandell, LJ (corresponding author), Washington Univ, Barnes Jewish Hosp, Sch Med, Dept Orthopaed Surg, 660 S Euclid Ave, St Louis, MO 63110 USA.			McAlinden, Audrey/0000-0001-8433-4224	NHLBI NIH HHS [HL 44015, HL 29594] Funding Source: Medline; NIAMS NIH HHS [AR 36994] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL029594, R01HL044015] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR036994] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		AUSUBEL RA, 1992, CURRENT PROTOCOLS MO; BACHINGER HP, 1980, EUR J BIOCHEM, V106, P619, DOI 10.1111/j.1432-1033.1980.tb04610.x; Beck K, 1997, EMBO J, V16, P3767, DOI 10.1093/emboj/16.13.3767; Brown JH, 1996, PROTEINS, V26, P134; BRUCKNER P, 1981, EUR J BIOCHEM, V118, P607, DOI 10.1111/j.1432-1033.1981.tb05562.x; Bulleid NJ, 1997, EMBO J, V16, P6694, DOI 10.1093/emboj/16.22.6694; CHESSLER SD, 1993, J BIOL CHEM, V268, P18218; CROUCH E, 1994, J BIOL CHEM, V269, P15808; Crouch EC, 1998, BBA-MOL BASIS DIS, V1408, P278, DOI 10.1016/S0925-4439(98)00073-8; Crouch EC, 1998, AM J RESP CELL MOL, V19, P177, DOI 10.1165/ajrcmb.19.2.140; DOEGE KJ, 1986, J BIOL CHEM, V261, P8924; DOLZ R, 1988, EUR J BIOCHEM, V178, P357, DOI 10.1111/j.1432-1033.1988.tb14458.x; FISHER LW, 1987, J BIOL CHEM, V262, P13457; FLEISCHMAJER R, 1986, J INVEST DERMATOL, V87, P553; Frank S, 2001, J MOL BIOL, V308, P1081, DOI 10.1006/jmbi.2001.4644; Goodman M, 1998, BIOPOLYMERS, V47, P127, DOI 10.1002/(SICI)1097-0282(1998)47:2<127::AID-BIP2>3.0.CO;2-W; Hakansson K, 1999, STRUCTURE, V7, P255, DOI 10.1016/S0969-2126(99)80036-7; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; HOPPE HJ, 1994, FEBS LETT, V344, P191, DOI 10.1016/0014-5793(94)00383-1; HU JC, 1993, PROTEIN SCI, V2, P1072, DOI 10.1002/pro.5560020701; Kishore U, 1996, BIOCHEM J, V318, P505, DOI 10.1042/bj3180505; Kohn WD, 1998, J MOL BIOL, V283, P993, DOI 10.1006/jmbi.1998.2125; LAMANDE SR, 1995, J BIOL CHEM, V270, P8642, DOI 10.1074/jbc.270.15.8642; Larrain J, 2000, DEVELOPMENT, V127, P821; Mazzorana M, 1996, J BIOL CHEM, V271, P29003, DOI 10.1074/jbc.271.46.29003; MCLACHLAN AD, 1975, J MOL BIOL, V98, P293, DOI 10.1016/S0022-2836(75)80119-7; Oganesian A, 1997, J HISTOCHEM CYTOCHEM, V45, P1469, DOI 10.1177/002215549704501104; PAGLIA L, 1979, BIOCHEMISTRY-US, V18, P5030, DOI 10.1021/bi00589a034; PERSSON A, 1990, J BIOL CHEM, V265, P5755; PETERKOFSKY B, 1971, BIOCHEMISTRY-US, V10, P988, DOI 10.1021/bi00782a009; RYAN MC, 1990, J BIOL CHEM, V265, P10334; Snellman A, 2000, EMBO J, V19, P5051, DOI 10.1093/emboj/19.19.5051; SU JY, 1994, BIOCHEMISTRY-US, V33, P15501, DOI 10.1021/bi00255a032; SU MW, 1989, GENOMICS, V4, P438, DOI 10.1016/0888-7543(89)90353-4; Tao YZ, 1997, STRUCTURE, V5, P789, DOI 10.1016/S0969-2126(97)00233-5; Tripet B, 2000, J MOL BIOL, V300, P377, DOI 10.1006/jmbi.2000.3866; Wagschal K, 1999, PROTEIN SCI, V8, P2312; WIESTNER M, 1979, J BIOL CHEM, V254, P7016; Wolf E, 1997, PROTEIN SCI, V6, P1179, DOI 10.1002/pro.5560060606; WOOLFSON DN, 1995, PROTEIN SCI, V4, P1596, DOI 10.1002/pro.5560040818; WU CH, 1986, J BIOL CHEM, V261, P482; Zhang PN, 2001, J BIOL CHEM, V276, P19862, DOI 10.1074/jbc.M100597200; Zhu Y, 1999, J CELL BIOL, V144, P1069, DOI 10.1083/jcb.144.5.1069	43	13	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 25	2002	277	43					41274	41281		10.1074/jbc.M202257200	http://dx.doi.org/10.1074/jbc.M202257200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	607KU	12194968	hybrid			2022-12-27	WOS:000178791400140
J	Suzuki, T; Yamakuni, T; Hagiwara, M; Ichinose, H				Suzuki, T; Yamakuni, T; Hagiwara, M; Ichinose, H			Identification of ATF-2 as a transcriptional regulator for the tyrosine hydroxylase gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAMP-RESPONSE ELEMENT; CYCLOHYDROLASE-I GENE; C-FOS TRANSCRIPTION; CYCLIC-AMP; BINDING PROTEIN; DNA-BINDING; ADRENAL-MEDULLA; FACTOR CREB; CELL-LINES; PHOSPHORYLATION	Transcriptional regulation of catecholamine-synthesizing genes is important for the determination of neurotransmitters during brain development. We found that three catecholamine-synthesizing genes were transcriptionally up-regulated in cloned PC12D cells over-expressing V-1, a protein that is highly expressed during postnatal brain development (1). To reveal the molecular mechanism to regulate the expression of tyrosine hydroxylase (TH), which is the rate-limiting enzyme for catecholamine biosynthesis, we analyzed the transcription factors responsible for TH induction in the V-1 clonal cells. First, by using reporter constructs, we found that the transcription mediated by cAMP-responsive element (CRE) was selectively enhanced in the V-1 cells, and TH promoter activity was totally dependent on the CRE in the promoter region of the TH gene. Next, immunoblot analyses and a transactivation assay using a GAL4 reporter system revealed that ATF-2, but not cAMP-responsive element-binding protein (CREB), was highly phosphorylated and activated in the V-1 cells, while both CREB and ATF-2 were bound to the TH-CRE. Finally, the enhanced TH promoter activity was competitively attenuated by expression of a plasmid containing the ATF-2 transactivation domain. These data demonstrated that activation of ATF-2 resulted in the increased transcription of the TH gene and suggest that ATF-2 may be deeply involved in the transcriptional regulation of catecholamine-synthesizing genes during neural development.	Fujita Hlth Univ, Inst Comprehens Med Sci, Div Mol Genet, Toyoake, Aichi 4701192, Japan; Tohoku Univ, Grad Sch Pharmaceut Sci, Dept Pharmaceut Mol Biol, Aoba Ku, Sendai, Miyagi 9808578, Japan; Mitsubishi Kagaku Inst Life Sci, Tokyo 1948511, Japan; Tokyo Med & Dent Univ, Inst Med Res, Dept Functional Genom, Tokyo 1138510, Japan	Fujita Health University; Tohoku University; Mitsubishi Kagaku Institute of Life Sciences (MITILS); Tokyo Medical & Dental University (TMDU)	Ichinose, H (corresponding author), Fujita Hlth Univ, Inst Comprehens Med Sci, Div Mol Genet, Toyoake, Aichi 4701192, Japan.		Yamakuni, Tohru/AAE-3541-2019; Ichinose, Hiroshi/D-8986-2015	Ichinose, Hiroshi/0000-0001-6008-6860; Yamakuni, Tohru/0000-0003-3968-7949				Beitner-Johnson D, 1998, J BIOL CHEM, V273, P19834, DOI 10.1074/jbc.273.31.19834; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cazorla P, 2000, J NEUROCHEM, V74, P1829, DOI 10.1046/j.1471-4159.2000.0741829.x; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Ghee M, 1998, MOL BRAIN RES, V55, P101, DOI 10.1016/S0169-328X(97)00370-7; GINTY DD, 1994, CELL, V77, P713, DOI 10.1016/0092-8674(94)90055-8; GIZANGGINSBERG E, 1990, GENE DEV, V4, P477, DOI 10.1101/gad.4.4.477; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Guo Z, 1998, J NEUROSCI, V18, P8163; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; HAI T, 1991, P NATL ACAD SCI USA, V88, P3720, DOI 10.1073/pnas.88.9.3720; HAI TW, 1989, GENE DEV, V3, P2083, DOI 10.1101/gad.3.12b.2083; Hirayama K, 2001, J NEUROCHEM, V79, P576, DOI 10.1046/j.1471-4159.2001.00583.x; HYMAN SE, 1988, MOL CELL BIOL, V8, P4225, DOI 10.1128/MCB.8.10.4225; ISHIGURO H, 1993, J BIOL CHEM, V268, P17987; Kapatos G, 2000, J BIOL CHEM, V275, P5947, DOI 10.1074/jbc.275.8.5947; Kawasaki H, 2000, NATURE, V405, P195, DOI 10.1038/35012097; KIM KS, 1993, J BIOL CHEM, V268, P15689; LaneLadd SB, 1997, J NEUROSCI, V17, P7890; LAZAROFF M, 1995, J BIOL CHEM, V270, P21579, DOI 10.1074/jbc.270.37.21579; Lebel M, 2001, J NEUROCHEM, V77, P558, DOI 10.1046/j.1471-4159.2001.00257.x; Leppa S, 2001, MOL CELL BIOL, V21, P4369, DOI 10.1128/MCB.21.13.4369-4378.2001; LEWIS EJ, 1987, P NATL ACAD SCI USA, V84, P3550, DOI 10.1073/pnas.84.11.3550; LIVINGSTONE C, 1995, EMBO J, V14, P1785, DOI 10.1002/j.1460-2075.1995.tb07167.x; Maekawa T, 1999, J BIOL CHEM, V274, P17813, DOI 10.1074/jbc.274.25.17813; MAEKAWA T, 1989, EMBO J, V8, P2023, DOI 10.1002/j.1460-2075.1989.tb03610.x; NagamotoCombs K, 1997, J BIOL CHEM, V272, P6051, DOI 10.1074/jbc.272.9.6051; Nankova B, 1996, MOL BRAIN RES, V35, P164, DOI 10.1016/0169-328X(95)00201-3; Nankova BB, 2000, J NEUROSCI, V20, P5647, DOI 10.1523/JNEUROSCI.20-15-05647.2000; Parker D, 1999, MOL CELL BIOL, V19, P5601; Piech-Dumas KM, 1999, MOL BRAIN RES, V70, P219, DOI 10.1016/S0169-328X(99)00149-7; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; Reimold AM, 1996, NATURE, V379, P262, DOI 10.1038/379262a0; Sakurada K, 1999, DEVELOPMENT, V126, P4017; Sano Y, 1998, J BIOL CHEM, V273, P29098, DOI 10.1074/jbc.273.44.29098; Sano Y, 1999, J BIOL CHEM, V274, P8949, DOI 10.1074/jbc.274.13.8949; SHENG M, 1990, NEURON, V4, P571, DOI 10.1016/0896-6273(90)90115-V; Shimomura A, 1998, J NEUROCHEM, V70, P1029; Sumi-Ichinose C, 2001, J BIOL CHEM, V276, P41150, DOI 10.1074/jbc.M102237200; Sun BY, 2002, J NEUROCHEM, V80, P295, DOI 10.1046/j.0022-3042.2001.00692.x; Suzuki T, 2002, BIOCHEM BIOPH RES CO, V293, P962, DOI 10.1016/S0006-291X(02)00343-1; Swanson DJ, 1997, J BIOL CHEM, V272, P27382, DOI 10.1074/jbc.272.43.27382; TAOKA M, 1994, J BIOL CHEM, V269, P9946; TAOKA M, 1992, EUR J BIOCHEM, V207, P615, DOI 10.1111/j.1432-1033.1992.tb17088.x; Tinti C, 1997, J BIOL CHEM, V272, P19158, DOI 10.1074/jbc.272.31.19158; Tinti C, 1996, J BIOL CHEM, V271, P25375, DOI 10.1074/jbc.271.41.25375; Trocme C, 1997, J NEUROSCI RES, V48, P489, DOI 10.1002/(SICI)1097-4547(19970615)48:6<489::AID-JNR1>3.0.CO;2-6; Usukura J, 2000, GENES CELLS, V5, P515, DOI 10.1046/j.1365-2443.2000.00345.x; VANDAM H, 1995, EMBO J, V14, P1798, DOI 10.1002/j.1460-2075.1995.tb07168.x; Wagner J, 1999, NAT BIOTECHNOL, V17, P653, DOI 10.1038/10862; Yamakuni T, 1998, J BIOL CHEM, V273, P27051, DOI 10.1074/jbc.273.42.27051; YAMAMOTO KK, 1990, CELL, V60, P611, DOI 10.1016/0092-8674(90)90664-Z; Zetterstrom RH, 1997, SCIENCE, V276, P248, DOI 10.1126/science.276.5310.248	54	31	32	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 25	2002	277	43					40768	40774		10.1074/jbc.M206043200	http://dx.doi.org/10.1074/jbc.M206043200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	607KU	12196528	hybrid			2022-12-27	WOS:000178791400079
J	Li, SL; Finley, J; Liu, ZJ; Qiu, SH; Chen, HL; Luan, CH; Carson, M; Tsao, J; Johnson, D; Lin, GD; Zhao, J; Thomas, W; Nagy, LA; Sha, BD; DeLucas, LJ; Wang, BC; Luo, M				Li, SL; Finley, J; Liu, ZJ; Qiu, SH; Chen, HL; Luan, CH; Carson, M; Tsao, J; Johnson, D; Lin, GD; Zhao, J; Thomas, W; Nagy, LA; Sha, BD; DeLucas, LJ; Wang, BC; Luo, M			Crystal structure of the cytoskeleton-associated protein glycine-rich (CAP-Gly) domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFRACTION DATA; MICROTUBULE; CLIP-170; RESOLUTION; CLONING; SYSTEM; MAPS	Cytoskeleton-associated proteins (CAPs) are involved in the organization of microtubules and transportation of vesicles and organelles along the cytoskeletal network. A conserved motif, CAP-Gly, has been identified in a number of CAPs, including CLIP-170 and dynactins. The crystal structure of the CAP-Gly domain of Caenorhabditis elegans F53F4.3 protein, solved by single wavelength sulfur-anomalous phasing, revealed a novel protein fold containing three beta-sheets. The most conserved sequence, GKNDG, is located in two consecutive sharp turns on the surface, forming the entrance to a groove. Residues in the groove are highly conserved as measured from the information content of the aligned sequences. The C-terminal tail of another molecule in the crystal is bound in this groove.	Univ Alabama Birmingham, SE Collab Struct Genom, Ctr Biophys Sci & Engn, Birmingham, AL 35294 USA; Univ Alabama Birmingham, SE Collab Struct Genom, Dept Cell Biol, Birmingham, AL 35294 USA; Univ Alabama Birmingham, SE Collab Struct Genom, Dept Microbiol, Birmingham, AL 35294 USA; Univ Georgia, SE Collab Struct Genom, Athens, GA 30602 USA; Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Luo, M (corresponding author), Univ Alabama Birmingham, SE Collab Struct Genom, Ctr Biophys Sci & Engn, Birmingham, AL 35294 USA.	mingluo@uab.edu	ID, IMCACAT/D-5867-2014; Liu, Zhi-Jie/A-3946-2012	Liu, Zhi-Jie/0000-0001-7279-2893	NIGMS NIH HHS [1P50-GM62407] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM062407] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Bignell GR, 2000, NAT GENET, V25, P160, DOI 10.1038/76006; BILBE G, 1992, EMBO J, V11, P2103, DOI 10.1002/j.1460-2075.1992.tb05269.x; BrUnger A. T., 1992, X PLOR VERSION 3 1 S; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; Collin GB, 1998, GENOMICS, V53, P359, DOI 10.1006/geno.1998.5542; Fuchs E, 1999, CELL, V98, P547, DOI 10.1016/S0092-8674(00)80041-0; Furey W, 1997, METHOD ENZYMOL, V277, P590, DOI 10.1016/S0076-6879(97)77033-2; Gibrat JF, 1996, CURR OPIN STRUC BIOL, V6, P377, DOI 10.1016/S0959-440X(96)80058-3; Goode BL, 2000, CURR OPIN CELL BIOL, V12, P63, DOI 10.1016/S0955-0674(99)00058-7; Houseweart MK, 1999, CURR BIOL, V9, pR864, DOI 10.1016/S0960-9822(00)80048-2; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KARLIN S, 1990, P NATL ACAD SCI USA, V87, P2264, DOI 10.1073/pnas.87.6.2264; Laity JH, 2001, CURR OPIN STRUC BIOL, V11, P39, DOI 10.1016/S0959-440X(00)00167-6; Lamzin VS, 2000, NAT STRUCT BIOL, V7, P978, DOI 10.1038/80763; Lantz VA, 1998, J CELL BIOL, V140, P897, DOI 10.1083/jcb.140.4.897; Li HP, 1997, P NATL ACAD SCI USA, V94, P1086, DOI 10.1073/pnas.94.4.1086; Liu ZJ, 2000, PROTEIN SCI, V9, P2085, DOI 10.1110/ps.9.11.2085; Norvell JC, 2000, NAT STRUCT BIOL, V7, P931, DOI 10.1038/80694; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PEARSON WR, 1990, METHOD ENZYMOL, V183, P63; Perez F, 1999, CELL, V96, P517, DOI 10.1016/S0092-8674(00)80656-X; PIERRE P, 1992, CELL, V70, P887, DOI 10.1016/0092-8674(92)90240-D; RIEHEMANN K, 1993, TRENDS BIOCHEM SCI, V18, P82, DOI 10.1016/0968-0004(93)90159-K; Scheel J, 1999, J BIOL CHEM, V274, P25883, DOI 10.1074/jbc.274.36.25883; Schuyler SC, 2001, CELL, V105, P421, DOI 10.1016/S0092-8674(01)00364-6; SHELDRICK GM, 1990, ACTA CRYSTALLOGR A, V46, P467, DOI 10.1107/S0108767390000277; Terwilliger TC, 1997, METHOD ENZYMOL, V276, P530; Vaughan KT, 1999, J CELL SCI, V112, P1437; Walhout AJM, 2000, METHOD ENZYMOL, V328, P575, DOI 10.1016/S0076-6879(00)28419-X; WANG BC, 1985, METHOD ENZYMOL, V115, P90; Watanabe TK, 1996, CYTOGENET CELL GENET, V72, P208, DOI 10.1159/000134191	34	79	86	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2002	277	50					48596	48601		10.1074/jbc.M208512200	http://dx.doi.org/10.1074/jbc.M208512200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	624YK	12221106	hybrid			2022-12-27	WOS:000179789600082
J	Schling, P; Schafer, T				Schling, P; Schafer, T			Human adipose tissue cells keep tight control on the angiotensin II levels in their vicinity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASCULAR SMOOTH-MUSCLE; LEUCINE AMINOPEPTIDASE; HUMAN PREADIPOCYTES; SYSTEM; ADIPOCYTES; CONVERSION; PROTEIN; EXPRESSION; VESICLES; BINDING	Human adipose tissue expresses all components necessary for the local production of angiotensin II, which has multiple functions in adipose tissue, ranging from regulation of local blood flow to complex influences on tissue homeostasis. Still the mechanisms controlling human adipose tissue angiotensin II concentrations are not yet known. We investigated whether angiotensin II is degraded by human primary cultured preadipocytes and adipocytes and which enzymes are responsible for its metabolism. Distinct but transient angiotensin II production was limited by degradation due to consecutive proteolytic cleavage by endopeptidase and aminopeptidase activities. The endopeptidase could be identified as neprilysin expressed on the surface of both preadipocytes and adipocytes. Degradation of angiotensin II was preceded by a lag phase that was considerably longer in preadipocytes. This time span could not be explained by an induction of neprilysin nor by an increase in its surface localization. Following the lag phase, adipocytes showed a higher degradation activity than preadipocytes as mirrored by increased neprilysin levels and activity measured in their membrane fractions. Our findings demonstrate that human preadipocytes and adipocytes differentially express functional neprilysin and aminopeptidase activity involved in the regulation of angiotensin II concentrations in human adipose tissue.	Univ Regensburg, Inst Clin Chem & Lab Med, D-93053 Regensburg, Germany; Heidelberg Univ, Zentrum Biochem, D-69120 Heidelberg, Germany	University of Regensburg; Ruprecht Karls University Heidelberg	Schling, P (corresponding author), Univ Regensburg, Inst Clin Chem & Lab Med, Franz Josef Str Allee 11, D-93053 Regensburg, Germany.	petra.schling@klinik.uni-regens-burg.de		Schaefer, Thorsten/0000-0003-4867-8374				Ailhaud G, 1999, ANN NY ACAD SCI, V892, P127, DOI 10.1111/j.1749-6632.1999.tb07791.x; Albiston AL, 2001, J BIOL CHEM, V276, P48623, DOI 10.1074/jbc.C100512200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CRANDALL DL, 1994, DRUG DEVELOP RES, V32, P117, DOI 10.1002/ddr.430320208; Engeli S, 1999, J HYPERTENS, V17, P555, DOI 10.1097/00004872-199917040-00014; Engeli S, 2000, HYPERTENSION, V35, P1270, DOI 10.1161/01.HYP.35.6.1270; ERDOS EG, 1989, FASEB J, V3, P145, DOI 10.1096/fasebj.3.2.2521610; Fontenele-Neto JD, 2001, J COMP NEUROL, V438, P399, DOI 10.1002/cne.1323; Ganju RK, 1996, BLOOD, V88, P4159; Gronthos S, 2001, J CELL PHYSIOL, V189, P54, DOI 10.1002/jcp.1138; Hattori A, 2000, J BIOCHEM-TOKYO, V128, P755, DOI 10.1093/oxfordjournals.jbchem.a022812; Herbst JJ, 1997, AM J PHYSIOL-ENDOC M, V272, pE600, DOI 10.1152/ajpendo.1997.272.4.E600; HERSHEY JC, 1995, J BIOL CHEM, V270, P25096, DOI 10.1074/jbc.270.42.25096; INDIG FE, 1989, FEBS LETT, V255, P237, DOI 10.1016/0014-5793(89)81098-1; Ishizaka N, 1998, HYPERTENSION, V32, P459, DOI 10.1161/01.HYP.32.3.459; Jones BH, 1997, ENDOCRINOLOGY, V138, P1512, DOI 10.1210/en.138.4.1512; Jonsson J R, 1994, Blood Press, V3, P72; KANDROR KV, 1994, J BIOL CHEM, V269, P30777; Karlsson C, 1998, J CLIN ENDOCR METAB, V83, P3925, DOI 10.1210/jc.83.11.3925; KELLER SR, 1995, J BIOL CHEM, V270, P23612, DOI 10.1074/jbc.270.40.23612; Kobayashi H., 1996, Zoophysiology, V35, P1; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MALLOW H, 1997, INT J OBES S2, V21, P92; MARI B, 1992, EMBO J, V11, P3875, DOI 10.1002/j.1460-2075.1992.tb05480.x; Massiera F, 2001, FASEB J, V15, P2727, DOI 10.1096/fj.01-0457fje; Mentlein R, 1996, PEPTIDES, V17, P709, DOI 10.1016/0196-9781(96)00066-6; MORTON JJ, 1985, CLIN SCI, V68, P483, DOI 10.1042/cs0680483; Mulholland F, 1986, Adv Exp Med Biol, V198 Pt A, P41; PAIRAULT J, 1979, P NATL ACAD SCI USA, V76, P5138, DOI 10.1073/pnas.76.10.5138; Pinterova L, 2000, GEN PHYSIOL BIOPHYS, V19, P329; Riemann D, 2001, BIOCHEM J, V354, P47, DOI 10.1042/0264-6021:3540047; ROSELL S, 1979, PHYSIOL REV, V59, P1078, DOI 10.1152/physrev.1979.59.4.1078; Sanker S, 1997, J BIOL CHEM, V272, P2963, DOI 10.1074/jbc.272.5.2963; SAYE JA, 1993, AM J PHYSIOL, V264, pC1570, DOI 10.1152/ajpcell.1993.264.6.C1570; Schling P, 2002, NEWS PHYSIOL SCI, V17, P99, DOI 10.1152/nips.01349.2001; Schling P, 2001, HORM METAB RES, V33, P189, DOI 10.1055/s-2001-14951; Schling P, 1999, INT J OBESITY, V23, P336, DOI 10.1038/sj.ijo.0800821; SIGMUND CD, 1992, CIRC RES, V70, P1070, DOI 10.1161/01.RES.70.5.1070; SPENCERDENE B, 1994, DEVELOPMENT, V120, P3213; Sumitomo M, 2000, J CLIN INVEST, V106, P1399, DOI 10.1172/JCI10536; TSUJIMOTO M, 1992, ARCH BIOCHEM BIOPHYS, V292, P388, DOI 10.1016/0003-9861(92)90007-J; WANG J, 1976, J NUTR, V106, P1687, DOI 10.1093/jn/106.12.1687; Waters SB, 1997, J BIOL CHEM, V272, P23323, DOI 10.1074/jbc.272.37.23323; WOLZ RL, 1995, METHOD ENZYMOL, V248, P325	44	52	53	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2002	277	50					48066	48075		10.1074/jbc.M204058200	http://dx.doi.org/10.1074/jbc.M204058200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	624YK	12196514	hybrid			2022-12-27	WOS:000179789600014
J	Koshland, DE; Hamadani, K				Koshland, DE; Hamadani, K			Proteomics and models for enzyme cooperativity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							APPARENT POSITIVE COOPERATIVITY; AFFINITY BINDING-SITES; NEGATIVE COOPERATIVITY; KINETIC COOPERATIVITY; ESCHERICHIA-COLI; ATPASE ACTIVITY; SUBUNIT COOPERATIVITY; ALKALINE-PHOSPHATASE; PYRUVATE-KINASE; CALCIUM-BINDING		Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Koshland, DE (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	dek@uclink4.berkeley.edu	Hamadani, Kambiz/AAM-4138-2020	Hamadani, Kambiz/0000-0002-2768-3361				ANDRALOJC PJ, 1990, BIOCHIM BIOPHYS ACTA, V1016, P55, DOI 10.1016/0005-2728(90)90006-P; ARNER P, 1983, ACTA DIABETOL LAT, V20, P197, DOI 10.1007/BF02581263; BACH R, 1986, BIOCHEMISTRY-US, V25, P4007, DOI 10.1021/bi00362a005; BALE JR, 1980, J BIOL CHEM, V255, P8424; BELKNAP WR, 1986, BIOCHEMISTRY-US, V25, P1864, DOI 10.1021/bi00356a004; BENBARUCH G, 1982, MOL PHARMACOL, V21, P287; BENHAYYIM G, 1990, PHYSIOL PLANTARUM, V80, P210, DOI 10.1111/j.1399-3054.1990.tb04398.x; BISSWANGER H, 1984, J BIOL CHEM, V259, P2457; Bohr C, 1904, SKAND ARCH PHYSIOL, V16, P402, DOI 10.1111/j.1748-1716.1904.tb01382.x; BUBIS J, 1988, BIOCHEMISTRY-US, V27, P1570, DOI 10.1021/bi00405a026; CASTUMA CE, 1983, BIOCHIM BIOPHYS ACTA, V729, P9, DOI 10.1016/0005-2736(83)90449-2; CLARK S, 1980, BIOCHEM BIOPH RES CO, V95, P1543, DOI 10.1016/S0006-291X(80)80073-8; CONTI J, 1987, BIOCHIM BIOPHYS ACTA, V902, P53, DOI 10.1016/0005-2736(87)90135-0; CONWAY A, 1968, BIOCHEMISTRY-US, V7, P4011, DOI 10.1021/bi00851a031; CORNISHBOWDEN A, 1985, ARCH BIOL MED EXP, V18, P293; CORTESE JD, 1989, BIOCHEMISTRY-US, V28, P3000, DOI 10.1021/bi00433a040; COUKELL MB, 1981, DIFFERENTIATION, V20, P29, DOI 10.1111/j.1432-0436.1981.tb01152.x; COX JA, 1981, BIOCHEMISTRY-US, V20, P5430, DOI 10.1021/bi00522a012; DAMODARAN S, 1980, J BIOL CHEM, V255, P8503; DANIELIUS RV, 1989, FEBS LETT, V250, P183, DOI 10.1016/0014-5793(89)80716-1; DEGTYAREV SK, 1982, FEBS LETT, V137, P95, DOI 10.1016/0014-5793(82)80322-0; DELARCO A, 1982, INT J BIOCHEM, V14, P127, DOI 10.1016/0020-711X(82)90152-5; DIDONATO A, 1987, BIOCHEM J, V241, P435, DOI 10.1042/bj2410435; DOUZHENKOVA IV, 1988, BIOCHIM BIOPHYS ACTA, V957, P60, DOI 10.1016/0167-4838(88)90157-4; EHRLICH R, 1981, CR ACAD SCI III-VIE, V292, P5; FOREMAN JE, 1985, J BIOL CHEM, V260, P19; GANELA EI, 1989, BIOSYSTEMS, V23, P7; GEEVES MA, 1987, BIOPHYS J, V52, P215, DOI 10.1016/S0006-3495(87)83208-3; GERHART JC, 1962, J BIOL CHEM, V237, P891; GORDON M, 1987, CELL BIOCHEM FUNCT, V5, P255, DOI 10.1002/cbf.290050404; GU JL, 1988, BIOCHEM BIOPH RES CO, V150, P694, DOI 10.1016/0006-291X(88)90447-0; HABER JE, 1967, P NATL ACAD SCI USA, V58, P2087, DOI 10.1073/pnas.58.5.2087; HABER RS, 1983, J GEN PHYSIOL, V81, P1, DOI 10.1085/jgp.81.1.1; HANSON KR, 1981, ARCH BIOCHEM BIOPHYS, V211, P564, DOI 10.1016/0003-9861(81)90491-4; HASINOFF BB, 1986, BIOCHEM J, V235, P891, DOI 10.1042/bj2350891; HENIS YI, 1980, EUR J BIOCHEM, V112, P59, DOI 10.1111/j.1432-1033.1980.tb04987.x; HEYNS W, 1983, J STEROID BIOCHEM, V19, P1689, DOI 10.1016/0022-4731(83)90345-X; HO C, 1992, ADV PROTEIN CHEM, V43, P153, DOI 10.1016/S0065-3233(08)60555-0; HOLT JM, 1995, FASEB J, V9, P210, DOI 10.1096/fasebj.9.2.7781923; IIDA S, 1986, J BIOCHEM-TOKYO, V99, P1765, DOI 10.1093/oxfordjournals.jbchem.a135654; Ikeda Y, 1997, J BIOL CHEM, V272, P20495, DOI 10.1074/jbc.272.33.20495; JOHAL S, 1985, J BIOL CHEM, V260, P9894; JONES MN, 1984, INT J BIOL MACROMOL, V6, P65, DOI 10.1016/0141-8130(84)90064-3; KAPOOR M, 1981, FEBS LETT, V123, P255, DOI 10.1016/0014-5793(81)80301-8; KIM HW, 1994, P NATL ACAD SCI USA, V91, P11547, DOI 10.1073/pnas.91.24.11547; KITAMURA E, 1984, BIOCHIM BIOPHYS ACTA, V800, P66, DOI 10.1016/0304-4165(84)90095-3; Kolodziej AF, 1996, BIOCHEMISTRY-US, V35, P14782, DOI 10.1021/bi961481v; KONISHI K, 1988, J BIOL CHEM, V263, P13381; Koshland DE, 1996, CURR OPIN STRUC BIOL, V6, P757, DOI 10.1016/S0959-440X(96)80004-2; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; KRUGER P, 1990, BIOL CHEM H-S, V371, P669, DOI 10.1515/bchm3.1990.371.2.669; KUO LC, 1982, P NATL ACAD SCI-BIOL, V79, P2250, DOI 10.1073/pnas.79.7.2250; LEE SL, 1980, INT J PEPT PROT RES, V16, P231; LEVITZKI A, 1969, P NATL ACAD SCI USA, V62, P1121, DOI 10.1073/pnas.62.4.1121; LOHMAN TM, 1988, BIOCHEMISTRY-US, V27, P2260, DOI 10.1021/bi00407a002; MADERSPACH K, 1982, BIOCHIM BIOPHYS ACTA, V692, P469, DOI 10.1016/0005-2736(82)90399-6; MAITRE M, 1983, NEUROCHEM RES, V8, P113, DOI 10.1007/BF00965658; MARASCO WA, 1985, J CELL BIOCHEM, V27, P359, DOI 10.1002/jcb.240270406; MATSUNOYAGI A, 1990, J BIOL CHEM, V265, P82; MCGREW SG, 1989, BIOCHEMISTRY-US, V28, P1686, DOI 10.1021/bi00430a039; MEGLASSON MD, 1983, DIABETES, V32, P1146, DOI 10.2337/diabetes.32.12.1146; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; MOORE GJ, 1989, GEN PHARMACOL, V20, P193, DOI 10.1016/0306-3623(89)90014-1; MURRAY JM, 1981, MOL CELL BIOCHEM, V35, P11, DOI 10.1007/BF02358183; NEUJAHR HY, 1988, BIOCHEMISTRY-US, V27, P3770, DOI 10.1021/bi00410a038; NEWTON AC, 1989, J BIOL CHEM, V264, P14909; NOTIDES AC, 1981, P NATL ACAD SCI-BIOL, V78, P4926, DOI 10.1073/pnas.78.8.4926; OLAVARRIA JM, 1985, ARCH BIOL MED EXP, V18, P285; OLEFSKY JM, 1981, BIOCHEMISTRY-US, V20, P4488, DOI 10.1021/bi00518a038; PALMA MS, 1983, PHYTOCHEMISTRY, V22, P1899, DOI 10.1016/0031-9422(83)80008-9; PERIYASAMY SM, 1985, EUR J PHARMACOL, V116, P17, DOI 10.1016/0014-2999(85)90180-3; PERUTZ MF, 1970, NATURE, V228, P726, DOI 10.1038/228726a0; PERUTZ MF, 1982, NATURE, V299, P421, DOI 10.1038/299421a0; PERUTZ MF, 1968, NATURE, V219, P902, DOI 10.1038/219902a0; Perutz MF, 1998, ANNU REV BIOPH BIOM, V27, P1, DOI 10.1146/annurev.biophys.27.1.1; PORTEU F, 1988, J BIOL CHEM, V263, P5091; PRY TA, 1980, BIOCHEMISTRY-US, V19, P951, DOI 10.1021/bi00546a020; RICARD J, 1989, BIOPHYS J, V56, P477, DOI 10.1016/S0006-3495(89)82695-5; ROUSTIAU S, 1985, BIOCHEM SYST ECOL, V13, P45, DOI 10.1016/0305-1978(85)90012-2; ROYER WE, 1989, J BIOL CHEM, V264, P21052; SAIFULLIN SR, 1986, MOL BIOL+, V20, P187; SCHEEK RM, 1980, BIOCHIM BIOPHYS ACTA, V613, P275, DOI 10.1016/0005-2744(80)90083-2; SCULLY MF, 1989, ARCH BIOCHEM BIOPHYS, V268, P438, DOI 10.1016/0003-9861(89)90311-1; SHILIN VI, 1983, DOKL AKAD NAUK SSSR+, V271, P505; SNOW LD, 1980, BIOCHIM BIOPHYS ACTA, V611, P333, DOI 10.1016/0005-2744(80)90069-8; STEVENS RC, 1992, P NATL ACAD SCI USA, V89, P5281, DOI 10.1073/pnas.89.12.5281; SWEADNER KJ, 1985, J BIOL CHEM, V260, P1508; TAIT JF, 1981, J BIOL CHEM, V256, P1086; TAKAMA M, 1981, FEBS LETT, V123, P100, DOI 10.1016/0014-5793(81)80028-2; TERUEL JA, 1987, J BIOENERG BIOMEMBR, V19, P383, DOI 10.1007/BF00768541; TOGNI A, 1990, J ORG CHEM, V55, P1649, DOI 10.1021/jo00292a046; TUNG PS, 1984, ANN NY ACAD SCI, V438, P435, DOI 10.1111/j.1749-6632.1984.tb38304.x; USERO JL, 1985, THROMB RES, V39, P379, DOI 10.1016/0049-3848(85)90233-6; WHITEHEAD EP, 1981, J THEOR BIOL, V93, P547, DOI 10.1016/0022-5193(81)90220-4; WILHELM F, 1984, FEBS LETT, V170, P239, DOI 10.1016/0014-5793(84)81320-4; WINKLE SA, 1981, NUCLEIC ACIDS RES, V9, P3175, DOI 10.1093/nar/9.13.3175; WOLODKO WT, 1981, P NATL ACAD SCI-BIOL, V78, P2140, DOI 10.1073/pnas.78.4.2140; WOOLERY GL, 1985, J AM CHEM SOC, V107, P2370, DOI 10.1021/ja00294a029	98	113	116	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2002	277	49					46841	46844		10.1074/jbc.R200014200	http://dx.doi.org/10.1074/jbc.R200014200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622TT	12189158	hybrid			2022-12-27	WOS:000179663700001
J	Borggrefe, T; Davis, R; Erdjument-Bromage, H; Tempst, P; Kornberg, RD				Borggrefe, T; Davis, R; Erdjument-Bromage, H; Tempst, P; Kornberg, RD			A complex of the Srb8,-9,-10, and-11 transcriptional regulatory proteins from yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; C-TERMINAL DOMAIN; MEDIATOR COMPLEXES; KINASES; CTD; HOLOENZYME; PHOSPHORYLATION; REVEALS; SRB10; FORMS	The Srb8, -9, -10, and -11 proteins of yeast have been isolated as a discrete, stoichiometric complex. The isolated complex phosphorylates the C-terminal domain (CTD) of the largest subunit of RNA polymerase 11 at serines 2 and 5. In addition to the previously reported human homologs of Srb10 and 11, we have identified TRAP230/ARC240 and TRAP240/ARC250 as the human homologs of Srb8 and Srb9, showing the entire Srb8/9/10/11 complex is conserved from yeast to humans.	Stanford Univ, Dept Biol Struct, Sch Med, Stanford, CA 94305 USA; Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA	Stanford University; Memorial Sloan Kettering Cancer Center	Borggrefe, T (corresponding author), Univ Ulm, Dept Immunol, D-89081 Ulm, Germany.			Tempst, Paul/0000-0002-6680-3987; Erdjument-Bromage, Hediye/0000-0003-0224-3594	NCI NIH HHS [P30 CA08748] Funding Source: Medline; NIGMS NIH HHS [GM36659] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM036659, R01GM036659] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akoulitchev S, 2000, NATURE, V407, P102, DOI 10.1038/35024111; Bienkiewicz EA, 2000, J MOL BIOL, V297, P119, DOI 10.1006/jmbi.2000.3545; Borggrefe T, 2001, J BIOL CHEM, V276, P47150, DOI 10.1074/jbc.M109581200; Carlson M, 1997, ANNU REV CELL DEV BI, V13, P1, DOI 10.1146/annurev.cellbio.13.1.1; Chi Y, 2001, GENE DEV, V15, P1078, DOI 10.1101/gad.867501; Corden JL, 1997, TRENDS BIOCHEM SCI, V22, P413, DOI 10.1016/S0968-0004(97)01125-0; CORDEN JL, 1993, CURR OPIN GENET DEV, V3, P213, DOI 10.1016/0959-437X(93)90025-K; Dahmus ME, 1996, J BIOL CHEM, V271, P19009, DOI 10.1074/jbc.271.32.19009; Erdjument-Bromage H, 1998, J CHROMATOGR A, V826, P167, DOI 10.1016/S0021-9673(98)00705-5; FEAVER WJ, 1994, CELL, V79, P1103, DOI 10.1016/0092-8674(94)90040-X; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Hengartner CJ, 1998, MOL CELL, V2, P43, DOI 10.1016/S1097-2765(00)80112-4; Ito M, 1999, MOL CELL, V3, P361, DOI 10.1016/S1097-2765(00)80463-3; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Kuchin S, 1998, MOL CELL BIOL, V18, P1163, DOI 10.1128/MCB.18.3.1163; Lee TI, 2000, ANNU REV GENET, V34, P77, DOI 10.1146/annurev.genet.34.1.77; LIAO SM, 1995, NATURE, V374, P193, DOI 10.1038/374193a0; Liu HY, 2001, J BIOL CHEM, V276, P7541, DOI 10.1074/jbc.M009112200; Liu Y, 2001, J BIOL CHEM, V276, P7169, DOI 10.1074/jbc.M009586200; Malik S, 2000, TRENDS BIOCHEM SCI, V25, P277, DOI 10.1016/S0968-0004(00)01596-6; Myers LC, 1997, METHODS, V12, P212, DOI 10.1006/meth.1997.0473; Myers LC, 1998, GENE DEV, V12, P45, DOI 10.1101/gad.12.1.45; Myers LC, 2000, ANNU REV BIOCHEM, V69, P729, DOI 10.1146/annurev.biochem.69.1.729; Oelgeschlager T, 2002, J CELL PHYSIOL, V190, P160, DOI 10.1002/JCP.10058; Patturajan M, 1998, J BIOL CHEM, V273, P4689, DOI 10.1074/jbc.273.8.4689; Proudfoot NJ, 2002, CELL, V108, P501, DOI 10.1016/S0092-8674(02)00617-7; Ramanathan Y, 2001, J BIOL CHEM, V276, P10913, DOI 10.1074/jbc.M010975200; Rickert P, 1999, ONCOGENE, V18, P1093, DOI 10.1038/sj.onc.1202399; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Sun XQ, 1998, MOL CELL, V2, P213, DOI 10.1016/S1097-2765(00)80131-8; SVEJSTRUP JQ, 1994, J BIOL CHEM, V269, P28044; Taatjes DJ, 2002, SCIENCE, V295, P1058, DOI 10.1126/science.1065249; Treisman JE, 2001, DEVELOPMENT, V128, P603; Trigon S, 1998, J BIOL CHEM, V273, P6769, DOI 10.1074/jbc.273.12.6769; Winkler GS, 2002, METHODS, V26, P260, DOI 10.1016/S1046-2023(02)00030-0; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724; Yuryev A, 1996, GENETICS, V143, P661; Zhou MS, 2000, MOL CELL BIOL, V20, P5077, DOI 10.1128/MCB.20.14.5077-5086.2000	38	126	133	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	2002	277	46					44202	44207		10.1074/jbc.M207195200	http://dx.doi.org/10.1074/jbc.M207195200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	615XE	12200444	hybrid			2022-12-27	WOS:000179272000087
J	Andreu, JM; Oliva, MA; Monasterio, O				Andreu, JM; Oliva, MA; Monasterio, O			Reversible unfolding of FtsZ cell division proteins from archaea and bacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-BETA-TUBULIN; ESCHERICHIA-COLI; SELF-ASSOCIATION; ACTIN; CHAPERONIN; RING; BINDING; COLCHICINE; STABILITY; POLYMERIZATION	The stability, refolding, and assembly properties of FtsZ cell division proteins from Methanococcus jannaschii and Escherichia coli have been investigated. Their guanidinium chloride unfolding has been studied by circular dichroism spectroscopy. FtsZ from E. coli and tubulin released the bound guanine nucleotide, coinciding with an initial unfolding stage at low denaturant concentrations, followed by unfolding of the apoprotein. FtsZ from M. jannaschii released its nucleotide without any detectable secondary structural change. It unfolded in an apparently two-state transition at larger denaturant concentrations. Isolated FtsZ polypeptide chains were capable of spontaneous refolding and GTP-dependent assembly. The homologous eukaryotic tubulin monomers misfold in solution, but fold within the cytosolic chaperonin CCT. Analysis of the extensive tubulin loop insertions in the FtsZ/tubulin common core and of the intermolecular contacts in model microtubules and tubulin-CCT complexes shows a loop insertion present at every element of lateral protofilament contact and at every contact of tubulin with CCT (except at loop T7). The polymers formed by purified FtsZ have a distinct limited protofilament association in comparison with microtubules. We propose that the loop insertions of tubulin and its CCT-assisted folding coevolved with the lateral association interfaces responsible for extended two-dimensional polymerization into microtubule polymers.	CSIC, Ctr Invest Biol, E-28006 Madrid, Spain; Univ Chile, Fac Ciencias, Dept Biol, Santiago, Chile	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Universidad de Chile	Andreu, JM (corresponding author), CSIC, Ctr Invest Biol, Velazquez 144, E-28006 Madrid, Spain.	j.m.andreu@cib.csic.es	Oliva, Marian/H-8867-2015	Oliva, Marian/0000-0002-2215-4639; Andreu, Jose M/0000-0001-8064-6933				ANDREU JM, 1982, BIOCHEMISTRY-US, V21, P6465, DOI 10.1021/bi00268a023; Andreu JM, 1998, BIOCHEMISTRY-US, V37, P8356, DOI 10.1021/bi9728553; Ben-Yehuda S, 2002, CELL, V109, P257, DOI 10.1016/S0092-8674(02)00698-0; BI E, 1991, NATURE, V354, P161, DOI 10.1038/354161a0; Chacon P, 2002, J MOL BIOL, V317, P375, DOI 10.1006/jmbi.2002.5438; CORREIA JJ, 1987, J BIOL CHEM, V262, P17278; dePereda JM, 1996, BIOCHEMISTRY-US, V35, P14203, DOI 10.1021/bi961357b; Diaz JF, 2001, J BIOL CHEM, V276, P17307, DOI 10.1074/jbc.M010920200; Dobrzynski JK, 2000, BIOCHEMISTRY-US, V39, P3988, DOI 10.1021/bi992110s; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; Eftink MR, 1995, METHOD ENZYMOL, V259, P487; Erickson HP, 1996, P NATL ACAD SCI USA, V93, P519, DOI 10.1073/pnas.93.1.519; Farr GW, 1997, CELL, V89, P927, DOI 10.1016/S0092-8674(00)80278-0; FASMAN GD, 1992, PRACTICAL HDB BIOCH, P81; FRIGON RP, 1975, BIOCHEMISTRY-US, V14, P4559, DOI 10.1021/bi00692a001; Galkin VE, 2002, CURR BIOL, V12, P570, DOI 10.1016/S0960-9822(02)00742-X; GAO YJ, 1992, CELL, V69, P1043, DOI 10.1016/0092-8674(92)90622-J; Guha S, 1997, BIOCHEMISTRY-US, V36, P13208, DOI 10.1021/bi970993m; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Houry WA, 1999, NATURE, V402, P147, DOI 10.1038/45977; Jaenicke R, 1998, CURR OPIN STRUC BIOL, V8, P738, DOI 10.1016/S0959-440X(98)80094-8; Jimenez MA, 1999, PROTEIN SCI, V8, P788; Jones LJF, 2001, CELL, V104, P913, DOI 10.1016/S0092-8674(01)00287-2; JONES WJ, 1983, ARCH MICROBIOL, V136, P254, DOI 10.1007/BF00425213; LEE JC, 1973, J BIOL CHEM, V248, P7253; Llorca O, 2001, J STRUCT BIOL, V135, P205, DOI 10.1006/jsbi.2001.4359; Llorca O, 2001, EMBO J, V20, P4065, DOI 10.1093/emboj/20.15.4065; Llorca O, 2000, EMBO J, V19, P5971, DOI 10.1093/emboj/19.22.5971; Lowe J, 1998, NATURE, V391, P203, DOI 10.1038/34472; Lowe J, 1999, EMBO J, V18, P2364, DOI 10.1093/emboj/18.9.2364; Lowe J, 2000, BIOL CHEM, V381, P993, DOI 10.1515/BC.2000.122; Lowe J, 2001, J MOL BIOL, V313, P1045, DOI 10.1006/jmbi.2001.5077; Lu CL, 1998, CELL MOTIL CYTOSKEL, V40, P71, DOI 10.1002/(SICI)1097-0169(1998)40:1<71::AID-CM7>3.3.CO;2-Z; Lu CL, 2000, J BACTERIOL, V182, P164, DOI 10.1128/JB.182.1.164-170.2000; Luduena RF, 1998, INT REV CYTOL, V178, P207; Menendez M, 1998, J BIOL CHEM, V273, P167, DOI 10.1074/jbc.273.1.167; Meurer-Grob P, 2001, BIOCHEMISTRY-US, V40, P8000, DOI 10.1021/bi010343p; Minton AP, 2000, BIOPHYS J, V78, P101, DOI 10.1016/S0006-3495(00)76576-3; Mukherjee A, 1999, J BACTERIOL, V181, P823, DOI 10.1128/JB.181.3.823-832.1999; Nogales E, 2000, ANNU REV BIOCHEM, V69, P277, DOI 10.1146/annurev.biochem.69.1.277; Nogales E, 1999, CELL, V96, P79, DOI 10.1016/S0092-8674(00)80961-7; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; Nogales E, 1998, NAT STRUCT BIOL, V5, P451, DOI 10.1038/nsb0698-451; Pace C. N., 1997, PROTEIN STRUCTURE PR, V2, P299; Pichoff S, 2002, EMBO J, V21, P685, DOI 10.1093/emboj/21.4.685; PRAKASH V, 1982, J MOL BIOL, V160, P499, DOI 10.1016/0022-2836(82)90310-2; Record MT, 1998, TRENDS BIOCHEM SCI, V23, P190, DOI 10.1016/S0968-0004(98)01207-9; Rivas G, 2000, J BIOL CHEM, V275, P11740, DOI 10.1074/jbc.275.16.11740; Romberg L, 2001, J BIOL CHEM, V276, P11743, DOI 10.1074/jbc.M009033200; Rothfield L, 1999, ANNU REV GENET, V33, P423, DOI 10.1146/annurev.genet.33.1.423; SACKETT DL, 1994, BIOCHEMISTRY-US, V33, P12868, DOI 10.1021/bi00209a019; Schuler H, 2000, EUR J BIOCHEM, V267, P476, DOI 10.1046/j.1432-1327.2000.01023.x; Shah C, 2001, BIOCHEMISTRY-US, V40, P4844, DOI 10.1021/bi002446y; Stricker J, 2002, P NATL ACAD SCI USA, V99, P3171, DOI 10.1073/pnas.052595099; Thulasiraman V, 1999, EMBO J, V18, P85, DOI 10.1093/emboj/18.1.85; Uehara T, 2001, GENES CELLS, V6, P803, DOI 10.1046/j.1365-2443.2001.00463.x; van den Ent F, 2001, NATURE, V413, P39, DOI 10.1038/35092500; Wolff J, 1996, BIOCHEMISTRY-US, V35, P5910, DOI 10.1021/bi9527395; YAFFE MB, 1992, NATURE, V358, P245, DOI 10.1038/358245a0; Yu XC, 1999, J CELL SCI, V112, P2301	60	33	33	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					43262	43270		10.1074/jbc.M206723200	http://dx.doi.org/10.1074/jbc.M206723200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12215443	hybrid, Green Published			2022-12-27	WOS:000179081200109
J	Nogues, G; Kadener, S; Cramer, P; Bentley, D; Kornblihtt, AR				Nogues, G; Kadener, S; Cramer, P; Bentley, D; Kornblihtt, AR			Transcriptional activators differ in their abilities to control alternative splicing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; PRE-MESSENGER-RNA; PROCESSING FACTORS; TERMINAL DOMAIN; P-TEFB; ELONGATION; HIV-1; ASSOCIATION; ENHANCER; ENZYMES	Promoter and enhancer elements can influence alternative splicing, but the basis for this phenomenon is not well understood. Here we investigated how different transcriptional activators affect the decision between inclusion and exclusion (skipping) of the fibronectin EDI exon. A mutant of the acidic VP16 activation domain called SW6 that preferentially inhibits polymerase 11 (pol 11) elongation caused a reduction in EDI exon skipping. Exon skipping was fully restored in the presence of the SW6 mutant by either the SV40 enhancer in cis or the human immunodeficiency virus (HIV) Tat in trans, both of which specifically stimulate pol 11 elongation. HIV Tat also cooperated with the Sp1 and CTF activation domains to enhance transcript elongation and EDI skipping. The extent of exon skipping correlated with the efficiency with which pol 11 transcripts reach the 3' end of the gene but not with the overall fold increase in transcript levels caused by different activators. The ability of activators to enhance elongation by RNA polymerase 11 therefore correlates with their ability to enhance exon skipping. Consistent with this observation, the elongation inhibitor dichlororibofuranosylbenzimidazole (DRB) enhanced EDI inclusion. Conversely, the histone deacetylase inhibitor trichostatin A that is thought to stimulate elongation caused a modest inhibition of EDI inclusion. Together our results support a kinetic coupling model in which the rate of transcript elongation determines the outcome of two competing splicing reactions that occur co-transcriptionally. Rapid, highly processive transcription favors EDI exon skipping, whereas slower, less processive transcription favors inclusion.	Univ Colorado, Hlth Sci Ctr, Dept Biochem & Mol Genet, Denver, CO 80262 USA; Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Fisiol Biol Mol & Celular, Lab Fisiol & Biol Mol, Buenos Aires, DF, Argentina	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Buenos Aires	Kornblihtt, AR (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Fisiol Biol Mol & Celular, Lab Fisiol & Biol Mol, CI428EHA,Ciudad Univ,Pabellon 2, Buenos Aires, DF, Argentina.	ark@fbmc.fcen.uba.ar		Kornblihtt, Alberto/0000-0003-4322-0831	NIGMS NIH HHS [GM58613, R01 GM058613] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058613] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bentley D, 2002, CURR OPIN CELL BIOL, V14, P336, DOI 10.1016/S0955-0674(02)00333-2; Blau J, 1996, MOL CELL BIOL, V16, P2044; Caceres JF, 2002, TRENDS GENET, V18, P186, DOI 10.1016/S0168-9525(01)02626-9; CAPUTI M, 1994, NUCLEIC ACIDS RES, V22, P1018, DOI 10.1093/nar/22.6.1018; CHODOSH LA, 1989, J BIOL CHEM, V264, P2250; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Cramer P, 1999, MOL CELL, V4, P251, DOI 10.1016/S1097-2765(00)80372-X; Cramer P, 1997, P NATL ACAD SCI USA, V94, P11456, DOI 10.1073/pnas.94.21.11456; EPERON LP, 1988, CELL, V54, P393, DOI 10.1016/0092-8674(88)90202-4; Fong YW, 2001, NATURE, V414, P929, DOI 10.1038/414929a; Kadener S, 2002, P NATL ACAD SCI USA, V99, P8185, DOI 10.1073/pnas.122246099; Kadener S, 2001, EMBO J, V20, P5759, DOI 10.1093/emboj/20.20.5759; KAO SY, 1987, NATURE, V330, P489, DOI 10.1038/330489a0; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Lai MC, 1999, J BIOL CHEM, V274, P11832, DOI 10.1074/jbc.274.17.11832; Licatalosi DD, 2002, MOL CELL, V9, P1101, DOI 10.1016/S1097-2765(02)00518-X; Madisen L, 1998, MOL CELL BIOL, V18, P6281, DOI 10.1128/MCB.18.11.6281; Mancebo HSY, 1997, GENE DEV, V11, P2633, DOI 10.1101/gad.11.20.2633; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; MARCINIAK RA, 1991, EMBO J, V10, P4189, DOI 10.1002/j.1460-2075.1991.tb04997.x; McCracken S, 1997, NATURE, V385, P357, DOI 10.1038/385357a0; McCracken S, 1997, GENE DEV, V11, P3306, DOI 10.1101/gad.11.24.3306; Monsalve M, 2000, MOL CELL, V6, P307, DOI 10.1016/S1097-2765(00)00031-9; NAHREINI P, 1995, J VIROL, V69, P1296, DOI 10.1128/JVI.69.2.1296-1301.1995; Parada CA, 1999, EMBO J, V18, P3688, DOI 10.1093/emboj/18.13.3688; Price DH, 2000, MOL CELL BIOL, V20, P2629, DOI 10.1128/MCB.20.8.2629-2634.2000; Proudfoot NJ, 2002, CELL, V108, P501, DOI 10.1016/S0092-8674(02)00617-7; Roberts GC, 1998, NUCLEIC ACIDS RES, V26, P5568, DOI 10.1093/nar/26.24.5568; Schroeder SC, 2000, GENE DEV, V14, P2435, DOI 10.1101/gad.836300; Travers A, 1999, P NATL ACAD SCI USA, V96, P13634, DOI 10.1073/pnas.96.24.13634; Vignali M, 2000, EMBO J, V19, P2629, DOI 10.1093/emboj/19.11.2629; WALKER S, 1993, MOL CELL BIOL, V13, P5233, DOI 10.1128/MCB.13.9.5233; Wittschieben BO, 1999, MOL CELL, V4, P123, DOI 10.1016/S1097-2765(00)80194-X; YANKULOV K, 1994, CELL, V77, P749, DOI 10.1016/0092-8674(94)90058-2; Zhou QA, 1996, SCIENCE, V274, P605, DOI 10.1126/science.274.5287.605	35	140	149	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					43110	43114		10.1074/jbc.M208418200	http://dx.doi.org/10.1074/jbc.M208418200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12221105	hybrid			2022-12-27	WOS:000179081200090
J	Rajala, RVS; McClellan, ME; Ash, JD; Anderson, RE				Rajala, RVS; McClellan, ME; Ash, JD; Anderson, RE			In Vivo regulation of phosphoinositide 3-kinase in retina through ligbt-induced tyrosine phosphorylation of the insulin receptor beta-subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR; PHOSPHATIDYLINOSITOL 3-KINASE; SIGNAL-TRANSDUCTION; SH2 DOMAINS; INDUCED APOPTOSIS; LIGHT; KINASE; ACTIVATION; BINDING; PROTEINS	Recently, we have shown that phosphoinositide 3-kinase (PI3K) in bovine rod outer segment (ROS) is activated in vitro by tyrosine phosphorylation of the C-terminal tail of the insulin receptor (Rajala, R. V. S., and Anderson, R. E. (2001) Invest. Ophthal. Vis. Sci. 42,31103117). In this study, we have investigated the in vivo mechanism of PI3K activation in the rodent retina and report the novel finding that light stimulates tyrosine phosphorylation of the beta-subunit of the insulin receptor (IRbeta) in ROS membranes, which leads to the association of PI3K enzyme activity with IRbeta. Retinas from light- or dark-adapted mice and rats were homogenized and immunoprecipitated with antibodies against phosphotyrosine, IRbeta, or the p85 regulatory subunit of PI3K, and PI3K activity was measured using PI-4,5-P-2 as substrate. We observed a light-dependent increase in tyrosine phosphorylation of IRbeta and an increase in PI3K enzyme activity in isolated ROS and in anti-phosphotyrosine and anti-IRbeta immunoprecipitates of retinal homogenates. The light effect was localized to photoreceptor neurons and is independent of insulin secretion. Our results suggest that light induces tyrosine phosphorylation of IRbeta in outer segment membranes, which leads to the binding of p85 through its N-terminal Src homology 2 domain and the generation of PI-3,4,5-P-3. We suggest that the physiological role of this process may be to provide neuroprotection of the retina against light damage by activating proteins that protect against stress-induced apoptosis.	Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73104 USA; Univ Oklahoma, Hlth Sci Ctr, Dept Ophthalmol, Oklahoma City, OK 73104 USA; Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA; Dean A McGee Eye Inst, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Rajala, RVS (corresponding author), 608 Stanton L Young Blvd,Rm 409, Oklahoma City, OK 73104 USA.	raju-rajala@ouhsc.edu		Ash, John/0000-0002-8330-7301	NEI NIH HHS [EY12190, EY04149, EY00871] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY004149, P30EY012190, R01EY000871] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ANDERSON D, 1990, SCIENCE, V250, P979, DOI 10.1126/science.2173144; Barber AJ, 2001, J BIOL CHEM, V276, P32814, DOI 10.1074/jbc.M104738200; BASINGER S, 1976, SCIENCE, V194, P1074, DOI 10.1126/science.1086510; BOWES C, 1990, NATURE, V347, P677, DOI 10.1038/347677a0; CARPENTER CL, 1990, J BIOL CHEM, V265, P19704; D'Mello SR, 1997, J NEUROSCI, V17, P1548; DHAND R, 1994, EMBO J, V13, P522, DOI 10.1002/j.1460-2075.1994.tb06290.x; Donovan M, 2001, J BIOL CHEM, V276, P23000, DOI 10.1074/jbc.M005359200; Fain GL, 2001, PHYSIOL REV, V81, P117, DOI 10.1152/physrev.2001.81.1.117; Fruman DA, 1998, ANNU REV BIOCHEM, V67, P481, DOI 10.1146/annurev.biochem.67.1.481; FRY MJ, 1994, BBA-MOL BASIS DIS, V1226, P237, DOI 10.1016/0925-4439(94)90036-1; Ghalayini AJ, 1998, EXP EYE RES, V66, P817, DOI 10.1006/exer.1998.0498; GHALAYINI AJ, 1995, CURR EYE RES, V14, P1025, DOI 10.3109/02713689508998525; Ghalayini AJ, 2002, J BIOL CHEM, V277, P1469, DOI 10.1074/jbc.M011432200; Guo XX, 1997, INVEST OPHTH VIS SCI, V38, P1873; Guo XX, 2000, MOL VIS, V6, P216; Hafezi F, 1997, EXP EYE RES, V64, P963, DOI 10.1006/exer.1997.0288; Hao WS, 1999, J BIOL CHEM, V274, P6085, DOI 10.1074/jbc.274.10.6085; HOLLYFIELD JG, 1979, INVEST OPHTH VIS SCI, V18, P117; HU P, 1993, MOL CELL BIOL, V13, P7677, DOI 10.1128/MCB.13.12.7677; Huang Z, 2000, J NEUROCHEM, V75, P355, DOI 10.1046/j.1471-4159.2000.0750355.x; IUVONE PM, 1984, FED PROC, V43, P2709; JAMES CRH, 1983, BRIT J OPHTHALMOL, V67, P80, DOI 10.1136/bjo.67.2.80; KAPLAN DR, 1987, CELL, V50, P1021, DOI 10.1016/0092-8674(87)90168-1; KLIPPEL A, 1992, MOL CELL BIOL, V12, P1451, DOI 10.1128/MCB.12.4.1451; KOCH CA, 1991, SCIENCE, V252, P668, DOI 10.1126/science.1708916; Kramer RH, 2001, J EXP BIOL, V204, P2921; LEM J, 1992, P NATL ACAD SCI USA, V89, P4422, DOI 10.1073/pnas.89.10.4422; Martin TFJ, 1998, ANNU REV CELL DEV BI, V14, P231, DOI 10.1146/annurev.cellbio.14.1.231; McGinnis JF, 2002, J NEUROSCI RES, V67, P290, DOI 10.1002/jnr.10120; MCGLADE CJ, 1992, MOL CELL BIOL, V12, P991, DOI 10.1128/MCB.12.3.991; Miyamoto Y, 1998, P NATL ACAD SCI USA, V95, P6097, DOI 10.1073/pnas.95.11.6097; MURESAN V, 1993, J CELL SCI, V104, P1229; Nagy F, 2001, J CELL SCI, V114, P475; Nakahata Y, 2000, J NEUROCHEM, V74, P2436, DOI 10.1046/j.1471-4159.2000.0742436.x; NOELL WK, 1971, SCIENCE, V172, P76, DOI 10.1126/science.172.3978.76; NOELL WK, 1980, VISION RES, V20, P1163, DOI 10.1016/0042-6989(80)90055-3; Obrietan K, 1998, NAT NEUROSCI, V1, P693, DOI 10.1038/3695; ORGANISCIAK DT, 1991, EXP EYE RES, V53, P773, DOI 10.1016/0014-4835(91)90113-S; OTSU M, 1991, CELL, V65, P91, DOI 10.1016/0092-8674(91)90411-Q; Pawson T, 2000, GENE DEV, V14, P1027; Peterson JE, 1996, J BIOL CHEM, V271, P31562, DOI 10.1074/jbc.271.49.31562; PITTLER SJ, 1991, P NATL ACAD SCI USA, V88, P8322, DOI 10.1073/pnas.88.19.8322; Rajala RVS, 2001, INVEST OPHTH VIS SCI, V42, P3110; ROOF D, 2000, PRINCIPLES PRACTICE; RUDERMAN NB, 1990, P NATL ACAD SCI USA, V87, P1411, DOI 10.1073/pnas.87.4.1411; SAARI JC, 1977, INVEST OPHTH VIS SCI, V16, P797; Saltiel AR, 2002, TRENDS CELL BIOL, V12, P65, DOI 10.1016/S0962-8924(01)02207-3; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; SIDMAN RL, 1965, J HERED, V56, P23, DOI 10.1093/oxfordjournals.jhered.a107364; SKOLNIK EY, 1991, CELL, V65, P83, DOI 10.1016/0092-8674(91)90410-Z; Spear N, 1997, J NEUROCHEM, V69, P53; Tabatabaie T, 2000, BIOCHEM BIOPH RES CO, V273, P699, DOI 10.1006/bbrc.2000.2959; WALDBILLIG RJ, 1987, EXP EYE RES, V45, P823, DOI 10.1016/S0014-4835(87)80099-4; WALDBILLIG RJ, 1987, EXP EYE RES, V45, P837, DOI 10.1016/S0014-4835(87)80100-8; Wetzel RK, 1999, J NEUROSCI, V19, P9878; WHELAN JP, 1988, J NEUROSCI RES, V20, P263, DOI 10.1002/jnr.490200216; WHITMAN M, 1988, NATURE, V332, P644, DOI 10.1038/332644a0; WILLIAMS LT, 1989, SCIENCE, V243, P1564, DOI 10.1126/science.2538922; YOAKIM M, 1992, J VIROL, V66, P5485, DOI 10.1128/JVI.66.9.5485-5491.1992; YU KT, 1985, J BIOL CHEM, V260, P5838	61	72	75	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					43319	43326		10.1074/jbc.M206355200	http://dx.doi.org/10.1074/jbc.M206355200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12213821	hybrid			2022-12-27	WOS:000179081200115
J	Taylor, NL; Day, DA; Millar, AH				Taylor, NL; Day, DA; Millar, AH			Environmental stress causes oxidative damage to plant mitochondria leading to inhibition of glycine decarboxylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PYRUVATE-DEHYDROGENASE COMPLEX; LIPID-PEROXIDATION; ALTERNATIVE OXIDASE; LIPOIC ACID; CARDIAC REPERFUSION; MAIZE SEEDLINGS; FATTY-ACID; RESPIRATION; ACETYLTRANSFERASE; INACTIVATION	A cytotoxic product of lipid peroxidation, 4-hydroxy-2-nonenal (HNE), rapidly inhibited glycine, malate/pyruvate, and 2-oxoglutarate-dependent O-2 consumption by pea leaf mitochondria. Dose- and time-dependence of inhibition showed that glycine oxidation was the most severely affected with a K-0.5 of 30 mum. Several mitochondrial proteins containing lipoic acid moieties differentially lost their reactivity to a lipoic acid antibody following HNE treatment. The most dramatic loss of antigenicity was seen with the 17-kDa glycine decarboxylase complex (GDC) H-protein, which was correlated with the loss of glycine-dependent O-2 consumption. Paraquat treatment of pea seedlings induced lipid peroxidation, which resulted in the rapid loss of glycine-dependent respiration and loss of H-protein reactivity with lipoic acid antibodies. Pea plants exposed to chilling and water deficit responded similarly. In contrast, the damage to other lipoic acid-containing mitochondrial enzymes was minor under these conditions. The implication of the acute sensitivity of glycine decarboxylase complex H-protein to lipid peroxidation products is discussed in the context of photorespiration and potential repair mechanisms in plant mitochondria.	Univ Western Australia, Fac Life & Phys Sci, Plant Mol Biol Grp, Sch Biomed & Chem Sci, Crawley, WA, Australia	University of Western Australia	Millar, AH (corresponding author), Univ Western Australia, Fac Life & Phys Sci, Plant Mol Biol Grp, Sch Biomed & Chem Sci, Crawley, WA, Australia.	hmillar@cyllene.uwa.edu.au	Millar, A. Harvey/A-5452-2008; Taylor, Nicolas L/A-5731-2008; Day, David/F-6325-2011	Millar, A. Harvey/0000-0001-9679-1473; Taylor, Nicolas L/0000-0003-2004-5217; Day, David/0000-0001-7967-2173				ALIN P, 1985, FEBS LETT, V179, P267, DOI 10.1016/0014-5793(85)80532-9; BUDDE RJA, 1990, P NATL ACAD SCI USA, V87, P673, DOI 10.1073/pnas.87.2.673; DAY DA, 1985, AUST J PLANT PHYSIOL, V12, P219, DOI 10.1071/PP9850219; De Santis A, 1999, PLANT PHYSIOL, V119, P743, DOI 10.1104/pp.119.2.743; DODGE AD, 1971, ENDEAVOUR, V30, P130, DOI 10.1016/0160-9327(71)90039-1; Douce R, 2001, TRENDS PLANT SCI, V6, P167, DOI 10.1016/S1360-1385(01)01892-1; ELTHON TE, 1989, PLANT PHYSIOL, V89, P1311, DOI 10.1104/pp.89.4.1311; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Gomez JM, 1999, FREE RADICAL RES, V31, pS11, DOI 10.1080/10715769900301261; Gronwald JW, 1998, PLANT PHYSIOL, V117, P877, DOI 10.1104/pp.117.3.877; Gueguen V, 2000, J BIOL CHEM, V275, P5016, DOI 10.1074/jbc.275.7.5016; Halliwell B., 1999, FREE RADICAL BIO MED, Vthird, P246; Halliwell B., 1999, FREE RADICAL BIO MED, V3, P36; HERNANDEZ JA, 1993, PHYSIOL PLANTARUM, V89, P103, DOI 10.1111/j.1399-3054.1993.tb01792.x; Hodges DM, 1999, PLANTA, V207, P604, DOI 10.1007/s004250050524; Hubatsch I, 1998, BIOCHEM J, V330, P175, DOI 10.1042/bj3300175; Humphries KM, 1998, BIOCHEMISTRY-US, V37, P15835, DOI 10.1021/bi981512h; Humphries KM, 1998, BIOCHEMISTRY-US, V37, P552, DOI 10.1021/bi971958i; Iturbe-Ormaetxe I, 1998, PLANT PHYSIOL, V116, P173, DOI 10.1104/pp.116.1.173; Jordan SW, 1997, J BIOL CHEM, V272, P17903, DOI 10.1074/jbc.272.29.17903; KRAUS TE, 1995, J PLANT PHYSIOL, V145, P570, DOI 10.1016/S0176-1617(11)81790-6; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liu F, 2001, PLANT CELL, V13, P1063, DOI 10.1105/tpc.13.5.1063; Lucas DT, 1998, P NATL ACAD SCI USA, V95, P510, DOI 10.1073/pnas.95.2.510; Lucas DT, 1999, P NATL ACAD SCI USA, V96, P6689, DOI 10.1073/pnas.96.12.6689; Mano J, 2001, BBA-BIOENERGETICS, V1504, P275, DOI 10.1016/S0005-2728(00)00256-5; Maxwell DP, 1999, P NATL ACAD SCI USA, V96, P8271, DOI 10.1073/pnas.96.14.8271; Millar AH, 1999, EUR J BIOCHEM, V264, P973, DOI 10.1046/j.1432-1327.1999.00707.x; Millar AH, 2001, PLANT PHYSIOL, V127, P1711, DOI 10.1104/pp.010387; Millar AH, 2000, FEBS LETT, V481, P117, DOI 10.1016/S0014-5793(00)01976-1; Moller IM, 2001, TRENDS PLANT SCI, V6, P560, DOI 10.1016/S1360-1385(01)02100-8; Oberschall A, 2000, PLANT J, V24, P437, DOI 10.1046/j.1365-313x.2000.00885.x; PALMEIRA CM, 1995, BBA-BIOENERGETICS, V1229, P187, DOI 10.1016/0005-2728(94)00202-G; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; PRASAD TK, 1994, PLANT CELL, V6, P65, DOI 10.1105/tpc.6.1.65; Purvis AC, 1997, PHYSIOL PLANTARUM, V100, P165, DOI 10.1034/j.1399-3054.1997.1000119.x; Takamura H, 1996, BBA-LIPID LIPID MET, V1303, P83, DOI 10.1016/0005-2760(96)00076-8; Thelen JJ, 1999, J BIOL CHEM, V274, P21769, DOI 10.1074/jbc.274.31.21769; Van Camp W, 1998, TRENDS PLANT SCI, V3, P330, DOI 10.1016/S1360-1385(98)01297-7; Vauclare P, 1996, PLANT PHYSIOL, V112, P1523, DOI 10.1104/pp.112.4.1523; VIANELLO A, 1986, J PLANT PHYSIOL, V125, P217, DOI 10.1016/S0176-1617(86)80144-4; VIANELLO A, 1987, PLANT CELL PHYSIOL, V28, P1263; WAGNER AM, 1995, PHYSIOL PLANTARUM, V95, P318, DOI 10.1111/j.1399-3054.1995.tb00844.x; Wingler A, 2000, PHILOS T R SOC B, V355, P1517, DOI 10.1098/rstb.2000.0712; ZHANG QS, 1995, ARCH BIOCHEM BIOPHYS, V320, P250, DOI 10.1016/0003-9861(95)90007-1	45	144	151	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					42663	42668		10.1074/jbc.M204761200	http://dx.doi.org/10.1074/jbc.M204761200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12213810	hybrid			2022-12-27	WOS:000179081200031
J	Tussie-Luna, MI; Michel, B; Hakre, S; Roy, AL				Tussie-Luna, MI; Michel, B; Hakre, S; Roy, AL			The SUMO ubiquitin-protein isopeptide ligase family member Miz1/PIASx beta/Siz2 is a transcriptional cofactor for TFII-I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WILLIAMS-BEUREN-SYNDROME; RETINOBLASTOMA-PROTEIN; SYNDROME DELETION; BINDING PROTEIN; YEAST SEPTINS; GENE; IDENTIFICATION; CONJUGATION; ENCODES; MOTIF	We have shown previously that a TFII-I-related protein, hMusTRD1/BEN, represses transcriptional activity of TFII-I. The repression by hMusTRD1/BEN was hypothesized to occur via a two-step competition mechanism involving a cytoplasmic shuttling factor and a nuclear cofactor required for transcriptional activation of TFII-I. Employing a two-hybrid approach with both yeast genomic and mouse cDNA libraries in parallel, we have identified the RING-like zinc finger containing Miz1/PIASxbeta/Siz2, which is a ubiquitin-protein isopeptide ligase in the SUMO pathway, as the potential nuclear cofactor that interacts with both TFII-I and hMus-TRD1/BEN. Our conclusion is based on the following observations. First, the interactions are biochemically confirmed in mammalian cells where Miz1/mPIASxbeta interacts with both TFII-I and hMusTRD1/BEN when these proteins are ectopically co-expressed. Second, coexpression of a nuclear localization signal-deficient mutant of Miz1/mPIASxbeta with wild type TFII-I fails to alter the subcellular localization of the former. Finally, ectopically expressed Miz1/mPIASxbeta augments the transcriptional activity of TFII-I and relieves the repression exerted by a mutant hMusTRD1/BEN that co-localized with TFII-I in the nucleus.	Tufts Univ, Sch Med, Dept Pathol, Boston, MA 02111 USA; Tufts Univ, Sch Med, Dept Biochem, Boston, MA 02111 USA; Tufts Univ, Sch Med, Program Immunol, Boston, MA 02111 USA; Tufts Univ, Sch Med, Genet Program, Boston, MA 02111 USA	Tufts University; Tufts University; Tufts University; Tufts University	Roy, AL (corresponding author), Tufts Univ, Sch Med, Dept Pathol, 136 Harrison Ave, Boston, MA 02111 USA.	ananda.roy@tufts.edu		Tussie-Luna, Maria Isabel/0000-0002-5033-408X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI045150, R01AI045150] Funding Source: NIH RePORTER; NIAID NIH HHS [AI45150] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aravind L, 2000, TRENDS BIOCHEM SCI, V25, P112, DOI 10.1016/S0968-0004(99)01537-6; Bayarsaihan D, 2000, P NATL ACAD SCI USA, V97, P7342, DOI 10.1073/pnas.97.13.7342; Cheriyath V, 2000, J BIOL CHEM, V275, P26300, DOI 10.1074/jbc.M002980200; Chung CD, 1997, SCIENCE, V278, P1803, DOI 10.1126/science.278.5344.1803; DUNAIEF JL, 1994, CELL, V79, P119, DOI 10.1016/0092-8674(94)90405-7; Franke Y, 1999, CYTOGENET CELL GENET, V86, P296, DOI 10.1159/000015322; Freemont PS, 2000, CURR BIOL, V10, pR84, DOI 10.1016/S0960-9822(00)00287-6; Hari KL, 2001, GENE DEV, V15, P1334, DOI 10.1101/gad.877901; Hochstrasser M, 2001, CELL, V107, P5, DOI 10.1016/S0092-8674(01)00519-0; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; James P, 1996, GENETICS, V144, P1425; Johnson ES, 2001, CELL, V106, P735, DOI 10.1016/S0092-8674(01)00491-3; Jurado LAP, 1998, HUM MOL GENET, V7, P325, DOI 10.1093/hmg/7.3.325; Kahyo T, 2001, MOL CELL, V8, P713, DOI 10.1016/S1097-2765(01)00349-5; Kentsis A, 2002, P NATL ACAD SCI USA, V99, P667, DOI 10.1073/pnas.012317299; Kotaja N, 2000, MOL ENDOCRINOL, V14, P1986, DOI 10.1210/me.14.12.1986; Kotaja N, 2002, MOL CELL BIOL, V22, P5222, DOI 10.1128/MCB.22.14.5222-5234.2002; Li SJ, 2000, MOL CELL BIOL, V20, P2367, DOI 10.1128/MCB.20.7.2367-2377.2000; Liu B, 1998, P NATL ACAD SCI USA, V95, P10626, DOI 10.1073/pnas.95.18.10626; Liu B, 2001, P NATL ACAD SCI USA, V98, P3203, DOI 10.1073/pnas.051489598; Moilanen AM, 1999, J BIOL CHEM, V274, P3700, DOI 10.1074/jbc.274.6.3700; NAKAI K, 1992, GENOMICS, V14, P897, DOI 10.1016/S0888-7543(05)80111-9; Novina CD, 1999, MOL CELL BIOL, V19, P5014; O'Mahoney JV, 1998, MOL CELL BIOL, V18, P6641, DOI 10.1128/MCB.18.11.6641; Osborne LR, 1999, GENOMICS, V57, P279, DOI 10.1006/geno.1999.5784; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Roy AL, 1997, EMBO J, V16, P7091, DOI 10.1093/emboj/16.23.7091; Roy AL, 2001, GENE, V274, P1, DOI 10.1016/S0378-1119(01)00625-4; Sachdev S, 2001, GENE DEV, V15, P3088, DOI 10.1101/gad.944801; Schmidt D, 2002, P NATL ACAD SCI USA, V99, P2872, DOI 10.1073/pnas.052559499; Strunnikov AV, 2001, GENETICS, V158, P95; Takahashi Y, 2001, J BIOL CHEM, V276, P48973, DOI 10.1074/jbc.M109295200; Takahashi Y, 2001, GENE, V275, P223, DOI 10.1016/S0378-1119(01)00662-X; Tassabehji M, 1999, EUR J HUM GENET, V7, P737, DOI 10.1038/sj.ejhg.5200396; Tussie-Luna MI, 2001, P NATL ACAD SCI USA, V98, P7789, DOI 10.1073/pnas.141222298; Wang YK, 1998, GENOMICS, V48, P163, DOI 10.1006/geno.1997.5182; Wu L, 1997, MECH DEVELOP, V65, P3, DOI 10.1016/S0925-4773(97)00032-4; Yan XM, 2000, BIOCHEM J, V345, P749, DOI 10.1042/0264-6021:3450749	38	28	29	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					43185	43193		10.1074/jbc.M207635200	http://dx.doi.org/10.1074/jbc.M207635200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12193603	hybrid			2022-12-27	WOS:000179081200100
J	Wang, XJ; Xu, SQ; Rivolta, C; Li, LY; Peng, GH; Swain, PK; Sung, CH; Swaroop, A; Berson, EL; Dryja, TP; Chen, SM				Wang, XJ; Xu, SQ; Rivolta, C; Li, LY; Peng, GH; Swain, PK; Sung, CH; Swaroop, A; Berson, EL; Dryja, TP; Chen, SM			Barrier to autointegration factor interacts with the cone-rod homeobox and represses its Transactivation function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BARDET-BIEDL-SYNDROME; DOMINANT RETINITIS-PIGMENTOSA; LEBER CONGENITAL AMAUROSIS; CRX TRANSCRIPTION FACTOR; GENE-EXPRESSION; RETROVIRAL DNA; LEUCINE-ZIPPER; HOMEODOMAIN PROTEIN; CRYSTAL-STRUCTURE; CELLULAR FACTOR	Crx (cone-rod homeobox) is a homeodomain transcription factor implicated in regulating the expression of photoreceptor and pineal genes. To identify proteins that interact with Crx in the retina, we carried out a yeast two-hybrid screen of a retinal cDNA library. One of the identified clones encodes Baf (barrier to autointegration factor), which was previously shown to have a role in mitosis and retroviral integration. Additional biochemical assays provided supporting evidence for a Baf-Crx interaction. The Baf protein is detectable in all nuclear layers of the mouse retina, including the photo-receptors and the bipolar cells where Crx is expressed. Transient transfection assays with a rhodopsin-luciferase reporter in HEK293 cells demonstrate that overexpression of Baf represses Crx-mediated transactivation, suggesting that Baf acts as a negative regulator of Crx. Consistent with this role for Baf, an E80A mutation of CRX associated with cone-rod dystrophy has a higher than normal transactivation potency but a reduced interaction with Baf. Although our studies did not identify a causative Baf mutation in retinopathies, we suggest that Baf may contribute to the phenotype of a photoreceptor degenerative disease by modifying the activity of Crx. In view of the ubiquitous expression of Baf, we hypothesize that it may play a role in regulating tissue- or cell type-specific gene expression by interacting with homeodomain transcription factors.	Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Ocular Mol Genet Inst, Boston, MA 02114 USA; Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Berman Gund Lab Study Retinal Degenerat, Boston, MA 02114 USA; Univ Michigan, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48105 USA; Univ Michigan, Dept Human Genet, Ann Arbor, MI 48105 USA; Cornell Univ, Weill Med Coll, Margaret M Dyson Vis Res Inst, Dept Cell Biol & Anat, New York, NY 10021 USA	Washington University (WUSTL); Washington University (WUSTL); Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Cornell University	Chen, SM (corresponding author), Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, 660 S Euclid Ave,Campus Box 8096, St Louis, MO 63110 USA.	chen@vision.wustl.edu	Huang, Yifei/ABE-7566-2020	Swaroop, Anand/0000-0002-1975-1141; Rivolta, Carlo/0000-0002-0733-9950	NEI NIH HHS [EY12543, EY00169, R01 EY012543, EY02687, EY08683, R01 EY011307, EY11115] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY011115, R37EY000169, R01EY011307, P30EY002687, R01EY012543, R01EY008683, R01EY000169] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Baas D, 2000, MOL BRAIN RES, V78, P26, DOI 10.1016/S0169-328X(00)00060-7; Beales PL, 1997, J MED GENET, V34, P92, DOI 10.1136/jmg.34.2.92; Bessant DAR, 1999, NAT GENET, V21, P355, DOI 10.1038/7678; Bibb LC, 2001, HUM MOL GENET, V10, P1571, DOI 10.1093/hmg/10.15.1571; Blackshaw S, 2001, CELL, V107, P579, DOI 10.1016/S0092-8674(01)00574-8; Bobola N, 1999, MECH DEVELOP, V82, P165, DOI 10.1016/S0925-4773(98)00162-2; Bruford EA, 1997, GENOMICS, V41, P93, DOI 10.1006/geno.1997.4613; Cai M, 1998, NAT STRUCT BIOL, V5, P903, DOI 10.1038/2345; CELENZA JL, 1989, MOL CELL BIOL, V9, P5045, DOI 10.1128/MCB.9.11.5045; Chau KY, 2000, J BIOL CHEM, V275, P37264, DOI 10.1074/jbc.M002763200; Chau KY, 2000, J NEUROSCI, V20, P7317; Chen HM, 1998, P NATL ACAD SCI USA, V95, P15270, DOI 10.1073/pnas.95.26.15270; Chen SM, 1996, J BIOL CHEM, V271, P28549, DOI 10.1074/jbc.271.45.28549; Chen SM, 2002, HUM MOL GENET, V11, P873, DOI 10.1093/hmg/11.8.873; Chen SM, 1997, NEURON, V19, P1017, DOI 10.1016/S0896-6273(00)80394-3; Cohen M, 2001, TRENDS BIOCHEM SCI, V26, P41, DOI 10.1016/S0968-0004(00)01727-8; Fei YJ, 2000, INVEST OPHTH VIS SCI, V41, P2849; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Fong SL, 1999, CURR EYE RES, V18, P283, DOI 10.1076/ceyr.18.4.283.5360; Freund C, 1996, HUM MOL GENET, V5, P1471, DOI 10.1093/hmg/5.Supplement_1.1471; Freund CL, 1998, NAT GENET, V18, P311, DOI 10.1038/ng0498-311; Freund CL, 1997, CELL, V91, P543, DOI 10.1016/S0092-8674(00)80440-7; Furukawa K, 1999, J CELL SCI, V112, P2485; Furukawa T, 1997, CELL, V91, P531, DOI 10.1016/S0092-8674(00)80439-0; Furukawa T, 1999, NAT GENET, V23, P466, DOI 10.1038/70591; Hagstrom SA, 1998, NAT GENET, V18, P174, DOI 10.1038/ng0298-174; HANSON IM, 1993, HUM MOL GENET, V2, P915; Haraguchi T, 2001, J CELL SCI, V114, P4575; Hegele RA, 2001, TRENDS MOL MED, V7, P121, DOI 10.1016/S1471-4914(01)01930-X; Humphries MM, 1997, NAT GENET, V15, P216, DOI 10.1038/ng0297-216; Jacobson SG, 1998, INVEST OPHTH VIS SCI, V39, P2417; JORDAN T, 1992, NAT GENET, V1, P328, DOI 10.1038/ng0892-328; Katsanis N, 1999, AM J HUM GENET, V65, P1672, DOI 10.1086/302684; KISSINGER CR, 1990, CELL, V63, P579, DOI 10.1016/0092-8674(90)90453-L; Kumar R, 1996, J BIOL CHEM, V271, P29612, DOI 10.1074/jbc.271.47.29612; La Spada AR, 2001, NEURON, V31, P913, DOI 10.1016/S0896-6273(01)00422-6; Lee KK, 2001, J CELL SCI, V114, P4567; LEE MS, 1994, P NATL ACAD SCI USA, V91, P9823, DOI 10.1073/pnas.91.21.9823; Lee MS, 1998, P NATL ACAD SCI USA, V95, P1528, DOI 10.1073/pnas.95.4.1528; Li XD, 1998, P NATL ACAD SCI USA, V95, P1876, DOI 10.1073/pnas.95.4.1876; Lin F, 2000, J BIOL CHEM, V275, P4840, DOI 10.1074/jbc.275.7.4840; LIU ISC, 1994, NEURON, V13, P377, DOI 10.1016/0896-6273(94)90354-9; Livesey FJ, 2000, CURR BIOL, V10, P301, DOI 10.1016/S0960-9822(00)00379-1; MANCINI MA, 1994, P NATL ACAD SCI USA, V91, P418, DOI 10.1073/pnas.91.1.418; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Mitton KP, 2000, J BIOL CHEM, V275, P29794, DOI 10.1074/jbc.M003658200; Morris GE, 2001, TRENDS MOL MED, V7, P572, DOI 10.1016/S1471-4914(01)02128-1; OLSSON JE, 1992, NEURON, V9, P815, DOI 10.1016/0896-6273(92)90236-7; Percin EF, 2000, NAT GENET, V25, P397, DOI 10.1038/78071; Rehemtulla A, 1996, P NATL ACAD SCI USA, V93, P191, DOI 10.1073/pnas.93.1.191; Rivolta C, 2001, HUM MUTAT, V18, P488, DOI 10.1002/humu.1226; Rogue RS, 1999, BRAIN RES, V836, P110, DOI 10.1016/S0006-8993(99)01625-X; Segura-Totten M, 2002, J CELL BIOL, V158, P475, DOI 10.1083/jcb.200202019; Shumaker DK, 2001, EMBO J, V20, P1754, DOI 10.1093/emboj/20.7.1754; Sohocki MM, 1998, AM J HUM GENET, V63, P1307, DOI 10.1086/302101; Swain PK, 2001, J BIOL CHEM, V276, P36824, DOI 10.1074/jbc.M105855200; Swain PK, 1997, NEURON, V19, P1329, DOI 10.1016/S0896-6273(00)80423-7; SWAROOP A, 1992, P NATL ACAD SCI USA, V89, P266, DOI 10.1073/pnas.89.1.266; Swaroop A, 1999, HUM MOL GENET, V8, P299, DOI 10.1093/hmg/8.2.299; Tai AW, 1999, CELL, V97, P877, DOI 10.1016/S0092-8674(00)80800-4; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TON CCT, 1991, CELL, V67, P1059, DOI 10.1016/0092-8674(91)90284-6; Umland TC, 2000, BIOCHEMISTRY-US, V39, P9130, DOI 10.1021/bi000572w; WALTHER C, 1991, DEVELOPMENT, V113, P1435; WILSON DS, 1995, CELL, V82, P709, DOI 10.1016/0092-8674(95)90468-9; Yanagi Y, 2000, BIOCHEM BIOPH RES CO, V269, P410, DOI 10.1006/bbrc.2000.2304; Young TL, 1999, AM J HUM GENET, V65, P1680, DOI 10.1086/302686; Zheng RL, 2000, P NATL ACAD SCI USA, V97, P8997, DOI 10.1073/pnas.150240197; Zhu XM, 2000, MOL CELL BIOL, V20, P5216, DOI 10.1128/MCB.20.14.5216-5226.2000	71	105	106	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					43288	43300		10.1074/jbc.M207952200	http://dx.doi.org/10.1074/jbc.M207952200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12215455	hybrid, Green Accepted			2022-12-27	WOS:000179081200112
J	Zalensky, AO; Siino, JS; Gineitis, AA; Zalenskaya, IA; Tomilin, NV; Yau, P; Bradbury, EM				Zalensky, AO; Siino, JS; Gineitis, AA; Zalenskaya, IA; Tomilin, NV; Yau, P; Bradbury, EM			Human testis/sperm-specific histone H2B (hTSH2B) - Molecular cloning and characterization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR BASIC-PROTEINS; HUMAN-SPERM CHROMATIN; N-TERMINUS; CENP-A; GENE; EXPRESSION; TH2B; SPERMATOGENESIS; RAT; SPERMIOGENESIS	Human sperm, unlike the sperm of other mammals, contain replacement histones with unknown biological functions. Here, we report the identification of the novel human gene coding for a testis/sperm-specific histone H2B (hTSH2B). This variant histone is 85% homologous to somatic H2B and has over 93% homology with the testis H2B of rodents. Using genomic PCR, two genetic alleles of hTSH2B were found in the human population. The hTSH2B gene is transcribed exclusively in testis, and the corresponding protein is also present in mature sperm. We expressed recombinant hTSH2B and identified this protein with a particular H2B subtype expressed in vivo. The subnuclear distribution of H2B variants in sperm was determined using biochemical fractionation and immunoblotting. The H2B variant associated with telomere-binding activity (15) was solubilized by Triton X-100 or micrococcal nuclease extraction, whereas hTSH2B was relatively tightly bound in nuclei. Immunofluorescence showed that hTSH2B was concentrated in spots located at the basal nuclear area of a subpopulation (20% of cells) of mature sperm. This fact may be of particular importance, because the hTSH2B "positive" and "negative" sperm cells may undergo significantly different decondensation processes following fertilization.	Univ Calif Davis, Sch Med, Dept Biol Chem, Davis, CA 95616 USA; Russian Acad Sci, Inst Cytol, St Petersburg 194064, Russia; Los Alamos Natl Lab, Biosci Div, Los Alamos, NM 87545 USA	University of California System; University of California Davis; Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Institute of Cytology RAS; United States Department of Energy (DOE); Los Alamos National Laboratory	Zalensky, AO (corresponding author), Univ Calif Davis, Sch Med, Dept Biol Chem, Davis, CA 95616 USA.	aozalensky@ucdavis.edu		Yau, Peter/0000-0002-1984-185X	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD039830] Funding Source: NIH RePORTER; NICHD NIH HHS [HD39830] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Albig W, 1999, BIOL CHEM, V380, P7, DOI 10.1515/BC.1999.002; Aul RB, 2002, DEV BIOL, V242, P268, DOI 10.1006/dbio.2002.0575; AUSUBEL F, 1989, CURRENT PROTOCOLES M; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Choi YC, 1996, DNA CELL BIOL, V15, P495, DOI 10.1089/dna.1996.15.495; CHOI YC, 1991, J BIOL CHEM, V266, P20504; de la Barre AE, 2001, EMBO J, V20, P6383, DOI 10.1093/emboj/20.22.6383; Doenecke D, 1997, HISTOCHEM CELL BIOL, V107, P1, DOI 10.1007/s004180050083; Drabent B, 2000, HISTOCHEM CELL BIOL, V113, P433; Fantz DA, 2001, BIOL REPROD, V64, P425, DOI 10.1095/biolreprod64.2.425; GATEWOOD JM, 1987, SCIENCE, V236, P962, DOI 10.1126/science.3576213; GATEWOOD JM, 1990, J BIOL CHEM, V265, P20662; Gineitis AA, 2000, J CELL BIOL, V151, P1591, DOI 10.1083/jcb.151.7.1591; GUSSE M, 1986, BIOCHIM BIOPHYS ACTA, V884, P124, DOI 10.1016/0304-4165(86)90235-7; HUH NE, 1991, NUCLEIC ACIDS RES, V19, P93, DOI 10.1093/nar/19.1.93; HURLEY CK, 1977, ANAL BIOCHEM, V80, P624, DOI 10.1016/0003-2697(77)90687-X; HWANG IH, 1989, MOL CELL BIOL, V9, P1005, DOI 10.1128/MCB.9.3.1005; Jedrusik MA, 2002, J CELL SCI, V115, P2881; KIM YJ, 1987, DEV BIOL, V124, P23, DOI 10.1016/0012-1606(87)90455-6; Kozik A, 1998, MOL REPROD DEV, V51, P98, DOI 10.1002/(SICI)1098-2795(199809)51:1&lt;98::AID-MRD12&gt;3.0.CO;2-Q; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIM K, 1992, J BIOL CHEM, V267, P15271; Lin QC, 2000, MOL CELL BIOL, V20, P2122, DOI 10.1128/MCB.20.6.2122-2128.2000; Luger K, 1999, METHOD ENZYMOL, V304, P3; Marret C, 1998, MOL REPROD DEV, V51, P22, DOI 10.1002/(SICI)1098-2795(199809)51:1&lt;22::AID-MRD3&gt;3.0.CO;2-Y; MAYERHOFER A, 1990, J CELL BIOL, V110, pB81; Meistrich M., 1989, HISTONES OTHER BASIC, P165; MEISTRICH ML, 1985, DEV BIOL, V112, P230, DOI 10.1016/0012-1606(85)90137-X; MOSS SB, 1989, DEV BIOL, V133, P83, DOI 10.1016/0012-1606(89)90299-6; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; PALMER DK, 1987, J CELL BIOL, V104, P805, DOI 10.1083/jcb.104.4.805; Rogakou EP, 2000, BIOTECHNIQUES, V28, P38, DOI 10.2144/00281bm06; Roux K H, 1997, Methods Mol Biol, V67, P39; TANPHAICHITR N, 1978, EXP CELL RES, V117, P347, DOI 10.1016/0014-4827(78)90148-9; Tseng TC, 1998, DNA CELL BIOL, V17, P823, DOI 10.1089/dna.1998.17.823; UNNI E, 1995, BIOL REPROD, V53, P820, DOI 10.1095/biolreprod53.4.820; UNNI E, 1995, MOL REPROD DEV, V42, P210, DOI 10.1002/mrd.1080420210; van Roijen JH, 1998, HUM REPROD, V13, P1559, DOI 10.1093/humrep/13.6.1559; WATTANASEREE J, 1983, ARCH BIOCHEM BIOPHYS, V225, P892, DOI 10.1016/0003-9861(83)90103-0; Wouters-Tyrou D, 1998, BIOCHIMIE, V80, P117, DOI 10.1016/S0300-9084(98)80018-7; Yoda K, 2000, P NATL ACAD SCI USA, V97, P7266, DOI 10.1073/pnas.130189697; Zalenskaya IA, 2000, BIOCHEM BIOPH RES CO, V279, P213, DOI 10.1006/bbrc.2000.3917; Zalensky AO, 1997, EXP CELL RES, V232, P29, DOI 10.1006/excr.1997.3482; ZALENSKY AO, 1995, CHROMOSOMA, V103, P577; ZALENSKY AO, 1993, CHROMOSOMA, V102, P509, DOI 10.1007/BF00368344; ZALENSKY AO, 1993, MOL REPROD DEV, V36, P164, DOI 10.1002/mrd.1080360207; Zweidler A, 1978, Methods Cell Biol, V17, P223, DOI 10.1016/S0091-679X(08)61145-0	47	108	119	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					43474	43480		10.1074/jbc.M206065200	http://dx.doi.org/10.1074/jbc.M206065200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12213818	hybrid			2022-12-27	WOS:000179081200132
J	Gutierrez, O; Pipaon, C; Inohara, N; Fontalba, A; Ogura, Y; Prosper, F; Nunez, G; Fernandez-Luna, JL				Gutierrez, O; Pipaon, C; Inohara, N; Fontalba, A; Ogura, Y; Prosper, F; Nunez, G; Fernandez-Luna, JL			Induction of Nod2 in myelomonocytic and intestinal epithelial cells via nuclear factor-kappa B activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTORS; INNATE; EXPRESSION; MUTATIONS; DIFFERENTIATION; SUSCEPTIBILITY; INHIBITION; INFLIXIMAB; APOPTOSIS; LINES	Nod2, a member of the Apaf1/Nod protein family, confers responsiveness to bacterial products and activates NF-kappaB, a transcription factor that plays a central role in innate immunity. Recently, genetic variation in Nod2 has been associated with susceptibility to Crohn's disease. Here, we report that expression of Nod2 is induced upon differentiation of CD34(+) hematopoietic progenitor cells into granulocyte or monocyte/macrophages. In peripheral blood cells, the highest levels of Nod2 were observed in CD14(+) (monocytes), CD15(+) (granulocytes), and CD40(+)/CD86(+) (dendritic cells) cell populations. Notably, stimulation of myeloblastic and epithelial cells with bacterial lipopolysaccharide or TNFalpha resulted in up-regulation of Nod2. A search for consensus sites within the Nod2 promoter revealed a NF-kappaB binding element that was required for transcriptional activity in response to TNFalpha. Moreover, ectopic expression of p65 induced transactivation, whereas that of dominant-negative IkappaBalpha blocked the transcriptional activity of the Nod2 promoter. Upon stimulation with TNFalpha or lipopolysaccharide, both p50 and p65 subunits of NF-kappaB were bound to the Nod2 promoter. Thus, Nod2 expression is enhanced by proinflammatory cytokines and bacterial components via NF-kappaB, a mechanism that may contribute to the amplification of the innate immune response and susceptibility to inflammatory disease.	Hosp Univ Marques Valdecilla, Unidad Genet Mol, Santander 39008, Spain; Univ Michigan, Sch Med, Ctr Comprehens Canc, Dept Pathol, Ann Arbor, MI 48109 USA; Univ Navarra Clin, Hematol Serv, Pamplona, Spain	Hospital Universitario Marques de Valdecilla (HUMV); University of Michigan System; University of Michigan; University of Navarra	Fernandez-Luna, JL (corresponding author), Hosp Univ Marques Valdecilla, Unidad Genet Mol, Santander 39008, Spain.	fluna@humv.es	Prosper, Felipe/H-6859-2017; Nuñez, Gabriel/A-7160-2014; Pipaon, Carlos/L-4922-2014	Prosper, Felipe/0000-0001-6115-8790; Pipaon, Carlos/0000-0002-3851-6710	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061707] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060421] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-61707] Funding Source: Medline; NIGMS NIH HHS [GM-60421] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Benito A, 1996, BLOOD, V87, P3837, DOI 10.1182/blood.V87.9.3837.bloodjournal8793837; Chin AI, 2002, NATURE, V416, P190, DOI 10.1038/416190a; Cuthbert AP, 2002, GASTROENTEROLOGY, V122, P867, DOI 10.1053/gast.2002.32415; Elson CO, 2002, NEW ENGL J MED, V346, P614, DOI 10.1056/NEJM200202213460812; Garcia R, 1997, CELL GROWTH DIFFER, V8, P1267; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Inohara N, 1999, J BIOL CHEM, V274, P14560, DOI 10.1074/jbc.274.21.14560; Inohara N, 2001, J BIOL CHEM, V276, P2551, DOI 10.1074/jbc.M009728200; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; Keller SA, 2000, BLOOD, V96, P2537; Kobayashi K, 2002, NATURE, V416, P194, DOI 10.1038/416194a; Lau R, 2001, J IMMUNOTHER, V24, P66, DOI 10.1097/00002371-200101000-00008; May MJ, 1998, IMMUNOL TODAY, V19, P80, DOI 10.1016/S0167-5699(97)01197-3; Miceli-Richard C, 2001, NAT GENET, V29, P19, DOI 10.1038/ng720; Muzio M, 2000, J IMMUNOL, V164, P5998, DOI 10.4049/jimmunol.164.11.5998; Neish AS, 2000, SCIENCE, V289, P1560, DOI 10.1126/science.289.5484.1560; Nickerson K, 2001, J BIOL CHEM, V276, P19089, DOI 10.1074/jbc.M101295200; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Present DH, 1999, NEW ENGL J MED, V340, P1398, DOI 10.1056/NEJM199905063401804; PRICE JE, 1990, CANCER RES, V50, P717; Sanz C, 1997, BLOOD, V89, P3199, DOI 10.1182/blood.V89.9.3199; Schwandner R, 1999, J BIOL CHEM, V274, P17406, DOI 10.1074/jbc.274.25.17406; Shuto T, 2002, J BIOL CHEM, V277, P17263, DOI 10.1074/jbc.M112190200; Silverman N, 2001, GENE DEV, V15, P2321, DOI 10.1101/gad.909001; Takeda K, 2001, GENES CELLS, V6, P733, DOI 10.1046/j.1365-2443.2001.00458.x; Zhang GL, 2001, J CLIN INVEST, V107, P13, DOI 10.1172/JCI11837	31	364	374	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					41701	41705		10.1074/jbc.M206473200	http://dx.doi.org/10.1074/jbc.M206473200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12194982	hybrid, Green Published			2022-12-27	WOS:000178985300052
J	Hourton-Cabassa, C; Mesneau, A; Miroux, B; Roussaux, J; Ricquier, D; Zachowski, A; Moreau, F				Hourton-Cabassa, C; Mesneau, A; Miroux, B; Roussaux, J; Ricquier, D; Zachowski, A; Moreau, F			Alteration of plant mitochondrial proton conductance by free fatty acids - Uncoupling protein involvement	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARABIDOPSIS-THALIANA; FUNCTIONAL RECONSTITUTION; POTATO MITOCHONDRIA; ELECTRON-TRANSPORT; GENE; NUCLEOTIDES; EXPRESSION; UCP1; YEAST; MICE	We characterized the uncoupling activity of the plant uncoupling protein from Solanum tuberosum (StUCP) using mitochondria from intact potato tubers or from yeast (Saccharomyces cerevisiae) expressing the StUCP gene. Compared with mitochondria from transfected yeast, StUCP is present at very low levels in intact potato mitochondrial membranes (at least thirty times lower) as shown by immunodetection with anti-UCP1 antibodies. Under conditions that ruled out undesirable effects of nucleotides and free fatty acids on uncoupling activity measurement in plant mitochondria, the linoleic acid-induced depolarization in potato mitochondria was insensitive to the nucleotides ATP, GTP, or GDP. In addition, sensitivity to linoleic acid was similar in potato and in control yeast mitochondria, suggesting that uncoupling occurring in potato mitochondria was because of a UCP-independent proton diffusion process. By contrast, yeast mitochondria expressing StUCP exhibited a higher sensitivity to free fatty acids than those from the control yeast and especially a marked proton conductance in the presence of low amounts of linoleic acid. However, this fatty acid-induced uncoupling was also insensitive to nucleotides. Altogether, these results suggest that uncoupling of oxidative phosphorylation and heat production cannot be the dominant feature of StUCP expressed in native potato tissues. However, it could play a role in preventing reactive oxygen species production as proposed for mammalian UCP2 and UCP3.	Univ Paris 06, CNRS, UMR 7632, Lab Physiol Cellulaire & Mol Plantes, F-75252 Paris 05, France; UPMC, Lab Biol Cellulaire Vegetale, F-75005 Paris, France; CNRS, UPR 9078, Ctr Rech Endocrinol Mol & Dev, F-92190 Meudon, France; IRNEM, F-75015 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Moreau, F (corresponding author), Univ Paris 06, CNRS, UMR 7632, Lab Physiol Cellulaire & Mol Plantes, 154,4 Pl Jussieu, F-75252 Paris 05, France.	fmoreau@ccr.jussieu.fr	Miroux, Bruno/E-9267-2017; ZACHOWSKI, Alain/A-9029-2011	Miroux, Bruno/0000-0002-3066-4700; Cabassa, Cecile/0000-0001-5643-4551				AKERMAN KEO, 1976, FEBS LETT, V68, P191, DOI 10.1016/0014-5793(76)80434-6; ARECHAGA I, 1993, BIOCHEM J, V296, P693, DOI 10.1042/bj2960693; Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Borecky J, 2001, FEBS LETT, V505, P240, DOI 10.1016/S0014-5793(01)02835-6; BOUILLAUD F, 1994, EMBO J, V13, P1990, DOI 10.1002/j.1460-2075.1994.tb06468.x; Caiveau O, 2001, J BIOL CHEM, V276, P5788, DOI 10.1074/jbc.M006231200; CHEN DC, 1992, CURR GENET, V21, P83, DOI 10.1007/BF00318659; Considine MJ, 2001, PLANT PHYSIOL, V126, P1619, DOI 10.1104/pp.126.4.1619; Costa ADT, 1999, J BIOENERG BIOMEMBR, V31, P527, DOI 10.1023/A:1005408809619; Couplan E, 2002, J BIOL CHEM, V277, P26268, DOI 10.1074/jbc.M202535200; Echtay KS, 1999, FEBS LETT, V450, P8, DOI 10.1016/S0014-5793(99)00460-3; Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a; Fleury C, 1997, NAT GENET, V15, P269, DOI 10.1038/ng0397-269; GUTMAN, 1971, BIOCHEMISTRY-US, V10, P4763, DOI 10.1021/bi00801a025; Ito K, 1999, PLANT SCI, V149, P167, DOI 10.1016/S0168-9452(99)00159-4; Jaburek M, 1999, J BIOL CHEM, V274, P26003, DOI 10.1074/jbc.274.37.26003; Jarmuszkiewicz W, 1998, J BIOL CHEM, V273, P34882, DOI 10.1074/jbc.273.52.34882; Jezek P, 1996, J BIOL CHEM, V271, P32743, DOI 10.1074/jbc.271.51.32743; Jezek P, 1998, BBA-BIOENERGETICS, V1365, P319, DOI 10.1016/S0005-2728(98)00084-X; KAMO N, 1979, J MEMBRANE BIOL, V49, P105, DOI 10.1007/BF01868720; Klingenberg M, 1999, BBA-BIOMEMBRANES, V1415, P271, DOI 10.1016/S0005-2736(98)00232-6; Klingenberg M, 2001, BBA-BIOENERGETICS, V1504, P128, DOI 10.1016/S0005-2728(00)00242-5; Kowaltowski AJ, 1998, FEBS LETT, V425, P213, DOI 10.1016/S0014-5793(98)00231-2; Laloi M, 1997, NATURE, V389, P135, DOI 10.1038/38156; Maia IG, 1998, FEBS LETT, V429, P403, DOI 10.1016/S0014-5793(98)00634-6; MIROUX B, 1992, J BIOL CHEM, V267, P13603; MOORE AL, 1991, PLANT PHYSIOL, V95, P34, DOI 10.1104/pp.95.1.34; MURDZAINGLIS DL, 1991, J BIOL CHEM, V266, P11871; Nantes IL, 1999, FEBS LETT, V457, P103, DOI 10.1016/S0014-5793(99)01017-0; Pastore D, 2000, FEBS LETT, V470, P88, DOI 10.1016/S0014-5793(00)01292-8; Rial E, 1999, EMBO J, V18, P5827, DOI 10.1093/emboj/18.21.5827; Ricquier D, 2000, BIOCHEM J, V345, P161, DOI 10.1042/0264-6021:3450161; RUSTIN P, 1980, PLANT PHYSIOL, V66, P457, DOI 10.1104/pp.66.3.457; Silva MAPE, 1999, PLANT SCI, V143, P27; VALERIO M, 1993, EUR J BIOCHEM, V216, P565, DOI 10.1111/j.1432-1033.1993.tb18175.x; VERCESI AE, 1995, NATURE, V375, P24, DOI 10.1038/375024a0; Vidal-Puig AJ, 2000, J BIOL CHEM, V275, P16258, DOI 10.1074/jbc.M910179199; Watanabe A, 1999, PLANT CELL PHYSIOL, V40, P1160, DOI 10.1093/oxfordjournals.pcp.a029501	38	28	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					41533	41538		10.1074/jbc.M202805200	http://dx.doi.org/10.1074/jbc.M202805200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12196511	hybrid			2022-12-27	WOS:000178985300031
J	Hu, KA; Carroll, J; Rickman, C; Davletov, B				Hu, KA; Carroll, J; Rickman, C; Davletov, B			Action of complexin on SNARE complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-FUSION; NEUROTRANSMITTER RELEASE; SYNAPTIC VESICLES; PROTEIN; SYNTAXIN; EXOCYTOSIS; SNAP-25; PALMITOYLATION; NEUROTOXINS; MACHINERY	Calcium-dependent synaptic vesicle exocytosis requires three SNARE (soluble N-ethylmaleimide-sensitive-factor attachment protein receptor) proteins: synaptobrevin/vesicle-associated membrane protein in the vesicular membrane and syntaxin and SNAP-25 in the presynaptic membrane. The SNAREs form a thermodynamically stable complex that is believed to drive fusion of vesicular and presynaptic membranes. Complexin, also known as synaphin, is a neuronal cytosolic protein that acts as a positive regulator of synaptic vesicle exocytosis. Complexin binds selectively to the neuronal SNARE complex, but how this promotes exocytosis remains unknown. Here we used purified full-length and truncated SNARE proteins and a gel shift assay to show that the action of complexin on SNARE complex depends strictly on the transmembrane regions of syntaxin and synaptobrevin. By means of a preparative immunoaffinity procedure to achieve total extraction of SNARE complex from brain, we demonstrated that complexin is the only neuronal protein that tightly associates with it. Our data indicated that, in the presence of complexin, the neuronal SNARE proteins assemble directly into a complex in which the transmembrane regions interact. We propose that complexin facilitates neuronal exocytosis by promoting interaction between the complementary syntaxin and synaptobrevin transmembrane regions that reside in opposing membranes prior to fusion.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Davletov, B (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.		Davletov, Bazbek/ABA-8569-2021	Davletov, Bazbek/0000-0003-4658-3275; Rickman, Colin/0000-0001-8938-524X				BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; Chen XC, 2002, NEURON, V33, P397, DOI 10.1016/S0896-6273(02)00583-4; Dulubova I, 1999, EMBO J, V18, P4372, DOI 10.1093/emboj/18.16.4372; Eastwood SL, 2000, MOL PSYCHIATR, V5, P425, DOI 10.1038/sj.mp.4000741; HAYASHI T, 1994, EMBO J, V13, P5051, DOI 10.1002/j.1460-2075.1994.tb06834.x; HESS DT, 1992, J NEUROSCI, V12, P4634; Hu K, 2002, NATURE, V415, P646, DOI 10.1038/415646a; ISHIZUKA T, 1995, BIOCHEM BIOPH RES CO, V213, P1107, DOI 10.1006/bbrc.1995.2241; Jahn R, 1999, ANNU REV BIOCHEM, V68, P863, DOI 10.1146/annurev.biochem.68.1.863; Laage R, 2000, J BIOL CHEM, V275, P17481, DOI 10.1074/jbc.M910092199; Lane SR, 1997, J NEUROCHEM, V69, P1864; Lawrence GW, 2002, J CELL SCI, V115, P667; Margittai M, 1999, FEBS LETT, V446, P40, DOI 10.1016/S0014-5793(99)00028-9; MCMAHON HT, 1995, CELL, V83, P111, DOI 10.1016/0092-8674(95)90239-2; McNew JA, 2000, J CELL BIOL, V150, P105, DOI 10.1083/jcb.150.1.105; McNew JA, 1999, MOL CELL, V4, P415, DOI 10.1016/S1097-2765(00)80343-3; MONCK JR, 1994, NEURON, V12, P707, DOI 10.1016/0896-6273(94)90325-5; Morton AJ, 2001, BRAIN RES BULL, V56, P111, DOI 10.1016/S0361-9230(01)00611-6; Otto H, 1997, P NATL ACAD SCI USA, V94, P6197, DOI 10.1073/pnas.94.12.6197; Pabst S, 2002, J BIOL CHEM, V277, P7838, DOI 10.1074/jbc.M109507200; Pabst S, 2000, J BIOL CHEM, V275, P19808, DOI 10.1074/jbc.M002571200; Reim K, 2001, CELL, V104, P71, DOI 10.1016/S0092-8674(01)00192-1; RuizMontasell B, 1996, EUR J NEUROSCI, V8, P2544, DOI 10.1111/j.1460-9568.1996.tb01548.x; Schiavo G, 2000, PHYSIOL REV, V80, P717, DOI 10.1152/physrev.2000.80.2.717; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; SUDHOF TC, 1989, NEURON, V2, P1475, DOI 10.1016/0896-6273(89)90193-1; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; TAKAHASHI S, 1995, FEBS LETT, V368, P455, DOI 10.1016/0014-5793(95)00713-J; Tokumaru H, 2001, CELL, V104, P421, DOI 10.1016/S0092-8674(01)00229-X; Veit M, 1996, FEBS LETT, V385, P119, DOI 10.1016/0014-5793(96)00362-6; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Whiteheart SW, 2001, INT REV CYTOL, V207, P71	34	62	70	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					41652	41656		10.1074/jbc.M205044200	http://dx.doi.org/10.1074/jbc.M205044200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12200427	hybrid			2022-12-27	WOS:000178985300046
J	Levy, L; Neuveut, C; Renard, CA; Charneau, P; Branchereau, S; Gauthier, F; Van Nhieu, JT; Cherqui, D; Petit-Bertron, AF; Mathieu, D; Buendia, MA				Levy, L; Neuveut, C; Renard, CA; Charneau, P; Branchereau, S; Gauthier, F; Van Nhieu, JT; Cherqui, D; Petit-Bertron, AF; Mathieu, D; Buendia, MA			Transcriptional activation of interleukin-8 by beta-catenin-Tcf4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN HEPATOCELLULAR-CARCINOMA; ENDOTHELIAL GROWTH-FACTOR; BETA-CATENIN; COLON-CARCINOMA; COLORECTAL CARCINOMAS; TRANSGENIC MICE; CYCLIN D1; EXPRESSION; TARGET; CELLS	Nuclear translocation of beta-catenin and its association with Tcf/Lef factors are key steps in transduction of the Wnt signal, which is aberrantly activated in a variety of human cancers. In a search for new beta-catenin-Tcf target genes, we analyzed beta-catenin-induced alterations of gene expression in primary human hepatocytes, after transduction of either dominant stable beta-catenin or its truncated, transactivation-deficient counterpart by means of a lentiviral vector. cDNA microarray analysis revealed a limited set of up-regulated genes, including known Writ targets such as matrilysin and keratin-1. In this screen, we identified the CXC chemokine interleukin 8 (IL-8) as a direct target of beta-catenin-Tcf4. IL-8 is constitutively expressed in various cancers, and it has been implicated in tumor progression through its mitogenic, motogenic, and angiogenic activities. The IL-8 promoter contains a unique consensus Tcf/Lef site that is critical for IL-8 activation by beta-catenin. We show here that the p300 coactivator was required for efficient transactivation of beta-catenin on this promoter. Ectopic expression of beta-catenin in hepatoma cells promoted IL-8 secretion, which stimulated endothelial cell migration. These data define IL-8 as a Wnt target and suggest that IL-8 induction by beta-catenin might be implicated in developmental and tumorigenic processes.	Inst Pasteur, Inserm U163, Unite Recombinaison & Express Genet, F-75015 Paris, France; Inst Pasteur, Grp Virol Mol & Vectorol, F-75015 Paris, France; Inst Pasteur, Unite Cytokines & Inflammat, Dept Mol Med, F-75015 Paris, France; Hop Bicetre, Serv Chirurg Pediat, F-94270 Le Kremlin Bicetre, France; Hop Henri Mondor, AP HP, Dept Pathol, F-94010 Creteil, France; Hop Henri Mondor, AP HP, Serv Chirurg Digest, F-94010 Creteil, France; Univ Paris 12, F-94010 Creteil, France; Inst Genet Mol, UMR 5535, IFR 24, F-34293 Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier	Buendia, MA (corresponding author), Inst Pasteur, Inserm U163, Unite Recombinaison & Express Genet, 28 Rue Dr Roux, F-75015 Paris, France.	rnbuendia@pasteur.fr	LEVY, Laurence/AAF-5672-2021; CHARNEAU, Pierre/M-1565-2017	CHARNEAU, Pierre/0000-0003-1184-5773; Neuveut, Christine/0000-0001-6520-271X				Akiba J, 2001, INT J ONCOL, V18, P257; Barker N, 2001, EMBO J, V20, P4935, DOI 10.1093/emboj/20.17.4935; Barolo S, 2002, GENE DEV, V16, P1167, DOI 10.1101/gad.976502; Bauer A, 2000, EMBO J, V19, P6121, DOI 10.1093/emboj/19.22.6121; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Billin AN, 2000, MOL CELL BIOL, V20, P6882, DOI 10.1128/MCB.20.18.6882-6890.2000; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Cadoret A, 2001, CANCER RES, V61, P3245; Crawford HC, 1999, ONCOGENE, V18, P2883, DOI 10.1038/sj.onc.1202627; de La Coste A, 1998, P NATL ACAD SCI USA, V95, P8847; Dong G, 2001, CANCER RES, V61, P5911; GUGUENGUILLOUZO C, 1982, CELL BIOL INT REP, V6, P625, DOI 10.1016/0309-1651(82)90187-4; Harada N, 2002, CANCER RES, V62, P1971; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hecht A, 2000, EMBO J, V19, P1839, DOI 10.1093/emboj/19.8.1839; Hecht A, 2000, EMBO REP, V1, P24, DOI 10.1093/embo-reports/kvd012; Hlubek F, 2001, CANCER RES, V61, P8089; Inoue K, 2000, CANCER RES, V60, P2290; Kitadai Y, 1998, AM J PATHOL, V152, P93; KOCH AE, 1992, SCIENCE, V258, P1798, DOI 10.1126/science.1281554; Koh TJ, 2000, J CLIN INVEST, V106, P533, DOI 10.1172/JCI9476; Kolligs FT, 2002, CANCER CELL, V1, P145, DOI 10.1016/S1535-6108(02)00035-1; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Kramps T, 2002, CELL, V109, P47, DOI 10.1016/S0092-8674(02)00679-7; Laurent-Puig P, 2001, GASTROENTEROLOGY, V120, P1763, DOI 10.1053/gast.2001.24798; Liao C, 2000, HEPATOLOGY, V32, P721, DOI 10.1053/jhep.2000.17967; Luca M, 1997, AM J PATHOL, V151, P1105; Mann B, 1999, P NATL ACAD SCI USA, V96, P1603, DOI 10.1073/pnas.96.4.1603; MARTY C, 1994, CRIT CARE MED, V22, P673, DOI 10.1097/00003246-199404000-00025; Monga SPS, 2002, CANCER RES, V62, P2064; Morin PJ, 1999, BIOESSAYS, V21, P1021, DOI 10.1002/(SICI)1521-1878(199912)22:1<1021::AID-BIES6>3.0.CO;2-P; Murdoch C, 1999, CYTOKINE, V11, P704, DOI 10.1006/cyto.1998.0465; Ougolkov AV, 2002, GASTROENTEROLOGY, V122, P60, DOI 10.1053/gast.2002.30306; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; Pennica D, 1998, P NATL ACAD SCI USA, V95, P14717, DOI 10.1073/pnas.95.25.14717; Playford MP, 2000, P NATL ACAD SCI USA, V97, P12103, DOI 10.1073/pnas.210394297; Polakis P, 2000, GENE DEV, V14, P1837; Renard CA, 2000, ONCOGENE, V19, P2678, DOI 10.1038/sj.onc.1203617; Rockman SP, 2001, J BIOL CHEM, V276, P45113, DOI 10.1074/jbc.M107742200; Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023; Satoh S, 2000, NAT GENET, V24, P245, DOI 10.1038/73448; Satyamoorthy K, 2002, CELL GROWTH DIFFER, V13, P87; SCHADENDORF D, 1993, J IMMUNOL, V151, P2667; Shimoda K, 1998, HEPATOLOGY, V28, P108, DOI 10.1002/hep.510280116; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Sirven A, 2001, MOL THER, V3, P438, DOI 10.1006/mthe.2001.0282; Staal FJT, 2002, EMBO REP, V3, P63, DOI 10.1093/embo-reports/kvf002; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Tordjman R, 2001, BLOOD, V97, P1968, DOI 10.1182/blood.V97.7.1968; Wei Y, 2000, ONCOGENE, V19, P498, DOI 10.1038/sj.onc.1203356; Wong NACS, 2002, AM J PATHOL, V160, P389, DOI 10.1016/S0002-9440(10)64856-0; Xie KP, 2001, CYTOKINE GROWTH F R, V12, P375, DOI 10.1016/S1359-6101(01)00016-8; Yoong KF, 1999, HEPATOLOGY, V30, P100, DOI 10.1002/hep.510300147; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443; Zennou V, 2000, CELL, V101, P173, DOI 10.1016/S0092-8674(00)80828-4; Zhang XB, 2001, CANCER RES, V61, P6050	56	113	114	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					42386	42393		10.1074/jbc.M207418200	http://dx.doi.org/10.1074/jbc.M207418200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12200448	hybrid, Green Published			2022-12-27	WOS:000178985300136
J	Yaman, I; Fernandez, J; Sarkar, B; Schneider, RJ; Snider, MD; Nagy, LE; Hatzoglou, M				Yaman, I; Fernandez, J; Sarkar, B; Schneider, RJ; Snider, MD; Nagy, LE; Hatzoglou, M			Nutritional control of mRNA stability is mediated by a conserved AU-rich element that binds the cytoplasmic shuttling protein HuR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID AVAILABILITY; MESSENGER-RNA STABILITY; 3'-UNTRANSLATED REGION; REGULATORY DOMAIN; HEAT-SHOCK; GENE; STABILIZATION; TRANSLATION; EXPRESSION; CAT-1	The cationic amino acid transporter, Cat-1, is a high affinity transporter of the essential amino acids, arginine and lysine. Expression of the cat-1 gene increases during nutritional stress as part of the adaptive response to starvation. Amino acid limitation induces coordinate increases in stability and translation of the cat-1 mRNA, at a time when global protein synthesis decreases. It is shown here that increased cat-1 mRNA stability requires an. 11 nucleotide AU-rich element within the distal 217 bases of the 3'-untranslated region. When this 217-nucleotide nutrient sensor AU-rich element (NS-ARE) is present in a chimeric mRNA it confers mRNA stabilization during amino acid starvation. HuR is a member of the EIAV family of RNA-binding proteins that has been implicated in regulating the stability of ARE-containing mRNAs. We show here that the cytoplasmic concentration of HuR increases during amino acid starvation, at a time when total cellular HuR levels decrease. In addition, RNA gel shift experiments in vitro demonstrated that HuR binds to the NS-ARE and binding was dependent on the 11 residue AU-rich element. Moreover, HuR binding to the NS-ARE in extracts from amino acid-starved cells increased in parallel with the accumulation of cytoplasmic HuR. It is proposed that an adaptive response of cells to nutritional stress results in increased mRNA stability mediated by HuR binding to the NS-ARE.	Case Western Reserve Univ, Sch Med, Dept Nutr, Cleveland, OH 44106 USA; Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA; NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA	Case Western Reserve University; Case Western Reserve University; New York University	Hatzoglou, M (corresponding author), Case Western Reserve Univ, Sch Med, Dept Nutr, 10900 Euclid Ave, Cleveland, OH 44106 USA.		yaman, ibrahim/A-7192-2016	yaman, ibrahim/0000-0002-3987-1984	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007319, R01DK053307] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA011975] Funding Source: NIH RePORTER; NIAAA NIH HHS [R01 AA011975, R01 AA011975-10] Funding Source: Medline; NIDDK NIH HHS [R01 DK053307, 5T32 DK07319, T32 DK007319, R01 DK53307-01] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aulak KS, 1999, J BIOL CHEM, V274, P30424, DOI 10.1074/jbc.274.43.30424; Aulak KS, 1996, J BIOL CHEM, V271, P29799, DOI 10.1074/jbc.271.47.29799; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; Bruhat A, 2001, CURR OPIN CLIN NUTR, V4, P439, DOI 10.1097/00075197-200109000-00016; Closs EI, 2002, CURR OPIN NEPHROL HY, V11, P99, DOI 10.1097/00041552-200201000-00015; Fafournoux P, 2000, BIOCHEM J, V351, P1, DOI 10.1042/0264-6021:3510001; Fan XHC, 1998, P NATL ACAD SCI USA, V95, P15293, DOI 10.1073/pnas.95.26.15293; Fan XHC, 1998, EMBO J, V17, P3448, DOI 10.1093/emboj/17.12.3448; Fernandez J, 2002, J BIOL CHEM, V277, P11780, DOI 10.1074/jbc.M110778200; Fernandez J, 2001, J BIOL CHEM, V276, P12285, DOI 10.1074/jbc.M009714200; FERNANDEZ JM, 2002, J BIOL CHEM, V4, P4; FERNANDEZ JM, 2001, J BIOL CHEM, V29, P29; Gallouzi IE, 2000, P NATL ACAD SCI USA, V97, P3073, DOI 10.1073/pnas.97.7.3073; HUTSON RG, 1994, BIOCHEM J, V304, P745, DOI 10.1042/bj3040745; Hyatt SL, 1997, J BIOL CHEM, V272, P19951, DOI 10.1074/jbc.272.32.19951; KATZ RA, 1983, BIOCHIM BIOPHYS ACTA, V739, P258, DOI 10.1016/0167-4781(83)90099-4; Keene JD, 1999, P NATL ACAD SCI USA, V96, P5, DOI 10.1073/pnas.96.1.5; Laroia G, 1999, SCIENCE, V284, P499, DOI 10.1126/science.284.5413.499; Lee WY, 2000, J BIOL CHEM, V275, P33998, DOI 10.1074/jbc.M005040200; Levy NS, 1998, J BIOL CHEM, V273, P6417, DOI 10.1074/jbc.273.11.6417; Loflin P, 2001, FEBS LETT, V509, P267, DOI 10.1016/S0014-5793(01)03176-3; Loflin P, 2001, FEBS LETT, V492, P233, DOI 10.1016/S0014-5793(01)02260-8; Mukherjee D, 2002, EMBO J, V21, P165, DOI 10.1093/emboj/21.1.165; PAIN VM, 1994, BIOCHIMIE, V76, P718, DOI 10.1016/0300-9084(94)90076-0; Palacin M, 1998, PHYSIOL REV, V78, P969, DOI 10.1152/physrev.1998.78.4.969; Peng SSY, 1998, EMBO J, V17, P3461, DOI 10.1093/emboj/17.12.3461; Rodriguez-Pascual F, 2000, J BIOL CHEM, V275, P26040, DOI 10.1074/jbc.M910460199; Wang WG, 2000, MOL CELL BIOL, V20, P760, DOI 10.1128/MCB.20.3.760-769.2000; Wang XM, 1998, BIOCHEM J, V334, P261, DOI 10.1042/bj3340261; Wang ZR, 2001, CELL, V107, P751, DOI 10.1016/S0092-8674(01)00592-X	30	100	102	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					41539	41546		10.1074/jbc.M204850200	http://dx.doi.org/10.1074/jbc.M204850200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12196519	hybrid, Green Accepted			2022-12-27	WOS:000178985300032
J	Pineda, AO; Savvides, SN; Waksman, G; Di Cera, E				Pineda, AO; Savvides, SN; Waksman, G; Di Cera, E			Crystal structure of the anticoagulant slow form of thrombin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ALPHA-THROMBIN; POTENT ANTICOAGULANT; SPECIFICITY; BINDING; MUTANT; SITE	Using the thrombin mutant R77aA devoid of the site of autoproteolytic degradation at exosite 1, we have solved for the first time the structure of thrombin free of any inhibitors and effector molecules and stabilized in the Na+-free slow form. The slow form shows subtle differences compared with the currently available structures of the Na+-bound fast form that carry inhibitors at the active site or exosite 1. The most notable differences are the displacement of Asp-189 in the S1 specificity pocket, a downward shift of the 190-193 strand, a rearrangement of the side chain of Glu-192, and a significant shift in the position of the catalytic Ser-195 that is no longer within H-bonding distance from His-57. The structure of the slow form explains the reduced specificity toward synthetic and natural substrates and suggests a molecular basis for its anticoagulant properties.	Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA	Washington University (WUSTL)	Di Cera, E (corresponding author), Washington Univ, Sch Med, Dept Biochem & Mol Biophys, Box 8231, St Louis, MO 63110 USA.	enrico@biochem.wustl.edu	Savvides, Savvas/E-1938-2011	Savvides, Savvas/0000-0003-3420-5947	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL049413, R01HL049413, R01HL058141] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 49413, HL 58141] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ayala YM, 2001, PROTEINS, V45, P107, DOI 10.1002/prot.1130; BODE W, 1992, PROTEIN SCI, V1, P426; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cantwell AM, 2000, J BIOL CHEM, V275, P39827, DOI 10.1074/jbc.C000751200; DANG QD, 1995, P NATL ACAD SCI USA, V92, P5977, DOI 10.1073/pnas.92.13.5977; Dang QD, 1997, NAT BIOTECHNOL, V15, P146, DOI 10.1038/nbt0297-146; Di Cera E, 1998, TRENDS CARDIOVAS MED, V8, P340, DOI 10.1016/S1050-1738(98)00030-9; Di Cera E, 2001, ANN NY ACAD SCI, V936, P133; DiCera E, 1997, CELL MOL LIFE SCI, V53, P701, DOI 10.1007/s000180050091; DICERA E, 1995, J BIOL CHEM, V270, P22089, DOI 10.1074/jbc.270.38.22089; GIBBS CS, 1995, NATURE, V378, P413, DOI 10.1038/378413a0; Gruber A, 2002, J BIOL CHEM, V277, P27581, DOI 10.1074/jbc.C200237200; Guinto ER, 1999, P NATL ACAD SCI USA, V96, P1852, DOI 10.1073/pnas.96.5.1852; Guinto ER, 1996, BIOCHEMISTRY-US, V35, P8800, DOI 10.1021/bi9608828; HOFSTEENGE J, 1988, BIOCHEMISTRY-US, V27, P2144, DOI 10.1021/bi00406a049; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Krem MM, 2002, J BIOL CHEM, V277, P40260, DOI 10.1074/jbc.M206173200; Krishnan R, 2000, ACTA CRYSTALLOGR D, V56, P406, DOI 10.1107/S0907444900001487; LEBONNIEC BF, 1991, P NATL ACAD SCI USA, V88, P7371, DOI 10.1073/pnas.88.16.7371; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PERONA JJ, 1995, PROTEIN SCI, V4, P337; Pineda AO, 2002, J BIOL CHEM, V277, P32015, DOI 10.1074/jbc.M205009200; VIJAYALAKSHMI J, 1994, PROTEIN SCI, V3, P2254, DOI 10.1002/pro.5560031211; WELLS CM, 1992, BIOCHEMISTRY-US, V31, P11721, DOI 10.1021/bi00162a008	24	43	47	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2002	277	43					40177	40180		10.1074/jbc.C200465200	http://dx.doi.org/10.1074/jbc.C200465200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	607KU	12205081	hybrid			2022-12-27	WOS:000178791400003
J	Goffredo, D; Rigamonti, D; Tartari, M; De Micheli, A; Verderio, C; Matteoli, M; Zuccato, C; Cattaneo, E				Goffredo, D; Rigamonti, D; Tartari, M; De Micheli, A; Verderio, C; Matteoli, M; Zuccato, C; Cattaneo, E			Calcium-dependent cleavage of endogenous wild-type huntingtin in primary cortical neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUTANT HUNTINGTIN; MOUSE MODEL; CELLULAR TOXICITY; CASPASE CLEAVAGE; DISEASE; CALPAIN; EXPRESSION; FRAGMENTS; BRAIN; PROTEOLYSIS	Huntington's disease (HD) is caused by a polyglutamine expansion in the amino-terminal region of huntingtin. Mutant huntingtin is proteolytically cleaved by caspases, generating amino-terminal aggregates that are toxic for cells. The addition of calpains to total brain homogenates also leads to cleavage of wild-type huntingtin, indicating that proteolysis of mutant and wildtype huntingtin may play a role in HD. Here we report that endogenous wild-type huntingtin is promptly cleaved by calpains in primary neurons. Exposure of primary neurons to glutamate or 3-nitropropionic acid increases intracellular calcium concentration, leading to loss of intact full-length wild-type huntingtin. This cleavage could be prevented by calcium chelators and calpain inhibitors. Degradation of wild-type huntingtin by calcium-dependent proteases thus occurs in HD neurons, leading to loss of wild-type huntingtin neuroprotective activity.	Univ Milan, Ctr Excellence Neurodegenerat Dis, I-20133 Milan, Italy; Univ Milan, Dept Pharmacol Sci, I-20133 Milan, Italy; Univ Milan, Dept Med Pharmacol, Inst Neurosci, Natl Res Council, I-20133 Milan, Italy	University of Milan; University of Milan; University of Milan	Cattaneo, E (corresponding author), Univ Milan, Ctr Excellence Neurodegenerat Dis, Via Balzaretti 9, I-20133 Milan, Italy.	elena.cattaneo@unimi.it	Matteoli, Michela/K-4526-2018; verderio, claudia/K-4415-2016	Matteoli, Michela/0000-0002-3569-7843; CATTANEO, ELENA/0000-0002-0755-4917; verderio, claudia/0000-0001-7216-5873; ZUCCATO, CHIARA/0000-0003-1771-3392	Telethon [E.0840] Funding Source: Medline	Telethon(Fondazione Telethon)		ALHO H, 1988, DEV BRAIN RES, V39, P193, DOI 10.1016/0165-3806(88)90023-5; Cattaneo E, 2001, TRENDS NEUROSCI, V24, P182, DOI 10.1016/S0166-2236(00)01721-5; Cepeda C, 2001, J NEUROSCI RES, V66, P525, DOI 10.1002/jnr.1244; Chan SL, 1999, J NEUROSCI RES, V58, P167, DOI 10.1002/(SICI)1097-4547(19991001)58:1<167::AID-JNR16>3.0.CO;2-K; Chen M, 2000, NAT MED, V6, P797, DOI 10.1038/77528; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Dragatsis I, 2000, NAT GENET, V26, P300, DOI 10.1038/81593; FERRANTE RJ, 1991, J NEUROSCI, V11, P3877; Gervais FG, 2002, NAT CELL BIOL, V4, P95, DOI 10.1038/ncb735; Grunewald T, 1999, ANN NY ACAD SCI, V893, P203, DOI 10.1111/j.1749-6632.1999.tb07827.x; Guttmann RP, 2001, J NEUROCHEM, V78, P1083, DOI 10.1046/j.1471-4159.2001.00493.x; Hansson O, 2001, EUR J NEUROSCI, V14, P1492, DOI 10.1046/j.0953-816x.2001.01767.x; Ho LW, 2001, J MED GENET, V38, P450, DOI 10.1136/jmg.38.7.450; Hodgson JG, 1999, NEURON, V23, P181, DOI 10.1016/S0896-6273(00)80764-3; Kim M, 1999, J NEUROSCI, V19, P964; Kim YJ, 2001, P NATL ACAD SCI USA, V98, P12784, DOI 10.1073/pnas.221451398; Kumar U, 1997, EXP NEUROL, V145, P412, DOI 10.1006/exnr.1997.6473; Leavitt BR, 2001, AM J HUM GENET, V68, P313, DOI 10.1086/318207; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mende-Mueller LM, 2001, J NEUROSCI, V21, P1830, DOI 10.1523/JNEUROSCI.21-06-01830.2001; Ona VO, 1999, NATURE, V399, P263, DOI 10.1038/20446; Panov AV, 2002, NAT NEUROSCI, V5, P731, DOI 10.1038/nn884; Rigamonti D, 2001, J BIOL CHEM, V276, P14545, DOI 10.1074/jbc.C100044200; Rigamonti D, 2000, J NEUROSCI, V20, P3705, DOI 10.1523/JNEUROSCI.20-10-03705.2000; SAITO KI, 1993, P NATL ACAD SCI USA, V90, P2628, DOI 10.1073/pnas.90.7.2628; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Sipione S, 2001, MOL NEUROBIOL, V23, P21; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; Wellington CL, 2000, J BIOL CHEM, V275, P19831, DOI 10.1074/jbc.M001475200; Wellington CL, 1998, J BIOL CHEM, V273, P9158, DOI 10.1074/jbc.273.15.9158; Zuccato C, 2001, SCIENCE, V293, P493, DOI 10.1126/science.1059581	31	65	66	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2002	277	42					39594	39598		10.1074/jbc.C200353200	http://dx.doi.org/10.1074/jbc.C200353200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	605EA	12200414	hybrid			2022-12-27	WOS:000178662500070
J	Hakimi, MA; Speicher, DW; Shiekhattar, R				Hakimi, MA; Speicher, DW; Shiekhattar, R			The motor protein kinesin-1 links neurofibromin and merlin in a common cellular pathway of neurofibromatosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYPE-1 GENE-PRODUCT; DYNEIN SUPERFAMILY PROTEINS; GAP-RELATED DOMAIN; TUMOR-SUPPRESSOR; ORGANELLE TRANSPORT; AXONAL-TRANSPORT; NF1; MICROTUBULES; IDENTIFICATION; CYTOSKELETON	Mutations in either of the two tumor suppressor genes NF1 (neurofibromin) and NF2 (merlin) result in Neurofibromatosis, a condition predisposing individuals to developing a variety of benign and malignant tumors of the central and peripheral nervous systems. Here we report the identification of two distinct NF1-containing complexes, one in the soluble and the other in the particulate fraction of HeLa extract. We show that the soluble NF1 complex delineates a large holo-NF1 complex (2 MDa) encompassing the components of a smaller particulate core-NF1 complex (400 kDa). Purification of the core-NF1 complex followed by mass spectrometric analysis revealed the motor protein, kinesin-1 heavy chain (HsuKHC/KIF5B), as a catalytic subunit of both NF-1-containing complexes. Importantly, although NF1 and NF2 are not in a stable association, NF2 is also a component of a distinct kinesin-1-containing complex. These results point to kinesin-1 as a common denominator between NF1 and NF2.	Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA	The Wistar Institute	Shiekhattar, R (corresponding author), Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA.	shiekhattar@wistar.upenn.edu	HAKIMI, Mohamed-ali/Q-6475-2019; HAKIMI, Mohamed-ali/GYJ-0879-2022; HAKIMI, Mohamed-Ali/F-9806-2014	HAKIMI, Mohamed-ali/0000-0002-2547-8233; HAKIMI, Mohamed-Ali/0000-0002-2547-8233	NATIONAL CANCER INSTITUTE [R01CA090758] Funding Source: NIH RePORTER; NCI NIH HHS [CA 90758-01] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BALLESTER R, 1990, CELL, V63, P851, DOI 10.1016/0092-8674(90)90151-4; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; Brendza RP, 2000, SCIENCE, V289, P2120, DOI 10.1126/science.289.5487.2120; BUCHBERG AM, 1990, NATURE, V347, P291, DOI 10.1038/347291a0; Cichowski K, 2001, CELL, V104, P593, DOI 10.1016/S0092-8674(01)00245-8; Costa RM, 2002, NATURE, V415, P526, DOI 10.1038/nature711; DECLUE JE, 1991, P NATL ACAD SCI USA, V88, P9914, DOI 10.1073/pnas.88.22.9914; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; EVANS DGR, 1992, J MED GENET, V29, P841, DOI 10.1136/jmg.29.12.841; Gautreau A, 2002, CURR OPIN CELL BIOL, V14, P104, DOI 10.1016/S0955-0674(01)00300-3; GREGORY PE, 1993, SOMAT CELL MOLEC GEN, V19, P265, DOI 10.1007/BF01233074; Guo HF, 2000, NATURE, V403, P895, DOI 10.1038/35002593; Guo HF, 1997, SCIENCE, V276, P795, DOI 10.1126/science.276.5313.795; GUTMANN DH, 1991, P NATL ACAD SCI USA, V88, P9658, DOI 10.1073/pnas.88.21.9658; Hirokawa N, 1998, CURR OPIN CELL BIOL, V10, P60, DOI 10.1016/S0955-0674(98)80087-2; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; Kamal A, 2000, NEURON, V28, P449, DOI 10.1016/S0896-6273(00)00124-0; Kamal A, 2001, NATURE, V414, P643, DOI 10.1038/414643a; Li CJ, 2001, DEV BRAIN RES, V130, P231, DOI 10.1016/S0165-3806(01)00190-0; MARTIN GA, 1990, CELL, V63, P843, DOI 10.1016/0092-8674(90)90150-D; Mautner VF, 1996, NEUROSURGERY, V38, P880, DOI 10.1097/00006123-199605000-00004; Miki H, 2001, P NATL ACAD SCI USA, V98, P7004, DOI 10.1073/pnas.111145398; NAVONE F, 1992, J CELL BIOL, V117, P1263, DOI 10.1083/jcb.117.6.1263; ROULEAU GA, 1993, NATURE, V363, P515, DOI 10.1038/363515a0; Sharp DJ, 2000, NATURE, V407, P41, DOI 10.1038/35024000; Silva AJ, 1997, NAT GENET, V15, P281, DOI 10.1038/ng0397-281; TROFATTER JA, 1993, CELL, V72, P791, DOI 10.1016/0092-8674(93)90406-G; Upadhyaya M, 1998, NEUROFIBROMATOSIS TY, P65; XU GF, 1990, CELL, V63, P835, DOI 10.1016/0092-8674(90)90149-9; Xu HM, 1997, BRAIN RES, V759, P149, DOI 10.1016/S0006-8993(97)00328-4; Xu HM, 1998, J NEUROSCI RES, V51, P403, DOI 10.1002/(SICI)1097-4547(19980201)51:3<403::AID-JNR13>3.0.CO;2-7; Zhu Y, 2001, GENE DEV, V15, P859, DOI 10.1101/gad.862101; Zhu Y, 2001, EXP CELL RES, V264, P19, DOI 10.1006/excr.2000.5138	33	26	28	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2002	277	40					36909	36912		10.1074/jbc.C200434200	http://dx.doi.org/10.1074/jbc.C200434200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	601LH	12191989	hybrid			2022-12-27	WOS:000178447100002
J	Dode, L; Vilsen, B; Van Baelen, K; Wuytack, F; Clausen, JD; Andersen, JP				Dode, L; Vilsen, B; Van Baelen, K; Wuytack, F; Clausen, JD; Andersen, JP			Dissection of the functional differences between sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA) 1 and 3 isoforms by steady-state and transient kinetic analyses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCLE SARCOPLASMIC-RETICULUM; ENDOPLASMIC-RETICULUM; MESSENGER-RNA; CALCIUM-PUMP; SKELETAL-MUSCLE; DEPENDENT RELAXATION; TISSUE DISTRIBUTION; SMOOTH-MUSCLE; CDNA CLONING; CA2+ PUMPS	Steady-state and transient-kinetic studies were conducted to characterize the overall and partial reactions of the Ca2+-transport cycle mediated by the human sarco(endo)plasmic reticulum Ca2+-ATPase 3 (SERCA3) isoforms: SERCA3a, SERCA3b, and SERCA3c. Relative to SERCA1a, all three human SERCA3 enzymes displayed a reduced apparent affinity for cytosolic Ca2+ in activation of the overall reaction due to a decreased E-2 to E1Ca2 transition rate and an increased rate of Ca2+ dissociation from E1Ca2. At neutral pH, the ATPase activity of the SERCA3 enzymes was not significantly enhanced upon permeabilization of the microsomal vesicles with calcium ionophore, indicating a difference from SERCA1a with respect to regulation of the lumenal Ca2+ level (either an enhanced efflux of lumenal Ca2+ through the pump in E-2 form or insensitivity to inhibition by lumenal Ca2+). Other differences from SERCA1a with respect to the overall ATPase reaction were an alkaline shift of the pH optimum, increased catalytic turnover rate at pH optimum (highest for SERCA3b, the isoform with the longest C terminus), and an increased sensitivity to inhibition by vanadate that disappeared under equilibrium conditions in the absence of Ca2+ and ATP. The transient-kinetic analysis traced several of the differences from SERCA1a to an enhancement of the rate of dephosphorylation of the E2P phosphoenzyme intermediate, which was most pronounced at alkaline pH and increased with the length of the alternatively spliced C terminus.	Univ Aarhus, Dept Physiol, DK-8000 Aarhus C, Denmark; Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; Katholieke Univ Leuven, Fysiol Lab, B-3000 Louvain, Belgium	Aarhus University; University of Oxford; Wellcome Centre for Human Genetics; KU Leuven	Andersen, JP (corresponding author), Univ Aarhus, Dept Physiol, Ole Worms Alle 160, DK-8000 Aarhus C, Denmark.	jpa@fi.au.dk		Andersen, Jens Peter/0000-0003-0654-4300; Vilsen, Bente/0000-0002-4727-9382				ANDERSEN JP, 1995, FEBS LETT, V359, P101, DOI 10.1016/0014-5793(95)00019-6; Andersen JP, 2001, J BIOL CHEM, V276, P23312, DOI 10.1074/jbc.M102384200; Andersen JP, 1998, TRENDS CARDIOVAS MED, V8, P41, DOI 10.1016/S1050-1738(97)00121-7; ANDERSEN JP, 1989, J BIOL CHEM, V264, P21018; ANDERSEN JP, 1985, J BIOL CHEM, V260, P371; ANGER M, 1993, FEBS LETT, V334, P45, DOI 10.1016/0014-5793(93)81677-R; BabaAissa F, 1996, MOL BRAIN RES, V41, P169, DOI 10.1016/0169-328X(96)00088-5; BAGINSKI ES, 1967, CLIN CHEM, V13, P326; BERS DM, 1994, METHOD CELL BIOL, V40, P3; BISHOP JE, 1988, J BIOL CHEM, V263, P1886; Bobe R, 1998, FEBS LETT, V423, P259, DOI 10.1016/S0014-5793(98)00106-9; BRANDL CJ, 1987, J BIOL CHEM, V262, P3768; BURK SE, 1989, J BIOL CHEM, V264, P18561; CHAMPEIL P, 1986, J BIOL CHEM, V261, P6372; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Corbett EF, 2000, TRENDS BIOCHEM SCI, V25, P307, DOI 10.1016/S0968-0004(00)01588-7; Cornish-Bowden A, 2001, FUNDAMENTALS ENZYME; deMeis L, 1996, BBA-BIOENERGETICS, V1275, P105, DOI 10.1016/0005-2728(96)00058-8; DEMEIS L, 1980, BIOCHEMISTRY-US, V19, P4252, DOI 10.1021/bi00559a017; DEMEIS L, 1979, ANNU REV BIOCHEM, V48, P275; Dode L, 1996, BIOCHEM J, V318, P689, DOI 10.1042/bj3180689; Dode L, 1998, J BIOL CHEM, V273, P13982, DOI 10.1074/jbc.273.22.13982; FORGE V, 1993, J BIOL CHEM, V268, P10953; Gelebart P, 2002, J BIOL CHEM, V277, P26310, DOI 10.1074/jbc.M201747200; GERDES U, 1983, BIOCHIM BIOPHYS ACTA, V734, P191, DOI 10.1016/0005-2736(83)90117-7; GOULD GW, 1986, BIOCHEM J, V237, P217, DOI 10.1042/bj2370217; HACK N, 1988, BIOCHEM J, V250, P355, DOI 10.1042/bj2500355; INESI G, 1989, J BIOL CHEM, V264, P5929; INESI G, 1990, PHYSIOL REV, V70, P749, DOI 10.1152/physrev.1990.70.3.749; Kao J, 1999, AM J PHYSIOL-LUNG C, V277, pL264, DOI 10.1152/ajplung.1999.277.2.L264; Legrand G, 2001, J BIOL CHEM, V276, P47608, DOI 10.1074/jbc.M107011200; Liu LH, 1997, J BIOL CHEM, V272, P30538, DOI 10.1074/jbc.272.48.30538; LYTTON J, 1992, J BIOL CHEM, V267, P14483; LYTTON J, 1988, J BIOL CHEM, V263, P15024; MacLennan DH, 1997, J BIOL CHEM, V272, P28815, DOI 10.1074/jbc.272.46.28815; Martin V, 2002, J BIOL CHEM, V277, P24442, DOI 10.1074/jbc.M202011200; Martin V, 2000, HYPERTENSION, V35, P91, DOI 10.1161/01.HYP.35.1.91; MARUYAMA K, 1988, P NATL ACAD SCI USA, V85, P3314, DOI 10.1073/pnas.85.10.3314; Mitidieri F, 1999, J BIOL CHEM, V274, P28344, DOI 10.1074/jbc.274.40.28344; ORLOWSKI S, 1988, J BIOL CHEM, V263, P17576; Ozog A, 1998, FEBS LETT, V427, P349, DOI 10.1016/S0014-5793(98)00464-5; PAPP B, 1993, BIOCHEM J, V295, P685, DOI 10.1042/bj2950685; PAPP B, 1991, J BIOL CHEM, V266, P14593; Paschen W, 2001, CELL CALCIUM, V29, P1, DOI 10.1054/ceca.2000.0162; Pinton P, 2001, EMBO J, V20, P2690, DOI 10.1093/emboj/20.11.2690; Poch E, 1998, AM J PHYSIOL-CELL PH, V275, pC1449, DOI 10.1152/ajpcell.1998.275.6.C1449; SHIGEKAWA M, 1978, J BIOL CHEM, V253, P1442; Sorensen T, 1997, J BIOL CHEM, V272, P30244, DOI 10.1074/jbc.272.48.30244; Sorensen TLM, 2000, J BIOL CHEM, V275, P5400, DOI 10.1074/jbc.275.8.5400; Sorensen TLM, 2000, J BIOL CHEM, V275, P28954, DOI 10.1074/jbc.M004072200; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Varadi A, 1999, DIABETOLOGIA, V42, P1240, DOI 10.1007/s001250051298; Varadi A, 1996, BIOCHEM J, V319, P521, DOI 10.1042/bj3190521; VERBOOMEN H, 1992, BIOCHEM J, V286, P591, DOI 10.1042/bj2860591; WAKABAYASHI S, 1990, BIOCHEMISTRY-US, V29, P10613, DOI 10.1021/bi00499a006; WAKABAYASHI S, 1986, J BIOL CHEM, V261, P9762; WU KD, 1995, AM J PHYSIOL-CELL PH, V269, pC775, DOI 10.1152/ajpcell.1995.269.3.C775; Wuytack F, 1995, BIOSCIENCE REP, V15, P299, DOI 10.1007/BF01788362; WUYTACK F, 1994, J BIOL CHEM, V269, P1410; YU X, 1994, J BIOL CHEM, V269, P16656; Zhang YL, 1995, GENOMICS, V30, P415, DOI 10.1006/geno.1995.1259	61	80	83	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2002	277	47					45579	45591		10.1074/jbc.M207778200	http://dx.doi.org/10.1074/jbc.M207778200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	618EE	12207029	hybrid			2022-12-27	WOS:000179404800124
J	Lin, DH; Sterling, H; Lerea, KM; Giebisch, G; Wang, WH				Lin, DH; Sterling, H; Lerea, KM; Giebisch, G; Wang, WH			Protein kinase C (PKC)-induced phosphorylation of ROMK1 is essential for the surface expression of ROMK1 channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							K+ CHANNEL; TYROSINE-PHOSPHATASE; POTASSIUM CHANNEL; GLIBENCLAMIDE; MODULATION; MECHANISM; CLONING; KIDNEY	We carried out in vitro phosphorylation assays to determine whether ROMK1 is a substrate of protein kinase C (PKC) and used the two-electrode voltage clamp method to investigate the role of serine residues 4, 183, and 201, the three putative PKC phosphorylation sites, in the regulation of ROMK1 channel activity. Incubation of the purified His-tagged ROMK1 protein with PKC and radiolabeled ATP resulted in P-32 incorporation into ROMK1 detected by autoradiography. Moreover, the in vitro phosphorylation study of three synthesized peptides corresponding to amino acids 1-16, 174-189, and 196-211 of ROMK1. revealed that serine residues 4 and 201 of ROMK1 were the two main PKC phosphorylation sites. In contrast, (32)p incorporation of peptide 174-189 was absent. In vitro phosphorylation studies with ROMK1 mutants, R1S4/NKA, R1S4/183A, and RlS183/201A, demonstrated that the phosphorylation levels of R1S4/201A were significantly lower than those of the other two mutants. Also, the Ba2+-sensitive K+ current in oocytes injected with green fluorescent protein (GFP)-R1S4/201A was only 5% of that in oocytes injected with wild type GFP-ROMK1. In contrast, the K+ current in oocytes injected with GFP-ROMK1 mutants containing either serine residue 4 or 201 was similar to those injected with wild type ROMK1. Confocal microscope imaging shows that the surface expression of the K+ channels was significantly diminished in oocytes injected with R1S4/201A and completely absent in oocytes injected with R1S4/183/201A. Furthermore, the biotin labeling technique confirmed that the membrane fraction of ROMK channels was almost absent in HEK293 cells transfected with either R1S4/201A or R1S4/183/201A. However, when serine residues 4 and 201 were mutated to aspartate, the K+ currents and the surface expression were completely restored. Finally, addition of calphostin C in the incubation medium significantly decreased the K+ current in comparison with that under control conditions. Biotin labeling technique further indicated that inhibition of PKC decreases the surface ROMK1 expression in human embryonic kidney (HEK) cells transfected with ROMK1. We conclude that ROMK1 is a substrate of PKC and that serine residues 4 and 201 are the two main PKC phosphorylation sites that are essential for the expression of ROMK1 in the cell surface.	New York Med Coll, Dept Pharmacol, Valhalla, NY 10595 USA; New York Med Coll, Dept Anat & Cell Biol, Valhalla, NY 10595 USA; Yale Univ, Dept Cellular & Mol Physiol, Sch Med, New Haven, CT 06511 USA	New York Medical College; New York Medical College; Yale University	Wang, WH (corresponding author), New York Med Coll, Dept Pharmacol, BSB Rm 537, Valhalla, NY 10595 USA.	wenhui_wang@nymc.edu	Lerea, Ken/GWU-8597-2022		NIDDK NIH HHS [R01 DK047402, DK 47402, DK 54983, R01 DK047402-13, R01 DK054983-08, R01 DK054983] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054983, R01DK047402, R29DK047402] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BOIM MA, 1995, AM J PHYSIOL-RENAL, V268, pF1132, DOI 10.1152/ajprenal.1995.268.6.F1132; Chen HC, 2002, J BIOL CHEM, V277, P23554, DOI 10.1074/jbc.M201152200; CHEPILKO S, 1995, AM J PHYSIOL-CELL PH, V268, pC389, DOI 10.1152/ajpcell.1995.268.2.C389; Dong K, 2001, J BIOL CHEM, V276, P44347, DOI 10.1074/jbc.M108072200; FRINDT G, 1987, AM J PHYSIOL, V252, pF458, DOI 10.1152/ajprenal.1987.252.3.F458; Giebisch G, 1998, AM J PHYSIOL-RENAL, V274, pF817, DOI 10.1152/ajprenal.1998.274.5.F817; HO K, 1993, NATURE, V362, P31, DOI 10.1038/362031a0; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; Lin DH, 2002, AM J PHYSIOL-RENAL, V283, pF671, DOI 10.1152/ajprenal.00160.2002; Liou HH, 1999, P NATL ACAD SCI USA, V96, P5820, DOI 10.1073/pnas.96.10.5820; Macica CM, 1996, AM J PHYSIOL-RENAL, V271, pF588, DOI 10.1152/ajprenal.1996.271.3.F588; Macica CM, 1998, AM J PHYSIOL-RENAL, V274, pF175, DOI 10.1152/ajprenal.1998.274.1.F175; McNicholas CM, 1996, P NATL ACAD SCI USA, V93, P8083, DOI 10.1073/pnas.93.15.8083; McNicholas CM, 1997, AM J PHYSIOL-RENAL, V273, pF843, DOI 10.1152/ajprenal.1997.273.5.F843; Mennitt PA, 1997, J AM SOC NEPHROL, V8, P1823; Moral Z, 2001, J BIOL CHEM, V276, P7156, DOI 10.1074/jbc.M008671200; Morita T, 1997, AM J PHYSIOL-RENAL, V273, pF615, DOI 10.1152/ajprenal.1997.273.4.F615; PALMER LG, 1994, J GEN PHYSIOL, V104, P693, DOI 10.1085/jgp.104.4.693; Palmer LG, 1997, AM J PHYSIOL-RENAL, V273, pF404, DOI 10.1152/ajprenal.1997.273.3.F404; Ruknudin A, 1998, J BIOL CHEM, V273, P14165, DOI 10.1074/jbc.273.23.14165; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Schrag JD, 2001, MOL CELL, V8, P633, DOI 10.1016/S1097-2765(01)00318-5; Simon DB, 1996, NAT GENET, V14, P152, DOI 10.1038/ng1096-152; STANTON BA, 1992, HDB PHYSL RENAL PHYS, P813; Sterling H, 2002, J BIOL CHEM, V277, P4317, DOI 10.1074/jbc.M109739200; WANG WH, 1993, J GEN PHYSIOL, V101, P673, DOI 10.1085/jgp.101.5.673; WANG WH, 1991, P NATL ACAD SCI USA, V88, P9722, DOI 10.1073/pnas.88.21.9722; Wang WH, 1997, ANNU REV PHYSIOL, V59, P413, DOI 10.1146/annurev.physiol.59.1.413; Wei Y, 2000, J BIOL CHEM, V275, P20502, DOI 10.1074/jbc.M000783200; WODA CB, 2000, AM J PHYSIOL, V280, pF786; Xu JZ, 1997, AM J PHYSIOL-RENAL, V273, pF739, DOI 10.1152/ajprenal.1997.273.5.F739; Yao XQ, 1996, J CLIN INVEST, V97, P2525, DOI 10.1172/JCI118700; ZHEN WZ, 2001, J AM SOC NEPHROL, V12, pA45	33	37	37	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2002	277	46					44278	44284		10.1074/jbc.M203702200	http://dx.doi.org/10.1074/jbc.M203702200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	615XE	12221079	hybrid, Green Accepted			2022-12-27	WOS:000179272000097
J	Johnson, EF; Hinz, W; Atreya, CE; Maley, F; Anderson, KS				Johnson, EF; Hinz, W; Atreya, CE; Maley, F; Anderson, KS			Mechanistic characterization of Toxoplasma gondii thymidylate synthase (TS-DHFR)-dihydrofolate reductase - Evidence for a TS intermediate and TS half-sites reactivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIHYDROFOLATE-REDUCTASE; ESCHERICHIA-COLI; LACTOBACILLUS-CASEI; LEISHMANIA-TROPICA; INACTIVE MUTANTS; ACTIVITY ENZYME; BINDING; GENE; RESTORATION; SIMULATION	This study describes the use of rapid transient kinetic methods to characterize the bifunctional thymidylate synthase-dihydrofolate reductase (TS-DHFR) enzyme from Toxoplasma gondii. In addition to elucidating the detailed kinetic scheme for this enzyme, this work provides the first direct kinetic evidence for the formation of a TS intermediate and for half-sites TS reactivity in human and Escherichia coli monofunctional TS and in T. gondii and Leishmania major bifunctional TS-DHFR. Comparison of the T. gondii TS-DHFR catalytic mechanism to that of the L. major enzyme reveals the mechanistic differences to be predominantly in DHFR activity. Specifically, TS ligand induced domain-domain communication involving DHFR activation is observed only in the L. major enzyme and, whereas both DHFR activities involve a rate-limiting conformational change, the change occurs at different positions along the kinetic pathway.	Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; New York State Dept Hlth, Albany, NY 12201 USA	Yale University; State University of New York (SUNY) System	Anderson, KS (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, 333 Cedar St, New Haven, CT 06520 USA.				NATIONAL CANCER INSTITUTE [R35CA044355] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044630] Funding Source: NIH RePORTER; NCI NIH HHS [CA44355] Funding Source: Medline; NIAID NIH HHS [AI44630] Funding Source: Medline; NIGMS NIH HHS [GMO7205] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BARSHOP BA, 1983, ANAL BIOCHEM, V130, P134, DOI 10.1016/0003-2697(83)90660-7; Berlett BS, 2000, ANAL BIOCHEM, V287, P329, DOI 10.1006/abio.2000.4876; BEVERLEY SM, 1986, P NATL ACAD SCI USA, V83, P2584, DOI 10.1073/pnas.83.8.2584; Blakley R.L., 1984, FOLATES PTERINS, V1, P191; BLAKLEY RL, 1960, NATURE, V188, P231, DOI 10.1038/188231a0; CARRERAS CW, 1995, ANNU REV BIOCHEM, V64, P721, DOI 10.1146/annurev.bi.64.070195.003445; CURTHOYS NP, 1972, J BIOL CHEM, V247, P1959; Dawson R. M. C., 1991, DATA BIOCH RES, V3rd, P363; Elcock AH, 1997, BIOCHEMISTRY-US, V36, P16049, DOI 10.1021/bi971709u; Elcock AH, 1996, J MOL BIOL, V262, P370, DOI 10.1006/jmbi.1996.0520; FINERMOORE J, 1993, J MOL BIOL, V232, P1101, DOI 10.1006/jmbi.1993.1463; GALIVAN JH, 1976, BIOCHEMISTRY-US, V15, P356, DOI 10.1021/bi00647a018; GRUMONT R, 1986, P NATL ACAD SCI USA, V83, P5387, DOI 10.1073/pnas.83.15.5387; GRUMONT R, 1988, BIOCHEMISTRY-US, V27, P3776, DOI 10.1021/bi00410a039; HARDY LW, 1987, SCIENCE, V235, P448, DOI 10.1126/science.3099389; KALLEN RG, 1966, J BIOL CHEM, V241, P5845; KAMB A, 1992, BIOCHEMISTRY-US, V31, P12876, DOI 10.1021/bi00166a024; Liang PH, 1998, BIOCHEMISTRY-US, V37, P12195, DOI 10.1021/bi9803168; MALEY F, 1995, BIOCHEMISTRY-US, V34, P1469, DOI 10.1021/bi00005a001; MATHEWS CK, 1960, J BIOL CHEM, V130, P134; MATTHEWS DA, 1990, J MOL BIOL, V214, P923, DOI 10.1016/0022-2836(90)90346-N; MEEK TD, 1985, BIOCHEMISTRY-US, V24, P678, DOI 10.1021/bi00324a021; MONTFORT WR, 1990, BIOCHEMISTRY-US, V29, P6964, DOI 10.1021/bi00482a004; Myllykallio H, 2002, SCIENCE, V297, P105, DOI 10.1126/science.1072113; PERRY KM, 1993, BIOCHEMISTRY-US, V32, P7116, DOI 10.1021/bi00079a007; ROLAND AR, 1996, OPPORTUNISTIC COMPLI, V5, P81; ROOS DS, 1993, J BIOL CHEM, V268, P6269; SANTI DV, 1984, FOLATES PTERIDINES, V1, P343; Saxl RL, 2001, BIOCHEMISTRY-US, V40, P5275, DOI 10.1021/bi002925x; Spencer HT, 1997, BIOCHEMISTRY-US, V36, P4212, DOI 10.1021/bi961794q; STROUD RM, 1994, NAT STRUCT BIOL, V1, P131, DOI 10.1038/nsb0394-131; Vasquez JR, 1996, MOL BIOCHEM PARASIT, V79, P153, DOI 10.1016/0166-6851(96)02647-3	32	30	30	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					43126	43136		10.1074/jbc.M206523200	http://dx.doi.org/10.1074/jbc.M206523200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12192007	hybrid			2022-12-27	WOS:000179081200093
J	Mulligan, C; Rochford, J; Denyer, G; Stephens, R; Yeo, G; Freeman, T; Siddle, K; O'Rahilly, S				Mulligan, C; Rochford, J; Denyer, G; Stephens, R; Yeo, G; Freeman, T; Siddle, K; O'Rahilly, S			Microarray analysis of insulin and insulin-like growth factor-1 (IGF-1) receptor signaling reveals the selective up-regulation of the mitogen heparin-binding EGF-like growth factor by IGF-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-I RECEPTOR; CYTOPLASMIC DOMAINS; GLYCOGEN-SYNTHESIS; WOUND FLUID; EXPRESSION; GENE; PHOSPHORYLATION; CELLS; FIBROBLASTS; HEPATOCYTES	Insulin and insulin-like growth factor-1 (IGF-1) act through highly homologous receptors that engage similar intracellular signaling pathways, yet these hormones serve largely distinct physiological roles in the control of metabolism and growth, respectively. In an attempt to uncover the molecular mechanisms underlying their divergent functions, we compared insulin receptor (IR) and IGF-1 receptor (IGF-IR) regulation of gene expression by microarray analysis, using 3T3-LI cells expressing either TrkC/IR or TrkC/IGF-IR chimeric receptors to ensure the highly selective activation of each receptor tyrosine kinase. Following stimulation of the chimeric receptors for 4 h, we detected 11 genes to be differentially regulated, of which 10 were up-regulated to a greater extent by the IGF-1R. These included genes involved in adhesion, transcription, transport, and proliferation. The expression of mRNA encoding heparin-binding epidermal growth factor-like growth factor (HB-EGF), a potent mitogen, was markedly increased by IGF-1R but not IR activation. This effect was dependent on MAPK, but not phosphatidylinositol 3-kinase, and did not require an autocrine loop through the epidermal growth factor receptor. HB-EGF mitogenic activity was detectable in the medium of 3T3-Ll preadipocytes expressing activated IGF-1R but not IR, indicating that the transcriptional response is accompanied by a parallel increase in mature HB-EGF protein. The differential abilities of the IR and IGF-1R tyrosine kinases to stimulate the synthesis and release of a growth factor may provide, at least in part, an explanation for the greater role of the IGF-1R in the control of cellular proliferation.	Univ Cambridge, Addenbrookes Hosp, Dept Clin Biochem, Cambridge CB2 2QR, England; Univ Sydney, Dept Biochem, Sydney, NSW 2006, Australia; MRC Human Genome Mapping Programme RC, Hinxton CB10 1SB, England; Univ Cambridge, Addenbrookes Hosp, Cambridge Inst Med Res, Cambridge CB2 2XY, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Sydney; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	O'Rahilly, S (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Clin Biochem, Hills Rd, Cambridge CB2 2QR, England.		denyer, gareth/E-3437-2010; O'Rahilly, Stephen/ABF-6509-2020	O'Rahilly, Stephen/0000-0003-2199-4449; Yeo, Giles See How/0000-0001-8823-3615; Rochford, Justin/0000-0002-5020-4939				Accili D, 1996, NAT GENET, V12, P106, DOI 10.1038/ng0196-106; BARNARD JA, 1994, J BIOL CHEM, V269, P22817; Blakesley VA, 1996, ENDOCRINOLOGY, V137, P410, DOI 10.1210/en.137.2.410; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; DEMEYTS P, 1995, METABOLISM, V44, P2, DOI 10.1016/0026-0495(95)90214-7; Dupont J, 2001, ENDOCRINOLOGY, V142, P4969, DOI 10.1210/en.142.11.4969; Dupont J, 2001, J BIOL CHEM, V276, P26699, DOI 10.1074/jbc.M102664200; Frade JN, 1996, DEVELOPMENT, V122, P2497; HIGASHIYAMA S, 1991, SCIENCE, V251, P936, DOI 10.1126/science.1840698; HIPSKIND RA, 1994, MOL CELL BIOL, V14, P6219, DOI 10.1128/MCB.14.9.6219; ITO N, 1994, BIOCHEM BIOPH RES CO, V198, P25, DOI 10.1006/bbrc.1994.1004; Joshi RL, 1996, EMBO J, V15, P1542, DOI 10.1002/j.1460-2075.1996.tb00498.x; KallooHosein HE, 1997, J BIOL CHEM, V272, P24325, DOI 10.1074/jbc.272.39.24325; KOBRIN MS, 1994, BIOCHEM BIOPH RES CO, V202, P1705, DOI 10.1006/bbrc.1994.2131; LAMMERS R, 1989, EMBO J, V8, P1369, DOI 10.1002/j.1460-2075.1989.tb03517.x; Le Bellego F, 2002, J ENDOCRINOL, V172, P45, DOI 10.1677/joe.0.1720045; Li SW, 1996, J BIOL CHEM, V271, P12254, DOI 10.1074/jbc.271.21.12254; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/0092-8674(93)90679-K; Marikovsky M, 1996, J INVEST DERMATOL, V106, P616, DOI 10.1111/1523-1747.ep12345413; MARIKOVSKY M, 1993, P NATL ACAD SCI USA, V90, P3889, DOI 10.1073/pnas.90.9.3889; MASTICK CC, 1994, ENDOCRINOLOGY, V135, P214, DOI 10.1210/en.135.1.214; Miele C, 2000, J BIOL CHEM, V275, P21695, DOI 10.1074/jbc.M000805200; NAGLICH JG, 1992, CELL, V69, P1051, DOI 10.1016/0092-8674(92)90623-K; Park BC, 1999, BIOCHEMISTRY-US, V38, P7517, DOI 10.1021/bi9830718; RAAB G, 1997, BIOCHIM BIOPHYS ACTA, V1333, P179; Roudabush FL, 2000, J BIOL CHEM, V275, P22583, DOI 10.1074/jbc.M002915200; Sasaoka T, 1996, ENDOCRINOLOGY, V137, P4427, DOI 10.1210/en.137.10.4427; Sugden MC, 2001, BIOCHEM SOC T, V29, P272, DOI 10.1042/0300-5127:0290272; TARTARE S, 1994, J BIOL CHEM, V269, P11449; Urso B, 1999, J BIOL CHEM, V274, P30864, DOI 10.1074/jbc.274.43.30864; Urso B, 2001, CELL SIGNAL, V13, P279, DOI 10.1016/S0898-6568(01)00130-9; ZAPF A, 1994, ENDOCRINOLOGY, V134, P2445, DOI 10.1210/en.134.6.2445	32	47	51	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					42480	42487		10.1074/jbc.M206206200	http://dx.doi.org/10.1074/jbc.M206206200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12213819	hybrid			2022-12-27	WOS:000179081200009
J	Wang, JW; Barsky, LW; Shum, CH; Jong, A; Weinberg, KI; Collins, SJ; Triche, TJ; Wu, LT				Wang, JW; Barsky, LW; Shum, CH; Jong, A; Weinberg, KI; Collins, SJ; Triche, TJ; Wu, LT			Retinoid-induced G(1) arrest and differentiation activation are associated with a switch to cyclin-dependent kinase-activating kinase hypophosphorylation of retinoic acid receptor alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR TFIIH; ACUTE PROMYELOCYTIC LEUKEMIA; DOMINANT-NEGATIVE ACTIVITY; CAK ASSEMBLY FACTOR; RAR-ALPHA; CELL-CYCLE; GRANULOCYTIC DIFFERENTIATION; SUBSTRATE-SPECIFICITY; INHIBITOR P27(KIP1); FUNCTIONS AF-1	Cell cycle G(1) exit is a critical stage where cells commonly commit to proliferate or to differentiate, but the biochemical events that regulate the proliferation/differentiation (P/D) transition at G(1) exit are presently unclear. We previously showed that MAT1 (menage a trois 1), an assembly factor and targeting subunit of the cyclin-dependent kinase (CDK)-activating kinase (CAK), modulates CAK activities to regulate G(1) exit. Here we find that the retinoid-induced G(1) arrest and differentiation activation of cultured human leukemic cells are associated with a switch to CAK hypophosphorylation of retinoic acid receptor alpha (RARalpha) from CAK hyperphosphorylation of RARa. The switch to CAK hypophosphorylation of RARa is accompanied by decreased MAT1 expression and MAT1. fragmentation that occurs in the differentiating cells through the all-trans-retinoic acid (ATRA)-mediated proteasome degradation pathway. Because HL60R cells that harbor a truncated ligand-dependent AF-2 domain of RARalpha do not demonstrate any changes in MAT1 levels or CAK phosphorylation of RARalpha following ATRA stimuli, these biochemical changes appear to be mediated directly through RARalpha. These studies indicate that significant changes in MAT1. levels and CAK activities on RARalpha phosphorylation accompany the ATRA-induced G(1) arrest and differentiation activation, which provide new insights to explore the inversely coordinated P/D transition at G(1) exit.	Univ So Calif, Dept Pathol, Childrens Hosp Los Angeles, Keck Sch Med,Res Inst, Los Angeles, CA 90027 USA; Childrens Hosp Los Angeles, Res Inst, Div Res Immunol Bone Marrow Transplant, Los Angeles, CA 90027 USA; Childrens Hosp Los Angeles, Res Inst, Div Hematol Oncol, Los Angeles, CA 90027 USA; Fred Hutchinson Canc Res Ctr, Human Biol Div, Seattle, WA 98109 USA; Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA	Children's Hospital Los Angeles; University of Southern California; Children's Hospital Los Angeles; Children's Hospital Los Angeles; Fred Hutchinson Cancer Center; University of Southern California	Wu, LT (corresponding author), Univ So Calif, Dept Pathol, Childrens Hosp Los Angeles, Keck Sch Med,Res Inst, Mail Stop 103,4650 Sunset Blvd, Los Angeles, CA 90027 USA.							Blain SW, 1997, J BIOL CHEM, V272, P25863, DOI 10.1074/jbc.272.41.25863; Burtelow MA, 2000, J BIOL CHEM, V275, P26343, DOI 10.1074/jbc.M001244200; Busso D, 2000, J BIOL CHEM, V275, P22815, DOI 10.1074/jbc.M002578200; COLLINS SJ, 1990, MOL CELL BIOL, V10, P2154, DOI 10.1128/MCB.10.5.2154; DAMM K, 1993, P NATL ACAD SCI USA, V90, P2989, DOI 10.1073/pnas.90.7.2989; Diehl JA, 1997, MOL CELL BIOL, V17, P7362, DOI 10.1128/MCB.17.12.7362; Drapkin R, 1996, P NATL ACAD SCI USA, V93, P6488, DOI 10.1073/pnas.93.13.6488; FEAVER WJ, 1994, CELL, V79, P1103, DOI 10.1016/0092-8674(94)90040-X; GAUB MP, 1992, EXP CELL RES, V201, P335, DOI 10.1016/0014-4827(92)90282-D; Inamoto S, 1997, J BIOL CHEM, V272, P29852, DOI 10.1074/jbc.272.47.29852; Kaldis P, 1999, CELL MOL LIFE SCI, V55, P284, DOI 10.1007/s000180050290; KATO JY, 1994, MOL CELL BIOL, V14, P2713, DOI 10.1128/MCB.14.4.2713; KATO JY, 1994, CELL, V79, P487, DOI 10.1016/0092-8674(94)90257-7; Ko LJ, 1997, MOL CELL BIOL, V17, P7220, DOI 10.1128/MCB.17.12.7220; Kopf E, 2000, J BIOL CHEM, V275, P33280, DOI 10.1074/jbc.M002840200; Larochelle S, 2001, EMBO J, V20, P3749, DOI 10.1093/emboj/20.14.3749; Liu TX, 2000, BLOOD, V96, P1496, DOI 10.1182/blood.V96.4.1496.h8001496_1496_1504; MATSUOKA M, 1994, MOL CELL BIOL, V14, P7265, DOI 10.1128/MCB.14.11.7265; Melnick A, 1999, BLOOD, V93, P3167, DOI 10.1182/blood.V93.10.3167.410k44_3167_3215; NAGPAL S, 1993, EMBO J, V12, P2349, DOI 10.1002/j.1460-2075.1993.tb05889.x; NERVI C, 1989, P NATL ACAD SCI USA, V86, P5854, DOI 10.1073/pnas.86.15.5854; Nigg EA, 1996, CURR OPIN CELL BIOL, V8, P312, DOI 10.1016/S0955-0674(96)80003-2; Ohnuma S, 2001, CURR OPIN NEUROBIOL, V11, P66, DOI 10.1016/S0959-4388(00)00175-6; Reardon JT, 1996, P NATL ACAD SCI USA, V93, P6482, DOI 10.1073/pnas.93.13.6482; ROBERTSON KA, 1992, MOL CELL BIOL, V12, P3743, DOI 10.1128/MCB.12.9.3743; ROBERTSON KA, 1992, BLOOD, V80, P1885; RochetteEgly C, 1997, CELL, V90, P97, DOI 10.1016/S0092-8674(00)80317-7; ROCHETTEEGLY C, 1991, J CELL BIOL, V115, P535, DOI 10.1083/jcb.115.2.535; ROCHETTEEGLY C, 1995, MOL ENDOCRINOL, V9, P860, DOI 10.1210/me.9.7.860; Rossi DJ, 2001, EMBO J, V20, P2844, DOI 10.1093/emboj/20.11.2844; Rossignol M, 1997, EMBO J, V16, P1628, DOI 10.1093/emboj/16.7.1628; SERIZAWA H, 1995, NATURE, V374, P280, DOI 10.1038/374280a0; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; SHIEKHATTAR R, 1995, NATURE, V374, P283, DOI 10.1038/374283a0; Slack JL, 2000, ANN HEMATOL, V79, P227, DOI 10.1007/s002770050585; Studzinski GP, 1999, INT REV CYTOL, V189, P1, DOI 10.1016/S0074-7696(08)61384-4; SUCOV HM, 1995, MOL NEUROBIOL, V10, P169, DOI 10.1007/BF02740674; Svejstrup JQ, 1996, J BIOL CHEM, V271, P643, DOI 10.1074/jbc.271.2.643; Taneja R, 1997, EMBO J, V16, P6452, DOI 10.1093/emboj/16.21.6452; TASSAN JP, 1995, EMBO J, V14, P5608, DOI 10.1002/j.1460-2075.1995.tb00248.x; TSAI S, 1992, GENE DEV, V6, P2258, DOI 10.1101/gad.6.12a.2258; Wu LT, 2001, MOL CELL BIOL, V21, P260, DOI 10.1128/MCB.21.1.260-270.2001; Wu LT, 1999, J BIOL CHEM, V274, P5564, DOI 10.1074/jbc.274.9.5564; Yankulov KY, 1997, EMBO J, V16, P1638, DOI 10.1093/emboj/16.7.1638; YEE A, 1995, CANCER RES, V55, P6058; Zhu J, 1999, P NATL ACAD SCI USA, V96, P14807, DOI 10.1073/pnas.96.26.14807; Zhu L, 2001, CURR OPIN GENET DEV, V11, P91, DOI 10.1016/S0959-437X(00)00162-3	47	41	50	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					43369	43376		10.1074/jbc.M206792200	http://dx.doi.org/10.1074/jbc.M206792200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12213824	hybrid			2022-12-27	WOS:000179081200121
J	Liu, PS; Rudick, M; Anderson, RGW				Liu, PS; Rudick, M; Anderson, RGW			Multiple functions of caveolin-1.	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							RICH MEMBRANE DOMAINS; NITRIC-OXIDE SYNTHASE; PLASMA-MEMBRANE; TYROSINE KINASE; SCAFFOLDING DOMAIN; PROTEIN-KINASE; ENDOPLASMIC-RETICULUM; CHOLESTEROL-BINDING; SIGNAL-TRANSDUCTION; UROKINASE RECEPTOR		Univ Texas, SW Med Ctr, Dept Cell Biol, Dallas, TX 75235 USA; Texas Womans Univ, Dept Biol, Denton, TX 76204 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Texas Womans University	Anderson, RGW (corresponding author), Univ Texas, SW Med Ctr, Dept Cell Biol, 5323 Harry Hines Blvd, Dallas, TX 75235 USA.	richard.anderson@utsouthwestern.edu	Liu, Pingsheng/B-7124-2012					Anderson RGW, 2002, SCIENCE, V296, P1821, DOI 10.1126/science.1068886; Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; Bilderback TR, 1997, J BIOL CHEM, V272, P10922; Bucci M, 2000, NAT MED, V6, P1362, DOI 10.1038/82176; Cao HM, 2002, J BIOL CHEM, V277, P8771, DOI 10.1074/jbc.C100661200; Carman CV, 1999, J BIOL CHEM, V274, P8858, DOI 10.1074/jbc.274.13.8858; CHANG WJ, 1992, J CELL BIOL, V118, P63, DOI 10.1083/jcb.118.1.63; Couet J, 1997, J BIOL CHEM, V272, P30429, DOI 10.1074/jbc.272.48.30429; Couet J, 1997, J BIOL CHEM, V272, P6525, DOI 10.1074/jbc.272.10.6525; Czarny M, 1999, J BIOL CHEM, V274, P2717, DOI 10.1074/jbc.274.5.2717; Fernandez I, 2002, P NATL ACAD SCI USA, V99, P11193, DOI 10.1073/pnas.172196599; Fielding CJ, 1997, J LIPID RES, V38, P1503; FRA AM, 1995, FEBS LETT, V375, P11, DOI 10.1016/0014-5793(95)95228-O; Gaillard S, 2001, FEBS LETT, V508, P49, DOI 10.1016/S0014-5793(01)03020-4; GarciaCardena G, 1996, J BIOL CHEM, V271, P27237, DOI 10.1074/jbc.271.44.27237; GLENNEY JR, 1989, J BIOL CHEM, V264, P20163; Graf GA, 1999, TRENDS CARDIOVAS MED, V9, P221, DOI 10.1016/S1050-1738(00)00031-1; Ito J, 2002, J BIOL CHEM, V277, P7929, DOI 10.1074/jbc.M103878200; Karpen HE, 2001, J BIOL CHEM, V276, P19503, DOI 10.1074/jbc.M010832200; Kasahara K, 1997, J BIOL CHEM, V272, P29947, DOI 10.1074/jbc.272.47.29947; Kim JH, 1999, BIOCHEMISTRY-US, V38, P3763, DOI 10.1021/bi982478+; KURZCHALIA TV, 1992, J CELL BIOL, V118, P1003, DOI 10.1083/jcb.118.5.1003; LANGE Y, 1994, J BIOL CHEM, V269, P3411; Le PU, 2002, J BIOL CHEM, V277, P3371, DOI 10.1074/jbc.M111240200; Lee H, 2001, J BIOL CHEM, V276, P35150, DOI 10.1074/jbc.M104530200; LI SW, 1995, J BIOL CHEM, V270, P15693, DOI 10.1074/jbc.270.26.15693; Li SW, 1996, J BIOL CHEM, V271, P29182, DOI 10.1074/jbc.271.46.29182; Li WP, 2001, J CELL SCI, V114, P1397; Liou JY, 2001, J BIOL CHEM, V276, P34975, DOI 10.1074/jbc.M105946200; Lisanti Michael P., 1994, Trends in Cell Biology, V4, P231, DOI 10.1016/0962-8924(94)90114-7; LISANTI MP, 1993, J CELL BIOL, V123, P595, DOI 10.1083/jcb.123.3.595; Liu PS, 2000, J BIOL CHEM, V275, P31648, DOI 10.1074/jbc.M004599200; Liu PS, 1999, NAT CELL BIOL, V1, P369, DOI 10.1038/14067; Liu PS, 1996, J BIOL CHEM, V271, P10299, DOI 10.1074/jbc.271.17.10299; Liu PS, 1997, P NATL ACAD SCI USA, V94, P13666, DOI 10.1073/pnas.94.25.13666; Lockwich TP, 2000, J BIOL CHEM, V275, P11934, DOI 10.1074/jbc.275.16.11934; Lu ML, 2001, J BIOL CHEM, V276, P13442, DOI 10.1074/jbc.M006598200; Machleidt T, 2000, J CELL BIOL, V148, P17, DOI 10.1083/jcb.148.1.17; Mastick CC, 1997, J BIOL CHEM, V272, P20706, DOI 10.1074/jbc.272.33.20706; Mineo C, 1996, J BIOL CHEM, V271, P11930, DOI 10.1074/jbc.271.20.11930; Minetti C, 1998, NAT GENET, V18, P365, DOI 10.1038/ng0498-365; Muller G, 2001, MOL CELL BIOL, V21, P4553, DOI 10.1128/MCB.21.14.4553-4567.2001; MURATA M, 1995, P NATL ACAD SCI USA, V92, P10339, DOI 10.1073/pnas.92.22.10339; Nichols BJ, 2002, NAT CELL BIOL, V4, P374, DOI 10.1038/ncb787; Okamoto T, 1998, J BIOL CHEM, V273, P5419, DOI 10.1074/jbc.273.10.5419; Parolini I, 1999, J BIOL CHEM, V274, P25718, DOI 10.1074/jbc.274.36.25718; Pelkmans L, 2001, NAT CELL BIOL, V3, P473, DOI 10.1038/35074539; Pol A, 2001, J CELL BIOL, V152, P1057, DOI 10.1083/jcb.152.5.1057; Razani B, 1999, J BIOL CHEM, V274, P26353, DOI 10.1074/jbc.274.37.26353; Razani B, 2002, J BIOL CHEM, V277, P8635, DOI 10.1074/jbc.M110970200; Razani B, 2001, J BIOL CHEM, V276, P38121; Razani B, 2001, J BIOL CHEM, V276, P6727, DOI 10.1074/jbc.M008340200; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Roy S, 1999, NAT CELL BIOL, V1, P98, DOI 10.1038/10067; SARGIACOMO M, 1995, P NATL ACAD SCI USA, V92, P9407, DOI 10.1073/pnas.92.20.9407; Scheiffele P, 1998, J CELL BIOL, V140, P795, DOI 10.1083/jcb.140.4.795; Schlegel A, 1999, J BIOL CHEM, V274, P22660, DOI 10.1074/jbc.274.32.22660; Schlegel A, 2001, BIOCHEM J, V359, P203, DOI 10.1042/0264-6021:3590203; Schreiber S, 2000, J BIOL CHEM, V275, P24115, DOI 10.1074/jbc.M001876200; Schubert AL, 2002, BIOCHEMISTRY-US, V41, P5754, DOI 10.1021/bi0121656; SMART EJ, 1994, J CELL BIOL, V127, P1185, DOI 10.1083/jcb.127.5.1185; Smart EJ, 1999, MOL CELL BIOL, V19, P7289; Smart EJ, 1996, J BIOL CHEM, V271, P29427, DOI 10.1074/jbc.271.46.29427; Song KS, 1996, J BIOL CHEM, V271, P9690, DOI 10.1074/jbc.271.16.9690; Stahlhut M, 2000, MOL BIOL CELL, V11, P325, DOI 10.1091/mbc.11.1.325; Thomsen P, 2002, MOL BIOL CELL, V13, P238, DOI 10.1091/mbc.01-06-0317; Trigatti BL, 1999, BIOCHEM BIOPH RES CO, V255, P34, DOI 10.1006/bbrc.1998.0123; Uittenbogaard A, 2000, J BIOL CHEM, V275, P25595, DOI 10.1074/jbc.M003401200; Uittenbogaard A, 1998, J BIOL CHEM, V273, P6525, DOI 10.1074/jbc.273.11.6525; Venema VJ, 1997, J BIOL CHEM, V272, P28187, DOI 10.1074/jbc.272.45.28187; Volonte D, 1999, J BIOL CHEM, V274, P12702, DOI 10.1074/jbc.274.18.12702; Wary KK, 1998, CELL, V94, P625, DOI 10.1016/S0092-8674(00)81604-9; Wei Y, 1996, SCIENCE, V273, P1551, DOI 10.1126/science.273.5281.1551; Wei Y, 1999, J CELL BIOL, V144, P1285, DOI 10.1083/jcb.144.6.1285; Wu DQ, 2002, CANCER RES, V62, P2423; Yamabhai M, 2002, J BIOL CHEM, V277, P24843, DOI 10.1074/jbc.C200277200; Yamamoto M, 1999, EXP CELL RES, V247, P380, DOI 10.1006/excr.1998.4379; Yamamoto M, 1998, J BIOL CHEM, V273, P26962, DOI 10.1074/jbc.273.41.26962	78	469	504	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					41295	41298		10.1074/jbc.R200020200	http://dx.doi.org/10.1074/jbc.R200020200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12189159	hybrid			2022-12-27	WOS:000178985300001
J	Swevers, L; Ito, K; Iatrou, K				Swevers, L; Ito, K; Iatrou, K			The BmE75 nuclear receptors function as dominant repressors of the nuclear receptor BmHR3A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ECDYSONE-INDUCIBLE GENE; DNA-BINDING PROPERTIES; DROSOPHILA METAMORPHOSIS; BOMBYX-MORI; DEVELOPMENTAL EXPRESSION; ORPHAN RECEPTOR; CHORISTONEURA HORMONE-RECEPTOR-3; HORMONAL-CONTROL; LIGAND-BINDING; MANDUCA-SEXTA	The orphan nuclear receptors BmE75 and BmHR3 are induced by 20-hydroxyecdysone in the ovary of the silk moth Bombyx mori at the beginning of pupation and show stage-specific expression in ovarian follicles during pharate adult development. To analyze the function of these receptors, we have developed a transactivation assay based on the transcriptional stimulation of a retinoic acid receptor-related receptor response element (RORE)-linked promoter-reporter construct. Co-transfection of a Bombyx cell line with a BmHR3A expression construct results in constitutive activation of the reporter, whereas expression of BmE75 has no measurable effects on reporter expression. However, when the BmE75 receptors are co-introduced with BmHR3A into the cells, the BmHR3A-mediated transactivation is repressed. Repression of BmHR3A by BmE75 occurs by two distinct mechanisms. Increasing doses of BmE75 efficiently displace BmHR3A bound to the RORE target site in gel retardation assays, indicating that both receptors compete for common DNA target sites. However, analysis of the function of deletion mutants of BmE75 in the transactivation assay indicates that repression can also occur in the absence of the DNA-binding domain and that the C-terminal F domain is sufficient for repression. In gel retardation assays, the two receptor types form a ternary complex on a single RORE, suggesting that repression is also mediated by protein interactions on the DNA target site. Yeast two-hybrid assays show that BmHR3A interacts with BmE75 and that this interaction is dependent on the C terminus of BmHR3A and the F domain of BmE75. Because the C terminus of BmHR3A contains a strong activation domain, we predict that BmE75 blocks activation by BmHR3A through competition for co-activator binding sites located at the C terminus of BmHR3A. Our data also indicate that the transcriptional activities of BmHR3A and BmE75 are integrated in such a way that activation of RORE-linked target genes depends on the relative expression levels of the two receptor types.	Natl Ctr Sci Res Demokritos, Inst Biol, Athens 15310, Greece; Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada	National Centre of Scientific Research "Demokritos"; University of Calgary	Iatrou, K (corresponding author), Natl Ctr Sci Res Demokritos, Inst Biol, POB 60228, Athens 15310, Greece.							Atkins GB, 1999, MOL ENDOCRINOL, V13, P1550, DOI 10.1210/me.13.9.1550; Burke LJ, 1998, MOL ENDOCRINOL, V12, P248, DOI 10.1210/me.12.2.248; Darimont BD, 1998, GENE DEV, V12, P3343, DOI 10.1101/gad.12.21.3343; Eystathioy T, 2001, MECH DEVELOP, V103, P107, DOI 10.1016/S0925-4773(01)00335-5; FORMAN BM, 1994, MOL ENDOCRINOL, V8, P1253, DOI 10.1210/me.8.9.1253; GIGUERE V, 1994, GENE DEV, V8, P538, DOI 10.1101/gad.8.5.538; Glass CK, 2000, GENE DEV, V14, P121; HARDING HP, 1995, MOL CELL BIOL, V15, P4791; HENRICH VC, 1995, INSECT BIOCHEM MOLEC, V25, P881, DOI 10.1016/0965-1748(95)00030-Y; HORNER MA, 1995, DEV BIOL, V168, P490, DOI 10.1006/dbio.1995.1097; Hu X, 1999, NATURE, V402, P93, DOI 10.1038/47069; HUET F, 1995, DEVELOPMENT, V121, P1195; JINDRA M, 1994, EUR J BIOCHEM, V221, P665, DOI 10.1111/j.1432-1033.1994.tb18779.x; Johansson L, 2000, MOL CELL BIOL, V20, P1124, DOI 10.1128/MCB.20.4.1124-1133.2000; JOHNSON R, 1992, VIROLOGY, V190, P815, DOI 10.1016/0042-6822(92)90919-G; Kageyama Y, 1997, GENES CELLS, V2, P559, DOI 10.1046/j.1365-2443.1997.1460344.x; Lam G, 1999, DEV BIOL, V212, P204, DOI 10.1006/dbio.1999.9343; Lam GT, 1997, DEVELOPMENT, V124, P1757; Lu M, 1997, J BIOL CHEM, V272, P30724, DOI 10.1074/jbc.272.49.30724; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; McInerney EM, 1998, GENE DEV, V12, P3357, DOI 10.1101/gad.12.21.3357; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; OGAJ S, 2000, GENBANK TM; PALLI SR, 1992, DEV BIOL, V150, P306, DOI 10.1016/0012-1606(92)90244-B; Palli SR, 1996, INSECT BIOCHEM MOLEC, V26, P485, DOI 10.1016/0965-1748(96)00004-5; Palli SR, 1997, ARCH INSECT BIOCHEM, V35, P33, DOI 10.1002/(SICI)1520-6327(1997)35:1/2<33::AID-ARCH4>3.3.CO;2-5; Palli SR, 1997, DEV GENET, V20, P36, DOI 10.1002/(SICI)1520-6408(1997)20:1&lt;36::AID-DVG5&gt;3.0.CO;2-A; SEGRAVES WA, 1990, GENE DEV, V4, P204, DOI 10.1101/gad.4.2.204; SEGRAVES WA, 1993, INSECT BIOCHEM MOLEC, V23, P91, DOI 10.1016/0965-1748(93)90086-8; Swevers L, 1999, INSECT BIOCHEM MOLEC, V29, P955, DOI 10.1016/S0965-1748(99)00059-4; Swevers L, 1996, INSECT BIOCHEM MOLEC, V26, P217, DOI 10.1016/0965-1748(95)00097-6; Swevers L, 1998, MECH DEVELOP, V72, P3, DOI 10.1016/S0925-4773(97)00180-9; SWEVERS L, IN PRESS INSECT BIOC; Thummel CS, 1997, BIOESSAYS, V19, P669, DOI 10.1002/bies.950190806; Torchia J, 1998, CURR OPIN CELL BIOL, V10, P373, DOI 10.1016/S0955-0674(98)80014-8; TSUCHIDA K, 1987, ARCH INSECT BIOCHEM, V5, P167, DOI 10.1002/arch.940050303; White KP, 1997, SCIENCE, V276, P114, DOI 10.1126/science.276.5309.114; Wurtz JM, 1996, NAT STRUCT BIOL, V3, P87, DOI 10.1038/nsb0196-87; Zamir I, 1996, MOL CELL BIOL, V16, P5458; Zhou BH, 1998, DEV BIOL, V193, P127, DOI 10.1006/dbio.1997.8798	40	32	35	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					41637	41644		10.1074/jbc.M203581200	http://dx.doi.org/10.1074/jbc.M203581200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12200421	hybrid			2022-12-27	WOS:000178985300044
J	Xu, QH; Konta, T; Furusu, A; Nakayama, K; Lucio-Cazana, J; Fine, LG; Kitamura, M				Xu, QH; Konta, T; Furusu, A; Nakayama, K; Lucio-Cazana, J; Fine, LG; Kitamura, M			Transcriptional induction of mitogen-activated protein kinase phosphatase 1 by retinoids - Selective roles of nuclear receptors and contribution to the antiapoptotic effect	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL KINASE; DUAL-SPECIFICITY PHOSPHATASE; ACID RECEPTOR; INDUCED APOPTOSIS; X-RECEPTOR; GRANULOCYTIC DIFFERENTIATION; CONDITIONAL EXPRESSION; CELL-PROLIFERATION; GENE-TRANSFER; C-MYC	All-trans-retinoic acid (t-RA) inhibits hydrogen peroxide (H2O2)-induced apoptosis by inhibiting the c-Jun N-terminal kinase (JNK)-activator protein 1 (AP-1) pathway. In this report, we examined the involvement of mitogen-activated protein kinase phosphatase 1 (MKP-1) in suppression of JNK and the antiapoptotic effect of t-RA and the roles of nuclear receptors in the regulation of MKP-1 by t-RA. We found that not only t-RA, but also a selective agonist of retinoic acid receptor (RAR), a selective agonist of retinoid X receptor (RXR), and a pan-agonist of RAR and RXR all induced MKP-1 at the transcriptional level. Activation of RAR was required for all of these triggering effects, but activation of RXR was required only for the RXR agonist-induced MKP-1 expression. Among the three RAR subtypes, RARalpha and RARgamma, but not RARbeta, mediated the t-RA-induced MKP-1 expression. The antiapoptotic effect of t-RA on H2O2-induced apoptosis in several cell types was correlated with the inducibility of MKP-1 by t-RA. Inhibition of MKP-1 by vanadate enhanced JNK phosphorylation and attenuated the antiapoptotic effect of t-RA. Furthermore, overexpression of MKP-1 inhibited H2O2-induced JNK phosphorylation and apoptosis. To our knowledge, this is the first to demonstrate that 1) MKP-1 is inducible by retinoids at the transcriptional level, 2) RXR and individual RAR subtypes have different roles in this process, and 3) the induced MKP-1 plays a significant role in mediating both JNK inhibition and the antiapoptotic effect of t-RA in oxidative stress.	UCL, Royal Free & Univ Coll Med Sch, Dept Med, London W1T 3AA, England; Univ Alcala de Henares, Fac Med, Dept Fisiol, E-28871 Alcala De Henares, Spain; Jikei Univ, Sch Med, Inst Clin Med & Res, Chiba 2778567, Japan; PLA, Gen Hosp Chinese, Dept Nephrol, Beijing 100853, Peoples R China	University of London; University College London; Universidad de Alcala; Jikei University	Xu, QH (corresponding author), UCL, Royal Free & Univ Coll Med Sch, Dept Med, 7th Floor, London W1T 3AA, England.	q.xu@ucl.ac.uk	Konta, Tsuneo/AAO-9286-2021; Lucio-Cazana, Francisco-Javier/B-8149-2009	Lucio-Cazana, Francisco-Javier/0000-0001-9249-8501				Agarwal C, 1996, J BIOL CHEM, V271, P12209, DOI 10.1074/jbc.271.21.12209; Assefa Z, 1999, J BIOL CHEM, V274, P8788, DOI 10.1074/jbc.274.13.8788; Bennett AM, 1997, SCIENCE, V278, P1288, DOI 10.1126/science.278.5341.1288; BERNARD BA, 1992, BIOCHEM BIOPH RES CO, V186, P977, DOI 10.1016/0006-291X(92)90842-9; Burrow CR, 2000, EXP NEPHROL, V8, P219; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COLLINS SJ, 1990, MOL CELL BIOL, V10, P2154, DOI 10.1128/MCB.10.5.2154; DE LUCA LM, 1991, FASEB J, V5, P2924; Desbois-Mouthon C, 2000, ENDOCRINOLOGY, V141, P922, DOI 10.1210/en.141.3.922; Ebisawa M, 1999, CHEM PHARM BULL, V47, P1778; Franklin CC, 1998, P NATL ACAD SCI USA, V95, P3014, DOI 10.1073/pnas.95.6.3014; Franklin CC, 1997, J BIOL CHEM, V272, P16917, DOI 10.1074/jbc.272.27.16917; Germain P, 2002, NATURE, V415, P187, DOI 10.1038/415187a; Goyette P, 2000, J BIOL CHEM, V275, P16497, DOI 10.1074/jbc.M909382199; GREENBERG ME, 1986, MOL CELL BIOL, V6, P1050, DOI 10.1128/MCB.6.4.1050; Haq R, 1991, Biochem Biophys Res Commun, V180, P1137; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; Ishikawa Y, 2000, KIDNEY INT, V58, P1078, DOI 10.1046/j.1523-1755.2000.00265.x; Ishikawa Y, 1999, J AM SOC NEPHROL, V10, P2290; Kang JX, 1999, CELL GROWTH DIFFER, V10, P591; KATO S, 1992, BIOCHEM J, V286, P755, DOI 10.1042/bj2860755; KEYSE SM, 1992, NATURE, V359, P644, DOI 10.1038/359644a0; Kikuchi K, 2001, BIOORG MED CHEM LETT, V11, P1215, DOI 10.1016/S0960-894X(01)00177-9; Kitamura M, 1996, P NATL ACAD SCI USA, V93, P7387, DOI 10.1073/pnas.93.14.7387; KITAMURA M, 1994, J CLIN INVEST, V94, P497, DOI 10.1172/JCI117361; Konta T, 2001, J BIOL CHEM, V276, P12697, DOI 10.1074/jbc.M011000200; Kosaka C, 2001, HYPERTENS RES, V24, P579, DOI 10.1291/hypres.24.579; KRUPITZA G, 1995, INT J CANCER, V61, P649, DOI 10.1002/ijc.2910610511; KWAK SP, 1994, J BIOL CHEM, V269, P3596; Le Q, 2000, ONCOGENE, V19, P1457, DOI 10.1038/sj.onc.1203436; Lee HY, 1999, MOL CELL BIOL, V19, P1973; LEID M, 1992, CELL, V68, P377, DOI 10.1016/0092-8674(92)90478-U; Li Y, 1999, J BIOL CHEM, V274, P15360, DOI 10.1074/jbc.274.22.15360; LIU YS, 1995, J BIOL CHEM, V270, P8377, DOI 10.1074/jbc.270.15.8377; LOPEZBARAHONA M, 1993, J BIOL CHEM, V268, P25617; LOVE JM, 1994, CURR OPIN CELL BIOL, V6, P825, DOI 10.1016/0955-0674(94)90051-5; MagiGalluzzi C, 1997, LAB INVEST, V76, P37; Moreno-Manzano V, 1999, J BIOL CHEM, V274, P20251, DOI 10.1074/jbc.274.29.20251; Moreno-Manzano V, 2000, J BIOL CHEM, V275, P12684, DOI 10.1074/jbc.275.17.12684; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Nagata D, 1999, KIDNEY INT, V55, P1259, DOI 10.1046/j.1523-1755.1999.00361.x; Peterson VJ, 2002, BIOCHEM J, V362, P173, DOI 10.1042/0264-6021:3620173; Radominska-Pandya A, 2000, J BIOL CHEM, V275, P22324, DOI 10.1074/jbc.M907722199; ROBERTSON KA, 1992, MOL CELL BIOL, V12, P3743, DOI 10.1128/MCB.12.9.3743; ROY DY, 1995, MOL CELL BIOL, V15, P6481; Ryser S, 2001, J BIOL CHEM, V276, P33319, DOI 10.1074/jbc.M102326200; SEEWALDT VL, 1995, CELL GROWTH DIFFER, V6, P1077; Slack DN, 2001, J BIOL CHEM, V276, P16491, DOI 10.1074/jbc.M010966200; Sommer A, 2000, FEBS LETT, V474, P146, DOI 10.1016/S0014-5793(00)01566-0; Soprano DR, 2000, J CELL BIOCHEM, V77, P604, DOI 10.1002/(SICI)1097-4644(20000615)77:4<604::AID-JCB8>3.3.CO;2-K; Srikanth S, 1999, MOL CELL BIOCHEM, V199, P169, DOI 10.1023/A:1006980326855; SUN H, 1993, CELL, V75, P487, DOI 10.1016/0092-8674(93)90383-2; Szondy Z, 1998, BIOCHEM J, V331, P767, DOI 10.1042/bj3310767; Taneja R, 1996, P NATL ACAD SCI USA, V93, P6197, DOI 10.1073/pnas.93.12.6197; Umemiya H, 1997, J MED CHEM, V40, P4222, DOI 10.1021/jm9704309; Vuligonda V, 2001, J MED CHEM, V44, P2298, DOI 10.1021/jm0100584; Wagner J, 2001, NEPHROL DIAL TRANSPL, V16, P441, DOI 10.1093/ndt/16.3.441; Whitmarsh AJ, 1996, J MOL MED-JMM, V74, P589, DOI 10.1007/s001090050063; Xu QH, 2002, EXP NEPHROL, V10, P171; Yamauchi T, 2001, J CLIN INVEST, V108, P1001, DOI 10.1172/JCI12864	61	63	67	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					41693	41700		10.1074/jbc.M207095200	http://dx.doi.org/10.1074/jbc.M207095200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12186877	hybrid			2022-12-27	WOS:000178985300051
J	Gell, D; Kong, Y; Eaton, SA; Weiss, MJ; Mackay, JP				Gell, D; Kong, Y; Eaton, SA; Weiss, MJ; Mackay, JP			Biophysical characterization of the alpha-globin binding protein alpha-hemoglobin stabilizing protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLOBULAR PROTEINS; BETA-TUBULIN; MACROMOLECULES; HYDRATION; VOLUMES; CHAINS; RBL2P	alpha-Hemoglobin stabilizing protein (AHSP) is a small (12 kDa) and abundant erythroid-specific protein that binds specifically to free alpha-(hemo)globin and prevents its precipitation. When present in excess over beta-globin, its normal binding partner, alpha-globin can have severe cytotoxic effects that contribute to important human diseases such as beta-thalassemia. Because AHSP might act as a chaperone to prevent the harmful aggregation of alpha-globin during normal erythroid cell development and in diseases of globin chain imbalance, it is important to characterize the biochemical properties of the AHSP(.)alpha-globin complex. Here we provide the first structural information about AHSP and its interaction with a-globin. We find that AHSP is a predominantly alpha-helical globular protein with a somewhat asymmetric shape. AHSP and alpha-globin are both monomeric in solution as determined by analytical ultracentrifugation and bind each other to form a complex with 1:1 subunit stoichiometry, as judged by gel filtration and amino acid analysis. We have used isothermal titration calorimetry to show that the interaction is of moderate affinity with an association constant of I X 10(7) M-1 and is thus likely to be biologically significant given the concentration of AHSP (similar to0.1 mm) and hemoglobin (similar to4 mm) in the late pro-erythroblast.	Univ Sydney, Sch Mol & Microbial Biosci, Sydney, NSW 2006, Australia; Childrens Hosp Philadelphia, Div Hematol, Philadelphia, PA 19104 USA	University of Sydney; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Mackay, JP (corresponding author), Univ Sydney, Sch Mol & Microbial Biosci, Sydney, NSW 2006, Australia.		Weiss, Mitchell J/W-9814-2018; Weiss, Mitchell J/A-1245-2013	Weiss, Mitchell J/0000-0003-2460-3036; Gell, David/0000-0003-0382-1181; Eaton, Sally/0000-0003-2036-1607	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061692] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK 61692, R01 DK061692] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abruzzi KC, 2002, MOL CELL BIOL, V22, P138, DOI 10.1128/MCB.22.1.138-147.2002; Archer JE, 1998, MOL CELL BIOL, V18, P1757, DOI 10.1128/MCB.18.3.1757; ARCHER JE, 1995, CELL, V82, P425, DOI 10.1016/0092-8674(95)90431-X; Ascoli F, 1981, Methods Enzymol, V76, P72; BEYCHOK S, 1967, J BIOL CHEM, V242, P2460; Bucci E, 1981, Methods Enzymol, V76, P97; CHEN YH, 1971, BIOCHEM BIOPH RES CO, V44, P1285, DOI 10.1016/S0006-291X(71)80225-5; Cuff JA, 1998, BIOINFORMATICS, V14, P892, DOI 10.1093/bioinformatics/14.10.892; DURCHSCHLAG H, 1986, THERMODYNAMIC DATA B, P45; HUANG SC, 2001, DISORDERS HEMOGLOBIN, P166; Ikeda-Saito M, 1981, Methods Enzymol, V76, P113; JOHNSON ML, 1981, BIOPHYS J, V36, P575, DOI 10.1016/S0006-3495(81)84753-4; Kihm AJ, 2002, NATURE, V417, P758, DOI 10.1038/nature00803; KUNTZ ID, 1971, J AM CHEM SOC, V93, P514, DOI 10.1021/ja00731a036; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Lee GJ, 1997, EMBO J, V16, P659, DOI 10.1093/emboj/16.3.659; MACDONALD VW, 1994, METHOD ENZYMOL, V231, P480; Miele G, 2001, NAT MED, V7, P361, DOI 10.1038/85515; NATHAN DG, 1966, AM J MED, V41, P815, DOI 10.1016/0002-9343(66)90039-8; PENA MC, 1988, BIOCHIM BIOPHYS ACTA, V957, P380, DOI 10.1016/0167-4838(88)90229-4; PERKINS SJ, 1986, EUR J BIOCHEM, V157, P169, DOI 10.1111/j.1432-1033.1986.tb09653.x; RACHMILEWITZ EA, 1971, J BIOL CHEM, V246, P3356; Rachmilewitz EA, 2001, DISORDERS HEMOGLOBIN, P233; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SHAEFFER JR, 1983, J BIOL CHEM, V258, P3172; Shirihai OS, 2000, EMBO J, V19, P2492, DOI 10.1093/emboj/19.11.2492; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; TELLER DC, 1976, NATURE, V260, P729, DOI 10.1038/260729a0; Turner B W, 1981, Methods Enzymol, V76, P596; WAKS M, 1973, J BIOL CHEM, V248, P6462; Waxman E, 1994, MODERN ANAL ULTRACEN, P189; WILLIAMS RC, 1976, BIOCHEMISTRY-US, V15, P2207, DOI 10.1021/bi00655a028; YIP YK, 1972, J BIOL CHEM, V247, P7237	33	88	95	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 25	2002	277	43					40602	40609		10.1074/jbc.M206084200	http://dx.doi.org/10.1074/jbc.M206084200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	607KU	12192002	hybrid			2022-12-27	WOS:000178791400058
J	Lobo, S; Greentree, WK; Linder, ME; Deschenes, RJ				Lobo, S; Greentree, WK; Linder, ME; Deschenes, RJ			Identification of a Ras palmitoyltransferase in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN ALPHA-SUBUNITS; POLYBASIC DOMAIN; IN-VITRO; H-RAS; PALMITOYLATION; PEPTIDE; MOTIF; AUTOACYLATION; PURIFICATION; ACYLATION	Most Ras proteins are posttranslationally modified by a palmitoyl lipid moiety through a thioester linkage. However, the mechanism by which this occurs is not known. Here, evidence is presented that the Ras2 protein of Saccharomyces cerevisiae is palmitoylated by a Ras protein acyltransferase (Ras PAT) encoded by the ERF2 and ERF4 genes. Erf2p is a 41-kDa protein localized to the membrane of the endoplasmic reticulum and contains a conserved DHHC cysteine-rich domain (DHHC-CRD). Erf2p co-purifies with Erf4p (26 kDa) when it is expressed in yeast or in Escherichia coli. The Erf2p/Erf4p complex is required for Ras PAT activity, and mutations within conserved residues (Cys(189), His(201) and Cys(203)) of the Erf2p DHHC-CRD domain abolish Ras PAT activity. Furthermore, a palmitoyl-Erf2p intermediate is detected suggesting that Erf2p is directly involved in palmitate transfer. ERF2 and ERF4 are the first genes identified that encode a palmitoyltransferase for a Ras GTPase.	Univ Iowa, Dept Biochem, Iowa City, IA 52240 USA; Univ Iowa, Genet Program, Iowa City, IA 52240 USA; Washington Univ, Dept Cell Biol & Physiol, St Louis, MO 63130 USA	University of Iowa; University of Iowa; Washington University (WUSTL)	Deschenes, RJ (corresponding author), Univ Iowa, Dept Biochem, 3135 MERF, Iowa City, IA 52242 USA.		Deschenes, Robert J/E-4926-2010; Linder, Maurine/AAU-9999-2021	Deschenes, Robert J/0000-0001-8325-4257; Linder, Maurine/0000-0003-2202-9712	NATIONAL CANCER INSTITUTE [R01CA050211] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051466] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA050211, R01 CA050211-15A2, CA 50211] Funding Source: Medline; NIGMS NIH HHS [GM 51466] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bano MC, 1998, BIOCHEM J, V330, P723, DOI 10.1042/bj3300723; Bartels DJ, 1999, MOL CELL BIOL, V19, P6775, DOI 10.1128/mcb.19.10.6775; BIZZOZERO OA, 1987, J BIOL CHEM, V262, P13550; Bohm S, 1997, NUCLEIC ACIDS RES, V25, P2464, DOI 10.1093/nar/25.12.2464; BONDE M, 1992, ANAL BIOCHEM, V200, P195, DOI 10.1016/0003-2697(92)90298-L; CAMP LA, 1993, J BIOL CHEM, V268, P22566; Chamoun Z, 2001, SCIENCE, V293, P2080, DOI 10.1126/science.1064437; CLARKE S, 1992, ANNU REV BIOCHEM, V61, P355, DOI 10.1146/annurev.bi.61.070192.002035; Duncan JA, 1996, J BIOL CHEM, V271, P23594, DOI 10.1074/jbc.271.38.23594; Dunphy JT, 2001, J BIOL CHEM, V276, P43300, DOI 10.1074/jbc.M104275200; HANCOCK JF, 1990, CELL, V63, P133, DOI 10.1016/0092-8674(90)90294-O; JUNG V, 1995, MOL CELL BIOL, V15, P1333; Lee JD, 2001, CURR BIOL, V11, P1147, DOI 10.1016/S0960-9822(01)00323-2; Li BJ, 2002, J BIOL CHEM, V277, P28870, DOI 10.1074/jbc.M202388200; Linder M.E., 2001, ENZYM, V21, P215; Liu L, 1999, J BIOL CHEM, V274, P3252; Liu L, 1996, J BIOL CHEM, V271, P23269, DOI 10.1074/jbc.271.38.23269; MA J, 1987, CELL, V48, P847, DOI 10.1016/0092-8674(87)90081-X; MITCHELL DA, 1993, YEAST, V9, P715, DOI 10.1002/yea.320090705; MITCHELL DA, 1994, J BIOL CHEM, V269, P21540; MUMBY SM, 1994, METHOD ENZYMOL, V237, P254; Putilina T, 1999, MOL CELL BIOCHEM, V195, P219, DOI 10.1023/A:1006932522197; QUESNEL S, 1994, BIOCHEMISTRY-US, V33, P13340, DOI 10.1021/bi00249a021; SCHAFER WR, 1992, ANNU REV GENET, V26, P209, DOI 10.1146/annurev.ge.26.120192.001233; SCHLESINGER MJ, 1993, LIPID MODIFICATIONS, P2; TAYLOR DC, 1990, ANAL BIOCHEM, V184, P311, DOI 10.1016/0003-2697(90)90686-4	26	343	355	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 25	2002	277	43					41268	41273		10.1074/JBC.M206573200	http://dx.doi.org/10.1074/JBC.M206573200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	607KU	12193598	hybrid			2022-12-27	WOS:000178791400139
J	Mchaourab, HS; Dodson, EK; Koteiche, HA				Mchaourab, HS; Dodson, EK; Koteiche, HA			Mechanism of chaperone function in small heat shock proteins - Two-mode binding of the excited states of T4 lysozyme mutants by alpha A-crystallin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DESMIN-RELATED MYOPATHY; LENS EPITHELIAL-CELLS; B-CRYSTALLIN; MOLECULAR CHAPERONE; THERMODYNAMIC CONSEQUENCES; PROTECTIVE ACTIVITY; HYDROGEN-EXCHANGE; MISSENSE MUTATION; CONSERVED DOMAIN; STRESS-PROTEINS	To elucidate the mechanism of alphaA-crystallin chaperone function, a detailed thermodynamic analysis of its binding to destabilized, site-directed mutants of T4 lysozyme was carried out. The selected mutants form a ladder of stabilities spanning the 5-10 kcal/mol range of free energy of unfolding. The crystal structures of the majority of the mutants have been previously determined and found to be similar to that of the wild type with no evidence of static local unfolding. Complex formation between aA-crystallin and T4 lysozyme was observed directly via the changes in the electron paramagnetic resonance lineshape of a nitroxide introduced at a non-destabilizing, solvent exposed site in T4 lysozyme. alphaA-Crystallin differentially interacts with the mutants, binding the more destabilized ones to a larger extent despite the similar structure of their native states. Our results suggest that the states recognized by aA-crystallin are non-native excited states distinct from the unfolded state. Stable complexes are formed when the free energy of binding to alphaA-crystallin is on the order of the free energy associated with the transition from the excited state to the native state. Biphasic binding isotherms reveal two modes of interactions with distinct affinities and stoichiometries. Highly destabilized mutants preferentially bind to the high capacity mode, suggesting conformational preference in the use of each mode. Furthermore, binding can be enhanced by increased temperature and pH, which may be reflecting conformational changes in aA-crystallin oligomeric structure.	Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA	Vanderbilt University	Mchaourab, HS (corresponding author), Vanderbilt Univ, Dept Mol Physiol & Biophys, 741 Light Hall, Nashville, TN 37232 USA.	hassane.mchaourab@vanderbilt.edu			NEI NIH HHS [EY R01 12683] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY012683] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ANDERSON DE, 1990, BIOCHEMISTRY-US, V29, P2403, DOI 10.1021/bi00461a025; Andley UP, 2001, FASEB J, V15, P221, DOI 10.1096/fj.00-0296com; Andley UP, 2000, J BIOL CHEM, V275, P36823, DOI 10.1074/jbc.M004233200; BAI YW, 1995, SCIENCE, V269, P192, DOI 10.1126/science.7618079; Berengian AR, 1997, BIOCHEMISTRY-US, V36, P9951, DOI 10.1021/bi9712347; Bettelheim FA, 1999, BIOCHEM BIOPH RES CO, V261, P292, DOI 10.1006/bbrc.1999.1031; BLABER M, 1993, BIOCHEMISTRY-US, V32, P11363, DOI 10.1021/bi00093a013; BOELENS WC, 1995, MOL BIOL REP, V21, P75, DOI 10.1007/BF00986495; Bova MP, 1999, P NATL ACAD SCI USA, V96, P6137, DOI 10.1073/pnas.96.11.6137; Bova MP, 1997, J BIOL CHEM, V272, P29511, DOI 10.1074/jbc.272.47.29511; Bruey JM, 2000, NAT CELL BIOL, V2, P645, DOI 10.1038/35023595; CASPERS GJ, 1995, J MOL EVOL, V40, P238, DOI 10.1007/BF00163229; Chang ZY, 1996, J BIOL CHEM, V271, P7218, DOI 10.1074/jbc.271.12.7218; Clark JI, 2000, CURR OPIN STRUC BIOL, V10, P52, DOI 10.1016/S0959-440X(99)00048-2; Clarke J, 1997, TRENDS BIOCHEM SCI, V22, P284, DOI 10.1016/S0968-0004(97)01087-6; Cobb BA, 2002, BIOCHEMISTRY-US, V41, P483, DOI 10.1021/bi0112457; DAOPIN S, 1991, BIOCHEMISTRY-US, V30, P11521, DOI 10.1021/bi00113a006; Das BK, 1997, CURR EYE RES, V16, P303, DOI 10.1076/ceyr.16.4.303.10691; DAS KP, 1995, BIOCHEM J, V311, P367, DOI 10.1042/bj3110367; DAS KP, 1995, FEBS LETT, V369, P321, DOI 10.1016/0014-5793(95)00775-5; de Jong WW, 1998, INT J BIOL MACROMOL, V22, P151, DOI 10.1016/S0141-8130(98)00013-0; DELAYE M, 1983, NATURE, V302, P415, DOI 10.1038/302415a0; Ehrnsperger M, 1999, J BIOL CHEM, V274, P14867, DOI 10.1074/jbc.274.21.14867; Ehrnsperger M, 1997, EMBO J, V16, P221, DOI 10.1093/emboj/16.2.221; Englander SW, 1998, TRENDS BIOCHEM SCI, V23, P378, DOI 10.1016/S0968-0004(98)01281-X; ERIKSSON AE, 1993, J MOL BIOL, V229, P747, DOI 10.1006/jmbi.1993.1077; FARAHBAKHSH ZT, 1995, BIOCHEMISTRY-US, V34, P509, DOI 10.1021/bi00002a015; Garrido C, 1999, FASEB J, V13, P2061, DOI 10.1096/fasebj.13.14.2061; Grantcharova V, 2001, CURR OPIN STRUC BIOL, V11, P70, DOI 10.1016/S0959-440X(00)00176-7; GROENEN PJTA, 1994, EUR J BIOCHEM, V225, P1, DOI 10.1111/j.1432-1033.1994.00001.x; HORWITZ J, 1993, INVEST OPHTH VIS SCI, V34, P10; Horwitz J, 2000, SEMIN CELL DEV BIOL, V11, P53, DOI 10.1006/scdb.1999.0351; Koteiche HA, 1998, BIOCHEMISTRY-US, V37, P12681, DOI 10.1021/bi9814078; Koteiche HA, 1999, J MOL BIOL, V294, P561, DOI 10.1006/jmbi.1999.3242; LEE GJ, 1995, J BIOL CHEM, V270, P10432, DOI 10.1074/jbc.270.18.10432; Lee GJ, 1997, EMBO J, V16, P659, DOI 10.1093/emboj/16.3.659; Litt M, 1998, HUM MOL GENET, V7, P471, DOI 10.1093/hmg/7.3.471; Llinas M, 1999, NAT STRUCT BIOL, V6, P1072; MacRae TH, 2000, CELL MOL LIFE SCI, V57, P899, DOI 10.1007/PL00000733; Matthews BW, 1996, FASEB J, V10, P35, DOI 10.1096/fasebj.10.1.8566545; MATTHEWS BW, 1995, ADV PROTEIN CHEM, V46, P249, DOI 10.1016/S0065-3233(08)60337-X; Mchaourab HS, 1996, BIOCHEMISTRY-US, V35, P7692, DOI 10.1021/bi960482k; Mehlen P, 1996, J BIOL CHEM, V271, P16510, DOI 10.1074/jbc.271.28.16510; Mehlen P, 1997, J BIOL CHEM, V272, P31657, DOI 10.1074/jbc.272.50.31657; Muchowski PJ, 1999, J MOL BIOL, V289, P397, DOI 10.1006/jmbi.1999.2759; Mulder FAA, 2001, NAT STRUCT BIOL, V8, P932, DOI 10.1038/nsb1101-932; Neal R, 2001, BIOCHEM BIOPH RES CO, V280, P14, DOI 10.1006/bbrc.2000.4092; Pace CN, 2000, PROTEINS, P1; PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253; Rajaraman K, 1996, J BIOL CHEM, V271, P27595, DOI 10.1074/jbc.271.44.27595; Reddy GB, 2000, J BIOL CHEM, V275, P4565, DOI 10.1074/jbc.275.7.4565; Rogalla T, 1999, J BIOL CHEM, V274, P18947, DOI 10.1074/jbc.274.27.18947; Treweek TM, 2000, BBA-PROTEIN STRUCT M, V1481, P175, DOI 10.1016/S0167-4838(00)00109-6; Vicart P, 1998, NAT GENET, V20, P92, DOI 10.1038/1765; Wang KY, 2001, EUR J BIOCHEM, V268, P6335, DOI 10.1046/j.0014-2956.2001.02580.x; Xu ZH, 1998, J STRUCT BIOL, V124, P129, DOI 10.1006/jsbi.1998.4060; Zhang XM, 1996, J SCI FOOD AGR, V70, P102, DOI 10.1002/(SICI)1097-0010(199601)70:1&lt;102::AID-JSFA468&gt;3.0.CO;2-C	57	72	75	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2002	277	43					40557	40566		10.1074/jbc.M206250200	http://dx.doi.org/10.1074/jbc.M206250200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	607KU	12189146	hybrid			2022-12-27	WOS:000178791400053
J	Wu, DQ; Terrian, DM				Wu, DQ; Terrian, DM			Regulation of caveolin-1 expression and secretion by a protein kinase C epsilon signaling pathway in human prostate cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SURVIVAL/CLONAL GROWTH; TUMOR-SUPPRESSOR; MYC EXPRESSION; UP-REGULATION; ANDROGEN; ACTIVATION; ELEMENTS; TRANSCRIPTION; PROLIFERATION; CARCINOMA	Caveolin-1, androgen receptor, c-Myc, and protein kinase Cepsilon (PKCepsilon) proteins are overrepresented in most advanced prostate cancer tumors. Previously, we demonstrated that PKCepsilon has the capacity to enhance the expression of both caveolin-1 and c-Myc in cultured prostate cancer cells and is sufficient to induce the growth of androgen-independent tumors. In this study, we have uncovered further evidence of a functional interplay among these proteins in the CWR22 model of human prostate cancer. The results demonstrated that PKCepsilon expression was naturally up-regulated in recurrent CWR22 tumors and that this oncoprotein was required to sustain the androgen-independent proliferation of CWR-R1 cells in culture. Gene transfer experiments demonstrated that PKCepsilon had the potential to augment the expression and secretion of a biologically active caveolin-1 protein that supports the growth of the CWR-R1 cell line. Antisense and pharmacological experiments provided additional evidence that the sequential activation of PKCepsilon, mitogen-activated protein kinases, c-Myc, and androgen receptor signaling drove the downstream expression of caveolin-1 in CWR-R1 cells. Finally, we demonstrate that mitogen-activated protein kinases were required downstream of PKCepsilon to derepress the transcriptional elongation of the c-myc gene. Our findings support the hypothesis that PKCepsilon may advance the recurrence of human prostate cancer by promoting the expression of several important downstream effectors of disease progression.	E Carolina Univ, Brody Sch Med, Dept Anat & Cell Biol, Greenville, NC 27858 USA	University of North Carolina; East Carolina University	Wu, DQ (corresponding author), E Carolina Univ, Brody Sch Med, Dept Anat & Cell Biol, Greenville, NC 27858 USA.				NCI NIH HHS [R01 CA256058] Funding Source: Medline; NIEHS NIH HHS [ES 8397] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES008397] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Albert T, 2001, J BIOL CHEM, V276, P20482, DOI 10.1074/jbc.M100265200; Balaji KC, 1997, UROLOGY, V50, P1007, DOI 10.1016/S0090-4295(97)00390-7; Bist A, 2000, BIOCHEMISTRY-US, V39, P1966, DOI 10.1021/bi991721h; Chen CM, 2001, J BIOL CHEM, V276, P38518, DOI 10.1074/jbc.M105702200; CHUNG J, 1987, CELL, V51, P1001, DOI 10.1016/0092-8674(87)90586-1; Cornford P, 1999, AM J PATHOL, V154, P137, DOI 10.1016/S0002-9440(10)65260-1; El Gedaily A, 2001, PROSTATE, V46, P184; Felsher DW, 1999, P NATL ACAD SCI USA, V96, P3940, DOI 10.1073/pnas.96.7.3940; Gavioli R, 2001, NAT CELL BIOL, V3, P283, DOI 10.1038/35060076; Ge K, 2000, INT J CANCER, V86, P155, DOI 10.1002/(SICI)1097-0215(20000415)86:2<155::AID-IJC2>3.0.CO;2-M; Grad JM, 1999, MOL ENDOCRINOL, V13, P1896, DOI 10.1210/me.13.11.1896; Gregory CW, 2001, CANCER RES, V61, P2892; He LS, 2000, EMBO J, V19, P1034, DOI 10.1093/emboj/19.5.1034; KEMPPAINEN JA, 1992, J BIOL CHEM, V267, P968; Kirillova I, 1999, CELL GROWTH DIFFER, V10, P819; Li LK, 2001, CANCER RES, V61, P4386; Li YK, 1996, J BIOL CHEM, V271, P27025, DOI 10.1074/jbc.271.43.27025; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; Marais R, 1998, SCIENCE, V280, P109, DOI 10.1126/science.280.5360.109; MOBERG KH, 1992, ONCOGENE, V7, P411; Ostermeyer AG, 2001, J CELL BIOL, V152, P1071, DOI 10.1083/jcb.152.5.1071; Prekeris R, 1998, J BIOL CHEM, V273, P26790, DOI 10.1074/jbc.273.41.26790; Prekeris R, 1996, J CELL BIOL, V132, P77, DOI 10.1083/jcb.132.1.77; Sakamuro D, 1996, NAT GENET, V14, P69, DOI 10.1038/ng0996-69; Sheflin L, 2000, BIOCHEM BIOPH RES CO, V276, P144, DOI 10.1006/bbrc.2000.3424; SHICHIRI M, 1993, CELL GROWTH DIFFER, V4, P93; Soh JW, 1999, MOL CELL BIOL, V19, P1313; Tahir SA, 2001, CANCER RES, V61, P3882; Timme TL, 2000, ONCOGENE, V19, P3256, DOI 10.1038/sj.onc.1203654; Vanaja DK, 2002, CELL STRESS CHAPERON, V7, P55, DOI 10.1379/1466-1268(2002)007<0055:EOGOAR>2.0.CO;2; WAINSTEIN MA, 1994, CANCER RES, V54, P6049; Wu DQ, 2002, CANCER RES, V62, P2423; Yang G, 1999, CANCER RES, V59, P5719; Yang G, 1998, CLIN CANCER RES, V4, P1873	34	43	44	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 25	2002	277	43					40449	40455		10.1074/jbc.M206270200	http://dx.doi.org/10.1074/jbc.M206270200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	607KU	12185081	hybrid			2022-12-27	WOS:000178791400039
J	Feng, B; Tabas, I				Feng, B; Tabas, I			ABCAl-mediated cholesterol efflux is defective in free cholesterol-loaded macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY LIPOPROTEIN; CTP-PHOSPHOCHOLINE CYTIDYLYLTRANSFERASE; ACYL-COENZYME-A; HUMAN ATHEROSCLEROTIC PLAQUES; PHOSPHATIDYLCHOLINE BIOSYNTHESIS; J774 MACROPHAGES; PLASMA-MEMBRANE; TANGIER-DISEASE; UP-REGULATION; CELLS	In advanced atherosclerosis, macrophage foam cells progressively accumulate large amounts of unesterified or "free" cholesterol (FC), a process that is thought to contribute to foam cell death and lesional necrosis. The cellular consequences of early FC accumulation, including those that lead to further FC accumulation, are poorly understood. In this context, we show that cholesterol and phospholipid efflux mediated by ABCA1, which is initially induced in the cholesterol-loaded macrophage, was inhibited by similar to80% in pre-toxic FC-loaded macrophages. Cholesterol efflux to HDL2, which is mediated by a non-ABCA1 pathway, was inhibited by only similar to20% in FC-loaded macrophages. FC loading led to decreased levels of ABCA1 protein via increased degradation of ABCA1, and not by decreased transcription or translation of AbcA1 mRNA. The decrease in ABCA1 protein occurred relatively early and was not prevented by caspase inhibitors, indicating that it was not a consequence of FC-induced apoptosis. However, inhibition of proteasomal function by lactacystin largely prevented the degradation of ABCA1 Importantly, the FC-induced decrease in ABCA1 function and protein was almost entirely prevented in macrophages that had partial deficiency of npc1 or were exposed to nanomolar concentrations of U18666A, both of which lead to defective cholesterol trafficking to the endoplasmic reticulum, but leave trafficking to the plasma membrane largely intact. Thus, a relatively early event during FC loading of macrophages is increased degradation of ABCA1, which appears to require trafficking of cholesterol to a peripheral cellular site, but not bulk trafficking of excess cholesterol to the plasma membrane. These findings provide new insight into the post-translational regulation of ABCA1 and the pathobiology of the FC-loaded macrophage.	Columbia Univ, Dept Med, New York, NY 10032 USA; Columbia Univ, Dept Anat & Cell Biol, New York, NY 10032 USA	Columbia University; Columbia University	Tabas, I (corresponding author), Columbia Univ, Dept Med, 630 W 168th St, New York, NY 10032 USA.				NHLBI NIH HHS [HL-54591] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL054591] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aiello RJ, 2002, ARTERIOSCL THROM VAS, V22, P630, DOI 10.1161/01.ATV.0000014804.35824.DA; Arakawa R, 2002, J BIOL CHEM, V277, P22426, DOI 10.1074/jbc.M202996200; Attie AD, 2001, J LIPID RES, V42, P1717; BALL RY, 1995, ATHEROSCLEROSIS, V114, P45, DOI 10.1016/0021-9150(94)05463-S; BASU SK, 1976, P NATL ACAD SCI USA, V73, P3178, DOI 10.1073/pnas.73.9.3178; Bauriedel G, 1997, Z KARDIOL, V86, P902, DOI 10.1007/s003920050130; BERBERIAN PA, 1990, AM J PATHOL, V136, P71; Blom TS, 2001, BIOCHEMISTRY-US, V40, P14635, DOI 10.1021/bi0156714; Chambenoit O, 2001, J BIOL CHEM, V276, P9955, DOI 10.1074/jbc.M010265200; Chen W, 2001, J BIOL CHEM, V276, P43564, DOI 10.1074/jbc.M107938200; Fazio S, 2001, J CLIN INVEST, V107, P163, DOI 10.1172/JCI10310; Fielding PE, 2000, BIOCHEMISTRY-US, V39, P14113, DOI 10.1021/bi0004192; FUSTER V, 1992, NEW ENGL J MED, V326, P242, DOI 10.1056/NEJM199201233260406; Gillotte-Taylor K, 2002, J BIOL CHEM, V277, P11811, DOI 10.1074/jbc.M108268200; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; Kellner-Weibel G, 1999, ATHEROSCLEROSIS, V146, P309, DOI 10.1016/S0021-9150(99)00155-0; Kolodgie FD, 2000, AM J PATHOL, V157, P1259, DOI 10.1016/S0002-9440(10)64641-X; Lange Y, 2000, J BIOL CHEM, V275, P17468, DOI 10.1074/jbc.M000875200; Leventhal AR, 2001, J BIOL CHEM, V276, P44976, DOI 10.1074/jbc.M106455200; Libby Peter, 1993, Current Opinion in Lipidology, V4, P355, DOI 10.1097/00041433-199310000-00003; LISCUM L, 1989, J BIOL CHEM, V264, P11796; Loftus SK, 1997, SCIENCE, V277, P232, DOI 10.1126/science.277.5323.232; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LUNDBERG B, 1985, ATHEROSCLEROSIS, V56, P93, DOI 10.1016/0021-9150(85)90087-5; Mallat Z, 1999, CIRCULATION, V99, P348, DOI 10.1161/01.CIR.99.3.348; Mitchinson MJ, 1996, CURR OPIN LIPIDOL, V7, P324, DOI 10.1097/00041433-199610000-00011; Mori M, 2001, J LIPID RES, V42, P1771; Oram JF, 2000, J BIOL CHEM, V275, P34508, DOI 10.1074/jbc.M006738200; Oram JF, 2001, J LIPID RES, V42, P1173; RAPP JH, 1983, J LIPID RES, V24, P1329; RINNINGER F, 1995, BBA-LIPID LIPID MET, V1255, P141, DOI 10.1016/0005-2760(94)00228-Q; ROSS AC, 1984, J BIOL CHEM, V259, P815; ROSS R, 1995, ANNU REV PHYSIOL, V57, P791, DOI 10.1146/annurev.ph.57.030195.004043; SCHAEFER EJ, 1980, ANN INTERN MED, V93, P261, DOI 10.7326/0003-4819-93-2-261; Schmitz Gerd, 2002, Curr Atheroscler Rep, V4, P243, DOI 10.1007/s11883-002-0026-2; SHIO H, 1979, LAB INVEST, V41, P160; SHIRATORI Y, 1994, J BIOL CHEM, V269, P11337; SHIRATORI Y, 1995, J BIOL CHEM, V270, P29894; Singaraja RR, 2002, J CLIN INVEST, V110, P35, DOI 10.1172/JCI200215748; SMALL DM, 1984, J CLIN INVEST, V73, P1590, DOI 10.1172/JCI111366; Tabas I, 1996, J BIOL CHEM, V271, P22773, DOI 10.1074/jbc.271.37.22773; TABAS I, 1987, J CLIN INVEST, V79, P418, DOI 10.1172/JCI112828; Tabas I, 2000, BBA-MOL CELL BIOL L, V1529, P164, DOI 10.1016/S1388-1981(00)00146-3; Tall AR, 2000, J CLIN INVEST, V106, P1205, DOI 10.1172/JCI11538; Tang W, 1999, BBA-MOL CELL BIOL L, V1437, P301, DOI 10.1016/S1388-1981(99)00023-2; Underwood KW, 1996, J LIPID RES, V37, P1556; van Dam MJ, 2002, LANCET, V359, P37, DOI 10.1016/S0140-6736(02)07277-X; Van Eck M, 2002, P NATL ACAD SCI USA, V99, P6298, DOI 10.1073/pnas.092327399; Wang N, 2001, J BIOL CHEM, V276, P23742, DOI 10.1074/jbc.M102348200; Wang YT, 2002, J BIOL CHEM, V277, P5692, DOI 10.1074/jbc.M109977200; WARNER GJ, 1995, J BIOL CHEM, V270, P5772, DOI 10.1074/jbc.270.11.5772; Yao PM, 2000, J BIOL CHEM, V275, P23807, DOI 10.1074/jbc.M002087200; Yao PM, 2001, J BIOL CHEM, V276, P42468, DOI 10.1074/jbc.M101419200; Zhang DJ, 2000, J BIOL CHEM, V275, P35368, DOI 10.1074/jbc.M007099200; Zhang DJ, 2001, CIRCULATION, V104, P45; Zheng P, 2001, BBA-MOL CELL BIOL L, V1534, P121, DOI 10.1016/S1388-1981(01)00183-4	56	122	130	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					43271	43280		10.1074/jbc.M207532200	http://dx.doi.org/10.1074/jbc.M207532200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12215451	hybrid			2022-12-27	WOS:000179081200110
J	Somalinga, BR; Roy, RP				Somalinga, BR; Roy, RP			Volume exclusion effect as a driving force for reverse proteolysis - Implications for polypeptide assemblage in a macromolecular crowded milieu	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELF-ASSOCIATION; PEPTIDE LIGATION; FRAGMENTS; THERMOLYSIN; PROTEINS; SEMISYNTHESIS; KINETICS; MEDIA; CELL	Macromolecular crowding, in principle, should affect any reaction that is accompanied by significant reduction in excluded volume. Here we have examined the influence of crowding on reverse proteolysis. We show that proteosynthesis of a polypeptide product with an interacting folding motif such as coiled coil is facilitated in crowded media as a consequence of the volume exclusion effect. Further, we demonstrate that crowding could also effect the conversion of a noncovalent protein complex (fragment complementing protein) obtained by limited proteolysis to the native covalent form, but only if the formation of the native protein results in large compaction leading to a substantial volume exclusion effect. Subtilisin-catalyzed reformation of native triosephosphate isomerase (TIM) from multiple fragments is facilitated by crowding. However, a single nick in ribonuclease S (RNase S) could not be ligated under similar conditions. The failure of generation of RNase A from RNase S is consistent with the fact that the crystal structure of the two forms are almost superimposable, and hence no significant difference of volume exclusion exists between reactant (RNase S) and product (RNase A). In contrast, considerable compaction, and consequently large reduction in excluded volume, is attained through the assembly of a TIM barrel structure. Taken together, these results have implications for both in vitro as well as in vivo polypeptide assemblage by reverse proteolysis.	Natl Inst Immunol, New Delhi 110067, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Roy, RP (corresponding author), Natl Inst Immunol, Aruna Asaf Ali Marg, New Delhi 110067, India.							Boon CL, 2000, PROTEIN SCI, V9, P1011, DOI 10.1110/ps.9.5.1011; BORSOOK H, 1953, ADV PROTEIN CHEM, V8, P127, DOI 10.1016/S0065-3233(08)60092-3; CHAIKEN IM, 1981, CRC CR REV BIOCH MOL, V11, P255, DOI 10.3109/10409238109108703; CROOK EM, 1960, BIOCHEM J, V74, P234, DOI 10.1042/bj0740234; DEFILIPPIS V, 1990, INT J PEPT PROT RES, V35, P219; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; Ellis RJ, 2001, TRENDS BIOCHEM SCI, V26, P597, DOI 10.1016/S0968-0004(01)01938-7; Ellis RJ, 2001, CURR OPIN STRUC BIOL, V11, P114, DOI 10.1016/S0959-440X(00)00172-X; FRUTON JS, 1982, ADV ENZYMOL RAMB, V53, P239; HOMANDBERG GA, 1979, BIOCHEMISTRY-US, V18, P586, DOI 10.1021/bi00571a006; Kumaran S, 1997, PROTEIN SCI, V6, P2233; Kumaran S, 2000, PROTEIN SCI, V9, P734; LINDNER R, 1995, BIOPHYS CHEM, V57, P15, DOI 10.1016/0301-4622(95)00063-4; MATTHEWS JM, 1995, BIOCHEMISTRY-US, V34, P6805, DOI 10.1021/bi00020a027; MIN W, 1994, NAT STRUCT BIOL, V1, P502, DOI 10.1038/nsb0894-502; Minton AP, 1997, CURR OPIN BIOTECH, V8, P65, DOI 10.1016/S0958-1669(97)80159-0; Minton AP, 2000, CURR OPIN STRUC BIOL, V10, P34, DOI 10.1016/S0959-440X(99)00045-7; Minton AP, 2001, J BIOL CHEM, V276, P10577, DOI 10.1074/jbc.R100005200; Minton AP, 2000, CURR BIOL, V10, pR97, DOI 10.1016/S0960-9822(00)00301-8; MONERA OD, 1993, J BIOL CHEM, V268, P19218; PARR GR, 1981, J BIOL CHEM, V256, P125; Ray SS, 1999, CHEM BIOL, V6, P625, DOI 10.1016/S1074-5521(99)80114-8; RICHARDS FM, 1959, J BIOL CHEM, V234, P1459; RICHARDS FREDERIC M., 1955, COMPT REND TRAV LAB CARLSBERG SER CHIM, V29, P322; Rivas G, 1999, BIOCHEMISTRY-US, V38, P9379, DOI 10.1021/bi990355z; Rivas G, 2001, P NATL ACAD SCI USA, V98, P3150, DOI 10.1073/pnas.051634398; Snyder R, 1975, Methods Enzymol, V41, P430; Srinivasulu S, 2002, PROTEIN SCI, V11, P1384, DOI 10.1110/ps.0201302; TANIUCHI H, 1977, J BIOL CHEM, V252, P125; TITANI K, 1972, BIOCHEMISTRY-US, V11, P2427, DOI 10.1021/bi00763a007; van den Berg B, 2000, EMBO J, V19, P3870, DOI 10.1093/emboj/19.15.3870; van den Berg B, 1999, EMBO J, V18, P6927, DOI 10.1093/emboj/18.24.6927; VOGEL K, 1994, J AM CHEM SOC, V116, P11164; WALLACE CJA, 1995, CURR OPIN BIOTECH, V6, P403, DOI 10.1016/0958-1669(95)80069-7; Zhou HX, 2001, BIOCHEMISTRY-US, V40, P11289, DOI 10.1021/bi0155504; ZIMMERMAN SB, 1993, ANNU REV BIOPH BIOM, V22, P27, DOI 10.1146/annurev.bb.22.060193.000331	36	29	30	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 8	2002	277	45					43253	43261		10.1074/jbc.M207974200	http://dx.doi.org/10.1074/jbc.M207974200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612MZ	12207031	hybrid			2022-12-27	WOS:000179081200108
J	Andersen, C; Schiffler, B; Charbit, A; Benz, R				Andersen, C; Schiffler, B; Charbit, A; Benz, R			pH-induced collapse of the extracellular loops closes Escherichia coli maltoporin and allows the study of asymmetric sugar binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER-MEMBRANE; SALMONELLA-TYPHIMURIUM; DIFFUSION CHANNELS; CRYSTAL-STRUCTURES; LIPID-MEMBRANES; RATE CONSTANTS; PORIN SCRY; IN-VITRO; LAMB; TRANSPORT	LamB (maltoporin) is essential for the uptake of maltose and malto-oligosaccharides across the outer membrane of Escherichia coli. Purified LamB was reconstituted in artificial lipid bilayer membranes forming channels in the permanently open configuration at neutral pH. Almost complete channel closure was observed when the pH on both sides of the membrane was lowered to pH 4. When LamB was added to only one side of the membrane, the cis-side, and the pH was lowered at either side of the membrane, the cis- or the trans-side, the response to pH was asymmetric, suggesting preferential orientation of maltoporin channels and pH-dependent closure of only one side of the channel. In experiments with LamB mutants in which major external loops L4, L6, and/or L9 were deleted, we identified the surface-exposed loops L4 and L6 as the cause of pH-mediated closure. The pH dependence of the LamB channel is consistent with the assumption that it inserts in a preferential orientation into the lipid bilayer. About 70-80% of the reconstituted channels are oriented with the extracellular entrance toward the side to which the protein was added (the cis-side) and with the periplasmic opening on the opposite side (the trans-side). The possibility of closing the channels, which are oriented in the reverse direction by low pH at the trans-side, allowed the deduction of channel asymmetry with respect to carbohydrate binding kinetics. Whereas maltose binding was found to be almost symmetric with respect to the channel orientation, the sucrose and trehalose binding to LamB was asymmetric. The results are discussed in respect to possible physiological function of the pH-dependent closure of maltoporin.	Univ Wurzburg, Biozentrum, Lehrstuhl Biotechnol, D-97074 Wurzburg, Germany; CHU Necker Enfants Malad, INSERM U411, F-75730 Paris 15, France	University of Wurzburg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Andersen, C (corresponding author), Univ Wurzburg, Biozentrum, Lehrstuhl Biotechnol, D-97074 Wurzburg, Germany.			charbit, alain/0000-0001-5243-4861; Benz, Roland/0000-0002-9510-9265				Andersen C, 1998, EUR J BIOCHEM, V254, P679, DOI 10.1046/j.1432-1327.1998.2540679.x; ANDERSEN C, 1995, J GEN PHYSIOL, V105, P385, DOI 10.1085/jgp.105.3.385; Andersen C, 2002, J MEMBRANE BIOL, V185, P83, DOI 10.1007/s00232-001-0113-2; Andersen C, 1999, MOL MICROBIOL, V32, P851, DOI 10.1046/j.1365-2958.1999.01406.x; Arnold CN, 2001, J BACTERIOL, V183, P2178, DOI 10.1128/JB.183.7.2178-2186.2001; BENZ R, 1978, BIOCHIM BIOPHYS ACTA, V511, P305, DOI 10.1016/0005-2736(78)90269-9; BENZ R, 1986, J BACTERIOL, V165, P978, DOI 10.1128/jb.165.3.978-986.1986; BENZ R, 1987, J MEMBRANE BIOL, V100, P21, DOI 10.1007/BF02209137; BENZ R, 1988, ANNU REV MICROBIOL, V42, P359, DOI 10.1146/annurev.mi.42.100188.002043; Chagneau C, 2001, J BACTERIOL, V183, P5675, DOI 10.1128/JB.183.19.5675-5683.2001; COWAN SW, 1992, NATURE, V358, P727, DOI 10.1038/358727a0; DELAVEGA AL, 1995, EMBO J, V14, P6058, DOI 10.1002/j.1460-2075.1995.tb00294.x; DONALDSON DM, 1974, INFECT IMMUN, V10, P657, DOI 10.1128/IAI.10.3.657-666.1974; Dutzler R, 1996, STRUCTURE, V4, P127, DOI 10.1016/S0969-2126(96)00016-0; Eppens EF, 1997, EMBO J, V16, P4295, DOI 10.1093/emboj/16.14.4295; Forst D, 1998, NAT STRUCT BIOL, V5, P37, DOI 10.1038/nsb0198-37; HEYDE M, 1987, MOL GEN GENET, V208, P511, DOI 10.1007/BF00328148; Jordy M, 1996, J MOL BIOL, V259, P666, DOI 10.1006/jmbi.1996.0348; Kullman L, 2002, BIOPHYS J, V82, P803, DOI 10.1016/S0006-3495(02)75442-8; LUCKEY M, 1980, P NATL ACAD SCI-BIOL, V77, P167, DOI 10.1073/pnas.77.1.167; Muller DJ, 1999, J MOL BIOL, V285, P1347, DOI 10.1006/jmbi.1998.2359; NIKAIDO H, 1994, J BIOL CHEM, V269, P3905; Orlik F, 2002, BIOPHYS J, V82, P2466, DOI 10.1016/S0006-3495(02)75589-6; Orlik F, 2002, BIOPHYS J, V83, P309, DOI 10.1016/S0006-3495(02)75171-0; REST RF, 1977, INFECT IMMUN, V16, P145, DOI 10.1128/IAI.16.1.145-151.1977; Saint N, 1996, J BIOL CHEM, V271, P20676, DOI 10.1074/jbc.271.34.20676; SCHIRMER T, 1995, SCIENCE, V267, P512, DOI 10.1126/science.7824948; SCHMID K, 1991, MOL MICROBIOL, V5, P941, DOI 10.1111/j.1365-2958.1991.tb00769.x; SCHULEIN K, 1995, MOL MICROBIOL, V17, P757, DOI 10.1111/j.1365-2958.1995.mmi_17040757.x; TODT JC, 1992, BIOCHEMISTRY-US, V31, P10471, DOI 10.1021/bi00158a009; TODT JC, 1992, BIOCHEM BIOPH RES CO, V189, P1498, DOI 10.1016/0006-291X(92)90244-F; Van Gelder P, 2000, BIOPHYS CHEM, V85, P153, DOI 10.1016/S0301-4622(99)00153-2; Wang YF, 1997, J MOL BIOL, V272, P56, DOI 10.1006/jmbi.1997.1224; XU GZ, 1986, BIOCHIM BIOPHYS ACTA, V862, P57, DOI 10.1016/0005-2736(86)90468-2; Zhang P, 1998, SOLID STATE NUCL MAG, V12, P221, DOI 10.1016/S0926-2040(98)00069-1	35	34	36	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					41318	41325		10.1074/jbc.M206804200	http://dx.doi.org/10.1074/jbc.M206804200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12185084	hybrid			2022-12-27	WOS:000178985300006
J	Jang, SI; Steinert, PM				Jang, SI; Steinert, PM			Loricrin expression in cultured human keratinocytes is controlled by a complex interplay between transcription factors of the Sp1, CREB, AP1, and AP2 families	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORNIFIED CELL ENVELOPES; PROLINE-RICH PROTEINS; PROXIMAL PROMOTER; IN-VITRO; C-FOS; MOUSE KERATINOCYTES; NUCLEAR-PROTEIN; GENE-EXPRESSION; BINDING; DIFFERENTIATION	The major protein component of the cornified cell envelope barrier structure of the epidermis is loricrin, and it is expressed late during terminal differentiation in epidermal keratinocytes. We have previously shown that an AP1 site located in the proximal promoter region (position -55) is essential for human loricrin promoter activity (Rossi, A., Jang, S-I., Ceci, R., Steinert, P. M., and Markova, N. G. (1998) J. Invest. Dermatol 110, 34-40). In this study we show that its regulation requires complex cooperative and competitive interactions between multiple transcription factors in keratinocytes located in different compartments of the epidermis. We show that as few as 154 base pairs of 5'-upstream sequences from the cap site can direct the keratinocyte-specific expression in cultured keratinocytes. Mutation and DNA-protein analyses show that Sp1, c-Jun, an unidentified regulator, and the co-activator p300/CREB-binding protein up-regulate whereas Sp3, CREB-1/CREMalpha/ATF-1, Jun B, and an AP2-like protein (termed the keratinocyte-specific repressor-1 (KSR-1)) suppress loricrin promoter activity. We show that CREB protein can compete with c-Jun for the AP1 site and repress loricrin promoter activity. We show here that the protein kinase A pathway can activate loricrin expression by manipulation of the Sp1, Sp3, and KSR-1 levels in the nucleus. Thus, in undifferentiated cells, loricrin expression is suppressed by Jun B, Sp3, and KSR-1 proteins. But in advanced differentiated cells, levels of Sp3, KSR-1, and CREB proteins are lower; the unidentified regulator protein can bind; Sp1 and c-Jun are increased; and then p300/CBP is recruited. Together, these events allow loricrin transcription to proceed. Indeed, the synergistic effects of the Sp1, c-Jun, and p300 factors indicate that p300/CBP might act as bridge to form an active transcription complex.	NIAMS, Skin Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Jang, SI (corresponding author), NIAMS, Skin Biol Lab, NIH, Bldg 50,Rm 1529, Bethesda, MD 20892 USA.	jangs@mail.nih.gov						Apt D, 1996, VIROLOGY, V224, P281, DOI 10.1006/viro.1996.0530; Banks EB, 1998, BIOCHEM J, V331, P61, DOI 10.1042/bj3310061; BLUMENBERG M, 1992, J INVEST DERMATOL, V98, pS42, DOI 10.1111/1523-1747.ep12462194; Brembeck FH, 2000, J BIOL CHEM, V275, P28230; BYRNE C, 1993, MOL CELL BIOL, V13, P3176, DOI 10.1128/MCB.13.6.3176; CHATTON B, 1994, ONCOGENE, V9, P375; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; COUREY AJ, 1988, CELL, V55, P887, DOI 10.1016/0092-8674(88)90144-4; Crish JF, 2002, ONCOGENE, V21, P738, DOI 10.1038/sj.onc.1205038; DiSepio D, 1999, DIFFERENTIATION, V64, P225, DOI 10.1046/j.1432-0436.1999.6440225.x; DISEPIO D, 1995, J BIOL CHEM, V270, P10792, DOI 10.1074/jbc.270.18.10792; Eckert RL, 1997, J INVEST DERMATOL, V109, P501, DOI 10.1111/1523-1747.ep12336477; Fuchs E, 1995, ANNU REV CELL DEV BI, V11, P123, DOI 10.1146/annurev.cb.11.110195.001011; FUCHS E, 1994, CURR OPIN GENET DEV, V4, P725, DOI 10.1016/0959-437X(94)90140-X; GILL G, 1994, P NATL ACAD SCI USA, V91, P192, DOI 10.1073/pnas.91.1.192; GINTY DD, 1994, CELL, V77, P713, DOI 10.1016/0092-8674(94)90055-8; GONZALEZ GA, 1989, NATURE, V337, P749, DOI 10.1038/337749a0; HADMAN M, 1993, ONCOGENE, V8, P1895; HAGEN G, 1994, EMBO J, V13, P3843, DOI 10.1002/j.1460-2075.1994.tb06695.x; HAGIWARA M, 1992, CELL, V70, P105, DOI 10.1016/0092-8674(92)90537-M; HAI T, 1991, P NATL ACAD SCI USA, V88, P3720, DOI 10.1073/pnas.88.9.3720; HAI TW, 1989, GENE DEV, V3, P2083, DOI 10.1101/gad.3.12b.2083; Hata Y, 1998, J BIOL CHEM, V273, P19294, DOI 10.1074/jbc.273.30.19294; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; HOHL D, 1993, AM J DERMATOPATH, V15, P20, DOI 10.1097/00000372-199302000-00004; HOHL D, 1991, J INVEST DERMATOL, V96, P414, DOI 10.1111/1523-1747.ep12469779; HOHL D, 1991, J BIOL CHEM, V266, P6626; Jang SI, 1996, J BIOL CHEM, V271, P24105, DOI 10.1074/jbc.271.39.24105; Jessen BA, 2000, GENE, V254, P77, DOI 10.1016/S0378-1119(00)00291-2; KAWACHI Y, 2001, J INVEST DERMATOL 2, V119, P376; Koch PJ, 2000, J CELL BIOL, V151, P389, DOI 10.1083/jcb.151.2.389; KWOK RPS, 1994, NATURE, V370, P223, DOI 10.1038/370223a0; LaPres JJ, 1996, J BIOL CHEM, V271, P23154, DOI 10.1074/jbc.271.38.23154; LEASK A, 1991, P NATL ACAD SCI USA, V88, P7948, DOI 10.1073/pnas.88.18.7948; Lee JH, 1996, J BIOL CHEM, V271, P4561; Lee JS, 1996, MOL CELL BIOL, V16, P4312; Lee JS, 1996, J BIOL CHEM, V271, P17666, DOI 10.1074/jbc.271.30.17666; MAGNALDO T, 1993, DNA CELL BIOL, V12, P911, DOI 10.1089/dna.1993.12.911; Marekov LN, 1998, J BIOL CHEM, V273, P17763, DOI 10.1074/jbc.273.28.17763; Mariniello L, 1995, J BIOL CHEM, V270, P31358, DOI 10.1074/jbc.270.52.31358; Marshall D, 2001, P NATL ACAD SCI USA, V98, P13031, DOI 10.1073/pnas.231489198; MEHREL T, 1990, CELL, V61, P1103, DOI 10.1016/0092-8674(90)90073-N; Monaco L, 1997, ONCOGENE, V15, P2493, DOI 10.1038/sj.onc.1201636; Ohtsuki Mamitaro, 1993, Gene Expression, V3, P201; POTHIER F, 1992, DNA CELL BIOL, V11, P83, DOI 10.1089/dna.1992.11.83; REDDY SPM, 1995, J BIOL CHEM, V270, P26451, DOI 10.1074/jbc.270.44.26451; RICE RH, 1979, CELL, V18, P681, DOI 10.1016/0092-8674(79)90123-5; ROOP D, 1995, SCIENCE, V267, P474, DOI 10.1126/science.7529942; Rossi A, 1998, J INVEST DERMATOL, V110, P34, DOI 10.1046/j.1523-1747.1998.00071.x; Rutberg SE, 1997, ONCOGENE, V15, P1337, DOI 10.1038/sj.onc.1201293; Rutberg SE, 1996, ONCOGENE, V13, P167; Rutberg SE, 1999, ONCOGENE, V18, P1569, DOI 10.1038/sj.onc.1202463; RYSECK RP, 1991, ONCOGENE, V6, P533; SADOVSKY Y, 1995, MOL CELL BIOL, V15, P1554; SAFFER JD, 1991, MOL CELL BIOL, V11, P2189, DOI 10.1128/MCB.11.4.2189; SEAMON KB, 1981, P NATL ACAD SCI-BIOL, V78, P3363, DOI 10.1073/pnas.78.6.3363; Sinha S, 2001, P NATL ACAD SCI USA, V98, P2455, DOI 10.1073/pnas.051633598; Steinert PM, 1998, J STRUCT BIOL, V122, P76, DOI 10.1006/jsbi.1998.3957; Steinert PM, 1998, J BIOL CHEM, V273, P11758, DOI 10.1074/jbc.273.19.11758; STEINERT PM, 1995, J BIOL CHEM, V270, P17702, DOI 10.1074/jbc.270.30.17702; STEVEN AC, 1994, J CELL SCI, V107, P693; TAMAI K, 1994, J BIOL CHEM, V269, P493; Watt FM, 1989, CURR OPIN CELL BIOL, V1, P1107, DOI 10.1016/S0955-0674(89)80058-4; Welter JF, 1995, ONCOGENE, V11, P2681; WELTER JF, 1995, J BIOL CHEM, V270, P12614, DOI 10.1074/jbc.270.21.12614; WU RL, 1994, J BIOL CHEM, V269, P28450; Xiao HY, 2000, J BIOL CHEM, V275, P1371, DOI 10.1074/jbc.275.2.1371; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959; YONEDA K, 1992, J BIOL CHEM, V267, P18060	69	76	82	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					42268	42279		10.1074/jbc.M205593200	http://dx.doi.org/10.1074/jbc.M205593200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12200429	hybrid			2022-12-27	WOS:000178985300122
J	Liao, VHC; Dong, J; Freedman, JH				Liao, VHC; Dong, J; Freedman, JH			Molecular characterization of a novel, cadmium-inducible gene from the nematode Caenorhabditis elegans - A New gene that contributes to the resistance to cadmium toxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUPEROXIDE-DISMUTASE GENE; DEPENDENT PROTEIN-KINASE; CELL-SPECIFIC EXPRESSION; STRUCTURAL ORGANIZATION; METALLOTHIONEIN GENES; REGULATORY ELEMENTS; SEQUENCE ANALYSES; RESPONSIVE GENES; OXIDATIVE STRESS; METAL RESISTANCE	Cadmium is an environmental contaminant that is both a human toxicant and carcinogen. To inhibit cadmium-induced damage, cells respond by increasing the expression of genes that encode stress-response proteins. We previously reported the identification of 48 cadmium-inducible mRNAs in the nematode Caenorhabditis elegans. Here we describe a new cadmium-responsive gene, designated cdr-1, whose rate and level of inducible expression parallel those of the C. elegans metallothioneins. The CDR-1 mRNA contains an open reading frame of 831 bp and encodes a predicted 32-kDa, integral membrane protein. Following cadmium exposure, cdr-1 is transcribed exclusively in intestinal cells of post-embryonic C. elegans. In vivo, the CDR-1 protein is targeted specifically to the intestinal cell lysosomes. cdr-1 transcription is significantly induced by cadmium but not by other tested stressors. These results indicate that cdr-1 expression is regulated by cadmium and in a cell-specific fashion. Inhibition of CDR-1 expression renders C. elegans susceptible to cadmium toxicity. In conclusion, cdr-1 defines a new class of cadmium-inducible genes and encodes an integral membrane, lysosomal protein. This protein functions to protect against cadmium toxicity.	Duke Univ, Nicholas Sch Environm & Earth Sci, Durham, NC 27708 USA; Feng Chia Univ, Dept Environm Sci & Engn, Taichung 40724, Taiwan; Duke Univ, Med Ctr, Dept Microbiol, Durham, NC 27710 USA	Duke University; Feng Chia University; Duke University	Freedman, JH (corresponding author), Duke Univ, Nicholas Sch Environm & Earth Sci, Box 90328, Durham, NC 27708 USA.	jonf@duke.edu		Liao, Vivian/0000-0002-4676-9953	NIEHS NIH HHS [ES09949] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES009949] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		ALAM J, 1989, J BIOL CHEM, V264, P6371; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andrews GK, 2000, BIOCHEM PHARMACOL, V59, P95, DOI 10.1016/S0006-2952(99)00301-9; Andrisani OM, 1999, CRIT REV EUKAR GENE, V9, P19, DOI 10.1615/CritRevEukaryotGeneExpr.v9.i1.20; Aylett B. J., 1979, CHEM BIOCH BIOL CADM, P1, DOI DOI 10.1007/978-1-59259-458-0; Bairoch A, 1997, NUCLEIC ACIDS RES, V25, P217, DOI 10.1093/nar/25.1.217; Britton C, 1998, J MOL BIOL, V283, P15, DOI 10.1006/jmbi.1998.2093; Broeks A, 1996, EMBO J, V15, P6132, DOI 10.1002/j.1460-2075.1996.tb01001.x; Cioci LK, 2000, ENVIRON TOXICOL CHEM, V19, P2122, DOI [10.1897/1551-5028(2000)019&lt;2122:TSOTNC&gt;2.3.CO;2, 10.1002/etc.5620190823]; CLOKEY GV, 1986, MECH AGEING DEV, V35, P79, DOI 10.1016/0047-6374(86)90068-0; CULOTTA VC, 1989, MOL CELL BIOL, V9, P1376, DOI 10.1128/MCB.9.3.1376; CUMMINS C, 1988, MOL CELL BIOL, V8, P5339, DOI 10.1128/MCB.8.12.5339; Eeckman FH, 1995, METHOD CELL BIOL, V48, P583; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Endo T, 2002, COMP BIOCHEM PHYS C, V131, P223, DOI 10.1016/S1532-0456(02)00009-1; FAGAN MJ, 1994, J MOL EVOL, V38, P57; Favello A, 1995, METHOD CELL BIOL, V48, P551; Fay RM, 1996, FOOD CHEM TOXICOL, V34, P1175, DOI 10.1016/S0278-6915(97)00094-X; FREEDMAN JH, 1993, J BIOL CHEM, V268, P2554; Friberg L., 1986, HDB TOXICOLOGY METAL, P130; Fukushige T, 1998, DEV BIOL, V198, P286, DOI 10.1016/S0012-1606(98)80006-7; Fukushige T, 1996, DEV BIOL, V178, P276, DOI 10.1006/dbio.1996.0218; GEORGE SG, 1979, BIOCHIM BIOPHYS ACTA, V580, P234, DOI 10.1016/0005-2795(79)90136-3; GIGLIO AM, 1994, BIOCHEM MOL BIOL INT, V33, P41; GIGLIO MP, 1994, BIOCHEM MOL BIOL INT, V33, P37; GROSS RE, 1990, J BIOL CHEM, V265, P6896; HAMER DH, 1986, ANNU REV BIOCHEM, V55, P913, DOI 10.1146/annurev.biochem.55.1.913; HATCHER EL, 1995, FREE RADICAL BIO MED, V19, P805, DOI 10.1016/0891-5849(95)00099-J; Havelaar AC, 1998, FEBS LETT, V436, P223, DOI 10.1016/S0014-5793(98)01133-8; HAWKINS MG, 1995, J BIOL CHEM, V270, P14666, DOI 10.1074/jbc.270.24.14666; Hein R, 1996, CURR BIOL, V6, P178, DOI 10.1016/S0960-9822(02)00450-5; HESCHL MFP, 1990, COMP BIOCHEM PHYS B, V96, P633, DOI 10.1016/0305-0491(90)90206-9; HEUCHEL R, 1994, EMBO J, V13, P2870, DOI 10.1002/j.1460-2075.1994.tb06581.x; HILL KK, 1995, GENETICS, V141, P595; Holland IB, 1999, J MOL BIOL, V293, P381, DOI 10.1006/jmbi.1999.2993; HU ED, 1990, J BIOL CHEM, V265, P5072; JAISWAL AK, 1994, BIOCHEM PHARMACOL, V48, P439, DOI 10.1016/0006-2952(94)90272-0; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kawasaki M, 1999, EMBO J, V18, P3604, DOI 10.1093/emboj/18.13.3604; KENYON C, 1988, SCIENCE, V240, P1448, DOI 10.1126/science.3287621; Kiang JG, 1998, PHARMACOL THERAPEUT, V80, P183, DOI 10.1016/S0163-7258(98)00028-X; KOIZUMI T, 1992, J TOXICOL ENV HEALTH, V37, P25, DOI 10.1080/15287399209531654; KOSTIC MM, 1993, EUR J HAEMATOL, V51, P86; KRAUSE M, 1987, CELL, V49, P753, DOI 10.1016/0092-8674(87)90613-1; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAND M, 1994, J BIOL CHEM, V269, P14820; Li ZS, 1997, P NATL ACAD SCI USA, V94, P42, DOI 10.1073/pnas.94.1.42; LIANG P, 1992, SCIENCE, V257, P967, DOI 10.1126/science.1354393; Liao VHC, 1998, J BIOL CHEM, V273, P31962, DOI 10.1074/jbc.273.48.31962; LU XY, 1990, J BIOL CHEM, V265, P3293; MACMORRIS M, 1992, MOL CELL BIOL, V12, P1652, DOI 10.1128/MCB.12.4.1652; MACMORRIS M, 1994, MOL CELL BIOL, V14, P484, DOI 10.1128/MCB.14.1.484; MARIGOMEZ JA, 1990, HISTOCHEMISTRY, V94, P191, DOI 10.1007/BF02440187; MARSHALL AT, 1994, J SUBMICR CYTOL PATH, V26, P59; MCGHEE JD, 1990, GENETICS, V125, P505; Mello C, 1995, METHOD CELL BIOL, V48, P451; Moilanen LH, 1999, J BIOL CHEM, V274, P29655, DOI 10.1074/jbc.274.42.29655; Murata M, 1999, J CELL PHYSIOL, V180, P105, DOI 10.1002/(SICI)1097-4652(199907)180:1<105::AID-JCP12>3.0.CO;2-5; NELSON FK, 1984, J EXP ZOOL, V231, P45, DOI 10.1002/jez.1402310107; Paulsen IT, 1997, J MEMBRANE BIOL, V156, P99, DOI 10.1007/s002329900192; PEARSON WR, 1990, METHOD ENZYMOL, V183, P63; RAY C, 1992, MOL BIOCHEM PARASIT, V51, P239, DOI 10.1016/0166-6851(92)90074-T; ROSS LH, 1995, J BIOL CHEM, V270, P22066, DOI 10.1074/jbc.270.37.22066; SALOVSKY P, 1992, HUM EXP TOXICOL, V11, P217, DOI 10.1177/096032719201100310; SLICE LW, 1990, J BIOL CHEM, V265, P256; SORGER PK, 1991, CELL, V65, P363, DOI 10.1016/0092-8674(91)90452-5; STOHS SJ, 1995, FREE RADICAL BIO MED, V18, P321, DOI 10.1016/0891-5849(94)00159-H; STRINGHAM EG, 1994, ENVIRON TOXICOL CHEM, V13, P1211, DOI 10.1897/1552-8618(1994)13[1211:THLSOT]2.0.CO;2; STRINGHAM EG, 1992, GENE, V113, P165, DOI 10.1016/0378-1119(92)90392-3; STUART GW, 1985, NATURE, V317, P828, DOI 10.1038/317828a0; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; SZCZYPKA MS, 1994, J BIOL CHEM, V269, P22853; Tatara CP, 1997, AQUAT TOXICOL, V39, P279, DOI 10.1016/S0166-445X(97)00030-1; Taub J, 1999, NATURE, V399, P162, DOI 10.1038/20208; Tawe WN, 1998, NUCLEIC ACIDS RES, V26, P1621, DOI 10.1093/nar/26.7.1621; Tcherepanova I, 2000, J BIOL CHEM, V275, P26359, DOI 10.1074/jbc.M000956200; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Vatamaniuk OK, 2001, J BIOL CHEM, V276, P20817, DOI 10.1074/jbc.C100152200; WAALKES MP, 1992, CRIT REV TOXICOL, V22, P175, DOI 10.3109/10408449209145323; WEMMIE JA, 1994, J BIOL CHEM, V269, P32592; WILLIAMS PL, 1990, ENVIRON TOXICOL CHEM, V9, P1285, DOI [10.1897/1552-8618(1990)9[1285:ATTUTN]2.0.CO;2, 10.1002/etc.5620091007]; Zhang B, 2001, MOL CELL BIOL, V21, P4505, DOI 10.1128/MCB.21.14.4505-4514.2001	83	57	60	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					42049	42059		10.1074/jbc.M206740200	http://dx.doi.org/10.1074/jbc.M206740200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12189149	hybrid			2022-12-27	WOS:000178985300094
J	Noga, AA; Zhao, Y; Vance, DE				Noga, AA; Zhao, Y; Vance, DE			An unexpected requirement for phosphatidylethanolamine N-methyltransferase in the secretion of very low density lipoproteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIGLYCERIDE TRANSFER PROTEIN; CULTURED RAT HEPATOCYTES; LIVER CELL-CULTURE; PHOSPHATIDYLCHOLINE BIOSYNTHESIS; MCA-RH7777 CELLS; METHYLATION; CHOLINE; EXPRESSION; MOUSE; GENE	Phosphatidylethanolamine N-methyltransferase (PEMT) catalyzes the conversion of phosphatidylethanolamine to phosphatidylcholine (PC). We investigated whether there was diminished secretion of lipoproteins from hepatocytes derived from mice that lacked PEMT (Pemt(-/-)) compared with Pemt(+/+) mice. Hepatocytes were incubated with 0.75 mm oleate, the media were harvested, and triacylglycerol (TG), PC, apolipoprotein (apo) B100, and apoB48 were isolated and quantified. Compared with hepatocytes from Pemt(+/+) mice, hepatocytes from Pemt(-/-) mice secreted 50% less TG, whereas secretion of PC was unaffected. Fractionation of the secreted lipoproteins on density gradients demonstrated that the decrease in TG was in the very low density lipoprotein (VLDL)/low density lipoprotein fractions. The secretion of apoB100 was decreased by similar to70% in VLDLs/low density lipoproteins, whereas there was no significant decrease in apoB48 secretion in any fraction. Transfection of McArdle hepatoma cells (that lack PEMT) with PEMT cDNA enhanced secretion of TG in the VLDLs. Because the levels of PC in the hepatocytes and hepatoma cells were unaffected by the lack of PEMT expression, there appears to be an unexpected requirement for PEMT in the secretion of apoB100-containing VLDLs.	Univ Alberta, Heritage Med Res Ctr 328, Dept Biochem, Edmonton, AB T6G 2S2, Canada; Univ Alberta, Canadian Inst Hlth Res Grp Mol & Cell Biol Lipids, Edmonton, AB T6G 2S2, Canada	University of Alberta; University of Alberta	Vance, DE (corresponding author), Univ Alberta, Heritage Med Res Ctr 328, Dept Biochem, Edmonton, AB T6G 2S2, Canada.							Asp L, 2000, J BIOL CHEM, V275, P26285, DOI 10.1074/jbc.M003520200; Best CH, 1932, J PHYSIOL-LONDON, V75, P405, DOI 10.1113/jphysiol.1932.sp002899; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Chang BHJ, 1999, J BIOL CHEM, V274, P6051, DOI 10.1074/jbc.274.10.6051; CHIANG PK, 1979, BIOCHEM PHARMACOL, V28, P1897, DOI 10.1016/0006-2952(79)90642-7; CHUNG BH, 1986, METHOD ENZYMOL, V128, P181; CUI Z, 1993, J BIOL CHEM, V268, P16655; DeLong CJ, 1999, J BIOL CHEM, V274, P29683, DOI 10.1074/jbc.274.42.29683; FAST DG, 1995, BBA-LIPID LIPID MET, V1258, P159, DOI 10.1016/0005-2760(95)00116-T; JAMIL H, 1995, J BIOL CHEM, V270, P6549, DOI 10.1074/jbc.270.12.6549; Jiang XC, 2001, NAT MED, V7, P847, DOI 10.1038/89977; KLAUNIG JE, 1981, IN VITRO CELL DEV B, V17, P913; KLAUNIG JE, 1981, IN VITRO CELL DEV B, V17, P926; KUKSIS A, 1978, NUTR REV, V36, P201; Lehner R, 1999, BIOCHEM J, V343, P1, DOI 10.1042/0264-6021:3430001; Lehner R, 1999, BIOCHEM J, V338, P761, DOI 10.1042/0264-6021:3380761; NishimakiMogami T, 1996, BBA-LIPID LIPID MET, V1304, P11, DOI 10.1016/S0005-2760(96)00101-4; NishimakiMogami T, 1996, BBA-LIPID LIPID MET, V1304, P21, DOI 10.1016/S0005-2760(96)00100-2; PRICHARD PH, 1982, J BIOL CHEM, V257, P6362; Raabe M, 1999, J CLIN INVEST, V103, P1287, DOI 10.1172/JCI6576; Reo NV, 2002, BBA-MOL CELL BIOL L, V1580, P171, DOI 10.1016/S1388-1981(01)00202-5; RIDGWAY ND, 1992, METHOD ENZYMOL, V209, P366; ROBINSON BS, 1989, BIOCHEM J, V260, P207, DOI 10.1042/bj2600207; SNYDER F, 1959, BIOCHIM BIOPHYS ACTA, V34, P244; SUNDLER R, 1975, J BIOL CHEM, V250, P3359; Tran K, 2000, J BIOL CHEM, V275, P25023, DOI 10.1074/jbc.M908971199; VANCE DE, 1988, PROG LIPID RES, V27, P61, DOI 10.1016/0163-7827(88)90005-7; VANCE JE, 1986, FEBS LETT, V204, P243, DOI 10.1016/0014-5793(86)80820-1; VANCE JE, 1986, BIOCHIM BIOPHYS ACTA, V875, P501, DOI 10.1016/0005-2760(86)90070-6; VERKADE HJ, 1993, J BIOL CHEM, V268, P24990; Vermeulen PS, 1997, J LIPID RES, V38, P447; Walkey CJ, 1997, P NATL ACAD SCI USA, V94, P12880, DOI 10.1073/pnas.94.24.12880; Walkey CJ, 1999, BBA-MOL CELL BIOL L, V1436, P405, DOI 10.1016/S0005-2760(98)00147-7; Wang YW, 1999, J BIOL CHEM, V274, P27793, DOI 10.1074/jbc.274.39.27793; Wu XJ, 1996, J LIPID RES, V37, P1198; YAO Z, 1990, BIOCHEM CELL BIOL, V68, P552, DOI 10.1139/o90-079; YAO ZM, 1988, J BIOL CHEM, V263, P2998; YAO ZM, 1989, J BIOL CHEM, V264, P11373; ZHOU X, 1992, J LIPID RES, V33, P1233	39	177	179	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					42358	42365		10.1074/jbc.M204542200	http://dx.doi.org/10.1074/jbc.M204542200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12193594	hybrid			2022-12-27	WOS:000178985300132
J	Vilhardt, F; Plastre, O; Sawada, M; Suzuki, K; Wiznerowicz, M; Kiyokawa, E; Trono, D; Krause, KH				Vilhardt, F; Plastre, O; Sawada, M; Suzuki, K; Wiznerowicz, M; Kiyokawa, E; Trono, D; Krause, KH			The HIV-1 Nef protein and phagocyte NADPH oxidase activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPIRATORY BURST OXIDASE; IMMUNODEFICIENCY-VIRUS TYPE-1; SUPEROXIDE-PRODUCTION; CYTOSOLIC COMPONENTS; MICROGLIAL CELLS; MEMBRANE; RAC1; BINDING; KINASE; VAV	Nef, a multifunctional HIV protein, activates the Vav/ Rac/p21-activated kinase (PAK) signaling pathway. Given the potential role of this pathway in the activation of the phagocyte NADPH oxidase, we have investigated the effect of the HIV-1 Nef protein on the phagocyte respiratory burst. Microglia (cell line and primary culture) were transduced with lentiviral expression vectors. Expression of Nef did not activate the NADPH oxidase by itself but led to a massive enhancement of the responses to a variety of stimuli (Ca2+ ionophore, formyl peptide, endotoxin). These effects were not caused by up-regulation of phagocyte NADPH oxidase subunits. Nef mutants lacking motifs involved in the interaction with Vav and PAK failed to reproduce the effects of wild type Nef, suggesting a role for the Vav/Rac/PAK signaling pathway. The following results suggest a key role for Rac in the priming effect of Nef. (i) Inactivation of Rac by Clostridium difficile toxin B abolished the Nef effect. (ii) The fraction of activated Rac1 was increased in Nef-transduced cells, and (iii) the dominant positive Rac1(V12) mutant mimicked the effect of Nef. These results are to our knowledge the first analysis of the effect of Rac activation on the NADPH oxidase in intact phagocytes. Rac activation is not sufficient to stimulate the phagocyte NADPH oxidase; however, it markedly enhances the NADPH oxidase response to other stimuli.	Univ Hosp Geneva, Dept Geriatr, Biol Ageing Lab, CH-1225 Geneva, Switzerland; Fujita Hlth Univ, Inst Comprehens Med Sci, Joint Res Div Therapies Intractable Dis, Aichi 4701192, Japan; Japan Sci & Technol Corp, Precursory Res Embryon Sci & Technol, Tokyo 3320012, Japan; NIID, Natl Inst Infect Dis, NIH, Shinjuku Ku, Tokyo 8640, Japan; Univ Geneva, Fac Med, Dept Genet & Microbiol, CH-1211 Geneva, Switzerland	University of Geneva; Fujita Health University; Japan Science & Technology Agency (JST); National Institute of Health Sciences - Japan; National Institute of Infectious Diseases (NIID); University of Geneva	Vilhardt, F (corresponding author), Univ Copenhagen, Panum Inst, Dept Med Anat, Struct Cell Biol Unit, Bldg 18-4,Blegdamsvej 3A, DK-2200 Copenhagen N, Denmark.	fvilhardt@hotmail.com	Krause, Karl-Heinz/E-8030-2011; Vilhardt, Frederik/AAX-4766-2021	Krause, Karl-Heinz/0000-0002-9033-6768; Vilhardt, Frederik/0000-0001-8604-7165				ABO A, 1991, NATURE, V353, P668, DOI 10.1038/353668a0; Ago T, 1999, J BIOL CHEM, V274, P33644, DOI 10.1074/jbc.274.47.33644; Ahmed S, 1998, J BIOL CHEM, V273, P15693, DOI 10.1074/jbc.273.25.15693; Aiken C, 1996, VIROLOGY, V217, P293, DOI 10.1006/viro.1996.0116; Aktories K, 1997, TRENDS MICROBIOL, V5, P282, DOI 10.1016/S0966-842X(97)01067-6; Ambruso DR, 2000, P NATL ACAD SCI USA, V97, P4654, DOI 10.1073/pnas.080074897; Bal-Price A, 2002, J NEUROCHEM, V80, P73, DOI 10.1046/j.0022-3042.2001.00675.x; Biggs TE, 1999, J MOL BIOL, V290, P21, DOI 10.1006/jmbi.1999.2849; BOKOCH GM, 1994, J BIOL CHEM, V269, P31674; BOKOCH GM, 1992, J CLIN INVEST, V89, P402, DOI 10.1172/JCI115599; Boquet P, 2001, TOXICON, V39, P1673, DOI 10.1016/S0041-0101(01)00154-4; Brigino E, 1997, P NATL ACAD SCI USA, V94, P3178, DOI 10.1073/pnas.94.7.3178; BROMBERG Y, 1994, J BIOL CHEM, V269, P7055; Bustelo XR, 2000, MOL CELL BIOL, V20, P1461, DOI 10.1128/MCB.20.5.1461-1477.2000; Caron E, 1998, SCIENCE, V282, P1717, DOI 10.1126/science.282.5394.1717; CLARK RA, 1990, J CLIN INVEST, V85, P714, DOI 10.1172/JCI114496; Cool RH, 1998, BIOCHEM J, V332, P5, DOI 10.1042/bj3320005; Crespo P, 1997, NATURE, V385, P169, DOI 10.1038/385169a0; Dang PMC, 2001, P NATL ACAD SCI USA, V98, P3001, DOI 10.1073/pnas.061029698; DeLeo FR, 1998, J CLIN INVEST, V101, P455, DOI 10.1172/JCI949; deMendez I, 1997, MOL CELL BIOL, V17, P2177, DOI 10.1128/MCB.17.4.2177; Diebold BA, 2001, NAT IMMUNOL, V2, P211, DOI 10.1038/85259; DORSEUIL O, 1992, J BIOL CHEM, V267, P20540; Dorseuil O, 1996, J BIOL CHEM, V271, P83, DOI 10.1074/jbc.271.1.83; Fackler OT, 2000, MOL CELL BIOL, V20, P2619, DOI 10.1128/MCB.20.7.2619-2627.2000; Fackler OT, 1999, MOL CELL, V3, P729, DOI 10.1016/S1097-2765(01)80005-8; Foti M, 1999, J BIOL CHEM, V274, P34765, DOI 10.1074/jbc.274.49.34765; FoyouziYoussefi R, 1997, BIOCHEM J, V322, P709, DOI 10.1042/bj3220709; GABIG TG, 1995, BLOOD, V85, P804, DOI 10.1182/blood.V85.3.804.bloodjournal853804; Geijsen N, 1999, BLOOD, V94, P1121, DOI 10.1182/blood.V94.3.1121.415k04_1121_1130; Geyer M, 2001, EMBO REP, V2, P580, DOI 10.1093/embo-reports/kve141; GIULIAN D, 1986, J NEUROSCI, V6, P2163; Gorzalczany Y, 2000, J BIOL CHEM, V275, P40073, DOI 10.1074/jbc.M006013200; Hanna Z, 1998, CELL, V95, P163, DOI 10.1016/S0092-8674(00)81748-1; He JL, 1997, NATURE, V385, P645, DOI 10.1038/385645a0; HEYWORTH PG, 1994, J BIOL CHEM, V269, P30749; Inoue H, 1999, GLIA, V28, P265, DOI 10.1002/(SICI)1098-1136(199912)28:3<265::AID-GLIA10>3.0.CO;2-F; Johnson JL, 1998, J BIOL CHEM, V273, P35147, DOI 10.1074/jbc.273.52.35147; Joneson T, 1998, J BIOL CHEM, V273, P17991, DOI 10.1074/jbc.273.29.17991; JORDAN CA, 1991, J VIROL, V65, P736, DOI 10.1128/JVI.65.2.736-742.1991; Kanai F, 2001, NAT CELL BIOL, V3, P675, DOI 10.1038/35083070; Kanzawa T, 2000, J NEUROSCI RES, V62, P383, DOI 10.1002/1097-4547(20001101)62:3<383::AID-JNR8>3.0.CO;2-6; Karnoub AE, 2001, MOL CELL BIOL, V21, P2847, DOI 10.1128/MCB.21.8.2847-2857.2001; KIRCHHOFF F, 1995, NEW ENGL J MED, V332, P228, DOI 10.1056/NEJM199501263320405; KNAUS UG, 1991, SCIENCE, V254, P1512, DOI 10.1126/science.1660188; KNAUS UG, 1995, SCIENCE, V269, P221, DOI 10.1126/science.7618083; KOENIG S, 1986, SCIENCE, V233, P1089, DOI 10.1126/science.3016903; Lu XB, 1996, CURR BIOL, V6, P1677, DOI 10.1016/S0960-9822(02)70792-6; MALY FE, 1994, J BIOL CHEM, V269, P18743; Marsh JW, 1999, ARCH BIOCHEM BIOPHYS, V365, P192, DOI 10.1006/abbi.1999.1208; Movilla N, 2001, ONCOGENE, V20, P8057, DOI 10.1038/sj.onc.1205000; NAUSEEF WM, 1991, J BIOL CHEM, V266, P5911; PARK JW, 1992, J BIOL CHEM, V267, P17327; Price MO, 2002, J BIOL CHEM, V277, P19220, DOI 10.1074/jbc.M200061200; Roberts AW, 1999, IMMUNITY, V10, P183, DOI 10.1016/S1074-7613(00)80019-9; SAKSELA K, 1995, EMBO J, V14, P484, DOI 10.1002/j.1460-2075.1995.tb07024.x; Salmon P, 2000, BLOOD, V96, P3392; Sander EE, 1998, J CELL BIOL, V143, P1385, DOI 10.1083/jcb.143.5.1385; Sankarapandi S, 1998, ARCH BIOCHEM BIOPHYS, V353, P312, DOI 10.1006/abbi.1998.0658; SAWAI ET, 1995, J BIOL CHEM, V270, P15307, DOI 10.1074/jbc.270.25.15307; Sundaresan M, 1996, BIOCHEM J, V318, P379, DOI 10.1042/bj3180379; Swingler S, 1999, NAT MED, V5, P997, DOI 10.1038/12433; WANG JF, 1993, ARCH BIOCHEM BIOPHYS, V304, P189, DOI 10.1006/abbi.1993.1338; Wolf D, 2001, NAT MED, V7, P1217, DOI 10.1038/nm1101-1217; WYMANN MP, 1987, ANAL BIOCHEM, V165, P371, DOI 10.1016/0003-2697(87)90284-3; Xie Z, 2002, J NEUROSCI, V22, P3484; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	67	75	77	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					42136	42143		10.1074/jbc.M200862200	http://dx.doi.org/10.1074/jbc.M200862200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12207012	hybrid, Green Published			2022-12-27	WOS:000178985300105
J	Zheng, GL; Dai, J; Woldegiorgis, G				Zheng, GL; Dai, J; Woldegiorgis, G			Identification by mutagenesis of a conserved glutamate (Glu(487)) residue important for catalytic activity in rat liver carnitine palmitoyltransferase II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MALONYL-COA; GENE; EXPRESSION; MUTATION; HEART; DEFICIENCY; MYOGLOBINURIA; HISTIDINE; ISOFORM; BINDING	Mammalian mitochondrial membranes express two active but distinct carnitine palmitoyltransferases: carnitine palmitoyltransferase I (CPTI), which is malonyl coA-sensitive and detergent-labile; and carnitine palmitoyltransferase II (CPTII), which is malonyl coA-insensitive and detergent-stable. To determine the role of the highly conserved C-terminal acidic residues glutamate 487 (Glu(487)) and glutamate 500 (Glu(500)) on catalytic activity in rat liver CPTII, we separately mutated these residues to alanine, aspartate, or lysine, and the effect of the mutations on CPTII activity was determined in the Escherichia coli-expressed mutants. Substitution of Glu(487) with alanine, aspartate, or lysine resulted in almost complete loss in CPTII activity. Because a conservative substitution mutation of this residue, Glu(487) with aspartate (E487D), resulted in a 97% loss in activity, we predicted that Glu(487) would be at the active-site pocket of CPTII The substantial loss in CPTII activity observed with the E487K mutant, along with the previously reported loss in activity observed in a child with a CPTII deficiency disease, establishes that Glu(487) is crucial for maintaining the configuration of the liver isoform of the CPTII active site. Substitution of the conserved Glu(500) in CPTII with alanine or aspartate reduced the V-max for both substrates, suggesting that Glu(500) may be important in stabilization of the enzyme-substrate complex. A conservative substitution of Glu(500) to aspartate resulted in a significant decrease in the V-max for the substrates. Thus, Glu(500) may play a role in substrate binding and catalysis. Our site-directed mutagenesis studies demonstrate that Glu(487) in the liver isoform of CPTII is essential for catalysis.	Oregon Hlth Sci Univ, OGI Sch Sci & Engn, Dept Biochem & Mol Biol, Beaverton, OR 97006 USA	Oregon Health & Science University	Woldegiorgis, G (corresponding author), Oregon Hlth Sci Univ, OGI Sch Sci & Engn, Dept Biochem & Mol Biol, 20000 NW Walker Rd, Beaverton, OR 97006 USA.				NHLBI NIH HHS [HL52571] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL052571] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Barycki JJ, 2001, J BIOL CHEM, V276, P36718, DOI 10.1074/jbc.M104839200; BIEBER LL, 1988, ANNU REV BIOCHEM, V57, P261, DOI 10.1146/annurev.bi.57.070188.001401; Bonnefont JP, 1999, MOL GENET METAB, V68, P424, DOI 10.1006/mgme.1999.2938; BREMER J, 1985, BIOCHIM BIOPHYS ACTA, V833, P9, DOI 10.1016/0005-2760(85)90247-4; BROWN NF, 1995, J BIOL CHEM, V270, P8952, DOI 10.1074/jbc.270.15.8952; BROWN NF, 1994, J BIOL CHEM, V269, P19157; BROWN NF, 1993, BIOCHEM J, V294, P79, DOI 10.1042/bj2940079; Bruno C, 2000, J CHILD NEUROL, V15, P390, DOI 10.1177/088307380001500607; Dai J, 2000, J BIOL CHEM, V275, P22020, DOI 10.1074/jbc.M002118200; DAY PJ, 1992, J BIOL CHEM, V267, P5122; deVries Y, 1997, BIOCHEMISTRY-US, V36, P5285, DOI 10.1021/bi962875p; FINOCCHIARO G, 1991, P NATL ACAD SCI USA, V88, P661, DOI 10.1073/pnas.88.2.661; Fraser F, 1997, BIOCHEM J, V323, P711, DOI 10.1042/bj3230711; JOHNSON TM, 1995, BIOCHEM J, V309, P689, DOI 10.1042/bj3090689; McGarry JD, 1997, EUR J BIOCHEM, V244, P1, DOI 10.1111/j.1432-1033.1997.00001.x; Morillas M, 2001, J BIOL CHEM, V276, P45001, DOI 10.1074/jbc.M106920200; PANDE SV, 1993, J CLIN INVEST, V91, P1247, DOI 10.1172/JCI116288; Shi JY, 1999, J BIOL CHEM, V274, P9421, DOI 10.1074/jbc.274.14.9421; Tao Bernard Y., 1994, P69; TARONI F, 1993, NAT GENET, V4, P314, DOI 10.1038/ng0793-314; VERDERIO E, 1995, HUM MOL GENET, V4, P19, DOI 10.1093/hmg/4.1.19; Vladutiu GD, 2000, MOL GENET METAB, V70, P134, DOI 10.1006/mgme.2000.3009; Wataya K, 1998, HUM MUTAT, V11, P377; WEIS BC, 1994, J BIOL CHEM, V269, P26443; WOELTJE KF, 1990, J BIOL CHEM, V265, P10720; YAMAZAKI N, 1995, FEBS LETT, V363, P41, DOI 10.1016/0014-5793(95)00277-G; Yamazaki N, 1996, BBA-GENE STRUCT EXPR, V1307, P157, DOI 10.1016/0167-4781(96)00069-3; Zhu HF, 1997, ARCH BIOCHEM BIOPHYS, V347, P53, DOI 10.1006/abbi.1997.0314	28	7	7	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 1	2002	277	44					42219	42223		10.1074/jbc.M202914200	http://dx.doi.org/10.1074/jbc.M202914200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610WR	12200419	hybrid			2022-12-27	WOS:000178985300116
J	Guo, XL; Kui, S; Wang, F; Lawrence, DS; Zhang, ZY				Guo, XL; Kui, S; Wang, F; Lawrence, DS; Zhang, ZY			Probing the molecular basis for potent and selective protein-tyrosine phosphatase 1B inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN BREAST-CANCER; SUBSTRATE-SPECIFICITY; MASS-SPECTROMETRY; INSULIN SENSITIVITY; KINETIC-ANALYSIS; STRUCTURAL BASIS; IN-VIVO; BINDING; IDENTIFICATION; RECEPTOR	Protein-tyrosine phosphatases (PTPs) are important for the control of proper cellular tyrosine phosphorylation. Despite the large number of PTPs encoded in the human genome and the emerging roles played by PTPs in human diseases, a detailed understanding of the role played by PTPs in normal physiology and in pathogenic conditions has been hampered by the absence of PTP-specific inhibitors. Such inhibitors could serve as useful tools for determining the physiological functions of PTPs and may constitute valuable therapeutics in the treatment of several human diseases. However, because of the highly conserved nature of the active site, it has been difficult to develop selective PTP inhibitors. By taking an approach to tether together two small ligands that can interact simultaneously with the active site and a unique proximal noncatalytic site, we have recently acquired Compound 2 (see Fig. 1), the most potent and selective PTP1B inhibitor identified to date, which exhibits several orders of magnitude selectivity in favor of PTP1B against a panel of PTPs. We describe an evaluation of the interaction between 2 and its analogs with PTP1B and its site-directed mutants selected based on hydrogen/deuterium exchange of PTP1B backbone amides in the presence and absence of 2. We have established the binding mode of Compound 2 and identified 12 PTP1B residues that are important for the potency and selectivity of Compound 2. Although many of the residues important for Compound 2 binding are not unique to PTP1B, the combinations of all contact residues differ between PTP isozymes, which suggest that the binding surface defined by these residues in individual PTPs determines inhibitor selectivity. Our results provide structural information toward understanding of the molecular basis for potent and selective PTP1B inhibition and further establish the feasibility of acquiring potent, yet highly selective, PTP inhibitory agents.	Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA; Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA; Albert Einstein Coll Med, Lab Macromol Anal & Proteom, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Zhang, ZY (corresponding author), Albert Einstein Coll Med, Dept Mol Pharmacol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	zyzhang@aecom.yu.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055242] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 55242] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AHMAD F, 1995, J BIOL CHEM, V270, P20503, DOI 10.1074/jbc.270.35.20503; Balsamo J, 1998, J CELL BIOL, V143, P523, DOI 10.1083/jcb.143.2.523; Bandyopadhyay D, 1997, J BIOL CHEM, V272, P1639, DOI 10.1074/jbc.272.3.1639; Bjorge JD, 2000, J BIOL CHEM, V275, P41439, DOI 10.1074/jbc.M004852200; Burke TR, 1998, BIOPOLYMERS, V47, P225, DOI 10.1002/(SICI)1097-0282(1998)47:3<225::AID-BIP3>3.0.CO;2-O; Deng H, 2002, BIOCHEMISTRY-US, V41, P5865, DOI 10.1021/bi016097z; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; Huyer G, 1997, J BIOL CHEM, V272, P843, DOI 10.1074/jbc.272.2.843; Iversen LF, 2001, BIOCHEMISTRY-US, V40, P14812, DOI 10.1021/bi011389l; JIA ZC, 1995, SCIENCE, V268, P1754, DOI 10.1126/science.7540771; Kenner KA, 1996, J BIOL CHEM, V271, P19810, DOI 10.1074/jbc.271.33.19810; Klaman LD, 2000, MOL CELL BIOL, V20, P5479, DOI 10.1128/MCB.20.15.5479-5489.2000; LaMontagne KR, 1998, MOL CELL BIOL, V18, P2965, DOI 10.1128/MCB.18.5.2965; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Liu F, 1997, BIOCHEM J, V327, P139, DOI 10.1042/bj3270139; Liu F, 1996, J BIOL CHEM, V271, P31290, DOI 10.1074/jbc.271.49.31290; Mandell JG, 1998, P NATL ACAD SCI USA, V95, P14705, DOI 10.1073/pnas.95.25.14705; Pannifer ADB, 1998, J BIOL CHEM, V273, P10454, DOI 10.1074/jbc.273.17.10454; Peters GH, 2000, J BIOL CHEM, V275, P18201, DOI 10.1074/jbc.M910273199; Puius YA, 1997, P NATL ACAD SCI USA, V94, P13420, DOI 10.1073/pnas.94.25.13420; Resing KA, 1999, PROG BIOPHYS MOL BIO, V71, P501, DOI 10.1016/S0079-6107(98)00048-0; Sarmiento M, 2000, BIOCHEMISTRY-US, V39, P8171, DOI 10.1021/bi000319w; Sarmiento M, 1998, J BIOL CHEM, V273, P26368, DOI 10.1074/jbc.273.41.26368; Shen K, 2001, J BIOL CHEM, V276, P47311, DOI 10.1074/jbc.M106568200; Solas D, 1996, J ORG CHEM, V61, P1537, DOI 10.1021/jo9517508; Taing M, 1999, BIOCHEMISTRY-US, V38, P3793, DOI 10.1021/bi9813781; Vetter SW, 2000, J BIOL CHEM, V275, P2265, DOI 10.1074/jbc.275.4.2265; Wang F, 1998, BIOCHEMISTRY-US, V37, P15289, DOI 10.1021/bi981481q; Wang F, 1997, BIOCHEMISTRY-US, V36, P3755, DOI 10.1021/bi963065g; WIENER JR, 1994, J NATL CANCER I, V86, P372, DOI 10.1093/jnci/86.5.372; Wu L, 1997, J BIOL CHEM, V272, P6994, DOI 10.1074/jbc.272.11.6994; Yokomatsu T, 1997, TETRAHEDRON, V53, P815, DOI 10.1016/S0040-4020(96)01063-0; ZHANG ZY, 1993, P NATL ACAD SCI USA, V90, P4446, DOI 10.1073/pnas.90.10.4446; ZHANG ZY, 1994, BIOCHEMISTRY-US, V33, P2285, DOI 10.1021/bi00174a040; ZHANG ZY, 1993, ANAL BIOCHEM, V211, P7, DOI 10.1006/abio.1993.1224; Zhang ZY, 2001, CURR OPIN CHEM BIOL, V5, P416, DOI 10.1016/S1367-5931(00)00223-4; Zhang ZY, 2002, ANNU REV PHARMACOL, V42, P209, DOI 10.1146/annurev.pharmtox.42.083001.144616; ZHANG ZY, 1994, BIOCHEMISTRY-US, V33, P15266, DOI 10.1021/bi00255a007; ZHANG ZY, 1991, J BIOL CHEM, V266, P1516; Zhao Y, 1998, J BIOL CHEM, V273, P5484, DOI 10.1074/jbc.273.10.5484	42	76	77	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 25	2002	277	43					41014	41022		10.1074/jbc.M207347200	http://dx.doi.org/10.1074/jbc.M207347200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	607KU	12193602	hybrid			2022-12-27	WOS:000178791400110
J	Werner, AB; de Vries, E; Tait, SWG; Bontjer, J; Borst, J				Werner, AB; de Vries, E; Tait, SWG; Bontjer, J; Borst, J			TRAIL receptor and CD95 signal to mitochondria via FADD, caspase-8/10, Bid, and Bax but differentially regulate events downstream from truncated Bid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOPTOSIS-INDUCING LIGAND; CYTOCHROME-C RELEASE; NF-KAPPA-B; DEPENDENT APOPTOSIS; KILLER/DR5 GENE; DEATH; ACTIVATION; BCL-2; FAMILY; MEMBER	The death receptor ligand TRAIL arouses much interest for clinical application. We found that TRAIL receptor could induce cytochrome c (Cyt c) release from mitochondria in cells that failed to respond to CD95. Therefore, we examined whether these two closely related death receptors use different intermediates to convey the apoptotic signal to mitochondria. Dominant negative FADD, FLIPL, or a Bid mutant lacking cleavage sites for caspase-8/10 completely inhibited Cyt c release in response to either receptor. Depletion of Bid from TRAIL- or CD95-activated cytosols blocked their capacity to mediate Cyt c release from mitochondria in vitro, whereas Bax depletion reduced it. We conclude that FADD, caspase-8/10, and caspase-cleaved Bid are required for TRAIL receptor and CD95 signaling to mitochondria, whereas Bax is a common accessory. In vitro, caspase-8 treatment of cytosol from CD95-resistant cells permitted generation of truncated Bid and its association with mitochondria. However, this cytosol impaired the ability of truncated Bid to liberate Cyt c from exogenous mitochondria. We conclude that the TRAIL receptor can bypass or neutralize the activity of cytosolic factor that blocks truncated Bid function. This may benefit the capacity of TRAIL to break apoptosis resistance in tumor cells.	Netherlands Canc Inst, Div Cellular Biochem, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute	Borst, J (corresponding author), Netherlands Canc Inst, Div Cellular Biochem, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	j.borst@nki.nl		Borst, Jannie/0000-0002-8043-5009; Tait, Stephen/0000-0001-7697-132X				Ashkenazi A, 1999, CURR OPIN CELL BIOL, V11, P255, DOI 10.1016/S0955-0674(99)80034-9; Ashkenazi A, 1999, J CLIN INVEST, V104, P155, DOI 10.1172/JCI6926; Bodmer JL, 2000, NAT CELL BIOL, V2, P241, DOI 10.1038/35008667; Boesen-de Cock JGR, 1999, J BIOL CHEM, V274, P14255, DOI 10.1074/jbc.274.20.14255; Bossy-Wetzel E, 1998, EMBO J, V17, P37, DOI 10.1093/emboj/17.1.37; Chaudhary PM, 1997, IMMUNITY, V7, P821, DOI 10.1016/S1074-7613(00)80400-8; Chinnaiyan AM, 2000, P NATL ACAD SCI USA, V97, P1754, DOI 10.1073/pnas.030545097; Deng YB, 2002, GENE DEV, V16, P33, DOI 10.1101/gad.949602; DHEIN J, 1995, NATURE, V373, P438, DOI 10.1038/373438a0; El-Deiry WS, 2001, CELL DEATH DIFFER, V8, P1066, DOI 10.1038/sj.cdd.4400943; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hu WH, 1999, J BIOL CHEM, V274, P30603, DOI 10.1074/jbc.274.43.30603; Huang DCS, 1999, P NATL ACAD SCI USA, V96, P14871, DOI 10.1073/pnas.96.26.14871; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Kinsella TM, 1996, HUM GENE THER, V7, P1405, DOI 10.1089/hum.1996.7.12-1405; Kischkel FC, 2000, IMMUNITY, V12, P611, DOI 10.1016/S1074-7613(00)80212-5; Kischkel FC, 2001, J BIOL CHEM, V276, P46639, DOI 10.1074/jbc.M105102200; Knight MJ, 2001, ONCOGENE, V20, P5789, DOI 10.1038/sj.onc.1204810; Kuang AA, 2000, J BIOL CHEM, V275, P25065, DOI 10.1074/jbc.C000284200; Lacour S, 2001, CANCER RES, V61, P1645; LeBlanc H, 2002, NAT MED, V8, P274, DOI 10.1038/nm0302-274; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Lin Y, 2000, MOL CELL BIOL, V20, P6638, DOI 10.1128/MCB.20.18.6638-6645.2000; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; MacFarlane M, 2000, J CELL BIOL, V148, P1239, DOI 10.1083/jcb.148.6.1239; Miyazaki T, 2001, NAT IMMUNOL, V2, P493, DOI 10.1038/88684; Murphy KM, 2000, J BIOL CHEM, V275, P17225, DOI 10.1074/jbc.C900590199; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Peter ME, 2000, CELL DEATH DIFFER, V7, P759, DOI 10.1038/sj.cdd.4400735; Peter ME, 1998, CURR OPIN IMMUNOL, V10, P545, DOI 10.1016/S0952-7915(98)80222-7; PETIT PX, 1990, EUR J BIOCHEM, V194, P389, DOI 10.1111/j.1432-1033.1990.tb15632.x; Rokhlin OW, 2001, ONCOGENE, V20, P2836, DOI 10.1038/sj.onc.1204410; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Schneider P, 1997, IMMUNITY, V7, P831, DOI 10.1016/S1074-7613(00)80401-X; Sheikh MS, 1998, CANCER RES, V58, P1593; Sprick MR, 2000, IMMUNITY, V12, P599, DOI 10.1016/S1074-7613(00)80211-3; STRASSER A, 1994, CELL, V79, P329, DOI 10.1016/0092-8674(94)90201-1; Takimoto R, 2000, ONCOGENE, V19, P1735, DOI 10.1038/sj.onc.1203489; Tepper AD, 2000, J CELL BIOL, V150, P155, DOI 10.1083/jcb.150.1.155; Thomas WD, 2000, J IMMUNOL, V165, P5612, DOI 10.4049/jimmunol.165.10.5612; Walczak H, 2000, CANCER RES, V60, P3051; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Wang XD, 2001, GENE DEV, V15, P2922; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wei MC, 2000, GENE DEV, V14, P2060; Werner AB, 2002, J BIOL CHEM, V277, P22781, DOI 10.1074/jbc.M201469200; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8; Wu GS, 1999, CANCER RES, V59, P2770; Yamada H, 1999, BIOCHEM BIOPH RES CO, V265, P130, DOI 10.1006/bbrc.1999.1641; YSSEL H, 1984, J IMMUNOL METHODS, V72, P219, DOI 10.1016/0022-1759(84)90450-2; Zha JP, 2000, SCIENCE, V290, P1761, DOI 10.1126/science.290.5497.1761; Zong WX, 2001, GENE DEV, V15, P1481, DOI 10.1101/gad.897601	53	55	58	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2002	277	43					40760	40767		10.1074/jbc.M204351200	http://dx.doi.org/10.1074/jbc.M204351200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	607KU	12196516	hybrid			2022-12-27	WOS:000178791400078
J	Kim, MS; Baek, MJ; Lee, MH; Park, JW; Lee, SY; Soderhall, K; Lee, BL				Kim, MS; Baek, MJ; Lee, MH; Park, JW; Lee, SY; Soderhall, K; Lee, BL			A new easter-type serine protease cleaves a masquerade-like protein during prophenoloxidase activation in Holotrichia diomphalia larvae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRO-PHENOL-OXIDASE; BETA-1,3-GLUCAN RECOGNITION PROTEIN; FRESH-WATER CRAYFISH; MANDUCA-SEXTA; MOLECULAR-CLONING; COLEOPTERAN INSECT; CDNA CLONING; PURIFICATION; SILKWORM; ENZYME	The prophenoloxidase (proPO) activation pathway, like the vertebrate complement system, consists of a protease cascade and functions as a non-self-recognition system in these animals. Determining the molecular mechanism by which pattern recognition molecules differentiate non-self from self and transduce signals that stimulate defense responses is a key for understanding the ways in which innate immune systems are regulated. However, the proPO system is poorly defined at the molecular level. The proPO-activating system of the insect Holotrichia diomphalia comprises several components, some of which have been cloned and characterized, such as the novel 27-kDa proPO-activating factor-III (PPAF-III) from the plasma of H. diomphalia larvae and two prophenoloxidases. The PPAF-III gene encodes an easter-type serine protease zymogen consisting of 351 amino acid residues with a mass of 40 kDa. The purified 27-kDa PPAF-III specifically cleaved a 55-kDa proPPAF-II to generate a 45-kDa PPAF-II with or without Ca2+ present. Furthermore, two Holotrichia prophenoloxidases (proPO-I and 41) have been characterized, and their structural changes during activation were examined by in vitro reconstitution experiments. When the proPOs were incubated with PPAF-I, the 79-kDa proPOs were converted to 76-kDa proPOs, which did not exhibit any phenoloxidase (PO) activity. However, when the proPOs were incubated simultaneously with PPAF-I, proPPAF-II, and PPAF-III in the presence of Ca2+, a 60-kDa protein (PO-1) with PO activity was detected in addition to the 76-kDa proPO-II protein. These results indicate that the conversion of Holotrichia proPOs to enzymatically active phenoloxidase is accomplished by PPAF-I, PAF-II, and PPAF-III through a two-step limited proteolysis in the presence of Ca2+.	Pusan Natl Univ, Coll Pharm, Kumjeong Ku, Pusan 609735, South Korea; Uppsala Univ, Evolutionary Biol Ctr, Dept Comparat Physiol, SE-75236 Uppsala, Sweden	Pusan National University; Uppsala University	Lee, BL (corresponding author), Pusan Natl Univ, Coll Pharm, Kumjeong Ku, Jangjeon Dong, Pusan 609735, South Korea.	brlee@pusan.ac.kr	Baek, Moo-Jun/W-1736-2019	Baek, Moo-Jun/0000-0003-3567-6687; Lee, So Young/0000-0003-3130-785X				Ahmed A, 1999, P NATL ACAD SCI USA, V96, P14795, DOI 10.1073/pnas.96.26.14795; Ashida Masaaki, 1998, P135; ASPAN A, 1991, INSECT BIOCHEM, V21, P363, DOI 10.1016/0020-1790(91)90002-V; Beschin A, 1998, J BIOL CHEM, V273, P24948, DOI 10.1074/jbc.273.38.24948; CHASAN R, 1989, CELL, V56, P391, DOI 10.1016/0092-8674(89)90242-0; Cho MY, 1999, EUR J BIOCHEM, V262, P737, DOI 10.1046/j.1432-1327.1999.00416.x; FULLMER CS, 1984, ANAL BIOCHEM, V142, P336, DOI 10.1016/0003-2697(84)90473-1; Gillespie JP, 1997, ANNU REV ENTOMOL, V42, P611, DOI 10.1146/annurev.ento.42.1.611; HALL M, 1995, P NATL ACAD SCI USA, V92, P7764, DOI 10.1073/pnas.92.17.7764; Hyuk T, 1997, MOL CELLS, V7, P90; Jiang HB, 1997, INSECT BIOCHEM MOLEC, V27, P835, DOI 10.1016/S0965-1748(97)00066-0; Jiang HB, 1998, P NATL ACAD SCI USA, V95, P12220, DOI 10.1073/pnas.95.21.12220; KAWABATA T, 1995, P NATL ACAD SCI USA, V92, P7774, DOI 10.1073/pnas.92.17.7774; Kwon TH, 2000, EUR J BIOCHEM, V267, P6188, DOI 10.1046/j.1432-1327.2000.01695.x; Lee SY, 2000, J BIOL CHEM, V275, P1337, DOI 10.1074/jbc.275.2.1337; Lee SY, 1998, EUR J BIOCHEM, V254, P50, DOI 10.1046/j.1432-1327.1998.2540050.x; Lee SY, 1998, EUR J BIOCHEM, V257, P615, DOI 10.1046/j.1432-1327.1998.2570615.x; LEGENDRE N, 1988, BIOTECHNIQUES, V6, P154; Ma CC, 2000, J BIOL CHEM, V275, P7505, DOI 10.1074/jbc.275.11.7505; MURUGASUOEI B, 1995, GENE DEV, V9, P139, DOI 10.1101/gad.9.2.139; MUTA T, 1990, J BIOL CHEM, V265, P22426; Ochiai M, 1999, J BIOL CHEM, V274, P11854, DOI 10.1074/jbc.274.17.11854; Ochiai M, 2000, J BIOL CHEM, V275, P4995, DOI 10.1074/jbc.275.7.4995; Satoh D, 1999, J BIOL CHEM, V274, P7441, DOI 10.1074/jbc.274.11.7441; SGARAMELLA V, 1972, J MOL BIOL, V72, P427, DOI 10.1016/0022-2836(72)90155-6; Soderhall K, 1998, CURR OPIN IMMUNOL, V10, P23, DOI 10.1016/S0952-7915(98)80026-5; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; Wang RG, 2001, EUR J BIOCHEM, V268, P895, DOI 10.1046/j.1432-1327.2001.01945.x; YOSHIDA H, 1986, INSECT BIOCHEM, V16, P539, DOI 10.1016/0020-1790(86)90031-4; Yu XQ, 2000, J BIOL CHEM, V275, P37373, DOI 10.1074/jbc.M003021200	30	118	138	0	19	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2002	277	42					39999	40004		10.1074/jbc.M205508200	http://dx.doi.org/10.1074/jbc.M205508200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	605EA	12185078	hybrid			2022-12-27	WOS:000178662500119
J	Dhe-Paganon, S; Duda, K; Iwamoto, M; Chi, YI; Shoelson, SE				Dhe-Paganon, S; Duda, K; Iwamoto, M; Chi, YI; Shoelson, SE			Crystal structure of the HNF4 alpha ligand binding domain in complex with endogenous fatty acid ligand	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR RECEPTORS; MUTATIONS; GENE; DIFFRACTION; YOUNG; RAR	HNF4alpha is an orphan member of the nuclear receptor family with prominent functions in liver, gut, kidney and pancreatic beta cells. We have solved the x-ray crystal structure of the HNF4alpha ligand binding domain, which adopts a canonical fold. Two conformational states are present within each homodimer: an open form with a helix 12 (alpha12) extended and collinear with alpha10 and a closed form with alpha12 folded against the body of the domain. Although the protein was crystallized without added ligands, the ligand binding pockets of both closed and open forms contain fatty acids. The carboxylic acid headgroup of the fatty acid ion pairs with the guanidinium group of Arg(226) at one end of the ligand binding pocket, while the aliphatic chain fills a long, narrow channel that is lined with hydrophobic residues. These findings suggest that fatty acids are endogenous ligands for HNF4alpha and establish a framework for understanding how HNF4alpha activity is enhanced by ligand binding and diminished by MODY1 mutations.	Harvard Univ, Sch Med, Joslin Diabet Ctr, Boston, MA 02215 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School	Shoelson, SE (corresponding author), Harvard Univ, Sch Med, Joslin Diabet Ctr, Boston, MA 02215 USA.	Steven.Shoelson@joslin.harvard.edu			NIDDK NIH HHS [T32 DK07260, R01 DK43123] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043123, T32DK007260] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		[Anonymous], 2001, NUCL RECEPTORS GENET; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bogan AA, 2000, J MOL BIOL, V302, P831, DOI 10.1006/jmbi.2000.4099; Bourguet W, 2000, MOL CELL, V5, P289, DOI 10.1016/S1097-2765(00)80424-4; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; CHEN WS, 1994, GENE DEV, V8, P2466, DOI 10.1101/gad.8.20.2466; Egea PF, 2000, EMBO J, V19, P2592, DOI 10.1093/emboj/19.11.2592; Fajans SS, 2001, NEW ENGL J MED, V345, P971, DOI 10.1056/NEJMra002168; Gampe RT, 2000, MOL CELL, V5, P545, DOI 10.1016/S1097-2765(00)80448-7; Hattersley AT, 1998, DIABETIC MED, V15, P15, DOI 10.1002/(SICI)1096-9136(199801)15:1<15::AID-DIA562>3.0.CO;2-M; HENDRICKSON WA, 1991, SCIENCE, V254, P51, DOI 10.1126/science.1925561; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; Lehto M, 1999, DIABETOLOGIA, V42, P1131, DOI 10.1007/s001250051281; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; Navas MA, 1999, DIABETES, V48, P1459, DOI 10.2337/diabetes.48.7.1459; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; RENAUD JP, 1995, NATURE, V378, P681, DOI 10.1038/378681a0; Ryffel GU, 2001, J MOL ENDOCRINOL, V27, P11, DOI 10.1677/jme.0.0270011; Shih DQ, 2000, DIABETES, V49, P832, DOI 10.2337/diabetes.49.5.832; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Yamagata K, 1996, NATURE, V384, P458, DOI 10.1038/384458a0	24	218	225	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2002	277	41					37973	37976		10.1074/jbc.C200420200	http://dx.doi.org/10.1074/jbc.C200420200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602XK	12193589	hybrid			2022-12-27	WOS:000178529600002
